PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alonso, A; Rahmouni, S; Williams, S; van Stipdonk, M; Jaroszewski, L; Godzik, A; Abraham, RT; Schoenberger, SP; Mustelin, T				Alonso, A; Rahmouni, S; Williams, S; van Stipdonk, M; Jaroszewski, L; Godzik, A; Abraham, RT; Schoenberger, SP; Mustelin, T			Tyrosine phosphorylation of VHR phosphatase by ZAP-70	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; MAP KINASE; INHIBITION; ACTIVATION; SELECTION; ERK	The ZAP-70 tyrosine kinase is a key component of the signaling machinery for the T cell antigen receptor (TCR). Whereas recruitment and activation of ZAP-70 are relatively well understood, the proteins phosphorylated by ZAP-70 are incompletely known. We report here that VHR, a Vaccinia virus VH1-related dual-specific protein phosphatase that inactivates the mitogen-activated kinases Erk2 and Jnk, is phosphorylated at Y138 by ZAP-70. Tyr138 phosphorylation was required for VHR to inhibit the Erk2-Elk-1 pathway and, conversely, the VHRY138F mutant augmented TCR-induced Erk2 kinase and activation of the gene encoding interleukin 2. These results suggest that VHR is a target for ZAP-70 and tempers activation of the Erk2 pathway in a ZAP-70-controlled manner.	Burnham Inst, Ctr Canc Res, Program Signal Transduct, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; La Jolla Institute for Immunology	Mustelin, T (corresponding author), Burnham Inst, Ctr Canc Res, Program Signal Transduct, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tmustelin@burnham-inst.org	Godzik, Adam/AAW-1467-2020; Alonso, Andrés/L-7523-2014; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Alonso, Andrés/0000-0001-8674-9378; Godzik, Adam/0000-0002-2425-852X; Mustelin, Tomas/0000-0001-5912-8840	NIAID NIH HHS [AI40552, AI35603, AI48032] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040552, R01AI035603, R01AI040552, R01AI048032] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso A, 2002, J BIOL CHEM, V277, P5524, DOI 10.1074/jbc.M107653200; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; LUO K, 1990, ONCOGENE, V5, P921; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; Mustelin GS, 2002, FRONT BIOSCI, V7, P85; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; TAMURA T, 1995, J IMMUNOL, V155, P4692; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; von Willebrand M, 1998, J BIOL CHEM, V273, P3994, DOI 10.1074/jbc.273.7.3994; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	27	87	94	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					44	48		10.1038/ni856	http://dx.doi.org/10.1038/ni856			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12447358				2022-12-18	WOS:000180053000013
J	Coombs, D; Kalergis, AM; Nathenson, SG; Wofsy, C; Goldstein, B				Coombs, D; Kalergis, AM; Nathenson, SG; Wofsy, C; Goldstein, B			Activated TCRs remain marked for internalization after dissociation from pMHC	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; CELL-ACTIVATION; LIGANDS; RECOGNITION; ENGAGEMENT; AFFINITY; ANTAGONISM; INTERFACE; KINETICS; PATTERN	To assess the roles of serial engagement and kinetic proofreading in T cell receptor (TCR) internalization, we have developed a mathematical model of this process. Our determination of TCR down-regulation for an array of TCR mutants, interpreted in the context of the model, has provided new information about peptide-induced TCR internalization. The amount of TCR down-regulation increases to a maximum value and then declines as a function of the half-life of the bond between the TCR and peptide-major histocompatibility complex (pMHC). The model shows that this behavior, which reflects competition between serial engagement and kinetic proofreading, arises only if it is postulated that activated TCRs remain marked for internalization after dissociation from pMHC. The model also predicts that because of kinetic proofreading, the range of TCR-pMHC-binding half-lives required for T cell activation depends on the concentrations and localization of intracellular signaling molecules. We show here that kinetic proofreading provides an explanation for the different requirements for activation observed in naive and memory T cells.	Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; University of New Mexico	Goldstein, B (corresponding author), Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.	bxg@lanl.gov		Coombs, Daniel/0000-0002-8038-6278; Kalergis, Alexis/0000-0001-7622-5263	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035556, R37GM035556] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35556] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Goyarts EC, 1998, MOL IMMUNOL, V35, P593, DOI 10.1016/S0161-5890(98)00056-X; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hlavacek WS, 2001, P NATL ACAD SCI USA, V98, P7295, DOI 10.1073/pnas.121172298; HONG DC, 2001, NATURE IMMUNOL, V2, P1067; Hudrisier D, 1998, J IMMUNOL, V161, P553; Itoh Y, 1999, J IMMUNOL, V162, P2073; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Penna D, 1999, J IMMUNOL, V163, P50; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Van Den Berg HA, 2001, J THEOR BIOL, V209, P465, DOI 10.1006/jtbi.2001.2281; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Wofsy C, 2001, BIOPHYS J, V80, P606, DOI 10.1016/S0006-3495(01)76041-9; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	33	87	88	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					926	931		10.1038/ni838	http://dx.doi.org/10.1038/ni838			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244312				2022-12-18	WOS:000178242100012
J	Weisel, FJ; Mullett, SJ; Elsner, RA; Menk, AV; Trivedi, N; Luo, W; Wikenheiser, D; Hawse, WF; Chikina, M; Smita, S; Conter, LJ; Joachim, SM; Wendell, SG; Jurczak, MJ; Winkler, TH; Delgoffe, GM; Shlomchik, MJ				Weisel, Florian J.; Mullett, Steven J.; Elsner, Rebecca A.; Menk, Ashley V.; Trivedi, Nikita; Luo, Wei; Wikenheiser, Daniel; Hawse, William F.; Chikina, Maria; Smita, Shuchi; Conter, Laura J.; Joachim, Stephen M.; Wendell, Stacy G.; Jurczak, Michael J.; Winkler, Thomas H.; Delgoffe, Greg M.; Shlomchik, Mark J.			Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis	NATURE IMMUNOLOGY			English	Article							PEROXISOMAL BETA-OXIDATION; TRANSCRIPTION FACTOR; MEMORY B; METABOLIC-REGULATION; AFFINITY MATURATION; CENTER HYPOXIA; C-MYC; RECEPTOR; SWITCH; MAINTENANCE	Germinal center B cells can undergo rapid proliferation. Shlomchik and colleagues show that germinal center B cells, unlike other rapidly proliferating cells, do not depend on glycolysis, but rather increase their peroxisome content and rewire their cellular metabolism to exclusively utilize fatty acid oxidation for their energetic needs. Germinal center B cells (GCBCs) are critical for generating long-lived humoral immunity. How GCBCs meet the energetic challenge of rapid proliferation is poorly understood. Dividing lymphocytes typically rely on aerobic glycolysis over oxidative phosphorylation for energy. Here we report that GCBCs are exceptional among proliferating B and T cells, as they actively oxidize fatty acids (FAs) and conduct minimal glycolysis. In vitro, GCBCs had a very low glycolytic extracellular acidification rate but consumed oxygen in response to FAs. [C-13(6)]-glucose feeding revealed that GCBCs generate significantly less phosphorylated glucose and little lactate. Further, GCBCs did not metabolize glucose into tricarboxylic acid (TCA) cycle intermediates. Conversely, [C-13(16)]-palmitic acid labeling demonstrated that GCBCs generate most of their acetyl-CoA and acetylcarnitine from FAs. FA oxidation was functionally important, as drug-mediated and genetic dampening of FA oxidation resulted in a selective reduction of GCBCs. Hence, GCBCs appear to uncouple rapid proliferation from aerobic glycolysis.	[Weisel, Florian J.; Elsner, Rebecca A.; Trivedi, Nikita; Luo, Wei; Wikenheiser, Daniel; Hawse, William F.; Smita, Shuchi; Conter, Laura J.; Joachim, Stephen M.; Delgoffe, Greg M.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA; [Mullett, Steven J.; Wendell, Stacy G.] Univ Pittsburgh, Hlth Sci Metabol & Lipid Core, Pittsburgh, PA USA; [Menk, Ashley V.; Delgoffe, Greg M.] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA USA; [Chikina, Maria; Smita, Shuchi] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Wendell, Stacy G.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Jurczak, Michael J.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA USA; [Jurczak, Michael J.] Univ Pittsburgh, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA; [Winkler, Thomas H.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Nikolaus Fiebiger Ctr Mol Med, Div Genet, Erlangen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Erlangen Nuremberg	Weisel, FJ; Shlomchik, MJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA.	fweisel@pitt.edu; mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020; Luo, Wei/ABD-3082-2021; Delgoffe, Greg M./HCH-2805-2022	Shlomchik, Mark J./0000-0002-2152-0959; Luo, Wei/0000-0003-2826-1723; Delgoffe, Greg M./0000-0002-2957-8135; Weisel, Florian/0000-0002-8679-9241	NIH [R01 AI-46303, R01 AI-105018]; Tumor Microenvironment Center at the University of Pittsburgh [SKF-015-039, SU2C-IRG-016-08]; Deutsche Forschungsgemeinschaft [TRR130]; ImageStreamX MARKII [NIH 1S10OD019942-01];  [S10OD023402]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tumor Microenvironment Center at the University of Pittsburgh; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ImageStreamX MARKII; 	We thank R. Moreci and M. Carter for supporting experimental procedures, and D. Falkner and A. Yates for cell sorting. This work was funded by NIH grant no. R01 AI-46303 and NIH grant no. R01 AI-105018 to M.J.S.; and by grant no. SKF-015-039, grant no. SU2C-IRG-016-08 and start-up funds to G.M.D. through the Tumor Microenvironment Center at the University of Pittsburgh. T.H.W. was funded by the Deutsche Forschungsgemeinschaft (grant no. TRR130) and S.G.W. through grant no. S10OD023402. This work benefitted from ImageStreamX MARKII grant no. NIH 1S10OD019942-01.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chaudhry R., 2018, STATPEARLS; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Choi SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06686-0; Degn SE, 2017, CELL, V170, P913, DOI 10.1016/j.cell.2017.07.026; Deng JC, 2017, J IMMUNOL, V198, P170, DOI 10.4049/jimmunol.1600613; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jung J, 2019, NAT CELL BIOL, V21, P85, DOI 10.1038/s41556-018-0217-x; Konigsberg M, 2013, REDOX BIOL, V1, P475, DOI 10.1016/j.redox.2013.09.004; LaPensee CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097090; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Martinez-Martin N, 2017, SCIENCE, V355, P641, DOI 10.1126/science.aal3908; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pound JD, 1997, BLOOD, V89, P919, DOI 10.1182/blood.V89.3.919; Raso F, 2018, J CLIN INVEST, V128, P4163, DOI 10.1172/JCI99597; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; Shlomchik MJ, 2019, IMMUNOL REV, V288, P5, DOI 10.1111/imr.12756; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Thapa D, 2019, J MOL CELL CARDIOL, V129, P174, DOI 10.1016/j.yjmcc.2019.02.012; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; VANDENBRANDEN C, 1985, FEBS LETT, V187, P331, DOI 10.1016/0014-5793(85)81270-9; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; WOLF HPO, 1992, HORM METAB RES, V26, P62; Yao Cong-Hui, 2018, PLoS Biol, V16, pe2003782, DOI 10.1371/journal.pbio.2003782; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	61	86	88	5	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					331	+		10.1038/s41590-020-0598-4	http://dx.doi.org/10.1038/s41590-020-0598-4		FEB 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066950	Green Accepted			2022-12-18	WOS:000514067400005
J	Seillet, C; Luong, K; Tellier, J; Jacquelot, N; Shen, RD; Hickey, P; Wimmer, VC; Whitehead, L; Rogers, K; Smyth, GK; Garnham, AL; Ritchie, ME; Belz, GT				Seillet, Cyril; Luong, Kylie; Tellier, Julie; Jacquelot, Nicolas; Shen, Rui Dong; Hickey, Peter; Wimmer, Verena C.; Whitehead, Lachlan; Rogers, Kelly; Smyth, Gordon K.; Garnham, Alexandra L.; Ritchie, Matthew E.; Belz, Gabrielle T.			The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; CIRCADIAN CLOCK; INTERLEUKIN-22; MICE; DIFFERENTIATION; TRAFFICKING; TRYPTOPHAN; BACTERIAL	Group 3 innate lymphoid cell (ILC3)-mediated production of the cytokine interleukin-22 (IL-22) is critical for the maintenance of immune homeostasis in the gastrointestinal tract. Here, we find that the function of ILC3s is not constant across the day, but instead oscillates between active phases and resting phases. Coordinate responsiveness of ILC3s in the intestine depended on the food-induced expression of the neuropeptide vasoactive intestinal peptide (VIP). Intestinal ILC3s had high expression of the G protein-coupled receptor vasoactive intestinal peptide receptor 2 (VIPR2), and activation by VIP markedly enhanced the production of IL-22 and the barrier function of the epithelium. Conversely, deficiency in signaling through VIPR2 led to impaired production of IL-22 by ILC3s and increased susceptibility to inflammation-induced gut injury. Thus, intrinsic cellular rhythms acted in synergy with the cyclic patterns of food intake to drive the production of IL-22 and synchronize protection of the intestinal epithelium through a VIP-VIPR2 pathway in ILC3s. Belz and colleagues show that the enteric neuron-derived neuropeptide VIP signals though its receptor VIPR on ILC3s to regulate the cyclic production of IL-22 in response to food intake.	[Seillet, Cyril; Luong, Kylie; Tellier, Julie; Jacquelot, Nicolas; Shen, Rui Dong; Hickey, Peter; Wimmer, Verena C.; Whitehead, Lachlan; Rogers, Kelly; Smyth, Gordon K.; Garnham, Alexandra L.; Ritchie, Matthew E.; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Seillet, Cyril; Luong, Kylie; Tellier, Julie; Jacquelot, Nicolas; Shen, Rui Dong; Hickey, Peter; Wimmer, Verena C.; Whitehead, Lachlan; Rogers, Kelly; Garnham, Alexandra L.; Ritchie, Matthew E.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia; [Belz, Gabrielle T.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Queensland	Seillet, C; Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Seillet, C; Belz, GT (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Belz, GT (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	seillet@wehi.edu.au; belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013; Jacquelot, Nicolas/AAY-6937-2020; Smyth, Gordon/B-5276-2008; Hickey, Peter/ABB-7174-2020	Belz, Gabrielle T/0000-0002-9660-9587; Smyth, Gordon/0000-0001-9221-2892; Luong, Kylie/0000-0002-1459-2604; Jacquelot, Nicolas/0000-0003-0282-1892; Hickey, Peter/0000-0002-8153-6258; Rogers, Kelly L./0000-0002-6755-0221; Tellier, Julie/0000-0003-2787-8174; Shen, Rui Dong/0000-0002-5704-4632	National Health and Medical Research Council (NHMRC) of Australia [APP1165443, 1122277, 1054925]; Cure Cancer and Cancer Australia [APP1163990]; Rebecca L. Cooper Medical Research Foundation; NHMRC [APP1135898, APP1123000, APP1154970]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer and Cancer Australia; Rebecca L. Cooper Medical Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank M. Camilleri, A. Lin, S. Cree, C. Alvarado and T. Putoczki for expert technical advice and support. We thank S. Wilcox for performing the sequencing, and S. Nutt for critical reading of the manuscript. Financial support for this work was provided by National Health and Medical Research Council (NHMRC) of Australia grants (APP1165443, 1122277 and 1054925 to G.T.B. and C.S.), Cure Cancer and Cancer Australia (APP1163990 to N.J.), The Rebecca L. Cooper Medical Research Foundation (to G.T.B.) and fellowships from the NHMRC (APP1135898 to G.T.B., APP1123000 to C.S. and APP1154970 to G.K.S.). This study was made possible through the Victorian State Government Operational Infrastructure Support Program and the Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme.X	Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Andoh A, 2005, J GASTROENTEROL, V40, P1089, DOI 10.1007/s00535-005-1727-4; Barrow AD, 2019, CURR OPIN IMMUNOL, V56, P82, DOI 10.1016/j.coi.2018.11.004; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Goetzl EJ, 2001, P NATL ACAD SCI USA, V98, P13854, DOI 10.1073/pnas.241503798; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Lun Aaron T L, 2016, F1000Res, V5, P2122; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Mielke LA, 2019, J EXP MED, V216, P1682, DOI 10.1084/jem.20181778; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Peters CP, 2016, IMMUNOL LETT, V172, P124, DOI 10.1016/j.imlet.2015.10.004; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Quatrini L, 2017, J EXP MED, V214, P3531, DOI 10.1084/jem.20171048; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Team R.C, 2015, R LANG ENV STAT COMP; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang YY, 2017, J IMMUNOL, V199, P3316, DOI 10.4049/jimmunol.1700152; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Yadav M, 2011, CELL IMMUNOL, V267, P124, DOI 10.1016/j.cellimm.2011.01.001; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	73	86	90	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					168	+		10.1038/s41590-019-0567-y	http://dx.doi.org/10.1038/s41590-019-0567-y		DEC 2019	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31873294				2022-12-18	WOS:000507726700002
J	Birkinshaw, RW; Pellicci, DG; Cheng, TY; Keller, AN; Sandoval-Romero, M; Gras, S; de Jong, A; Uldrich, AP; Moody, DB; Godfrey, DI; Rossjohn, J				Birkinshaw, Richard W.; Pellicci, Daniel G.; Cheng, Tan-Yun; Keller, Andrew N.; Sandoval-Romero, Maria; Gras, Stephanie; de Jong, Annemieke; Uldrich, Adam P.; Moody, D. Branch; Godfrey, Dale I.; Rossjohn, Jamie			alpha beta T cell antigen receptor recognition of CD1a presenting self lipid ligands	NATURE IMMUNOLOGY			English	Article							CRYSTAL-STRUCTURE; COMPLEX; MHC; HETEROGENEITY; RESOLUTION; TETRAMERS; SELECTION; ANGSTROM; SYSTEM; PHENIX	A central paradigm in ab T cell-mediated immunity is the simultaneous co-recognition of antigens and antigen-presenting molecules by the ab T cell antigen receptor (TCR). CD1a presents a broad repertoire of lipid-based antigens. We found that a prototypical autoreactive TCR bound CD1a when it was presenting a series of permissive endogenous ligands, while other lipid ligands were nonpermissive to TCR binding. The structures of two TCR-CD1a-lipid complexes showed that the TCR docked over the A' roof of CD1a in a manner that precluded direct contact with permissive ligands. Nonpermissive ligands indirectly inhibited TCR binding by disrupting the TCR-CD1a contact zone. The exclusive recognition of CD1a by the TCR represents a previously unknown mechanism whereby ab T cells indirectly sense self antigens that are bound to an antigen-presenting molecule.	[Birkinshaw, Richard W.; Keller, Andrew N.; Sandoval-Romero, Maria; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Birkinshaw, Richard W.; Keller, Andrew N.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Pellicci, Daniel G.; Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Pellicci, Daniel G.; Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3052, Australia; [Cheng, Tan-Yun; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Cheng, Tan-Yun; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA USA; [de Jong, Annemieke] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Monash University; Monash University; University of Melbourne; University of Melbourne; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; Cardiff University	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	bmoody@partners.org; godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Birkinshaw, Richard/AAC-7809-2019; Pellicci, Daniel/AAX-8539-2020; Rossjohn, Jamie/F-9032-2013; Uldrich, Adam/AAX-3785-2020	Birkinshaw, Richard/0000-0003-1825-0182; Rossjohn, Jamie/0000-0002-2020-7522; Godfrey, Dale/0000-0002-3009-5472; ULDRICH, ADAM/0000-0002-6350-5976; Pellicci, Daniel/0000-0001-5305-2398; gras, stephanie/0000-0001-7416-038X; de Jong, Annemieke/0000-0001-6707-6585	NIAID [R01 AR048632, R01 AI049313]; National Health and Medical Research Council of Australia [1013667, 1020770, AF50]; Australian Research Council [CE140100011, LE110100106]; Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Tan, M. Bhati, J. Waddington, B. O'Sullivan, M. Ciula and staff at the Australian synchrotron and the Monash macromolecular crystallization facility for technical assistance; P. Savage (Brigham Young University) for alpha-galactosylceramide; S.A. Porcelli (Albert Einstein College of Medicine) for the BK6 clone; and J. Altman for the design of CD1a protein expression constructs. Supported by NIAID (R01 AR048632 and AI049313 to D.B.M.), the National Health and Medical Research Council of Australia (1013667; Early Career Fellowship to D.G.P.; Senior Principal Research Fellowship 1020770 to D.I.G.; and NHMRC Australia Fellowship AF50 to J.R.), the Australian Research Council (CE140100011 and LE110100106; Future Fellowships to S.G. and A.P.U.) and the Dermatology Foundation (A.d.J.).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhati M, 2014, PROTEIN SCI, V23, P260, DOI 10.1002/pro.2412; Bourgeois EA, 2015, J EXP MED, V212, P149, DOI 10.1084/jem.20141505; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/NMETH.2648, 10.1038/nmeth.2648]; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Eckle SBG, 2013, CURR OPIN IMMUNOL, V25, P653, DOI 10.1016/j.coi.2013.07.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gapin L, 2013, CURR OPIN IMMUNOL, V25, P168, DOI 10.1016/j.coi.2013.01.002; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasmar AG, 2013, J IMMUNOL, V191, P4499, DOI 10.4049/jimmunol.1301660; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Ly D, 2014, CELL MOL LIFE SCI, V71, P3069, DOI 10.1007/s00018-014-1603-6; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	46	86	88	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					258	U215		10.1038/ni.3098	http://dx.doi.org/10.1038/ni.3098			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25642819	Green Accepted			2022-12-18	WOS:000349842100009
J	Schliehe, C; Flynn, EK; Vilagos, B; Richson, U; Swaminathan, S; Bosnjak, B; Bauer, L; Kandasamy, RK; Griesshammer, IM; Kosack, L; Schmitz, F; Litvak, V; Sissons, J; Lercher, A; Bhattacharya, A; Khamina, K; Trivett, AL; Tessarollo, L; Mesteri, I; Hladik, A; Merkler, D; Kubicek, S; Knapp, S; Epstein, MM; Symer, DE; Aderem, A; Bergthaler, A				Schliehe, Christopher; Flynn, Elizabeth K.; Vilagos, Bojan; Richson, Udochuku; Swaminathan, Savitha; Bosnjak, Berislav; Bauer, Lisa; Kandasamy, Richard K.; Griesshammer, Isabel M.; Kosack, Lindsay; Schmitz, Frank; Litvak, Vladimir; Sissons, James; Lercher, Alexander; Bhattacharya, Anannya; Khamina, Kseniya; Trivett, Anna L.; Tessarollo, Lino; Mesteri, Ildiko; Hladik, Anastasiya; Merkler, Doron; Kubicek, Stefan; Knapp, Sylvia; Epstein, Michelle M.; Symer, David E.; Aderem, Alan; Bergthaler, Andreas			The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TARGETED DISRUPTION; LYSINE METHYLATION; INNATE IMMUNITY; INFLUENZA; CHROMATIN; PNEUMONIA; DEFENSE; PATHOGENESIS; INTERFERONS	Immune responses are tightly regulated to ensure efficient pathogen clearance while avoiding tissue damage. Here we report that Setdb2 was the only protein lysine methyltransferase induced during infection with influenza virus. Setdb2 expression depended on signaling via type I interferons, and Setdb2 repressed expression of the gene encoding the neutrophil attractant CXCL1 and other genes that are targets of the transcription factor NF-kappa B. This coincided with occupancy by Setdb2 at the Cxcl1 promoter, which in the absence of Setdb2 displayed diminished trimethylation of histone H3 Lys9 (H3K9me3). Mice with a hypomorphic gene-trap construct of Setdb2 exhibited increased infiltration of neutrophils during sterile lung inflammation and were less sensitive to bacterial superinfection after infection with influenza virus. This suggested that a Setdb2-mediated regulatory crosstalk between the type I interferons and NF-kappa B pathways represents an important mechanism for virus-induced susceptibility to bacterial superinfection.	[Schliehe, Christopher; Vilagos, Bojan; Richson, Udochuku; Bauer, Lisa; Kandasamy, Richard K.; Griesshammer, Isabel M.; Kosack, Lindsay; Lercher, Alexander; Bhattacharya, Anannya; Khamina, Kseniya; Hladik, Anastasiya; Kubicek, Stefan; Knapp, Sylvia; Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Flynn, Elizabeth K.; Trivett, Anna L.; Tessarollo, Lino; Symer, David E.] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Swaminathan, Savitha; Schmitz, Frank; Sissons, James; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Bosnjak, Berislav; Epstein, Michelle M.] Med Univ Vienna, DIAID, Dept Dermatol, Vienna, Austria; [Litvak, Vladimir] Univ Massachusetts, Worcester, MA 01605 USA; [Mesteri, Ildiko] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Hladik, Anastasiya; Knapp, Sylvia] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Merkler, Doron] Dept Pathol & Immunol, Div Clin Pathol, Geneva, Switzerland; [Merkler, Doron] Univ Hosp Geneva, Geneva, Switzerland; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, Gottingen, Germany; [Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Infectious Disease Research; Medical University of Vienna; University of Massachusetts System; University of Massachusetts Worcester; Medical University of Vienna; Medical University of Vienna; University of Geneva; University of Gottingen; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Bergthaler, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	abergthaler@cemm.oeaw.ac.at	Bhattacharya, Anannya/J-4555-2019; Merkler, Doron/N-9157-2016; Bošnjak, Berislav/H-7370-2019; Kandasamy, Richard Kumaran/C-8981-2009; Kubicek, Stefan/C-2089-2017; Knapp, Sylvia/J-3973-2013; Bergthaler, Andreas/ABG-5047-2020	Merkler, Doron/0000-0002-0247-2007; Bošnjak, Berislav/0000-0003-3374-7488; Kandasamy, Richard Kumaran/0000-0002-0894-1222; Kubicek, Stefan/0000-0003-0855-8343; Knapp, Sylvia/0000-0001-9016-5244; Bergthaler, Andreas/0000-0003-0597-1976; Trivett, Anna/0000-0001-7143-105X; Epstein, Michelle/0000-0002-4755-0224; Bhattacharya, Anannya/0000-0001-6385-4028; Bauer, Lisa/0000-0002-9461-7284; Lercher, Alexander/0000-0003-3478-5304	German Academic Exchange Service; National Cancer Institute, Center for Cancer Research, of the US National Institutes of Health; European Molecular Biology Organization [ALTF 48-2008, ALTF 314-2012]; Austrian Academy of Sciences; Swiss National Science Foundation [PP00P3_152928]; Klaus-Tschira Foundation; Gebert-Ruf Foundation; Ohio State University Comprehensive Cancer Center; US National Institutes of Health [R01AI032972, R01AI025032, U19AI100627]; Swiss Foundation for Medical-Biological Stipends; Austrian Science Fund [P-25360]; NATIONAL CANCER INSTITUTE [ZICBC011265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI025032, R01AI032972] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 25360] Funding Source: researchfish	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Cancer Institute, Center for Cancer Research, of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Academy of Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Klaus-Tschira Foundation; Gebert-Ruf Foundation; Ohio State University Comprehensive Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Foundation for Medical-Biological Stipends; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the Superti-Furga laboratory (Research Center for Molecular Medicine of the Austrian Academy of Sciences) for antibody to Zbp1; S. Schuchner and E. Ogris (Max F. Perutz Laboratories Monoclonal antibody facility in Vienna) for help with generating the antibody to Setdb2; E. Southon and M. E. Palko for technical help in generating the Setdb2<SUP>GT/GT</SUP> mice; Y. Guo for technical help; B. Marzolf and P. Troisch (microarray core facility of the Institute for Systems Biology) for technical help in generating microarray data; M. Farlik, T. Penz, M. Schuster and C. Bock (Biosequencing Facility of the Research Center for Molecular Medicine of the Austrian Academy of Sciences) for technical help and advice for generating RNA-Seq data; M. Muller and B. Strobl (University of Veterinary Medicine Vienna) for Irf7<SUP>-/-</SUP> and Stat1<SUP>-/-</SUP> mice; M. Gorna, F. Grebien, L. Heinz, T. Karonitsch, M. Rebsamen, C. Rosenberger and S. Saluzzo for advice; and D. Barlow, R.A. Flavell, A.N. Hegazy, A. Jamieson, R. Medzhitov and G. Superti-Furga for discussions. Supported by the German Academic Exchange Service (C.S.), the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, of the US National Institutes of Health (E.K.F., A.L.T., L.T. and D.E.S.), the European Molecular Biology Organization (ALTF 48-2008 to A.Be.; and ALTF 314-2012 to R.K.K.), the Austrian Academy of Sciences (A.Bh.), the Swiss National Science Foundation (PP00P3_152928 to D.M.), the Klaus-Tschira Foundation (D.M.), the Gebert-Ruf Foundation (D.M.), the Ohio State University Comprehensive Cancer Center (D.E.S.), the US National Institutes of Health (R01AI032972, R01AI025032 and U19AI100627 to A.A.), the Swiss Foundation for Medical-Biological Stipends (A.Be.), the Austrian Academy of Sciences (A.Be.) and the Austrian Science Fund (P-25360 to A.Be.).	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Falandry C, 2010, J BIOL CHEM, V285, P20234, DOI 10.1074/jbc.M109.052399; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hogarth CA, 2011, BIOL REPROD, V84, P34, DOI 10.1095/biolreprod.110.086215; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van der Sluijs KF, 2010, CRIT CARE, V14, DOI 10.1186/cc8893; Xu PF, 2010, P NATL ACAD SCI USA, V107, P2521, DOI 10.1073/pnas.0914396107; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	50	86	90	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					67	+		10.1038/ni.3046	http://dx.doi.org/10.1038/ni.3046			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25419628	Green Accepted			2022-12-18	WOS:000346494200010
J	Taketomi, Y; Ueno, N; Kojima, T; Sato, H; Murase, R; Yamamoto, K; Tanaka, S; Sakanaka, M; Nakamura, M; Nishito, Y; Kawana, M; Kambe, N; Ikeda, K; Taguchi, R; Nakamizo, S; Kabashima, K; Gelb, MH; Arita, M; Yokomizo, T; Nakamura, M; Watanabe, K; Hirai, H; Nakamura, M; Okayama, Y; Ra, C; Aritake, K; Urade, Y; Morimoto, K; Sugimoto, Y; Shimizu, T; Narumiya, S; Hara, S; Murakami, M				Taketomi, Yoshitaka; Ueno, Noriko; Kojima, Takumi; Sato, Hiroyasu; Murase, Remi; Yamamoto, Kei; Tanaka, Satoshi; Sakanaka, Mariko; Nakamura, Masanori; Nishito, Yasumasa; Kawana, Momoko; Kambe, Naotomo; Ikeda, Kazutaka; Taguchi, Ryo; Nakamizo, Satoshi; Kabashima, Kenji; Gelb, Michael H.; Arita, Makoto; Yokomizo, Takehiko; Nakamura, Motonao; Watanabe, Kikuko; Hirai, Hiroyuki; Nakamura, Masataka; Okayama, Yoshimichi; Ra, Chisei; Aritake, Kosuke; Urade, Yoshihiro; Morimoto, Kazushi; Sugimoto, Yukihiko; Shimizu, Takao; Narumiya, Shuh; Hara, Shuntaro; Murakami, Makoto			Mast cell maturation is driven via a group III phospholipase A(2)-prostaglandin D-2-DP1 receptor paracrine axis	NATURE IMMUNOLOGY			English	Article							PROSTAGLANDIN D SYNTHASE; MICE LACKING; HISTIDINE-DECARBOXYLASE; ALLERGIC INFLAMMATION; LIPID MEDIATORS; A(2); ACTIVATION; EXPRESSION; DEFICIENT; IGE	Microenvironment-based alterations in phenotypes of mast cells influence the susceptibility to anaphylaxis, yet the mechanisms underlying proper maturation of mast cells toward an anaphylaxis-sensitive phenotype are incompletely understood. Here we report that PLA2G3, a mammalian homolog of anaphylactic bee venom phospholipase A(2), regulates this process. PLA2G3 secreted from mast cells is coupled with fibroblastic lipocalin-type PGD(2) synthase (L-PGDS) to provide PGD2, which facilitates mast-cell maturation via PGD2 receptor DP1. Mice lacking PLA2G3, L-PGDS or DP1, mast cell-deficient mice reconstituted with PLA2G3-null or DP1-null mast cells, or mast cells cultured with L-PGDS-ablated fibroblasts exhibited impaired maturation and anaphylaxis of mast cells. Thus, we describe a lipid-driven PLA2G3-L-PGDS-DP1 loop that drives mast cell maturation.	[Taketomi, Yoshitaka; Ueno, Noriko; Kojima, Takumi; Sato, Hiroyasu; Murase, Remi; Yamamoto, Kei; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 113, Japan; [Taketomi, Yoshitaka; Sato, Hiroyasu; Murase, Remi; Kawana, Momoko; Hara, Shuntaro] Showa Univ, Sch Pharm, Tokyo, Japan; [Tanaka, Satoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Immunobiol, Okayama, Japan; [Sakanaka, Mariko] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Nakamura, Masanori] Showa Univ, Sch Dent, Tokyo 142, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Tokyo 113, Japan; [Kambe, Naotomo] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Aichi, Japan; [Nakamizo, Satoshi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Gelb, Michael H.] Univ Washington, Dept Chem, Washington, DC USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Washington, DC USA; [Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Nakamura, Motonao; Shimizu, Takao] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Watanabe, Kikuko] Koshien Univ, Dept Nutr, Takarazuka, Hyogo, Japan; [Hirai, Hiroyuki] Bio Med Labs, Dept Adv Med & Dev, Saitama, Japan; [Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan; [Okayama, Yoshimichi; Ra, Chisei] Nihon Univ, Grad Sch Med Sci, Adv Med Res Ctr, Div Mol Cell Immunol & Allergol, Tokyo, Japan; [Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Bihavioral Biol, Osaka, Japan; [Morimoto, Kazushi; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; Okayama University; Mukogawa Women's University; Showa University; Tokyo Metropolitan Institute of Medical Science; Chiba University; Keio University; Chubu University; Kyoto University; University of Washington; University of Washington; University of Tokyo; Juntendo University; University of Tokyo; Tokyo Medical & Dental University (TMDU); Nihon University; Kumamoto University; Kyoto University	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Bunkyo Ku, Tokyo 113, Japan.	murakami-mk@igakuken.or.jp	Kambe, Naotomo/H-3987-2017; Shimizu, Takao/AAV-7052-2021; Sugimoto, Yukihiko/AAV-6470-2021; Yokomizo, Takehiko/P-5673-2016; Okayama, Yoshimichi/AAG-4352-2021; TANAKA, Satoshi/B-1624-2011; Nakamizo, Satoshi/ABH-2121-2021; Tanaka, Satoshi/H-6800-2019; Kabashima, Kenji/G-2521-2014	Kambe, Naotomo/0000-0001-9610-4952; Sugimoto, Yukihiko/0000-0001-6973-932X; Yokomizo, Takehiko/0000-0002-5219-1553; TANAKA, Satoshi/0000-0002-3468-7694; Nakamizo, Satoshi/0000-0001-9332-0369; Tanaka, Satoshi/0000-0002-3468-7694; Arita, Makoto/0000-0001-9902-0463; gelb, michael/0000-0001-7000-5219; Sakanaka-Yokoyama, Mariko/0000-0001-5517-2545; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Education, Culture, Sports, Science and Technology of Japan [22116005, 24390021, 23790119, 24117724]; Promoting Individual Research to Nurture the Seeds of Future Innovation and Organizing Unique Innovative Network (PRESTO) of Japan Science and Technology Agency; Uehara Foundation; Mitsubishi Foundation; Terumo Foundation; Mochida Foundation; Toray Science Foundation; Grants-in-Aid for Scientific Research [22116005, 23659044, 24619007, 23590067] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL036235] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promoting Individual Research to Nurture the Seeds of Future Innovation and Organizing Unique Innovative Network (PRESTO) of Japan Science and Technology Agency; Uehara Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Terumo Foundation; Mochida Foundation; Toray Science Foundation(Toray Industries, Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Y. Tanoue, H. Ohkubo, K. Araki and K. Yamamura for generating Ptges2<SUP>-/-</SUP> mice. This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22116005 and 24390021 to M.M. and 23790119 and 24117724 to Y.T.), Promoting Individual Research to Nurture the Seeds of Future Innovation and Organizing Unique Innovative Network (PRESTO) of Japan Science and Technology Agency (to M.M.), and the Uehara, Mitsubishi, Terumo, Mochida and Toray Science Foundations (to M.M.).	Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; DUDLER T, 1995, J IMMUNOL, V155, P2605; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gerena RL, 2000, J ANDROL, V21, P848; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Iwashita M, 2009, J MED CHEM, V52, P5837, DOI 10.1021/jm900598m; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MATSUDA H, 1991, J EXP MED, V174, P7, DOI 10.1084/jem.174.1.7; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakatani N, 2000, BIOCHEM J, V352, P311, DOI 10.1042/0264-6021:3520311; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Tanaka S, 2004, EUR J IMMUNOL, V34, P1472, DOI 10.1002/eji.200324636; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492	50	86	88	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					554	+		10.1038/ni.2586	http://dx.doi.org/10.1038/ni.2586			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23624557	Green Accepted			2022-12-18	WOS:000319107600008
J	Herdy, B; Jaramillo, M; Svitkin, YV; Rosenfeld, AB; Kobayashi, M; Walsh, D; Alain, T; Sean, P; Robichaud, N; Topisirovic, I; Furic, L; Dowling, RJO; Sylvestre, A; Rong, LW; Colina, R; Costa-Mattioli, M; Fritz, JH; Olivier, M; Brown, E; Mohr, I; Sonenberg, N				Herdy, Barbara; Jaramillo, Maritza; Svitkin, Yuri V.; Rosenfeld, Amy B.; Kobayashi, Mariko; Walsh, Derek; Alain, Tommy; Sean, Polen; Robichaud, Nathaniel; Topisirovic, Ivan; Furic, Luc; Dowling, Ryan J. O.; Sylvestre, Annie; Rong, Liwei; Colina, Rodney; Costa-Mattioli, Mauro; Fritz, Joerg H.; Olivier, Martin; Brown, Earl; Mohr, Ian; Sonenberg, Nahum			Translational control of the activation of transcription factor NF-kappa B and production of type I interferon by phosphorylation of the translation factor eIF4E	NATURE IMMUNOLOGY			English	Article							INITIATION-FACTOR 4E; BINDING PROTEIN EIF4E; EUKARYOTIC TRANSLATION; SIGNALING PATHWAYS; NITRIC-OXIDE; BETA; DEPHOSPHORYLATION; REDISTRIBUTION; INVOLVEMENT; INHIBITION	Type I interferon is an integral component of the antiviral response, and its production is tightly controlled at the levels of transcription and translation. The eukaryotic translation-initiation factor eIF4E is a rate-limiting factor whose activity is regulated by phosphorylation of Ser209. Here we found that mice and fibroblasts in which eIF4E cannot be phosphorylated were less susceptible to virus infection. More production of type I interferon, resulting from less translation of Nfkbia mRNA (which encodes the inhibitor I kappa B alpha), largely explained this phenotype. The lower abundance of IkBa resulted in enhanced activity of the transcription factor NF-kappa B, which promoted the production of interferon-beta (IFN-beta). Thus, regulated phosphorylation of eIF4E has a key role in antiviral host defense by selectively controlling the translation of an mRNA that encodes a critical suppressor of the innate antiviral response.	[Herdy, Barbara; Jaramillo, Maritza; Svitkin, Yuri V.; Rosenfeld, Amy B.; Alain, Tommy; Sean, Polen; Robichaud, Nathaniel; Topisirovic, Ivan; Dowling, Ryan J. O.; Sylvestre, Annie; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Herdy, Barbara; Jaramillo, Maritza; Svitkin, Yuri V.; Rosenfeld, Amy B.; Alain, Tommy; Sean, Polen; Robichaud, Nathaniel; Topisirovic, Ivan; Dowling, Ryan J. O.; Sylvestre, Annie; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Kobayashi, Mariko; Mohr, Ian] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Kobayashi, Mariko; Mohr, Ian] NYU, Sch Med, NYU Canc Inst, New York, NY USA; [Furic, Luc] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Walsh, Derek] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland; [Rong, Liwei] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Colina, Rodney] Univ Republ, Reg Norte Salto, Mol Virol Lab, Salto, Uruguay; [Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Fritz, Joerg H.] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Fritz, Joerg H.; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Olivier, Martin] McGill Univ, Ctr Study Host Resistance, McGill Univ Hlth Ctr, Res Inst,Dept Med, Montreal, PQ, Canada; [Brown, Earl] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Brown, Earl] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON, Canada	McGill University; McGill University; New York University; New York University; Monash University; Dublin City University; Lady Davis Institute; McGill University; Universidad de la Republica, Uruguay; Baylor College of Medicine; McGill University; McGill University; McGill University; University of Ottawa; University of Ottawa	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	nahum.sonenberg@mcgill.ca	Rosenfeld, Anatoly B/D-1989-2014; Topisirovic, Ivan/A-9426-2008; walsh, Derek/C-7274-2015; Furic, Luc/F-4886-2012; Jaramillo, Maritza/T-7467-2019; Dowling, Ryan/Q-8912-2018	Topisirovic, Ivan/0000-0002-5510-9762; Furic, Luc/0000-0002-1893-9812; Jaramillo, Maritza/0000-0002-1910-5684; Robichaud, Nathaniel/0000-0002-7653-0767; Svitkin, Yuri/0000-0003-3819-2143; Dowling, Ryan/0000-0002-5381-8805; Colina, Rodney/0000-0003-3731-5383	Canadian Institutes of Health Research [MOP-7214]; US National Institutes of Health [AI 073898, GM056927, T32 AI007647]; Irma Hirschl Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, T32AI007180, R01AI073898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056927] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma Hirschl Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Frey (NYU School of Medicine) for rat antibody immunoglobulin G; M. Olivier (McGill University) for tumor necrosis factor; J. Bell (University of Ottawa) for antibody to VSV proteins and VSV-GFP; J. Pelletier (McGill University) for the retroviral vectors MSCV-GFP and MSCV-eIF4E; M. Gale (University of Washington) for the PRDII luciferase reporter Ifnb1PRDII-Luc; D. A. Muruve (University of Calgary) for the luciferase reporters Ifnb1-pGL3 and Nfkb1; R. Fukunaga (Kyoto University) for wild-type and Mnk1-Mnk2-deficient mice; J. Berlanga (Universidad Autonoma de Madrid) for Sindbis virus; and C. Lister for assistance. Supported by the Canadian Institutes of Health Research (MOP-7214 to N.S.), the US National Institutes of Health (AI 073898 and GM056927 to I. M., and T32 AI007647 to M. K.) and the Irma Hirschl Trust (I.M.).	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Benboudjema L, 2003, J VIROL, V77, P9192, DOI 10.1128/JVI.77.17.9192-9203.2003; BOTH GW, 1975, P NATL ACAD SCI USA, V72, P1189, DOI 10.1073/pnas.72.3.1189; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; Huber MA, 2002, J BIOL CHEM, V277, P1268, DOI 10.1074/jbc.M109358200; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jaramillo M, 2004, J IMMUNOL, V172, P5734, DOI 10.4049/jimmunol.172.9.5734; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kleijn M, 1996, VIROLOGY, V217, P486, DOI 10.1006/viro.1996.0143; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Liu SF, 1997, J IMMUNOL, V159, P3976; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Morley SJ, 1997, BIOCHEM SOC T, V25, P503, DOI 10.1042/bst0250503; Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; ZAWATZKY R, 1985, P NATL ACAD SCI USA, V82, P1136, DOI 10.1073/pnas.82.4.1136	49	86	87	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					543	+		10.1038/ni.2291	http://dx.doi.org/10.1038/ni.2291			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22544393	Green Accepted, Green Published			2022-12-18	WOS:000304203900008
J	Basha, G; Omilusik, K; Chavez-Steenbock, A; Reinicke, AT; Lack, N; Choi, KB; Jefferies, WA				Basha, Genc; Omilusik, Kyla; Chavez-Steenbock, Ana; Reinicke, Anna T.; Lack, Nathan; Choi, Kyung Bok; Jefferies, Wilfred A.			A CD74-dependent MHC class I endolysosomal cross-presentation pathway	NATURE IMMUNOLOGY			English	Article							INVARIANT CHAIN; DENDRITIC CELLS; ANTIGEN PRESENTATION; T-CELLS; EXOGENOUS ANTIGEN; MOLECULES; COMPLEX; GENERATION; EXPRESSION; CROSSPRESENTATION	Immune responses are initiated and primed by dendritic cells (DCs) that cross-present exogenous antigen. The chaperone CD74 (invariant chain) is thought to promote DC priming exclusively in the context of major histocompatibility complex (MHC) class II. However, we demonstrate here a CD74-dependent MHC class I cross-presentation pathway in DCs that had a major role in the generation of MHC class I-restricted, cytolytic T lymphocyte (CTL) responses to viral protein- and cell-associated antigens. CD74 associated with MHC class I in the endoplasmic reticulum of DCs and mediated the trafficking of MHC class I to endolysosomal compartments for loading with exogenous peptides. We conclude that CD74 has a previously undiscovered physiological function in endolysosomal DC cross-presentation for priming MHC class I-mediated CTL responses.	[Basha, Genc; Omilusik, Kyla; Chavez-Steenbock, Ana; Reinicke, Anna T.; Lack, Nathan; Choi, Kyung Bok; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Michael Smith Labs, Ctr Blood Res,Brain Res Ctr,Dept Microbiol & Immu, Vancouver, BC V5Z 1M9, Canada; [Basha, Genc; Omilusik, Kyla; Chavez-Steenbock, Ana; Reinicke, Anna T.; Lack, Nathan; Choi, Kyung Bok; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Biomed Res Ctr, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada; [Basha, Genc; Omilusik, Kyla; Chavez-Steenbock, Ana; Reinicke, Anna T.; Lack, Nathan; Choi, Kyung Bok; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Biomed Res Ctr, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, WA (corresponding author), Univ British Columbia, Biomed Res Ctr, Michael Smith Labs, Ctr Blood Res,Brain Res Ctr,Dept Microbiol & Immu, Vancouver, BC V5Z 1M9, Canada.	wilf@interchange.ubc.ca		Omilusik, Kyla/0000-0003-3675-048X	Canadian Institutes of Health Research [MOP-77631, MOP-86739]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank D. Mathis (Institut de Genetique et de Biologie Moleculaire et Cellulaire and The Harvard Stem Cell Institute) for Cd74<SUP>-/-</SUP> (H-2K<SUP>b</SUP>) mice; N. Shastri (University of California, Berkeley) for the B3Z T cell hybridoma; J. Yewdell (US National Institutes of Health) for antibody 25. D1.16; I. Shachar (Weizmann Institute of Sciences) for the CD74 constructs; and B. Barber and D. Williams (University of Toronto) for antiserum directed toward the region of H-2K<SUP>b</SUP> encoded by exon 8. Supported by the Canadian Institutes of Health Research (K.O.; and MOP-77631 and MOP-86739 to W.A.J.).	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; Chiu I, 1999, P NATL ACAD SCI USA, V96, P13944, DOI 10.1073/pnas.96.24.13944; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kruger T, 2005, CANCER IMMUNOL IMMUN, V54, P826, DOI 10.1007/s00262-004-0650-5; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; LOSS GE, 1993, J IMMUNOL, V150, P3187; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Machold RP, 1996, J EXP MED, V184, P2251, DOI 10.1084/jem.184.6.2251; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; Merzougui N, 2011, EMBO REP, V12, P1257, DOI 10.1038/embor.2011.203; NUCHTERN JG, 1990, NATURE, V343, P74, DOI 10.1038/343074a0; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Powis SJ, 2006, FEBS LETT, V580, P3112, DOI 10.1016/j.febslet.2006.04.060; RASHID A, 1992, J IMMUNOL, V148, P1382; Reber AJ, 2002, IMMUNOGENETICS, V54, P74, DOI 10.1007/s00251-002-0446-8; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Reinicke AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007210; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Song R, 1996, J IMMUNOL, V156, P4182; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tourne S, 1996, P NATL ACAD SCI USA, V93, P1464, DOI 10.1073/pnas.93.4.1464; van Lith M, 2003, EUR J IMMUNOL, V33, P1145, DOI 10.1002/eji.200323472; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vigna JL, 1996, J IMMUNOL, V157, P4503; Vitalis TZ, 2005, PLOS PATHOG, V1, P289, DOI 10.1371/journal.ppat.0010036; Zwickey HL, 1999, J IMMUNOL, V162, P6341	51	86	97	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					237	U53		10.1038/ni.2225	http://dx.doi.org/10.1038/ni.2225			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22306692	Green Accepted			2022-12-18	WOS:000300510600010
J	Ippagunta, SK; Malireddi, RKS; Shaw, PJ; Neale, GA; Vande Walle, L; Green, DR; Fukui, Y; Lamkanfi, M; Kanneganti, TD				Ippagunta, Sirish K.; Malireddi, R. K. Subbarao; Shaw, Patrick J.; Neale, Geoffrey A.; Vande Walle, Lieselotte; Green, Douglas R.; Fukui, Yoshinori; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization	NATURE IMMUNOLOGY			English	Article							SPECK-LIKE PROTEIN; HOST-DEFENSE; LISTERIA-MONOCYTOGENES; CASPASE-1 ACTIVATION; AIM2 INFLAMMASOME; INDUCED ARTHRITIS; INDEPENDENT ROLE; VIRAL-INFECTION; CARD ASC; IPAF	The adaptor ASC contributes to innate immunity through the assembly of inflammasome complexes that activate the cysteine protease caspase-1. Here we demonstrate that ASC has an inflammasome-independent, cell-intrinsic role in cells of the adaptive immune response. ASC-deficient mice showed defective antigen presentation by dendritic cells (DCs) and lymphocyte migration due to impaired actin polymerization mediated by the small GTPase Rac. Genome-wide analysis showed that ASC, but not the cytoplasmic receptor NLRP3 or caspase-1, controlled the mRNA stability and expression of Dock2, a guanine nucleotide-exchange factor that mediates Rac-dependent signaling in cells of the immune response. Dock2-deficient DCs showed defective antigen uptake similar to that of ASC-deficient cells. Ectopic expression of Dock2 in ASC-deficient cells restored Rac-mediated actin polymerization, antigen uptake and chemotaxis. Thus, ASC shapes adaptive immunity independently of inflammasomes by modulating Dock2-dependent Rac activation and actin polymerization in DCs and lymphocytes.	[Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Ippagunta, Sirish K.; Malireddi, R. K. Subbarao; Shaw, Patrick J.; Green, Douglas R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey A.] St Jude Childrens Res Hosp, Dept Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] VIB, Dept Med Prot Res, Ghent, Belgium; [Fukui, Yoshinori] Kyushu Univ, Div Immunogenet, Kyushu, Japan; [Fukui, Yoshinori] Kyushu Univ, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Kyushu, Japan	Ghent University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Kyushu University; Kyushu University	Lamkanfi, M (corresponding author), Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be; thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013; Kanneganti, Thirumala-Devi/Y-2503-2019; Green, Douglas R/N-8083-2018; Nuñez, Gabriel/A-7160-2014	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Green, Douglas R/0000-0002-7332-1417; Ippagunta, Sirish Kumar/0000-0002-7449-0511; Fukui, Yoshinori/0000-0003-2335-8745	US National Institutes of Health [R01AR056296, R21AI088177]; American Lebanese Syrian Associated Charities; European Union [256432]; Fund for Scientific Research-Flanders; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); European Union(European Commission); Fund for Scientific Research-Flanders(FWO); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell (Yale University School of Medicine), G. Nunez (University of Michigan) and S. Akira (Osaka University) for mutant mice; P. Vandenabeele (Ghent University) for anti-caspase-1; and H. Chi (St. Jude Children's Research Hospital) for retroviral plasmids and mutant mice. Supported by the US National Institutes of Health (R01AR056296 and R21AI088177 to T.-D.K.), the American Lebanese Syrian Associated Charities (T.-D.K.), the European Union Framework Program 7 (Marie-Curie grant 256432 to M.L.) and the Fund for Scientific Research-Flanders (M.L. and L.V.W.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	54	86	90	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					1010	U122		10.1038/ni.2095	http://dx.doi.org/10.1038/ni.2095			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21892172	Green Accepted			2022-12-18	WOS:000295084500017
J	Shembade, N; Pujari, R; Harhaj, NS; Abbott, DW; Harhaj, EW				Shembade, Noula; Pujari, Rajeshree; Harhaj, Nicole S.; Abbott, Derek W.; Harhaj, Edward W.			The kinase IKK alpha inhibits activation of the transcription factor NF-kappa B by phosphorylating the regulatory molecule TAX1BP1	NATURE IMMUNOLOGY			English	Article							T-CELL LEUKEMIA; TUMOR-SUPPRESSOR CYLD; DEUBIQUITINATING ENZYME; HTLV-I; DOWN-REGULATION; A20; TAX; INFLAMMATION; NF-KAPPA-B2; TERMINATION	In response to stimulation with proinflammatory cytokines, the deubiquitinase A20 inducibly interacts with the regulatory molecules TAX1BP1, Itch and RNF11 to form the A20 ubiquitin-editing complex. However, the molecular signal that coordinates the assembly of this complex has remained elusive. Here we demonstrate that TAX1BP1 was inducibly phosphorylated on Ser593 and Ser624 in response to proinflammatory stimuli. The kinase IKK alpha, but not IKK beta, was required for phosphorylation of TAX1BP1 and directly phosphorylated TAX1BP1 in response to stimulation with tumor necrosis factor (TNF) or interleukin 1 (IL-1). TAX1BP1 phosphorylation was pivotal for cytokine-dependent interactions among TAX1BP1, A20, Itch and RNF11 and downregulation of signaling by the transcription factor NF-kappa B. IKK alpha therefore serves a key role in the negative feedback of NF-kappa B canonical signaling by orchestrating assembly of the A20 ubiquitin-editing complex to limit inflammatory gene activation.	[Shembade, Noula; Pujari, Rajeshree; Harhaj, Nicole S.; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	University of Miami; Case Western Reserve University	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	eharhaj@med.miami.edu		Abbott, Derek/0000-0003-4387-8094	US National Institutes of Health [RO1GM083143, RO1CA135362]; NATIONAL CANCER INSTITUTE [R01CA135362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550, R01GM083143] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Sun (University of Texas MD Anderson) for hemagglutinin-tagged IKK alpha, IKK alpha(K44M), IKK beta and IKK gamma (NEMO), and I kappa B alpha amino acids 1-54 fused to GST; W. Greene (Gladstone Institute of Virology) for Jurkat Tax Tet-on cells; M. Maeda (Kyoto University) for TL-OM1 cells; M. Birnbaum (University of Pennsylvania) for MEFs doubly deficient in both Akt1 and Akt2; M. Karin (University of California San Diego) for Ikka<SUP>-/-</SUP>, Ikbkb<SUP>-/-</SUP> and Ikbkg<SUP>-/-</SUP> MEFs; E. Androphy (University of Massachusetts) for Flag-TAX1BP1 amino acids 1-789; and J. Leszyk for mass spectrometry and analysis. Supported by the US National Institutes of Health (RO1GM083143 and RO1CA135362 to E.W.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, National Institute of General Medical Sciences or the US National Institutes of Health.	Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Harhaj NS, 2007, VIROLOGY, V362, P99, DOI 10.1016/j.virol.2006.12.020; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miura H, 2005, EXP CELL RES, V308, P29, DOI 10.1016/j.yexcr.2005.04.005; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2010, CELL CYCLE, V9, P2481, DOI 10.4161/cc.9.13.12269; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang XY, 2009, J VIROL, V83, P2274, DOI 10.1128/JVI.01791-08; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	53	86	91	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					834	U51		10.1038/ni.2066	http://dx.doi.org/10.1038/ni.2066			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21765415	Green Accepted			2022-12-18	WOS:000294461200007
J	Johnson, AL; Aravind, L; Shulzhenko, N; Morgun, A; Choi, SY; Crockford, TL; Lambe, T; Domaschenz, H; Kucharska, EM; Zheng, LX; Vinuesa, CG; Lenardo, MJ; Goodnow, CC; Cornall, RJ; Schwartz, RH				Johnson, Andy L.; Aravind, L.; Shulzhenko, Natalia; Morgun, Andre; Choi, See-Young; Crockford, Tanya L.; Lambe, Teresa; Domaschenz, Heather; Kucharska, Edyta M.; Zheng, Lixin; Vinuesa, Carola G.; Lenardo, Michael J.; Goodnow, Christopher C.; Cornall, Richard J.; Schwartz, Ronald H.			Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; RECEPTOR TRANSGENIC MICE; NF-KAPPA-B; LINEAGE COMMITMENT; TARGET GENE; PROTEIN; AUTOIMMUNE; EXPRESSION; TOLERANCE; DELETION	T cell antigen receptor (TCR) signaling in CD4(+)CD8(+) double-positive thymocytes determines cell survival and lineage commitment, but the genetic and molecular basis of this process is poorly defined. To address this issue, we used ethylnitrosourea mutagenesis to identify a previously unknown T lineage-specific gene, Themis, which is critical for the completion of positive selection. Themis contains a tandem repeat of a unique globular domain (called 'CABIT' here) that includes a cysteine motif that defines a family of five uncharacterized vertebrate proteins with orthologs in most animal species. Themis-deficient thymocytes showed no substantial impairment in early TCR signaling but did show altered expression of genes involved in the cell cycle and survival before and during positive selection. Our data suggest a unique function for Themis in sustaining positive selection.	[Johnson, Andy L.; Crockford, Tanya L.; Lambe, Teresa; Cornall, Richard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Johnson, Andy L.; Shulzhenko, Natalia; Morgun, Andre; Choi, See-Young; Schwartz, Ronald H.] NIAID, Cellular & Mol Immunol Lab, Bethesda, MD 20892 USA; [Aravind, L.] NIH, Natl Lib Med, Bethesda, MD 20892 USA; [Domaschenz, Heather; Kucharska, Edyta M.; Vinuesa, Carola G.; Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Genet Lab, Australian Canc Res Fdn, Canberra, ACT 2601, Australia; [Domaschenz, Heather; Kucharska, Edyta M.; Vinuesa, Carola G.; Goodnow, Christopher C.] Australian Phen Facil, Canberra, ACT, Australia; [Zheng, Lixin; Lenardo, Michael J.] NIH, Immunol Lab, Bethesda, MD 20892 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA	Cornall, RJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	richard.cornall@ndm.ox.ac.uk; rschwartz@niaid.nih.gov	Lambe, Teresa/E-5733-2016; Goodnow, Christopher C/V-8108-2018; Vinuesa, Carola G/B-1108-2010	Lambe, Teresa/0000-0001-7711-897X; Goodnow, Christopher C/0000-0001-5296-6155; Vinuesa, Carola G/0000-0001-9799-0298; Aravind, L/0000-0003-0771-253X	Intramural NIH HHS [Z01 AI000485-21] Funding Source: Medline; Medical Research Council [G0700830] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0700830] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000994, ZIAAI000566, ZIAAI000769, Z01AI000485, ZIAAI000485] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asano A, 2007, MAMM GENOME, V18, P779, DOI 10.1007/s00335-007-9062-0; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Burack WR, 2002, CURR OPIN IMMUNOL, V14, P312, DOI 10.1016/S0952-7915(02)00347-3; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; FU G, 2009, NAT IMMUNOL     0713, DOI DOI 10.1038/NI1766; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kose H, 2007, GENOMICS, V89, P673, DOI 10.1016/j.ygeno.2007.03.001; Lee YS, 2004, PROG SAFETY SCI TECH, V4, P1109; LESOURNE R, 2009, NAT IMMUNOL     0713, DOI DOI 10.1038/NI1768; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; MITCHELL BS, 1980, ANN INTERN MED, V92, P826, DOI 10.7326/0003-4819-92-6-826; Nakamura M, 2003, CANCER RES, V63, P737; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaupp CJ, 2005, BIOTECHNIQUES, V38, P117, DOI 10.2144/05381MT01; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Silver KL, 2007, EUR J IMMUNOL, V37, P2734, DOI 10.1002/eji.200737293; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Treeck O, 2005, CYTOKINE, V32, P137, DOI 10.1016/j.cyto.2005.08.008; Treeck O, 2002, LEUKEMIA RES, V26, P765, DOI 10.1016/S0145-2126(02)00005-X; Tsukamoto H, 2008, EUR J IMMUNOL, V38, P518, DOI 10.1002/eji.200737430; Vinuesa CG, 2004, IMMUNITY, V20, P669, DOI 10.1016/j.immuni.2004.05.012; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Weerkamp F, 2006, LEUKEMIA, V20, P1197, DOI 10.1038/sj.leu.2404255; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yang Y, 1996, BIOCHEM BIOPH RES CO, V228, P807, DOI 10.1006/bbrc.1996.1736	49	86	91	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					831	U52		10.1038/ni.1769	http://dx.doi.org/10.1038/ni.1769			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19597497	Green Accepted			2022-12-18	WOS:000268141400011
J	Rub, A; Dey, R; Jadhav, M; Kamat, R; Chakkaramakkil, S; Majumdar, S; Mukhopadhyaya, R; Saha, B				Rub, Abdur; Dey, Ranadhir; Jadhav, Meenakshi; Kamat, Rohan; Chakkaramakkil, Santhosh; Majumdar, Subrata; Mukhopadhyaya, Robin; Saha, Bhaskar			Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function	NATURE IMMUNOLOGY			English	Article							INHIBITS CYTOKINE PRODUCTION; CELL-MEDIATED-IMMUNITY; PLASMA-MEMBRANE; INTERFERON-GAMMA; LIPID RAFTS; RECEPTOR; DOMAINS; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; STIMULATION	CD40, a costimulatory molecule expressed on macrophages, induces expression of interleukin 12 (IL-12) in uninfected macrophages and IL-10 in macrophages infected with Leishmania major. IL-12 suppresses, whereas IL-10 enhances, L. major infection. The mechanisms that regulate this difference in CD40-induced cytokine production remain unclear, but it is known that L. major depletes cholesterol. Here we show that cholesterol influenced the assembly of distinct CD40 signalosomes. Depletion of membrane cholesterol inhibited the assembly of an IL-12-inducing CD40 signalosome containing the adaptors TRAF2, TRAF3 and TRAF5 and the kinase Lyn and promoted the assembly of an IL-10-inducing CD40 signalosome containing the adaptor TRAF6 and the kinase Syk. Thus, cholesterol depletion might represent an immune-evasion strategy used by L. major.	[Rub, Abdur; Dey, Ranadhir; Jadhav, Meenakshi; Saha, Bhaskar] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Kamat, Rohan; Chakkaramakkil, Santhosh; Mukhopadhyaya, Robin] Adv Ctr Treatment Res & Educ Canc, Kharghar 410210, Navi Mumbai, India; [Majumdar, Subrata] Calcutta Improvement Trust Scheme, Bose Inst, Kolkata 7000054, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Department of Science & Technology (India); Bose Institute	Saha, B (corresponding author), Natl Ctr Cell Sci, Pune 411007, Maharashtra, India.	sahab@nccs.res.in	Rub, Abdur/H-6417-2019	RUB, ABDUR/0000-0003-1301-0761	Department of Biotechnology, New Delhi; Government of India; Centre Franco-Indien pour la Promotion de la Recherche Avancee, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Government of India; Centre Franco-Indien pour la Promotion de la Recherche Avancee, New Delhi; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Anti-CD40 was from G. Klaus (National Institute of Medical Research). Supported by the Department of Biotechnology, New Delhi; the Government of India; Centre Franco-Indien pour la Promotion de la Recherche Avancee, New Delhi; and the Council of Scientific and Industrial Research, New Delhi (A. R.).	Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; Chakraborty D, 2005, J IMMUNOL, V175, P3214, DOI 10.4049/jimmunol.175.5.3214; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Frank C, 2008, EXP NEUROL, V212, P407, DOI 10.1016/j.expneurol.2008.04.019; Gegg ME, 2005, J IMMUNOL, V174, P2327, DOI 10.4049/jimmunol.174.4.2327; Grammer A C, 2000, Adv Immunol, V76, P61; Groux H, 1999, J IMMUNOL, V162, P1723; Guigas G, 2008, BIOPHYS J, V95, pL25, DOI 10.1529/biophysj.108.136069; Gupta S, 2008, J IMMUNOL, V180, P79, DOI 10.4049/jimmunol.180.1.79; Hagenbaugh A, 1997, J EXP MED, V185, P2101, DOI 10.1084/jem.185.12.2101; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lal CS, 2007, CLIN CHIM ACTA, V382, P151, DOI 10.1016/j.cca.2007.04.007; LI L, 1994, J IMMUNOL, V153, P3967; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Mathur RK, 2004, NAT MED, V10, P755, DOI 10.1038/nm0704-755b; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; MOND JJ, 1986, J IMMUNOL, V137, P3534; MOSMANN TR, 1986, J IMMUNOL, V136, P2357; Murugaiyan G, 2007, J IMMUNOL, V178, P2047, DOI 10.4049/jimmunol.178.4.2047; Murugaiyan G, 2006, J IMMUNOL, V177, P6642, DOI 10.4049/jimmunol.177.10.6642; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; Nishitsuji H, 2004, MICROBES INFECT, V6, P76, DOI 10.1016/j.micinf.2003.10.009; Pandit SA, 2004, BIOPHYS J, V87, P3312, DOI 10.1529/biophysj.104.046078; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pucadyil TJ, 2007, BBA-BIOMEMBRANES, V1768, P655, DOI 10.1016/j.bbamem.2007.01.002; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Santhosh CV, 2008, BIOCHEM BIOPH RES CO, V371, P546, DOI 10.1016/j.bbrc.2008.04.106; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SEFTON BM, 1994, CURR OPIN IMMUNOL, V6, P372, DOI 10.1016/0952-7915(94)90115-5; Shrivastava S, 2007, BIOCHEM BIOPH RES CO, V356, P705, DOI 10.1016/j.bbrc.2007.03.032; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Waiczies S, 2005, J IMMUNOL, V174, P5630, DOI 10.4049/jimmunol.174.9.5630; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Yamada A, 2002, TRANSPLANTATION, V73, pS36, DOI 10.1097/00007890-200201151-00012	55	86	89	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					273	280		10.1038/ni.1705	http://dx.doi.org/10.1038/ni.1705			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19198591				2022-12-18	WOS:000263456500011
J	Douglas, NC; Jacobs, H; Bothwell, ALM; Hayday, AC				Douglas, NC; Jacobs, H; Bothwell, ALM; Hayday, AC			Defining the specific physiological requirements for c-Myc in T cell development	NATURE IMMUNOLOGY			English	Article							CHAIN GENE REARRANGEMENT; HEMATOPOIETIC STEM-CELLS; RECEPTOR-DEFICIENT MICE; N-MYC; BETA-CHAIN; ALPHA-BETA; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; EMBRYONIC LETHALITY; TARGETED DISRUPTION	c-Myc is associated with cell growth and cycling in many tissues and its deregulated expression is causally implicated in cancer, particularly lymphomagenesis. However, the contribution of c-Myc to lymphocyte development is unresolved. We show here that the formation of normal lymphocytes by c-Myc(-/-) cells is selectively defective. c-Myc(-/-) cells are inefficient, in an age-dependent manner, at populating the thymus, and subsequent thymocyte maturation is ineffective: they fail to grow and proliferate normally at the late double-negative (DN) CD4(-)CD8(-) stage. Because N-Myc expression in thymocytes usually declines at the late DN stage, these results confirm that the nonredundant contributions of Myc family members to development are related to their distinct patterns of developmental gene expression.	Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Immunobiol Sect, New Haven, CT 06520 USA; Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Yale University; Yale University; Yale University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, AC (corresponding author), Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA.			HAYDAY, ADRIAN/0000-0002-9495-5793; Douglas, Nataki/0000-0001-8443-8875	NIGMS NIH HHS [GM37759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BroussardDiehl C, 1996, J IMMUNOL, V156, P3141; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COLCUCCI FA, 2000, J IMMUNOL, V164, P5140; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; GARDINER E, 1991, SEMIN VIROL, V2, P341; Hartlen J, 1996, WASTE MANAGE, V16, P1, DOI 10.1016/S0956-053X(96)00024-4; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LEFRANCOIS L, 1991, IMMUNOL TODAY, V12, P436, DOI 10.1016/0167-5699(91)90015-L; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; Malynn BA, 2000, GENE DEV, V14, P1390; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; MOSLEY RL, 1992, J EXP MED, V176, P1365, DOI 10.1084/jem.176.5.1365; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Papaioannou V., 1993, Gene targeting: a practical approach., P107; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pearson R, 2000, EMBO J, V19, P6112, DOI 10.1093/emboj/19.22.6112; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SCHEUERMANN RH, 1993, METHOD ENZYMOL, V218, P446; SECKINGER P, 1994, EUR J IMMUNOL, V24, P716, DOI 10.1002/eji.1830240334; SHORES EW, 1990, EUR J IMMUNOL, V20, P69, DOI 10.1002/eji.1830200111; SMITH RK, 1992, MOL CELL BIOL, V12, P1578, DOI 10.1128/MCB.12.4.1578; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 1998, IMMUNOL REV, V165, P111; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	56	86	92	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					307	315		10.1038/86308	http://dx.doi.org/10.1038/86308			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276201				2022-12-18	WOS:000167982900011
J	Huang, YT; Happonen, KE; Burrola, PG; O'Connor, C; Hah, N; Huang, L; Nimmerjahn, A; Lemke, G				Huang, Youtong; Happonen, Kaisa E.; Burrola, Patrick G.; O'Connor, Carolyn; Hah, Nasun; Huang, Ling; Nimmerjahn, Axel; Lemke, Greg			Microglia use TAM receptors to detect and engulf amyloid beta plaques	NATURE IMMUNOLOGY			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; A-BETA; TREM2 DEFICIENCY; TRANSGENIC MICE; BRAIN; PATHOLOGY; CELLS; PHAGOCYTOSIS; CLEARANCE	How microglia sense amyloid plaques in Alzheimer's disease has remained mysterious. Lemke and colleagues report that TAM receptor kinases are absolutely required for normal microglial recognition of, response to and phagocytosis of A beta plaques. Surprisingly, TAM-mediated microglial phagocytosis of A beta material does not constrain, but rather promotes, the formation of dense-core plaques. Two microglial TAM receptor tyrosine kinases, Axl and Mer, have been linked to Alzheimer's disease, but their roles in disease have not been tested experimentally. We find that in Alzheimer's disease and its mouse models, induced expression of Axl and Mer in amyloid plaque-associated microglia was coupled to induced plaque decoration by the TAM ligand Gas6 and its co-ligand phosphatidylserine. In the APP/PS1 mouse model of Alzheimer's disease, genetic ablation of Axl and Mer resulted in microglia that were unable to normally detect, respond to, organize or phagocytose amyloid-beta plaques. These major deficits notwithstanding, TAM-deficient APP/PS1 mice developed fewer dense-core plaques than APP/PS1 mice with normal microglia. Our findings reveal that the TAM system is an essential mediator of microglial recognition and engulfment of amyloid plaques and that TAM-driven microglial phagocytosis does not inhibit, but rather promotes, dense-core plaque development.	[Huang, Youtong; Happonen, Kaisa E.; Burrola, Patrick G.; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Huang, Youtong] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA; [O'Connor, Carolyn] Salk Inst Biol Studies, Flow Cytometry Core, La Jolla, CA 92037 USA; [Hah, Nasun] Salk Inst Biol Studies, Chapman Fdn Genom Sequencing Core, La Jolla, CA 92037 USA; [Huang, Ling] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Nimmerjahn, Axel] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; Salk Institute; Salk Institute; Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	lemke@salk.edu		Happonen, Kaisa/0000-0002-8346-6302	US National Institutes of Health [RF1 AG060748, R01 AI101400, DP2 NS083038, R01 NS108034, U01 NS103522, P30 AG062429, P30 CA014195, S10-OD023689]; Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Leona M. and Harry B. Helmsley Charitable Trust; Goeddel's Chancellor's graduate fellowship; Marguerite Vogt graduate fellowship; H. A. and Mary K. Chapman Charitable Trust graduate fellowship; Anderson postdoctoral fellowship; Nomis postdoctoral fellowship; Sweden-America Foundation postdoctoral fellowship	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Leona M. and Harry B. Helmsley Charitable Trust; Goeddel's Chancellor's graduate fellowship; Marguerite Vogt graduate fellowship; H. A. and Mary K. Chapman Charitable Trust graduate fellowship; Anderson postdoctoral fellowship; Nomis postdoctoral fellowship; Sweden-America Foundation postdoctoral fellowship	We thank J. Hash for technical assistance, M. Mercken (Janssen Pharmaceuticals) for A ss 42 antibodies, R. Rissman and the ADRC at UCSD for AD brain sections, M. Shokhirev for advice on bioinformatic analyses, S. Parylak and F. Gage for advice on fear-conditioning assays and members of the Lemke laboratory and the Nomis Center for discussions. The research was supported by grants from the US National Institutes of Health (RF1 AG060748 and R01 AI101400 to G.L.; DP2 NS083038, R01 NS108034 and U01 NS103522 to A.N.; P30 AG062429 to the UCSD ADRC; and P30 CA014195 and S10-OD023689 to the Salk Institute), the Cure Alzheimer's Fund and the Coins for Alzheimer's Research Trust (to G.L.) and the Leona M. and Harry B. Helmsley Charitable Trust (to the Salk Institute); by Goeddel's Chancellor's, Marguerite Vogt and H. A. and Mary K. Chapman Charitable Trust graduate fellowships (to Y.H.) and by Anderson, Nomis and Sweden-America Foundation postdoctoral fellowships (to K.E.H.).	Baik SH, 2016, GLIA, V64, P2274, DOI 10.1002/glia.23074; Bais AS, 2020, BIOINFORMATICS, V36, P1150, DOI 10.1093/bioinformatics/btz698; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Benoist C, 2016, NAT IMMUNOL, V17, P741, DOI 10.1038/ni.3478; Bernier LP, 2019, CELL REP, V27, P2895, DOI 10.1016/j.celrep.2019.05.010; Blanco-Suarez E, 2018, NEURON, V100, P1116, DOI 10.1016/j.neuron.2018.09.043; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Gonzalez H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0201-8; Greenberg SM, 2020, NAT REV NEUROL, V16, P30, DOI 10.1038/s41582-019-0281-2; Hassiotis S, 2018, EUR J NEUROSCI, V47, P1043, DOI 10.1111/ejn.13913; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Imbimbo BP, 2009, BRIT J PHARMACOL, V156, P982, DOI 10.1111/j.1476-5381.2008.00097.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim DK, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0326-z; Kim YE, 2010, NAT PROTOC, V5, P1396, DOI 10.1038/nprot.2010.101; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Labzin LI, 2018, ANNU REV MED, V69, P437, DOI 10.1146/annurev-med-050715-104343; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2019, NAT REV IMMUNOL, V19, P539, DOI 10.1038/s41577-019-0167-y; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nimmerjahn A, 2012, COLD SPRING HARB PRO, DOI 10/1101/pdb.prot068155; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Sainaghi PP, 2017, J ALZHEIMERS DIS, V55, P59, DOI 10.3233/JAD-160599; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schmidt SD, 2012, METHODS MOL BIOL, V849, P507, DOI 10.1007/978-1-61779-551-0_34; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Spangenberg E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11674-z; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tufail Y, 2017, NEURON, V93, P574, DOI 10.1016/j.neuron.2016.12.021; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986	60	85	86	19	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					586	+		10.1038/s41590-021-00913-5	http://dx.doi.org/10.1038/s41590-021-00913-5		APR 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33859405	Green Accepted			2022-12-18	WOS:000640493700003
J	Rubelt, F; Busse, CE; Bukhari, SAC; Burckert, JP; Mariotti-Ferrandiz, E; Cowell, LG; Watson, CT; Marthandan, N; Faison, WJ; Hershberg, U; Laserson, U; Corrie, BD; Davis, MM; Peters, B; Lefranc, MP; Scott, JK; Breden, F; Prak, ETL; Kleinstein, SH				Rubelt, Florian; Busse, Christian E.; Bukhari, Syed Ahmad Chan; Buerckert, Jean-Philippe; Mariotti-Ferrandiz, Encarnita; Cowell, Lindsay G.; Watson, Corey T.; Marthandan, Nishanth; Faison, William J.; Hershberg, Uri; Laserson, Uri; Corrie, Brian D.; Davis, Mark M.; Peters, Bjoern; Lefranc, Marie-Paule; Scott, Jamie K.; Breden, Felix; Prak, Eline T. Luning; Kleinstein, Steven H.		AIRR Community	Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data	NATURE IMMUNOLOGY			English	Article							MICROARRAY EXPERIMENT MIAME; MINIMUM INFORMATION; REVEALS	High-throughput sequencing of B and T cell receptors is routinely being applied in studies of adaptive immunity. The Adaptive Immune Receptor Repertoire (AIRR) Community was formed in 2015 to address issues in AIRR sequencing studies, including the development of reporting standards for the sharing of data sets.	[Rubelt, Florian; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Rubelt, Florian; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Busse, Christian E.] German Canc Res Ctr, Heidelberg, Germany; [Bukhari, Syed Ahmad Chan] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Buerckert, Jean-Philippe] Luxembourg Inst Hlth, Dept Infect & Immun, Luxembourg, Luxembourg; [Mariotti-Ferrandiz, Encarnita] UPMC, Univ Paris 06, UMR S 959 Immunol Immunopathol Immunotherapy I3, Sorbonne Univ,INSERM, Paris, France; [Cowell, Lindsay G.] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA; [Watson, Corey T.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Marthandan, Nishanth; Scott, Jamie K.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Faison, William J.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Hershberg, Uri] Drexel Univ, Coll Med, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Hershberg, Uri] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Laserson, Uri] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Corrie, Brian D.; Scott, Jamie K.; Breden, Felix] Simon Fraser Univ, iReceptor, Burnaby, BC, Canada; [Corrie, Brian D.; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Lefranc, Marie-Paule] Univ Montpellier, Inst Genet Humaine IGH, Int ImMunogenet Informat Syst, IMGT,LIGM,CNRS, Montpellier, France; [Scott, Jamie K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Prak, Eline T. Luning] Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Prak, Eline T. Luning] Univ Penn, Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kleinstein, Steven H.] Yale Univ, Dept Immunobiol, Yale Sch Med, New Haven, CT USA; [Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT USA	Stanford University; Stanford University; Helmholtz Association; German Cancer Research Center (DKFZ); Yale University; Luxembourg Institute of Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Louisville; Simon Fraser University; Duke University; Drexel University; Drexel University; Icahn School of Medicine at Mount Sinai; Simon Fraser University; Simon Fraser University; Howard Hughes Medical Institute; Stanford University; La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; Universite de Montpellier; Simon Fraser University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University; Yale University	Prak, ETL (corresponding author), Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Prak, ETL (corresponding author), Univ Penn, Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	luning@pennmedicine.upenn.edu; steven.kleinstein@yale.edu	Bukhari, Syed Abdul Rehman/ABI-5806-2020; Hershberg, Uri/AAQ-6255-2020; Bukhari, Syed Ahmad Chan/F-4327-2012; Mariotti-Ferrandiz, Encarnita/O-3262-2019; Rosenfeld, Aaron/ABB-9927-2020	Bukhari, Syed Abdul Rehman/0000-0002-6861-2623; Hershberg, Uri/0000-0002-6425-5980; Bukhari, Syed Ahmad Chan/0000-0002-6517-5261; Mariotti-Ferrandiz, Encarnita/0000-0002-8770-0186; Watson, Corey/0000-0001-7248-8787; Davis, Mark/0000-0001-6868-657X; Corrie, Brian/0000-0003-3888-6495; Coffey, David G./0000-0003-3544-8836; Busse, Christian/0000-0001-7553-905X; Burckert, Jean-Philippe/0000-0001-7741-1164; /0000-0001-7593-5511	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022511, R01AI104739, U19AI057229, R01AI097403] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI057229, R01 AI097403, R01 AI104739, R37 AI022511] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Breden F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01418; Burel JG, 2016, TRENDS IMMUNOL, V37, P53, DOI 10.1016/j.it.2015.11.006; Contreras JL, 2015, TRENDS GENET, V31, P55, DOI 10.1016/j.tig.2014.12.006; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; European Commission, 2016, H2020 PROGR GUID FAI; Friedensohn S, 2017, TRENDS BIOTECHNOL, V35, P203, DOI 10.1016/j.tibtech.2016.09.010; Gadala-Maria D, 2015, P NATL ACAD SCI USA, V112, pE862, DOI 10.1073/pnas.1417683112; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Greiff V, 2015, TRENDS IMMUNOL, V36, P738, DOI 10.1016/j.it.2015.09.006; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hou DN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00336; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Liu XS, 2017, CELL, V168, P600, DOI 10.1016/j.cell.2017.01.014; Nakamura Y, 2013, NUCLEIC ACIDS RES, V41, pD21, DOI 10.1093/nar/gks1084; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Toby IT, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1214-3; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wardemann H, 2017, TRENDS IMMUNOL, V38, P471, DOI 10.1016/j.it.2017.05.003; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yaari G, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0243-2	24	85	87	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1274	1278		10.1038/ni.3873	http://dx.doi.org/10.1038/ni.3873			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144493	Green Accepted			2022-12-18	WOS:000415324900002
J	Ulas, T; Pirr, S; Fehlhaber, B; Bickes, MS; Loof, TG; Vogl, T; Mellinger, L; Heinemann, AS; Burgmann, J; Schoning, J; Schreek, S; Pfeifer, S; Reuner, F; Vollger, L; Stanulla, M; von Kockritz-Blickwede, M; Glander, S; Barczyk-Kahlert, K; von Kaisenberg, CS; Friesenhagen, J; Fischer-Riepe, L; Zenker, S; Schultze, JL; Roth, J; Viemann, D				Ulas, Thomas; Pirr, Sabine; Fehlhaber, Beate; Bickes, Marie S.; Loof, Torsten G.; Vogl, Thomas; Mellinger, Lara; Heinemann, Anna S.; Burgmann, Johanna; Schoening, Jennifer; Schreek, Sabine; Pfeifer, Sandra; Reuner, Friederike; Voellger, Lena; Stanulla, Martin; von Koeckritz-Blickwede, Maren; Glander, Shirin; Barczyk-Kahlert, Katarzyna; von Kaisenberg, Constantin S.; Friesenhagen, Judith; Fischer-Riepe, Lena; Zenker, Stefanie; Schultze, Joachim L.; Roth, Johannes; Viemann, Dorothee			S100-alarmin-induced innate immune programming protects newborn infants from sepsis	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; BACTERIAL-GROWTH; GENE-EXPRESSION; HOST-DEFENSE; MRP14; TRIF; INFLAMMATION; ACTIVATION; RECEPTORS; RESPONSES	The high risk of neonatal death from sepsis is thought to result from impaired responses by innate immune cells; however, the clinical observation of hyperinflammatory courses of neonatal sepsis contradicts this concept. Using transcriptomic, epigenetic and immunological approaches, we demonstrated that high amounts of the perinatal alarmins S100A8 and S100A9 specifically altered MyD88-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed. Steady-state expression of TRIF-dependent genes increased only gradually during the first year of life in human neonates, shifting immune regulation toward the adult phenotype. Disruption of this critical sequence of transient alarmin programming and subsequent reprogramming of regulatory pathways increased the risk of hyperinflammation and sepsis. Collectively these data suggest that neonates are characterized by a selective, transient microbial unresponsiveness that prevents harmful hyperinflammation in the delicate neonate while allowing for sufficient immunological protection.	[Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Pirr, Sabine; Fehlhaber, Beate; Bickes, Marie S.; Mellinger, Lara; Heinemann, Anna S.; Burgmann, Johanna; Schoening, Jennifer; Schreek, Sabine; Voellger, Lena; Friesenhagen, Judith; Viemann, Dorothee] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany; [Loof, Torsten G.; Pfeifer, Sandra; Reuner, Friederike; von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [Loof, Torsten G.; Pfeifer, Sandra; Reuner, Friederike; von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Vogl, Thomas; Barczyk-Kahlert, Katarzyna; Fischer-Riepe, Lena; Zenker, Stefanie; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany; [Glander, Shirin] Univ Munster, Inst Human Genet, Dept Genet Epidemiol, Munster, Germany; [von Kaisenberg, Constantin S.] Hannover Med Sch, Dept Gynaecol & Prenatal Med, Hannover, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigenom, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Bonn, Germany	University of Bonn; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Munster; Hannover Medical School; University of Munster; Hannover Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Viemann, D (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany.	viemann.dorothee@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021; Stanulla, Martin/N-4674-2017; Schultze, Joachim L./ABA-8176-2020	Stanulla, Martin/0000-0002-3834-0727; Schultze, Joachim L./0000-0003-2812-9853; Viemann, Dorothee/0000-0002-9009-3559	Interdisciplinary Center of Clinical Research at the University of Muenster [Vo2/004/14, Ro2/003/15]; Cluster of Excellence Cells in Motion; collaborative research center 1009 of the German Research Foundation; collaborative research center TRR34 of the German Research Foundation; Appenrodt Foundation; German Research Foundation [VI 538/6-1, SFB 832, SFB 704, INST 217/577-1]; Volkswagen Foundation	Interdisciplinary Center of Clinical Research at the University of Muenster; Cluster of Excellence Cells in Motion; collaborative research center 1009 of the German Research Foundation; collaborative research center TRR34 of the German Research Foundation; Appenrodt Foundation; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	We thank U. Nordhues and A. Weitz for excellent technical support. We thank W. Kolanus, S. Burgdorf, M. Beyer and A. Schlitzer for critical reading of the manuscript. ER-Hoxb8 was kindly provided by the laboratory of G. Haecker (University Hospital of Freiburg, Freiburg, Germany). This work was supported by the Interdisciplinary Center of Clinical Research at the University of Muenster (grants Vo2/004/14 and Ro2/003/15 to T.V. and J.R.), the Cluster of Excellence Cells in Motion (T.V., J.R. and K.B.-K.), the collaborative research centers 1009 and TRR34 of the German Research Foundation (grants B8 and B9 and grant C13, respectively, to T.V., J.R. and K.B.-K.), the Appenrodt Foundation (D.V.), the German Research Foundation (grant VI 538/6-1 to D.V.), the Volkswagen Foundation (D.V.) and the German Research Foundation (grants SFB 832, SFB 704 and INST 217/577-1 to J.L.S.). J.L.S. is a member of the Cluster of Excellence ImmunoSensation and an associated member of the German epigenome program DEEP.	Achouiti A, 2014, THORAX, V69, P1034, DOI 10.1136/thoraxjnl-2014-205668; Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cho H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005026; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cuenca AG, 2015, J IMMUNOL, V194, P1169, DOI 10.4049/jimmunol.1302676; Cuenca AG, 2011, INFECT IMMUN, V79, P2746, DOI 10.1128/IAI.01291-10; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Hansen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032394; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Kanagavelu S, 2015, INFECT IMMUN, V83, P4404, DOI 10.1128/IAI.00674-15; Kolb JP, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005442; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lissner MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132061; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Oesper L, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-7; Qin H, 2014, NAT MED, V20, P676, DOI 10.1038/nm.3560; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Singh VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062845; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanimura N, 2014, INT IMMUNOL, V26, P307, DOI 10.1093/intimm/dxt071; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2011, J IMMUNOL, V186, P164, DOI 10.4049/jimmunol.0904170; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Weighardt H, 2006, J IMMUNOL, V177, P5623, DOI 10.4049/jimmunol.177.8.5623; Weiss M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/245804; Wynn JL, 2015, MOL MED, V21, P496, DOI 10.2119/molmed.2015.00064; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	50	85	91	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					622	+		10.1038/ni.3745	http://dx.doi.org/10.1038/ni.3745			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28459433				2022-12-18	WOS:000401520900007
J	Cader, MZ; Boroviak, K; Zhang, Q; Assadi, G; Kempster, SL; Sewell, GW; Saveljeva, S; Ashcroft, JW; Clare, S; Mukhopadhyay, S; Brown, KP; Tschurtschenthaler, M; Raine, T; Doe, B; Chilvers, ER; Griffin, JL; Kaneider, NC; Floto, RA; D'Amato, M; Bradley, A; Wakelam, MJO; Dougan, G; Kaser, A				Cader, M. Zaeem; Boroviak, Katharina; Zhang, Qifeng; Assadi, Ghazaleh; Kempster, Sarah L.; Sewell, Gavin W.; Saveljeva, Svetlana; Ashcroft, Jonathan W.; Clare, Simon; Mukhopadhyay, Subhankar; Brown, Karen P.; Tschurtschenthaler, Markus; Raine, Tim; Doe, Brendan; Chilvers, Edwin R.; Griffin, Jules L.; Kaneider, Nicole C.; Floto, R. Andres; D'Amato, Mauro; Bradley, Allan; Wakelam, Michael J. O.; Dougan, Gordon; Kaser, Arthur			C13orf31 (FAMIN) is a central regulator of immunometabolic function	NATURE IMMUNOLOGY			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; FATTY-ACID SYNTHASE; BACTERICIDAL ACTIVITY; MITOCHONDRIAL ROS; T-CELLS; METABOLISM; EXPRESSION; OXIDATION; POLARIZATION; PATHOGENESIS	Single-nucleotide variations in C13orf31 (LACC1) that encode p.C284R and p.I254V in a protein of unknown function (called 'FAMIN' here) are associated with increased risk for systemic juvenile idiopathic arthritis, leprosy and Crohn's disease. Here we set out to identify the biological mechanism affected by these coding variations. FAMIN formed a complex with fatty acid synthase (FASN) on peroxisomes and promoted flux through de novo lipogenesis to concomitantly drive high levels of fatty-acid oxidation (FAO) and glycolysis and, consequently, ATP regeneration. FAMIN-dependent FAO controlled inflammasome activation, mitochondrial and NADPH-oxidase-dependent production of reactive oxygen species (ROS), and the bactericidal activity of macrophages. As p.I254V and p.C284R resulted in diminished function and loss of function, respectively, FAMIN determined resilience to endotoxin shock. Thus, we have identified a central regulator of the metabolic function and bioenergetic state of macrophages that is under evolutionary selection and determines the risk of inflammatory and infectious disease.	[Cader, M. Zaeem; Kempster, Sarah L.; Sewell, Gavin W.; Saveljeva, Svetlana; Ashcroft, Jonathan W.; Tschurtschenthaler, Markus; Raine, Tim; Kaneider, Nicole C.; Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Div Gastroenterol & Hepatol, Dept Med, Cambridge, England; [Boroviak, Katharina; Clare, Simon; Mukhopadhyay, Subhankar; Doe, Brendan; Bradley, Allan; Dougan, Gordon] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England; [Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge, England; [Assadi, Ghazaleh; D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Brown, Karen P.; Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Cambridge Ctr Lung Infect, Cambridge, England; [Chilvers, Edwin R.; Floto, R. Andres] Univ Cambridge, Addenbrookes Hosp, Div Resp Med, Dept Med, Cambridge, England; [Chilvers, Edwin R.; Floto, R. Andres] Univ Cambridge, Papworth Hosp, Div Resp Med, Dept Med, Cambridge, England; [Griffin, Jules L.] Univ Cambridge, Dept Biochem, Cambridge, England; [D'Amato, Mauro] Basque Fdn Sci, BioDonostia Hlth Res Inst San Sebastian, Bilbao, Spain; [D'Amato, Mauro] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Karolinska Institutet; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Cambridge; Basque Foundation for Science; Basque Foundation for Science	Kaser, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Gastroenterol & Hepatol, Dept Med, Cambridge, England.	ak729@cam.ac.uk	D'Amato, Mauro/F-2450-2010; Tschurtschenthaler, Markus/O-8931-2019; D'Amato, Mauro/B-5050-2019	D'Amato, Mauro/0000-0003-2743-5197; Tschurtschenthaler, Markus/0000-0002-0060-4790; D'Amato, Mauro/0000-0003-2743-5197; Bradley, Allan/0000-0002-2349-8839; Sewell, Gavin/0000-0002-3002-9248; Chilvers, Edwin/0000-0002-4230-9677; Cader, Mohammed Zaeem/0000-0002-4121-748X; Saveljeva, Svetlana/0000-0002-0644-9752; kempster, sarah/0000-0002-4309-1489; Wakelam, Michael/0000-0003-4059-9276; Mukhopadhyay, Subhankar/0000-0002-7110-6473; Raine, Tim/0000-0002-5855-9873; Ashcroft, Jonathan/0000-0002-6224-4233	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC Grant [260961]; Wellcome Trust [106260/Z/14/Z]; Wellcome Trust Sanger Institute; US National Institutes of Health [5U420D011174, 5U54HG006348]; Biotechnology and Biological Sciences Research Council; National Institute for Health Research Cambridge Biomedical Research Centre; European Crohn's and Colitis Organisation; Swedish Medical Research Council; Olle Engkvist foundation; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/000C0411, BBS/E/B/000C0413, BBS/E/B/000C0417] Funding Source: researchfish; Medical Research Council [MR/P011705/1, MC_UP_A090_1006] Funding Source: researchfish; BBSRC [BBS/E/B/000C0411, BBS/E/B/000C0413, BBS/E/B/000C0415, BBS/E/B/000C0417] Funding Source: UKRI; MRC [MC_UP_A090_1006, MR/P011705/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011174] Funding Source: NIH RePORTER	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Sanger Institute(Wellcome Trust); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Crohn's and Colitis Organisation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Olle Engkvist foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Brown for help with laccase assays; J. Murkin and M. Deery for proteomics; L. Porter for metabolic-flux assays; J. Skepper for electron microscopy; I. Purvis for help with in vivo procedures; R. Rodrigues, M. Md-Ibrahim and J. Jones for cellular assays; S. Dhillon for the generation of constructs; T. Lawley, M. Pardo, J. Choudhary, K. Smith, J. Lee, D. Thomas, G. Schneditz, L. Haag, M. Parkes and R. Blumberg for discussions; all National Institute for Health Research Cambridge BioResource volunteers for the participation; the Cambridge BioResource staff for help with volunteer recruitment; members of the Cambridge BioResource SAB and Management Committee for support of this study; and the National Institute for Health Research Cambridge BRC Cell Phenotyping Hub for expertise and help. Access to Cambridge BioResource volunteers and their data and samples is governed by the Cambridge BioResource SAB (documents on access arrangements and contact details, http://www.cambridgebioresource.org.uk/). Supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement 260961 (A.K.), the Wellcome Trust (investigator award 106260/Z/14/Z to A.K.; a PhD fellowship for clinicians to M.Z.C.; and a Career Re-Entry Fellowship to N.C.K.), the Wellcome Trust Sanger Institute (G.D., A.B., S.M., S.C. and K.B.), the US National Institutes of Health (5U420D011174 and 5U54HG006348 to A.B. and K.B.), the Biotechnology and Biological Sciences Research Council (M.J.O.W.), the National Institute for Health Research Cambridge Biomedical Research Centre, the European Crohn's and Colitis Organisation (M.T.) and the Swedish Medical Research Council and the Olle Engkvist foundation (M.D'A.).	Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hillebrand M, 2012, J BIOL CHEM, V287, P210, DOI 10.1074/jbc.M111.272732; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jensen-Urstad APL, 2013, J LIPID RES, V54, P1848, DOI 10.1194/jlr.M036103; Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Kim Y, 2006, PROTEINS, V63, P1097, DOI 10.1002/prot.20589; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu H, 2015, NAT GENET, V47, P267, DOI 10.1038/ng.3212; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Mulders-Manders CM, 2015, SEMIN IMMUNOPATHOL, V37, P371, DOI 10.1007/s00281-015-0492-6; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; NEWSHOLME EA, 1977, BIOCHEM J, V166, P123, DOI 10.1042/bj1660123; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Patel N, 2014, GUT, V63, P1831, DOI 10.1136/gutjnl-2014-307859; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	47	85	87	4	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1046	1056		10.1038/ni.3532	http://dx.doi.org/10.1038/ni.3532			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27478939	Green Accepted, Green Submitted			2022-12-18	WOS:000381832000008
J	Ulges, A; Klein, M; Reuter, S; Gerlitzki, B; Hoffmann, M; Grebe, N; Staudt, V; Stergiou, N; Bohn, T; Bruhl, TJ; Muth, S; Yurugi, H; Rajalingam, K; Bellinghausen, I; Tuettenberg, A; Hahn, S; Reissig, S; Haben, I; Zipp, F; Waisman, A; Probst, HC; Beilhack, A; Buchou, T; Filhol-Cochet, O; Boldyreff, B; Breloer, M; Jonuleit, H; Schild, H; Schmitt, E; Bopp, T				Ulges, Alexander; Klein, Matthias; Reuter, Sebastian; Gerlitzki, Bastian; Hoffmann, Markus; Grebe, Nadine; Staudt, Valerie; Stergiou, Natascha; Bohn, Toszka; Bruehl, Till-Julius; Muth, Sabine; Yurugi, Hajime; Rajalingam, Krishnaraj; Bellinghausen, Iris; Tuettenberg, Andrea; Hahn, Susanne; Reissig, Sonja; Haben, Irma; Zipp, Frauke; Waisman, Ari; Probst, Hans-Christian; Beilhack, Andreas; Buchou, Thierry; Filhol-Cochet, Odile; Boldyreff, Brigitte; Breloer, Minka; Jonuleit, Helmut; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias			Protein kinase CK2 enables regulatory T cells to suppress excessive T(H)2 responses in vivo	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IRF4; DENDRITIC CELLS; EXPRESSION; WNT; TOLERANCE; DISRUPTION; INHIBITORS; INDUCTION; PROMOTE; SHP-1	The quality of the adaptive immune response depends on the differentiation of distinct CD4(+) helper T cell subsets, and the magnitude of an immune response is controlled by CD4(+)Foxp3(+) regulatory T cells (T-reg cells). However, how a tissue- and cell type-specific suppressor program of T-reg cells is mechanistically orchestrated has remained largely unexplored. Through the use of T-reg cell-specific gene targeting, we found that the suppression of allergic immune responses in the lungs mediated by T helper type 2 (T(H)2) cells was dependent on the activity of the protein kinase CK2. Genetic ablation of the beta-subunit of CK2 specifically in Treg cells resulted in the proliferation of a hitherto-unexplored ILT3(+) T-reg cell subpopulation that was unable to control the maturation of IRF4(+)PD-L2(+) dendritic cells required for the development of T(H)2 responses in vivo.	[Ulges, Alexander; Klein, Matthias; Gerlitzki, Bastian; Hoffmann, Markus; Grebe, Nadine; Staudt, Valerie; Stergiou, Natascha; Bohn, Toszka; Bruehl, Till-Julius; Muth, Sabine; Yurugi, Hajime; Rajalingam, Krishnaraj; Probst, Hans-Christian; Schmitt, Edgar; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Inst Immunol, Univ Med Ctr, Mainz, Germany; [Reuter, Sebastian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin 3, Dept Pulm Med, D-55122 Mainz, Germany; [Bellinghausen, Iris; Tuettenberg, Andrea; Hahn, Susanne; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany; [Reissig, Sonja; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Haben, Irma; Breloer, Minka] Bernhard Nocht Inst Trop Med, Dept Virol & Immunol, D-20359 Hamburg, Germany; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, D-55122 Mainz, Germany; [Beilhack, Andreas] Univ Wurzburg, Zentrum Expt Mol Med, Expt Stammzelltransplantat Med Klin & Poliklin 2, D-97070 Wurzburg, Germany; [Buchou, Thierry] Univ Grenoble 1, Fac Med, Inst Albert Boniot, INSERM,U823, La Tronche, France; [Filhol-Cochet, Odile] Commissariat Energie Atom & Enerigies Alternat, Inst Rech Technol & Sci Vivant Biol Canc & Infect, INSERM, U1036, Grenoble, France; [Boldyreff, Brigitte] KinaseDetect, Aarslev, Denmark	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Bernhard Nocht Institut fur Tropenmedizin; Johannes Gutenberg University of Mainz; University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bopp, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Immunol, Univ Med Ctr, Obere Zahlbacher Str 67, Mainz, Germany.	boppt@uni-mainz.de	Breloer, Minka/F-3999-2018; BUCHOU, Thierry/F-3136-2019; Baumgart, Nadine/AAO-9686-2020; Zipp, Frauke/C-9968-2015; Waisman, Ari/C-7383-2015; Jonuleit, Helmut/D-8059-2011; Filhol-Cochet, Odile/I-3962-2016; Bopp, Tobias/A-4328-2018	Breloer, Minka/0000-0001-6199-4908; BUCHOU, Thierry/0000-0002-9206-2377; Zipp, Frauke/0000-0002-1231-1928; Waisman, Ari/0000-0003-4304-8234; Jonuleit, Helmut/0000-0002-5672-9365; Bopp, Tobias/0000-0002-3232-8065; PROBST, Hans Christian/0000-0002-7926-0651; Reuter, Sebastian/0000-0002-1784-0124; Filhol, Odile/0000-0003-1964-7958; Baumgart, Nadine/0000-0002-6684-0198	Deutsche Forschungsgemeinschaft [DFG BO 3306/1-1, SCHM 1014/7-1, SCHM 1014/5-1, SFB TR128, SFB 1066, BR 3754/2-1]; International Graduate School of Immunotherapy [GRK 1043]; Forschungszentrum Immunologie of the University Medical Center of the Johannes Gutenberg-University Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Immunotherapy; Forschungszentrum Immunologie of the University Medical Center of the Johannes Gutenberg-University Mainz	We thank S. Sakaguchi (Osaka University) for BALB/c Foxp3-IRES-Cre mice; B. Boldyreff (University of Southern Denmark) for Csnk2b<SUP>fl</SUP> mice on the C57BL/6 background; T. Sparwasser (TWINCORE) for C57BL/6 DEREG mice; K.A. Hogquist (University of Minnesota) for Nur77<SUP>GFP</SUP> mice; M. Lohoff (Philipps University Marburg) for C57BL/6 Irf4<SUP>-/-</SUP> mice; H.C. Probst (University Medical Center Mainz) for Ly5.1<SUP>+</SUP> C57BL/6 mice; A. Waisman (University Medical Center Mainz) for CD90.1<SUP>+</SUP> C57BL/6 mice; A. Nikolaev and S. Fischer for technical help, and D. O'Neill for critical reading of the manuscript. Supported by Deutsche Forschungsgemeinschaft (DFG BO 3306/1-1, SCHM 1014/7-1, SCHM 1014/5-1, SFB TR128 projects B4 (T.Bop. and F.Z.), A7 (A.W.) and A9 (H.J.), SFB 1066 projects B1 (E.S.) and B8 (T.Bop.), and BR 3754/2-1 (I.H. and M.B.)), International Graduate School of Immunotherapy (GRK 1043 project C4 (E.S. and T.Bop.)) and Forschungszentrum Immunologie of the University Medical Center of the Johannes Gutenberg-University Mainz (E.S. and T.Bop.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Bottema RWB, 2010, EUR RESPIR J, V35, P54, DOI 10.1183/09031936.00018909; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Cozza G, 2012, EXPERT OPIN THER PAT, V22, P1081, DOI 10.1517/13543776.2012.717615; Dehzad N, 2011, J IMMUNOL, V186, P2238, DOI 10.4049/jimmunol.1002027; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2011, ADV IMMUNOL, V112, P1, DOI 10.1016/B978-0-12-387827-4.00001-2; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Larriba Maria Jesus, 2013, Cancers (Basel), V5, P1242, DOI 10.3390/cancers5041242; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Lu-Kuo JM, 1999, J BIOL CHEM, V274, P5791, DOI 10.1074/jbc.274.9.5791; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; Ponce DP, 2011, MOL CELL BIOCHEM, V356, P127, DOI 10.1007/s11010-011-0965-4; Ponce DP, 2011, J CELL PHYSIOL, V226, P1953, DOI 10.1002/jcp.22527; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rochat MK, 2010, CLIN EXP ALLERGY, V40, P786, DOI 10.1111/j.1365-2222.2009.03428.x; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; Song DH, 2003, J BIOL CHEM, V278, P24018, DOI 10.1074/jbc.M212260200; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Tuettenberg A, 2006, INT J CANCER, V118, P2617, DOI 10.1002/ijc.21679; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xystrakis E, 2007, CURR OPIN ALLERGY CL, V7, P535, DOI 10.1097/ACI.0b013e3282f14d7c; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	49	85	89	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					267	U227		10.1038/ni.3083	http://dx.doi.org/10.1038/ni.3083			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25599562				2022-12-18	WOS:000349842100010
J	Wang, HK; Geng, JL; Wen, XM; Bi, EG; Kossenkov, AV; Wolf, AI; Tas, J; Choi, YS; Takata, H; Day, TJ; Chang, LY; Sprout, SL; Becker, EK; Willen, J; Tian, LF; Wang, XX; Xiao, CC; Jiang, P; Crotty, S; Victora, GD; Showe, LC; Tucker, HO; Erikson, J; Hu, H				Wang, Haikun; Geng, Jianlin; Wen, Xiaomin; Bi, Enguang; Kossenkov, Andrew V.; Wolf, Amaya I.; Tas, Jeroen; Choi, Youn Soo; Takata, Hiroshi; Day, Timothy J.; Chang, Li-Yuan; Sprout, Stephanie L.; Becker, Emily K.; Willen, Jessica; Tian, Lifeng; Wang, Xinxin; Xiao, Changchun; Jiang, Ping; Crotty, Shane; Victora, Gabriel D.; Showe, Louise C.; Tucker, Haley O.; Erikson, Jan; Hu, Hui			The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; CENTER B-CELL; EXPRESSION; GENERATION; IL-21; BCL6; RESPONSES; FH; INTERLEUKIN-21	CD4(+) follicular helper T cells (T-FH cells) are essential for germinal center (GC) responses and long-lived antibody responses. Here we report that naive CD4(+) T cells deficient in the transcription factor Foxp1 'preferentially' differentiated into T-FH cells, which resulted in substantially enhanced GC and antibody responses. We found that Foxp1 used both constitutive Foxp1A and Foxp1D induced by stimulation of the T cell antigen receptor (TCR) to inhibit the generation of T-FH cells. Mechanistically, Foxp1 directly and negatively regulated interleukin 21 (IL-21); Foxp1 also dampened expression of the costimulatory molecule ICOS and its downstream signaling at early stages of T cell activation, which rendered Foxp1-deficient CD4(+) T cells partially resistant to blockade of the ICOS ligand (ICOSL) during T-FH cell development. Our findings demonstrate that Foxp1 is a critical negative regulator of T-FH cell differentiation.	[Wang, Haikun; Geng, Jianlin; Wen, Xiaomin; Bi, Enguang; Kossenkov, Andrew V.; Wolf, Amaya I.; Takata, Hiroshi; Day, Timothy J.; Chang, Li-Yuan; Sprout, Stephanie L.; Becker, Emily K.; Willen, Jessica; Tian, Lifeng; Wang, Xinxin; Jiang, Ping; Showe, Louise C.; Erikson, Jan; Hu, Hui] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Tas, Jeroen; Victora, Gabriel D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Choi, Youn Soo; Crotty, Shane] La Jolla Inst Allergy Immunol, La Jolla, CA USA; [Xiao, Changchun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Tucker, Haley O.] Univ Texas Austin, Dept Mol Genet, Austin, TX 78712 USA; [Tucker, Haley O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	The Wistar Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; La Jolla Institute for Immunology; Scripps Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hu, H (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	immhulab@gmail.com	BI, ENGUANG/K-4033-2014; Crotty, Shane/AAE-8446-2019; Geng, Jianlin/C-7981-2018; Wang, Xin/AAN-8435-2021; Wen, Xiaomin/H-5611-2019; Crotty, Shane/AAC-6703-2019	Geng, Jianlin/0000-0001-5642-9330; Wang, Xin/0000-0002-4457-7376; Crotty, Shane/0000-0002-6484-6262; Victora, Gabriel/0000-0001-8807-348X; Takata, Hiroshi/0000-0003-1457-6919; WEN, XIAOMIN/0000-0002-0472-9021; wang, hai kun/0000-0002-4714-4672	US National Institutes of Health [AI095439, AI103162, CA132098, 1S10RR024693, CA31534, AI083022, 5DP5OD012146, AI063107]; Alliance for Cell Gene Therapy Foundation; Wawa Foundation; Martha W Rogers Trust; Wistar Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [R01CA031534, R01CA132098, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095439, R01AI072543, R01AI063107, R01AI103162, U19AI083022] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Cell Gene Therapy Foundation; Wawa Foundation; Martha W Rogers Trust; Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Rajewsky (Max Delbruck Center for Molecular Medicine) for the Rosa26 targeting vector; E.J. Wherry (University of Pennsylvania) for the SMARTA mice; M.E. Pipkin (The Scripps Research Institute) for the plasmid MigR1-Bcl-6-GFP; N.A. Speck (University of Pennsylvania) for the plasmid MigR1-Cre-GFP; W. Pear (University of Pennsylvania) for the plasmid MSCV-IRES-hNGFR; K. Mozdzanowska and). Hayden for technical help with histology; J.S. Faust, D.E. Ambrose and S. Weiss for technical help with flow cytometry; M.S. Wright, M. Houston-Leslie and D. DiFrancesco for help at the Animal Facility of the Wistar Institute; and P. Wickramasinghe for help with microarray data and accession codes. Supported by the US National Institutes of Health (AI095439 and AI103162 to H.H.; CA132098 and 1S10RR024693 to L.C.S.; CA31534 to H.O.T.; AI083022 to J.E.; 5DP5OD012146 to G.D.V.; and AI063107 to S.C.), the Alliance for Cell Gene Therapy Foundation (H.H.), the Wawa Foundation (H.H.), the Martha W Rogers Trust (H.H.), and the Wistar Cancer Center (P30 CA10815).	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	45	85	93	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					667	675		10.1038/ni.2890	http://dx.doi.org/10.1038/ni.2890			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24859450	Green Accepted, Bronze			2022-12-18	WOS:000337715600013
J	Xiao, NM; Eto, D; Elly, C; Peng, GY; Crotty, S; Liu, YC				Xiao, Nengming; Eto, Danelle; Elly, Chris; Peng, Guiying; Crotty, Shane; Liu, Yun-Cai			The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells	NATURE IMMUNOLOGY			English	Article							FOXO TRANSCRIPTION FACTORS; GERMINAL CENTER FORMATION; IMMUNE-RESPONSES; B-CELLS; EXPRESSION; BCL6; REGULATORS; INDUCTION; MICE; INTERLEUKIN-21	Follicular helper T cells (T-FH cells) are responsible for effective B cell-mediated immunity, and Bcl-6 is a central factor for the differentiation of T-FH cells. However, the molecular mechanisms that regulate the induction of T-FH cells remain unclear. Here we found that the E3 ubiquitin ligase Itch was essential for the differentiation of T-FH cells, germinal center responses and immunoglobulin G (IgG) responses to acute viral infection. Itch acted intrinsically in CD4(+) T cells at early stages of T-FH cell development. Itch seemed to act upstream of Bcl-6 expression, as Bcl-6 expression was substantially impaired in itch(-/-) cells, and the differentiation of Itch(-/-) T cells into T-FH cells was restored by enforced expression of Bcl-6. Itch associated with the transcription factor Foxo1 and promoted its ubiquitination and degradation. The defective T-FH differentiation of Itch(-/-) T cells was rectified by deletion of Foxo1. Thus, our results indicate that Itch acts as an essential positive regulator in the differentiation of T-FH cells.	[Xiao, Nengming; Elly, Chris; Peng, Guiying; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Eto, Danelle; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@liai.org; yuncail@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; LIU, YUN-CAI/0000-0002-0996-7109; Peng, Guiying/0000-0002-0358-2515	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [RO1AI062969, RO1AI078272, RO1AI072543, RO1AI063107]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072543, R01AI062969, R01AI078272, R01AI063107] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R.A. DePinho (The University of Texas MD Anderson Cancer Center) for Foxo1<SUP>fl/fl</SUP> and Foxo3a<SUP>fl/fl</SUP> mice, and members of Liu and Crotty laboratories for advice and help. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (RO1AI062969 and RO1AI078272 to Y.-C.L.; and RO1AI072543 and RO1AI063107 to S.C.).	Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Grusby MJ, 1997, BIOCHEM SOC T, V25, P359, DOI 10.1042/bst0250359; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; HUSTAD CM, 1995, GENETICS, V140, P255; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jin HS, 2013, J CLIN INVEST, V123, P4923, DOI 10.1172/JCI69355; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	48	85	91	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					657	666		10.1038/ni.2912	http://dx.doi.org/10.1038/ni.2912			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24859451	Green Accepted			2022-12-18	WOS:000337715600012
J	Kimura, MY; Pobezinsky, LA; Guinter, TI; Thomas, J; Adams, A; Park, JH; Tai, XG; Singer, A				Kimura, Motoko Y.; Pobezinsky, Leonid A.; Guinter, Terry I.; Thomas, Julien; Adams, Anthony; Park, Jung-Hyun; Tai, Xuguang; Singer, Alfred			IL-7 signaling must be intermittent, not continuous, during CD8(+) T cell homeostasis to promote cell survival instead of cell death	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; INTERFERON-GAMMA; POSITIVE SELECTION; INTERLEUKIN-7 RECEPTOR; MEDIATED APOPTOSIS; THYMIC EMIGRANTS; NAIVE; ACTIVATION; PROLIFERATION; TRANSCRIPTION	The maintenance of naive CD8(+) T cells is necessary for lifelong immunocompetence but for unknown reasons requires signaling via both interleukin 7 (IL-7) and the T cell antigen receptor (TCR). We now report that naive CD8(+) T cells required IL-7 signaling to be intermittent, not continuous, because prolonged IL-7 signaling induced naive CD8(+) T cells to proliferate, produce interferon-gamma (IFN-gamma) and undergo IFN-gamma-triggered cell death. Homeostatic engagement of the TCR interrupted IL-7 signaling and thereby supported the survival and quiescence of CD8(+) T cells. However, CD8(+) T cells with insufficient TCR affinity for self ligands received prolonged IL-7 signaling and died during homeostasis. In this study we identified regulation of the duration of IL-7 signaling by homeostatic engagement of the TCR as the basis for in vivo CD8(+) T cell homeostasis.	[Kimura, Motoko Y.; Pobezinsky, Leonid A.; Guinter, Terry I.; Thomas, Julien; Adams, Anthony; Park, Jung-Hyun; Tai, Xuguang; Singer, Alfred] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov	Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055	Uehara Memorial Foundation; Kanae Foundation; US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011214, ZIABC011116, ZIABC011215, ZICBC009255, ZIABC011111, ZIABC009273, ZIABC011112, ZIABC011106, ZIABC011117, ZIABC011114, ZIABC011113] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation; US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Hodes and N. Taylor for critical reading of the manuscript; S. Sharrow and L. Granger for flow cytometry; and members of the Singer laboratory for discussions. Supported by the Uehara Memorial Foundation (M.Y.K.), the Kanae Foundation (M.Y.K.), and the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Lohman BL, 1998, J VIROL, V72, P7815, DOI 10.1128/JVI.72.10.7815-7821.1998; Markiewicz MA, 2003, EUR J IMMUNOL, V33, P2917, DOI 10.1002/eji.200324273; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Nesic D, 1998, J IMMUNOL, V160, P3705; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V377, P1001, DOI 10.1016/j.bbrc.2008.10.103; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2003, CURR OPIN IMMUNOL, V15, P321, DOI 10.1016/S0952-7915(03)00049-9; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swainson L, 2007, BLOOD, V109, P1034, DOI 10.1182/blood-2006-06-027912; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tomita Y, 2003, INT J CANCER, V104, P400, DOI 10.1002/ijc.10956; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	40	85	88	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					143	151		10.1038/ni.2494	http://dx.doi.org/10.1038/ni.2494			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23242416	Green Accepted			2022-12-18	WOS:000313918400009
J	Huang, GH; Wang, YY; Vogel, P; Kanneganti, TD; Otsu, K; Chi, HB				Huang, Gonghua; Wang, Yanyan; Vogel, Peter; Kanneganti, Thirumala-Devi; Otsu, Kinya; Chi, Hongbo			Signaling via the kinase p38 alpha programs dendritic cells to drive T(H)17 differentiation and autoimmune inflammation	NATURE IMMUNOLOGY			English	Article							T-HELPER-CELLS; IL-6 PRODUCTION; RECEPTOR; EFFECTOR; IMMUNITY; PATHWAY; CNS; ENCEPHALOMYELITIS; ACTIVATION; INDUCTION	Dendritic cells (DCs) bridge innate and adaptive immunity, but how DC-derived signals regulate T cell lineage choices remains unclear. We report here that the mitogen-activated protein kinase p38 alpha programmed DCs to drive the differentiation of the T(H)17 subset of helper T cells. Deletion of p38 alpha in DCs protected mice from T(H)17 cell-mediated autoimmune neuroinflammation, but deletion of p38 alpha in macrophages or T cells did not. We also found that p38 alpha orchestrated the expression of cytokines and costimulatory molecules in DCs and further 'imprinted' signaling via the receptor for interleukin 23 (IL-23R) in responding T cells to promote T(H)17 differentiation. Moreover, p38 alpha was required for tissue-infiltrating DCs to sustain T(H)17 responses. This activity of p38 alpha was conserved in mouse and human DCs and was dynamically regulated by pattern recognition and fungal infection. Our results identify p38 alpha signaling as a central pathway for the integration of instructive signals in DCs for T(H)17 differentiation and inflammation.	[Huang, Gonghua; Wang, Yanyan; Kanneganti, Thirumala-Devi; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan; [Otsu, Kinya] Kings Coll London, Cardiovasc Div, London WC2R 2LS, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Osaka University; University of London; King's College London	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Vogel, Peter/N-2490-2018; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Chi, Hongbo/M-9397-2018	Vogel, Peter/0000-0002-7535-0545; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Chi, Hongbo/0000-0002-9997-2496	US National Institutes of Health [R01 NS064599, K01 AR053573]; National Multiple Sclerosis Society [RG4180-A-1]; Cancer Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Cancer Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. R. Green for critical reading of the manuscript; C. Cloer and S. Shrestha for help with animal colony management; R. K. Subbarao Malireddi for help with fungal infection; B. Reizis (Columbia University) for CD11c-Cre mice; T. Ludwig (Columbia University) for Rosa26-Cre-ER<SUP>T2</SUP> mice; V. K. Kuchroo (Harvard University) for 2D2 mice; S. Arthur (University of Dundee) for p38 beta<SUP>KO</SUP> mice; D. R. Littman (New York University) for the IL-23R expressing retrovirus; and St. Jude Immunology FACS core facility for cell sorting. Supported by the US National Institutes of Health (R01 NS064599 and K01 AR053573), the National Multiple Sclerosis Society (RG4180-A-1) and the Cancer Research Institute (H. C.).	Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P3567, DOI 10.1167/iovs.09-4393; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li LQ, 2010, J IMMUNOL, V185, P4148, DOI 10.4049/jimmunol.1001536; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perona-Wright G, 2009, J IMMUNOL, V182, P2808, DOI 10.4049/jimmunol.0803553; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suter T, 2003, EUR J IMMUNOL, V33, P2998, DOI 10.1002/eji.200323611; Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	42	85	93	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					152	161		10.1038/ni.2207	http://dx.doi.org/10.1038/ni.2207			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22231518	Green Accepted			2022-12-18	WOS:000299315000012
J	Yamada, T; Park, CS; Mamonkin, M; Lacorazza, HD				Yamada, Takeshi; Park, Chun Shik; Mamonkin, Maksim; Lacorazza, H. Daniel			Transcription factor ELF4 controls the proliferation and homing of CD8(+) T cells via the Kruppel-like factors KLF4 and KLF2	NATURE IMMUNOLOGY			English	Article							ETS PROTEIN MEF; PLURIPOTENT STEM-CELLS; TUMOR-SUPPRESSOR; EMERGING ROLE; MEMORY CELLS; L-SELECTIN; LYMPHOCYTE; EXPRESSION; HOMEOSTASIS; GENE	Transcription factors that regulate the quiescence, proliferation and homing of lymphocytes are critical for effective immune system function. Here we demonstrate that the transcription factor ELF4 directly activated the tumor suppressor KLF4 'downstream' of T cell antigen receptor signaling to induce cell cycle arrest in naive CD8(+) T cells. Elf4- and Klf4-deficient mice accumulated CD8(+)CD44(hi) T cells during steady-state conditions and generated more memory T cells after immunization. The homeostatic population expansion of CD8(+)CD44(hi) T cells in Elf4- null mice resulted in a redistribution of cells to nonlymphoid tissue because of lower expression of the transcription factor KLF2 and the surface proteins CCR7 and CD62L. Our work describes the combinatorial effect of lymphocyte-intrinsic factors on the homeostasis, activation and homing of T cells.	[Yamada, Takeshi; Park, Chun Shik; Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Mamonkin, Maksim; Lacorazza, H. Daniel] Texas Childrens Hosp, Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lacorazza, HD (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	hdl@bcm.edu		Park, Chun Shik/0000-0002-4329-3953; Lacorazza, Daniel/0000-0003-0660-617X; Mamonkin, Maksim/0000-0001-7178-8163	Japanese Foundation for AIDS prevention; National Cancer Institute of the US National Institutes of Health [KO1 CA099156-01]; Dan Duncan Cancer Center at Baylor College of Medicine; Curtis Hankamer Basic Research Fund; US National Institute of Allergy and Infectious Diseases [1RO1AI077536-01]; NATIONAL CANCER INSTITUTE [K01CA099156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077536] Funding Source: NIH RePORTER	Japanese Foundation for AIDS prevention; National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dan Duncan Cancer Center at Baylor College of Medicine; Curtis Hankamer Basic Research Fund; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Finegold for support; T. Matano for support from the Japanese Foundation for AIDS prevention (to T.Y.); S. Nimer (Memorial Sloan-Kettering Cancer Center) for Elf4<SUP>-/-</SUP> and Vav-ELF4 mice; T. Tan (Baylor College of Medicine) for CD4-Cre mice. K. Kaestner (University of Pennsylvania) for mice with loxP-flanked Klf4; M. Puppi and L. Bae for assistance; M. Cubbage, C. Threeton and T. Goltsova for cell sorting; the Gulf Coast Digestive Disease Morphology Core and T.-A. Mistretta for microarray analysis; and C. Rooney for critical review of the manuscript. Supported by the National Cancer Institute of the US National Institutes of Health (KO1 CA099156-01 to H. D. L.), the Dan Duncan Cancer Center at Baylor College of Medicine (H. D. L.), the Curtis Hankamer Basic Research Fund (H. D. L.) and the US National Institute of Allergy and Infectious Diseases (1RO1AI077536-01 to H. D. L.).	Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bista P, 2008, MOL IMMUNOL, V45, P3618, DOI 10.1016/j.molimm.2008.05.001; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Ginaldi L, 2001, AM J HEMATOL, V67, P63, DOI 10.1002/ajh.1082; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Hogquist KA, 2008, IMMUNOL CELL BIOL, V86, P297, DOI 10.1038/icb.2008.20; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2003, BLOOD CELL MOL DIS, V31, P342, DOI 10.1016/S1079-9796(03)00162-1; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Marsden VS, 2006, INT ARCH ALLERGY IMM, V139, P63, DOI 10.1159/000090000; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yao JJ, 2007, ONCOGENE, V26, P4032, DOI 10.1038/sj.onc.1210170; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; Zhang ML, 2007, J IMMUNOL, V178, P3483, DOI 10.4049/jimmunol.178.6.3483; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	53	85	88	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					618	U85		10.1038/ni.1730	http://dx.doi.org/10.1038/ni.1730			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19412182	Green Accepted			2022-12-18	WOS:000266384100014
J	Boehm, T; Bleul, CC				Boehm, Thomas; Bleul, Conrad C.			The evolutionary history of lymphoid organs	NATURE IMMUNOLOGY			English	Article							AGNATHAN SEA LAMPREY; IMMUNE-SYSTEM; SOMATIC DIVERSIFICATION; BONE-MARROW; THYMUS; RECEPTORS; CELL; LYMPHOCYTES; MICROENVIRONMENT; DIFFERENTIATION	Lymphoid organs are important regulators of lymphocyte development and immune responses. During vertebrate evolution, primary lymphoid organs appeared earlier than secondary lymphoid organs. Among the sites of primary lymphopoiesis during evolution and ontogeny, those for B cell differentiation have differed considerably, although they often have had myelolymphatic characteristics. In contrast, only a single site for T cell differentiation has occurred, exclusively the thymus. Based on those observations and the known features of variable-diversity-joining gene recombination, we propose a model for the successive specification of different lymphocyte lineages during vertebrate evolution. According to our model, T cells were the first lymphocytes to acquire variable-diversity-joining - type receptors, and the thymus was the first lymphoid organ to evolve in vertebrates to deal with potentially autoreactive, somatically diversified T cell receptors.	Max Planck Inst Immunobiol, D-79279 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunobiol, D-79279 Freiburg, Germany.	boehm@immunbio.mpg.de						Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; ARDAVIN CF, 1988, THYMUS, V11, P59; ARDAVIN CF, 1987, DEV COMP IMMUNOL, V11, P79, DOI 10.1016/0145-305X(87)90010-3; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2006, NAT REV IMMUNOL, V6, P79, DOI 10.1038/nri1749; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Boehm T, 2006, TRENDS IMMUNOL, V27, P477, DOI 10.1016/j.it.2006.08.004; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Du Pasquier L, 1973, Curr Top Microbiol Immunol, V61, P37; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; KNIGHT KL, 1994, ADV IMMUNOL, V56, P179, DOI 10.1016/S0065-2776(08)60452-6; Kondo M, 2001, CURR OPIN GENET DEV, V11, P520, DOI 10.1016/S0959-437X(00)00227-6; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; LEDOUARIN N, 1986, CURR TOP DEV BIOL, V20, P291, DOI 10.1016/S0070-2153(08)60670-5; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Matsunaga T, 1998, IMMUNOL REV, V166, P177, DOI 10.1111/j.1600-065X.1998.tb01262.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MILLER JF, 1961, LANCET, V2, P748; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2004, P NATL ACAD SCI USA, V101, P13273, DOI 10.1073/pnas.0405529101; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Porter R., 1997, GREATEST BENEFIT MAN; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Shintani S, 2000, P NATL ACAD SCI USA, V97, P7417, DOI 10.1073/pnas.110505597; Tagaya H, 2000, BLOOD, V95, P3363, DOI 10.1182/blood.V95.11.3363.011k29_3363_3370; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WATSON FL, 2005, SCIENCE, V18, P1826	48	85	93	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					131	135		10.1038/ni1435	http://dx.doi.org/10.1038/ni1435			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242686				2022-12-18	WOS:000243597600009
J	Visan, I; Tan, JB; Yuan, JS; Harper, JA; Koch, U; Guidos, CJ				Visan, Ioana; Tan, Joanne B.; Yuan, Julie S.; Harper, James A.; Koch, Ute; Guidos, Cynthia J.			Regulation of T lymphopoiesis by Notch1 and Lunatic fringe-mediated competition for intrathymic niches	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; ZONE B-CELLS; LINEAGE DECISION; LYMPHOID DEVELOPMENT; LIGAND INTERACTIONS; SEGMENTATION CLOCK; ALPHA-BETA; IN-VITRO; PRE-TCR; DIFFERENTIATION	Notch1 activation regulates T lineage commitment and early T cell development. Fringe glycosyltransferases alter the sensitivity of Notch receptors to Delta-like versus Jagged Notch ligands, but their functions in T lymphopoiesis have not been defined. Here we show that developmental stage-specific expression of the glycosyltransferase lunatic fringe (Lfng) is required for coordination of the access of T cell progenitors to intrathymic niches that support Notch1-dependent phases of T cell development. Lfng-null progenitors generated few thymocytes in competitive assays, whereas Lfng overexpression converted thymocytes into 'supercompetitors' with enhanced binding of Delta-like ligands and blocked T lymphopoiesis from normal progenitors. We suggest that the ability of Lfng and Notch1 to control progenitor competition for limiting cortical niches is an important mechanism for the homeostatic regulation of thymus size.	Univ Toronto, Fac Med, Program Dev Biol, Hosp Sick Children Res Inst, Toronto, ON M5G 1L7, Canada; Univ Toronto, Fac Med, Dept Immunol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Guidos, CJ (corresponding author), Univ Toronto, Fac Med, Program Dev Biol, Hosp Sick Children Res Inst, Toronto, ON M5G 1L7, Canada.	cynthia.guidos@sickkids.ca		Koch, Ute/0000-0001-7914-7061				Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Foss DL, 2002, INT IMMUNOL, V14, P331, DOI 10.1093/intimm/14.3.331; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Koch U, 2003, SEMIN IMMUNOL, V15, P99, DOI 10.1016/S1044-5323(03)00006-X; LEHAR SM, 2004, BLOOD; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; OKA C, 1995, DEVELOPMENT, V121, P3291; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Witt CM, 2003, MOL CELL BIOL, V23, P8637, DOI 10.1128/MCB.23.23.8637-8650.2003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	60	85	85	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					634	643		10.1038/ni1345	http://dx.doi.org/10.1038/ni1345			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16699526				2022-12-18	WOS:000237751200019
J	Koliaraki, V; Prados, A; Armaka, M; Kollias, G				Koliaraki, Vasiliki; Prados, Alejandro; Armaka, Marietta; Kollias, George			The mesenchymal context in inflammation, immunity and cancer	NATURE IMMUNOLOGY			English	Review							FIBROBLASTIC RETICULAR CELLS; STROMAL CELLS; STEM-CELL; INTESTINAL INFLAMMATION; INNATE; HETEROGENEITY; RECEPTOR; MECHANISMS; PERICYTES; MATRIX	Koliaraki, Prados, Armaka & Kollias review the roles of fibroblastic mesenchymal cells in tissue homeostasis and immunopathologic diseases, including chronic inflammatory disease, tissue fibrosis and cancer. Mesenchymal cells are mesoderm-derived stromal cells that are best known for providing structural support to organs, synthesizing and remodeling the extracellular matrix (ECM) and regulating development, homeostasis and repair of tissues. Recent detailed mechanistic insights into the biology of fibroblastic mesenchymal cells have revealed they are also significantly involved in immune regulation, stem cell maintenance and blood vessel function. It is now becoming evident that these functions, when defective, drive the development of complex diseases, such as various immunopathologies, chronic inflammatory disease, tissue fibrosis and cancer. Here, we provide a concise overview of the contextual contribution of fibroblastic mesenchymal cells in physiology and disease and bring into focus emerging evidence for both their heterogeneity at the single-cell level and their tissue-specific, spatiotemporal functional diversity.	[Koliaraki, Vasiliki; Armaka, Marietta; Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Fundamental Biomed Res, Vari, Greece; [Prados, Alejandro; Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Bioinnovat, Vari, Greece; [Kollias, George] Natl & Kapodistrian Univ Athens, Sch Med, Dept Physiol, Athens, Greece	Alexander Fleming Biomedical Sciences Research Center; Alexander Fleming Biomedical Sciences Research Center; Athens Medical School; National & Kapodistrian University of Athens	Koliaraki, V; Kollias, G (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Fundamental Biomed Res, Vari, Greece.; Kollias, G (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Bioinnovat, Vari, Greece.; Kollias, G (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Physiol, Athens, Greece.	koliaraki@fleming.gr; kollias@fleming.gr	Koliaraki, Vasiliki/B-8618-2015; Armaka, Marietta/Q-6139-2017; Prados, Alejandro/C-4987-2009	Koliaraki, Vasiliki/0000-0003-1694-6987; Armaka, Marietta/0000-0003-0985-9076; Prados, Alejandro/0000-0002-8610-7559	Stavros Niarchos Foundation; FP7 Advanced ERC Grant MCs-inTEST [340217]	Stavros Niarchos Foundation; FP7 Advanced ERC Grant MCs-inTEST	We would like to thank the co-organizers, presenters and attendees of the EMBO meeting "Mesenchymal Cells in Immunity, Inflammation and Cancer", held in Athens in 2019, for insightful discussions on mesenchymal cells. This work was supported by a grant from the Stavros Niarchos Foundation to the BSRC 'Alexander Fleming'' as part of the Foundation's initiative to support the Greek research center ecosystem, and the FP7 Advanced ERC Grant MCs-inTEST (grant 340217) to G.K.	Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Armaka M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02935-4; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bartoschek M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07582-3; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brown FD, 2019, NAT IMMUNOL, V20, P1668, DOI 10.1038/s41590-019-0515-x; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Chang JE, 2019, NAT IMMUNOL, V20, P1506, DOI 10.1038/s41590-019-0505-z; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Salzer MC, 2018, CELL, V175, P1575, DOI 10.1016/j.cell.2018.10.012; Comazzetto S, 2019, CELL STEM CELL, V24, P477, DOI 10.1016/j.stem.2018.11.022; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Denton AE, 2019, J EXP MED, V216, P2242, DOI 10.1084/jem.20181705; Di Carlo SE, 2018, J CLIN INVEST, V128, P54, DOI 10.1172/JCI93558; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Dubey LK, 2019, CELL REP, V27, P2442, DOI 10.1016/j.celrep.2019.04.079; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Ershaid N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12370-8; Firestein G.S., 2016, KELLEY FIRESTEINS TX, VVolume 1; Fu YJ, 2017, ONCOTARGET, V8, P57813, DOI 10.18632/oncotarget.18175; Gieniec KA, 2019, BRIT J CANCER, V121, P293, DOI 10.1038/s41416-019-0509-3; Gil-Cruz C, 2016, NAT IMMUNOL, V17, P1388, DOI 10.1038/ni.3566; Glasser SW, 2016, AM J PATHOL, V186, P1066, DOI 10.1016/j.ajpath.2016.01.018; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Guo MZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07770-1; He ZX, 2019, GASTROENTEROLOGY, V157, P1572, DOI 10.1053/j.gastro.2019.08.025; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Heichler C, 2019, GUT, V69, P1269; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kobayashi H, 2019, NAT REV GASTRO HEPAT, V16, P282, DOI 10.1038/s41575-019-0115-0; Koliaraki V, 2019, CELL REP, V26, P536, DOI 10.1016/j.celrep.2018.12.072; Koliaraki V, 2015, J EXP MED, V212, P2235, DOI 10.1084/jem.20150542; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; LeBleu VS, 2020, FASEB J, V34, P3519, DOI 10.1096/fj.201903188R; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Lemos DR, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan5174; Lewis MJ, 2019, CELL REP, V28, P2455, DOI 10.1016/j.celrep.2019.07.091; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Lu E, 2019, NATURE, V567, P244, DOI 10.1038/s41586-019-1003-z; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Majumder S, 2019, NAT IMMUNOL, V20, P534, DOI 10.1038/s41590-019-0367-4; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Mohammadi H, 2018, NAT CELL BIOL, V20, P766, DOI 10.1038/s41556-018-0131-2; Monteran L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01835; Montero-Melendez T, 2020, NAT COMMUN, V11; Nagashima K, 2017, NAT IMMUNOL, V18, P675, DOI 10.1038/ni.3732; Neuzillet C, 2019, J PATHOL, V248, P51, DOI 10.1002/path.5224; Ng B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1237; Nguyen HN, 2017, IMMUNITY, V46, P220, DOI 10.1016/j.immuni.2017.01.004; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Oherle K, 2020, IMMUNITY, V52, P275, DOI [10.1016/j.immuni.7020.01.005, 10.1016/j.immuni.2020.01.005]; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Ollila S, 2018, J CLIN INVEST, V128, P402, DOI 10.1172/JCI93597; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Peyser R, 2019, AM J RESP CELL MOL, V61, P74, DOI 10.1165/rcmb.2018-0313OC; Pinho S, 2019, NAT REV MOL CELL BIO, V20, P303, DOI 10.1038/s41580-019-0103-9; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Raz Y, 2018, J EXP MED, V215, P3075, DOI 10.1084/jem.20180818; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Roulis M, 2014, P NATL ACAD SCI USA, V111, pE4658, DOI 10.1073/pnas.1415762111; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shook BA, 2018, SCIENCE, V362, P909, DOI 10.1126/science.aar2971; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Sun L, 2015, SCI REP, V5; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; van der Poel CE, 2019, CELL REP, V29, P2745, DOI 10.1016/j.celrep.2019.10.086; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; Vomero M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01577; Wang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05992-x; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002; Wohlfahrt T, 2019, NATURE, V566, P344, DOI 10.1038/s41586-019-0896-x; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	133	84	83	8	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					974	982		10.1038/s41590-020-0741-2	http://dx.doi.org/10.1038/s41590-020-0741-2		AUG 2020	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32747813				2022-12-18	WOS:000555394500001
J	Nehar-Belaid, D; Hong, S; Marches, R; Chen, G; Bolisetty, M; Baisch, J; Walters, L; Punaro, M; Rossi, RJ; Chung, CH; Huynh, RP; Singh, P; Flynn, WF; Tabanor-Gayle, JA; Kuchipudi, N; Mejias, A; Collet, MA; Lucido, AL; Palucka, K; Robson, P; Lakshminarayanan, S; Ramilo, O; Wright, T; Pascual, V; Banchereau, JF				Nehar-Belaid, Djamel; Hong, Seunghee; Marches, Radu; Chen, Guo; Bolisetty, Mohan; Baisch, Jeanine; Walters, Lynnette; Punaro, Marilynn; Rossi, Robert J.; Chung, Cheng-Han; Huynh, Richie P.; Singh, Prashant; Flynn, William F.; Tabanor-Gayle, Joy-Ann; Kuchipudi, Navya; Mejias, Asuncion; Collet, Magalie A.; Lucido, Anna Lisa; Palucka, Karolina; Robson, Paul; Lakshminarayanan, Santhanam; Ramilo, Octavio; Wright, Tracey; Pascual, Virginia; Banchereau, Jacques F.			Mapping systemic lupus erythematosus heterogeneity at the single-cell level	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON; BLOOD; EXPRESSION; SUBSETS; ALPHA; ONSET; STAGE	Patients with systemic lupus erythematosus (SLE) display a complex blood transcriptome whose cellular origin is poorly resolved. Using single-cell RNA sequencing, we profiled -276,000 peripheral blood mononuclear cells from 33 children with SLE with different degrees of disease activity and 11 matched controls. Increased expression of interferon-stimulated genes (ISGs) distinguished cells from children with SLE from healthy control cells. The high ISG expression signature (ISG(hi)) derived from a small number of transcriptionally defined subpopulations within major cell types, including monocytes, CD4(+) and CD8(+) T cells, natural killer cells, conventional and plasmacytoid dendritic cells, B cells and especially plasma cells. Expansion of unique subpopulations enriched in ISGs and/or in monogenic lupus-associated genes classified patients with the highest disease activity. Profiling of similar to 82,000 single peripheral blood mononuclear cells from adults with SLE confirmed the expansion of similar subpopulations in patients with the highest disease activity. This study lays the groundwork for resolving the origin of the SLE transcriptional signatures and the disease heterogeneity towards precision medicine applications.	[Nehar-Belaid, Djamel; Marches, Radu; Chen, Guo; Bolisetty, Mohan; Rossi, Robert J.; Chung, Cheng-Han; Huynh, Richie P.; Singh, Prashant; Flynn, William F.; Collet, Magalie A.; Lucido, Anna Lisa; Palucka, Karolina; Robson, Paul; Banchereau, Jacques F.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Hong, Seunghee; Baisch, Jeanine; Pascual, Virginia] Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA; [Hong, Seunghee; Baisch, Jeanine; Pascual, Virginia] Weill Cornell Med, Dept Pediat, New York, NY 10065 USA; [Walters, Lynnette; Punaro, Marilynn; Wright, Tracey] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Punaro, Marilynn; Wright, Tracey] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Tabanor-Gayle, Joy-Ann; Kuchipudi, Navya; Lakshminarayanan, Santhanam] Univ Connecticut, Sch Med, Dept Med, Farmington, CT USA; [Mejias, Asuncion; Ramilo, Octavio] Nationwide Childrens Hosp, Div Pediat Infect Dis, Columbus, OH USA; [Mejias, Asuncion; Ramilo, Octavio] Ohio State Univ, Sch Med, Columbus, OH 43210 USA; [Robson, Paul] Univ Connecticut, Sch Med, Inst Syst Genom, Farmington, CT USA; [Robson, Paul] Univ Connecticut, Sch Med, Dept Genet & Genome Sci, Farmington, CT USA	Jackson Laboratory; Cornell University; Cornell University; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Connecticut; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Connecticut; University of Connecticut	Banchereau, JF (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Pascual, V (corresponding author), Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA.; Pascual, V (corresponding author), Weill Cornell Med, Dept Pediat, New York, NY 10065 USA.	vip2021@med.cornell.edu; Jacques.banchereau@jax.org	Nehar-Belaid, Djamel/GQZ-4299-2022; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020	Nehar-Belaid, Djamel/0000-0001-6002-5021; Mejias, Asuncion/0000-0002-5983-8006; Chen, Guo/0000-0002-3857-3600	NCI [P30CA034196]; NIAMS CORT [P50AR070594]; NIAID NIH [U19 AI082715, U01 AI131386]; Jackson Laboratory; Drukier Institute for Children's Health at Weill Cornell Medicine	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS CORT; NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jackson Laboratory; Drukier Institute for Children's Health at Weill Cornell Medicine	We are grateful to the patients with SLE, their families, the healthy individuals who participated in our study and the members of the Pediatric Rheumatology Clinics at Texas Scottish Rite Hospital for Children and the Children's Medical Center in Dallas, TX and M. Sansone, T. Jackson and F. Jawed for help with recruiting adults with SLE. We gratefully acknowledge the contribution of Flow Cytometry, Single Cell Biology and Genome Technologies Scientific Services at The Jackson Laboratory, which are partially supported by NCI P30CA034196, and thank them for expert assistance with the work described in this publication. In addition, we thank JAX Research IT (particularly Sandeep Namburi) for the support with maintaining the R Shiny application. This work was supported by grants NIAMS CORT P50AR070594 Center for Lupus Research (to V.P. and J.F.B.), NIAID NIH U19 AI082715 (to V.P.) and U01 AI131386 (to O.R. and J.F.B.) and start-up funds from the Jackson Laboratory and the Drukier Institute for Children's Health at Weill Cornell Medicine.	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Gatto M, 2019, NAT REV RHEUMATOL, V15, P30, DOI 10.1038/s41584-018-0133-2; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gill MA, 2002, HUM IMMUNOL, V63, P1172, DOI 10.1016/S0198-8859(02)00756-5; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hong S, 2019, J EXP MED, V216, P1154, DOI 10.1084/jem.20190185; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Jiang SH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10242-9; Karnell JL, 2011, J IMMUNOL, V187, P3603, DOI 10.4049/jimmunol.1003319; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Lou WY, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1639-8; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Omarjee O, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102361; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Polaski K., 2019, BIOINFORMATICS, V36, P964; Rice GI, 2017, J CLIN IMMUNOL, V37, P123, DOI 10.1007/s10875-016-0359-1; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Rodriguez-Pla A, 2014, J IMMUNOL, V192, P5586, DOI 10.4049/jimmunol.1301319; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scharer CD, 2019, NAT IMMUNOL, V20, P1071, DOI 10.1038/s41590-019-0419-9; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Tucci M, 2008, ARTHRITIS RHEUM-US, V58, P251, DOI 10.1002/art.23186; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Weisberg SP, 2019, CELL REP, V29, P3916, DOI 10.1016/j.celrep.2019.11.056; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005	57	84	86	4	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1094	+		10.1038/s41590-020-0743-0	http://dx.doi.org/10.1038/s41590-020-0743-0		AUG 2020	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32747814	Green Accepted			2022-12-18	WOS:000555394500003
J	Zheng, XH; Qian, YB; Fu, BQ; Jiao, DF; Jiang, Y; Chen, P; Shen, YQ; Zhang, HF; Sun, R; Tian, ZG; Wei, HM				Zheng, Xiaohu; Qian, Yeben; Fu, Binqing; Jiao, Defeng; Jiang, Yong; Chen, Peng; Shen, Yiqing; Zhang, Huafeng; Sun, Rui; Tian, Zhigang; Wei, Haiming			Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance	NATURE IMMUNOLOGY			English	Article							METABOLISM; FUSION; ACTIVATION; PROMOTES; FISSION; SHAPE	Natural killer (NK) cells have crucial roles in tumor surveillance. We found that tumor-infiltrating NK cells in human liver cancers had small, fragmented mitochondria in their cytoplasm, whereas liver NK cells outside tumors, as well as peripheral NK cells, had normal large, tubular mitochondria. This fragmentation was correlated with reduced cytotoxicity and NK cell loss, resulting in tumor evasion of NK cell-mediated surveillance, which predicted poor survival in patients with liver cancer. The hypoxic tumor microenvironment drove the sustained activation of mechanistic target of rapamycin-GTPase dynamin-related protein 1 (mTOR-Drp1) in NK cells, resulting in excessive mitochondria! fission into fragments. Inhibition of mitochondria! fragmentation improved mitochondria! metabolism, survival and the antitumor capacity of NK cells. These data reveal a mechanism of immune escape that might be targetable and could invigorate NK cell-based cancer treatments.	[Zheng, Xiaohu; Fu, Binqing; Jiao, Defeng; Shen, Yiqing; Zhang, Huafeng; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Sch Life Sci, Div Mol Med, Hefei Natl Lab Phys Sci Microscale,CAS Key Lab In, Hefei, Anhui, Peoples R China; [Zheng, Xiaohu; Fu, Binqing; Jiao, Defeng; Shen, Yiqing; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China; [Qian, Yeben; Jiang, Yong; Chen, Peng] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University	Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Sch Life Sci, Div Mol Med, Hefei Natl Lab Phys Sci Microscale,CAS Key Lab In, Hefei, Anhui, Peoples R China.; Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Chen, Peng/ABB-1894-2020; Tian, Zhigang/J-3512-2013		Natural Science Foundation of China [81330071, 81788101, 81872318, 81602491]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB1002, XDA12020217]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank W. Tao for advice regarding RNA sequencing data analyses. This work was supported by the Natural Science Foundation of China (reference numbers 81330071, 81788101, 81872318 and 81602491) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB1002 and XDA12020217).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Assmann N, 2017, NAT IMMUNOL, V18, P1197, DOI 10.1038/ni.3838; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cong JJ, 2018, CELL METAB, V28, P243, DOI 10.1016/j.cmet.2018.06.021; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gemta LF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aap9520; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Keating SE, 2016, J IMMUNOL, V196, P2552, DOI 10.4049/jimmunol.1501783; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Krzywinska E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01599-w; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; O'Brien KL, 2019, NAT REV IMMUNOL, V19, P282, DOI 10.1038/s41577-019-0139-2; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sugiura A, 2018, J IMMUNOL, V200, P400, DOI 10.4049/jimmunol.1701041; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vaupel P, 2014, ADV EXP MED BIOL, V812, P19, DOI 10.1007/978-1-4939-0620-8_3; Yang MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12730; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	48	84	93	11	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1656	+		10.1038/s41590-019-0511-1	http://dx.doi.org/10.1038/s41590-019-0511-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31636463				2022-12-18	WOS:000497949800020
J	Neumann, C; Blume, J; Roy, U; Teh, PP; Vasanthakumar, A; Beller, A; Liao, Y; Heinrich, F; Arenzana, TL; Hackney, JA; Eidenschenk, C; Galvez, EJC; Stehle, C; Heinz, GA; Maschmeyer, P; Sidwell, T; Hu, YF; Amsen, D; Romagnani, C; Chang, HD; Kruglov, A; Mashreghi, MF; Shi, W; Strowig, T; Rutz, S; Kallies, A; Scheffold, A				Neumann, Christian; Blume, Jonas; Roy, Urmi; Teh, Peggy P.; Vasanthakumar, Ajithkumar; Beller, Alexander; Liao, Yang; Heinrich, Frederik; Arenzana, Teresita L.; Hackney, Jason A.; Eidenschenk, Celine; Galvez, Eric J. C.; Stehle, Christina; Heinz, Gitta A.; Maschmeyer, Patrick; Sidwell, Tom; Hu, Yifang; Amsen, Derk; Romagnani, Chiara; Chang, Hyun-Dong; Kruglov, Andrey; Mashreghi, Mir-Farzin; Shi, Wei; Strowig, Till; Rutz, Sascha; Kallies, Axel; Scheffold, Alexander			c-Maf-dependent T-reg cell control of intestinal T(H)17 cells and IgA establishes host-microbiota homeostasis	NATURE IMMUNOLOGY			English	Article							B-CELL; FLOW-CYTOMETRY; MOUSE MODEL; INFLAMMATION; COLITIS; DIFFERENTIATION; POPULATION; EXPRESSION; SEQUENCES; IMMUNITY	Foxp3(+) regulatory T cells (T-reg cells) are crucial for the maintenance of immune homeostasis both in lymphoid tissues and in non-lymphoid tissues. Here we demonstrate that the ability of intestinal T-reg cells to constrain microbiota-dependent interleukin (IL)-17-producing helper T cell (T(H)17 cell) and immunoglobulin A responses critically required expression of the transcription factor c-Maf. The terminal differentiation and function of several intestinal T-reg cell populations, including ROR gamma t(+) T-reg cells and follicular regulatory T cells, were c-Maf dependent. c-Maf controlled T-reg cell-derived IL-10 production and prevented excessive signaling via the kinases PI(3)K (phosphatidylinositol-3-OH kinase) and Akt and the metabolic checkpoint kinase complex mTORC1 (mammalian target of rapamycin) and expression of inflammatory cytokines in intestinal T-reg cells. c-Maf deficiency in T-reg cells led to profound dysbiosis of the intestinal microbiota, which when transferred to germ-free mice was sufficient to induce exacerbated intestinal T(H)17 responses, even in a c-Maf-competent environment. Thus, c-Maf acts to preserve the identity and function of intestinal T-reg cells, which is essential for the establishment of host-microbe symbiosis.	[Neumann, Christian] Charite Univ Med Berlin, Clin Rheumatol & Clin Immunol, Dept Cellular Immunol, Berlin, Germany; [Neumann, Christian; Beller, Alexander; Heinrich, Frederik; Stehle, Christina; Heinz, Gitta A.; Maschmeyer, Patrick; Romagnani, Chiara; Chang, Hyun-Dong; Kruglov, Andrey; Mashreghi, Mir-Farzin] German Rheumatism Res Ctr DRFZ Berlin, Leibniz Assoc, Berlin, Germany; [Blume, Jonas; Teh, Peggy P.; Vasanthakumar, Ajithkumar; Sidwell, Tom; Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Blume, Jonas; Teh, Peggy P.; Vasanthakumar, Ajithkumar; Sidwell, Tom; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Melbourne, Vic, Australia; [Roy, Urmi; Galvez, Eric J. C.; Strowig, Till] Helmholtz Ctr Infect Res, Res Grp Microbial Immune Regulat, Braunschweig, Germany; [Liao, Yang; Hu, Yifang; Shi, Wei] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Liao, Yang; Hu, Yifang; Shi, Wei] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic, Australia; [Arenzana, Teresita L.; Rutz, Sascha] Genentech Inc, Dept Canc Immunol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Hackney, Jason A.] Genentech Inc, Dept Bioinformat & Computat Biol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Eidenschenk, Celine] Genentech Inc, Dept Biochem & Cellular Pharmacol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Amsen, Derk] Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst, Sanquin Res,Dept Hematopoiesis, Amsterdam, Netherlands; [Amsen, Derk] Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst, Landsteiner Lab, Amsterdam, Netherlands; [Romagnani, Chiara] Charite Univ Med Berlin, Med Dept 1, Berlin, Germany; [Romagnani, Chiara] Free Univ Berlin, Berlin, Germany; [Romagnani, Chiara] Humboldt Univ, Berlin, Germany; [Romagnani, Chiara] Berlin Inst Hlth, Berlin, Germany; [Kruglov, Andrey] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kruglov, Andrey] Moscow MV Lomonosov State Univ, Biol Fac, Moscow, Russia; [Scheffold, Alexander] Christian Albrechts Univ Kiel, Inst Immunol, Kiel, Germany; [Scheffold, Alexander] Univ Klin Schleswig Holstein, Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Melbourne; Helmholtz Association; Helmholtz-Center for Infection Research; University of Melbourne; Walter & Eliza Hall Institute; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Amsterdam; University of Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Lomonosov Moscow State University; Lomonosov Moscow State University; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Kallies, A (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Melbourne, Vic, Australia.; Rutz, S (corresponding author), Genentech Inc, Dept Canc Immunol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.; Scheffold, A (corresponding author), Christian Albrechts Univ Kiel, Inst Immunol, Kiel, Germany.; Scheffold, A (corresponding author), Univ Klin Schleswig Holstein, Kiel, Germany.	saschar@gene.com; axel.kallies@unimelb.edu.au; alexander.scheffold@uksh.de	Scheffold, Alexander/S-2090-2016; Romagnani, Chiara/E-4708-2016; Mashreghi, Mir-Farzin/S-2911-2019; Kruglov, Andrey A/F-7543-2017; Gálvez, Eric J.C./ABA-2950-2021; Kruglov, Andrey/AAP-2023-2021; Chang, Hyun-Dong/T-3697-2017	Scheffold, Alexander/0000-0002-0626-343X; Romagnani, Chiara/0000-0002-5167-7463; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Kruglov, Andrey A/0000-0002-4597-2087; Gálvez, Eric J.C./0000-0001-7459-3871; Heinz, Gitta Anne/0000-0002-9330-3689; Kallies, Axel/0000-0002-6312-6968; Chang, Hyun-Dong/0000-0002-7341-4533; VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781; Hackney, Jason/0000-0002-5922-563X; Stehle, Christina/0000-0001-5016-0588	Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy-EXC [2167-390884018, SFB650, CRC/TR 241]; German Federal Ministry of Education and Science (BMBF)-Project InfectControl 2020 Projekt DIAT [FKZ: 03ZZ0827A]; state of Berlin; 'European Regional Development Fund' ERDF 2014-2020 [EFRE 1.8/11]; Helmholtz Association [VH-NG-933]; National Health and Medical Research Council (NHMRC) [1069075, 1106378]; Sylvia and Charles Viertel Foundation; Walter and Eliza Institute Centenary Fellowship - CSL; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy-EXC(German Research Foundation (DFG)); German Federal Ministry of Education and Science (BMBF)-Project InfectControl 2020 Projekt DIAT(Federal Ministry of Education & Research (BMBF)); state of Berlin; 'European Regional Development Fund' ERDF 2014-2020; Helmholtz Association(Helmholtz Association); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Walter and Eliza Institute Centenary Fellowship - CSL; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy-EXC 2167-390884018 (to A.S.), SFB650 (to A.S.) and CRC/TR 241 (to A.S. and C.R.), the German Federal Ministry of Education and Science (BMBF)-Project InfectControl 2020 Projekt DIAT FKZ: 03ZZ0827A (to A.S.), the state of Berlin and the 'European Regional Development Fund' ERDF 2014-2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum (to F.H., G.A.H, P.M. and M.F.M), the Helmholtz Association project grant VH-NG-933 (to T. Strowig), the National Health and Medical Research Council (NHMRC) project grants (1069075, 1106378 to A. Kallies), the Sylvia and Charles Viertel Foundation (fellowship to A. Kallies), a Walter and Eliza Institute Centenary Fellowship funded by the CSL (to W.S.), a fellowship by the Deutsche Forschungsgemeinschaft (to J.B.) and the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme. We thank the DRFZ Flow Cytometry Core Facility and the BCRT Flow Cytometry Lab for cell sorting. In addition, we thank Renee Gloury and Victoria von Gotze for technical and experimental help.	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bunker JJ, 2018, IMMUNITY, V49, P211, DOI 10.1016/j.immuni.2018.08.011; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Galvez EJC, 2017, CELL REP, V21, P3914, DOI 10.1016/j.celrep.2017.12.027; Gratz IK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00333; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Okkenhaug K, 2002, SCIENCE, V297, P1031; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy U, 2017, CELL REP, V21, P994, DOI 10.1016/j.celrep.2017.09.097; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wheaton JD, 2017, J IMMUNOL, V199, P3931, DOI 10.4049/jimmunol.1701134; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Zimmermann J, 2016, EUR J IMMUNOL, V46, P1300, DOI 10.1002/eji.201646297; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	60	84	87	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					471	+		10.1038/s41590-019-0316-2	http://dx.doi.org/10.1038/s41590-019-0316-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30778241				2022-12-18	WOS:000461904200017
J	Cockburn, IA; Seder, RA				Cockburn, Ian A.; Seder, Robert A.			Malaria prevention: from immunological concepts to effective vaccines and protective antibodies	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM SPOROZOITES; BLOOD-STAGE INFECTION; LIVER-STAGE; CIRCUMSPOROZOITE PROTEIN; PFSPZ VACCINE; HUMORAL IMMUNITY; STERILE PROTECTION; ACQUIRED-IMMUNITY; GAMMA-INTERFERON	Development of a malaria vaccine remains a critical priority to decrease clinical disease and mortality and facilitate eradication. Accordingly, RTS,S, a protein-subunit vaccine, has completed phase III clinical trials and confers similar to 30% protection against clinical infection over 4 years. Whole-attenuated-sporozoite and viral-subunit vaccines induce between 20% and 100% protection against controlled human malaria infection, but there is limited published evidence to date for durable, high-level efficacy (>50%) against natural exposure. Importantly, fundamental scientific advances related to the potency, durability, breadth and location of immune responses will be required for improving vaccine efficacy with these and other vaccine approaches. In this Review, we focus on the current understanding of immunological mechanisms of protection from animal models and human vaccine studies, and on how these data should inform the development of next-generation vaccines. Furthermore, we introduce the concept of using passive immunization with monoclonal antibodies as a new approach to prevent and eliminate malaria.	[Cockburn, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov		Cockburn, Ian/0000-0001-8220-9294				Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; Bijker EM, 2014, J INFECT DIS, V210, P1605, DOI 10.1093/infdis/jiu293; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chaudhury S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08526-5; Chaudhury S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1348-9; Chen L, 2017, ELIFE, V6, DOI [10.7554/elife.21347, 10.7554/eLife.21347.001, 10.7554/eLife.21347]; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Cockburn IA, 2014, INFECT IMMUN, V82, P1460, DOI 10.1128/IAI.01500-13; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; De Rosa SC, 2004, J IMMUNOL, V172, P1637, DOI 10.4049/jimmunol.172.3.1637; Deal C, 2014, P NATL ACAD SCI USA, V111, P12528, DOI 10.1073/pnas.1407362111; Doll KL, 2016, J IMMUNOL, V196, P4253, DOI 10.4049/jimmunol.1600155; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Draper SJ, 2015, VACCINE, V33, P7433, DOI 10.1016/j.vaccine.2015.09.093; Dups JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00625; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Favuzza P, 2017, ELIFE, V6, DOI [10.7554/eLife.20383, 10.7554/elife.20383]; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Foquet L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00524; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060; Kimura K, 2013, INFECT IMMUN, V81, P3825, DOI 10.1128/IAI.00570-13; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kublin JG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9099; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kurtovic L, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1054-2; Kwong PD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029470; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Lusingu JPA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-163; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Mensah VA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01551; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; MULLIGAN H. W., 1941, JOUR MALARIA INST INDIA, V4, P25; Murugan R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8029; Nahrendorf W, 2015, ELIFE, V4, DOI 10.7554/eLife.05165; Nielsen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137302; NUSSENZWEIG RS, 1972, EXP PARASITOL, V31, P88, DOI 10.1016/0014-4894(72)90051-3; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Oliveira GA, 2008, INFECT IMMUN, V76, P1200, DOI 10.1128/IAI.00566-07; Olotu A, 2018, AM J TROP MED HYG, V98, P308, DOI 10.4269/ajtmh.17-0449; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Palacpac NMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064073; Payne RO, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96381; Peng K, 2016, CELL MICROBIOL, V18, P1739, DOI 10.1111/cmi.12608; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; RENIA L, 1993, J IMMUNOL, V150, P1471; RICHARDS W. H. G., 1966, NATURE, V212, P1492, DOI 10.1038/2121492a0; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; RODRIGUES M, 1992, J EXP MED, V175, P895, DOI 10.1084/jem.175.4.895; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sack BK, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0028-2; Sagara I, 2002, AM J TROP MED HYG, V66, P310, DOI 10.4269/ajtmh.2002.66.310; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Scally SW, 2018, J EXP MED, V215, P63, DOI 10.1084/jem.20170869; Schats R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124243; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schussek S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15354-0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shao WG, 2018, NUCLEIC ACIDS RES, V46, pD1237, DOI 10.1093/nar/gkx664; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Sokhna CS, 2001, AM J TROP MED HYG, V65, P167, DOI 10.4269/ajtmh.2001.65.167; Speake C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159449; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Srinivasan P, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0015-7; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; SUSS G, 1988, INFECT IMMUN, V56, P3081; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Volz JC, 2016, CELL HOST MICROBE, V20, P60, DOI 10.1016/j.chom.2016.06.004; Walk J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0923-4; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Wu YM, 2015, ADV PARASIT, V89, P109, DOI 10.1016/bs.apar.2015.04.001; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x; Zaidi I, 2017, J IMMUNOL, V199, P3781, DOI 10.4049/jimmunol.1700314; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zenklusen I, 2018, J INFECT DIS, V217, P1569, DOI 10.1093/infdis/jiy080	160	84	86	0	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1199	1211		10.1038/s41590-018-0228-6	http://dx.doi.org/10.1038/s41590-018-0228-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333613	hybrid			2022-12-18	WOS:000447632200015
J	Tsagaratou, A; Gonzalez-Avalos, E; Rautio, S; Scott-Browne, JP; Togher, S; Pastor, WA; Rothenberg, EV; Chavez, L; Landesmaki, H; Rao, A				Tsagaratou, Ageliki; Gonzalez-Avalos, Edahi; Rautio, Sini; Scott-Browne, James P.; Togher, Susan; Pastor, William A.; Rothenberg, Ellen V.; Chavez, Lukas; Landesmaki, Harri; Rao, Anjana			TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells	NATURE IMMUNOLOGY			English	Article							DNA DEMETHYLATION; DYNAMIC CHANGES; T-CELLS; ROLES; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; CHROMATIN; DIFFERENTIATION; DIOXYGENASE; METHYLATION	TET proteins oxidize 5-methylcytosine in DNA to 5-hydroxymethylcytosine and other oxidation products. We found that simultaneous deletion of Tet2 and Tet3 in mouse CD4(+)CD8(+) double-positive thymocytes resulted in dysregulated development and proliferation of invariant natural killer T cells (iNKT cells). Tet2-Tet3 double-knockout (DKO) iNKT cells displayed pronounced skewing toward the NKT17 lineage, with increased DNA methylation and impaired expression of genes encoding the key lineage-specifying factors T-bet and ThPOK. Transfer of purified Tet2-Tet3 DKO MKT cells into immunocompetent recipient mice resulted in an uncontrolled expansion that was dependent on the nonclassical major histocompatibility complex (MHC) protein CD1d, which presents lipid antigens to iNKT cells. Our data indicate that TET proteins regulate MKT cell fate by ensuring their proper development and maturation and by suppressing aberrant proliferation mediated by the T cell antigen receptor (TCR).	[Tsagaratou, Ageliki; Gonzalez-Avalos, Edahi; Scott-Browne, James P.; Togher, Susan; Pastor, William A.; Rao, Anjana] La Jolla Inst Allergy & Immunol, Dept Signaling & Gene Express, La Jolla, CA 92037 USA; [Rautio, Sini; Landesmaki, Harri] Aalto Univ, Sch Sci, Dept Comp Sci, Aalto, Finland; [Scott-Browne, James P.; Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Chavez, Lukas] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Rao, Anjana] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Rao, Anjana] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Pastor, William A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	La Jolla Institute for Immunology; Aalto University; California Institute of Technology; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, Dept Signaling & Gene Express, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Rao, A (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	arao@lji.org		Rao, Anjana/0000-0002-1870-1775; Rothenberg, Ellen/0000-0002-3901-347X; Tsagaratou, Ageliki/0000-0002-7121-3789; Chavez, Lukas/0000-0002-8718-8848; Rautio, Sini/0000-0001-5215-4456; Tsangaratou, Angeliki/0000-0001-9895-0394	US National Institutes of Health [R01 AI44432, CA151535, R35CA210043]; Leukemia and Lymphoma Society (Translation Research Project grant) [6187-12]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; Albert Billings Ruddock Professorship at Caltech; Cancer Research Institute (Irvington Institute postdoctoral fellowship); Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation [DRG-2069-11]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA151535, R35CA210043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016262] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (Translation Research Project grant)(Leukemia and Lymphoma Society); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; Albert Billings Ruddock Professorship at Caltech; Cancer Research Institute (Irvington Institute postdoctoral fellowship); Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Kim, K. van Gunst, L. Nosworthy, D. Hinz and R. Simmons at the LJI Flow Cytometry Core for help with fluorescence-activated cell sorting; G. Seumois and J. Day at the LJI Functional Genomics Center for assistance with next-generation sequencing (Illumina HiSeq 2500); M. Kronenberg, I. Engel and C.-W. Lio (LJI) for discussions, the LJI Bioinformatics Core for routine analysis; Z. Mikulski and B. Kiosses at the LJI microscopy core, M. Chadwell at the LJI Histology core, and the Histology Core at the University of California at San Diego Moores Cancer Center; and R. Bosselut (National Cancer Institute) for pMX-ThPOK-IRES-GFP. Supported by US National Institutes of Health (R01 AI44432, CA151535 and R35CA210043), the Leukemia and Lymphoma Society (Translation Research Project grant 6187-12 to A.R.), the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (H.L. and. S.R.), an Albert Billings Ruddock Professorship at Caltech (E.V.R.), the Cancer Research Institute (Irvington Institute postdoctoral fellowship to A.T.), the Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation (DRG-2069-11 to J.P.S.-B.) and the National Science Foundation (W.A.P.).	An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Carr T, 2015, J EXP MED, V212, P793, DOI 10.1084/jem.20141849; Dobenecker MW, 2015, J EXP MED, V212, P297, DOI 10.1084/jem.20141499; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee YJ, 2016, J IMMUNOL, V197, P1460, DOI 10.4049/jimmunol.1600643; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Nair VS, 2016, J IMMUNOL, V196, P2119, DOI 10.4049/jimmunol.1502352; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Uddin MN, 2016, P NATL ACAD SCI USA, V113, P7608, DOI 10.1073/pnas.1521846113; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702	48	84	90	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					45	53		10.1038/ni.3630	http://dx.doi.org/10.1038/ni.3630			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27869820	Green Accepted			2022-12-18	WOS:000390080000009
J	Zhong, C; Cui, KR; Wilhelm, C; Hu, GQ; Mao, KR; Belkaid, Y; Zhao, KJ; Zhu, JF				Zhong, Chao; Cui, Kairong; Wilhelm, Christoph; Hu, Gangqing; Mao, Kairui; Belkaid, Yasmine; Zhao, Keji; Zhu, Jinfang			Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment	NATURE IMMUNOLOGY			English	Article							FACTOR T-BET; FATE; DIFFERENTIATION; IMMUNITY	The transcription factor GATA-3 is indispensable for the development of all innate lymphoid cells (ILCs) that express the interleukin 7 receptor alpha-chain (IL-7R alpha). However, the function of low GATA-3 expression in committed group 3 ILCs (ILC3 cells) has not been identified. We found that GATA-3 regulated the homeostasis of ILC3 cells by controlling IL-7Ra expression. In addition, GATA-3 served a critical function in the development of the NKp46(+) ILC3 subset by regulating the balance between the transcription factors T-bet and ROR gamma t. Among NKp46(+) ILC3 cells, although GATA-3 positively regulated genes specific to the NKp46(+) ILC3 subset, it negatively regulated genes specific to lymphoid tissue-inducer (LTi) or LTi-like ILC3 cells. Furthermore, GATA-3 was required for IL-22 production in both ILC3 subsets. Thus, despite its low expression, GATA-3 was critical for the homeostasis, development and function of ILC3 subsets.	[Zhong, Chao; Zhu, Jinfang] NIAID, Mol & Cellular Immunoregulat Unit, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cui, Kairong; Hu, Gangqing; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Wilhelm, Christoph; Belkaid, Yasmine] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA; [Wilhelm, Christoph] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Univ Hosp Bonn, Bonn, Germany; [Mao, Kairui] NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Mol & Cellular Immunoregulat Unit, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fzhu@niaid.nih.gov	HU, GANGQING/K-5849-2012; Hu, Gangqing/ABA-3507-2020; Zhu, Jinfang/B-7574-2012; Wilhelm, Christoph/ABE-7176-2020	HU, GANGQING/0000-0001-5453-6888; Zhu, Jinfang/0000-0002-0117-4745; Wilhelm, Christoph/0000-0002-9839-0291; Belkaid, Yasmine/0000-0001-9962-3571	US National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D.R. Littman (New York University) for Rorc-Cre mice on the C57BL/6 background; A. Singer (National Cancer Institute) for Tg-hCD2-Il7ra mice on the C57BL/6 background; C. Dulac (Harvard) for Tbx21-Cre mice; D. Artis (University of Pennsylvania) for C. rodentium strain DBS100; A. Bhandoola, R. Germain, J. O'Shea, P. Schwartzberg and A. Sher for critical reading of our manuscript; L. Guo for suggestions and technical assistance in analyzing ILCs; K. Weng for assistance in cell sorting; L. Feigenbaum for assistance in generating ROR gamma t-E2-Crimson mice; and the DNA Sequencing and Computational Biology Core of the National Heart, Lung, and Blood Institute for sequencing the RNA-Seq and ChIP-Seq libraries. Supported by the Intramural Research Program of the US National Institutes of Health, the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute.	Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	33	84	85	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					169	178		10.1038/ni.3318	http://dx.doi.org/10.1038/ni.3318			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26595886	Green Accepted			2022-12-18	WOS:000368571500010
J	Hsu, LC; Enzler, T; Seita, J; Timmer, AM; Lee, CY; Lai, TY; Yu, GY; Lai, LC; Temkin, V; Sinzig, U; Aung, T; Nizet, V; Weissman, IL; Karin, M				Hsu, Li-Chung; Enzler, Thomas; Seita, Jun; Timmer, Anjuli M.; Lee, Chih-Yuan; Lai, Ting-Yu; Yu, Guann-Yi; Lai, Liang-Chuan; Temkin, Vladislav; Sinzig, Ursula; Aung, Thiha; Nizet, Victor; Weissman, Irving L.; Karin, Michael			IL-1 beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKK beta	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; STEM-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; MYELOID CELLS; ACTIVATION; APOPTOSIS; CANCER; INHIBITOR; PATHWAY	Transcription factor NF-kappa B and its activating kinase IKK beta are associated with inflammation and are believed to be critical for innate immunity. Despite the likelihood of immune suppression, pharmacological blockade of IKK beta-NF-kappa B has been considered as a therapeutic strategy. However, we found neutrophilia in mice with inducible deletion of IKK beta (Ikk beta(Delta) mice). These mice had hyperproliferative granulocyte-macrophage progenitors and pregranulocytes and a prolonged lifespan of mature neutrophils that correlated with the induction of genes encoding prosurvival molecules. Deletion of interleukin 1 receptor 1 (IL-1R1) in Ikk beta(Delta) mice normalized blood cellularity and prevented neutrophil-driven inflammation. However, Ikk beta(Delta)Il1r1(-/-) mice, unlike Ikk beta(Delta) mice, were highly susceptible to bacterial infection, which indicated that signaling via IKK beta-NF-kappa B or IL-1R1 can maintain antimicrobial defenses in each other's absence, whereas inactivation of both pathways severely compromises innate immunity.	[Hsu, Li-Chung; Lee, Chih-Yuan; Lai, Ting-Yu] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Hsu, Li-Chung; Enzler, Thomas; Yu, Guann-Yi; Temkin, Vladislav; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, Sch Med, La Jolla, CA 92093 USA; [Hsu, Li-Chung; Enzler, Thomas; Yu, Guann-Yi; Temkin, Vladislav; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Enzler, Thomas] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Seita, Jun; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Timmer, Anjuli M.; Nizet, Victor] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Lai, Liang-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	National Taiwan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; Stanford University; University of California System; University of California San Diego; National Taiwan University; University of California System; University of California San Diego	Hsu, LC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan.	lichunghsu@ntu.edu.tw; karinoffice@ucsd.edu	Lai, Liang-Chuan/B-4768-2009; lai, ting/HGD-7592-2022; Seita, Jun/AAM-1478-2020; Nizet, Victor/AAF-3190-2019; Yu, Guann-Yi/O-5139-2019	Lai, Liang-Chuan/0000-0002-3913-5338; Seita, Jun/0000-0002-3008-3615; Yu, Guann-Yi/0000-0002-0580-8282; Enzler, Thomas/0000-0002-8775-1493; Hsu, Li-Chung/0000-0001-7206-5231; Nizet, Victor/0000-0003-3847-0422; Lee, Chih-Yuan/0000-0001-5034-3544	US National Institutes of Health [AI043477, AI77780, U01HL099999-02]; National Taiwan University; National Health Research Institutes, Taiwan [NHRI-EX99-9825SC]; Leukemia and Lymphoma Society of America; California Institute for Regenerative Medicine; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI043477] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Taiwan University(National Taiwan University); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Kaushansky, G. Wulf and N. Zatula for advice and support; L. Jerabek and A. Mosley for laboratory and animal management; C. Richter and N. Teja for antibody production; and the National Clinical Trial & Research Center at National Taiwan University Hospital, and the Bioinformatics and Biostatistics Core, Research Center for Medical Excellence at National Taiwan University, Taiwan, for microarray services and assistance in data analysis. Supported by the US National Institutes of Health (AI043477 to M. K., AI77780 to V. N. and U01HL099999-02 to I. L. W.), National Taiwan University (L.-C. H.), National Health Research Institutes, Taiwan (NHRI-EX99-9825SC to L.-C. H.)., Leukemia and Lymphoma Society of America (T. E.), California Institute for Regenerative Medicine (J.S.) and American Cancer Society (M.K. and I.L.W.).	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; HESTDAL K, 1991, J IMMUNOL, V147, P22; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Klebanoff S.J., 1978, NEUTROPHIL FUNCTION; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lane AA, 2005, MOL CELL BIOL, V25, P23, DOI 10.1128/MCB.25.1.23-33.2005; Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196, DOI 10.1002/jlb.65.2.196; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; METCALF D, 1995, HEMATOPOIETIC COLONY, P109; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; QUIE PG, 1980, SCAND J INFECT DIS, P30; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; STANLEY ER, 1986, CELL, V45, P667, DOI 10.1016/0092-8674(86)90781-6; Straus DS, 2009, EXPERT OPIN DRUG DIS, V4, P823, DOI 10.1517/17460440903143739; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Vitale C, 1999, P NATL ACAD SCI USA, V96, P15091, DOI 10.1073/pnas.96.26.15091; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	48	84	90	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					144	U54		10.1038/ni.1976	http://dx.doi.org/10.1038/ni.1976			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21170027	Green Accepted			2022-12-18	WOS:000286378400008
J	Gill, N; Wlodarska, M; Finlay, BB				Gill, Navkiran; Wlodarska, Marta; Finlay, B. Brett			The future of mucosal immunology: studying an integrated system-wide organ	NATURE IMMUNOLOGY			English	Article							GUT MICROBIOTA; PROTECTION		[Gill, Navkiran; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Gill, N (corresponding author), Univ British Columbia, Michael Smith Labs, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Artenstein AW, 1997, J INFECT DIS, V175, P265, DOI 10.1093/infdis/175.2.265; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Gallichan WS, 2001, J IMMUNOL, V166, P3451, DOI 10.4049/jimmunol.166.5.3451; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Ishikawa H, 2008, CLIN EXP IMMUNOL, V153, P127, DOI 10.1111/j.1365-2249.2008.03668.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sobko T, 2010, PAEDIATR PERINAT EP, V24, P88, DOI 10.1111/j.1365-3016.2009.01080.x	15	84	92	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					558	560		10.1038/ni0710-558	http://dx.doi.org/10.1038/ni0710-558			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562837				2022-12-18	WOS:000278926400007
J	Reavie, L; Della Gatta, G; Crusio, K; Aranda-Orgilles, B; Buckley, SM; Thompson, B; Lee, E; Gao, J; Bredemeyer, AL; Helmink, BA; Zavadil, J; Sleckman, BP; Palomero, T; Ferrando, A; Aifantis, I				Reavie, Linsey; Della Gatta, Giusy; Crusio, Kelly; Aranda-Orgilles, Beatriz; Buckley, Shannon M.; Thompson, Benjamin; Lee, Eugine; Gao, Jie; Bredemeyer, Andrea L.; Helmink, Beth A.; Zavadil, Jiri; Sleckman, Barry P.; Palomero, Teresa; Ferrando, Adolfo; Aifantis, Iannis			Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex	NATURE IMMUNOLOGY			English	Article							C-MYC; SELF-RENEWAL; TUMOR-SUPPRESSOR; EXPRESSION; QUIESCENCE; MICROARRAY; INSIGHTS; BIOLOGY; CYCLE; ACTS	Hematopoietic stem cell (HSC) differentiation is regulated by cell-intrinsic and cell-extrinsic cues. In addition to transcriptional regulation, post-translational regulation may also control HSC differentiation. To test this hypothesis, we visualized the ubiquitin-regulated protein stability of a single transcription factor, c-Myc. The stability of c-Myc protein was indicative of HSC quiescence, and c-Myc protein abundance was controlled by the ubiquitin ligase Fbw7. Fine changes in the stability of c-Myc protein regulated the HSC gene-expression signature. Using whole-genome genomic approaches, we identified specific regulators of HSC function directly controlled by c-Myc binding; however, adult HSCs and embryonic stem cells sensed and interpreted c-Myc-regulated gene expression in distinct ways. Our studies show that a ubiquitin ligase-substrate pair can orchestrate the molecular program of HSC differentiation.	[Reavie, Linsey; Crusio, Kelly; Aranda-Orgilles, Beatriz; Buckley, Shannon M.; Thompson, Benjamin; Lee, Eugine; Gao, Jie; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA; [Reavie, Linsey; Crusio, Kelly; Aranda-Orgilles, Beatriz; Buckley, Shannon M.; Thompson, Benjamin; Lee, Eugine; Gao, Jie; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Reavie, Linsey; Crusio, Kelly; Aranda-Orgilles, Beatriz; Buckley, Shannon M.; Thompson, Benjamin; Lee, Eugine; Gao, Jie; Zavadil, Jiri; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY USA; [Della Gatta, Giusy; Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY USA; [Bredemeyer, Andrea L.; Helmink, Beth A.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Zavadil, Jiri] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA	Howard Hughes Medical Institute; New York University; New York University; New York University; Columbia University; Washington University (WUSTL); New York University	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA.	iannis.aifantis@nyumc.org	Gao, Jie/C-2159-2011; Ferrando, Adolfo A/Q-7026-2016; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Bredemeyer, Andrea/0000-0003-2970-5998; Helmink, Beth/0000-0002-8206-0351; Lee, Eugine/0000-0002-7090-852X	National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, R56AI070310, P30CA016087, RO1AI41428, RO1AI072039, R01CA120196]; American Cancer Society [RSG0806801]; Edward Mallinckrodt Jr. Foundation; Irma T. Hirschl Trust; Alex's Lemonade Stand Foundation; Alexander von Humboldt Foundation; NYU Hematology/Oncology Program; NYU Molecular Oncology and Immunology Training [5T32CA009161]; Leukemia & Lymphoma Society; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA120196, R01CA133379, T32CA009161, R01CA105129, P30CA016087, R21CA141399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041428, R56AI070310, R01AI072039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Edward Mallinckrodt Jr. Foundation; Irma T. Hirschl Trust; Alex's Lemonade Stand Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NYU Hematology/Oncology Program; NYU Molecular Oncology and Immunology Training; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Aifantis Lab and specifically B. King for advice as well as time and effort spent on this manuscript; P. Lopez and the NYU Flow Cytometry Facility for cell sorting; the NYU Cancer Institute Genomics Facility for help with microarray processing; M. Gostissa (Harvard University) and F. Alt (Harvard University) for Myc<SUP>flox</SUP> mice; and I. Lemischka and his laboratory (Mount Sinai) for the Nanog-GFP line and technical advice. Supported by the National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, R56AI070310 and P30CA016087 to I. A.; RO1AI41428 and RO1AI072039 to B. P. S.; and R01CA120196 to A. F.), the American Cancer Society (RSG0806801 to I. A.), the Edward Mallinckrodt Jr. Foundation, the Irma T. Hirschl Trust, the Alex's Lemonade Stand Foundation (I. A.), the Alexander von Humboldt Foundation (B. A.-O.), the NYU Hematology/Oncology Program (S. M. B.), an NYU Molecular Oncology and Immunology Training Grant (5T32CA009161 to K. C.), the Leukemia & Lymphoma Society (I. A. and A. F.) and the Howard Hughes Medical Institute (I. A.).	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Karlsson S, 2009, BLOOD, V113, P1208, DOI 10.1182/blood-2008-11-189738; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaniel C, 2006, NAT METHODS, V3, P397, DOI 10.1038/nmeth0506-397; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whetton AD, 2008, CELL STEM CELL, V2, P215, DOI 10.1016/j.stem.2008.02.003; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	45	84	86	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					207	U3		10.1038/ni.1839	http://dx.doi.org/10.1038/ni.1839			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20081848	Green Accepted			2022-12-18	WOS:000274605800008
J	Gounari, F; Chang, R; Cowan, J; Guo, ZY; Dose, M; Gounaris, E; Khazaie, K				Gounari, F; Chang, R; Cowan, J; Guo, ZY; Dose, M; Gounaris, E; Khazaie, K			Loss of adenomatous polyposis coli gene function disrupts thymic development	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; COMMON LYMPHOID PROGENITORS; GERM-LINE MUTATIONS; BETA-CATENIN; APC GENE; PRE-TCR; CHROMOSOMAL INSTABILITY; TUMOR-SUPPRESSOR; DESMOID TUMORS; BONE-MARROW	Loss of the adenomatous polyposis coli (APC) protein is a common initiating event in colon cancer. Here we show that thymocyte-specific loss of APC deregulated beta-catenin signaling and suppressed Notch-dependent transcription. These events promoted the proliferation of cells of the double-negative 3 and 4 stages and reduced rearrangements between the variable, diversity and joining regions of the gene encoding T cell receptor (TCR) beta, encouraging developmental progression of aberrant thymocytes lacking pre-TCR and alpha beta TCR. Simultaneously, the loss of APC prolonged the mitotic metaphase-to-anaphase checkpoint and impaired chromosome segregation, blocking development beyond the double-negative 4 stage. The result was extensive thymic atrophy and increased frequencies of thymocytes with chromosomal abnormalities. Thus, loss of APC in immature thymocytes has consequences distinct from those of deregulation of beta-catenin signaling and is essential for T cell differentiation.	Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Pediat, Boston, MA 02111 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University	Khazaie, K (corresponding author), Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	khashayarsha_khazaie@dfci.harvard.edu	Gounaris, Elias/B-3184-2011	Dose, Marei/0000-0001-5394-9779; Gounaris, Elias/0000-0001-8679-9711	NCI NIH HHS [R01 CA104547-01A1, R01 CA104547] Funding Source: Medline; NIAID NIH HHS [R01 AI059676-01, R01 AI059676-02, R01 AI059676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hodgkin P D, 1997, Int Rev Immunol, V15, P101, DOI 10.3109/08830189709068173; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Martinez Arias Alfonso, 1998, International Journal of Developmental Biology, V42, P325; MCDOUGALL S, 1988, SCIENCE, V241, P205, DOI 10.1126/science.2968651; MIYAKI M, 1993, CANCER RES, V53, P5079; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; MOORE NC, 1994, IMMUNOLOGY, V81, P115; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1995, CANCER RES, V55, P2972; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; vonBoehmer H, 1997, IMMUNOL TODAY, V18, P260, DOI 10.1016/S0167-5699(97)80018-7; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	50	84	87	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					800	809		10.1038/ni1228	http://dx.doi.org/10.1038/ni1228			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16025118	Green Accepted			2022-12-18	WOS:000230646200021
J	Liu, XL; Bosselut, R				Liu, XL; Bosselut, R			Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; POSITIVE SELECTION; ANTIGEN RECEPTOR; CD4 LINEAGE; NEGATIVE SELECTION; THYMIC SELECTION; THYMOCYTE DIFFERENTIATION; CD4(+)CD8(+) THYMOCYTES; STOCHASTIC MECHANISM; TYROSINE KINASE	The duration of T cell receptor (TCR) signaling is thought to be important for thymocyte differentiation into the CD4 or CD8 lineage. However, the in vivo relevance of this hypothesis is unclear. Here we divided T cell positive selection into genetically separable developmental steps by confining TCR signal transduction to discrete thymocyte developmental windows. TCR signals confined to the double-positive thymocyte stage promoted CD8, but not CD4, lineage differentiation. Major histocompatibility complex (MHC) class II-restricted thymocytes were, instead, redirected into the CD8 lineage. These findings support the hypothesis that distinct kinetics of MHC class I- and MHC class II-induced TCR signals direct intrathymic developmental decisions.	NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bosselut, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov			DIVISION OF BASIC SCIENCES - NCI [Z01BC010414] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; Bhandoola A, 2000, INT IMMUNOL, V12, P1035, DOI 10.1093/intimm/12.7.1035; Bhandoola A, 1999, IMMUNITY, V10, P301, DOI 10.1016/S1074-7613(00)80030-8; Bommhardt U, 1997, EUR J IMMUNOL, V27, P1152, DOI 10.1002/eji.1830270516; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chan S, 1999, EUR J IMMUNOL, V29, P2916, DOI 10.1002/(SICI)1521-4141(199909)29:09<2916::AID-IMMU2916>3.0.CO;2-I; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; GAO EK, 1988, NATURE, V336, P176, DOI 10.1038/336176a0; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; JUNE CH, 1991, CURRENT PROTOCOLS IM; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Sebzda E, 1997, IMMUNITY, V6, P643, DOI 10.1016/S1074-7613(00)80352-0; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Sohn SJ, 2001, J IMMUNOL, V166, P2209, DOI 10.4049/jimmunol.166.4.2209; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	66	84	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					280	288		10.1038/ni1040	http://dx.doi.org/10.1038/ni1040			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14770180				2022-12-18	WOS:000189344600011
J	Schneemann, M; Schoedon, G				Schneemann, M; Schoedon, G			Species differences in macrophage NO production are important	NATURE IMMUNOLOGY			English	Letter							NITRIC-OXIDE SYNTHASE; HUMAN MONONUCLEAR PHAGOCYTES; MESSENGER-RNA; EXPRESSION		Univ Zurich Hosp, Dept Med, Med Clin B, Res Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Schneemann, M (corresponding author), Univ Zurich Hosp, Dept Med, Med Clin B, Res Unit, CH-8091 Zurich, Switzerland.							Albina JE, 1995, J LEUKOCYTE BIOL, V58, P643, DOI 10.1002/jlb.58.6.643; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; DENIS M, 1994, J LEUKOCYTE BIOL, V55, P682, DOI 10.1002/jlb.55.5.682; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; Jungi TW, 1996, VET IMMUNOL IMMUNOP, V54, P323, DOI 10.1016/S0165-2427(96)05690-5; KARGES HE, 1994, ARZNEIMITTEL-FORSCH, V44-1, P793; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Linscheid P, 1998, CIRCULATION, V98, P1703, DOI 10.1161/01.CIR.98.17.1703; MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; SCHOEDON G, 1993, EUR J BIOCHEM, V213, P833, DOI 10.1111/j.1432-1033.1993.tb17826.x; VODOVOTZ Y, 1994, J IMMUNOL, V152, P4110; WEINBERG JB, 1995, BLOOD, V86, P1184	14	84	89	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					102	102		10.1038/ni0202-102a	http://dx.doi.org/10.1038/ni0202-102a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812978	Bronze			2022-12-18	WOS:000173562400002
J	Campos, JLS; Mongkolsapaya, J; Screaton, GR				Campos, Jose Luis Slon; Mongkolsapaya, Juthathip; Screaton, Gavin R.			The immune response against flaviviruses	NATURE IMMUNOLOGY			English	Review							WEST-NILE-VIRUS; CD8(+) T-CELLS; ANTIBODY-DEPENDENT ENHANCEMENT; JAPANESE ENCEPHALITIS-VIRUS; TETRAVALENT DENGUE VACCINE; ORIGINAL ANTIGENIC SIN; STRUCTURAL BASIS; MONOCLONAL-ANTIBODIES; PROTECTIVE ROLE; CYTOKINE PRODUCTION	Arthropod-borne flaviviruses are important human pathogens that cause a diverse range of clinical conditions, including severe hemorrhagic syndromes, neurological complications and congenital malformations. Consequently, there is an urgent need to develop safe and effective vaccines, a process requiring better understanding of the immunological mechanisms involved during infection. Decades of research suggest a paradoxical role of the immune response against flaviviruses: although the immune response is crucial for the control, clearance and prevention of infection, poor clinical outcomes are commonly associated with virus-specific immunity and immunopathogenesis. This relationship is further complicated by the high homology among viruses and the implication of cross-reactive immune responses in protection and pathogenesis. This Review examines the dual role of the adaptive immune response against flaviviruses, particularly emphasizing the most recent findings regarding cross-reactive T cell and antibody responses, and the effects that these concepts have on vaccine-development endeavors.	[Campos, Jose Luis Slon; Mongkolsapaya, Juthathip] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand; [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; Mahidol University; University of Oxford	Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford, England.	gavin.screaton@medsci.ox.ac.uk		Screaton, Gavin/0000-0002-3549-4309; Slon Campos, Jose Luis/0000-0002-0012-5247	Wellcome Trust, UK; Newton-Medical Research Council, UK; Wellcome Trust	Wellcome Trust, UK(Wellcome Trust); Newton-Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, UK, and the Newton-Medical Research Council, UK. G.R.S. is supported as a Wellcome Trust Senior Investigator.	Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Biswas SM, 2009, J GEN VIROL, V90, P818, DOI 10.1099/vir.0.008045-0; Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]; Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Chuang YC, 2016, J IMMUNOL, V196, P1218, DOI 10.4049/jimmunol.1500057; Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x; Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334; Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1; de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; FAGBAMI AH, 1987, CYTOBIOS, V49, P49; Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999; George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1; Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]; Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309; Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643; Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058; Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329; James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; King A. M. Q., 2012, FAMILY FLAVIVIRIDAE, P1003; Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953; Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Modis Y, 2014, CURR OPIN VIROL, V5, P34, DOI 10.1016/j.coviro.2014.01.009; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Phares TW, 2012, J VIROL, V86, P2416, DOI 10.1128/JVI.06797-11; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738; Qiu XD, 2018, NAT MICROBIOL, V3, P287, DOI 10.1038/s41564-017-0099-x; Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1; Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SAGE Working Group on Dengue Vaccines and WHO Secretariat, 2016, SAGE M APR 2018; Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8; Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Talarico LB, 2017, EBIOMEDICINE, V20, P202, DOI 10.1016/j.ebiom.2017.04.033; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042; Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15; Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157	125	83	85	1	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1189	1198		10.1038/s41590-018-0210-3	http://dx.doi.org/10.1038/s41590-018-0210-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333606	Bronze			2022-12-18	WOS:000447632200014
J	Nagashima, K; Sawa, S; Nitta, T; Tsutsumi, M; Okamura, T; Penninger, JM; Nakashima, T; Takayanagi, H				Nagashima, Kazuki; Sawa, Shinichiro; Nitta, Takeshi; Tsutsumi, Masanori; Okamura, Tadashi; Penninger, Josef M.; Nakashima, Tomoki; Takayanagi, Hiroshi			Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota	NATURE IMMUNOLOGY			English	Article							KAPPA-B LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; ISOLATED LYMPHOID FOLLICLES; RECEPTOR ACTIVATOR; PEYERS-PATCHES; T-CELLS; INTESTINAL HOMEOSTASIS; RETICULAR CELLS; STROMAL CELLS; EXPRESSION	Immunoglobulin A (IgA) maintains a symbiotic equilibrium with intestinal microbes. IgA induction in the gut-associated lymphoid tissues (GALTs) is dependent on microbial sampling and cellular interaction in the subepithelial dome (SED). However it is unclear how IgA induction is predominantly initiated in the SED. Here we show that previously unrecognized mesenchymal cells in the SED of GALTs regulate bacteria-specific IgA production and diversify the gut microbiota. Mesenchymal cells expressing the cytokine RANKL directly interact with the gut epithelium to control CCL20 expression and microfold (M) cell differentiation. The deletion of mesenchymal RANKL impairs M cell-dependent antigen sampling and B cell-dendritic cell interaction in the SED, which results in a reduction in IgA production and a decrease in microbial diversity. Thus, the subepithelial mesenchymal cells that serve as M cell inducers have a fundamental role in the maintenance of intestinal immune homeostasis.	[Nagashima, Kazuki; Sawa, Shinichiro; Nitta, Takeshi; Tsutsumi, Masanori; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Nagashima, Kazuki; Sawa, Shinichiro; Nitta, Takeshi; Tsutsumi, Masanori; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Sawa, Shinichiro] Hokkaido Univ, Inst Genet Med, Dept Mol Virol, Sapporo, Hokkaido, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo, Japan; [Okamura, Tadashi] Res Inst Natl Ctr Global Hlth & Med, Sect Anim Models, Dept Infect Dis, Tokyo, Japan; [Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Nakashima, Tomoki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Nakashima, Tomoki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Nakashima, Tomoki] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Hokkaido University; National Center for Global Health & Medicine - Japan; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan.; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp	Nagashima, Kazuki/I-3320-2017; Penninger, Josef M/I-6860-2013	Nagashima, Kazuki/0000-0002-8593-136X; Penninger, Josef M/0000-0002-8194-3777	Japan Society for Promotion of Science (JSPS) [15H05703]; JST; Yakult Bio-Science Foundation; JSPS [25111503, 16H05202]; Japanese Society for Immunology (JSI) Kibou Scholarship for Doctoral Students in Immunology; Grants-in-Aid for Scientific Research [16H05202] Funding Source: KAKEN	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Yakult Bio-Science Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society for Immunology (JSI) Kibou Scholarship for Doctoral Students in Immunology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Yamada (Tokyo Institute of Technology), H. Mori (Tokyo Institute of Technology), K. Hase (Keio University), Y. Obata (Keio University), H. Kiyono (the University of Tokyo), Y. Morishita and H. Tanaka (Okayama University) for insightful discussion and valuable technical assistance. We thank all our laboratory members for discussion. We thank S. Nitta, Y. Nakayama, K. Kaneki, Y. Ogiwara, K. Kusubata, R. Yanobu-Takanashi and K. Nakano for technical assistance. D. Kioussis (UK National Institute for Medical Research) provided Vav-iCre mice. Supported in part by a Grant-in-Aid for Specially Promoted Research from the Japan Society for Promotion of Science (JSPS) (15H05703); grants for Exploratory Research for Advanced Technology (ERATO) Program and PRESTO from JST; Yakult Bio-Science Foundation; and JSPS KAKENHI (25111503 and 16H05202). K.N. was supported by Japanese Society for Immunology (JSI) Kibou Scholarship for Doctoral Students in Immunology.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cella M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00282; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Debard N, 2001, GASTROENTEROLOGY, V120, P1173, DOI 10.1053/gast.2001.22476; Donaldson DS, 2015, MUCOSAL IMMUNOL, V8, P582, DOI 10.1038/mi.2014.90; Ebisawa M, 2011, INT IMMUNOL, V23, P261, DOI 10.1093/intimm/dxq478; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Franchimont N, 2004, CLIN EXP IMMUNOL, V138, P491, DOI 10.1111/j.1365-2249.2004.02643.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kimura S, 2015, MUCOSAL IMMUNOL, V8, P650, DOI 10.1038/mi.2014.99; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Liu Y, 2016, ONCOTARGET, V7, P25328, DOI 10.18632/oncotarget.8291; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Taylor RT, 2007, J IMMUNOL, V178, P5659, DOI 10.4049/jimmunol.178.9.5659; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	50	83	85	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					675	+		10.1038/ni.3732	http://dx.doi.org/10.1038/ni.3732			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28436956				2022-12-18	WOS:000401520900012
J	Stadinski, BD; Shekhar, K; Gomez-Tourio, I; Jung, J; Sasaki, K; Sewell, AK; Peakman, M; Chakraborty, AK; Huseby, ES				Stadinski, Brian D.; Shekhar, Karthik; Gomez-Tourio, Iria; Jung, Jonathan; Sasaki, Katsuhiro; Sewell, Andrew K.; Peakman, Mark; Chakraborty, Arup K.; Huseby, Eric S.			Hydrophobic CDR3 residues promote the development of self-reactive T cells	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NONOBESE DIABETIC MICE; THYMIC SELECTION; NEGATIVE SELECTION; POSITIVE SELECTION; AMINO-ACIDS; NOD MICE; REPERTOIRE; MHC; ANTIGEN	Studies of individual T cell antigen receptors (TCRs) have shed some light on structural features that underlie self-reactivity. However, the general rules that can be used to predict whether TCRs are self-reactive have not been fully elucidated. Here we found that the interfacial hydrophobicity of amino acids at positions 6 and 7 of the complementarity-determining region CDR3 beta robustly promoted the development of self-reactive TCRs. This property was found irrespective of the member of the beta-chain variable region (V-beta) family present in the TCR or the length of the CDR3 beta. An index based on these findings distinguished V-beta(2+), V-beta(6+) and V(beta)8.2(+) regulatory T cells from conventional T cells and also distinguished CD4(+) T cells selected by the major histocompatibility complex (MHC) class II molecule I-A(g7) (associated with the development of type 1 diabetes in NOD mice) from those selected by a non-autoimmunity-promoting MHC class II molecule I-A(b). Our results provide a means for distinguishing normal T cell repertoires versus autoimmunity-prone T cell repertoires.	[Stadinski, Brian D.; Jung, Jonathan; Sasaki, Katsuhiro; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Shekhar, Karthik] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gomez-Tourio, Iria; Peakman, Mark] Kings Coll London, Dept Immunobiol, London, England; [Sewell, Andrew K.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; King's College London; Cardiff University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Huseby, ES (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	eric.huseby@umassmed.edu	Gomez-Tourino, Iria/AAA-9948-2019; Sewell, Andrew/GPT-4220-2022	Gomez-Tourino, Iria/0000-0001-6594-6110; Sewell, Andrew/0000-0003-3194-3135; Jung, Jonathan/0000-0002-3342-1245; Peakman, Mark/0000-0003-3328-3513	US National Institutes of Health [RO1-DK095077, U19 AI109858, T32 AI 007349]; University of Massachusetts Diabetes and Endocrine Research Center [DK32520]; Marie Curie Research; Fundacion Barrie; National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Diabetes and Endocrine Research Center; Marie Curie Research(European Commission); Fundacion Barrie; National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the US National Institutes of Health (RO1-DK095077 and U19 AI109858 to E.S.H., and T32 AI 007349 to B.D.S.), the University of Massachusetts Diabetes and Endocrine Research Center (DK32520 for E.S.H.), Marie Curie Research (I.G.T.), Fundacion Barrie (I.G.T.), the National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London (M.P.) and the Ragon Institute of MGH, MIT and Harvard (A.K.C.).	Aronesty E., 2011, EA UTILS COMMAND LIN; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cover TM, 2006, ELEMENTS INFORM THEO; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kruschke J. K, 2010, DOING BAYESIAN DATA; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Liu X, 2009, IMMUNITY, V31, P909, DOI 10.1016/j.immuni.2009.09.023; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Pham-Gia T, 2000, COMMUN STAT-THEOR M, V29, P2693, DOI 10.1080/03610920008832632; Ridgway WM, 1998, J EXP MED, V188, P2267, DOI 10.1084/jem.188.12.2267; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Suri A, 2008, CURR OPIN IMMUNOL, V20, P105, DOI 10.1016/j.coi.2007.10.007; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Vanguri V, 2013, P NATL ACAD SCI USA, V110, P288, DOI 10.1073/pnas.1208328110; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008; Yang X, 2015, J IMMUNOL, V194, P446, DOI 10.4049/jimmunol.1400711; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	56	83	83	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					946	+		10.1038/ni.3491	http://dx.doi.org/10.1038/ni.3491			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27348411	Green Accepted, Green Submitted			2022-12-18	WOS:000380647000012
J	Decque, A; Joffre, O; Magalhaes, JG; Cossec, JC; Blecher-Gonen, R; Lapaquette, P; Silvin', A; Manel, N; Joubert, PE; Seeler, JS; Albert, ML; Amit, I; Amigorena, S; Dejean, A				Decque, Adrien; Joffre, Olivier; Magalhaes, Joao G.; Cossec, Jack-Christophe; Blecher-Gonen, Ronnie; Lapaquette, Pierre; Silvin', Aymeric; Manel, Nicolas; Joubert, Pierre -Emmanuel; Seeler, Jacob-Sebastian; Albert, Matthew L.; Amit, Ido; Amigorena, Sebastian; Dejean, Anne			Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing	NATURE IMMUNOLOGY			English	Article							NEGATIVE REGULATION; BETA-GENE; INTERFERON; ACTIVATION; ENHANCER; SUMO; TRANSREPRESSION; MACROPHAGES; CONJUGATION; PATHWAYS	Innate sensing of pathogens initiates inflammatory cytokine responses that need to be tightly controlled. We found here that after engagement of Toll-like receptors (TLRs) in myeloid cells, deficient sumoylation caused increased secretion of transcription factor NF-kappa B-dependent inflammatory cytokines and a massive type I interferon signature. In mice, diminished sumoylation conferred susceptibility to endotoxin shock and resistance to viral infection. Overproduction of several NF-kappa B-dependent inflammatory cytokines required expression of the type I interferon receptor, which identified type I interferon as a central sumoylation-controlled hub for inflammation. Mechanistically, the small ubiquitin-like modifier SUMO operated from a distal enhancer of the gene encoding interferon-beta (Ifnb1) to silence both basal and stimulus-induced activity of the Ifnb1 promoter. Therefore, sumoylation restrained inflammation by silencing Ifnb1 expression and by strictly suppressing an unanticipated priming by type I interferons of the TLR-induced production of inflammatory cytokines.	[Decque, Adrien; Cossec, Jack-Christophe; Lapaquette, Pierre; Seeler, Jacob-Sebastian; Dejean, Anne] Inst Pasteur, Nucl Org & Oncogenesis Unit, Paris, France; [Decque, Adrien; Cossec, Jack-Christophe; Lapaquette, Pierre; Seeler, Jacob-Sebastian; Dejean, Anne] INSERM, U993, Paris, France; [Joffre, Olivier; Magalhaes, Joao G.; Silvin', Aymeric; Manel, Nicolas; Amigorena, Sebastian] Inst Curie, Ctr Rech, Paris, France; [Joffre, Olivier; Magalhaes, Joao G.; Silvin', Aymeric; Manel, Nicolas; Amigorena, Sebastian] INSERM, U932, Paris, France; [Joffre, Olivier] Univ Toulouse 3, Univ Toulouse, Ctr Physiopathol Toulouse Purpan, INSERM,U1043, F-31062 Toulouse, France; [Blecher-Gonen, Ronnie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Joubert, Pierre -Emmanuel; Albert, Matthew L.] INSERM, U818, Lab Dendrit Cell Immunobiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dejean, A (corresponding author), Inst Pasteur, Nucl Org & Oncogenesis Unit, Paris, France.; Dejean, A (corresponding author), INSERM, U993, Paris, France.; Amigorena, S (corresponding author), Inst Curie, Ctr Rech, Paris, France.; Amigorena, S (corresponding author), INSERM, U932, Paris, France.	sebastian.amigorena@curie.fr	Lapaquette, Pierre/AAF-5537-2020; Magalhaes, Joao/AAK-2686-2020; Albert, Matthew L/C-9782-2009; Dejean, Anne/L-5145-2018; Manel, Nicolas/E-2128-2011; JOUBERT, Pierre-Emmanuel/ABE-4335-2021; Joffre, Olivier P/K-1235-2014	Manel, Nicolas/0000-0002-1481-4430; Joffre, Olivier P/0000-0003-1168-8165; Dejean, Anne/0000-0003-4778-6840; Seeler, Jacob-Sebastian/0000-0001-8209-8555; Cossec, Jack-Christophe/0000-0002-0836-1009; Amigorena, Sebastian/0000-0001-8583-8416; Joubert, Pierre-Emmanuel/0000-0001-9859-6479; Blecher, Ronnie/0000-0003-2847-1149; Lapaquette, Pierre/0000-0002-2680-351X	Institut National du Cancer [PLBIO13-057]; Agence Nationale de la Recherche [ANR-14-CE16]; Ligue Nationale Contre le Cancer (Equipes labellisees); Fondation pour la Recherche Medicale (FRM) [AJE201212]; Region-Midi-Pyrenees [NVEQ 2014]; European Research Council ('SUMOSTRESS'); European Research Council ('HIVINNATE') [309848]; European Research Council [DC-BIOX340046]; Ecole Normale Superieure; Odyssey-RE	Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Equipes labellisees); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region-Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Research Council ('SUMOSTRESS'); European Research Council ('HIVINNATE'); European Research Council(European Research Council (ERC)European Commission); Ecole Normale Superieure; Odyssey-RE	We thank M. Dasso (US National Institutes of Health) for antibody to SUMO-2; A. Garcia-Sastre(Icahn School of Medicine at Mount Sinai) for antibody to HA; A. Andrieux and J.-M. Carpier for technical help; Philippe Sansonetti (Pasteur Institute, Paris) for S. flexneri; and M. Yaniv for critical reading of the manuscript. Sequencing was performed by the Institut Genetique Biologie Moleculaire Cellulaire Microarray and Sequencing platform, a member of the 'France Genomique' consortium (ANR-10-INBS-0009). Supported by Institut National du Cancer (PLBIO13-057 to S.A.), Agence Nationale de la Recherche (ANR-14-CE16 to S.A.), Ligue Nationale Contre le Cancer (Equipes labellisees, A. Dejean and S.A.), Fondation pour la Recherche Medicale (FRM, AJE201212 to O.J.), Region-Midi-Pyrenees (NVEQ 2014 to O.J.), European Research Council ('SUMOSTRESS' to A. Dejean, 'DC-BIOX340046' to S.A., and 'HIVINNATE' (309848) to N.M.), Ecole Normale Superieure (A. Decque) and Odyssey-RE (A. Decque).	Banerjee AR, 2014, NUCLEIC ACIDS RES, V42, P12537, DOI 10.1093/nar/gku1018; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Begitt A, 2011, BLOOD, V118, P1002, DOI 10.1182/blood-2011-04-347930; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Chow NA, 2014, CELL REP, V9, P1718, DOI 10.1016/j.celrep.2014.11.011; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fu JH, 2011, MOL IMMUNOL, V48, P415, DOI 10.1016/j.molimm.2010.09.003; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Liu YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037636; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Racke M.K., 2001, CURR PROTOC NEUROSCI, P1; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tempe D, 2014, ONCOGENE, V33, P921, DOI 10.1038/onc.2013.4; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514	42	83	88	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					140	149		10.1038/ni.3342	http://dx.doi.org/10.1038/ni.3342			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26657003				2022-12-18	WOS:000368571500007
J	Brennecke, P; Reyes, A; Pinto, S; Rattay, K; Nguyen, M; Kuchlert, R; Huber, W; Kyewski, B; Steinmetz, LM				Brennecke, Philip; Reyes, Alejandro; Pinto, Sheena; Rattay, Kristin; Nguyen, Michelle; Kuechlert, Rita; Huber, Wolfgang; Kyewski, Bruno; Steinmetz, Lars M.			Single-cell transcriptome analysis reveals coordinated ectopic gene-expression patterns in medullary thymic epithelial cells	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA-SEQ; NEGATIVE SELECTION; SELF-TOLERANCE; AIRE; CHROMATIN; REPERTOIRE; LANDSCAPE; ANTIGENS	Expression of tissue-restricted self antigens (TRAs) in medullary thymic epithelial cells (mTECs) is essential for the induction of self-tolerance and prevents autoimmunity, with each TRA being expressed in only a few mTECs. How this process is regulated in single mTECs and is coordinated at the population level, such that the varied single-cell patterns add up to faithfully represent TRAs, is poorly understood. Here we used single-cell RNA sequencing and obtained evidence of numerous recurring TRA-co-expression patterns, each present in only a subset of mTECs. Co-expressed genes clustered in the genome and showed enhanced chromatin accessibility. Our findings characterize IRA expression in mTECs as a coordinated process that might involve local remodeling of chromatin and thus ensures a comprehensive representation of the immunological self.	[Brennecke, Philip; Nguyen, Michelle; Steinmetz, Lars M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Brennecke, Philip; Nguyen, Michelle; Steinmetz, Lars M.] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Reyes, Alejandro; Huber, Wolfgang; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Pinto, Sheena; Rattay, Kristin; Kuechlert, Rita; Kyewski, Bruno] German Canc Res Ctr, Div Dev Immunol, Heidelberg, Germany	Stanford University; Stanford University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Huber, W (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.	whuber@embl.de; b.kyewski@dkfz.de; larsms@stanford.edu	Reyes, Alejandro/D-8258-2017; Rattay, Kristin/AAF-4661-2020	Reyes, Alejandro/0000-0001-8717-6612; Huber, Wolfgang/0000-0002-0474-2218; Steinmetz, Lars/0000-0002-3962-2865; Rattay, Kristin/0000-0003-3503-2136	European Union; Helmholtz Center; Sonderforschungsbereich (DFG 938); European Research Council [ERC-2012-AdG]; US National Institutes of Health [P01 HG000205, R01 GM068717]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	European Union(European Commission); Helmholtz Center; Sonderforschungsbereich (DFG 938)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Hexel and S. Schmitt for single-cell sorting; S. Egle for technical help; C. Sebening and T. Loukanov (University of Heidelberg) for human thymic tissue; The Genomics Core Facility of the European Molecular Biology Laboratory for initial sequencing, and M. Miranda and E. Hopmans for support during subsequent sequencing at the Stanford Genome Technology Center; J. Buenrostro and C. Chabbert for discussions about ATAC-seq experiments and data, respectively; C. Michel and S. Anders for advice and comments on the manuscript; W Wei and M. Sikora for help with data transfer; and The Central Animal Facility (German Cancer Research Center) for animal care. Supported by the European Union 7th Framework Programme (Health) via Project Radiant (W.H. and A.R.), The Helmholtz Center (K.R.), the Sonderforschungsbereich (DFG 938 to S.P.), the European Research Council (ERC-2012-AdG to B.K.) and the US National Institutes of Health (P01 HG000205 and R01 GM068717 to P.B., M.N. and L.M.S.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; DeVoss JJ, 2007, CURR OPIN GENET DEV, V17, P193, DOI 10.1016/j.gde.2007.04.001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pinto S, 2014, EUR J IMMUNOL, V44, P2811, DOI 10.1002/eji.201444499; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; St-Pierre C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01860; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tykocinski LO, 2010, P NATL ACAD SCI USA, V107, P19426, DOI 10.1073/pnas.1009265107; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	44	83	84	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					933	941		10.1038/ni.3246	http://dx.doi.org/10.1038/ni.3246			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26237553	Green Accepted			2022-12-18	WOS:000359876900011
J	Bossen, C; Murre, CS; Chang, AN; Mansson, R; Rodewald, HR; Murre, C				Bossen, Claudia; Murre, Caroline S.; Chang, Aaron N.; Mansson, Robert; Rodewald, Hans-Reimer; Murre, Cornelis			The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth	NATURE IMMUNOLOGY			English	Article							DNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; GENE-EXPRESSION; SWI/SNF; IKAROS; LOCUS; COMPLEXES; E2A; MYC	Early B cell development is orchestrated by the combined activities of the transcriptional regulators E2A, EBF1, Foxo1 and Ikaros. However, how the genome-wide binding patterns of these regulators are modulated during B lineage development remains to be determined. Here we found that in lymphoid progenitor cells, the chromatin remodeler Brg1 specified the B cell fate. In committed pro-B cells, Brg1 regulated contraction of the locus encoding the immunoglobulin heavy chain (Igh) and controlled expression of the gene encoding the transcription factor c-Myc (Myc) to modulate the expression of genes encoding products that regulate ribosome biogenesis. In committed pro-B cells, Brg1 suppressed a pre-B lineage-specific pattern of gene expression. Finally, we found that Brg1 acted mechanistically to establish B cell fate and modulate cell growth by facilitating access of lineage-specific transcription factors to enhancer repertoires.	[Bossen, Claudia; Murre, Caroline S.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, San Diego, CA 92103 USA; [Chang, Aaron N.] Univ Calif San Diego, Ctr Computat Biol, Inst Genom Med, San Diego, CA 92103 USA; [Mansson, Robert] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Mansson, Robert] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, San Diego, CA 92103 USA.	murre@biomail.ucsd.edu	Mansson, Robert/D-4372-2014	Mansson, Robert/0000-0003-0738-0328	US National Institutes of Health [P30CA023100, NS047101, RO1 AI109599-25]; Deutsche Forschungsgemeinschaft-Sonderforschungsbereich [873, B11]; European Molecular Biology Organization; Swiss National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109599, R01AI100880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft-Sonderforschungsbereich(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Edsall, S. Kuan, B. Li and B. Ren for sequencing; the Murre laboratory for discussions; A. Bortnick for comments on the manuscript; C. Benner for help with the Hi-C analysis; B. Bruneau (Gladstone Institute of Cardiovascular Disease) and P. Chambon (Institut Genetique Biologie Moleculaire Cellulaire) for Smarca4<SUP>fl/fl</SUP> mice; Y. Zhuang (Duke University) for E2A-GFP mice; and S. Smale (University of California, Los Angeles) for plasmids pRVGP and pRVGP-BB and antibody Ik-C. ATAC-Seq was conducted in part at the IGM Genomics Center of the University of California, San Diego (supported by the US National Institutes of Health (P30CA023100)). Imaging was performed at the microscopy core of the School of Medicine, University of California, San Diego (supported by the US National Institutes of Health (NS047101)). Supported by Deutsche Forschungsgemeinschaft-Sonderforschungsbereich 873 (project B11 to H.-R.R.), the European Molecular Biology Organization (C.B.), the Swiss National Science Foundation (C.B.) and the US National Institutes of Health (RO1 AI109599-25 to C.M.).	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeKoter RP, 2007, BLOOD CELL MOL DIS, V39, P316, DOI 10.1016/j.bcmd.2007.06.004; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Osipovich OA, 2009, J IMMUNOL, V183, P1509, DOI 10.4049/jimmunol.0900896; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Sakamoto S, 2012, J IMMUNOL, V188, P5547, DOI 10.4049/jimmunol.1002346; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Vallespinos M, 2011, J IMMUNOL, V186, P6726, DOI 10.4049/jimmunol.1002753; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031	45	83	85	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					775	+		10.1038/ni.3170	http://dx.doi.org/10.1038/ni.3170			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	25985234	Green Accepted			2022-12-18	WOS:000356445600014
J	Huang, CX; Hatzi, K; Melnick, A				Huang, Chuanxin; Hatzi, Katerina; Melnick, Ari			Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; GERMINAL-CENTER FORMATION; CENTER B-CELL; TRANSCRIPTIONAL REPRESSION; IN-VITRO; T-CELLS; COREPRESSOR; DOMAIN; GENE; EXPRESSION	The transcription factor Bcl-6 orchestrates germinal center (GC) reactions through its actions in B cells and T cells and regulates inflammatory signaling in macrophages. Here we found that genetic replacement with mutated Bcl6 encoding Bcl-6 that cannot bind corepressors to its BTB domain resulted in disruption of the formation of GCs and affinity maturation of immunoglobulins due to a defect in the proliferation and survival of B cells. In contrast, loss of function of the BIB domain had no effect on the differentiation and function of follicular helper T cells or that of other helper T cell subsets. Bcl6-null mice had a lethal inflammatory phenotype, whereas mice with a mutant BIB domain had normal healthy lives with no inflammation. The repression of inflammatory responses by Bcl-6 in macrophages was accordingly independent of the repressor function of the BIB domain. Bcl-6 thus mediates its actions through lineage-specific biochemical functions.	[Huang, Chuanxin; Hatzi, Katerina; Melnick, Ari] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA	Cornell University	Melnick, A (corresponding author), Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA.	amm2014@med.cornell.edu	Melnick, Ari/AAA-5763-2020		US National Cancer Institute [R01 104348]; Burroughs Wellcome Foundation; Chemotherapy Foundation; March of Dimes; NATIONAL CANCER INSTITUTE [R01CA104348, R01CA143032] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Chemotherapy Foundation; March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Ye (Albert Einstein College of Medicine) for Bcl6<SUP>-/-</SUP> mice; W Pear (University of Pennsylvania) for the MIGR1 expression vector; and D. Wen and S. Rafii for assistance in generating Bcl6<SUP>BTBMUT</SUP> mice. Supported by the US National Cancer Institute (R01 104348 to A.M.), the Burroughs Wellcome Foundation and Chemotherapy Foundation (A.M.) and the March of Dimes (A.M.), and facilitated by the Sackler Center for Biomedical and Physical Sciences at Weill Cornell Medical College.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cerchietti LC, 2008, CANCER RES, V68, P3361, DOI 10.1158/0008-5472.CAN-07-5817; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Goteri G, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-97; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Mondal A, 2010, J IMMUNOL, V184, P4123, DOI 10.4049/jimmunol.0901242; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Ranuncolo SA, 2008, BLOOD CELL MOL DIS, V41, P95, DOI 10.1016/j.bcmd.2008.02.003; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171	46	83	90	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					380	388		10.1038/ni.2543	http://dx.doi.org/10.1038/ni.2543			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23455674	Green Accepted			2022-12-18	WOS:000316648700013
J	Xu, S; Liu, XG; Bao, Y; Zhu, XH; Han, CF; Zhang, P; Zhang, XM; Li, WH; Cao, XT				Xu, Sheng; Liu, Xingguang; Bao, Yan; Zhu, Xuhui; Han, Chaofeng; Zhang, Peng; Zhang, Xuemin; Li, Weihua; Cao, Xuetao			Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway	NATURE IMMUNOLOGY			English	Article							SIGNAL-TRANSDUCTION; TYROSINE KINASE; CELL TOLERANCE; CUTTING EDGE; FPS/FES; FAMILY; ACTIVATION; RECEPTOR; FES; BETA(2)-MICROGLOBULIN	The molecular mechanisms that fine-tune Toll-like receptor (TLR)-triggered innate inflammatory responses remain to be fully elucidated. Major histocompatibility complex (MHC) molecules can mediate reverse signaling and have nonclassical functions. Here we found that constitutively expressed membrane MHC class I molecules attenuated TLR-triggered innate inflammatory responses via reverse signaling, which protected mice from sepsis. The intracellular domain of MHC class I molecules was phosphorylated by the kinase Src after TLR activation, then the tyrosine kinase Fps was recruited via its Src homology 2 domain to phosphorylated MHC class I molecules. This led to enhanced Fps activity and recruitment of the phosphatase SHP-2, which interfered with TLR signaling mediated by the signaling molecule TRAF6. Thus, constitutive MHC class I molecules engage in crosstalk with TLR signaling via the Fps-SHP-2 pathway and control TLR-triggered innate inflammatory responses.	[Xu, Sheng; Liu, Xingguang; Bao, Yan; Zhu, Xuhui; Han, Chaofeng; Zhang, Peng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Xu, Sheng; Liu, Xingguang; Bao, Yan; Zhu, Xuhui; Han, Chaofeng; Zhang, Peng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Zhang, Xuemin; Li, Weihua] Natl Ctr Biomed Anal, Beijing, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Mol Biol, Beijing 100730, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@immunol.org		Liu, Xingguang/0000-0002-1928-8847; xu, sheng/0000-0002-9547-8052	National Key Basic Research Program of China [2012CB910202, 2010CB911903]; National 125 Key Project [2012ZX10002-014, 2012AA020901]; National Natural Science Foundation of China [81123006]; Shanghai Committee of Science and Technology [10DZ1910300]	National Key Basic Research Program of China(National Basic Research Program of China); National 125 Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank G. Feng (University of California, San Diego) for mice with loxP-flanked alleles encoding SHP-2; H. Shen (University of Pennsylvania School of Medicine) for L. monocytogenes; N. van Rooijen (Free University of Amsterdam) for liposomes; J. Long, X. Zuo and P. Ma for technical assistance; and T. Chen and Y. Han for discussions. Supported by the National Key Basic Research Program of China (2012CB910202 and 2010CB911903), the National 125 Key Project (2012ZX10002-014 and 2012AA020901), the National Natural Science Foundation of China (81123006) and the Shanghai Committee of Science and Technology (10DZ1910300).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Antoniou AN, 2003, CURR OPIN IMMUNOL, V15, P75, DOI 10.1016/S0952-7915(02)00010-9; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Brizzi MF, 1996, J BIOL CHEM, V271, P3562; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Colonna M, 1998, J IMMUNOL, V160, P3096; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Gadola SD, 2000, CLIN EXP IMMUNOL, V121, P173, DOI 10.1046/j.1365-2249.2000.01264.x; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hellwig S, 2011, FRONT BIOSCI-LANDMRK, V16, P3146, DOI 10.2741/3902; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LITTLE AM, 1995, J IMMUNOL, V154, P5205; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; MATSUDA T, 1995, J BIOL CHEM, V270, P11037, DOI 10.1074/jbc.270.19.11037; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Pedersen AE, 1999, APMIS, V107, P887, DOI 10.1111/j.1699-0463.1999.tb01488.x; Pedersen AE, 1998, EXP CELL RES, V240, P144, DOI 10.1006/excr.1998.4014; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; RAULET DH, 1994, ADV IMMUNOL, V55, P381; Rubio G, 2004, J LEUKOCYTE BIOL, V76, P116, DOI 10.1189/jlb.1103597; Rui YX, 2007, J IMMUNOL, V179, P7344, DOI 10.4049/jimmunol.179.11.7344; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Skov S, 1998, TISSUE ANTIGENS, V51, P215; SKOV S, 1995, J IMMUNOL, V154, P1167; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; TSCHERNING T, 1994, SCAND J IMMUNOL, V39, P117, DOI 10.1111/j.1365-3083.1994.tb03349.x; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yang J, 2006, CANCER CELL, V10, P295, DOI 10.1016/j.ccr.2006.08.025; Zhang XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001158; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112; Zirngibl RA, 2002, MOL CELL BIOL, V22, P2472, DOI 10.1128/MCB.22.8.2472-2486.2002	45	83	92	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					551	+		10.1038/ni.2283	http://dx.doi.org/10.1038/ni.2283			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22522491				2022-12-18	WOS:000304203900009
J	Navarro, MN; Goebel, J; Feijoo-Carnero, C; Morrice, N; Cantrell, DA				Navarro, Maria N.; Goebel, Jurgen; Feijoo-Carnero, Carmen; Morrice, Nick; Cantrell, Doreen A.			Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes	NATURE IMMUNOLOGY			English	Article							NUCLEAR EXPORT; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; ENZYMATIC-ACTIVITY; PHOSPHORYLATION; KINASE; ACTIVATION; EXPRESSION; APOPTOSIS; CELLS	Here we report an unbiased analysis of the cytotoxic T lymphocyte (CTL) serine-threonine phosphoproteome by high-resolution mass spectrometry. We identified approximately 2,000 phosphorylations in CTLs, of which approximately 450 were controlled by T cell antigen receptor (TCR) signaling. A significantly overrepresented group of molecules identified included transcription activators, corepressors and chromatin regulators. A focus on chromatin regulators showed that CTLs had high expression of the histone deacetylase HDAC7 but continually phosphorylated and exported this transcriptional repressor from the nucleus. Dephosphorylation of HDAC7 resulted in its accumulation in the nucleus and suppressed expression of genes encoding key cytokines, cytokine receptors and adhesion molecules that determine CTL function. Screening of the CTL phosphoproteome has thus identified intrinsic pathways of serine-threonine phosphorylation that target chromatin regulators and determine the CTL functional program.	[Navarro, Maria N.; Goebel, Jurgen; Feijoo-Carnero, Carmen; Cantrell, Doreen A.] Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee, Scotland; [Morrice, Nick] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Dundee; Beatson Institute	Cantrell, DA (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk		Navarro, Maria N./0000-0003-3977-812X; Cantrell, Doreen/0000-0001-7525-3350	Wellcome Trust [065975/Z/01/A]; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Biological Services Unit, R. Clarke of the Flow Cytometry Facility and members of the Cantrell laboratory for critical reading of the manuscript; and the Finnish DNA Microarray Centre at the Centre for Biotechnology (Turku, Finland) and N. Schurch for microarray analysis. Supported by the Wellcome Trust (065975/Z/01/A) and the Medical Research Council (J.G.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; BROCKMEYER C, 2010, J BIOL CHEM     1228, DOI DOI 10.1074//JBC.M110.201236; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kasler HG, 2007, MOL CELL BIOL, V27, P5184, DOI 10.1128/MCB.02091-06; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lin JX, 2008, BLOOD, V111, P525, DOI 10.1182/blood-2007-02-072207; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2009, IMMUNOL REV, V228, P241, DOI 10.1111/j.1600-065X.2008.00759.x; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	51	83	88	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					352	U111		10.1038/ni.2008	http://dx.doi.org/10.1038/ni.2008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21399638	Green Accepted			2022-12-18	WOS:000288593400014
J	Delker, RK; Fugmann, SD; Papavasiliou, FN				Delker, Rebecca K.; Fugmann, Sebastian D.; Papavasiliou, F. Nina			A coming-of-age story: activation-induced cytidine deaminase turns 10	NATURE IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; ANTIBODY DIVERSIFICATION ENZYME; INDUCED CYTOSINE DEAMINASE; RNA EDITING ENZYME; HEAVY-CHAIN LOCUS; PROTEIN-KINASE-A; SOMATIC HYPERMUTATION; B-CELLS; IMMUNOGLOBULIN GENES	The discovery and characterization of activation-induced cytidine deaminase (AID) 10 years ago provided the basis for a mechanistic understanding of secondary antibody diversification and the subsequent generation and maintenance of cellular memory in B lymphocytes, which signified a major advance in the field of B cell immunology. Here we celebrate and review the triumphs in the mission to understand the mechanisms through which AID influences antibody diversification, as well as the implications of AID function on human physiology. We also take time to point out important ongoing controversies and outstanding questions in the field and highlight key experiments and techniques that hold the potential to elucidate the remaining mysteries surrounding this vital protein.	[Delker, Rebecca K.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Fugmann, Sebastian D.] NIA, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, 1230 York Ave, New York, NY 10021 USA.	papavasiliou@rockefeller.edu			Department of Defense; US National Institutes of Health [CA098495]; National Institute on Aging of the National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA098495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000387] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Department of Defense (R. K. D.), the US National Institutes of Health (CA098495 for AID-related work in the F. N. P. laboratory) and the Intramural Program of the National Institute on Aging of the National Institutes of Health (S. D. F.).	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2007, ADV EXP MED BIOL, V596, P129; Begum NA, 2009, P NATL ACAD SCI USA, V106, P2752, DOI 10.1073/pnas.0813252106; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Burnet F M, 1976, CA Cancer J Clin, V26, P119, DOI 10.3322/canjclin.26.2.119; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; CREWS S, 1981, CELL, V25, P59, DOI 10.1016/0092-8674(81)90231-2; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; DELKER R, 2009, KEYST M TAOS NM; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; DUNNICK W, 2003, J EXP MED IN PRESS; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Durandy A, 2004, ADV IMMUNOL, V82, P295, DOI 10.1016/S0065-2776(04)82007-8; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kothapalli N, 2008, J IMMUNOL, V180, P2019, DOI 10.4049/jimmunol.180.4.2019; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Mayorov VI, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-10; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Nonaka T, 2009, P NATL ACAD SCI USA, V106, P2747, DOI 10.1073/pnas.0812957106; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Schoetz U, 2006, J IMMUNOL, V177, P395, DOI 10.4049/jimmunol.177.1.395; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2001, INT IMMUNOL, V13, P665, DOI 10.1093/intimm/13.5.665; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Shivarov V, 2008, P NATL ACAD SCI USA, V105, P15866, DOI 10.1073/pnas.0806641105; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Storb U, 2007, ADV EXP MED BIOL, V596, P83; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0; Winter DB, 1997, MOL IMMUNOL, V34, P359, DOI 10.1016/S0161-5890(97)00073-4; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8; Yang SY, 2006, J EXP MED, V203, P2919, DOI 10.1084/jem.20061835; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200	104	83	89	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1147	1153		10.1038/ni.1799	http://dx.doi.org/10.1038/ni.1799			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841648	Green Accepted			2022-12-18	WOS:000270955900006
J	Ni, ZY; El Hassan, MA; Xu, ZD; Yu, T; Bremner, R				Ni, Zuyao; El Hassan, Mohamed Abou; Xu, Zhaodong; Yu, Tao; Bremner, Rod			The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTIONAL REGULATION; TRANSACTIVATOR CIITA; DOMAIN ACTIVATION; HUMAN GENOME; BAF COMPLEX; CELL-LINES; IFN-GAMMA; INTERFERON; EXPRESSION; GENES	The chromatin-remodeling enzyme BRG1 is critical for interferon-gamma (IFN-gamma)-mediated gene induction. Promoter-proximal elements are sufficient to mediate BRG1 dependency at some IFN-gamma targets. In contrast, we show here that at CIITA, which encodes the 'master regulator' of induction of major histocompatibility complex class II, distal elements conferred BRG1 dependency. At the uninduced locus, many sites formed BRG1-independent loops. One loop juxtaposed a far downstream element adjacent to a far upstream site. Notably, BRG1 was recruited to the latter site, which triggered the appearance of a histone 'mark' linked to activation. This subtle change was crucial, as subsequent IFN-gamma-induced recruitment of the transcription factors STAT1, IRF1 and p300, as well as histone modifications, accessibility and additional loops, showed BRG1 dependency. Like BRG1, each remote element was critical for the induction of CIITA expression. Thus, BRG1 regulates CIITA through many interdependent remote enhancers, not through the promoter alone.	[Ni, Zuyao; El Hassan, Mohamed Abou; Xu, Zhaodong; Yu, Tao; Bremner, Rod] Univ Toronto, Genet & Dev Div, Toronto Western Res Inst,Dept Lab Med & Pathobiol, Univ Hlth Network,Dept Ophthalmol & Vis Sci, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bremner, R (corresponding author), Univ Toronto, Genet & Dev Div, Toronto Western Res Inst,Dept Lab Med & Pathobiol, Univ Hlth Network,Dept Ophthalmol & Vis Sci, Toronto, ON M5T 2S8, Canada.	rbremner@uhnres.utoronto.ca	Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212; xu, zhaodong/0000-0002-4729-4734				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baiker A, 2000, NAT CELL BIOL, V2, P182, DOI 10.1038/35004061; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Christova R, 2007, J CELL SCI, V120, P3262, DOI 10.1242/jcs.012328; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; O'Neill D, 1999, P NATL ACAD SCI USA, V96, P349, DOI 10.1073/pnas.96.2.349; PATTENDEN S, 2003, THESIS U TORONTO; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; STEGER DJ, 2008, MOL CELL BIOL; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Ullrich E, 2007, CANCER RES, V67, P851, DOI 10.1158/0008-5472.CAN-06-3766; van der Stoep N, 2007, MOL IMMUNOL, V44, P2036, DOI 10.1016/j.molimm.2006.09.013; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005	53	83	85	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					785	793		10.1038/ni.1619	http://dx.doi.org/10.1038/ni.1619			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18500344				2022-12-18	WOS:000256904900017
J	Shan, Q; Zeng, ZH; Xing, SJ; Li, FY; Hartwig, SM; Gullicksrud, JA; Kurup, SP; Van Braeckel-Budimir, N; Su, Y; Martin, MD; Varga, SM; Taniuchi, I; Harty, JT; Peng, WQ; Badovinac, VP; Xue, HH				Shan, Qiang; Zeng, Zhouhao; Xing, Shaojun; Li, Fengyin; Hartwig, Stacey M.; Gullicksrud, Jodi A.; Kurup, Samarchith P.; Van Braeckel-Budimir, Natalija; Su, Yao; Martin, Matthew D.; Varga, Steven M.; Taniuchi, Ichiro; Harty, John T.; Peng, Weiqun; Badovinac, Vladimir P.; Xue, Hai-Hui			The transcription factor Runx3 guards cytotoxic CD8(+) effector T cells against deviation towards follicular helper T cell lineage	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; VIRAL-INFECTION; GENE-EXPRESSION; RNA-SEQ; DIFFERENTIATION; HETEROGENEITY; TCF-1; HOMEOSTASIS; REPRESSION; UPSTREAM	Activated CD8(+) T cells differentiate into cytotoxic effector (T-EFF) cells that eliminate target cells. How T-EFF cell identity is established and maintained is not fully understood. We found that Runx3 deficiency limited clonal expansion and impaired upregulation of cytotoxic molecules in T-EFF cells. Runx3-deficient CD8(+) T-EFF cells aberrantly upregulated genes characteristic of follicular helper T (T-FH) cell lineage, including Bcl6, Tcf7 and Cxcr5. Mechanistically, the Runx3-CBF beta transcription factor complex deployed H3K27me3 to Bcl6 and Tcf7 genes to suppress the T-FH program. Ablating Tcf7 in Runx3-deficient CD8(+) T-EFF cells prevented the upregulation of T-FH genes and ameliorated their defective induction of cytotoxic genes. As such, Runx3-mediated Tcf7 repression coordinately enforced acquisition of cytotoxic functions and protected the cytotoxic lineage integrity by preventing T-FH-lineage deviation.	[Shan, Qiang; Xing, Shaojun; Li, Fengyin; Hartwig, Stacey M.; Gullicksrud, Jodi A.; Kurup, Samarchith P.; Van Braeckel-Budimir, Natalija; Martin, Matthew D.; Varga, Steven M.; Harty, John T.; Badovinac, Vladimir P.; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Zeng, Zhouhao; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Hartwig, Stacey M.; Martin, Matthew D.; Varga, Steven M.; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Gullicksrud, Jodi A.; Varga, Steven M.; Harty, John T.; Badovinac, Vladimir P.; Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA USA; [Su, Yao] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Taniuchi, Ichiro] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	University of Iowa; George Washington University; University of Iowa; University of Iowa; Chinese Academy of Sciences; Institute of Microbiology, CAS; RIKEN	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.; Peng, WQ (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.; Xue, HH (corresponding author), Univ Iowa, Interdisciplinary Immunol Grad Program, Iowa City, IA USA.	wpeng@gwu.edu; hai-hui-xue@uiowa.edu	/AAI-2516-2019; Li, Fengyin/AAG-9476-2019; Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290; Peng, Weiqun/0000-0001-5521-9091; Shan, Qiang/0000-0002-7089-0278; Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439; Xing, Shaojun/0000-0003-0777-2196; Kurup, Samarchith/0000-0002-0640-0502; Xue, Hai-Hui/0000-0002-9163-7669	US National Institutes of Health (NIH) [AI112579, AI115149, AI119160, AI042767, AI114543, GM113961, AI121080, AI113806]; US Department of Veteran Affairs [I01 BX002903]; Carver College of Medicine, Holden Comprehensive Cancer; Iowa City Veteran's Administration Medical Center; National Cancer Institute [P30CA086862]; National Center for Research Resources of the NIH [S10 OD016199]; T32 Post-doctoral Training Grant [4T32AI007260-30]; Ballard and Seashore Dissertation Fellowship; Grants-in-Aid for Scientific Research [17H05805] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119160, R01AI121080, R37AI042767, R21AI113806, R21AI115149, R21AI042767, R01AI112579, T32AI007260, R01AI042767, R01AI114543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113961] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016199] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veteran Affairs(US Department of Veterans Affairs); Carver College of Medicine, Holden Comprehensive Cancer; Iowa City Veteran's Administration Medical Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); T32 Post-doctoral Training Grant; Ballard and Seashore Dissertation Fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank J. Fishbaugh, H. Vignes and M. Shey (University of Iowa Flow Cytometry Core Facility) for cell sorting, J. Bair and E. Snir (Genomics Division, Iowa Institute of Human Genetics) for ChIP-Seq, J. Shao (University of Iowa Central Microscopy Research Facility) for assistance with immunofluorescence staining, I. Antoshechkin (California Institute of Technology) for RNA-Seq, S. Crotty (La Jolla Institute) for sharing the protein immunization protocol, T.J. Waldschmidt for helpful discussions on B cell responses, W. Chen (Beijing Institute of Genomics) for help with RNA-Seq data analysis, and Y. Groner (Weizmann Institute of Science, Israel) for sharing high-throughput data on Runx3. This study was supported by grants from the US National Institutes of Health (NIH; AI112579 and AI115149 to H.-H.X., AI119160 to H.-H.X. and V.P.B., AI042767 to J.T.H., AI114543 and GM113961 to V.P.B., AI121080 to H.-H.X. and W.P., and AI113806 to W.P.) and the US Department of Veteran Affairs (I01 BX002903 to H.-H.X.). The flow cytometry core facility at the University of Iowa is supported by the Carver College of Medicine, Holden Comprehensive Cancer Center, the Iowa City Veteran's Administration Medical Center, and by grants from the National Cancer Institute (P30CA086862) and the National Center for Research Resources of the NIH (S10 OD016199). M.D.M. is supported by a T32 Post-doctoral Training Grant (4T32AI007260-30). J.A.G. is a recipient of the Ballard and Seashore Dissertation Fellowship.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Djuretic IM, 2009, ADV IMMUNOL, V104, P1, DOI 10.1016/S0065-2776(08)04001-7; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Gullicksrud Jodi A, 2017, [Frontiers in Biology, 生物学前沿], V12, P83; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jing XF, 2008, J BIOL CHEM, V283, P24326, DOI 10.1074/jbc.M804487200; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Lamb TJ, 2008, IMMUNITY, V28, P288, DOI 10.1016/j.immuni.2008.02.003; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Mittrucker HW, 2014, ARCH IMMUNOL THER EX, V62, P449, DOI 10.1007/s00005-014-0293-y; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Taylor JJ, 2012, TRENDS IMMUNOL, V33, P590, DOI 10.1016/j.it.2012.07.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	52	82	84	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					931	+		10.1038/ni.3773	http://dx.doi.org/10.1038/ni.3773			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28604718	Green Accepted			2022-12-18	WOS:000405821100016
J	Kathania, M; Khare, P; Zeng, MH; Cantarel, B; Zhang, HY; Ueno, H; Venuprasad, K				Kathania, Mahesh; Khare, Prashant; Zeng, Minghui; Cantarel, Brandi; Zhang, Haiying; Ueno, Hideki; Venuprasad, K.			Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-gamma t ubiquitination	NATURE IMMUNOLOGY			English	Article							E3 LIGASE ITCH; CELLS; RECEPTOR; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; TH17; POLYUBIQUITINATION; EXPRESSION; PATHWAYS	Dysregulated expression of interleukin 17 (IL-17) in the colonic mucosa is associated with colonic inflammation and cancer. However, the cell-intrinsic molecular mechanisms by which IL-17 expression is regulated remain unclear. We found that deficiency in the ubiquitin ligase Itch led to spontaneous colitis and increased susceptibility to colon cancer. Itch deficiency in the T(H)17 subset of helper T cells, innate lymphoid cells and gamma delta T cells resulted in the production of elevated amounts of IL-17 in the colonic mucosa. Mechanistically, Itch bound to the transcription factor ROR-gamma t and targeted ROR-gamma t for ubiquitination. Inhibition or genetic inactivation of ROR-gamma t attenuated IL-17 expression and reduced spontaneous colonic inflammation in Itch(-/-) mice. Thus, we have identified a previously unknown role for Itch in regulating IL-17-mediated colonic inflammation and carcinogenesis.	[Kathania, Mahesh; Khare, Prashant; Zeng, Minghui; Venuprasad, K.] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Cantarel, Brandi] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Zhang, Haiying] Baylor Univ, Med Ctr, Dept Pathol, Dallas, TX USA; [Ueno, Hideki] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; Icahn School of Medicine at Mount Sinai	Venuprasad, K (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	venuprasad.poojary@BSWHealth.org	Cantarel, Brandi/ABF-5756-2020; Khare, Prashant/O-8447-2017; Kathania, Mahesh/AAA-5766-2021; Ueno, Hideki/L-1237-2016	Cantarel, Brandi/0000-0003-4126-4478; Khare, Prashant/0000-0001-5792-3082; Ueno, Hideki/0000-0001-7747-0738; poojary, venuprasd/0000-0001-8986-9092; Kathania, Mahesh/0000-0002-4784-8581	American Cancer Society [122713-RSG-12-260-01-LIB]; Cancer Prevention Research Institute of Texas [RP160577]; Baylor Charles A. Sammons Cancer Center	American Cancer Society(American Cancer Society); Cancer Prevention Research Institute of Texas; Baylor Charles A. Sammons Cancer Center	We thank M. Ramsay, S. Oh and A. Theiss for discussions; C. Harrod for critical reading of the manuscript; and K. Kayembe for help with the analysis of flow cytometry data. Supported by the American Cancer Society (122713-RSG-12-260-01-LIB), the Cancer Prevention Research Institute of Texas (RP160577) and the Baylor Charles A. Sammons Cancer Center (K.V.).	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Deng L, 2015, MOL CELL, V58, P804, DOI 10.1016/j.molcel.2015.03.033; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Han L, 2014, J BIOL CHEM, V289, P25546, DOI 10.1074/jbc.M114.565291; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin HS, 2013, J CLIN INVEST, V123, P4923, DOI 10.1172/JCI69355; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pearson C, 2012, TRENDS IMMUNOL, V33, P289, DOI 10.1016/j.it.2012.04.004; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	46	82	85	5	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					997	+		10.1038/ni.3488	http://dx.doi.org/10.1038/ni.3488			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27322655				2022-12-18	WOS:000380647000018
J	Chiu, C; Openshaw, PJ				Chiu, Christopher; Openshaw, Peter J.			Antiviral B cell and T cell immunity in the lungs	NATURE IMMUNOLOGY			English	Review							RESPIRATORY SYNCYTIAL VIRUS; FOLLICULAR HELPER-CELL; INFLUENZA-A VIRUS; HEMAGGLUTINATION INHIBITION ASSAY; DENDRITIC CELLS; ANTIBODY-RESPONSES; EPITHELIAL-CELLS; VIRAL-INFECTION; GERMINAL CENTER; NEUTRALIZATION ASSAY	Respiratory viruses are frequent causes of repeated common colds, bronchitis and pneumonia, which often occur unpredictably as epidemics and pandemics. Despite those decimating effects on health and decades of intensive research, treatments remain largely supportive. The only commonly available vaccines are against influenza virus, and even these need improvement. The lung shares some features with other mucosal sites, but preservation of its especially delicate anatomical structures necessitates a fine balance of pro- and anti-inflammatory responses; well-timed, appropriately placed and tightly regulated T cell and B cell responses are essential for protection from infection and limitation of symptoms, whereas poorly regulated inflammation contributes to tissue damage and disease. Recent advances in understanding adaptive immunity should facilitate vaccine development and reduce the global effect of respiratory viruses.	[Chiu, Christopher; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England	Imperial College London	Openshaw, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England.	c.chiu@imperial.ac.uk; p.openshaw@imperial.ac.uk	Openshaw, Peter/AAL-9442-2020	Openshaw, Peter/0000-0002-7220-2555	MRC [MC_G1001212, G0902266] Funding Source: UKRI; National Institute for Health Research [NF-SI-0513-10150] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; Medical Research Council [G0902266, MC_G1001212, G1000758] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Asner SA, 2014, INFLUENZA OTHER RESP, V8, P436, DOI 10.1111/irv.12255; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barik S, 2013, CURR TOP MICROBIOL, V372, P173, DOI 10.1007/978-3-642-38919-1_9; Barlow PG, 2014, FUTURE MICROBIOL, V9, P55, DOI 10.2217/fmb.13.135; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Boyden AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040733; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chevrier S, 2014, J EXP MED, V211, P827, DOI 10.1084/jem.20131831; Chirkova TV, 2011, CLIN VACCINE IMMUNOL, V18, P1710, DOI 10.1128/CVI.05116-11; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Chiu C, 2013, ANN NY ACAD SCI, V1283, P13, DOI 10.1111/nyas.12012; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crowe James E Jr, 2003, Paediatr Respir Rev, V4, P112, DOI 10.1016/S1526-0542(03)00033-2; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Swart RL, 2002, J VIROL, V76, P11561, DOI 10.1128/JVI.76.22.11561-11569.2002; Esposito S, 2005, CLIN MICROBIOL INFEC, V11, P933, DOI 10.1111/j.1469-0691.2005.01270.x; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Falsey AR, 2006, J MED VIROL, V78, P1493, DOI 10.1002/jmv.20724; Falsey AR, 2009, J CLIN VIROL, V46, P314, DOI 10.1016/j.jcv.2009.09.020; FISHAUT M, 1980, J PEDIATR-US, V96, P179, DOI 10.1016/S0022-3476(80)80799-2; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Glanville N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003669; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Gupta N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069390; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Heidema J, 2008, J IMMUNOL, V181, P5551, DOI 10.4049/jimmunol.181.8.5551; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Herd KA, 2010, J GEN VIROL, V91, P1302, DOI 10.1099/vir.0.015396-0; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Kroll JL, 2011, SEMIN RESP CRIT CARE, V32, P447, DOI 10.1055/s-0031-1283284; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li YS, 2010, AM J PHYSIOL-LUNG C, V298, pL558, DOI 10.1152/ajplung.00225.2009; Liang B, 2001, J VIROL, V75, P5416, DOI 10.1128/JVI.75.11.5416-5420.2001; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Martinelli M, 2014, VIRUS RES, V189, P293, DOI 10.1016/j.virusres.2014.06.006; McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McNamara PS, 2013, THORAX, V68, P76, DOI 10.1136/thoraxjnl-2012-202288; Mikhak Z, 2013, J EXP MED, V210, P1855, DOI 10.1084/jem.20130091; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Morokutti A, 2013, J CLIN VIROL, V56, P323, DOI 10.1016/j.jcv.2012.12.002; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Raz E, 2007, NAT IMMUNOL, V8, P3, DOI 10.1038/ni0107-3; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmidt AC, 2011, SEMIN RESP CRIT CARE, V32, P527, DOI 10.1055/s-0031-1283289; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van Remmerden Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-253; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Walsh KB, 2014, J VIROL, V88, P6281, DOI 10.1128/JVI.00464-14; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woodland DL, 2004, SEMIN IMMUNOL, V16, P163, DOI 10.1016/j.smim.2004.02.003; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yewdell JW, 2011, CURR OPIN VIROL, V1, P177, DOI 10.1016/j.coviro.2011.05.005; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	140	82	86	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					18	26		10.1038/ni.3056	http://dx.doi.org/10.1038/ni.3056			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521681	Green Published, Bronze			2022-12-18	WOS:000346494200005
J	Vuong, BQ; Lee, M; Kabir, S; Irimia, C; Macchiarulo, S; McKnight, GS; Chaudhuri, J				Vuong, Bao Q.; Lee, Mieun; Kabir, Shaheen; Irimia, Cristina; Macchiarulo, Stephania; McKnight, G. Stanley; Chaudhuri, Jayanta			Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; ANTIBODY DIVERSIFICATION ENZYME; SOMATIC HYPERMUTATION; B-CELLS; AID; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; MECHANISM	Immunoglobulin class-switch recombination (CSR) requires activation-induced cytidine deaminase ( AID). Deamination of DNA by AID in transcribed switch (S) regions leads to double-stranded breaks in DNA that serve as obligatory CSR intermediates. Here we demonstrate that the catalytic and regulatory subunits of protein kinase A (PKA) were specifically recruited to S regions to promote the localized phosphorylation of AID, which led to binding of replication protein A and subsequent propagation of the CSR cascade. Accordingly, inactivation of PKA resulted in considerable disruption of CSR because of decreased AID phosphorylation and recruitment of replication protein A to S regions. We propose that PKA nucleates the formation of active AID complexes specifically on S regions to generate the high density of DNA lesions required for CSR.	[Vuong, Bao Q.; Lee, Mieun; Kabir, Shaheen; Irimia, Cristina; Macchiarulo, Stephania; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Irimia, Cristina; Chaudhuri, Jayanta] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	chaudhuj@mskcc.org		Vuong, Bao/0000-0001-5416-9635	US National Institutes of Health [T32CA09149]; Damon Runyon Cancer Research Foundation; Bressler Scholars Foundation; Frederick Adler Chair for Junior Faculty; SloanKettering Institute; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Bressler Scholars Foundation; Frederick Adler Chair for Junior Faculty; SloanKettering Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Honjo (Kyoto University) for AID-deficient mice; J. Allison (Memorial Sloan-Kettering Cancer Center) for anti-CD3 and anti-CD28; P. Rothman (University of Iowa) for the plasmid pMIG-hPim1; and L. Denzin and D. Sant'Angelo, as well as members of their laboratories and members of the Chaudhuri laboratory, for discussions and technical assistance. Supported by the US National Institutes of Health (T32CA09149 to B. V.), the Damon Runyon Cancer Research Foundation (J. C.), the Bressler Scholars Foundation (J. C.), the Frederick Adler Chair for Junior Faculty (J. C.) and the SloanKettering Institute (J. C.).	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chatterji M, 2007, J IMMUNOL, V179, P5274, DOI 10.4049/jimmunol.179.8.5274; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; CHENG HL, P NATL ACAD IN PRESS; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Howe DG, 2006, J NEUROBIOL, V66, P256, DOI 10.1002/neu.20217; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lin Y C, 1992, Curr Top Microbiol Immunol, V182, P157; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Shinkura R, 2007, ADV EXP MED BIOL, V596, P71; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	53	82	84	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					420	426		10.1038/ni.1708	http://dx.doi.org/10.1038/ni.1708			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19234474	Green Accepted			2022-12-18	WOS:000264425800016
J	Kawli, T; Tan, MW				Kawli, Trupti; Tan, Man-Wah			Neuroendocrine signals modulate the innate immunity of Caenorhabditis elegans through insulin signaling	NATURE IMMUNOLOGY			English	Article							SYNAPTIC-TRANSMISSION; LIFE-SPAN; UNC-31 CAPS; DAF-16; RECEPTOR; PATHWAY; VESICLE; PROTEIN; BETA; EXPRESSION	Communication between the immune and nervous systems, each of which is able to react rapidly to environmental stimuli, may confer a survival advantage. However, precisely how the nervous system influences the immune response and whether neural modulation of immune function is biologically important are not well understood. Here we report that neuronal exocytosis of neuropeptides from dense core vesicles suppressed the survival of Caenorhabditis elegans and their clearance of infection with the human bacterial pathogen Pseudomonas aeruginosa. This immunomodulatory function was mediated by INS-7, an insulin-like neuropeptide whose induction was associated with Pseudomonas virulence. INS-7 secreted from the nervous system functioned in a non-cell autonomous way to activate the insulin pathway and alter basal and inducible expression of immunity-related genes in intestinal cells.	[Tan, Man-Wah] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Tan, MW (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Dept Genet, Stanford, CA 94305 USA.	mwtan@stanford.edu			US National Institutes of Health National Center for Research Resources; Ministry of Education, Culture, Science, Sports and Technology, Japan; US National Institutes of Health [GM66269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066269] Funding Source: NIH RePORTER	US National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Culture, Science, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Chen and E. Evans for strain construction (ins-7(lf) 'rescue' under Pins-7 and Punc-119); A. Fire (Stanford University) for advice, vectors and use of the microinjection apparatus; S. Cohen for microscope use; K. Miller (Oklahoma Medical Research Foundation), K. Strange (Vanderbilt University), C. Darby (University of California, San Francisco), C. Kenyon (University of California, San Francisco), and K. Shen (Stanford University) for sharing strains and vectors; and all members of the Tan laboratory, A. Brunet and V. Nanjundiah for critical review and discussion of this work. Some nematode strains were provided by the Caenorhabditis Genetics Center (funded by the US National Institutes of Health National Center for Research Resources); the ins-7 mutant was provided by the Japanese National BioResource Project (funded by the Ministry of Education, Culture, Science, Sports and Technology, Japan). Supported by the US National Institutes of Health (GM66269 to M.-W.T.).	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1993, GENETICS, V134, P454; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Darby C, 2001, INFECT IMMUN, V69, P6271, DOI 10.1128/IAI.69.10.6271-6275.2001; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Morita K, 1999, DEVELOPMENT, V126, P1337; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nonet ML, 1998, J NEUROSCI, V18, P70; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Nurrish SJ, 2002, TRAFFIC, V3, P2, DOI 10.1034/j.1600-0854.2002.30102.x; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; RICHMOND J, 2005, WORMBOOK        1230, DOI DOI 10.1895/WORMBOOK.1.69.1; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhang Y, 2008, CURR OPIN MICROBIOL, V11, P257, DOI 10.1016/j.mib.2008.04.003	50	82	85	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1415	1424		10.1038/ni.1672	http://dx.doi.org/10.1038/ni.1672			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18854822				2022-12-18	WOS:000260888700017
J	Honjo, T; Nagaoka, H; Shinkura, R; Muramatsu, M				Honjo, T; Nagaoka, H; Shinkura, R; Muramatsu, M			AID to overcome the limitations of genomic information	NATURE IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; ACTIVATION-INDUCED DEAMINASE; NOVO PROTEIN-SYNTHESIS; B MESSENGER-RNA; IMMUNOGLOBULIN SOMATIC HYPERMUTATION; INDUCED CYTOSINE DEAMINASE; ANTIBODY DIVERSIFICATION; MISMATCH REPAIR	The limitations of genomic information forced our ancestors to adopt a strategy for introducing somatic DNA alterations with the risk of genome instability. Although activation-induced deaminase ( AID) is involved in DNA cleavage in somatic hypermutation and class-switch recombination, its mechanism of action has been debated extensively, with the two main hypotheses being distinguished by the chief target of AID: RNA or DNA. The principle distinction between the two hypotheses is the requirement for translation of edited mRNA or uracil removal from DNA for DNA cleavage. Although a series of experiments has provided support for the `RNA-editing' hypothesis and requires reevaluation of the `DNA-deamination' hypothesis, definitive proof is yet to come.	Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015	Muramatsu, Masamichi/0000-0002-0153-3533				AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Barreto VM, 2005, TRENDS IMMUNOL, V26, P90, DOI 10.1016/j.it.2004.12.004; Begum NA, 2004, P NATL ACAD SCI USA, V101, P13003, DOI 10.1073/pnas.0405219101; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Bemark M, 2003, GENE CHROMOSOME CANC, V38, P32, DOI 10.1002/gcc.10241; Besmer E, 2004, CURR OPIN IMMUNOL, V16, P241, DOI 10.1016/j.coi.2004.01.005; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Bross Linda, 2003, Clin Dev Immunol, V10, P83, DOI 10.1080/10446670310001626571; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;317::AID-IMMU317&gt;3.0.CO;2-S; Kodama M, 2001, INT IMMUNOL, V13, P1415, DOI 10.1093/intimm/13.11.1415; Kong QZ, 2001, GENETICS, V158, P369; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Lee GS, 2004, MOL CELL, V16, P505, DOI 10.1016/S1097-2765(04)00682-3; Luo ZH, 2004, J ALLERGY CLIN IMMUN, V114, P726, DOI 10.1016/j.jaci.2004.07.049; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Storb U, 1998, IMMUNOL REV, V162, P153; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	102	82	83	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					655	661		10.1038/ni1218	http://dx.doi.org/10.1038/ni1218			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970938				2022-12-18	WOS:000229975500008
J	Pouillon, V; Hascakova-Bartova, R; Pajak, B; Adam, E; Bex, F; Dewaste, V; Van Lint, C; Leo, O; Erneux, C; Schurmans, S				Pouillon, V; Hascakova-Bartova, R; Pajak, B; Adam, E; Bex, F; Dewaste, V; Van Lint, C; Leo, O; Erneux, C; Schurmans, S			Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development	NATURE IMMUNOLOGY			English	Article							1,4,5-TRISPHOSPHATE 3-KINASE; CALCIUM OSCILLATIONS; RECEPTOR GAP1(IP4BP); NEGATIVE SELECTION; CD4+8+ THYMOCYTES; RAT-BRAIN; CELLS; EXPRESSION; IDENTIFICATION; INVOLVEMENT	Inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3) is phosphorylated by Ins(1,4,5)P-3 3-kinase, generating inositol 1,3,4,5-tetrakisphosphate (Ins( 1,3,4,5) P-4). The physiological function of Ins( 1,3,4,5) P 4 is still unclear, but it has been reported to be a potential modulator of calcium mobilization. Disruption of the gene encoding the ubiquitously expressed Ins(1,4,5) P-3 3-kinase isoform B (Itpkb) in mice caused a severe T cell deficiency due to major alterations in thymocyte responsiveness and selection. However, we were unable to detect substantial defects in Ins(1,4,5) P-3 amounts or calcium mobilization in Itpkb(-/-) thymocytes. These data indicate that Itpkb and Ins(1,3,4,5) P-4 define an essential signaling pathway for T cell precursor responsiveness and development.	IRIBHN, IBMM, B-6041 Gosselies, Belgium; IRIBHN, B-1070 Brussels, Belgium; IBMM, Physiol Anim Lab, B-6041 Gosselies, Belgium; IBMM, Chim Biol Lab, B-6041 Gosselies, Belgium; CERIA, Microbiol Lab, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Schurmans, S (corresponding author), IRIBHN, IBMM, Rue Prof Jeener & Brachet 12, B-6041 Gosselies, Belgium.							Amsen D, 2000, EUR J IMMUNOL, V30, P2832, DOI 10.1002/1521-4141(200010)30:10<2832::AID-IMMU2832>3.0.CO;2-D; BAUS E, 1994, J IMMUNOL METHODS, V173, P41, DOI 10.1016/0022-1759(94)90281-X; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; COMMUNI D, 1995, CELL SIGNAL, V7, P643, DOI 10.1016/0898-6568(95)00035-N; COULIE PG, 1991, EUR J IMMUNOL, V21, P1703, DOI 10.1002/eji.1830210718; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Cullen PJ, 1998, BBA-MOL CELL BIOL L, V1436, P35, DOI 10.1016/S0005-2760(98)00149-0; DASILVA CP, 1994, J BIOL CHEM, V269, P12521; Dewaste V, 2003, BIOCHEM J, V374, P41, DOI 10.1042/BJ20021963; Dewaste V, 2002, BIOCHEM BIOPH RES CO, V291, P400, DOI 10.1006/bbrc.2002.6456; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; El-Daher SS, 2000, BLOOD, V95, P3412, DOI 10.1182/blood.V95.11.3412.011k03_3412_3422; FARR AG, 1985, J IMMUNOL, V134, P2971; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jun KS, 1998, LEARN MEMORY, V5, P317; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Loomis-Husselbee JW, 1998, BIOCHEM J, V331, P947, DOI 10.1042/bj3310947; MAILLEUX P, 1991, BRAIN RES, V539, P203, DOI 10.1016/0006-8993(91)91622-8; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Pajak B, 2000, J CLIN PATHOL, V53, P518, DOI 10.1136/jcp.53.7.518; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Singer SM, 2000, INFECT IMMUN, V68, P170, DOI 10.1128/IAI.68.1.170-175.2000; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TAKAZAWA K, 1990, BIOCHEM J, V268, P213, DOI 10.1042/bj2680213; TAKAZAWA K, 1991, BIOCHEM BIOPH RES CO, V174, P529, DOI 10.1016/0006-291X(91)91449-M; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Walker SA, 2002, J BIOL CHEM, V277, P48779, DOI 10.1074/jbc.M204839200; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Zhu DM, 1996, BIOCHEMISTRY-US, V35, P7214, DOI 10.1021/bi952471h; ZILBERMAN Y, 1987, EMBO J, V6, P957, DOI 10.1002/j.1460-2075.1987.tb04845.x	40	82	88	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1136	1143		10.1038/ni980	http://dx.doi.org/10.1038/ni980			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14517551				2022-12-18	WOS:000186241100018
J	Shortman, K; Heath, WR				Shortman, K; Heath, WR			Immunity or tolerance? That is the question for dendritic cells	NATURE IMMUNOLOGY			English	News Item							CD8(+) T-CELLS; CROSS-PRESENTATION; SELF-TOLERANCE; HELP; MATURATION		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Shortman, K (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	shortman@wehi.edu.au		Heath, William/0000-0001-9670-259X				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789	13	82	91	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					988	989		10.1038/ni1101-988	http://dx.doi.org/10.1038/ni1101-988			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685217				2022-12-18	WOS:000172049800007
J	Bevan, MJ; Fink, PJ				Bevan, MJ; Fink, PJ			The CD8 response on autopilot	NATURE IMMUNOLOGY			English	News Item							CELL; ANTIGENS; HELP		Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.							Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Busch DH, 2000, J IMMUNOL, V164, P4063, DOI 10.4049/jimmunol.164.8.4063; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Morgan DJ, 1999, J IMMUNOL, V163, P723; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	9	82	84	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					381	382		10.1038/87676	http://dx.doi.org/10.1038/87676			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323687				2022-12-18	WOS:000168549800007
J	Schild, H; Rammensee, HG				Schild, H; Rammensee, HG			Gp96 - The immune system's Swiss army knife	NATURE IMMUNOLOGY			English	News Item								Tumor vaccines comprised of the chaperone gp96 can instigate specific immunity to tumor peptides. A receptor on macrophages for the uptake of peptide-loaded gp96 has been identified as CD91, the alpha(2)-macroglobulin receptor.	Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schild, H (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Morgenstelle 15, D-72076 Tubingen, Germany.	rammensee@uni-tuebingen.de						Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Green DR, 2000, NATURE, V405, P28, DOI 10.1038/35011175; Gregory CD, 2000, CURR OPIN IMMUNOL, V12, P27, DOI 10.1016/S0952-7915(99)00047-3; Moroi Y, 2000, P NATL ACAD SCI USA, V97, P3485, DOI 10.1073/pnas.070550797; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411	12	82	92	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					100	101		10.1038/77770	http://dx.doi.org/10.1038/77770			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248798				2022-12-18	WOS:000089814900007
J	Allen, TM; Brehm, MA; Bridges, S; Ferguson, S; Kumar, P; Mirochnitchenko, O; Palucka, K; Pelanda, R; Sanders-Beer, B; Shultz, LD; Su, L; PrabhuDas, M				Allen, Todd M.; Brehm, Michael A.; Bridges, Sandra; Ferguson, Stacy; Kumar, Priti; Mirochnitchenko, Oleg; Palucka, Karolina; Pelanda, Roberta; Sanders-Beer, Brigitte; Shultz, Leonard D.; Su, Lishan; PrabhuDas, Mercy			Humanized immune system mouse models: progress, challenges and opportunities	NATURE IMMUNOLOGY			English	Article							MICE; INFECTION; CELLS		[Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Bridges, Sandra; Sanders-Beer, Brigitte] NIAID, Div AIDS, NIH, Rockville, MD USA; [Ferguson, Stacy; PrabhuDas, Mercy] NIAID, Div Allergy Immunol & Transplantat, NIH, Rockville, MD 20852 USA; [Kumar, Priti] Yale Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT USA; [Mirochnitchenko, Oleg] NIH, Off Res Infrastruct Programs, Div Program Coordinat Planning & Strateg Initiat, Off Director, Bldg 10, Bethesda, MD 20892 USA; [Palucka, Karolina] Jackson Lab, Farmington, CT USA; [Pelanda, Roberta] Univ Colorado, Dept Immunol & Microbiol, Aurora, CO USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Su, Lishan] Univ N Carolina, Chapel Hill, NC 27515 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; National Institutes of Health (NIH) - USA; Jackson Laboratory; University of Colorado System; University of Colorado Anschutz Medical Campus; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill	PrabhuDas, M (corresponding author), NIAID, Div Allergy Immunol & Transplantat, NIH, Rockville, MD 20852 USA.	mprabhudas@niaid.nih.gov	Allen, Todd/F-5473-2011	Allen, Todd/0000-0002-6609-1318; Brehm, Michael/0000-0001-6813-3262	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052310, R01AI124474] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI136990, R01 AI052310, R01 AI138797, R01 AI124474, R01 AI127346] Funding Source: Medline; NIDDK NIH HHS [R01 DK119937] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Carrillo MA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00746; Cheng L, 2015, ANTIVIR RES, V121, P1, DOI 10.1016/j.antiviral.2015.06.012; Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Dusseaux M, 2017, GASTROENTEROLOGY, V153, P1647, DOI 10.1053/j.gastro.2017.08.034; Ernst W, 2016, COMP IMMUNOL MICROB, V49, P29, DOI 10.1016/j.cimid.2016.08.006; Garcia JV, 2016, CURR OPIN VIROL, V19, P56, DOI 10.1016/j.coviro.2016.06.010; Goettel JA, 2015, BLOOD, V125, P3886, DOI 10.1182/blood-2014-12-618363; Kenney LL, 2016, AM J TRANSPLANT, V16, P389, DOI 10.1111/ajt.13520; Lang J, 2016, J EXP MED, V213, P93, DOI 10.1084/jem.20151039; Lavender KJ, 2018, AIDS, V32, P1, DOI [10.1097/qad.0000000000001674, 10.1097/QAD.0000000000001674]; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026; Shultz LD, 2019, MAMM GENOME, V30, P123, DOI 10.1007/s00335-019-09796-2; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tan SL, 2017, P NATL ACAD SCI USA, V114, P10954, DOI 10.1073/pnas.1710415114; Wege AK, 2018, BIODRUGS, V32, P245, DOI 10.1007/s40259-018-0275-4	21	81	81	8	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					770	774		10.1038/s41590-019-0416-z	http://dx.doi.org/10.1038/s41590-019-0416-z			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31160798	Green Submitted, Green Accepted			2022-12-18	WOS:000471891900002
J	Gorman, JA; Hundhausen, C; Errett, JS; Stone, AE; Allenspach, EJ; Ge, Y; Arkatkar, T; Clough, C; Dai, XZ; Khim, S; Pestal, K; Liggitt, D; Cerosaletti, K; Stetson, DB; James, RG; Oukka, M; Concannon, P; Gale, M; Buckner, JH; Rawlings, DJ				Gorman, Jacquelyn A.; Hundhausen, Christian; Errett, John S.; Stone, Amy E.; Allenspach, Eric J.; Ge, Yan; Arkatkar, Tanvi; Clough, Courtnee; Dai, Xuezhi; Khim, Socheath; Pestal, Kathleen; Liggitt, Denny; Cerosaletti, Karen; Stetson, Daniel B.; James, Richard G.; Oukka, Mohamed; Concannon, Patrick; Gale, Michael, Jr.; Buckner, Jane H.; Rawlings, David J.			The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity	NATURE IMMUNOLOGY			English	Article							OF-FUNCTION MUTATIONS; HEPATITIS-C VIRUS; RIG-I; IFN-ALPHA; GENE 5; RECOGNITION; ASSOCIATION; MDA5; ROLES; SUSCEPTIBILITY	The single-nucleotide polymorphism rs1990760 in the gene encoding the cytosolic viral sensor IFIH1 results in an amino-acid change (A946T; IFIH1(T946)) that is associated with multiple autoimmune diseases. The effect of this polymorphism on both viral sensing and autoimmune pathogenesis remains poorly understood. Here we found that human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the risk variant IFIH1(T946) exhibited heightened basal and ligand-triggered production of type I interferons. Consistent with those findings, mice with a knock-in mutation encoding IFIH1(T946) displayed enhanced basal expression of type I interferons, survived a lethal viral challenge and exhibited increased penetrance in autoimmune models, including a combinatorial effect with other risk variants. Furthermore, IFIH1(T946) mice manifested an embryonic survival defect consistent with enhanced responsiveness to RNA self ligands. Together our data support a model wherein the production of type I interferons driven by an autoimmune risk variant and triggered by ligand functions to protect against viral challenge, which probably accounts for its selection within human populations but provides this advantage at the cost of modestly promoting the risk of autoimmunity.	[Gorman, Jacquelyn A.; Allenspach, Eric J.; Arkatkar, Tanvi; Clough, Courtnee; Dai, Xuezhi; Khim, Socheath; James, Richard G.; Oukka, Mohamed; Rawlings, David J.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Hundhausen, Christian; Cerosaletti, Karen; Buckner, Jane H.] Benaroya Res Inst, Seattle, WA USA; [Errett, John S.; Stone, Amy E.; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Errett, John S.; Stone, Amy E.; Pestal, Kathleen; Stetson, Daniel B.; Oukka, Mohamed; Gale, Michael, Jr.; Rawlings, David J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Allenspach, Eric J.; James, Richard G.; Oukka, Mohamed; Rawlings, David J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ge, Yan; Concannon, Patrick] Univ Florida, Genet Inst, Gainesville, FL USA; [Ge, Yan; Concannon, Patrick] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Liggitt, Denny] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Seattle Children's Hospital; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle	Rawlings, DJ (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA.; Rawlings, DJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Rawlings, DJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	drawling@uw.edu	Arkatkar, Tanvi/AAU-8429-2021; Rawlings, David/CAI-4751-2022; Arkatkar, Tanvi/AAC-5286-2020; Stone, Amy/T-7852-2019	Arkatkar, Tanvi/0000-0003-3836-1963; james, richard/0000-0002-2302-7367; STONE, AMY E/0000-0002-9140-6510; Clough, Courtnee/0000-0002-7859-7252; Pestal, Kathleen/0000-0001-6886-804X; Ge, Yan/0000-0003-2129-9438; Allenspach, Eric/0000-0001-7346-5835	US National Institutes of Health [DP3-DK097672, DP3-DK111802, R01-AI084914, R01-AI104002, R01-AI060389, R01-AI127463, U19-AI083019, U19-AI100625, R01-DK106718, T32-AR007108, T32-GM007270]; Juvenile Diabetes Research Foundation [3-APF-2016-177-A-N]; Children's Guild Association Endowed Chair in Pediatric Immunology; Benaroya Family Gift Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI118916, R01AI104002, R01AI084914, R01AI060389, R01AI127463, U19AI100625, R21AI124735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097672, R01DK046635, R01DK106718, DP3DK111802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Children's Guild Association Endowed Chair in Pediatric Immunology; Benaroya Family Gift Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Sommer for laboratory management and assistance with manuscript editing; the University of Washington Histology and Imaging Core and Benaroya Clinical Core; M. Kinsman for technical assistance with RNA preparation; and E. Whalen and V. Gersuk for assistance with Fluidigm assays. Supported by the US National Institutes of Health (DP3-DK097672 to J.H.B.; DP3-DK111802 to D.J.R.; R01-AI084914 to D.B.S.; R01-AI104002, R01-AI060389 and R01-AI127463 to M.G.; U19-AI083019 to M.G.; U19-AI100625 to M.G.; R01-DK106718 to P.C.; T32-AR007108 to J.A.G; and T32-GM007270 to K.P.), the Juvenile Diabetes Research Foundation (3-APF-2016-177-A-N to Y.G.), the Children's Guild Association Endowed Chair in Pediatric Immunology and the Benaroya Family Gift Fund (D.J.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	bit Harmsen L., 2015, PLOS ONE, V10; Buers I, 2016, CYTOKINE GROWTH F R, V29, P101, DOI 10.1016/j.cytogfr.2016.03.005; Chen G, 2012, INT J IMMUNOGENET, V39, P137, DOI 10.1111/j.1744-313X.2011.01068.x; Chistiakov DA, 2010, HUM IMMUNOL, V71, P1128, DOI 10.1016/j.humimm.2010.08.005; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Curininghame Graham D. S., 2011, PLOS GENET, V7; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Duany YD, 2015, CURR OPIN VIROL, V12, P20, DOI 10.1016/j.coviro.2015.01.011; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Fumagalli M, 2010, MOL BIOL EVOL, V27, P2555, DOI 10.1093/molbev/msq141; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Hai X., 2013, J CLIN INVEST, V123; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heraud-Farlow JE, 2016, J MOL MED, V94, P1095, DOI 10.1007/s00109-016-1416-1; Hoffmann FS, 2015, HEPATOLOGY, V61, P460, DOI 10.1002/hep.27344; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Irutsch F., 2015, AM J HUM GENET, V96, P275; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Jin Y, 2017, J INVEST DERMATOL, V137, P522, DOI 10.1016/j.jid.2016.09.021; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Klarquist J, 2015, JOVE-J VIS EXP, DOI 10.3791/53319; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Li YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/jid.2010.214; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lincez PJ, 2015, DIABETES, V64, P2184, DOI 10.2337/db14-1223; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ma ZJ, 2006, J IMMUNOL, V177, P7444, DOI 10.4049/jimmunol.177.10.7444; Martinez A, 2008, ANN RHEUM DIS, V67, P137, DOI 10.1136/ard.2007.073213; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pedergnana V, 2016, HEPATOLOGY, V63, P1059, DOI 10.1002/hep.27951; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Sharma S, 2015, J AUTOIMMUN, V60, P51, DOI 10.1016/j.jaut.2015.04.002; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasseur F., 2011, MOL GENET, V20, P4462; Vergara C, 2016, HEPATOLOGY, V63, P1061, DOI 10.1002/hep.27954; Wanclstrat A., 2001, NAT IMMUNOL, V2, P802; Wang C, 2013, GENES IMMUN, V14, P217, DOI 10.1038/gene.2013.9	58	81	82	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					744	+		10.1038/ni.3766	http://dx.doi.org/10.1038/ni.3766			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28553952	Green Accepted			2022-12-18	WOS:000403676300009
J	Bando, JK; Liang, HE; Locksley, RM				Bando, Jennifer K.; Liang, Hong-Erh; Locksley, Richard M.			Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TISSUE INDUCER CELLS; PEYERS-PATCHES; ORGANOGENESIS; LYMPHOTOXIN; DIFFERENTIATION; EXPRESSION; DEFICIENT; CYTOKINES; RESPONSES	Fetal lymphoid tissue inducer (LTi) cells are required for lymph node and Peyer's patch (PP) organogenesis, but where these specialized group 3 innate lymphoid cells (ILC3s) develop remains unclear. Here, we identify extrahepatic arginase-1(+) Id2(+) fetal ILC precursors that express a transitional developmental phenotype (ftILCPs) and differentiate into ILC1s, ILC2s and ILC3s in vitro. These cells populate the intestine by embryonic day (E) 13.5 and, before PP organogenesis (E14.5-15), are broadly dispersed in the proximal gut, correlating with regions where PPs first develop. At E16.5, after PP development begins, ftILCPs accumulate at PP anlagen in a lymphotoxin-alpha-dependent manner. Thus, ftILCPs reside in the intestine during PP development, where they aggregate at PP anlagen after stromal cell activation and become a localized source of ILC populations.	[Bando, Jennifer K.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Bando, Jennifer K.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			Howard Hughes Medical Institute; National Institutes of Health [AI026918, AI030663, AI119944]; Sandler Asthma Basic Research Center at UCSF; UCSF Biomedical Sciences (BMS) Graduate Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, R01AI030663] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Asthma Basic Research Center at UCSF; UCSF Biomedical Sciences (BMS) Graduate Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Nguyen (UCSF Flow Cytometry Core) and Z. Wang (Sabre Sorting Facility) for cell sorting, and D. Sheppard, D. Kioussis (MRC National Institute for Medical Research), D. Littman (New York University), E. Robey (University of California, Berkeley), H. Luche and H. Fehling (University Clinics Ulm, Germany) for providing mice for these studies. We also thank J. Cyster and L. Lanier for critical reading of the manuscript. Supported by the Howard Hughes Medical Institute (R.M.L.), National Institutes of Health (AI026918, AI030663 and AI119944 to R.M.L.), the Sandler Asthma Basic Research Center at UCSF (R.M.L.) and the UCSF Biomedical Sciences (BMS) Graduate Program (J.K.B.).	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munder M, 1998, J IMMUNOL, V160, P5347; Okuda M, 2007, J IMMUNOL, V179, P804, DOI 10.4049/jimmunol.179.2.804; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	29	81	82	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					153	+		10.1038/ni.3057	http://dx.doi.org/10.1038/ni.3057			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ		Green Submitted, Green Accepted			2022-12-18	WOS:000348143100007
J	Ho, PC; Tsui, YC; Peng, XD; Greaves, DR; Wei, LN				Ho, Ping-Chih; Tsui, Yao-Chen; Peng, Xudong; Greaves, David R.; Wei, Li-Na			NF-kappa B-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance	NATURE IMMUNOLOGY			English	Article							INTERACTING PROTEIN 140; MACROPHAGE ACTIVATION; NEGATIVE REGULATION; ADIPOCYTE DIFFERENTIATION; SIGNALING PATHWAYS; GENE-EXPRESSION; RECEPTOR; UBIQUITIN; PHOSPHORYLATION; COREPRESSOR	Tolerance to endotoxins that is triggered by prior exposure to Toll-like receptor (TLR) ligands provides a mechanism with which to dampen inflammatory cytokines. The receptor-interacting protein RIP140 interacts with the transcription factor NF-kappa B to regulate the expression of genes encoding proinflammatory cytokines. Here we found lipopolysaccharide stimulation of kinase Syk-mediated tyrosine phosphorylation of RIP140 and interaction of the NF-kappa B subunit RelA with RIP140. These events resulted in more recruitment of the E3 ligase SCF to tyrosine-phosphorylated RIP140, which degraded RIP140 to inactivate genes encoding inflammatory cytokines. Macrophages expressing nondegradable RIP140 were resistant to the establishment of endotoxin tolerance for specific 'tolerizable' genes. Our results identify RelA as an adaptor with which SCF fine tunes NF-kappa B target genes by targeting the coactivator RIP140 and show an unexpected role for RIP140 degradation in resolving inflammation and endotoxin tolerance.	[Ho, Ping-Chih; Tsui, Yao-Chen; Peng, Xudong; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Minnesota System; University of Minnesota Twin Cities; University of Oxford	Wei, LN (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	weixx009@umn.edu		Ho, Ping-Chih/0000-0003-3078-3774; Greaves, David/0000-0003-2856-9410	US National Insitutes of Health [DK60521, DK54733, DA11190, K02-DA 13926]; University of of Minnesota; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054733, R01DK060521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA013926, R01DA011190] Funding Source: NIH RePORTER	US National Insitutes of Health; University of of Minnesota; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P.-T. Liu, S.C. Chan, K.-C. Chang, Y.-S. Chuang, A. Smith, C. Korteum and P. Lam for technical help and S. Kaech for critical reading. Supported by US National Insitutes of Health (DK60521, DK54733, DA11190 and K02-DA 13926). the Distinguished McKnigh Professorship of the University of of Minnesota (L.-N. Wei) and the American Heart Association (P.-C. Ho).	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; FREUDENBERG MA, 1988, INFECT IMMUN, V56, P1352, DOI 10.1128/IAI.56.5.1352-1357.1988; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002658; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Ho PC, 2011, CELL SIGNAL, V23, P1396, DOI 10.1016/j.cellsig.2011.03.023; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Huq MDM, 2009, J PROTEOME RES, V8, P1156, DOI 10.1021/pr800569c; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Yoon CH, 2010, EMBO REP, V11, P393, DOI 10.1038/embor.2010.45; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	48	81	91	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					379	386		10.1038/ni.2238	http://dx.doi.org/10.1038/ni.2238			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22388040	Green Accepted			2022-12-18	WOS:000301886800012
J	McGeachy, MJ				McGeachy, Mandy J.			GM-CSF: the secret weapon in the T(H)17 arsenal	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS	Identification of the pathogenic cytokines that underlie the IL-23-dependent disease progression of experimental autoimmune encephalomyelitis has proven elusive. Evidence now points to GM-CSF.	Merck Res, Palo Alto, CA USA	Merck & Company	McGeachy, MJ (corresponding author), Merck Res, Palo Alto, CA USA.	mandy.mcgeachy@merck.com						Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119	10	81	82	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					521	522		10.1038/ni.2044	http://dx.doi.org/10.1038/ni.2044			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21587311				2022-12-18	WOS:000290707100011
J	Colvin, RA; Means, TK; Diefenbach, TJ; Moita, LF; Friday, RP; Sever, S; Campanella, GSV; Abrazinski, T; Manice, LA; Moita, C; Andrews, NW; Wu, DQ; Hacohen, N; Luster, AD				Colvin, Richard A.; Means, Terry K.; Diefenbach, Thomas J.; Moita, Luis F.; Friday, Robert P.; Sever, Sanja; Campanella, Gabriele S. V.; Abrazinski, Tabitha; Manice, Lindsay A.; Moita, Catarina; Andrews, Norma W.; Wu, Dianqing; Hacohen, Nir; Luster, Andrew D.			Synaptotagmin-mediated vesicle fusion regulates cell migration	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CXCR4; LENTIVIRAL RNAI LIBRARY; MYOSIN HEAVY-CHAIN; PHOSPHOINOSITIDE-3 KINASE; SIGNAL-TRANSDUCTION; NEUTROPHIL FUNCTION; LEADING LAMELLA; PLASMA-MEMBRANE; CHEMOTAXIS; FIBROBLASTS	Chemokines and other chemoattractants direct leukocyte migration and are essential for the development and delivery of immune and inflammatory responses. To probe the molecular mechanisms that underlie chemoattractant-guided migration, we did an RNA-mediated interference screen that identified several members of the synaptotagmin family of calcium-sensing vesicle-fusion proteins as mediators of cell migration: SYT7 and SYTL5 were positive regulators of chemotaxis, whereas SYT2 was a negative regulator of chemotaxis. SYT7-deficient leukocytes showed less migration in vitro and in a gout model in vivo. Chemoattractant-induced calcium-dependent lysosomal fusion was impaired in SYT7-deficient neutrophils. In a chemokine gradient, SYT7-deficient lymphocytes accumulated lysosomes in their uropods and had impaired uropod release. Our data identify a molecular pathway required for chemotaxis that links chemoattractant-induced calcium flux to exocytosis and uropod release.	[Colvin, Richard A.; Means, Terry K.; Moita, Luis F.; Friday, Robert P.; Campanella, Gabriele S. V.; Abrazinski, Tabitha; Manice, Lindsay A.; Moita, Catarina; Hacohen, Nir; Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Colvin, Richard A.; Means, Terry K.; Moita, Luis F.; Friday, Robert P.; Campanella, Gabriele S. V.; Abrazinski, Tabitha; Manice, Lindsay A.; Moita, Catarina; Hacohen, Nir; Luster, Andrew D.] Harvard Univ, Sch Med, Boston, MA USA; [Diefenbach, Thomas J.] MIT, Ragon Inst MGH, Boston, MA USA; [Moita, Luis F.; Moita, Catarina] Univ Lisbon, Fac Med, Inst Mol Med, Cell Biol Immune Syst Unit, P-1699 Lisbon, Portugal; [Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Wu, Dianqing] Yale Univ, Sch Med, New Haven, CT USA; [Hacohen, Nir] Broad Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland College Park; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Luster, AD (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	aluster@mgh.harvard.edu	Allen, Andrew/B-8045-2011; Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013	Allen, Andrew/0000-0003-0304-7544; Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Andrews, Norma/0000-0002-0611-2412; Ferreira Moita, Catarina/0000-0002-9910-2343	US National Institutes of Health [R01 DK074449, R01 GM064625]; Defense Advanced Research Projects Agency [W81XWH-04-C-0139]; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074449, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064625, R01GM054597] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Immune Circuits and RNAi Platform groups of the Broad Institute and W. Xu for discussions and the Imaging Core of the Ragon Institute of MGH, MIT and Harvard. Supported by the US National Institutes of Health (R01 DK074449 to A. D. L. and R01 GM064625 to N.W.A.), the Defense Advanced Research Projects Agency (W81XWH-04-C-0139 to N.H.), Fundacao Luso-Americana para o Desenvolvimento (L. F. M.) and Fundacao para a Ciencia e a Tecnologia (L. F. M.).	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Burt D, 2007, AM J PATHOL, V171, P1789, DOI 10.2353/ajpath.2007.070398; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Hannigan MO, 2004, CURR TOP MICROBIOL, V282, P165; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Huber TB, 2002, J IMMUNOL, V168, P6244, DOI 10.4049/jimmunol.168.12.6244; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Kehrl JH, 2009, CURR TOP MICROBIOL, V334, P107, DOI 10.1007/978-3-540-93864-4_5; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kuroda TS, 2002, BIOCHEM BIOPH RES CO, V293, P899, DOI 10.1016/S0006-291X(02)00320-0; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LIU G, 1994, J CELL SCI, V107, P1737; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MALCHOW D, 1981, EUR J BIOCHEM, V117, P213; Manes S, 2005, SEMIN IMMUNOL, V17, P77, DOI 10.1016/j.smim.2004.09.005; MARCUS PI, 1962, COLD SPRING HARB SYM, V27, P351, DOI 10.1101/SQB.1962.027.001.033; Martin WJ, 2009, ARTHRITIS RHEUM-US, V60, P281, DOI 10.1002/art.24185; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Masztalerz A, 2007, J CELL SCI, V120, P219, DOI 10.1242/jcs.03328; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	59	81	82	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					495	U60		10.1038/ni.1878	http://dx.doi.org/10.1038/ni.1878			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20473299	Green Accepted			2022-12-18	WOS:000277821300010
J	Perona-Wright, G; Mohrs, K; Mohrs, M				Perona-Wright, Georgia; Mohrs, Katja; Mohrs, Markus			Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node	NATURE IMMUNOLOGY			English	Article							TYROSINE-PHOSPHATASE SHP-1; IFN-GAMMA; TH2 RESPONSE; DOWN-REGULATION; RECEPTOR-ALPHA; T-HELPER-1 TH1; IL-4 RECEPTOR; STAT6; MECHANISMS; EXPRESSION	Cytokines are soluble proteins that regulate immune responses. The present paradigm is that cytokine production in lymphoid tissues is tightly localized and signaling occurs between conjugate cells. Here we assess cytokine signaling during infection by measuring in vivo phosphorylation of intracellular signal transducer and activator of transcription (STAT) proteins. We show that interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) signaled to the majority of lymphocytes throughout the reactive lymph node and that IL-4 conditioning of naive, bystander cells was sufficient to override opposing T helper type 1 (T(H)1) polarization. Our results demonstrate that despite localized production, cytokines can permeate a lymph node and modify the majority of cells therein. Cytokine conditioning of bystander cells could provide a mechanism by which chronic worm infections subvert the host response to subsequent infections or vaccination attempts.	[Perona-Wright, Georgia; Mohrs, Katja; Mohrs, Markus] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Mohrs, M (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	mmohrs@trudeauinstitute.org		Altan-Bonnet, Gregoire/0000-0002-7283-3162	Trudeau Institute and the National Institutes of Health [AI072296, AI076479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076479, R01AI072296] Funding Source: NIH RePORTER	Trudeau Institute and the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. L. Johnson for T. gondii infection; J.-S. Lin and S.T. Smiley (both with the Trudeau Institute) for heat-killed Y. pestis; E.J. Pearce (Trudeau Institute) for S. mansoni eggs; R. T. Robinson and A. M. Cooper (both with the Trudeau Institute) for Ifng<SUP>-/-</SUP> mice; and E.J. Pearce and D. Gray for discussion and comments on the manuscript. Supported by the Trudeau Institute and the National Institutes of Health (AI072296 and AI076479).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Ekkens MJ, 2003, J IMMUNOL, V170, P384, DOI 10.4049/jimmunol.170.1.384; Elliott DE, 2008, J IMMUNOL, V181, P2414, DOI 10.4049/jimmunol.181.4.2414; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; GALIZZI JP, 1989, J BIOL CHEM, V264, P6984; Hanson EM, 2003, J BIOL CHEM, V278, P3903, DOI 10.1074/jbc.M211747200; Haque SJ, 1997, P NATL ACAD SCI USA, V94, P8563, DOI 10.1073/pnas.94.16.8563; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Hotson AN, 2009, J IMMUNOL, V182, P7558, DOI 10.4049/jimmunol.0803666; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Maldonado RA, 2009, J EXP MED, V206, P877, DOI 10.1084/jem.20082900; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mayer KD, 2005, J IMMUNOL, V174, P7732, DOI 10.4049/jimmunol.174.12.7732; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 1999, J IMMUNOL, V162, P7302; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Perona-Wright G, 2010, J IMMUNOL, V184, P615, DOI 10.4049/jimmunol.0902408; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Robinson RT, 2008, J IMMUNOL, V181, P5560, DOI 10.4049/jimmunol.181.8.5560; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Skrenta H, 2000, J IMMUNOL, V164, P3506, DOI 10.4049/jimmunol.164.7.3506; Sutton TL, 2008, INFECT IMMUN, V76, P4772, DOI 10.1128/IAI.00744-07; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	50	81	81	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					520	U88		10.1038/ni.1866	http://dx.doi.org/10.1038/ni.1866			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20418876	Green Accepted			2022-12-18	WOS:000277821300013
J	Lo, WL; Felix, NJ; Walters, JJ; Rohrs, H; Gross, ML; Allen, PM				Lo, Wan-Lin; Felix, Nathan J.; Walters, James J.; Rohrs, Henry; Gross, Michael L.; Allen, Paul M.			An endogenous peptide positively selects and augments the activation and survival of peripheral CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							THYMIC SELECTION; SELF-PEPTIDES; HOMEOSTATIC PROLIFERATION; NEGATIVE SELECTION; AFFINITY THRESHOLD; ANTIGEN RECEPTOR; TRANSGENIC MICE; LIGAND; RECOGNITION; REPERTOIRE	Although CD4(+) and CD8(+) T cells differ in the strength of their positively selecting signal, endogenous positively selecting ligands have been identified only for major histocompatibility complex (MHC) class I-restricted T cell antigen receptors (TCRs). Here we screened for ligands able to positively select MHC class II-restricted TCRs using thymocytes from four I-E-k-restricted TCR-transgenic mice and a large panel of self peptides. One peptide, gp250, induced positive selection of AND CD4(+) T cells, had no homology with the AND TCR agonist ligand and was recognized with a high degree of specificity. The gp250 peptide acted as a coagonist to initiate the activation and enhance the survival of peripheral AND CD4(+) T cells. Thus, positively selecting ligands are critical in thymocyte development and in the activation and maintenance of peripheral T cells.	[Lo, Wan-Lin; Felix, Nathan J.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Walters, James J.; Rohrs, Henry; Gross, Michael L.] Washington Univ, Sch Med, Dept Chem, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu		Lo, Wan-Lin/0000-0002-9074-6847	US National Institutes of Health [AI-24157, 2P41 RR 000954]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024157, R37AI024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. G. Farr (University of Washington) for ANV41.2 cells; B. Stockinger (Medical Research Council National Institute for Medical Research) for the A1 TCR-transgenic mouse; C. D. Surh for advice on homeostatic proliferation; D. Kreamalmeyer for maintaining the mouse colony; S. Horvath for peptide synthesis and purification; C. Morley for suggestions and reading the manuscript; and G. Morris, D. Donermeyer, E. Unanue, C. Hsieh and Y. Huang for critical reading of the manuscript and comments. Supported by the US National Institutes of Health (AI-24157 to P. M. A. and 2P41 RR 000954 to M. L. G.).	Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; EBERT PJ, 2009, NAT IMMUNOL     1004, DOI DOI 10.1038/NI1797; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Fremont DH, 2002, J EXP MED, V195, P1043, DOI 10.1084/jem.20011971; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Grakoui A, 1999, J IMMUNOL, V162, P1923; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kersh GJ, 1998, J IMMUNOL, V161, P585; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Masteller EL, 2003, J IMMUNOL, V171, P5587, DOI 10.4049/jimmunol.171.10.5587; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sasada T, 2001, J EXP MED, V194, P883, DOI 10.1084/jem.194.7.883; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stefanski HE, 2001, J IMMUNOL, V166, P6602, DOI 10.4049/jimmunol.166.11.6602; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; VANHECKE D, 1995, J IMMUNOL, V155, P4711; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wang RF, 1998, P NATL ACAD SCI USA, V95, P3804, DOI 10.1073/pnas.95.7.3804; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zelenika D, 1998, J IMMUNOL, V161, P1868	50	81	81	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1155	U35		10.1038/ni.1796	http://dx.doi.org/10.1038/ni.1796			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19801984	Green Accepted			2022-12-18	WOS:000270955900007
J	Xu, JS; Gao, XP; Ramchandran, R; Zhao, YY; Vogel, SM; Malik, AB				Xu, Jingsong; Gao, Xiao-Pei; Ramchandran, Ramaswamy; Zhao, You-Yang; Vogel, Stephen M.; Malik, Asrar B.			Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating beta(2) integrins	NATURE IMMUNOLOGY			English	Article							MICROVASCULAR PERMEABILITY; ACTIN CYTOSKELETON; IN-VIVO; ADHESION; SRC; PHOSPHORYLATION; INJURY; LEUKOCYTES; CELLS; INHIBITOR	Nonmuscle myosin light-chain kinase (MYLK) mediates increased lung vascular endothelial permeability in lipopolysaccharide-induced lung inflammatory injury, the chief cause of the acute respiratory distress syndrome. In a lung injury model, we demonstrate here that MYLK was also essential for neutrophil transmigration, but that this function was mostly independent of myosin II regulatory light chain, the only known substrate of MYLK. Instead, MYLK in neutrophils was required for the recruitment and activation of the tyrosine kinase Pyk2, which mediated full activation of beta(2) integrins. Our results demonstrate that MYLK-mediated activation of beta(2) integrins through Pyk2 links beta(2) integrin signaling to the actin motile machinery of neutrophils.	[Xu, Jingsong; Gao, Xiao-Pei; Ramchandran, Ramaswamy; Zhao, You-Yang; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Xu, Jingsong] Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60612 USA; [Xu, Jingsong] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xu, JS (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.	jingsong@uic.edu; abmalik@uic.edu		Malik, Asrar/0000-0002-8205-7128; ZHAO, YOU-YANG/0000-0002-0041-0339	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046350, P01HL077806] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL77806, P01 HL077806, R01 HL046350, HL46350, P01 HL077806-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148; Advani A, 2002, DIABETOLOGIA, V45, P719, DOI 10.1007/s00125-002-0802-0; Anderson SI, 2000, J CELL SCI, V113, P2737; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Betsuyaku T, 1999, J CLIN INVEST, V103, P825, DOI 10.1172/JCI5191; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; COHEN MS, 1994, CLIN INFECT DIS, V18, pS170, DOI 10.1093/clinids/18.Supplement_2.S170; CrockettTorabi E, 1996, EUR J ANAESTH, V13, P235, DOI 10.1046/j.1365-2346.1996.00982.x; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mansfield PJ, 2002, BLOOD, V99, P1434, DOI 10.1182/blood.V99.4.1434; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; SIMPSON SQ, 1989, CRIT CARE CLIN, V5, P27; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sutton TA, 2001, AM J PHYSIOL-RENAL, V281, pF810, DOI 10.1152/ajprenal.2001.281.5.F810; THAKUR ML, 1977, J NUCL MED, V18, P1022; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Vilitkevich E L, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P577; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1	46	81	91	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					880	886		10.1038/ni.1628	http://dx.doi.org/10.1038/ni.1628			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18587400	Green Accepted			2022-12-18	WOS:000257780700011
J	Gallagher, E; Enzler, T; Matsuzawa, A; Anzelon-Mills, A; Otero, D; Holzer, R; Janssen, E; Gao, M; Karin, M				Gallagher, Ewen; Enzler, Thomas; Matsuzawa, Atsushi; Anzelon-Mills, Amy; Otero, Dennis; Holzer, Ryan; Janssen, Edith; Gao, Min; Karin, Michael			Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; IMMUNE-RESPONSES; ANTIGEN RECEPTOR; PROTEIN-KINASES; CYCLIN D2; TRAF2; BINDING; CD40; UBIQUITINATION; INNATE	Mice lacking activity of the kinase MEKK1 ('Map3k1(Delta KD)' mice) have defective activation of the kinase Jnk and increased production of T helper type 2 cytokines after T cell receptor ligation. Here we show that Map3k1(Delta KD) mice had defective germinal center formation and diminished production of antibodies recognizing thymus-dependent antigens. Those defects were B cell intrinsic, as MEKK1 was necessary for CD40-mediated activation of the kinases Jnk and p38 and transcription factor c-Jun, as well as for expression of cyclin D2 and activation-induced deaminase. MEKK1 was recruited to CD40 and adaptor molecule TRAF2 after CD40 ligation, and Map3k1(Delta KD) B cells were hypoproliferative after CD40 stimulation. Our data emphasize that MEKK1 is an essential component of signaling cascades needed for thymus-dependent antigen-induced B cell proliferation and antibody production.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Burke Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Matsuzawa, Atsushi/GLU-1387-2022	Enzler, Thomas/0000-0002-8775-1493; Matsuzawa, Atsushi/0000-0001-8303-3905	NIEHS NIH HHS [ES04151, ES06376] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151, R01ES006376] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gallagher ED, 2002, J BIOL CHEM, V277, P45785, DOI 10.1074/jbc.M207702200; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hardy Richard R, 2004, Methods Mol Biol, V271, P1; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kracker Sven, 2004, Methods Mol Biol, V271, P149; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li ZW, 2004, MOL IMMUNOL, V41, P701, DOI 10.1016/j.molimm.2004.04.012; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	40	81	84	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					57	63		10.1038/ni1421	http://dx.doi.org/10.1038/ni1421			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17143273				2022-12-18	WOS:000242934400014
J	Huseby, ES; Crawford, F; White, J; Marrack, P; Kappler, JW				Huseby, Eric S.; Crawford, Frances; White, Janice; Marrack, Philippa; Kappler, John W.			Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide	NATURE IMMUNOLOGY			English	Article							ALANINE-SCANNING MUTAGENESIS; MHC CLASS-I; NEGATIVE SELECTION; POSITIVE SELECTION; REPERTOIRE SELECTION; ANTIGEN PRESENTATION; RECOGNITION; BINDING; LIGAND; THYMUS	T cell receptors ( TCRs) bind complexes of cognate major histocompatibility complex ( MHC) and peptide at relatively low affinities ( 1 - 200 mu M). Nevertheless, TCR-MHC-peptide interactions are usually specific for the peptide and the allele encoding the MHC. Here we show that to escape thymocyte negative selection, TCRs must interact with many of the side chains of MHC-peptide complexes as 'hot spots' for TCR binding. Moreover, even when the 'parental' side chain did not contribute binding affinity, some MHC-peptide residues contributed to TCR specificity, as amino acid substitutions substantially reduced binding affinity. The presence of such 'interface-disruptive' side chains helps to explain how TCRs generate specificity at low-affinity interfaces and why TCRs often 'accommodate' a subset of amino acids at a given MHC-peptide position.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NCI NIH HHS [P30CA046934] Funding Source: Medline; NIAID NIH HHS [AI-18785, AI-22295, AI-52225, AI-17134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI018785, R56AI017134, R01AI017134, R01AI052225, R37AI018785, R37AI017134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; BOEHNCKE WH, 1993, J IMMUNOL, V150, P331; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gagnon SJ, 2005, J MOL BIOL, V353, P556, DOI 10.1016/j.jmb.2005.08.024; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Henderson SC, 1998, J IMMUNOL, V161, P175; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; WILSON DB, 1970, J EXP MED, V131, P391, DOI 10.1084/jem.131.2.391; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; YEH ETH, 1984, J EXP MED, V160, P799, DOI 10.1084/jem.160.3.799; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	50	81	82	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1191	1199		10.1038/ni1401	http://dx.doi.org/10.1038/ni1401			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17041605				2022-12-18	WOS:000241437200014
J	Staton, TL; Habtezion, A; Winslow, MM; Sato, T; Love, PE; Butcher, EC				Staton, TL; Habtezion, A; Winslow, MM; Sato, T; Love, PE; Butcher, EC			CD8(+) recent thymic emigrants home to and efficiently repopulate the small intestine epithelium	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; INTRAEPITHELIAL LYMPHOCYTES; RHODAMINE ISOTHIOCYANATE; MUCOSAL LYMPHOCYTES; EXCISION CIRCLES; LYMPHOID ORGANS; DENDRITIC CELLS; GUT EPITHELIUM; IN-VIVO; MICE	Prevailing knowledge dictates that naive ab T cells require activation in lymphoid tissues before differentiating into effector or memory T cells capable of trafficking to nonlymphoid tissues. Here we demonstrate that CD8(+) recent thymic emigrants (RTEs) migrated directly into the small intestine. CCR9, CCL25 and alpha(4)beta(7) integrin were required for gut entry of CD8(+) RTEs. After T cell receptor stimulation, intestinal CD8+ RTEs proliferated and acquired a surface phenotype resembling that of intraepithelial lymphocytes. CD8(+) RTEs efficiently populated the gut of lymphotoxin-alpha-deficient mice, which lack lymphoid organs. These studies challenge the present understanding of naive alpha beta T cell trafficking and suggest that RTEs may be involved in maintaining a diverse immune repertoire at mucosal surfaces.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Butcher, EC (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	ebutcher@stanford.edu			NIAID NIH HHS [AI47822, T32 AI007290] Funding Source: Medline; NIDDK NIH HHS [DK07056, DK060000, DK56339] Funding Source: Medline; NIGMS NIH HHS [GM37734] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI047822, R37AI047822, R21AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007056, P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734, R01GM037734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; BARNARD JA, 1993, GASTROENTEROLOGY, V105, P67, DOI 10.1016/0016-5085(93)90011-Z; BERINS SP, 1998, J EXP MED, V187, P1839; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; BLUMBERG RS, 1993, J IMMUNOL, V150, P5144; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; BUTCHER EC, 1980, J IMMUNOL METHODS, V37, P109, DOI 10.1016/0022-1759(80)90196-9; BUTCHER EC, 1980, J IMMUNOL METHODS, V37, P97, DOI 10.1016/0022-1759(80)90195-7; Camerini V, 1998, J IMMUNOL, V160, P2608; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; FERGUSON A, 1977, GUT, V18, P921, DOI 10.1136/gut.18.11.921; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOLMES GKT, 1974, GUT, V15, P278, DOI 10.1136/gut.15.4.278; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; Kim SK, 1999, J IMMUNOL, V163, P4125; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; LEFRANCOIS L, 1987, J IMMUNOL, V138, P3375; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Staton TL, 2004, J IMMUNOL, V172, P7282, DOI 10.4049/jimmunol.172.12.7282; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Ye P, 2002, J IMMUNOL, V168, P4968, DOI 10.4049/jimmunol.168.10.4968	49	81	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					482	488		10.1038/ni1319	http://dx.doi.org/10.1038/ni1319			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16582913				2022-12-18	WOS:000237008800013
J	Terashima, Y; Onai, N; Murai, M; Enomoto, M; Poonpiriya, V; Hamada, T; Motomura, K; Suwa, M; Ezaki, T; Haga, T; Kanegasaki, S; Matsushima, K				Terashima, Y; Onai, N; Murai, M; Enomoto, M; Poonpiriya, V; Hamada, T; Motomura, K; Suwa, M; Ezaki, T; Haga, T; Kanegasaki, S; Matsushima, K			Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR 2; INTERLEUKIN-8 RECEPTOR; SIGNAL-TRANSDUCTION; CARBOXYL-TERMINUS; LEADING-EDGE; CELL-LINE; MICE; COMPLEX; PHOSPHORYLATION; INTERNALIZATION	Ligation of the chemokine receptor CCR2 on monocytes and macrophages with its ligand CCL2 results in activation of the cascade consisting of phosphatidylinositol-3-OH kinase (PI(3)K), the small G protein Rac and lamellipodium protrusion. We show here that a unique clathrin heavy-chain repeat homology protein, FROUNT, directly bound activated CCR2 and formed clusters at the cell front during chemotaxis. Overexpression of FROUNT amplified the chemokine-elicited PI(3)K-Rac-lamellipodium protrusion cascade and subsequent chemotaxis. Blocking FROUNT function by using a truncated mutant or antisense strategy substantially diminished signaling via CCR2. In a mouse peritonitis model, suppression of endogenous FROUNT markedly prevented macrophage infiltration. Thus, FROUNT links activated CCR2 to the PI(3)K-Rac-lamellipodium protrusion cascade and could be a therapeutic target in chronic inflammatory immune diseases associated with macrophage infiltration.	Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med & Solut Oriented Res Sci & T, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Effector Cell Inst, Meguro Ku, Tokyo 1538904, Japan; Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koutou Ku, Tokyo 1350064, Japan; Tokyo Womens Med Univ, Sch Med, Dept Anat & Dev Biol, Tokyo 1628666, Japan; Gakushuin Univ, Inst Biomol SCi, Toshima Ku, Tokyo 1718588, Japan	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Women's Medical University; Gakushuin University	Matsushima, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med & Solut Oriented Res Sci & T, Bunkyo Ku, Tokyo 1130033, Japan.	koujim@m.u-tokyo.ac.jp	Kanegasaki, Shiro/AAM-4921-2021; Kanegasaki, Shiro/AAI-5324-2020; ezaki, taichi/C-3502-2013	Kanegasaki, Shiro/0000-0001-7867-0109; Terashima, Yuya/0000-0003-3127-367X				Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Le Gouill C, 1999, J BIOL CHEM, V274, P12548, DOI 10.1074/jbc.274.18.12548; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nanoff C, 1997, NEUROPHARMACOLOGY, V36, P1211, DOI 10.1016/S0028-3908(97)00135-4; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Onai N, 2000, BLOOD, V96, P2074; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Richardson RM, 1998, J BIOL CHEM, V273, P10690, DOI 10.1074/jbc.273.17.10690; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sambrano GR, 1999, J BIOL CHEM, V274, P20178, DOI 10.1074/jbc.274.29.20178; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Vestergaard C, 1999, J CLIN INVEST, V104, P1097, DOI 10.1172/JCI7613; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wong LM, 1997, J BIOL CHEM, V272, P1038, DOI 10.1074/jbc.272.2.1038; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	41	81	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					827	835		10.1038/ni1222	http://dx.doi.org/10.1038/ni1222			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	15995708				2022-12-18	WOS:000230646200024
J	Woodgett, JR; Ohashi, PS				Woodgett, JR; Ohashi, PS			GSK3: an in-Toll-erant protein kinase?	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION	Toll-like receptors are crucial in modulating immune responses. Glycogen synthase kinase 3 is involved in Toll-like receptor signaling and regulates the production of proinflammatory cytokines and septic shock.	Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Campbell Family Inst Breast Canc Res, Toronto, ON M5C 2M1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Woodgett, JR (corresponding author), Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	jwoodget@uhnres.utoronto.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Ohashi, Pamela S./0000-0003-2915-9317				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andreakos E, 2004, IMMUNOL REV, V202, P250, DOI 10.1111/j.0105-2896.2004.00202.x; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734	13	81	84	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					751	752		10.1038/ni0805-751	http://dx.doi.org/10.1038/ni0805-751			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034428				2022-12-18	WOS:000230646200005
J	Gounari, F; Aifantis, I; Martin, C; Fehling, HJ; Hoeflinger, S; Leder, P; von Boehmer, H; Reizis, B				Gounari, F; Aifantis, I; Martin, C; Fehling, HJ; Hoeflinger, S; Leder, P; von Boehmer, H; Reizis, B			Tracing lymphopoiesis with the aid of a pT alpha-controlled reporter gene	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; HEMATOPOIETIC STEM-CELLS; MURINE FETAL THYMUS; B-CELL; BONE-MARROW; LYMPHOID DIFFERENTIATION; COORDINATE REGULATION; LINEAGE COMMITMENT; PRECURSOR CELLS; EXPRESSION	A transgenic reporter mouse strain, which expressed the human CD25 (hCD25) surface marker as a reporter under the control of the pre-T cell receptor alpha (pTalpha) promoter, was used to identify lymphoid precursors that expressed pTalpha intracellularly. The hCD25 reporter marked intra- and extrathymic precursors of lymphocytes but not myeloid cells. The earliest intrathymic precursors were CD4(lo)CD8(-)CD25(-)CD44(+)c-Kit(+) cells that expressed elevated levels of Notch-I mRNA. Clonogenic assays showed that the extrathymic precursors were common lymphoid progenitors (CLPs) that included CD19(-), B220(+), ThyI(+) and CD4(+) cells. Thus, the pTalpha reporter can be used to trace lymphopoiesis between CLPs and alphabeta T ceIIs.The slower extinction of the hCD25 reporter compared to pTa enabled us to define points at which pTalpha(-) lineages branched off.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Univ Clin Ulm, Fac Med, Dept Immunol, D-89070 Ulm, Germany; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Ulm University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.			Reizis, Boris/0000-0003-1140-7853	NIAID NIH HHS [R01AI 45846, R01AI47281] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045846, R01AI047281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bruno L, 1997, J EXP MED, V185, P875, DOI 10.1084/jem.185.5.875; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DEJBAKHSHJONES S, 1995, J IMMUNOL, V155, P3338; Douagi I, 2000, EUR J IMMUNOL, V30, P2201, DOI 10.1002/1521-4141(2000)30:8<2201::AID-IMMU2201>3.0.CO;2-2; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Kawamoto H, 1999, J IMMUNOL, V162, P2725; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	42	81	82	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					489	496		10.1038/ni778	http://dx.doi.org/10.1038/ni778			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11927910				2022-12-18	WOS:000175411200019
J	Yamada, T; Sato, S; Sotoyama, Y; Orba, Y; Sawa, H; Yamauchi, H; Sasaki, M; Takaoka, A				Yamada, Taisho; Sato, Seiichi; Sotoyama, Yuki; Orba, Yasuko; Sawa, Hirofumi; Yamauchi, Hajime; Sasaki, Michihito; Takaoka, Akinori			RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells	NATURE IMMUNOLOGY			English	Article							RNA; SARS-COV-2; ACTIVATION; HELICASE; GENOME; SENSOR; COPD; SARS	Efficient immune responses against viral infection are determined by sufficient activation of nucleic acid sensor-mediated innate immunity(1,2). Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains an ongoing global pandemic. It is an urgent challenge to clarify the innate recognition mechanism to control this virus. Here we show that retinoic acid-inducible gene-I (RIG-I) sufficiently restrains SARS-CoV-2 replication in human lung cells in a type I/III interferon (IFN)-independent manner. RIG-I recognizes the 3 ' untranslated region of the SARS-CoV-2 RNA genome via the helicase domains, but not the C-terminal domain. This new mode of RIG-I recognition does not stimulate its ATPase, thereby aborting the activation of the conventional mitochondrial antiviral-signaling protein-dependent pathways, which is in accordance with lack of cytokine induction. Nevertheless, the interaction of RIG-I with the viral genome directly abrogates viral RNA-dependent RNA polymerase mediation of the first step of replication. Consistently, genetic ablation of RIG-I allows lung cells to produce viral particles that expressed the viral spike protein. By contrast, the anti-SARS-CoV-2 activity was restored by all-trans retinoic acid treatment through upregulation of RIG-I protein expression in primary lung cells derived from patients with chronic obstructive pulmonary disease. Thus, our findings demonstrate the distinctive role of RIG-I as a restraining factor in the early phase of SARS-CoV-2 infection in human lung cells.	[Yamada, Taisho; Sato, Seiichi; Sotoyama, Yuki; Yamauchi, Hajime; Takaoka, Akinori] Hokkaido Univ, Inst Genet Med, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Yamada, Taisho; Sato, Seiichi; Sotoyama, Yuki; Takaoka, Akinori] Hokkaido Univ, Grad Sch Chem Sci & Engn, Mol Med Biochem Unit, Biol Chem & Engn Course, Sapporo, Hokkaido, Japan; [Orba, Yasuko; Sawa, Hirofumi; Sasaki, Michihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan; [Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Int Collaborat Unit, Sapporo, Hokkaido, Japan; [Sawa, Hirofumi] Global Virus Network, Baltimore, MD USA	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Takaoka, A (corresponding author), Hokkaido Univ, Inst Genet Med, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan.; Takaoka, A (corresponding author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Mol Med Biochem Unit, Biol Chem & Engn Course, Sapporo, Hokkaido, Japan.	takaoka@igm.hokudai.ac.jp	Sawa, Hirofumi/AAW-8816-2021; Yamada, Taisho/GPP-5936-2022; Sawa, Hirofumi/F-6954-2012; Sasaki, Michihito/AAY-1900-2021	Sawa, Hirofumi/0000-0003-2569-2755; Sasaki, Michihito/0000-0003-1607-2175; Yamada, Taisho/0000-0002-2584-9583	Japan Society for the Promotion of Science (JSPS) [JP17H06265, JP19K16664]; Japan Agency for Medical Research and Development (AMED) [JP18fk0310101, JP20fk0108251]; Naito Foundation; Asai Germanium Research Institute; Akiyama Life Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Naito Foundation(Naito Memorial Foundation); Asai Germanium Research Institute; Akiyama Life Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank M. Shimojima (the National Institute of Infectious Diseases, Japan) for SARS-CoV-2 (JPN/TY/WK-521), H. Miyoshi (RIKEN RBC, Japan) for lentiviral vector CSII-CMV-MCS-IRES2-Bsd, T. Miyazaki for influenza virus (strain A/Puerto Rico/8/34) and J. Miyazaki for the pCXN2-Flag vector. This work was supported by grants from the Japan Society for the Promotion of Science (JSPS; Grant-in-Aid for Challenging Research (Pioneering), JP17H06265, to A.T.); Grant-in-Aid for Young Scientists (B; JP19K16664, to T.Y.); Japan Agency for Medical Research and Development (AMED; Program on the Innovative Development and the Application of New Drugs for Hepatitis B, JP18fk0310101 (to A.T.) and JP20fk0108251 (to H.S.)); the Naito Foundation and Asai Germanium Research Institute (to A.T.); Akiyama Life Science Foundation (to A.T.); and the Uehara Memorial Foundation (to A.T.).	Attaway AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100515; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gao L, 2018, NAT IMMUNOL, V19, P233, DOI 10.1038/s41590-017-0043-5; Garcia-Valero J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217803; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gunzl A, 2002, METHODS, V26, P162, DOI 10.1016/S1046-2023(02)00019-1; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kim B, 2021, NAT PROTOC, V16, P516, DOI 10.1038/s41596-020-00429-6; Kim B, 2020, MOL CELL, V78, P624, DOI 10.1016/j.molcel.2020.04.013; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Rangan R, 2020, RNA, V26, P937, DOI 10.1261/rna.076141.120; Sanchez-Ramirez DC, 2020, RESP MED, V171, DOI 10.1016/j.rmed.2020.106096; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Sin DD, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100546; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takaoka A, 2019, INT IMMUNOL, V31, P477, DOI 10.1093/intimm/dxz034; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Yao H, 2015, MOL CELL, V58, P541, DOI 10.1016/j.molcel.2015.03.014; Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628; Zhao QW, 2020, J MED VIROL, V92, P1915, DOI 10.1002/jmv.25889; Zhong X, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008457; Zhou Q, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01061; Zipeto D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.576745; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07	49	80	82	5	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					820	+		10.1038/s41590-021-00942-0	http://dx.doi.org/10.1038/s41590-021-00942-0		MAY 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	33976430	Green Submitted, Bronze			2022-12-18	WOS:000649213200001
J	Miyauchi, K; Sugimoto-Ishige, A; Harada, Y; Adachi, Y; Usami, Y; Kaji, T; Inoue, K; Hasegawa, H; Watanabe, T; Hijikata, A; Fukuyama, S; Maemura, T; Okada-Hatakeyama, M; Ohara, O; Kawaoka, Y; Takahashi, Y; Takemori, T; Kubo, M				Miyauchi, Kosuke; Sugimoto-Ishige, Akiko; Harada, Yasuyo; Adachi, Yu; Usami, Yoshiko; Kaji, Tomohiro; Inoue, Kentaro; Hasegawa, Hideki; Watanabe, Takashi; Hijikata, Atsushi; Fukuyama, Satoshi; Maemura, Tadashi; Okada-Hatakeyama, Mariko; Ohara, Osamu; Kawaoka, Yoshihiro; Takahashi, Yoshimasa; Takemori, Toshitada; Kubo, Masato			Protective neutralizing influenza antibody response in the absence of T follicular helper cells	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER RESPONSES; ACUTE VIRAL-INFECTION; MEMORY B-CELLS; DIFFERENTIATION; IL-21; IMMUNITY; CENTERS; BCL6; REPERTOIRE; MECHANISMS	Virus infection induces the development of T follicular helper (T-FH) and T helper 1 (T(H)1) cells. Although T-FH cells are important in anti-viral humoral immunity, the contribution of T(H)1 cells to a protective antibody response remains unknown. We found that IgG2 antibodies predominated in the response to vaccination with inactivated influenza A virus (IAV) and were responsible for protective immunity to lethal challenge with pathogenic H5N1 and pandemic H1N1 IAV strains, even in mice that lacked T-FH cells and germinal centers. The cytokines interleukin-21 and interferon-gamma, which are secreted from T(H)1 cells, were essential for the observed greater persistence and higher titers of IgG2 protective antibodies. Our results suggest that T(H)1 induction could be a promising strategy for producing effective neutralizing antibodies against emerging influenza viruses.	[Miyauchi, Kosuke; Usami, Yoshiko; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Integrat Med Sci IMS, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan; [Sugimoto-Ishige, Akiko; Kaji, Tomohiro; Takemori, Toshitada] RIKEN Yokohama Inst, Drug Discovery Antibody Platform Unit, IMS, Yokohama, Kanagawa, Japan; [Harada, Yasuyo; Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba, Japan; [Adachi, Yu; Takahashi, Yoshimasa] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Kaji, Tomohiro] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Dept Biol Res, Tokyo, Japan; [Inoue, Kentaro; Okada-Hatakeyama, Mariko] RIKEN Yokohama Inst, Lab Integrated Cellular Syst, IMS, Yokohama, Kanagawa, Japan; [Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Watanabe, Takashi] RIKEN Yokohama Inst, Lab Integrat Genom, IMS, Yokohama, Kanagawa, Japan; [Hijikata, Atsushi] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Japan; [Fukuyama, Satoshi; Maemura, Tadashi; Kawaoka, Yoshihiro] Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Fukuyama, Satoshi; Maemura, Tadashi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; [Fukuyama, Satoshi; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Madison, WI USA; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	RIKEN; RIKEN; Tokyo University of Science; National Institute of Infectious Diseases (NIID); Daiichi Sankyo Company Limited; RIKEN; National Institute of Infectious Diseases (NIID); RIKEN; University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST)	Kubo, M (corresponding author), RIKEN Yokohama Inst, Res Ctr Integrat Med Sci IMS, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan.; Kubo, M (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba, Japan.	masato.kubo@riken.jp	Hasegawa, Hideki/C-7978-2014; Ohara, Osamu/G-5448-2015; Inoue, Kentaro/P-4920-2016	Ohara, Osamu/0000-0002-3328-9571; Takahashi, Yoshimasa/0000-0001-6342-4087; Hijikata, Atsushi/0000-0003-4297-8368; Inoue, Kentaro/0000-0002-7447-5856	Takeda Science Foundation; Uehara Foundation; Naito Foundation;  [24249058]; Grants-in-Aid for Scientific Research [16K15296] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Ito and A. Komano for helpful advice about the IAV infection experiments. We thank Y. Harada, Y. Motomura, H. Fujimoto, Y. Hachiman and Y. Suzuki for technical support and animal maintenance. We thank P. Burrows for helpful comments on the manuscript. We thank B. Malissen (CIML) for the Cd3e-deficient mice. This work was supported by a Grant-in-Aid for Scientific Research (A) (24249058) to M.K., and by Takeda Science Foundation, Uehara Foundation and The Naito Foundation.	Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Carpio VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144654; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaji T, 2013, INT IMMUNOL, V25, P683, DOI 10.1093/intimm/dxt030; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Karachunski PI, 2000, J IMMUNOL, V164, P5236, DOI 10.4049/jimmunol.164.10.5236; Koh CY, 2000, CELL IMMUNOL, V204, P135, DOI 10.1006/cimm.2000.1703; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Purdy A, 2003, J EXP MED, V197, P233, DOI 10.1084/jem.20021499; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Slifka MK, 1996, ANN NY ACAD SCI, V797, P166, DOI 10.1111/j.1749-6632.1996.tb52958.x; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Xiao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12781; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yoo JK, 2012, J EXP MED, V209, P1853, DOI 10.1084/jem.20112256; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	80	80	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1447	1458		10.1038/ni.3563	http://dx.doi.org/10.1038/ni.3563			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27798619				2022-12-18	WOS:000388056400015
J	Starokadomskyy, P; Gemelli, T; Rios, JJ; Xing, C; Wang, RC; Li, HY; Pokatayev, V; Dozmorov, I; Khan, S; Miyata, N; Fraile, G; Raj, P; Xu, Z; Xu, ZG; Ma, L; Lin, ZM; Wang, HJ; Yang, Y; Ben-Amitai, D; Orenstein, N; Mussaffi, H; Baselga, E; Tadini, G; Grunebaum, E; Sarajlija, A; Krzewski, K; Wakeland, EK; Yan, N; de la Morena, MT; Zinn, AR; Burstein, E				Starokadomskyy, Petro; Gemelli, Terry; Rios, Jonathan J.; Xing, Chao; Wang, Richard C.; Li, Haiying; Pokatayev, Vladislav; Dozmorov, Igor; Khan, Shaheen; Miyata, Naoteru; Fraile, Guadalupe; Raj, Prithvi; Xu, Zhe; Xu, Zigang; Ma, Lin; Lin, Zhimiao; Wang, Huijun; Yang, Yong; Ben-Amitai, Dan; Orenstein, Naama; Mussaffi, Huda; Baselga, Eulalia; Tadini, Gianluca; Grunebaum, Eyal; Sarajlija, Adrijan; Krzewski, Konrad; Wakeland, Edward K.; Yan, Nan; de la Morena, Maria Teresa; Zinn, Andrew R.; Burstein, Ezra			DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis	NATURE IMMUNOLOGY			English	Article							RETICULATE PIGMENTARY DISORDER; NF-KAPPA-B; SYSTEMIC MANIFESTATIONS; CUTANEOUS AMYLOIDOSIS; DEFICIENCY; DISEASE; HUMANS; FAMILY; ENCEPHALITIS; REPLICATION	Aberrant nucleic acids generated during viral replication are the main trigger for antiviral immunity, and mutations that disrupt nucleic acid metabolism can lead to autoinflammatory disorders. Here we investigated the etiology of X-linked reticulate pigmentary disorder (XLPDR), a primary immunodeficiency with autoinflammatory features. We discovered that XLPDR is caused by an intronic mutation that disrupts the expression of POLA1, which encodes the catalytic subunit of DNA polymerase-alpha. Unexpectedly, POLA1 deficiency resulted in increased production of type I interferons. This enzyme is necessary for the synthesis of RNA: DNA primers during DNA replication and, strikingly, we found that POLA1 is also required for the synthesis of cytosolic RNA: DNA, which directly modulates interferon activation. Together this work identifies POLA1 as a critical regulator of the type I interferon response.	[Starokadomskyy, Petro; Li, Haiying; Pokatayev, Vladislav; Miyata, Naoteru; Yan, Nan; de la Morena, Maria Teresa; Zinn, Andrew R.; Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gemelli, Terry; Rios, Jonathan J.; Xing, Chao; Zinn, Andrew R.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Rios, Jonathan J.] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Rios, Jonathan J.; de la Morena, Maria Teresa] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wang, Richard C.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Dozmorov, Igor; Khan, Shaheen; Raj, Prithvi; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Fraile, Guadalupe] Ramon y Cajal Univ Hosp, Dept Internal Med, Madrid, Spain; [Xu, Zhe; Xu, Zigang; Ma, Lin] Capital Med Univ, Beijing Childrens Hosp, Dept Dermatol, Beijing, Peoples R China; [Lin, Zhimiao; Wang, Huijun; Yang, Yong] Peking Univ, Hosp 1, Dept Dermatol, Beijing 100871, Peoples R China; [Wang, Huijun; Yang, Yong] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Wang, Huijun] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Ben-Amitai, Dan] Schneider Childrens Med Ctr Israel, Unit Pediat Dermatol, Petah Tiqwa, Israel; [Ben-Amitai, Dan; Mussaffi, Huda] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Orenstein, Naama] Schneider Childrens Med Ctr Israel, Genet Unit, Petah Tiqwa, Israel; [Mussaffi, Huda] Schneider Childrens Med Ctr, Pulmonol Inst, Petah Tiqwa, Israel; [Baselga, Eulalia] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain; [Tadini, Gianluca] Univ Milan, Dept Pathophysiol & Transplantat, Pediat Dermatol Unit, Milan, Italy; [Tadini, Gianluca] Univ Milan, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Tadini, Gianluca] IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Grunebaum, Eyal] Hosp Sick Children, Dev & Stem Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Grunebaum, Eyal] Univ Toronto, Hosp Sick Children, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; [Sarajlija, Adrijan] Mother & Child Hlth Care Inst Serbia, Belgrade, Serbia; [Sarajlija, Adrijan] Univ Belgrade, Sch Med, Belgrade, Serbia; [Krzewski, Konrad] NIAID, Immunogenet Lab, Receptor Cell Biol Sect, NIH, Rockville, MD USA; [Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [de la Morena, Maria Teresa] Childrens Hlth, Dallas, TX USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hospital Universitario Ramon y Cajal; Capital Medical University; Peking University; Peking University; Tel Aviv University; Sackler Faculty of Medicine; Hospital of Santa Creu i Sant Pau; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Belgrade; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zinn, AR; Burstein, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Zinn, AR (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Burstein, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	andrew.zinn@utsouthwestern.edu; ezra.burstein@utsouthwestern.edu	Wang, Richard/AAW-3066-2021; wang, hui/GRS-4730-2022; RAJ, PROFESSORDES/AAA-1007-2020	Wang, Richard/0000-0003-4543-8295; RAJ, PROFESSORDES/0000-0002-4050-4778; Khan, Shaheen/0000-0002-1472-8129; Zinn, Andrew/0000-0002-4935-3291; Xing, Chao/0000-0002-1838-0502	US National Institutes of Health [R01DK073639, R56AI113274, UL1TR001105, T32AI005284, R01AI098569, P30CA142543]; Children's Medical Center Foundation; National Natural Science Foundation of China [81271744]; XLPDR International Association; NATIONAL CANCER INSTITUTE [P30CA142543, K08CA164047] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284, R56AI113274, R01AI098569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073639] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Center Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); XLPDR International Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the patients and their families for their participation in this research project and, in particular, the XLPDR International Association for support for the study of this disease; T. Hyatt for technical assistance with allelic discrimination assays; D. Baltimore (Caltech) for the lentiviral packaging plasmids pHCMV-VSV-G, pMDLg/pRRE and pRSV-Rev; Y. Pavlov (University of Nebraska) for the plasmid pcDNA3-POLA1; L. Schmitz (Justus-Liebig-University) for the HeLa fluorescent ubiquitination-based cell cycle indicator; J. Shay (University of Texas Southwestern Medical Center) for the gene encoding human telomerase; and H. Hobbs, J. Cohen, M. Attanasio and Z. (J.) Chen for comments and suggestions. Supported by the US National Institutes of Health (R01DK073639 to Ez.B.; R56AI113274 to Ez.B. and A.R.Z.; UL1TR001105 to J.J.R.; T32AI005284 to V.P.; R01AI098569 to N.Y.; and P30CA142543 for the UT Southwestern Live Cell Imaging Facility), the Children's Medical Center Foundation (A.R.Z.) and the National Natural Science Foundation of China (81271744 to Y.Y.).	ADES LC, 1993, PEDIATR DERMATOL, V10, P344, DOI 10.1111/j.1525-1470.1993.tb00396.x; Anderson RC, 2005, PEDIATR DERMATOL, V22, P122, DOI 10.1111/j.1525-1470.2005.22206.x; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; BROWN M, 1981, P NATL ACAD SCI-BIOL, V78, P3049, DOI 10.1073/pnas.78.5.3049; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; de Lendonck LY, 2013, P NATL ACAD SCI USA, V110, pE3189, DOI 10.1073/pnas.1219221110; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; DONG Q, 1993, J BIOL CHEM, V268, P24163; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012657; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Fernandez-Guarino M, 2008, EUR J DERMATOL, V18, P102; Foley SB, 2015, EBIOMEDICINE, V2, P74, DOI 10.1016/j.ebiom.2014.12.003; Fraile G, 2008, SCAND J GASTROENTERO, V43, P506, DOI 10.1080/03014460701723912; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kim BS, 2010, INT J DERMATOL, V49, P421, DOI 10.1111/j.1365-4632.2010.04102.x; Kishore S, 2008, GENE, V427, P104, DOI 10.1016/j.gene.2008.09.021; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li HY, 2015, METHODS MOL BIOL, V1280, P371, DOI 10.1007/978-1-4939-2422-6_22; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Megarbane H, 2005, GENET COUNSEL, V16, P85; MURAKAMI Y, 1985, P NATL ACAD SCI USA, V82, P1761, DOI 10.1073/pnas.82.6.1761; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; PARTINGTON MW, 1989, AM J MED GENET, V32, P115, DOI 10.1002/ajmg.1320320125; PARTINGTON MW, 1981, AM J MED GENET, V10, P65, DOI 10.1002/ajmg.1320100109; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pezzani L, 2013, AM J MED GENET A, V161A, P1414, DOI 10.1002/ajmg.a.35882; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Santos LJJ, 2008, HUM GENET, V123, P469, DOI 10.1007/s00439-008-0498-4; Starokadomskyy P, 2013, J CLIN INVEST, V123, P2244, DOI 10.1172/JCI66466; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	50	80	85	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					495	+		10.1038/ni.3409	http://dx.doi.org/10.1038/ni.3409			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27019227	Green Submitted, Green Accepted			2022-12-18	WOS:000374323100008
J	Lu, D; Liu, L; Ji, X; Gao, YN; Chen, X; Liu, Y; Liu, Y; Zhao, XY; Li, Y; Li, YQ; Jin, Y; Zhang, Y; McNutt, MA; Yin, YX				Lu, Dan; Liu, Liang; Ji, Xin; Gao, Yanan; Chen, Xi; Liu, Yu; Liu, Yang; Zhao, Xuyang; Li, Yan; Li, Yunqiao; Jin, Yan; Zhang, Yu; McNutt, Michael A.; Yin, Yuxin			The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates T(H)17 differentiation	NATURE IMMUNOLOGY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; T-CELLS; RESPONSES; IL-17; PAC1; GENERATION; DISEASE; TARGET; MKP-1; MODEL	Deregulation of the T(H)17 subset of helper T cells is closely linked with immunological disorders and inflammatory diseases. However, the mechanism by which T(H)17 cells are regulated remains elusive. Here we found that the phosphatase DUSP2 (PAC1) negatively regulated the development of T(H)17 cells. DUSP2 was directly associated with the signal transducer and transcription activator STAT3 and attenuated its activity through dephosphorylation of STAT3 at Tyr705 and Ser727. DUSP2-deficient mice exhibited severe susceptibility to experimental colitis, with enhanced differentiation of T(H)17 cells and secretion of proinflammatory cytokines. In clinical patients with ulcerative colitis, DUSP2 was downregulated by DNA methylation and was not induced during T cell activation. Our data demonstrate that DUSP2 is a true STAT3 phosphatase that modulates the development of T(H)17 cells in the autoimmune response and inflammation.	[Lu, Dan; Liu, Liang; Ji, Xin; Chen, Xi; Liu, Yu; Liu, Yang; Zhao, Xuyang; Li, Yunqiao; Jin, Yan; McNutt, Michael A.; Yin, Yuxin] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100871, Peoples R China; [Liu, Liang; Yin, Yuxin] Peking Univ, Dept Pathol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Gao, Yanan; Li, Yan; Zhang, Yu] Peking Univ, Dept Immunol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Yin, Yuxin] Peking Univ, Peking Tsinghua Ctr Life Sci, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Yin, YX (corresponding author), Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100871, Peoples R China.	yinyuxin@hsc.pku.edu.cn	LI, YUNQIAO/ABE-3216-2021	Li, Yunqiao/0000-0001-9937-1634; Lu, Dan/0000-0002-3000-5094	National Natural Science Foundation of China [81430056, 31420103905, 81372491]; China National Major Scientific Program [2010CB912202]; Shu Fan Education Foundation; Lam Chung Nin Foundation for Systems Biomedicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Major Scientific Program; Shu Fan Education Foundation; Lam Chung Nin Foundation for Systems Biomedicine	We thank C. Huang for help with the generation of Dusp2<SUP>-/-</SUP> mice; Y. Li for technical support; Y. Zhou for analysis of mouse phenotypes; J. Zhang for critical reading of the manuscript and comments; and C.Y. Wang for long-term support. Supported by the National Natural Science Foundation of China (81430056, 31420103905 and 81372491 to Y.Y.), the China National Major Scientific Program (2010CB912202 to Y.Y.), the Shu Fan Education Foundation and the Lam Chung Nin Foundation for Systems Biomedicine.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Farooq A, 2003, STRUCTURE, V11, P155, DOI 10.1016/S0969-2126(02)00943-7; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Holmes DA, 2015, EMBO J, V34, P218, DOI 10.15252/embj.201489456; Huang CY, 2012, EUR J IMMUNOL, V42, P476, DOI 10.1002/eji.201041295; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kinney CM, 2009, AM J PHYSIOL-CELL PH, V296, pC242, DOI 10.1152/ajpcell.00492.2008; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Lin SC, 2011, J CLIN INVEST, V121, P1905, DOI 10.1172/JCI44362; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Musso A, 2005, INFLAMM BOWEL DIS, V11, P91, DOI 10.1097/00054725-200502000-00001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wei W, 2013, GENES IMMUN, V14, P1, DOI 10.1038/gene.2012.54; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu J, 2007, ONCOGENE, V26, P6526, DOI 10.1038/sj.onc.1210484; Yang CY, 2014, J IMMUNOL, V192, P1547, DOI 10.4049/jimmunol.1300989; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	41	80	83	0	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1263	1273		10.1038/ni.3278	http://dx.doi.org/10.1038/ni.3278			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26479789				2022-12-18	WOS:000365062100010
J	Wang, CH; Wu, L; Bulek, K; Martin, BN; Zepp, JA; Kang, ZZ; Liu, CN; Herjan, T; Misra, S; Carman, JA; Gao, J; Dongre, A; Han, SJ; Bunting, KD; Ko, JS; Xiao, H; Kuchroo, VK; Ouyang, WJ; Li, XX				Wang, Chenhui; Wu, Ling; Bulek, Katarzyna; Martin, Bradley N.; Zepp, Jarod A.; Kang, Zizhen; Liu, Caini; Herjan, Tomasz; Misra, Saurav; Carman, Julie A.; Gao, Ji; Dongre, Ashok; Han, Shujie; Bunting, Kevin D.; Ko, Jennifer S.; Xiao, Hui; Kuchroo, Vijay K.; Ouyang, Wenjun; Li, Xiaoxia			The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENOME-WIDE ASSOCIATION; HYPER-IGE; T-CELLS; PULMONARY INFLAMMATION; EPIDERMAL HYPERPLASIA; SKIN INFLAMMATION; RECEPTOR; SUSCEPTIBILITY; PATHOGENESIS	Act1 is an essential adaptor in interleukin 17 (IL-17)-mediated signaling and is recruited to the receptor for IL-17 after stimulation with IL-17. Here we found that Act1 was a 'client' protein of the molecular chaperone hsp90. The D10N variant of Act1 (Act1(D10N)) that is linked to susceptibility to psoriasis was defective in its interaction with hsp90, which resulted in a global loss of Act1 function. Act1-deficient mice modeled the mechanistic link between loss of Act1 function and susceptibility to psoriasis. Although Act1 was necessary for IL-17-mediated inflammation, Act1-deficient mice had a hyperactive response of the T(H)17 subset of helper T cells and developed spontaneous IL-22-dependent skin inflammation. In the absence of IL-17 signaling, IL-22 was the main contributor to skin inflammation, which provides a molecular mechanism for the association of Act1(D10N) with psoriasis susceptibility.	[Wang, Chenhui; Wu, Ling; Bulek, Katarzyna; Martin, Bradley N.; Zepp, Jarod A.; Kang, Zizhen; Liu, Caini; Herjan, Tomasz; Li, Xiaoxia] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Wu, Ling; Martin, Bradley N.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Misra, Saurav] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Carman, Julie A.; Gao, Ji; Dongre, Ashok] Bristol Myers Squibb Co, Discovery Biol, Princeton, NJ USA; [Han, Shujie; Bunting, Kevin D.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Han, Shujie; Bunting, Kevin D.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA; [Ko, Jennifer S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Anat Pathol & Clin Pathol, Cleveland, OH 44195 USA; [Xiao, Hui] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Kuchroo, Vijay K.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Harvard Univ, Sch Med, Boston, MA USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Bristol-Myers Squibb; Emory University; Children's Healthcare of Atlanta (CHOA); Cleveland Clinic Foundation; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Roche Holding; Genentech	Li, XX (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Herjan, Tomasz/AAM-9625-2020; Martin, Bradley/AAM-5041-2020; Ouyang, Wenjun/ABA-8763-2020; Bulek, Katarzyna/L-7517-2015; Han, Shujie/GZM-0351-2022	, Zizhen/0000-0001-5621-8912; Martin, Bradley/0000-0002-8902-8805; Dongre, Ashok/0000-0001-9624-4584; Misra, Saurav/0000-0002-1385-8554; Ouyang, Wenjun/0000-0002-1811-5864; Wang, Chenhui/0000-0002-3186-3066	US National Institutes of Health [1R01NS071996, 1P01 HL103453]; Case Western Reserve University Medical Scientist Training Program [T32 GM007250]; Case Western Reserve University Immunology Training Program [T32 AI 89474-1]; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271, T32GM088088, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University Medical Scientist Training Program; Case Western Reserve University Immunology Training Program; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank AML Laboratories and the Lerner Research Institute Histology Core for processing tissue samples for histology; J. Ma and W. Qian for technical support; and N. Volokh and D. Kish for discussions. Supported by the US National Institutes of Health (1R01NS071996 and 1P01 HL103453 to X.L.; and T32 GM007250 to the Case Western Reserve University Medical Scientist Training Program and T32 AI 89474-1 to the Case Western Reserve University Immunology Training Program, for support of L.W.) and the American Asthma Foundation (X.L.).	Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Cerchietti LC, 2009, NAT MED, V15, P1369, DOI 10.1038/nm.2059; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Guilloteau K, 2010, J IMMUNOL; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Li LF, 2005, CLIN EXP DERMATOL, V30, P125, DOI 10.1111/j.1365-2230.2004.01717.x; Li XL, 2007, J EUR ACAD DERMATOL, V21, P424, DOI 10.1111/j.1468-3083.2006.01918.x; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Matsushima Y, 2010, J IMMUNOL, V185, P2340, DOI 10.4049/jimmunol.0900694; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Ouyang WJ, 2010, CYTOKINE GROWTH F R, V21, P435, DOI 10.1016/j.cytogfr.2010.10.007; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Ryzhakov G, 2011, J MOL EVOL, V72, P521, DOI 10.1007/s00239-011-9450-7; Saraceno R, 2009, ACTA DERM-VENEREOL, V89, P412, DOI 10.2340/00015555-0613; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	48	80	81	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					72	81		10.1038/ni.2479	http://dx.doi.org/10.1038/ni.2479			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23202271	Green Accepted, Green Submitted			2022-12-18	WOS:000312433800012
J	Kessler, JH; Khan, S; Seifert, U; Le Gall, S; Chow, KM; Paschen, A; Bres-Vloemans, SA; de Ru, A; van Montfoort, N; Franken, KLMC; Benckhuijsen, WE; Brooks, JM; van Hall, T; Ray, K; Mulder, A; Doxiadis, IIN; van Swieten, PF; Overkleeft, HS; Prat, A; Tomkinson, B; Neefjes, J; Kloetzel, PM; Rodgers, DW; Hersh, LB; Drijfhout, JW; van Veelen, PA; Ossendorp, F; Melief, CJM				Kessler, Jan H.; Khan, Selina; Seifert, Ulrike; Le Gall, Sylvie; Chow, K. Martin; Paschen, Annette; Bres-Vloemans, Sandra A.; de Ru, Arnoud; van Montfoort, Nadine; Franken, Kees L. M. C.; Benckhuijsen, Willemien E.; Brooks, Jill M.; van Hall, Thorbald; Ray, Kallol; Mulder, Arend; Doxiadis, Ilias I. N.; van Swieten, Paul F.; Overkleeft, Hermen S.; Prat, Annik; Tomkinson, Birgitta; Neefjes, Jacques; Kloetzel, Peter M.; Rodgers, David W.; Hersh, Louis B.; Drijfhout, Jan W.; van Veelen, Peter A.; Ossendorp, Ferry; Melief, Cornelis J. M.			Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes	NATURE IMMUNOLOGY			English	Article							TRIPEPTIDYL PEPTIDASE-II; DISTINCT PROTEOLYTIC PROCESSES; ARGININE DIBASIC CONVERTASE; SUBSTRATE-SPECIFICITY; PROTEASOME INHIBITORS; ENDOPLASMIC-RETICULUM; FLANKING SEQUENCES; BINDING-SITE; CYTOSOL; PATHWAY	Cytotoxic T lymphocytes (CTLs) recognize peptides presented by HLA class I molecules on the cell surface. The C terminus of these CTL epitopes is considered to be produced by the proteasome. Here we demonstrate that the cytosolic endopeptidases nardilysin and thimet oligopeptidase (TOP) complemented proteasome activity. Nardilysin and TOP were required, either together or alone, for the generation of a tumor-specific CTL epitope from PRAME, an immunodominant CTL epitope from Epstein-Barr virus protein EBNA3C, and a clinically important epitope from the melanoma protein MART-1. TOP functioned as C-terminal trimming peptidase in antigen processing, and nardilysin contributed to both the C-terminal and N-terminal generation of CTL epitopes. By broadening the antigenic peptide repertoire, nardilysin and TOP strengthen the immune defense against intracellular pathogens and cancer.	[Kessler, Jan H.; Khan, Selina; Bres-Vloemans, Sandra A.; de Ru, Arnoud; van Montfoort, Nadine; Franken, Kees L. M. C.; Benckhuijsen, Willemien E.; Mulder, Arend; Doxiadis, Ilias I. N.; Drijfhout, Jan W.; van Veelen, Peter A.; Ossendorp, Ferry; Melief, Cornelis J. M.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [Seifert, Ulrike; Kloetzel, Peter M.] Humboldt Univ, Inst Biochem Charite, Fac Med, Berlin, Germany; [Le Gall, Sylvie] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Chow, K. Martin; Ray, Kallol; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Chow, K. Martin; Ray, Kallol; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Paschen, Annette] Univ Clin Essen, Dept Dermatol, Essen, Germany; [Brooks, Jill M.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England; [van Hall, Thorbald] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands; [van Swieten, Paul F.; Overkleeft, Hermen S.] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [Prat, Annik] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Tomkinson, Birgitta] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kentucky; University of Kentucky; University of Duisburg Essen; Cancer Research UK; University of Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Uppsala University; Netherlands Cancer Institute	Kessler, JH (corresponding author), Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands.	j.h.kessler@amc.uva.nl	Drijfhout, Jan Wouter/ABA-6318-2021; Franken, Kees/ABA-7095-2021; Benckhuijsen, Willemina/Y-2490-2018; van Montfoort, Nadine/ABB-7907-2020; Doxiadis, ilias/AAH-9875-2020; Kessler, Jan/C-5559-2009; Neefjes, Jacques J.C./H-8780-2017; Prat, Annik/S-6757-2018; van Hall, Thorbald/Y-5651-2018	Drijfhout, Jan Wouter/0000-0003-4808-5296; Franken, Kees/0000-0002-4747-6060; Benckhuijsen, Willemina/0000-0002-8898-5195; Neefjes, Jacques J.C./0000-0001-6763-2211; Prat, Annik/0000-0002-8007-5277; van Hall, Thorbald/0000-0002-9115-558X; Overkleeft, Herman/0000-0001-6976-7005; Le Gall, Sylvie/0000-0003-0385-926X; van Veelen, Peter/0000-0002-7898-9408; van Montfoort, Nadine/0000-0002-7906-7202	Dutch Cancer Society [UL 2005-3245]; Stichting Vanderes	Dutch Cancer Society(KWF Kankerbestrijding); Stichting Vanderes	We thank T. Dannenberg and K. Textoris-Taube for technical assistance. Supported by the Dutch Cancer Society (UL 2005-3245) and Stichting Vanderes.	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; BALOW RM, 1986, J BIOL CHEM, V261, P2409; Benham AM, 1998, J IMMUNOL, V161, P83; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; BROOKS JM, 1993, J EXP MED, V178, P879, DOI 10.1084/jem.178.3.879; Chow KM, 2000, J BIOL CHEM, V275, P19545, DOI 10.1074/jbc.M909020199; Chow KM, 2003, BIOCHEMISTRY-US, V42, P2239, DOI 10.1021/bi027178d; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Csuhai E, 1998, BIOCHEMISTRY-US, V37, P3787, DOI 10.1021/bi971969b; Fumagalli P, 1998, GENOMICS, V47, P238, DOI 10.1006/geno.1997.5078; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Kessler JH, 2003, HUM IMMUNOL, V64, P245, DOI 10.1016/S0198-8859(02)00787-5; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; KNIGHT CG, 1995, BIOCHEM J, V308, P145, DOI 10.1042/bj3080145; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; Luckey CJ, 1998, J IMMUNOL, V161, P112; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; Mo XY, 1999, J IMMUNOL, V163, P5851; Mulder A, 2010, MOL IMMUNOL, V47, P809, DOI 10.1016/j.molimm.2009.10.004; NEISIG A, 1995, J IMMUNOL, V154, P1273; Oliveira V, 2002, EUR J BIOCHEM, V269, P4326, DOI 10.1046/j.1432-1033.2002.03129.x; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Romero P, 1997, J IMMUNOL, V159, P2366; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schneider J, 1998, INT J CANCER, V75, P451, DOI 10.1002/(SICI)1097-0215(19980130)75:3<451::AID-IJC20>3.0.CO;2-A; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Sigman JA, 2005, BIOCHEM J, V388, P255, DOI 10.1042/BJ20041481; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; TOMKINSON B, 1990, BIOCHEM J, V267, P149, DOI 10.1042/bj2670149; van Endert P, 2008, EUR J IMMUNOL, V38, P609, DOI 10.1002/eji.200838181; van Swieten PF, 2007, BIOORG MED CHEM LETT, V17, P3402, DOI 10.1016/j.bmcl.2007.03.092; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	50	80	81	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					45	U67		10.1038/ni.1974	http://dx.doi.org/10.1038/ni.1974			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21151101	Green Published			2022-12-18	WOS:000285465100012
J	Hasham, MG; Donghia, NM; Coffey, E; Maynard, J; Snow, KJ; Ames, J; Wilpan, RY; He, YS; King, BL; Mills, KD				Hasham, Muneer G.; Donghia, Nina M.; Coffey, Eliot; Maynard, Jane; Snow, Kathy J.; Ames, Jacquelyn; Wilpan, Robert Y.; He, Yishu; King, Benjamin L.; Mills, Kevin D.			Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination	NATURE IMMUNOLOGY			English	Article							CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; B-CELLS; DNA-DAMAGE; XRCC2; REPAIR; GENE; MICE; AID; TRANSLOCATIONS	Activation-induced cytidine deaminase (AID) is required for somatic hypermutation and immunoglobulin class switching in activated B cells. Because AID has no known target-site specificity, there have been efforts to identify non-immunoglobulin AID targets. We show here that AID acts promiscuously, generating widespread DNA double-strand breaks (DSBs), genomic instability and cytotoxicity in B cells with less homologous recombination ability. We demonstrate that the homologous-recombination factor XRCC2 suppressed AID-induced off-target DSBs, promoting B cell survival. Finally, we suggest that aberrations that affect human chromosome 7q36, including XRCC2, correlate with genomic instability in B cell cancers. Our findings demonstrate that AID has promiscuous genomic DSB-inducing activity, identify homologous recombination as a safeguard against off-target AID action, and have implications for genomic instability in B cell cancers.	[Hasham, Muneer G.; Donghia, Nina M.; Coffey, Eliot; Maynard, Jane; Snow, Kathy J.; Ames, Jacquelyn; Wilpan, Robert Y.; He, Yishu; King, Benjamin L.; Mills, Kevin D.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Mills, KD (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	kevin.mills@jax.org	King, Benjamin/AAI-1492-2019	Hasham, Muneer/0000-0002-4498-0210; King, Benjamin/0000-0001-6463-1336	US National Institutes of Health [R01CA138646, P20RR018789-06, T32DK07449-26, P30CA034196]; Maine Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA138646, P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007449] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Honjo (Kyoto Univesity), R. Maser and S. LaSalle (The Jackson Laboratory) and A.Y. Tsygankov (Temple University School of Medicine) for reagents and mice; C. Boboila, B. Schwer and F.W. Alt (Children's Hospital, Boston) and J. Chaudhuri (Memorial Sloan-Kettering Cancer Center) for reagents and technical assistance; and the Jackson Laboratory Gene Expression, Molecular Biology and Flow Cytometry Services for technical support. Supported by the US National Institutes of Health (R01CA138646, P20RR018789-06, T32DK07449-26 and P30CA034196) and the Maine Cancer Foundation.	Adam J, 2007, DNA REPAIR, V6, P224, DOI 10.1016/j.dnarep.2006.10.024; BORZILLO GV, 1992, ONCOGENE, V7, P869; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Caddle LB, 2008, MOL CELL BIOL, V28, P2295, DOI 10.1128/MCB.02139-07; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Danoy P, 2007, BIOCHEM BIOPH RES CO, V352, P763, DOI 10.1016/j.bbrc.2006.11.083; Deans B, 2003, CANCER RES, V63, P8181; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7; Hasham MG, 2004, VIROLOGY, V320, P313, DOI 10.1016/j.virol.2003.11.032; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu Nan, 2002, Journal of Biomedicine & Biotechnology, V2, P106, DOI 10.1155/S1110724302204040; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; Mao X, 2001, BRIT J DERMATOL, V145, P117, DOI 10.1046/j.1365-2133.2001.04294.x; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; THACKER J, 1995, HUM MOL GENET, V4, P113, DOI 10.1093/hmg/4.1.113; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Woo Y, 2007, ONCOGENE, V26, P6010, DOI 10.1038/sj.onc.1210430; Wright SM, 2009, CANCER RES, V69, P4454, DOI 10.1158/0008-5472.CAN-08-4515; Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763	40	80	83	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					820	U72		10.1038/ni.1909	http://dx.doi.org/10.1038/ni.1909			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20657597	Green Accepted			2022-12-18	WOS:000281115500010
J	Delgado, P; Cubelos, B; Calleja, E; Martinez-Martin, N; Cipres, A; Merida, I; Bellas, C; Bustelo, XR; Alarcon, B				Delgado, Pilar; Cubelos, Beatriz; Calleja, Enrique; Martinez-Martin, Nuria; Cipres, Angel; Merida, Isabel; Bellas, Carmen; Bustelo, Xose R.; Alarcon, Balbino			Essential function for the GTPase TC21 in homeostatic antigen receptor signaling	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; SURVIVAL SIGNALS; RAS; PROLIFERATION; ACTIVATION; P110-DELTA; PROTEIN; NAIVE	T cell antigen receptors (TCRs) and B cell antigen receptors (BCRs) transmit low-grade signals necessary for the survival and maintenance of mature cell pools. We show here that TC21, a small GTPase encoded by Rras2, interacted constitutively with both kinds of receptors. Expression of a dominant negative TC21 mutant in T cells produced a rapid decrease in cell viability, and Rras2(-/-) mice were lymphopenic, possibly as a result of diminished homeostatic proliferation and impaired T cell and B cell survival. In contrast, TC21 was overexpressed in several human lymphoid malignancies. Finally, the p110 delta catalytic subunit of phosphatidylinositol-3-OH kinase (PI(3) K) was recruited to the TCR and BCR in a TC21-dependent way. Consequently, we propose TC21 directly links antigen receptors to PI(3) K-mediated survival pathways.	[Delgado, Pilar; Cubelos, Beatriz; Calleja, Enrique; Martinez-Martin, Nuria; Alarcon, Balbino] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Cipres, Angel; Merida, Isabel] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Bellas, Carmen] Hosp Univ Puerta Hierro, Dept Pathol, Lab Mol Pathol, Madrid, Spain; [Bustelo, Xose R.] Univ Salamanca, CSIC, Ctr Invest Canc, E-37008 Salamanca, Spain; [Bustelo, Xose R.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Puerta de Hierro-Majadahonda; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Alarcon, B (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	balarcon@cbm.uam.es	Bustelo, Xose R./AAD-2081-2022; Alarcon, Balbino/N-9648-2016; Delgado, Pilar/F-3365-2016; Martinez-Martin, Nuria/A-9160-2017; Merida, Isabel/A-9713-2014; Bustelo, Xose R./A-9526-2010; Ciprés, Ángel/ABH-6863-2020	Bustelo, Xose R./0000-0001-9398-6072; Alarcon, Balbino/0000-0001-7820-1070; Delgado, Pilar/0000-0002-8431-8002; Martinez-Martin, Nuria/0000-0003-2309-8920; Merida, Isabel/0000-0003-2762-6241; Bustelo, Xose R./0000-0001-9398-6072; Cipres, Angel/0000-0001-7086-2704; Cubelos Alvarez, Beatriz/0000-0002-2280-8233				ARONHEIM A, 2000, METH MOL B, V177, P319; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; CHAN AML, 1994, P NATL ACAD SCI USA, V91, P7558, DOI 10.1073/pnas.91.16.7558; Clark GJ, 1996, ONCOGENE, V12, P169; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Fabre Stephanie, 2006, Bull Cancer, V93, pE36; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Graham SM, 1996, MOL CELL BIOL, V16, P6132; GRAHAM SM, 1994, MOL CELL BIOL, V14, P4108, DOI 10.1128/MCB.14.6.4108; Grande Shannon M, 2006, Future Oncol, V2, P301, DOI 10.2217/14796694.2.2.301; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG Y, 1995, ONCOGENE, V11, P1255; Jarrett RF, 2006, J PATHOL, V208, P176, DOI 10.1002/path.1905; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin J, 2001, J CELL SCI, V114, P243; LopezBarahona M, 1996, ONCOGENE, V12, P463; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; Movilla N, 1999, ONCOGENE, V18, P5860, DOI 10.1038/sj.onc.1202968; Murphy GA, 2002, J BIOL CHEM, V277, P9966, DOI 10.1074/jbc.M109059200; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; PETER ME, 1993, EUR J IMMUNOL, V23, P461, DOI 10.1002/eji.1830230224; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2003, CURR OPIN IMMUNOL, V15, P321, DOI 10.1016/S0952-7915(03)00049-9; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Sharma R, 2005, ONCOLOGY-BASEL, V69, P10, DOI 10.1159/000087283; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001	56	80	85	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					880	U109		10.1038/ni.1749	http://dx.doi.org/10.1038/ni.1749			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19561613				2022-12-18	WOS:000268141400018
J	Bilic, I; Koesters, C; Unger, B; Sekimata, M; Hertweck, A; Maschek, R; Wilson, CB; Ellmeier, W				Bilic, I; Koesters, C; Unger, B; Sekimata, M; Hertweck, A; Maschek, R; Wilson, CB; Ellmeier, W			Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR	NATURE IMMUNOLOGY			English	Article							PERIPHERAL T-CELLS; GENE-EXPRESSION; LINEAGE COMMITMENT; DNA METHYLATION; N-COR; THYMOCYTES; SILENCER; DIFFERENTIATION; TRANSCRIPTION; DELETION	Coreceptor expression is tightly regulated during thymocyte development. Deletion of specific Cd8 enhancers leads to variegated expression of CD8 alpha beta heterodimers in double-positive thymocytes. Here we show CD8 variegation is correlated with an epigenetic 'off' state, linking Cd8 enhancer function with chromatin remodeling of the adjacent genes Cd8a and Cd8b1 ( Cd8). The zinc finger protein MAZR bound the Cd8 enhancer and interacted with the nuclear receptor corepressor N-CoR complex in double-negative thymocytes. MAZR was downregulated in double-positive and CD8 single-positive thymocytes. 'Enforced' expression of MAZR led to impaired Cd8 activation and variegated CD8 expression. Our results demonstrate epigenetic control of the Cd8 loci and identify MAZR as an important regulator of Cd8 expression.	Med Univ Vienna, Inst Immunol, A-1090 Vienna, Austria; K Plus Competence Ctr Biomol Therapeut, A-1090 Vienna, Austria; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Medical University of Vienna; University of Washington; University of Washington Seattle	Ellmeier, W (corresponding author), Med Univ Vienna, Inst Immunol, A-1090 Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at		Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund FWF [Y 163] Funding Source: Medline; NICHD NIH HHS [R01 HD018184, HD39454, HD18184, R01 HD039454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018184, R37HD018184, R01HD039454] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; AUSUBEL FM, 1992, CURRENT PROTOCOLS MO, pCH10; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; CARBONE AM, 1988, SCIENCE, V242, P1174, DOI 10.1126/science.2460926; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Donda A, 1996, EUR J IMMUNOL, V26, P493, DOI 10.1002/eji.1830260232; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Fisher AG, 2002, NAT REV IMMUNOL, V2, P977, DOI 10.1038/nri958; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Hamerman JA, 1997, J IMMUNOL, V159, P1240; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, J IMMUNOL, V158, P4270; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kobayashi A, 2000, MOL CELL BIOL, V20, P1733, DOI 10.1128/MCB.20.5.1733-1746.2000; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; Wack A, 2000, J IMMUNOL, V165, P1236, DOI 10.4049/jimmunol.165.3.1236; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	40	80	82	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					392	400		10.1038/ni1311	http://dx.doi.org/10.1038/ni1311			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16491076	Green Accepted			2022-12-18	WOS:000236171000013
J	Fischer, A				Fischer, A			Human primary immunodeficiency diseases: a perspective	NATURE IMMUNOLOGY			English	Review							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; HYPER-IGM SYNDROME; ANHIDROTIC ECTODERMAL DYSPLASIA; AUTOSOMAL RECESSIVE FORM; LINKED SYNDROME IPEX; B-CELL DEVELOPMENT; IMMUNE DYSREGULATION; LYMPHOPROLIFERATIVE SYNDROME	Primary immunodeficiency diseases consist of a group of more than 100 inherited conditions, mostly monogenic, predisposing individuals to different sets of infections, allergy, autoimmunity and cancer. Primary immunodeficiencies therefore represent exquisite models of various immunopathological settings. The identification of the associated genes, 100 so far, has generated a plethora of information about the immune system and spurred the analysis of many aspects of the development, function and regulation of both innate and adaptive immunity. These findings can potentially contribute to improved care of affected individuals by providing new diagnostic and/or therapeutic tools.	Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fischer, A (corresponding author), Hop Necker Enfants Malad, INSERM, U429, 149 Rue Sevres, F-75015 Paris, France.	fischer@necker.fr						Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; BASILE GD, 2001, CURR OPIN IMMUNOL, V13, P549; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baud O, 2001, NEW ENGL J MED, V344, P1758, DOI 10.1056/NEJM200106073442304; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BRUTON OC, 1952, AMA AM J DIS CHILD, V84, P632; Buckley RH, 2000, NEW ENGL J MED, V343, P1313, DOI 10.1056/NEJM200011023431806; Casal J, 2003, CURR OPIN INFECT DIS, V16, P219, DOI 10.1097/00001432-200306000-00006; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chae KM, 2001, J AM ACAD DERMATOL, V44, P124, DOI 10.1067/mjd.2001.111337; Chapel H, 2003, CLIN EXP IMMUNOL, V132, P9, DOI 10.1046/j.1365-2249.2003.02110.x; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Clark R, 2003, CURR OPIN IMMUNOL, V15, P516, DOI 10.1016/S0952-7915(03)00113-4; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; COOPER KD, 1990, J INVEST DERMATOL, V94, P769, DOI 10.1111/1523-1747.ep12874631; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Dadi HK, 2003, NEW ENGL J MED, V349, P1821, DOI 10.1056/NEJMoa031178; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Fadeel B, 1999, BRIT J HAEMATOL, V106, P406, DOI 10.1046/j.1365-2141.1999.01538.x; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; *FINN GERM APECED, 1997, NAT GENET, V17, P349; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; Frazer IH, 1999, IMMUNOL REV, V168, P131, DOI 10.1111/j.1600-065X.1999.tb01288.x; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Good RA, 2002, IMMUNOL REV, V185, P136, DOI 10.1034/j.1600-065X.2002.18513.x; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Henter JI, 1998, HEMATOL ONCOL CLIN N, V12, P417, DOI 10.1016/S0889-8588(05)70520-7; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Imai K, 2003, J CLIN INVEST, V112, P136, DOI 10.1172/JCI200318161; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kenter AL, 2003, CURR OPIN IMMUNOL, V15, P190, DOI 10.1016/S0952-7915(03)00018-9; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; LANDMANPARKER J, 1993, BRIT J HAEMATOL, V85, P37, DOI 10.1111/j.1365-2141.1993.tb08642.x; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Loy AL, 2002, CURR OPIN IMMUNOL, V14, P260, DOI 10.1016/S0952-7915(02)00331-X; Manis JP, 2003, J CLIN INVEST, V112, P19, DOI 10.1172/JCI200319091; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Notarangelo LD, 2000, CLIN EXP IMMUNOL, V120, P399, DOI 10.1046/j.1365-2249.2000.01142.x; Notarangelo LD, 1999, CURR OPIN IMMUNOL, V11, P435, DOI 10.1016/S0952-7915(99)80073-9; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; RAMIRO AR, 2003, NAT IMMUNOL, V422, P726; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; RATHMELL JC, 1995, CURR BIOL, V5, P1218, DOI 10.1016/S0960-9822(95)00241-7; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Suzuki N, 2002, TRENDS IMMUNOL, V23, P503, DOI 10.1016/S1471-4906(02)02298-6; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tchernev VT, 2002, MOL MED, V8, P56, DOI 10.1007/BF03402003; Tommasini A, 2002, CLIN EXP IMMUNOL, V130, P127, DOI 10.1046/j.1365-2249.2002.01940.x; Van Parijs L, 1998, SCIENCE, V280, P243; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	102	80	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					23	30		10.1038/ni1023	http://dx.doi.org/10.1038/ni1023			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699405				2022-12-18	WOS:000187635800010
J	Aoki, K; Kurooka, M; Chen, JJ; Petryniak, J; Nabel, EG; Nabel, GJ				Aoki, K; Kurooka, M; Chen, JJ; Petryniak, J; Nabel, EG; Nabel, GJ			Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity	NATURE IMMUNOLOGY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN FAS LIGAND; INDUCED APOPTOSIS; DOWN-REGULATION; VITRONECTIN; EXPRESSION; MICE; FORM; PURIFICATION; REJECTION	Fas ligand (CD95L) is synthesized both on the cell surface membrane and in a soluble form. Although CD95L contributes to immune privilege in the cornea and testis, the functions of these alternatively processed proteins are not well understood. Some reports suggest that the cytotoxicity of soluble CD95L is insignificant, whereas others show potent responses in vivo, including hepatocyte apoptosis that causes liver failure. We show here that extracellular matrix proteins interact with soluble CD95L and potentiate its pro-apoptotic activity. The cytotoxicity of supernatants from CD95L-expressing cells was increased by incubation on tissue culture plates coated with these matrix proteins; this effect was mediated by trimeric soluble CD95L. With the use of immunoprecipitation, it was found that CD95L binds directly to fibronectin. In addition, immunohistochemical analysis of the cornea revealed that soluble CD95L binds primarily to extracellular matrix. The retention of soluble CD95L on extracellular matrices is likely to play an important role in the development of peripheral tolerance in immune-privileged sites.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005601] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arai H, 1997, NAT MED, V3, P843, DOI 10.1038/nm0897-843; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dick AD, 1999, INVEST OPHTH VIS SCI, V40, P2258; ERICKSON LA, 1990, NATURE, V346, P74, DOI 10.1038/346074a0; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; KAYAGAKI N, 1997, P NATL ACAD SCI USA, V94, P5986; Lau HT, 1996, SCIENCE, V273, P109, DOI 10.1126/science.273.5271.109; LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PEITSCH MC, 1995, MOL IMMUNOL, V32, P761, DOI 10.1016/0161-5890(95)00016-8; RENSINGEHL A, 1995, EUR J IMMUNOL, V25, P2253, DOI 10.1002/eji.1830250821; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SEIFFERT D, 1990, J CELL BIOL, V111, P1283, DOI 10.1083/jcb.111.3.1283; Sotozono C, 2000, CURR EYE RES, V20, P54, DOI 10.1076/0271-3683(200001)20:1;1-H;FT054; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Tanaka M, 1997, J IMMUNOL, V158, P2303; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	32	80	80	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					333	337		10.1038/86336	http://dx.doi.org/10.1038/86336			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276204				2022-12-18	WOS:000167982900014
J	Schubart, K; Massa, S; Schubart, D; Corcoran, LM; Rolink, AG; Matthias, P				Schubart, K; Massa, S; Schubart, D; Corcoran, LM; Rolink, AG; Matthias, P			B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1	NATURE IMMUNOLOGY			English	Article							OCTAMER-BINDING PROTEINS; CHAIN GENE; PROMOTER ACTIVITY; OCA-B; COACTIVATOR; EXPRESSION; ACTIVATION; RECEPTOR; ANTIGEN; IDENTIFICATION	Oct-2 and OBF-1 (also called OCA-B or Bob-1) are B cell-specific transcription factors that bind to the conserved octamer site of immunoglobulin promoters, yet their role in immunoglobulin transcription has remained unclear. We generated mice in which the lymphoid compartment was reconstituted with cells that lack both Oct-2 and OBF-1. Even in the absence of these two transcription factors, B cells develop normally to the membrane immunoglobulin M-positive (IgM(+)) stage and immunoglobulin gene transcription is essentially unaffected. These observations imply that the ubiquitous factor Oct-1 plays a previously unrecognized role in the control of immunoglobulin gene transcription and suggest the existence of another, as yet unidentified, cofactor. In addition, both factors are essential for germinal center formation, although OBF-1 is more important than Oct-2 for IgG production after immunization.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; Basel Inst Immunol, CH-4005 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Walter & Eliza Hall Institute	Matthias, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Schubart, Daniel/AAV-6487-2021; Corcoran, Lynn M/C-9316-2013	Schubart, Dr. Karin/0000-0002-3364-6575; Schubart, Daniel/0000-0002-8069-0122				Arulampalam V, 1997, IMMUNOL TODAY, V18, P549, DOI 10.1016/S0167-5699(97)01154-7; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; BERTOLINO E, 2000, IN PRESS TRANSCRIPTI; CHRISTENSEN SM, 1992, J IMMUNOL, V148, P3610; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; FELDHAUS AL, 1993, EMBO J, V12, P2763, DOI 10.1002/j.1460-2075.1993.tb05937.x; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; HERMANSON GG, 1989, P NATL ACAD SCI USA, V86, P7341, DOI 10.1073/pnas.86.19.7341; Humbert PO, 1997, J IMMUNOL, V159, P5273; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; KANG SM, 1992, MOL CELL BIOL, V12, P3149, DOI 10.1128/MCB.12.7.3149; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KONIG H, 1995, GENE DEV, V9, P1598, DOI 10.1101/gad.9.13.1598; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LUO Y, 1995, MOL CELL BIOL, V15, P4115; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; Matthias P, 1998, SEMIN IMMUNOL, V10, P155, DOI 10.1006/smim.1998.0117; MIZUSHIMASUGANO J, 1986, P NATL ACAD SCI USA, V83, P8511, DOI 10.1073/pnas.83.22.8511; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROLINK A, 1995, IMMUNOLOGIST, V3, P125; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SAUTER P, 1997, IMMUNOBIOLOGY, V197, P293; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Shah PC, 1997, EMBO J, V16, P7105, DOI 10.1093/emboj/16.23.7105; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; THEVENIN C, 1993, J BIOL CHEM, V268, P5949; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; Wolf I, 1998, J BIOL CHEM, V273, P28831, DOI 10.1074/jbc.273.44.28831; Zwilling S, 1997, SCIENCE, V277, P221, DOI 10.1126/science.277.5323.221	44	80	82	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					69	74		10.1038/83190	http://dx.doi.org/10.1038/83190			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135581				2022-12-18	WOS:000166261500017
J	Jia, MT; Qin, DH; Zhao, CY; Chai, L; Yu, ZX; Wang, WW; Tong, L; Lv, L; Wang, YY; Rehwinkel, J; Yu, JM; Zhao, W				Jia, Mutian; Qin, Danhui; Zhao, Chunyuan; Chai, Li; Yu, Zhongxia; Wang, Wenwen; Tong, Li; Lv, Lin; Wang, Yuanyuan; Rehwinkel, Jan; Yu, Jinming; Zhao, Wei			Redox homeostasis maintained by GPX4 facilitates STING activation	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; DNA; INFLAMMATION; FERROPTOSIS; ADAPTER; TRAFFICKING; RECOGNITION; SENSITIVITY; INFECTION; VIRUSES	Stimulator-of-interferon genes (STING) is vital for sensing cytosolic DNA and initiating innate immune responses against microbial infection and tumors. Redox homeostasis is the balance of oxidative and reducing reactions present in all living systems. Yet, how the intracellular redox state controls STING activation is unclear. Here, we show that cellular redox homeostasis maintained by glutathione peroxidase 4 (GPX4) is required for STING activation. GPX4 deficiency enhanced cellular lipid peroxidation and thus specifically inhibited the cGAS-STING pathway. Concordantly, GPX4 deficiency inhibited herpes simplex virus-1 (HSV-1)-induced innate antiviral immune responses and promoted HSV-1 replication in vivo. Mechanistically, GPX4 inactivation increased production of lipid peroxidation, which led to STING carbonylation at C88 and inhibited its trafficking from the endoplasmic reticulum (ER) to the Golgi complex. Thus, cellular stress-induced lipid peroxidation specifically attenuates the STING DNA-sensing pathway, suggesting that GPX4 facilitates STING activation by maintaining redox homeostasis of lipids. Zhao and colleagues show that STING activation is sensitive to membrane lipid peroxidation that occurs upon reactive oxygen species (ROS) production. The lipid hydroperoxidase glutathione peroxidase 4 (GPX4) reduces such oxidized lipids. Lack of GPX4 leads to STING protein carbonylation, which impedes its trafficking from the ER to the Golgi.	[Jia, Mutian; Qin, Danhui; Chai, Li; Yu, Zhongxia; Wang, Wenwen; Tong, Li; Lv, Lin; Wang, Yuanyuan; Zhao, Wei] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Chinese Minist Educ,Dept Immunol, Jinan, Shandong, Peoples R China; [Jia, Mutian; Qin, Danhui; Chai, Li; Yu, Zhongxia; Wang, Wenwen; Tong, Li; Lv, Lin; Wang, Yuanyuan; Zhao, Wei] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Chinese Minist Educ,Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Jia, Mutian; Qin, Danhui; Zhao, Chunyuan; Chai, Li; Yu, Zhongxia; Wang, Wenwen; Tong, Li; Lv, Lin; Wang, Yuanyuan; Zhao, Wei] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Zhao, Chunyuan] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Cell Biol, Jinan, Shandong, Peoples R China; [Rehwinkel, Jan] Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Human Immunol Unit,Radcliffe Dept Med, Oxford, England; [Yu, Jinming] Shandong Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhao, W (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Chinese Minist Educ,Dept Immunol, Jinan, Shandong, Peoples R China.; Zhao, W (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Chinese Minist Educ,Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.; Zhao, W (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.	wzhao@sdu.edu.cn	Rehwinkel, Jan/CAG-1436-2022; wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022	Rehwinkel, Jan/0000-0003-3841-835X; Zhao, Wei/0000-0001-8440-2274; Jia, Mutian/0000-0002-2652-3411	National Key Research and Developmental Program of China [2017YFC1001100]; National Natural Science Foundation of China [81622030, 31870866, 81861130369, NAF\R1\180232]; MRC [MC_UU_00008/8] Funding Source: UKRI	National Key Research and Developmental Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Y. Liew for expertise and advice. This work was supported by grants from the National Key Research and Developmental Program of China (grant no. 2017YFC1001100 to W.Z.), the National Natural Science Foundation of China (grant nos. 81622030, 31870866 and 81861130369 to W.Z.). W.Z. is a Newton Advanced Fellow of the Academy of Medical Sciences (NAF\R1\180232 to W.Z.).	Agmon E, 2017, CURR OPIN CHEM BIOL, V39, P83, DOI 10.1016/j.cbpa.2017.06.002; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Banerjee I, 2018, IMMUNITY, V49, P413, DOI 10.1016/j.immuni.2018.07.006; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Canli O, 2017, CANCER CELL, V32, P869, DOI 10.1016/j.ccell.2017.11.004; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chen Y, 2018, J AM CHEM SOC, V140, P4712, DOI 10.1021/jacs.8b01462; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Czerwinska J, 2014, NUCLEIC ACIDS RES, V42, P11119, DOI 10.1093/nar/gku783; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/nchembio.2239, 10.1038/NCHEMBIO.2239]; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Gao JJ, 2018, ACS CENTRAL SCI, V4, P960, DOI 10.1021/acscentsci.8b00112; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hansen AL, 2018, P NATL ACAD SCI USA, V115, pE7768, DOI 10.1073/pnas.1806239115; Huai WW, 2016, P NATL ACAD SCI USA, V113, P11925, DOI 10.1073/pnas.1601556113; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kang R, 2018, CELL HOST MICROBE, V24, P97, DOI 10.1016/j.chom.2018.05.009; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mathew SS, 2010, FREE RADICAL BIO MED, V49, P383, DOI 10.1016/j.freeradbiomed.2010.04.026; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Song H, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060025; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Ursini F, 2016, REDOX BIOL, V8, P205, DOI 10.1016/j.redox.2016.01.010; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wong CM, 2013, FREE RADICAL BIO MED, V65, P1126, DOI 10.1016/j.freeradbiomed.2013.09.005; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Xia PY, 2018, NAT IMMUNOL, V19, P141, DOI 10.1038/s41590-017-0014-x; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Yoo SE, 2012, FREE RADICAL BIO MED, V52, P1820, DOI 10.1016/j.freeradbiomed.2012.02.043; Yu ZX, 2017, J EXP MED, V214, P3553, DOI 10.1084/jem.20170180	56	79	85	24	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					727	+		10.1038/s41590-020-0699-0	http://dx.doi.org/10.1038/s41590-020-0699-0		JUN 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32541831				2022-12-18	WOS:000540408200003
J	Svedberg, FR; Brown, SL; Krauss, MZ; Campbell, L; Sharpe, C; Clausen, M; Howell, GJ; Clark, H; Madsen, J; Evans, CM; Sutherland, TE; Ivens, AC; Thornton, DJ; Grencis, RK; Hussell, T; Cunoosamy, DM; Cook, PC; MacDonald, AS				Svedberg, Freya R.; Brown, Sheila L.; Krauss, Maria Z.; Campbell, Laura; Sharpe, Catherine; Clausen, Maryam; Howell, Gareth J.; Clark, Howard; Madsen, Jens; Evans, Christopher M.; Sutherland, Tara E.; Ivens, Alasdair C.; Thornton, David J.; Grencis, Richard K.; Hussell, Tracy; Cunoosamy, Danen M.; Cook, Peter C.; MacDonald, Andrew S.			The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation	NATURE IMMUNOLOGY			English	Article							TISSUE-RESIDENT MACROPHAGES; GLUCOSE-HOMEOSTASIS; FETAL MONOCYTES; TH2 INDUCTION; RESPONSES; IMMUNOMETABOLISM; PROTECTION; PATHWAYS; PROMOTES; CELLS	Fine control of macrophage activation is needed to prevent inflammatory disease, particularly at barrier sites such as the lungs. However, the dominant mechanisms that regulate the activation of pulmonary macrophages during inflammation are poorly understood. We found that alveolar macrophages (AlvMs) were much less able to respond to the canonical type 2 cytokine IL-4, which underpins allergic disease and parasitic worm infections, than macrophages from lung tissue or the peritoneal cavity. We found that the hyporesponsiveness of AlvMs to IL-4 depended upon the lung environment but was independent of the host microbiota or the lung extracellular matrix components surfactant protein D (SP-D) and mucin 5b (Muc5b). AlvMs showed severely dysregulated metabolism relative to that of cavity macrophages. After removal from the lungs, AlvMs regained responsiveness to IL-4 in a glycolysis-dependent manner. Thus, impaired glycolysis in the pulmonary niche regulates AlvM responsiveness during type 2 inflammation.	[Svedberg, Freya R.; Brown, Sheila L.; Howell, Gareth J.; Sutherland, Tara E.; Hussell, Tracy; Cook, Peter C.; MacDonald, Andrew S.] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester Collaborat Ctr Inflammat Res, Manchester Acad Hlth Sci Ctr,Fac Biol Med & Hlth, Manchester, Lancs, England; [Krauss, Maria Z.; Campbell, Laura; Sharpe, Catherine; Thornton, David J.; Grencis, Richard K.] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Wellcome Trust Ctr Cell Matrix Res, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Clausen, Maryam] AstraZeneca, Discovery Sci IMED, Gothenburg, Sweden; [Clark, Howard; Madsen, Jens] Univ Southampton, Southampton Gen Hosp, Div Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs,Dept Child Hlth, Southampton, Hants, England; [Clark, Howard; Madsen, Jens] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Clark, Howard; Madsen, Jens] Univ Hosp Southampton NHS Fdn Trust, Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Southampton Ctr Biomed Res, Southampton, Hants, England; [Evans, Christopher M.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Ivens, Alasdair C.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Cunoosamy, Danen M.] AstraZeneca RIA IMED, Gothenburg, Sweden; [Svedberg, Freya R.] VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specialisat, Ghent, Belgium; [Svedberg, Freya R.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	University of Manchester; University of Manchester; AstraZeneca; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Edinburgh; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Cook, PC; MacDonald, AS (corresponding author), Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester Collaborat Ctr Inflammat Res, Manchester Acad Hlth Sci Ctr,Fac Biol Med & Hlth, Manchester, Lancs, England.	peter.c.cook@manchester.ac.uk; andrew.macdonald@manchester.ac.uk	Sutherland, Tara/S-1427-2019; Cook, Peter/E-6731-2015; Hussell, Tracy/O-4630-2014	Sutherland, Tara/0000-0001-9334-8206; Cook, Peter/0000-0002-5208-4985; Z Krauss, Maria/0000-0003-0599-8669; Campbell, Laura/0000-0001-8888-3917; Svedberg, Freya/0000-0002-7401-0741; Clark, Howard/0000-0001-7354-2028; Hussell, Tracy/0000-0001-7186-6141; Thornton, David/0000-0001-7148-1970	MCCIR PhD studentship; Medical Research Council [MR/P026907/1]; National Institutes of Health [HL080396, HL130938]; Wellcome Trust Institutional Strategic Support Fund [105610]; Medical Research Foundation UK; Asthma UK [MRFAUK-2015-302]; University of Manchester Dean's Prize Early Career Research Fellowship; Springboard Award (Academy of Medical Sciences) [SBF002/1076]; MCCIR; Wellcome Trust [097820/Z/11/B]; BBSRC; University of Manchester Strategic Fund	MCCIR PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Medical Research Foundation UK; Asthma UK; University of Manchester Dean's Prize Early Career Research Fellowship; Springboard Award (Academy of Medical Sciences); MCCIR; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund	We thank members of the MCCIR and MacDonald laboratory (University of Manchester) for scientific discussions and some experimental assistance. We thank J. Allen (University of Manchester) for critical reading of the manuscript, the University of Manchester Single Cell Facility for flow cytometry, cell sorting and ImageStream, K. Couper and J. Grainger (University of Manchester) for provision of Pep3 and CX3CR1eGFP mice and M. Travis for providing recombinant TGF-ss. This research was supported by a MCCIR PhD studentship (F.R.S.), the Medical Research Council (grant no. MR/P026907/1, H.C. and J.M.), the National Institutes of Health (grant no. HL080396 and HL130938, C.M.E.), the Wellcome Trust Institutional Strategic Support Fund (grant no. 105610, R.K.G., D.J.T. and M.Z.K.), Medical Research Foundation UK joint funding with Asthma UK (grant no. MRFAUK-2015-302, T.E.S.), BBSRC studentship (C.S.), a University of Manchester Dean's Prize Early Career Research Fellowship (P.C.C.), Springboard Award (Academy of Medical Sciences, grant no. SBF002/1076, P.C.C.) and MCCIR core funding (A.S.M. and T.H.). This work was also made possible through use of the Manchester Gnotobiotic Facility that was established with the support of the Wellcome Trust (grant no. 097820/Z/11/B), using founder mice obtained from the Clean Mouse Facility, University of Bern, Switzerland. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome Trust and the University of Manchester Strategic Fund.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Baker EH, 2018, CHEST, V153, P507, DOI 10.1016/j.chest.2017.05.031; Bhatia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015943; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cheung AKL, 2009, P NATL ACAD SCI USA, V106, P14478, DOI 10.1073/pnas.0900198106; Cook PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7920; Dai Shipan, 2016, PLoS Pathog, V12, pe1005504, DOI 10.1371/journal.ppat.1005504; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Garnett JP, 2012, J IMMUNOL, V189, P373, DOI 10.4049/jimmunol.1200718; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gill SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27636; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Ho WE, 2013, AM J RESP CELL MOL, V48, P204, DOI 10.1165/rcmb.2012-0246OC; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Mallia P, 2018, J ALLERGY CLIN IMMUN, V142, P815, DOI 10.1016/j.jaci.2017.10.017; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Pelgrom LR, 2017, EUR J IMMUNOL, V47, P1266, DOI 10.1002/eji.201646728; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Robbe P, 2015, AM J PHYSIOL-LUNG C, V308, pL358, DOI 10.1152/ajplung.00341.2014; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Sinclair C, 2017, SCIENCE, V357, P1014, DOI 10.1126/science.aaj2155; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Thawer S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005461; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wiesner DL, 2017, J IMMUNOL, V198, P1627, DOI 10.4049/jimmunol.1600821; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007	58	79	79	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					571	+		10.1038/s41590-019-0352-y	http://dx.doi.org/10.1038/s41590-019-0352-y			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30936493	Green Submitted, Green Accepted			2022-12-18	WOS:000465084800014
J	Saphire, EO; Schendel, SL; Gunn, BM; Milligan, JC; Alter, G				Saphire, Erica Ollmann; Schendel, Sharon L.; Gunn, Bronwyn M.; Milligan, Jacob C.; Alter, Galit			Antibody-mediated protection against Ebola virus	NATURE IMMUNOLOGY			English	Article							DEPENDENT-CELLULAR-CYTOTOXICITY; HUMAN MONOCLONAL-ANTIBODY; FC-GAMMA RECEPTORS; EFFECTOR FUNCTIONS; IN-VIVO; THERAPEUTIC ANTIBODIES; NONHUMAN-PRIMATES; METABOLIC CONTROL; STRUCTURAL BASIS; HUMAN IGG1	Recent Ebola virus disease epidemics have highlighted the need for effective vaccines and therapeutics to prevent future outbreaks. Antibodies are clearly critical for control of this deadly disease; however, the specific mechanisms of action of protective antibodies have yet to be defined. In this Perspective we discuss the antibody features that correlate with in vivo protection during infection with Ebola virus, based on the results of a systematic and comprehensive study of antibodies directed against this virus. Although neutralization activity mediated by the Fab domains of the antibody is strongly correlated with protection, recruitment of immune effector functions by the Fc domain has also emerged as a complementary, and sometimes alternative, route to protection. For a subset of antibodies, Fc-mediated clearance and killing of infected cells seems to be the main driver of protection after exposure and mirrors observations in vaccination studies. Continued analysis of antibodies that achieve protection partially or wholly through Fc-mediated functions, the precise functions required, the intersection with specificity and the importance of these functions in different animal models is needed to identify and begin to capitalize on Fc-mediated protection in vaccines and therapeutics alike.	[Saphire, Erica Ollmann; Schendel, Sharon L.; Milligan, Jacob C.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Gunn, Bronwyn M.; Alter, Galit] Ragon Inst MIT MGH & Harvard, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Saphire, EO (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.; Alter, G (corresponding author), Ragon Inst MIT MGH & Harvard, Cambridge, MA 02139 USA.	erica@scripps.edu; galter@mgh.harvard.edu		Gunn, Bronwyn/0000-0001-8904-9334; Schendel, Sharon/0000-0002-5062-7261; Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID of the US National Institutes of Health [U19AI107962]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109762, U19AI135995] Funding Source: NIH RePORTER	NIAID of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge U19AI107962 (a Center of Excellence in Translational Research (CETR) award from NIAID of the US National Institutes of Health), and the members of the Viral Hemorrhagic Fever Immunotherapeutic Consortium who contributed antibodies (many of which were unpublished) and analytical efforts on the project, including K.G. Andersen, A.B. Ward and D.R. Burton; R. Ahmed and C.W. Davis (Emory University); M.J. Aman (Integrated BioTherapeutics); A. Bukreyev (University of Texas Medical Branch); K. Chandran and J.R. Lai (Albert Einstein College of Medicine); J.E. Crowe, Jr. (Vanderbilt University School of Medicine); J.M. Dye (USAMRIID); B. Doranz (Integral Molecular); H. Feldmann (NIAID Rocky Mountain Lab); G. Georgiou (University of Texas); G. G. Olinger and L. Hensley (NIAID Integrated Research Facility); Y. Kawaoka (University of Wisconsin); G.P. Kobinger(Universite Laval); K. Wagh and B. Korber (Los Alamos National Labs); F. Krammer (Icahn School of Medicine at Mt. Sinai); C.A. Kyratsous (Regeneron); C. Nykiforuk (Emergent Biosciences); X. Qiu (Public Health Agency of Canada); A. Sprecher (Medecins Sans Frontieres); A.R. Townsend (University of Oxford); V. Volchkov (Universite Lyon); L.M. Walker (Adimab); C.-I. Wang (A*STAR); L. Zeitlin (Mapp Biopharmaceutical); and the students, postdoctoral fellows, technicians and staff scientists in their labs, as well as J.V. Ravetch (Rockefeller University) for discussions. This is manuscript # 29662 from Scripps Research.	Ackerman ME, 2017, IMMUNOL REV, V275, P262, DOI 10.1111/imr.12503; Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Almagro JC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01751; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anthony RM, 2011, CURR OPIN ORGAN TRAN, V16, P7, DOI 10.1097/MOT.0b013e328342538f; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881; Bakema JE, 2014, CURR TOP MICROBIOL, V382, P373, DOI 10.1007/978-3-319-07911-0_17; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Bootz A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006601; Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bournazos S, 2014, CURR TOP MICROBIOL, V382, P237, DOI 10.1007/978-3-319-07911-0_11; Burton DR, 2015, P NATL ACAD SCI USA, V112, P10082, DOI 10.1073/pnas.1513050112; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; Casadevall A, 1996, EMERG INFECT DIS, V2, P200, DOI 10.3201/eid0203.960306; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Cimini E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005645; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Ghazi A, 2012, EXPERT OPIN BIOL TH, V12, P113, DOI 10.1517/14712598.2012.642359; Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254; Gillis CM, 2017, J ALLERGY CLIN IMMUN, V139, P1253, DOI 10.1016/j.jaci.2016.06.058; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Hampton CM, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.168; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hills AE, 2001, BIOTECHNOL BIOENG, V75, P239, DOI 10.1002/bit.10022; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Horton HM, 2011, J IMMUNOL, V186, P4223, DOI 10.4049/jimmunol.1003412; Horwitz JA, 2017, CELL, V170, P637, DOI 10.1016/j.cell.2017.06.048; Howes SC, 2018, CURR OPIN MICROBIOL, V43, P132, DOI 10.1016/j.mib.2018.01.009; Hoy SM, 2015, DRUGS, V75, P285, DOI 10.1007/s40265-014-0340-3; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Jurczak W., 2015, BLOOD, V126, P1528; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kellner C, 2013, LEUKEMIA, V27, P1595, DOI 10.1038/leu.2012.373; Kellner C, 2014, METHODS, V65, P105, DOI 10.1016/j.ymeth.2013.06.036; King LB, 2018, CELL HOST MICROBE, V23, P101, DOI 10.1016/j.chom.2017.12.003; Kumar A, 2015, BRIT J HAEMATOL, V168, P902, DOI 10.1111/bjh.13152; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LEATHERBARROW RJ, 1985, MOL IMMUNOL, V22, P407, DOI 10.1016/0161-5890(85)90125-7; Lee EM, 2015, HAEMATOLOGICA, V100, P914, DOI 10.3324/haematol.2014.113092; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2008, J MOL BIOL, V375, P202, DOI 10.1016/j.jmb.2007.10.017; Lewis GK, 2017, AIDS RES HUM RETROV, V33, P760, DOI [10.1089/aid.2016.0299, 10.1089/AID.2016.0299]; Lewis GK, 2014, IMMUNOLOGY, V142, P46, DOI 10.1111/imm.12232; Li G, 2010, CANCER RES, V70, P10243, DOI 10.1158/0008-5472.CAN-10-1996; Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45552; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Mahan AE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005456; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Nimmerjahn F, 2016, J CLIN IMMUNOL, V36, pS83, DOI 10.1007/s10875-016-0249-6; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Pascal KE, 2018, J INFECT DIS, V218, pS612, DOI 10.1093/infdis/jiy285; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Popp O, 2018, MABS-AUSTIN, V10, P290, DOI 10.1080/19420862.2017.1405203; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Ram S, 2016, IMMUNOBIOLOGY, V221, P1110, DOI 10.1016/j.imbio.2016.05.016; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Robak T, 2009, CURR OPIN INVEST DR, V10, P588; Salazar G, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0019-3; Saphire EO, 2017, NATURE, V541, P283, DOI 10.1038/541283a; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schuster M, 2005, CANCER RES, V65, P7934, DOI 10.1158/0008-5472.CAN-04-4212; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; Sheeley DM, 1997, ANAL BIOCHEM, V247, P102, DOI 10.1006/abio.1997.2036; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sneddon LU, 2017, J EXP BIOL, V220, P3007, DOI 10.1242/jeb.147058; Sondermann P, 2016, CURR OPIN IMMUNOL, V40, P78, DOI 10.1016/j.coi.2016.03.005; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tobinai K, 2017, ADV THER, V34, P324, DOI 10.1007/s12325-016-0451-1; Treffers LW, 2018, EUR J IMMUNOL, V48, P344, DOI 10.1002/eji.201747215; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Yu XQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01020-16, 10.1128/aac.01020-16]; Zalevsky J, 2009, BLOOD, V113, P3735, DOI 10.1182/blood-2008-10-182048; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108; Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006	123	79	80	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1169	1178		10.1038/s41590-018-0233-9	http://dx.doi.org/10.1038/s41590-018-0233-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333617	Green Accepted			2022-12-18	WOS:000447632200012
J	Dunning, J; Blankley, S; Hoang, LT; Cox, M; Graham, CM; James, PL; Bloom, CI; Chaussabel, D; Banchereau, J; Brett, SJ; Moffatt, MF; O'Garra, A; Openshaw, PJM				Dunning, Jake; Blankley, Simon; Hoang, Long T.; Cox, Mike; Graham, Christine M.; James, Philip L.; Bloom, Chloe I.; Chaussabel, Damien; Banchereau, Jacques; Brett, Stephen J.; Moffatt, Miriam F.; O'Garra, Anne; Openshaw, Peter J. M.		MOSAIC Investigators	Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza	NATURE IMMUNOLOGY			English	Article							VIRUS-INFECTION; UNITED-KINGDOM; LUNG INJURY; DISEASE; PROCALCITONIN; METAANALYSIS; CIRCULATION; BIOLOGY; MARKERS; HUMANS	Transcriptional profiles and host-response biomarkers are used increasingly to investigate the severity, subtype and pathogenesis of disease. We now describe whole-blood mRNA signatures and concentrations of local and systemic immunological mediators in 131 adults hospitalized with influenza, from whom extensive clinical and investigational data were obtained by MOSAIC investigators. Signatures reflective of interferon-related antiviral pathways were common up to day 4 of symptoms in patients who did not require mechanical ventilator support; in those who needed mechanical ventilation, an inflammatory, activated-neutrophil and cell-stress or death ('bacterial') pattern was seen, even early in disease. Identifiable bacterial co-infection was not necessary for this 'bacterial' signature but was able to enhance its development while attenuating the early 'viral' signature. Our findings emphasize the importance of timing and severity in the interpretation of host responses to acute viral infection and identify specific patterns of immune-system activation that might enable the development of novel diagnostic and therapeutic tools for severe influenza.	[Dunning, Jake; Hoang, Long T.; Openshaw, Peter J. M.] Imperial Coll London, Natl Heart & Lung Inst, Resp Infect Sect, London, England; [Blankley, Simon; Graham, Christine M.; Bloom, Chloe I.; O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England; [Cox, Mike; James, Philip L.; Moffatt, Miriam F.] Imperial Coll London, Natl Heart & Lung Inst, Genom Med, London, England; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Brett, Stephen J.] Imperial Coll London, Natl Heart & Lung Inst, Surg & Canc, London, England; [Dunning, Jake] Publ Hlth England, Natl Infect Serv, London, England	Imperial College London; Francis Crick Institute; Imperial College London; Sidra Medical & Research Center; Jackson Laboratory; Imperial College London; Public Health England	O'Garra, A (corresponding author), Francis Crick Inst, Lab Immunoregulat & Infect, London, England.	anne.ogarra@crick.ac.uk; p.openshaw@imperial.ac.uk	Semple, Malcolm Gracie/A-8790-2008; Chaussabel, Damien/AAX-1909-2020; Hoang, Long/ABC-7442-2020; Openshaw, Peter/AAL-9442-2020; Dunning, Jake/U-7181-2019; Bloom, Chloe/ABC-1693-2020; Hussell, Tracy/O-4630-2014	Semple, Malcolm Gracie/0000-0001-9700-0418; Hoang, Long/0000-0002-6808-6758; Openshaw, Peter/0000-0002-7220-2555; Dunning, Jake/0000-0002-4035-4562; Bloom, Chloe/0000-0003-1285-7602; Ho, Ling Pei/0000-0001-8319-301X; Herberg, Jethro/0000-0001-6941-6491; Thwaites, Ryan/0000-0003-3052-2793; Aston, Stephen/0000-0002-0701-8364; Blankley, Simon/0000-0001-9602-9075; Adamson, Walt/0000-0002-9786-2349; Drumright, Lydia/0000-0002-3361-8080; Kellam, Paul/0000-0003-3166-4734; Banchereau, Jacques/0000-0003-3535-7221; Cox, Michael/0000-0002-4002-1506; Barclay, Wendy/0000-0002-3948-0895; Aylin, Paul/0000-0003-4589-1743; Griffiths, Mark/0000-0002-1615-1896; Baillie, John Kenneth/0000-0001-5258-793X; O'Garra, Anne/0000-0001-9845-6134; Hume, David/0000-0002-2615-1478; Gordon, Stephen/0000-0001-6576-1116; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Simmonds, Peter/0000-0002-7964-4700; Hussell, Tracy/0000-0001-7186-6141; Johnston, Sebastian/0000-0003-3009-9200; Levin, Michael/0000-0003-2767-6919	Medical Research Council [090382/Z/09/Z]; UK National Institute for Health Research (NIHR) Comprehensive Local Research Networks (CLRNs); Biomedical Research Centre (NIHR Imperial BRC); Biomedical Research Unit (NIHR Liverpool BRU); Health Protection Research Unit in Respiratory Infections; Health Protection Agency Microbiology Services, Colindale; Medical Research Council, United Kingdom [U117565642]; Francis Crick Institute, London [AOG10126]; Francis Crick Institute, London (Cancer Research UK) [FC001126]; UK Medical Research Council [FC001126, MR/U117565642/1]; Wellcome Trust [090382/Z/09/Z, FC001126]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MR/J010723/1]; MRC CRTF; Public Health England (PHE) at Imperial College London (NIHR HPRU RI); MRC [MR/R502121/1, MC_U117565642, MC_G1001212, G0600371] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR) Comprehensive Local Research Networks (CLRNs); Biomedical Research Centre (NIHR Imperial BRC); Biomedical Research Unit (NIHR Liverpool BRU); Health Protection Research Unit in Respiratory Infections; Health Protection Agency Microbiology Services, Colindale; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute, London; Francis Crick Institute, London (Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC CRTF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England (PHE) at Imperial College London (NIHR HPRU RI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MOSAIC Study was supported by a joint award from the Wellcome Trust and the Medical Research Council (090382/Z/09/Z). We gratefully acknowledge the support of the MOSAIC administrative team (M. Cross, L.-A. Cumming, M. Minns, T. Ford, B. Cerutti, D. Gardner and Z. Williams) and the generosity of our patients and their families, healthy volunteers, and staff at participating National Health Service (NHS) hospitals (Alder Hey Children's Hospital; Brighton & Sussex University Hospitals NHS Trust; Central Manchester University Hospitals NHS Foundation Trust; Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College Healthcare NHS Trust; Liverpool Women's NHS Foundation Trust; Royal Liverpool and Broadgreen University Hospitals NHS Trust; Royal Brompton and Harefield NHS Foundation Trust; University Hospitals Coventry and Warwickshire NHS Trust). In particular, we thank K. Alshafi, S. Ashton, E. Bailey, A. Bermingham, M. Berry, C. Bloom, A. Booth, E. Brannigan, S. Bremang, J. Clark, M. Cross, L. A. Cumming, S. Dyas, J. England-Smith, J. Enstone, D. Ferreira, N. Goddard, A. Godlee, S. Gormley, M. Guiver, M. O. Hassan-Ibrahim, H. Hill, P. Holloway, K. Hoschler, G. Houghton, F. Hughes, R. R. Israel, A. Jepson, K. D. Jones, W. P. Kelleher, M. Kidd, K. Knox, A. Lackenby, G. Lloyd, H. Longworth, S. Mookerjee, S. Mt-Isa, D. Muir, A. Paras, V. Pascual, L. Rae, S. Rodenhurst, F. Rozakeas, E. Scott, E. Sergi, N. Shah, V. Sutton, J. Vernazza, A. W. Walker, C. Wenden, T. Wotherspoon, A. D. Wright and F. Wurie. We also thank E. Anguiano and members of the Genomic Core, BIIR, Dallas, for assistance with the microarray analysis; and M. Berry for guidance. We especially thank the MOSAIC Data Team (L. Drumright, L. Garcia-Alvarez, J. Lieber, S. Mookerjee and B. Pamba) for assistance in collating and validating clinical data; R. Smyth for careful review of the manuscript; and K. Strimmer for statistical advice in revisions of the manuscript. F. Rozakeas helped with recruiting samples from all the healthy control subjects at NIMR (Mill Hill). The MOSAIC consortium (ClinicalTrials.gov identifier NCT00965354) was supported by UK National Institute for Health Research (NIHR) Comprehensive Local Research Networks (CLRNs), the Biomedical Research Centre (NIHR Imperial BRC) and Unit (NIHR Liverpool BRU), the Health Protection Research Unit in Respiratory Infections in partnership with Public Health England (PHE) at Imperial College London (NIHR HPRU RI), the Health Protection Agency (latterly PHE) Microbiology Services, Colindale and the staff of the Roslin Institute, Edinburgh, Scotland. A.O.G. and C.G. were supported by the Medical Research Council, United Kingdom (U117565642), The Francis Crick Institute, London (AOG10126, which receives its core funding from Cancer Research UK (FC001126)), the UK Medical Research Council (FC001126), the Wellcome Trust (FC001126) and the UK Medical Research Council (MR/U117565642/1). S.B. was in part jointly funded by the UK Medical Research Council (MRC) as above and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (MR/J010723/1). C.B. was funded by an MRC CRTF. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, Public Health England or the Department of Health (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Blankley S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0427; Carr MJ, 2009, J CLIN VIROL, V45, P196, DOI 10.1016/j.jcv.2009.06.001; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Elderfield RA, 2014, J VIROL, V88, P13269, DOI 10.1128/JVI.01636-14; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Gregory DJ, 2015, AM J PHYSIOL-LUNG C, V309, pL1041, DOI 10.1152/ajplung.00283.2015; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Marshall JC, 2006, CRIT CARE, V10, DOI 10.1186/cc5087; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ruggiero T, 2013, INFLUENZA OTHER RESP, V7, P1416, DOI 10.1111/irv.12146; Rykkvin R, 2013, EUROSURVEILLANCE, V18, P3; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Stohr K, 2003, BRIT MED J, V326, P1223, DOI 10.1136/bmj.326.7401.1223; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Wu MH, 2013, INFLUENZA OTHER RESP, V7, P349, DOI 10.1111/j.1750-2659.2012.00386.x; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	43	79	80	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					625	+		10.1038/s41590-018-0111-5	http://dx.doi.org/10.1038/s41590-018-0111-5			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777224	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-18	WOS:000433041500028
J	Salmond, RJ; Brownlie, RJ; Morrison, VL; Zamoyska, R				Salmond, Robert J.; Brownlie, Rebecca J.; Morrison, Vicky L.; Zamoyska, Rose			The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals	NATURE IMMUNOLOGY			English	Article							REGULATORY FACTOR 4; T-CELLS; HOMEOSTATIC EXPANSION; MULTIPLE-SCLEROSIS; LYMPHOCYTE; EFFECTOR; ACTIVATION; MEMORY; CD8; PROLIFERATION	T cells must be tolerant of self antigens to avoid autoimmunity but responsive to foreign antigens to provide protection against infection. We found that in both naive T cells and effector T cells, the tyrosine phosphatase PTPN22 limited signaling via the T cell antigen receptor (TCR) by weak agonists and self antigens while not impeding responses to strong agonist antigens. T cells lacking PTPN22 showed enhanced formation of conjugates with antigen-presenting cells pulsed with weak peptides, which led to activation of the T cells and their production of inflammatory cytokines. This effect was exacerbated under conditions of lymphopenia, with the formation of potent memory T cells in the absence of PTPN22. Our data address how loss-of-function PTPN22 alleles can lead to the population expansion of effector and/or memory T cells and a predisposition to human autoimmunity.	[Salmond, Robert J.; Brownlie, Rebecca J.; Zamoyska, Rose] Univ Edinburgh, Ashworth Labs, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Morrison, Vicky L.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee, Scotland	University of Edinburgh; University of Dundee	Zamoyska, R (corresponding author), Univ Edinburgh, Ashworth Labs, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	rose.zamoyska@ed.ac.uk		Morrison, Vicky/0000-0002-4351-8737; Zamoyska, Rose/0000-0001-9816-2638; Brownlie, Rebecca/0000-0003-4897-1044	Wellcome Trust [096669, 095831]; Biotechnology and Biological Sciences Research Council [801148]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Shen (University of Pennsylvania) for the attenuated OVA-expressing L. monocytogenes strain with deletion of the actin assembly-inducing protein; D. Wright and C. Garcia for technical assistance, and P. Travers for reading the manuscript. Supported by the Wellcome Trust (096669 to R.Z., and 095831 for the Centre for Immunity, Infection and Evolution of the University of Edinburgh) and the Biotechnology and Biological Sciences Research Council (801148 to V.L.M.).	Bottini N, 2014, ANNU REV IMMUNOL, V32, P83, DOI 10.1146/annurev-immunol-032713-120249; Brownlie RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003365; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Le Campion A, 2009, BLOOD, V114, P1784, DOI 10.1182/blood-2008-12-192120; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shields BJ, 2013, MOL CELL BIOL, V33, P557, DOI 10.1128/MCB.01016-12; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wiede F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4073; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Wu DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086677; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zikherman J, 2011, J CLIN INVEST, V121, P4618, DOI 10.1172/JCI60001	41	79	83	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					875	883		10.1038/ni.2958	http://dx.doi.org/10.1038/ni.2958			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25108421	Green Accepted, Green Submitted			2022-12-18	WOS:000340739400015
J	Li, LQ; Jothi, R; Cui, KR; Lee, JY; Cohen, T; Gorivodsky, M; Tzchori, I; Zhao, YG; Hayes, SM; Bresnick, EH; Zhao, KJ; Westphal, H; Love, PE				Li, LiQi; Jothi, Raja; Cui, Kairong; Lee, Jan Y.; Cohen, Tsadok; Gorivodsky, Marat; Tzchori, Itai; Zhao, Yangu; Hayes, Sandra M.; Bresnick, Emery H.; Zhao, Keji; Westphal, Heiner; Love, Paul E.			Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							PROGENITOR CELLS; SELF-RENEWAL; PROTEIN LMO2; LEUKEMIA; MICE; IDENTIFICATION; EXPRESSION; COMPLEXES; DIFFERENTIATION; SCL/TAL1	The nuclear adaptor Ldb1 functions as a core component of multiprotein transcription complexes that regulate differentiation in diverse cell types. In the hematopoietic lineage, Ldb1 forms a complex with the non-DNA-binding adaptor Lmo2 and the transcription factors E2A, Scl and GATA-1 (or GATA-2). Here we demonstrate a critical and continuous requirement for Ldb1 in the maintenance of both fetal and adult mouse hematopoietic stem cells (HSCs). Deletion of Ldb1 in hematopoietic progenitors resulted in the downregulation of many transcripts required for HSC maintenance. Genome-wide profiling by chromatin immunoprecipitation followed by sequencing (ChIP-Seq) identified Ldb1 complex-binding sites at highly conserved regions in the promoters of genes involved in HSC maintenance. Our results identify a central role for Ldb1 in regulating the transcriptional program responsible for the maintenance of HSCs.	[Li, LiQi; Lee, Jan Y.; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Jothi, Raja] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Cohen, Tsadok; Gorivodsky, Marat; Tzchori, Itai; Zhao, Yangu; Westphal, Heiner] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mammalian Mol Genet, NIH, Bethesda, MD USA; [Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA; [Bresnick, Emery H.] Univ Wisconsin, Sch Med & Publ Hlth, Paul Carbone Canc Ctr, Wisconsin Inst Med Res, Madison, WI USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Wisconsin System; University of Wisconsin Madison	Love, PE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA.	lovep@mail.nih.gov	Jothi, Raja/G-3780-2015	Jothi, Raja/0000-0002-4833-1090	National Institutes of Health [DK068634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000071, ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068634, R01DK068634, R37DK050107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D. El-Khoury and A. Grinberg for technical support, and M. Mukhopadhyay for advice about mouse experiments. Supported by the Intramural Research Program of the National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development, L. L., J.Y.L., T. C., M. G., I. T., Y.Z., H. W. and P. E. L.; National Institute of Environmental Health Sciences, R.J.; National Heart, Lung, and Blood Institute, K. C. and K.Z.) and the National Institutes of Health (DK068634 to E.H.B.).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hwang M, 2008, STEM CELLS, V26, P1490, DOI 10.1634/stemcells.2007-1099; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Li LQ, 2010, J EXP MED, V207, P2543, DOI 10.1084/jem.20100504; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LORD BI, 1991, BLOOD, V77, P2154; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	45	79	82	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					129	U38		10.1038/ni.1978	http://dx.doi.org/10.1038/ni.1978			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21186366	Green Accepted			2022-12-18	WOS:000286378400006
J	Nowak, U; Matthews, AJ; Zheng, SM; Chaudhuri, J				Nowak, Urszula; Matthews, Allysia J.; Zheng, Simin; Chaudhuri, Jayanta			The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA	NATURE IMMUNOLOGY			English	Article							RNA-POLYMERASE-II; PROTEIN-KINASE-A; ANTIBODY DIVERSIFICATION; TRANSCRIPTION; RECOMBINATION; HYPERMUTATION; REPRESSOR; GENOME; ENZYME; SITES	During immunoglobulin class-switch recombination (CSR), the cytidine deaminase AID induces double-strand breaks into transcribed, repetitive DNA elements called switch sequences. The mechanism that promotes the binding of AID specifically to switch regions remains to be elucidated. Here we used a proteomic screen with in vivo biotinylation of AID to identify the splicing regulator PTBP2 as a protein that interacts with AID. Knockdown of PTBP2 mediated by short hairpin RNA in B cells led to a decrease in binding of AID to transcribed switch regions, which resulted in considerable impairment of CSR. PTBP2 is thus an effector of CSR that promotes the binding of AID to switch-region DNA.	[Nowak, Urszula; Matthews, Allysia J.; Zheng, Simin; Chaudhuri, Jayanta] Weill Cornell Med Sch, Grad Program Immunol & Microbial Pathogenesi, New York, NY 10065 USA; [Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Chaudhuri, J (corresponding author), Weill Cornell Med Sch, Grad Program Immunol & Microbial Pathogenesi, New York, NY 10065 USA.	chaudhuj@mskcc.org		Zheng, Simin/0000-0002-3442-1255	Damon Runyon Cancer Research Fund; Alfred Bressler Foundation; National Institutes of Health; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Fund; Alfred Bressler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Honjo (University of Kyoto) for AID-deficient (Aicda<SUP>-/-</SUP>) mice and CH12 cells; S. Orkin (Harvard Medical School) for the biotag vector and BirA plasmids and all members of the Chaudhuri laboratory for discussions and suggestions. Supported by the Damon Runyon Cancer Research Fund (J.C.), the Alfred Bressler Foundation (J.C.), the National Institutes of Health (J.C.) and the Cancer Research Institute (U.N.).	Ashiya M, 1997, RNA, V3, P996; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sharma Shalini, 2008, V488, P1, DOI 10.1007/978-1-60327-475-3_1; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8	37	79	80	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					160	U73		10.1038/ni.1977	http://dx.doi.org/10.1038/ni.1977			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21186367	Green Accepted			2022-12-18	WOS:000286378400010
J	Kang, YJ; Kim, SO; Shimada, S; Otsuka, M; Seit-Nebi, A; Kwon, BS; Watts, TH; Han, JH				Kang, Young Jun; Kim, Sung Ouk; Shimada, Shigeki; Otsuka, Motoyuki; Seit-Nebi, Alim; Kwon, Byoung S.; Watts, Tania H.; Han, Jiahuai			Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; BINDING-PROTEIN; NUCLEAR-FACTOR; MESSENGER-RNA; IN-VIVO; RECEPTOR; EXPRESSION; ACTIVATION; LIPOPOLYSACCHARIDE	The stimulation of Toll-like receptors (TLRs) on macrophages triggers production of the cytokine tumor necrosis factor (TNF). TNF production occurs within 1 h of TLR stimulation and is sustained for 1 d. Here we document a function for the TNF family member 4-1BB ligand (4-1BBL) in sustaining TLR-induced TNF production. TLR signaling induced 4-1BBL, and 4-1BBL interacted with TLRs on the macrophage surface. The influence of 4-1BBL on TNF production was independent of its receptor (4-1BB) and did not require the adaptors MyD88 or TRIF. It did not influence TLR4-induced activation of transcription factor NF-kappa B (an early response) but was required for TLR4-induced activation of transcription factors CREB and C/EBP ( a late event). Transient TLR4-MyD88 complexes appeared during the first hour after lipopolysaccharide stimulation, and TLR4-4-1BBL interactions were detected between 2 h and 8 h after lipopolysaccharide stimulation. Our results indicate that two different TLR4 complexes sequentially form and selectively control early and late TNF production.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Scripps Research Institute; Western University (University of Western Ontario); University of Ulsan; University of Toronto	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jhan@scripps.edu	KIM, Sung Ouk/A-1309-2008; Han, J/G-4671-2010; Otsuka, Motoyuki/H-9067-2019; Kim, Sung Ouk/AAO-1795-2020	Otsuka, Motoyuki/0000-0003-2869-2881; Kim, Sung Ouk/0000-0002-0282-6661; Seit-Nebi, Alim/0000-0003-4371-3206; Kang, Young Jun/0000-0001-9778-1963	NEI NIH HHS [EY13325] Funding Source: Medline; NIAID NIH HHS [AI41637, AI54696] Funding Source: Medline; NIGMS NIH HHS [GM37696, GM67101] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101, P01GM037696] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALDERSON MR, 1994, EUR J IMMUNOL, V24, P2219, DOI 10.1002/eji.1830240943; Ameloot P, 2001, J BIOL CHEM, V276, P27098, DOI 10.1074/jbc.M104486200; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; HAN JH, 1991, BIOCHIM BIOPHYS ACTA, V1090, P22, DOI 10.1016/0167-4781(91)90032-H; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; Klaffenbach D, 2005, AM J REPROD IMMUNOL, V53, P77, DOI 10.1111/j.1600-0897.2004.00247.x; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; MEDZHITOV R, 1997, NATURE, V388, P397; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; POLLOK KE, 1993, J IMMUNOL, V150, P771; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; Roach SK, 2005, INFECT IMMUN, V73, P514, DOI 10.1128/IAI.73.1.514-522.2005; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shin HH, 2006, FEBS LETT, V580, P1601, DOI 10.1016/j.febslet.2006.01.091; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Vinay DS, 2004, J IMMUNOL, V173, P4218, DOI 10.4049/jimmunol.173.6.4218; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhou HM, 2006, MOL CELL BIOL, V26, P3824, DOI 10.1128/MCB.26.10.3824-3834.2006	47	79	82	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					601	609		10.1038/ni1471	http://dx.doi.org/10.1038/ni1471			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17496895				2022-12-18	WOS:000246703300014
J	Ota, N; Brett, TJ; Murphy, TL; Fremont, DH; Murphy, KM				Ota, N; Brett, TJ; Murphy, TL; Fremont, DH; Murphy, KM			N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; CD4(+) T-CELLS; TYROSINE PHOSPHORYLATION; DNA-BINDING; SERINE PHOSPHORYLATION; SIGNAL TRANSDUCERS; GENE-REGULATION; TRANSCRIPTION; RECOGNITION; PATHWAY	The N-terminal protein interaction domain (N-domain) of the signal transducer and activator of transcription-4 (STAT4) is believed to stabilize interactions between two phosphorylated STAT4 dimers to form STAT4 tetramers. Here, we show that nonphosphorylated STAT4 dimers form in vivo before cytokine receptor-driven activation. Mutations in the N-domain dimerization interface abolished assembly of nonphosphorylated STAT4 dimers and prevented STAT4 phosphorylation mediated by cytokine receptors. In addition, N-domain dimerization occurred for other STAT family members but was homotypic in character. This implies a conserved role for N-domain dimerization, which might include influencing interactions with cytokine receptors, favoring homodimer formation or accelerating formation of the phosphorylated STAT dimer.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@immunology.wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Fremont, Daved/0000-0002-8544-2689				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; BRAUNSTEIN J, 2003, J BIOL CHEM; CHANG HC, 2003, J BIOL CHEM; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cho SS, 1996, J IMMUNOL, V157, P4781; Dajee M, 1996, MOL ENDOCRINOL, V10, P171, DOI 10.1210/me.10.2.171; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Farrar JD, 2000, IMMUNOL TODAY, V21, P484, DOI 10.1016/S0167-5699(00)01710-2; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Haan S, 2000, BIOCHEM J, V345, P417, DOI 10.1042/0264-6021:3450417; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; John S, 1999, MOL CELL BIOL, V19, P1910; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Murphy TL, 2000, MOL CELL BIOL, V20, P7121, DOI 10.1128/MCB.20.19.7121-7131.2000; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Ranganath S, 1998, J IMMUNOL, V161, P3822; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; SYMES A, 1994, MOL ENDOCRINOL, V8, P1750, DOI 10.1210/me.8.12.1750; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z	46	79	80	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					208	215		10.1038/ni1032	http://dx.doi.org/10.1038/ni1032			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14704793				2022-12-18	WOS:000188512000017
J	Greer, SF; Zika, E; Conti, B; Zhu, XS; Ting, JPY				Greer, SF; Zika, E; Conti, B; Zhu, XS; Ting, JPY			Enhancement of CIITA transcriptional function by ubiquitin	NATURE IMMUNOLOGY			English	Article							CLASS-II TRANSACTIVATOR; BARE LYMPHOCYTE SYNDROME; CREB BINDING-PROTEIN; NF-KAPPA-B; GENE-EXPRESSION; HISTONE H2B; COMPLEX; ACTIVATION; ENHANCEOSOME; INTERACTS	Although increasing evidence indicates that there is a direct link between ubiquitination and mono-ubiquitination and transcription in yeast, this link has not been demonstrated in higher eukaryotes. Here we show that the major histocompatibility complex (MHC) class II transactivator (CIITA), which is required for expression of genes encoding MHC class II molecules, is ubiquitinated. This ubiquitination enhanced the association of CIITA with both MHC class II transcription factors and the MHC class II promoter, resulting in an increase in transactivation function and in the expression of MHC class II mRNA. The degree of CIITA ubiquitination was controlled by histone acetylases (HATs) and deacetylases (HDACs), indicating that the crucial cellular processes mediated by these enzymes are linked to regulate transcription. Thus, ubiquitin positively regulates a mammalian coactivator by enhancing its assembly at the promoter.	Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038108] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38108] Funding Source: Medline; PHS HHS [29564, 45580, 41751] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; Fontes JD, 1999, MICROBES INFECT, V1, P863, DOI 10.1016/S1286-4579(99)80529-2; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Johnson ES, 2002, NAT CELL BIOL, V4, pE295, DOI 10.1038/ncb1202-e295; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2002, EMBO J, V21, P1379, DOI 10.1093/emboj/21.6.1379; Osborne A, 2001, MOL CELL BIOL, V21, P6495, DOI 10.1128/MCB.21.19.6495-6506.2001; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wong AW, 2002, J IMMUNOL, V169, P3112, DOI 10.4049/jimmunol.169.6.3112; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	44	79	81	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1074	1082		10.1038/ni985	http://dx.doi.org/10.1038/ni985			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14528304				2022-12-18	WOS:000186241100011
J	Weetman, AP				Weetman, AP			Determinants of autoimmune thyroid disease	NATURE IMMUNOLOGY			English	News Item							GRAVES-DISEASE; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CANDIDATE GENES; CTLA-4 GENE; RECEPTOR	Graves' disease and other autoimmune syndromes affecting the thyroid are the archetypes of organ-specific autoimmunity. Despite intensive research, the relative contribution of genetic and environmental factors to disease pathogenesis is not clear. Here, the latest developments in understanding the determinants of these diseases are discussed.	Univ Sheffield, No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield	Weetman, AP (corresponding author), Univ Sheffield, No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England.	k.f.watson@sheffield.ac.uk						Akamizu T, 2000, J CLIN ENDOCR METAB, V85, P2116, DOI 10.1210/jc.85.6.2116; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P1580, DOI 10.1210/jc.83.5.1580; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398; IMAGAWA A, 1995, J CLIN ENDOCR METAB, V80, P922, DOI 10.1210/jc.80.3.922; Imrie H, 2001, J CLIN ENDOCR METAB, V86, P626, DOI 10.1210/jc.86.2.626; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Many MC, 1999, J IMMUNOL, V162, P4966; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; Valyasevi RW, 2001, J CLIN ENDOCR METAB, V86, P903, DOI 10.1210/jc.86.2.903; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707	16	79	81	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					769	770		10.1038/ni0901-769	http://dx.doi.org/10.1038/ni0901-769			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526381				2022-12-18	WOS:000170781200007
J	Miyazaki, T; Reed, JC				Miyazaki, T; Reed, JC			A GTP-binding adaptor protein couples TRAIL receptors to apoptosis-inducing proteins	NATURE IMMUNOLOGY			English	Article							INDUCED CELL-DEATH; NECROSIS-FACTOR RECEPTOR; HUMAN DENDRITIC CELLS; FAS-INDUCED APOPTOSIS; LIGAND TRAIL; MEDIATED CYTOTOXICITY; 2 RECEPTORS; T-CELLS; FADD; ACTIVATION	Apoptosis-inducing tumor necrosis factor (TNF) family receptors recruit the proforms of caspase family cell death proteases to ligand-receptor complexes through interactions with intracellular adapter proteins. We have found that the GTP-binding protein DAP3 binds directly (with high affinity) to the death domain of TNF-related apoptosis-inducing ligand (TRAIL) receptors, and is required for TRAIL-induced apoptosis. DAP3 also associates with the pro-caspase-8-binding adapter protein pas-associated death domain (FADD), and links FADD to the TRAIL receptors DR4 and DR5. We have also found that binding of DAP3 to FADD and activation of pro-caspase-8 in an in vitro reconstituted system is GTP-dependent. Elucidation of this mechanism suggests GTP-binding proteins as potential targets for pharmacological intervention in TRAIL-induced apoptosis.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Miyazaki, Tadaaki/D-9368-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061694] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61694] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Berger T, 2000, J CELL SCI, V113, P3603; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clarke P, 2000, J VIROL, V74, P8135, DOI 10.1128/JVI.74.17.8135-8139.2000; Degli-Esposti M, 1999, J LEUKOCYTE BIOL, V65, P535, DOI 10.1002/jlb.65.5.535; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; FRENCH LE, 1999, NAT MED, V5, P157; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hulkko SM, 2000, BIOCHEM J, V349, P885, DOI 10.1042/bj3490885; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Marsters SA, 1999, RECENT PROG HORM RES, V54, P225; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Moreno MB, 1996, J IMMUNOL, V157, P3845; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1996, GENES CELLS, V1, P873, DOI 10.1046/j.1365-2443.1996.d01-214.x; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Peter ME, 2000, CELL DEATH DIFFER, V7, P759, DOI 10.1038/sj.cdd.4400735; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Sedger LM, 1999, J IMMUNOL, V163, P920; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Vidalain PO, 2000, J VIROL, V74, P556, DOI 10.1128/JVI.74.1.556-559.2000; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang J, 1997, CURR OPIN IMMUNOL, V9, P818, DOI 10.1016/S0952-7915(97)80184-7; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	49	79	87	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					493	500		10.1038/88684	http://dx.doi.org/10.1038/88684			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376335				2022-12-18	WOS:000169078000011
J	van Oers, NSC; Tohlen, B; Malissen, B; Moomaw, CR; Afendis, S; Slaughter, CA				van Oers, NSC; Tohlen, B; Malissen, B; Moomaw, CR; Afendis, S; Slaughter, CA			The 21-and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations	NATURE IMMUNOLOGY			English	Article							T-CELL RECEPTOR; CHAIN SIGNALING MOTIFS; ANTIGEN RECEPTOR; TYROSINE PHOSPHORYLATION; MURINE THYMOCYTES; ZAP-70; ACTIVATION; TRANSDUCTION; COMPLEX; EXPRESSION	The T cell receptor (TCR) zeta subunit contains three immunoreceptor tyrosine-based activation motifs (ITAMs) that translate effective extracellular ligand binding into intracellular signals by becoming phosphorylated into 21- and 23-kD forms. We report here that the 21-kD form of TCR zeta is generated by phosphorylation of the tyrosines in the second and third ITAMs, whereas the 23-kD form is formed by the additional phosphorylation of the membrane-proximal ITAM tyrosines. The stable formation of the 21- and 23-kD species requires the binding of the tandem SH2 domains of ZAP-70. We also report that TCR-mediated signaling processes can proceed independently of either the 21- or 23-kD species of TCR zeta.	Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille, France	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	van Oers, NSC (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA.		Van+Oers, Nicolai/ABA-2437-2021; Malissen, Bernard/AAK-4659-2020	van Oers, Nicolai/0000-0002-6545-8405; Malissen, Bernard/0000-0003-1340-9342	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042953] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI42953] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; FRANK SJ, 1992, J BIOL CHEM, V267, P13656; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jensen WA, 1997, EUR J IMMUNOL, V27, P707, DOI 10.1002/eji.1830270320; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KOYASU S, 1992, J BIOL CHEM, V267, P3375; Liu HY, 1999, J IMMUNOL, V163, P599; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Malissen B, 1998, SCIENCE, V281, P528, DOI 10.1126/science.281.5376.528; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smyth LA, 1998, P NATL ACAD SCI USA, V95, P13348; van Oers NSC, 1998, J IMMUNOL, V160, P163; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	35	79	79	1	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					322	328		10.1038/79774	http://dx.doi.org/10.1038/79774			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017104				2022-12-18	WOS:000089869700015
J	Galletti, G; De Simone, G; Mazza, EMC; Puccio, S; Mezzanotte, C; Bi, TM; Davydov, AN; Metsger, M; Scamardella, E; Alvisi, G; De Paoli, F; Zanon, V; Scarpa, A; Camisa, B; Colombo, FS; Anselmo, A; Peano, C; Polletti, S; Mavilio, D; Gattinoni, L; Boi, SK; Youngblood, BA; Jones, RE; Baird, DM; Gostick, E; Llewellyn-Lacey, S; Ladell, K; Price, DA; Chudakov, DM; Newell, EW; Casucci, M; Lugli, E				Galletti, Giovanni; De Simone, Gabriele; Mazza, Emilia M. C.; Puccio, Simone; Mezzanotte, Claudia; Bi, Timothy M.; Davydov, Alexey N.; Metsger, Maria; Scamardella, Eloise; Alvisi, Giorgia; De Paoli, Federica; Zanon, Veronica; Scarpa, Alice; Camisa, Barbara; Colombo, Federico S.; Anselmo, Achille; Peano, Clelia; Polletti, Sara; Mavilio, Domenico; Gattinoni, Luca; Boi, Shannon K.; Youngblood, Benjamin A.; Jones, Rhiannon E.; Baird, Duncan M.; Gostick, Emma; Llewellyn-Lacey, Sian; Ladell, Kristin; Price, David A.; Chudakov, Dmitriy M.; Newell, Evan W.; Casucci, Monica; Lugli, Enrico			Two subsets of stem-like CD8(+)memory T cell progenitors with distinct fate commitments in humans	NATURE IMMUNOLOGY			English	Article							DIFFERENTIATION; EXHAUSTION; EFFECTOR; EXPRESSION; STATES; PD-1; RECONSTITUTION; DYSFUNCTION; INFECTION; CHROMATIN	The identity of stem-cell memory progenitor cells has been unclear. Lugli and colleagues use high-dimensional approaches to identify two new progenitor populations of human T cells-one giving rise to a functional lineage, the other to an exhausted-like one. T cell memory relies on the generation of antigen-specific progenitors with stem-like properties. However, the identity of these progenitors has remained unclear, precluding a full understanding of the differentiation trajectories that underpin the heterogeneity of antigen-experienced T cells. We used a systematic approach guided by single-cell RNA-sequencing data to map the organizational structure of the human CD8(+)memory T cell pool under physiological conditions. We identified two previously unrecognized subsets of clonally, epigenetically, functionally, phenotypically and transcriptionally distinct stem-like CD8(+)memory T cells. Progenitors lacking the inhibitory receptors programmed death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT) were committed to a functional lineage, whereas progenitors expressing PD-1 and TIGIT were committed to a dysfunctional, exhausted-like lineage. Collectively, these data reveal the existence of parallel differentiation programs in the human CD8(+)memory T cell pool, with potentially broad implications for the development of immunotherapies and vaccines.	[Galletti, Giovanni; De Simone, Gabriele; Mazza, Emilia M. C.; Puccio, Simone; Scamardella, Eloise; Alvisi, Giorgia; De Paoli, Federica; Zanon, Veronica; Scarpa, Alice; Lugli, Enrico] IRCCS, Humanitas Clin & Res Ctr, Lab Translat Immunol, Milan, Italy; [Mezzanotte, Claudia; Camisa, Barbara; Casucci, Monica] IRCCS San Raffaele Sci Inst, Innovat Immunotherapies Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Bi, Timothy M.; Newell, Evan W.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Davydov, Alexey N.; Metsger, Maria] Cent European Inst Technol, Brno, Czech Republic; [Colombo, Federico S.; Anselmo, Achille; Lugli, Enrico] IRCCS, Humanitas Clin & Res Ctr, Humanitas Flow Cytometry Core, Milan, Italy; [Peano, Clelia] CNR, UoS Milan, Inst Genet & Biomed Res, Milan, Italy; [Peano, Clelia] IRCCS, Genom Unit, Humanitas Clin & Res Ctr, Milan, Italy; [Polletti, Sara] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Mavilio, Domenico] IRCCS, Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy; [Mavilio, Domenico] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Gattinoni, Luca] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Gattinoni, Luca] Regensburg Ctr Intervent Immunol, Regensburg, Germany; [Gattinoni, Luca] Univ Regensburg, Regensburg, Germany; [Boi, Shannon K.; Youngblood, Benjamin A.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Jones, Rhiannon E.; Baird, Duncan M.] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, Wales; [Gostick, Emma; Llewellyn-Lacey, Sian; Ladell, Kristin] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, Wales; [Price, David A.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, Wales; [Chudakov, Dmitriy M.] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Chudakov, Dmitriy M.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Chudakov, Dmitriy M.] Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fred Hutchinson Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Humanitas University; University of Milan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Regensburg; St Jude Children's Research Hospital; Cardiff University; Cardiff University; Cardiff University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; Skolkovo Institute of Science & Technology	Lugli, E (corresponding author), IRCCS, Humanitas Clin & Res Ctr, Lab Translat Immunol, Milan, Italy.; Lugli, E (corresponding author), IRCCS, Humanitas Clin & Res Ctr, Humanitas Flow Cytometry Core, Milan, Italy.	enrico.lugli@humanitasresearch.it	Scamardella, Eloise/HGT-7775-2022; Puccio, Simone/P-9571-2018; Peano, Clelia/C-4015-2018; Polletti, Sara/AAA-9543-2021; Chudakov, Dmitriy M/G-7741-2014; Galletti, Giovanni/ABG-1255-2020; Metsger, Maria/GWN-0866-2022; Gattinoni, Luca/A-2281-2008; Davydov, Alexey/AAI-7348-2021; Newell, Evan W/F-9711-2012; Price, David A/C-7876-2013; Colombo, Federico Simone/J-5586-2015; Metsger, Maria/AAI-7303-2021; Scamardella, Eloise/ABG-9061-2020; Lugli, Enrico/AAB-7933-2019; Ladell, Kristin/C-8301-2013	Puccio, Simone/0000-0003-4007-4365; Peano, Clelia/0000-0001-7055-3629; Polletti, Sara/0000-0002-5433-0502; Chudakov, Dmitriy M/0000-0003-0430-790X; Galletti, Giovanni/0000-0001-6613-2354; Gattinoni, Luca/0000-0003-2239-3282; Newell, Evan W/0000-0002-2889-243X; Price, David A/0000-0001-9416-2737; Colombo, Federico Simone/0000-0003-4480-3481; Metsger, Maria/0000-0001-9722-0533; Lugli, Enrico/0000-0002-1964-7678; Casucci, Monica/0000-0003-4500-9060; Bi, Timothy/0000-0002-5237-7024; Baird, Duncan/0000-0001-8408-5467; Ladell, Kristin/0000-0002-9856-2938; Alvisi, Giorgia/0000-0002-7708-851X	European Research Council (ERC-2014-STG PERSYST) [640511]; Associazione Italiana per la Ricerca sul Cancro [AIRC IG 20676, AIRC IG 21567]; Italian Ministry of Health (Bando Ricerca Finalizzata) [PE-2016-02363915]; Intramural Research Fund of the Humanitas Clinical and Research Center; Cancer Research UK [C17199/A18246/A29202]; Fondazione Italiana per la Ricerca sul Cancro-Associazione Italiana per la Ricerca sul Cancro (FIRC-AIRC); Ministry of Education, Youth, and Sports of the Czech Republic [CEITEC 2020 LQ1601]; Wellcome Trust Senior Investigator Award [100326/Z/12/Z]; Ministry of Health of the Russian Federation [0908300057056]; Italian Ministry of Health [82/2015]	European Research Council (ERC-2014-STG PERSYST); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (Bando Ricerca Finalizzata); Intramural Research Fund of the Humanitas Clinical and Research Center; Cancer Research UK(Cancer Research UK); Fondazione Italiana per la Ricerca sul Cancro-Associazione Italiana per la Ricerca sul Cancro (FIRC-AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Wellcome Trust Senior Investigator Award(Wellcome Trust); Ministry of Health of the Russian Federation; Italian Ministry of Health(Ministry of Health, Italy)	The authors thank G. Natoli (European Institute of Oncology, Milan) for assistance with the ATAC-seq protocol, R. Roychoudhuri (University of Cambridge) and M. Iannacone (San Raffaele Scientific Institute, Milan) for critical discussions, and G. Cugini and G. Colombo (Humanitas Clinical and Research Center, Milan) for the provision of lymph node samples. This work was funded by the European Research Council (ERC-2014-STG PERSYST no. 640511 to E.L.) and by the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 20676 to E.L.). Additional support was provided by the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 21567 to D.M.), the Italian Ministry of Health (Bando Ricerca Finalizzata PE-2016-02363915 to D.M.), the Intramural Research Fund of the Humanitas Clinical and Research Center (5 x1000 2019 Program to D.M.) and Cancer Research UK (C17199/A18246/A29202 to D.M.B.). G.G., G.D.S., S.P. and E.S. were supported by Fellowships from the Fondazione Italiana per la Ricerca sul Cancro-Associazione Italiana per la Ricerca sul Cancro (FIRC-AIRC). A.N.D. and M.M. were supported by the Ministry of Education, Youth, and Sports of the Czech Republic (CEITEC 2020 LQ1601). D.A.P. was supported by a Wellcome Trust Senior Investigator Award (100326/Z/12/Z). D.M.C. was supported by the Ministry of Health of the Russian Federation (0908300057056). The purchase of a FACSSymphony A5 was defrayed in part by a grant from the Italian Ministry of Health (Agreement 82/2015).	Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brummelman J, 2019, NAT PROTOC, V14, P1946, DOI 10.1038/s41596-019-0166-2; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Falcone L, 2016, METHODS MOL BIOL, V1393, P105, DOI 10.1007/978-1-4939-3338-9_10; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Giordano M, 2015, EMBO J, V34, P2042, DOI 10.15252/embj.201490786; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kondo T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15338; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02981; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lugli E, 2020, TRENDS IMMUNOL, V41, P17, DOI 10.1016/j.it.2019.11.004; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Lugli E, 2011, BLOOD, V118, P2520, DOI 10.1182/blood-2011-05-351155; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberto A, 2015, BLOOD, V125, P2855, DOI 10.1182/blood-2014-11-608406; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Stephen TL, 2017, IMMUNITY, V46, P51, DOI 10.1016/j.immuni.2016.12.015; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Widjaja CE, 2017, J CLIN INVEST, V127, P3609, DOI 10.1172/JCI90895; Yang ZZ, 2014, LEUKEMIA, V28, P1872, DOI 10.1038/leu.2014.84; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	70	78	78	7	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1552	+		10.1038/s41590-020-0791-5	http://dx.doi.org/10.1038/s41590-020-0791-5		OCT 2020	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33046887	Green Accepted			2022-12-18	WOS:000577043300002
J	Li, N; van Unen, V; Abdelaal, T; Guo, NN; Kasatskaya, SA; Ladell, K; McLaren, JE; Egorov, ES; Izraelson, M; Lopes, SMCD; Hollt, T; Britanova, OV; Eggermont, J; de Miranda, NFCC; Chudakov, DM; Price, DA; Lelieveldt, BPF; Koning, F				Li, Na; van Unen, Vincent; Abdelaal, Tamim; Guo, Nannan; Kasatskaya, Sofya A.; Ladell, Kristin; McLaren, James E.; Egorov, Evgeny S.; Izraelson, Mark; Lopes, Susana M. Chuva de Sousa; Hollt, Thomas; Britanova, Olga V.; Eggermont, Jeroen; de Miranda, Noel F. C. C.; Chudakov, Dmitriy M.; Price, David A.; Lelieveldt, Boudewijn P. F.; Koning, Frits			Memory CD4(+) T cells are generated in the human fetal intestine	NATURE IMMUNOLOGY			English	Article							REPERTOIRE	The fetus is thought to be protected from exposure to foreign antigens, yet CD45RO(+) T cells reside in the fetal intestine. Here we combined functional assays with mass cytometry, single-cell RNA sequencing and high-throughput T cell antigen receptor (TCR) sequencing to characterize the CD4(+) T cell compartment in the human fetal intestine. We identified 22 CD4(+) T cell clusters, including naive-like, regulatory-like and memory-like subpopulations, which were confirmed and further characterized at the transcriptional level. Memory-like CD4(+) T cells had high expression of Ki-67, indicative of cell division, and CD5, a surrogate marker of TCR avidity, and produced the cytokines IFN-gamma and IL-2. Pathway analysis revealed a differentiation trajectory associated with cellular activation and proinflammatory effector functions, and TCR repertoire analysis indicated clonal expansions, distinct repertoire characteristics and interconnections between subpopulations of memory-like CD4(+) T cells. Imaging mass cytometry indicated that memory-like CD4(+) T cells colocalized with antigen-presenting cells. Collectively, these results provide evidence for the generation of memory-like CD4(+) T cells in the human fetal intestine that is consistent with exposure to foreign antigens.	[Li, Na; van Unen, Vincent; Guo, Nannan; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Abdelaal, Tamim; Hollt, Thomas] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [Abdelaal, Tamim; Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Dept Pattern Recognit & Bioinformat Grp, Delft, Netherlands; [Kasatskaya, Sofya A.; Egorov, Evgeny S.; Izraelson, Mark; Britanova, Olga V.; Chudakov, Dmitriy M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Kasatskaya, Sofya A.; Chudakov, Dmitriy M.] Skolkovo Inst Sci & Technol, Ctr Data Intens Biomed & Biotechnol, Moscow, Russia; [Ladell, Kristin; McLaren, James E.; Price, David A.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Hollt, Thomas] Delft Univ Technol, Comp Graph & Visualizat Grp, Delft, Netherlands; [Eggermont, Jeroen; Lelieveldt, Boudewijn P. F.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [de Miranda, Noel F. C. C.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Chudakov, Dmitriy M.] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Chudakov, Dmitriy M.] Pirogov Russian Natl Res Med Univ, Dept Mol Technol, Moscow, Russia; [Chudakov, Dmitriy M.] MiLaboratory LLC, Skolkovo Innovat Ctr, Moscow, Russia; [Chudakov, Dmitriy M.] Privolzhsky Res Med Univ, Nizhnii Novgorod, Russia; [Price, David A.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, S Glam, Wales	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Skolkovo Institute of Science & Technology; Cardiff University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Masaryk University Brno; Pirogov Russian National Research Medical University; Privolzhsky Research Medical University; Cardiff University	Koning, F (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	F.Koning@lumc.nl	Chudakov, Dmitriy M/G-7741-2014; Solodushenkova, Anastasia/H-1732-2019; Li, Na/AAO-8117-2020; Price, David A/C-7876-2013; van Unen, Vincent/L-9105-2019; Izraelson, Mark/GWQ-6867-2022; Kasatskaya, Sofya/AAR-9841-2021; de Miranda, NFCC/I-2520-2015; Ladell, Kristin/C-8301-2013; Lelieveldt, Boudewijn/B-6501-2008	Chudakov, Dmitriy M/0000-0003-0430-790X; Li, Na/0000-0001-5380-8554; Price, David A/0000-0001-9416-2737; van Unen, Vincent/0000-0001-9339-8430; Izraelson, Mark/0000-0001-8606-9575; Kasatskaya, Sofya/0000-0002-5522-7443; de Miranda, NFCC/0000-0001-6122-1024; Ladell, Kristin/0000-0002-9856-2938; Lelieveldt, Boudewijn/0000-0001-8269-7603; Koning, Frits/0000-0002-4007-5715; McLaren, James/0000-0002-7021-5934	Leiden University Medical Center; Netherlands Organization for Scientific Research (NWO Applied Technical Sciences) [12721]; Netherlands Organization for Scientific Research (ZonMW) [91112008]; Russian Science Foundation [16-15-00149]; Wellcome Trust [100326/Z/12/Z]; European Commission under an MSCA-ITN award [675743/ISPIC]; China Scholarship Council	Leiden University Medical Center; Netherlands Organization for Scientific Research (NWO Applied Technical Sciences)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Russian Science Foundation(Russian Science Foundation (RSF)); Wellcome Trust(Wellcome Trust); European Commission under an MSCA-ITN award; China Scholarship Council(China Scholarship Council)	We thank the Center for Contraception, Abortion and Sexuality (Leiden and The Hague) for collection and provision of fetal material, K. Lodder, T. van Herwaarden, M. Bialecka and F. Wang for dissection of fetal tissues, and S. L. Kloet for assistance with single-cell RNA sequencing. This research was supported by Leiden University Medical Center (N.L., V.v.U., N.G., F.K.), the Netherlands Organization for Scientific Research (NWO Applied Technical Sciences grant no. 12721 and ZonMW grant no. 91112008) (T.A., T.H., J.E., B.P.F.L.), the Russian Science Foundation (grant no. 16-15-00149) (S.A.K., E.S.E., M.I., O.V.B, D.M.C.), the Wellcome Trust (grant no. 100326/Z/12/Z) (K.L., J.E.M., D.A.P), the European Commission under an MSCA-ITN award (grant no. 675743/ISPIC) (T.A.), and the China Scholarship Council (N.L. and N.G.).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Allenspach EJ, 2017, J ALLERGY CLIN IMMUN, V140, P616, DOI 10.1016/j.jaci.2017.02.017; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bean DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106035; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bunders MJ, 2012, BLOOD, V120, P4383, DOI 10.1182/blood-2012-06-437566; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; Egorov ES, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01618; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Hollt T, 2016, COMPUT GRAPH FORUM, V35, P171, DOI 10.1111/cgf.12893; Hornef M, 2017, MUCOSAL IMMUNOL, V10, P598, DOI 10.1038/mi.2016.141; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jolliffe I, 2011, INT ENCY STAT SCI, DOI 10.1007/978-3-642-04898-2_455; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Li N, 2018, J EXP MED, V215, P1383, DOI 10.1084/jem.20171934; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Pezzotti N, 2017, IEEE T VIS COMPUT GR, V23, P1739, DOI 10.1109/TVCG.2016.2570755; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Quigley Maire F, 2011, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1033s94; Rackovsky S, 2010, P NATL ACAD SCI USA, V107, P8623, DOI 10.1073/pnas.1001299107; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Staton TL, 2006, NAT IMMUNOL, V7, P482, DOI 10.1038/ni1319; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Unen V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01689-9; van Unen V, 2016, IMMUNITY, V44, P1227, DOI 10.1016/j.immuni.2016.04.014; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	49	78	79	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					301	+		10.1038/s41590-018-0294-9	http://dx.doi.org/10.1038/s41590-018-0294-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30664737	Green Accepted			2022-12-18	WOS:000458893600015
J	Shinde, R; Hezaveh, K; Halaby, MJ; Kloetgen, A; Chakravarthy, A; Medina, TD; Deol, R; Manion, KP; Baglaenko, Y; Eldh, M; Lamorte, S; Wallace, D; Chodisetti, SB; Ravishankar, B; Liu, HY; Chaudhary, K; Munn, DH; Tsirigos, A; Madaio, M; Gabrielsson, S; Touma, Z; Wither, J; De Carvalho, DD; McGaha, TL				Shinde, Rahul; Hezaveh, Kebria; Halaby, Marie Jo; Kloetgen, Andreas; Chakravarthy, Ankur; Medina, Tiago da Silva; Deol, Reema; Manion, Kieran P.; Baglaenko, Yuriy; Eldh, Maria; Lamorte, Sara; Wallace, Drew; Chodisetti, Sathi Babu; Ravishankar, Buvana; Liu, Haiyun; Chaudhary, Kapil; Munn, David H.; Tsirigos, Aristotelis; Madaio, Michael; Gabrielsson, Susanne; Touma, Zahi; Wither, Joan; De Carvalho, Daniel D.; McGaha, Tracy L.			Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans	NATURE IMMUNOLOGY			English	Article							ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; MARGINAL ZONE; INFLAMMATORY RESPONSES; DEPENDENT MECHANISM; DIOXIN RECEPTOR; GENE-EXPRESSION; DENDRITIC CELLS; NUCLEIC-ACIDS; LIGAND	The transcription factor AhR modulates immunity at multiple levels. Here we report that phagocytes exposed to apoptotic cells exhibited rapid activation of AhR, which drove production of the cytokine IL-10. Activation of AhR was dependent on interactions between apoptotic-cell DNA and the pattern-recognition receptor TLR9 that was required for the prevention of immune responses to DNA and histones in vivo. Moreover, disease progression in mouse systemic lupus erythematosus (SLE) correlated with strength of the AhR signal, and the disease course could be altered by modulation of AhR activity. Deletion of AhR in the myeloid lineage caused systemic autoimmunity in mice, and an enhanced AhR transcriptional signature correlated with disease in patients with SLE. Thus, AhR activity induced by apoptotic cell phagocytes maintains peripheral tolerance.	[Shinde, Rahul; Hezaveh, Kebria; Halaby, Marie Jo; Medina, Tiago da Silva; Deol, Reema; Lamorte, Sara; Wallace, Drew; De Carvalho, Daniel D.; McGaha, Tracy L.] Univ Hlth Network, Princess Margaret Canc Ctr, Tumor Immunotherapy Program, Toronto, ON, Canada; [Shinde, Rahul; Hezaveh, Kebria; Halaby, Marie Jo; Manion, Kieran P.; Baglaenko, Yuriy; Lamorte, Sara; Wither, Joan; McGaha, Tracy L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kloetgen, Andreas; Tsirigos, Aristotelis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Chakravarthy, Ankur; De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Manion, Kieran P.; Baglaenko, Yuriy; Wither, Joan] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Eldh, Maria; Gabrielsson, Susanne] Karolinska Inst, Dept Med, Unit Immunol & Allergy, Stockholm, Sweden; [Chodisetti, Sathi Babu] Penn State Univ, Sch Med, Dept Immunol, Hershey, PA USA; [Ravishankar, Buvana] Genentech Inc, Dept Canc Immunol, San Francisco, CA USA; [Liu, Haiyun] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Chaudhary, Kapil] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Tsirigos, Aristotelis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA; [Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Madaio, Michael] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Touma, Zahi] Univ Toronto, Lupus Clin, Toronto, ON, Canada; [Touma, Zahi] Univ Hlth Network, Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada; [Touma, Zahi; Wither, Joan] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; New York University; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Roche Holding; Genentech; Johns Hopkins University; Washington University (WUSTL); University System of Georgia; Augusta University; New York University; New York University; University System of Georgia; Augusta University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	McGaha, TL (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Tumor Immunotherapy Program, Toronto, ON, Canada.; McGaha, TL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tmcgaha@uhnresearch.ca	Medina, Tiago S/B-3084-2018; Gabrielsson, S./E-4145-2014; Chodisetti, Sathi Babu/H-3239-2018; Eldh, Maria/AFO-1744-2022; Shinde, Rahul/O-2463-2019; Touma, Zahi/ABE-7431-2021; De Carvalho, Daniel D/J-5503-2014	Medina, Tiago S/0000-0001-8674-8842; Gabrielsson, S./0000-0003-1771-1346; Chodisetti, Sathi Babu/0000-0001-7473-9420; Shinde, Rahul/0000-0001-8767-5032; Touma, Zahi/0000-0001-5177-2076; De Carvalho, Daniel D/0000-0002-8572-5259; Manion, Kieran/0000-0001-8945-9384; McGaha, Tracy/0000-0003-4721-9301; Munn, David/0000-0002-7711-2858; Kloetgen, Andreas/0000-0003-0991-4442; Wither, Joan/0000-0001-5961-9228; Baglaenko, Yuriy/0000-0002-9020-6824; Eldh, Maria/0000-0003-2173-1796; Tsirigos, Aristotelis/0000-0002-7512-8477	US National Institutes of Health [AI105500, AR067763, CA190449]; Medicine by Design/Canada First Research Excellence Fund; Swedish Medical Research Council; Karolinska Institute; NATIONAL CANCER INSTITUTE [R01CA211229, R01CA103320, R01CA190449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicine by Design/Canada First Research Excellence Fund; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank F. Barrat (Weill Cornell College of Medicine) for the TLR inhibitor and control oligonucleotides; M. Shlomchik, A. Marinov and Z. Rahman for assistance with the analysis of SLE-prone mice; N. Winegarden and the Princess Margaret Genomics Centre for assistance with sequence analysis; K. Hultenby and B. Calvieri for performing electron microscopy; J.C. Zuniga-Pflucker for advice during development of the research report; M. Butler for assistance with the acquisition of PBMCs from healthy control subjects; and P. Ohashi and D. Brooks for reading and critiquing the manuscript. Supported by the US National Institutes of Health (AI105500, AR067763 and CA190449), the Medicine by Design/Canada First Research Excellence Fund (T.L.M.), the Swedish Medical Research Council and the Karolinska Institute (S.G.).	BACSI SG, 1995, MOL PHARMACOL, V47, P432; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bradlow HL, 2010, IN VIVO, V24, P387; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Cohen J J, 1992, Semin Immunol, V4, P363; Dieker J, 2016, ARTHRITIS RHEUMATOL, V68, P462, DOI 10.1002/art.39417; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flaveny Colin A, 2009, Mol Cell Pharmacol, V1, P119; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pa.35.040195.001515; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Legge KL, 2000, J EXP MED, V191, P2039, DOI 10.1084/jem.191.12.2039; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; McGaha TL, 2016, IMMUNOL REV, V269, P26, DOI 10.1111/imr.12382; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qazi KR, 2009, BLOOD, V113, P2673, DOI 10.1182/blood-2008-04-153536; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Ravishankar B, 2015, P NATL ACAD SCI USA, V112, P10774, DOI 10.1073/pnas.1504276112; Ravishankar B, 2014, P NATL ACAD SCI USA, V111, P4215, DOI 10.1073/pnas.1320924111; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Shinde R, 2015, J IMMUNOL, V195, P2374, DOI 10.4049/jimmunol.1402854; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217	52	78	79	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					571	+		10.1038/s41590-018-0107-1	http://dx.doi.org/10.1038/s41590-018-0107-1			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29760532	Green Accepted			2022-12-18	WOS:000433041500023
J	Araki, K; Morita, M; Bederman, AG; Konieczny, BT; Kissick, HT; Sonenberg, N; Ahmed, R				Araki, Koichi; Morita, Masahiro; Bederman, Annelise G.; Konieczny, Bogumila T.; Kissick, Haydn T.; Sonenberg, Nahum; Ahmed, Rafi			Translation is actively regulated during the differentiation of CD8(+) effector T cells	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSE; MEMORY; MTOR; EXPRESSION; INTEGRATION; ACTIVATION; INITIATION; INFECTION; CANCER; PD-1	Translation is a critical process in protein synthesis, but translational regulation in antigen-specific T cells in vivo has not been well defined. Here we have characterized the translatome of virus-specific CD8(+) effector T cells (T-eff cells) during acute infection of mice with lymphocytic choriomeningitis virus (LCMV). Antigen-specific T cells exerted dynamic translational control of gene expression that correlated with cell proliferation and stimulation via the T cell antigen receptor (TCR). The translation of mRNAs that encode translation machinery, including ribosomal proteins, was upregulated during the T cell clonal-expansion phase, followed by inhibition of the translation of those transcripts when the CD8(+) T-eff cells stopped dividing just before the contraction phase. That translational suppression was more pronounced in terminal effector cells than in memory precursor cells and was regulated by antigenic stimulation and signals from the kinase mTOR. Our studies show that translation of transcripts encoding ribosomal proteins is regulated during the differentiation of CD8(+) T-eff cells and might have a role in fate 'decisions' involved in the formation of memory cells.	[Araki, Koichi; Bederman, Annelise G.; Konieczny, Bogumila T.; Kissick, Haydn T.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Araki, Koichi; Bederman, Annelise G.; Konieczny, Bogumila T.; Kissick, Haydn T.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Morita, Masahiro; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Morita, Masahiro; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA; [Morita, Masahiro] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Morita, Masahiro] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	Emory University; Emory University; McGill University; McGill University; Emory University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Araki, K; Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Araki, K; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	karaki@emory.edu; rahmed@emory.edu	Kissick, Haydn/AAS-6292-2021; Morita, Masahiro/ABC-1150-2020	Kissick, Haydn/0000-0001-7624-5598; Araki, Koichi/0000-0003-3478-6315; Morita, Masahiro/0000-0002-8627-084X	US National Institutes of Health [R01 AI030048]; Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI030048] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (R01 AI030048 to R.A.) and the Merieux Foundation (R.A.).	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Bjur E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003494; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meyuhas O, 2015, BBA-GENE REGUL MECH, V1849, P801, DOI 10.1016/j.bbagrm.2014.08.015; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Pien GC, 2002, J IMMUNOL, V169, P5827, DOI 10.4049/jimmunol.169.10.5827; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Santini E, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005832; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Shin HM, 2013, IMMUNITY, V39, P661, DOI 10.1016/j.immuni.2013.08.032; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhang LJ, 2016, CELL REP, V14, P1206, DOI 10.1016/j.celrep.2015.12.095; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	78	80	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					1046	+		10.1038/ni.3795	http://dx.doi.org/10.1038/ni.3795			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28714979	Green Published, Green Accepted			2022-12-18	WOS:000408137700014
J	Shen, Y; Wen, ZK; Li, YY; Matteson, EL; Hong, JS; Goronzy, JJ; Weyand, CM				Shen, Yi; Wen, Zhenke; Li, Yinyin; Matteson, Eric L.; Hong, Jison; Goronzy, Jorg J.; Weyand, Cornelia M.			Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells	NATURE IMMUNOLOGY			English	Article							RHEUMATOID-ARTHRITIS; ACTIVATION; MEMORY; POLYMERIZATION; DEFICIENCY; MIGRATION	Pathogenic T cells in individuals with rheumatoid arthritis (RA) infiltrate non-lymphoid tissue sites, maneuver through extracellular matrix and form lasting inflammatory microstructures. Here we found that RA T cells abundantly express the podosome scaffolding protein TKS5, which enables them to form tissue-invasive membrane structures. TKS5 overexpression was regulated by the intracellular metabolic environment of RA T cells-specifically, by reduced glycolytic flux that led to deficiencies in ATP and pyruvate. ATP(lo)pyruvate(lo) conditions triggered fatty acid biosynthesis and the formation of cytoplasmic lipid droplets. Restoration of pyruvate production or inhibition of fatty acid synthesis corrected the tissue-invasiveness of RA T cells in vivo and reversed their proarthritogenic behavior. Thus, metabolic control of T cell locomotion provides new opportunities to interfere with T cell invasion into specific tissue sites.	[Shen, Yi; Wen, Zhenke; Li, Yinyin; Hong, Jison; Goronzy, Jorg J.; Weyand, Cornelia M.] Stanford Univ, Dept Med, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Matteson, Eric L.] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN USA	Stanford University; Mayo Clinic	Weyand, CM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021; Hong, Jison/F-9107-2015	Wen, Zhenke/0000-0003-0542-0349; Hong, Jison/0000-0002-7192-5647; Goronzy, Jorg/0000-0001-7670-1856	US National Institutes of Health [R01 AR042527, R01 HL 117913, R01 AI108906, P01 HL129941, R01 AI108891, R01 AG045779, U19 AI057266, I01 BX001669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117913, P01HL129941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129191, U19AI057266, R01AI108891, R01AI108906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015043, R01AG045779] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001669] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the US National Institutes of Health (grants R01 AR042527, R01 HL 117913, R01 AI108906 and P01 HL129941 to C.M.W.; grants R01 AI108891, R01 AG045779, U19 AI057266 and I01 BX001669 to J.J.G.).	Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1; Broux B, 2012, TRENDS MOL MED, V18, P446, DOI 10.1016/j.molmed.2012.06.003; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hwang SH, 2015, P NATL ACAD SCI USA, V112, pE6535, DOI 10.1073/pnas.1514152112; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Marx N, 2002, CIRC RES, V91, P373, DOI 10.1161/01.RES.0000033472.61704.CE; McInnes IB, 2016, NAT REV RHEUMATOL, V12, P63, DOI 10.1038/nrrheum.2015.171; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Robichaud PP, 2013, J LIPID RES, V54, P2665, DOI 10.1194/jlr.M037044; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Seyler TM, 2005, J CLIN INVEST, V115, P3083, DOI 10.1172/JCI25265; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Thompson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003638; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walsh MJ, 2010, PROBE REPORTS NIH MO; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Weyand CM, 2006, NAT CLIN PRACT RHEUM, V2, P201, DOI 10.1038/ncprheum0142; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0542-4; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang XY, 2005, ARTHRITIS RHEUM-US, V52, P3839, DOI 10.1002/art.21482	48	78	79	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					1025	+		10.1038/ni.3808	http://dx.doi.org/10.1038/ni.3808			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28737753	Green Accepted			2022-12-18	WOS:000408137700012
J	Backer, RA; Helbig, C; Gentek, R; Kent, A; Laidlaw, BJ; Dominguez, CX; de Souza, YS; van Trierum, SE; van Beek, R; Rimmelzwaan, GF; ten Brinke, A; Willemsen, AM; van Kampen, AHC; Kaech, SM; Blander, JM; van Gisbergen, K; Amsen, D				Backer, Ronald A.; Helbig, Christina; Gentek, Rebecca; Kent, Andrew; Laidlaw, Brian J.; Dominguez, Claudia X.; de Souza, Yevan S.; van Trierum, Stella E.; van Beek, Ruud; Rimmelzwaan, Guus F.; ten Brinke, Anja; Willemsen, A. Marcel; van Kampen, Antoine H. C.; Kaech, Susan M.; Blander, J. Magarian; van Gisbergen, Klaas; Amsen, Derk			A central role for Notch in effector CD8(+) T cell differentiation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; VIRAL-INFECTION; CD25 EXPRESSION; DENDRITIC CELLS; VIRUS-INFECTION; IN-VIVO; MEMORY; PATHWAY; METABOLISM; RESPONSES	Activated CD8(+) T cells choose between terminal effector cell (TEC) or memory precursor cell (MPC) fates. We found that the signaling receptor Notch controls this 'choice'. Notch promoted the differentiation of immediately protective TECs and was correspondingly required for the clearance of acute infection with influenza virus. Notch activated a major portion of the TEC-specific gene-expression program and suppressed the MPC-specific program. Expression of Notch was induced on naive CD8(+) T cells by inflammatory mediators and interleukin 2 (IL-2) via pathways dependent on the metabolic checkpoint kinase mTOR and the transcription factor T-bet. These pathways were subsequently amplified downstream of Notch, creating a positive feedback loop. Notch thus functions as a central hub where information from different sources converges to match effector T cell differentiation to the demands of an infection.	[Backer, Ronald A.; Helbig, Christina; Gentek, Rebecca; de Souza, Yevan S.; Amsen, Derk] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Backer, Ronald A.; Helbig, Christina; van Gisbergen, Klaas; Amsen, Derk] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands; [Kent, Andrew; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Kent, Andrew; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, New York, NY 10029 USA; [Laidlaw, Brian J.; Dominguez, Claudia X.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Laidlaw, Brian J.; Dominguez, Claudia X.; Kaech, Susan M.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [van Trierum, Stella E.; van Beek, Ruud; Rimmelzwaan, Guus F.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Trierum, Stella E.; van Beek, Ruud; Rimmelzwaan, Guus F.] Viroclin Biosci BV, Rotterdam, Netherlands; [ten Brinke, Anja] Sanquin Res & Landsteiner Lab, Dept Immunopathol, Amsterdam, Netherlands; [Willemsen, A. Marcel; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Howard Hughes Medical Institute; Yale University; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Amsen, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.amsen@sanquin.nl	Backer, Ronald/F-5437-2013	Backer, Ronald/0000-0003-1464-3755; Gentek, Rebecca/0000-0001-6574-7242; ten Brinke, Anja/0000-0002-0135-7496; Blander, Julie Magarian/0000-0001-9207-1700; van Gisbergen, Klaas/0000-0003-3623-7555	NWO-ALW; Landsteiner Foundation for Blood Research; Academic Medical Center; US National Institutes of Health [AI095245, DK072201]; Burroughs Wellcome Trust Fund; Leukemia and Lymphoma Society; Irma-Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Research; Academic Medical Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Trust Fund(Wellcome Trust); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Irma-Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J.C. Zuniga Pflucker (Sunnybrook Research Institute) and D. Vignali (University of Pittsburgh) for the pMIY and pMIY-myr-Akt retroviral expression constructs; T.N.M. Schumacher (Netherlands Cancer Institute) for OVA-influenza; J. den Haan (Free University of Amsterdam) for MyD88-deficient mice; M. Suresh and E.H. Kim for advice on the staining of phosphorylated proteins for flow cytometry; M. Wolkers, M. Nolte, R. van Lier and M. van Ham for suggestions and proofreading of the manuscript; and the tetramer facility of the US National Institutes of Health for tetramers of major histocompatibility complex. Supported by NWO-ALW, the Landsteiner Foundation for Blood Research, the Academic Medical Center (D.A.), the US National Institutes of Health (AI095245 and DK072201 to J.M.B.), the Burroughs Wellcome Trust Fund (J.M.B.), the Leukemia and Lymphoma Society (J.M.B.), the Irma-Hirschl Charitable Trust and Monique Weill-Caulier Charitable Trust (J.M.B.).	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Cho OH, 2009, J IMMUNOL, V182, P3380, DOI 10.4049/jimmunol.0802598; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ito T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002341; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuijk LM, 2013, BLOOD, V121, P2638, DOI 10.1182/blood-2012-07-442962; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rohr JC, 2014, TRENDS IMMUNOL, V35, P170, DOI 10.1016/j.it.2014.02.006; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	53	78	87	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1143	1151		10.1038/ni.3027	http://dx.doi.org/10.1038/ni.3027			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25344724	Green Accepted			2022-12-18	WOS:000344841900011
J	Ji, QY; Castelli, L; Goverman, JM				Ji, Qingyong; Castelli, Luca; Goverman, Joan M.			MHC class I restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							NERVOUS-SYSTEM AUTOIMMUNITY; MULTIPLE-SCLEROSIS LESIONS; DENDRITIC CELLS; BASIC-PROTEIN; CEREBROSPINAL-FLUID; CLONAL EXPANSIONS; PATHOGENIC ROLE; AXONAL-INJURY; CUTTING EDGE; ANTIGEN	Myelin presentation to T cells in the central nervous system (CNS) sustains inflammation in multiple sclerosis (MS). CD4(+) and CD8(+) T cells contribute to MS, but only cells that present myelin to CD4(+) T cells have been identified. We show that MHC class l-restricted myelin basic protein (MBP) was presented by oligodendrocytes and cross-presented by Tip-dendritic cells (DCs) during experimental autoimmune encephalomyelitis (EAE), an animal model of MS initiated by CD4(+) T cells. Tip-DCs activated naive and effector CD8(+) T cells ex vivo, and naive MBP-specific CD8(+) T cells were activated in the CNS during CD4(+) T cell-induced EAE. These results demonstrate that CD4(+) T cell-mediated CNS autoimmunity leads to determinant spreading to myelin-specific CD8(+) T cells that can directly recognize oligodendrocytes.	[Ji, Qingyong; Castelli, Luca; Goverman, Joan M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Goverman, JM (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	goverman@u.washington.edu		Goverman, Joan/0000-0002-7361-9424	US National Institutes of Health [AI072737, AI073748]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, R01AI072737] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Mitiku, S. Lee, E. Pierson and S. Swarts for critical reading of the manuscript. This work was supported US National Institutes of Health grants (AI072737 and AI073748 to J.M.G.)	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Cudrici C, 2007, EXP MOL PATHOL, V83, P198, DOI 10.1016/j.yexmp.2007.05.006; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Deshpande P, 2007, J IMMUNOL, V178, P6695, DOI 10.4049/jimmunol.178.11.6695; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Gay FW, 1997, BRAIN, V120, P1461, DOI 10.1093/brain/120.8.1461; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Huseby ES, 1999, J IMMUNOL, V163, P1115; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Mars LT, 2007, J IMMUNOL, V179, P5090, DOI 10.4049/jimmunol.179.8.5090; Mars LT, 2011, BBA-MOL BASIS DIS, V1812, P151, DOI 10.1016/j.bbadis.2010.07.006; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120; Zozulya AL, 2008, HUM IMMUNOL, V69, P797, DOI 10.1016/j.humimm.2008.07.014	51	78	79	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					254	261		10.1038/ni.2513	http://dx.doi.org/10.1038/ni.2513			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23291597	Green Accepted			2022-12-18	WOS:000315065400015
J	Chikuma, S; Suita, N; Okazaki, IM; Shibayama, S; Honjo, T				Chikuma, Shunsuke; Suita, Naomasa; Okazaki, Il-Mi; Shibayama, Shiro; Honjo, Tasuku			TRIM28 prevents autoinflammatory T cell development in vivo	NATURE IMMUNOLOGY			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; HOST-DEFENSE; REG-CELLS; TIF1 BETA; TGF-BETA; COREPRESSOR; GENERATION; EFFECTOR; FAMILY; KAP-1	TRIM28 is a component of heterochromatin complexes whose function in the immune system is unknown. By studying mice with conditional T cell-specific deletion of TRIM28 (CKO mice), we found that TRIM28 was phosphorylated after stimulation via the T cell antigen receptor (TCR) and was involved in the global regulation of CD4(+) T cells. The CKO mice had a spontaneous autoimmune phenotype that was due in part to early lymphopenia associated with a defect in the production of interleukin 2 (IL-2) as well as incomplete cell-cycle progression of their T cells. In addition, CKO T cells showed derepression of the cytokine TGF-beta 3, which resulted in an altered cytokine balance; this caused the accumulation of autoreactive cells of the T(H)17 subset of helper T cells and of Foxp3(+) T cells. Notably, CKO Foxp3(+) T cells were unable to prevent the autoimmune phenotype in vivo. Our results show critical roles for TRIM28 in both T cell activation and T cell tolerance.	[Chikuma, Shunsuke; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Suita, Naomasa] Ono Pharmaceut, Tsukuba Res Inst, Adv Med Res Labs, Tsukuba, Ibaraki, Japan; [Okazaki, Il-Mi] Univ Tokushima, Inst Genome Res, Div Immune Regulat, Tsukuba, Ibaraki, Japan; [Shibayama, Shiro] Ono Pharmaceut, Tsukuba Res Inst, Exploratory Res Labs, Tsukuba, Ibaraki, Japan	Kyoto University; Novartis; Ono Pharmaceutical Co Ltd; Tokushima University; Novartis; Ono Pharmaceutical Co Ltd	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Chikuma, Shunsuke/Y-1016-2019	Okazaki, Il-mi/0000-0001-8644-0100	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [21790465, 23790534]; National Institute of Biomedical Innovation	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	We thank X. Zhou, A. Shimizu, S. Bailey-Bucktrout, K. Ikuta, T. Eagar, K. Ogasawara and M. Aida for discussions; K. Yurimoto for assistance in mouse genotyping; P. Chambon and R. Losson (Institut de Genetique et de Biologie Moleculaire et Cellulaire, France) for mice with loxP-flanked Trim28 alleles; J. Takeda (Osaka University) for mice with Cre expression driven by the Lck promoter; J. Bluestone (University of California-San Francisco) for Foxp3-GFP-Cre-transgenic mice; S. Nagata (Kyoto University) for CD45.1<SUP>+</SUP> mice; K. Kabashima (Kyoto University) for Rag2<SUP>-/-</SUP> mice; and J. Bluestone and N. Minato for critical reading of the manuscript. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI Grant-in-Aid for Scientific Research Young Scientist (B) 21790465 and 23790534 to S. C.) and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (T.H.).	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Caver TE, 1996, J CLIN INVEST, V98, P2496, DOI 10.1172/JCI119068; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Munoz-Valle JF, 2012, RHEUMATOL INT, V32, P367, DOI 10.1007/s00296-010-1624-x; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kench JA, 1999, CLIN IMMUNOL, V92, P300, DOI 10.1006/clim.1999.4754; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Linton PJ, 1997, IMMUNOL REV, V160, P9, DOI 10.1111/j.1600-065X.1997.tb01023.x; LOWRANCE JH, 1994, J EXP MED, V180, P1693, DOI 10.1084/jem.180.5.1693; Maloy Kevin J, 2007, Methods Mol Biol, V380, P327; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Okazaki I, 2011, P NATL ACAD SCI USA, V108, P7920, DOI 10.1073/pnas.1104423108; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	46	78	80	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					596	+		10.1038/ni.2293	http://dx.doi.org/10.1038/ni.2293			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22544392				2022-12-18	WOS:000304203900014
J	Norman, JM; Mashiba, M; McNamara, LA; Onafuwa-Nuga, A; Chiari-Fort, E; Shen, WW; Collins, KL				Norman, Jason M.; Mashiba, Michael; McNamara, Lucy A.; Onafuwa-Nuga, Adewunmi; Chiari-Fort, Estelle; Shen, Wenwen; Collins, Kathleen L.			The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells	NATURE IMMUNOLOGY			English	Article							URACIL-DNA; CYTIDINE DEAMINASE; CUTTING EDGE; HLA-B; VIRUS; NKG2D; DEGRADATION; EXPRESSION; VPR; IDENTIFICATION	APOBEC3G (A3G) is an intrinsic antiviral factor that inhibits the replication of human immunodeficiency virus (HIV) by deaminating cytidine residues to uridine. This causes guanosine-to-adenosine hypermutation in the opposite strand and results in inactivation of the virus. HIV counteracts A3G through the activity of viral infectivity factor (Vif), which promotes degradation of A3G. We report that viral protein R (Vpr), which interacts with a uracil glycosylase, also counteracted A3G by diminishing the incorporation of uridine. However, this process resulted in activation of the DNA-damage-response pathway and the expression of natural killer (NK) cell-activating ligands. Our results show that pathogen-induced deamination of cytidine and the DNA-damage response to virus-mediated repair of the incorporation of uridine enhance the recognition of HIV-infected cells by NK cells.	[Norman, Jason M.; McNamara, Lucy A.; Collins, Kathleen L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Mashiba, Michael; Collins, Kathleen L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [McNamara, Lucy A.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Onafuwa-Nuga, Adewunmi; Chiari-Fort, Estelle; Shen, Wenwen; Collins, Kathleen L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, KL (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	klcollin@umich.edu		McNamara, Lucy/0000-0001-8240-7493	Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; University of Michigan Flow Cytometry core, Sequencing Core (US National Institutes of Health) [P30CAO46592]; Hybridoma Core (US National Institutes of Health) [P30AR048310]; Center for Statistical Consultation for services; US National Institutes of Health (National Center for Research Resources) [R01 AI051192, T32GM007863, T32AI007413, UL1RR024986]; US National Science Foundation [DGE 0718128]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051192, R56AI051192, T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Michigan Flow Cytometry core, Sequencing Core (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hybridoma Core (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Statistical Consultation for services; US National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; M. Gately (Hoffmann La Roche) for human recombinant interleukin 2; H. Zhang, Y. Zhou and R. Siliciano (Johns Hopkins University) for pNL4-3-Delta E-EGFP (11100); K. Strebel (National Institute of Allergy and Infectious Diseases, US National Institutes of Health) for A3G antiserum (ApoC17); M.H. Malim (King's College London) for monoclonal antibody 319 to HIV-1 Vif; BioMolecular Technologies for antiserum to HIV-1<INF>SF2</INF> p24; and the University of Michigan Flow Cytometry core, Sequencing Core (US National Institutes of Health grant P30CAO46592) and Hybridoma Core (US National Institutes of Health grant P30AR048310) and the Center for Statistical Consultation for services. Supported by US National Institutes of Health (R01 AI051192; T32GM007863 and T32AI007413 to M.M.; and UL1RR024986 (National Center for Research Resources) to A.O.-N.), US National Science Foundation (DGE 0718128 to L.A.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of National Center for Research Resources or the US National Institutes of Health.	Altan-Bonnet G, 2003, PHYS REV LETT, V90, DOI [10.1103/PhysRevLett.90.138101, 10.1103/PhysRevLEtt.90.138101]; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fogli M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000101; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jem P, 2009, PLOS PATHOG, V5; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Kijak GH, 2008, VIROLOGY, V376, P101, DOI 10.1016/j.virol.2008.03.017; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Nakai-Murakami C, 2007, ONCOGENE, V26, P477, DOI 10.1038/sj.onc.1209831; Pauli EK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-38; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sire J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-45; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	47	78	80	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					975	U83		10.1038/ni.2087	http://dx.doi.org/10.1038/ni.2087			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21874023	Green Accepted			2022-12-18	WOS:000295084500013
J	Chen, J; McLean, PA; Neel, BG; Okunade, G; Shull, GE; Wortis, HH				Chen, J; McLean, PA; Neel, BG; Okunade, G; Shull, GE; Wortis, HH			CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity	NATURE IMMUNOLOGY			English	Article							B-CELL ACTIVATION; HUMAN RED-CELLS; CA2+ PUMP; TYROSINE PHOSPHORYLATION; CD22-DEFICIENT MICE; NEGATIVE REGULATOR; DISTINCT PATHWAYS; T-LYMPHOCYTES; RECEPTOR; MODULATION	Binding of antigen to the B cell receptor induces a calcium response, which is required for proliferation and antibody production. CD22, a B cell surface protein, inhibits this signal through mechanisms that have been obscure. We report here that CD22 augments calcium efflux after B cell receptor crosslinking. Inhibition of plasma membrane calcium-ATPase (PMCA) attenuated these effects, as did disruption by homologous recombination of the gene encoding PMCA4a and PMCA4b. PMCA coimmunoprecipitated with CD22 in an activation-dependent way. CD22 cytoplasmic tyrosine residues were required for association with PMCA and enhancement of calcium efflux. Moreover, CD22 regulation of efflux and the calcium response required the tyrosine phosphatase SHP-1. Thus, SHP-1 and PMCA provide a mechanism by which CD22, a tissue-specific negative regulator, can affect calcium responses.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Sackler Sch Grad Biomed Sci, Grad Program Genet, Boston, MA 02111 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; University of Cincinnati	Wortis, HH (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	henry.wortis@tufts.edu						BALASUBRAMANYAM M, 1995, CELL CALCIUM, V18, P526, DOI 10.1016/0143-4160(95)90015-2; BALASUBRAMANYAM M, 1993, AM J PHYSIOL, V265, pC321, DOI 10.1152/ajpcell.1993.265.2.C321; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; BRANDT P, 1992, J BIOL CHEM, V267, P4376; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Chen J, 2000, J BIOL CHEM, V275, P28739, DOI 10.1074/jbc.M000910200; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DIPOLO R, 1978, NATURE, V274, P390, DOI 10.1038/274390a0; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Hashimoto A, 1999, J BIOL CHEM, V274, P11203, DOI 10.1074/jbc.274.16.11203; Herscher CJ, 1997, ANN NY ACAD SCI, V834, P407, DOI 10.1111/j.1749-6632.1997.tb52284.x; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Klishin A, 1998, AM J PHYSIOL-CELL PH, V274, pC1117, DOI 10.1152/ajpcell.1998.274.4.C1117; Lajas AI, 2001, CELL SIGNAL, V13, P451, DOI 10.1016/S0898-6568(01)00161-9; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liu BF, 1996, J BIOL CHEM, V271, P5536, DOI 10.1074/jbc.271.10.5536; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Monteith GR, 1998, J PHARMACOL TOXICOL, V40, P183, DOI 10.1016/S1056-8719(99)00004-0; Nadler MJS, 1997, J IMMUNOL, V159, P4233; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RESINK TJ, 1986, ANN NY ACAD SCI, V488, P252; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHARFF O, 1983, BIOCHIM BIOPHYS ACTA, V730, P295, DOI 10.1016/0005-2736(83)90346-2; SCHATZMANN HJ, 1966, EXPERIENTIA, V22, P364, DOI 10.1007/BF01901136; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; Snitsarev VA, 1999, CELL CALCIUM, V25, P409, DOI 10.1054/ceca.1999.0041; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; ZHANG BX, 1992, J BIOL CHEM, V267, P15419	50	78	84	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					651	657		10.1038/ni1072	http://dx.doi.org/10.1038/ni1072			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15133509				2022-12-18	WOS:000221664000025
J	Anderton, SM; Viner, NJ; Matharu, P; Lowrey, PA; Wraith, DC				Anderton, SM; Viner, NJ; Matharu, P; Lowrey, PA; Wraith, DC			Influence of a dominant cryptic epitope on autoimmune T cell tolerance	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS; ALTERED PEPTIDE LIGAND; MHC BINDING-AFFINITY; CLASS-II MOLECULES; FINE SPECIFICITY; ANTIGENIC DETERMINANTS; TISSUE DISTRIBUTION; SJL/J MICE	The rules governing which T cells are inactivated during peptide-induced tolerance are unclear. Here we show that MBP(89-101) contains three overlapping but distinct T cell epitopes that are restricted by a single major histocompatibility complex (MHC) class II molecule. The dominant epitope is not processed from MBP and is not relevant to the induction of autoimmunity. Pathogenic T cells recognize two minor epitopes that are processed from MBP but are presented only poorly after exposure to MBP(89-101). Induction of immunological tolerance by MBP(89-101) therefore inactivates T cells that recognize the dominant epitope and disease-relevant T cells escape tolerance. The topology of the three epitopes implicates asparagine endopeptidase as the enzyme that controls recognition of this region of MBP. Our results highlight the need to use peptides that mimic the binding of processed antigen fragments to MHC molecules for successful modulation of disease-relevant T cells.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England	University of Edinburgh; University of Bristol	Anderton, SM (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.			Wraith, David/0000-0003-2147-5614				Anderton SM, 1998, J IMMUNOL, V161, P3357; ANDERTON SM, 1995, J EXP MED, V181, P943, DOI 10.1084/jem.181.3.943; Anderton SM, 1998, EUR J IMMUNOL, V28, P1251, DOI 10.1002/(SICI)1521-4141(199804)28:04<1251::AID-IMMU1251>3.0.CO;2-O; Anderton SM, 1999, EUR J IMMUNOL, V29, P1850, DOI 10.1002/(SICI)1521-4141(199906)29:06<1850::AID-IMMU1850>3.0.CO;2-N; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Bates IR, 2000, PROTEIN EXPRES PURIF, V20, P285, DOI 10.1006/prep.2000.1307; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; CHOU YK, 1989, J NEUROSCI RES, V22, P181, DOI 10.1002/jnr.490220211; CROSS AH, 1991, J NEUROIMMUNOL, V31, P59, DOI 10.1016/0165-5728(91)90087-N; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; FRANCO A, 1994, EUR J IMMUNOL, V24, P940, DOI 10.1002/eji.1830240424; Gaur A, 1997, J NEUROIMMUNOL, V74, P149, DOI 10.1016/S0165-5728(96)00220-2; Hemmer B, 1997, NEUROLOGY, V49, P1116, DOI 10.1212/WNL.49.4.1116; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; JONES PP, 1981, IMMUNOGENETICS, V12, P321, DOI 10.1007/BF01561674; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; KARIN N, 1994, J EXP MED, V180, P2227, DOI 10.1084/jem.180.6.2227; KONO DH, 1988, J EXP MED, V168, P213, DOI 10.1084/jem.168.1.213; LIU GY, 1995, INT IMMUNOL, V7, P1255, DOI 10.1093/intimm/7.8.1255; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MANOURY B, 2002, NATURE IMMUNOL, V3; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; MARTIN R, 1992, J IMMUNOL, V148, P1359; MARTIN R, 1990, J IMMUNOL, V145, P540; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Metzler B, 2000, IMMUNOL INVEST, V29, P61, DOI 10.3109/08820130009105145; METZLER B, 1993, INT IMMUNOL, V5, P1159, DOI 10.1093/intimm/5.9.1159; Moudgil KD, 1998, IMMUNOL TODAY, V19, P217, DOI 10.1016/S0167-5699(97)01233-4; Nelson CA, 1996, IMMUNOL REV, V151, P81, DOI 10.1111/j.1600-065X.1996.tb00704.x; OFFNER H, 1989, J EXP MED, V170, P355, DOI 10.1084/jem.170.2.355; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; SAKAI K, 1988, P NATL ACAD SCI USA, V85, P8608, DOI 10.1073/pnas.85.22.8608; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; TUOHY VK, 1989, J IMMUNOL, V142, P1523; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; Viner NJ, 1996, J IMMUNOL, V156, P2365; Vremec D, 1997, J IMMUNOL, V159, P565; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WAUBEN MHM, 1994, J IMMUNOL, V152, P4211; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	48	78	82	1	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					175	181		10.1038/ni756	http://dx.doi.org/10.1038/ni756			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812995				2022-12-18	WOS:000173562400018
J	Franco, A; Tilly, DA; Gramaglia, I; Croft, M; Cipolla, L; Meldal, M; Grey, HM				Franco, A; Tilly, DA; Gramaglia, I; Croft, M; Cipolla, L; Meldal, M; Grey, HM			Epitope affinity for MHC class I determines helper requirement for CTL priming	NATURE IMMUNOLOGY			English	Article							T-CELL RESPONSES; FREE SYNTHETIC PEPTIDE; DENDRITIC CELLS; LYMPHOCYTES-T; VIRUS-INFECTION; B-CELLS; MEMORY; GENERATION; INVIVO; MICE	We show here that priming and memory generation of antigen-specific CD8(+) cytotoxic T lymphocytes (CTL) does not require help if the immunogen binds major histocompatibility complex (MHC) class I molecules with high affinity. This conclusion was based on the study of three chemically distinct optimal length CTL epitopes with high affinity for the restriction element K-b. In contrast, when two subdominant epitopes with intermediate MHC binding affinity were studied, either a class II MHC-restricted T helper cell epitope or administration of antibody to CD40 was required to obtain significant CTL priming. Depending on the epitope, one source of help was much more efficient than the other.	La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA; Carlsberg Labs, Dept Chem, DK-2500 Valby, Denmark	La Jolla Institute for Immunology	Franco, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA.	alessandra_franco@liai.org	Meldal, Morten/B-7626-2016	Meldal, Morten/0000-0001-6114-9018				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AICHELE P, 1990, J EXP MED, V171, P1815, DOI 10.1084/jem.171.5.1815; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2595, DOI 10.1002/eji.1830261109; BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Chan OTM, 2000, J IMMUNOL, V164, P1658, DOI 10.4049/jimmunol.164.4.1658; COOLEY MA, 1979, J IMMUNOL, V123, P2328; DiRosa F, 1996, J EXP MED, V183, P2153, DOI 10.1084/jem.183.5.2153; FINBERG R, 1979, J IMMUNOL, V123, P1210; Franco A, 1999, J IMMUNOL, V162, P3388; Franco A, 1997, J IMMUNOL, V159, P2001; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; MALTOUBIAN M, 1994, J VIROL, V68, P8056; Markiewicz MA, 1999, CRIT REV ONCOGENESIS, V10, P247; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; OROURKE AM, 1992, NATURE, V358, P253, DOI 10.1038/358253a0; PILARSKI LM, 1977, J EXP MED, V145, P709, DOI 10.1084/jem.145.3.709; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rock KL, 1996, J IMMUNOL, V156, P3721; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Sauzet JP, 1996, INT IMMUNOL, V8, P457, DOI 10.1093/intimm/8.4.457; SCHAEFFER EB, 1989, P NATL ACAD SCI USA, V86, P4649, DOI 10.1073/pnas.86.12.4649; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; SETTE A, 1994, J IMMUNOL, V153, P5586; SIMPSON E, 1977, IMMUNOL REV, V35, P59, DOI 10.1111/j.1600-065X.1977.tb00235.x; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; STHILAIRE PM, 1999, J CHEM SOC P1, V1, P3559; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TRIPP RA, 1995, J IMMUNOL, V155, P2955; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; VANBLEEK GM, 1990, NATURE, V348, P213; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; YEWDELL JW, 1995, CLIN VIROLOGY; ZINKERNAGEL RM, 1978, J EXP MED, V147, P897, DOI 10.1084/jem.147.3.897	48	78	82	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					145	150		10.1038/77827	http://dx.doi.org/10.1038/77827			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248807				2022-12-18	WOS:000089814900015
J	Flament, H; Rouland, M; Beaudoin, L; Toubal, A; Bertrand, L; Lebourgeois, S; Rousseau, C; Soulard, P; Gouda, Z; Cagninacci, L; Monteiro, AC; Hurtado-Nedelec, M; Luce, S; Bailly, K; Andrieu, M; Saintpierre, B; Letourneur, F; Jouan, Y; Si-Tahar, M; Baranek, T; Paget, C; Boitard, C; Vallet-Pichard, A; Gautier, JF; Ajzenberg, N; Terrier, B; Pene, F; Ghosn, J; Lescure, X; Yazdanpanah, Y; Visseaux, B; Descamps, D; Timsit, JF; Monteiro, RC; Lehuen, A				Flament, Heloise; Rouland, Matthieu; Beaudoin, Lucie; Toubal, Amine; Bertrand, Leo; Lebourgeois, Samuel; Rousseau, Camille; Soulard, Pauline; Gouda, Zouriatou; Cagninacci, Lucie; Monteiro, Antoine C.; Hurtado-Nedelec, Margarita; Luce, Sandrine; Bailly, Karine; Andrieu, Muriel; Saintpierre, Benjamin; Letourneur, Franck; Jouan, Youenn; Si-Tahar, Mustapha; Baranek, Thomas; Paget, Christophe; Boitard, Christian; Vallet-Pichard, Anais; Gautier, Jean-Francois; Ajzenberg, Nadine; Terrier, Benjamin; Pene, Frederic; Ghosn, Jade; Lescure, Xavier; Yazdanpanah, Yazdan; Visseaux, Benoit; Descamps, Diane; Timsit, Jean-Francois; Monteiro, Renato C.; Lehuen, Agnes			Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity	NATURE IMMUNOLOGY			English	Article							INVARIANT T-CELLS; IMMUNITY; TCR	Severe COVID-19 is characterized by hyperinflammation, and there is a need for accurate predictive biomarkers of progression. Lehuen et al. demonstrate that patients with severe COVID-19 show a dramatic loss of MAIT cells, and those that do remain are in a highly activated state. Immune system dysfunction is paramount in coronavirus disease 2019 (COVID-19) severity and fatality rate. Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in mucosal immunity and protection against viral infections. Here, we studied the immune cell landscape, with emphasis on MAIT cells, in cohorts totaling 208 patients with various stages of disease. MAIT cell frequency is strongly reduced in blood. They display a strong activated and cytotoxic phenotype that is more pronounced in lungs. Blood MAIT cell alterations positively correlate with the activation of other innate cells, proinflammatory cytokines, notably interleukin (IL)-18, and with the severity and mortality of severe acute respiratory syndrome coronavirus 2 infection. We also identified a monocyte/macrophage interferon (IFN)-alpha-IL-18 cytokine shift and the ability of infected macrophages to induce the cytotoxicity of MAIT cells in an MR1-dependent manner. Together, our results suggest that altered MAIT cell functions due to IFN-alpha-IL-18 imbalance contribute to disease severity, and their therapeutic manipulation may prevent deleterious inflammation in COVID-19 aggravation.	[Flament, Heloise; Hurtado-Nedelec, Margarita; Monteiro, Renato C.] Bichat Claude Bernard Univ Hosp, AP HP, Lab Immunol Dysfunct, Paris, France; [Flament, Heloise; Hurtado-Nedelec, Margarita; Monteiro, Renato C.] Univ Paris, Ctr Res Inflammat, INSERM, U1149, Paris, France; [Flament, Heloise; Hurtado-Nedelec, Margarita; Monteiro, Renato C.] CNRS, Inflamex Lab, ERL8252, Paris, France; [Rouland, Matthieu; Beaudoin, Lucie; Toubal, Amine; Bertrand, Leo; Rousseau, Camille; Soulard, Pauline; Gouda, Zouriatou; Cagninacci, Lucie; Luce, Sandrine; Bailly, Karine; Andrieu, Muriel; Saintpierre, Benjamin; Letourneur, Franck; Boitard, Christian; Vallet-Pichard, Anais; Pene, Frederic; Lehuen, Agnes] Univ Paris, Inflamex Lab, Inst Cochin, Inserm,U1016,CNRS,UMR 8104, Paris, France; [Lebourgeois, Samuel; Monteiro, Antoine C.; Visseaux, Benoit; Descamps, Diane] Bichat Claude Bernard Univ Hosp, AP HP, Dept Virol, Paris, France; [Lebourgeois, Samuel; Monteiro, Antoine C.; Ghosn, Jade; Lescure, Xavier; Yazdanpanah, Yazdan; Visseaux, Benoit; Descamps, Diane; Timsit, Jean-Francois] Univ Paris, Infect Antimicrobials Modelling Evolut UMR 1137, Paris, France; [Jouan, Youenn; Si-Tahar, Mustapha; Baranek, Thomas; Paget, Christophe] Univ Tours, Ctr Etud Pathol Resp UMR 1100, INSERM, Tours, Indre & Loire, France; [Jouan, Youenn] Tours Reg Univ Hosp, Intens Care Med Unit, Tours, France; [Boitard, Christian] Cochin Univ Hosp, AP HP, Dept Diabetol, Paris, France; [Vallet-Pichard, Anais] Cochin Univ Hosp, AP HP, Dept Hepatol, Paris, France; [Gautier, Jean-Francois] Lariboisiere Hosp, AP HP, Dept Diabet & Endocrinol, Paris, France; [Ajzenberg, Nadine] Bichat Claude Bernard Univ Hosp, AP HP, Dept Hematol, Paris, France; [Ajzenberg, Nadine] Univ Paris, INSERM, LVTS, Paris, France; [Terrier, Benjamin] Cochin Univ Hosp, AP HP, Dept Internal Med, Paris, France; [Pene, Frederic] Cochin Univ Hosp, AP HP, Med Intens Care Unit, Paris, France; [Ghosn, Jade; Lescure, Xavier; Yazdanpanah, Yazdan] Bichat Claude Bernard Univ Hosp, AP HP, Dept Infect & Trop Dis, Paris, France; [Timsit, Jean-Francois] Bichat Claude Bernard Univ Hosp, AP HP, Med & Infect Dis Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Lehuen, A (corresponding author), Univ Paris, Inflamex Lab, Inst Cochin, Inserm,U1016,CNRS,UMR 8104, Paris, France.	agnes.lehuen@inserm.fr	Flament, Heloïse/AAJ-3795-2021; SI-TAHAR, Mustapha/L-4149-2014; Paget, Christophe/P-5165-2014	SI-TAHAR, Mustapha/0000-0002-5792-7742; ROULAND, Matthieu/0000-0002-8019-7629; Bertrand, Leo/0000-0001-5584-3476; LUCE, Sandrine/0000-0002-9519-333X; Paget, Christophe/0000-0002-5374-5407; Toubal, Amine/0000-0001-7760-3852; GOUDA, Zouriatou/0000-0001-5562-9322	Laboratory of Excellence INFLAMEX [ANR-11-IDEX-0005-02]; Fondation pour la Recherche Medicale [EQU201903007779, EQU201903007816]; Universite de Paris COVID-19 grant; Fondation Francophone pour la Recherche sur le Diabete; Juvenile Diabetes Research Foundation; Recherche Hospitalo-Universitaire (RHU) QUID-NASH program [ANR-17-RHUS-009]; French Ministry of Research grants; RHU QUID-NASH;  [ANR-17-CE14-0002-01];  [ANR-19-CE14-0020]	Laboratory of Excellence INFLAMEX; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Universite de Paris COVID-19 grant; Fondation Francophone pour la Recherche sur le Diabete; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Recherche Hospitalo-Universitaire (RHU) QUID-NASH program; French Ministry of Research grants; RHU QUID-NASH; ; 	We thank all the patients and the physicians, nurses and technician staff who helped with the study. We thank the Department of Biological Hematology and the Department of Biochemistry of Bichat-Claude Bernard University Hospital for measuring white blood cells and CRP. We are grateful to M. Diedisheim for discussion about biostatistics and bioinformatics and the National Institutes of Health Tetramer Core Facility for human MR1 tetramers. The laboratories of A.L. and R.C.M. are supported by ANR-11-IDEX-0005-02 Laboratory of Excellence INFLAMEX and Fondation pour la Recherche Medicale (EQU201903007779 to A.L. and EQU201903007816 to R.C.M.). R.C.M. received a Universite de Paris COVID-19 grant. The laboratory of A.L. is also supported by ANR-17-CE14-0002-01, ANR-19-CE14-0020, Fondation Francophone pour la Recherche sur le Diabete and Juvenile Diabetes Research Foundation. A.L., C.B., A.V.-P. and J.-F.G. are supported by the Recherche Hospitalo-Universitaire (RHU) QUID-NASH program (ANR-17-RHUS-009). We thank D. Valla and A. Brzustowski, coordinator and manager of the RHU QUID-NASH. M.R. and L. Bertrand were supported by French Ministry of Research grants. A.T., Z.G. and L.C. were supported by RHU QUID-NASH. C.R. was supported by Fondation Francophone pour la Recherche sur le Diabete. P.S. was supported by the Juvenile Diabetes Research Foundation. We also thank Servier Medical Art for the free medical images, licensed under the Creative Commons Attribution 3.0 Unported License.	[Anonymous], LANCET, DOI DOI 10.1016/S0140-6736(20)30211-7; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Czernichow S, 2020, OBESITY, V28, P2282, DOI 10.1002/oby.23014; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; Fan J, 2020, J INFECTION, V81, pE64, DOI 10.1016/j.jinf.2020.06.047; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hasnain SE, 2003, J BIOSCIENCES, V28, P349, DOI 10.1007/BF02970153; Hegde P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04450-y; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Kragten NAM, 2018, EUR J IMMUNOL, V48, P1644, DOI 10.1002/eji.201847771; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Leng TQ, 2019, CELL REP, V28, P3077, DOI 10.1016/j.celrep.2019.08.050; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Parrot T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe1670; Perrin S, 2017, BIOINFORMATICS, V33, P2212, DOI 10.1093/bioinformatics/btx154; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Riegert P, 1998, J IMMUNOL, V161, P4066; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Stehle C, 2018, IMMUNOL REV, V286, P102, DOI 10.1111/imr.12712; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Toubal A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17307-0; Toubal A, 2019, NAT REV IMMUNOL, V19, P643, DOI 10.1038/s41577-019-0191-y; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2018, IMMUNOL CELL BIOL, V96, P630, DOI 10.1111/imcb.12008; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041	51	77	77	7	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					322	+		10.1038/s41590-021-00870-z	http://dx.doi.org/10.1038/s41590-021-00870-z		FEB 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33531712	hybrid			2022-12-18	WOS:000613997900001
J	Gabrysova, L; Alvarez-Martinez, M; Luisier, R; Cox, LS; Sodenkamp, J; Hosking, C; Perez-Mazliah, D; Whicher, C; Kannan, Y; Potempa, K; Wu, XM; Bhaw, L; Wende, H; Sieweke, MH; Elgar, G; Wilson, M; Briscoe, J; Metzis, V; Langhorne, J; Luscombe, NM; O'Garra, A				Gabrysova, Leona; Alvarez-Martinez, Marisol; Luisier, Raphaelle; Cox, Luke S.; Sodenkamp, Jan; Hosking, Caroline; Perez-Mazliah, Damian; Whicher, Charlotte; Kannan, Yashaswini; Potempa, Krzysztof; Wu, Xuemei; Bhaw, Leena; Wende, Hagen; Sieweke, Michael H.; Elgar, Greg; Wilson, Mark; Briscoe, James; Metzis, Vicki; Langhorne, Jean; Luscombe, Nicholas M.; O'Garra, Anne			c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; REG CELLS; TH2 CELLS; IN-VIVO; DIFFERENTIATION; EXPRESSION; TH17; PROMOTES; JUN	The transcription factor c-Maf induces the anti-inflammatory cytokine IL-10 in CD4(+) T cells in vitro. However, the global effects of c-Maf on diverse immune responses in vivo are unknown. Here we found that c-Maf regulated IL-10 production in CD4(+) T cells in disease models involving the T(H)1 subset of helper T cells (malaria), T(H)2 cells (allergy) and T(H)17 cells (autoimmunity) in vivo. Although mice with c-Maf deficiency targeted to T cells showed greater pathology in T(H)1 and T(H)2 responses, T(H)17 cell-mediated pathology was reduced in this context, with an accompanying decrease in T(H)17 cells and increase in Foxp3(+) regulatory T cells. Bivariate genomic footprinting elucidated the c-Maf transcription-factor network, including enhanced activity of NFAT; this led to the identification and validation of c-Maf as a negative regulator of IL-2. The decreased expression of the gene encoding the transcription factor ROR gamma t (Rorc) that resulted from c-Maf deficiency was dependent on IL-2, which explained the in vivo observations. Thus, c-Maf is a positive and negative regulator of the expression of cytokine-encoding genes, with context-specific effects that allow each immune response to occur in a controlled yet effective manner.	[Gabrysova, Leona; Alvarez-Martinez, Marisol; Cox, Luke S.; Whicher, Charlotte; Potempa, Krzysztof; Wu, Xuemei; O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England; [Luisier, Raphaelle; Luscombe, Nicholas M.] Francis Crick Inst, Computat Biol Lab, London, England; [Sodenkamp, Jan; Hosking, Caroline; Perez-Mazliah, Damian; Langhorne, Jean] Francis Crick Inst, Malaria Lab, London, England; [Kannan, Yashaswini; Wilson, Mark] Francis Crick Inst, Helminth Immunol Lab, London, England; [Bhaw, Leena; Elgar, Greg] Francis Crick Inst, Adv Sequencing Facil Lab, London, England; [Wende, Hagen] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Sieweke, Michael H.] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med Helmholtzgemeinschaft MD, Berlin, Germany; [Briscoe, James; Metzis, Vicki] Francis Crick Inst, Dev Dynam Lab, London, England; [Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London, England; [O'Garra, Anne] Imperial Coll London, Natl Heart & Lung Inst, London, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Francis Crick Institute; University of London; University College London; Imperial College London	O'Garra, A (corresponding author), Francis Crick Inst, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	anne.ogarra@crick.ac.uk	Perez-Mazliah, Damian/AAN-3767-2021; Luisier, Raphaelle/AAA-9283-2022; Sieweke, Michael/AAR-7515-2020; Metzis, Vicki/AAU-5081-2020	Perez-Mazliah, Damian/0000-0002-2156-2585; Sieweke, Michael/0000-0002-3228-9537; Metzis, Vicki/0000-0002-0399-1722; Hosking, Caroline/0000-0003-4238-5650; Cox, Luke/0000-0002-5477-8622; Elgar, Greg/0000-0001-7323-1596; Whicher, Charlotte/0000-0001-5474-2948; O'Garra, Anne/0000-0001-9845-6134; Wende, Hagen/0000-0002-9168-8095; Gabrysova, Leona/0000-0003-3529-1306	Francis Crick Institute (Crick Core) from Cancer Research UK [FC001126, FC010110]; UK Medical Research Council [FC001126, FC010110, MRC U117565642]; Wellcome Trust [FC001126, FC010110, WT098326MA, 103760/Z/14/Z]; European Research Council [695093, 294682-TB-PATH (Crick 10127)]; UK Medical Research Council (MRC Centenary Award); UK Medical Research Council (MRC eMedLab Medical Bioinformatics Infrastructure Award) [MR/L016311/1]; Crick Core projects [10101, FC001051]; Agence Nationale de la Recherche [ANR-11-BSV3-0026]; Fondation pour la Recherche Medicale [DEQ. 20110421320]; Inserm/CNRS [ANR-11-BSV3-0026]; MRC [MC_U117565642] Funding Source: UKRI	Francis Crick Institute (Crick Core) from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council (MRC Centenary Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council (MRC eMedLab Medical Bioinformatics Infrastructure Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Crick Core projects; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Inserm/CNRS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R.A. Flavell (Yale University) for Foxp3RFP IL-10GFP mice; M. Sieweke and C. Birchmeier (Max Delbruck Centre for Molecular Medicine) for Maf<SUP>fl/fl</SUP> mice; G. Trinchieri (Wistar Institute) for anti-IL-12p40 (C17.8.20); The Francis Crick Institute, Biological Services for breeding and maintenance of the mice; the Advanced Sequencing Platform and A. Sesay for help with sequence sample processing; the Flow Cytometry Platform; Bioinformatics Platform and G. Kelly for help with statistics; Photographics and M. Butt for help with figures; V. Stavropoulos for help with in vivo experiments; and A. Singhania and L. Moreira-Teixeira from the AOG laboratory for review and discussion of the manuscript. Supported by the Francis Crick Institute (Crick Core), which since 1 April 2015 has received its core funding from Cancer Research UK (FC001126 and FC010110), the UK Medical Research Council (FC001126 and FC010110) and the Wellcome Trust (FC001126 and FC010110), and before that from the UK Medical Research Council (MRC U117565642) and the European Research Council (294682-TB-PATH (Crick 10127)) (all for A.O.G., L.G., K.P., M.A.-M., L.S.C. and C.W.), the UK Medical Research Council (MRC Centenary Award for L. G.; and MRC eMedLab Medical Bioinformatics Infrastructure Award MR/L016311/1 for N.M.L.), Crick Core projects (10101 for J.L. and FC001051 for J.B. and V. M.), the Wellcome Trust (WT098326MA for J.B. and V.M.; and Joint Investigator Award 103760/Z/14/Z for N.M.L.), Inserm/CNRS and Agence Nationale de la Recherche (ANR-11-BSV3-0026), Fondation pour la Recherche Medicale (DEQ. 20110421320) and the European Research Council (695093 for M.H.S.).	Andris F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00480; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Baek S, 2017, CELL REP, V19, P1710, DOI 10.1016/j.celrep.2017.05.003; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 1998, J IMMUNOL, V161, P3299; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Coomes SM, 2017, MUCOSAL IMMUNOL, V10, P150, DOI 10.1038/mi.2016.47; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Li W, 2014, INT IMMUNOL, V26, P269, DOI 10.1093/intimm/dxt065; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Perez-Mazliah D, 2017, EBIOMEDICINE, V24, P216, DOI 10.1016/j.ebiom.2017.08.030; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wheaton JD, 2017, J IMMUNOL, V199, P3931, DOI 10.4049/jimmunol.1701134; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	52	77	81	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					497	+		10.1038/s41590-018-0083-5	http://dx.doi.org/10.1038/s41590-018-0083-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29662170	Green Accepted			2022-12-18	WOS:000430562400013
J	Gringhuis, SI; Hertoghs, N; Kaptein, TM; Zijlstra-Willems, EM; Sarrami-Fooroshani, R; Sprokholt, JK; van Teijlingen, NH; Kootstra, NA; Booiman, T; van Dort, KA; Ribeiro, CMS; Drewniak, A; Geijtenbeek, TBH				Gringhuis, Sonja I.; Hertoghs, Nina; Kaptein, Tanja M.; Zijlstra-Willems, Esther M.; Sarrami-Fooroshani, Ramin; Sprokholt, Joris K.; van Teijlingen, Nienke H.; Kootstra, Neeltje A.; Booiman, Thijs; van Dort, Karel A.; Ribeiro, Carla M. S.; Drewniak, Agata; Geijtenbeek, Teunis B. H.			HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3	NATURE IMMUNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELL MATURATION; INNATE IMMUNE-RESPONSE; DC-SIGN; KAPPA-B; INFECTION; INTERFERON; KINASE; INHIBITOR; TRANSCRIPTION	The mechanisms by which human immunodeficiency virus 1 (HIV-1) avoids immune surveillance by dendritic cells (DCs), and thereby prevents protective adaptive immune responses, remain poorly understood. Here we showed that HIV-1 actively arrested antiviral immune responses by DCs, which contributed to efficient HIV-1 replication in infected individuals. We identified the RNA helicase DDX3 as an HIV-1 sensor that bound abortive HIV-1 RNA after HIV-1 infection and induced DC maturation and type I interferon responses via the signaling adaptor MAVS. Notably, HIV-1 recognition by the C-type lectin receptor DC-SIGN activated the mitotic kinase PLK1, which suppressed signaling downstream of MAVS, thereby interfering with. intrinsic host defense during HIV-1 infection. Finally, we showed that PLK1-mediated suppression of DDX3-MAVS signaling was a viral strategy that accelerated HIV-1 replication in infected individuals.	[Gringhuis, Sonja I.; Hertoghs, Nina; Kaptein, Tanja M.; Zijlstra-Willems, Esther M.; Sarrami-Fooroshani, Ramin; Sprokholt, Joris K.; van Teijlingen, Nienke H.; Kootstra, Neeltje A.; Booiman, Thijs; van Dort, Karel A.; Ribeiro, Carla M. S.; Drewniak, Agata; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Gringhuis, SI; Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.	s.i.gringhuis@amc.uva.nl; t.b.geijtenbeek@amc.uva.nl	Hertoghs, Nina/D-4255-2018	Sarrami-Forooshani, Ramin/0000-0002-6999-9145; Kootstra, Neeltje A./0000-0001-9429-7754; Gringhuis, Sonja/0000-0003-0383-4978; Sprokholt, Joris/0000-0001-8104-0028; Ribeiro, Carla/0000-0002-5682-4143	Aids Fonds [2012042]; Netherlands Organization for Scientific Research (NWO) [VICI 918.10.619]; European Research Council [670424]	Aids Fonds; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank L. Westera, C. Buskens and W. Bemelman (AMC, Amsterdam, the Netherlands) for the intestinal tissue cell suspensions and C.L. Verweij (VUmc, Amsterdam, the Netherlands) for the IFNB,ISG15 and Mx2 primer sequences. HIV-2 virus, MT-2 cells, AZT and gp120 were obtained through the NIH AIDS Research and Reference Reagent Program. Supported by Aids Fonds (2012042; S.I.G.), the Netherlands Organization for Scientific Research (NWO) VICI 918.10.619; T.B.H.G.) and the European Research Council (Advanced grant 670424; T.B.H.G.).	ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hertoghs N, 2015, J IMMUNOL, V194, P4431, DOI 10.4049/jimmunol.1403016; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Ji JH, 2010, FEBS LETT, V584, P4299, DOI 10.1016/j.febslet.2010.09.025; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li SS, 2013, MINI-REV MED CHEM, V13, P2014, DOI 10.2174/13895575113136660103; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Miller E, 2013, IMMUNOL REV, V254, P170, DOI 10.1111/imr.12082; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Pothlichet J, 2011, EMBO MOL MED, V3, P142, DOI 10.1002/emmm.201000120; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Simmons DP, 2012, J IMMUNOL, V188, P3116, DOI 10.4049/jimmunol.1101313; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wheeler LA, 2016, CELL REP, V15, P1715, DOI 10.1016/j.celrep.2016.04.048; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	43	77	79	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					225	235		10.1038/ni.3647	http://dx.doi.org/10.1038/ni.3647			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28024153				2022-12-18	WOS:000392360900016
J	Veiga-Fernandes, H; Pachnis, V				Veiga-Fernandes, Henrique; Pachnis, Vassilis			Neuroimmune regulation during intestinal development and homeostasis	NATURE IMMUNOLOGY			English	Review							ENTERIC NERVOUS-SYSTEM; INNATE LYMPHOID-CELLS; NITRIC-OXIDE PRODUCTION; PEYERS PATCH ORGANOGENESIS; NEURO-IMMUNE INTERACTIONS; KINASE RECEPTOR RET; RETINOIC ACID; T-CELLS; GLIAL-CELLS; GASTROINTESTINAL-TRACT	Interactions between the nervous system and immune system are required for organ function and homeostasis. Evidence suggests that enteric neurons and intestinal immune cells share common regulatory mechanisms and can coordinate their responses to developmental challenges and environmental aggressions. These discoveries shed light on the physiology of system interactions and open novel perspectives for therapy designs that target underappreciated neurological-immunological commonalities. Here we highlight findings that address the importance of neuroimmune cell units (NICUs) in intestinal development, homeostasis and disease.	[Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, Edificio Egas Moniz, Lisbon, Portugal; [Veiga-Fernandes, Henrique] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal; [Pachnis, Vassilis] Francis Crick Inst, London, England	Universidade de Lisboa; Fundacao Champalimaud; Francis Crick Institute	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Med Mol, Edificio Egas Moniz, Lisbon, Portugal.; Veiga-Fernandes, H (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal.	henrique.veigafernandes@research.fchampalimaud.org; Vassilis.Pachnis@crick.ac.uk		Pachnis, Vassilis/0000-0001-9733-7686; Veiga-Fernandes, Henrique/0000-0001-6216-1836	European Research Council [647274]; European Union; Chron's and Colitis Foundation of America; Kenneth Rainin Foundation; Fundacao para a Ciencia e Tecnologia, Portugal; Medical Research Council; Francis Crick Institute; Biotechnology and Biological Sciences Research Council; The Francis Crick Institute [10128] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Chron's and Colitis Foundation of America; Kenneth Rainin Foundation; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Francis Crick Institute	We thank the members of our laboratories for discussions. Supported by the European Research Council (647274 for the H.V.-F. laboratory), the European Union (H.V.-F. laboratory), the Chron's and Colitis Foundation of America (H.V.-F. laboratory), the Kenneth Rainin Foundation (H.V.-F. laboratory), Fundacao para a Ciencia e Tecnologia, Portugal (H.V.-F. laboratory), the Medical Research Council (V.P. laboratory), the Francis Crick Institute. (V.P. laboratory) and the Biotechnology and Biological Sciences Research Council (V.P. laboratory).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Almeida ARM, 2014, EUR J IMMUNOL, V44, P3605, DOI 10.1002/eji.201344422; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avetisyan M, 2015, J CLIN INVEST, V125, P899, DOI 10.1172/JCI76307; Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Boesmans W, 2015, GLIA, V63, P229, DOI 10.1002/glia.22746; Brun P, 2015, MOL CELL NEUROSCI, V68, P24, DOI 10.1016/j.mcn.2015.03.018; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cirillo C, 2011, NEUROGASTROENT MOTIL, V23, pE372, DOI 10.1111/j.1365-2982.2011.01748.x; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; Fernandes SM, 2014, J INFECT DIS, V210, P630, DOI 10.1093/infdis/jiu126; Ferreira M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00219; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; GEBOES K, 1992, GASTROENTEROLOGY, V103, P439, DOI 10.1016/0016-5085(92)90832-J; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Goverse G, 2016, J IMMUNOL, V196, P5148, DOI 10.4049/jimmunol.1501106; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Heanue TA, 2008, MECH DEVELOP, V125, P687, DOI 10.1016/j.mod.2008.04.006; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kabouridis PS, 2015, J CLIN INVEST, V125, P956, DOI 10.1172/JCI76308; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kioussis D, 2009, IMMUNITY, V31, P705, DOI 10.1016/j.immuni.2009.09.009; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; KORETZ K, 1987, AM J PATHOL, V129, P493; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Liu YA, 2013, NEUROGASTROENT MOTIL, V25, pe324, DOI 10.1111/nmo.12115; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Margolis KG, 2016, TRENDS IMMUNOL, V37, P487, DOI 10.1016/j.it.2016.05.003; Almeida ARM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052949; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Neufeld KAM, 2013, NEUROGASTROENT MOTIL, V25, P183, DOI 10.1111/nmo.12049; Neunlist M, 2013, NAT REV GASTRO HEPAT, V10, P90, DOI 10.1038/nrgastro.2012.221; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Nijhuis LEJ, 2010, BIOCHEM PHARMACOL, V80, P2002, DOI 10.1016/j.bcp.2010.06.034; Ohno H, 2016, J BIOCHEM, V159, P151, DOI 10.1093/jb/mvv121; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Roberts RR, 2007, AM J PHYSIOL-GASTR L, V292, pG930, DOI 10.1152/ajpgi.00444.2006; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rumio C, 2006, J CELL PHYSIOL, V208, P47, DOI 10.1002/jcp.20632; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schemann M, 2013, GASTROENTEROLOGY, V144, P698, DOI 10.1053/j.gastro.2013.01.040; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talbot S, 2016, ANNU REV IMMUNOL, V34, P421, DOI 10.1146/annurev-immunol-041015-055340; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Uesaka T, 2016, DEV BIOL, V417, P158, DOI 10.1016/j.ydbio.2016.04.016; Uesaka T, 2010, J NEUROSCI, V30, P5211, DOI 10.1523/JNEUROSCI.6244-09.2010; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; van Diest SA, 2012, BBA-MOL BASIS DIS, V1822, P74, DOI 10.1016/j.bbadis.2011.03.019; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2015, NAT IMMUNOL, V16, P215, DOI 10.1038/ni.3100; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	126	77	79	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					116	122		10.1038/ni.3634	http://dx.doi.org/10.1038/ni.3634			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28092371				2022-12-18	WOS:000392360900002
J	Salzer, E; Cagdas, D; Hons, M; Mace, EM; Garncarz, W; Petronczki, OY; Platzer, R; Pfajfer, L; Bilic, I; Ban, SA; Willmann, KL; Mukherjee, M; Supper, V; Hsu, HT; Banerjee, PP; Sinha, P; McClanahan, F; Zlabinger, GJ; Pick, WF; Gribben, JG; Stockinger, H; Bennett, KL; Huppa, JB; Dupre, L; Sanal, O; Jager, U; Sixt, M; Tezcan, I; Orange, JS; Boztug, K				Salzer, Elisabeth; Cagdas, Deniz; Hons, Miroslav; Mace, Emily M.; Garncarz, Wojciech; Petronczki, Ozlem Yuce; Platzer, Rene; Pfajfer, Laurene; Bilic, Ivan; Ban, Sol A.; Willmann, Katharina L.; Mukherjee, Malini; Supper, Verena; Hsu, Hsiang Ting; Banerjee, Pinaki P.; Sinha, Papiya; McClanahan, Fabienne; Zlabinger, Gerhard J.; Pick, Winfried F.; Gribben, John G.; Stockinger, Hannes; Bennett, Keiryn L.; Huppa, Johannes B.; Dupre, Loic; Sanal, Ozden; Jager, Ulrich; Sixt, Michael; Tezcan, Ilhan; Orange, Jordan S.; Boztug, Kaan			RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; MULTIPLE-MYELOMA; HUMAN IMMUNOLOGY; RAS ACTIVATION; LENALIDOMIDE; DYNEIN; LOCALIZATION; PROTEIN; MOUSE; MICE	RASGRP1 is an important guanine nucleotide exchange factor and activator of the RAS-MAPK pathway following T cell antigen receptor (TCR) signaling. The consequences of RASGRP1 mutations in humans are unknown. In a patient with recurrent bacterial and viral infections, born to healthy consanguineous parents, we used homozygosity mapping and exome sequencing to identify a biallelic stop-gain variant in RASGRP1. This variant segregated perfectly with the disease and has not been reported in genetic databases. RASGRP1 deficiency was associated in T cells and B cells with decreased phosphorylation of the extracellular-signal-regulated serine kinase ERK, which was restored following expression of wild-type RASGRP1. RASGRP1 deficiency also resulted in defective proliferation, activation and motility of T cells and B cells. RASGRP1-deficient natural killer (NK) cells exhibited impaired cytotoxicity with defective granule convergence and actin accumulation. Interaction proteomics identified the dynein light chain DYNLL1 as interacting with RASGRP1, which links RASGRP1 to cytoskeletal dynamics. RASGRP1-deficient cells showed decreased activation of the GTPase RhoA. Treatment with lenalidomide increased RhoA activity and reversed the migration and activation defects of RASGRP1-deficient lymphocytes.	[Salzer, Elisabeth; Garncarz, Wojciech; Petronczki, Ozlem Yuce; Pfajfer, Laurene; Bilic, Ivan; Ban, Sol A.; Willmann, Katharina L.; Bennett, Keiryn L.; Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Salzer, Elisabeth; Garncarz, Wojciech; Petronczki, Ozlem Yuce; Pfajfer, Laurene; Boztug, Kaan] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Cagdas, Deniz] Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Sect Pediat Immunol, Ankara, Turkey; [Hons, Miroslav; Sixt, Michael] IST Austria, Klosterneuburg, Austria; [Mace, Emily M.; Orange, Jordan S.] Baylor Coll Med, Ctr Human Immunobiol, Houston, TX 77030 USA; [Mace, Emily M.; Mukherjee, Malini; Orange, Jordan S.] Texas Childrens Hosp, Houston, TX 77030 USA; [Platzer, Rene; Supper, Verena; Huppa, Johannes B.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria; Queen Mary Univ London, CR UK Ctr Excellence, Ctr Haematooncol, Barts Canc Inst, London, England; [Gribben, John G.] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Zlabinger, Gerhard J.] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Pick, Winfried F.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Dupre, Loic] Toulouse Purpan Univ Hosp, CPTP, INSERM, UMR1043, Toulouse, France; [Jager, Ulrich] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria; [Ban, Sol A.; Mukherjee, Malini; Huppa, Johannes B.; Tezcan, Ilhan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Garncarz, Wojciech; Banerjee, Pinaki P.] Med Univ Vienna, St Anna Kinderspital & Childrens Canc Res Inst, Dept Pediat, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Hacettepe University; Institute of Science & Technology - Austria; Baylor College of Medicine; Baylor College of Medicine; Medical University of Vienna; University of London; Queen Mary University London; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital	Boztug, K (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.; Boztug, K (corresponding author), Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria.	kaan.bortug@rud.lbg.ac.at	Hons, Miroslav/I-2197-2018; Stockinger, Hannes/E-5173-2011; dupre, loic/L-8174-2014; Hons, Miroslav/AAK-5115-2021; Cagdas, Deniz/I-9104-2013; Huppa, Johannes Bernhard/AAY-9471-2021; Pfajfer, Laurene/GRO-2420-2022; Boztug, Kaan/AAM-4161-2021; Pinos, Jakub/D-6536-2015; Salzer, Elisabeth/G-8066-2017	Hons, Miroslav/0000-0002-6625-3348; Stockinger, Hannes/0000-0001-6404-4430; dupre, loic/0000-0002-7278-6503; Hons, Miroslav/0000-0002-6625-3348; Cagdas, Deniz/0000-0003-2213-4627; Huppa, Johannes Bernhard/0000-0003-2634-8198; Pfajfer, Laurene/0000-0002-1281-9342; Boztug, Kaan/0000-0001-8387-9185; Pickl, Winfried F./0000-0003-0430-4952; Pinos, Jakub/0000-0001-6993-8660; Lucas, Fabienne/0000-0002-4388-0349; Willmann, Katharina/0000-0002-7714-5801; Sixt, Michael/0000-0002-6620-9179; Mace, Emily/0000-0003-0226-7393; Zlabinger, Gerhard/0000-0002-7478-4173; Bennett, Keiryn L./0000-0001-9356-7708; orange, jordan/0000-0001-7117-7725; Salzer, Elisabeth/0000-0002-8118-4934	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant [310857]; Vienna Science and Technology Fund (WWTF) [LS14-031]; Celgene Austria; National Institutes of Health [R01AI067946]; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [M1809-B19]; French Agence Nationale de la Recherche [ANR-13-BSV1-0031]; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [M 1809] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant(European Research Council (ERC)); Vienna Science and Technology Fund (WWTF); Celgene Austria(Bristol-Myers SquibbCelgene Corporation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the patient and his family for participating in this study; B. Fleckenstein and M. Schmidt for generating and providing patient-derived T cell lines; and G. Superti-Furga, J. Bigenzahn for providing the inducible protein expression system used for Jurkat T cells and together with N. Serwas, C.D. Conde, A. Kalinichenko, K. Ackerman and R. Martins for critically reviewing the manuscript and providing comments. The research leading to these results was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement 310857 (K.B.), the Vienna Science and Technology Fund (WWTF) through project LS14-031 (J.B.H. and K.B.), an unrestricted research grant from Celgene Austria (U.J.), the National Institutes of Health (R01AI067946 to J.S.O.), Boehringer Ingelheim Fonds (R.P.), the Austrian Science Fund (FWF): Project M1809-B19 (K.L.W.), and the French Agence Nationale de la Recherche (ANR-13-BSV1-0031 to L.D.).	Bartlett A, 2013, J IMMUNOL, V191, P3605, DOI 10.4049/jimmunol.1202892; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Chen Y, 2012, J IMMUNOL, V189, P61, DOI 10.4049/jimmunol.1103272; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Depeille P, 2015, NAT CELL BIOL, V17, P804, DOI 10.1038/ncb3175; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Espinos C, 2009, J MED GENET, V46, P407, DOI 10.1136/jmg.2008.060632; Fuller DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038796; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Huse M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00235; Jayappa KD, 2015, J VIROL, V89, P3497, DOI 10.1128/JVI.03347-14; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Khanna R, 2011, IMMUNOL CELL BIOL, V89, P330, DOI 10.1038/icb.2010.173; Kremer KN, 2011, J IMMUNOL, V187, P3177, DOI 10.4049/jimmunol.1100206; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; LIU Y., 2007, FRONTIERS EARTH SCI, V1, P1; Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55; McGhee SA, 2010, DIS MARKERS, V29, P151, DOI [10.1155/2010/397291, 10.3233/DMA-2010-0740]; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Navarro MN, 2014, NAT IMMUNOL, V15, P808, DOI 10.1038/ni.2941; Notarangelo LD, 2013, J ALLERGY CLIN IMMUN, V131, P1297, DOI 10.1016/j.jaci.2013.01.020; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Okamura SM, 2006, J BIOL CHEM, V281, P36132, DOI 10.1074/jbc.M605093200; Perussia B, 2005, MOL IMMUNOL, V42, P385, DOI 10.1016/j.molimm.2004.07.017; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Ramsay AG, 2013, BLOOD, V121, P2704, DOI 10.1182/blood-2012-08-448332; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Shen SD, 2011, J IMMUNOL, V187, P4467, DOI 10.4049/jimmunol.1003798; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Tangye SG, 2002, MIAN YI XUE ZA ZHI, V169, P4298; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Warnecke N, 2012, EMBO REP, V13, P386, DOI 10.1038/embor.2012.17; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zenz T, 2013, BLOOD, V121, P1485, DOI 10.1182/blood-2013-01-475939	49	77	79	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1352	1360		10.1038/ni.3575	http://dx.doi.org/10.1038/ni.3575			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27776107	Green Accepted			2022-12-18	WOS:000388056400005
J	Munoz-Ruiz, M; Ribot, JC; Grosso, AR; Goncalves-Sousa, N; Pamplona, A; Pennington, DJ; Regueiro, JR; Fernandez-Malave, E; Silva-Santos, B				Munoz-Ruiz, Miguel; Ribot, Julie C.; Grosso, Ana R.; Goncalves-Sousa, Natacha; Pamplona, Ana; Pennington, Daniel J.; Regueiro, Jose R.; Fernandez-Malave, Edgar; Silva-Santos, Bruno			TCR signal strength controls thymic differentiation of discrete proinflammatory gamma delta T cell subsets	NATURE IMMUNOLOGY			English	Article							ALPHA-BETA; IFN-GAMMA; INTERFERON-GAMMA; PIVOTAL ROLE; NK CELLS; RECEPTOR; LINEAGE; EXPRESSION; CD3-GAMMA; INFLAMMATION	The mouse thymus produces discrete gamma delta T cell subsets that make either interferon-gamma (IFN-gamma) or interleukin 17 (IL-17), but the role of the T cell antigen receptor (TCR) in this developmental process remains controversial. Here we show that Cd3g(+/-) Cd3d(+/-) (CD3 double-haploinsufficient (CD3DH)) mice have reduced TCR expression and signaling strength on gamma delta T cells. CD3DH mice had normal numbers and phenotypes of alpha beta thymocyte subsets, but impaired differentiation of fetal V gamma 6(+) (but not V gamma 4(+)) IL-17-producing gamma delta T cells and a marked depletion of IFN-gamma-producing CD122(+) NK1.1(+) gamma delta T cells throughout ontogeny. Adult CD3DH mice showed reduced peripheral IFN-gamma(+) gamma delta T cells and were resistant to experimental cerebral malaria. Thus, TCR signal strength within specific thymic developmental windows is a major determinant of the generation of proinflammatory gamma delta T cell subsets and their impact on pathophysiology.	[Munoz-Ruiz, Miguel; Regueiro, Jose R.; Fernandez-Malave, Edgar] Univ Complutense, Sch Med, Dept Immunol, E-28040 Madrid, Spain; [Munoz-Ruiz, Miguel; Ribot, Julie C.; Grosso, Ana R.; Goncalves-Sousa, Natacha; Pamplona, Ana; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Pennington, Daniel J.] Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, London, England	Complutense University of Madrid; Universidade de Lisboa; University of London; Queen Mary University London	Fernandez-Malave, E (corresponding author), Univ Complutense, Sch Med, Dept Immunol, E-28040 Madrid, Spain.; Silva-Santos, B (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	edfernan@med.ucm.es; bssantos@medicina.ulisboa.pt	Muñoz-Ruiz, Miguel/AAC-3549-2021; Pamplona, Ana/J-4465-2013; Pamplona, Ana/U-2126-2019; Regueiro, José R./B-5499-2014; Grosso, Ana Rita/I-6656-2013; Ribot, Julie/D-5487-2014	Muñoz-Ruiz, Miguel/0000-0001-7986-3527; Pamplona, Ana/0000-0001-5338-2768; Regueiro, José R./0000-0001-8442-7762; Grosso, Ana Rita/0000-0001-6974-4209; Ribot, Julie/0000-0002-7852-343X; Goncalves Sousa, Natacha/0000-0001-5190-1122; Silva-Santos, Bruno/0000-0003-4141-9302; Pennington, Daniel/0000-0001-7889-9923	European Research Council [StG_260352, CoG_646701]; MINECO [SAF2011-24235, BES-2012-055054, SAF2014-54708-R]; CAM [S2010/ BMD-2316/2326]; Lair Foundation [2012/0070]; FIS [PI11/02198]; National Institute on Minority Health and Health Disparities [P20MD002316] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); CAM; Lair Foundation; FIS(Instituto de Salud Carlos III); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank K. Serre, J. Martins, N. Schmolka, A. Amorim, V.Z. Luis and M.M. Mota (all at iMM Lisboa); and B. Garcillan, D. de Juan, M. Mazariegos, M. Sanz-Rodriguez and S. Diaz-Castroverde (Complutense University) for help and advice; A. Hayday (King's College London) and P. Pereira (Pasteur Institute) for insightful discussions; and the staff of the animal and flow cytometry facilities at iMM Lisboa and Complutense University for technical assistance. This work was funded by the European Research Council (StG_260352 and CoG_646701 to B.S.-S.); MINECO (SAF2011-24235 and BES-2012-055054 to J.R.R.), CAM (S2010/ BMD-2316/2326 to J.R.R.) and the Lair Foundation (2012/0070 to J.R.R.); and FIS PI11/02198 and MINECO SAF2014-54708-R to E.F.-M.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Coffey F, 2014, J EXP MED, V211, P329, DOI 10.1084/jem.20131540; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Fernandez-Malave E, 2006, BLOOD, V108, P3420, DOI 10.1182/blood-2006-03-010850; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gu XG, 2003, J IMMUNOL, V170, P4095, DOI 10.4049/jimmunol.170.8.4095; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Hayes SM, 2002, J EXP MED, V196, P1355, DOI 10.1084/jem.20021196; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; R Development Core Team, 2011, R LANG ENV STAT COMP; Rei M, 2014, P NATL ACAD SCI USA, V111, pE3562, DOI 10.1073/pnas.1403424111; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schmolka N, 2015, SEMIN IMMUNOL, V27, P19, DOI 10.1016/j.smim.2015.01.001; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Siegers GM, 2007, J EXP MED, V204, P2537, DOI 10.1084/jem.20070782; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Zapata DA, 1999, J BIOL CHEM, V274, P35119, DOI 10.1074/jbc.274.49.35119	53	77	78	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					721	+		10.1038/ni.3424	http://dx.doi.org/10.1038/ni.3424			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27043412	Green Accepted			2022-12-18	WOS:000376162200017
J	Deng, ZH; Ma, SX; Zhou, H; Zang, AP; Fang, YY; Li, TT; Shi, HJ; Liu, M; Du, M; Taylor, PR; Zhu, HH; Chen, JY; Meng, GX; Li, FB; Chen, CB; Zhang, Y; Jia, XM; Lin, X; Zhang, XM; Pearlman, E; Li, XX; Feng, GS; Xiao, H				Deng, Zihou; Ma, Shixin; Zhou, Hao; Zang, Aiping; Fang, Yiyuan; Li, Tiantian; Shi, Huanjing; Liu, Mei; Du, Min; Taylor, Patricia R.; Zhu, Helen He; Chen, Jiangye; Meng, Guangxun; Li, Fubin; Chen, Changbin; Zhang, Yan; Jia, Xin-Ming; Lin, Xin; Zhang, Xiaoming; Pearlman, Eric; Li, Xiaoxia; Feng, Gen-Sheng; Xiao, Hui			Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal T(H)17 responses	NATURE IMMUNOLOGY			English	Article							PATTERN-RECOGNITION RECEPTOR; DENDRITIC CELLS; FUNGAL-INFECTIONS; CANDIDA-ALBICANS; IMMUNE-RESPONSES; INNATE IMMUNITY; HOST-DEFENSE; DECTIN-1; INDUCTION; PATHWAY	Fungal infection stimulates the canonical C-type lectin receptor (CLR) signaling pathway via activation of the tyrosine kinase Syk. Here we identify a crucial role for the tyrosine phosphatase SHP-2 in mediating CLR-induced activation of Syk. Ablation of the gene encoding SHP-2 (Ptpn11; called 'Shp-2' here) in dendritic cells (DCs) and macrophages impaired Syk-mediated signaling and abrogated the expression of genes encoding pro-inflammatory molecules following fungal stimulation. Mechanistically, SHP-2 operated as a scaffold, facilitating the recruitment of Syk to the CLR dectin-1 or the adaptor FcR gamma, through its N-SH2 domain and a previously unrecognized carboxy-terminal immunoreceptor tyrosine-based activation motif (ITAM). We found that DC-derived SHP-2 was crucial for the induction of interleukin 1 beta (IL-1 beta), IL-6 and IL-23 and anti-fungal responses of the T(H)17 subset of helper T cells in controlling infection with Candida albicans. Together our data reveal a mechanism by which SHP-2 mediates the activation of Syk in response to fungal infection.	[Deng, Zihou; Ma, Shixin; Zang, Aiping; Fang, Yiyuan; Li, Tiantian; Shi, Huanjing; Liu, Mei; Du, Min; Meng, Guangxun; Chen, Changbin; Zhang, Yan; Zhang, Xiaoming; Xiao, Hui] Chinese Acad Sci, Vaccine Ctr, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Ma, Shixin; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Taylor, Patricia R.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Zhu, Helen He] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Renji Med X Clin Stem Cell Res Ctr,State Key Lab, Shanghai 200030, Peoples R China; [Chen, Jiangye] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Li, Fubin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Li, Fubin] Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, Shanghai 200030, Peoples R China; [Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China; [Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Cleveland Clinic Foundation; Case Western Reserve University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Xiao, H (corresponding author), Chinese Acad Sci, Vaccine Ctr, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	huixiao@ips.ac.cn		Xiao, Hui/0000-0001-5304-243X	National Science and Technology Major Projects [2014CB541902, 81270627]; National Natural Science Foundation of China [31070779, 31170862, 31270917, 31100623]; US National Institutes of Health [R01HL096125, P01 HL103453, R01EY018612]; Chinese Academy of Sciences; National Program for Returned Overseas Talents; Science and Technology Commission of Shanghai Municipality [12PJ1406100]; NATIONAL EYE INSTITUTE [R01EY018612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL103453, R01HL129763, R01HL096125] Funding Source: NIH RePORTER	National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); National Program for Returned Overseas Talents(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J.V. Ravetch (The Rockefeller University) for FcR gamma-deficient mice; Y. Iwakura (The University of Tokyo) for dectin-1-deficient mice; S. Yamasaki (Kyushu University) for Mincle-deficient mice; B. Qian for technical assistance in histology; and Y. Xu and J. Yan for technical assistance in confocal microscopy. Support by National Science and Technology Major Projects (2014CB541902 to H.X.; and 81270627 to H.H.Z.), the National Natural Science Foundation of China (31070779 and 31170862 to H.X.; 31270917 to M.D.; and 31100623 to A.Z.), the US National Institutes of Health (R01HL096125 to G.-S.F.; P01 HL103453 to X. Li; and R01EY018612 to E.P.), the Chinese Academy of Sciences "100-talent" program (H. X.), the National Program for Returned Overseas Talents (H. X.) and the Science and Technology Commission of Shanghai Municipality (Pujiang program 12PJ1406100 for H.H.Z.).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2012, CELL HOST MICROBE, V11, P422, DOI 10.1016/j.chom.2012.04.010; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gorjestani S, 2012, J BIOL CHEM, V287, P44143, DOI 10.1074/jbc.M112.414276; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Lefevre L, 2013, IMMUNITY, V38, P1038, DOI 10.1016/j.immuni.2013.04.010; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2012, CURR OPIN IMMUNOL, V24, P449, DOI 10.1016/j.coi.2012.04.007; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li XJ, 2015, J BIOL CHEM, V290, P3894, DOI 10.1074/jbc.M114.614057; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Roy RM, 2012, CELL HOST MICROBE, V11, P436, DOI 10.1016/j.chom.2012.04.005; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wevers BA, 2013, FUTURE MICROBIOL, V8, P839, DOI 10.2217/fmb.13.56; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Wuthrich M, 2003, J EXP MED, V197, P1405, DOI 10.1084/jem.20030109; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	50	77	86	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					642	+		10.1038/ni.3155	http://dx.doi.org/10.1038/ni.3155			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25915733	Green Submitted, Green Accepted			2022-12-18	WOS:000354751900017
J	Lee, MN; Roy, M; Ong, SE; Mertins, P; Villani, AC; Li, WB; Dotiwala, F; Sen, J; Doench, JG; Orzalli, MH; Kramnik, I; Knipe, DM; Lieberman, J; Carr, SA; Hacohen, N				Lee, Mark N.; Roy, Matthew; Ong, Shao-En; Mertins, Philipp; Villani, Alexandra-Chloe; Li, Weibo; Dotiwala, Farokh; Sen, Jayita; Doench, John G.; Orzalli, Megan H.; Kramnik, Igor; Knipe, David M.; Lieberman, Judy; Carr, Steven A.; Hacohen, Nir			Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach	NATURE IMMUNOLOGY			English	Article							AICARDI-GOUTIERES-SYNDROME; EXONUCLEASE TREX1; RIG-I; MUTATIONS; RECOGNITION; PHOSPHATASE; INHIBITION; ACTIVATION; INITIATION; SAMHD1	The innate immune system senses viral DNA that enters mammalian cells, or in aberrant situations self-DNA, and triggers type I interferon production. Here we present an integrative approach that combines quantitative proteomics, genomics and small molecule perturbations to identify genes involved in this pathway. We silenced 809 candidate genes, measured the response to dsDNA and connected resulting hits with the known signaling network. We identified ABCF1 as a critical protein that associates with dsDNA and the DNA-sensing components HMGB2 and IFI204. We also found that CDC37 regulates the stability of the signaling molecule TBK1 and that chemical inhibition of the CDC37-HSP90 interaction and several other pathway regulators potently modulates the innate immune response to DNA and retroviral infection.	[Lee, Mark N.; Roy, Matthew; Ong, Shao-En; Mertins, Philipp; Villani, Alexandra-Chloe; Li, Weibo; Doench, John G.; Carr, Steven A.; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lee, Mark N.; Roy, Matthew; Li, Weibo; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Lee, Mark N.; Roy, Matthew; Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dotiwala, Farokh; Lieberman, Judy] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Dotiwala, Farokh; Lieberman, Judy] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Dotiwala, Farokh; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Sen, Jayita; Orzalli, Megan H.; Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Kramnik, Igor] Boston Univ, Sch Med, Dept Med, Natl Emerging Infect Dis Lab,Pulm Ctr, Boston, MA 02118 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	nhacohen@partners.org	Lieberman, Judy/A-2717-2015; Carr, Steven A./AAH-8366-2019; Dotiwala, Farokh/S-5367-2019; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Dotiwala, Farokh/0000-0002-7387-2219; Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Kramnik, Igor/0000-0001-6511-9246; Lee, Mark/0000-0002-9576-9589; Orzalli, Megan/0000-0003-2177-1587	US National Human Genome Research Institute [HG005062]; US National Institutes of Health [DP2OD002230]; National Institutes of Health; GlaxoSmithKline Immune Disease Institute; National Institute of Allergy and Infectious Diseases [AI102816]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG005062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline Immune Disease Institute; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Y.J. Crow for AGS patient fibroblasts and control cells; T. Lindahl for Trex1<SUP>-/-</SUP> MEFs and wild-type control MEFs; D. Sabatini and D. Kwiatkowski for p53<SUP>-/-</SUP> MEFs; N.A. DeLuca for HSV-1 d109 virus; C. Shamu (Institute of Chemistry and Cell Biology at Harvard Medical School) for the siRNA library and expert advice; The RNAi Consortium at the Broad Institute for assistance with siRNA screening; J. Qiao for assistance with mass spectrometry; M. Rooney and C. Ye for advice about statistical analyses; D. Londono for help with microscopy; J. Kagan, N. Haining, L. Glimcher and M. Brenner for valuable discussions; and W.F. Pendergraft III and other members of the Hacohen laboratory for critical review of the manuscript. This work was supported by the US National Human Genome Research Institute grant HG005062 and US National Institutes of Health Director's New Innovator award DP2OD002230 (N.H.). M.N.L. is supported by a National Institutes of Health Medical Scientist Training Program fellowship; F.D. by a GlaxoSmithKline Immune Disease Institute fellowship; and J.L. by National Institute of Allergy and Infectious Diseases grant AI102816.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; ROTEM Z, 1963, NATURE, V197, P564, DOI 10.1038/197564a0; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Shimp SK, 2012, INFLAMM RES, V61, P521, DOI 10.1007/s00011-012-0442-x; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Yan N, 2011, P NATL ACAD SCI USA, V108, P9244, DOI 10.1073/pnas.1102943108; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	40	77	78	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					179	185		10.1038/ni.2509	http://dx.doi.org/10.1038/ni.2509			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23263557	Green Accepted			2022-12-18	WOS:000313918400013
J	Kohn, LA; Hao, QL; Sasidharan, R; Parekh, C; Ge, SD; Zhu, YH; Mikkola, HKA; Crooks, GM				Kohn, Lisa A.; Hao, Qian-Lin; Sasidharan, Rajkumar; Parekh, Chintan; Ge, Shundi; Zhu, Yuhua; Mikkola, Hanna K. A.; Crooks, Gay M.			Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; UMBILICAL-CORD BLOOD; MEASURED IN-VITRO; LINEAGE COMMITMENT; DENDRITIC CELLS; NATURAL-KILLER; PROGENITOR; ADULT; IDENTIFICATION; FETAL	Expression of the cell-surface antigen CD10 has long been used to define the lymphoid commitment of human cells. Here we report a unique lymphoid-primed population in human bone marrow that was generated from hematopoietic stem cells (HSCs) before onset of the expression of CD10 and commitment to the B cell lineage. We identified this subset by high expression of the homing molecule L-selectin (CD62L). CD10-CD62L(hi) progenitors had full lymphoid and monocytic potential but lacked erythroid potential. Gene-expression profiling placed the CD10-CD62L(hi) population at an intermediate stage of differentiation between HSCs and lineage-negative (Lin(-)) CD34(+)CD10(+) progenitors. CD62L was expressed on immature thymocytes, and its ligands were expressed at the cortico-medullary junction of the thymus, which suggested a possible role for this molecule in homing to the thymus. Our studies identify the earliest stage of lymphoid priming in human bone marrow.	[Kohn, Lisa A.; Ge, Shundi; Zhu, Yuhua; Crooks, Gay M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Hao, Qian-Lin] Childrens Hosp Los Angeles, Div Res Immunol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA; [Sasidharan, Rajkumar; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Parekh, Chintan; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.; Crooks, Gay M.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Crooks, GM (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA.	gcrooks@mednet.ucla.edu			US National Institutes of Health [P01 HL073104, RO1 HL077912]; California Institute of Regenerative Medicine [RC1-00108, RM1-01717, RN1-00557-1]; Flow Cytometry Core of the Broad Stem Cell Research Center of the University of California, Los Angeles; Jonsson Comprehensive Cancer Center Genomics Shared Resource of the University of California, Los Angeles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077912, P01HL073104, F30HL110458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Flow Cytometry Core of the Broad Stem Cell Research Center of the University of California, Los Angeles; Jonsson Comprehensive Cancer Center Genomics Shared Resource of the University of California, Los Angeles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Scholes, F. Codrea, X. Li and S. Dandekar for technical assistance; and D. Kohn, G. Dravid, S. Sandoval and M. Corselli for advice on the manuscript. Supported by the US National Institutes of Health (P01 HL073104 and RO1 HL077912), the California Institute of Regenerative Medicine (RC1-00108 and RM1-01717 to G.M.C.; and RN1-00557-1 to H.K.A.M.), Flow Cytometry Core of the Broad Stem Cell Research Center of the University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center Genomics Shared Resource of the University of California, Los Angeles.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arakawa-Hoyt J, 1999, BONE MARROW TRANSPL, V24, P1167, DOI 10.1038/sj.bmt.1702048; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BIASSONI R, 1988, J IMMUNOL, V140, P1685; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Cho S, 2011, J IMMUNOL, V187, P5203, DOI 10.4049/jimmunol.1102119; De Smedt M, 2011, HAEMATOL-HEMATOL J, V96, P646, DOI 10.3324/haematol.2010.036343; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Ichii M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012954; Kim DK, 1999, STEM CELLS, V17, P286, DOI 10.1002/stem.170286; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; LANIER LL, 1992, J IMMUNOL, V149, P1876; Leavy O, 2011, NAT REV IMMUNOL, V11, P78, DOI 10.1038/nri2923; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Perry SS, 2006, J IMMUNOL, V177, P2880, DOI 10.4049/jimmunol.177.5.2880; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Storms RW, 2000, BLOOD, V96, P2125; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	40	77	79	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					963	971		10.1038/ni.2405	http://dx.doi.org/10.1038/ni.2405			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22941246	Green Accepted			2022-12-18	WOS:000309038600012
J	Anders, AK; Call, MJ; Schulze, MSED; Fowler, KD; Schubert, DA; Seth, NP; Sundberg, EJ; Wucherpfennig, KW				Anders, Anne-Kathrin; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Fowler, Kevin D.; Schubert, David A.; Seth, Nilufer P.; Sundberg, Eric J.; Wucherpfennig, Kai W.			HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide	NATURE IMMUNOLOGY			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; RESTRICTED ANTIGEN PRESENTATION; INVARIANT-CHAIN; CUTTING EDGE; HYDROGEN-BONDS; KINETIC STABILITY; CRYSTAL-STRUCTURE; IN-VIVO; HLA-DR1	The mechanisms of HLA-DM-catalyzed peptide exchange remain uncertain. Here we found that all stages of the interaction of HLA-DM with HLA-DR were dependent on the occupancy state of the peptide-binding groove. High-affinity peptides were protected from removal by HLA-DM through two mechanisms: peptide binding induced the dissociation of a long-lived complex of empty HLA-DR and HLA-DM, and high-affinity HLA-DR-peptide complexes bound HLA-DM only very slowly. Nonbinding covalent HLA-DR-peptide complexes were converted into efficient HLA-DM binders after truncation of an N-terminal peptide segment that emptied the P1 pocket and disrupted conserved hydrogen bonds to HLA-DR. HLA-DM thus binds only to HLA-DR conformers in which a critical part of the binding site is already vacant because of spontaneous peptide motion.	[Anders, Anne-Kathrin; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Schubert, David A.; Seth, Nilufer P.; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; [Anders, Anne-Kathrin; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA; [Schulze, Monika-Sarah E. D.] Free Univ Berlin, Fachbereich Biol, D-1000 Berlin, Germany; [Fowler, Kevin D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Sundberg, Eric J.] Boston Biomed Res Inst, Watertown, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Free University of Berlin; Massachusetts Institute of Technology (MIT); Boston Biomedical Research Institute	Wucherpfennig, KW (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu		Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [R01 AI057493, NS044914]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI057493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Chakraborty for discussions; H. Ploegh and G. Grotenbreg (Massachusetts Institute of Technology) for the photolabile peptide; J. Fraser (University of Auckland) for human rhinovirus 3C protease; and J. Pyrdol for help with the purification of HLA-DR-peptide complexes. Supported by the National Institutes of Health (R01 AI057493 and NS044914 to K. W. W.) and the Cancer Research Institute (Irvington Institute Fellowship Program, D.A.S.).	Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; JENSEN PE, 1992, J EXP MED, V176, P793, DOI 10.1084/jem.176.3.793; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pathak SS, 2001, J IMMUNOL, V167, P632, DOI 10.4049/jimmunol.167.2.632; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	49	77	78	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					54	U76		10.1038/ni.1967	http://dx.doi.org/10.1038/ni.1967			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21131964	Green Accepted			2022-12-18	WOS:000285465100013
J	Sakaguchi, S; Hombauer, M; Bilic, I; Naoe, Y; Schebesta, A; Taniuchi, I; Ellmeier, W				Sakaguchi, Shinya; Hombauer, Matthias; Bilic, Ivan; Naoe, Yoshinori; Schebesta, Alexandra; Taniuchi, Ichiro; Ellmeier, Wilfried			The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; GENE-EXPRESSION; REGULATORY ELEMENTS; SILENCER ELEMENT; RUNX PROTEINS; DIFFERENTIATION; COMMITMENT; THPOK; REPRESSION; DELETION	The CD4 versus CD8 lineage specification of thymocytes is linked to coreceptor expression. The transcription factor MAZR has been identified as an important regulator of Cd8 expression. Here we show that variegated CD8 expression by loss of Cd8 enhancers was reverted in MAZR-deficient mice, which confirms that MAZR negatively regulates the Cd8 loci during the transition to the double-positive (DP) stage. Moreover, loss of MAZR led to partial redirection of major histocompatibility complex (MHC) class I-restricted thymocytes into CD4(+) helper-like T cells, which correlated with derepression of Th-POK, a central transcription factor for helper-lineage development. MAZR bound the silencer of the gene encoding Th-POK, which indicated direct regulation of this locus by MAZR. Thus, MAZR is part of the transcription factor network that regulates the CD8 lineage differentiation of DP thymocytes.	[Sakaguchi, Shinya; Hombauer, Matthias; Bilic, Ivan; Schebesta, Alexandra; Ellmeier, Wilfried] Med Univ Vienna, Div Immunobiol, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Naoe, Yoshinori; Taniuchi, Ichiro] RIKEN, Lab Transcript Regulat, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan	Medical University of Vienna; RIKEN	Ellmeier, W (corresponding author), Med Univ Vienna, Div Immunobiol, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Sakaguchi, Shinya/0000-0002-0591-2469; Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund [P16708, P19930]; Austrian Ministry of Science and Research [Y-163]; Ernst Schering Foundation	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Ernst Schering Foundation	We thank M. Sibilia (Medical University of Vienna) for OT-I TCR-transgenic mice; D. Stoiber-Sakaguchi (Medical University of Vienna) for OT-II TCR-transgenic mice; W. Held (Glaxo) for recombinant human interleukin 2; J. Kaye for information about primer sequences that detect Tox expression; M. Willheim and G. Hofbauer for cell sorting; H. Tanaka for technical advice; E. Pfeiffer for help with irradiation; M. Busslinger for help with some animal experiments; D. Stoiber-Sakaguchi, J. Raberger and N. Boucheron for critical reading of the manuscript; and the National Institutes of Health Tetramer facility for CD1d reagents with and without PBS57. Supported by the Austrian Science Fund (P16708 and P19930), the START Program of the Austrian Ministry of Science and Research (project Y-163), the RIKEN Research Center for Allergy and Immunology (International Collaboration Program) and the Ernst Schering Foundation (M. H.).	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Egawa T, 2009, J CELL BIOCHEM, V107, P1037, DOI 10.1002/jcb.22212; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Jepsen K, 2002, J CELL SCI, V115, P689; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kobayashi A, 2000, MOL CELL BIOL, V20, P1733, DOI 10.1128/MCB.20.5.1733-1746.2000; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2009, CURR OPIN IMMUNOL, V21, P127, DOI 10.1016/j.coi.2009.03.012; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	36	77	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					442	U106		10.1038/ni.1860	http://dx.doi.org/10.1038/ni.1860			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20383150	Green Accepted			2022-12-18	WOS:000276852200014
J	Mingueneau, M; Sansoni, A; Gregoire, C; Roncagalli, R; Aguado, E; Weiss, A; Malissen, M; Malissen, B				Mingueneau, Michaeel; Sansoni, Amandine; Gregoire, Claude; Roncagalli, Romain; Aguado, Enrique; Weiss, Arthur; Malissen, Marie; Malissen, Bernard			The proline-rich sequence of CD3 epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4(+) CD8(+) thymocytes	NATURE IMMUNOLOGY			English	Article							INDUCED CONFORMATIONAL-CHANGE; REGULATES TCR EXPRESSION; MICE LACKING; TYROSINE PHOSPHORYLATION; THYMIC SELECTION; CD4+CD8+ CELLS; COMPLEX; ALPHA; DIFFERENTIATION; SENSITIVITY	Antigen recognition by T cell antigen receptors (TCRs) is thought to `unmask' a proline-rich sequence (PRS) present in the CD3 epsilon cytosolic segment, which allows it to trigger T cell activation. Using `knock-in' mice with deletion of the PRS, we demonstrate here that elimination of the CD3e PRS had no effect on mature T cell responsiveness. In contrast, in preselection CD4(+)CD8(+) thymocytes, the CD3 epsilon PRS acted together with the adaptor protein SLAP to promote CD3 zeta degradation, thereby contributing to downregulation of TCR expression on the cell surface. In addition, analysis of CD4(+)CD8(+) thymocytes of TCR-transgenic mice showed that the CD3 epsilon PRS enhanced TCR sensitivity to weak ligands. Our results identify previously unknown functions for the evolutionarily conserved CD3 epsilon PRS at the CD4(+)CD8(+) developmental stage and suggest a rather limited function in mature T cells.	[Mingueneau, Michaeel; Sansoni, Amandine; Gregoire, Claude; Roncagalli, Romain; Aguado, Enrique; Malissen, Marie; Malissen, Bernard] Univ Aix Marseille 2, CNRS UMR 6102, INSERM U631, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Malissen, B (corresponding author), Univ Aix Marseille 2, CNRS UMR 6102, INSERM U631, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.	bernardm@ciml.univ-mrs.fr	Aguado, Enrique/L-4908-2014; Mingueneau, Michael/O-5313-2019; Roncagalli, Romain/ABB-8786-2020; Malissen, Bernard/AAK-4659-2020	Aguado, Enrique/0000-0002-7232-2661; Mingueneau, Michael/0000-0002-3873-7329; Roncagalli, Romain/0000-0001-7554-0552; Malissen, Bernard/0000-0003-1340-9342; Malissen, Marie/0000-0003-2331-1445				Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; BONIFACINO JS, 1990, NATURE, V344, P247, DOI 10.1038/344247a0; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Dave VP, 1999, J IMMUNOL, V162, P5764; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davodeau F, 2001, EMBO J, V20, P4717, DOI 10.1093/emboj/20.17.4717; Eck SC, 2006, J IMMUNOL, V176, P2229, DOI 10.4049/jimmunol.176.4.2229; ERICSSON PO, 1995, INT IMMUNOL, V7, P617, DOI 10.1093/intimm/7.4.617; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Laurent J, 2004, INT IMMUNOL, V16, P1069, DOI 10.1093/intimm/dxh108; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Norment AM, 1997, J EXP MED, V185, P121, DOI 10.1084/jem.185.1.121; Riberdy JM, 1998, P NATL ACAD SCI USA, V95, P4493, DOI 10.1073/pnas.95.8.4493; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Risueno RM, 2006, P NATL ACAD SCI USA, V103, P9625, DOI 10.1073/pnas.0601785103; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; WATANABE Y, 1992, CELL IMMUNOL, V142, P385, DOI 10.1016/0008-8749(92)90299-5; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	48	77	80	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					522	532		10.1038/ni.1608	http://dx.doi.org/10.1038/ni.1608			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18408722				2022-12-18	WOS:000255153500014
J	Rowland-Jones, SL; Whittle, HC				Rowland-Jones, Sarah L.; Whittle, Hilton C.			Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-2; T-CELL RESPONSES; GUINEA-BISSAU; LEVEL VIREMIA; VIRAL LOAD; INFECTION; ACTIVATION; VILLAGERS; MORTALITY; SURVIVAL	Most people infected with human immunodeficiency virus 2 ( HIV-2) do not progress to disease, even though the minority who do cannot be distinguished clinically from HIV-1-infected patients. Here we review what is known about the basis of viral control in HIV-2 infection.				srowland-jones@mrc.gm			MRC [MC_U137884180] Funding Source: UKRI; Medical Research Council [MC_U137884180] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berry N, 2002, AIDS RES HUM RETROV, V18, P1167, DOI 10.1089/08892220260387904; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; DARBY SC, 1995, NATURE, V377, P79, DOI 10.1038/377079a0; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gillespie GMA, 2005, EUR J IMMUNOL, V35, P1445, DOI 10.1002/eji.200526007; Grassly NC, 1998, J VIROL, V72, P7895, DOI 10.1128/JVI.72.10.7895-7899.1998; Jaffar S, 2005, AIDS RES HUM RETROV, V21, P560, DOI 10.1089/aid.2005.21.560; Jaye A, 2004, J INFECT DIS, V189, P498, DOI 10.1086/381185; Lopes AR, 2003, J IMMUNOL, V171, P307, DOI 10.4049/jimmunol.171.1.307; Martinez-Steele E, 2007, AIDS, V21, P317, DOI 10.1097/QAD.0b013e328011d7ab; Nuvor SV, 2006, J VIROL, V80, P2529, DOI 10.1128/JVI.80.5.2529-2538.2006; Ota MOC, 2000, AIDS, V14, P435, DOI 10.1097/00002030-200003100-00018; Popper SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000; Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9; Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; van der Loeff MFS, 2001, AIDS, V15, P2303, DOI 10.1097/00002030-200111230-00012; WEISS RA, 1988, AIDS, V2, P95, DOI 10.1097/00002030-198804000-00004; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zheng NN, 2004, J VIROL, V78, P13934, DOI 10.1128/JVI.78.24.13934-13942.2004	28	77	78	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					329	331		10.1038/ni0407-329	http://dx.doi.org/10.1038/ni0407-329			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375091				2022-12-18	WOS:000245075900004
J	Iversen, AKN; Stewart-Jones, G; Learn, GH; Christie, N; Sylvester-Hviid, C; Armitage, AE; Kaul, R; Beattie, T; Lee, JK; Li, YP; Chotiyarnwong, P; Dong, T; Xu, XN; Luscher, MA; MacDonald, K; Ullum, H; Klarlund-Pedersen, B; Skinhoj, P; Fugger, L; Buus, S; Mullins, JI; Jones, EY; van der Merwe, PA; McMichael, AJ				Iversen, AKN; Stewart-Jones, G; Learn, GH; Christie, N; Sylvester-Hviid, C; Armitage, AE; Kaul, R; Beattie, T; Lee, JK; Li, YP; Chotiyarnwong, P; Dong, T; Xu, XN; Luscher, MA; MacDonald, K; Ullum, H; Klarlund-Pedersen, B; Skinhoj, P; Fugger, L; Buus, S; Mullins, JI; Jones, EY; van der Merwe, PA; McMichael, AJ			Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope	NATURE IMMUNOLOGY			English	Article							CTL ESCAPE; LYMPHOCYTE RESPONSES; MAXIMUM-LIKELIHOOD; HIV-INFECTION; CD8-T-CELL MEMORY; POPULATION-LEVEL; CD4-T-CELL HELP; TCR BINDING; TYPE-1; PEPTIDE	Cytotoxic T lymphocytes (CTLs) are critical for the control of human immunodeficiency virus, but containment of virus replication can be undermined by mutations in CTL epitopes that lead to virus escape. We analyzed the evolution in vivo of an immunodominant, HLA-A2-restricted CTL epitope and found two principal, diametrically opposed evolutionary pathways that exclusively affect T cell-receptor contact residues. One pathway was characterized by acquisition of CTL escape mutations and the other by selection for wild-type amino acids. The pattern of CTL responses to epitope variants shaped which variant(s) prevailed in the virus population. The pathways notably influenced the amount of plasma virus, as patients with efficient CTL selection had lower plasma viral loads than did patients without efficient selection. Thus, viral escape from CTL responses does not necessarily correlate with disease progression.	Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9AD, England; Wellcome Trust Ctr Human Genet, Struct Biol Grp, Oxford, England; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Toronto, Dept Med, Div Clin Sci, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON M5G 1X5, Canada; Univ Copenhagen, Dept Microbiol & Immunol, DK-2200 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Clin Immunol, DK-8200 Aarhus N, Denmark; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University of Copenhagen; Aarhus University; University of Oxford	Iversen, AKN (corresponding author), Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9AD, England.	aiversen@hammer.imm.ox.ac.uk	MacDonald, Kelly S/L-3315-2019; Jones, Yvonne/J-2293-2016; Buus, Soren/F-5446-2010; Pedersen, Bente Klarlund/AGR-3217-2022; Stewart-Jones, Guillaume/E-7013-2013; Jones, Yvonne/N-8111-2019; chotiyarnwong, pojchong/AAC-8700-2021; Learn, Gerald H/B-6934-2011; Learn, Jerry/E-3356-2012; van der Merwe, P. Anton/F-8539-2011	Jones, Yvonne/0000-0002-3834-1893; Pedersen, Bente Klarlund/0000-0001-6508-6288; Jones, Yvonne/0000-0002-3834-1893; Learn, Gerald H/0000-0003-0434-7733; Ullum, Henrik/0000-0001-7306-9058; Buus, Soren/0000-0001-8363-1999; Beattie, Tara/0000-0001-9156-7341; Kaul, Rupert/0000-0002-1586-4093; Armitage, Andrew/0000-0001-5977-6602; Dong, Tao/0000-0003-3545-3758; chotiyarnwong, pojchong/0000-0002-0287-222X	MRC [G9900061, MC_U137881016, G9722488, MC_U137884177] Funding Source: UKRI; Medical Research Council [G9900061, MC_U137881016, G19/31, G9722488, MC_U137884177] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld M, 2005, J VIROL, V79, P5000, DOI 10.1128/JVI.79.8.5000-5005.2005; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brander C, 1999, J VIROL, V73, P10191, DOI 10.1128/JVI.73.12.10191-10198.1999; Brander C, 2003, NAT MED, V9, P1359, DOI 10.1038/nm941; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; Browning M, 1996, IMMUNOL TODAY, V17, P165, DOI 10.1016/0167-5699(96)80614-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dong T, 1996, EUR J IMMUNOL, V26, P335, DOI 10.1002/eji.1830260210; Edwards CTT, 2005, J VIROL, V79, P9363, DOI 10.1128/JVI.79.14.9363-9366.2005; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GARBOCZI DN, 1994, J MOL BIOL, V239, P581, DOI 10.1006/jmbi.1994.1398; Goulder PJR, 1997, EUR J IMMUNOL, V27, P1515, DOI 10.1002/eji.1830270630; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 2001, IMMUNOL LETT, V79, P109, DOI 10.1016/S0165-2478(01)00272-3; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Iversen AKN, 1998, J INFECT DIS, V178, P1334, DOI 10.1086/314433; Iversen AKN, 1999, AIDS PATIENT CARE ST, V13, P695, DOI 10.1089/apc.1999.13.695; Iversen AKN, 1999, J ACQ IMMUN DEF SYND, V22, P325; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; Kan-Mitchell J, 2004, J IMMUNOL, V172, P5249, DOI 10.4049/jimmunol.172.9.5249; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; LEITNER T, 2004, HIV SEQUENCE COMPEND; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maddison WP, 2001, MACCLADE ANAL PHYLOG; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; McMichael A, 2002, SCIENCE, V296, P1410, DOI 10.1126/science.1072492; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen R, 1998, GENETICS, V148, P929; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; SETTE A, 1994, J IMMUNOL, V153, P5586; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; SWOFFORD DL, 1999, PAUP 4 0 PHYLOG AN U; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004	64	77	80	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					179	189		10.1038/ni1298	http://dx.doi.org/10.1038/ni1298			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16388312				2022-12-18	WOS:000234801700019
J	Myers, MD; Sosinowski, T; Dragone, LL; White, C; Band, H; Gu, H; Weiss, A				Myers, MD; Sosinowski, T; Dragone, LL; White, C; Band, H; Gu, H; Weiss, A			Src-like adaptor protein regulates TCR expression on thymocytes by linking the ubiquitin ligase c-Cbl to the TCR complex	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; TYROSINE KINASE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; CD4(+)CD8(+) THYMOCYTES; GENETIC-EVIDENCE; ZAP-70; ACTIVATION; ZETA	The adaptor molecule SLAP and E3 ubiquitin ligase c-Cbl each regulate expression of T cell receptor (TCR)-CD3 on thymocytes. Here we provide genetic and biochemical evidence that both molecules function in the same pathway. TCR-CD3 expression was similar in the absence of SLAP and/or c-Cbl. SLAP and c-Cbl were found to interact, and their expression together downregulated CD3 epsilon. This required multiple domains in SLAP and the ring finger of c-Cbl. Furthermore, expression of SLAP and c-Cbl together induced TCR zeta ubiquitination and degradation, preventing the accumulation of fully assembled recycling TCR complexes. These studies indicate that SLAP links the E3 ligase activity of c-Cbl to the TCR, allowing for stage-specific regulation of TCR expression.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA; Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Univ Calif San Francisco, Dept Pediat, Div Pediat Immunol Rheumatol, San Francisco, CA 94143 USA; Northwestern Univ, Dept Med, Evanston NW Healthcare Res Inst, Feinberg Sch Med,Dept Biochem, Evanston, IL 60201 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60201 USA; Columbia Univ, Dept Microbiol, Coll Phys & Surg, New York, NY 10032 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; National Jewish Health; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Columbia University	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthritis, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA072531] Funding Source: NIH RePORTER; NCI NIH HHS [CA987986, CA72531] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; DALLANEGRA A, 1988, IMMUNOL LETT, V19, P115, DOI 10.1016/0165-2478(88)90129-0; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; FINKEL TH, 1987, NATURE, V330, P179, DOI 10.1038/330179a0; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Holland SJ, 2001, J EXP MED, V194, P1263, DOI 10.1084/jem.194.9.1263; HOU D, 1994, J BIOL CHEM, V269, P14244; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KEARSE KP, 1995, BIOESSAYS, V17, P1049, DOI 10.1002/bies.950171209; Loreto MP, 2002, MOL CELL BIOL, V22, P4241, DOI 10.1128/MCB.22.12.4241-4255.2002; Love PE, 2003, CURR OPIN IMMUNOL, V15, P199, DOI 10.1016/S0952-7915(03)00002-5; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Pandey A, 2002, J BIOL CHEM, V277, P19131, DOI 10.1074/jbc.M110318200; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Roche S, 1998, CURR BIOL, V8, P975, DOI 10.1016/S0960-9822(98)70400-2; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tang J, 1999, P NATL ACAD SCI USA, V96, P9775, DOI 10.1073/pnas.96.17.9775; TELERMAN A, 1987, EUR J IMMUNOL, V17, P991, DOI 10.1002/eji.1830170715; Thien CBF, 1999, J IMMUNOL, V162, P7133; Tsygankov AY, 1996, J BIOL CHEM, V271, P27130, DOI 10.1074/jbc.271.43.27130; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413	51	77	83	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					57	66		10.1038/ni1291	http://dx.doi.org/10.1038/ni1291			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16327786				2022-12-18	WOS:000234139700019
J	Salvador, JM; Mittelstadt, PR; Belova, GI; Fornace, AJ; Ashwell, JD				Salvador, JM; Mittelstadt, PR; Belova, GI; Fornace, AJ; Ashwell, JD			The autoimmune suppressor Gadd45 alpha inhibits the T cell alternative p38 activation pathway	NATURE IMMUNOLOGY			English	Article							MAP KINASE ACTIVATION; IFN-GAMMA PRODUCTION; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; MICE; GADD45A; JNK; APOPTOSIS; ARREST	The p38 MAP kinase ( MAPK) is phosphorylated and activated by upstream MAPK kinases. T cells have an alternative pathway in which T cell receptor - activated tyrosine kinase Zap70 phosphorylates p38 on Tyr323. Mice lacking Gadd45 alpha, a small p38-binding molecule, develop a lupus-like autoimmune disease. Here we show that resting T cells but not B cells from Gadd45a(-/-) mice had spontaneously increased p38 activity in the absence of 'upstream' MAPK kinase activation. The p38 from resting Gadd45a(-/-) T cells was spontaneously phosphorylated on Tyr323, and its activity was specifically inhibited by recombinant Gadd45a in vitro. Thus, constitutive activation of T cell p38 through the alternative pathway is prevented by Gadd45a, the absence of which results in p38 activation, T cell hyperproliferation and autoimmunity.	NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Gen Response Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Salvador, Jesus Maria/0000-0002-1087-9675	DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Haeryfar SMM, 2001, INT IMMUNOPHARMACOL, V1, P689, DOI 10.1016/S1567-5769(01)00002-9; Hildesheim J, 2002, CANCER RES, V62, P7305; Hoffmeyer A, 2001, MOL CELL BIOL, V21, P3137, DOI 10.1128/MCB.21.9.3137-3143.2001; Hollander MC, 2001, CANCER RES, V61, P2487; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; SALVADOR JM, 2005, NAT IMMUNOL     0227; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Vairapandi M, 1996, ONCOGENE, V12, P2579; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Ward SG, 1997, BIOCHEM SOC T, V25, pS304, DOI 10.1042/bst025304s; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang J, 1999, J IMMUNOL, V162, P3819	42	77	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					396	402		10.1038/ni1176	http://dx.doi.org/10.1038/ni1176			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15735649				2022-12-18	WOS:000227860000014
J	Tassiulas, I; Hu, XY; Ho, H; Kashyap, Y; Paik, P; Hu, YM; Lowell, CA; Ivashkiv, LB				Tassiulas, I; Hu, XY; Ho, H; Kashyap, Y; Paik, P; Hu, YM; Lowell, CA; Ivashkiv, LB			Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASE SYK; INTERFERON-ALPHA; TARGETED DISRUPTION; GENE-EXPRESSION; CROSS-TALK; RECEPTOR; GAMMA; CELLS; TRANSCRIPTION; SIGNAL	A key function of interferons is priming multiple cell types for enhanced activation by cytokines and inflammatory factors, including tumor necrosis factor, bacterial lipopolysaccharide and interferons themselves. Here we show that interferon-alpha (IFN-alpha)-induced activation of the transcriptional activator STAT1 and inflammatory STAT1 target genes was enhanced in IFN-gamma-primed macrophages. Enhanced IFN-alpha signaling and proinflammatory function were dependent on the tyrosine kinase Syk and on adaptor proteins that activate Syk through immunoreceptor tyrosine activation motifs. Increased STAT1 expression contributed to enhanced IFN-alpha-induced STAT1 activation in primed macrophages. These results identify a mechanism by which crosstalk between cytokine and immune cell-specific immunoreceptor tyrosine activation motif-dependent signaling pathways regulates macrophage responses to IFN-alpha.	Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; Hosp Special Surg, Dept Med, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol, New York, NY 10021 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cornell University; University of California System; University of California San Francisco	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998				ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.iy.02.040184.001435; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bulanova E, 2001, J IMMUNOL, V167, P6292, DOI 10.4049/jimmunol.167.11.6292; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Fasler-Kan E, 1998, EUR J BIOCHEM, V254, P514, DOI 10.1046/j.1432-1327.1998.2540514.x; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Ivashkiv LB, 2003, AUTOIMMUNITY, V36, P473, DOI 10.1080/08916930310001605882; Jaster R, 1999, CELL SIGNAL, V11, P331, DOI 10.1016/S0898-6568(98)00049-7; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kuroiwa T, 2003, CLIN IMMUNOL, V106, P65, DOI 10.1016/S1521-6616(02)00022-0; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Prejean C, 2000, SEMIN CANCER BIOL, V10, P83, DOI 10.1006/scbi.2000.0311; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sharif MN, 2004, J IMMUNOL, V172, P6476, DOI 10.4049/jimmunol.172.10.6476; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strobl B, 2001, EMBO J, V20, P5431, DOI 10.1093/emboj/20.19.5431; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zhou YJ, 2000, MOL CELL BIOL, V20, P4371, DOI 10.1128/MCB.20.12.4371-4380.2000	58	77	77	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1181	1189		10.1038/ni1126	http://dx.doi.org/10.1038/ni1126			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15467722				2022-12-18	WOS:000224692700016
J	Recher, M; Lang, KS; Hunziker, L; Freigang, S; Eschli, B; Harris, NL; Navarini, A; Senn, BM; Fink, K; Lotscher, M; Hangartner, L; Zellweger, R; Hersberger, M; Theocharides, A; Hengartner, H; Zinkernagel, RM				Recher, M; Lang, KS; Hunziker, L; Freigang, S; Eschli, B; Harris, NL; Navarini, A; Senn, BM; Fink, K; Lotscher, M; Hangartner, L; Zellweger, R; Hersberger, M; Theocharides, A; Hengartner, H; Zinkernagel, RM			Deliberate removal of T cell help improves virus-neutralizing antibody production	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-RESPONSES; CLASS-II; IN-VITRO; INFECTION; MICE; INTERFERON; ALPHA/BETA; ESCAPE	The B cell response to lymphocytic choriomeningitis virus is characterized by a CD4(+) T cell-dependent polyclonal hypergammaglobulinemia and delayed formation of virus-specific neutralizing antibodies. Here we provide evidence that, paradoxically, because of polyclonal B cell activation, virus-specific T cell help impairs the induction of neutralizing antibody responses. Experimental reduction in CD4(+) T cell help in vivo resulted in potent neutralizing antibody responses without impairment of CD8(+) T cell activity. These unexpected consequences of polyclonal B cell activation may affect vaccine strategies and the treatment of clinically relevant chronic bacterial, parasitic and viral infections in which hypergammaglobulinemia is regularly found.	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Basel Hosp, Dept Pneumol, CH-4021 Basel, Switzerland; Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Zurich; University Zurich Hospital; University of Basel	Recher, M (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	mike.recher@usz.ch	Lang, Karl S/R-2505-2016; Fink, Katja/AAI-1881-2021; Navarini, Alexander/C-5504-2014; Hangartner, Lars/AAS-1320-2021; Freigang, Stefan/A-8682-2013; Hangartner, Lars/H-3503-2011; harris, nicola/E-5342-2019	Fink, Katja/0000-0002-3571-0390; Navarini, Alexander/0000-0001-7059-632X; Hangartner, Lars/0000-0002-3165-2058; Freigang, Stefan/0000-0003-4438-7828; harris, nicola/0000-0003-2922-0210; Lang, Karl/0000-0001-9783-7605; Hersberger, Martin/0000-0002-4472-329X; Theocharides, Alexandre/0000-0002-1535-8692; Hunziker, Lukas/0000-0003-0081-8518; Recher, Mike/0000-0002-9121-6936				Arnaout RA, 2000, J THEOR BIOL, V204, P431, DOI 10.1006/jtbi.2000.2027; Baldridge JR, 1997, J VIROL, V71, P755, DOI 10.1128/JVI.71.1.755-758.1997; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; BRUNS M, 1983, VIROLOGY, V130, P247, DOI 10.1016/0042-6822(83)90135-6; Ciurea A, 2000, P NATL ACAD SCI USA, V97, P2749, DOI 10.1073/pnas.040558797; COBBOLD S, 1986, TRANSPLANTATION, V42, P239, DOI 10.1097/00007890-198609000-00003; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; COUTELIER JP, 1994, J AUTOIMMUN, V7, P589, DOI 10.1006/jaut.1994.1043; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DIXON JE, 1987, CELL IMMUNOL, V107, P8, DOI 10.1016/0008-8749(87)90260-7; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Ferrantelli F, 2002, VACCINE, V20, pA61, DOI 10.1016/S0264-410X(02)00389-4; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunziker L, 2003, P NATL ACAD SCI USA, V100, P6015, DOI 10.1073/pnas.1031671100; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamperschroer C, 1999, CELL IMMUNOL, V193, P134, DOI 10.1006/cimm.1999.1458; KETTMAN J, 1970, J IMMUNOL, V104, P1558; Kimura T, 2002, J INFECT DIS, V185, P53, DOI 10.1086/338099; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lehmann-Grube F, 1972, J Clin Pathol Suppl (R Coll Pathol), V6, P8, DOI 10.1136/jcp.s3-6.1.8; LEHMANNGRUBE F, 1988, ANN NY ACAD SCI, V532, P238, DOI 10.1111/j.1749-6632.1988.tb36343.x; LEIST TP, 1989, J VIROL, V63, P2813, DOI 10.1128/JVI.63.6.2813-2819.1989; LEIST TP, 1988, J EXP MED, V167, P1749, DOI 10.1084/jem.167.5.1749; MORREY BF, 1998, SHOULDER, P233; MOSKOPHIDIS D, 1994, J VIROL, V68, P1951, DOI 10.1128/JVI.68.3.1951-1955.1994; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Rasmussen RA, 2002, AIDS, V16, P829, DOI 10.1097/00002030-200204120-00002; Senn BM, 2003, EUR J IMMUNOL, V33, P950, DOI 10.1002/eji.200323340; Shata MT, 2002, J VIRAL HEPATITIS, V9, P400, DOI 10.1046/j.1365-2893.2002.00373.x; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Silverstein AM, 2003, NAT IMMUNOL, V4, P931, DOI 10.1038/ni1003-931; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	47	77	77	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					934	942		10.1038/ni1102	http://dx.doi.org/10.1038/ni1102			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15300247	Green Published, Green Submitted			2022-12-18	WOS:000223612500022
J	Verfaillie, CM				Verfaillie, CM			Hematopoietic stem cells for transplantation	NATURE IMMUNOLOGY			English	Editorial Material							EX-VIVO EXPANSION; HIGH-DOSE CHEMOTHERAPY; RHESUS PERIPHERAL-BLOOD; HUMAN MARROW-CELLS; HUMAN CORD BLOOD; PROGENITOR CELLS; BONE-MARROW; IN-VITRO; CD34(+) CELLS; GROWTH-FACTOR		Univ Minnesota, Sch Med, Dept Med, Div Hematol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Verfaillie, CM (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Hematol, Minneapolis, MN 55455 USA.	verfa001@tc.umn.edu	Verfaillie, Catherine/H-5148-2013	Verfaillie, Catherine/0000-0001-7564-4079				Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bertolini F, 1997, BLOOD, V89, P2679, DOI 10.1182/blood.V89.8.2679; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BJORNSON C, 1999, SCIENCE, V283, P354; Bomberger C, 1998, BLOOD, V91, P2588, DOI 10.1182/blood.V91.7.2588.2588_2588_2600; BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503; BRUNO E, 1995, EXP HEMATOL, V23, P1212; Civin CI, 1996, BLOOD, V88, P4102, DOI 10.1182/blood.V88.11.4102.bloodjournal88114102; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Dao MA, 1998, BLOOD, V92, P4612, DOI 10.1182/blood.V92.12.4612.424k04_4612_4621; DEREVEL T, 1994, BLOOD, V83, P3795, DOI 10.1182/blood.V83.12.3795.bloodjournal83123795; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Donahue RE, 2001, HUM GENE THER, V12, P607, DOI 10.1089/104303401300057289; DORSHKIND K, 2002, NATURE IMMUNOL, V3, P323; Dunbar CE, 1996, P NATL ACAD SCI USA, V93, P11871, DOI 10.1073/pnas.93.21.11871; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Giet O, 2001, EXP HEMATOL, V29, P515, DOI 10.1016/S0301-472X(00)00682-2; Glaspy JA, 1997, BLOOD, V90, P2939, DOI 10.1182/blood.V90.8.2939; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; Hao QL, 1996, BLOOD, V88, P3306, DOI 10.1182/blood.V88.9.3306.bloodjournal8893306; Holyoake TL, 1997, BONE MARROW TRANSPL, V19, P1095, DOI 10.1038/sj.bmt.1700799; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; ITOH K, 1989, EXP HEMATOL, V17, P145; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kato S, 2001, BONE MARROW TRANSPL, V28, P587, DOI 10.1038/sj.bmt.1703186; Kawashima I, 1996, BLOOD, V87, P4136, DOI 10.1182/blood.V87.10.4136.bloodjournal87104136; Kiem HP, 1996, HUM GENE THER, V7, P89, DOI 10.1089/hum.1996.7.1-89; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Kollet O, 1999, BLOOD, V94, P923, DOI 10.1182/blood.V94.3.923.415k08_923_931; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lemischka IR, 1997, STEM CELLS, V15, P63, DOI 10.1002/stem.5530150810; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; McNiece I, 2000, BLOOD, V96, P3001; McNiece I, 1999, HEMATOL CELL THER, V41, P82, DOI 10.1007/s00282-999-0082-y; McNiece I, 2001, EXP HEMATOL, V29, P3, DOI 10.1016/S0301-472X(00)00610-X; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; MUENCH MO, 1993, BLOOD, V81, P3463; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; NOLTA JA, 1994, BLOOD, V83, P3041, DOI 10.1182/blood.V83.10.3041.3041; Ogawa M, 1999, INT J HEMATOL, V69, P2; Ohneda O, 1998, BLOOD, V92, P908; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Orschell-Traycoff CM, 2000, BLOOD, V96, P1380, DOI 10.1182/blood.V96.4.1380.h8001380_1380_1387; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Peters SO, 1996, BLOOD, V87, P30; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Prosper F, 1996, BLOOD, V88, P2033, DOI 10.1182/blood.V88.6.2033.bloodjournal8862033; Punzel M, 1999, BLOOD, V93, P3750, DOI 10.1182/blood.V93.11.3750.411a37_3750_3756; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Reiffers J, 1999, LANCET, V354, P1092, DOI 10.1016/S0140-6736(99)03113-X; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Robertson JD, 2001, BONE MARROW TRANSPL, V27, P1283, DOI 10.1038/sj.bmt.1703069; Robin C, 1999, BRIT J HAEMATOL, V104, P809, DOI 10.1046/j.1365-2141.1999.01266.x; Rondelli D, 1995, BLOOD, V86, P1936; Rosler ES, 2000, BLOOD, V96, P3414; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Stiff P, 2000, BLOOD, V95, P2169, DOI 10.1182/blood.V95.6.2169; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Szilvassy SJ, 1996, BLOOD, V88, P3642, DOI 10.1182/blood.V88.9.3642.bloodjournal8893642; Szilvassy SJ, 2001, BLOOD, V98, P2108, DOI 10.1182/blood.V98.7.2108; Takenaka K, 1996, BLOOD, V88, P2871, DOI 10.1182/blood.V88.8.2871.bloodjournal8882871; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Tisdale JF, 1998, BLOOD, V92, P1131, DOI 10.1182/blood.V92.4.1131.416k41_1131_1141; Uchida N, 2001, J CLIN INVEST, V108, P1071, DOI 10.1172/JCI200113297; UDOMSAKDI C, 1992, BLOOD, V80, P2513; van der Loo JCM, 1998, BLOOD, V92, P2556, DOI 10.1182/blood.V92.7.2556.2556_2556_2570; VANZANT G, 1994, BLOOD CELLS, V20, P482; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Verfaillie CM, 2000, EXP HEMATOL, V28, P1071, DOI 10.1016/S0301-472X(00)00506-3; Wang LS, 2000, EXP HEMATOL, V28, P907, DOI 10.1016/S0301-472X(00)00485-9; WEILBAECHER K, 1991, BLOOD, V78, P945; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	99	77	91	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					314	317		10.1038/ni0402-314	http://dx.doi.org/10.1038/ni0402-314			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919566	Green Published			2022-12-18	WOS:000174623600003
J	Morteau, O; Lu, B; Gerard, C; Gerard, NP				Morteau, O; Lu, B; Gerard, C; Gerard, NP			Hemokinin I is a full agonist at the substance P receptor	NATURE IMMUNOLOGY			English	Letter							GUINEA-PIG LUNG		Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Morteau, O (corresponding author), Childrens Hosp, Ina Sue Perlmutter Lab, 300 Longwood Ave, Boston, MA 02115 USA.							Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; COATS SR, 1989, AM J RESP CELL MOL, V1, P269, DOI 10.1165/ajrcmb/1.4.269; RAMESHWAR P, 1993, BLOOD, V81, P391; STIMLERGERARD NP, 1987, J CLIN INVEST, V79, P1819, DOI 10.1172/JCI113023; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	5	77	80	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1088	1088		10.1038/ni1201-1088	http://dx.doi.org/10.1038/ni1201-1088			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725292	Bronze			2022-12-18	WOS:000172473200004
J	Silverstein, AM				Silverstein, AM			Autoimmunity versus horror autotoxicus: The struggle for recognition	NATURE IMMUNOLOGY			English	Editorial Material									Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.							ACKROYD JF, 1949, CLIN SCI, V8, P269; BERGSMA D, 1968, IMMUNOLOGICAL DEFICI; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bordet J., 1898, ANN I PASTEUR PARIS, V12, P688; BOYD W, 1956, FUNDAMENTALS IMMUNOL; Breinl F., 1930, Z PHYSL CHEM, V192, P45; Burnet FM, 1949, PRODUCTION ANTIBODIE; BURNET FM, 1959, CLONAL SELECTION THE; CHAUFFARD A, 1908, SEM MED PARIS, V25, P411; COLLINS RC, 1953, AM J OPHTHALMOL, V36, P150, DOI 10.1016/0002-9394(53)90165-2; COOMBS RRA, 1945, BRIT J EXP PATHOL, V26, P255; DACLE JV, 1962, HAEMOLYTIC ANEMIAS; Dameshek W, 1938, NEW ENGL J MED, V218, P15, DOI 10.1056/NEJM193801062180105; DIENES L., 1929, AMER REV TUBERC, V20, P92; Donath J., 1906, Z KLIN MED, V58, P173; Donath J., 1913, Z IMMUNITATSFORSCH, V18, P701; Donath J., 1908, ZBL BAKT PARASIT, V45, P205; Donath J., 1904, Z KLIN MED, V52, P1; Donath J, 1904, MUNCHENER MEDIZINISC, V51, P1590; Ehrlich P., 1901, BERL KLIN WOCHENSCHR, V38, P251; EHRLICH P, 1900, BERL KLIN WOCHENSCHR, V37, P681; EHRLICH P, 2001, COLLECTED PAPERS P E, V38, P569; Ehrlich P., 1899, BERL KLIN WOCHENSCHR, V36, P6; EHRLICH P, 2002, 73 VERH GES DTSCH NA, V1, P250; EHRLICH P, 1901, BERL KLIN WOCHENSCHR, V38, P255; Ehrlich P., 1899, BERL KLIN WOCHENSCHR, V36, P481; Ehrlich P., 1900, BERLINER KLIN WOCHEN, V37, P453; EISCHNIG A, 1910, A VANGRAEFES ARCH OP, V76, P509; Fleck Ludwik, 1936, GENESIS DEV SCI FACT; Gell PGH, 1968, CLIN ASPECTS IMMUNOL, VSecond, P580; GOLTZ D, 1980, HORROR AUTOTOXICUS B; Humphrey J.H., 1963, IMMUNOLOGY STUDENTS; Kabat E.A., 1968, STRUCTURAL CONCEPTS; KABAT EA, 1949, J EXP MED, V89, P395, DOI 10.1084/jem.89.4.395; KABAT EA, 1947, J EXP MED, V85, P117, DOI 10.1084/jem.85.1.117; Kabat EA, 1948, EXPT IMMUNOCHEMISTRY; KRUSIUS FF, 1910, ARCH AUGENHEILKD, V67, P6; LANDSTEINER K, 1910, HDB BIOCH, V1, P492; Landsteiner K., 1900, CENTRALBL BAKTERIOL, V27, P357; LANDSTEINER K, 1926, SPECIFICITY SEROLOGI; Landsteiner K., 1901, WIEN KLIN WSCHR, V14, P1132; LEVINE P, 1926, P SOC SOC EXP BIOL M, V24, P600; LEVINE P, 1926, P SOC SOC EXP BIOL M, V24, P941; MARRACK JR, 1934, CHEM ANTIGENS ANTIBO; MEDAWAR P B, 1956, Harvey Lect, P144; Metalnikoff Serge, 1900, ANN I PASTEUR, V14, P577; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pressman D, 1968, STRUCTURAL BASIS ANT; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; ROITT IM, 1956, LANCET, V2, P820; Romer P., 1912, ARCH OPHTHALMOL-CHIC, V81, P367; ROSE NR, 1956, J IMMUNOL, V76, P417; ROSE NR, 1985, AUTOIMMUNE DIS, pR4; ROSE NR, 1986, COMMUNICATOIN; Silverstein AM, 2000, NAT IMMUNOL, V1, P453, DOI 10.1038/82691; Silverstein AM, 2000, NAT IMMUNOL, V1, P93, DOI 10.1038/77874; SILVERSTEIN AM, 1991, CELL IMMUNOL, V132, P515, DOI 10.1016/0008-8749(91)90047-F; SILVERSTEIN AM, 1898, CELL IMMUNOL, V97, P173; SIMON FA, 1934, ALLERGY, V5, P439; SIMON FA, 1934, ALLERGY, V5, P451; VOLSIN G, 1951, ANN I PASTEUR, V81, P48; Wells H.G., 1924, CHEM ASPECTS IMMUNIT; WIENER A, 1940, P SOC SOC EXP BIOL M, V43, P223; WITEBSKY E, 1954, Ann N Y Acad Sci, V59, P168, DOI 10.1111/j.1749-6632.1954.tb45929.x; WITEBSKY E, 1956, J IMMUNOL, V76, P408; Witebsky E., 1954, ANN NY ACAD SCI, V59, P173; Zinsser H, 1925, J EXP MED, V41, P159; Zinsser H, 1921, J EXP MED, V34, P495, DOI 10.1084/jem.34.5.495; 1907, ERQ ALLQ PATHOL, V11, P515	72	77	80	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					279	281		10.1038/86280	http://dx.doi.org/10.1038/86280			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276193				2022-12-18	WOS:000167982900004
J	Mehandru, S; Merad, M				Mehandru, Saurabh; Merad, Miriam			Pathological sequelae of long-haul COVID	NATURE IMMUNOLOGY			English	Review							ACUTE RESPIRATORY SYNDROME; PULMONARY-FUNCTION; EXERCISE CAPACITY; FETAL MONOCYTES; SURVIVORS; RECEPTOR; RNA; MANIFESTATIONS; INFLAMMATION; CORONAVIRUS	It is increasingly obvious that individuals are experiencing post-COVID-19 syndromes, or 'long-haul COVID'. Here, Merad and Mehandru eview currently available knowledge of the underlying pathophysiological mechanisms of these sequelae, elaborating on persistent inflammation, induced autoimmunity and putative viral reservoirs. The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants. At the same time, persistent, prolonged and often debilitating sequelae are increasingly recognized in convalescent individuals, named 'post-COVID-19 syndrome' or 'long-haul COVID'. Clinical symptomatology includes fatigue, malaise, dyspnea, defects in memory and concentration and a variety of neuropsychiatric syndromes as the major manifestations, and several organ systems can be involved. The underlying pathophysiological mechanisms are poorly understood at present. This Review details organ-specific sequelae of post-COVID-19 syndromes and examines the underlying pathophysiological mechanisms available so far, elaborating on persistent inflammation, induced autoimmunity and putative viral reservoirs. Finally, we propose diagnostic strategies to better understand this heterogeneous disorder that continues to afflict millions of people worldwide.	[Mehandru, Saurabh; Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Mehandru, Saurabh] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, Dept Med, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mehandru, S; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Mehandru, S (corresponding author), Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, Dept Med, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	saurabh.mehandru@mssm.edu; miriam.merad@mssm.edu			Gates Foundation [U24 AI118644-05S1, P30 CA196521-05S2];  [DK123749 0S1]	Gates Foundation(Bill & Melinda Gates Foundation); 	This work was supported by grant numbers U24 AI118644-05S1, P30 CA196521-05S2, Fast Grant (George Mason University) and Gates Foundation (M.M.) and DK123749 0S1 (S.M.).	Abrantes TF, 2021, J AM ACAD DERMATOL, V85, P975, DOI 10.1016/j.jaad.2021.07.021; Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9; Arnold DT, 2021, THORAX, V76, P399, DOI 10.1136/thoraxjnl-2020-216086; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Barzilai O, 2007, CURR OPIN RHEUMATOL, V19, P636, DOI 10.1097/BOR.0b013e3282f0ad25; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bergamaschi L, 2021, IMMUNITY, V54, P1257, DOI 10.1016/j.immuni.2021.05.010; Blomberg B, 2021, NAT MED, V27, P1607, DOI 10.1038/s41591-021-01433-3; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Bowles L, 2020, NEW ENGL J MED, V383, P288, DOI 10.1056/NEJMc2013656; Brancatella A, 2020, J CLIN ENDOCR METAB, V105, P2367, DOI 10.1210/clinem/dgaa276; Brandini DA, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2226; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Carvalho-Schneider C, 2021, CLIN MICROBIOL INFEC, V27, P258, DOI 10.1016/j.cmi.2020.09.052; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Chang SE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25509-3; Chopra V, 2021, ANN INTERN MED, V174, P576, DOI 10.7326/M20-5661; Chun HJ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.148476; Coker RK, 2001, THORAX, V56, P549, DOI 10.1136/thorax.56.7.549; Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16; Dennis A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048391; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ferini-Strambi L, 2021, J NEUROL, V268, P409, DOI 10.1007/s00415-020-10070-8; Freeman EE, 2020, J AM ACAD DERMATOL, V83, P1118, DOI 10.1016/j.jaad.2020.06.1016; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Gemayel C, 2001, J AM COLL CARDIOL, V38, P1773, DOI 10.1016/S0735-1097(01)01654-0; Gentile S, 2020, DIABETES OBES METAB, V22, P2507, DOI 10.1111/dom.14170; Gutierrez-Ortiz C, 2020, NEUROLOGY, V95, pE601, DOI 10.1212/WNL.0000000000009619; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Han XY, 2021, RADIOLOGY, V299, pE177, DOI 10.1148/radiol.2021203153; Heneka MT, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00640-3; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Hui DS, 2005, THORAX, V60, P401, DOI 10.1136/thx.2004.030205; Jhaveri KD, 2020, KIDNEY INT, V98, P509, DOI 10.1016/j.kint.2020.05.025; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Lazzerini PE, 2019, NAT REV IMMUNOL, V19, P63, DOI 10.1038/s41577-018-0098-z; Lee SH, 2019, PSYCHIAT INVEST, V16, P59, DOI 10.30773/pi.2018.10.22.3; Leentjens J, 2021, LANCET HAEMATOL, V8, DOI 10.1016/S2352-3026(21)00105-8; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Livanos AE, 2021, GASTROENTEROLOGY, V160, P2435, DOI 10.1053/j.gastro.2021.02.056; Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048; LongCovidSOS, 2021, IMP COVID VACC SYMPT; Malkud S, 2015, J CLIN DIAGN RES, V9, pWE1, DOI 10.7860/JCDR/2015/15219.6492; Manolis TA, 2021, J NEUROPSYCH CLIN N, V33, P266, DOI 10.1176/appi.neuropsych.20110277; Mao R, 2020, LANCET GASTROENTEROL, V5, P667, DOI 10.1016/S2468-1253(20)30126-6; Martin-Villares C, 2021, EUR ARCH OTO-RHINO-L, V278, P1605, DOI 10.1007/s00405-020-06220-3; Mateu-Salat M, 2020, J ENDOCRINOL INVEST, V43, P1527, DOI 10.1007/s40618-020-01366-7; Melms JC, 2021, NATURE, V595, P114, DOI 10.1038/s41586-021-03569-1; Mendez R, 2021, ANN AM THORAC SOC, V18, P1253, DOI 10.1513/AnnalsATS.202011-1452RL; Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37; Montefusco L, 2021, NAT METAB, V3, P774, DOI 10.1038/s42255-021-00407-6; Moody WE, 2021, J AM SOC ECHOCARDIOG, V34, P562, DOI 10.1016/j.echo.2021.01.020; Muccioli L, 2020, ANN NEUROL, V88, P860, DOI 10.1002/ana.25855; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Ong KC, 2004, EUR RESPIR J, V24, P436, DOI 10.1183/09031936.04.00007104; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patell R, 2020, BLOOD, V136, P1342, DOI 10.1182/blood.2020007938; Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017; Phetsouphanh C., 2022, NAT IMMUNOL, DOI [10.1038/s41590-021-01113-x(2022, DOI 10.1038/S41590-021-01113-X(2022]; Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557; Rajpal S, 2021, JAMA CARDIOL, V6, P116, DOI 10.1001/jamacardio.2020.4916; Ramlall V, 2020, NAT MED, V26, P1609, DOI 10.1038/s41591-020-1021-2; Randall RE, 2017, CURR OPIN VIROL, V23, P35, DOI 10.1016/j.coviro.2017.03.001; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2; Robbins-Juarez SY, 2020, KIDNEY INT REP, V5, P1149, DOI 10.1016/j.ekir.2020.06.013; Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0; Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5; Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]; Salamanna F, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.653516; Salvio G, 2020, CLIN REV BONE MINER, V18, P51, DOI 10.1007/s12018-020-09274-3; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Shah AS, 2021, THORAX, V76, P402, DOI 10.1136/thoraxjnl-2020-216308; Shah W, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n136; Shaw B, 2021, RADIOL MED, V126, P40, DOI 10.1007/s11547-020-01295-8; South K, 2020, INT J STROKE, V15, P722, DOI 10.1177/1747493020943815; Stevens JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244131; Suarez-Farinas M, 2021, GASTROENTEROLOGY, V160, P287, DOI 10.1053/j.gastro.2020.09.029; Sun JF, 2020, EMERG INFECT DIS, V26, P1834, DOI 10.3201/eid2608.201097; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; Tee LY, 2021, SINGAP MED J, V62, P265, DOI 10.11622/smedj.2020106; Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191; Truffaut L, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01625-y; Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; van Gassel RJJ, 2021, AM J RESP CRIT CARE, V203, P371, DOI 10.1164/rccm.202010-3823LE; Venkatesan P, 2021, LANCET RESP MED, V9, P129, DOI 10.1016/S2213-2600(21)00031-X; Weerahandi H, 2021, J GEN INTERN MED, V36, P738, DOI 10.1007/s11606-020-06338-4; Weng JR, 2021, LANCET GASTROENTEROL, V6, P344, DOI 10.1016/S2468-1253(21)00076-5; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2; Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4; Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472	109	76	77	56	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					194	202		10.1038/s41590-021-01104-y	http://dx.doi.org/10.1038/s41590-021-01104-y		FEB 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35105985	Green Accepted, Bronze			2022-12-18	WOS:000749438000003
J	LaFleur, MW; Nguyen, TH; Coxe, MA; Miller, BC; Yates, KB; Gillis, JE; Sen, DR; Gaudiano, EF; Al Abosy, R; Freeman, GJ; Haining, WN; Sharpe, AH				LaFleur, Martin W.; Nguyen, Thao H.; Coxe, Matthew A.; Miller, Brian C.; Yates, Kathleen B.; Gillis, Jacob E.; Sen, Debattama R.; Gaudiano, Emily F.; Al Abosy, Rose; Freeman, Gordon J.; Haining, W. Nicholas; Sharpe, Arlene H.			PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EXPRESSION; CHROMATIN; IMMUNOTHERAPY; PERSISTENCE; DYSFUNCTION; TOLERANCE; INFECTION; EXPANSION; BLOCKADE	CD8(+) Tcell exhaustion is a state of dysfunction acquired in chronic viral infection and cancer, characterized by the formation of Slamf6+ progenitor exhausted and Tim-3(+) terminally exhausted subpopulations through unknown mechanisms. Here we establish the phosphatase PTPN2 as a new regulator of the differentiation of the terminally exhausted subpopulation that functions by attenuating type 1 interferon signaling. Deletion of Ptpn2 in CD8(+) Tcells increased the generation, proliferative capacity and cytotoxicity of Tim-3(+) cells without altering Slamf6(+) numbers during lymphocytic choriomeningitis virus clone 13 infection. Likewise, Ptpn2 deletion in CD8(+) Tcells enhanced Tim-3+ anti-tumor responses and improved tumor control. Deletion of Ptpn2 throughout the immune system resulted in MC38 tumor clearance and improved programmed cell death-1 checkpoint blockade responses to B16 tumors. Our results indicate that increasing the number of cytotoxic Tim-3(+)CD8(+) Tcells can promote effective anti-tumor immunity and implicate PTPN2 in immune cells as an attractive cancer immunotherapy target.	[LaFleur, Martin W.; Nguyen, Thao H.; Coxe, Matthew A.; Miller, Brian C.; Gillis, Jacob E.; Gaudiano, Emily F.; Sharpe, Arlene H.] Harvard Med Sch, Dept Immunol, Blavatnik Inst, Boston, MA 02115 USA; [LaFleur, Martin W.; Miller, Brian C.; Yates, Kathleen B.; Sen, Debattama R.; Al Abosy, Rose; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [LaFleur, Martin W.; Nguyen, Thao H.; Coxe, Matthew A.; Miller, Brian C.; Gillis, Jacob E.; Gaudiano, Emily F.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [LaFleur, Martin W.; Nguyen, Thao H.; Coxe, Matthew A.; Miller, Brian C.; Gillis, Jacob E.; Gaudiano, Emily F.; Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [LaFleur, Martin W.; Sen, Debattama R.] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Miller, Brian C.; Yates, Kathleen B.; Sen, Debattama R.; Haining, W. Nicholas; Sharpe, Arlene H.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Miller, Brian C.; Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Sharpe, AH (corresponding author), Harvard Med Sch, Dept Immunol, Blavatnik Inst, Boston, MA 02115 USA.; Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Haining, WN; Sharpe, AH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	nick.haining@merck.com; Arlene_Sharpe@hms.harvard.edu	Freeman, Gordon/AAC-5380-2019; Sen, Debattama/AAC-5679-2020	Freeman, Gordon/0000-0002-7210-5616; Sen, Debattama/0000-0002-0947-8284; Miller, Brian/0000-0001-5931-4184; Al Abosy, Rose/0000-0001-5400-1306; Nguyen, Thao/0000-0002-2767-0528	National Cancer Institute [T32CA207021, P50CA101942, U54 CA225088, R01 CA229851]; 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant [16-40-15-MILL]; National Center for Advancing Translational Sciences/National Institutes of Health [KL2 TR002542]; Jane C. Wright, MD, Endowed Young Investigator Award from ASCO; National Institute of Allergy and Infectious Diseases [U19AI133524, P01 AI108545]; NATIONAL CANCER INSTITUTE [U54CA225088, R01CA229851, P50CA101942, T32CA207021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002541, KL2TR002542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI133524, P01AI108545] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant; National Center for Advancing Translational Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Jane C. Wright, MD, Endowed Young Investigator Award from ASCO; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Collins (Dana-Farber Cancer Institute), C. Kadoch (Dana-Farber Cancer Institute), D. Vignali (University of Pittsburgh), E.J. Wherry (University of Pennsylvania) and G. Dranoff (Novartis Institutes for BioMedical Research) for sharing cancer cell lines and F. Zhang (Broad Institute of MIT and Harvard) for sharing loxP-STOP-loxPCas9 mice. This work was supported by funding from grant no. T32CA207021 from the National Cancer Institute to M.W.L., the 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant no. 16-40-15-MILL, National Center for Advancing Translational Sciences/National Institutes of Health Award no. KL2 TR002542, the Jane C. Wright, MD, Endowed Young Investigator Award from ASCO to B. C. M. and grant nos. P50CA101942 from the National Cancer Institute to G.J.F., U19AI133524 from the National Institute of Allergy and Infectious Diseases to A.H.S and W. N. H. and U54 CA225088 from the National Cancer Institute, R01 CA229851 from the National Cancer Institute and P01 AI108545 from the National Institute of Allergy and Infectious Diseases to A.H.S.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cornberg M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00475; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeTomaso D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1176-5; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Hashimoto M, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028464; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Spalinger MR, 2018, CELL REP, V22, P1835, DOI 10.1016/j.celrep.2018.01.052; Starbeck-Miller GR, 2014, J EXP MED, V211, P105, DOI 10.1084/jem.20130901; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson MND, 2019, J CLIN INVEST, V129, P1193, DOI 10.1172/JCI123267; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Trombetta J. J., 2014, CURR PROTOC MOL BIOL, V107, P22; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wiede F, 2014, J AUTOIMMUN, V53, P105, DOI 10.1016/j.jaut.2014.05.008; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	57	76	79	7	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1335	+		10.1038/s41590-019-0480-4	http://dx.doi.org/10.1038/s41590-019-0480-4			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31527834	Green Accepted			2022-12-18	WOS:000486615900017
J	Scharer, CD; Blalock, EL; Mi, T; Barwick, BG; Jenks, SA; Deguchi, T; Cashman, KS; Neary, BE; Patterson, DG; Hicks, SL; Khosroshahi, A; Lee, FEH; Wei, CW; Sanz, I; Boss, JM				Scharer, Christopher D.; Blalock, Emily L.; Mi, Tian; Barwick, Benjamin G.; Jenks, Scott A.; Deguchi, Tsuneo; Cashman, Kevin S.; Neary, Bridget E.; Patterson, Dillon G.; Hicks, Sakeenah L.; Khosroshahi, Arezou; Lee, F. Eun-Hyung; Wei, Chungwen; Sanz, Inaki; Boss, Jeremy M.			Epigenetic programming underpins B cell dysfunction in human SLE	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; DIFFERENTIATION; RECEPTOR; GROWTH; CHROMATIN; POPULATION; COMPLEXES; EVOLUTION; RESPONSES	Systemic lupus erythematosus (SLE) is characterized by the expansion of extrafollicular pathogenic B cells derived from newly activated naive cells. Although these cells express distinct markers, their epigenetic architecture and how it contributes to SLE remain poorly understood. To address this, we determined the DNA methylomes, chromatin accessibility profiles and transcriptomes from five human B cell subsets, including a newly defined effector B cell subset, from subjects with SLE and healthy controls. Our data define a differentiation hierarchy for the subsets and elucidate the epigenetic and transcriptional differences between effector and memory B cells. Importantly, an SLE molecular signature was already established in resting naive cells and was dominated by enrichment of accessible chromatin in motifs for AP-1 and EGR transcription factors. Together, these factors acted in synergy with T-BET to shape the epigenome of expanded SLE effector B cell subsets. Thus, our data define the molecular foundation of pathogenic B cell dysfunction in SLE.	[Scharer, Christopher D.; Mi, Tian; Patterson, Dillon G.; Hicks, Sakeenah L.; Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Blalock, Emily L.; Jenks, Scott A.; Deguchi, Tsuneo; Cashman, Kevin S.; Neary, Bridget E.; Khosroshahi, Arezou; Wei, Chungwen; Sanz, Inaki] Emory Univ, Sch Med, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Blalock, Emily L.; Jenks, Scott A.; Deguchi, Tsuneo; Cashman, Kevin S.; Neary, Bridget E.; Khosroshahi, Arezou; Lee, F. Eun-Hyung; Sanz, Inaki] Emory Univ, Sch Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Barwick, Benjamin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Lee, F. Eun-Hyung] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Sanz, I (corresponding author), Emory Univ, Sch Med, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA.; Sanz, I (corresponding author), Emory Univ, Sch Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.	ignacio.sanz@emory.edu; jmboss@emory.edu	Patterson, Dillon/GRF-1093-2022	Patterson, Dillon/0000-0001-6053-5216; Blalock, Emily/0000-0001-9978-1000; Barwick, Benjamin/0000-0001-9810-3566; Scharer, Christopher/0000-0001-7716-8504	NIH [U19 AI110483, P01 AI125180, RO1 AI113021, F31 AI112261, T32 GM008490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109962, R01AI123733, F31AI112261, R01AI121252, P01AI125180, U01AI141993, R37AI049660, R01AI113021, U19AI110483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Boss and Sanz laboratories for critical reading of the manuscript, the New York University Genome Technology Center for Illumina sequencing, the Yerkes Genomics Core for RNA-seq library preparation, the Emory Pediatrics Flow Cytometry core for flow cytometry isolation of cell subsets and the Emory Integrated Genetics and Computational Core for Bioanalyzer and sequencing library quality control. This work was supported by NIH grants U19 AI110483 to J.M.B. and I.S., P01 AI125180 to I.S., F.E.-H.L. and J.M.B., RO1 AI113021 to J.M.B., F31 AI112261 to B.G.B., and T32 GM008490 to J.M.B.	Ashouri JF, 2017, J IMMUNOL, V198, P657, DOI 10.4049/jimmunol.1601301; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Barwick BG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04234-4; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Buchta CM, 2014, J IMMUNOL, V192, P145, DOI 10.4049/jimmunol.1301901; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chattopadhyay S, 2015, EMBO REP, V16, P1535, DOI 10.15252/embr.201540337; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gomez-Martin D, 2010, AUTOIMMUN REV, V9, P454, DOI 10.1016/j.autrev.2009.12.006; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jadhav Kavita, 2017, Liver Res, V1, P96, DOI 10.1016/j.livres.2017.08.001; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Juilland M, 2016, BLOOD, V127, P1780, DOI 10.1182/blood-2015-07-655647; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li T, 2014, ONCOGENE, V33, P4746, DOI 10.1038/onc.2013.415; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manni M, 2018, NAT IMMUNOL, V19, P407, DOI 10.1038/s41590-018-0056-8; Mo JS, 2017, GENES GENOM, V39, P445, DOI 10.1007/s13258-017-0515-x; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; Nagaoka M, 2017, J IMMUNOL, V199, P2958, DOI 10.4049/jimmunol.1601911; Oh YK, 2015, IMMUNE NETW, V15, P161, DOI 10.4110/in.2015.15.3.161; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Poovassery JS, 2012, J IMMUNOL, V189, P1757, DOI 10.4049/jimmunol.1200624; Price MJ, 2018, CELL REP, V23, P3152, DOI 10.1016/j.celrep.2018.05.053; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Scharer CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04125-8; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Ulff-Moller CJ, 2018, ARTHRITIS RHEUMATOL, V70, P878, DOI 10.1002/art.40422; Veleeparambil M, 2018, J IMMUNOL, V200, P2809, DOI 10.4049/jimmunol.1700691; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	76	76	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1071	+		10.1038/s41590-019-0419-9	http://dx.doi.org/10.1038/s41590-019-0419-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31263277	Green Accepted			2022-12-18	WOS:000476621200021
J	Whibley, N; Tucci, A; Powrie, F				Whibley, Natasha; Tucci, Andrea; Powrie, Fiona			Regulatory T cell adaptation in the intestine and skin	NATURE IMMUNOLOGY			English	Review							ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; CHAIN FATTY-ACIDS; DENDRITIC CELLS; IMMUNE DYSREGULATION; ADIPOSE-TISSUE; RETINOIC-ACID; TGF-BETA; SUPPRESSOR-CELLS; SELF-TOLERANCE	The intestine and skin are distinct microenvironments with unique physiological functions and are continually exposed to diverse environmental challenges. Host adaptation at these sites is an active process that involves interaction between immune cells and tissue cells. Regulatory T cells (T-reg cells) play a pivotal role in enforcing homeostasis at barrier surfaces, illustrated by the development of intestinal and skin inflammation in diseases caused by primary deficiency in T-reg cells. T-reg cells at barrier sites are phenotypically distinct from their lymphoid-organ counterparts, and these 'tissue' signatures often reflect their tissue-adapted function. We discuss current understanding of T-reg cell adaptation in the intestine and skin, including unique phenotypes, functions and metabolic demands, and how increased knowledge of T-reg cells at barrier sites might guide precision medicine therapies.	[Whibley, Natasha; Tucci, Andrea; Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England	University of Oxford	Powrie, F (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.	fiona.powrie@kennedy.ox.ac.uk		Powrie, Fiona/0000-0003-3312-5929				Ali N, 2017, IMMUNOLOGY, V152, P372, DOI 10.1111/imm.12791; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bilate AM, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf7471; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Edwards JP, 2016, EUR J IMMUNOL, V46, P1480, DOI 10.1002/eji.201546204; Edwards JP, 2014, J IMMUNOL, V193, P2843, DOI 10.4049/jimmunol.1401102; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Gajardo T, 2015, IMMUNOLOGY, V146, P81, DOI 10.1111/imm.12483; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Gupta A, 2015, ALIMENT PHARM THER, V42, P406, DOI 10.1111/apt.13281; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Halabi-Tawil M, 2009, BRIT J DERMATOL, V160, P645, DOI 10.1111/j.1365-2133.2008.08835.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Harrison O. J, 2018, SCIENCE, V363; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Howie D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89160; Ikeda K, 2017, CELL REP, V21, P1824, DOI 10.1016/j.celrep.2017.10.082; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leichner TM, 2017, J AUTOIMMUN, V79, P39, DOI 10.1016/j.jaut.2017.01.003; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Malhotra N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao6923; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mesinkovska NA, 2016, CLEV CLIN J MED, V83, P731, DOI 10.3949/ccjm.83a.15061; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Povoleri GAM, 2018, NAT IMMUNOL, V19, P1403, DOI 10.1038/s41590-018-0230-z; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russler-Germain EV, 2017, MUCOSAL IMMUNOL, V10, P1375, DOI 10.1038/mi.2017.65; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salem M, 2019, CANCER RES, V79, P1178, DOI 10.1158/0008-5472.CAN-18-2623; Salomon BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00444; Sanford JA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4609; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Scharschmidt TC, 2017, CELL HOST MICROBE, V21, P467, DOI 10.1016/j.chom.2017.03.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Shinde R, 2018, TRENDS IMMUNOL, V39, P1005, DOI 10.1016/j.it.2018.10.010; Siede J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161507; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stockenhuber K, 2018, J EXP MED, V215, P1987, DOI 10.1084/jem.20172094; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Uhlig HH, 2018, ANNU REV IMMUNOL, V36, P755, DOI 10.1146/annurev-immunol-042617-053055; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; Vasanthakumar A, 2017, CELL REP, V20, P2906, DOI 10.1016/j.celrep.2017.08.068; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Verma R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat6975; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wang Z, 2014, MUCOSAL IMMUNOL, V7, P1290, DOI 10.1038/mi.2014.17; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Worthington JJ, 2011, GASTROENTEROLOGY, V141, P1802, DOI 10.1053/j.gastro.2011.06.057; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamazaki S, 2018, J IMMUNOL, V200, P119, DOI 10.4049/jimmunol.1701056; Yamazaki S, 2014, J IMMUNOL, V193, P5488, DOI 10.4049/jimmunol.1400985; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Ye J, 2017, CELL REP, V21, P2277, DOI 10.1016/j.celrep.2017.10.114; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang CQ, 2017, CELL PHYSIOL BIOCHEM, V43, P2155, DOI 10.1159/000484295; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	150	76	77	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					386	396		10.1038/s41590-019-0351-z	http://dx.doi.org/10.1038/s41590-019-0351-z			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30890797	Green Submitted			2022-12-18	WOS:000461904200010
J	Jochems, SP; Marcon, F; Carniel, BF; Holloway, M; Mitsi, E; Smith, E; Gritzfeld, JF; Solorzano, C; Reine, J; Pojar, S; Nikolaou, E; German, EL; Hyder-Wright, A; Hill, H; Hales, C; Piters, WAAD; Bogaert, D; Adler, H; Zaidi, S; Connor, V; Gordon, SB; Rylance, J; Nakaya, HI; Ferreira, DM				Jochems, Simon P.; Marcon, Fernando; Carniel, Beatriz F.; Holloway, Mark; Mitsi, Elena; Smith, Emma; Gritzfeld, Jenna F.; Solorzano, Carla; Reine, Jesus; Pojar, Sherin; Nikolaou, Elissavet; German, Esther L.; Hyder-Wright, Angie; Hill, Helen; Hales, Caz; Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby; Adler, Hugh; Zaidi, Seher; Connor, Victoria; Gordon, Stephen B.; Rylance, Jamie; Nakaya, Helder I.; Ferreira, Daniela M.			Inflammation induced by influenza virus impairs human innate immune control of pneumococcus	NATURE IMMUNOLOGY			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; INTERFERON INDUCTION; SEASONAL INFLUENZA; ANTIBODY-RESPONSES; SYSTEMS-ANALYSIS; COINFECTION; VACCINATION; INFECTION; TRANSMISSION	Colonization of the upper respiratory tract by pneumococcus is important both as a determinant of disease and for transmission into the population. The immunological mechanisms that contain pneumococcus during colonization are well studied in mice but remain unclear in humans. Loss of this control of pneumococcus following infection with influenza virus is associated with secondary bacterial pneumonia. We used a human challenge model with type 6B pneumococcus to show that acquisition of pneumococcus induced early degranulation of resident neutrophils and recruitment of monocytes to the nose. Monocyte function was associated with the clearance of pneumococcus. Prior nasal infection with live attenuated influenza virus induced inflammation, impaired innate immune function and altered genome-wide nasal gene responses to the carriage of pneumococcus. Levels of the cytokine CXCL10, promoted by viral infection, at the time pneumococcus was encountered were positively associated with bacterial load.	[Jochems, Simon P.; Carniel, Beatriz F.; Holloway, Mark; Mitsi, Elena; Smith, Emma; Gritzfeld, Jenna F.; Solorzano, Carla; Reine, Jesus; Pojar, Sherin; Nikolaou, Elissavet; German, Esther L.; Hyder-Wright, Angie; Hill, Helen; Hales, Caz; Adler, Hugh; Zaidi, Seher; Connor, Victoria; Gordon, Stephen B.; Rylance, Jamie; Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Marcon, Fernando; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil; [Hyder-Wright, Angie; Hill, Helen; Hales, Caz; Connor, Victoria] Royal Liverpool & Broadgreen Univ Hosp, Liverpool, Merseyside, England; [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Med Ctr Utrecht, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands; [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Gordon, Stephen B.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	Liverpool School of Tropical Medicine; Universidade de Sao Paulo; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Edinburgh; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Malawi	Jochems, SP; Ferreira, DM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil.	simon.jochems@lstmed.ac.uk; hnakaya@usp.br; daniela.ferreira@lstmed.ac.uk	Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020; Hales, Caz/AAS-1820-2020; de Steenhuijsen Piters, Wouter/AAI-9952-2020; Jochems, Simon/AAT-9156-2021; Ferreira, Daniela M/AFF-4763-2022; Passos, Fernando Marcon/AAI-3922-2020; Jochems, Simon/FFT-0345-2022; Mitsi, Elena/AFI-7191-2022; Ferreira, Daniela M/AAE-9881-2022; Rylance, Jamie/ABD-9314-2021; Mitsi, Elena/AAF-3899-2022	Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Hales, Caz/0000-0002-3197-1657; de Steenhuijsen Piters, Wouter/0000-0002-1144-4067; Jochems, Simon/0000-0002-4835-1032; Ferreira, Daniela M/0000-0002-0594-0902; Passos, Fernando Marcon/0000-0001-5128-1410; Mitsi, Elena/0000-0001-7586-6050; Mitsi, Elena/0000-0001-7586-6050; Reine, Jesus/0000-0001-7462-2054; Pojar, Sherin/0000-0002-7746-3279; Nikolaou, Elissavet/0000-0003-4797-4710; Solorzano, Carla/0000-0001-9129-5569; Rylance, Jamie/0000-0002-2323-3611	Medical Research Council [MR/M011569/1]; Bill and Melinda Gates Foundation [OPP1117728]; National Institute for Health Research Local Comprehensive Research Network; Royal Society of Tropical Medicine and Hygiene; Sao Paulo Research Foundation (FAPESP) [2013/08216-2, 2012/19278-6]; Wellcome Trust Multi-User Equipment Grant [104936/Z/14/Z]; MRC [MR/M011569/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute for Health Research Local Comprehensive Research Network; Royal Society of Tropical Medicine and Hygiene; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Wellcome Trust Multi-User Equipment Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.B.G. and D.M.F. are supported by the Medical Research Council (grant MR/M011569/1), the Bill and Melinda Gates Foundation (grant OPP1117728) and the National Institute for Health Research Local Comprehensive Research Network. Flow cytometric acquisition was performed on a BD LSR II funded by a Wellcome Trust Multi-User Equipment Grant (104936/Z/14/Z). S.P.J. received support from the Royal Society of Tropical Medicine and Hygiene for NanoString analysis. H.I.N. is supported by the Sao Paulo Research Foundation (FAPESP; grants 2013/08216-2 and 2012/19278-6). We thank all volunteers for participating in this study, and R. Robinson, C. Lowe, L. Lazarova, K. Piddock and I. Wheeler for clinical support. We also acknowledge M. Mina for his input in study design.	Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; Alpkvist H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140112; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Cox MA, 2017, CURR OPIN IMMUNOL, V48, P61, DOI 10.1016/j.coi.2017.07.016; CRAFT AW, 1976, BRIT MED J, V1, P1570, DOI 10.1136/bmj.1.6025.1570; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Glennie S, 2016, MUCOSAL IMMUNOL, V9, P56, DOI 10.1038/mi.2015.35; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gritzfeld JF, 2014, CLIN MICROBIOL INFEC, V20, pO1145, DOI 10.1111/1469-0691.12752; Gritzfeld JF, 2013, JOVE-J VIS EXP, DOI 10.3791/50115; Hoffmann J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38532; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Jochems SP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006665; Jochems SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169805; Karppinen S, 2017, AM J RESP CRIT CARE, V196, P1172, DOI 10.1164/rccm.201702-0357OC; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Luo H, 2012, EXP THER MED, V3, P76, DOI 10.3892/etm.2011.350; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Mina MJ, 2014, LANCET RESP MED, V2, P750, DOI 10.1016/S2213-2600(14)70131-6; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morton B, 2016, SHOCK, V46, P635, DOI 10.1097/SHK.0000000000000715; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1; Rylance J., 2018, BIORXIV, DOI [10.1101/343319, DOI 10.1101/343319]; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Seyoum B, 2011, VACCINE, V29, P8002, DOI 10.1016/j.vaccine.2011.08.064; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/erv.12.53, 10.1586/ERV.12.53]; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thors V, 2016, AM J RESP CRIT CARE, V193, P1401, DOI 10.1164/rccm.201510-2000OC; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Wu WX, 2015, VIROLOGY, V482, P181, DOI 10.1016/j.virol.2015.03.048; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	58	76	77	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1299	+		10.1038/s41590-018-0231-y	http://dx.doi.org/10.1038/s41590-018-0231-y			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30374129	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000452873000011
J	Lee, CH; Romain, G; Yan, WP; Watanabe, M; Charab, W; Todorova, B; Lee, J; Triplett, K; Donkor, M; Lungu, OI; Lux, A; Marshall, N; Lindorfer, MA; Goff, ORL; Balbino, B; Kang, TH; Tanno, H; Delidakis, G; Alford, C; Taylor, RP; Nimmerjahn, F; Varadarajan, N; Bruhns, P; Zhang, YJ; Georgiou, G				Lee, Chang-Han; Romain, Gabrielle; Yan, Wupeng; Watanabe, Makiko; Charab, Wissam; Todorova, Biliana; Lee, Jiwon; Triplett, Kendra; Donkor, Moses; Lungu, Oana I.; Lux, Anja; Marshall, Nicholas; Lindorfer, Margaret A.; Goff, Odile Richard-Le; Balbino, Bianca; Kang, Tae Hyun; Tanno, Hidetaka; Delidakis, George; Alford, Corrine; Taylor, Ronald P.; Nimmerjahn, Falk; Varadarajan, Navin; Bruhns, Pierre; Zhang, Yan Jessie; Georgiou, George			IgG Fc domains that bind C1q but not effector Fc gamma receptors delineate the importance of complement-mediated effector functions	NATURE IMMUNOLOGY			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODIES; THERAPEUTIC ACTIVITY; MOUSE COMPLEMENT; HUMAN CD20; RITUXIMAB; ACTIVATION; AFFINITY; CELLS; GLYCOSYLATION	Engineered crystallizable fragment (Fc) regions of antibody domains, which assume a unique and unprecedented asymmetric structure within the homodimeric Fc polypeptide, enable completely selective binding to the complement component C1q and activation of complement via the classical pathway without any concomitant engagement of the Fc gamma receptor (Fc gamma R). We used the engineered Fc domains to demonstrate in vitro and in mouse models that for therapeutic antibodies, complement-dependent cell-mediated cytotoxicity (CDCC) and complement-dependent cell-mediated phagocytosis (CDCP) by immunological effector molecules mediated the clearance of target cells with kinetics and efficacy comparable to those of the Fc gamma R-dependent effector functions that are much better studied, while they circumvented certain adverse reactions associated with Fc gamma R engagement. Collectively, our data highlight the importance of CDCC and CDCP in monoclonal-antibody function and provide an experimental approach for delineating the effect of complement-dependent effector-cell engagement in various therapeutic settings.	[Lee, Chang-Han; Watanabe, Makiko; Charab, Wissam; Lee, Jiwon; Donkor, Moses; Lungu, Oana I.; Marshall, Nicholas; Kang, Tae Hyun; Tanno, Hidetaka; Delidakis, George; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Romain, Gabrielle; Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Yan, Wupeng; Triplett, Kendra; Zhang, Yan Jessie; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Todorova, Biliana; Goff, Odile Richard-Le; Balbino, Bianca; Bruhns, Pierre] Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France; [Todorova, Biliana; Goff, Odile Richard-Le; Balbino, Bianca; Bruhns, Pierre] INSERM, U760, Paris, France; [Lux, Anja; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Inst Genet, Dept Biol, Erlangen, Germany; [Lindorfer, Margaret A.; Taylor, Ronald P.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Balbino, Bianca] Univ Paris 06, Paris, France; [Alford, Corrine; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhang, Yan Jessie; Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Donkor, Moses] Medimmune Inc, Dept Infect Dis, Gaithersburg, MD 20878 USA; [Marshall, Nicholas] Merck, Dept Biochem Engn & Struct, Kenilworth, NJ USA	University of Texas System; University of Texas Austin; University of Houston System; University of Houston; University of Texas System; University of Texas Austin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Erlangen Nuremberg; University of Virginia; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; AstraZeneca; Medimmune; Merck & Company	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	gg@che.utexas.edu	Bruhns, Pierre/F-5567-2013; Lee, Chang-Han/AAG-9178-2019; GOFF, odile RICHARD-LE/ABH-9553-2020	Bruhns, Pierre/0000-0002-4709-8936; Lee, Chang-Han/0000-0002-7156-4423; Lux, Anja/0000-0001-9475-2147; Yan, Wupeng/0000-0001-5387-6362; richard-le goff, odile/0000-0002-6263-2375; Tanno, Hidetaka/0000-0001-6749-0938	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Cancer Prevention Research Training Program [RP110782, RP140108, RP160015, RP130570]; Clayton Foundation; Institut Pasteur; Institut National de la Sante et de la Recherche Medicale; European Research Council Seventh Frame-work Program [ERC-2013-CoG 616050]; Pasteur-Paris University International PhD program; American Cancer Society [123506-PF-13-354-01-CDD]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [CRC1181-A07]; US National Institutes of Health [R01CA174385, R01 GM104896]; Welch Foundation [F-1778]; NATIONAL CANCER INSTITUTE [R01CA174385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Cancer Prevention Research Training Program; Clayton Foundation; Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Research Council Seventh Frame-work Program; Pasteur-Paris University International PhD program; American Cancer Society(American Cancer Society); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tanno for assistance with protein expression; A. Bui for assistance with liquid chromatography-tandem mass spectrometry; P. Tucker (University of Texas at Austin) for cancer cell lines; D. Lee (MD Anderson Cancer Center) for patient-derived primary acute lymphocytic leukemia cells; the Macromolecular Crystallography Facility of the University of Texas at Austin; the Berkeley Center for Structural Biology; the Advanced Light Source (supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract DE-AC02-05CH11231); the Proteomics Facility at the University of Texas at Austin (supported by grant RP110782 from the Cancer Prevention Research Training Program); and A. Nicola and the Plate-Forme d'Imagerie Dynamique (Institut Pasteur, Paris) for help with the bioluminescence experiments. Supported by the Clayton Foundation, the Institut Pasteur (P.B. laboratory), the Institut National de la Sante et de la Recherche Medicale (P.B. laboratory), the European Research Council Seventh Frame-work Program (ERC-2013-CoG 616050 for the P.B. laboratory), the Pasteur-Paris University International PhD program (B.B.), the Cancer Prevention Research Training Program (RP140108 to M.D.; RP160015 to H.T.; and RP130570 to N.V.), the American Cancer Society (123506-PF-13-354-01-CDD to N.M.), Uehara Memorial Foundation (H.T.), Japan Society for the Promotion of Science (H.T.), Deutsche Forschungsgemeinschaft (CRC1181-A07 to F.N.), the US National Institutes of Health (R01CA174385 to N.V.; and R01 GM104896 to Y.J.Z.) and the Welch Foundation (F-1778 to Y.J.Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Cancer Prevention and Research Institute of Texas.	Ackerman M, 2013, ANTIBODY FC LINKING; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Beum PV, 2008, J IMMUNOL, V181, P822, DOI 10.4049/jimmunol.181.1.822; Bologna L, 2013, J IMMUNOL, V190, P231, DOI 10.4049/jimmunol.1202645; Boross P, 2012, AM J CANCER RES, V2, P676; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank M, 2014, J MOL BIOL, V426, P1799, DOI 10.1016/j.jmb.2014.01.011; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Golay J, 2012, ARCH BIOCHEM BIOPHYS, V526, P146, DOI 10.1016/j.abb.2012.02.011; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Jung ST, 2013, ACS CHEM BIOL, V8, P368, DOI 10.1021/cb300455f; Kelton W, 2014, CHEM BIOL, V21, P1603, DOI 10.1016/j.chembiol.2014.10.017; Kennedy AD, 2004, J IMMUNOL, V172, P3280, DOI 10.4049/jimmunol.172.5.3280; KLAUS GGB, 1979, IMMUNOLOGY, V38, P687; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee CF, 2013, J PROTEOME RES, V12, P4302, DOI 10.1021/pr400201d; Li FJ, 2014, CURR TOP MICROBIOL, V382, P29, DOI 10.1007/978-3-319-07911-0_2; Liadi I, 2013, JOVE-J VIS EXP, DOI 10.3791/50058; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; Lu JH, 2015, P NATL ACAD SCI USA, V112, P833, DOI 10.1073/pnas.1418812112; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merouane A, 2015, BIOINFORMATICS, V31, P3189, DOI 10.1093/bioinformatics/btv355; Min XY, 2014, IMMUNOBIOLOGY, V219, P671, DOI 10.1016/j.imbio.2014.03.018; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Nimmerjahn Falk, 2012, Cancer Immun, V12, P13; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawluczkowycz AW, 2009, J IMMUNOL, V183, P749, DOI 10.4049/jimmunol.0900632; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; RAMOS OF, 1985, P NATL ACAD SCI USA, V82, P5470, DOI 10.1073/pnas.82.16.5470; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Romain G, 2014, BLOOD, V124, P3241, DOI 10.1182/blood-2014-04-569061; Schneider S, 2012, MOL IMMUNOL, V51, P66, DOI 10.1016/j.molimm.2012.02.111; SCHREIBER AD, 1972, J CLIN INVEST, V51, P583, DOI 10.1172/JCI106847; Sondermann P, 2016, CURR OPIN IMMUNOL, V40, P78, DOI 10.1016/j.coi.2016.03.005; Taylor RP, 2014, METHODS, V65, P18, DOI 10.1016/j.ymeth.2013.07.027; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; van de Donk NWCJ, 2016, IMMUNOL REV, V270, P95, DOI 10.1111/imr.12389; Vaughan A. T., 2015, J BIOL CHEM; Wang SY, 2008, BLOOD, V111, P1456, DOI 10.1182/blood-2007-02-074716; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	63	76	79	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					889	+		10.1038/ni.3770	http://dx.doi.org/10.1038/ni.3770			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28604720	Green Submitted, Green Accepted			2022-12-18	WOS:000405821100011
J	Chan, YK; Gack, MU				Chan, Ying Kai; Gack, Michaela U.			A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity	NATURE IMMUNOLOGY			English	Article							HEPATITIS-C-VIRUS; ANTIVIRAL SIGNALING PROTEIN; RIG-I; NONSTRUCTURAL PROTEINS; STRUCTURAL BASIS; STRAIN 16681; INFECTION; VACCINE; BINDING; CELLS	14-3-3 proteins regulate biological processes by binding to phosphorylated serine or phosphorylated threonine motifs of cellular proteins. Among the 14-3-3 proteins, 14-3-3 epsilon serves a crucial function in antiviral immunity by mediating the cytosol-to-mitochondrial membrane translocation of the pathogen sensor RIG-I. Here we found that the NS3 protein of dengue virus (DV) bound to 14-3-3 epsilon and prevented translocation of RIG-I to the adaptor MAVS and thereby blocked antiviral signaling. Intriguingly, a highly conserved phosphomimetic RxEP motif in NS3 was essential for the binding of 14-3-3 epsilon. A recombinant mutant DV deficient in binding to 14-3-3 epsilon showed impairment in antagonism of RIG-I and elicited a markedly augmented innate immune response and enhanced T cell activation. Our work reveals a novel phosphomimetic-based mechanism for viral antagonism of 14-3-3-mediated immunity, which might guide the rational design of therapeutics.	[Chan, Ying Kai; Gack, Michaela U.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; University of Chicago	Gack, MU (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.; Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgack@uchicago.edu			US National Institutes of Health [R01 AI087846]; Giovanni Armenise-Harvard Foundation; William F. Milton Fund; John and Virginia Kaneb Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087846] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; William F. Milton Fund; John and Virginia Kaneb Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Huang (Center for Disease Control and Prevention) for the DV2 16681 infectious clone pD2/IC-30P; E. Harris (University of California, Berkeley) for antibody E1D8 to NS3; M. Diamond (Washington University in St. Louis) for cDNA encoding NS3 of WNV strain NY99 or Kunjin; Z. Chen (University of Texas Southwestern Medical Center) for cDNA encoding NS3 of HCV strain Con1 and plasmids encoding the HCV NS3-NS4A protease complex and its S139A catalytically-inactive mutant; R. Kuhn (Purdue University) for cDNA encoding NS3 of YFV strain 17D; J. Jung (University of Southern California) for Huh7.5 cells; M. Farzan (Scripps Institute Florida) for Huh7, BHK-21, C6/36 and K562 cells; N. Hacohen (Massachusetts General Hospital) for HEK293T ISRE-luciferase cells, L. Gehrke (Harvard University) for DV4 strain 814699; D. Knipe (Harvard University) for herpes simplex virus type 1; S. Whelan (Harvard University) for VSV-GFP; and A. Garcia-Sastre (Icahn School of Medicine at Mount Sinai) for NDV-GFP. Supported by the US National Institutes of Health (R01 AI087846), the Giovanni Armenise-Harvard Foundation, the William F. Milton Fund, and a John and Virginia Kaneb Fellowship (M.U.G.).	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chan YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034508; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Khumthong R, 2002, J BIOCHEM MOL BIOL, V35, P206; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	45	76	78	4	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					523	+		10.1038/ni.3393	http://dx.doi.org/10.1038/ni.3393			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26998762	Green Accepted, Green Submitted			2022-12-18	WOS:000374323100011
J	Charbonnier, LM; Wang, S; Georgiev, P; Sefik, E; Chatila, TA				Charbonnier, Louis-Marie; Wang, Sen; Georgiev, Peter; Sefik, Esen; Chatila, Talal A.			Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling	NATURE IMMUNOLOGY			English	Article							GATA3 EXPRESSION; FOXP3 EXPRESSION; RBP-J; DIFFERENTIATION; ACTIVATION; PATHWAY; MAINTENANCE; CD4(+); GENE	Receptors of the Notch family direct the differentiation of helper T cell subsets, but their influence on regulatory T cell (T-reg cell) responses is obscure. We found here that lineage-specific deletion of components of the Notch pathway enhanced Treg cell mediated suppression of type 1 helper T cell (T(H)1 cell) responses and protected against their T(H)1 skewing and apoptosis. In contrast, expression in Tin cells of a gain-of-function transgene encoding the Notchl intracellular domain resulted in lymphoproliferation, exacerbated T(H)1 responses and autoimmunity. Cell-intrinsic canonical Notch signaling impaired Treg cell fitness and promoted the acquisition by Treg cells of a T(H)1 cell like phenotype, whereas non-canonical Notch signaling dependent on the adaptor Rictor activated the kinase AKT-transcription factor Foxo1 axis and impaired the epigenetic stability of Foxp3. Our findings establish a critical role for Notch signaling in controlling peripheral T-reg cell function.	[Charbonnier, Louis-Marie; Wang, Sen; Georgiev, Peter; Chatila, Talal A.] Harvard Univ, Sch Med, Dept Pediat, Div Immunol,Boston Childrens Hosp, Boston, MA 02115 USA; [Sefik, Esen] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Chatila, TA (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Div Immunol,Boston Childrens Hosp, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu		Chatila, Talal/0000-0001-7439-2762; Charbonnier, Louis-Marie/0000-0002-4594-7893; Sefik, Esen/0000-0002-6807-3498; Georgiev, Peter/0000-0002-4613-1255	US National Institutes of Health [2R01AI065617, 2R01AI085090, 1R56AI115699-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, R56AI115699, R01AI085090] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Benoist for critical reading of the manuscript; P. Stanley (Albert Einstein College of Medicine) for Pofut1<SUP>fl/fl</SUP> mice; and T. Honjo (Kyoto University) for Rbpj<SUP>fl/fl</SUP> mice. Supported by the US National Institutes of Health (2R01AI065617, 2R01AI085090 and 1R56AI115699-01 to T.A.C.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Cho OH, 2009, J IMMUNOL, V182, P3380, DOI 10.4049/jimmunol.0802598; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Ou-Yang HF, 2009, MOL CELL BIOCHEM, V320, P109, DOI 10.1007/s11010-008-9912-4; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Perumalsamy LR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002859; Piggott K, 2011, CIRCULATION, V123, P309, DOI 10.1161/CIRCULATIONAHA.110.936203; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Roderick JE, 2013, J EXP MED, V210, P1311, DOI 10.1084/jem.20112615; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Sandy AR, 2013, J IMMUNOL, V190, P5818, DOI 10.4049/jimmunol.1203452; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Tran IT, 2013, J CLIN INVEST, V123, P1590, DOI 10.1172/JCI65477; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	47	76	79	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1162	1173		10.1038/ni.3288	http://dx.doi.org/10.1038/ni.3288			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26437242	Green Accepted, Green Submitted			2022-12-18	WOS:000363096000010
J	Bedel, R; Matsuda, JL; Brigl, M; White, J; Kappler, J; Marrack, P; Gapin, L				Bedel, Romain; Matsuda, Jennifer L.; Brigl, Manfred; White, Janice; Kappler, John; Marrack, Philippa; Gapin, Laurent			Lower TCR repertoire diversity in Traj18-deficient mice	NATURE IMMUNOLOGY			English	Letter							T-CELLS		[Bedel, Romain; Matsuda, Jennifer L.; Kappler, John; Marrack, Philippa; Gapin, Laurent] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Bedel, Romain; Matsuda, Jennifer L.; Kappler, John; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Denver, CO 80202 USA; [Brigl, Manfred] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [White, Janice; Kappler, John; Marrack, Philippa] Univ Colorado Denver, Howard Hughes Med Inst, Aurora, CO USA; [White, Janice; Kappler, John; Marrack, Philippa] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Kappler, John] Univ Colorado Denver, Program Biomol Struct, Aurora, CO USA; [Marrack, Philippa] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Denver; Harvard University; Brigham & Women's Hospital; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bedel, R (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA.		Marrack, Philippa/AHE-6316-2022	Matsuda, Jennifer/0000-0002-9191-9893; Marrack, Philippa/0000-0003-1883-3687; Gapin, Laurent/0000-0001-9730-5174	NIAID NIH HHS [R01 AI092108] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092108] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Genolet R, 2012, EMBO J, V31, P1666, DOI 10.1038/emboj.2012.48; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Hager E, 2007, J IMMUNOL, V179, P2228, DOI 10.4049/jimmunol.179.4.2228; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Riegert P, 1999, J IMMUNOL, V162, P3471; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471	11	76	76	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					705	706		10.1038/ni.2347	http://dx.doi.org/10.1038/ni.2347			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814339	Green Accepted			2022-12-18	WOS:000306569600001
J	Shen, ZJ; Esnault, S; Schinzel, A; Borner, C; Malter, JS				Shen, Zhong-Jian; Esnault, Stephane; Schinzel, Anna; Borner, Christoph; Malter, James S.			The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; FACTOR MESSENGER-RNA; INDUCED APOPTOSIS; PHOSPHORYLATION; CELLS; EXPRESSION; PROTEIN; BCL-2; KINASE; AIRWAY	The mechanisms by which cytokine signals prevent the activation and mitochondrial targeting of the proapoptotic protein Bax are unclear. Here we show, using primary human eosinophils, that in the absence of the prosurvival cytokines granulocyte-macrophage colony-stimulating factor and interleukin 5, Bax spontaneously underwent activation and initiated mitochondrial disruption. Inhibition of Bax resulted in less eosinophil apoptosis, even in the absence of cytokines. Granulocyte-macrophage colony-stimulating factor induced activation of the kinase Erk1/2, which phosphorylated Thr167 of Bax; this facilitated new interaction of Bax with the prolyl isomerase Pin1. Blockade of Pin1 led to cleavage and mitochondrial translocation of Bax and caspase activation, regardless of the presence of cytokines. Our findings indicate that Pin1 is a key mediator of prosurvival signaling and is a regulator of Bax function.	[Shen, Zhong-Jian; Esnault, Stephane; Malter, James S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Waisman Ctr Dev Disabil, Madison, WI 53705 USA; [Schinzel, Anna; Borner, Christoph] Univ Freiburg, Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Freiburg	Malter, JS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Waisman Ctr Dev Disabil, Madison, WI 53705 USA.	jsmalter@wisc.edu	Esnault, Stephane/AAJ-4511-2020; Esnault, Stephane/AAO-4712-2020	Esnault, Stephane/0000-0001-7238-8671	National Institutes of Health [R01HL087950, P01HL088594, P30HD03352]; Jose Carreras Leukemia Foundation of Germany; Deutsche Forschungsgesellschaft; Excellence Cluster Centre for Biological Signalling Studies; Bundesministerium fur Bildung und Forschung; Swiss National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL087950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jose Carreras Leukemia Foundation of Germany; Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Excellence Cluster Centre for Biological Signalling Studies; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Sedgwick () for eosinophils; K. P. Lu (Harvard University) for the Pin1 WW domain cDNA; N. Jarjour (University of Wisconsin) for bronchoscopy samples; S. Dowdy (Washington University) for pHisTAT; and members of the lab and the University of Wisconsin Asthma Working Group for suggestions. Supported by the National Institutes of Health (R01HL087950, P01HL088594 and P30HD03352 to J. S. M.), the Jose Carreras Leukemia Foundation of Germany (C. B.), Deutsche Forschungsgesellschaft (GRK1004, Graduate School GSC- 4 and Excellence Cluster Centre for Biological Signalling Studies; C. B.) and Bundesministerium fur Bildung und Forschung (HepatoSys; C. B.) and the Swiss National Science Foundation (A. S.).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ARM JP, 1992, ADV IMMUNOL, V51, P323, DOI 10.1016/S0065-2776(08)60491-5; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Brightling CE, 2003, THORAX, V58, P528, DOI 10.1136/thorax.58.6.528; Daniel PT, 1999, BLOOD, V94, P1100, DOI 10.1182/blood.V94.3.1100.415a16_1100_1107; Dewson G, 2001, BLOOD, V98, P2239, DOI 10.1182/blood.V98.7.2239; Dibbert B, 1998, BLOOD, V92, P778, DOI 10.1182/blood.V92.3.778.415k38_778_783; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Esnault S, 2006, J IMMUNOL, V177, P6999, DOI 10.4049/jimmunol.177.10.6999; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gibson PG, 2000, J ALLERGY CLIN IMMUN, V105, P752, DOI 10.1067/mai.2000.105319; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hirai K, 1997, CRIT REV IMMUNOL, V17, P325, DOI 10.1615/CritRevImmunol.v17.i3-4.40; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; IWAI K, 1994, BLOOD, V84, P1201; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Pazdrak K, 1998, J EXP MED, V188, P421, DOI 10.1084/jem.188.3.421; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Pinon LGP, 1997, DEVELOPMENT, V124, P4173; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Schwalm K, 2008, AM J PHYSIOL-LUNG C, V294, pL1102, DOI 10.1152/ajplung.00424.2007; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Simon HU, 2006, CHEM IMMUNOL ALLERGY, V91, P49; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tesfaigzi Y, 2002, J IMMUNOL, V169, P5919, DOI 10.4049/jimmunol.169.10.5919; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427	50	76	76	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					257	265		10.1038/ni.1697	http://dx.doi.org/10.1038/ni.1697			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19182807	Green Accepted			2022-12-18	WOS:000263456500009
J	O'Garra, A; Stockinger, B; Veldhoen, M				O'Garra, Anne; Stockinger, Brigitta; Veldhoen, Marc			Differentiation of human T-H-17 cells does require TGF-beta!	NATURE IMMUNOLOGY			English	Editorial Material							T-HELPER-CELLS; INTERLEUKIN-17; TH17	Three new studies demonstrate that development of human T-H-17 cells requires transforming growth factor-beta and one or more proinflammatory cytokines, which are the same requirements as for mouse T-H-17 development.	[O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Stockinger, Brigitta; Veldhoen, Marc] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk	Veldhoen, Marc/AAM-5357-2021; Veldhoen, Marc/AAJ-2759-2020	Veldhoen, Marc/0000-0002-1478-9562; Stockinger, Brigitta/0000-0001-8781-336X; O'Garra, Anne/0000-0001-9845-6134	MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; GEROSA F, IN PRESS J EXP MED; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L., 2008, NATURE; ZHOU L, 2008, NATURE          0326; 2007, NATURE, V448, P627	15	76	78	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					588	590		10.1038/ni0608-588	http://dx.doi.org/10.1038/ni0608-588			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490908				2022-12-18	WOS:000256067900008
J	Corren, J; Ziegler, SF				Corren, Jonathan; Ziegler, Steven F.			TSLP: from allergy to cancer	NATURE IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; CD4(+) T-CELLS; RESPIRATORY SYNCYTIAL VIRUS; GENOME-WIDE ASSOCIATION; INNATE LYMPHOID-CELLS; IGM(+) B-CELLS; MOLECULAR-CLONING; DENDRITIC CELLS; EPITHELIAL-CELLS	The cytokine TSLP has been shown to be a key factor in maintaining immune homeostasis and regulating inflammatory responses at mucosal barriers. While the role of TSLP in type 2 immune responses has been investigated extensively, recent studies have found an expanding role for TSLP in inflammatory diseases and cancer. In this Review, we will highlight major recent advances in TSLP biology, along with results from emerging clinical trials of anti-TSLP agents used for the treatment of a variety of inflammatory conditions.	[Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy & Clin Immunol, Los Angeles, CA 90095 USA; [Ziegler, Steven F.] Benaroya Res Inst, Immunol Program, Seattle, WA 98101 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Benaroya Research Institute	Ziegler, SF (corresponding author), Benaroya Res Inst, Immunol Program, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org		Ziegler, Steven/0000-0003-0657-5529	NATIONAL CANCER INSTITUTE [R01CA182783] Funding Source: NIH RePORTER; U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI) [5RO1CA182783] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)		ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Barnes PJ, 2018, NAT REV IMMUNOL, V18, P454, DOI 10.1038/s41577-018-0006-6; Barooei R, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0653-4; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bjerkan L, 2015, MUCOSAL IMMUNOL, V8, P49, DOI 10.1038/mi.2014.41; Brunetto E, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0521-4; Camelo A, 2017, BLOOD ADV, V1, P577, DOI 10.1182/bloodadvances.2016002352; Chang J, 2017, JAMA DERMATOL, V153, P275, DOI 10.1001/jamadermatol.2016.4467; Chapiro E, 2010, LEUKEMIA, V24, P642, DOI 10.1038/leu.2009.231; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Datta A, 2013, J IMMUNOL, V191, P4867, DOI 10.4049/jimmunol.1300588; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2016, J CLIN INVEST, V126, P1458, DOI 10.1172/JCI83724; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Dong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39559; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Ensor HM, 2011, BLOOD, V117, P2129, DOI 10.1182/blood-2010-07-297135; Fornasa G, 2015, J ALLERGY CLIN IMMUN, V136, P413, DOI 10.1016/j.jaci.2015.04.011; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fujio K, 2000, BLOOD, V95, P2204; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Ghirelli C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178438; Guen Salabert-Le, 2018, J ALLERGY CLIN IMMUN, V141; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V144, P482, DOI 10.1016/j.jaci.2018.11.053; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Han H, 2018, MUCOSAL IMMUNOL, V11, P577, DOI 10.1038/mi.2017.82; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; Han JY, 2012, J ALLERGY CLIN IMMUN, V130, P1175, DOI 10.1016/j.jaci.2012.08.033; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Iseki M, 2012, INT IMMUNOL, V24, P183, DOI 10.1093/intimm/dxr113; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Kuan EL, 2018, NAT IMMUNOL, V19, P366, DOI 10.1038/s41590-018-0066-6; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Levin SD, 1999, J IMMUNOL, V162, P677; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Loose D, 2009, CANCER BIOTHER RADIO, V24, P369, DOI 10.1089/cbr.2008.0593; Mack MR, 2018, TRENDS IMMUNOL, V39, P980, DOI 10.1016/j.it.2018.10.001; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Martin MD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01527; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ochiai S, 2018, P NATL ACAD SCI USA, V115, P1033, DOI 10.1073/pnas.1714348115; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park JH, 2017, AUTOIMMUN REV, V16, P55, DOI 10.1016/j.autrev.2016.09.014; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Qin HY, 2015, BLOOD, V126, P629, DOI 10.1182/blood-2014-11-612903; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Roll JD, 2010, CANCER RES, V70, P7347, DOI 10.1158/0008-5472.CAN-10-1528; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sano Y, 2013, CLIN EXP IMMUNOL, V171, P330, DOI 10.1111/cei.12021; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Simpson EL, 2019, J AM ACAD DERMATOL, V80, P1013, DOI 10.1016/j.jaad.2018.11.059; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sonesson A, 2011, EXP DERMATOL, V20, P1004, DOI 10.1111/j.1600-0625.2011.01391.x; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stier MT, 2016, J ALLERGY CLIN IMMUN, V138, P814, DOI 10.1016/j.jaci.2016.01.050; Takahashi N, 2016, CANCER RES, V76, P6241, DOI 10.1158/0008-5472.CAN-16-0992; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tsakok T, 2016, J ALLERGY CLIN IMMUN, V137, P1071, DOI 10.1016/j.jaci.2015.10.049; Uller L, 2018, J ALLERGY CLIN IMMUN, V142, P712, DOI 10.1016/j.jaci.2018.01.051; Varricchi G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01595; Volpe E, 2014, J ALLERGY CLIN IMMUN, V134, P373, DOI 10.1016/j.jaci.2014.04.022; Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709; Watanabe J, 2015, YONAGO ACTA MED, V58, P137; Watson CT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02188-7; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wu TC, 2018, CANCER RES, V78, P5243, DOI 10.1158/0008-5472.CAN-18-0413; Xie F, 2013, AM J REPROD IMMUNOL, V70, P69, DOI 10.1111/aji.12104; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Xu L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190116; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zhang Y, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12612; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	107	75	77	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1603	1609		10.1038/s41590-019-0524-9	http://dx.doi.org/10.1038/s41590-019-0524-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745338				2022-12-18	WOS:000497949800015
J	Afzali, B; Gronholm, J; Vandrovcova, J; O'Brien, C; Sun, HW; Vanderleyden, I; Davis, FP; Khoder, A; Zhang, Y; Hegazy, AN; Villarino, AV; Palmer, IW; Kaufman, J; Watts, NR; Kazemian, M; Kamenyeva, O; Keith, J; Sayed, A; Kasperaviciute, D; Mueller, M; Hughes, JD; Fuss, IJ; Sadiyah, MF; Montgomery-Recht, K; McElwee, J; Restifo, NP; Strober, W; Linterman, MA; Wingfield, PT; Uhlig, HH; Roychoudhuri, R; Aitman, TJ; Kelleher, P; Lenardo, MJ; O'Shea, JJ; Cooper, N; Laurence, ADJ				Afzali, Behdad; Gronholm, Juha; Vandrovcova, Jana; O'Brien, Charlotte; Sun, Hong-Wei; Vanderleyden, Ine; Davis, Fred P.; Khoder, Ahmad; Zhang, Yu; Hegazy, Ahmed N.; Villarino, Alejandro V.; Palmer, Ira W.; Kaufman, Joshua; Watts, Norman R.; Kazemian, Majid; Kamenyeva, Olena; Keith, Julia; Sayed, Anwar; Kasperaviciute, Dalia; Mueller, Michael; Hughes, Jason D.; Fuss, Ivan J.; Sadiyah, Mohammed F.; Montgomery-Recht, Kim; McElwee, Joshua; Restifo, Nicholas P.; Strober, Warren; Linterman, Michelle A.; Wingfield, Paul T.; Uhlig, Holm H.; Roychoudhuri, Rahul; Aitman, Timothy J.; Kelleher, Peter; Lenardo, Michael J.; O'Shea, John J.; Cooper, Nichola; Laurence, Arian D. J.			BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency	NATURE IMMUNOLOGY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; T-CELLS; DATABASE; CLASSIFICATION; IDENTIFICATION; AUTOIMMUNITY; METAANALYSIS	The transcriptional programs that guide lymphocyte differentiation depend on the precise expression and timing of transcription factors (TFs). The TF BACH2 is essential for T and B lymphocytes and is associated with an archetypal super-enhancer (SE). Single-nucleotide variants in the BACH2 locus are associated with several autoimmune diseases, but BACH2 mutations that cause Mendelian monogenic primary immunodeficiency have not previously been identified. Here we describe a syndrome of BACH2-related immunodeficiency and autoimmunity (BRIDA) that results from BACH2 haploinsufficiency. Affected subjects had lymphocyte-maturation defects that caused immunoglobulin deficiency and intestinal inflammation. The mutations disrupted protein stability by interfering with homodimerization or by causing aggregation. We observed analogous lymphocyte defects in Bach2-heterozygous mice. More generally, we observed that genes that cause monogenic haploinsufficient diseases were substantially enriched for TFs and SE architecture. These findings reveal a previously unrecognized feature of SE architecture in Mendelian diseases of immunity: heterozygous mutations in SE-regulated genes identified by whole-exome/genome sequencing may have greater significance than previously recognized.	[Afzali, Behdad; Sun, Hong-Wei; Davis, Fred P.; Villarino, Alejandro V.; Palmer, Ira W.; Kaufman, Joshua; Watts, Norman R.; Wingfield, Paul T.; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Biodata Min & Discovery Sect,NIH, Bethesda, MD 20892 USA; [Afzali, Behdad; Sun, Hong-Wei; Davis, Fred P.; Villarino, Alejandro V.; Palmer, Ira W.; Kaufman, Joshua; Watts, Norman R.; Wingfield, Paul T.; O'Shea, John J.] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Afzali, Behdad] Kings Coll London, MRC Ctr Transplantat, London, England; [Gronholm, Juha; Zhang, Yu; Kamenyeva, Olena; Fuss, Ivan J.; Strober, Warren; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, NIAID Clin Genom Program, Biol Imaging Sect,Res Technol Branch,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gronholm, Juha; Zhang, Yu; Kamenyeva, Olena; Fuss, Ivan J.; Strober, Warren; Lenardo, Michael J.] NIAID, Mucosal Immun Sect, Bethesda, MD 20892 USA; [Vandrovcova, Jana] UCL, Fac Brain Sci, Inst Neurol, Mol Neurosci, London, England; [Vandrovcova, Jana; O'Brien, Charlotte; Khoder, Ahmad; Sayed, Anwar; Aitman, Timothy J.; Kelleher, Peter; Cooper, Nichola] Imperial Coll London, Dept Med, London, England; [Vanderleyden, Ine; Sadiyah, Mohammed F.; Linterman, Michelle A.; Roychoudhuri, Rahul] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Hegazy, Ahmed N.; Keith, Julia; Uhlig, Holm H.; Laurence, Arian D. J.] John Radcliffe Hosp, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England; [Hegazy, Ahmed N.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford, England; [Kazemian, Majid] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Kazemian, Majid] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Kasperaviciute, Dalia; Mueller, Michael] Hammersmith Hosp, Imperial BRC Genom Facil, London, England; [Hughes, Jason D.; McElwee, Joshua] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Montgomery-Recht, Kim] Leidos Biomed Res Inc, Clin Res Directorate CMRP, NCI Frederick, Frederick, MD USA; [Restifo, Nicholas P.] NCI, NIH, Bethesda, MD 20892 USA; [Uhlig, Holm H.] Univ Oxford, Dept Paediat, Oxford, England; [Aitman, Timothy J.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Laurence, Arian D. J.] Northern Ctr Canc Care, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; University College London; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Oxford; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Imperial College London; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Edinburgh	Afzali, B (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Biodata Min & Discovery Sect,NIH, Bethesda, MD 20892 USA.; Afzali, B (corresponding author), NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA.; Afzali, B (corresponding author), Kings Coll London, MRC Ctr Transplantat, London, England.; Cooper, N (corresponding author), Imperial Coll London, Dept Med, London, England.	behdad.afzali@nih.gov; n.cooper@imperial.ac.uk	Afzali, Behdad/H-8565-2013; Sayed, Anwar/AEH-5779-2022; Restifo, Nicholas Phillip/M-6549-2019; Villarino, Alejandro/AAE-3517-2020; Grönholm, Juha/Q-4078-2017; Restifo, Nicholas Phillip/Z-1614-2019; Kazemian, Majid/C-7917-2018; Laurence, Arian/A-8770-2009; Linterman, Michelle/AAN-4210-2021; Roychoudhuri, Rahul/A-7442-2010	Afzali, Behdad/0000-0003-2968-1156; Sayed, Anwar/0000-0002-2243-0971; Villarino, Alejandro/0000-0001-8068-2176; Grönholm, Juha/0000-0002-4190-0000; Kazemian, Majid/0000-0001-7080-8820; Laurence, Arian/0000-0003-0942-8292; Linterman, Michelle/0000-0001-6047-1996; Davis, Fred/0000-0001-8294-1610; Roychoudhuri, Rahul/0000-0002-5392-1853; Aitman, Timothy/0000-0002-7875-4502; Restifo, Nicholas P./0000-0003-4229-4580; Uhlig, Holm/0000-0002-6111-7355; Wingfield, Paul/0000-0002-9515-4752; Hegazy, Ahmed N./0000-0002-2946-8251	Intramural Research Programs of NIAMS, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center; National Human Genome Research Institute, National Institutes of Health; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Crohn's & Colitis Foundation of America; US National Institutes of Health [KHL125593A]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Wellcome Trust [097261/Z/11/Z, 105663/Z/14/Z]; European Molecular Biology Organization [ALTF 11602012]; Marie Curie fellowship [330621]; Imperial College National Institute for Health Research (NIHR) Biomedical Research Centre; Oxford NIHR Biomedical Research Centre; Chelsea & Westminster Hospital Charity; UK Biotechnology and Biological Sciences Research Council [BB/N0077941/1]; Cancer Research UK [C52623/A22597]; Westminster Medical School Research Trust; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407]; Cambridge Trust; Leona M. and Harry B. Helmsley Charitable Trust; ESPGHAN; MRC Clinical Sciences Centre (CSC); CSC Genomics Core Laboratory; MRC; NIHR Oxford Biomedical Research Centre; NIGMS [P41-GM103311]; BBSRC [BB/N007794/1, BBS/E/B/000C0427, 1642652, BBS/E/B/000C0407, BBS/E/B/000C0409, BBS/E/B/000C0428] Funding Source: UKRI; MRC [MC_U120061454] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0428, BBS/E/B/000C0409, 1642652, BB/N007794/1, BBS/E/B/000C0427] Funding Source: researchfish; Cancer Research UK [22597] Funding Source: researchfish; National Institute for Health Research [CL-2014-21-004] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL125593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041207, ZIAAR041167, ZIAAR041159, ZIHAR041173, ZIGAR041168, ZICAR041169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Crohn's & Colitis Foundation of America; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie fellowship(European Commission); Imperial College National Institute for Health Research (NIHR) Biomedical Research Centre; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Chelsea & Westminster Hospital Charity; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Westminster Medical School Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Trust; Leona M. and Harry B. Helmsley Charitable Trust; ESPGHAN; MRC Clinical Sciences Centre (CSC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSC Genomics Core Laboratory; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all subjects and healthy donors for their support, and we thank H. Matthews and C. Neurwirth for coordinating control blood samples. This research was supported by the Intramural Research Programs of NIAMS, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center, and National Human Genome Research Institute, National Institutes of Health. This project was funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. This work was supported by the Crohn's & Colitis Foundation of America (A.D.J.L. and H.H.U.), the US National Institutes of Health (grant KHL125593A to M.K.), the Sigrid Juselius and Emil Aaltonen Foundations (both to J.G.), the Wellcome Trust (grant 097261/Z/11/Z to B.A.; grant 105663/Z/14/Z to R.R.), the European Molecular Biology Organization (grant ALTF 11602012 to A.N.H.), a Marie Curie fellowship (FP7-PEOPLE-2012-IEF, proposal 330621, to A.N.H.), the Imperial College National Institute for Health Research (NIHR) Biomedical Research Centre (N.C. and P.K.), the Oxford NIHR Biomedical Research Centre (H.H.U.), the Chelsea & Westminster Hospital Charity (C.O'B.), the UK Biotechnology and Biological Sciences Research Council (BB/N0077941/1 to R.R. and M.F.S.), Cancer Research UK (C52623/A22597 to R.R.), the Westminster Medical School Research Trust (P.K.), the Biotechnology and Biological Sciences Research Council (grant BBS/E/B/000C0407 to M.A.L. and I.V.), the Cambridge Trust (I.V.), the Leona M. and Harry B. Helmsley Charitable Trust and ESPGHAN (H.H.U.), the MRC Clinical Sciences Centre (CSC) (T.J.A.) and the CSC Genomics Core Laboratory, and by MRC transition funding (T.J.A.). We acknowledge the contribution of the BRC Gastrointestinal biobankOxford IBD cohort study, which is supported by the NIHR Oxford Biomedical Research Centre. We thank G. Vahedi, E. Mathe, S. Parker, C. Kanellopoulou and S. Muljo for critical reading of the manuscript; J. Kabat for help with confocal image analysis; and S.S. De Ravin and H. Malech for advice on the use of MaxCyte. Molecular graphics and analyses were done with the UCSF Chimera package, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). This study used high-performance computational capabilities of Helix Systems at the NIH (http://helix.nih.gov).	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arason GJ, 2010, SCAND J IMMUNOL, V71, P317, DOI 10.1111/j.1365-3083.2010.02386.x; Bible PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127285; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Deane S, 2009, INT ARCH ALLERGY IMM, V150, P311, DOI 10.1159/000226232; Deau MC, 2015, J CLIN INVEST, V125, P1764, DOI 10.1172/JCI81746; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Khoder A, 2014, BLOOD, V124, P2034, DOI 10.1182/blood-2014-04-571125; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lo B, 2016, BLOOD, V128, P1037, DOI 10.1182/blood-2016-04-712612; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nakayama Y, 2006, J CELL BIOCHEM, V99, P1308, DOI 10.1002/jcb.20952; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Povoleri GAM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00169; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Rosbrook GO, 2012, ACTA CRYSTALLOGR D, V68, P26, DOI 10.1107/S0907444911048335; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salzer U, 2006, CURR OPIN RHEUMATOL, V18, P377, DOI 10.1097/01.bor.0000231906.12172.6e; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Uhlig HH, 2014, GASTROENTEROLOGY, V147, P990, DOI 10.1053/j.gastro.2014.07.023; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	64	75	76	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					813	+		10.1038/ni.3753	http://dx.doi.org/10.1038/ni.3753			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28530713	Green Submitted, Green Accepted			2022-12-18	WOS:000403676300016
J	Shaw, LA; Belanger, S; Omilusik, KD; Cho, S; Scott-Browne, JP; Nance, JP; Goulding, J; Lasorella, A; Lu, LF; Crotty, S; Goldrath, AW				Shaw, Laura A.; Belanger, Simon; Omilusik, Kyla D.; Cho, Sunglim; Scott-Browne, James P.; Nance, J. Philip; Goulding, John; Lasorella, Anna; Lu, Li-Fan; Crotty, Shane; Goldrath, Ananda W.			Id2 reinforces T(H)1 differentiation and inhibits E2A to repress T-FH differentiation	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; TRANSCRIPTIONAL REGULATOR ID2; BCL6; EXPRESSION; INDUCTION; PROTEINS; CD4(+); ORCHESTRATE; T-HELPER-1; RESPONSES	The differentiation of helper T cells into effector subsets is critical to host protection. Transcription factors of the E-protein and Id families are important arbiters of T cell development, but their role in the differentiation of the T(H)1 and T-FH subsets of helper T cells is not well understood. Here, T(H)1 cells showed more robust Id2 expression than that of T-FH cells, and depletion of Id2 via RNA-mediated interference increased the frequency of T-FH cells. Furthermore, T(H)1 differentiation was blocked by Id2 deficiency, which led to E-protein-dependent accumulation of effector cells with mixed characteristics during viral infection and severely impaired the generation of T(H)1 cells following infection with Toxoplasma gondii. The T-FH cell-defining transcriptional repressor Bcl6 bound the Id2 locus, which provides a mechanism for the bimodal Id2 expression and reciprocal development of T(H)1 cells and T-FH cells.	[Shaw, Laura A.; Omilusik, Kyla D.; Cho, Sunglim; Goulding, John; Lu, Li-Fan; Goldrath, Ananda W.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Belanger, Simon; Nance, J. Philip; Crotty, Shane] La Jolla Inst Allergy Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Scott-Browne, James P.] La Jolla Inst Allergy Immunol, Div Signaling & Gene Express, La Jolla, CA USA; [Lasorella, Anna] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; La Jolla Institute for Immunology; La Jolla Institute for Immunology; Columbia University; University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA.; Crotty, S (corresponding author), La Jolla Inst Allergy Immunol, Div Vaccine Discovery, La Jolla, CA USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	shane@lji.org; agoldrath@ucsd.edu	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; Lu, Li-Fan/0000-0002-9727-0036; Omilusik, Kyla/0000-0003-3675-048X	US National Institutes of Health [1F31AG043222-01A1, AI108651, AI067545, AI109976]; Fonds de la recherche Quebec-Sante; Damon Runyon Cancer Research Foundation (Fraternal Order of Eagles Fellowship) [DRG-2069-11]; Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, U19AI109976, R01AI067545, R01AI108651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043222] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la recherche Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Damon Runyon Cancer Research Foundation (Fraternal Order of Eagles Fellowship); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Goldrath and Crotty laboratories for discussions; B. Yu for assistance with bioinformatics analysis; and I. Bilic and M. Busslinger for E2A Bio-ChiP-seq data. Supported by the US National Institutes of Health (1F31AG043222-01A1 to L.A.S., AI108651 to L.-F.L., AI067545 to A.W.G., AI109976 to A.W.G. and S.C.), the Fonds de la recherche Quebec-Sante (Postdoctoral Training Award to S.B.), The Damon Runyon Cancer Research Foundation (Fraternal Order of Eagles Fellowship DRG-2069-11 to J.P.S.-B.) and the Leukemia and Lymphoma Society (K.D.O. and A.W.G.).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; D'Cruz LM, 2014, J IMMUNOL, V192, P2227, DOI 10.4049/jimmunol.1302904; D'Cruz LM, 2012, EUR J IMMUNOL, V42, P2031, DOI 10.1002/eji.201242497; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Gao P, 2014, J EXP MED, V211, P2651, DOI 10.1084/jem.20132681; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Lin YY, 2012, J IMMUNOL, V189, P1400, DOI 10.4049/jimmunol.1200491; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Masson F, 2013, J IMMUNOL, V190, P4585, DOI 10.4049/jimmunol.1300099; Miyazaki M, 2015, GENE DEV, V29, P409, DOI 10.1101/gad.255331.114; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nance JP, 2015, P NATL ACAD SCI USA, V112, P13324, DOI 10.1073/pnas.1507312112; Nance JP, 2015, J IMMUNOL, V194, P5599, DOI 10.4049/jimmunol.1500200; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Sher A, 2003, IMMUNOL RES, V27, P521, DOI 10.1385/IR:27:2-3:521; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xiao R, 2015, DEV COMP IMMUNOL, V49, P149, DOI 10.1016/j.dci.2014.10.014; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	54	75	80	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					834	+		10.1038/ni.3461	http://dx.doi.org/10.1038/ni.3461			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27213691	Green Accepted			2022-12-18	WOS:000378283200016
J	Shaked, I; Hanna, RN; Shaked, H; Chodaczek, G; Nowyhed, HN; Tweet, G; Tacke, R; Basat, AB; Mikulski, Z; Togher, S; Miller, J; Blatchley, A; Salek-Ardakani, S; Darvas, M; Kaikkonen, MU; Thomas, GD; Lai-Wing-Sun, S; Rezk, A; Bar-Or, A; Glass, CK; Bandukwala, H; Hedrick, CC				Shaked, Iftach; Hanna, Richard N.; Shaked, Helena; Chodaczek, Grzegorz; Nowyhed, Heba N.; Tweet, George; Tacke, Robert; Basat, Alp Bugra; Mikulski, Zbigniew; Togher, Susan; Miller, Jacqueline; Blatchley, Amy; Salek-Ardakani, Shahram; Darvas, Martin; Kaikkonen, Minna U.; Thomas, Graham D.; Lai-Wing-Sun, Sonia; Rezk, Ayman; Bar-Or, Amit; Glass, Christopher K.; Bandukwala, Hozefa; Hedrick, Catherine C.			Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NUCLEAR RECEPTOR; NGFI-B; PRAZOSIN TREATMENT; CELL-DEVELOPMENT; T-CELLS; MONOCYTES; NUR77; DIFFERENTIATION; CATECHOLAMINES	The molecular mechanisms that link the sympathetic stress response and inflammation remain obscure. Here we found that the transcription factor Nr4a1 regulated the production of norepinephrine (NE) in macrophages and thereby limited experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. Lack of Nr4a1 in myeloid cells led to enhanced NE production, accelerated infiltration of leukocytes into the central nervous system (CNS) and disease exacerbation in vivo. In contrast, myeloid-specific deletion of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, protected mice against EAE. Furthermore, we found that Nr4a1 repressed autocrine NE production in macrophages by recruiting the corepressor CoREST to the Th promoter. Our data reveal a new role for macrophages in neuroinflammation and identify Nr4a1 as a key regulator of catecholamine production by macrophages.	[Shaked, Iftach; Hanna, Richard N.; Shaked, Helena; Nowyhed, Heba N.; Tweet, George; Tacke, Robert; Basat, Alp Bugra; Togher, Susan; Miller, Jacqueline; Blatchley, Amy; Thomas, Graham D.; Bandukwala, Hozefa; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Chodaczek, Grzegorz; Mikulski, Zbigniew] La Jolla Inst Allergy & Immunol, Microscopy Core, La Jolla, CA USA; [Salek-Ardakani, Shahram] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Darvas, Martin] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kaikkonen, Minna U.] Univ Eastern Finland, Dept Biotechnol & Mol Med, Kuopio, Finland; [Lai-Wing-Sun, Sonia; Rezk, Ayman; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; University of Eastern Finland; McGill University; University of California System; University of California San Diego	Shaked, I (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.	Iftach@lji.org; hedrick@lji.org	Glass, Christopher/AAI-3933-2021; Chodaczek, Grzegorz/AAH-1681-2022; Chodaczek, Grzegorz/AFL-9576-2022; Chodaczek, Grzegorz/G-4073-2014; Darvas, Martin/E-2935-2015; Shaked, Iftach/AAS-9961-2020; Shaked, Iftach/GNM-9959-2022; Mikulski, Zbigniew/AAB-4447-2020; Bar-Or, Amit/AIC-1416-2022; Kaikkonen, Minna U/AAK-3612-2020	Glass, Christopher/0000-0003-4344-3592; Darvas, Martin/0000-0002-7942-2526; Mikulski, Zbigniew/0000-0002-1918-9216; Kaikkonen, Minna U/0000-0001-6294-0979; Thomas, Graham/0000-0001-9778-8874	American Heart Association [13SDG17060117, 12SDG12070005]; La Jolla Institute Board of Directors; Fondation Leducq; Sigrid Juselius Foundation; Academy of Finland; Pacific Northwest Udall Center [P50-NS062684]; US National Institutes of Health [R01 DK091183-21, R01 HL118765]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); La Jolla Institute Board of Directors; Fondation Leducq(Leducq Foundation); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Pacific Northwest Udall Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Metzger (Institut Genetique Biologie Moleculaire Cellulaire) and H. Ichinose (Tokyo Institute of Technology) for Nr4a1<SUP>fl/fl</SUP> mice; K. Ley for discussions; A. Rao for guidance in composing the manuscript; A. Crotti for guidance on microglia culture; and D. Yoakum for assistance with mouse colony management. Supported by the American Heart Association (13SDG17060117 to I.S. and 12SDG12070005 to R.N.H.), the La Jolla Institute Board of Directors (R.N.H.), Fondation Leducq (M.U.K.), the Sigrid Juselius Foundation (M.U.K.), the Academy of Finland (M.U.K.), the Pacific Northwest Udall Center (P50-NS062684 to M.D.) and the US National Institutes of Health (R01 DK091183-21 to C.K.G. and R01 HL118765 to C.C.H.).	Achiron A, 2011, J NEUROL SCI, V311, P9, DOI 10.1016/j.jns.2011.06.038; Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BROSNAN CF, 1985, P NATL ACAD SCI USA, V82, P5915, DOI 10.1073/pnas.82.17.5915; BROSNAN CF, 1986, J IMMUNOL, V137, P3451; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Campos-Melo D, 2011, NEUROTOX RES, V20, P289, DOI 10.1007/s12640-011-9243-1; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; CLAUDIO L, 1992, BRAIN RES, V594, P233, DOI 10.1016/0006-8993(92)91130-7; Cosentino M, 2013, J NEUROIMMUNE PHARM, V8, P163, DOI 10.1007/s11481-012-9410-z; Dimitrijevic M, 2007, EUR J PHARMACOL, V577, P170, DOI 10.1016/j.ejphar.2007.08.021; Fan ZG, 2010, NAT MED, V16, P718, DOI 10.1038/nm.2155; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilbert F, 2006, BIOL PSYCHIAT, V60, P538, DOI 10.1016/j.biopsych.2006.04.023; Gold SM, 2005, TRENDS IMMUNOL, V26, P644, DOI 10.1016/j.it.2005.09.010; GOLDMUNTZ EA, 1986, J IMMUNOL, V137, P3444; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; He XB, 2011, STEM CELLS, V29, P1861, DOI 10.1002/stem.739; Helbling JC, 2014, J NEUROSCI RES, V92, P825, DOI 10.1002/jnr.23366; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Malkani S, 2000, MOL BRAIN RES, V80, P153, DOI 10.1016/S0169-328X(00)00130-3; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nowyhed HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep09059; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yi SH, 2014, DEVELOPMENT, V141, P761, DOI 10.1242/dev.095802	54	75	76	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1228	1234		10.1038/ni.3321	http://dx.doi.org/10.1038/ni.3321			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26523867	Green Accepted			2022-12-18	WOS:000365062100006
J	Ubelhart, R; Hug, E; Bach, MP; Wossning, T; Duhren-von Minden, M; Horn, AHC; Tsiantoulas, D; Kometani, K; Kurosaki, T; Binder, CJ; Sticht, H; Nitschke, L; Reth, M; Jumaa, H				Uebelhart, Rudolf; Hug, Eva; Bach, Martina P.; Wossning, Thomas; Duehren-von Minden, Marcus; Horn, Anselm H. C.; Tsiantoulas, Dimitrios; Kometani, Kohei; Kurosaki, Tomohiro; Binder, Christoph J.; Sticht, Heinrich; Nitschke, Lars; Reth, Michael; Jumaa, Hassan			Responsiveness of B cells is regulated by the hinge region of IgD	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-D; POSITIVE SELECTION; ANTIGEN; SURFACE; ANTIBODIES; RECEPTOR; MICE; LYMPHOCYTES; ACTIVATION; EXPRESSION	Mature B cells express immunoglobulin M (IgM)- and IgD-isotype B cell antigen receptors, but the importance of IgD for B cell function has been unclear. By using a cellular in vitro system and corresponding mouse models, we found that antigens with low valence activated IgM receptors but failed to trigger IgD signaling, whereas polyvalent antigens activated both receptor types. Investigations of the molecular mechanism showed that deletion of the IgD-specific hinge region rendered IgD responsive to monovalent antigen, whereas transferring the hinge to IgM resulted in responsiveness only to polyvalent antigen. Our data suggest that the increased IgD/IgM ratio on conventional B-2 cells is important for preferential immune responses to antigens in immune complexes, and that the increased IgM expression on B-1 cells is essential for B-1 cell homeostasis and function.	[Uebelhart, Rudolf; Hug, Eva; Bach, Martina P.; Duehren-von Minden, Marcus; Jumaa, Hassan] Univ Hosp Ulm, Inst Immunol, Ulm, Germany; [Wossning, Thomas; Reth, Michael; Jumaa, Hassan] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Duehren-von Minden, Marcus; Reth, Michael; Jumaa, Hassan] Univ Freiburg, Dept Mol Immunol, Biol 3, Fac Biol, D-79106 Freiburg, Germany; [Horn, Anselm H. C.; Sticht, Heinrich] Univ Erlangen Nurnberg, Dept Bioinformat, Inst Biochem, D-91054 Erlangen, Germany; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, A-1010 Vienna, Austria; [Kometani, Kohei; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Turumi Ku, Yokohama, Kanagawa, Japan; [Kurosaki, Tomohiro] Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Nitschke, Lars] Univ Erlangen Nurnberg, Chair Genet, Dept Biol, D-91054 Erlangen, Germany	Ulm University; University of Freiburg; University of Freiburg; University of Erlangen Nuremberg; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society; RIKEN; Osaka University; University of Erlangen Nuremberg	Jumaa, H (corresponding author), Univ Hosp Ulm, Inst Immunol, Ulm, Germany.	hassan.jumaa@uni-ulm.de	Tsiantoulas, Dimitrios/AAK-9521-2021; Kurosaki, Tomohiro/D-1306-2009	Tsiantoulas, Dimitrios/0000-0002-7743-3192; Kurosaki, Tomohiro/0000-0002-6352-304X; Sticht, Heinrich/0000-0001-5644-045X; Kometani, Kohei/0000-0003-4281-4371; Binder, Christoph J./0000-0001-8313-7050; Horn, Anselm/0000-0003-3539-8103	Deutsche Forschungsgemeinschaft [JU 463/2-1, TRR130]; Deutsche Krebshilfe [108935]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank P. Nielsen for scientific discussion and critical reading of the manuscript; U. Stauffer, N. Joswig and C. Johner for mouse work; A. Wurch and M. Knoblauch for help with flow cytometry experiments; H.-P. Pircher (University of Freiburg) and A. Weiss (University of California, San Francisco) for providing MD4 and ML5 mice, respectively; and F.D. Batista (London Research Institute) for providing cDNA encoding for immunoglobulin HC and LC genes of the HH10 BCR. This work was supported by the Deutsche Forschungsgemeinschaft (JU 463/2-1 and TRR130) and the Deutsche Krebshilfe (Project 108935).	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; AVRAMEAS S, 1979, J IMMUNOL, V122, P648; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; CARSETTI R, 1993, EUR J IMMUNOL, V23, P168, DOI 10.1002/eji.1830230127; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kim KM, 1995, ANN NY ACAD SCI, V766, P81, DOI 10.1111/j.1749-6632.1995.tb26651.x; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LAVOIE TB, 1992, J IMMUNOL, V148, P503; Lutz C, 1998, NATURE, V393, P797, DOI 10.1038/31716; MAYUMI M, 1994, J ALLERGY CLIN IMMUN, V94, P612, DOI 10.1016/0091-6749(94)90137-6; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nezlin R, 1990, Adv Immunol, V48, P1, DOI 10.1016/S0065-2776(08)60750-6; NITSCHKE L, 1993, P NATL ACAD SCI USA, V90, P1887, DOI 10.1073/pnas.90.5.1887; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; Tsiantoulas D, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00415; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	50	75	77	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					534	543		10.1038/ni.3141	http://dx.doi.org/10.1038/ni.3141			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25848865				2022-12-18	WOS:000353305200016
J	Mowen, KA; David, M				Mowen, Kerri A.; David, Michael			Unconventional post-translational modifications in immunological signaling	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; PROTEIN ARGININE METHYLATION; DEIMINASE TYPE-II; PEPTIDYLARGININE DEIMINASE; LYSINE METHYLATION; GENE-EXPRESSION; CITRULLINATED PROTEINS; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; DNA-BINDING	The activity of a cell is governed by the signals it receives from the extracellular milieu, which are 'translated' into the appropriate biological output, such as activation, survival, proliferation, migration or differentiation. Signaling pathways are responsible for converting environmental cues into discrete intracellular events. The alteration of existing proteins by post-translational modification (PTM) is a key feature of signal-transduction pathways that allows the modulation of protein function. Research into PTMs has long been dominated by the investigation of protein phosphorylation; other PTMs, such as methylation of lysine and arginine residues, acetylation, and nitrosylation of thiol groups and tyrosine residues, have received comparatively little attention. This Review aims to present an overview of these PTMs, with an emphasis on their role in cells of the immune system.	[Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Mowen, Kerri A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [David, Michael] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [David, Michael] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	midavid@ucsd.edu						Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Akiyama K, 1999, NEUROSCI LETT, V274, P53, DOI 10.1016/S0304-3940(99)00678-3; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Arandjelovic S, 2012, J IMMUNOL, V189, P4112, DOI 10.4049/jimmunol.1201098; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 2002, NEUROSCI LETT, V326, P129, DOI 10.1016/S0304-3940(02)00334-8; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen WG, 2004, J IMMUNOL, V172, P6744, DOI 10.4049/jimmunol.172.11.6744; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Chung JH, 2013, J BIOL CHEM, V288, P35534, DOI 10.1074/jbc.M113.510669; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Dwivedi N, 2012, ARTHRITIS RHEUM-US, V64, P982, DOI 10.1002/art.33432; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fathman JW, 2010, P NATL ACAD SCI USA, V107, P3663, DOI 10.1073/pnas.0914700107; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FORSTERMANN U, 1991, BIOCHEM PHARMACOL, V42, P1849, DOI 10.1016/0006-2952(91)90581-O; Foulquier C., 2007, ARTHRITIS RHEUM, V56, P3541; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Herzog J, 2005, P NATL ACAD SCI USA, V102, P7928, DOI 10.1073/pnas.0502255102; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Infantino S, 2010, J EXP MED, V207, P711, DOI 10.1084/jem.20091303; Iwasaki H, 2010, CIRC RES, V107, P992, DOI 10.1161/CIRCRESAHA.110.225326; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Komyod W, 2005, J BIOL CHEM, V280, P21700, DOI 10.1074/jbc.C400606200; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lee HJ, 2010, J BIOL CHEM, V285, P39655, DOI 10.1074/jbc.M110.170290; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li J, 2013, J IMMUNOL, V190, P597, DOI 10.4049/jimmunol.1102513; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Llovera M, 2001, BRIT J PHARMACOL, V132, P419, DOI 10.1038/sj.bjp.0703838; Lu T, 2013, P NATL ACAD SCI USA, V110, P13510, DOI 10.1073/pnas.1311770110; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mechin M.-C., 2007, International Journal of Cosmetic Science, V29, P147, DOI 10.1111/j.1467-2494.2007.00377.x; Moscarello MA, 2002, J NEUROCHEM, V81, P335, DOI 10.1046/j.1471-4159.2002.00834.x; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(01)00269-0; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Raijmakers R, 2006, J COMP NEUROL, V498, P217, DOI 10.1002/cne.21055; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Rho J, 2001, J VIROL, V75, P8031, DOI 10.1128/JVI.75.17.8031-8044.2001; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Sambandam T, 2004, BIOCHEM BIOPH RES CO, V325, P1324, DOI 10.1016/j.bbrc.2004.10.173; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoshida Mamoru, 2006, Mod Rheumatol, V16, P276; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao XY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2478; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	123	75	80	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					512	520		10.1038/ni.2873	http://dx.doi.org/10.1038/ni.2873			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840982				2022-12-18	WOS:000336419300005
J	Schmolka, N; Serre, K; Grosso, AR; Rei, M; Pennington, DJ; Gomes, AQ; Silva-Santos, B				Schmolka, Nina; Serre, Karine; Grosso, Ana R.; Rei, Margarida; Pennington, Daniel J.; Gomes, Anita Q.; Silva-Santos, Bruno			Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory gamma delta T cell subsets	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA; PIVOTAL ROLE; INTERLEUKIN-17; MEMORY; FATE; IDENTIFICATION; LYMPHOCYTES; ACTIVATION; CHROMATIN; CYTOKINE	Two distinct subsets of gamma delta T cells that produce interleukin 17 (IL-17) (CD27(-) gamma delta T cells) or interferon-gamma (IFN-gamma) (CD27(+) gamma delta T cells) develop in the mouse thymus, but the molecular determinants of their functional potential in the periphery remain unknown. Here we conducted a genome-wide characterization of the methylation patterns of histone H3, along with analysis of mRNA encoding transcription factors, to identify the regulatory networks of peripheral IFN-gamma-producing or IL-17-producing gamma delta T cell subsets in vivo. We found that CD27(+) gamma delta T cells were committed to the expression of Ifng but not Il17, whereas CD27(-) gamma delta T cells displayed permissive chromatin configurations at loci encoding both cytokines and their regulatory transcription factors and differentiated into cells that produced both IL-17 and IFN-gamma in a tumor microenvironment.	[Schmolka, Nina; Serre, Karine; Grosso, Ana R.; Rei, Margarida; Gomes, Anita Q.; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Rei, Margarida; Pennington, Daniel J.] Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, London, England; [Gomes, Anita Q.] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal; [Silva-Santos, Bruno] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; University of London; Queen Mary University London; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Silva-Santos, B (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	anitagomes@fm.ul.pt; bssantos@fm.ul.pt	Grosso, Ana Rita/I-6656-2013; Gomes, Anita Q./C-3580-2014; Serre, Karine/AAK-2387-2020	Grosso, Ana Rita/0000-0001-6974-4209; Gomes, Anita Q./0000-0002-3348-0448; Silva-Santos, Bruno/0000-0003-4141-9302; Serre, Karine/0000-0001-9152-4739; Pennington, Daniel/0000-0001-7889-9923; Schmolka, Nina/0000-0002-4460-8195	European Research Council [StG_260352]; Wellcome Trust; European Molecular Biology Organization; Fundacao para a Ciencia e Tecnologia; Graduate Program in Areas of Basic and Applied Biology of Universidade do Porto	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Graduate Program in Areas of Basic and Applied Biology of Universidade do Porto	We thank V. Benes for technical assistance with the ChIP-seq experiments; J. Ribot, S. de Almeida and N. Goncalves-Sousa for technical advice; H. Kulbe, F. Balkwill and R. Thompson for help with the ID8 tumor model; M. J. Nunes and E. Rodrigues for help with ChIP procedures; and M. Soares, A. Vieira and S. Marques for help with cell sorting; A. Hayday, L. Lefrancois and M. Saraiva for discussions; B. Arnold and C. Niehrs (Deutsches Krebsforschungszentrum, Heidelberg) for Dkk3-deficient mice; C. Terhorst and B. van Driel (Harvard Medical School) for Slamf1-deficient mice; K. Roby (University of Kansas) for ID8 ovarian cancer cells; A. Pamplona (Instituto de Medicina Molecular) for Plasmodium berghei ANKA with transgenic expression of GFP; P. Simas (Instituto de Medicina Molecular) for murid herpes virus 4; M. Correia-Neves (Universidade do Minho) for Mycobacterium avium strain 244.; C. Reis e Sousa (The London Research Institute) for Candida albicans yeast strain WT-SC 3314; and the staff of the animal and flow cytometry facilities of our institutes for experimental assistance. Supported by the European Research Council (StG_260352 to B. S.-S.), the Wellcome Trust (D. J. P.), the European Molecular Biology Organization (B. S.-S.), Fundacao para a Ciencia e Tecnologia (K. S., A. R. G. and M. R.) and the Graduate Program in Areas of Basic and Applied Biology of Universidade do Porto (M.R.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097; Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Basu A, 2010, J IMMUNOL, V184, P545, DOI 10.4049/jimmunol.0900397; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Feng J., 2011, CURR PROTOC BIOINFOR, V34, P2141; Furuichi K, 2008, J IMMUNOL, V181, P8670, DOI 10.4049/jimmunol.181.12.8670; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hirahara K, 2011, IMMUNOLOGY, V134, P235, DOI 10.1111/j.1365-2567.2011.03483.x; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papatriantafyllou M, 2012, P NATL ACAD SCI USA, V109, P1631, DOI 10.1073/pnas.1115980109; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2018, R LANG ENV STAT COMP; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Schnekenburger M, 2007, MOL CELL BIOL, V27, P7089, DOI 10.1128/MCB.00838-07; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yin ZN, 2002, J IMMUNOL, V168, P1566, DOI 10.4049/jimmunol.168.4.1566; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	61	75	75	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1093	+		10.1038/ni.2702	http://dx.doi.org/10.1038/ni.2702			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23995235	Green Accepted, Green Published			2022-12-18	WOS:000324584700018
J	Liang, YM; Cucchetti, M; Roncagalli, R; Yokosuka, T; Malzac, A; Bertosio, E; Imbert, J; Nijman, IJ; Suchanek, M; Saito, T; Wulfing, C; Malissen, B; Malissen, M				Liang, Yinming; Cucchetti, Margot; Roncagalli, Romain; Yokosuka, Tadashi; Malzac, Aurelie; Bertosio, Elodie; Imbert, Jean; Nijman, Isaac J.; Suchanek, Miloslav; Saito, Takashi; Wuelfing, Christoph; Malissen, Bernard; Malissen, Marie			The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells	NATURE IMMUNOLOGY			English	Article							CAPPING PROTEIN; RECEPTOR MICROCLUSTERS; POINT MUTATION; MOTIF; MICE; ACTIVATION; EXPRESSION; COMPLEX; DOMAIN; IDENTIFICATION	Although T cell activation can result from signaling via T cell antigen receptor (TCR) alone, physiological T cell responses require costimulation via the coreceptor CD28. Through the use of an N-ethyl-N-nitrosourea-mutagenesis screen, we identified a mutation in Rltpr. We found that Rltpr was a lymphoid cell-specific, actin-uncapping protein essential for costimulation via CD28 and the development of regulatory T cells. Engagement of TCR-CD28 at the immunological synapse resulted in the colocalization of CD28 with both wild-type and mutant Rltpr proteins. However, the connection between CD28 and protein kinase C-theta and Carma1, two key effectors of CD28 costimulation, was abrogated in T cells expressing mutant Rltpr, and CD28 costimulation did not occur in those cells. Our findings provide a more complete model of CD28 costimulation in which Rltpr has a key role.	[Liang, Yinming; Cucchetti, Margot; Roncagalli, Romain; Malzac, Aurelie; Bertosio, Elodie; Malissen, Bernard; Malissen, Marie] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Liang, Yinming; Cucchetti, Margot; Roncagalli, Romain; Malzac, Aurelie; Bertosio, Elodie; Malissen, Bernard; Malissen, Marie] INSERM, U1104, F-13258 Marseille, France; [Liang, Yinming; Cucchetti, Margot; Roncagalli, Romain; Malzac, Aurelie; Bertosio, Elodie; Malissen, Bernard; Malissen, Marie] CNRS, Unite Mixte Rech 7280, Marseille, France; [Yokosuka, Tadashi; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa, Japan; [Yokosuka, Tadashi] Japan Sci & Technol Agcy, Saitama, Japan; [Imbert, Jean] Aix Marseille Univ, Technol Avancee Genome & Clin, Unite Mixte Rech S1090, Marseille, France; [Imbert, Jean] INSERM, U1090, F-13258 Marseille, France; [Nijman, Isaac J.] Hubrecht Inst, Genome Biol & Bioinformat Grp, Utrecht, Netherlands; [Suchanek, Miloslav] Exbio Praha, Vestec, Czech Republic; [Saito, Takashi] Osaka Univ, Immunol Frontier Ctr, World Premier Int Res Ctr, Osaka, Japan; [Wuelfing, Christoph] Univ Bristol, Sch Cell & Mol Med, Bristol, Avon, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); RIKEN; Japan Science & Technology Agency (JST); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Osaka University; University of Bristol	Malissen, B (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France.	bernardm@ciml.univ-mrs.fr	Imbert, Jean/G-3248-2013; Saito, Takashi/C-9684-2009; Liang, Yinming/AAM-6226-2020; Roncagalli, Romain/ABB-8786-2020; Imbert, Jean/AAG-1165-2020; Malissen, Bernard/AAK-4659-2020	Imbert, Jean/0000-0002-0478-9593; Saito, Takashi/0000-0001-9495-3547; Liang, Yinming/0000-0001-9174-4037; Imbert, Jean/0000-0002-0478-9593; Malissen, Bernard/0000-0003-1340-9342; Wuelfing, Christoph/0000-0002-6156-9861; Nijman, Isaac/0000-0002-1840-1158; Roncagalli, Romain/0000-0001-7554-0552; Yokosuka, Tadashi/0000-0002-3914-3995; Malissen, Marie/0000-0003-2331-1445	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de Recherche (ADAPT project); European Community; Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency; National Science Foundation [NSF 1121793]; Groupe d'Interet Scientifique-Infrastructures en Biologie Sante et Agronomie; Centre d'Immunophenomique; AXA Research Fund; China Scholarship Council; Grants-in-Aid for Scientific Research [25113725] Funding Source: KAKEN	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de Recherche (ADAPT project)(French National Research Agency (ANR)); European Community(European Commission); Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency; National Science Foundation(National Science Foundation (NSF)); Groupe d'Interet Scientifique-Infrastructures en Biologie Sante et Agronomie; Centre d'Immunophenomique; AXA Research Fund(AXA Research Fund); China Scholarship Council(China Scholarship Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. Beutler, D. Ordonez-Rueda, H. Holota, J. Ewbank and R. Lasserre for advice; and G. Kollias for leading the MUGEN European network. Supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Agence Nationale de Recherche (ADAPT project to M.M.), European Communities (MASTERSWITCH, SYBILLA and MUGEN projects to B.M.), Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency (T.Y.), Grant-in-Aid for Scientific Research on Innovative Areas (T.Y.), National Science Foundation (NSF 1121793 to C. W.), Groupe d'Interet Scientifique-Infrastructures en Biologie Sante et Agronomie, Centre d'Immunophenomique, the AXA Research Fund (M.C.) and the China Scholarship Council (Y.L.).	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2017, DOI 10.1002/eji.1830260908; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cefai D, 1998, J IMMUNOL, V160, P2223; Chevrier S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00027; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Matsuzaka Y, 2004, GENE, V343, P291, DOI 10.1016/j.gene.2004.09.004; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Ordonez-Rueda D, 2012, EUR J IMMUNOL, V42, P2395, DOI 10.1002/eji.201242589; Pagan AJ, 2012, J IMMUNOL, V189, P2909, DOI 10.4049/jimmunol.1103231; Pointon JJ, 2010, ANN RHEUM DIS, V69, P1243, DOI 10.1136/ard.2009.115147; Raab M, 2001, IMMUNITY, V15, P921, DOI 10.1016/S1074-7613(01)00248-5; RESKEKUNZ AB, 1985, EUR J IMMUNOL, V15, P1048, DOI 10.1002/eji.1830151017; Roman E, 2010, J IMMUNOL, V185, P3819, DOI 10.4049/jimmunol.0900665; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takeda S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035005; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Wang XH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00197; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	58	75	79	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					858	+		10.1038/ni.2634	http://dx.doi.org/10.1038/ni.2634			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23793062				2022-12-18	WOS:000322010600015
J	Pelzer, C; Cabalzar, K; Wolf, A; Gonzalez, M; Lenz, G; Thome, M				Pelzer, Christiane; Cabalzar, Katrin; Wolf, Annette; Gonzalez, Montserrat; Lenz, Georg; Thome, Margot			The protease activity of the paracaspase MALT1 is controlled by monoubiquitination	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; API2-MALT1 FUSION ONCOPROTEIN; T-CELL-ACTIVATION; CASPASE ACTIVATION; LYMPHOMA; RECEPTOR; RELB; CLEAVAGE; LYMPHOCYTES; PROTEINS	The protease activity of the paracaspase MALT1 is central to lymphocyte activation and lymphomagenesis, but how this activity is controlled remains unknown. Here we identify a monoubiquitination of MALT1 on Lys644 that activated the protease function of MALT1. Monoubiquitinated MALT1 had enhanced protease activity, whereas a ubiquitination-deficient MALT1 mutant with replacement of that lysine with arginine (MALT1(K644R)) had less protease activity, which correlated with impaired induction of interleukin 2 (IL-2) via the T cell antigen receptor in activated T cells. Expression of MALT1(K644R) diminished the survival of cells derived from diffuse large B cell lymphoma of the activated B cell like subtype (ABC DLBCL), which require constitutive protease activity of MALT1 for survival. Thus, monoubiquitination of MALT1 is essential for its catalytic activation and is therefore a potential target for the treatment of ABC-DLBCL and for immunomodulation.	[Pelzer, Christiane; Cabalzar, Katrin; Gonzalez, Montserrat; Thome, Margot] Univ Lausanne, Dept Biochem, Ctr Immun & Infect, CH-1066 Epalinges, Switzerland; [Wolf, Annette; Lenz, Georg] Charite, Mol Canc Res Ctr, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany	University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thome, M (corresponding author), Univ Lausanne, Dept Biochem, Ctr Immun & Infect, CH-1066 Epalinges, Switzerland.	margot.thomemiazza@unil.ch	Thome, Margot/F-8167-2011; Lenz, Georg/I-6844-2012	Thome, Margot/0000-0002-5656-2139; 	Swiss National Science Foundation; Swiss Cancer League (Oncosuisse); Fondation Pierre Mercier Pour la Science; Fondation Emma Muschamp; Ono Pharmaceutical; Boehringer Ingelheim Foundation; German Research Foundation; Deutsche Krebshilfe	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League (Oncosuisse); Fondation Pierre Mercier Pour la Science; Fondation Emma Muschamp; Ono Pharmaceutical; Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Research Foundation(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank S. Valitutti (Centre Hospitalier Universitaire Purpan) for monoclonal antibody OKT3; R. Iggo (University of Bordeaux) for lentiviral vector pRDI_292. containing the EF1 promoter; J.-E. Charton (University of Lausanne) for purified T cells; M. Jaworski (University of Lausanne) for the lentiviral NF-kappa B reporter construct; Z. Chen (University of Texas Southwestern Medical Center) for ubiquitin mutants; N. Clipstone (Loyola University) for the pMSCV-IRES-GFP vector; K. Maslowski for manuscript corrections; S. Hailfinger for support and advice; K. Hofmann and I. Dikic for advice; and F. Martinon for critical reading of the manuscript. Supported by the Swiss National Science Foundation, the Swiss Cancer League (Oncosuisse), Fondation Pierre Mercier Pour la Science, Fondation Emma Muschamp, a collaboration agreement with Ono Pharmaceutical, the Boehringer Ingelheim Foundation (K.C.), the German Research Foundation (G.L.) and the Deutsche Krebshilfe (G.L.).	Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kingeter LM, 2010, CELL SIGNAL, V22, P9, DOI 10.1016/j.cellsig.2009.09.033; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rosebeck S, 2011, FUTURE ONCOL, V7, P613, DOI [10.2217/fon.11.35, 10.2217/FON.11.35]; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Weih F, 1996, J IMMUNOL, V157, P3974; Weih F, 1996, ONCOGENE, V12, P445; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yu JW, 2011, P NATL ACAD SCI USA, V108, P21004, DOI 10.1073/pnas.1111708108	36	75	76	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					337	345		10.1038/ni.2540	http://dx.doi.org/10.1038/ni.2540			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23416615				2022-12-18	WOS:000316648700008
J	Lo, WL; Donermeyer, DL; Allen, PM				Lo, Wan-Lin; Donermeyer, David L.; Allen, Paul M.			A voltage-gated sodium channel is essential for the positive selection of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							NEGATIVE SELECTION; CALCIUM-CHANNELS; ION CHANNELS; MICE LACKING; IN-VIVO; ACTIVATION; THYMOCYTES; THRESHOLD; RESURGENT; MECHANISM	The sustained entry of Ca2+ into CD4(+)CD8(+) double-positive thymocytes is required for positive selection. Here we identified a voltage-gated Na+ channel (VGSC) that was essential for positive selection of CD4(+) T cells. Pharmacological inhibition of VGSC activity inhibited the sustained Ca2+ influx induced by positively selecting ligands and the in vitro positive selection of CD4(+) but not CD8(+) T cells. In vivo short hairpin RNA (shRNA)-mediated knockdown of the gene encoding a regulatory beta-subunit of a VGSC specifically inhibited the positive selection of CD4(+) T cells. Ectopic expression of VGSC in peripheral AND CD4(+) T cells bestowed the ability to respond to a positively selecting ligand, which directly demonstrated that VGSC expression was responsible for the enhanced sensitivity. Thus, active VGSCs in thymocytes provide a mechanism by which a weak positive selection signal can induce the sustained Ca2+ signals required for CD4(+) T cell development.	[Lo, Wan-Lin; Donermeyer, David L.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	pallen@wustl.edu		Lo, Wan-Lin/0000-0002-9074-6847	US National Institutes of Health [AI-24157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024157, R37AI024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Farr (University of Washington) for the ANV41.2 the cortical epithelial cell line; D. Kreamalmeyer for maintaining the mouse colony; S. Horvath for peptide synthesis and purification; M. Cella for advice on the production of the SCN4B-immunoglobulin fusion protein; M. Colonna (Washington University School of Medicine) for the Ceacam4-Ig fusion protein; S. Chan, S. Srivatsan and D. Bhattacharya for advice on shRNA-mediated knockdown experiments; R. Schreiber for mouse IFN-gamma; J. Silva, C. Nichols and S. Goldstein (University of Chicago) for the human SCN5A-GFP construct; J. Nerbonne for discussions; N. Felix for initiating the gp250 project; G. Morris for critical data analysis and assistance with the manuscript; and K. Weber, C. Morley, A. Shaw, M. Vig, Y. Huang, K. Murphy and T. Egawa for critical reading of the manuscript and comments. Supported by the US National Institutes of Health (AI-24157 to P.M.A.).	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Allen PM, 2009, NAT IMMUNOL, V10, P805, DOI 10.1038/ni0809-805; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Beyersdorf N, 2009, J IMMUNOL, V182, P3390, DOI 10.4049/jimmunol.0802888; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Brackenbury WJ, 2008, NEUROSCIENTIST, V14, P571, DOI 10.1177/1073858408320293; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Dravid SM, 2004, J NEUROCHEM, V89, P739, DOI 10.1111/j.1471-4159.2004.02407.x; Fekete A, 2009, J NEUROCHEM, V111, P745, DOI 10.1111/j.1471-4159.2009.06368.x; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kane LP, 1996, J IMMUNOL, V156, P4594; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Singer A, 2010, SEMIN IMMUNOL, V22, P253, DOI 10.1016/j.smim.2010.06.001; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Yu FH, 2003, J NEUROSCI, V23, P7577	40	75	79	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					880	887		10.1038/ni.2379	http://dx.doi.org/10.1038/ni.2379			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22842345	Green Accepted			2022-12-18	WOS:000307863600017
J	von Herrath, M; Nepom, GT				von Herrath, Matthias; Nepom, Gerald T.			Animal models of human type 1 diabetes	NATURE IMMUNOLOGY			English	Editorial Material							TRANSGENIC NOD MICE; T-LYMPHOCYTES; BETA-CELLS; ONSET; MELLITUS; INSULIN; MOUSE; AUTOIMMUNITY; TOLERANCE; ANTIGENS	Type 1 diabetes is an immune-mediated disease in which pancreatic insulin-producing beta cells are damaged and destroyed. Animal models have served a prominent function in the development of the present ideas of pathogenesis and approaches to therapy. This commentary addresses the utility and limitations of these models for facilitating the 'translation' of immunology research into clinical applications.	[von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Type Diabet Res 1, La Jolla, CA 92037 USA; [Nepom, Gerald T.] Benaroya Res Inst, Seattle, WA 98101 USA	La Jolla Institute for Immunology; Benaroya Research Institute	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Type Diabet Res 1, La Jolla, CA 92037 USA.	matthias@liai.org		Nepom, Gerald/0000-0002-8063-1464				Appleby MW, 2008, CURR TOP MICROBIOL, V321, P151; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cihakova D, 2004, METH MOLEC MED, V102, P175; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Enee E, 2008, J IMMUNOL, V180, P5430, DOI 10.4049/jimmunol.180.8.5430; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; Petersen JS, 2003, CLIN EXP IMMUNOL, V134, P38, DOI 10.1046/j.1365-2249.2003.02255.x; Rewers M, 2004, ADV EXP MED BIOL, V552, P219; Seewaldt S, 2000, DIABETES, V49, P1801, DOI 10.2337/diabetes.49.11.1801; Serreze DV, 2007, ANN NY ACAD SCI, V1103, P103, DOI 10.1196/annals.1394.019; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253; Taylor JA, 2004, J IMMUNOL, V172, P2651, DOI 10.4049/jimmunol.172.4.2651; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143	23	75	80	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					129	132		10.1038/ni0209-129	http://dx.doi.org/10.1038/ni0209-129			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148193				2022-12-18	WOS:000263178500002
J	Astrakhan, A; Omori, M; Nguyen, T; Becker-Herman, S; Iseki, M; Aye, T; Hudkins, K; Dooley, J; Farr, A; Alpers, CE; Ziegler, SF; Rawlings, DJ				Astrakhan, Alexander; Omori, Miyuki; Nguyen, Thuc; Becker-Herman, Shirly; Iseki, Masanori; Aye, Theingi; Hudkins, Kelly; Dooley, James; Farr, Andrew; Alpers, Charles E.; Ziegler, Steven F.; Rawlings, David J.			Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development	NATURE IMMUNOLOGY			English	Article							MOUSE BONE-MARROW; TRANSGENIC MICE; IN-VITRO; INTERLEUKIN-7-TRANSGENIC MICE; LYMPHOPROLIFERATIVE DISORDERS; ALLERGIC INFLAMMATION; GROWTH-FACTOR; EXPRESSION; RECEPTOR; TSLP	The cytokine thymic stromal lymphopoietin ( TSLP) drives immature B cell development in vitro and may regulate T helper type 2 responses. Here we analyzed the involvement of TSLP in B cell development in vivo with a doxycycline-inducible, keratin 5 driven transgene encoding TSLP (K5-TSLP). K5-TSLP-transgenic mice given doxycycline showed an influx of immature B cells into the periphery, with population expansion of follicular mature B cells, near-complete loss of marginal zone and marginal zone precursor B cells, and 'preferential' population expansion of peritoneal B-1b B cells. These changes promoted cryoglobulin production and immune complex-mediated renal disease. Identical events occurred in mice without T cells, in alternative TSLP-transgenic models and in K5-TSLP-transgenic mice with undetectable systemic TSLP. These observations suggest that signals mediating localized TSLP expression may modulate systemic B cell development and promote humoral autoimmunity.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Benaroya Res Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rawlings, DJ (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	sziegler@benaroyaresearch.org; drawling@u.washington.edu	Rawlings, David/CAI-4751-2022	Astrakhan, Alexander/0000-0002-7625-2955; Dooley, James/0000-0003-3154-4708; Omori-Miyake, Miyuki/0000-0002-4643-4045	NIAID NIH HHS [R01 AI44259, R01 AI068731] Funding Source: Medline; NICHD NIH HHS [R01 HD37091] Funding Source: Medline; NIDDK NIH HHS [R01 DK072295, P30 DK47754, R01 DK66802] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044259, R01AI068731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072295, R01DK066802, P30DK047754] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Brunner C, 2003, J EXP MED, V197, P1205, DOI 10.1084/jem.20022014; Cariappa A, 2005, J IMMUNOL, V175, P2925, DOI 10.4049/jimmunol.175.5.2925; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Ceredig R, 2003, EUR J IMMUNOL, V33, P2567, DOI 10.1002/eji.200324134; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Ferri C, 1998, LUPUS, V7, P275, DOI 10.1191/096120398678920091; FISHER AG, 1993, LEUKEMIA, V7, pS66; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Levin SD, 1999, J IMMUNOL, V162, P677; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Mertsching E, 1996, EUR J IMMUNOL, V26, P28, DOI 10.1002/eji.1830260105; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Osborn MJ, 2004, BLOOD, V103, P843, DOI 10.1182/blood-2003-05-1557; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; REYNOLDS PJ, 1990, MOL CELL BIOL, V10, P4266, DOI 10.1128/MCB.10.8.4266; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Taneda S, 2001, AM J PATHOL, V159, P2355, DOI 10.1016/S0002-9440(10)63085-4; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	45	75	81	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					522	531		10.1038/ni1452	http://dx.doi.org/10.1038/ni1452			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17401368				2022-12-18	WOS:000245831600017
J	Gu, Y; Chae, HD; Siefring, JE; Jasti, AC; Hildeman, DA; Williams, DA				Gu, Yi; Chae, Hee-Don; Siefring, Jamie E.; Jasti, Aparna C.; Hildeman, David A.; Williams, David A.			RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development	NATURE IMMUNOLOGY			English	Article							ANTIGEN RECEPTOR; HEMATOPOIETIC-CELLS; NEGATIVE SELECTION; TYROSINE KINASE; GENE-TRANSFER; ALPHA-BETA; ZAP-70; LYMPHOCYTES; EXPRESSION; TRANSDUCTION	RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family with unknown physiological function. Here we demonstrate that Rhoh(-/-) mice have impaired T cell receptor ( TCR)-mediated thymocyte selection and maturation, resulting in T cell deficiency. RhoH deficiency resulted in defective CD3 zeta phosphorylation, impaired translocation of the signaling molecule Zap70 to the immunological synapse and reduced activation of Zap70-mediated signaling in thymic and peripheral T cells. Proteomic analyses demonstrated that RhoH is a component of TCR signaling and is required for recruitment of Zap70 to the TCR through interaction with RhoH noncanonical immunoreceptor tyrosine-based activation motifs ( ITAMs). In vivo reconstitution studies also demonstrated that RhoH function depends on phosphorylation of the RhoH ITAMs. These findings suggest that RhoH is a critical regulator of thymocyte development and TCR signaling by mediating recruitment and activation of Zap70.	Univ Cincinnati, Coll Med, Div Expt Hematol, Childrens Res Fdn, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Immunobiol, Childrens Res Fdn, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Gu, Y (corresponding author), Univ Cincinnati, Coll Med, Div Expt Hematol, Childrens Res Fdn, Cincinnati, OH 45229 USA.	yi.gu@cchmc.org; david.williams@cchmc.org	Hildeman, David/I-4884-2015; Hildeman, David/AAA-1757-2020; Chae, Hee-Don/D-2620-2011	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; 	NCI NIH HHS [R01 CA113969, K01 CA107110] Funding Source: Medline; NIDDK NIH HHS [R01 DK62757] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA107110, R01CA113969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO;2-C; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; DALLERY E, 1995, ONCOGENE, V10, P2171; Delaguillaumie A, 2002, J CELL SCI, V115, P433; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; FOWLKES BJ, 1985, J EXP MED, V162, P802, DOI 10.1084/jem.162.3.802; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kumaraguru U, 2000, J IMMUNOL, V165, P750, DOI 10.4049/jimmunol.165.2.750; Lahousse S, 2004, GENE, V343, P55, DOI 10.1016/j.gene.2004.08.022; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; LITTMAN DR, 1994, ADV EXP MED BIOL, V365, P63; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Movassagh M, 2000, HUM GENE THER, V11, P1189, DOI 10.1089/10430340050015239; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHORTMAN K, 1992, CURR OPIN IMMUNOL, V4, P140, DOI 10.1016/0952-7915(92)90003-W; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	53	75	79	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1182	1190		10.1038/ni1396	http://dx.doi.org/10.1038/ni1396			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17028588				2022-12-18	WOS:000241437200013
J	Bour-Jordan, H; Grogan, JL; Tang, QZ; Auger, JA; Locksley, RM; Bluestone, JA				Bour-Jordan, H; Grogan, JL; Tang, QZ; Auger, JA; Locksley, RM; Bluestone, JA			CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; CD4(+) T-CELLS; TRANSCRIPTION FACTOR GATA-3; IN-VIVO; INTERLEUKIN-4-INDUCED TRANSCRIPTION; TH2 DEVELOPMENT; IGE PRODUCTION; STAT6; IL-4; MICE	The relative importance of the cytokine milieu versus cytolytic T lymphocyte-associated antigen 4 (CTLA-4) and T cell receptor signal strength on T cell differentiation remains unclear. Here we have generated mice deficient for signal transducer and activator of transcription 6 (STAT6) and CTLA-4 to determine the role of CTLA-4 in cytokine-driven T cell differentiation. CTLA-4-deficient T cells bypass the need for STAT6 in the differentiation of T helper type 2 (T(H)2) cells. T(H)2 differentiation of cells deficient for both STAT6 and CTLA-4 is accompanied by induction of GATA-3 and the migration of T(H)2 cells to peripheral tissues. CTLA-4 deficiency also affects the balance of the nuclear factors NFATc1 and NFATc2, and enhances activation of NF-kappaB. These results suggest that CTLA-4 has a critical role in T cell differentiation and that STAT6-dependent T(H)2 lineage commitment and stabilization can be bypassed by increasing the strength of signaling through the T cell receptor.	Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Immunol Applicat Core Facil, Chicago, IL 60637 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Chicago; University of Chicago	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Tang, Qizhi/0000-0001-7313-3574				Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; CROFT M, 1994, J IMMUNOL, V152, P2675; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dent AL, 1999, J IMMUNOL, V163, P2098; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Fraser JH, 1999, EUR J IMMUNOL, V29, P838; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harlin H, 2002, EUR J IMMUNOL, V32, P2095, DOI 10.1002/1521-4141(200208)32:8<2095::AID-IMMU2095>3.0.CO;2-E; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jeppson JD, 1998, J IMMUNOL, V161, P1738; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kato T, 2000, J IMMUNOL, V164, P3554, DOI 10.4049/jimmunol.164.7.3554; Khattri R, 1999, J IMMUNOL, V162, P5784; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pioli C, 2000, J IMMUNOL, V165, P5530, DOI 10.4049/jimmunol.165.10.5530; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Rulifson IC, 1997, J IMMUNOL, V158, P658; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Smith JA, 1998, J IMMUNOL, V160, P4841; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tang QZ, 2002, J IMMUNOL, V168, P4480, DOI 10.4049/jimmunol.168.9.4480; Tinnell SB, 1998, INT IMMUNOL, V10, P1529, DOI 10.1093/intimm/10.10.1529; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	47	75	78	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					182	188		10.1038/ni884	http://dx.doi.org/10.1038/ni884			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12524538				2022-12-18	WOS:000180686500019
J	O'Shea, JJ; Paul, WE				O'Shea, JJ; Paul, WE			Regulation of THI differentiation - controlling the controllers	NATURE IMMUNOLOGY			English	Editorial Material							T-BET; INTERFERON-GAMMA; COMMITMENT	Although cytokines and STATs are accepted as being integral to T(H)1 differentiation, T-bet had emerged as a possible master control switch. Fresh data forces a reexamination of the factors that control T-H cell development.	NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	12	75	77	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					506	508		10.1038/ni0602-506	http://dx.doi.org/10.1038/ni0602-506			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032561				2022-12-18	WOS:000175874700006
J	Andre, P; Biassoni, R; Colonna, M; Cosman, D; Lanier, LL; Long, EO; Lopez-Botet, M; Moretta, A; Moretta, L; Parham, P; Trowsdale, J; Vivier, E; Wagtmann, N; Wilson, MJ				Andre, P; Biassoni, R; Colonna, M; Cosman, D; Lanier, LL; Long, EO; Lopez-Botet, M; Moretta, A; Moretta, L; Parham, P; Trowsdale, J; Vivier, E; Wagtmann, N; Wilson, MJ			New nomenclature for MHC receptors	NATURE IMMUNOLOGY			English	Letter							HUMAN NATURAL-KILLER; CLASS-I MOLECULES; CELLS		Innate Pharma, Marseille, France; Ist Nazl Ric Canc, I-16132 Genoa, Italy; Basel Inst Immunol, Basel, Switzerland; Immunex Corp, Seattle, WA USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA; NIAID, Immunogenet Lab, NIH, Rockville, MA USA; Univ Pompeu Fabra, CEXS Immunol, Barcelona, Spain; Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; Ist Giannina Gaslini, I-16148 Genoa, Italy; Stanford Univ, Sch Med, Dept Cell Biol, Stanford, CA 94305 USA; Univ Cambridge, Dept Pathol, Div Immunol, Cambridge, England; Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; Novo Nordisk AS, Dept Mol Genet, DK-2880 Bagsvaerd, Denmark; GlaxoSmithKline, Stevenage, Herts, England	University of Genoa; IRCCS AOU San Martino IST; Immunex Corporation; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pompeu Fabra University; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Stanford University; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Novo Nordisk; GlaxoSmithKline	Andre, P (corresponding author), Innate Pharma, Marseille, France.		Lopez-Botet, Miguel/I-5434-2014; Moretta, Lorenzo/AAA-7239-2020; Vivier, Eric/F-8939-2010; Long, Eric O/G-5475-2011; Lanier, Lewis L/E-2139-2014; BIASSONI, ROBERTO/J-4677-2018	Lopez-Botet, Miguel/0000-0003-4882-065X; Moretta, Lorenzo/0000-0003-4658-1747; Vivier, Eric/0000-0001-7022-8287; Long, Eric O/0000-0002-7793-3728; Lanier, Lewis L/0000-0003-1308-3952; BIASSONI, ROBERTO/0000-0002-4365-8166; Colonna, Marco/0000-0001-5222-4987	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000525, Z01AI000842, ZIAAI000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X	8	75	77	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					661	661		10.1038/90589	http://dx.doi.org/10.1038/90589			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477395	Bronze			2022-12-18	WOS:000170230100002
J	Alculumbre, SG; Saint-Andre, V; Di Domizio, J; Vargas, P; Sirven, P; Bost, P; Maurin, M; Maiuri, P; Wery, M; San Roman, M; Savey, L; Touzot, M; Terrier, B; Saadoun, D; Conrad, C; Gilliet, M; Morillon, A; Soumelis, V				Alculumbre, Solana G.; Saint-Andre, Violaine; Di Domizio, Jeremy; Vargas, Pablo; Sirven, Philemon; Bost, Pierre; Maurin, Mathieu; Maiuri, Paolo; Wery, Maxime; San Roman, Mabel; Savey, Lea; Touzot, Maxime; Terrier, Benjamin; Saadoun, David; Conrad, Curdin; Gilliet, Michel; Morillon, Antonin; Soumelis, Vassili			Diversification of human plasmacytoid predendritic cells in response to a single stimulus	NATURE IMMUNOLOGY			English	Article							INTERFERON-PRODUCING CELLS; LONG NONCODING RNAS; DENDRITIC CELLS; CUTTING EDGE; I INTERFERON; T-CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION; INNATE	Innate immune cells adjust to microbial and inflammatory stimuli through a process termed environmental plasticity, which links a given individual stimulus to a unique activated state. Here, we report that activation of human plasmacytoid predendritic cells (pDCs) with a single microbial or cytokine stimulus triggers cell diversification into three stable subpopulations (P1-P3). P1-pDCs (PD-L1(+)CD80(-)) displayed a plasmacytoid morphology and specialization for type I interferon production. P3-pDCs (PD-L1-CD80(+)) adopted a dendritic morphology and adaptive immune functions. P2-pDCs (PD-L1(+)CD80(+)) displayed both innate and adaptive functions. Each subpopulation expressed a specific coding-and long-noncoding-RNA signature and was stable after secondary stimulation. P1-pDCs were detected in samples from patients with lupus or psoriasis. pDC diversification was independent of cell divisions or preexisting heterogeneity within steady-state pDCs but was controlled by a TNF autocrine and/or paracrine communication loop. Our findings reveal a novel mechanism for diversity and division of labor in innate immune cells.	[Alculumbre, Solana G.; Saint-Andre, Violaine; Vargas, Pablo; Sirven, Philemon; Bost, Pierre; Maurin, Mathieu; Maiuri, Paolo; Wery, Maxime; San Roman, Mabel; Morillon, Antonin; Soumelis, Vassili] PSL Res Univ, Inst Curie, Ctr Rech, Paris, France; [Alculumbre, Solana G.; Sirven, Philemon; Bost, Pierre; Maurin, Mathieu; San Roman, Mabel; Soumelis, Vassili] INSERM, Immun & Canc, U932, Paris, France; [Saint-Andre, Violaine; Wery, Maxime; Morillon, Antonin] Univ Paris 06, CNRS UMR 3244, ncRNA Epigenet & Genome Fluid, Paris, France; [Di Domizio, Jeremy; Conrad, Curdin; Gilliet, Michel] Univ Hosp CHUV, Dept Dermatol, Lausanne, Switzerland; [Vargas, Pablo] CNRS UMR144, Paris, France; [Bost, Pierre] PSL Res Univ, Dept Biol, Ecole Normale Super, Paris, France; [Maiuri, Paolo] IFOM Fdn, Inst FIRC Mol Oncol, Milan, Italy; [Savey, Lea; Saadoun, David] UPMC Univ Paris, Sorbonne Univ, UMR7211, Paris, France; [Savey, Lea; Saadoun, David] UPMC Univ Paris, Sorbonne Univ, Inflammat Immunopathol Biotherapy Dept DHU i2B, Paris, France; [Savey, Lea; Saadoun, David] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol, Natl Reference Ctr Autoimmune & System Dis, Paris, France; [Touzot, Maxime] AURA Paris Plaisance, Paris, France; [Terrier, Benjamin] Univ Paris 05, Cochin Hosp, AP HP, Dept Internal Med,Natl Referral Ctr Rare Autoimmm, Paris, France; [Soumelis, Vassili] CIC IGR Curie 1428, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); IFOM - FIRC Institute of Molecular Oncology; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Soumelis, V (corresponding author), PSL Res Univ, Inst Curie, Ctr Rech, Paris, France.; Soumelis, V (corresponding author), INSERM, Immun & Canc, U932, Paris, France.; Soumelis, V (corresponding author), CIC IGR Curie 1428, Paris, France.	vassili.soumelis@curie.fr	Morillon, Antonin/M-4751-2017; Wery, Maxime/AAR-2426-2020; Di Domizio, Jeremy/L-1777-2019; Saint-André, Violaine/AAQ-8488-2020; VARGAS, Pablo/HHM-4543-2022; Vargas, Pablo/L-9858-2017	Morillon, Antonin/0000-0002-0575-5264; Wery, Maxime/0000-0003-3004-471X; VARGAS, Pablo/0000-0002-6475-494X; Vargas, Pablo/0000-0002-6475-494X; DI DOMIZIO, Jeremy/0000-0002-6281-3918; touzot, Maxime/0000-0002-0510-2431; Maiuri, Paolo/0000-0001-5079-445X; Bost, Pierre/0000-0003-1498-9385; Conrad, Curdin/0000-0002-2547-3440	INSERM [BIO2014-08]; FRM [ANR-13-BSV1-0024-02, ANR-10-IDEX-0001-02 PSL*, ANR-11-LABX-0043]; ERC [IT-DC 281987, HEALTH 2011-261366, 2013/COG/616180 DARK]; CIC IGR-Curie [1428]; IC fellowship; LabEx DCbiol; Agence Nationale de la Recherche ('Investissements d'Avenir' program) [ANR-10-EQPX-03, ANR-10-INBS-09-08]; Canceropole Ile-de-France; SiRIC-Curie program, SiRIC [INCa-DGOS-4654];  [ARF20150934193]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRM(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); CIC IGR-Curie; IC fellowship; LabEx DCbiol; Agence Nationale de la Recherche ('Investissements d'Avenir' program)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); SiRIC-Curie program, SiRIC; 	We thank the Cytometry Core facility of IC for cell sorting. We thank INSERM U932, particularly P. Michea, for frequent discussions. We thank S. Amigorena, N. Manel and L. Pattarini for critical reading of the manuscript. This work was supported by funding from INSERM (BIO2014-08), FRM, ANR-13-BSV1-0024-02, ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043, ERC (IT-DC 281987, HEALTH 2011-261366 and 2013/COG/616180 DARK) and CIC IGR-Curie 1428. S.G.A. was supported by an IC fellowship and LabEx DCbiol. V.S-A. is supported as a Fondation pour la Recherche Medicale fellow (ARF20150934193). High-throughput sequencing was performed by the ICGex NGS platform of the Institut Curie, supported by grants ANR-10-EQPX-03 (Equipex) and ANR-10-INBS-09-08 (France Genomique Consortium) from the Agence Nationale de la Recherche ('Investissements d'Avenir' program), by the Canceropole Ile-de-France and by the SiRIC-Curie program, SiRIC Grant INCa-DGOS-4654.	Alculumbre S, 2016, METHODS MOL BIOL, V1423, P153, DOI 10.1007/978-1-4939-3606-9_11; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bao MS, 2013, PROTEIN CELL, V4, P40, DOI 10.1007/s13238-012-2104-8; Bauer J, 2016, J IMMUNOL, V196, P4447, DOI 10.4049/jimmunol.1500383; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cavaleiro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000667; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen XY, 2015, CLIN IMMUNOL, V157, P249, DOI 10.1016/j.clim.2014.12.009; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jaehn PS, 2008, EUR J IMMUNOL, V38, P1822, DOI 10.1002/eji.200737552; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kim S, 2014, EUR J IMMUNOL, V44, P807, DOI 10.1002/eji.201343806; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; MILLER JG, 1971, BEHAV SCI, V16, P277, DOI 10.1002/bs.3830160402; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Peritt D, 1998, J IMMUNOL, V161, P5821; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Prinz JC, 2011, NAT REV RHEUMATOL, V7, P429, DOI 10.1038/nrrheum.2011.35; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Roubinet C, 2014, CURR OPIN CELL BIOL, V31, P84, DOI 10.1016/j.ceb.2014.09.005; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang H, 2017, P NATL ACAD SCI USA, V114, P1988, DOI 10.1073/pnas.1610630114; Zucchini N, 2008, INT IMMUNOL, V20, P45, DOI 10.1093/intimm/dxm119	62	74	75	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					63	+		10.1038/s41590-017-0012-z	http://dx.doi.org/10.1038/s41590-017-0012-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29203862				2022-12-18	WOS:000419765300014
J	Lee, J; Zhou, YJ; Ma, WJ; Zhang, WW; Aljoufi, A; Luh, T; Lucero, K; Liang, DG; Thomsen, M; Bhagat, G; Shen, YF; Liu, K				Lee, Jaeyop; Zhou, Yu Jerry; Ma, Wenji; Zhang, Wanwei; Aljoufi, Arafat; Luh, Thomas; Lucero, Kimberly; Liang, Deguang; Thomsen, Matthew; Bhagat, Govind; Shen, Yufeng; Liu, Kang			Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors	NATURE IMMUNOLOGY			English	Article							BONE-MARROW; MYELOID PROGENITORS; IN-VIVO; COMMITMENT; BLOOD; DIFFERENTIATION; FLT3; IDENTIFICATION; MACROPHAGES; PRECURSORS	The origin and specification of human dendritic cells (DCs) have not been investigated at the clonal level. Through the use of clonal assays, combined with statistical computation, to quantify the yield of granulocytes, monocytes, lymphocytes and three subsets of DCs from single human CD34(+) progenitor cells, we found that specification to the DC lineage occurred in parallel with specification of hematopoietic stem cells (HSCs) to the myeloid and lymphoid lineages. This started as a lineage bias defined by specific transcriptional programs that correlated with the combinatorial 'dose' of the transcription factors IRF8 and PU.1, which was transmitted to most progeny cells and was reinforced by upregulation of IRF8 expression driven by the hematopoietic cytokine FLT3L during cell division. We propose a model in which specification to the DC lineage is driven by parallel and inheritable transcriptional programs in HSCs and is reinforced over cell division by recursive interactions between transcriptional programs and extrinsic signals.	[Lee, Jaeyop; Zhou, Yu Jerry; Zhang, Wanwei; Aljoufi, Arafat; Luh, Thomas; Lucero, Kimberly; Liang, Deguang; Liu, Kang] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA; [Ma, Wenji; Shen, Yufeng] Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10027 USA; [Ma, Wenji; Shen, Yufeng] Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA; [Thomsen, Matthew; Bhagat, Govind] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Liu, K (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA.; Shen, YF (corresponding author), Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10027 USA.; Shen, YF (corresponding author), Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA.	ys2411@cumc.columbia.edu; kl2529@cumc.columbia.edu	Bhagat, Govind/AAE-9493-2021; Ma, Wenji/AFN-8974-2022	Bhagat, Govind/0000-0001-6250-048X; Ma, Wenji/0000-0003-2840-3015	Empire State Stem Cell Fund through the New York State Department of Health [C029562]; US National Institute of Health [AI101251]; Office of the Director of the US National Institutes of Health [S10RR027050, S10OD020056]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056, R21OD023291] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through the New York State Department of Health; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director of the US National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Goff, S. Reiner and R. Belsky for discussions. Supported by the Empire State Stem Cell Fund through the New York State Department of Health (C029562 to K.L.) and The US National Institute of Health (AI101251 to K.L.). Research reported in this manuscript was performed partly by the Columbia Center for Translational Immunology Flow Cytometry Core, supported in part by the Office of the Director of the US National Institutes of Health (S10RR027050 and S10OD020056).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mercier FE, 2015, CELL, V163, P1568, DOI 10.1016/j.cell.2015.12.013; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Notta F., 2015, SCIENCE, V351; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Rahman N.A., 1968, COURSE THEORETICAL S; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	39	74	74	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					877	+		10.1038/ni.3789	http://dx.doi.org/10.1038/ni.3789			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28650480	Green Accepted			2022-12-18	WOS:000405821100010
J	Xu, HP; Chaudhri, VK; Wu, ZG; Biiouris, K; Dienger-Stambaugh, K; Rochman, Y; Singh, H				Xu, Heping; Chaudhri, Virendra K.; Wu, Zhiguo; Biiouris, Konstantinos; Dienger-Stambaugh, Krista; Rochman, Yrina; Singh, Harinder			Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER B; DIFFERENTIATION; ARCHITECTURE; EXPRESSION; PROGRAM; DIRECTS	Upon recognition of antigen, B cells undertake a bifurcated response in which some cells rapidly differentiate into plasmablasts while others undergo affinity maturation in germinal centers (GCs). Here we identified a double-negative feedback loop between the transcription factors IRF4 and IRF8 that regulated the initial developmental bifurcation of activated B cells as well as the GC response. IRF8 dampened signaling via the B cell antigen receptor (BCR), facilitated antigen-specific interaction with helper T cells, and promoted antibody affinity maturation while antagonizing IRF4-driven differentiation of plasmablasts. Genomic analysis revealed concentration-dependent actions of IRF4 and IRF8 in regulating distinct gene-expression programs. Stochastic modeling suggested that the double-negative feedback was sufficient to initiate bifurcation of the B cell developmental trajectories.	[Singh, Harinder] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Singh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.	harinder.singh@cchmc.org	Chaudhri, Virendra/S-9767-2019	Chaudhri, Virendra/0000-0003-3528-4667; Singh, Harinder/0000-0002-6330-8526; Xu, Heping/0000-0003-2149-7004	Cincinnati Children's Research Foundation; Leukemia & Lymphoma Society Career Development Program [5442-16]	Cincinnati Children's Research Foundation; Leukemia & Lymphoma Society Career Development Program	We thank core facilities of the Cincinnati Children's Hospital Medical Center for help with mouse colony management, cell sorting and high-throughput DNA sequencing. Supported by the Cincinnati Children's Research Foundation (H.S.) and the Leukemia & Lymphoma Society Career Development Program (5442-16 for H.X.).	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Burne-Taney MJ, 2003, J IMMUNOL, V171, P3210, DOI 10.4049/jimmunol.171.6.3210; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chew V, 2007, J BIOL CHEM, V282, P27181, DOI 10.1074/jbc.M704625200; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; Chu C, 2014, J IMMUNOL, V193, P3860, DOI 10.4049/jimmunol.1401660; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Pathak S, 2013, J IMMUNOL, V191, P6222, DOI 10.4049/jimmunol.1301169; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Singh H, 2014, COLD SPRING HARB SYM, V78, P101; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004	31	74	75	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1274	1281		10.1038/ni.3287	http://dx.doi.org/10.1038/ni.3287			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26437243				2022-12-18	WOS:000365062100011
J	Dominguez-Villar, M; Gautron, AS; de Marcken, M; Keller, MJ; Hafler, DA				Dominguez-Villar, Margarita; Gautron, Anne-Sophie; de Marcken, Marine; Keller, Marla J.; Hafler, David A.			TLR7 induces anergy in human CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR NFAT1; EXPRESSION; CALCINEURIN; RECOGNITION; RESPONSES; TOLL-LIKE-RECEPTOR-7; STIMULATION; INHIBITION; INDUCTION; INFECTION	The recognition of microbial patterns by Toll-like receptors (TLRs) is critical for activation of the innate immune system. Although TLRs are expressed by human CD4(+) T cells, their function is not well understood. Here we found that engagement of TLR7 in CD4(+) T cells induced intracellular calcium flux with activation of an anergic gene-expression program dependent on the transcription factor NFATc2, as well as unresponsiveness of T cells. As chronic infection with RNA viruses such as human immunodeficiency virus type 1 (HIV-1) induces profound dysfunction of CD4(+) T cells, we investigated the role of TLR7-induced anergy in HIV-1 infection. Silencing of TLR7 markedly decreased the frequency of HIV-1-infected CD4(+) T cells and restored the responsiveness of those HIV-1(+) CD4(+) T cells. Our results elucidate a previously unknown function for microbial pattern-recognition receptors in the downregulation of immune responses.	[Dominguez-Villar, Margarita; Gautron, Anne-Sophie; de Marcken, Marine; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Dominguez-Villar, Margarita; Gautron, Anne-Sophie; de Marcken, Marine; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Keller, Marla J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Keller, Marla J.] Montefiore Med Ctr, Bronx, NY 10467 USA	Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Dominguez-Villar, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	margarita.dominguez-villar@yale.edu; david.hafler@yale.edu		Dominguez-Villar, Margarita/0000-0002-9719-0028	National MS Society [CA1061-A-18]; US National Institutes of Health [P01 AI045757, U19 AI046130, U19 AI070352, P01 AI039671, R01 AI065309]; Penates Foundation; Nancy Taylor Foundation for Chronic Diseases; Race to Erase MS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI045757, U19AI046130, U19AI070352] Funding Source: NIH RePORTER	National MS Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penates Foundation; Nancy Taylor Foundation for Chronic Diseases; Race to Erase MS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Devine and Z. Wang for technical assistance; Y. Tsunetsugu-Yokota (Tokyo University of Technology) for HIV-1<INF>NL-D</INF> proviral DNA; D. Bruce, H. Zapata and B.C. Herold and the laboratory of B.C. Herold for the recruitment of patients; and R. Medzhitov, A. Iwasaki and members of the Hafler laboratory for comments and suggestions. Supported by the National MS Society (CA1061-A-18), the US National Institutes of Health (P01 AI045757, U19 AI046130, U19 AI070352 and P01 AI039671 to D.A.H., and R01 AI065309 to M.J.K.), the Penates Foundation (D.A.H.), the Nancy Taylor Foundation for Chronic Diseases (D.A.H.) and the Race to Erase MS Foundation (M.D.-V.).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; BIGBY M, 1990, J IMMUNOL, V144, P3111; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Cayota A, 1996, BLOOD, V87, P4746, DOI 10.1182/blood.V87.11.4746.bloodjournal87114746; Chamberlain ND, 2013, ANN RHEUM DIS, V72, P418, DOI 10.1136/annrheumdis-2011-201203; Chappert P, 2010, CURR OPIN IMMUNOL, V22, P552, DOI 10.1016/j.coi.2010.08.005; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; CLOYD MW, 1989, VIROLOGY, V173, P581, DOI 10.1016/0042-6822(89)90569-2; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de la Casa-Esperon Elena, 2012, Int J Evol Biol, V2012, P679045, DOI 10.1155/2012/679045; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dzopalic T, 2010, INT IMMUNOPHARMACOL, V10, P1428, DOI 10.1016/j.intimp.2010.08.010; FAITH A, 1992, IMMUNOLOGY, V76, P177; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gibellini D, 2004, J CLIN VIROL, V29, P282, DOI 10.1016/S1386-6532(03)00169-0; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim JO, 2003, FEBS LETT, V541, P163, DOI 10.1016/S0014-5793(03)00326-0; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P6, DOI 10.1038/nri3587; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Luo C, 1996, MOL CELL BIOL, V16, P3955; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MAGGI E, 1987, EUR J IMMUNOL, V17, P1685, DOI 10.1002/eji.1830171202; Miedema F, 1992, Immunodefic Rev, V3, P173; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pawar RD, 2007, J AM SOC NEPHROL, V18, P1721, DOI 10.1681/ASN.2006101162; QUILL H, 1987, J IMMUNOL, V138, P3704; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Walker B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007054; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	47	74	80	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					118	+		10.1038/ni.3036	http://dx.doi.org/10.1038/ni.3036			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25401424	Green Accepted			2022-12-18	WOS:000346494200015
J	Jelicic, K; Cimbro, R; Nawaz, F; Huang, DW; Zheng, X; Yang, J; Lempicki, RA; Pascuccio, M; Van Ryk, D; Schwing, C; Hiatt, J; Okwara, N; Wei, DL; Roby, G; David, A; Hwang, IY; Kehrl, JH; Arthos, J; Cicala, C; Fauci, AS				Jelicic, Katija; Cimbro, Raffaello; Nawaz, Fatima; Huang, Da Wei; Zheng, Xin; Yang, Jun; Lempicki, Richard A.; Pascuccio, Massimiliano; Van Ryk, Donald; Schwing, Catherine; Hiatt, Joseph; Okwara, Noreen; Wei, Danlan; Roby, Gregg; David, Antonio; Hwang, Il Young; Kehrl, John H.; Arthos, James; Cicala, Claudia; Fauci, Anthony S.			The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta 1 production and FcRL4 expression	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; INTEGRIN ALPHA(4)BETA(7); IGA PRODUCTION; TISSUE; ACTIVATION; RESPONSES; RECEPTOR; MECHANISMS; ANTIBODY; SWITCH	The humoral immune response after acute infection with HIV-1 is delayed and ineffective. The HIV-1 envelope protein gp120 binds to and signals through integrin alpha(4)beta(7) on T cells. We found that gp120 also bound to and signaled through alpha(4)beta(7) on naive B cells, which resulted in an abortive proliferative response. In primary B cells, signaling by gp120 through alpha(4)beta(7) resulted in increased expression of the immunosuppressive cytokine TGF-beta 1 and FcRL4, an inhibitory receptor expressed on B cells. Coculture of B cells with HIV-1-infected autologous CD4(+) T cells also increased the expression of FcRL4 by B cells. Our findings indicated that in addition to mediating chronic activation of the immune system, viral proteins contributed directly to HIV-1-associated B cell dysfunction. Our studies identify a mechanism whereby the virus may subvert the early HIV-1-specific humoral immune response.	[Jelicic, Katija; Cimbro, Raffaello; Nawaz, Fatima; Pascuccio, Massimiliano; Van Ryk, Donald; Schwing, Catherine; Hiatt, Joseph; Okwara, Noreen; Wei, Danlan; Roby, Gregg; Hwang, Il Young; Kehrl, John H.; Arthos, James; Cicala, Claudia; Fauci, Anthony S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Cimbro, Raffaello; Zheng, Xin; Yang, Jun; Lempicki, Richard A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Nawaz, Fatima] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA; [Huang, Da Wei] Sci Applicat Int Corp, Lab Immunopathogenesis & Bioinformat, Frederick, MD USA; [David, Antonio] Univ Messina, Dept Internal Med, Fac Med, Messina, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; New York University; Science Applications International Corporation (SAIC); University of Messina	Cicala, C (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	ccicala@niaid.nih.gov	Kehrl, John/AAE-6292-2019; Lempicki, Richard A/E-1844-2012	Lempicki, Richard A/0000-0002-7059-409X; Hiatt, Joseph/0000-0002-8015-9614; Cimbro, Raffaello/0000-0002-6251-5160; Kehrl, John/0000-0002-6526-159X	Intramural Research Program of the US National Institutes of Health (National Institute of Allergy and Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739, ZIAAI000883, ZIAAI000887] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health (National Institute of Allergy and Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Derdeyn for HIV sequence information; A. Introini for suggestions; and J. Weddle and A. Weddle for assistance with figure preparation. Supported by the Intramural Research Program of the US National Institutes of Health (National Institute of Allergy and Infectious Diseases).	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; AMADORI A, 1988, CLIN IMMUNOL IMMUNOP, V46, P342, DOI 10.1016/0090-1229(88)90053-0; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chaoul N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-43; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Ehrhardt GRA, 2003, P NATL ACAD SCI USA, V100, P13489, DOI 10.1073/pnas.1935944100; ERLE DJ, 1994, J IMMUNOL, V153, P517; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Falini B, 2003, BLOOD, V102, P3684, DOI 10.1182/blood-2003-03-0750; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; Haynes BF, 2011, TRENDS MOL MED, V17, P108, DOI 10.1016/j.molmed.2010.10.008; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; JANOFF EN, 1994, J INFECT DIS, V170, P299, DOI 10.1093/infdis/170.2.299; KEHRL JH, 1989, J IMMUNOL, V143, P1868; KEHRL JH, 1991, J IMMUNOL, V146, P4016; KEKOW J, 1991, J CLIN INVEST, V87, P1010, DOI 10.1172/JCI115059; Kuppers R, 2008, IMMUNOL CELL BIOL, V86, P635, DOI 10.1038/icb.2008.59; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Legendre C, 1998, INT IMMUNOL, V10, P1847, DOI 10.1093/intimm/10.12.1847; Lehnert K, 1998, EUR J IMMUNOL, V28, P3605, DOI 10.1002/(SICI)1521-4141(199811)28:11<3605::AID-IMMU3605>3.3.CO;2-A; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Naniche D, 2009, CURR TOP MICROBIOL, V330, P151; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; PEACOCK DB, 1973, CLIN EXP IMMUNOL, V13, P497; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Polson AG, 2006, INT IMMUNOL, V18, P1363, DOI 10.1093/intimm/dxl069; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Scamurra RW, 2002, J IMMUNOL, V169, P4008, DOI 10.4049/jimmunol.169.7.4008; Shen Xiaoying, 2011, Curr HIV/AIDS Rep, V8, P23, DOI 10.1007/s11904-010-0064-2; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Szabo MC, 1997, J IMMUNOL, V158, P5584; Tangye SG, 2004, IMMUNOLOGY, V112, P509, DOI 10.1111/j.1365-2567.2004.01950.x; Tangye SG, 2002, J IMMUNOL, V169, P4298, DOI 10.4049/jimmunol.169.8.4298; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wiercinska-Drapalo A, 2004, VIRAL IMMUNOL, V17, P109, DOI 10.1089/088282404322875502; Wilson TJ, 2012, J IMMUNOL, V188, P4741, DOI 10.4049/jimmunol.1102651; Worthington JJ, 2012, IMMUNOBIOLOGY, V217, P1259, DOI 10.1016/j.imbio.2012.06.009; Yates NL, 2013, MUCOSAL IMMUNOL, V6, P692, DOI 10.1038/mi.2012.107; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	59	74	75	0	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1256	+		10.1038/ni.2746	http://dx.doi.org/10.1038/ni.2746			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24162774	Green Accepted			2022-12-18	WOS:000327149400011
J	Will, B; Vogler, TO; Bartholdy, B; Garrett-Bakelman, F; Mayer, J; Barreyro, L; Pandolfi, A; Todorova, TI; Okoye-Okafor, UC; Stanley, RF; Bhagat, TD; Verma, A; Figueroa, ME; Melnick, A; Roth, M; Steidl, U				Will, Britta; Vogler, Thomas O.; Bartholdy, Boris; Garrett-Bakelman, Francine; Mayer, Jillian; Barreyro, Laura; Pandolfi, Ashley; Todorova, Tihomira I.; Okoye-Okafor, Ujunwa C.; Stanley, Robert F.; Bhagat, Tushar D.; Verma, Amit; Figueroa, Maria E.; Melnick, Ari; Roth, Michael; Steidl, Ulrich			Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment	NATURE IMMUNOLOGY			English	Article							BINDING-PROTEIN 1; GENE-EXPRESSION; CHROMATIN; DIVISION; PROLIFERATION; INHIBITION; INTERPLAY; DORMANCY; FATE	How hematopoietic stem cells (HSCs) coordinate the regulation of opposing cellular mechanisms such as self-renewal and differentiation commitment remains unclear. Here we identified the transcription factor and chromatin remodeler Satb1 as a critical regulator of HSC fate. HSCs lacking Satb1 had defective self-renewal, were less quiescent and showed accelerated lineage commitment, which resulted in progressive depletion of functional HSCs. The enhanced commitment was caused by less symmetric self-renewal and more symmetric differentiation divisions of Satb1-deficient HSCs. Satb1 simultaneously repressed sets of genes encoding molecules involved in HSC activation and cellular polarity, including Numb and Myc, which encode two key factors for the specification of stem-cell fate. Thus, Satb1 is a regulator that promotes HSC quiescence and represses lineage commitment.	[Will, Britta; Vogler, Thomas O.; Bartholdy, Boris; Mayer, Jillian; Barreyro, Laura; Pandolfi, Ashley; Todorova, Tihomira I.; Okoye-Okafor, Ujunwa C.; Stanley, Robert F.; Roth, Michael; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Will, Britta; Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Garrett-Bakelman, Francine; Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Bhagat, Tushar D.; Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA; [Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Figueroa, Maria E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan	Steidl, U (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	ulrich.steidl@einstein.yu.edu	Figueroa, Maria/AAE-8662-2019; Melnick, Ari/AAA-5763-2020	Figueroa, Maria Eugenia/0000-0003-4887-4981; Okoye-Okafor, Ujunwa/0000-0001-8824-1666; Eckel, Ashley/0000-0002-2130-4965; Will, Britta/0000-0002-9534-6690; Barreyro, Laura/0000-0002-9515-5579	American Cancer Society [121366-PF-12-89-01-TBG]; Sass Foundation; National Cancer Institute [1K08CA169055-01, R00CA131503]; US National Institutes of Health [F31CA162770, F30HL117545]; New York State Stem Cell Science [C024306, C026416, C028116, C024172]; NATIONAL CANCER INSTITUTE [R01CA166429, K08CA169055, F31CA162770, R00CA131503] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL117545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Sass Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kohwi-Shigematsu (Lawrence Berkeley National Laboratory) for Satb1<SUP>-/-</SUP> mice; J. Bradner (Dana-Farber Cancer Institute, Harvard Medical School) for JQ1; T. Kohwi-Shigematsu, E. Passegue, M. Alberich-Jord~ and the members of the Steidl laboratory for discussions and suggestions; G. Simkin, and S. Narayanagari of the Einstein Human Stem Cell FACS and Xenotransplantation Facility; and P. Schultes, C. Sheridan and the Epigenomics Core Facility of Weill Cornell Medical College for technical assistance. Supported by the American Cancer Society (121366-PF-12-89-01-TBG to B. W.), the Sass Foundation (F. G. B.), the National Cancer Institute (1K08CA169055-01 to F. G. B. and R00CA131503 to U.S.), the US National Institutes of Health (F31CA162770 to U.C.O.-O. and F30HL117545 to A. P.) and New York State Stem Cell Science (C024306, C026416 and C028116 to U.S., and C024172 to E. Bouhassira). U.S. is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Alvarez JD, 2000, GENE DEV, V14, P521; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chang KC, 2010, DEV CELL, V19, P778, DOI 10.1016/j.devcel.2010.10.007; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kossenkov AV, 2009, METHOD ENZYMOL, V467, P59, DOI 10.1016/S0076-6879(09)67003-8; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MAGGIOPRICE L, 1988, EXP HEMATOL, V16, P653; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Perry JM, 2008, GENE DEV, V22, P1107, DOI 10.1101/gad.1670708; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Rebeiz M, 2011, DEVELOPMENT, V138, P215, DOI 10.1242/dev.050161; Reddy CNL, 2010, MOL MED REP, V3, P857, DOI 10.3892/mmr.2010.338; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Szilvassy Stephen J, 2002, Methods Mol Med, V63, P167, DOI 10.1385/1-59259-140-X:167; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Till J.E., 1961, RADIAT RES, V175, P145; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419	58	74	75	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					437	+		10.1038/ni.2572	http://dx.doi.org/10.1038/ni.2572			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23563689	Green Accepted			2022-12-18	WOS:000317732100008
J	Siggs, OM; Arnold, CN; Huber, C; Pirie, E; Xia, Y; Lin, P; Nemazee, D; Beutler, B				Siggs, Owen M.; Arnold, Carrie N.; Huber, Christoph; Pirie, Elaine; Xia, Yu; Lin, Pei; Nemazee, David; Beutler, Bruce			The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow	NATURE IMMUNOLOGY			English	Article							P-TYPE ATPASES; CELL-DEVELOPMENT; LYMPHOCYTE-ACTIVATION; ANTIBODY-RESPONSES; ENU MUTAGENESIS; IL-7 RECEPTOR; PRO-B; MICE; EXPRESSION; INTERLEUKIN-7	B lymphopoiesis begins in the fetal liver, switching after birth to the bone marrow, where it persists for life. The unique developmental outcomes of each phase are well documented, yet their molecular requirements are not. Here we describe two allelic X-linked mutations in mice that caused cell-intrinsic arrest of adult B lymphopoiesis. Mutant fetal liver progenitors generated B cells in situ but not in irradiated adult bone marrow, which emphasizes a necessity for the affected pathway only in the context of adult bone marrow. The causative mutations were ascribed to Atp11c, which encodes a P4-type ATPase with no previously described function. Our data establish an essential, cell-autonomous and context-sensitive function for ATP11C, a putative aminophospholipid flippase, in B cell development.	[Siggs, Owen M.; Arnold, Carrie N.; Pirie, Elaine; Xia, Yu; Lin, Pei; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Huber, Christoph; Nemazee, David] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA.	bruce@scripps.edu		Siggs, Owen/0000-0003-2840-4851	Bill & Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN272200700038C]; General Sir John Monash Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167, R01AI059714] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); General Sir John Monash Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Gutierrez for animal care; T. Robinson, S. Kalina and C. Ross for genotyping; C. Goodnow (John Curtin School of Medical Research) and R. Brink (Garvan Institute) for mice; A. Feeney for discussions; and D. La Vine for Figure 6f. Supported by the Bill & Melinda Gates Foundation, the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (HHSN272200700038C to (B.B.), The General Sir John Monash Foundation (O.M.S.) and the Cancer Research Institute (C.N.A.).	Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eidenschenk C, 2010, P NATL ACAD SCI USA, V107, P9759, DOI 10.1073/pnas.1005186107; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Georgel Philippe, 2008, V415, P1, DOI 10.1007/978-1-59745-570-1_1; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Janas ML, 2008, J IMMUNOL, V180, P739, DOI 10.4049/jimmunol.180.2.739; Jensen CT, 2008, BLOOD, V112, P2297, DOI 10.1182/blood-2008-04-150508; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Miosge L, 2005, IMMUNOL CELL BIOL, V83, P318, DOI 10.1111/j.1440-1711.2005.01353.x; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Purohit SJ, 2003, EMBO J, V22, P5511, DOI 10.1093/emboj/cdg522; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Tung JW, 2007, CURR OPIN IMMUNOL, V19, P150, DOI 10.1016/j.coi.2007.02.012; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	51	74	76	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					434	U89		10.1038/ni.2012	http://dx.doi.org/10.1038/ni.2012			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21423172	Green Accepted			2022-12-18	WOS:000289666600014
J	Au-Yeung, BB; Levin, SE; Zhang, C; Hsu, LY; Cheng, DA; Killeen, N; Shokat, KM; Weiss, A				Au-Yeung, Byron B.; Levin, Susan E.; Zhang, Chao; Hsu, Lih-Yun; Cheng, Debra A.; Killeen, Nigel; Shokat, Kevan M.; Weiss, Arthur			A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity	NATURE IMMUNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; PROTEIN-TYROSINE KINASE; ADAPTER PROTEINS; IN-VIVO; ZAP-70; ACTIVATION; TCR; RECEPTOR; IL-2; LYMPHOCYTES	To investigate the role of the kinase Zap70 in T cells, we generated mice expressing a Zap70 mutant whose catalytic activity can be selectively blocked by a small-molecule inhibitor. We found that conventional naive, effector and memory T cells were dependent on the kinase activity of Zap70 for their activation, which demonstrated a nonredundant role for Zap70 in signals induced by the T cell antigen receptor (TCR). In contrast, the catalytic activity of Zap70 was not required for activation of the GTPase Rap1 and inside-out signals that promote integrin adhesion. This Zap70 kinase-independent pathway was sufficient for the suppressive activity of regulatory T cells (T-reg cells), which was unperturbed by inhibition of the catalytic activity of Zap70. Our results indicate Zap70 is a likely therapeutic target.	[Au-Yeung, Byron B.; Levin, Susan E.; Hsu, Lih-Yun; Cheng, Debra A.; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Dept Med,Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Rosalind Russell Med Res Ctr Arthrit, Dept Med,Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu		Au-Yeung, Byron/0000-0002-6446-9102	National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health [RC2AR058947, F32AR056174]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058947, F32AR056174, K01AR060807] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Gately (Hoffmann-La Roche) for recombinant human IL-2; A. Roque for assistance in animal husbandry; C. MacArthur for cell sorting; and J. Wei for generating the Zap70(AS) BAC transgene construct. Supported by the National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health (RC2AR058947 to A. W. and F32AR056174 to L.-Y.H.).	AUYEUNG BB, 2009, ZAPImmunol Rev, V228, P41; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chu DH, 1999, J IMMUNOL, V163, P2610; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gelkop S, 2005, J IMMUNOL, V175, P8123, DOI 10.4049/jimmunol.175.12.8123; Gelkop S, 1999, J BIOL CHEM, V274, P21519, DOI 10.1074/jbc.274.31.21519; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Li LQ, 2005, J IMMUNOL, V175, P3133, DOI 10.4049/jimmunol.175.5.3133; Marski M, 2005, J IMMUNOL, V175, P7889, DOI 10.4049/jimmunol.175.12.7889; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Zhang WY, 2003, J BIOL CHEM, V278, P23978, DOI 10.1074/jbc.M212671200	29	74	75	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1085	U95		10.1038/ni.1955	http://dx.doi.org/10.1038/ni.1955			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21037577	Green Accepted			2022-12-18	WOS:000284262200007
J	Li, LQ; Iwamoto, Y; Berezovskaya, A; Boussiotis, VA				Li, Lequn; Iwamoto, Yoshiko; Berezovskaya, Alla; Boussiotis, Vassiliki A.			A pathway regulated by cell cycle inhibitor p27(Kip1) and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; DEPENDENT-KINASE; DOWN-REGULATION; TGF-BETA; TARGETED DISRUPTION; EFFECTOR FUNCTION; CLONAL EXPANSION; MICE LACKING; G(1) ARREST; IN-VIVO	Peripheral tolerance is essential for immunological homeostasis. Tolerant T cells are thought to arise after T cell receptor ligation in conditions that are nonpermissive for replication. Here we have investigated the function of the cell cycle inhibitor p27(Kip1) in tolerance induction in vivo using naive T cell receptor - transgenic cells lacking the cyclin-dependent kinase ( Cdk) - binding domain of p27(Kip1)( p27 Delta). Wild-type but not p27 Delta cells underwent tolerization. Tolerized wild-type cells had impaired Cdk2 and Cdc2 kinase activity and failed to phosphorylate the checkpoint inhibitor Smad3, leading to enhanced expression of the Cdk inhibitor p15. In contrast, p27 Delta cells proliferated in tolerizing conditions because of Cdk kinase activation and phosphorylation of Smad3, which resulted in no upregulation of p15. Smad3 'knockdown' prevented tolerance induction, whereas expression of a Smad3 mutant resistant to Cdk-mediated phosphorylation recapitulated molecular and functional events of tolerance. Thus, p27(Kip1) is required during induction of tolerance and Smad3 regulates T cell responses 'downstream' of p27(Kip1).	Harvard Univ, Transplantat Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Div Hematol & Oncol, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Boussiotis, VA (corresponding author), Harvard Univ, Transplantat Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA.	vboussiotis@partners.org			NATIONAL CANCER INSTITUTE [R01CA104596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043552, R21AI043552, R01AI046548] Funding Source: NIH RePORTER; NCI NIH HHS [CA104596] Funding Source: Medline; NIAID NIH HHS [AI 46548, AI 043552] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Cardoso AA, 1997, BLOOD, V90, P549, DOI 10.1182/blood.V90.2.549.549_549_561; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GILBERT KM, 1993, J IMMUNOL, V151, P1245; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; JENKINS MK, 1992, IMMUNOL TODAY, V13, P69, DOI 10.1016/0167-5699(92)90137-V; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kubsch S, 2003, EUR J IMMUNOL, V33, P1988, DOI 10.1002/eji.200323600; Kwon TK, 1997, J IMMUNOL, V158, P5642; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Powell JD, 1999, J IMMUNOL, V162, P2775; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; ROWELL EA, IN PRESS J IMMUNOL; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Shaffer DR, 2005, P NATL ACAD SCI USA, V102, P210, DOI 10.1073/pnas.0407362102; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wells AD, 2000, J IMMUNOL, V165, P2432, DOI 10.4049/jimmunol.165.5.2432; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang SM, 2000, J IMMUNOL, V165, P6270, DOI 10.4049/jimmunol.165.11.6270	44	74	85	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1157	1165		10.1038/ni1398	http://dx.doi.org/10.1038/ni1398			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17013388				2022-12-18	WOS:000241437200010
J	Metz, CN; Tracey, KJ				Metz, CN; Tracey, KJ			It takes nerve to dampen inflammation	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; SIGNAL; RAFTS	Stimulation of the vagus nerve via the alpha 7 nicotinic acetylcholine receptor can dampen macrophage function. This anti-inflammatory pathway seems to signal through the Jak2-STAT3 pathway.	Herman & Susan Merinoff Ctr Patient Oriented Res, Inst Med Res N Shore LIJ, Manhasset, NY 11021 USA	Northwell Health	Metz, CN (corresponding author), Herman & Susan Merinoff Ctr Patient Oriented Res, Inst Med Res N Shore LIJ, Manhasset, NY 11021 USA.	cmetz@nshs.edu		Christine, Metz/0000-0002-1013-1691; Tracey, Kevin J/0000-0003-1884-6314				de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kehlet H, 2001, AM J SURG, V182, p3S, DOI 10.1016/S0002-9610(01)00781-4; Miedema BW, 2003, LANCET ONCOL, V4, P365, DOI 10.1016/S1470-2045(03)01118-5; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WAXMAN SG, 2003, CLIN NEUROANATOMY, P117	12	74	75	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					756	757		10.1038/ni0805-756	http://dx.doi.org/10.1038/ni0805-756			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034431				2022-12-18	WOS:000230646200008
J	Picker, LJ; Watkins, DI				Picker, LJ; Watkins, DI			HIV pathogenesis: The first cut is the deepest	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL DEPLETION; IMMUNODEFICIENCY VIRUS-INFECTION; GASTROINTESTINAL-TRACT; CCR5 EXPRESSION; DYNAMICS; DISEASE	HIV pathogenesis is thought of as a chronic infection involving slow degradation of immunity that ultimately leads to AIDS. This scenario, however, could reflect the decay of an immune system mortally wounded during acute HIV infection.	Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	watkins@primate.wisc.edu						Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; MATTAPALLIL JJ, NATURE; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Veazey R, 2003, AIDS RES HUM RETROV, V19, P227, DOI 10.1089/088922203763315731; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000	12	74	86	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					430	432		10.1038/ni0505-430	http://dx.doi.org/10.1038/ni0505-430			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843796				2022-12-18	WOS:000228634300005
J	Giannakis, N; Sansbury, BE; Patsalos, A; Hays, TT; Riley, CO; Han, XL; Spite, M; Nagy, L				Giannakis, Nikolas; Sansbury, Brian E.; Patsalos, Andreas; Hays, Tristan T.; Riley, Colin O.; Han, Xianlin; Spite, Matthew; Nagy, Laszlo			Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration	NATURE IMMUNOLOGY			English	Article							PRO-RESOLVING MEDIATORS; RESOLUTION; MONOCYTES; D2; IDENTIFICATION; INFLAMMATION; INFECTION; MECHANISMS; MODELS; INJURY	Muscle damage elicits a sterile immune response that facilitates complete regeneration. Here, we used mass spectrometry-based lipidomics to map the mediator lipidome during the transition from inflammation to resolution and regeneration in skeletal muscle injury. We observed temporal regulation of glycerophospholipids and production of pro-inflammatory lipid mediators (for example, leukotrienes and prostaglandins) and specialized pro-resolving lipid mediators (for example, resolvins and lipoxins) that were modulated by ibuprofen. These time-dependent profiles were recapitulated in sorted neutrophils and Ly6C(hi) and Ly6C(lo) muscle-infiltrating macrophages, with a distinct pro-resolving signature observed in Ly6C(lo) macrophages. RNA sequencing of macrophages stimulated with resolvin D2 showed similarities to transcriptional changes found during the temporal transition from Ly6C(hi) macrophage to Ly6C(lo) macrophage. In vivo, resolvin D2 increased Ly6C(lo) macrophages and functional improvement of the regenerating muscle. These results reveal dynamic lipid mediator signatures of innate immune cells and provide a proof of concept for their exploitable effector roles in muscle regeneration.	[Giannakis, Nikolas; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary; [Giannakis, Nikolas; Nagy, Laszlo] UD Genomed, Debrecen, Hungary; [Sansbury, Brian E.; Riley, Colin O.; Spite, Matthew] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Sansbury, Brian E.; Riley, Colin O.; Spite, Matthew] Harvard Med Sch, Boston, MA 02115 USA; [Patsalos, Andreas; Hays, Tristan T.; Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Dept Med, St Petersburg, FL USA; [Patsalos, Andreas; Hays, Tristan T.; Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Dept Biol Chem, St Petersburg, FL USA; [Patsalos, Andreas; Hays, Tristan T.; Nagy, Laszlo] Johns Hopkins All Childrens Hosp, St Petersburg, FL USA; [Han, Xianlin] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Res, San Antonio, TX 78229 USA; [Han, Xianlin] Sanford Burnham Prebys Med Discovery Inst, Genom Control Metab Program, Orlando, FL USA	University of Debrecen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Health San Antonio; Sanford Burnham Prebys Medical Discovery Institute	Nagy, L (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary.; Nagy, L (corresponding author), UD Genomed, Debrecen, Hungary.; Spite, M (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.; Spite, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Nagy, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, St Petersburg, FL USA.; Nagy, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, St Petersburg, FL USA.; Nagy, L (corresponding author), Johns Hopkins All Childrens Hosp, St Petersburg, FL USA.	mspite@bwh.harvard.edu; lnagy@jhmi.edu	Nagy, Laszlo/A-3814-2008; Patsalos, Andreas/GQY-7136-2022; Patsalos, Andreas/L-8957-2019	Nagy, Laszlo/0000-0001-6653-2155; Patsalos, Andreas/0000-0002-9022-4985; Patsalos, Andreas/0000-0002-9022-4985; Giannakis, Nikolas/0000-0002-5005-1928; Spite, Matthew/0000-0002-8868-3648	'Chromatin3D' ITN - European Union under the Horizon2020 Framework Programme [622934]; EU-FP7 PEOPLE-2013 program [PITN-GA-2013-606806]; Hungarian Scientific Research Fund [K124298, K126885, K116855]; NIH [R01DK115924, GM095467, HL106173]; NRSA from the NIH [HL136044]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL136044, R01HL106173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	'Chromatin3D' ITN - European Union under the Horizon2020 Framework Programme; EU-FP7 PEOPLE-2013 program; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for the outstanding technical contribution of M. Peloquin and acknowledge the discussions and comments on the manuscript from members of the Nagy and Spite laboratories. The authors also thank L. Thomas for excellent administrative assistance. N.G. and L.N. are supported by 'Chromatin3D' ITN funded by the European Union under the Horizon2020 Framework Programme (Grant Agreement no. 622934). A.P. and L.N. are supported by 'NR-NET' ITN PITN-GA-2013-606806 from the EU-FP7 PEOPLE-2013 program, by grants from the Hungarian Scientific Research Fund (numbers K124298, K126885, K116855 to L.N.) and by the NIH (no. R01DK115924). M.S. acknowledges the support of NIH grant numbers GM095467 (Project 3 and Core B) and HL106173. B.E.S. is supported by an NRSA from the NIH (no. HL136044).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baker LA, 2018, J CELL BIOCHEM, V119, P6094, DOI 10.1002/jcb.26807; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Childers MK, 2011, JOVE-J VIS EXP, DOI 10.3791/2623; Dadgar S, 2014, J CELL BIOL, V207, P139, DOI 10.1083/jcb.201402079; Dalli J, 2019, BRIT J PHARMACOL, V176, P1024, DOI 10.1111/bph.14336; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; English JT, 2017, PROSTAG LEUKOTR ESS, V117, P17, DOI 10.1016/j.plefa.2017.01.004; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Glaudemans AWJM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/623036; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Guardiola O, 2017, JOVE-J VIS EXP, V119, pe54515; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hellmann J, 2018, J INVEST DERMATOL, V138, P2051, DOI 10.1016/j.jid.2018.03.1498; Ho ATV, 2017, P NATL ACAD SCI USA, V114, P6675, DOI 10.1073/pnas.1705420114; Inoue Y, 2018, J BURN CARE RES, V39, P423, DOI 10.1097/BCR.0000000000000617; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Motwani MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94463; Patsalos A, 2017, J PHYSIOL-LONDON, V595, P5815, DOI 10.1113/JP274361; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Sager HB, 2017, J THORAC DIS, V9, pS30, DOI 10.21037/jtd.2016.11.17; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Thul S, 2017, EUR J PREV CARDIOL, V24, P903, DOI 10.1177/2047487317694464; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vaidyanathan S, 2015, CLIN RADIOL, V70, P787, DOI 10.1016/j.crad.2015.03.010; Varga T, 2016, J IMMUNOL, V196, P4771, DOI 10.4049/jimmunol.1502490; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wang M, 2016, PROG LIPID RES, V61, P83, DOI 10.1016/j.plipres.2015.12.002; Wang Miao, 2014, Methods Mol Biol, V1198, P203, DOI 10.1007/978-1-4939-1258-2_13; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang MJ, 2016, CIRCULATION, V134, P666, DOI 10.1161/CIRCULATIONAHA.116.021894	58	73	74	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					626	+		10.1038/s41590-019-0356-7	http://dx.doi.org/10.1038/s41590-019-0356-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30936495	Green Accepted			2022-12-18	WOS:000465084800019
J	Chou, C; Pinto, AK; Curtis, JD; Persaud, SP; Cella, M; Lin, CC; Edelson, BT; Allen, PM; Colonna, M; Pearce, EL; Diamond, MS; Egawa, T				Chou, Chun; Pinto, Amelia K.; Curtis, Jonathan D.; Persaud, Stephen P.; Cella, Marina; Lin, Chih-Chung; Edelson, Brian T.; Allen, Paul M.; Colonna, Marco; Pearce, Erika L.; Diamond, Michael S.; Egawa, Takeshi			c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							EMBRYONIC STEM; DIFFERENTIATION; EFFECTOR; EXPRESSION; INFECTION; EXPANSION; DURATION	Although the transcription factor c-Myc is essential for the establishment of a metabolically active and proliferative state in T cells after priming, its expression is transient. It remains unknown how T cell activation is maintained after c-Myc expression is downregulated. Here we identified AP4 as the transcription factor that was induced by c-Myc and sustained activation of antigen-specific CD8(+) T cells. Despite normal priming, AP4-deficient CD8(+) T cells failed to continue transcription of a broad range of c-Myc-dependent targets. Mice lacking AP4 specifically in CD8(+) T cells showed enhanced susceptibility to infection with West Nile virus. Genome-wide analysis suggested that many activation-induced genes encoding molecules involved in metabolism were shared targets of c-Myc and AP4. Thus, AP4 maintains c-Myc-initiated cellular activation programs in CD8(+) T cells to control microbial infection.	[Chou, Chun; Curtis, Jonathan D.; Persaud, Stephen P.; Cella, Marina; Lin, Chih-Chung; Edelson, Brian T.; Allen, Paul M.; Colonna, Marco; Pearce, Erika L.; Diamond, Michael S.; Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Pinto, Amelia K.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Egawa, T (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	tegawa@wustl.edu	Pinto, Amelia/AAD-7059-2020; Diamond, Michael/AAH-1733-2019; Pinto, Amelia K/O-6658-2018; Cella, Marina/ABA-8564-2020	Pinto, Amelia/0000-0002-7147-3978; Diamond, Michael/0000-0002-8791-3165; Pinto, Amelia K/0000-0002-7147-3978; Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987; Allen, Paul/0000-0003-3796-6047; Edelson, Brian/0000-0003-2856-7650; Chou, Chun/0000-0001-7147-4236; Persaud, Stephen/0000-0002-7733-5509	Lucille P. Markey Pathway Program; Burroughs Wellcome Fund; McDonnell International Scholars Academy at Washington University; US National Institutes of Health [P30 AR048335, R01 AI097244, U54 AI081680]; Edward Mallinckrodt Jr. Foundation; Washington University Institute of Clinical and Translational Sciences of the National Center for Advancing Translational Sciences of the US National Institutes of Health [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244, R01AI024157, U54AI081680, R01AI091965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	Lucille P. Markey Pathway Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); McDonnell International Scholars Academy at Washington University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; Washington University Institute of Clinical and Translational Sciences of the National Center for Advancing Translational Sciences of the US National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M.J. Bevan (University of Washington, Seattle) for LM-OVA; I. Taniuchi (RIKEN, Yokohama) and D.R. Littman (New York University) for CD8-Cre mice; B.P. Sleckman (Washington University School of Medicine) for c-Myc-GFP knock-in mice; F.W. Alt (Harvard Medical School) and D.R. Green (St. Jude Children's Research Hospital) for MycF mice; T. Hansen (Washington University School of Medicine) for the H-2K<SUP>b</SUP>-OVA single-chain tetramer; S. Hsiung, J. Govero and M.J. Sunshine for technical assistance; and E. Oltz, C.-S. Hsieh and D.R. Littman for discussions and critical reading of the manuscript. Supported by the Lucille P. Markey Pathway Program (C.C.), the Burroughs Wellcome Fund (B.T.E.), the McDonnell International Scholars Academy at Washington University (C.-C.L.), the US National Institutes of Health (P30 AR048335 to the Rheumatic Diseases Core Center; R01 AI097244 to T.E.; and U54 AI081680 to M.S.D.), the Edward Mallinckrodt Jr. Foundation (T.E.) and the Washington University Institute of Clinical and Translational Sciences of the National Center for Advancing Translational Sciences of the US National Institutes of Health (UL1 TR000448).	Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Porter BB, 2006, INFECT IMMUN, V74, P1528, DOI 10.1128/IAI.74.3.1528-1536.2006; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	42	73	74	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					884	893		10.1038/ni.2943	http://dx.doi.org/10.1038/ni.2943			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25029552	Green Accepted			2022-12-18	WOS:000340739400016
J	Frelin, C; Herrington, R; Janmohamed, S; Barbara, M; Tran, G; Paige, CJ; Benveniste, P; Zuniga-Pflucker, JC; Souabni, A; Busslinger, M; Iscove, NN				Frelin, Catherine; Herrington, Robert; Janmohamed, Salima; Barbara, Mary; Tran, Gary; Paige, Christopher J.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos; Souabni, Abdallah; Busslinger, Meinrad; Iscove, Norman N.			GATA-3 regulates the self-renewal of long-term hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							P38 MAPK; PYRIMIDINYLIMIDAZOLE INHIBITORS; GENE-EXPRESSION; IN-VIVO; KINASE; CYTOKINE; DIFFERENTIATION; ALPHA; 5-FLUOROURACIL; AMPLIFICATION	The transcription factor GATA-3 is expressed and required for differentiation and function throughout the T lymphocyte lineage. Despite evidence it may also be expressed in multipotent hematopoietic stem cells (HSCs), any role for GATA-3 in these cells has remained unclear. Here we found GATA-3 was in the cytoplasm in quiescent long-term stem cells from steady-state bone marrow but relocated to the nucleus when HSCs cycled. Relocation depended on signaling via the mitogen-activated protein kinase p38 and was associated with a diminished capacity for long-term reconstitution after transfer into irradiated mice. Deletion of Gata3 enhanced the repopulating capacity and augmented the self-renewal of long-term HSCs in cell-autonomous fashion without affecting the cell cycle. Our observations position GATA-3 as a regulator of the balance between self-renewal and differentiation in HSCs that acts downstream of the p38 signaling pathway.	[Frelin, Catherine; Herrington, Robert; Barbara, Mary; Tran, Gary; Paige, Christopher J.; Iscove, Norman N.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Frelin, Catherine; Tran, Gary; Paige, Christopher J.; Iscove, Norman N.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Janmohamed, Salima; Paige, Christopher J.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos; Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos] Sunnybrook Res Inst, Toronto, ON, Canada; [Souabni, Abdallah; Busslinger, Meinrad] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Iscove, Norman N.] McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Iscove, NN (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	iscove@uhnresearch.ca	Busslinger, Meinrad J./J-1249-2016; Zuniga-Pflucker, Juan C/H-1295-2012	Busslinger, Meinrad J./0000-0002-9111-9351; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Benveniste, Patricia/0000-0002-5673-0542	Terry Fox Foundation; Canadian Cancer Research Institute; Canadian Institutes of Health Research; Stem Cell Network; Fondation de France; Fondation pour la Recherche Medicale; McEwen Centre for Regenerative Medicine; Princess Margaret Hospital Foundation; Campbell Family Institute for Cancer Research; Ontario Ministry of Health and Long Term Care	Terry Fox Foundation; Canadian Cancer Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); McEwen Centre for Regenerative Medicine; Princess Margaret Hospital Foundation; Campbell Family Institute for Cancer Research; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We thank F. Melchers (Max Planck Institute for Infection Biology) for conditioned medium from transduced mouse cells that produce IL-7; P. A. Penttila for assistance with flow cytometry and M. F. Monroy for help with animal procedures. Supported by the Terry Fox Foundation, the Canadian Cancer Research Institute, the Canadian Institutes of Health Research, the Stem Cell Network, the Fondation de France (C. F.), the Fondation pour la Recherche Medicale (C. F.), the McEwen Centre for Regenerative Medicine, the Princess Margaret Hospital Foundation, the Campbell Family Institute for Cancer Research and the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care.	Adams JL, 2001, BIOORG MED CHEM LETT, V11, P2867, DOI 10.1016/S0960-894X(01)00570-4; Adams JL, 1998, BIOORG MED CHEM LETT, V8, P3111, DOI 10.1016/S0960-894X(98)00549-6; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Billia F, 2001, BLOOD, V97, P2257, DOI 10.1182/blood.V97.8.2257; Boehm JC, 2001, BIOORG MED CHEM LETT, V11, P1123, DOI 10.1016/S0960-894X(01)00163-9; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Hardy RR, 2012, J IMMUNOL, V189, P1213; HARRISON DE, 1991, BLOOD, V78, P1237; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jia YT, 2007, J IMMUNOL, V179, P7808, DOI 10.4049/jimmunol.179.11.7808; Kapur R, 2002, BLOOD, V100, P1287, DOI 10.1182/blood.V100.4.1287.h81602001287_1287_1293; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Pisegna S, 2004, BLOOD, V104, P4157, DOI 10.1182/blood-2004-05-1860; QUESNIAUX VFJ, 1993, BLOOD, V81, P1497; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Wang Y, 2011, STEM CELLS DEV, V20, P1143, DOI 10.1089/scd.2010.0413; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamashita M, 2012, J IMMUNOL, V188, P2825, DOI 10.4049/jimmunol.1103220; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	49	73	76	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1037	+		10.1038/ni.2692	http://dx.doi.org/10.1038/ni.2692			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	23974957	Green Accepted			2022-12-18	WOS:000324584700012
J	Fu, WX; Wojtkiewicz, G; Weissleder, R; Benoist, C; Mathis, D				Fu, Wenxian; Wojtkiewicz, Gregory; Weissleder, Ralph; Benoist, Christophe; Mathis, Diane			Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging	NATURE IMMUNOLOGY			English	Article							ALTERNATIVE PATHWAY; DENDRITIC CELLS; INFLAMMATION; ACTIVATION; MOUSE; MACROPHAGES; PROGRESSION; INHIBITOR; MONOCYTES; AUTOANTIBODIES	All juvenile mice of the nonobese diabetic (NOD) strain develop insulitis, but there is considerable variation in their progression to diabetes. Here we used a strategy based on magnetic resonance imaging (MRI) of magnetic nanoparticles to noninvasively visualize local effects of pancreatic-islet inflammation to predict the onset of diabetes in NOD mice. MRI signals acquired during a narrow early time window allowed us to sort mice into groups that would progress to clinical disease or not and to estimate the time to diabetes development. We exploited this approach to identify previously unknown molecular and cellular elements correlated with disease protection, including the complement receptor of the immunoglobulin superfamily (CRIg), which marked a subset of macrophages associated with diabetes resistance. Administration of a fusion of CRIg and the Fc portion of immunoglobulin resulted in lower MRI signals and diabetes incidence. In addition to identifying regulators of disease progression, we show here that diabetes is set at an early age in NOD mice.	[Fu, Wenxian; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Wojtkiewicz, Gregory; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph; Benoist, Christophe; Mathis, Diane] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mathis, Diane] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Wojtkiewicz, Gregory/L-3660-2018	Wojtkiewicz, Gregory/0000-0002-3148-8411; /0000-0003-0828-4143; Fu, Wenxian/0000-0003-0684-8929	US National Institutes of Health [P01 AI054904]; Joslin Diabetes Center [P30 DK036836]; Juvenile Diabetes Research Foundation Center on Immunological Tolerance at Harvard Medical School [4-2007-1057]; Massachusetts General Hospital [U24CA092782]; American Diabetes Association [7-07-BETA-14]; NATIONAL CANCER INSTITUTE [U24CA092782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center; Juvenile Diabetes Research Foundation Center on Immunological Tolerance at Harvard Medical School; Massachusetts General Hospital(General Electric); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. van Lookeren Campagne (Genentech) for discussions and for monoclonal antibody to CRIg and the CRIg-Fc fusion protein; G. Eisenbarth and L. Vu for measuring autoantibodies to insulin; U. Mahmood and A. Guimaraes for MRI protocol setup and discussions; C. Kaufman and J. Chan for assistance with MRI; J. Pagan, K. Hattori, P. Waterman and A. Sumski for assistance with mice; J. Hill, K. Leatherbee, M. Painter and S. Davis for microarray experimentation and analysis; J. Nishio for histology and diabetes monitoring; and I. LaVecchio and G. Buruzala for help with flow cytometry. Supported by the US National Institutes of Health (P01 AI054904 to D.M., C.B. and R.W.), the core facilities of the Joslin Diabetes Center (P30 DK036836), the Manipulated NOD Mouse Core of the Juvenile Diabetes Research Foundation Center on Immunological Tolerance at Harvard Medical School (4-2007-1057), the Mouse Imaging Resource at the Massachusetts General Hospital (U24CA092782) and the American Diabetes Association (7-07-BETA-14 to W.F.).	Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BOHME J, 1990, SCIENCE, V249, P293, DOI 10.1126/science.2115690; Carlsson PO, 1998, ENDOCRINOLOGY, V139, P3534, DOI 10.1210/en.139.8.3534; Chen J, 2011, J SURG RES, V167, pE131, DOI 10.1016/j.jss.2009.05.041; Chen M, 2010, EUR J IMMUNOL, V40, P2870, DOI 10.1002/eji.201040323; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; Guo S, 2010, CLIN IMMUNOL, V136, P282, DOI 10.1016/j.clim.2010.03.007; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mathis D., 2010, MOL IMAGING, P1130; MILLS AN, 1991, J THORAC CARDIOV SUR, V101, P909; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Papaccio G, 2002, J CELL BIOCHEM, V86, P651, DOI 10.1002/jcb.10250; Papaccio G, 1998, AUTOIMMUNITY, V27, P65, DOI 10.3109/08916939809008037; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Robles DT, 2003, DIABETES, V52, P882, DOI 10.2337/diabetes.52.3.882; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tanaka M, 2008, CLIN EXP IMMUNOL, V154, P38, DOI 10.1111/j.1365-2249.2008.03733.x; Turvey SE, 2005, J CLIN INVEST, V115, P2454, DOI 10.1172/JCI25048; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; WEISSLEDER R, 1994, RADIOLOGY, V191, P225, DOI 10.1148/radiology.191.1.8134576; Xu SX, 2010, IMMUNOL LETT, V128, P46, DOI 10.1016/j.imlet.2009.11.003; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	36	73	74	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					361	368		10.1038/ni.2233	http://dx.doi.org/10.1038/ni.2233			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22366893	Green Accepted, Green Submitted			2022-12-18	WOS:000301886800010
J	Wang, PH; Arjona, A; Zhang, Y; Sultana, H; Dai, JF; Yang, L; LeBlanc, PM; Doiron, K; Saleh, M; Fikrig, E				Wang, Penghua; Arjona, Alvaro; Zhang, Yue; Sultana, Hameeda; Dai, Jianfeng; Yang, Long; LeBlanc, Philippe M.; Doiron, Karine; Saleh, Maya; Fikrig, Erol			Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ANTIVIRAL INNATE IMMUNITY; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; CELL-DEATH PROGRAM; PROGRESSIVE CEREBELLAR; INFLAMMATORY CASPASES; INDUCED APOPTOSIS; UBIQUITIN LIGASE; ER STRESS	Caspase-12 has been shown to negatively modulate inflammasome signaling during bacterial infection. Its function in viral immunity, however, has not been characterized. We now report an important role for caspase-12 in controlling viral infection via the pattern-recognition receptor RIG-I. After challenge with West Nile virus (WNV), caspase-12-deficient mice had greater mortality, higher viral burden and defective type I interferon response compared with those of challenged wild-type mice. In vitro studies of primary neurons and mouse embryonic fibroblasts showed that caspase-12 positively modulated the production of type I interferon by regulating E3 ubiquitin ligase TRIM25-mediated ubiquitination of RIG-I, a critical signaling event for the type I interferon response to WNV and other important viral pathogens.	[LeBlanc, Philippe M.; Doiron, Karine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ, Canada; [Wang, Penghua; Arjona, Alvaro; Zhang, Yue; Sultana, Hameeda; Dai, Jianfeng; Yang, Long; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Sultana, Hameeda; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	McGill University; Yale University; Howard Hughes Medical Institute	Saleh, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	maya.saleh@mcgill.ca; erol.fikrig@yale.edu	Arjona, PhD, Alvaro/AAX-8914-2021; wang, Penghua/AAL-4011-2020; Dai, Jianfeng/ACP-1114-2022	Saleh, Maya/0000-0003-1538-9146	National Institutes of Health [AI-055749, AI-50031]; Howard Hughes Medical Institute; Northeast Biodefense Center [U54-AI057158-Lipkin]; Canadian Institutes for Health Research [79410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055749, N01AI050031, U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Northeast Biodefense Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.F. Anderson (Connecticut Agricultural Experiment Station) for WNV, and J.U. Jung (University of Southern California) for plasmids. Supported by the National Institutes of Health (AI-055749 and AI-50031), the Howard Hughes Medical Institute (E.F.), the Northeast Biodefense Center (U54-AI057158-Lipkin to P.W.) and the Canadian Institutes for Health Research (79410 to M.S.).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barton GHM, 2003, NAT IMMUNOL, V4, P432, DOI 10.1038/ni0503-432; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; Clark HB, 1997, J NEUROSCI, V17, P7385; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; DI SANO F, 2006, J BIOL CHEM, V281, P2693; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Fabian Z, 2007, J VIROL, V81, P2817, DOI 10.1128/JVI.02490-06; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim MJ, 2008, J IMMUNOL, V181, P7324, DOI 10.4049/jimmunol.181.10.7324; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Roy S, 2008, P NATL ACAD SCI USA, V105, P4133, DOI 10.1073/pnas.0706658105; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tian ZG, 2000, J IMMUNOL, V165, P3959, DOI 10.4049/jimmunol.165.7.3959; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	50	73	75	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					912	U61		10.1038/ni.1933	http://dx.doi.org/10.1038/ni.1933			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20818395	Green Accepted			2022-12-18	WOS:000281926900010
J	Herz, J; Pardo, J; Kashkar, H; Schramm, M; Kuzmenkina, E; Bos, E; Wiegmann, K; Wallich, R; Peters, PJ; Herzig, S; Schmelzer, E; Kronke, M; Simon, MM; Utermohlen, O				Herz, Jasmin; Pardo, Julian; Kashkar, Hamid; Schramm, Michael; Kuzmenkina, Elza; Bos, Erik; Wiegmann, Katja; Wallich, Reinhard; Peters, Peter J.; Herzig, Stefan; Schmelzer, Elmon; Kroenke, Martin; Simon, Markus M.; Utermoehlen, Olaf			Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes	NATURE IMMUNOLOGY			English	Article							MEDIATED APOPTOSIS; GRANZYME-B; LYSOSOMAL SPHINGOMYELINASE; CHORIOMENINGITIS VIRUS; IMMUNOLOGICAL SYNAPSE; DEFICIENT MICE; CELLS; MEMBRANE; CERAMIDE; FUSION	Granule-mediated cytotoxicity is the main effector mechanism of cytotoxic CD8(+) T cells. We report that CD8(+) T cells from acid sphingomyelinase (ASMase)-deficient (ASMase-KO) mice are defective in exocytosis of cytolytic effector molecules; this defect resulted in attenuated cytotoxic activity of ASMase-KO CD8(+) T cells and delayed elimination of lymphocytic choriomeningitis virus from ASMase-KO mice. Cytolytic granules of ASMase-KO and wild-type CD8(+) T cells were equally loaded with granzymes and perforin, and correctly directed to the immunological synapse. In wild-type CD8(+) T cells, secretory granules underwent shrinkage by 82% after fusion with the plasma membrane. In ASMase-KO CD8(+) T cells, the contraction of secretory granules was markedly impaired. Thus, ASMase is required for contraction of secretory granules and expulsion of cytotoxic effector molecules.	[Herz, Jasmin; Kashkar, Hamid; Schramm, Michael; Wiegmann, Katja; Kroenke, Martin; Utermoehlen, Olaf] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Med Ctr, D-5000 Cologne 41, Germany; [Herz, Jasmin; Kashkar, Hamid; Schramm, Michael; Herzig, Stefan; Kroenke, Martin; Utermoehlen, Olaf] Univ Cologne, Ctr Mol Med, D-5000 Cologne 41, Germany; [Kuzmenkina, Elza; Herzig, Stefan] Univ Cologne, Dept Pharmacol, D-5000 Cologne 41, Germany; [Pardo, Julian; Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, Freiburg, Germany; [Bos, Erik; Peters, Peter J.] Netherlands Canc Inst, Amsterdam, Netherlands; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Schmelzer, Elmon] Max Planck Inst Plant Breeding Res, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Netherlands Cancer Institute; Ruprecht Karls University Heidelberg; Max Planck Society	Kronke, M (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, Med Ctr, D-5000 Cologne 41, Germany.	m.kroenke@uni-koeln.de; olaf.utermoehlen@uk-koeln.de	Pardo, Julián/K-6764-2014	Pardo, Julián/0000-0003-0154-0730; Herzig, Stefan/0000-0001-8107-5204				Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; FRUTH U, 1988, EUR J IMMUNOL, V18, P773, DOI 10.1002/eji.1830180518; FRUTH U, 1987, EUR J IMMUNOL, V17, P613, DOI 10.1002/eji.1830170506; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Henkart P A, 1997, Semin Immunol, V9, P135, DOI 10.1006/smim.1997.0063; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kasai H, 2005, J PHYSIOL-LONDON, V568, P891, DOI 10.1113/jphysiol.2005.093047; Kronke M, 1999, CHEM PHYS LIPIDS, V101, P109, DOI 10.1016/S0009-3084(99)00059-6; LEHMANNGRUBE F, 1985, J IMMUNOL, V134, P608; Lopez-Montero I, 2007, BBA-BIOMEMBRANES, V1768, P553, DOI 10.1016/j.bbamem.2007.01.001; Lowin B, 1996, INT IMMUNOL, V8, P57, DOI 10.1093/intimm/8.1.57; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MOSKOPHIDIS D, 1989, P NATL ACAD SCI USA, V86, P3291, DOI 10.1073/pnas.86.9.3291; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; OLLMANN M, 1987, BIOCHEMISTRY-US, V26, P5943, DOI 10.1021/bi00392a055; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Powell AD, 2007, J NEUROSCI METH, V162, P272, DOI 10.1016/j.jneumeth.2007.01.022; Raja SM, 2003, CURR OPIN IMMUNOL, V15, P528, DOI 10.1016/S0952-7915(03)00111-0; Raja SM, 2002, J BIOL CHEM, V277, P49523, DOI 10.1074/jbc.M209607200; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; SASSAROLI M, 1990, BIOPHYS J, V57, P281, DOI 10.1016/S0006-3495(90)82530-3; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; SCHUTZE S, 1995, CYTOKINES PRACTICAL, P93; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; Vergne I, 1998, ANAL BIOCHEM, V255, P127, DOI 10.1006/abio.1997.2466; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Williams RM, 2000, J CELL SCI, V113, P3839	50	73	74	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					761	U121		10.1038/ni.1757	http://dx.doi.org/10.1038/ni.1757			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19525969				2022-12-18	WOS:000267142600016
J	Cantor, J; Browne, CD; Ruppert, R; Feral, CC; Fassler, R; Rickert, RC; Ginsberg, MH				Cantor, Joseph; Browne, Cecille D.; Ruppert, Raphael; Feral, Chloe C.; Faessler, Reinhard; Rickert, Robert C.; Ginsberg, Mark H.			CD98hc facilitates B cell proliferation and adaptive humoral immunity	NATURE IMMUNOLOGY			English	Article							AMINO-ACID-TRANSPORT; CYCLIN D1 EXPRESSION; IMMUNOLOGICAL-SYNAPSE; LYMPHOCYTE-ACTIVATION; TARGETED DISRUPTION; SLC3A2 INTERACTION; INTEGRINS; ANTIGEN; BETA-1-INTEGRIN; IDENTIFICATION	The proliferation of antigen-specific lymphocytes and resulting clonal expansion are essential for adaptive immunity. We report here that B cell-specific deletion of the heavy chain of CD98 (CD98hc) resulted in lower antibody responses due to total suppression of B cell proliferation and subsequent plasma cell formation. Deletion of CD98hc did not impair early B cell activation but did inhibit later activation of the mitogen-activated protein kinase Erk1/2 and downregulation of the cell cycle inhibitor p27. Reconstitution of CD98hc-deficient B cells with CD98hc mutants showed that the integrin-binding domain of CD98hc was required for B cell proliferation but that the amino acid-transport function of CD98hc was dispensable for this. Thus, CD98hc supports integrin-dependent rapid proliferation of B cells. We propose that the advantage of adaptive immunity favored the appearance of CD98hc in vertebrates.	[Cantor, Joseph; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Browne, Cecille D.; Rickert, Robert C.] Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Ruppert, Raphael; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Feral, Chloe C.] Nice Sophia Antipolis Univ, INSERM, Nice, France	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	robert@burnham.org; mhginsberg@ucsd.edu	FERAL, Chloe/AAB-6111-2020; Feral, Chloe C/O-5781-2016	FERAL, Chloe/0000-0001-9756-2082; Feral, Chloe C/0000-0001-9756-2082	NHLBI NIH HHS [P01 HL057900, HL0780784, P01 HL057900-12A10002, HL31950, P01 HL078784-05, T32 HL007444, P01 HL031950, P01 HL078784, P01 HL031950-240012, P01 HL057900-12A19001] Funding Source: Medline; NIAMS NIH HHS [R01 AR027214, R37 AR027214, AR27214, R01 AR027214-30] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, P01HL057900, P01HL031950, T32HL007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214, R37AR027214] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Batista FD, 2007, IMMUNOL REV, V218, P197, DOI 10.1111/j.1600-065X.2007.00540.x; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; BURNET FM, 1959, CLONAL SELECTION THE, P49; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Diaz LA, 1997, INT IMMUNOL, V9, P1221, DOI 10.1093/intimm/9.9.1221; ESTEBAN F, 1990, CANCER, V66, P1493, DOI 10.1002/1097-0142(19901001)66:7<1493::AID-CNCR2820660710>3.0.CO;2-0; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FERNANDEZHERRERA J, 1989, J INVEST DERMATOL, V92, P247, DOI 10.1111/1523-1747.ep12276789; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FRIEDMAN AW, 1994, CELL IMMUNOL, V154, P253, DOI 10.1006/cimm.1994.1075; Hara K, 1999, BIOCHEM BIOPH RES CO, V262, P720, DOI 10.1006/bbrc.1999.1051; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; KEHRL JH, 1983, T ASSOC AM PHYSICIAN, V96, P182; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Mondino A, 2007, SEMIN IMMUNOL, V19, P162, DOI 10.1016/j.smim.2007.02.008; Motti ML, 2007, CELL CYCLE, V6, P2817, DOI 10.4161/cc.6.22.4883; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Prager GW, 2007, J BIOL CHEM, V282, P24477, DOI 10.1074/jbc.M702877200; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Schwartz MA, 2001, J CELL SCI, V114, P2553; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Tangye SG, 2004, IMMUNOLOGY, V112, P509, DOI 10.1111/j.1365-2567.2004.01950.x; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Uinuk-ool T, 2002, P NATL ACAD SCI USA, V99, P14356, DOI 10.1073/pnas.212527699; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Warren AP, 2000, IMMUNOLOGY, V99, P62, DOI 10.1046/j.1365-2567.2000.00953.x; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059	50	73	76	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					412	419		10.1038/ni.1712	http://dx.doi.org/10.1038/ni.1712			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19270713	Green Submitted, Green Accepted			2022-12-18	WOS:000264425800015
J	Leinwand, J; Miller, G				Leinwand, Joshua; Miller, George			Regulation and modulation of antitumor immunity in pancreatic cancer	NATURE IMMUNOLOGY			English	Review							TUMOR-INFILTRATING MACROPHAGES; FOCAL ADHESION KINASE; T-CELL IMMUNITY; DUCTAL ADENOCARCINORNA; IMPROVES SURVIVAL; NK CELLS; PHASE-II; PROMOTES; PROGRESSION; IMMUNOTHERAPY	Pancreatic ductal adenocarcinoma carries a dismal prognosis, and outcomes have improved little with modern therapeutics. Checkpoint-based immunotherapy has failed to elicit responses in the vast majority of patients with pancreatic cancer. Alongside tumor cell-intrinsic mechanisms associated with oncogenic KRAS-induced inflammation, the tolerogenic myeloid cell infiltrate has emerged as a critical impediment to adaptive antitumor immune responses. Furthermore, the discovery of an intratumoral microbiome and the elucidation of host-microbe interactions that curtail antitumor immunity also present opportunities for intervention. Here we review the mechanisms of immunotherapy resistance in pancreatic ductal adenocarcinoma and discuss strategies to directly augment T cell responses in parallel with myeloid cell- and microbiome-targeted approaches that may enable immune-mediated control of this malignancy.	[Leinwand, Joshua; Miller, George] NYU, Dept Surg, Sch Med, SA Localio Lab, New York, NY 10016 USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Miller, G (corresponding author), NYU, Dept Surg, Sch Med, SA Localio Lab, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	george.miller@nyumc.org						Aglietta M, 2014, ANN ONCOL, V25, P1750, DOI 10.1093/annonc/mdu205; Ames E, 2015, J IMMUNOL, V195, P4010, DOI 10.4049/jimmunol.1500447; AndrenSandberg A, 1997, SCAND J GASTROENTERO, V32, P97, DOI 10.3109/00365529709000177; Aykut B, 2019, NATURE, V574, P264, DOI 10.1038/s41586-019-1608-2; Balachandran VP, 2019, GASTROENTEROLOGY, V156, P2056, DOI 10.1053/j.gastro.2018.12.038; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Barilla RM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09416-2; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2018, GASTROENTEROLOGY, V155, P29, DOI 10.1053/j.gastro.2018.03.029; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Blando J, 2019, P NATL ACAD SCI USA, V116, P1692, DOI 10.1073/pnas.1811067116; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Candido JB, 2018, CELL REP, V23, P1448, DOI 10.1016/j.celrep.2018.03.131; Canon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Carmichael J, 1996, BRIT J CANCER, V73, P101, DOI 10.1038/bjc.1996.18; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Carstens JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15095; CASPER ES, 1994, INVEST NEW DRUG, V12, P29, DOI 10.1007/BF00873232; Chao T, 2016, CANCER IMMUNOL RES, V4, P968, DOI 10.1158/2326-6066.CIR-16-0188; Chen PY, 2018, CANCER RES, V78, P985, DOI 10.1158/0008-5472.CAN-17-2129; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Das S, 2020, CANCER RES, V80, P1088, DOI 10.1158/0008-5472.CAN-19-2080; Das S, 2019, ONCOGENE, V38, P3316, DOI 10.1038/s41388-018-0668-3; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deicher A, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0585-0; Dey P, 2020, CANCER DISCOV, V10, P608, DOI 10.1158/2159-8290.CD-19-0297; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gnerlich JL, 2010, J IMMUNOL, V185, P4063, DOI 10.4049/jimmunol.0902609; Gurlevik E, 2016, GASTROENTEROLOGY, V151, P338, DOI 10.1053/j.gastro.2016.05.004; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hegde S, 2020, CANCER CELL, V37, P289, DOI 10.1016/j.ccell.2020.02.008; Hiraoka N, 2015, BRIT J CANCER, V112, P1782, DOI 10.1038/bjc.2015.145; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Howlader N, 2019, NIH, V1; Hu H, 2016, TUMOR BIOL, V37, P8657, DOI 10.1007/s13277-015-4741-z; Hu S, 2019, AM J CANCER RES, V9, P1757; Hundeyin M, 2019, CANCER DISCOV, V9, P1288, DOI 10.1158/2159-8290.CD-19-0161; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jang JE, 2017, CELL REP, V20, P558, DOI 10.1016/j.celrep.2017.06.062; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Jun E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01354; Kamath SD, 2020, ONCOLOGIST, V25, pE808, DOI 10.1634/theoncologist.2019-0473; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Kang YW, 2018, CANCER LETT, V438, P174, DOI 10.1016/j.canlet.2018.09.013; Keenan BP, 2014, GASTROENTEROLOGY, V146, P1784, DOI 10.1053/j.gastro.2014.02.055; Kenkel JA, 2017, CANCER RES, V77, P4158, DOI 10.1158/0008-5472.CAN-16-2212; Kinsey CG, 2019, NAT MED, V25, P620, DOI 10.1038/s41591-019-0367-9; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Lee J, 2019, CANCER IMMUNOL RES, V7, P219, DOI 10.1158/2326-6066.CIR-18-0317; Lee KE, 2016, CANCER DISCOV, V6, P256, DOI 10.1158/2159-8290.CD-15-0822; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li JY, 2018, IMMUNITY, V49, P178, DOI 10.1016/j.immuni.2018.06.006; Li XY, 2011, PANCREAS, V40, P753, DOI 10.1097/MPA.0b013e318213d51b; Lim SA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00496; Lin M, 2017, J CANCER RES CLIN, V143, P2607, DOI 10.1007/s00432-017-2513-4; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Long KB, 2016, CANCER DISCOV, V6, P400, DOI 10.1158/2159-8290.CD-15-1032; Maekawa T, 2018, BIOCHEM BIOPH RES CO, V506, P962, DOI 10.1016/j.bbrc.2018.10.169; Marabelle A, 2020, J CLIN ONCOL, V38, P1, DOI 10.1200/JCO.19.02105; Markosyan N, 2019, J CLIN INVEST, V129, P3594, DOI 10.1172/JCI127755; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Meng QD, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00384; Meyer MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03600-6; Mirlekar B, 2020, CANCER IMMUNOL RES, V8, P292, DOI 10.1158/2326-6066.CIR-19-0349; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Monti P, 2003, CANCER RES, V63, P7451; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189; Nywening TM, 2018, GUT, V67, P1112, DOI 10.1136/gutjnl-2017-313738; Nywening TM, 2016, LANCET ONCOL, V17, P651, DOI 10.1016/S1470-2045(16)00078-4; O'Reilly EM, 2019, JAMA ONCOL, V5, P1431, DOI 10.1001/jamaoncol.2019.1588; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Osipov A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0667-0; Overman M, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000587; Panni RZ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9240; Peng YP, 2016, ONCOTARGET, V7, P66586, DOI 10.18632/oncotarget.11953; Peng YP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-738; Peng YP, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-262; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Pylayeva-Gupta Y, 2016, CANCER DISCOV, V6, P247, DOI 10.1158/2159-8290.CD-15-0843; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Saung MT, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0435-6; Seifert L, 2016, GASTROENTEROLOGY, V150, P1659, DOI 10.1053/j.gastro.2016.02.070; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Seo YD, 2019, CLIN CANCER RES, V25, P3934, DOI 10.1158/1078-0432.CCR-19-0081; Sethi V, 2018, GASTROENTEROLOGY, V155, P33, DOI 10.1053/j.gastro.2018.04.001; Shang J, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0712-y; Shen T, 2017, SCI REP, V7; Slaney CY, 2014, CANCER RES, V74, P7168, DOI 10.1158/0008-5472.CAN-14-2458; Smaglo B. G, 2019, P IMM CELL THER CANC; Spear S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00542; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Stromnes IM, 2014, GUT, V63, P1769, DOI 10.1136/gutjnl-2013-306271; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Thomas RM, 2018, CARCINOGENESIS, V39, P1068, DOI 10.1093/carcin/bgy073; Van Audenaerde JRM, 2017, ONCOTARGET, V8, P56968, DOI 10.18632/oncotarget.18185; Vonderheide RH, 2019, CANC RES, V79, pabstr I12; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Weiss GJ, 2017, BRIT J CANCER, V117, P33, DOI 10.1038/bjc.2017.145; WIDDISON AL, 1994, GUT, V35, P1306, DOI 10.1136/gut.35.9.1306; Wilky BA, 2019, IMMUNOL REV, V290, P6, DOI 10.1111/imr.12766; Zambirinis CP, 2017, TRENDS MOL MED, V23, P365, DOI 10.1016/j.molmed.2017.03.003; Zhang AB, 2017, CANCER MED-US, V6, P463, DOI 10.1002/cam4.993; Zhang YQ, 2020, CANCER DISCOV, V10, P422, DOI 10.1158/2159-8290.CD-19-0958; Zhang YQ, 2017, GUT, V66, P124, DOI 10.1136/gutjnl-2016-312078; Zhang YY, 2019, J CANCER, V10, P4420, DOI 10.7150/jca.29898; Zhao Y., 2018, ONCOTARGET, V9, P14803, DOI [10.18632/oncotarget.22976, DOI 10.18632/ONCOTARGET.22976]; Zheng L, 2013, GASTROENTEROLOGY, V144, P1230, DOI 10.1053/j.gastro.2012.12.042; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	132	72	73	6	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1152	1159		10.1038/s41590-020-0761-y	http://dx.doi.org/10.1038/s41590-020-0761-y		AUG 2020	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32807942				2022-12-18	WOS:000561014100002
J	Samie, M; Lim, JH; Verschueren, E; Baughman, JM; Peng, I; Wong, A; Kwon, YS; Senbabaoglu, Y; Hackney, JA; Keir, M; Mckenzie, B; Kirkpatrick, DS; Campagne, MV; Murthy, A				Samie, Mohammad; Lim, Junghyun; Verschueren, Erik; Baughman, Joshua M.; Peng, Ivan; Wong, Aaron; Kwon, Youngsu; Senbabaoglu, Yasin; Hackney, Jason A.; Keir, Mary; Mckenzie, Brent; Kirkpatrick, Donald S.; Campagne, Menno van Lookeren; Murthy, Aditya			Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling	NATURE IMMUNOLOGY			English	Article							WIDE ASSOCIATION SCAN; TOLL-LIKE RECEPTORS; NF-KAPPA-B; GENE-EXPRESSION; CROHNS-DISEASE; VARIANT; ATG16L1; RECOGNITION; SALMONELLA; MECHANISMS	Defective autophagy is linked to diseases such as rheumatoid arthritis, lupus and inflammatory bowel disease (IBD). However, the mechanisms by which autophagy limits inflammation remain poorly understood. Here we found that loss of the autophagy-related gene Atg1611 promoted accumulation of the adaptor TRIF and downstream signaling in macrophages. Multiplex proteomic profiling identified SQSTM1 and TaxlBP1 as selective autophagy-related receptors that mediated the turnover of TRIF. Knockdown of Taxlbpl increased production of the cytokines IFN-beta and IL-1 beta. Mice lacking Atg1611 in myeloid cells succumbed to lipopolysaccharide-mediated sepsis but enhanced their clearance of intestinal Salmonella typhimurium in an interferon receptor-dependent manner. Human macrophages with the Crohn's disease-associated Atg1611 variant T300A exhibited more production of IFN-beta and IL-1 beta. An elevated interferon-response gene signature was observed in patients with IBD who were resistant to treatment with an antibody to the cytokine TNF. These findings identify selective autophagy as a key regulator of signaling via the innate immune system.	[Samie, Mohammad; Lim, Junghyun; Murthy, Aditya] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Verschueren, Erik; Baughman, Joshua M.; Kirkpatrick, Donald S.] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA USA; [Peng, Ivan; Wong, Aaron; Kwon, Youngsu; Mckenzie, Brent] Genentech Inc, Dept Translat Immunol, San Francisco, CA USA; [Senbabaoglu, Yasin; Hackney, Jason A.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Keir, Mary] Genentech Inc, Biomarker Discovery OMNI, San Francisco, CA USA; [Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Murthy, A (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	murthy.aditya@gene.com		Kirkpatrick, Donald/0000-0003-3091-2804; Hackney, Jason/0000-0002-5922-563X				Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Dejager L, 2014, J INFECT DIS, V209, P960, DOI 10.1093/infdis/jit600; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gentle IE, 2017, FEBS J, V284, P1987, DOI 10.1111/febs.14091; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Grimm WA, 2016, GUT, V65, P456, DOI 10.1136/gutjnl-2014-308735; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Kirkpatrick DS, 2013, P NATL ACAD SCI USA, V110, P19426, DOI 10.1073/pnas.1309473110; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Lamour G, 2017, BIOPHYS J, V112, P584, DOI 10.1016/j.bpj.2016.12.036; Lapaquette P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/398483; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Mathew R, 2014, MOL CELL, V55, P916, DOI 10.1016/j.molcel.2014.07.019; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Owen KA, 2016, MBIO, V7, DOI 10.1128/mBio.02051-15; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sotolongo J, 2011, J EXP MED, V208, P2705, DOI 10.1084/jem.20110547; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Whang MI, 2017, IMMUNITY, V46, P405, DOI 10.1016/j.immuni.2017.02.018; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang Q, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006600; Zhuang GL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003572	61	72	74	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					246	+		10.1038/s41590-017-0042-6	http://dx.doi.org/10.1038/s41590-017-0042-6			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29358708				2022-12-18	WOS:000427007500014
J	Kwon, HK; Chen, HM; Mathis, D; Benoist, C				Kwon, Ho-Keun; Chen, Hui-Min; Mathis, Diane; Benoist, Christophe			Different molecular complexes that mediate transcriptional induction and repression by FoxP3	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; HISTONE ACETYLTRANSFERASE; LINEAGE SPECIFICATION; NUCLEAR-ENVELOPE; DNA-BINDING; EXPRESSION; RESPONSES; ACETYLATION; ACTIVATION; MECHANISMS	FoxP3 conditions the transcriptional signature and functional facets of regulatory T cells (T-reg cells). Its mechanism of action, whether as an activator or a repressor, has remained unclear. Here, chromatin analysis showed that FoxP3 bound active enhancer elements, not repressed chromatin, around loci over-or under-expressed in T-reg cells. We evaluated the impact of a panel of FoxP3 mutants on its transcriptional activity and interactions with DNA, transcriptional cofactors and chromatin. Computational integration, confirmed by biochemical interaction and size analyses, showed that FoxP3 existed in distinct multimolecular complexes. It was active and primarily an activator when complexed with the transcriptional factors RELA, IKZF2 and KAT5. In contrast, FoxP3 was inactive when complexed with the histone methyltransferase EZH2 and transcription factors YY1 and IKZF3. The latter complex partitioned to a peripheral region of the nucleus, as shown by super-resolution microscopy. Thus, FoxP3 acts in multimodal fashion to directly activate or repress transcription, in a context-and partner-dependent manner, to govern T-reg cell phenotypes.	[Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA USA; Brigham & Womens Hosp, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu		KWON, HOKEUN/0000-0003-3175-0376	US National Institutes of Health [AI116834]; GlaxoSmithKline; NRF [357-2011-1C00084]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116834] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NRF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Arvey, L. Chen, T. Chatila, K. Struhl, J. Waters and A. Rudensky for discussions: K. Hattori, C. Araneo and A. Rhoads for help with mice, cell sorting, profiling and software; and the HMS Cell Biology Microscopy Facility and L. Shao for super-resolution microscopy. Supported by the US National Institutes of Health (AI116834), GlaxoSmithKline (Sponsored Research Agreement+ and NRF (357-2011-1C00084 to H.-K.K.).	Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Benoist C, 2013, IMMUNE TOLERANCE, P31; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hahn S, 2014, GENETICS, V198, P455, DOI 10.1534/genetics.114.167361; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; HIRAOKA Y, 1990, J CELL BIOL, V111, P2815, DOI 10.1083/jcb.111.6.2815; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hwang SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10789; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	59	72	73	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1238	+		10.1038/ni.3835	http://dx.doi.org/10.1038/ni.3835			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28892470	Green Accepted, Green Submitted			2022-12-18	WOS:000413457300010
J	Weist, BM; Kurd, N; Boussier, J; Chan, SW; Robey, EA				Weist, Brian M.; Kurd, Nadia; Boussier, Jeremy; Chan, Shiao Wei; Robey, Ellen A.			Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition	NATURE IMMUNOLOGY			English	Article							RECEPTOR; SELECTION; INTERLEUKIN-2; INDUCTION; SUBSETS; AUTOIMMUNITY; ACTIVATION; EXPRESSION; MEDULLA; GOVERN	The thymic production of regulatory T cells (T-reg cells) requires interleukin 2 (IL-2) and agonist T cell antigen receptor (TCR) ligands and is controlled by competition for a limited developmental niche, but the thymic sources of IL-2 and the factors that limit access to the niche are poorly understood. Here we found that IL-2 produced by antigen-bearing dendritic cells (DCs) had a key role in T-reg cell development and that existing T-reg cells limited new development of T-reg cells by competing for IL-2. Our data suggest that antigen-presenting cells (APCs) that can provide both IL-2 and a TCR ligand constitute the thymic niche and that competition by existing T-reg cells for a limited supply of IL-2 provides negative feedback for new production of T-reg cells.	[Weist, Brian M.; Kurd, Nadia; Chan, Shiao Wei; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Boussier, Jeremy] Ecole Normale Super, F-75231 Paris, France	University of California System; University of California Berkeley; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.	erobey@berkeley.edu		Boussier, Jay/0000-0002-2249-377X	US National Institutes of Health [R01AI064227, T32AI100829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100829, R01AI064227] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the members of the Robey Lab for critical reading of the manuscript; H. Chu, H. Melichar and K. Taylor for technical assistance and suggestions; H. Nolla and A. Valeros for help with cell sorting; and N. Shastri (University of California, Berkeley) for the CTLL2 cell line. Supported by US National Institutes of Health (R01AI064227 to E.A.R. and T32AI100829 to B.M.W.).	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coquet JM, 2013, J EXP MED, V210, P715, DOI 10.1084/jem.20112061; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dzhagalov Ivan L, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1226s60; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kulhankova K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043609; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Roman E, 2010, J IMMUNOL, V185, P3819, DOI 10.4049/jimmunol.0900665; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	49	72	74	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					635	+		10.1038/ni.3171	http://dx.doi.org/10.1038/ni.3171			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25939026	Green Accepted			2022-12-18	WOS:000354751900016
J	Ivanov, SS; Roy, CR				Ivanov, Stanimir S.; Roy, Craig R.			Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR	NATURE IMMUNOLOGY			English	Article							REGULATES AKT UBIQUITINATION; PROTEIN COMPLEXES; LEGIONELLA; TRANSLATION; AUTOPHAGY; GROWTH; IDENTIFICATION; TRANSLOCATION; RAPAMYCIN; DEFENSE	The mammalian immune system has the ability to discriminate between pathogenic microbes and nonpathogenic microbes to control inflammation. Here we investigated the ubiquitination profiles of host proteins after infection of macrophages with a virulent strain of the intracellular bacterium Legionella pneumophila or a nonpathogenic mutant of L. pneumophila. Only infection with pathogenic L. pneumophila resulted in ubiquitination of positive regulators of the metabolic checkpoint kinase mTOR and led to diminished mTOR activity. Detection of pathogen signatures resulted in translational biasing toward proinflammatory cytokines through mTOR-mediated regulation of cap-dependent translation. Thus, there is a pathogen-detection program in macrophages that stimulates protein ubiquitination and the degradation of regulators of mTOR, which suppresses mTOR function and directs a proinflammatory cytokine program.	[Ivanov, Stanimir S.; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	craig.roy@yale.edu	Ivanov, Stanimir/J-4289-2019	Ivanov, Stanimir/0000-0002-3294-7595; Roy, Craig/0000-0003-4490-440X	US National Institutes of Health [AI097847, AI048770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048770, R21AI097847] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Walters (University of California, San Francisco) for the antibody to puromycin; R. Vance (University of California Berkeley) for the L. pneumophila Delta 5less strain; P. Kaiser (University of California Irvine) for the biotinylation sequence expression vector; W. Mothes (Yale University) for the HL116 interferon reporter cell line; A.-M. Dragoi for suggestions and manuscript critique; C. Godecke and F. Sewald for technical assistance with flow cytometry; and X. Liu for assistance with analysis of the proteomics data. Supported by the US National Institutes of Health (AI097847 and AI048770 to C.R.).	Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Chakrabarti S, 2012, CELL HOST MICROBE, V12, P60, DOI 10.1016/j.chom.2012.06.001; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Randow F, 2011, AUTOPHAGY, V7, P304, DOI 10.4161/auto.7.3.14539; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Schabbauer G, 2010, J IMMUNOL, V185, P468, DOI 10.4049/jimmunol.0902221; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/nmeth.1314, 10.1038/NMETH.1314]; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	50	72	73	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1219	+		10.1038/ni.2740	http://dx.doi.org/10.1038/ni.2740			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24121838	Green Accepted			2022-12-18	WOS:000327149400007
J	Tang, DL; Lotze, MT				Tang, Daolin; Lotze, Michael T.			Tumor immunity times out: TIM-3 and HMGB1	NATURE IMMUNOLOGY			English	Editorial Material							REGULATES AUTOPHAGY; CELL; MATURATION; EXPRESSION; RELEASE	The characteristics of the tumor microenvironment vary widely. New work shows that after tumor-associated expression of the receptor TIM-3 by dendritic cells, TIM-3 inhibits the antitumor efficacy of DNA vaccines and chemotherapy by binding to the damage-associated molecular pattern molecule, HMGB1.	[Tang, Daolin] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA 15260 USA; [Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Dept Immunol, Inst Canc, Pittsburgh, PA USA; [Lotze, Michael T.] Univ Pittsburgh, Dept Bioengn, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, DL (corresponding author), Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA 15260 USA.	tangd2@upmc.edu; lotzemt@upmc.edu	Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021	Tang, Daolin/0000-0002-1903-6180	NCI NIH HHS [R01 CA160417] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA160417] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ben Lu T. N., 2012, NATURE, DOI [10.1038/nature11290, DOI 10.1038/NATURE11290]; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang D., IMMUNOL REV IN PRESS; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Venereau E., J EXP MED IN PRESS; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weiner LM, 2012, NEW ENGL J MED, V366, P1156, DOI 10.1056/NEJMcibr1114526; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806	15	72	81	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					808	810		10.1038/ni.2396	http://dx.doi.org/10.1038/ni.2396			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910384	Green Accepted			2022-12-18	WOS:000307863600005
J	Tun-Kyi, A; Finn, G; Greenwood, A; Nowak, M; Lee, TH; Asara, JM; Tsokos, GC; Fitzgerald, K; Israel, E; Li, XX; Exley, M; Nicholson, LK; Lu, KP				Tun-Kyi, Adrian; Finn, Greg; Greenwood, Alex; Nowak, Michael; Lee, Tae Ho; Asara, John M.; Tsokos, George C.; Fitzgerald, Kate; Israel, Elliot; Li, Xiaoxia; Exley, Mark; Nicholson, Linda K.; Lu, Kun Ping			Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; MURINE CYTOMEGALOVIRUS; INTERLEUKIN-1 RECEPTOR; ADAPTIVE IMMUNITY; ALPHA INDUCTION; VIRAL-INFECTION; DENDRITIC CELLS; RESPONSES; KINASE	Toll-like receptors (TLRs) shape innate and adaptive immunity to microorganisms. The enzyme IRAK1 transduces signals from TLRs, but mechanisms for its activation and regulation remain unknown. We found here that TLR7 and TLR9 activated the isomerase Pin1, which then bound to IRAK1; this resulted in activation of IRAK1 and facilitated its release from the receptor complex to activate the transcription factor IRF7 and induce type I interferons. Consequently, Pin1-deficient cells and mice failed to mount TLR-mediated, interferon-dependent innate and adaptive immune responses. Given the critical role of aberrant activation of IRAK1 and type I interferons in various immune diseases, controlling IRAK1 activation via inhibition of Pin1 may represent a useful therapeutic approach.	[Tun-Kyi, Adrian; Finn, Greg; Nowak, Michael; Lee, Tae Ho; Asara, John M.; Tsokos, George C.; Exley, Mark; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Greenwood, Alex; Nicholson, Linda K.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Fitzgerald, Kate] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Israel, Elliot] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA.	klu@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Fitzgerald, Katherine/ABE-6317-2020; Greenwood, Alex/GWU-8292-2022; Lee, Tae Ho/AAT-1721-2020	tsokos, george C/0000-0001-9589-2360; Exley, Mark/0000-0002-5088-1032; Fitzgerald, Kate/0000-0003-3175-609X	Swiss Foundation for Grants in Biology and Medicine; US National Institutes of Health [AG029385, DK066917, GM058556]; American Asthma Foundation; Alliance for Lupus Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029385, R01AG017870] Funding Source: NIH RePORTER	Swiss Foundation for Grants in Biology and Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Alliance for Lupus Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Cantley, T. Hunter, H. Wu and S. Lin for advice and critical reading of the manuscript; L. Brossay (Brown University) and J.D. Hamilton (Duke University Medical Center) for MCMV-GFP; R. Welsh (University of Massachusetts) for H1N1 virus; and S. Whelan (Harvard Medical School) for VSV-GFP. Supported by the Swiss Foundation for Grants in Biology and Medicine (A.T.K.), the US National Institutes of Health (AG029385 to L.K.N. and K.P.L.; DK066917 to M.A.E.; and GM058556), the American Asthma Foundation (K.P.L.) and the Alliance for Lupus Research (K.P.L.).	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chiang EY, 2011, J IMMUNOL, V186, P1279, DOI 10.4049/jimmunol.1002821; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henry SC, 2000, J VIROL METHODS, V89, P61, DOI 10.1016/S0166-0934(00)00202-0; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Li XX, 1999, MOL CELL BIOL, V19, P4643; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Rahman AH, 2006, SPRINGER SEMIN IMMUN, V28, P131, DOI 10.1007/s00281-006-0034-3; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Steinberg C, 2009, EUR J IMMUNOL, V39, P1007, DOI 10.1002/eji.200838814; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas JA, 1999, J IMMUNOL, V163, P978; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957	50	72	77	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					733	U142		10.1038/ni.2069	http://dx.doi.org/10.1038/ni.2069			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21743479	Green Accepted			2022-12-18	WOS:000292870700011
J	Scheffold, A; Murphy, KM; Hofer, T				Scheffold, Alexander; Murphy, Kenneth M.; Hoefer, Thomas			Competition for cytokines: T-reg cells take all	NATURE IMMUNOLOGY			English	Editorial Material							SUPPRESSION; MECHANISMS; FOXP3; IL-2	Thymus-derived regulatory T cells are thought to suppress target cells by either a cell contact-dependent mechanism or the production of inhibitory cytokines. A new study suggests a third strategy of apoptosis induced by the consumption of interleukin 2 and other T cell growth factors by regulatory T cells.	Deutsch Rheumaforsch Zentrum Berlin, D-10115 Berlin, Germany; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA; German Canc Res Ctr, Bioquantzentrum, D-69120 Heidelberg, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Helmholtz Association; German Cancer Research Center (DKFZ)	Scheffold, A (corresponding author), Deutsch Rheumaforsch Zentrum Berlin, D-10115 Berlin, Germany.	kmurphy@wustl.edu	Scheffold, Alexander/S-2090-2016; Höfer, Thomas/G-5665-2013	Scheffold, Alexander/0000-0002-0626-343X; Höfer, Thomas/0000-0003-3560-8780				Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180	13	72	77	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1285	1287		10.1038/ni1207-1285	http://dx.doi.org/10.1038/ni1207-1285			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026078				2022-12-18	WOS:000251267000007
J	Kienast, A; Preuss, M; Winkler, M; Dick, TP				Kienast, Alexandra; Preuss, Marc; Winkler, Monique; Dick, Tobias P.			Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; HLA CLASS-I; DISULFIDE BOND FORMATION; LOADING COMPLEX; ENDOPLASMIC-RETICULUM; OXIDOREDUCTASE ERP57; ANTIGEN PRESENTATION; QUALITY-CONTROL; BINDING; BETA(2)-MICROGLOBULIN	The function of the oxidoreductase ERp57 in the major histocompatibility complex (MHC) class I peptide-loading complex has remained elusive. Here we show that in the absence of tapasin, the alpha(2) disulfide bond in the MHC class I peptide-binding groove was rapidly reduced. Covalent sequestration of ERp57 by tapasin was needed to protect the alpha(2) disulfide bond against reduction and thus to maintain the binding groove in a peptide-receptive state. Allelic variations in MHC class I tapasin dependency reflected their susceptibility to reduction of the alpha(2) disulfide bond. In the absence of sequestration, ERp57 acted directly on the alpha(2) disulfide bond. Our work provides insight into how the immune system customizes 'quality control' in the endoplasmic reticulum to fit the needs of antigen presentation.	German Canc Res Ctr, Redox Regulat Res Grp, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Dick, TP (corresponding author), German Canc Res Ctr, Redox Regulat Res Grp, D-69120 Heidelberg, Germany.	t.dick@dkfz.de						Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, METHOD ENZYMOL, V348, P49, DOI 10.1016/S0076-6879(02)48625-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Santos SG, 2007, J BIOL CHEM, V282, P17587, DOI 10.1074/jbc.M702212200; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; STAM NJ, 1986, J IMMUNOL, V137, P2299; STEINLE A, 1994, TISSUE ANTIGENS, V44, P268, DOI 10.1111/j.1399-0039.1994.tb02394.x; TAHARA T, 1990, IMMUNOGENETICS, V32, P351, DOI 10.1007/BF00211650; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; WANG H, 1994, J BIOL CHEM, V269, P22276; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	44	72	75	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					864	872		10.1038/ni1483	http://dx.doi.org/10.1038/ni1483			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17603488				2022-12-18	WOS:000248169400014
J	El Abdaloussi, E; Graves, S; Meng, FY; Mandal, M; Mashayekhi, M; Aifantis, I				El Abdaloussi, E; Graves, S; Meng, FY; Mandal, M; Mashayekhi, M; Aifantis, I			Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; SONIC-HEDGEHOG; GENE-EXPRESSION; MOUSE; ACTIVATION; DROSOPHILA; EMBRYOS; PROLIFERATION; INACTIVATION; LYMPHOCYTES	Commitment of hematopoietic progenitors to the T cell lineage requires the integration of multiple signaling pathways. Evidence has suggested involvement of hedgehog (Hh) signaling in T cell differentiation through its signal transducer smoothened (Smo). However, the precise function of the Hh pathway remains controversial, mainly because T cell-specific in vivo genetic models have not been used. Using pre-T cell-specific, mature T cell-specific and poly( I)(.)poly(C)- inducible deletions of Smo and antagonists of Smo signaling, we report here that Hh is an essential positive regulator of T cell progenitor differentiation. Furthermore, we localize Hh function to a stage preceding pre-T cell receptor signaling, connect Smo signaling to the activity of the Gli1 and Gli2 transcription factors and demonstrate that Hh affects regulators of thymocyte survival and proliferation.	Univ Chicago, Rheumatol Sect, Dept Med, Chicago, IL 60637 USA; Pasteur Inst Morocco, Immunohematol Sect, Casablanca 20100, Morocco	University of Chicago	Aifantis, I (corresponding author), Univ Chicago, Rheumatol Sect, Dept Med, Chicago, IL 60637 USA.	iaifanti@medicine.bsd.uchicago.edu		Mashayekhi, Mona/0000-0003-0331-2395				Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gutierrez-Frias C, 2004, J IMMUNOL, V173, P5046, DOI 10.4049/jimmunol.173.8.5046; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Long FX, 2001, DEVELOPMENT, V128, P5099; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Shah DK, 2004, J IMMUNOL, V172, P2296, DOI 10.4049/jimmunol.172.4.2296; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; STJOHNSTON D, 1992, CELL, V68, P201; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; von Boehmer H, 1999, COLD SPRING HARB SYM, V64, P283, DOI 10.1101/sqb.1999.64.283; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	41	72	76	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					418	426		10.1038/ni1313	http://dx.doi.org/10.1038/ni1313			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16518394				2022-12-18	WOS:000236171000016
J	Gilboa, E				Gilboa, E			The risk of autoimmunity associated with tumor immunotherapy	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL TOLERANCE; DENDRITIC CELLS; TRANSGENIC MICE; DIFFERENTIATION ANTIGEN; IMMUNE-RESPONSE; VIRUS-INFECTION; REJECTION; ERADICATION; VACCINATION; INDUCTION	The development of increasingly powerful methods to stimulate anti-tumor immune responses carries the risk of breaking tolerance to self and causing autoimmune pathology. How concerned should we be?	Duke Univ, Durham, NC 27710 USA	Duke University	Gilboa, E (corresponding author), Duke Univ, Box 2601 Med Ctr, Durham, NC 27710 USA.	e.gilboa@cgct.duke.edu						Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Bronte V, 2000, CANCER RES, V60, P253; Dittel BN, 1999, J IMMUNOL, V163, P32; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Fong L, 1997, J IMMUNOL, V159, P3113; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Heiser A, 2000, J IMMUNOL, V164, P5508, DOI 10.4049/jimmunol.164.10.5508; HU J, 1993, J EXP MED, V177, P1681, DOI 10.1084/jem.177.6.1681; Ludewig B, 2000, J EXP MED, V191, P795, DOI 10.1084/jem.191.5.795; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Melero I, 1997, J VIROL, V71, P3998, DOI 10.1128/JVI.71.5.3998-4004.1997; Morgan DJ, 1998, J IMMUNOL, V160, P643; Naftzger C, 1996, P NATL ACAD SCI USA, V93, P14809, DOI 10.1073/pnas.93.25.14809; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Poplonski L, 1996, EUR J IMMUNOL, V26, P601, DOI 10.1002/eji.1830260315; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; SCHILD H, 1990, SCIENCE, V247, P1587, DOI 10.1126/science.2321019; Schreurs MWJ, 2000, CANCER RES, V60, P6995; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	34	72	74	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					789	792		10.1038/ni0901-789	http://dx.doi.org/10.1038/ni0901-789			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526387				2022-12-18	WOS:000170781200012
J	Gomez, M; Tybulewicz, V; Cantrell, DA				Gomez, M; Tybulewicz, V; Cantrell, DA			Control of pre-T cell proliferation and differentiation by the GTPase Rac-I	NATURE IMMUNOLOGY			English	Article							EXCHANGE FACTOR VAV; RHO-FAMILY; SIGNALING PATHWAYS; SELECTION; RECEPTOR; THYMOCYTES; EXPRESSION; MICE; CDC42; PROTOONCOGENE	The GTPase Rac-1 has the potential for pleiotropic functions due to its ability to interact with multiple effecters, Here, activation of Rac-1 is shown to potently regulate pre-T cell differentiation and proliferation at the point of T cell antigen receptor (TCR) beta selection. An activated Rac-1 effector domain mutant that restricts signaling to particular actions on actin dynamics can drive prei cell differentiation. Rac-1 activation cannot fully substitute for the pre-TCR complex but can fully correct defects in pre-T cell development in mice lacking the adapter molecule Vav-1. The present study identifies the subset of Rac-1 responses that mediate Vav-1 action as critical regulators of TCR beta selection.	Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England; Natl Inst Med Res, London NW7 1AA, England	Cancer Research UK; MRC National Institute for Medical Research	Cantrell, DA (corresponding author), Imperial Canc Res Fund, Lymphocyte Activat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	d.cantrell@icrf.icnet.uk						Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Genot E, 1998, ONCOGENE, V17, P1731, DOI 10.1038/sj.onc.1202101; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	37	72	73	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					348	352		10.1038/79808	http://dx.doi.org/10.1038/79808			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017108				2022-12-18	WOS:000089869700019
J	Howden, AJM; Hukelmann, JL; Brenes, A; Spinelli, L; Sinclair, LV; Lamond, AI; Cantrell, DA				Howden, Andrew J. M.; Hukelmann, Jens L.; Brenes, Alejandro; Spinelli, Laura; Sinclair, Linda V.; Lamond, Angus I.; Cantrell, Doreen A.			Quantitative analysis of T cell proteomes and environmental sensors during T cell differentiation	NATURE IMMUNOLOGY			English	Article							PROTEIN; MTORC1; METABOLISM; GLUCOSE; TRANSLATION; EXPRESSION; RAPAMYCIN; PATHWAYS; REVEALS; EVENTS	Quantitative mass spectrometry reveals how CD4(+) and CD8(+) T cells restructure proteomes in response to antigen and mammalian target of rapamycin complex 1 (mTORC1). Analysis of copy numbers per cell of >9,000 proteins provides new understanding of T cell phenotypes, exposing the metabolic and protein synthesis machinery and environmental sensors that shape T cell fate. We reveal that lymphocyte environment sensing is controlled by immune activation, and that CD4(+) and CD8(+) T cells differ in their intrinsic nutrient transport and biosynthetic capacity. Our data also reveal shared and divergent outcomes of mTORC1 inhibition in naive versus effector T cells: mTORC1 inhibition impaired cell cycle progression in activated naive cells, but not effector cells, whereas metabolism was consistently impacted in both populations. This study provides a comprehensive map of naive and effector T cell proteomes, and a resource for exploring and understanding T cell phenotypes and cell context effects of mTORC1.	[Howden, Andrew J. M.; Spinelli, Laura; Sinclair, Linda V.; Cantrell, Doreen A.] Univ Dundee, Cell Signalling & Immunol, Dundee, Scotland; [Hukelmann, Jens L.; Brenes, Alejandro; Lamond, Angus I.] Univ Dundee, Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Cell Signalling & Immunol, Dundee, Scotland.; Lamond, AI (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Dundee, Scotland.	a.i.lamond@dundee.ac.uk; d.a.cantrell@dundee.ac.uk		Howden, Andrew/0000-0002-4332-9469; Cantrell, Doreen/0000-0001-7525-3350; Brenes, Alejandro J/0000-0001-8298-2463; Spinelli, Laura/0000-0002-5801-6297	Wellcome Trust [205023/Z/16/Z, 202950/Z/16/Z, 105024/Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank members of the Cantrell laboratory for comments on the manuscript, T. Ly for discussions on the data, A. Whigham and R. Clarke from the Flow Cytometry Facility for cell sorting and advice on flow cytometry, and the biological sciences research unit at the University of Dundee. This research was supported by a Wellcome Trust Principal Research Fellowship to D.A.C. (205023/Z/16/Z), a Wellcome Trust Strategic Award to D.A.C. and A.I.L. (105024/Z/14/Z) and a Wellcome Trust Equipment Award to D.A.C. (202950/Z/16/Z). This work is dedicated to Olivia Mason.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Brenes A, 2018, NUCLEIC ACIDS RES, V46, pD1202, DOI 10.1093/nar/gkx807; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuadrado E, 2018, IMMUNITY, V48, P1046, DOI 10.1016/j.immuni.2018.04.008; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Duguet F, 2017, MOL CELL PROTEOMICS, V16, P1416, DOI 10.1074/mcp.M116.062745; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; Jabara HH, 2016, NAT GENET, V48, P74, DOI 10.1038/ng.3465; Klein-Hessling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00612-6; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lingel H, 2017, CELL DEATH DIFFER, V24, P1739, DOI 10.1038/cdd.2017.102; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Mehta MM, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0184-5; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Ricciardi S, 2018, CELL METAB, V28, P895, DOI 10.1016/j.cmet.2018.08.009; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04366-7, 10.1038/S41467-018-04366-7]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; So L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8463; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; TERADA N, 1993, J CELL PHYSIOL, V154, P7, DOI 10.1002/jcp.1041540103; TERADA N, 1993, J BIOL CHEM, V268, P12062; Valvezan AJ, 2019, NAT METAB, V1, P321, DOI 10.1038/s42255-019-0038-7; Varanasi SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191533; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	48	71	71	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1542	+		10.1038/s41590-019-0495-x	http://dx.doi.org/10.1038/s41590-019-0495-x			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591570	Green Accepted, Green Submitted			2022-12-18	WOS:000492309600023
J	Garber, C; Vasek, MJ; Vollmer, LL; Sun, T; Jiang, XP; Klein, RS				Garber, Charise; Vasek, Michael J.; Vollmer, Lauren L.; Sun, Tony; Jiang, Xiaoping; Klein, Robyn S.			Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1	NATURE IMMUNOLOGY			English	Article							WEST-NILE-VIRUS; NEURAL PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; SUSTAINED IL-1-BETA; SUBVENTRICULAR ZONE; ENCEPHALITIS-VIRUS; ALZHEIMERS-DISEASE; NEURONAL SURVIVAL; BETA-CATENIN	Memory impairment following West Nile virus neuroinvasive disease (WNND) is associated with loss of hippocampal synapses with lack of recovery. Adult neurogenesis and synaptogenesis are fundamental features of hippocampal repair, which suggests that viruses affect these processes. Here, in an established model of WNND-induced cognitive dysfunction, transcriptional profiling revealed alterations in the expression of genes encoding molecules that limit adult neurogenesis, including interleukin 1 (IL-1). Mice that had recovered from WNND exhibited fewer neuroblasts and increased astrogenesis without recovery of hippocampal neurogenesis at 30 d. Analysis of cytokine production in microglia and astrocytes isolated ex vivo revealed that the latter were the predominant source of IL-1. Mice deficient in the IL-1 receptor IL-1R1 and that had recovered from WNND exhibited normal neurogenesis, recovery of presynaptic termini and resistance to spatial learning defects, the last of which likewise occurred after treatment with an IL-1R1 antagonist. Thus, 'preferential' generation of proinflammatory astrocytes impaired the homeostasis of neuronal progenitor cells via expression of IL-1; this might underlie the long-term cognitive consequences of WNND but also provides a therapeutic target.	[Garber, Charise; Vasek, Michael J.; Vollmer, Lauren L.; Sun, Tony; Jiang, Xiaoping; Klein, Robyn S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA.	rklein@wustl.edu		Klein, Robyn/0000-0003-0281-1352; Garber, Charise/0000-0001-5270-8500; Vollmer, Lauren/0000-0001-6496-7235; Vasek, Michael/0000-0002-1112-4346	National Institutes of Health [U19 AI083019, R01 NS052632, HDTRA11510032]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health [P30AR048335]; Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101400, U19AI083019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatic Diseases Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Enikolopov (Cold Spring Harbor Laboratories) for Nestin-GFP mice; and M. Diamond (Washington University) for WNV-NS5-E218A. Supported by the National Institutes of Health (U19 AI083019, R01 NS052632 and HDTRA11510032 to R.S.K.), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health (P30AR048335) and the Speed Congenics Facility of the Rheumatic Diseases Core Center (experimental support). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Belarbi K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00145; Ben Menachem-Zidon O, 2014, NEUROPSYCHOPHARMACOL, V39, P401, DOI 10.1038/npp.2013.208; Bialas AR, 2017, NATURE, V546, P539, DOI 10.1038/nature22821; Ceccaldi PE, 2004, FEMS MICROBIOL LETT, V233, P1, DOI 10.1016/j.femsle.2004.01.035; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Cheffer A, 2013, STEM CELL REV REP, V9, P794, DOI 10.1007/s12015-013-9460-5; Chen E, 2013, CURR MOL MED, V13, P1474; Covey MV, 2011, ANN NEUROL, V70, P616, DOI 10.1002/ana.22473; Cunningham C, 2008, BRAIN BEHAV IMMUN, V22, P1117, DOI 10.1016/j.bbi.2008.05.007; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Feldmann M., 2014, J BIOL METH, V1, P1; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Green HF, 2012, MOL CELL NEUROSCI, V49, P311, DOI 10.1016/j.mcn.2012.01.001; Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Lambert SL, 2016, PEDIATR TRANSPLANT, V20, P836, DOI 10.1111/petr.12768; Larson SJ, 2007, BEHAV NEUROSCI, V121, P1415, DOI 10.1037/0735-7044.121.6.1415; Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11; Leyssen P, 2003, BRAIN PATHOL, V13, P279; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lieberwirth C, 2016, BRAIN RES, V1644, P127, DOI 10.1016/j.brainres.2016.05.015; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Ming G. L., NEURON, V70; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6; Peng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019439; Prieto GA, 2015, P NATL ACAD SCI USA, V112, pE5078, DOI 10.1073/pnas.1514486112; Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039; Riazi K, 2015, J NEUROSCI, V35, P4942, DOI 10.1523/JNEUROSCI.4485-14.2015; Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Sun T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096442; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wu MD, 2013, BRAIN BEHAV IMMUN, V32, P9, DOI 10.1016/j.bbi.2013.03.003; Wu MD, 2012, BRAIN BEHAV IMMUN, V26, P292, DOI 10.1016/j.bbi.2011.09.012; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Zhang B, 2010, J NEUROIMMUNOL, V224, P28, DOI 10.1016/j.jneuroim.2010.05.003	70	71	73	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					151	+		10.1038/s41590-017-0021-y	http://dx.doi.org/10.1038/s41590-017-0021-y			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29292385	Green Accepted			2022-12-18	WOS:000423435200015
J	Newell, EW; Cheng, Y				Newell, Evan W.; Cheng, Yang			Mass cytometry: blessed with the curse of dimensionality	NATURE IMMUNOLOGY			English	Article							FLOW-CYTOMETRY; CELL; IMMUNE; EXPRESSION	Immunologists are being compelled to develop new high-dimensional perspectives of cellular heterogeneity and to determine which applications best exploit the power of mass cytometry and associated multiplex approaches.	[Newell, Evan W.; Cheng, Yang] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Newell, Evan W.; Cheng, Yang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Newell, EW (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.; Newell, EW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	evan_newell@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012; Cheng, Yang/I-7107-2016	Newell, Evan W/0000-0002-2889-243X; Cheng, Yang/0000-0002-5906-7694				Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bellman RE, 1957, DYNAMIC PROGRAMMING; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Leipold MD, 2015, METHODS MOL BIOL, V1343, P81, DOI 10.1007/978-1-4939-2963-4_7; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Robinson JP, 2015, SCIENCE, V350, P739, DOI 10.1126/science.aad6770; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	25	71	71	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					890	895		10.1038/ni.3485	http://dx.doi.org/10.1038/ni.3485			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434000				2022-12-18	WOS:000380647000002
J	Adams, JJ; Narayanan, S; Birnbaum, ME; Sidhu, SS; Blevins, SJ; Gee, MH; Sibener, LV; Baker, BM; Kranz, DM; Garcia, KC				Adams, Jarrett J.; Narayanan, Samanthi; Birnbaum, Michael E.; Sidhu, Sachdev S.; Blevins, Sydney J.; Gee, Marvin H.; Sibener, Leah V.; Baker, Brian M.; Kranz, David M.; Garcia, K. Christopher			Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; DIFFRACTION DATA; AMINO-ACIDS; SPECIFICITY; REPERTOIRE; ANTIGENS; SELF; BIAS	The T cell antigen receptor (TCR)-peptide-major histocompatibility complex (MHC) interface is composed of conserved and diverse regions, yet the relative contribution of each in shaping recognition by T cells remains unclear. Here we isolated cross-reactive peptides with limited homology, which allowed us to compare the structural properties of nine peptides for a single TCR-MHC pair. The TCR's cross-reactivity was rooted in highly similar recognition of an apical 'hot-spot' position in the peptide with tolerance of sequence variation at ancillary positions. Furthermore, we found a striking structural convergence onto a germline-mediated interaction between the TCR CDR1. region and the MHC. 2 helix in twelve TCR-peptide-MHC complexes. Our studies suggest that TCR-MHC germline-mediated constraints, together with a focus on a small peptide hot spot, might place limits on peptide antigen cross-reactivity.	[Adams, Jarrett J.; Birnbaum, Michael E.; Gee, Marvin H.; Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Adams, Jarrett J.; Birnbaum, Michael E.; Gee, Marvin H.; Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Program Immunol, Stanford, CA 94305 USA; [Adams, Jarrett J.; Birnbaum, Michael E.; Gee, Marvin H.; Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Program Immunol, Stanford, CA 94305 USA; [Adams, Jarrett J.; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON, Canada; [Adams, Jarrett J.; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada; [Narayanan, Samanthi; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Blevins, Sydney J.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Adams, Jarrett J.; Narayanan, Samanthi; Birnbaum, Michael E.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Toronto; University of Toronto; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame; University of Notre Dame	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Birnbaum, Michael/0000-0002-2281-3518	Canadian Institutes of Health Research; National Science Foundation; US National Institutes of Health [AI103867, AI045757, AI057229, GM55767]; Jordan family; Howard Hughes Medical Institute; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; US National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103867, R56AI048540, R01AI048540, P01AI045757, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM055767, R01GM067079] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jordan family; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. O'Herrin (Ben May Institute for Cancer Research) for the 58 alpha<SUP>-</SUP>/beta<SUP>-</SUP> cell line; J.M. Connolly (Washington University School of Medicine) for the LM1.8-H-2L<SUP>d</SUP>W97R cell line; and N. Goriatcheva, E. Ozkan, D. Wittrup, E. Newell, N. Jarvik and M. McLaughlin for discussions. Supported by the Canadian Institutes of Health Research (J.J.A.), the National Science Foundation (M.E.B.), the US National Institutes of Health (AI103867, AI045757 and AI057229 to K.C.G., and GM55767 to D.M.K.), the Jordan family, and the Howard Hughes Medical Institute (K.C.G.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the US National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alajez NM, 2005, BLOOD, V105, P4583, DOI 10.1182/blood-2004-10-3848; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Gagnon SJ, 2005, J MOL BIOL, V353, P556, DOI 10.1016/j.jmb.2005.08.024; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piepenbrink KH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2948; Pinilla C, 1999, CURR OPIN IMMUNOL, V11, P193, DOI 10.1016/S0952-7915(99)80033-8; Rangarajan S, 2014, CELL MOL LIFE SCI, V71, P3059, DOI 10.1007/s00018-014-1600-9; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Udaka K, 2000, IMMUNOGENETICS, V51, P816, DOI 10.1007/s002510000217; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809	54	71	71	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					87	+		10.1038/ni.3310	http://dx.doi.org/10.1038/ni.3310			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26523866	Green Accepted			2022-12-18	WOS:000366675800014
J	Itoh-Nakadai, A; Hikota, R; Muto, A; Kometani, K; Watanabe-Matsui, M; Sato, Y; Kobayashi, M; Nakamura, A; Miura, Y; Yano, Y; Tashiro, S; Sun, JY; Ikawa, T; Ochiai, K; Kurosaki, T; Igarashi, K				Itoh-Nakadai, Ari; Hikota, Reina; Muto, Akihiko; Kometani, Kohei; Watanabe-Matsui, Miki; Sato, Yuki; Kobayashi, Masahiro; Nakamura, Atsushi; Miura, Yuichi; Yano, Yoko; Tashiro, Satoshi; Sun, Jiying; Ikawa, Tomokatsu; Ochiai, Kyoko; Kurosaki, Tomohiro; Igarashi, Kazuhiko			The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program	NATURE IMMUNOLOGY			English	Article							LINEAGE-COMMITMENT; STEM-CELLS; GENE-EXPRESSION; SPI-C; PROTEINS; NETWORK; EBF1; SPECIFICATION; INTERLEUKIN-7; MACROPHAGES	Mature lymphoid cells express the transcription repressor Bach2, which imposes regulation on humoral and cellular immunity. Here we found critical roles for Bach2 in the development of cells of the B lineage, commencing from the common lymphoid progenitor (CLP) stage, with Bach1 as an auxiliary. Overexpression of Bach2 in pre-pro-B cells deficient in the transcription factor EBF1 and single-cell analysis of CLPs revealed that Bach2 and Bach1 repressed the expression of genes important for myeloid cells ('myeloid genes'). Bach2 and Bach1 bound to presumptive regulatory regions of the myeloid genes. Bach2(hi) CLPs showed resistance to myeloid differentiation even when cultured under myeloid conditions. Our results suggest that Bach2 functions with Bach1 and EBF1 to promote B cell development by repressing myeloid genes in CLPs.	[Itoh-Nakadai, Ari; Hikota, Reina; Muto, Akihiko; Watanabe-Matsui, Miki; Sato, Yuki; Kobayashi, Masahiro; Nakamura, Atsushi; Miura, Yuichi; Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan; [Itoh-Nakadai, Ari; Muto, Akihiko; Ochiai, Kyoko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi, Japan; [Kometani, Kohei; Kurosaki, Tomohiro] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Yano, Yoko; Tashiro, Satoshi; Sun, Jiying] Hiroshima Univ, Grad Sch Biomed Sci, Res Inst Radiat Biol & Med, Dept Biol Celular, Hiroshima, Japan; [Ikawa, Tomokatsu] RIKEN, Ctr Integrat Med Sci, Lab Immune Regenerat, Yokohama, Kanagawa, Japan; [Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	Tohoku University; Japan Science & Technology Agency (JST); RIKEN; Hiroshima University; RIKEN; Tohoku University; Osaka University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan.	igarashi@med.tohoku.ac.jp	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Kometani, Kohei/0000-0003-4281-4371; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [09J07369, 21229007, 00250738, 21249014]; Network Medicine Global-CUE Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Foundation; Takeda Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Astellas Foundation for Research on Metabolic Disorders; Japan Society for the Promotion of Science; Tohoku University Institute for International Advanced Research and Education; Grants-in-Aid for Scientific Research [24689042] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Network Medicine Global-CUE Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Astellas Foundation for Research on Metabolic Disorders; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Institute for International Advanced Research and Education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Singh (Cincinnati Children's Hospital Medical Center) for discussions, the Ebf1 retroviral construct and Ebf1<SUP>-/-</SUP> cells; M.R. Clark (University of Chicago) for the retroviral construct encoding constitutively active STAT5b; K. Takatsu (Toyama University) for OP9 stroma cells; T. lino, A. Akashi, A. Brydun and M. Matsumoto for advice on DNA microarray analysis; A. Brydun for the generation of antibody to Bach1; R. Yamashita for advice on the analysis of modules from the Immunological Genome Project; H. Kawamoto and members of the Igarashi laboratory for discussions; A. Arakawa for help in the generation of Bach2 reporter mice; K. Watanabe for help with experiments; M. Satake for discussions about repressors; and the Biomedical Research Core of Tohoku University Graduate School of Medicine for their technical support. Supported by Grants-in-Aid from the Japan Society for the Promotion of Science (09J07369 to A.I.-N.; 21229007 to T.K.; 00250738, 21249014 and 00250738 to K.I.), the Network Medicine Global-CUE Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Uehara Foundation, the Takeda Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science and Astellas Foundation for Research on Metabolic Disorders, and the Japan Society for the Promotion of Science and the Tohoku University Institute for International Advanced Research and Education (A.I.-N.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ishikawa F, 2007, BLOOD, V110, P3591, DOI 10.1182/blood-2007-02-071613; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Smith EMK, 2005, BLOOD, V106, P1995, DOI 10.1182/blood-2004-12-4744; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; WILLIAMS DE, 1990, BLOOD, V75, P1132; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109; Zhu X, 2008, EUR J IMMUNOL, V38, P2587, DOI 10.1002/eji.200838323	41	71	74	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1171	1180		10.1038/ni.3024	http://dx.doi.org/10.1038/ni.3024			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25344725				2022-12-18	WOS:000344841900014
J	Tan, YX; Manz, BN; Freedman, TS; Zhang, C; Shokat, KM; Weiss, A				Tan, Ying Xim; Manz, Boryana N.; Freedman, Tanya S.; Zhang, Chao; Shokat, Kevan M.; Weiss, Arthur			Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling	NATURE IMMUNOLOGY			English	Article							SRC-FAMILY KINASES; T-CELL DEVELOPMENT; ADAPTER PROTEIN; ACTIVATION; CD28; CBP; SELECTION; P50(CSK); PATHWAY; BINDING	Signaling via the T cell antigen receptor (TCR) is initiated by Src-family kinases (SFKs). To understand how the kinase Csk, a negative regulator of SFKs, controls the basal state and the initiation of TCR signaling, we generated mice that express a Csk variant sensitive to an analog of the common kinase inhibitor PP]. (Csk(As)). Inhibition of Csk(As) in thymocytes, without engagement of the TCR, induced potent activation of SFKs and proximal TCR signaling up to phospholipase C-gamma 1 (PLC-gamma 1). Unexpectedly, increases in inositol phosphates, intracellular calcium and phosphorylation of the kinase Erk were impaired. Altering the actin cytoskeleton pharmacologically or providing costimulation via CD28 'rescued' those defects. Thus, Csk has a critical role in preventing TCR signaling. However, our studies also revealed a requirement for actin remodeling, initiated by costimulation, for full TCR signaling.	[Tan, Ying Xim; Manz, Boryana N.; Freedman, Tanya S.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA; [Zhang, Chao] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Shokat, Kevan M.; Weiss, Arthur] Howard Hughes Med Inst, Chevy Chase, MD USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Southern California; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA.	aweiss@medicine.ucst.edu	Freedman, Tanya/T-4660-2019	Freedman, Tanya/0000-0001-5168-5829	Agency for Science, Technology and Research in Singapore; Cancer Research Institute; US National Institutes of Health [PO1 AI091580, 5R01EB001987]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	Agency for Science, Technology and Research in Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J.A. Bluestone (University of California, San Francisco) for CD80-CD86-deficient mice; J.B. Bolen (Moderna Therapeutics) for the anti-Lck hybridoma; H. Wang (University of California, San Francisco) for anti-zeta. Roque and Z. Wang for assisting with animal husbandry and cell sorting, respectively; N. Killeen and Z. Yang for technical assistance with BAC transgenesis; J.S. Shin for technical assistance with isolation of thymic DCs; H. Liu and the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Mass Spectrometry Core Facility for technical and analytical expertise; and A. DeFranco, C. Lowell and H. Wang for critical reading of the manuscript and discussions. Supported by the Agency for Science, Technology and Research in Singapore (Y.X.T.), the Cancer Research Institute (B.N.M.) and the US National Institutes of Health (PO1 AI091580 to A.W. and 5R01EB001987 to K.M.S.).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Buhlmann JE, 2003, J IMMUNOL, V170, P5421, DOI 10.4049/jimmunol.170.11.5421; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Dautigny N, 1999, J IMMUNOL, V162, P1294; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gamper CJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00312; GROSS JA, 1992, J IMMUNOL, V149, P380; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Patsoukis N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000409; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005	46	71	74	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					186	194		10.1038/ni.2772	http://dx.doi.org/10.1038/ni.2772			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24317039	Green Accepted, Green Submitted			2022-12-18	WOS:000330150600013
J	Schjerven, H; McLaughlin, J; Arenzana, TL; Frietze, S; Cheng, DH; Wadsworth, SE; Lawson, GW; Bensinger, SJ; Farnham, PJ; Witte, ON; Smale, ST				Schjerven, Hilde; McLaughlin, Jami; Arenzana, Teresita L.; Frietze, Seth; Cheng, Donghui; Wadsworth, Sarah E.; Lawson, Gregory W.; Bensinger, Steven J.; Farnham, Peggy J.; Witte, Owen N.; Smale, Stephen T.			Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IIIA; DNA-BINDING PROTEINS; BCR-ABL; LYMPHOBLASTIC-LEUKEMIA; EXPRESSION ANALYSIS; GENE-EXPRESSION; GENOME BROWSER; CELL; FAMILY; CTCF	C2H2 zinc fingers are found in several key transcriptional regulators in the immune system. However, these proteins usually contain more fingers than are needed for sequence-specific DNA binding, which suggests that different fingers regulate different genes and functions. Here we found that mice lacking finger 1 or finger 4 of Ikaros exhibited distinct subsets of the hematological defects of Ikaros-null mice. Most notably, the two fingers controlled different stages of lymphopoiesis, and finger 4 was selectively required for tumor suppression. The distinct defects support the hypothesis that only a small number of genes that are targets of Ikaros are critical for each of its biological functions. The subcategorization of functions and target genes by mutagenesis of individual zinc fingers will facilitate efforts to understand how zinc-finger transcription factors regulate development, immunity and disease.	[Schjerven, Hilde; McLaughlin, Jami; Arenzana, Teresita L.; Cheng, Donghui; Wadsworth, Sarah E.; Witte, Owen N.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Schjerven, Hilde; Arenzana, Teresita L.; Wadsworth, Sarah E.; Bensinger, Steven J.; Witte, Owen N.; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Frietze, Seth; Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Cheng, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Lawson, Gregory W.] Univ Calif Los Angeles, Div Lab Anim Med, Los Angeles, CA USA; [Lawson, Gregory W.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Witte, Owen N.; Smale, Stephen T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	smale@mednet.ucla.edu	; Schjerven, Hilde/I-1437-2013	Farnham, Peggy/0000-0003-4469-7914; Schjerven, Hilde/0000-0001-9287-3375	US National Institutes of Health [RO1DK043726, U54HG004558]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043726] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Aliahmad, D. Bhatt, K. Dorshkind, C. Li and E. Montecino-Rodriguez for advice and/or critical reading of the manuscript; the Division of Laboratory Animal Medicine of the University of California, Los Angeles, for ongoing care of mice; and H. Mak, T. Jacob, C. Garcia, J. Flores and J. Lorenzano for assistance with the mouse colony. ChIP-seq and RNA-Seq libraries were sequenced at the Epigenome Data Production Facility of the University of Southern California, and the Broad Stem Cell Research Center High Throughput Sequencing Core of the University of California, Los Angeles. Supported by the US National Institutes of Health (RO1DK043726 to S. T. S. and U54HG004558 to P. J. F.). O.N.W. is an Investigator of the Howard Hughes Medical Institute.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lu Q, 2010, J PATHOL, V222, P119, DOI 10.1002/path.2755; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Marcais A, 2010, LEUKEMIA RES, V34, P426, DOI 10.1016/j.leukres.2009.09.012; McCarty AS, 2003, MOL CELL, V11, P459, DOI 10.1016/S1097-2765(03)00043-1; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nurmemmedov E, 2009, BIOPHYS CHEM, V145, P116, DOI 10.1016/j.bpc.2009.09.009; O'Geen H, 2010, METHODS MOL BIOL, V649, P437, DOI 10.1007/978-1-60761-753-2_27; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Ravasi T, 2003, GENOME RES, V13, P1430, DOI 10.1101/gr.949803; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shastry BS, 1996, J CELL SCI, V109, P535; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Virely C, 2010, LEUKEMIA, V24, P1200, DOI 10.1038/leu.2010.63; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	75	71	74	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1073	+		10.1038/ni.2707	http://dx.doi.org/10.1038/ni.2707			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24013668	Green Accepted, Green Submitted			2022-12-18	WOS:000324584700016
J	Bezbradica, JS; Medzhitov, R				Bezbradica, Jelena S.; Medzhitov, Ruslan			Integration of cytokine and heterologous receptor signaling pathways	NATURE IMMUNOLOGY			English	Review							RETRACTED ARTICLE. SEE; FC-GAMMA-RI; NK CELL ACTIVATION; IFN-GAMMA; INTERFERON-GAMMA; TYROSINE PHOSPHORYLATION; DENDRITIC CELLS; IL-15 RECEPTOR; SERINE PHOSPHORYLATION; HUMAN MONOCYTES	Cytokines are soluble mediators of cell communication that are critical in immune regulation. They induce specific gene-expression programs in responsive cells. Recent findings, however, indicate that cytokine receptors can regulate immune cell functions by transcription-independent mechanisms. Here we review the current understanding of how cytokine signaling regulates the functions of other signaling pathways by first discussing the 'traditional' transcription- mediated consequences of cytokine signaling and then providing a detailed description of transcription- independent lateral communications between cytokine receptors and other cellular receptors.	[Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	jelena.bezbradica@yale.edu; ruslan.medzhitov@yale.edu		Bezbradica, Jelena/0000-0003-1441-1727	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Antoniv TT, 2006, ARTHRITIS RHEUM, V54, P2711, DOI 10.1002/art.22055; Aronica MA, 2000, CYTOKINE, V12, P578, DOI 10.1006/cyto.1999.0603; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Bode JG, 2003, J IMMUNOL, V171, P257, DOI 10.4049/jimmunol.171.1.257; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Brilot F, 2007, J CLIN INVEST, V117, P3316, DOI 10.1172/JCI31751; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulanova E, 2001, J IMMUNOL, V167, P6292, DOI 10.4049/jimmunol.167.11.6292; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Dylke J, 2007, IMMUNOL LETT, V112, P47, DOI 10.1016/j.imlet.2007.06.005; FELDMAN GM, 1995, J IMMUNOL, V154, P318; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Gadina M, 2000, J BIOL CHEM, V275, P26959; Gadina M, 1998, J IMMUNOL, V160, P4657; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; HARPUR AG, 1992, ONCOGENE, V7, P1347; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Kim ST, 2007, P NATL ACAD SCI USA, V104, P17052, DOI 10.1073/pnas.0708293104; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kiu H, 2007, GROWTH FACTORS, V25, P319, DOI 10.1080/08977190701830151; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McDonald PP, 1998, BLOOD, V92, P4828, DOI 10.1182/blood.V92.12.4828.424k09_4828_4835; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Mizukoshi E, 1999, J INTERF CYTOK RES, V19, P1019, DOI 10.1089/107999099313235; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okayama Y, 2000, J IMMUNOL, V164, P4332, DOI 10.4049/jimmunol.164.8.4332; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ratthe C, 2004, J LEUKOCYTE BIOL, V76, P162, DOI 10.1189/jlb.0605298; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Stanley P, 2009, ESSENTIALS GLYCOBIOL; STEVENS TL, 1994, J IMMUNOL, V152, P4397; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Tangye SG, 2000, SEMIN IMMUNOL, V12, P149, DOI 10.1006/smim.2000.0217; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; WILKS AF, 1991, METHOD ENZYMOL, V200, P533; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	109	71	73	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					333	339		10.1038/ni.1713	http://dx.doi.org/10.1038/ni.1713			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295629				2022-12-18	WOS:000264425800003
J	Lee, SW; Park, Y; So, T; Kwon, BS; Cheroutre, H; Mittler, RS; Croft, M				Lee, Seung-Woo; Park, Yunji; So, Takanori; Kwon, Byoung S.; Cheroutre, Hilde; Mittler, Robert S.; Croft, Michael			Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; MOUSE BONE-MARROW; HEMATOPOIETIC STEM; FACTOR RECEPTOR; STEADY-STATE; IN-VIVO; RESPONSES; LIGAND; FAMILY; CD137	The costimulatory molecule 4-1BB and its ligand 4-1BBL can control adaptive immunity, but here we show that their interaction also suppressed myelopoiesis. We found that 4-1BBL was expressed on hematopoietic stem cells, differentiating common myeloid progenitors and granulocyte-macrophage progenitors, and 4-1BB was inducible on activated myeloid progenitors. Steady-state numbers of granulocyte-macrophage progenitors, myeloid-lineage cells and mature dendritic cells were higher in 4-1BB- and 4-1BBL-deficient mice, indicative of a negative function, and we confirmed that result with bone marrow chimeras and in vitro, where the absence of interactions between 4-1BB and 4-1BBL led to enhanced differentiation into dendritic cell lineages. The regulatory activity was mediated by 4-1BBL, with binding by 4-1BB inhibiting differentiation of myeloid progenitors. Thus, 4-1BB and 4-1BBL have a previously unknown function in limiting myelopoiesis and the development of dendritic cells.	[Lee, Seung-Woo; So, Takanori; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; [Park, Yunji; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; [Kwon, Byoung S.] Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea; [Kwon, Byoung S.] Natl Canc Ctr, Goyang, Kyonggi Do, South Korea; [Mittler, Robert S.] Emory Univ, Univ Sch Med, Dept Surg, Atlanta, GA 30329 USA; [Mittler, Robert S.] Emory Univ, Univ Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology; University of Ulsan; National Cancer Center - Korea (NCC); Emory University; Emory University	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	mick@liai.org	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526; Park, Yunji/0000-0003-0042-202X	NCI NIH HHS [CA85860, R01 CA085860] Funding Source: Medline; NEI NIH HHS [R01 EY013325, EY013325] Funding Source: Medline; NIAID NIH HHS [R01 AI042944-08, R01 AI042944-06, AI42944, R01 AI042944, R01 AI042944-07, R01 AI042944-05A1, R01 AI050265, AI050265, R01 AI059290, R56 AI050265, AI059290, R01 AI042944-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085860] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050265, R01AI042944, R01AI059290, R01AI050265] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lee SC, 2005, INFECT IMMUN, V73, P5144, DOI 10.1128/IAI.73.8.5144-5151.2005; Lee SW, 2006, J IMMUNOL, V177, P4464, DOI 10.4049/jimmunol.177.7.4464; Lee SW, 2005, J IMMUNOL, V174, P6803, DOI 10.4049/jimmunol.174.11.6803; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Saito K, 2004, J BIOL CHEM, V279, P13555, DOI 10.1074/jbc.M303791200; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; Shin HH, 2006, FEBS LETT, V580, P1601, DOI 10.1016/j.febslet.2006.01.091; Shin HH, 2007, FEBS LETT, V581, P4355, DOI 10.1016/j.febslet.2007.08.015; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Steptoe RJ, 2002, J IMMUNOL, V168, P5032, DOI 10.4049/jimmunol.168.10.5032; Tan JT, 1999, J IMMUNOL, V163, P4859; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Zhu GF, 2001, J IMMUNOL, V167, P2671, DOI 10.4049/jimmunol.167.5.2671	49	71	74	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					917	926		10.1038/ni.1632	http://dx.doi.org/10.1038/ni.1632			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604213	Green Accepted			2022-12-18	WOS:000257780700015
J	Phan, RT; Saito, M; Kitagawal, Y; Means, AR; Dalla-Favera, R				Phan, Ryan T.; Saito, Masumichi; Kitagawal, Yukiko; Means, Anthony R.; Dalla-Favera, Riccardo			Genotoxic stress regulates expression of the proto-oncogene Bc16 in germinal center B cells	NATURE IMMUNOLOGY			English	Article							PROLYL ISOMERASE PIN1; DNA-DAMAGE RESPONSE; DEREGULATED BCL6 EXPRESSION; CHROMOSOMAL TRANSLOCATIONS; TRANSCRIPTIONAL REPRESSION; LYMPHOCYTE DIFFERENTIATION; NEGATIVE AUTOREGULATION; SOMATIC HYPERMUTATION; KINASE; ATM	Antigen-specific B cells are selected in germinal centers, the structure in which these cells proliferate while accomplishing genome-remodeling processes such as class-switch recombination and somatic hypermutation. These events are associated with considerable genotoxic stress, which cells tolerate through suppression of DNA-damage responses by Bcl-6, a transcription factor required for the formation of germinal centers. Here we show that the expression of Bcl-6 is regulated by DNA damage through a signaling pathway that promotes Bcl-6 degradation. After DNA damage accumulated, the kinase ATM promoted Bcl-6 phosphorylation, leading to its interaction with the isomerase Pin1 and its degradation by the ubiquitin-proteasome system. Because Bcl-6 is required for the maintenance of germinal centers, our findings suggest that the extent of genotoxic stress controls the fate of germinal center B cells by means of Bcl-6.	Columbia Univ, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res, Boston, MA 02115 USA	Columbia University; Columbia University; Duke University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Dalla-Favera, R (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	rd10@columbia.edu						Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 1998, BLOOD, V91, P603, DOI 10.1182/blood.V91.2.603.603_603_607; Dalla-Favera R, 1999, CURR TOP MICROBIOL, V246, P257; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gumy-Pause F, 2004, LEUKEMIA, V18, P238, DOI 10.1038/sj.leu.2403221; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Theard D, 2001, BIOCHEM BIOPH RES CO, V289, P1199, DOI 10.1006/bbrc.2001.6095; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	55	71	77	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1132	1139		10.1038/ni1508	http://dx.doi.org/10.1038/ni1508			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17828269				2022-12-18	WOS:000249691400028
J	Lambolez, F; Arcangeli, ML; Joret, AM; Pasqualetto, V; Cordier, C; Di Santo, JP; Rocha, B; Ezine, S				Lambolez, F; Arcangeli, ML; Joret, AM; Pasqualetto, V; Cordier, C; Di Santo, JP; Rocha, B; Ezine, S			The thymus exports long-lived fully committed T cell precursors that can colonize primary lymphoid organs	NATURE IMMUNOLOGY			English	Article							INTRAEPITHELIAL LYMPHOCYTES; HEMATOPOIETIC PROGENITORS; PRE-TCR; LINEAGE; EXPRESSION; THYMOCYTES; IDENTIFICATION; ANTIGEN; DIFFERENTIATION; INACTIVATION	Thymic export of cells is believed to be restricted to mature T cells. Here we show that the thymus also exports fully committed T cell precursors that colonize primary lymphoid organs. These precursor cells exited the thymus before T cell receptor rearrangements and colonized lymphoid organs such as the thymus and the gut. Migration of the thymic T cell-committed precursors led to permanent colonization of the gut precursor compartment, improved the capacity of gut precursors to further differentiate into T cells and was sufficient for the generation of 'euthymic like' CD8 alpha alpha(+) intraepithelial lymphocytes. These data demonstrate a new function for the thymus in peripheral seeding with T cell precursors that become long lived after thymus export.	Inst Pasteur, Inst Natl Sante & Rech Med, U591, Necker Inst,Med Fac Rene Descartes, F-75015 Paris, France; Inst Pasteur, Inst Natl Sante & Rech Med, U668, Dept Immunol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rocha, B (corresponding author), Inst Pasteur, Inst Natl Sante & Rech Med, U591, Necker Inst,Med Fac Rene Descartes, F-75015 Paris, France.	rocha@necker.fr	Cordier, Corinne/F-9966-2018; Ricoux, Valerie/X-1921-2019; Di Santo, James P/M-4298-2014; Arcangeli, Marie-Laure/L-5991-2017	Cordier, Corinne/0000-0003-4799-6143; Ricoux, Valerie/0000-0002-9812-8701; Di Santo, James P/0000-0002-7146-1862; Arcangeli, Marie-Laure/0000-0002-1726-1472				Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Arcangeli ML, 2005, J IMMUNOL, V174, P1980, DOI 10.4049/jimmunol.174.4.1980; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Lambolez F, 2001, ADV EXP MED BIOL, V495, P15; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Lancrin C, 2002, J EXP MED, V195, P919, DOI 10.1084/jem.20011475; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; LIN T, 1994, EUR J IMMUNOL, V24, P1785, DOI 10.1002/eji.1830240810; Lin TS, 1999, J CLIN INVEST, V104, P1297, DOI 10.1172/JCI7437; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; OHTEKI T, 1993, EUR J IMMUNOL, V23, P1251, DOI 10.1002/eji.1830230609; Pelayo R, 2005, CURR OPIN IMMUNOL, V17, P100, DOI 10.1016/j.coi.2005.01.012; Perry SS, 2003, J IMMUNOL, V170, P1877, DOI 10.4049/jimmunol.170.4.1877; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Rocha B, 2005, SCIENCE, V308, DOI 10.1126/science.1107363; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; ROCHA B, 1995, CURR OPIN IMMUNOL, V7, P235, DOI 10.1016/0952-7915(95)80008-5; RODEWALD HR, 1991, J BIOL CHEM, V266, P15974; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Suzuki K, 2000, IMMUNITY, V13, P691, DOI 10.1016/S1074-7613(00)00068-6; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WANG J, 1994, SCIENCE, V265, P1860, DOI 10.1126/science.8091211; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	39	71	73	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					76	82		10.1038/ni1293	http://dx.doi.org/10.1038/ni1293			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16341216				2022-12-18	WOS:000234139700021
J	Harris, RS; Sheehy, AM; Craig, HM; Malim, MH; Neuberger, MS				Harris, RS; Sheehy, AM; Craig, HM; Malim, MH; Neuberger, MS			DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; RNA EDITING ENZYME; G->A HYPERMUTATION; VIF PROTEIN; REVERSE TRANSCRIPTION; TYPE-1; ACTIVATION; AID; INFECTION	New insights into APOBEC editing functions suggest this family of enzymes might protect against invasive attack by foreign DNA.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	MRC Laboratory Molecular Biology; University of London; King's College London	Harris, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rsharris@mrc-lmb.cam.ac.uk; msn@mrc-lmb.cam.ac.uk		Malim, Michael/0000-0002-7699-2064				Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; MANGEAT B, 2003, NATURE ADV ONLI 0528; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NEUBERGER MS, 2003, TRENDS BIOCH SC 0523; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; ZHANG H, 2003, NATURE ADV ONLI 0528	29	71	76	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					641	643		10.1038/ni0703-641	http://dx.doi.org/10.1038/ni0703-641			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830140				2022-12-18	WOS:000183952500007
J	Kondo, T; Cortese, I; Markovic-Plese, S; Wandinger, KP; Carter, C; Brown, M; Leitman, S; Martin, R				Kondo, T; Cortese, I; Markovic-Plese, S; Wandinger, KP; Carter, C; Brown, M; Leitman, S; Martin, R			Dendritic cells signal T cells in the absence of exogenous antigen	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; MULTIPLE-SCLEROSIS; ACTIVATION; RECEPTOR; SURVIVAL; COMPLEX; PEPTIDE; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION	Interactions with self-major histocompatibility complex molecules on dendritic cells (DCs) are important for the survival of mature CD4(+)T cells. We have followed the DC-mediated signal from the T cell surface to the nucleus and identified a pattern of activation that correlates with increased in vitro survival. This response is induced exclusively by DCs and is likely associated with a modulation of the T cell activation threshold. We have also found that DC-mediated activation results in antigen-independent cytokine gene expression, which points to a new role for DCs in shaping the cytokine milieu. Such antigen-independent activation of T cells may play a role in protective immunity, but may also induce and perpetuate autoimmune states such as multiple sclerosis.	NINCDS, Cellular Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Martin, R (corresponding author), NINCDS, Cellular Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA.			Martin, Roland/0000-0002-0982-1329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002205] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamsen T G, 1991, J Clin Apher, V6, P48, DOI 10.1002/jca.2920060110; Aiba S, 1999, J DERMATOL SCI, V20, P1, DOI 10.1016/S0923-1811(99)00005-5; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Chang JT, 2000, J IMMUNOL, V164, P100, DOI 10.4049/jimmunol.164.1.100; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Drakesmith H, 2000, IMMUNOL TODAY, V21, P214, DOI 10.1016/S0167-5699(00)01610-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hemmer B, 1998, J IMMUNOL, V160, P5807; Huang YM, 1999, J NEUROIMMUNOL, V99, P82, DOI 10.1016/S0165-5728(99)00106-X; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Link H, 1999, J NEUROIMMUNOL, V100, P102, DOI 10.1016/S0165-5728(99)00197-6; MARTIN R, 1991, J EXP MED, V173, P19, DOI 10.1084/jem.173.1.19; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Muranski P, 2000, J IMMUNOL, V164, P3087, DOI 10.4049/jimmunol.164.6.3087; OLSSON T, 1990, J CLIN INVEST, V86, P981, DOI 10.1172/JCI114800; Palucka KA, 1998, J IMMUNOL, V160, P4587; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Vergelli M, 1996, EUR J IMMUNOL, V26, P2624, DOI 10.1002/eji.1830261113; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2	39	71	73	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					932	938		10.1038/ni711	http://dx.doi.org/10.1038/ni711			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11561182				2022-12-18	WOS:000171361500012
J	Mackay, IR; Rose, NR				Mackay, IR; Rose, NR			Autoimmunity and lymphoma: tribulations of B cells	NATURE IMMUNOLOGY			English	Editorial Material							DOUBLE-STRAND BREAKS; LYMPHOPROLIFERATIVE SYNDROME; GENE; MALIGNANCY; DISORDERS; DISEASE; BCL10	In early July 2001 a small meeting was held in Baltimore on the associations of lymphomas with autoimmune conditions. Topics ranged from the effects of defective apoptosis to questions of antigen-drive lymphoproliferation.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Mol Microbiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Immunol, Baltimore, MD 21205 USA	Monash University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Mackay, IR (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia.	nrrose@jhsph.edu	Mackay, Ian R/A-7228-2010					AbuShakra M, 1996, ARTHRITIS RHEUM, V39, P1050, DOI 10.1002/art.1780390625; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ansell SM, 1999, SEMIN ONCOL, V26, P316; Bernacchi E, 1999, EXP DERMATOL, V8, P480, DOI 10.1111/j.1600-0625.1999.tb00306.x; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Burke JS, 1999, AM J CLIN PATHOL, V111, pS133; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; CONLEY CL, 1981, JOHNS HOPKINS MED J, V149, P101; Damle RN, 2000, CURR TOP MICROBIOL, V252, P285; Desiderio S, 2000, NAT IMMUNOL, V1, P463, DOI 10.1038/82704; Du MQ, 2000, BLOOD, V95, P3885; Fleisher TA, 2001, CLIN REV ALLERG IMMU, V20, P109, DOI 10.1385/CRIAI:20:1:109; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; Jacobs H, 2001, PHILOS T ROY SOC B, V356, P119, DOI 10.1098/rstb.2000.0756; KAPLAN HS, 1959, LANCET, V1; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mellemkjaer L, 1997, ARTHRITIS RHEUM-US, V40, P761, DOI 10.1002/art.1780400424; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mellors R C, 1966, Int Rev Exp Pathol, V5, P217; Miklos JA, 2000, BLOOD, V95, P3878; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; SOKOL RJ, 1981, BRIT MED J, V282, P2023, DOI 10.1136/bmj.282.6281.2023; Sorrentino D, 1996, GUT, V38, P837, DOI 10.1136/gut.38.6.837; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; TALAL N, 1992, RHEUM DIS CLIN N AM, V18, P507; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5	29	71	74	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					793	795		10.1038/ni0901-793	http://dx.doi.org/10.1038/ni0901-793			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526388				2022-12-18	WOS:000170781200013
J	Utzschneider, DT; Gabriel, SS; Chisanga, D; Gloury, R; Gubser, PM; Vasanthakumar, A; Shi, W; Kallies, A				Utzschneider, Daniel T.; Gabriel, Sarah S.; Chisanga, David; Gloury, Renee; Gubser, Patrick M.; Vasanthakumar, Ajithkumar; Shi, Wei; Kallies, Axel			Early precursor T cells establish and propagate T cell exhaustion in chronic infection	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY; EFFECTOR; PD-1; BACH2; DIFFERENTIATION; PHENOTYPE; STATES; LIMITS; IRF4	The developmental timing for exhaustion is still obscure. Kallies and colleagues demonstrate that CD8(+)T cell 'exhaustion' actually begins in the less-differentiated TCF1(+)'precursor' T cell pool during chronic viral infections. CD8(+)T cells responding to chronic infections or tumors acquire an 'exhausted' state associated with elevated expression of inhibitory receptors, including PD-1, and impaired cytokine production. Exhausted T cells are continuously replenished by T cells with precursor characteristics that self-renew and depend on the transcription factor TCF1; however, their developmental requirements are poorly understood. In the present study, we demonstrate that high antigen load promoted the differentiation of precursor T cells, which acquired hallmarks of exhaustion within days of infection, whereas early effector cells retained polyfunctional features. Early precursor T cells showed epigenetic imprinting characteristic of T cell receptor-dependent transcription factor binding and were restricted to the generation of cells displaying exhaustion characteristics. Transcription factors BACH2 and BATF were key regulators with opposing functions in the generation of early precursor T cells. Overall, we demonstrate that exhaustion manifests first in TCF1(+)precursor T cells and is propagated subsequently to the pool of antigen-specific T cells.	[Utzschneider, Daniel T.; Gabriel, Sarah S.; Gloury, Renee; Gubser, Patrick M.; Vasanthakumar, Ajithkumar; Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Chisanga, David; Shi, Wei] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Chisanga, David; Vasanthakumar, Ajithkumar; Shi, Wei; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Chisanga, David] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Chisanga, David; Shi, Wei] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia; [Shi, Wei] Univ Melbourne, Sch Comp & Informat Syst, Melbourne, Vic, Australia	University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; University of Melbourne	Utzschneider, DT; Kallies, A (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.	daniel.utzschneider@unimelb.edu.au; axel.kallies@unimelb.edu.au	Chisanga, David/AAB-1751-2019; Utzschneider, Daniel/D-5855-2016	Chisanga, David/0000-0002-0421-3957; VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781; Gabriel, Sarah Sharon/0000-0002-6359-485X; Kallies, Axel/0000-0002-6312-6968; Utzschneider, Daniel/0000-0003-2205-9057	National Health and Medical Research Council [1085151, 1139607]; Swiss National Science Foundation [P300PA_177907, P400PM_180807, P300PB_177934]; Novartis Foundation for Medical-Biological Research; Leukemia and Lymphoma Society [338719]; WEHI Centenary Fellowship - CSL Ltd.	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); WEHI Centenary Fellowship - CSL Ltd.	We thank T. Mason for technical support and T. Gebhardt, S. Nutt and members of the Kallies lab for discussions. This work was funded by the National Health and Medical Research Council (project grant no. 1085151 and Senior Research Fellowship no. 1139607 to A.K.), the Swiss National Science Foundation (fellowship nos. P300PA_177907 to D.T.U., P400PM_180807 to S.S.G. and P300PB_177934 to P.M.G.) and the Novartis Foundation for Medical-Biological Research (fellowship to S.S.G.). D.T.U. is a Special Fellow of the Leukemia and Lymphoma Society (fellowship no. 338719). W.S.is supported by a WEHI Centenary Fellowship funded by a donation from CSL Ltd. We acknowledge the Melbourne Cytometry Platform for provision of flow cytometry services.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lugli E, 2020, TRENDS IMMUNOL, V41, P17, DOI 10.1016/j.it.2019.11.004; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Menner AJ, 2015, J IMMUNOL, V195, P2103, DOI 10.4049/jimmunol.1402607; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sidwell T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14112-2; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	60	70	70	3	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1256	+		10.1038/s41590-020-0760-z	http://dx.doi.org/10.1038/s41590-020-0760-z		AUG 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32839610	Bronze			2022-12-18	WOS:000562393000005
J	Charbonnier, LM; Cui, Y; Stephen-Victor, E; Harb, H; Lopez, D; Bleesing, JJ; Garcia-Lloret, MI; Chen, K; Ozen, A; Carmeliet, P; Li, MO; Pellegrini, M; Chatila, TA				Charbonnier, Louis-Marie; Cui, Ye; Stephen-Victor, Emmanuel; Harb, Hani; Lopez, David; Bleesing, Jack J.; Garcia-Lloret, Maria, I; Chen, Karin; Ozen, Ahmet; Carmeliet, Peter; Li, Ming O.; Pellegrini, Matteo; Chatila, Talal A.			Functional reprogramming of regulatory T cells in the absence of Foxp3	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; DIFFERENTIATION; EXPRESSION; EFFECTOR; PHOSPHORYLATION; METABOLISM; TOLERANCE; MTOR; DEGRADATION; GLYCOLYSIS	Regulatory T cells (T-reg cells) deficient in the transcription factor Foxp3 lack suppressor function and manifest an effector T (T-eff) cell-like phenotype. We demonstrate that Foxp3 deficiency dysregulates metabolic checkpoint kinase mammalian target of rapamycin (mTOR) complex 2 (mTORC2) signaling and gives rise to augmented aerobic glycolysis and oxidative phosphorylation. Specific deletion of the mTORC2 adaptor gene Rictor in Foxp3-deficient T-reg cells ameliorated disease in a Foxo1 transcription factor-dependent manner. Rictor deficiency re-established a subset of T-reg cell genetic circuits and suppressed the T-eff cell-like glycolytic and respiratory programs, which contributed to immune dysregulation. Treatment of T-reg cells from patients with FOXP3 deficiency with mTOR inhibitors similarly antagonized their T-eff cell-like program and restored suppressive function. Thus, regulatory function can be re-established in Foxp3-deficient T-reg cells by targeting their metabolic pathways, providing opportunities to restore tolerance in T-reg cell disorders.	[Charbonnier, Louis-Marie; Cui, Ye; Stephen-Victor, Emmanuel; Harb, Hani; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Charbonnier, Louis-Marie; Cui, Ye; Stephen-Victor, Emmanuel; Harb, Hani; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lopez, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Bleesing, Jack J.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Garcia-Lloret, Maria, I] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, Los Angeles, CA 90095 USA; [Chen, Karin] Univ Utah, Sch Med, Dept Pediat, Div Allergy & Immunol, Salt Lake City, UT USA; [Ozen, Ahmet] Marmara Univ, Fac Med, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Carmeliet, Peter] VIB KU Leuven Ctr Canc Biol, Lab Angiogenesis & Vasc Metab, Leuven, Belgium; [Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Cincinnati Children's Hospital Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Marmara University; Flanders Institute for Biotechnology (VIB); Memorial Sloan Kettering Cancer Center	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Ozen, Ahmet/R-6749-2017; Harb, Hani/HGB-7333-2022; Carmeliet, Peter/AAQ-5140-2020; Harb, Hani/J-6517-2019; Stephen Victor, Emmanuel/HDN-0252-2022	Ozen, Ahmet/0000-0002-9065-1901; Harb, Hani/0000-0001-8218-2538; Carmeliet, Peter/0000-0001-7961-1821; Harb, Hani/0000-0001-8218-2538; Stephen Victor, Emmanuel/0000-0001-5049-7017; Charbonnier, Louis-Marie/0000-0002-4594-7893; li, ming/0000-0002-1383-0535	National Institutes of Health [2R01 AI065617, RO1 AI102888-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, R01AI102888, R01AI085090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants 2R01 AI065617 (to T.A.C.) and RO1 AI102888-01A1 (to M.O.L.).	Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; Bin Dhuban K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai9297; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chapman NM, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00686; Charbonnier LM, 2015, NAT IMMUNOL, V16, P1162, DOI 10.1038/ni.3288; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Leach MW, 1996, AM J PATHOL, V148, P1503; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu CH, 2015, J LEUKOCYTE BIOL, V97, P837, DOI 10.1189/jlb.2RI0814-408R; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rivas MN, 2012, J CLIN INVEST, V122, P1933, DOI 10.1172/JCI40591; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Valmori D, 2006, J IMMUNOL, V177, P944, DOI 10.4049/jimmunol.177.2.944; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang LJ, 2016, CELL REP, V14, P1206, DOI 10.1016/j.celrep.2015.12.095	54	70	73	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1208	+		10.1038/s41590-019-0442-x	http://dx.doi.org/10.1038/s41590-019-0442-x			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31384057	Green Accepted			2022-12-18	WOS:000482212600020
J	Willcox, BE; Willcox, CR				Willcox, Benjamin E.; Willcox, Carrie R.			gamma delta TCR ligands: the quest to solve a 500-million-year-old mystery	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; BUTYROPHILIN 3A1; PHOSPHORYLATED ANTIGENS; STRESS-SURVEILLANCE; CLASS-I; RECOGNITION; SPECIFICITY; GENES; LYMPHOCYTES	gamma delta T cells have been retained as a lineage over the majority of vertebrate evolution, are able to respond to immune challenges in unique ways, and are of increasing therapeutic interest. However, one central mystery has endured: the identity of the ligands recognized by the gamma delta T cell antigen receptor. Here we discuss the inherent challenges in answering this question, the new opportunities provided by recent studies, and the criteria by which the field might judge success.	[Willcox, Benjamin E.] Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England; [Willcox, Carrie R.] Univ Birmingham, Sch Canc Sci, Birmingham Canc Res UK Canc Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Willcox, BE (corresponding author), Univ Birmingham, Canc Immunol & Immunotherapy Ctr, Birmingham, W Midlands, England.; Willcox, CR (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham Canc Res UK Canc Ctr, Birmingham, W Midlands, England.	b.willcox@bham.ac.uk; c.r.willcox@bham.ac.uk			Wellcome Trust Investigator Award [099266/Z/12/Z]	Wellcome Trust Investigator Award(Wellcome Trust)	Funded by a Wellcome Trust Investigator Award to B.E.W., supporting C.R.W. (099266/Z/12/Z). We would like to thank Professor Adrian Hayday, Dr Martin Davey, and Dr Pierre Vantourout for fruitful discussions.	ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Aydintug MK, 2014, MOL IMMUNOL, V60, P116, DOI 10.1016/j.molimm.2014.04.007; Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Bonneville M, 2015, CELL IMMUNOL, V296, P3, DOI 10.1016/j.cellimm.2014.11.001; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Bruder J, 2012, J BIOL CHEM, V287, P20986, DOI 10.1074/jbc.M112.356709; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Davey MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02106; Davey MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04076-0; Davey MS, 2018, TRENDS IMMUNOL, V39, P446, DOI 10.1016/j.it.2018.03.003; Davey MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14760; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Garcia VE, 1999, J IMMUNOL, V162, P6114; Garcia VE, 1998, J IMMUNOL, V160, P4322; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Gu SY, 2018, SEMIN CELL DEV BIOL, V84, P65, DOI 10.1016/j.semcdb.2018.02.007; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; HOHLFELD R, 1991, NEW ENGL J MED, V324, P877, DOI 10.1056/NEJM199103283241303; Hunter S, 2018, J HEPATOL, V69, P654, DOI 10.1016/j.jhep.2018.05.007; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Jonsson P, 2016, P NATL ACAD SCI USA, V113, P5682, DOI 10.1073/pnas.1513918113; Kalyan S, 2013, CELL MOL IMMUNOL, V10, P21, DOI 10.1038/cmi.2012.44; Khairallah C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00105; Khairallah C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004702; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Lafarge X, 2005, EUR J IMMUNOL, V35, P1896, DOI 10.1002/eji.200425837; Lebrero-Fernandez C, 2016, IMMUN INFLAMM DIS, V4, P191, DOI 10.1002/iid3.105; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Mamedov MR, 2018, IMMUNITY, V48, P350, DOI 10.1016/j.immuni.2018.01.009; Marlin R, 2017, P NATL ACAD SCI USA, V114, P3163, DOI 10.1073/pnas.1621052114; MATIS LA, 1989, SCIENCE, V245, P746, DOI 10.1126/science.2528206; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; PLUSCHKE G, 1992, J EXP MED, V176, P1785, DOI 10.1084/jem.176.6.1785; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Rhodes DA, 2016, ANNU REV IMMUNOL, V34, P151, DOI 10.1146/annurev-immunol-041015-055435; Riano F, 2014, EUR J IMMUNOL, V44, P2571, DOI 10.1002/eji.201444712; Ribot JC, 2014, J IMMUNOL, V192, P2237, DOI 10.4049/jimmunol.1303119; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Roy S, 2016, J IMMUNOL, V196, P1933, DOI 10.4049/jimmunol.1502202; Salim M, 2016, J BIOL CHEM, V291, P9310, DOI 10.1074/jbc.M116.722066; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sciammas R, 1998, J IMMUNOL, V161, P5187; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sell S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004481; Silva-Santos B, 2012, EUR J IMMUNOL, V42, P3101, DOI 10.1002/eji.201270101; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Ugur M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27339-8; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Vantourout P, 2018, P NATL ACAD SCI USA, V115, P1039, DOI 10.1073/pnas.1701237115; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wang H, 2015, J IMMUNOL, V195, P4583, DOI 10.4049/jimmunol.1500314; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Willcox CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01501; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011	74	70	71	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					121	128		10.1038/s41590-018-0304-y	http://dx.doi.org/10.1038/s41590-018-0304-y			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30664765				2022-12-18	WOS:000456279100010
J	Hsin, JP; Lu, YH; Loeb, GB; Leslie, CS; Rudensky, AY				Hsin, Jing-Ping; Lu, Yuheng; Loeb, Gabriel B.; Leslie, Christina S.; Rudensky, Alexander Y.			The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types	NATURE IMMUNOLOGY			English	Article							MICRORNA TARGETING SPECIFICITY; NUCLEOTIDE RESOLUTION; CIRCULAR RNAS; MIR-155; EXPRESSION; BINDING; SITES; REVEALS; PROTEIN; SYSTEM	Numerous microRNAs and their target mRNAs are coexpressed across diverse cell types. However, it is unknown whether they are regulated in a manner independent of or dependent on cellular context. Here, we explored transcriptome-wide targeting and gene regulation by miR-155, whose activation-induced expression plays important roles in innate and adaptive immunity. Through mapping of miR-155 targets through differential iCLIP, mRNA quantification with RNA-seq, and 3' untranslated region (UTR)-usage analysis with poly(A)-seq in macrophages, dendritic cells, and T and B lymphocytes either sufficient or deficient in activated miR-155, we identified numerous targets differentially bound by miR-155. Whereas alternative cleavage and polyadenylation (ApA) contributed to differential miR-155 binding to some transcripts, in most cases, identical 3'-UTR isoforms were differentially regulated across cell types, thus suggesting ApA-independent and cellular-context-dependent miR-155-mediated gene regulation. Our study provides comprehensive maps of miR-155 regulatory networks and offers a valuable resource for dissecting context-dependent and context-independent miRNA-mediated gene regulation in key immune cell types.	[Hsin, Jing-Ping; Loeb, Gabriel B.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Hsin, Jing-Ping; Loeb, Gabriel B.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Hsin, Jing-Ping; Loeb, Gabriel B.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Lu, Yuheng; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Lu, Yuheng] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Loeb, Gabriel B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.; Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA.	cleslie@cbio.mskcc.org; rudenska@mskcc.org			National Institutes of Health [Al034206, HG007893, CA164190, P30 CA008748]; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Irvington Fellowship of the Cancer Research Institute; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA209975, U01CA164190, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Irvington Fellowship of the Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Chaudhry and other laboratory members for experimental assistance and discussions. This work was supported by National Institutes of Health grants Al034206 (A.Y.R.), HG007893 (A.Y.R. and C.S.L.), CA164190 (C.S.L.), and P30 CA008748, as well as the Hilton-Ludwig Cancer Prevention Initiative funded by the Conrad N. Hilton Foundation and Ludwig Cancer Research. J.-P.H. was supported by an Irvington Fellowship of the Cancer Research Institute. A.Y.R. is supported as an Investigator with the Howard Hughes Medical Institute. We thank J. Chaudhuri (Memorial Sloan Kettering Cancer Center) for providing antibodies.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Erhard F, 2014, GENOME RES, V24, P906, DOI 10.1101/gr.166702.113; Farazi TA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r9; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Gruber AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6465; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	55	70	72	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1137	+		10.1038/s41590-018-0208-x	http://dx.doi.org/10.1038/s41590-018-0208-x			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30224821	Green Accepted			2022-12-18	WOS:000445968600019
J	Brameshuber, M; Kellner, F; Rossboth, BK; Ta, H; Alge, K; Sevcsik, E; Gohring, J; Axmann, M; Baumgart, F; Gascoigne, NRJ; Davis, SJ; Stockinger, H; Schutz, GJ; Huppa, JB				Brameshuber, Mario; Kellner, Florian; Rossboth, Benedikt K.; Ta, Haisen; Alge, Kevin; Sevcsik, Eva; Goehring, Janett; Axmann, Markus; Baumgart, Florian; Gascoigne, Nicholas R. J.; Davis, Simon J.; Stockinger, Hannes; Schuetz, Gerhard J.; Huppa, Johannes B.			Monomeric TCRs drive T cell antigen recognition	NATURE IMMUNOLOGY			English	Article							LIGAND-SPECIFIC OLIGOMERIZATION; RECEPTOR; ACTIVATION; MOLECULE; REVEALS; STOICHIOMETRY; MULTIVALENT; BINDING	T cell antigen recognition requires T cell antigen receptors (TCRs) engaging MHC-embedded antigenic peptides (pMHCs) within the contact region of a T cell with its conjugated antigen-presenting cell. Despite micromolar TCR:pMHC affinities, T cells respond to even a single antigenic pMHC, and higher-order TCRs have been postulated to maintain high antigen sensitivity and trigger signaling. We interrogated the stoichiometry of TCRs and their associated CD3 subunits on the surface of living T cells through single-molecule brightness and single-molecule coincidence analysis, photon-antibunching-based fluorescence correlation spectroscopy and Forster resonance energy transfer measurements. We found exclusively monomeric TCR-CD3 complexes driving the recognition of antigenic pMHCs, which underscores the exceptional capacity of single TCR-CD3 complexes to elicit robust intracellular signaling.	[Brameshuber, Mario; Rossboth, Benedikt K.; Sevcsik, Eva; Goehring, Janett; Baumgart, Florian; Schuetz, Gerhard J.] TU Wien, Inst Appl Phys, Vienna, Austria; [Kellner, Florian; Alge, Kevin; Goehring, Janett; Stockinger, Hannes; Huppa, Johannes B.] Med Univ Vienna, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Ta, Haisen] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany; [Axmann, Markus] Med Univ Vienna, Inst Med Chem & Pathobiochem, Ctr Pathobiochem & Genet, Vienna, Austria; [Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford, England	Technische Universitat Wien; Medical University of Vienna; Max Planck Society; Medical University of Vienna; National University of Singapore; University of Oxford; University of Oxford	Brameshuber, M (corresponding author), TU Wien, Inst Appl Phys, Vienna, Austria.	brameshuber@iap.tuwien.ac.at; johannes.huppa@meduniwien.ac.at	Huppa, Johannes Bernhard/AAY-9471-2021; Schuetz, Gerhard/B-1243-2008; Göhring, Janett/AAM-7175-2021; Stockinger, Hannes/E-5173-2011	Huppa, Johannes Bernhard/0000-0003-2634-8198; Schuetz, Gerhard/0000-0003-1542-1089; Göhring, Janett/0000-0002-6755-5305; Stockinger, Hannes/0000-0001-6404-4430; Sevcsik, Eva/0000-0002-2155-1675; Kellner, Florian/0000-0001-5931-3798; Baumgart, Florian/0000-0003-1352-8632; Davis, Simon/0000-0002-2280-1170; Rossboth, Benedikt/0000-0002-9002-9434; Brameshuber, Mario/0000-0001-8672-2255; Axmann, Markus/0000-0001-9818-9734	Austrian Science Fund (FWF) [1953-B20, P25775-B2, P275941-B28, V538-B26]; Singapore National Medical Research Council [NMRC/CBRG/0064/2014]; Wellcome Trust [098274/Z/12/Z]; MRC [MC_UU_12010/4, MC_UU_00008/4] Funding Source: UKRI	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Singapore National Medical Research Council(National Medical Research Council, Singapore); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	we would like to thank S, Hell (Max plank institute for Biophysical Chemistry) for Providing imaging infrastructure and support (H.T.) and M. Fonke Tejkl for offering help and Infrastructure concerning peptide mass spectrometry. This work was supported by Austrian Science Fund (FWF) projects 1953-B20 (M.B,), P25775-B2 (K.A., J.B.H,), P275941-B28 (F.B) and V538-B26 (E.S.), by Vienna Science and Technology Fund (WWTF) protect LS13-030 (F.K.,G.J.S.), by the Singapore National Medical Research Council under NMRC/CBRG/0064/2014 (N.R.I.G. and by the Wellcome Trust, grant 098274/Z/12/Z (S.J.D.),	ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Axmann M, 2015, JOVE-J VIS EXP, DOI 10.3791/53158; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Brameshuber M, 2012, METHOD ENZYMOL, V505, P159, DOI 10.1016/B978-0-12-388448-0.00017-6; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cai E, 2017, SCIENCE, V356, DOI 10.1126/science.aal3118; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fairhead M, 2014, J MOL BIOL, V426, P199, DOI 10.1016/j.jmb.2013.09.016; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Harms GS, 1999, BIOPHYS J, V77, P2864, DOI 10.1016/S0006-3495(99)77118-3; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Huppa JB, 2013, ADV IMMUNOL, V119, P1, DOI 10.1016/B978-0-12-407707-2.00001-1; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, DOI 10.1007/978-0-387-46312-4; lames I. R., 2007, P NATL ACAD SCI USA, V104, P17662; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Ruprecht V, 2010, SOFT MATTER, V6, P568, DOI 10.1039/b916734j; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Swamy M, 2016, IMMUNITY, V44, P1091, DOI 10.1016/j.immuni.2016.04.011; Sykora J, 2007, ANAL CHEM, V79, P4040, DOI 10.1021/ac062024f; Ta H, 2010, PHYS CHEM CHEM PHYS, V12, P10295, DOI 10.1039/c0cp00363h; Tang Q., 2002, J IMMUNOL, V168, P4140; Taylor MJ, 2017, CELL, V169, P108, DOI 10.1016/j.cell.2017.03.006; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang F, 2016, NAT IMMUNOL, V17, P844, DOI 10.1038/ni.3462; WEISSMAN AM, 1986, NATURE, V324, P480, DOI 10.1038/324480a0; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Xie JM, 2012, NAT IMMUNOL, V13, P674, DOI 10.1038/ni.2344	58	70	70	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					487	+		10.1038/s41590-018-0092-4	http://dx.doi.org/10.1038/s41590-018-0092-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29662172	Green Accepted			2022-12-18	WOS:000430562400012
J	Bando, JK; Colonna, M				Bando, Jennifer K.; Colonna, Marco			Innate lymphoid cell function in the context of adaptive immunity	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; STEM-CELLS; HOST PROTECTION; TYPE-2 IMMUNITY; TUFT CELLS; NK CELLS; DIFFERENTIATION; NFIL3; ALPHA; IDENTIFICATION	Innate lymphoid cells (ILCs) are a family of innate immune cells that have diverse functions during homeostasis and disease. Subsets of ILCs have phenotypes that mirror those of polarized helper T cell subsets in their expression of core transcription factors and effector cytokines. Given the similarities between these two classes of lymphocytes, it is important to understand which functions of ILCs are specialized and which are redundant with those of T cells. Here we discuss genetic mouse models that have been used to delineate the contributions of ILCs versus those of T cells and review the current understanding of the specialized in vivo functions of ILCs.	[Bando, Jennifer K.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987; Bando, Jennifer/0000-0002-1331-7424	US National Institutes of Health [AI095542, DE021255, DK103039, T32 HL731737]; Kenneth Rainin Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Robinette, M. Patnode, M. Cella and G. Oltz for critical reading of the manuscript, and J. O'Shea for discussion. Supported by the US National Institutes of Health (AI095542, DE021255 and DK103039; and T32 HL731737 for J.K.B.), the Kenneth Rainin Foundation and the Cancer Research Institute (J.K.B.).	Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Ben Merzoug L, 2014, EUR J IMMUNOL, V44, P3380, DOI 10.1002/eji.201444643; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Boulenouar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00043; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Korn LL, 2014, MUCOSAL IMMUNOL, V7, P1045, DOI 10.1038/mi.2013.121; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Redhead ML, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.138495; Robinette ML, 2016, HLA, V87, P5, DOI 10.1111/tan.12723; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Taylor RT, 2004, J IMMUNOL, V173, P7183, DOI 10.4049/jimmunol.173.12.7183; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Van Gool F, 2014, BLOOD, V124, P3572, DOI 10.1182/blood-2014-07-587493; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	86	70	71	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					783	789		10.1038/ni.3484	http://dx.doi.org/10.1038/ni.3484			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328008	Green Accepted			2022-12-18	WOS:000378283200010
J	Wang, YQ; Misumi, I; Gu, AD; Curtis, TA; Su, LS; Whitmire, JK; Wan, YSY				Wang, Yunqi; Misumi, Ichiro; Gu, Ai-Di; Curtis, T. Anthony; Su, Lishan; Whitmire, Jason K.; Wan, Yisong Y.			GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; C-MYC; EXPRESSION; DIFFERENTIATION; NAIVE; NOTCH; FATE; INFLAMMATION; ACTIVATION; SUFFICIENT	GATA-3 controls T helper type 2 (TH2) differentiation. However, whether GATA-3 regulates the function of mature T cells beyond TH2 determination remains poorly understood. We found that signaling via the T cell antigen receptor (TCR) and cytokine stimulation promoted GATA-3 expression in CD8(+) T cells, which controlled cell proliferation. Although GATA-3-deficient CD8+ T cells were generated, their peripheral maintenance was impaired, with lower expression of the receptor for interleukin 7 (IL-7R). GATA-3-deficient T cells had defective responses to viral infection and alloantigen. The proto-oncoprotein c-Myc was a critical target of GATA-3 in promoting T cell proliferation. Our study thus demonstrates an essential role for GATA-3 in controlling the maintenance and proliferation of T cells and provides insight into immunoregulation.	[Wang, Yunqi; Gu, Ai-Di; Curtis, T. Anthony; Su, Lishan; Wan, Yisong Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wang, Yunqi; Misumi, Ichiro; Gu, Ai-Di; Curtis, T. Anthony; Su, Lishan; Whitmire, Jason K.; Wan, Yisong Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Misumi, Ichiro; Whitmire, Jason K.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wan, YSY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	wany@email.unc.edu	Wan, Yisong/ABE-1200-2021; Misumi, Ichiro/H-8573-2019; WANG, YUNQI/F-4668-2014	Wan, Yisong/0000-0003-4346-9717; Misumi, Ichiro/0000-0003-3892-7605; Whitmire, Jason/0000-0003-2578-6073	US National Institutes of Health [R01AI097392]; National Multiple Sclerosis Society [RG4654]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097392, R01AI095097] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Busslinger and A. Souabni (Research Institute of Molecular Pathology) for Gata3<SUP>fl/fl</SUP> mice; N. Fisher and J. Kalnitsky for cell sorting; and M. Su for discussions. Supported by the US National Institutes of Health (R01AI097392), National Multiple Sclerosis Society (RG4654) and the University Cancer Research Fund (Y.Y.W.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Potvin E, 2010, MOL CELL BIOL, V30, P5348, DOI 10.1128/MCB.00353-09; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; van Hamburg JP, 2008, MOL IMMUNOL, V45, P3085, DOI 10.1016/j.molimm.2008.03.018; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	48	70	70	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					714	+		10.1038/ni.2623	http://dx.doi.org/10.1038/ni.2623			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23708251	Green Accepted			2022-12-18	WOS:000320509100013
J	McMichael, AJ; Haynes, BF				McMichael, Andrew J.; Haynes, Barton F.			Lessons learned from HIV-1 vaccine trials: new priorities and directions	NATURE IMMUNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; STRUCTURAL BASIS; EFFICACY TRIAL; DOUBLE-BLIND; T-CELLS; INFECTION; RESPONSES; BROAD; PROTECTION	A vaccine against human immunodeficiency virus (HIV) seems to be on the horizon. Correlates of risk of infection for the RV144 trial have been found. There is understanding of what makes HIV envelope-specific antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability.	[McMichael, Andrew J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Ctr HIV AIDS Vaccine Immunol, Durham, NC 27706 USA	University of Oxford; Duke University; Duke University	McMichael, AJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	andrew.mcmichael@ndm.ox.ac.uk			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854] Funding Source: NIH RePORTER; Medical Research Council [G1000800a] Funding Source: researchfish; Medical Research Council Funding Source: Medline; NIAID NIH HHS [U19 AI067854, U01 AI067854, AI067854] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cohen J, 2009, SCIENCE, V326, P652, DOI 10.1126/science.326_652; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Duerr A, 2012, J INFECT DI IN PRESS; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes B, 2012, NAT BIOTECH IN PRESS; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Montefiori D, 2012, J INFECT DI IN PRESS; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Mureithi MW, 2011, AIDS RES HUM RETROV, V27, P501, DOI 10.1089/aid.2010.0237; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Verkoczy L, 2011, J IMMUNOL, V187, P3785, DOI 10.4049/jimmunol.1101633; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	66	70	75	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					423	427		10.1038/ni.2264	http://dx.doi.org/10.1038/ni.2264			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513323	Bronze, Green Accepted			2022-12-18	WOS:000303048400002
J	Hida, S; Yamasaki, S; Sakamoto, Y; Takamoto, M; Obata, K; Takai, T; Karasuyama, H; Sugane, K; Saito, T; Taki, S				Hida, Shigeaki; Yamasaki, Sho; Sakamoto, Yuzuru; Takamoto, Masaya; Obata, Kazushige; Takai, Toshiyuki; Karasuyama, Hajime; Sugane, Kazuo; Saito, Takashi; Taki, Shinsuke			Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils	NATURE IMMUNOLOGY			English	Article							SIGNAL-TRANSDUCTION; TYROSINE KINASE; BETA-CHAIN; T-CELLS; CYTOKINE; SYK; MECHANISM; ITAM; DIFFERENTIATION; MICE	The Fc receptor common gamma-chain (FcR gamma) is a widely expressed adaptor bearing an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals from various immunoreceptors. We show here that basophils lacking FcR gamma developed normally and proliferated efficiently in response to interleukin 3 (IL-3) but were very impaired in IL-3-induced production of IL-4 and in supporting T helper type 2 differentiation. Through its transmembrane portion, FcR gamma associated constitutively with the common beta-chain of the IL-3 receptor and signaled by recruiting the kinase Syk. Retrovirus-mediated complementation demonstrated the essential function of the ITAM of FcR gamma in IL-3 signal transduction. Our results identify a previously unknown mechanism whereby FcR gamma functions to 'route' selective cytokine-triggered signals into the ITAM-mediated IL-4 production pathway.	[Hida, Shigeaki; Sakamoto, Yuzuru; Takamoto, Masaya; Sugane, Kazuo; Taki, Shinsuke] Shinshu Univ, Grad Sch Med, Dept Immunol & Infect Dis, Matsumoto, Nagano 3908621, Japan; [Yamasaki, Sho; Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan; [Obata, Kazushige; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo 1138519, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	Shinshu University; RIKEN; Tokyo Medical & Dental University (TMDU); Tohoku University	Taki, S (corresponding author), Shinshu Univ, Grad Sch Med, Dept Immunol & Infect Dis, Matsumoto, Nagano 3908621, Japan.	takishin@shinshu-u.ac.jp	Karasuyama, Hajime/A-7966-2011; Saito, Takashi/C-9684-2009; Sakamoto, Yuzuru/L-7690-2019	Karasuyama, Hajime/0000-0003-0689-0836; Saito, Takashi/0000-0001-9495-3547; Sakamoto, Yuzuru/0000-0002-4863-3179; Obata-Ninomiya, Kazushige/0000-0002-0984-6518; Taki, Shinsuke/0000-0001-5143-3496	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [17047016, 18060016, 19591162]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank S. Akira (Osaka University) for Stat6<SUP>-/-</SUP> mice; W. R. Heath (Walter and Eliza Hall Institute) for OT-II TCR-Tg mice; T. Kitamura (University of Tokyo) for the original pMX-IRES-GFP retroviral vector; and K. Takatsu (University of Toyama) for the Y16 cell line; and acknowledge the late N. Azuta for technical assistance. Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research 17047016, 18060016 to S. T. and 19591162 to S. H.).	Bezbradica JS, 2006, IMMUNITY, V25, P487, DOI 10.1016/j.immuni.2006.06.017; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Falcone FH, 2000, BLOOD, V96, P4028; Falcone FH, 2006, EXP DERMATOL, V15, P855, DOI 10.1111/j.1600-0625.2006.00477.x; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Geijsen N, 2001, CYTOKINE GROWTH F R, V12, P19, DOI 10.1016/S1359-6101(00)00019-8; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Honorio-Fransa AC, 2001, J LEUKOCYTE BIOL, V69, P289; Kitamura K, 2007, J IMMUNOL, V178, P480, DOI 10.4049/jimmunol.178.1.480; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; Lach-Trifilieff E, 2000, BLOOD, V96, P2506; Launay P, 1999, J BIOL CHEM, V274, P7216, DOI 10.1074/jbc.274.11.7216; LOPEZ AF, 1987, P NATL ACAD SCI USA, V84, P2761; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; MITA S, 1991, INT IMMUNOL, V3, P665, DOI 10.1093/intimm/3.7.665; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; NICOLA NA, 1994, STEM CELLS, V12, P3; Nicola NA, 1996, BLOOD, V87, P2665, DOI 10.1182/blood.V87.7.2665.bloodjournal8772665; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Padigel UM, 2005, J IMMUNOL, V174, P6340, DOI 10.4049/jimmunol.174.10.6340; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takagi M, 1998, ENERGY WATCH SER, V9, P35; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Tsubokawa M, 1997, EUR J BIOCHEM, V249, P792, DOI 10.1111/j.1432-1033.1997.t01-2-00792.x; Wines BD, 2006, J BIOL CHEM, V281, P17108, DOI 10.1074/jbc.M601640200; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407	49	70	76	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					214	222		10.1038/ni.1686	http://dx.doi.org/10.1038/ni.1686			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19098920	Green Submitted			2022-12-18	WOS:000263178500015
J	Yang, BL; Gay, DL; MacLeod, MKL; Cao, X; Hala, T; Sweezer, EM; Kappler, J; Marrack, P; Oliver, PM				Yang, Baoli; Gay, Denise L.; MacLeod, Megan K. L.; Cao, Xiao; Hala, Tamara; Sweezer, Eileen M.; Kappler, John; Marrack, Philippa; Oliver, Paula M.			Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells	NATURE IMMUNOLOGY			English	Article							CD28 COSTIMULATION; CD28-DEFICIENT MICE; PROTEIN-DEGRADATION; CUTTING EDGE; WW DOMAINS; IN-VITRO; LIGASES; PTEN; EXPRESSION; ANTIGEN	Nedd4 and Itch are E3 ubiquitin ligases that ubiquitinate similar targets in vitro and thus are thought to function similarly. T cells lacking Itch show spontaneous activation and T helper type 2 polarization. To test whether loss of Nedd4 affects T cells in the same way, we generated Nedd4(+/+) and Nedd4(-/-) fetal liver chimeras. Nedd4(-/-) T cells developed normally but proliferated less, produced less interleukin 2 and provided inadequate help to B cells. Nedd4(-/-) T cells contained more of the E3 ubiquitin ligase Cbl-b, and Nedd4 was required for polyubiquitination of Cbl-b induced by CD28 costimulation. Our data demonstrate that Nedd4 promotes the conversion of naive T cells into activated T cells. We propose that Nedd4 and Itch ubiquitinate distinct target proteins in vivo.	[MacLeod, Megan K. L.; Kappler, John; Marrack, Philippa; Oliver, Paula M.] Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; [MacLeod, Megan K. L.; Kappler, John; Marrack, Philippa; Oliver, Paula M.] Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA; [Yang, Baoli; Cao, Xiao; Sweezer, Eileen M.] Univ Iowa, Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Gay, Denise L.; Hala, Tamara] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kappler, John; Marrack, Philippa] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; [Kappler, John] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; [Marrack, Philippa] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA; [MacLeod, Megan K. L.; Kappler, John; Marrack, Philippa; Oliver, Paula M.] Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health	Oliver, PM (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	paulao@mail.med.upenn.edu	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; MacLeod, Megan/0000-0003-1843-8580	NIAID NIH HHS [R37 AI018785, P01 AI022295-24, P01 AI022295, R37 AI018785-20, R01 AI093566] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R37AI018785, R01AI093566] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Bonnevier JL, 2005, ARTHRITIS RES THER, V7, P233, DOI 10.1186/ar1842; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; CAO XR, 2001, SCI SIGNAL IN PRESS; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; UMLAUF SW, 1995, MOL CELL BIOL, V15, P3197; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Villalba M, 1999, J IMMUNOL, V163, P5813; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236	46	70	73	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1356	1363		10.1038/ni.1670	http://dx.doi.org/10.1038/ni.1670			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18931680	Green Accepted			2022-12-18	WOS:000260888700010
J	Adams, EJ; Strop, P; Shin, S; Chien, YH; Garcia, KC				Adams, Erin J.; Strop, Pavel; Shin, Sunny; Chien, Yueh-Hsiu; Garcia, K. Christopher			An autonomous CDR3 delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gamma delta T cells	NATURE IMMUNOLOGY			English	Article							CRYSTAL-STRUCTURE; RECEPTOR-DELTA; ANTIGEN-SPECIFICITY; LYMPHOCYTES-T; HIGH-AFFINITY; PEPTIDE-MHC; COMPLEX; ANTIBODY; REGION; CD4	It remains unclear whether gamma delta T cell antigen receptors (TCRs) detect antigens in a way similar to antibodies or alpha beta TCRs. Here we show that reactivity between the G8 and KN6 gamma delta TCRs and the major histocompatibility complex class Ib molecule T22 could be recapitulated, with retention of wild-type ligand affinity, in an alpha beta TCR after grafting of a G8 or KN6 complementarity-determining region 3-delta (CDR3 delta) loop in place of the CDR3 alpha loop of an alpha beta TCR. We also found that a shared sequence motif in CDR3 delta loops of all T22-reactive gamma delta TCRs bound T22 in energetically distinct ways, and that T10(d), which bound G8 with weak affinity, was converted into a high-affinity ligand by a single point mutation. Our results demonstrate unprecedented autonomy of a single CDR3 loop in antigen recognition.	[Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Strop, Pavel; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Strop, Pavel; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Shin, Sunny; Chien, Yueh-Hsiu] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Shin, Sunny; Chien, Yueh-Hsiu] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Chicago; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	ejadams@uchicago.edu; kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065504, R01AI073922] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI065504, R01 AI073922, R01AI65504, R01 AI065504-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Battistini L, 1997, J IMMUNOL, V159, P3723; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; De Libero G, 2000, SPRINGER SEMIN IMMUN, V22, P219, DOI 10.1007/s002810000043; ELLIOTT JF, 1988, NATURE, V331, P627; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; FISCH P, 1990, J EXP MED, V171, P1567, DOI 10.1084/jem.171.5.1567; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; JOHNSON RM, 1992, J IMMUNOL, V148, P983; Kapp JA, 2004, IMMUNOL RES, V29, P93, DOI 10.1385/IR:29:1-3:093; KODANDAPANI R, 1995, J BIOL CHEM, V270, P2268, DOI 10.1074/jbc.270.5.2268; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MORIWAKI S, 1993, P NATL ACAD SCI USA, V90, P11396, DOI 10.1073/pnas.90.23.11396; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PATTEN PA, 1993, J IMMUNOL, V150, P2281; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PRESTA LG, 1993, J IMMUNOL, V151, P2623; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; WEINTRAUB BC, 1994, J IMMUNOL, V153, P3051; Wen L, 1998, J IMMUNOL, V160, P1965; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310; WRIGHT A, 1989, J EXP MED, V169, P1557, DOI 10.1084/jem.169.5.1557	49	70	70	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					777	784		10.1038/ni.1620	http://dx.doi.org/10.1038/ni.1620			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18516039	Green Accepted			2022-12-18	WOS:000256904900016
J	Ishimaru, N; Kishimoto, H; Hayashi, Y; Sprent, J				Ishimaru, Naozumi; Kishimoto, Hidehiro; Hayashi, Yoshio; Sprent, Jonathan			Regulation of naive T cell function by the NF-kappa B2 pathway	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LYMPHOTOXIN-BETA-RECEPTOR; DEFICIENT MICE; NUCLEAR FACTOR; MULTIORGAN INFLAMMATION; TRANSCRIPTION FACTORS; SJOGRENS-SYNDROME; IMMUNE-RESPONSES; SELF-TOLERANCE; CUTTING EDGE	T cell activation involves the orchestration of several signaling pathways, including that of the 'classical' transcription factor NF-kappa B components NF-kappa B1-RelA. The function of the 'nonclassical' NF-kappa B2-RelB pathway is less clear, although T cells lacking components of this pathway have activation defects. Here we show that mice deficient in NF-kappa B-inducing kinase have a complex phenotype consisting of immunosuppression mediated by CD25-Foxp3-memory CD4(+) cells and, in the absence of those cells, hyper-responsive naive CD4(+) T cells, which caused autoimmune lesions after adoptive transfer into hosts deficient in recombination-activating genes. Biochemical studies indicated involvement of a cell-intrinsic mechanism in which NF-kappa B2 (p100) limits nuclear translocation of NF-kappa B1-RelA and thereby functions as a regulatory 'brake' for the activation of naive T cells.	Scripps Res Inst, La Jolla, CA 92037 USA; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Scripps Research Institute; Tokushima University; Tokyo University of Science; Garvan Institute of Medical Research	Sprent, J (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	j.sprent@garvan.org.au			NATIONAL CANCER INSTITUTE [R37CA038355, R01CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487, R01AI046710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001743] Funding Source: NIH RePORTER; NCI NIH HHS [CA38355] Funding Source: Medline; NIAID NIH HHS [AI21487, AI46710] Funding Source: Medline; NIA NIH HHS [AG01743] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Artis D, 2003, J IMMUNOL, V170, P1995, DOI 10.4049/jimmunol.170.4.1995; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Hilliard B, 1999, J IMMUNOL, V163, P2937; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ishimaru N, 2003, AM J PATHOL, V163, P1481, DOI 10.1016/S0002-9440(10)63505-5; IVANOV VN, 1995, INT IMMUNOL, V7, P1709, DOI 10.1093/intimm/7.11.1709; KahnPerles B, 1997, J BIOL CHEM, V272, P21774, DOI 10.1074/jbc.272.35.21774; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Kishimoto H, 1999, J IMMUNOL, V163, P1817; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lu LF, 2005, J IMMUNOL, V175, P1651, DOI 10.4049/jimmunol.175.3.1651; Matsumoto M, 2002, J IMMUNOL, V169, P1151, DOI 10.4049/jimmunol.169.3.1151; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Olashaw NE, 1996, J BIOL CHEM, V271, P30307; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; PIMENTELMUINOS FX, 1994, J BIOL CHEM, V269, P24424; Prasad AS, 2002, J LAB CLIN MED, V140, P272, DOI 10.1067/mlc.2002.127908; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Tsubata R, 1996, EUR J IMMUNOL, V26, P2742, DOI 10.1002/eji.1830261129; Weih F, 1996, J IMMUNOL, V157, P3974; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weil R, 2004, CURR OPIN IMMUNOL, V16, P374, DOI 10.1016/j.coi.2004.03.003; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019	54	70	75	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					763	772		10.1038/ni1351	http://dx.doi.org/10.1038/ni1351			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16732290				2022-12-18	WOS:000238377700022
J	Papoutsopoulou, S; Symons, A; Tharmalingham, T; Belich, MP; Kaiser, F; Kioussis, D; O'Garra, A; Tybulewicz, V; Ley, SC				Papoutsopoulou, Stamatia; Symons, Antony; Tharmalingham, Tharsana; Belich, Monica P.; Kaiser, Frank; Kioussis, Dimitris; O'Garra, Anne; Tybulewicz, Victor; Ley, Steven C.			ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; COLONY-STIMULATING FACTOR; INDUCED P105 PROTEOLYSIS; CD4(+) T-CELLS; NF-KAPPA-B1 P105; PROTEIN-KINASE; LIPOPOLYSACCHARIDE ACTIVATION; A20-BINDING INHIBITOR; SIGNAL-TRANSDUCTION	The TPL-2 MEK kinase is essential for activation of the Erk MAP kinase pathway during innate immune responses. TPL-2 is found in complex with ABIN-2 (A20-binding inhibitor of NF-kappa B 2). Here, using antigen-presenting cells from ABIN-2-deficient mice, we show that ABIN-2 was required for optimal activation of Erk induced by receptors that signal via TPL-2, including Toll-like receptor 4 and tumor necrosis factor receptor 1 in macrophages, and CD40 in B cells. ABIN-2 was necessary for the maintenance of TPL-2 protein stability. In contrast, ABIN-2 deficiency did not affect agonist-induced regulation of transcription factor NF-kappa B. Stimulation of ABIN-2-deficient macrophages via Toll-like receptor 4 showed that different thresholds of Erk signaling were required for optimal induction of tumor necrosis factor and interleukin 1 beta. Thus, ABIN-2 acts to positively regulate the Erk signaling potential by stabilizing TPL-2.	Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Ley, SC (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	sley@nimr.mrc.ac.uk	Papoutsopoulou, Stamatia/K-6420-2019; Papoutsopoulou, Stamatia/AAK-8066-2021	O'Garra, Anne/0000-0001-9845-6134; Tybulewicz, Victor/0000-0003-2439-0798	Medical Research Council [U117532003] Funding Source: researchfish; MRC [MC_U117527252, MC_U117565642, MC_U117512796] Funding Source: UKRI; Medical Research Council [MC_U117527252, MC_U117512796, MC_U117565642] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; AOKI M, 1993, J BIOL CHEM, V268, P22723; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Beinke S, 2002, J BIOL CHEM, V277, P24162, DOI 10.1074/jbc.M201576200; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Ranganath S, 1998, J IMMUNOL, V161, P3822; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WARREN MK, 1985, J IMMUNOL, V134, P982; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	50	70	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					606	615		10.1038/ni1334	http://dx.doi.org/10.1038/ni1334			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16633345				2022-12-18	WOS:000237751200016
J	Sakaguchi, S				Sakaguchi, S			Regulatory T cells: mediating compromises between host and parasite	NATURE IMMUNOLOGY			English	Editorial Material							LEISHMANIA-MAJOR; IMMUNITY	Although elimination may be key to a healthy response to some microbes, a recent paper in Nature reports that regulatory T cells actually aid the survival of some intracellular parasites, which ensures a memory response.	Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan	Kyoto University	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Hori S, 2002, EUR J IMMUNOL, V32, P1282, DOI 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Papiernik M, 2001, IMMUNOL REV, V182, P180, DOI 10.1034/j.1600-065X.2001.1820114.x; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; XU D, 2003, IN PRESS J IMMUNOL	12	70	75	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					10	11		10.1038/ni0103-10	http://dx.doi.org/10.1038/ni0103-10			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496970				2022-12-18	WOS:000180053000006
J	Aifantis, I; Borowski, C; Gounari, F; Lacorazza, HD; Nikolich-Zugich, J; von Boehmer, H				Aifantis, I; Borowski, C; Gounari, F; Lacorazza, HD; Nikolich-Zugich, J; von Boehmer, H			A critical role for the cytoplasmic tail of pT alpha in T lymphocyte development	NATURE IMMUNOLOGY			English	Article							BETA GENE-EXPRESSION; CELL-RECEPTOR; PRE-TCR; ACTIVATION; DOMAIN; COSTIMULATION; CD2; LCK	Signals that emanate from the pre-T cell receptor (pre-TCR) regulate multiple processes required for the development of the alphabeta T cell lineage. In contrast to the gammadelta TCR, the pre-TCR localizes cellautonomously to membrane rafts, where it appears to signal in a constitutive and ligand-independent manner.We addressed here the role played by structural features specific to the cytoplasmic domain of the pre-TCRalpha chain (pTalpha). More specifically, we examined a COON-terminal proline-rich sequence that might play a role in signal transduction and a juxtamembrane cysteine residue that could be a target for palmitoylation, thus allowing spontaneous raft localization. Expression of pTalpha mutants in transgenic mice, retrovirally transduced T cell precursors and cell lines showed that the pTalpha cytoplasmic tail, in particular the proline-rich domain, plays a crucial role in pre-TCR signaling and T cell development. In contrast, the pTalpha juxtamembrane cysteine appeared to be dispensable for pre-TCR function.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Lab Mol Aspects Hematopoiesis, New York, NY 10021 USA; Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Memorial Sloan Kettering Cancer Center	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.			Nikolich-Zugich, Janko/0000-0001-5830-5323	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047281, R01AI045846] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47281, AI45846] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Barber DF, 1998, J IMMUNOL, V161, P11; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; HAHN WC, 1993, J EXP MED, V178, P1831, DOI 10.1084/jem.178.5.1831; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Lacorazza HD, 2001, J IMMUNOL, V167, P5689, DOI 10.4049/jimmunol.167.10.5689; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; Ramiro AR, 1996, J EXP MED, V184, P519, DOI 10.1084/jem.184.2.519; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Saint-Ruf C, 1998, EUR J IMMUNOL, V28, P3824, DOI 10.1002/(SICI)1521-4141(199811)28:11<3824::AID-IMMU3824>3.0.CO;2-9; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	27	70	70	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					483	488		10.1038/ni779	http://dx.doi.org/10.1038/ni779			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11927911				2022-12-18	WOS:000175411200018
J	Castells, MC; Klickstein, LB; Hassani, K; Cumplido, JA; Lacouture, ME; Austen, KF; Katz, HR				Castells, MC; Klickstein, LB; Hassani, K; Cumplido, JA; Lacouture, ME; Austen, KF; Katz, HR			gp49BI-alpha(v)beta(3) interaction inhibits antigen-induced mast cell activation	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CLASS-I MOLECULES; IMMUNOGLOBULIN-SUPERFAMILY; NK CELLS; INTEGRIN ALPHA(V)BETA(3); FIBRONECTIN-BINDING; LYMPHOID-CELLS; GP49B GENE; RECEPTORS; MOUSE	We have identified the integrin alpha (v)beta (3) as a ligand for mouse gp49B1,thus identifying a new class of ligand for a member of the family of inhibitory immunoreceptors that bear C2-type immunoglobulinlike domains,The specific interaction was shown by both cell-protein and cell-cell binding assays, In addition, we found that the interaction of alpha (v)beta (3) with gp49BI on bone marrow-derived mouse mast cells inhibited antigen-induced immunoglobulin E-mediated cell activation. Because neither gp49BI nor alpha (v)beta (3) exhibit substantive allelic variation, their newly appreciated interaction may reflect an innate pathway for down-regulating the activity of mast cells.	Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Castells, MC (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.			Lacouture, Mario/0000-0002-4818-3710	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001414, R01AI041144, U19AI031599, R01AI022531, R37AI022531, U01AI031599, T32AI007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047243, R03AR045025] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36110] Funding Source: Medline; NIAID NIH HHS [AI-07306, AI-22531, AI-01414, AI-31599, AI-41144] Funding Source: Medline; NIAMS NIH HHS [AR-45025, AR-47243] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARM JP, 1991, J BIOL CHEM, V266, P15966; Arm JP, 1997, J IMMUNOL, V159, P2342; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Borges L, 1997, J IMMUNOL, V159, P5192; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.3.CO;2-6; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; DANDREA A, 1995, J IMMUNOL, V155, P2306; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GURISH MF, 1992, J IMMUNOL, V149, P1964; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; HU DD, 1995, J BIOL CHEM, V270, P9917, DOI 10.1074/jbc.270.17.9917; HUMPHRIES MJ, 1995, CIBA F SYMP, V189, P177; Illera MJ, 2000, BIOL REPROD, V62, P1285, DOI 10.1095/biolreprod62.5.1285; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; KATZ HR, 1989, J IMMUNOL, V142, P919; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1999, P NATL ACAD SCI USA, V96, P5343, DOI 10.1073/pnas.96.10.5343; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LEBLANC PA, 1982, J RETICULOENDOTH SOC, V32, P219; Lu-Kuo JM, 1999, J BIOL CHEM, V274, P5791, DOI 10.1074/jbc.274.9.5791; MAKAREM R, 1994, J BIOL CHEM, V269, P4005; Matsumoto Y, 1997, DEV GROWTH DIFFER, V39, P591, DOI 10.1046/j.1440-169X.1997.t01-4-00006.x; Matsumoto Y, 2001, J IMMUNOL, V166, P781, DOI 10.4049/jimmunol.166.2.781; McCormick MJ, 1999, IMMUNOGENETICS, V50, P286, DOI 10.1007/s002510050604; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; Morton HC, 1999, J EXP MED, V189, P1715; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Olcese L, 1996, J IMMUNOL, V156, P4531; Olcese L, 1997, J IMMUNOL, V158, P5083; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Rojo S, 2000, MOL CELL BIOL, V20, P7178, DOI 10.1128/MCB.20.19.7178-7182.2000; Rojo S, 1997, J IMMUNOL, V158, P9; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wang LL, 1997, J IMMUNOL, V158, P13; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	52	70	70	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					436	442		10.1038/87749	http://dx.doi.org/10.1038/87749			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323698				2022-12-18	WOS:000168549800017
J	Mittelbrunn, M; Kroemer, G				Mittelbrunn, Maria; Kroemer, Guido			Hallmarks of T cell aging	NATURE IMMUNOLOGY			English	Review							THYMIC INVOLUTION; SENESCENCE; HOMEOSTASIS; AGE; ACCUMULATION; AUTOPHAGY; RESPONSES; DISEASE; NAIVE; MICE	In this Review, Mittelbrunn and Kroemer propose that ten molecular hallmarks represent the common denominators of T cell aging. The aged adaptive immune system is characterized by progressive dysfunction as well as increased autoimmunity. This decline is responsible for elevated susceptibility to infection and cancer, as well as decreased vaccination efficacy. Recent evidence indicates that CD4(+) T cell-intrinsic alteratins contribute to chronic inflammation and are sufficient to accelerate an organism-wide aging phenotype, supporting the idea that T cell aging plays a major role in body-wide deterioration. In this Review, we propose ten molecular hallmarks to represent common denominators of T cell aging. These hallmarks are grouped into four primary hallmarks (thymic involution, mitochondrial dysfunction, genetic and epigenetic alterations, and loss of proteostasis) and four secondary hallmarks (reduction of the TCR repertoire, naive-memory imbalance, T cell senescence, and lack of effector plasticity), and together they explain the manifestation of the two integrative hallmarks (immunodeficiency and inflammaging). A major challenge now is weighing the relative impact of these hallmarks on T cell aging and understanding their interconnections, with the final goal of defining molecular targets for interventions in the aging process.	[Mittelbrunn, Maria] Inst Invest Sanitaria Hosp 12 Octubre imas12, Madrid, Spain; [Mittelbrunn, Maria] Univ Autonoma Madrid UAM, Consejo Super Invest Cient CSIC, Ctr Biol Mol Severo Ochoa CBMSO, Madrid, Spain; [Kroemer, Guido] Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,Inserm U1138,Inst Un, Paris, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China; [Kroemer, Guido] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Karolinska Institutet; Karolinska University Hospital	Mittelbrunn, M (corresponding author), Inst Invest Sanitaria Hosp 12 Octubre imas12, Madrid, Spain.; Mittelbrunn, M (corresponding author), Univ Autonoma Madrid UAM, Consejo Super Invest Cient CSIC, Ctr Biol Mol Severo Ochoa CBMSO, Madrid, Spain.; Kroemer, G (corresponding author), Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc,Inserm U1138,Inst Un, Paris, France.; Kroemer, G (corresponding author), Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Chinese Acad Med Sci, Suzhou Inst Syst Med, Suzhou, Peoples R China.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	mmittelbrunn@cbm.csic.es; kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Mittelbrunn, Maria/I-5882-2015	KROEMER, Guido/0000-0002-9334-4405; Mittelbrunn, Maria/0000-0003-3487-8762	Miguel Servet Program [CP 19/014]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI19/855]; European Regional Development Fund (ERDF); European Commission through H2020-EU.1.1; European Research Council grant ERC-2016-StG [715322]; Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs; AMMICa [US23/CNRS UMS3655]; Association pour la recherche sur le cancer (ARC); Association 'Ruban Rose'; Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix); Fondation pour la Recherche Medicale (FRM); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea; European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China [GDW20171100085]; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; LabEx Immuno-Oncology [ANR-18-IDEX-0001]; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); IdEx Universite de Paris [ANR-18-IDEX-0001]	Miguel Servet Program; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); European Commission through H2020-EU.1.1; European Research Council grant ERC-2016-StG; Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs(French National Research Agency (ANR)); AMMICa; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association 'Ruban Rose'; Canceropole Ile-de-France(Region Ile-de-France); Chancelerie des universites de Paris (Legs Poix); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea; European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); IdEx Universite de Paris	M.M. is supported by the Miguel Servet Program (CP 19/014, Fundacion de Investigacion del Hospital 12 de Octubre; the Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (PI19/855), the European Regional Development Fund (ERDF), and the European Commission through H2020-EU.1.1 and European Research Council grant ERC-2016-StG 715322-EndoMitTalk. G.K. is supported by the Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association 'Ruban Rose'; Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China (GDW20171100085), Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology (ANR-18-IDEX-0001); the RHU Torino Lumiere; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Universite de Paris ANR-18-IDEX-0001.	Ahmed R, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108501; Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Almanan M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0806; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arata Y, 2019, GENES CELLS, V24, P801, DOI 10.1111/gtc.12728; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Bektas A, 2019, AGING-US, V11, P9234, DOI 10.18632/aging.102438; Betjes MGH, 2020, TOXINS, V12, DOI 10.3390/toxins12040224; Betjes MGH, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00175-z; Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015; Bohme J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19095-z; Buono R, 2019, CELL, V178, P1038, DOI 10.1016/j.cell.2019.07.052; Buque A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17644-0; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Callender LA, 2020, AGING CELL, V19, DOI 10.1111/acel.13067; Callender LA, 2018, AGING CELL, V17, DOI 10.1111/acel.12675; Carriche GM, 2021, J ALLERGY CLIN IMMUN, V147, P335, DOI 10.1016/j.jaci.2020.04.037; Chambers ES, 2020, J ALLERGY CLIN IMMUN, V145, P1323, DOI 10.1016/j.jaci.2020.03.016; Chambers ES, 2021, NATURE AGING, V1, P101, DOI DOI 10.1038/S43587-020-00010-6; Chen BH, 2017, AGING-US, V9, P1983, DOI 10.18632/aging.101293; Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509; Chou JP, 2013, CURR PHARM DESIGN, V19, P1680; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Crepin T, 2020, NEPHROL DIAL TRANSPL, V35, P624, DOI 10.1093/ndt/gfy276; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Derhovanessian E, 2009, CURR OPIN IMMUNOL, V21, P440, DOI 10.1016/j.coi.2009.05.012; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Desdin-Mico G, 2018, MITOCHONDRION, V41, P51, DOI 10.1016/j.mito.2017.10.006; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; DiToro D, 2020, IMMUNITY, V52, P650, DOI 10.1016/j.immuni.2020.03.013; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duggal NA, 2018, AGING CELL, V17, DOI 10.1111/acel.12750; Dumauthioz N, 2021, CELL MOL IMMUNOL, V18, P1761, DOI 10.1038/s41423-020-0365-3; Egorov ES, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01618; Ekiz HA, 2020, J IMMUNOL, V204, P2064, DOI 10.4049/jimmunol.1901484; El-Kadiry AE, 2019, CYTOKINE, V120, P202, DOI 10.1016/j.cyto.2019.05.009; Elyahu Y, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101231; Elyahu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8330; Fahy GM, 2019, AGING CELL, V18, DOI 10.1111/acel.13028; Fali T, 2019, J IMMUNOL, V202, P1962, DOI 10.4049/jimmunol.1801475; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046; Goronzy JJ, 2012, SEMIN IMMUNOL, V24, P365, DOI 10.1016/j.smim.2012.04.003; Goronzy JJ, 2019, NAT REV IMMUNOL, V19, P573, DOI 10.1038/s41577-019-0180-1; Guo ZL, 2020, J CLIN INVEST, V130, P5893, DOI 10.1172/JCI136466; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hashimoto K, 2019, P NATL ACAD SCI USA, V116, P24242, DOI 10.1073/pnas.1907883116; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hsu HC, 2005, MECH AGEING DEV, V126, P87, DOI 10.1016/j.mad.2004.09.016; Hu B, 2019, AGING CELL, V18, DOI 10.1111/acel.12957; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Huang H, 2019, P NATL ACAD SCI USA, V116, P8995, DOI 10.1073/pnas.1902649116; Huang SB, 2016, J ATHEROSCLER THROMB, V23, P632, DOI 10.5551/jat.31575; Jergovic M, 2019, MED MICROBIOL IMMUN, V208, P263, DOI 10.1007/s00430-019-00605-w; Ji Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09882-8; Jin J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1808; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Kallemeijn MJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00448; Kared H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14442-6; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Kim C, 2019, CELL REP, V29, P2202, DOI 10.1016/j.celrep.2019.10.044; Kinsella S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01745; Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001; Lanfermeijer J, 2020, AGING CELL, V19, DOI 10.1111/acel.13262; Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Le Texier L, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86850; Lefebvre JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25051; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Macian F, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00213; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Maeda T, 2016, CANCER RES, V76, P6839, DOI 10.1158/0008-5472.CAN-16-1149; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Marquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9; Miller JFAP, 2020, SCIENCE, V369, P522, DOI 10.1126/science.aba2429; Minato N, 2020, INT IMMUNOL, V32, P223, DOI 10.1093/intimm/dxaa006; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Mold JE, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000383; Moon JS, 2020, AGING CELL, V19, DOI 10.1111/acel.13195; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Oh J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140313; Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3; Palmer S, 2018, P NATL ACAD SCI USA, V115, P1883, DOI 10.1073/pnas.1714478115; Pan XX, 2021, CARDIOVASC RES, V117, P271, DOI 10.1093/cvr/cvaa032; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Pereira BI, 2020, NAT IMMUNOL, V21, P684, DOI 10.1038/s41590-020-0643-3; Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5; Popescu I, 2019, AM J RESP CRIT CARE, V199, P362, DOI 10.1164/rccm.201805-0825OC; Preite S, 2019, IMMUNOL REV, V291, P154, DOI 10.1111/imr.12790; Quinn KM, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1091; Quinn KM, 2018, CELL REP, V23, P3512, DOI 10.1016/j.celrep.2018.05.057; Ramstead AG, 2020, CELL REP, V30, P2889, DOI 10.1016/j.celrep.2020.02.042; Raz Y, 2017, J GERONTOL A-BIOL, V72, P1201, DOI 10.1093/gerona/glx020; Renkema KR, 2014, J IMMUNOL, V192, P151, DOI 10.4049/jimmunol.1301453; Rezzani R, 2014, AGE, V36, P313, DOI 10.1007/s11357-013-9564-5; Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115; Sanderson SL, 2017, AGING CELL, V16, P1234, DOI 10.1111/acel.12640; Sato K, 2017, J IMMUNOL, V199, P138, DOI 10.4049/jimmunol.1602005; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Schober K, 2020, NAT IMMUNOL, V21, P434, DOI 10.1038/s41590-020-0628-2; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Senda T, 2019, MUCOSAL IMMUNOL, V12, P378, DOI 10.1038/s41385-018-0110-8; Sharma R, 2020, AGEING RES REV, V63, DOI 10.1016/j.arr.2020.101141; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stepensky P, 2015, BLOOD, V125, P753, DOI 10.1182/blood-2014-08-593202; Suzuki J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05854-6; Swadling L, 2020, CELL REP, V30, P687, DOI 10.1016/j.celrep.2019.12.050; Tedone E, 2019, AGING CELL, V18, DOI 10.1111/acel.12859; Terao C, 2020, NATURE, V584, P130, DOI 10.1038/s41586-020-2426-2; Thapa P, 2019, THORAC SURG CLIN, V29, P123, DOI 10.1016/j.thorsurg.2018.12.001; Thol F, 2017, LEUKEMIA, V31, P1286, DOI 10.1038/leu.2016.345; Thomas R, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-0173-8; Thome JJC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6506; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; van Beek JJP, 2021, NAT IMMUNOL, V22, P104, DOI 10.1038/s41590-020-00858-1; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Velardi E, 2021, NAT REV IMMUNOL, V21, P277, DOI 10.1038/s41577-020-00457-z; Vukmanovic-Stejic M, 2018, J ALLERGY CLIN IMMUN, V142, P844, DOI 10.1016/j.jaci.2017.10.032; Wagner CL, 2018, J CLIN INVEST, V128, P5222, DOI 10.1172/JCI120216; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291; Witkowski JM, 2018, EXP GERONTOL, V107, P161, DOI 10.1016/j.exger.2017.10.009; Wong YT, 2011, AGE, V33, P229, DOI 10.1007/s11357-010-9174-4; Xu K, 2021, SCIENCE, V371, P405, DOI 10.1126/science.abb2683; Xu WL, 2019, EBIOMEDICINE, V39, P44, DOI 10.1016/j.ebiom.2018.11.053; Ye ZD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05552-3; Yoshida S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16347-w; Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113; Younes SA, 2018, J CLIN INVEST, V128, P5083, DOI 10.1172/JCI120245; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3; Zhang HL, 2020, AUTOPHAGY, V16, P181, DOI 10.1080/15548627.2019.1687967	151	69	71	16	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					687	698		10.1038/s41590-021-00927-z	http://dx.doi.org/10.1038/s41590-021-00927-z		MAY 2021	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	33986548	Green Submitted			2022-12-18	WOS:000650101600001
J	Sas, AR; Carbajal, KS; Jerome, AD; Menon, R; Yoon, C; Kalinski, AL; Giger, RJ; Segal, BM				Sas, Andrew R.; Carbajal, Kevin S.; Jerome, Andrew D.; Menon, Rajasree; Yoon, Choya; Kalinski, Ashley L.; Giger, Roman J.; Segal, Benjamin M.			A new neutrophil subset promotes CNS neuron survival and axon regeneration	NATURE IMMUNOLOGY			English	Article							CELL-LINE HL-60; BRAIN-INJURY; MACROPHAGES; DIFFERENTIATION; INFLAMMATION; PHENOTYPE; EXPRESSION; PLASTICITY	Segal and colleagues identify a neuroprotective immature-like neutrophil subset that participates in dectin-1-dependent axon repair and regeneration in the central nervous system. Transected axons typically fail to regenerate in the central nervous system (CNS), resulting in chronic neurological disability in individuals with traumatic brain or spinal cord injury, glaucoma and ischemia-reperfusion injury of the eye. Although neuroinflammation is often depicted as detrimental, there is growing evidence that alternatively activated, reparative leukocyte subsets and their products can be deployed to improve neurological outcomes. In the current study, we identify a unique granulocyte subset, with characteristics of an immature neutrophil, that had neuroprotective properties and drove CNS axon regeneration in vivo, in part via secretion of a cocktail of growth factors. This pro-regenerative neutrophil promoted repair in the optic nerve and spinal cord, demonstrating its relevance across CNS compartments and neuronal populations. Our findings could ultimately lead to the development of new immunotherapies that reverse CNS damage and restore lost neurological function across a spectrum of diseases.	[Sas, Andrew R.; Jerome, Andrew D.; Segal, Benjamin M.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Sas, Andrew R.; Jerome, Andrew D.; Segal, Benjamin M.] Ohio State Univ, Neurosci Res Inst, Columbus, OH 43210 USA; [Sas, Andrew R.; Carbajal, Kevin S.; Segal, Benjamin M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Menon, Rajasree] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yoon, Choya; Kalinski, Ashley L.; Giger, Roman J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Giger, Roman J.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Segal, BM (corresponding author), Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA.; Segal, BM (corresponding author), Ohio State Univ, Neurosci Res Inst, Columbus, OH 43210 USA.; Segal, BM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI USA.	benjamin.segal@osumc.edu		Segal, Benjamin/0000-0002-0906-6319; Jerome, Andrew/0000-0002-6748-8114; Menon, Rajasree/0000-0001-6280-9639; Kalinski, Ashley/0000-0001-7611-0810	National Eye Institute (NEI), National Institutes of Health [R01EY029159, R01EY028350, K08EY029362]; Wings of Life Foundation; Dr. Miriam and Sheldon G. Adelson Research Foundation	National Eye Institute (NEI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wings of Life Foundation; Dr. Miriam and Sheldon G. Adelson Research Foundation	We thank S. Atkins for technical support. Financial support for this research was provided by the National Eye Institute (NEI), National Institutes of Health (R01EY029159 and R01EY028350 to B.M.S. and R.J.G; K08EY029362 to A.R.S.), the Wings of Life Foundation (C.Y.) and the Dr. Miriam and Sheldon G. Adelson Research Foundation (R.J.G.). B.M.S. holds the Stanley D. and Joan H. Ross chair in neuromodulation at the Ohio State University.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Bollaerts I, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9478542; BOSS MA, 1980, BLOOD, V56, P910; Brennan FH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98254; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Dai XM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09544-9; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Giles DA, 2018, J CLIN INVEST, V128, P5322, DOI 10.1172/JCI123708; Giles DA, 2018, ANN NEUROL, V83, P131, DOI 10.1002/ana.25128; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Grifka-Walk HM, 2015, EUR J IMMUNOL, V45, P2780, DOI 10.1002/eji.201545800; Herz J, 2015, STROKE, V46, P2916, DOI 10.1161/STROKEAHA.115.010620; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Hou Y, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105970; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Liu CY, 2010, J CANCER RES CLIN, V136, P35, DOI 10.1007/s00432-009-0634-0; Lorber B, 2009, J NEUROSCI RES, V87, P2645, DOI 10.1002/jnr.22095; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mistry P, 2019, P NATL ACAD SCI USA, V116, P25222, DOI 10.1073/pnas.1908576116; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; OLSSON I, 1981, EXP CELL RES, V131, P225, DOI 10.1016/0014-4827(81)90422-5; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Segal BM, 2005, J NEUROL SCI, V228, P210, DOI 10.1016/j.jns.2004.10.014; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696; Stoolman JS, 2014, J IMMUNOL, V193, P564, DOI 10.4049/jimmunol.1400825; Tourki B, 2017, FASEB J, V31, P4226, DOI 10.1096/fj.201700109R; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; von Leden RE, 2019, EXP NEUROL, V317, P144, DOI 10.1016/j.expneurol.2019.03.004; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552	48	69	69	7	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1496	+		10.1038/s41590-020-00813-0	http://dx.doi.org/10.1038/s41590-020-00813-0		OCT 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33106668	Green Accepted			2022-12-18	WOS:000583963700002
J	Lai, JY; Mardiana, S; House, IG; Sek, K; Henderson, MA; Giuffrida, L; Chen, AXY; Todd, KL; Petley, EV; Chan, JD; Carrington, EM; Lew, AM; Solomon, BJ; Trapani, JA; Kedzierska, K; Evrard, M; Vervoort, SJ; Waithman, J; Darcy, PK; Beavis, PA				Lai, Junyun; Mardiana, Sherly; House, Imran G.; Sek, Kevin; Henderson, Melissa A.; Giuffrida, Lauren; Chen, Amanda X. Y.; Todd, Kirsten L.; Petley, Emma, V; Chan, Jack D.; Carrington, Emma M.; Lew, Andrew M.; Solomon, Benjamin J.; Trapani, Joseph A.; Kedzierska, Katherine; Evrard, Maximilien; Vervoort, Stephin J.; Waithman, Jason; Darcy, Phillip K.; Beavis, Paul A.			Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity	NATURE IMMUNOLOGY			English	Article							COLON-CARCINOMA; RECEPTOR; RESPONSES; EFFICACY; IMMUNOTHERAPY; CHEMOTHERAPY; TRAFFICKING; PROGENITORS; ERADICATION; ACTIVATION	Immunoselection underpins tumor antigenic variability and is a key impediment to adoptive cell therapies. Darcy, Beavis and colleagues use T cells engineered to express the dendritic cell growth factor Flt3L to co-opt the host endogenous adaptive immune response and control experimental tumor models. Adoptive cell therapies using genetically engineered T cell receptor or chimeric antigen receptor T cells are emerging forms of immunotherapy that redirect T cells to specifically target cancer. However, tumor antigen heterogeneity remains a key challenge limiting their efficacy against solid cancers. Here, we engineered T cells to secrete the dendritic cell (DC) growth factor Fms-like tyrosine kinase 3 ligand (Flt3L). Flt3L-secreting T cells expanded intratumoral conventional type 1 DCs and substantially increased host DC and T cell activation when combined with immune agonists poly (I:C) and anti-4-1BB. Importantly, combination therapy led to enhanced inhibition of tumor growth and the induction of epitope spreading towards antigens beyond those recognized by adoptively transferred T cells in solid tumor models of T cell receptor and chimeric antigen receptor T cell therapy. Our data suggest that augmenting endogenous DCs is a promising strategy to overcome the clinical problem of antigen-negative tumor escape following adoptive cell therapy.	[Lai, Junyun; Mardiana, Sherly; House, Imran G.; Sek, Kevin; Henderson, Melissa A.; Giuffrida, Lauren; Chen, Amanda X. Y.; Todd, Kirsten L.; Petley, Emma, V; Chan, Jack D.; Solomon, Benjamin J.; Trapani, Joseph A.; Vervoort, Stephin J.; Darcy, Phillip K.; Beavis, Paul A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Lai, Junyun; Mardiana, Sherly; House, Imran G.; Sek, Kevin; Henderson, Melissa A.; Giuffrida, Lauren; Chen, Amanda X. Y.; Todd, Kirsten L.; Petley, Emma, V; Chan, Jack D.; Solomon, Benjamin J.; Trapani, Joseph A.; Vervoort, Stephin J.; Darcy, Phillip K.; Beavis, Paul A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Carrington, Emma M.; Lew, Andrew M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Carrington, Emma M.; Lew, Andrew M.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Kedzierska, Katherine; Evrard, Maximilien] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Kedzierska, Katherine; Evrard, Maximilien] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Waithman, Jason] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Darcy, Phillip K.] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia; [Darcy, Phillip K.] Monash Univ, Dept Immunol, Clayton, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Telethon Kids Institute; University of Western Australia; University of Melbourne; Monash University	Darcy, PK; Beavis, PA (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia.; Darcy, PK (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic, Australia.; Darcy, PK (corresponding author), Monash Univ, Dept Immunol, Clayton, Vic, Australia.	phil.darcy@petermac.org; paul.beavis@petermac.org	Vervoort, Stephin/AAP-7854-2020	Petley, Emma/0000-0002-2527-269X; Solomon, Benjamin/0000-0003-3059-5730; Vervoort, Stephin/0000-0001-7459-126X; Beavis, Paul/0000-0002-2116-013X; Chan, Jack/0000-0002-5942-8592; Evrard, Maximilien/0000-0002-2105-1160; Giuffrida, Lauren/0000-0001-7643-847X; Sek, Kevin/0000-0003-4634-7600; Lai, Junyun/0000-0001-5884-2786	National Health and Medical Research Council (NHMRC) [1062580, 1143976, 1150425]; Cancer Council Victoria [1156382]; National Breast Cancer Foundation [IIRS-19-016 19-22]; CLEARbridge Foundation; Tour de Cure Foundation; National Breast Cancer Foundation Fellowship [ECF-17-005]; NHMRC Research Fellowships [APP1041828, APP1080321, APP1102792]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Breast Cancer Foundation; CLEARbridge Foundation; Tour de Cure Foundation; National Breast Cancer Foundation Fellowship; NHMRC Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge assistance from the staff of the Animal Facility, the Centre for Advanced Histology and Microscopy, the Flow Cytometry Facility, the Molecular Genomics Core and the Pathology departments at the Peter MacCallum Cancer Centre. We also acknowledge the contribution of consumer advocates K. Gill, M. Rear and G. Sissing for this study. This work was funded by the National Health and Medical Research Council (NHMRC; grant nos. 1062580, 1143976 and 1150425), the Cancer Council Victoria (grant no. 1156382), the National Breast Cancer Foundation (grant no. IIRS-19-016 19-22), the CLEARbridge Foundation and the Tour de Cure Foundation. P.A.B. is supported by a National Breast Cancer Foundation Fellowship (ID no. ECF-17-005). P.K.D., A.M.L. and K.K. are supported by NHMRC Research Fellowships (grant nos. APP1041828, APP1080321 and APP1102792, respectively).	Adachi K, 2018, NAT BIOTECHNOL, V36, P346, DOI 10.1038/nbt.4086; Adusumilli PS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010162; Alizadeh D, 2019, CANCER IMMUNOL RES, V7, P759, DOI 10.1158/2326-6066.CIR-18-0466; Avanzi MP, 2018, CELL REP, V23, P2130, DOI 10.1016/j.celrep.2018.04.051; Beavis PA, 2018, CANCER IMMUNOL RES, V6, P1069, DOI 10.1158/2326-6066.CIR-18-0291; Beavis PA, 2017, J CLIN INVEST, V127, P929, DOI 10.1172/JCI89455; BETEL I, 1967, BIOCHIM BIOPHYS ACTA, V143, P62, DOI 10.1016/0005-2728(67)90109-0; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Canale FP, 2018, CANCER RES, V78, P5175, DOI 10.1158/0008-5472.CAN-18-0950; Chang ZNL, 2018, NAT CHEM BIOL, V14, P317, DOI [10.1038/nchembio.2565, 10.1038/NCHEMBIO.2565]; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chmielewski M, 2017, CELL REP, V21, P3205, DOI 10.1016/j.celrep.2017.11.063; Chmielewski M, 2011, CANCER RES, V71, P5697, DOI 10.1158/0008-5472.CAN-11-0103; Darcy PK, 2000, J IMMUNOL, V164, P3705, DOI 10.4049/jimmunol.164.7.3705; Duong CPM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063037; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Durai V, 2018, J EXP MED, V215, P1417, DOI 10.1084/jem.20171784; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hammerich L, 2019, NAT MED, V25, P814, DOI 10.1038/s41591-019-0410-x; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Haynes NM, 2001, J IMMUNOL, V166, P182, DOI 10.4049/jimmunol.166.1.182; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Jackson HJ, 2015, CANCER DISCOV, V5, P1238, DOI 10.1158/2159-8290.CD-15-1275; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Koneru M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.994446; Kuhn NF, 2019, CANCER CELL, V35, P473, DOI 10.1016/j.ccell.2019.02.006; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Mardiana S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2293; Mardiana S, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1046; Mardiana S, 2017, CANCER RES, V77, P1296, DOI 10.1158/0008-5472.CAN-16-1831; Marigo I, 2016, CANCER CELL, V30, P651, DOI 10.1016/j.ccell.2016.09.009; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; Michie J, 2019, CANCER IMMUNOL RES, V7, P183, DOI 10.1158/2326-6066.CIR-18-0428; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Newick K, 2016, CANCER IMMUNOL RES, V4, P541, DOI 10.1158/2326-6066.CIR-15-0263; Piechocki MP, 2003, J IMMUNOL, V171, P5787, DOI 10.4049/jimmunol.171.11.5787; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Rafiq S, 2018, NAT BIOTECHNOL, V36, P847, DOI 10.1038/nbt.4195; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Segal NH, 2018, CLIN CANCER RES, V24, P1816, DOI 10.1158/1078-0432.CCR-17-1922; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Tchou J, 2017, CANCER IMMUNOL RES, V5, P1152, DOI 10.1158/2326-6066.CIR-17-0189; Wang LXJ, 2010, CANCER RES, V70, P9591, DOI 10.1158/0008-5472.CAN-10-2884; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	62	69	71	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					914	+		10.1038/s41590-020-0676-7	http://dx.doi.org/10.1038/s41590-020-0676-7		MAY 2020	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32424363				2022-12-18	WOS:000533852800004
J	Lo, WL; Shah, NH; Ahsan, N; Horkova, V; Stepanek, O; Salomon, AR; Kuriyan, J; Weiss, A				Lo, Wan-Lin; Shah, Neel H.; Ahsan, Nagib; Horkova, Veronika; Stepanek, Ondrej; Salomon, Arthur R.; Kuriyan, John; Weiss, Arthur			Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; PHOSPHOTYROSINE-BINDING DOMAIN; LYMPHOPROLIFERATIVE DISEASE; STRUCTURAL BASIS; SH2 DOMAIN; ACTIVATION; ZAP-70; ASSOCIATION; REQUIREMENT; INSIGHTS	T cell-antigen receptor (TCR) signaling requires the sequential activities of the kinases Lck and Zap7O. Upon TCR stimulation, Lck phosphorylates the TCR, thus leading to the recruitment, phosphorylation, and activation of Zap7O. Lck binds and stabilizes phosho-Zap7O by using its SH2 domain, and Zap7O phosphorylates the critical adaptors LAT and SLP76, which coordinate downstream signaling. It is unclear whether phosphorylation of these adaptors occurs through passive diffusion or active recruitment. We report the discovery of a conserved proline-rich motif in LAT that mediates efficient LAT phosphorylation. Lck associates with this motif via its SH3 domain, and with phospho-Zap7O via its SH2 domain, thereby acting as a molecular bridge that facilitates the colocalization of Zap70 and LAT. Elimination of this proline-rich motif compromises TCR signaling and T cell development. These results demonstrate the remarkable multifunctionality of Lck, wherein each of its domains has evolved to orchestrate a distinct step in TCR signaling.	[Lo, Wan-Lin; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA 94143 USA; [Shah, Neel H.; Kuriyan, John] Univ Calif Berkeley, Dept Mol, Berkeley, CA 94720 USA; [Shah, Neel H.; Kuriyan, John] Univ Calif Berkeley, Dept Cell Biol, Berkeley, CA 94720 USA; [Ahsan, Nagib] Brown Univ, Div Biol & Med, Alpert Med Sch, Providence, RI 02912 USA; [Ahsan, Nagib] Rhode Isl Hosp, Prote Core Facil, Ctr Canc Res Dev, Providence, RI USA; [Horkova, Veronika; Stepanek, Ondrej] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Brown University; Brown University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA 94143 USA.; Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	art.weiss@ucsf.edu	Shah, Neel H/AAD-9217-2022; Stepanek, Ondrej/AAG-3180-2020	Shah, Neel H/0000-0002-1186-0626; Stepanek, Ondrej/0000-0002-2735-3311; Weiss, Arthur/0000-0002-2414-9024; Horkova, Veronika/0000-0002-3679-2236	Coffin Childs Fund [61-1560]; Damon Runyon Cancer Research Foundation [2198-14]; Czech Science Foundation [BIB-09208Y]; Howard Hughes Medical Institute; NIH, NIAID [P01 AI09158006, R01 AI083636, P30 GM110759]; DRC Center Grant [P30 DK063720]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580, R01AI083636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110759] Funding Source: NIH RePORTER	Coffin Childs Fund; Damon Runyon Cancer Research Foundation; Czech Science Foundation(Grant Agency of the Czech Republic); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DRC Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Samelson and C. Sommers (NIH) for sharing the LAT deficient mouse line; T. Kadlecek for generating the ILck mutant Jurkat cell clone; A. Roque for animal husbandry, W Paster (Medical University Vienna) for sharing the ClIt8 express on vector; T. Brdicka Prague) for sharing the Lek encoding DNA sequence; the UCSF Parnassus Flow Cytometry Core for maintaining FACSAria instruments and services; the NIH Tetratner Core Facility for providing the H-21(b OVA tetramers and H-2K<SUP>b</SUP> OVA tetramers; and D, L. Donermeyer, B. B. Au-Yeung, H. Wang, and C. Morley for critical reading of the manuscript and providing comments. This work was supported by the Jane Coffin Childs Fund 61-1560 (to W-L.L.); the Damon Runyon Cancer Research Foundation 2198-14 (to N.H.S.); the Czech Science Foundation (BIB-09208Y (to U.S.); the Howard Hughes Medical Institute (to A.W. and J.K.); NIH, NIAID P01 A109158006 (to AIM, J.K., and A.R.S.), R01 AI083636 and P30 GM110759 (to A.R.S.); and DRC Center Grant P30 DK063720 (UCSF Parnassus Flow Cytometry Core).	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Ahsan N, 2017, J PROTEOMICS, V165, P69, DOI 10.1016/j.jprot.2017.06.013; Arbulo-Echevarria MM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00115; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Courtney AH, 2017, MOL CELL, V67, P498, DOI 10.1016/j.molcel.2017.06.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Hartmann J, 2017, EMBO MOL MED, V9, P1183, DOI 10.15252/emmm.201607485; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Luis BS, 2014, FEBS J, V281, P696, DOI 10.1111/febs.12615; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Mayer BJ, 2015, NAT REV MOL CELL BIO, V16, P691, DOI 10.1038/nrm4068; McCoy ME, 2010, J IMMUNOL, V185, P3285, DOI 10.4049/jimmunol.0900027; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Miyaji M, 2009, P NATL ACAD SCI USA, V106, P14502, DOI 10.1073/pnas.0903894106; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Pratt JC, 1999, J IMMUNOL, V163, P2586; Purbhoo M. A., J BIOL CHEM, V276; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; Rudd ML, 2006, MOL CELL BIOL, V26, P7892, DOI 10.1128/MCB.00968-06; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Thill PA, 2016, MOL CELL BIOL, V36, P2396, DOI 10.1128/MCB.00165-16; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yu KB, 2009, PROTEOMICS, V9, P5350, DOI 10.1002/pmic.200900119; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	48	69	69	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					733	+		10.1038/s41590-018-0131-1	http://dx.doi.org/10.1038/s41590-018-0131-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29915297	Green Accepted			2022-12-18	WOS:000436341300018
J	Graham, BS; Sullivan, NJ				Graham, Barney S.; Sullivan, Nancy J.			Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic	NATURE IMMUNOLOGY			English	Review							TICK-BORNE ENCEPHALITIS; NEUTRALIZING HUMAN-ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; EBOLA-VIRUS INFECTION; ZIKA VIRUS; FUSION GLYCOPROTEIN; PROTECTIVE EFFICACY; STRUCTURAL BASIS; YELLOW-FEVER; DOUBLE-BLIND	Emerging infectious diseases will continue to threaten public health and are sustained by global commerce, travel and disruption of ecological systems. Most pandemic threats are caused by viruses from either zoonotic sources or vector-borne sources. Developing better ways to anticipate and manage the ongoing microbial challenge will be critical for achieving the United Nations Sustainable Development Goals and, conversely, each such goal will affect the ability to control infectious diseases. Here we discuss how technology can be applied effectively to better prepare for and respond to new viral diseases with a focus on new paradigms for vaccine development.	[Graham, Barney S.; Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov; nsullivan@nih.gov	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005080, ZIAAI005081, ZIAAI005128, ZIAAI005079] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Mascola, K. Kelley, T. Pierson and K. Morabito for editorial comments, and A. Fauci, H. Achincloss, J. Gall, K. Modjarrad, S. Plotkin and C. Cassetti for discussions. Supported by the National Institute of Allergy and Infectious Diseases (intramural funding).	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Andrews S. F., 2017, COLD SPRING HARB PER; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Bailey AL, 2016, J VIROL, V90, P630, DOI 10.1128/JVI.01433-15; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P97; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7; Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632; Dormitzer PR, 2015, CURR TOP MICROBIOL, V386, P237, DOI 10.1007/82_2014_399; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023; Effio CL, 2015, BIOTECHNOL J, V10, P715, DOI 10.1002/biot.201400392; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Furman D, 2015, VACCINE, V33, P5271, DOI 10.1016/j.vaccine.2015.06.117; Gilbert SC, 2017, VACCINE, V35, P4461, DOI 10.1016/j.vaccine.2017.04.085; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; Graham BS, 2013, IMMUNOL REV, V255, P230, DOI 10.1111/imr.12098; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; Muhlebach MD, 2017, VIRUS GENES, V53, P733, DOI 10.1007/s11262-017-1486-3; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020; Plotkin S. A., 2017, HUM VACC IMMUNOTHER; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Prausnitz MR, 2017, ANNU REV CHEM BIOMOL, V8, P177, DOI 10.1146/annurev-chembioeng-060816-101514; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Slaoui Moncef, 2015, Nat Rev Drug Discov, V14, P452, DOI 10.1038/nrd4669; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Suschak JJ, 2017, HUM VACC IMMUNOTHER, V13, P2837, DOI 10.1080/21645515.2017.1330236; Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Ulmer JB, 2016, CURR OPIN IMMUNOL, V41, P18, DOI 10.1016/j.coi.2016.05.008; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; US Food & Drug Administration, 2016, EM US AUTH; Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062; Villar RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36298; Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; World Health Organization, 2004, CAUS SPEC MORT MORB, P47; World Health Organization, 2004, BURD DIS DALYS 4; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006	95	69	71	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					20	28		10.1038/s41590-017-0007-9	http://dx.doi.org/10.1038/s41590-017-0007-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29199281	Bronze, Green Published			2022-12-18	WOS:000419765300010
J	Fernandez, E; Dejnirattisai, W; Cao, C; Scheaffer, SM; Supasa, P; Wongwiwat, W; Esakky, P; Drury, A; Mongkolsapaya, J; Moley, KH; Mysorekar, IU; Screaton, GR; Diamond, MS				Fernandez, Estefania; Dejnirattisai, Wanwisa; Cao, Bin; Scheaffer, Suzanne M.; Supasa, Piyada; Wongwiwat, Wiyada; Esakky, Prabagaran; Drury, Andrea; Mongkolsapaya, Juthathip; Moley, Kelle H.; Mysorekar, Indira U.; Screaton, Gavin R.; Diamond, Michael S.			Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection	NATURE IMMUNOLOGY			English	Article							MALE SEXUAL TRANSMISSION; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; STRUCTURAL BASIS; BIRTH-DEFECTS; PROTECTION; DISEASE; NEUTRALIZATION; REPLICATION; PERSISTENCE	The Zika virus (ZIKV) epidemic has resulted in congenital abnormalities in fetuses and neonates. Although some cross-reactive dengue virus (DENV)-specific antibodies can enhance ZIKV infection in mice, those recognizing the DENV E-dimer epitope (EDE) can neutralize ZIKV infection in cell culture. We evaluated the therapeutic activity of human monoclonal antibodies to DENV EDE for their ability to control ZIKV infection in the brains, testes, placentas, and fetuses of mice. A single dose of the EDE1-B10 antibody given 3 d after ZIKV infection protected against lethality, reduced ZIKV levels in brains and testes, and preserved sperm counts. In pregnant mice, wild-type or engineered LALA variants of EDE1-B10, which cannot engage Fc gamma receptors, diminished ZIKV burden in maternal and fetal tissues, and protected against fetal demise. Because neutralizing antibodies to EDE have therapeutic potential against ZIKV, in addition to their established inhibitory effects against DENV, it may be possible to develop therapies that control disease caused by both viruses.	[Fernandez, Estefania; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England; [Cao, Bin; Scheaffer, Suzanne M.; Esakky, Prabagaran; Drury, Andrea; Moley, Kelle H.; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand; [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Med Sci Div Off, Oxford, England; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); Imperial College London; Washington University (WUSTL); Mahidol University; University of Oxford; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Screaton, GR (corresponding author), Imperial Coll, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.; Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Med Sci Div Off, Oxford, England.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	g.screaton@imperial.ac.uk; diamond@wusm.wustl.edu	amsalu, ribka/G-8780-2019; Wongwiwat, Wiyada/AAJ-8936-2021; Diamond, Michael/AAH-1733-2019; Mysorekar, Indira U./GRS-4574-2022	Diamond, Michael/0000-0002-8791-3165; Mysorekar, Indira U./0000-0003-3917-8677; Screaton, Gavin/0000-0002-3549-4309; ESAKKY, PRABAGARAN/0000-0003-4688-2427; Wongwiwat, Wiyada/0000-0002-5889-0929	NIH [R01 AI073755, R01 AI127828, R01 HD091218, HHSN272201400018C, T32 AI007163]; WellcomeTrust; MRC-NEWTON UK; National Institute for Health Research Biomedical Research Centre funding scheme UK; MRC [G0801508, G0600000] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD091218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755, T32AI007163, R01AI127828] Funding Source: NIH RePORTER; Medical Research Council [G0801508, G0600000] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WellcomeTrust(Wellcome TrustEuropean Commission); MRC-NEWTON UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre funding scheme UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Haina Shin for advice on the intravaginal infection experiments, S. Whitehead (US National Institutes of Health (NIH)) for ZIKV-Brazil (Paraiba, 2015), S. Shresta(La Jolla Institute of Allergy and Immunology) for DENV-2 strain D2S20, P. Malasit and S. Noisakran (Mahidol University) for DENV-1, DENV-3, and DENV-4 isolates from patients, C. Simmons (University of Melbourne) for DENV-2 strain DF-699, A. Kohl, R.F. de Oliveira Freitas, and L.J. Pena (University of Glasgow) for ZIKV-Brazil PE243, and A. Sakuntabhai (Institut Pasteur) for ZIKV-Africa HD78788. Supported by grants and contracts from the NIH (R01 AI073755 (M.S.D.), R01 AI127828 (M.S.D.), R01 HD091218 (I.U.M. and M.S.D.), HHSN272201400018C (M.S.D.), T32 AI007163 (E.F.)), the WellcomeTrust (G.R.S.), MRC-NEWTON UK (J.M.), and the National Institute for Health Research Biomedical Research Centre funding scheme UK (G.R.S.).	Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316; Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Magdelaine-Beuzelin C, 2010, MABS-AUSTIN, V2, P176, DOI 10.4161/mabs.2.2.11205; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; National Research Council, 2011, COMM UPD GUID CAR US, V8th; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	55	69	70	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1261	+		10.1038/ni.3849	http://dx.doi.org/10.1038/ni.3849			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28945244	Green Accepted, Green Submitted			2022-12-18	WOS:000413457300012
J	Karwacz, K; Miraldi, ER; Pokrovskii, M; Madi, A; Yosef, N; Wortman, I; Chen, X; Watters, A; Carriero, N; Awasthi, A; Regev, A; Bonneau, R; Littman, D; Kuchroo, VK				Karwacz, Katarzyna; Miraldi, Emily R.; Pokrovskii, Maria; Madi, Asaf; Yosef, Nir; Wortman, Ivo; Chen, Xi; Watters, Aaron; Carriero, Nicholas; Awasthi, Amit; Regev, Aviv; Bonneau, Richard; Littman, Dan; Kuchroo, Vijay K.			Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; T-CELLS; C-MAF; GENE; TR1; EFFECTOR; IL-27; RNA; INTERLEUKIN-27; EXPRESSION	Type 1 regulatory T cells (Tr1 cells) are induced by interleukin-27 (IL-27) and have critical roles in the control of autoimmunity and resolution of inflammation. We found that the transcription factors IRF1 and BATF were induced early on after treatment with IL-27 and were required for the differentiation and function of Tr1 cells in vitro and in vivo. Epigenetic and transcriptional analyses revealed that both transcription factors influenced chromatin accessibility and expression of the genes required for Tr1 cell function. IRF1 and BATF deficiencies uniquely altered the chromatin landscape, suggesting that these factors serve a pioneering function during Tr1 cell differentiation.	[Karwacz, Katarzyna; Madi, Asaf; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Karwacz, Katarzyna; Madi, Asaf; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Miraldi, Emily R.; Watters, Aaron; Carriero, Nicholas; Bonneau, Richard] Simons Fdn, Flatiron Inst, Ctr Computat Biol, New York, NY USA; [Miraldi, Emily R.; Pokrovskii, Maria; Littman, Dan] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Yosef, Nir] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Wortman, Ivo; Regev, Aviv] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Chen, Xi; Bonneau, Richard] NYU, Dept Biol, New York, NY 10003 USA; [Awasthi, Amit] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Ctr Human Microbial Ecol, Faridabad, India	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; New York University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Kuchroo, VK (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	vkuchroo@evergrande.hms.harvard.edu	Bonneau, Richard/GZL-2900-2022; Bonneau, Richard/ABD-6737-2021	Madi, Asaf/0000-0003-3441-3228	Cancer Center Support Grant [P30CA016087]; US national Institutes of Health [R01 NS 030843, R01 NS 045937, P01 AI073748, P01 NS076410, P01 AI039671, 5P01 AI056299-10, P01NS076410, 5T32AI100853, 1R01-DK103358-01, 1R01-GM112192-01]; National Multiple Sclerosis Society; Marie Sklodowska-Curie Actions (of the European Commission / Research Executive Agency) [302915]; Marie Curie International Outgoing Fellowship; National Science Foundation [IOS-1126971]; DBT-Wellcome Trust [IA/I/12/1/500524]; Klarman Cell Observatory at the Broad Institute; Howard Hughes Medical Institute; National Cancer Institute (Koch Institute Support) [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA093373, P30CA014051, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI039671, P01AI056299, T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, P01NS076410, R01NS030843] Funding Source: NIH RePORTER	Cancer Center Support Grant; US national Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Marie Sklodowska-Curie Actions (of the European Commission / Research Executive Agency); Marie Curie International Outgoing Fellowship(European Commission); National Science Foundation(National Science Foundation (NSF)); DBT-Wellcome Trust(Wellcome Trust DBT India Alliance); Klarman Cell Observatory at the Broad Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (Koch Institute Support); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz (Evergrande Center) for cell sorting, F. Quintana (Harvard Medical School) for providing AhR mutant mice, the New York University Langone Medical Center genomics core (A. Heguy and P. Zappile) for help with sequencing, and the Genome Technology Center (at the Laura and Isaac Perlmutter Cancer Center supported by the Cancer Center Support Grant P30CA016087) for help with sequencing. We are most thankful to M. Collins for advice and editing of the manuscript. This work was supported by the US national Institutes of Health (R01 NS 030843, R01 NS 045937, P01 AI073748, P01 NS076410, P01 AI039671 and 5P01 AI056299-10 to V.K.K.; P01NS076410 to D.L. and M.P.; 5T32AI100853 to M. P.; 1R01-DK103358-01 to E.R.M., R.B. and D.L.; and 1R01-GM112192-01 to R.B.), the National Multiple Sclerosis Society (K.K.), Marie Sklodowska-Curie Actions (of the European Commission / Research Executive Agency), grant agreement number 302915, Marie Curie International Outgoing Fellowship (K.K.), the National Science Foundation (IOS-1126971 to R.B.), the DBT-Wellcome Trust (IA/I/12/1/500524 to A. A.), the Klarman Cell Observatory at the Broad Institute (A.R.), the Howard Hughes Medical Institute (A.R.) and the National Cancer Institute (Koch Institute Support (P30-CA14051 to A.R.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Blatti C, 2015, NUCLEIC ACIDS RES, V43, P3998, DOI 10.1093/nar/gkv195; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eason DE, 1999, BBA-GENE STRUCT EXPR, V1446, P140, DOI 10.1016/S0167-4781(99)00078-0; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy MT, 2014, BIOINFORMATICS, V30, P1302, DOI 10.1093/bioinformatics/btt774; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Sjostrand M, 2013, J IMMUNOL, V191, P3753, DOI 10.4049/jimmunol.1202341; Tripathi SK, 2014, IMMUNOL REV, V261, P62, DOI 10.1111/imr.12204; Wang H, 2011, IMMUNOL LETT, V136, P21, DOI 10.1016/j.imlet.2010.11.007; WATTERS AM, FAST ADAPTING UNPUB; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Yoshida K, 2005, INT IMMUNOL, V17, P1463, DOI 10.1093/intimm/dxh324	48	69	71	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					412	+		10.1038/ni.3683	http://dx.doi.org/10.1038/ni.3683			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28166218	Green Accepted, Green Published			2022-12-18	WOS:000396815800009
J	Migueles, SA; Connors, M				Migueles, Stephen A.; Connors, Mark			Success and failure of the cellular immune response against HIV-1	NATURE IMMUNOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; HIGHLY PATHOGENIC SIV; LONG-TERM SURVIVOR; ELITE CONTROLLERS; LYMPHOCYTE RESPONSES; REPLICATION CAPACITY; VIRAL REPLICATION; DURABLE CONTROL; HIGH-FREQUENCY	The cellular immune response to HIV-1 has now been studied in extraordinary detail. A very large body of data provides the most likely reasons that the HIV-specific cellular immune response succeeds in a small number of people but fails in most. Understanding the success and failure of the HIV-specific cellular immune response has implications that extend not only to immunotherapies and vaccines for HIV-1 but also to the cellular immune response in other disease states. This Review focuses on the mechanisms that are most likely responsible for durable and potent immunologic control of HIV-1. Although we now have a detailed picture of the cellular immune responses to HIV-1, important questions remain regarding the nature of these responses and how they arise.	[Migueles, Stephen A.; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Connors, M (corresponding author), NIAID, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mconnors@niaid.nih.gov			National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.A.M. and M.C. are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buckheit RW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1697; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Cohen OJ, 1998, J VIROL, V72, P6215, DOI 10.1128/JVI.72.7.6215-6217.1998; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Quiros JCLB, 2000, J VIROL, V74, P2023, DOI 10.1128/JVI.74.4.2023-2028.2000; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Haigwood NL, 1996, IMMUNOL LETT, V51, P107, DOI 10.1016/0165-2478(96)02563-1; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kloosterboer N, 2005, VIROLOGY, V339, P70, DOI 10.1016/j.virol.2005.06.001; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; Lecuroux C, 2014, J VIROL, V88, P176, DOI 10.1128/JVI.02098-13; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mendoza D, 2012, J VIROL, V86, P4014, DOI 10.1128/JVI.06982-11; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2015, EBIOMEDICINE, V2, P46, DOI 10.1016/j.ebiom.2014.12.009; Migueles SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002002; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Nou E, 2009, J VIROL, V83, P6941, DOI 10.1128/JVI.00306-09; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Salgado M, 2014, J VIROL, V88, P3340, DOI 10.1128/JVI.03380-13; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Tan WG, 2013, J VIROL, V87, P1359, DOI 10.1128/JVI.02055-12; Tilton JC, 2007, J VIROL, V81, P2713, DOI 10.1128/JVI.01830-06; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Vigano S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003423; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Yue L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004565; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	116	69	70	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					563	570		10.1038/ni.3161	http://dx.doi.org/10.1038/ni.3161			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988888				2022-12-18	WOS:000354751900004
J	Chaturvedi, A; Martz, R; Dorward, D; Waisberg, M; Pierce, SK				Chaturvedi, Akanksha; Martz, Rebecca; Dorward, David; Waisberg, Michael; Pierce, Susan K.			Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments	NATURE IMMUNOLOGY			English	Article							CELL ANTIGEN-RECEPTOR; TRANSCRIPTION FACTORS; B-LYMPHOCYTES; LIPID RAFTS; C/EBP-BETA; T-CELLS; INTERNALIZATION; ACTIVATION; ENDOSOMES; CLATHRIN	Binding of antigen to the B cell antigen receptor (BCR) triggers both BCR signaling and endocytosis. How endocytosis regulates BCR signaling remains unknown. Here we report that BCR signaling was not extinguished by endocytosis of BCRs; instead, BCR signaling initiated at the plasma membrane continued as the BCR trafficked intracellularly with the sequential phosphorylation of kinases. Blocking the endocytosis of BCRs resulted in the recruitment of both proximal and downstream kinases to the plasma membrane, where mitogen-activated protein kinases (MAPKs) were hyperphosphorylated and the kinase Akt and its downstream target Foxo were hypophosphorylated, which led to the dysregulation of gene transcription controlled by these pathways. Thus, the cellular location of the BCR serves to compartmentalize kinase activation to regulate the outcome of signaling.	[Chaturvedi, Akanksha; Martz, Rebecca; Waisberg, Michael; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Dorward, David] NIAID, Microscopy Unit, Rocky Mt Labs, Res Technol Sect,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chaturvedi, A (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	achaturvedi@niaid.nih.gov; spierce@nih.gov			US National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000899, ZICAI001052] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Kirchhausen (Harvard Medical School) for dynasore. Supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Chaturvedi A, 2002, NAT IMMUNOL, V3, P951, DOI 10.1038/ni839; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chen XN, 1997, BLOOD, V90, P156; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Clark MR, 2003, ANN NY ACAD SCI, V987, P26, DOI 10.1111/j.1749-6632.2003.tb06030.x; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jacob M, 2008, INT IMMUNOL, V20, P485, DOI 10.1093/intimm/dxn010; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malhotra S, 2009, J BIOL CHEM, V284, P36202, DOI 10.1074/jbc.M109.040089; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Omerovic J, 2009, FEBS J, V276, P1817, DOI 10.1111/j.1742-4658.2009.06928.x; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Snyder MD, 2006, TRAFFIC, V7, P993, DOI 10.1111/j.1600-0854.2006.00450.x; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001	42	69	69	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1119	U130		10.1038/ni.2116	http://dx.doi.org/10.1038/ni.2116			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21964606	Green Accepted			2022-12-18	WOS:000296500100018
J	Gerold, G; Abu Ajaj, K; Bienert, M; Laws, HJ; Zychlinsky, A; de Diego, JL				Gerold, Gisa; Abu Ajaj, Khalid; Bienert, Michael; Laws, Hans-Juergen; Zychlinsky, Arturo; de Diego, Juana L.			A Toll-like receptor 2-integrin beta(3) complex senses bacterial lipopeptides via vitronectin	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; LIPOPOLYSACCHARIDE-BINDING-PROTEIN; ESCHERICHIA-COLI; OUTER-MEMBRANE; GLANZMANN THROMBASTHENIA; MICROBIAL LIPOPROTEINS; STAPHYLOCOCCUS-AUREUS; BORRELIA-BURGDORFERI; CELL ACTIVATION; INNATE IMMUNITY	Toll-like receptor 2 (TLR2) initiates inflammation in response to bacterial lipopeptide (BLP). However, the molecular mechanisms enabling the detection of BLP by TLR2 are unknown. Here we investigated the interaction of BLP with human serum proteins and identified vitronectin as a BLP-recognition molecule. Vitronectin and its receptor, integrin beta(3), were required for BLP-induced TLR2-mediated activation of human monocytes. Furthermore, monocytes from patients with Glanzmann thrombasthenia, which lack integrin beta(3), were completely unresponsive to BLP. In addition, integrin beta(3) formed a complex with TLR2 and this complex dissociated after BLP stimulation. Notably, vitronectin and integrin beta(3) coordinated responses to other TLR2 agonists such as lipoteichoic acid and zymosan. Our findings show that vitronectin and integrin beta(3) contribute to the initiation of TLR2 responses.	[Gerold, Gisa; Zychlinsky, Arturo; de Diego, Juana L.] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; [Abu Ajaj, Khalid; Bienert, Michael] Leibniz Inst Mol Pharmacol, Dept Peptide Chem & Biochem, D-13125 Berlin, Germany; [Laws, Hans-Juergen] Dusseldorf Univ Hosp, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany	Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	de Diego, JL (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany.	diego@mpiib-berlin.mpg.de	Gerold, Gisa/AAU-5064-2021; Horstmann, Britta/C-2154-2008	Gerold, Gisa/0000-0002-1326-5038; 				Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; BRAUN V, 1972, P NATL ACAD SCI USA, V69, P970, DOI 10.1073/pnas.69.4.970; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; Cuzzola M, 2000, J IMMUNOL, V164, P5871, DOI 10.4049/jimmunol.164.11.5871; GAN ZR, 1988, J BIOL CHEM, V263, P19827; GINSBERG MH, 1987, J BIOL CHEM, V262, P5437; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Heumann D, 2003, J ENDOTOXIN RES, V9, P381, DOI 10.1179/0963805103225003312; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Nurden AT, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-10; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Scibelli A, 2007, VET J, V173, P482, DOI 10.1016/j.tvjl.2006.01.010; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; Switala-Jelen K, 2004, FOLIA BIOL-PRAGUE, V50, P143; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; UNDERWOOD PA, 1993, J CELL SCI, V104, P793; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 1998, J IMMUNOL, V160, P5485; YLANNE J, 1995, J BIOL CHEM, V270, P9550	49	69	70	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					761	768		10.1038/ni.1618	http://dx.doi.org/10.1038/ni.1618			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18516040				2022-12-18	WOS:000256904900014
J	Cua, DJ; Kastelein, RA				Cua, DJ; Kastelein, RA			TGF-beta, a 'double agent' in the immune pathology war	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE INFLAMMATION; T-CELLS; IL-23; CYTOKINE; DISTINCT; INTERLEUKIN-12; LINEAGE; ROLES; IL-12	T helper cells that produce interleukin 17 can promote a range of immune-mediated inflammatory diseases. Papers in Nature and Immunity suggest transforming growth factor-beta promotes the differentiation of these pathogenic cells.	Schering Plough Biopharma, Discovery Res, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Schering Plough Biopharma, Discovery Res, Palo Alto, CA 94304 USA.	daniel.cua@dnax.org; rob.kastelein@spcorp.com						BETTELLI E, 2006, NATURE          0430; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MANGAN PR, 2006, NATURE          0430; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	12	69	82	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					557	559		10.1038/ni0606-557	http://dx.doi.org/10.1038/ni0606-557			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715066				2022-12-18	WOS:000237751200009
J	Liu, N; Phillips, T; Zhang, ML; Wang, Y; Opferman, JT; Shah, R; Ashton-Rickardt, PG				Liu, N; Phillips, T; Zhang, ML; Wang, Y; Opferman, JT; Shah, R; Ashton-Rickardt, PG			Serine protease inhibitor 2A is a protective factor for memory T cell development	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LYMPHOCYTIC CHORIOMENINGITIS; GENE-EXPRESSION; APOPTOSIS; PERFORIN; DIFFERENTIATION; ACTIVATION; CYTOTOXICITY; HOMEOSTASIS; EFFECTORS	An essential event in the development of memory CD8(+) T lymphocytes is the escape of progenitors from programmed cell death, but how this is mediated is unclear. Here we report that the gene encoding serine protease inhibitor 2A (Spi2A), an inhibitor of lysosomal executioner proteases dependent on transcription factor NF-kappaB, is upregulated in memory cell precursors. Spi2A upregulation protected lymphocytic choriomeningitis virus-specific memory progenitors from programmed cell death. Thus, Spi2A promotes the survival of cytotoxic T lymphocytes, allowing them to differentiate into memory CD8 T cells. These findings suggest a model in which commitment to the memory lineage is facilitated by the upregulation of protective genes.	Univ Chicago, Ben May Inst Canc Res, Dept Pathol, Comm Immunol & Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ashton-Rickardt, PG (corresponding author), Univ Chicago, Ben May Inst Canc Res, Dept Pathol, Comm Immunol & Dev Biol, 924 E 57th St, Chicago, IL 60637 USA.	pashtonr@midway.uchicago.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621	NIAID NIH HHS [AI45108] Funding Source: Medline; NIGMS NIH HHS [GM07281] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Chen L, 2003, EUR J IMMUNOL, V33, P769, DOI 10.1002/eji.200323783; Coligan J, 1995, CURRENT PROTOCOLS IM; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Hettmann T, 2003, IMMUNOL LETT, V85, P297, DOI 10.1016/S0165-2478(02)00260-2; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mora AL, 2003, CELL DEATH DIFFER, V10, P1032, DOI 10.1038/sj.cdd.4401257; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ober BT, 2000, INT IMMUNOL, V12, P1353, DOI 10.1093/intimm/12.9.1353; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; RAZVI ES, 1995, AM J PATHOL, V147, P79; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; SUZUKI Y, 1990, J BIOCHEM, V108, P344, DOI 10.1093/oxfordjournals.jbchem.a123204; Wognum AW, 2000, HUM GENE THER, V11, P2129, DOI 10.1089/104303400750001435; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	46	69	71	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					919	926		10.1038/ni1107	http://dx.doi.org/10.1038/ni1107			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15311278				2022-12-18	WOS:000223612500020
J	Wolan, DW; Teyton, L; Rudolph, MG; Villmow, B; Bauer, S; Busch, DH; Wilson, IA				Wolan, DW; Teyton, L; Rudolph, MG; Villmow, B; Bauer, S; Busch, DH; Wilson, IA			Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 angstrom	NATURE IMMUNOLOGY			English	Article							INHIBITORY RECEPTOR; T-CELLS; RECOGNITION; COMPLEX; MOLECULES; CD94; CD94/NKG2C; EXPRESSION; BINDING; FAMILY	NKG2D, a homodimeric lectin-like receptor, is a unique stimulatory molecule that is found on natural killer cells,T cells and activated macrophages. The natural ligands for murine NKG2D are distant major histocompatibility complex homologs, retinoic acid early transcript (Rael) and H-60 minor histocompatibility antigen. The crystal structure of the extracellular region of murine NKG2D reveals close homology with other C-type lectin receptors such as CD94, Ly49A, rat MBP-A and CD69, However, the precise mode of dimeric assembly varies among these natural killer receptors, as well as their surface topography and electrostatic properties,The NKG2D structure provides the first structural insights into the role and ligand specificity of this stimulatory receptor in the innate and adaptive immune system.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Technical University of Munich	Busch, DH (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dirk.busch@lrz.tum.de; wilson@scripps.edu		Rudolph, Markus/0000-0003-0447-1101; Wolan, Dennis/0000-0001-9879-8353; Bauer, Stefan/0000-0002-8462-1845	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055037] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI42266] Funding Source: Medline; NIDDK NIH HHS [DK55037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chalupny J, 2000, FASEB J, V14, pA1018; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; COSMAN D, 2000, FASEB J, V14, P1018; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; LLERA AS, 2001, IN PRESS J BIOL CHEM; Lopez-Botet M, 2000, SEMIN IMMUNOL, V12, P109, DOI 10.1006/smim.2000.0213; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Renedo M, 2000, GENOMICS, V65, P129, DOI 10.1006/geno.2000.6163; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SHER PK, 1987, PEDIATR NEUROL, V3, P197; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379	53	69	75	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					248	254		10.1038/85311	http://dx.doi.org/10.1038/85311			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224525				2022-12-18	WOS:000167413800018
J	Marar, C; Starich, B; Wirtz, D				Marar, Carolyn; Starich, Bartholomew; Wirtz, Denis			Extracellular vesicles in immunomodulation and tumor progression	NATURE IMMUNOLOGY			English	Review								Extracellular vesicles have emerged as prominent regulators of the immune response during tumor progression. EVs contain a diverse repertoire of molecular cargo that plays a critical role in immunomodulation. Here, we identify the role of EVs as mediators of communication between cancer and immune cells. This expanded role of EVs may shed light on the mechanisms behind tumor progression and provide translational diagnostic and prognostic tools for immunologists. Extracellular vesicles (EVs) can exert potent immunomodulatory effects. Wirtz and colleagues review the types of EV and their influence on tumor responses.	[Marar, Carolyn; Starich, Bartholomew; Wirtz, Denis] Johns Hopkins Univ, Inst NanoBiotechnol INBT, Baltimore, MD 21218 USA; [Marar, Carolyn] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Starich, Bartholomew; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Wirtz, Denis] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Canc Ctr, Sch Med, Baltimore, MD 21218 USA; [Wirtz, Denis] Johns Hopkins Univ, Dept Pathol, Sidney Kimmel Canc Ctr, Sch Med, Baltimore, MD 21218 USA; [Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Marar, Carolyn] Boston Univ, Biomed Engn Dept, Boston, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Boston University	Wirtz, D (corresponding author), Johns Hopkins Univ, Inst NanoBiotechnol INBT, Baltimore, MD 21218 USA.; Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.; Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Canc Ctr, Sch Med, Baltimore, MD 21218 USA.; Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Pathol, Sidney Kimmel Canc Ctr, Sch Med, Baltimore, MD 21218 USA.; Wirtz, D (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA.	wirtz@jhu.edu		Starich, Bartholomew/0000-0002-0006-0236; Wirtz, Denis/0000-0001-6147-3045	National Institutes of Health [T32GM008764]; National Cancer Institute [U54CA143868]; National Institute on Aging [U01AG060903]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported through grants from the National Institutes of Health (T32GM008764) to C.M. and the National Cancer Institute (U54CA143868) and the National Institute on Aging (U01AG060903) to D.W. Figures designed with BioRender.com.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Aiello S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08617-3; Al-Samadi A, 2017, ONCOTARGET, V8, P60123, DOI 10.18632/oncotarget.17768; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Alvarez-Jimenez VD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00272; Asadirad A, 2019, LIFE SCI, V219, P152, DOI 10.1016/j.lfs.2019.01.005; Battke C, 2011, CANCER IMMUNOL IMMUN, V60, P639, DOI 10.1007/s00262-011-0979-5; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184496; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Becker PD, 2021, AM J TRANSPLANT, V21, P1415, DOI 10.1111/ajt.16088; Bell BM, 2016, NANOMED-NANOTECHNOL, V12, P163, DOI 10.1016/j.nano.2015.09.011; Berchem G, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062968; Besse B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1071008; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Capello M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08109-6; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Chen L, 2019, MED SCI MONITOR, V25, P4877, DOI 10.12659/MSM.917058; Chen SS, 2018, INT J BIOL MACROMOL, V113, P1182, DOI 10.1016/j.ijbiomac.2018.02.034; Chiou NT, 2018, CELL REP, V25, P3358, DOI 10.1016/j.celrep.2018.11.073; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cordonnier M, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1710899; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cui XJ, 2020, MOL CELL ENDOCRINOL, V506, DOI 10.1016/j.mce.2020.110756; Czystowska-Kuzmicz M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10979-3; Daassi D, 2020, NAT REV IMMUNOL, V20, P209, DOI 10.1038/s41577-019-0264-y; Danesh A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00956; Dassler-Plenker J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1219827; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Diamond JM, 2018, CANCER IMMUNOL RES, V6, P910, DOI 10.1158/2326-6066.CIR-17-0581; Dionisi M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02481; Dusoswa SA, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1648995; Fitzgerald W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27190-x; Follain G, 2020, NAT REV CANCER, V20, P107, DOI 10.1038/s41568-019-0221-x; Fraley SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1711; Gao YW, 2016, ONCOL REP, V36, P1243, DOI 10.3892/or.2016.4947; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gobbo J, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv330; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Gu XY, 2015, INT J CANCER, V136, pE74, DOI 10.1002/ijc.29100; Guo DF, 2018, IMMUNOLOGY, V154, P132, DOI 10.1111/imm.12874; Haderk F, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5509; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu YL, 2018, MOL THER, V26, P568, DOI 10.1016/j.ymthe.2017.11.016; Huang F, 2017, CELL PHYSIOL BIOCHEM, V44, P240, DOI 10.1159/000484677; Huang F, 2017, CANCER IMMUNOL IMMUN, V66, P1321, DOI 10.1007/s00262-017-2028-5; Huang L, 2019, PATHOBIOLOGY, V86, P111, DOI 10.1159/000493013; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jeyaram A, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0160-y; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kano A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08913; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kaur S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20936-7; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kim DH, 2015, BIOMATERIALS, V48, P161, DOI 10.1016/j.biomaterials.2015.01.023; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kitai Y, 2017, J IMMUNOL, V198, P1649, DOI 10.4049/jimmunol.1601694; Koh E, 2017, BIOMATERIALS, V121, P121, DOI 10.1016/j.biomaterials.2017.01.004; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kremer AN, 2018, EUR J IMMUNOL, V48, P1621, DOI 10.1002/eji.201747152; Lee H, 2018, CARBOHYD POLYM, V202, P323, DOI 10.1016/j.carbpol.2018.08.141; Lenzini S, 2020, NAT NANOTECHNOL, V15, P217, DOI 10.1038/s41565-020-0636-2; Li Q, 2018, EXP CELL RES, V363, P141, DOI 10.1016/j.yexcr.2017.12.005; Lin WZ, 2020, THERANOSTICS, V10, P4871, DOI 10.7150/thno.43539; Lindenbergh MFS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00448; Lu Z, 2017, J HEPATOL, V67, P739, DOI 10.1016/j.jhep.2017.05.019; Luan X, 2017, ACTA PHARMACOL SIN, V38, P754, DOI 10.1038/aps.2017.12; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Ma JW, 2018, CANCER IMMUNOL RES, V6, P1057, DOI 10.1158/2326-6066.CIR-17-0716; Mahaweni NM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22492; Maji S, 2017, MOL CANCER RES, V15, P93, DOI 10.1158/1541-7786.MCR-16-0163; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Matsumoto A, 2020, BIOMATERIALS, V252, DOI 10.1016/j.biomaterials.2020.120112; Matsumoto A, 2019, BIOMATERIALS, V225, DOI 10.1016/j.biomaterials.2019.119518; Menay F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00286; Meng XD, 2016, ADV EXP MED BIOL, V924, P3, DOI 10.1007/978-3-319-42044-8_1; Monleon I, 2001, J IMMUNOL, V167, P6736, DOI 10.4049/jimmunol.167.12.6736; Morishita M, 2017, MOL PHARMACEUT, V14, P4079, DOI 10.1021/acs.molpharmaceut.7b00760; Morishita M, 2016, BIOMATERIALS, V111, P55, DOI 10.1016/j.biomaterials.2016.09.031; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Muller L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008347; Naqvi AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32925; Ochyl LJ, 2018, BIOMATERIALS, V182, P157, DOI 10.1016/j.biomaterials.2018.08.016; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Ostheimer C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01305; Park JE, 2019, ONCOGENE, V38, P5158, DOI 10.1038/s41388-019-0782-x; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Qazi KR, 2009, BLOOD, V113, P2673, DOI 10.1182/blood-2008-04-153536; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Rossowska J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00211; Rughetti A, 2014, CANCER IMMUNOL RES, V2, P177, DOI 10.1158/2326-6066.CIR-13-0112-T; Ruhland MK, 2020, CANCER CELL, V37, P786, DOI 10.1016/j.ccell.2020.05.002; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salamon P, 2020, CANCER IMMUNOL IMMUN, V69, P373, DOI 10.1007/s00262-019-02459-w; Salimu J, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1368823; Schierer S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800093; Scholl JN, 2020, NANOMEDICINE-UK, V15, P1001, DOI 10.2217/nnm-2019-0431; Segura E, 2005, BLOOD CELL MOL DIS, V35, P89, DOI 10.1016/j.bcmd.2005.05.003; Seo N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02865-1; Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9; Squadrito ML, 2018, NAT METHODS, V15, P183, DOI [10.1038/NMETH.4579, 10.1038/nmeth.4579]; Sullivan JA, 2020, CELL REP, V30, P1039, DOI 10.1016/j.celrep.2019.12.081; Sun HL, 2019, NANOSCALE, V11, P17759, DOI 10.1039/c9nr04669k; Tran TH, 2015, CLIN IMMUNOL, V160, P46, DOI 10.1016/j.clim.2015.03.021; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tkach M, 2017, EMBO J, V36, P3012, DOI 10.15252/embj.201696003; Torralba D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05077-9; Torri A, 2017, J BIOL CHEM, V292, P2903, DOI 10.1074/jbc.M116.769893; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Tung SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24531-8; Tung SL, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00317; Utsugi-Kobukai S, 2003, IMMUNOL LETT, V89, P125, DOI 10.1016/S0165-2478(03)00128-7; Van de Velde LA, 2017, J BIOL CHEM, V292, P15, DOI 10.1074/jbc.M116.766238; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vignard V, 2020, CANCER IMMUNOL RES, V8, P255, DOI 10.1158/2326-6066.CIR-19-0522; Vincent-Schneider H, 2002, INT IMMUNOL, V14, P713, DOI 10.1093/intimm/dxf048; Watson DC, 2016, BIOMATERIALS, V105, P195, DOI 10.1016/j.biomaterials.2016.07.003; Wei Gao, 2017, Sci Rep, V7, P42996, DOI 10.1038/srep42996; Whitford W, 2019, FUTURE MED CHEM, V11, P1225, DOI 10.4155/fmc-2018-0417; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Xu YP, 2016, IMMUNOLOGY, V149, P157, DOI 10.1111/imm.12630; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yuen A, 2014, HYPOXIA, V2, P91, DOI 10.2147/HP.S52636; Zeng FR, 2018, SEMIN IMMUNOPATHOL, V40, P477, DOI 10.1007/s00281-018-0679-8; Zhang HF, 2015, CANCER IMMUNOL RES, V3, P196, DOI 10.1158/2326-6066.CIR-14-0177; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937; Zhao Z, 2019, LAB CHIP, V19, P1877, DOI 10.1039/c8lc01279b; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhu L, 2019, BIOMATERIALS, V190, P38, DOI 10.1016/j.biomaterials.2018.10.034; Zhu L, 2018, ARTIF CELL NANOMED B, V46, pS166, DOI 10.1080/21691401.2018.1489824; Zhu L, 2017, THERANOSTICS, V7, P2732, DOI 10.7150/thno.18752; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Zuo BF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15569-2	156	68	68	13	84	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					560	570		10.1038/s41590-021-00899-0	http://dx.doi.org/10.1038/s41590-021-00899-0		MAR 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33753940	Green Accepted			2022-12-18	WOS:000631489400004
J	Roquilly, A; Jacqueline, C; Davieau, M; Molle, A; Sadek, A; Fourgeux, C; Rooze, P; Broquet, A; Misme-Aucouturier, B; Chaumette, T; Vourc'h, M; Cinotti, R; Marec, N; Gauttier, V; McWilliam, HEG; Altare, F; Poschmann, J; Villadangos, JA; Asehnoune, K				Roquilly, Antoine; Jacqueline, Cedric; Davieau, Marion; Molle, Alice; Sadek, Abderrahmane; Fourgeux, Cynthia; Rooze, Paul; Broquet, Alexis; Misme-Aucouturier, Barbara; Chaumette, Tanguy; Vourc'h, Mickael; Cinotti, Raphael; Marec, Nadege; Gauttier, Vanessa; McWilliam, Hamish E. G.; Altare, Frederic; Poschmann, Jeremie; Villadangos, Jose A.; Asehnoune, Karim			Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis	NATURE IMMUNOLOGY			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; ATTRIBUTABLE MORTALITY; TRAINED IMMUNITY; DENDRITIC CELLS; RESIDENT; MEMORY; SUSCEPTIBILITY; INFECTIONS; ACTIVATION	Sepsis and physical trauma can increase the susceptibility of patients to pneumonia. Roquilly and colleagues demonstrate that sepsis results in durable impairment of alveolar phagocytic function that is dependent on the localized expression of the inhibitory receptor SIRP alpha. Sepsis and trauma cause inflammation and elevated susceptibility to hospital-acquired pneumonia. As phagocytosis by macrophages plays a critical role in the control of bacteria, we investigated the phagocytic activity of macrophages after resolution of inflammation. After resolution of primary pneumonia, murine alveolar macrophages (AMs) exhibited poor phagocytic capacity for several weeks. These paralyzed AMs developed from resident AMs that underwent an epigenetic program of tolerogenic training. Such adaptation was not induced by direct encounter of the pathogen but by secondary immunosuppressive signals established locally upon resolution of primary infection. Signal-regulatory protein alpha (SIRP alpha) played a critical role in the establishment of the microenvironment that induced tolerogenic training. In humans with systemic inflammation, AMs and also circulating monocytes still displayed alterations consistent with reprogramming six months after resolution of inflammation. Antibody blockade of SIRP alpha restored phagocytosis in monocytes of critically ill patients in vitro, which suggests a potential strategy to prevent hospital-acquired pneumonia.	[Roquilly, Antoine; Jacqueline, Cedric; Davieau, Marion; Rooze, Paul; Broquet, Alexis; Misme-Aucouturier, Barbara; Chaumette, Tanguy; Vourc'h, Mickael; Asehnoune, Karim] Univ Nantes, EA3826 Therapeut AntiInfect, Inst Rech Sante Nantes Biotech 2, Nantes, France; [Roquilly, Antoine; Rooze, Paul; Vourc'h, Mickael; Cinotti, Raphael; Asehnoune, Karim] Univ Nantes, CHU Nantes, Pole Anesthesie Reanimat, Serv Anesthesie Reanimat Chirurgicale,Hotel Dieu, Nantes, France; [Roquilly, Antoine; McWilliam, Hamish E. G.; Villadangos, Jose A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Molle, Alice; Sadek, Abderrahmane; Fourgeux, Cynthia; Gauttier, Vanessa; Poschmann, Jeremie] Univ Nantes, INSERM, CHU Nantes, ITUN,Ctr Rech Transplantat & Immunol,UMR1064, Nantes, France; [Sadek, Abderrahmane] Moulay Ismail Univ, Fac Sci, Dept Biol, Zitoune, Meknes, Morocco; [Marec, Nadege] SFR Francois Bonamy, Plateforme Cytocell, Nantes, France; [McWilliam, Hamish E. G.; Villadangos, Jose A.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Altare, Frederic] Univ Nantes, CHU Nantes, INSERM, CRCINA, Nantes, France	Nantes Universite; Nantes Universite; CHU de Nantes; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Moulay Ismail University of Meknes; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Roquilly, A; Asehnoune, K (corresponding author), Univ Nantes, EA3826 Therapeut AntiInfect, Inst Rech Sante Nantes Biotech 2, Nantes, France.; Roquilly, A; Asehnoune, K (corresponding author), Univ Nantes, CHU Nantes, Pole Anesthesie Reanimat, Serv Anesthesie Reanimat Chirurgicale,Hotel Dieu, Nantes, France.; Roquilly, A; Villadangos, JA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia.; Poschmann, J (corresponding author), Univ Nantes, INSERM, CHU Nantes, ITUN,Ctr Rech Transplantat & Immunol,UMR1064, Nantes, France.	antoine.roquilly@chu-nante.fr; jeremie.poschmann@inserm.fr; j.villadangos@unimelb.edu.au; karim.asehnoune@chu-nantes.fr	McWilliam, Hamish EG/AAM-8665-2021; altare, frederic/K-8664-2015; Jacqueline, Cédric/G-5650-2010; Villadangos, Jose A/AAU-1404-2020	McWilliam, Hamish EG/0000-0003-3479-3419; altare, frederic/0000-0002-5077-4616; Jacqueline, Cédric/0000-0001-9606-5930; Villadangos, Jose A/0000-0001-6771-8891; VOURC'H, Mickael/0000-0002-1576-7728; Broquet, Alexis/0000-0002-6635-9601; Chaumette, Tanguy/0000-0002-5830-8767; Roquilly, Antoine/0000-0002-1029-6242; Molle, Alice/0000-0001-5195-4275	Region Pays de la Loire; National Health and Medical Research Council of Australia (NHMRC); Sylvia and Charles Viertel Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme	Region Pays de la Loire(Region Pays de la Loire); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia)	We thank the Biological Resource Centre for biobanking (CHU Nantes, Hotel Dieu, Centre de Ressources Biologiques (CRB), Nantes, France (BRIF: BB-0033-00040)), the Cytometry Facilty 'Cytocell', University of Nantes, and the Genomics and Bioinformatics Core Facility of Nantes (GenoBiRD, Biogenouest) for its technical support. OSE Immunotherapeutics provided Sirpa<SUP>-/-</SUP> mice and anti-Sirpa antibody but had no role in data analyses or revision of the manuscript. A.R. and J.P. received funding from the Region Pays de la Loire. This work was funded with grants from the National Health and Medical Research Council of Australia (NHMRC) to J.V., the Sylvia and Charles Viertel Foundation (Senior Medical Research Fellowship to A.K.), the Victorian State Government Operational Infrastructure Support and the Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Allhoff M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw680; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Bao YY, 2017, VIRUS GENES, V53, P357, DOI 10.1007/s11262-017-1438-y; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Berrien-Elliott MM, 2019, IMMUNITY, V51, P479, DOI 10.1016/j.immuni.2019.06.016; Bouras M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02590; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eber MR, 2010, ARCH INTERN MED, V170, P347, DOI 10.1001/archinternmed.2009.509; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kim KW, 2016, IMMUNITY, V45, P468, DOI 10.1016/j.immuni.2016.09.006; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu MG, 2019, NAT IMMUNOL, V20, P265, DOI 10.1038/s41590-018-0292-y; Ma KC, 2018, AM J RESP CRIT CARE, V197, P300, DOI 10.1164/rccm.201612-2460PP; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006; Netea MG, 2018, CELL, V175, P1463, DOI 10.1016/j.cell.2018.11.007; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Roquilly A, 2019, LANCET RESP MED, V7, P710, DOI 10.1016/S2213-2600(19)30140-7; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Roquilly A, 2016, EUR RESPIR J, V47, P1219, DOI 10.1183/13993003.01314-2015; Roquilly A, 2015, MOL IMMUNOL, V68, P120, DOI 10.1016/j.molimm.2015.06.030; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Sun WJ, 2016, CELL, V167, P1385, DOI 10.1016/j.cell.2016.10.031; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vega-Ramos J, 2014, J IMMUNOL, V193, P3851, DOI 10.4049/jimmunol.1303215; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005; Weiss E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1755-5; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042	63	68	71	7	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					636	+		10.1038/s41590-020-0673-x	http://dx.doi.org/10.1038/s41590-020-0673-x		MAY 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424365				2022-12-18	WOS:000533852800006
J	Pereira, BI; De Maeyer, RPH; Covre, LP; Nehar-Belaid, D; Lanna, A; Ward, S; Marches, R; Chambers, ES; Gomes, DCO; Riddell, NE; Maini, MK; Teixeira, VH; Janes, SM; Gilroy, DW; Larbi, A; Mabbott, NA; Ucar, D; Kuchel, GA; Henson, SM; Strid, J; Lee, JH; Banchereau, J; Akbar, AN				Pereira, Branca, I; De Maeyer, Roel P. H.; Covre, Luciana P.; Nehar-Belaid, Djamel; Lanna, Alessio; Ward, Sophie; Marches, Radu; Chambers, Emma S.; Gomes, Daniel C. O.; Riddell, Natalie E.; Maini, Mala K.; Teixeira, Vitor H.; Janes, Samuel M.; Gilroy, Derek W.; Larbi, Anis; Mabbott, Neil A.; Ucar, Duygu; Kuchel, George A.; Henson, Sian M.; Strid, Jessica; Lee, Jun H.; Banchereau, Jacques; Akbar, Arne N.			Sestrins induce natural killer function in senescent-like CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							IMMUNE-SYSTEM; NKG2D; DIFFERENTIATION; ACTIVATION; EXPRESSION; DISTINCT; RECEPTOR; LIGANDS	Aging is associated with remodeling of the immune system to enable the maintenance of life-long immunity. In the CD8(+) T cell compartment, aging results in the expansion of highly differentiated cells that exhibit characteristics of cellular senescence. Here we found that CD27(-)CD28(-)CD8(+) T cells lost the signaling activity of the T cell antigen receptor (TCR) and expressed a protein complex containing the agonistic natural killer (NK) receptor NKG2D and the NK adaptor molecule DAP12, which promoted cytotoxicity against cells that expressed NKG2D ligands. Immunoprecipitation and imaging cytometry indicated that the NKG2D-DAP12 complex was associated with sestrin 2. The genetic inhibition of sestrin 2 resulted in decreased expression of NKG2D and DAP12 and restored TCR signaling in senescent-like CD27(-)CD28(-)CD8(+) T cells. Therefore, during aging, sestrins induce the reprogramming of non-proliferative senescent-like CD27(-)CD28(-)CD8(+) T cells to acquire a broad-spectrum, innate-like killing activity. Akbar and colleagues show that sestrins induce the reprogramming of non-proliferative, senescent-like CD27(-)CD28(-)CD8(+) T cells to acquire an innate-like killing activity modulated by the NK receptor NKG2D and the adaptor molecule DAP12.	[Pereira, Branca, I; De Maeyer, Roel P. H.; Covre, Luciana P.; Lanna, Alessio; Chambers, Emma S.; Riddell, Natalie E.; Maini, Mala K.; Akbar, Arne N.] UCL, Div Infect & Immun, London, England; [Covre, Luciana P.; Gomes, Daniel C. O.] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil; [Nehar-Belaid, Djamel; Marches, Radu; Ucar, Duygu; Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Lanna, Alessio] Univ Oxford, Nuffield Dept Med, Oxford, England; [Ward, Sophie; Strid, Jessica] Imperial Coll London, Dept Med, London, England; [Riddell, Natalie E.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Teixeira, Vitor H.; Janes, Samuel M.] UCL, Lungs Living Res Ctr, UCL Resp, London, England; [Gilroy, Derek W.] UCL, Div Med, London, England; [Larbi, Anis] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore; [Mabbott, Neil A.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Mabbott, Neil A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Kuchel, George A.] Univ Connecticut, Ctr Aging, Farmington, CT USA; [Henson, Sian M.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Lee, Jun H.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of London; University College London; Universidade Federal do Espirito Santo; Jackson Laboratory; University of Oxford; Imperial College London; University of Surrey; University of London; University College London; University of London; University College London; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Connecticut; University of London; Queen Mary University London; University of Michigan System; University of Michigan	Akbar, AN (corresponding author), UCL, Div Infect & Immun, London, England.	a.akbar@ucl.ac.uk	Nehar-Belaid, Djamel/GQZ-4299-2022; De Maeyer, Roel/AAP-2919-2020; Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020; Pereira, Branca/AAC-3251-2021; Chambers, Emma/AAI-3521-2021; Larbi, Anis/ABE-5868-2020	Nehar-Belaid, Djamel/0000-0001-6002-5021; De Maeyer, Roel/0000-0003-4041-0867; Gilroy, Derek/0000-0003-3476-0844; Chambers, Emma/0000-0003-0990-8835; Riddell, Natalie/0000-0001-5392-6366; Kuchel, George/0000-0001-8387-7040; Henson, Sian/0000-0003-1893-4912; Maini, Mala/0000-0001-6384-1462	Portuguese Foundation for Science and Technology; Gulbenkian Institute for Science; Medical Research Council [MR/P00184X/1]; Ministry of Education of Brazil [BEX9414/14-2]; Wellcome Trust [AZR00630]; University College London Business; National Institutes of Health [R01DK102850, R01DK111465]; NIH/NIAID [R01 AG052608, R01 AI142086]; Biotechnology and Biological Science Research Council [BB/L005336/1]; NIHR UCL Hospital Biomedical Research Centre; Springboard award from the Academy of Medical Science; University of Oxford; Rosetrees Trust; Welton Trust; Garfield Weston Trust; UCLH Charitable Foundation; Roy Castle Lung Cancer Foundation; National Institute of General Medical Sciences (NIGMS) [GM124922]; Travelers Chair in Geriatrics and Gerontology; National Institute on Aging [AG061456, AG048023, AG063528, AG060746, AG021600, AG052608, AG051647]; BBSRC [BBS/E/D/10002071] Funding Source: UKRI; MRC [MR/T015853/1, MR/P00184X/1] Funding Source: UKRI	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Gulbenkian Institute for Science; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education of Brazil; Wellcome Trust(Wellcome Trust); University College London Business; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR UCL Hospital Biomedical Research Centre; Springboard award from the Academy of Medical Science; University of Oxford; Rosetrees Trust(Rosetrees Trust); Welton Trust; Garfield Weston Trust; UCLH Charitable Foundation; Roy Castle Lung Cancer Foundation; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Travelers Chair in Geriatrics and Gerontology; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Toubert from INSERM U.1160 and Laboratoire dImmunologie et dHistocompatibilite, Hopital Saint-Louis, Universite Paris Diderot, Sorbonne Paris Cite for the kind gift of the C1R<SUP>-</SUP>MICA cell line. B.I.P. was supported by the Portuguese Foundation for Science and Technology and the Gulbenkian Institute for Science sponsoring the Advanced Medical Program for Physicians (PFMA). This work was supported by the Medical Research Council (grant MR/P00184X/1 to A.N.A.), the Ministry of Education of Brazil (grant BEX9414/14-2 to L.P.C.), the Wellcome Trust (grant AZR00630 to A. Lanna), University College London Business (to S.M.H. and A.N.A. for the microarray work), the National Institutes of Health (R01DK102850 and R01DK111465 to J.H.L.), the NIH/NIAID (R01 AG052608 and R01 AI142086 to J.B.) and the Biotechnology and Biological Science Research Council (grant BB/L005336/1 to N.E.R.). R.P.H.D was supported, in part, by the NIHR UCL Hospital Biomedical Research Centre, and S.M.H. is funded by the Springboard award from the Academy of Medical Science and the Wellcome Trust. A.L. is a Sir Henry Wellcome Trust Fellow sponsored by M. L. Dustin (University of Oxford). S.M.J. is a Wellcome Trust Senior Fellow in Clinical Science and is supported by the Rosetrees Trust, the Welton Trust, the Garfield Weston Trust and the UCLH Charitable Foundation. S.M.J. and V.H.T. have been funded by the Roy Castle Lung Cancer Foundation. D.U. is supported by the National Institute of General Medical Sciences (NIGMS) under award number GM124922. G.A.K. is supported by the Travelers Chair in Geriatrics and Gerontology, as well as the National Institute on Aging (AG061456, AG048023, AG063528, AG060746, AG021600, AG052608 and AG051647).	Akbar AN, 2004, NAT REV IMMUNOL, V4, P737, DOI 10.1038/nri1440; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bernardini G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00012; Callender LA, 2018, AGING CELL, V17, DOI 10.1111/acel.12675; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Dunne PJ, 2005, BLOOD, V106, P558, DOI 10.1182/blood-2004-11-4469; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588; Jackson SE, 2017, GEROSCIENCE, V39, P273, DOI 10.1007/s11357-017-9986-6; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; McInnes L., 2018, ARXIV PREPRINT ARXIV, DOI DOI 10.21105/JOSS.00861; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Pawelec G, 2014, EXP GERONTOL, V54, P1, DOI 10.1016/j.exger.2013.11.010; Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5; Plunkett FJ, 2007, J IMMUNOL, V178, P7710, DOI 10.4049/jimmunol.178.12.7710; Polanski K, 2020, BIOINFORMATICS, V36, P964, DOI 10.1093/bioinformatics/btz625; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vallejo AN, 2011, AGEING RES REV, V10, P354, DOI 10.1016/j.arr.2010.09.006; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	51	68	68	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					684	+		10.1038/s41590-020-0643-3	http://dx.doi.org/10.1038/s41590-020-0643-3		MAR 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32231301	Green Submitted, Green Accepted			2022-12-18	WOS:000522383000002
J	Dong, H; Adams, NM; Xu, YC; Cao, J; Allan, DSJ; Carlyle, JR; Chen, X; Sun, JC; Glimcher, LH				Dong, Han; Adams, Nicholas M.; Xu, Yichi; Cao, Jin; Allan, David S. J.; Carlyle, James R.; Chen, Xi; Sun, Joseph C.; Glimcher, Laurie H.			The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc	NATURE IMMUNOLOGY			English	Article							NK CELLS; ER STRESS; SIGNALING PATHWAYS; VIRAL-INFECTION; MESSENGER-RNA; TRANSCRIPTION; XBP1; GENE; EXPRESSION; ANTITUMOR	Natural killer (NK) cells are critical mediators of host immunity to pathogens. Here, we demonstrate that the endoplasmic reticulum stress sensor inositol-requiring enzyme 1 (IRE1 alpha) and its substrate transcription factor X-box-binding protein 1 (XBP1) drive NK cell responses against viral infection and tumors in vivo. IRE1 alpha-XBP1 were essential for expansion of activated mouse and human NK cells and are situated downstream of the mammalian target of rapamycin signaling pathway. Transcriptome and chromatin immunoprecipitation analysis revealed c-Myc as a new and direct downstream target of XBP1 for regulation of NK cell proliferation. Genetic ablation or pharmaceutical blockade of IRE1 alpha downregulated c-Myc, and NK cells with c-Myc haplo-insufficency phenocopied IRE1 alpha-XBP1 deficiency. c-Myc overexpression largely rescued the proliferation defect in IRE1 alpha(-/-) NK cells. Like c-Myc, IRE1 alpha-XBP1 also promotes oxidative phosphorylation in NK cells. Overall, our study identifies a IRE1 alpha-XBP1-cMyc axis in NK cell immunity, providing insight into host protection against infection and cancer.	[Dong, Han; Glimcher, Laurie H.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Dong, Han; Glimcher, Laurie H.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Dong, Han; Glimcher, Laurie H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Xu, Yichi] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA; [Cao, Jin; Chen, Xi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cao, Jin; Chen, Xi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Cao, Jin; Chen, Xi] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Allan, David S. J.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Carlyle, James R.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Carlyle, James R.] Sunnybrook Res Inst, Toronto, ON, Canada; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cornell University	Glimcher, LH (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA.; Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org; laurie_glimcher@dfci.harvard.edu	Carlyle, James R/A-1224-2008	Chen, Xi/0000-0002-7995-6202; Adams, Nicholas/0000-0001-5751-0480; Sun, Joseph/0000-0001-8062-9033; Carlyle, James/0000-0002-3579-0300	Dana-Farber Cancer Institute; Helen Gurley Brown Presidential Initiative Award (Dana-Farber Cancer Institute); Ludwig Center for Cancer Immunotherapy; American Cancer Society; Burroughs Wellcome Fund; NIH [1 R37 CA228304-01]; MSTP Grant from the National Institute of General Medical Sciences of the NIH [T32GM007739]; National Institue of Allergy and Infectious Diseases of the NIH [F30 AI136239]; NATIONAL CANCER INSTITUTE [R37CA228304, P30CA006516, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130043, R01AI100874, F30AI136239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute; Helen Gurley Brown Presidential Initiative Award (Dana-Farber Cancer Institute); Ludwig Center for Cancer Immunotherapy; American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP Grant from the National Institute of General Medical Sciences of the NIH; National Institue of Allergy and Infectious Diseases of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Vivier (Aix Marseille University) for Ncr1<SUP>iCre</SUP> mice; R. Wang (Nationwide Children's Hospital) for Myc<SUP>fl/fl</SUP> mice; R. Sears (Oregon Health & Science University) for Myc<SUP>fsf/fsf</SUP> mice; J. Ritz (Dana-Farber Cancer Institute) for the NKL cell line; C. Hurley (Georgetown University) for the KHYG-1 cell line; D. Lyden (Weill Cornell Medicine) for the B16F10 cell line; members of the Sun laboratory for sharing viral reagents, cytokines and flow cytometry antibodies and for providing experimental assistance; members of the Glimcher laboratory-M. Raundhal, C. Lentucci, R. Xu, S. Ghosh and A. Gonzalez for technical support; S. Adoro (Case Western Reserve University) and J. Cubillos-Ruiz (Weill Cornell Medicine) for critical reading of the manuscript and helpful discussion; M. Song (Weill Cornell Medicine) and the Wucherpfennig laboratory (Dana-Farber Cancer Institute) for insightful comments; J. Xiang (Weill Cornell Genomics and Epigenomics Core) for RNA-seq; J. McCormick (Weill Cornell Medicine) and DFCI Jimmy Fund Flow Cytometry Core for cell sorting; Specialized Histopathology Core at Brigham & Women's Hospital for histology; L. Cohen-Gould and J. Jimenez (Microscopy and Image Analysis Core Facility at Weill Cornell Medicine) for electron microscopy; X. Liu (Metabolism and Mitochondrial Research Core, Beth Israel Deaconess Medical Center) for metabolic flux assays; D. Neuberg (Dana-Farber Cancer Institute) for advising on statistical analysis; and S. Schneider (Dana-Farber Cancer Institute) for manuscript editing. L.H.G. and H. D. were supported by Institutional Funding from The Dana-Farber Cancer Institute. H. D. was also supported by a Helen Gurley Brown Presidential Initiative Award (Dana-Farber Cancer Institute). J. C. S. was supported by the Ludwig Center for Cancer Immunotherapy, the American Cancer Society, the Burroughs Wellcome Fund and the NIH (grant nos. AI100874, AI130043 and P30CA008748). N.M.A. was supported by an MSTP Grant from the National Institute of General Medical Sciences of the NIH to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program (grant no. T32GM007739) and by an F30 Predoctoral Fellowship from National Institue of Allergy and Infectious Diseases of the NIH (no. F30 AI136239). X. C. was supported by a NIH grant (no. 1 R37 CA228304-01).	Adams NM, 2018, IMMUNITY, V48, P1172, DOI 10.1016/j.immuni.2018.04.018; Allan DSJ, 2015, MUCOSAL IMMUNOL, V8, P340, DOI 10.1038/mi.2014.71; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Beaulieu AM, 2016, METHODS MOL BIOL, V1441, P1, DOI 10.1007/978-1-4939-3684-7_1; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brandt C, 2018, CELL, V175, P1321, DOI 10.1016/j.cell.2018.10.015; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chou C, 2014, NAT IMMUNOL, V15, P884, DOI 10.1038/ni.2943; Cichocki F, 2009, BLOOD, V113, P3245, DOI 10.1182/blood-2008-07-166389; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; de Andrade LF, 2018, SCIENCE, V359, P1537, DOI 10.1126/science.aao0505; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2014, IMMUNOL REV, V258, P45, DOI 10.1111/imr.12157; Frazier WR, 2013, J IMMUNOL, V190, P6198, DOI 10.4049/jimmunol.1300464; Hsu HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14612-5; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Loftus RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04719-2; Lu YQ, 2018, CANCER RES, V78, P64, DOI 10.1158/0008-5472.CAN-17-0815; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Mao YM, 2016, BLOOD, V128, P1475, DOI 10.1182/blood-2016-02-698027; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; Morrish F, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014225; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; O'Sullivan TE, 2017, J MOL BIOL, V429, P3577, DOI 10.1016/j.jmb.2017.08.014; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Orr MT, 2009, J EXP MED, V206, P807, DOI 10.1084/jem.20090168; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rabacal W, 2016, P NATL ACAD SCI USA, V113, P5370, DOI 10.1073/pnas.1521491113; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Siddiquey MNA, 2018, J VIROL, V92, DOI 10.1128/JVI.00896-18; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029538; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, J EXP MED, V208, P357, DOI 10.1084/jem.20100479; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wagner JA, 2017, J CLIN INVEST, V127, P4042, DOI 10.1172/JCI90387; Wang YF, 2019, NAT IMMUNOL, V20, P10, DOI 10.1038/s41590-018-0265-1; Yan DY, 2016, CELL REP, V16, P2914, DOI 10.1016/j.celrep.2016.08.035; Yang C, 2018, ELIFE, V7, DOI 10.7554/eLife.35619; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zakiryanova GK, 2017, IMMUN INFLAMM DIS, V5, P493, DOI 10.1002/iid3.179; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; Zhao N, 2018, J CLIN INVEST, V128, P1283, DOI 10.1172/JCI95873; Zheng HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27278-4	73	68	71	2	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					865	+		10.1038/s41590-019-0388-z	http://dx.doi.org/10.1038/s41590-019-0388-z			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31086333	Green Accepted			2022-12-18	WOS:000471891900017
J	Natoli, G; Ostuni, R				Natoli, Gioacchino; Ostuni, Renato			Adaptation and memory in immune responses	NATURE IMMUNOLOGY			English	Review							GENE-EXPRESSION; BETA-GLUCAN; MACROPHAGE POLARIZATION; T-CELLS; TISSUE; TRANSCRIPTION; RECEPTOR; INFLAMMATION; ACTIVATION; ENHANCERS	Adaptation is the ability of cells, tissues and organisms to rapidly and reversibly modify their properties to maximize fitness in a changing environment. The activity of immune-system components unfolds in the remarkably heterogeneous milieus to which they are exposed in different tissues, during homeostasis or during various acute or chronic pathological states. Therefore, adaptation is essential for immune cells to tune their responses to a large variety of contexts and conditions. The adaptation of immune cells reflects the integration of multiple inputs acting simultaneously or in a temporal sequence, which eventually leads to transcriptional reprogramming and to various functional consequences, some of which extend beyond the duration of the stimulus. A range of adaptive responses have been observed in both adaptive immune cells and innate immune cells; these are referred to with terms such as 'plasticity', 'priming', 'training', 'exhaustion' and 'tolerance', among others, all of which can be useful for defining a certain immunological process or outcome but whose underlying molecular frameworks are often incompletely understood. Here we review and analyze mechanisms of adaptation and memory in immunity with the aim of providing basic concepts that rationalize the properties and molecular bases of these essential processes.	[Natoli, Gioacchino] Humanitas Univ, Milan, Italy; [Natoli, Gioacchino] IRCCS Humanitas, Milan, Italy; [Ostuni, Renato] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Ostuni, Renato] Univ Vita Salute San Raffaele, Milan, Italy	Humanitas University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Natoli, G (corresponding author), Humanitas Univ, Milan, Italy.; Natoli, G (corresponding author), IRCCS Humanitas, Milan, Italy.; Ostuni, R (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy.; Ostuni, R (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	gioacchino.natoli@hunimed.eu; ostuni.renato@hsr.it	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020; Ostuni, Renato/AAB-8832-2022	Ostuni, Renato/0000-0003-0460-3426; Natoli, Gioacchino/0000-0003-0711-2411	European Research Council (ERC Advanced Grant) [692789]; European Commission; Cariplo Foundation; Italian Ministry of University and Research (MIUR); METRIC (METabolic Regulation of Inflammatory Cells); European Research Council [759532]; Italian Telethon Foundation [F04]; Italian Ministry of Health [GR-2016-02362156]; Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG) [20247]; European Union [Infect-ERA 126]; Cariplo Foundation [2015-0990]	European Research Council (ERC Advanced Grant)(European Research Council (ERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Cariplo Foundation(Fondazione Cariplo); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); METRIC (METabolic Regulation of Inflammatory Cells); European Research Council(European Research Council (ERC)European Commission); Italian Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG)(Fondazione AIRC per la ricerca sul cancro); European Union(European Commission); Cariplo Foundation(Fondazione Cariplo)	We are grateful to members of the G.N. and R.O. laboratories for scientific discussions and to S. Monticelli for critical reading of the manuscript. Research on related topics in the G.N. laboratory is supported by the European Research Council (ERC Advanced Grant 692789, MEDICI), the European Commission (Consortium grant SYSCYD), the Cariplo Foundation and the Italian Ministry of University and Research (MIUR, grant METRIC (METabolic Regulation of Inflammatory Cells). Research in the R.O. laboratory is supported by grants from the European Research Council (ERC Starting Grant 759532, X-TAM), the Italian Telethon Foundation (SR-Tiget grant award F04), the Italian Ministry of Health (GR-2016-02362156), the Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG, 20247), the Cariplo Foundation (2015-0990) and the European Union (Infect-ERA 126).	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chen KQ, 2015, EBIOMEDICINE, V2, P324, DOI 10.1016/j.ebiom.2015.03.001; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Daniel B, 2018, IMMUNITY, V49, P615, DOI 10.1016/j.immuni.2018.09.005; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ditadi A, 2017, NAT REV MOL CELL BIO, V18, P56, DOI 10.1038/nrm.2016.127; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gentek R, 2018, J EXP MED, V215, P2994, DOI 10.1084/jem.20181206; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kamada R, 2018, P NATL ACAD SCI USA, V115, pE9162, DOI 10.1073/pnas.1720930115; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Kaveh DA, 2014, VACCINE, V32, P6911, DOI 10.1016/j.vaccine.2014.10.041; Kayama H, 2018, P NATL ACAD SCI USA, V115, P8418, DOI 10.1073/pnas.1808426115; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; Lira FS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-82; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Miura T, 1995, BIOL PHARM BULL, V18, P1797; Miura T, 1997, BIOL PHARM BULL, V20, P1103; Monticelli S, 2019, TRENDS BIOCHEM SCI, V44, P589, DOI 10.1016/j.tibs.2019.01.009; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nelson VL, 2018, GENE DEV, V32, P1035, DOI 10.1101/gad.312355.118; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; NONO I, 1991, J PHARMACOBIO-DYNAM, V14, P9, DOI 10.1248/bpb1978.14.9; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Ozment TR, 2012, J PHARMACOL EXP THER, V342, P808, DOI 10.1124/jpet.112.196329; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Pope SD, 2018, MOL CELL, V71, P389, DOI 10.1016/j.molcel.2018.07.017; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Queiroz A, 2017, REV SOC BRAS MED TRO, V50, P9, DOI 10.1590/0037-8682-0230-2016; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Ruckerl D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006233; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Seeley JJ, 2017, J LEUKOCYTE BIOL, V101, P107, DOI 10.1189/jlb.3MR0316-118RR; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Smith FL, 2019, CURR OPIN IMMUNOL, V57, P23, DOI 10.1016/j.coi.2018.12.001; Smith NL, 2018, CELL, V174, P117, DOI 10.1016/j.cell.2018.05.029; Stone B. A, 2009, CHEM BIOCH BIOL 1 3; Sun JC, 2014, EMBO J, V33, P1295, DOI 10.1002/embj.201387651; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhu Y, 2017, IMMUNITY, V47, P597, DOI 10.1016/j.immuni.2017.08.018	113	68	69	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					783	792		10.1038/S41590-019-0399-9	http://dx.doi.org/10.1038/S41590-019-0399-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213714				2022-12-18	WOS:000471891900010
J	Altman, MC; Gill, MA; Whalen, E; Babineau, DC; Shao, BM; Liu, AH; Jepson, B; Gruchalla, RS; O'Connor, GT; Pongracic, JA; Kercsmar, CM; Hershey, GKK; Zoratti, EM; Johnson, CC; Teach, SJ; Kattan, M; Bacharier, LB; Beigelman, A; Sigelman, SM; Presnell, S; Gern, JE; Gergen, PJ; Wheatley, LM; Togias, A; Busse, WW; Jackson, DJ				Altman, Matthew C.; Gill, Michelle A.; Whalen, Elizabeth; Babineau, Denise C.; Shao, Baomei; Liu, Andrew H.; Jepson, Brett; Gruchalla, Rebecca S.; O'Connor, George T.; Pongracic, Jacqueline A.; Kercsmar, Carolyn M.; Hershey, Gurjit K. Khurana; Zoratti, Edward M.; Johnson, Christine C.; Teach, Stephen J.; Kattan, Meyer; Bacharier, Leonard B.; Beigelman, Avraham; Sigelman, Steve M.; Presnell, Scott; Gern, James E.; Gergen, Peter J.; Wheatley, Lisa M.; Togias, Alkis; Busse, William W.; Jackson, Daniel J.			Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children	NATURE IMMUNOLOGY			English	Article							BRONCHIAL EPITHELIAL-CELLS; EPIDERMAL-GROWTH-FACTOR; GENOME-WIDE EXPRESSION; CHILDHOOD ASTHMA; INFECTIONS; ENVIRONMENT; INHALATION; BRADYKININ; RECEPTORS; INDUCTION	Respiratory infections are common precursors to asthma exacerbations in children, but molecular immune responses that determine whether and how an infection causes an exacerbation are poorly understood. By using systems-scale network analysis, we identify repertoires of cellular transcriptional pathways that lead to and underlie distinct patterns of asthma exacerbation. Specifically, in both virus-associated and nonviral exacerbations, we demonstrate a set of core exacerbation modules, among which epithelial-associated SMAD3 signaling is upregulated and lymphocyte response pathways are downregulated early in exacerbation, followed by later upregulation of effector pathways including epidermal growth factor receptor signaling, extracellular matrix production, mucus hypersecretion, and eosinophil activation. We show an additional set of multiple inflammatory cell pathways involved in virus-associated exacerbations, in contrast to squamous cell pathways associated with nonviral exacerbations. Our work introduces an in vivo molecular platform to investigate, in a clinical setting, both the mechanisms of disease pathogenesis and therapeutic targets to modify exacerbations.	[Altman, Matthew C.] Univ Washington, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [Altman, Matthew C.; Whalen, Elizabeth; Presnell, Scott] Benaroya Res Inst, Syst Immunol Program, Seattle, WA 98101 USA; [Gill, Michelle A.; Shao, Baomei; Gruchalla, Rebecca S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Babineau, Denise C.; Jepson, Brett] Rho Inc, Chapel Hill, NC USA; [Liu, Andrew H.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Allergy & Immunol, Aurora, CO USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Pongracic, Jacqueline A.] Ann Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Kercsmar, Carolyn M.; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Zoratti, Edward M.; Johnson, Christine C.] Henry Ford Hlth Syst, Detroit, MI USA; [Teach, Stephen J.] Childrens Natl Hlth Syst, Washington, DC USA; [Kattan, Meyer] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Bacharier, Leonard B.; Beigelman, Avraham] Washington Univ, Div Allergy Immunol & Pulm Med, St Louis, MO USA; [Sigelman, Steve M.; Gergen, Peter J.; Wheatley, Lisa M.; Togias, Alkis] NIAID, Div Allergy Immunol & Transplantat, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gern, James E.; Busse, William W.; Jackson, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rho; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Boston University; Ann & Robert H. Lurie Children's Hospital of Chicago; Cincinnati Children's Hospital Medical Center; Henry Ford Health System; Henry Ford Hospital; Children's National Health System; Columbia University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison	Altman, MC (corresponding author), Univ Washington, Dept Allergy & Infect Dis, Seattle, WA 98195 USA.; Altman, MC (corresponding author), Benaroya Res Inst, Syst Immunol Program, Seattle, WA 98101 USA.	maltman@benaroyaresearch.org		Altman, Matthew/0000-0002-1784-8505; Bacharier, Leonard/0000-0003-0432-2704	federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services [1UM1AI114271, UM2AI117870]; CTSA [UL1TR000150, UL1TR001422, 5UL1TR001425]; NCRR/NIH [UL1TR000451]; CTSI [1UL1TR001430]; CCTSI [UL1TR001082, 5UM1AI114271]; NCATS/NIH [UL1 TR001876, UL1TR002345]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR001876, UL1TR001425, UL1TR002345, UL1TR001422, UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI114271, UM2AI117870] Funding Source: NIH RePORTER	federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CTSI; CCTSI; NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, under contract numbers 1UM1AI114271 awarded to W.W.B. and UM2AI117870 awarded to Rho, Inc. Additional support comes from CTSA UL1TR000150 and UL1TR001422 to J.A.P., 5UL1TR001425 to G.K.K.H., NCRR/NIH UL1TR000451 to M.A.G. and R.S.G., CTSI 1UL1TR001430 to G.T.O., CCTSI UL1TR001082 to A.H.L., 5UM1AI114271 to W.W.B. and J.E.G., NCATS/NIH UL1 TR001876 to S.J.T., and UL1TR002345 to L.B.B. We are grateful to all participants and their families who took part in this study. We thank all of the investigators and staff of the National Institutes of Allergy and Infectious Diseases Inner City Asthma Consortium. We thank the Benaroya Research Institute Genomics and Bioinformatics cores for assistance with sample handling, data generation, and RNA sequencing alignment. We would like to thank P. Woodruff, J. Boyce, and S. Durham for assistance with methodological development as well as advice and discussion.	Al-Alawi M, 2014, RESP MED, V108, P1409, DOI 10.1016/j.rmed.2014.08.008; Altman MC, 2018, J ALLERGY CLIN IMMUN, V142, P451, DOI 10.1016/j.jaci.2017.10.004; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2007, J ALLERGY CLIN IMMUN, V120, pS94, DOI 10.1016/j.jaci.2007.09.029; Berube JC, 2014, EXPERT REV CLIN IMMU, V10, P985, DOI 10.1586/1744666X.2014.932249; Bigler J, 2017, AM J RESP CRIT CARE, V195, P1311, DOI 10.1164/rccm.201604-0866OC; Bochkov YA, 2014, J CLIN MICROBIOL, V52, P2461, DOI 10.1128/JCM.00075-14; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bonser LR, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120112; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; CHRISTIANSEN SC, 1992, AM REV RESPIR DIS, V145, P900, DOI 10.1164/ajrccm/145.4_Pt_1.900; Coggins CRE, 1998, TOXICOL PATHOL, V26, P307, DOI 10.1177/019262339802600301; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; Drazen JM, 2018, NEW ENGL J MED, V378, P2533, DOI 10.1056/NEJMe1806037; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Fahy JV, 2001, AM J RESP CRIT CARE, V163, P1470, DOI 10.1164/ajrccm.163.6.9901105; Farne HA, 2017, CURR OPIN IMMUNOL, V48, P31, DOI 10.1016/j.coi.2017.07.017; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim JT, 1997, J IMMUNOL, V159, P926; Kloepfer KM, 2012, AM J RESP CRIT CARE, V185, P1275, DOI 10.1164/rccm.201109-1635OC; Kuo CHS, 2017, AM J RESP CRIT CARE, V195, P443, DOI 10.1164/rccm.201512-2452OC; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Loffredo LF, 2017, ALLERGY, V72, P1988, DOI 10.1111/all.13222; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Mihaylova VT, 2018, CELL REP, V24, P3000, DOI 10.1016/j.celrep.2018.08.033; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Patel DA, 2014, J ALLERGY CLIN IMMUN, V134, P1402, DOI 10.1016/j.jaci.2014.07.013; Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Persson H, 2015, J ALLERGY CLIN IMMUN, V136, P638, DOI 10.1016/j.jaci.2015.02.026; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Reeves SR, 2014, J ALLERGY CLIN IMMUN, V134, P663, DOI 10.1016/j.jaci.2014.04.007; Ricciardolo FLM, 2018, EUR J PHARMACOL, V827, P181, DOI 10.1016/j.ejphar.2018.03.017; Ricciardolo FLM, 2013, THORAX, V68, P803, DOI 10.1136/thoraxjnl-2012-202741; Ricciardolo FLM, 1999, AM J RESP CRIT CARE, V159, P557, DOI 10.1164/ajrccm.159.2.9804022; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V136, P885, DOI 10.1016/j.jaci.2015.02.035; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wesolowska-Andersen A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1140-8; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003	66	68	70	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					637	+		10.1038/s41590-019-0347-8	http://dx.doi.org/10.1038/s41590-019-0347-8			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30962590	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000465084800020
J	Milpied, P; Cervera-Marzal, I; Mollichella, ML; Tesson, B; Brisou, G; Traverse-Glehen, A; Salles, G; Spinelli, L; Nadel, B				Milpied, Pierre; Cervera-Marzal, Inaki; Mollichella, Marie-Laure; Tesson, Bruno; Brisou, Gabriel; Traverse-Glehen, Alexandra; Salles, Gilles; Spinelli, Lionel; Nadel, Bertrand			Human germinal center transcriptional programs are de-synchronized in B cell lymphoma	NATURE IMMUNOLOGY			English	Article							FOLLICULAR LYMPHOMA; MONOCLONAL-ANTIBODIES; CENTER LIGHT; EXPRESSION; TRANSFORMATION; PATHOGENESIS; GENERATION; DYNAMICS; PROMOTES; CYCLE	Most adult B cell lymphomas originate from germinal center (GC) B cells, but it is unclear to what extent B cells in overt lymphoma retain the functional dynamics of GC B cells or are blocked at a particular stage of the GC reaction. Here we used integrative single-cell analysis of phenotype, gene expression and variable-region sequence of the immunoglobulin heavy-chain locus to track the characteristic human GC B cell program in follicular lymphoma B cells. By modeling the cyclic continuum of GC B cell transitional states, we identified characteristic patterns of synchronously expressed gene clusters. GC-specific gene-expression synchrony was lost in single lymphoma B cells. However, distinct follicular lymphoma-specific cell states co-existed within single patient biopsies. Our data show that lymphoma B cells are not blocked in a GC B cell state but might adopt new dynamic modes of functional diversity, which opens the possibility of novel definitions of lymphoma identity.	[Milpied, Pierre; Cervera-Marzal, Inaki; Mollichella, Marie-Laure; Brisou, Gabriel; Spinelli, Lionel; Nadel, Bertrand] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Tesson, Bruno] Inst Carnot CALYM, Pierre Benite, France; [Traverse-Glehen, Alexandra; Salles, Gilles] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, INSERM 1052, Pierre Benite, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Milpied, P; Nadel, B (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	milpied@ciml.univ-mrs.fr; nadel@ciml.univ-mrs.fr	Salles, Gilles/Z-2336-2019; Milpied, Pierre J/Q-1380-2015; Nadel, Bertrand/J-2197-2014; Spinelli, Lionel/M-5189-2016	Salles, Gilles/0000-0002-9541-8666; Milpied, Pierre J/0000-0003-1873-5358; Spinelli, Lionel/0000-0001-9228-8141; Nadel, Bertrand/0000-0002-4644-5617; Cervera-Marzal, Inaki/0000-0002-9341-2252	Fondation ARC [PGA 120150202381]; Canceropole Provence-Alpes-Cote d'Azur; Medimmune [11799A10]; Fondation pour la Recherche Medicale; GEFLUC Marseille	Fondation ARC; Canceropole Provence-Alpes-Cote d'Azur; Medimmune(AstraZenecaMedimmune); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); GEFLUC Marseille	We thank all members of the Nadel laboratory, especially S. Roulland, for discussions and comments; the bioinformatics platform of Centre d'Immunologie de Marseille-Luminy; J. Hardwigsen (Assistance Publique - Hopitaux de Marseille) for normal human spleen samples; Mi-Mabs and Canceropole Provence-Alpes-Cote d'Azur for support in the single-cell qPCR analysis platform; and HalioDX for providing access to the 10x Genomics Chromium system. Supported by Fondation ARC (fellowship to P.M.; PGA 120150202381 to B.N.; and grants to P.M.), Canceropole Provence-Alpes-Cote d'Azur (I.C.-M.; and grants to P.M.), Medimmune (11799A10 for M.-L.M.), Fondation pour la Recherche Medicale (G.B.) and GEFLUC Marseille (grants to P.M.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Carlotti E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134833; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Garcia-Ramirez I, 2017, BLOOD, V129, P2645, DOI 10.1182/blood-2016-08-733469; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Hardianti MS, 2004, LEUKEMIA, V18, P826, DOI 10.1038/sj.leu.2403323; Hashwah H, 2017, P NATL ACAD SCI USA, V114, P9701, DOI 10.1073/pnas.1619555114; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Jiang YW, 2016, CURR OPIN HEMATOL, V23, P377, DOI 10.1097/MOH.0000000000000249; Koues OI, 2015, IMMUNITY, V42, P186, DOI 10.1016/j.immuni.2014.12.021; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Kridel R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002197; Kridel R, 2012, J CLIN INVEST, V122, P3424, DOI 10.1172/JCI63186; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mourcin F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00280; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Roulland S, 2011, ADV IMMUNOL, V111, P1, DOI 10.1016/B978-0-12-385991-4.00001-5; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; Tellier J, 2014, BLOOD, V123, P3462, DOI 10.1182/blood-2013-12-545954; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	57	68	70	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1013	+		10.1038/s41590-018-0181-4	http://dx.doi.org/10.1038/s41590-018-0181-4			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30104629				2022-12-18	WOS:000442365100022
J	Rollenske, T; Szijarto, V; Lukasiewicz, J; Guachalla, LM; Stojkovic, K; Hartl, K; Stulik, L; Kocher, S; Lasitschka, F; Al-Saeedi, M; Schroder-Braunstein, J; von Frankenberg, M; Gaebelein, G; Hoffmann, P; Klein, S; Heeg, K; Nagy, E; Nagy, G; Wardemann, H				Rollenske, Tim; Szijarto, Valeria; Lukasiewicz, Jolanta; Guachalla, Luis M.; Stojkovic, Katarina; Hartl, Katharina; Stulik, Lukas; Kocher, Simone; Lasitschka, Felix; Al-Saeedi, Mohammed; Schroeder-Braunstein, Jutta; von Frankenberg, Moritz; Gaebelein, Gereon; Hoffmann, Peter; Klein, Sabrina; Heeg, Klaus; Nagy, Eszter; Nagy, Gabor; Wardemann, Hedda			Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; EFFICIENT GENERATION; LIPOPOLYSACCHARIDE; GUT; IGA; DIFFERENTIATION; POLYSACCHARIDE; IDENTIFICATION; MICROBIOTA	Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM(+)) and IgA(+) memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.	[Rollenske, Tim; Wardemann, Hedda] Max Planck Inst Infect Biol, Max Planck Res Grp Mol Immunol, Berlin, Germany; [Rollenske, Tim; Kocher, Simone; Wardemann, Hedda] German Canc Res Ctr, Div Cell Immunol B, Heidelberg, Germany; [Szijarto, Valeria; Guachalla, Luis M.; Hartl, Katharina; Stulik, Lukas; Nagy, Eszter; Nagy, Gabor] Arsanis Biosci, Vienna, Austria; [Lukasiewicz, Jolanta; Stojkovic, Katarina] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland; [Lasitschka, Felix] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Al-Saeedi, Mohammed] Univ Hosp Heidelberg, Dept Gen & Transplant Surg, Heidelberg, Germany; [Schroeder-Braunstein, Jutta] Univ Hosp Heidelberg, Inst Immunol, Heidelberg, Germany; [von Frankenberg, Moritz] Hosp Salem, Dept Gen Abdominal & Minimal Invas Surg, Heidelberg, Germany; [Gaebelein, Gereon] Univ Hosp Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany; [Hoffmann, Peter] Univ Hosp Heidelberg, Dept Gastroenterol, Heidelberg, Germany; [Klein, Sabrina; Heeg, Klaus] Univ Hosp Heidelberg, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Gaebelein, Gereon] Saarland Univ, Med Ctr, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leipzig University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes	Wardemann, H (corresponding author), Max Planck Inst Infect Biol, Max Planck Res Grp Mol Immunol, Berlin, Germany.; Wardemann, H (corresponding author), German Canc Res Ctr, Div Cell Immunol B, Heidelberg, Germany.	h.wardemann@dkfz.de		Wardemann, Hedda/0000-0003-3921-5933; Lasitschka, Felix/0000-0002-3212-1881; Lukasiewicz, Jolanta/0000-0001-8081-7261; Guachalla, Luis Miguel/0000-0003-1152-9930; /0000-0003-1982-3253; Stulik, Lukas/0000-0002-9055-3690	European Funding Program Eurostars by EUREKA [E! 7563 - KLEBSICURE]; German Federal Ministry of Education and Research; International Max Planck Research School for Infectious Diseases and Immunology; European Funding Program Eurostars by European Community	European Funding Program Eurostars by EUREKA; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); International Max Planck Research School for Infectious Diseases and Immunology; European Funding Program Eurostars by European Community	We thank S. Kaluzewski (National Institute of Public Health-National Institute of Hygiene) for an unencapsulated mutant of a prototype O3:K55 strain 5505; S. Melegh (University of Pecs) for clinical isolates Kp2 (O3:K60) and Kp14 (O3:K35); A. Valverde (University Hospital Ramon y Cajal) for clinical isolate Kp81 (O3b:K non-typeable); A. Heidtmann, L. Kummer, B. Jocher and J. Braun for help with sample acquisition; C. Varga for performing animal experiments; C. Busse for help with experimental design; M. Nussenzweig (The Rockefeller University) for recombinant gp140 from strain YU2; and P. Sehr, R. Murugan, P. Thiele, C. Winter, D. Foster, A. Gotze and the DKFZ High-Throughput Sequencing Unit of the Genomics and Proteomics Core Facility and the DKFZ and MPIIB Flow Cytometry Core Facilities for technical support. Supported by the European Funding Program Eurostars (E! 7563 - KLEBSICURE), powered by EUREKA and the European Community; the German Federal Ministry of Education and Research (H.W.); and the International Max Planck Research School for Infectious Diseases and Immunology (T.R.).	Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bayhan GI, 2015, JPN J INFECT DIS, V68, P50, DOI 10.7883/yoken.JJID.2014.051; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104; Coughlin RT, 1998, VACCINE, V16, P1761, DOI 10.1016/S0264-410X(98)00139-X; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guachalla LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06682-2; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Imkeller K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0920-1; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Julianelle LA, 1926, J EXP MED, V44, P683, DOI 10.1084/jem.44.5.683; Kubinak JL, 2016, NAT REV IMMUNOL, V16, P767, DOI 10.1038/nri.2016.114; Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Lorin V, 2015, J IMMUNOL METHODS, V422, P102, DOI 10.1016/j.jim.2015.04.010; Macpherson AJ, 2015, TRENDS IMMUNOL, V36, P460, DOI 10.1016/j.it.2015.06.006; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Murugan R, 2015, EUR J IMMUNOL, V45, P2698, DOI 10.1002/eji.201545526; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Polonskaya Z, 2017, J CLIN INVEST, V127, P1491, DOI 10.1172/JCI91192; RCore Team, 2022, R LANG ENV STAT COMP; SHATTOCK PMF, 1955, J GEN MICROBIOL, V12, P367, DOI 10.1099/00221287-12-2-367; Stojkovic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00684; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Szijarto V, 2015, ANTIMICROB AGENTS CH, V59, P3109, DOI 10.1128/AAC.04494-14; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tillett WS, 1929, J EXP MED, V50, P551, DOI 10.1084/jem.50.5.551; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warnes G.R., 2009, R PACKAGE VERSION, V2, P1; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002	51	68	69	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					617	+		10.1038/s41590-018-0106-2	http://dx.doi.org/10.1038/s41590-018-0106-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29760533				2022-12-18	WOS:000433041500027
J	Jin, GX; Xu, C; Zhang, X; Long, J; Rezaeian, AH; Liu, CF; Furth, ME; Kridel, S; Pasche, B; Bian, XW; Lin, HK				Jin, Guoxiang; Xu, Chuan; Zhang, Xian; Long, Jie; Rezaeian, Abdol Hossein; Liu, Chunfang; Furth, Mark E.; Kridel, Steven; Pasche, Boris; Bian, Xiu-Wu; Lin, Hui-Kuan			Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; MEMBRANE PROTEIN; PINK1; MITOCHONDRIA; AUTOPHAGY; PARKIN; METABOLISM; MAINTENANCE; RECEPTORS; REMOVAL	Although deletion of certain autophagy-related genes has been associated with defects in hematopoiesis, it remains unclear whether hyperactivated mitophagy affects the maintenance and differentiation of hematopoietic stem cells (HSCs) and committed progenitor cells. Here we report that targeted deletion of the gene encoding the AAA+-ATPase Atad3a hyperactivated mitophagy in mouse hematopoietic cells. Affected mice showed reduced survival, severely decreased bone-marrow cellularity, erythroid anemia and B cell lymphopenia. Those phenotypes were associated with skewed differentiation of stem and progenitor cells and an enlarged HSC pool. Mechanistically, Atad3a interacted with the mitochondrial channel components Tom40 and Tim23 and served as a bridging factor to facilitate appropriate transportation and processing of the mitophagy protein Pink1. Loss of Atad3a caused accumulation of Pink1 and activated mitophagy. Notably, deletion of Pink1 in Atad3a-deficient mice significantly 'rescued' the mitophagy defect, which resulted in restoration of the progenitor and HSC pools. Our data indicate that Atad3a suppresses Pink1-dependent mitophagy and thereby serves a key role in hematopoietic homeostasis.	[Jin, Guoxiang; Xu, Chuan; Bian, Xiu-Wu] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China; [Jin, Guoxiang; Xu, Chuan; Bian, Xiu-Wu] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China; [Jin, Guoxiang; Xu, Chuan; Zhang, Xian; Long, Jie; Liu, Chunfang; Kridel, Steven; Pasche, Boris; Lin, Hui-Kuan] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27101 USA; [Jin, Guoxiang; Xu, Chuan; Zhang, Xian; Long, Jie; Rezaeian, Abdol Hossein; Liu, Chunfang; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Chuan] Chengdu Mil Gen Hosp, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Long, Jie] Guangzhou Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Furth, Mark E.] Wake Forest Baptist Med Ctr, Wake Forest Innovat, Winston Salem, NC USA; [Lin, Hui-Kuan] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lin, Hui-Kuan] Asia Univ, Dept Biotechnol, Taichung, Taiwan	Army Medical University; Army Medical University; Wake Forest University; University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; Wake Forest University; Wake Forest Baptist Medical Center; China Medical University Taiwan; Asia University Taiwan	Bian, XW (corresponding author), Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China.; Bian, XW (corresponding author), Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing, Peoples R China.; Lin, HK (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27101 USA.; Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Lin, HK (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Lin, HK (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	bianxiuwu@263.net; hulin@wakehealth.edu	Rezaeian, Abdol-Hossein/AAV-6900-2021; Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; XU, CHUAN/0000-0002-5320-2277; Zhang, Xian/0000-0001-9674-7886	National Key Research and Development Program of China [2016YFA0101200]; National Natural Science Foundation of China [61327902-04]; US National Institutes of Health [R01 CA182424, R01 CA193813]; Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA193813, R01CA182424] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank X. Lin (MD Anderson Cancer Center) for the for FLP transgenic mouse; T.L. Schwarz (Boston Children's Hospital) for the Pink1-encoding plasmid; J. Baudier (Universite d<SUP>1</SUP>Aix-Marseille) and D. Rousseau (University Grenoble Alpes) for antibodies to Atad3a; J. Parker-Thornburg and J. Alana for blastocyst microinjection; D.P. Pollock for microarray analysis; K. Dunner for transmission-electron-microscopy imaging; B. Zhen and S. Zhang for technical assistance; the flow cytometry core facility at MD Anderson Cancer Center and Wake Forest School of Medicine for flow cytometry analysis; D. D. Sarbassov and the members of the Lin laboratory for comments and suggestions; and X. Zhou for the assistance in statistical analysis. Supported by the National Key Research and Development Program of China (2016YFA0101200 to X.-W.B.), the National Natural Science Foundation of China (61327902-04 to X.-W.B.), the US National Institutes of Health (R01 CA182424 and R01 CA193813 to H.-K.L.) and Wake Forest University School of Medicine (start-up funds to H.-K.L.).	Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Goller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054799; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Joshi A, 2013, AUTOPHAGY, V9, P1737, DOI 10.4161/auto.26681; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1; Kim HR, 2008, J KOREAN MED SCI, V23, P1062, DOI 10.3346/jkms.2008.23.6.1062; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lelliott CJ, 2009, ADV EXP MED BIOL, V646, P133, DOI 10.1007/978-1-4020-9173-5_15; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vannini N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13125; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007	45	68	71	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					29	+		10.1038/s41590-017-0002-1	http://dx.doi.org/10.1038/s41590-017-0002-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242539	Green Accepted			2022-12-18	WOS:000419765300011
J	Kaplan, DH				Kaplan, Daniel H.			Ontogeny and function of murine epidermal Langerhans cells	NATURE IMMUNOLOGY			English	Review							DERMAL DENDRITIC CELLS; REGULATORY T-CELLS; ALLERGIC CONTACT-DERMATITIS; STEADY-STATE CONDITIONS; IN-VIVO; IMMUNE-RESPONSES; TISSUE-RESIDENT; TGF-BETA; AUTOCRINE/PARACRINE TGF-BETA-1; ATOPIC-DERMATITIS	Langerhans cells (LCs) are epidermis-resident antigen-presenting cells that share a common ontogeny with macrophages but function as dendritic cells (DCs). Their development, recruitment and retention in the epidermis is orchestrated by interactions with keratinocytes through multiple mechanisms. LC and dermal DC subsets often show functional redundancy, but LCs are required for specific types of adaptive immune responses when antigen is concentrated in the epidermis. This Review will focus on those developmental and functional properties that are unique to LCs.	[Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA.; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	dankaplan@pitt.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health [R01AR060744, R01AR067187, R01AR071720]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067187, R01AR071720, R01AR060744] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health (R01AR060744, R01AR067187, and R01AR071720). We would like to apologize to all authors whose work was not cited or discussed in depth. Given the length limitation, we were unable to be comprehensive in this review.	Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Antonopoulos H, 2001, J IMMUNOL, V166, P3672, DOI 10.4049/jimmunol.166.6.3672; Bauer T, 2012, J EXP MED, V209, P2033, DOI 10.1084/jem.20120493; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2011, BLOOD, V117, P7063, DOI 10.1182/blood-2011-01-329185; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carpentier S, 2016, J IMMUNOL METHODS, V432, P35, DOI 10.1016/j.jim.2016.02.023; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Deckers J., 2017, J ALLERGY CLIN IMMUN; Didovic S, 2016, EUR J IMMUNOL, V46, P981, DOI 10.1002/eji.201545710; Eaton LH, 2015, IMMUNOLOGY, V144, P139, DOI 10.1111/imm.12359; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Flacher V, 2014, EMBO MOL MED, V6, P1191, DOI 10.15252/emmm.201303283; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Griffiths CEM, 2005, CYTOKINE, V32, P67, DOI 10.1016/j.cyto.2005.07.011; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kashem SW, 2017, ANNU REV IMMUNOL, V35, P469, DOI 10.1146/annurev-immunol-051116-052215; Kashem SW, 2015, IMMUNITY, V42, P356, DOI 10.1016/j.immuni.2015.01.008; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KLARESKOG L, 1977, NATURE, V265, P248, DOI 10.1038/265248a0; Kobayashi C, 2012, J INVEST DERMATOL, V132, P241, DOI 10.1038/jid.2011.280; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levin C, 2017, J INVEST DERMATOL, V137, P1905, DOI 10.1016/j.jid.2017.04.016; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Linehan JL, 2015, P NATL ACAD SCI USA, V112, P12782, DOI 10.1073/pnas.1513532112; Martini E, 2017, J INVEST DERMATOL, V137, P865, DOI 10.1016/j.jid.2016.11.033; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Park HY, 2013, J IMMUNOL, V191, P4919, DOI 10.4049/jimmunol.1301947; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; ROWDEN G, 1977, NATURE, V268, P247, DOI 10.1038/268247a0; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Scholz F, 2015, J IMMUNOL, V195, P2335, DOI 10.4049/jimmunol.1500935; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; SILBERBERGSINAKIN I, 1976, CELL IMMUNOL, V25, P137, DOI 10.1016/0008-8749(76)90105-2; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Sparber F, 2015, J INVEST DERMATOL, V135, P119, DOI 10.1038/jid.2014.324; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; STINGL G, 1977, NATURE, V268, P245, DOI 10.1038/268245a0; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Strandt H, 2017, J IMMUNOL, V199, P1626, DOI 10.4049/jimmunol.1602098; Tan SY, 2015, IMMUNOL CELL BIOL, V93, P337, DOI 10.1038/icb.2015.16; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Villablanca EJ, 2008, EUR J IMMUNOL, V38, P2975, DOI 10.1002/eji.200838919; Wang B, 1996, IMMUNOLOGY, V88, P284, DOI 10.1111/j.1365-2567.1996.tb00016.x; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yao C, 2015, J ALLERGY CLIN IMMUN, V136, P1387, DOI 10.1016/j.jaci.2015.04.001; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Zaric M, 2015, J INVEST DERMATOL, V135, P425, DOI 10.1038/jid.2014.415; Zimara N, 2014, EUR J IMMUNOL, V44, P2955, DOI 10.1002/eji.201344263	110	68	74	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1068	1075		10.1038/ni.3815	http://dx.doi.org/10.1038/ni.3815			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926543	Green Accepted			2022-12-18	WOS:000411134000011
J	Yang, XO; Angkasekwinai, P; Zhu, JF; Peng, J; Liu, ZD; Nurieva, R; Liu, XK; Chung, Y; Chang, SH; Sun, B; Dong, C				Yang, Xuexian O.; Angkasekwinai, Pornpimon; Zhu, Jinfang; Peng, Juan; Liu, Zhiduo; Nurieva, Roza; Liu, Xikui; Chung, Yeonseok; Chang, Seon Hee; Sun, Bing; Dong, Chen			Requirement for the basic helix-loop-helix transcription factor Dec2 in initial T(H)2 lineage commitment	NATURE IMMUNOLOGY			English	Article							T-CELLS; SCHISTOSOMA-MANSONI; TH2 DIFFERENTIATION; EXPRESSION; RESPONSES; GENE; JUNB; IL-2; IDENTIFICATION; GENERATION	How naive CD4(+) T cells commit to the T helper type 2 (T(H)2) lineage is poorly understood. Here we show that the basic helix-loop-helix transcription factor Dec2 was selectively expressed in T(H)2 cells. CD4(+) T cells from Dec2- deficient mice showed defective T(H)2 differentiation in vitro and in vivo in an asthma model and in response to challenge with a parasite antigen. Dec2 promoted expression of interleukin 4 (IL-4), IL-5 and IL-13 during early T(H)2 differentiation and directly bound to and activated transcription of genes encoding the transcription factors JunB and GATA-3. As GATA-3 induces Dec2 expression, our findings also indicate a feed-forward regulatory circuit during T(H)2 differentiation.	[Yang, Xuexian O.; Angkasekwinai, Pornpimon; Peng, Juan; Nurieva, Roza; Liu, Xikui; Chung, Yeonseok; Chang, Seon Hee; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Angkasekwinai, Pornpimon] Thammasat Univ, Fac Allied Hlth Sci, Pathum Than, Thailand; [Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Peng, Juan] Wuhan Univ, Zhongnan Hosp, Dept Resp Dis, Wuhan, Hubei, Peoples R China; [Liu, Zhiduo; Sun, Bing] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Thammasat University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xoyang@mdanderson.org; bsun@sibs.ac.cn; cdong@mdanderson.org	dong, chen/B-3181-2009; Zhu, Jinfang/B-7574-2012; Chang, Seon Hee/AAQ-9521-2020; Yang, Xuexian/Y-2472-2019; Angkasekwinai, Pornpimon/AAX-6124-2020	dong, chen/0000-0002-0084-9130; Zhu, Jinfang/0000-0002-0117-4745; Chang, Seon Hee/0000-0002-9389-508X; Yang, Xuexian/0000-0001-6816-7024; Angkasekwinai, Pornpimon/0000-0003-0303-9544; Chung, Yeonseok/0000-0001-5780-4841	National Institutes of Health; MD Anderson Center for Targeted Therapy; American Heart Association; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Ministry of Education of China; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050761, R01AI050761, U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Center for Targeted Therapy; American Heart Association(American Heart Association); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education of China(Ministry of Education, China); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Rivera and J. Parker-Thornburg of the MD Anderson Genetic Engineered Mouse Facility for help in generating knockout and transgenic animals; K. Murphy (Washington University) for the GFP-RV and GFP-RV-GATA-3 vectors; Y. Belkaid (National Institute of Allergy and Infectious Diseases, National Institutes of Health) for S. mansoni eggs and suggestions; and members of the Dong laboratory for help and discussion. Supported by the National Institutes of Health (C.D. and R.N.), the MD Anderson Center for Targeted Therapy (C.D. and R.N.), the American Heart Association (X.O.Y. and R.N.), the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (J.Z.), the Ministry of Education of China (J.P.) and the Leukemia and Lymphoma Society (C.D.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Bunting K, 2006, VITAM HORM, V74, P105, DOI 10.1016/S0083-6729(06)74005-5; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Dong C, 2003, IMMUNOL RES, V28, P39, DOI 10.1385/IR:28:1:39; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Glimcher LH, 2000, GENE DEV, V14, P1693; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J IMMUNOL, V148, P1240; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Voice J, 2004, J IMMUNOL, V172, P7289, DOI 10.4049/jimmunol.172.12.7289; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	40	68	72	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1260	U5		10.1038/ni.1821	http://dx.doi.org/10.1038/ni.1821			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19881507	Green Accepted			2022-12-18	WOS:000271872800009
J	Chirifu, M; Hayashi, C; Nakamura, T; Toma, S; Shuto, T; Kai, H; Yamagata, Y; Davis, SJ; Ikemizu, S				Chirifu, Mami; Hayashi, Chiharu; Nakamura, Teruya; Toma, Sachiko; Shuto, Tsuyoshi; Kai, Hirofumi; Yamagata, Yuriko; Davis, Simon J.; Ikemizu, Shinji			Crystal structure of the IL-15-IL-15R alpha complex, a cytokine-receptor unit presented in trans	NATURE IMMUNOLOGY			English	Article							T-CELL PROLIFERATION; COMMON GAMMA-CHAIN; ALPHA-CHAIN; NATURAL-KILLER; BETA-CHAIN; INTERLEUKIN-2; IL-15; PROTEIN; HOMEOSTASIS; ACTIVATION	Interleukin 15 (IL-15) and IL-2, which promote the survival of memory CD8(+) T cells and regulatory T cells, respectively, bind receptor complexes that share beta- and gamma-signaling subunits. Receptor specificity is provided by unique, nonsignaling alpha-subunits. Whereas IL-2 receptor-alpha (IL-2R alpha) is expressed together in cis with the beta- and gamma-subunits on T cells and B cells, IL-15R alpha is expressed in trans on antigen-presenting cells. Here we present a 1.85-angstrom crystal structure of the human IL-15-IL-15R alpha complex. The structure provides insight into the molecular basis of the specificity of cytokine recognition and emphasizes the importance of water in generating this very high-affinity complex. Despite very low IL-15-IL-2 sequence homology and distinct receptor architecture, the topologies of the IL-15-IL-15R alpha and IL-2-IL-2R alpha complexes are very similar. Our data raise the possibility that IL-2, like IL-15, might be capable of being presented in trans in the context of its unique receptor a-chain.	Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; Kumamoto Univ, 21st Century Ctr Excellence Project, Kumamoto 8620973, Japan; Univ Tokyo, Grad Sch Sci & Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Med, Oxford OX3 9DS, England; Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England	Kumamoto University; Kumamoto University; University of Tokyo; University of Oxford; University of Oxford	Ikemizu, S (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, 5-1 Oe-honmachi, Kumamoto 8620973, Japan.	ikemizu@gpo.kumamoto-u.ac.jp		Nakamura, Teruya/0000-0003-2013-3057	Wellcome Trust [081894] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alves NL, 2007, IMMUNOL LETT, V108, P113, DOI 10.1016/j.imlet.2006.11.006; ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eicher DM, 1998, J IMMUNOL, V161, P5430; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liparoto SF, 2002, BIOCHEMISTRY-US, V41, P2543, DOI 10.1021/bi011692m; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Oh S, 2003, P NATL ACAD SCI USA, V100, P3392, DOI 10.1073/pnas.0630592100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettit DK, 1997, J BIOL CHEM, V272, P2312; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x	56	68	79	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					1001	1007		10.1038/ni1492	http://dx.doi.org/10.1038/ni1492			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17643103	Bronze			2022-12-18	WOS:000248918200024
J	Ferch, U; zum Bueschenfelde, CM; Gewies, A; Wegener, E; Rauser, S; Peschel, C; Krappmann, D; Ruland, J				Ferch, Uta; zum Bueschenfelde, Christian Meyer; Gewies, Andreas; Wegener, Elmar; Rauser, Sandra; Peschel, Christian; Krappmann, Daniel; Ruland, Juergen			MALT1 directs B cell receptor-induced canonical nuclear factor-kappa B signaling selectively to the c-Rel subunit	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE DEVELOPMENT; T-CELL; EXPRESSION; ACTIVATION; PROLIFERATION; TRANSCRIPTION; CARMA1; BCR; PHOSPHORYLATION; INDUCTION	NF-kappa B (Rel) transcription factors control physiological and pathological immune cell function. The scaffold proteins Bcl-10 and MALT1 couple antigen-receptor signals to the canonical NF-kappa B pathway and are pivotal in lymphomagenesis. Here we found that Bcl-10 and MALT1 differentially regulated B cell receptor-induced activation of RelA and c-Rel. Bcl-10 was essential for recruitment of the kinase IKK into lipid rafts for the activation of RelA and c-Rel, for blocking apoptosis and for inducing division after B cell receptor ligation. In contrast, MALT1 participated in survival signaling but was not involved in IKK recruitment or activation and was dispensable for RelA induction and proliferation. MALT1 selectively activated c-Rel to control a distinct subprogram. Our results provide mechanistic insights into B cell receptor-induced survival and proliferation signals and demonstrate the selective control of c-Rel in the canonical NF-kappa B pathway.	Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-81675 Munich, Germany; GSF Res Ctr Environm & Hlth, Inst Pathol, D-85764 Neuherberg, Germany; GSF Res Ctr Environm & Hlth, Inst Toxicol, D-85764 Neuherberg, Germany	Technical University of Munich	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-81675 Munich, Germany.	jruland@lrz.tum.de	Krappmann, Daniel/ABF-4038-2021; Krappmann, Daniel/AAT-4354-2021; Ruland, Jürgen/Q-6680-2018	Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Ruland, Jürgen/0000-0002-8381-3597; Gewies, Andreas/0000-0002-7606-6482				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Moreno-Garcia ME, 2006, ADV EXP MED BIOL, V584, P89; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schram BR, 2003, J IMMUNOL, V170, P3118, DOI 10.4049/jimmunol.170.6.3118; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Solvason N, 1998, J EXP MED, V187, P1081, DOI 10.1084/jem.187.7.1081; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vigorito E, 2005, BLOOD, V106, P2391, DOI 10.1182/blood-2004-12-4894; Wegener E, 2007, SCI STKE, V384, P21; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	42	68	72	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					984	991		10.1038/ni1493	http://dx.doi.org/10.1038/ni1493			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17660823				2022-12-18	WOS:000248918200022
J	Krieg, AM				Krieg, AM			A role for Toll in autoimmunity	NATURE IMMUNOLOGY			English	Editorial Material							SYSTEMIC LUPUS-ERYTHEMATOSUS; MURINE B-CELLS; BACTERIAL-DNA; CPG MOTIFS; STIMULATION; METHYLATION; INHIBITORS; ACTIVATION		Coley Pharmaceut Grp, Wellesley, MA 02481 USA	Coley Pharmaceutical Group	Krieg, AM (corresponding author), Coley Pharmaceut Grp, 93 Worcester St,Suite 101, Wellesley, MA 02481 USA.		Krieg, Arthur M/K-8109-2019; Krieg, Art/R-6166-2019					Chen Y, 2001, GENE THER, V8, P1024, DOI 10.1038/sj.gt.3301482; Gilkeson GS, 1996, J EXP MED, V183, P1389, DOI 10.1084/jem.183.4.1389; Goeckeritz BE, 1999, INT IMMUNOL, V11, P1693, DOI 10.1093/intimm/11.10.1693; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; KRIEG AM, 1995, J CLIN IMMUNOL, V15, P284, DOI 10.1007/BF01541318; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert P, 2001, ANTISENSE NUCLEIC A, V11, P247, DOI 10.1089/108729001317022241; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Sun SQ, 1997, J IMMUNOL, V159, P3119; Yi AK, 1998, J IMMUNOL, V160, P4755; YUNG RL, 1995, J IMMUNOL, V154, P3025	12	68	74	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					423	424		10.1038/ni0502-423	http://dx.doi.org/10.1038/ni0502-423			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976718				2022-12-18	WOS:000175411200009
J	Nathan, C; Muller, WA				Nathan, C; Muller, WA			Putting the brakes on innate immunity: a regulatory role for CD200?	NATURE IMMUNOLOGY			English	News Item							HYDROGEN-PEROXIDE; MACROPHAGES		Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Weill Cornell Med Coll, Dept Pathol, New York, NY 10021 USA; Weill Cornell Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.							Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; NATHAN CF, 1986, HOST RESISTANCE MECH, P165; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6	12	68	74	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					17	19		10.1038/83124	http://dx.doi.org/10.1038/83124			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135572				2022-12-18	WOS:000166261500009
J	Diamond, MS; Kanneganti, TD				Diamond, Michael S.; Kanneganti, Thirumala-Devi			Innate immunity: the first line of defense against SARS-CoV-2	NATURE IMMUNOLOGY			English	Review							INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; COVID-19; SARS; REPLICATION; MODULATION; CORONAVIRUSES; INTERFERONS; MECHANISMS; PANOPTOSIS	Kanneganti and Diamond review the key role played by innate immunity in the control and immunopathology of COVID-19. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2, continues to cause substantial morbidity and mortality. While most infections are mild, some patients experience severe and potentially fatal systemic inflammation, tissue damage, cytokine storm and acute respiratory distress syndrome. The innate immune system acts as the first line of defense, sensing the virus through pattern recognition receptors and activating inflammatory pathways that promote viral clearance. Here, we discuss innate immune processes involved in SARS-CoV-2 recognition and the resultant inflammation. Improved understanding of how the innate immune system detects and responds to SARS-CoV-2 will help identify targeted therapeutic modalities that mitigate severe disease and improve patient outcomes.	[Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443	US National Institutes of Health [AI101935, AI124346, AI160179, AR056296, CA253095]; American Lebanese Syrian Associated Charities; SARS-CoV-2 in the Diamond laboratory [AI157155]; NIAID Centers of Excellence for Influenza Research and Response [75N93021C00014]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); SARS-CoV-2 in the Diamond laboratory; NIAID Centers of Excellence for Influenza Research and Response	We apologize to our colleagues in the field whose work could not be cited due to space limitations. We thank members of the Kanneganti laboratory for their comments and suggestions. Additionally, we thank M. Zheng for scientific discussions and suggestions. Work from the Kanneganti laboratory is supported by the US National Institutes of Health (AI101935, AI124346, AI160179, AR056296 and CA253095 to T.-D.K.) and the American Lebanese Syrian Associated Charities (to T.-D.K.). Work on SARS-CoV-2 in the Diamond laboratory is supported by AI157155 and NIAID Centers of Excellence for Influenza Research and Response contract 75N93021C00014.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; American Association of Pediatrics and the Children's Hospital Association, CHILDR COVID 19 STAT; Amezcua-Guerra LM, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218100; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Banoth B, 2020, J BIOL CHEM, V295, P18276, DOI 10.1074/jbc.RA120.015924; Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bayati A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100306; Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360; Bhattacharjee Sukrita, 2020, SN Compr Clin Med, V2, P2048, DOI 10.1007/s42399-020-00521-8; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Booth A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247461; Borghi MO, 2020, FRONT IMMUNOL, V11, DOI [10.1101/2020.06.17.20134114, 10.3389/fimmu.2020.584241]; Briard B, 2020, PHYSIOLOGY, V35, P112, DOI 10.1152/physiol.00022.2019; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Burke JM, 2021, RNA, V27, P1318, DOI 10.1261/rna.078923.121; Burke SJ, 2018, MOL METAB, V14, P95, DOI 10.1016/j.molmet.2018.06.003; Campbell GR, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102295; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Caricchio R, 2021, JAMA-J AM MED ASSOC, V326, P230, DOI 10.1001/jama.2021.9508; Chen KL, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010047; Choudhury A, 2020, J MED VIROL, V92, P2105, DOI 10.1002/jmv.25987; Christgen S, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00237; Christgen S, 2020, CURR OPIN IMMUNOL, V62, P39, DOI 10.1016/j.coi.2019.11.007; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Doring Y, 2010, IMMUNOBIOLOGY, V215, P230, DOI 10.1016/j.imbio.2009.03.002; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Escobar LE, 2020, P NATL ACAD SCI USA, V117, P17720, DOI 10.1073/pnas.2008410117; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fajgenbaum David C, 2021, N Engl J Med, V384, pe59, DOI 10.1056/NEJMc2036236; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Feld JJ, 2021, LANCET RESP MED, V9, P498, DOI 10.1016/S2213-2600(20)30566-X; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Ferreira AC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00428-w; Forman R, 2021, HEALTH POLICY, V125, P553, DOI 10.1016/j.healthpol.2021.03.013; Franz KM, 2018, P NATL ACAD SCI USA, V115, pE2058, DOI 10.1073/pnas.1716937115; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2100433, 10.1056/NEJMoa2103417]; Gomes AMC, 2021, EUR J IMMUNOL, V51, P3194, DOI 10.1002/eji.202149311; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gursel M, 2020, ALLERGY, V75, P1815, DOI 10.1111/all.14345; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Han LL, 2021, J MED VIROL, V93, P5376, DOI 10.1002/jmv.27050; Hensel J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75491-x; Hoagland DA, 2021, IMMUNITY, V54, P557, DOI 10.1016/j.immuni.2021.01.017; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hsu JCC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101161118; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Humphries F, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi9002; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Hurst J, 2009, IMMUNOBIOLOGY, V214, P683, DOI 10.1016/j.imbio.2008.12.003; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jagannathan P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22177-1; Johns Hopkins University, 2021, COVID 19 DASHB; Jung S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5735; Junqueira Caroline, 2021, Res Sq, DOI [10.1101/2021.03.06.21252796, 10.21203/rs.3.rs-153628/v1]; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Kanneganti TD, 2020, IMMUNOL REV, V297, P5, DOI 10.1111/imr.12912; Karki R, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109858; Karki R, 2021, TRENDS IMMUNOL, V42, P681, DOI 10.1016/j.it.2021.06.001; Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025; Karki R, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136720; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kesavardhana S, 2020, J BIOL CHEM, V295, P8325, DOI 10.1074/jbc.RA120.013752; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185; Kumar A, 2021, MOL ASPECTS MED, V80, DOI 10.1016/j.mam.2021.101008; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Kyriazopoulou E, 2021, ELIFE, V10, DOI 10.7554/eLife.66125; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Lee S, 2021, NATURE, V597, P415, DOI 10.1038/s41586-021-03875-8; Lee S, 2020, TRENDS IMMUNOL, V41, P1083, DOI 10.1016/j.it.2020.10.005; Leentjens J, 2021, LANCET HAEMATOL, V8, DOI 10.1016/S2352-3026(21)00105-8; Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Lescure FX, 2021, LANCET RESP MED, V9, P522, DOI 10.1016/S2213-2600(21)00099-0; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Li MH, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi9007; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Liu GQ, 2021, NAT MICROBIOL, V6, P467, DOI 10.1038/s41564-021-00884-1; Liu W, 2021, J VIROL, V95, DOI 10.1128/JVI.00490-21; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211211; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Ma J, 2021, EMBO J, V40, DOI 10.15252/embj.2021108249; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Malireddi R K Subbarao, 2021, Immunohorizons, V5, P568, DOI 10.4049/immunohorizons.2100059; Malireddi R K Subbarao, 2020, Immunohorizons, V4, P789, DOI 10.4049/immunohorizons.2000097; Malireddi RKS, 2020, J EXP MED, V217, DOI 10.1084/jem.20191644; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Malireddi RKS, 2010, J IMMUNOL, V185, P3127, DOI 10.4049/jimmunol.1001512; Mao TY, 2022, J EXP MED, V219, DOI 10.1084/jem.20211818; Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7; Martin-Sancho L, 2021, MOL CELL, V81, P2656, DOI 10.1016/j.molcel.2021.04.008; Mudd PA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe3024; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Obatat R, 2021, JPN J INFECT DIS, V74, P307, DOI 10.7883/yoken.JJID.2020.884; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pan P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25015-6; Petruk G, 2020, J MOL CELL BIOL, V12, P916, DOI 10.1093/jmcb/mjaa067; Pfaender S., 2020, NAT MICROBIOL, V5, P1330, DOI DOI 10.1038/s41564-020-0769-y; Pontali E, 2021, J ALLERGY CLIN IMMUN, V147, P1217, DOI 10.1016/j.jaci.2021.01.024; Poor HD, 2021, CHEST, V160, P1471, DOI 10.1016/j.chest.2021.06.016; Potapov I, 2022, TRENDS IMMUNOL, V43, P4, DOI 10.1016/j.it.2021.11.004; Povysil G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147834; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rebendenne A, 2021, J VIROL, V95, DOI 10.1128/JVI.02415-20; Regeneron Pharmaceuticals Inc, 2020, FACT SHEET HLTH CAR; Ritter LA, 2021, J INTENSIVE CARE MED, V36, P1201, DOI 10.1177/08850666211032175; Rivas MN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145157; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Rosas IO, 2021, INTENS CARE MED, V47, P1258, DOI 10.1007/s00134-021-06507-x; Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5; Rui YJ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00515-5; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Sancho-Lopez A, 2021, INFECT DIS THER, V10, P2735, DOI 10.1007/s40121-021-00543-2; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schultze JL, 2021, CELL, V184, P1671, DOI 10.1016/j.cell.2021.02.029; Shahbazi M, 2021, J INTERF CYTOK RES, V41, P149, DOI 10.1089/jir.2020.0187; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Silverstein Noah J, 2021, medRxiv, DOI 10.1101/2021.01.14.21249839; Singh KK, 2020, AM J PHYSIOL-CELL PH, V319, pC258, DOI 10.1152/ajpcell.00224.2020; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Stanifer ML, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107863; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sui LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662989; Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Theobald SJ, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202114150; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Thorne LG, 2021, EMBO J, V40, DOI 10.15252/embj.2021107826; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; US Food & Drug Administration, 2021, EM US AUTH; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005; Wang S, 2021, NAT CELL BIOL, V23, P718, DOI 10.1038/s41556-021-00710-0; WHO, 2021, COVID 19 VACC TRACK; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wu J, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108761; Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu H., 2020, MICROBIOLOGY, DOI [10.27.357731, 10.1101/2020.10.27.357731]; Yamada T, 2021, NAT IMMUNOL, V22, P820, DOI 10.1038/s41590-021-00942-0; Yang DM, 2021, MILITARY MED RES, V8, DOI [10.1101/2021.02.10.430677, 10.1186/s40779-021-00340-5]; Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628; Yosuke F, 2021, J MED VIROL, V93, P4559, DOI 10.1002/jmv.26993; Zhang F, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00881-3; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhao JC, 2012, J VIROL, V86, P11416, DOI 10.1128/JVI.01410-12; Zhao YC, 2021, CELL RES, V31, P818, DOI 10.1038/s41422-021-00495-9; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zheng M, 2020, J BIOL CHEM, V295, P14040, DOI 10.1074/jbc.RA120.015036; Zheng M, 2020, CELL, V181, P674, DOI 10.1016/j.cell.2020.03.040; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou Q, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01061; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052	181	67	67	29	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					165	176		10.1038/s41590-021-01091-0	http://dx.doi.org/10.1038/s41590-021-01091-0		FEB 2022	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35105981	Bronze			2022-12-18	WOS:000749438000002
J	Liu, YY; Zhou, NN; Zhou, L; Wang, J; Zhou, YB; Zhang, TZ; Fang, Y; Deng, JW; Gao, YF; Liang, XY; Lv, JD; Wang, ZF; Xie, J; Xue, YB; Zhang, HF; Ma, JW; Tang, K; Fang, YL; Cheng, FR; Zhang, CJ; Dong, B; Zhao, YZ; Yuan, P; Gao, QL; Zhang, HZ; Qin, FXF; Huang, B				Liu, Yuying; Zhou, Nannan; Zhou, Li; Wang, Jing; Zhou, Yabo; Zhang, Tianzhen; Fang, Yi; Deng, Jinwei; Gao, Yunfeng; Liang, Xiaoyu; Lv, Jiadi; Wang, Zhenfeng; Xie, Jing; Xue, Yuanbo; Zhang, Huafeng; Ma, Jingwei; Tang, Ke; Fang, Yiliang; Cheng, Feiran; Zhang, Chengjuan; Dong, Bing; Zhao, Yuzhou; Yuan, Peng; Gao, Quanli; Zhang, Haizeng; Xiao-Feng Qin, F.; Huang, Bo			IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor	NATURE IMMUNOLOGY			English	Article							PD-1 EXPRESSION; INTERLEUKIN-2; DIFFERENTIATION; PROLIFERATION; HOMEOSTASIS; INDUCTION; TOLERANCE; EFFECTOR; LIMITS; TIM-3	CD8(+) T cell exhaustion dampens antitumor immunity. Although several transcription factors have been identified that regulate T cell exhaustion, the molecular mechanisms by which CD8(+) T cells are triggered to enter an exhausted state remain unclear. Here, we show that interleukin-2 (IL-2) acts as an environmental cue to induce CD8(+) T cell exhaustion within tumor microenvironments. We find that a continuously high level of IL-2 leads to the persistent activation of STAT5 in CD8(+) T cells, which in turn induces strong expression of tryptophan hydroxylase 1, thus catalyzing the conversion to tryptophan to 5-hydroxytryptophan (5-HTP). 5-HTP subsequently activates AhR nuclear translocation, causing a coordinated upregulation of inhibitory receptors and downregulation of cytokine and effector-molecule production, thereby rendering T cells dysfunctional in the tumor microenvironment. This molecular pathway is not only present in mouse tumor models but is also observed in people with cancer, identifying IL-2 as a novel inducer of T cell exhaustion.	[Liu, Yuying; Zhou, Nannan; Zhou, Li; Zhou, Yabo; Zhang, Tianzhen; Gao, Yunfeng; Liang, Xiaoyu; Lv, Jiadi; Wang, Zhenfeng; Xie, Jing; Fang, Yiliang; Cheng, Feiran; Huang, Bo] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Liu, Yuying; Zhou, Nannan; Zhou, Li; Zhou, Yabo; Zhang, Tianzhen; Gao, Yunfeng; Liang, Xiaoyu; Lv, Jiadi; Wang, Zhenfeng; Xie, Jing; Fang, Yiliang; Cheng, Feiran; Huang, Bo] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing, Peoples R China; [Liu, Yuying; Huang, Bo] CAMS, Clin Immunol Ctr, Beijing, Peoples R China; [Wang, Jing; Fang, Yi; Zhang, Haizeng] CAMS, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China; [Deng, Jinwei] Weifang Hosp Tradit Chinese Med, Weifang, Peoples R China; [Xue, Yuanbo] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Guangzhou, Peoples R China; [Xue, Yuanbo] Canc Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China; [Zhang, Huafeng; Ma, Jingwei; Tang, Ke; Huang, Bo] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan, Peoples R China; [Zhang, Chengjuan] Zhengzhou Univ, Affiliated Canc Hosp, Ctr Bio Repository, Zhengzhou, Peoples R China; [Zhang, Chengjuan] Zhengzhou Univ, Prov Cooperat Innovat Ctr Canc Chemoprevent, Zhengzhou, Peoples R China; [Dong, Bing] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou, Peoples R China; [Zhao, Yuzhou] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Surg, Zhengzhou, Peoples R China; [Yuan, Peng] Zhengzhou Univ, Affiliated Canc Hosp, Dept Breast Surg, Zhengzhou, Peoples R China; [Gao, Quanli] Zhengzhou Univ, Affiliated Canc Hosp, Dept Immunol, Zhengzhou, Peoples R China; [Gao, Quanli] Henan Canc Hosp, Zhengzhou, Peoples R China; [Xiao-Feng Qin, F.] Suzhou Inst Syst Med, Suzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Southern Medical University - China; Huazhong University of Science & Technology; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Huang, B (corresponding author), Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing, Peoples R China.; Huang, B (corresponding author), CAMS, Clin Immunol Ctr, Beijing, Peoples R China.; Huang, B (corresponding author), Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan, Peoples R China.	tjhuangbo@hotmail.com	Liu, Yuying/ABD-9637-2021	Liu, Yuying/0000-0003-2182-7210; Zhou, Yabo/0000-0002-0519-2158; QIN, FRANK XIAOFENG/0000-0002-5395-0304	National Natural Science Foundation of China [81788101, 81773062, 91942314]; Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (CAMS-I2M) [2016-I2M-1-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (CAMS-I2M)	This work was supported by National Natural Science Foundation of China (81788101, 81773062, 91942314) and Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (CAMS-I2M) 2016-I2M-1-007.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Ames RY, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00364-17; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Beltra JC, 2016, P NATL ACAD SCI USA, V113, pE5444, DOI 10.1073/pnas.1604256113; Bittinger MA, 2003, MOL PHARMACOL, V64, P550, DOI 10.1124/mol.64.3.550; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cheng LE, 2002, P NATL ACAD SCI USA, V99, P3001, DOI 10.1073/pnas.052676899; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Ehrlich AK, 2017, EUR J IMMUNOL, V47, P1989, DOI 10.1002/eji.201747121; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Herr F, 2014, J IMMUNOL, V192, P5660, DOI 10.4049/jimmunol.1300422; Kalia V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02987; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu C, 2020, NAT IMMUNOL, V21, P1010, DOI 10.1038/s41590-020-0733-2; Liu YY, 2018, CANCER CELL, V33, P480, DOI 10.1016/j.ccell.2018.02.005; Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mujib S, 2012, J IMMUNOL, V188, P3745, DOI 10.4049/jimmunol.1102609; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Tanaka Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00621; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Van Parijs L, 1998, SCIENCE, V280, P243; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; Welsh RM, 2009, IMMUNITY, V31, P178, DOI 10.1016/j.immuni.2009.08.005; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Xing XR, 2012, J CELL PHYSIOL, V227, P3812, DOI 10.1002/jcp.24092; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Zi-Ning, 2015, Biomed Res Int, V2015, P916936, DOI 10.1155/2015/916936; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	50	67	68	7	73	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					358	+		10.1038/s41590-020-00850-9	http://dx.doi.org/10.1038/s41590-020-00850-9		JAN 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33432230				2022-12-18	WOS:000607030200001
J	Behr, FM; Parga-Vidal, L; Kragten, NAM; van Dam, TJP; Wesselink, TH; Sheridan, BS; Arens, R; van Lier, RAW; Stark, R; van Gisbergen, KPJM				Behr, Felix M.; Parga-Vidal, Loreto; Kragten, Natasja A. M.; van Dam, Teunis J. P.; Wesselink, Thomas H.; Sheridan, Brian S.; Arens, Ramon; van Lier, Rene A. W.; Stark, Regina; van Gisbergen, Klaas P. J. M.			Tissue-resident memory CD8(+)T cells shape local and systemic secondary T cell responses	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; SUBSETS; DIFFERENTIATION; TRAFFICKING; LYMPHOCYTES; POPULATION; EXPRESSION; HISTORY; BLIMP-1; TRIGGER	Tissue-resident memory CD8(+)T cells (T(RM)cells) are crucial in protecting against reinvading pathogens, but the impact of reinfection on their tissue confinement and contribution to recall responses is unclear. We developed a unique lineage tracer mouse model exploiting the T-RM-defining transcription factor homolog of Blimp-1 in T cells (Hobit) to fate map the T(RM)progeny in secondary responses. After reinfection, a sizeable fraction of secondary memory T cells in the circulation developed downstream of T(RM)cells. These tissue-experienced ex-T(RM)cells shared phenotypic properties with the effector memory T cell population but were transcriptionally and functionally distinct from other secondary effector memory T cell cells. Adoptive transfer experiments of T(RM)cells corroborated their potential to form circulating effector and memory cells during recall responses. Moreover, specific ablation of primary T(RM)cell populations substantially impaired the secondary T cell response, both locally and systemically. Thus, T(RM)cells retain developmental plasticity and shape both local and systemic T cell responses on reinfection. Van Gisbergen and colleagues show that tissue-resident memory T cells, genetically marked in Hobit reporter mice, can exit tissues upon reinfection and contribute to systemic memory responses.	[Behr, Felix M.; Parga-Vidal, Loreto; Kragten, Natasja A. M.; van Dam, Teunis J. P.; Wesselink, Thomas H.; van Lier, Rene A. W.; Stark, Regina; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Amsterdam UMC, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Behr, Felix M.; Stark, Regina; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands; [van Dam, Teunis J. P.] Univ Amsterdam, Amsterdam UMC, Dept Mol & Cellular Hemostasis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Sheridan, Brian S.] SUNY Stony Brook, Dept Microbiol & Immunol, Renaissance Sch Med, Stony Brook, NY 11794 USA; [Arens, Ramon] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Gisbergen, KPJM (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.; van Gisbergen, KPJM (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands.	k.vangisbergen@sanquin.nl	Arens, Ramon/V-4010-2018; van Dam, John/P-6049-2015	Arens, Ramon/0000-0001-5058-4110; Behr, Felix M./0000-0002-1158-5011; Stark, Regina/0000-0001-7693-799X; Wesselink, Thomas/0000-0002-6789-9618; van Dam, John/0000-0002-8122-190X; Parga-Vidal, Loreto/0000-0003-4348-1679	Vidi grant from the Netherlands Organization for Scientific Research (NWO) [917.13.338]; Landsteiner Foundation of Blood Transfusion Research; Alexander von Humboldt Foundation; Veni grant from NWO [016.186.116]	Vidi grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation of Blood Transfusion Research; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Veni grant from NWO	We thank members of the van Gisbergen laboratory and Department of Hematopoiesis, as well as M. Wolkers, for fruitful discussions. F.M.B., L.P.V. and K.P.J.M.v.G. were supported by Vidi grant no. 917.13.338 from the Netherlands Organization for Scientific Research (NWO) and a fellowship from the Landsteiner Foundation of Blood Transfusion Research. R.S. was supported by a fellowship from the Alexander von Humboldt Foundation and by Veni grant no. 016.186.116 from the (NWO).	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Behr FM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00400; Behr FM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01770; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kragten NAM, 2018, EUR J IMMUNOL, V48, P1644, DOI 10.1002/eji.201847771; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Osborn JF, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007633; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Simmini S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6728; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Van Braeckel-Budimir N, 2018, CELL REP, V24, P3374, DOI 10.1016/j.celrep.2018.08.073; van Gisbergen KPJM, 2012, NAT IMMUNOL, V13, P864, DOI 10.1038/ni.2393; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410	54	67	68	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1070	+		10.1038/s41590-020-0723-4	http://dx.doi.org/10.1038/s41590-020-0723-4		JUL 2020	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32661361				2022-12-18	WOS:000555034000001
J	Mendiola, AS; Ryu, JK; Bardehle, S; Meyer-Franke, A; Ang, KKH; Wilson, C; Baeten, KM; Hanspers, K; Merlini, M; Thomas, S; Petersen, MA; Williams, A; Thomas, R; Rafalski, VA; Meza-Acevedo, R; Tognatta, R; Yan, ZQ; Pfaff, SJ; Machado, MR; Bedard, C; Coronado, PER; Jiang, XQ; Wang, J; Pleiss, MA; Green, AJ; Zamvil, SS; Pico, AR; Bruneau, BG; Arkin, MR; Akassoglou, K				Mendiola, Andrew S.; Ryu, Jae Kyu; Bardehle, Sophia; Meyer-Franke, Anke; Ang, Kenny Kean-Hooi; Wilson, Chris; Baeten, Kim M.; Hanspers, Kristina; Merlini, Mario; Thomas, Sean; Petersen, Mark A.; Williams, Alexander; Thomas, Reuben; Rafalski, Victoria A.; Meza-Acevedo, Rosa; Tognatta, Reshmi; Yan, Zhaoqi; Pfaff, Samuel J.; Machado, Michael R.; Bedard, Catherine; Coronado, Pamela E. Rios; Jiang, Xiqian; Wang, Jin; Pleiss, Michael A.; Green, Ari J.; Zamvil, Scott S.; Pico, Alexander R.; Bruneau, Benoit G.; Arkin, Michelle R.; Akassoglou, Katerina			Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation	NATURE IMMUNOLOGY			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CENTRAL-NERVOUS-SYSTEM; PROGRESSIVE MULTIPLE-SCLEROSIS; MICROGLIA; PATHWAY; GLUTAMYLTRANSFERASE; DEMYELINATION; INFLAMMATION; ASSOCIATION; GLUTATHIONE	Oxidative stress is a central part of innate immune-induced neurodegeneration. However, the transcriptomic landscape of central nervous system (CNS) innate immune cells contributing to oxidative stress is unknown, and therapies to target their neurotoxic functions are not widely available. Here, we provide the oxidative stress innate immune cell atlas in neuroinflammatory disease and report the discovery of new druggable pathways. Transcriptional profiling of oxidative stress-producing CNS innate immune cells identified a core oxidative stress gene signature coupled to coagulation and glutathione-pathway genes shared between a microglia cluster and infiltrating macrophages. Tox-seq followed by a microglia high-throughput screen and oxidative stress gene network analysis identified the glutathione-regulating compound acivicin, with potent therapeutic effects that decrease oxidative stress and axonal damage in chronic and relapsing multiple sclerosis models. Thus, oxidative stress transcriptomics identified neurotoxic CNS innate immune populations and may enable discovery of selective neuroprotective strategies. Oxidative stress can promote neurodegeneration. Akassoglou and colleagues describe Tox-seq, a functional single-cell RNA sequencing method to identify oxidative stress transcriptional signatures in CNS-resident cells. Tox-seq identified coagulation and glutathione-redox pathway genes that are coupled to oxidative stress and that could be targeted by the glutathione-regulating small molecule acivicin.	[Mendiola, Andrew S.; Ryu, Jae Kyu; Bardehle, Sophia; Meyer-Franke, Anke; Baeten, Kim M.; Hanspers, Kristina; Merlini, Mario; Thomas, Sean; Petersen, Mark A.; Williams, Alexander; Thomas, Reuben; Rafalski, Victoria A.; Meza-Acevedo, Rosa; Tognatta, Reshmi; Yan, Zhaoqi; Machado, Michael R.; Bedard, Catherine; Coronado, Pamela E. Rios; Pleiss, Michael A.; Pico, Alexander R.; Bruneau, Benoit G.; Akassoglou, Katerina] Gladstone Inst, San Francisco, CA 94158 USA; [Ryu, Jae Kyu; Green, Ari J.; Zamvil, Scott S.; Akassoglou, Katerina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ryu, Jae Kyu; Green, Ari J.; Zamvil, Scott S.; Akassoglou, Katerina] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Ang, Kenny Kean-Hooi; Wilson, Chris; Pfaff, Samuel J.; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Ang, Kenny Kean-Hooi; Wilson, Chris; Pfaff, Samuel J.; Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA; [Petersen, Mark A.; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Jiang, Xiqian; Wang, Jin] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Green, Ari J.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Akassoglou, K (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.	kakassoglou@gladstone.ucsf.edu	Arkin, Michelle/AAO-2009-2021; Wang, Jin/AAC-7292-2019; Pico, Alexander/HCH-4305-2022; Yan, Zhaoqi/ABB-9357-2021; Jiang, Xiqian/C-7877-2017; Petersen, Mark/AAN-5634-2020; arkin, michelle/AAN-4298-2021; Merlini, Mario/AAJ-1542-2021	Wang, Jin/0000-0003-3625-7919; Yan, Zhaoqi/0000-0001-9326-2920; Jiang, Xiqian/0000-0001-5568-3417; arkin, michelle/0000-0002-9366-6770; RYU, JAE KYU/0000-0002-3992-4011; Merlini, Mario/0000-0003-4145-3025; Mendiola, Andrew/0000-0002-2897-3299; Hanspers, Kristina/0000-0001-5410-599X; Baeten, Kim/0000-0001-7745-3882; Akassoglou, Katerina/0000-0002-2632-1465	Younger Family Fund; NIH [R01 AI131624, R01 NS092835, R21 NS108159]; National Multiple Sclerosis Society (NMSS) [RG1701-26628, RG-1801-29861]; Race to Erase MS; Weill Institute; Maisin Foundation; NIH/NIGMS [R01 GM115622]; NRNB NIH/NIGMS [P41 GM103504]; NMSS Postdoctoral Fellowships [FG 1944-A-1, FG-1507-05496, FG-1708-28925]; German Research Foundation (DFG) postdoc fellowship; UCSF Immunology NIH/NIAID [T32 AI007334]; NIH/NINDS [F32 NS096920, R35 NS097976]; Race to Erase MS Young Investigator Award; American Heart Association Scientist Development Grant [16SDG30170014]; FastForward/NMSS grant; Ray and the Dagmar Dolby Family Fund; Simon Family Trust; Conrad N. Hilton Foundation [17348]; NIH/NIA [RF1 AG064926]	Younger Family Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Race to Erase MS; Weill Institute; Maisin Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NRNB NIH/NIGMS; NMSS Postdoctoral Fellowships; German Research Foundation (DFG) postdoc fellowship(German Research Foundation (DFG)); UCSF Immunology NIH/NIAID; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Race to Erase MS Young Investigator Award; American Heart Association Scientist Development Grant(American Heart Association); FastForward/NMSS grant; Ray and the Dagmar Dolby Family Fund; Simon Family Trust; Conrad N. Hilton Foundation; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Quintana for sharing the NOD EAE protocol, I. Kathiriya for advice on scRNA-seq and the Gladstone Flow Cytometry (M. Cavrois, M. Maiti and N. Raman) and Genomics Cores (R. Chadwick, J. McGuire, Y. Hao and N. Carli) for expert technical assistance with flow cytometry, library preparations and sequencing. We thank S. Zeitlin and S. Chen for helpful advice and testing of cell-imaging algorithms, S.J. Won and R. Swanson for advice, B. Cabriga for technical assistance, G. Maki for graphics and K. Claiborn for editorial assistance. B.G.B. acknowledges support from Younger Family Fund, Jr. S.S.Z. is supported by research grants from the NIH (R01 AI131624, R01 NS092835, R21 NS108159), the National Multiple Sclerosis Society (NMSS) (RG1701-26628; RG-1801-29861), Race to Erase MS, the Weill Institute and the Maisin Foundation. J.W. is supported by NIH/NIGMS R01 GM115622. A.R.P. and K.H. are supported by NRNB NIH/NIGMS P41 GM103504. This research was supported by NMSS Postdoctoral Fellowships FG 1944-A-1, FG-1507-05496 and FG-1708-28925 to S.B., J.K.R. and A.S.M., respectively; the German Research Foundation (DFG) postdoc fellowship to S.B.; UCSF Immunology NIH/NIAID T32 AI007334 to A.S.M.; NIH/NINDS F32 NS096920 to V.A.R.; Race to Erase MS Young Investigator Award and American Heart Association Scientist Development Grant 16SDG30170014 to J.K.R.; the FastForward/NMSS grant to K.A. and M.R.A., the Ray and the Dagmar Dolby Family Fund, the Simon Family Trust, Conrad N. Hilton Foundation (17348) and NIH/NIA RF1 AG064926 and NIH/NINDS R35 NS097976 to K.A.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Aronesty E, 2011, EA UTILS COMMAND LIN; Back SA, 1998, J NEUROSCI, V18, P6241; Birkner K, 2020, J CLIN INVEST, V130, P715, DOI 10.1172/JCI126381; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Choi BY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0325-5; Corti A, 2010, ANTICANCER RES, V30, P1169; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Davalos D, 2014, ANN NEUROL, V75, P303, DOI 10.1002/ana.24078; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Geirsdottir L, 2019, CELL, V179, P1609, DOI 10.1016/j.cell.2019.11.010; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jiang XQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16087; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Junker A, 2020, BRAIN PATHOL, V30, P641, DOI 10.1111/bpa.12813; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Koga M, 2011, BIOCHEM BIOPH RES CO, V409, P596, DOI 10.1016/j.bbrc.2011.04.087; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kunutsor SK, 2016, ALZHEIMERS DEMENT, V12, P931, DOI 10.1016/j.jalz.2016.03.003; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Locatelli G, 2018, NAT NEUROSCI, V21, P1196, DOI 10.1038/s41593-018-0212-3; Magliozzi R, 2019, ANN CLIN TRANSL NEUR, V6, P2150, DOI 10.1002/acn3.50893; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Patsopoulos NA, 2019, SCIENCE, V365, P1417, DOI 10.1126/science.aav7188; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Ravuri C, 2011, FREE RADICAL RES, V45, P600, DOI 10.3109/10715762.2011.564164; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Sedlak TW, 2019, P NATL ACAD SCI USA, V116, P2701, DOI 10.1073/pnas.1817885116; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shu YQ, 2017, MULT SCLER RELAT DIS, V18, P65, DOI 10.1016/j.msard.2017.09.021; Tsuji T, 2009, MAMM GENOME, V20, P711, DOI 10.1007/s00335-009-9221-6; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Yamamoto S, 2011, J PHARMACOL EXP THER, V339, P945, DOI 10.1124/jpet.111.183004; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	71	67	67	7	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					513	+		10.1038/s41590-020-0654-0	http://dx.doi.org/10.1038/s41590-020-0654-0		APR 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32284594	Green Submitted, Green Accepted			2022-12-18	WOS:000526627600002
J	Langston, PK; Nambu, A; Jung, J; Shibata, M; Aksoylar, HI; Lei, JH; Xu, PN; Doan, MT; Jiang, HL; MacArthur, MR; Gao, X; Kong, Y; Chouchani, ET; Locasale, JW; Synder, NW; Horng, T				Langston, P. Kent; Nambu, Aya; Jung, Jonathan; Shibata, Munehiko; Aksoylar, H. Ibrahim; Lei, Jiahui; Xu, Peining; Doan, Mary T.; Jiang, Helen; MacArthur, Michael R.; Gao, Xia; Kong, Yong; Chouchani, Edward T.; Locasale, Jason W.; Synder, Nathaniel W.; Horng, Tiffany			Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; SUCCINATE-DEHYDROGENASE; OXIDATIVE-METABOLISM; DENDRITIC CELL; ACYL-COENZYME; INNATE; IDENTIFICATION; MITOCHONDRIA; INHIBITION; MECHANISM	Macrophages are activated during microbial infection to coordinate inflammatory responses and host defense. Here we find that in macrophages activated by bacterial lipopolysaccharide (LPS), mitochondria! glycerol 3-phosphate dehydrogenase (GPD2) regulates glucose oxidation to drive inflammatory responses. GPD2, a component of the glycerol phosphate shuttle, boosts glucose oxidation to fuel the production of acetyl coenzyme A, acetylation of histones and induction of genes encoding inflammatory mediators. While acute exposure to LPS drives macrophage activation, prolonged exposure to LPS triggers tolerance to LPS, where macrophages induce immunosuppression to limit the detrimental effects of sustained inflammation. The shift in the inflammatory response is modulated by GPD2, which coordinates a shutdown of oxidative metabolism; this limits the availability of acetyl coenzyme A for histone acetylation at genes encoding inflammatory mediators and thus contributes to the suppression of inflammatory responses. Therefore, GPD2 and the glycerol phosphate shuttle integrate the extent of microbial stimulation with glucose oxidation to balance the beneficial and detrimental effects of the inflammatory response.	[Langston, P. Kent; Nambu, Aya; Jung, Jonathan; Shibata, Munehiko; Aksoylar, H. Ibrahim; Lei, Jiahui; MacArthur, Michael R.; Horng, Tiffany] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Jung, Jonathan] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Xu, Peining; Doan, Mary T.; Jiang, Helen; Synder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA; [Gao, Xia; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Kong, Yong] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT USA; [Chouchani, Edward T.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Horng, Tiffany] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; University of Glasgow; Drexel University; Duke University; Yale University; Harvard University; Harvard Medical School; ShanghaiTech University	Horng, T (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Horng, T (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	tsyhorng@shanghaitech.edu.cn	Locasale, Jason W/ABE-6505-2020; MacArthur, Michael Robert/AAA-3173-2022; Lei, Jiahui/HGV-0100-2022; Gao, Xia/CAF-4717-2022; Chouchani, Edward T./HCH-3775-2022; Kong, Yong/B-5105-2014	Locasale, Jason W/0000-0002-7766-3502; MacArthur, Michael Robert/0000-0003-3593-6995; Gao, Xia/0000-0003-0979-9990; Nambu, Aya/0000-0002-2797-6420; Langston, Paul/0000-0001-6655-1911; Doan, Mary/0000-0001-6295-4895; Kong, Yong/0000-0002-2881-5274; Aksoylar, Halil Ibrahim/0000-0002-0527-6124	British Society for Immunology; National Institutes of Health (NIH) [R01AI102964, R21AI119763]; NIH [R03 HD092630]; Canadian Institutes of Health Research [146818]; Claudia Adams Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD092630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119763, R01AI102964] Funding Source: NIH RePORTER	British Society for Immunology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Claudia Adams Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J. J. was supported by the British Society for Immunology and T.H. by National Institutes of Health (NIH) grants (nos. R01AI102964 and R21AI119763). N.W.S. was supported by a NIH grant (no. R03 HD092630), X.G. by the Canadian Institutes of Health Research (grant no. 146818) and E.T.C. by the Claudia Adams Barr Program. We thank J.F. Mohan for helpful suggestions for CRISPR-Cas9 genome editing, L.B. Sullivan for technical advice on the GPD2 Seahorse assay, R.L.S. Goncalves for technical advice on the NAD(P) H autofluorescence assay and H. Affronti and K.E. Wellen for sharing reagents.	Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chandel N.S., 2015, NAVIGATING METABOLIS; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Frey AJ, 2016, ANAL BIOANAL CHEM, V408, P3651, DOI 10.1007/s00216-016-9448-5; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; HARD G C, 1970, British Journal of Experimental Pathology, V51, P97; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Jung J, 2019, NAT CELL BIOL, V21, P85, DOI 10.1038/s41556-018-0217-x; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lacy-Hulbert A, 2006, CELL METAB, V4, P7, DOI 10.1016/j.cmet.2006.06.001; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Sacta MS, 2018, ELIFE, V7, DOI 10.7554/eLife.34864; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Sanin DE, 2018, IMMUNITY, V49, P1021, DOI 10.1016/j.immuni.2018.10.011; Seeley JJ, 2017, J LEUKOCYTE BIOL, V101, P107, DOI 10.1189/jlb.3MR0316-118RR; Sivanand S, 2018, TRENDS BIOCHEM SCI, V43, P61, DOI 10.1016/j.tibs.2017.11.004; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Snyder NW, 2015, ANAL BIOCHEM, V474, P59, DOI 10.1016/j.ab.2014.12.014; Trefely S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1360-7; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wong BW, 2017, NATURE, V542, P49, DOI 10.1038/nature21028	43	67	69	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1186	+		10.1038/s41590-019-0453-7	http://dx.doi.org/10.1038/s41590-019-0453-7			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31384058	Green Accepted			2022-12-18	WOS:000482212600018
J	Hubel, P; Urban, C; Bergant, V; Schneider, WM; Knauer, B; Stukalov, A; Scaturro, P; Mann, A; Brunotte, L; Hoffmann, HH; Schoggins, JW; Schwemmle, M; Mann, M; Rice, CM; Pichlmair, A				Hubel, Philipp; Urban, Christian; Bergant, Valter; Schneider, William M.; Knauer, Barbara; Stukalov, Alexey; Scaturro, Pietro; Mann, Angelika; Brunotte, Linda; Hoffmann, Heinrich H.; Schoggins, John W.; Schwemmle, Martin; Mann, Matthias; Rice, Charles M.; Pichlmair, Andreas			A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape	NATURE IMMUNOLOGY			English	Article							COMPUTATIONAL PLATFORM; RECEPTOR; REVEALS; COMPLEX; TARGET; CELLS	Interferon-stimulated genes (ISGs) form the backbone of the innate immune system and are important for limiting intra- and intercellular viral replication and spread. We conducted a mass-spectrometry-based survey to understand the fundamental organization of the innate immune system and to explore the molecular functions of individual ISGs. We identified interactions between 104 ISGs and 1,401 cellular binding partners engaging in 2,734 high-confidence interactions. 90% of these interactions are unreported so far, and our survey therefore illuminates a far wider activity spectrum of ISGs than is currently known. Integration of the resulting ISG-interaction network with published datasets and functional studies allowed us to identify regulators of immunity and processes related to the immune system. Given the extraordinary robustness of the innate immune system, this ISG network may serve as a blueprint for therapeutic targeting of cellular systems to efficiently fight viral infections.	[Hubel, Philipp; Knauer, Barbara; Stukalov, Alexey; Scaturro, Pietro; Mann, Angelika; Pichlmair, Andreas] Max Planck Inst Biochem, Innate Immun Lab, Munich, Germany; [Urban, Christian; Bergant, Valter; Stukalov, Alexey; Scaturro, Pietro; Pichlmair, Andreas] Tech Univ Munich, Sch Med, Inst Virol, Munich, Germany; [Schneider, William M.; Hoffmann, Heinrich H.; Schoggins, John W.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Brunotte, Linda] Westfaelische Wilhelms Univ Muenster, Inst Virol, Munster, Germany; [Brunotte, Linda] Westfaelische Wilhelms Univ Muenster, Cluster Excellence Cells In Mot, Munster, Germany; [Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX USA; [Schwemmle, Martin] Med Ctr Univ Freiburg, Inst Virol, Freiburg, Germany; [Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Munich, Germany; [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany	Max Planck Society; Technical University of Munich; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; German Center for Infection Research	Pichlmair, A (corresponding author), Max Planck Inst Biochem, Innate Immun Lab, Munich, Germany.; Pichlmair, A (corresponding author), Tech Univ Munich, Sch Med, Inst Virol, Munich, Germany.; Pichlmair, A (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.	andreas.pichlmair@tum.de	Stukalov, Alexey/AAS-3208-2021	Stukalov, Alexey/0000-0002-4981-8124; Urban, Christian/0000-0002-4080-2468; Scaturro, Pietro/0000-0001-9098-3087	Max-Planck Free Floater program; ERC starting grant (ERC-StG iVIP) [311339]; ERC consolidator grant (ERC-CoG ProDAP) [817798]; Infect-Era; German Federal Ministry of Education and Research (ERASE); German Research Foundation [PI 1084/2, PI 1084/3, P1083/4 TRR179, TRR237, MS 632/15]; NIH [R01-AI091707]	Max-Planck Free Floater program; ERC starting grant (ERC-StG iVIP); ERC consolidator grant (ERC-CoG ProDAP); Infect-Era; German Federal Ministry of Education and Research (ERASE); German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the innate immunity laboratory for critical discussions and suggestions. We thank K. Mayr, I. Paron and G. Sowa for maintaining mass spectrometers and the MPI-B core facility for support. We further thank G. Kochs for the FluAV mini replicon and A549 cells, G. Zimmer for VSV-Luc and A. Merits for SFV-gLuc and SFV-NanoLuc. We also thank M. Feulner for technical assistance. The work in the authors' laboratories was supported by the Max-Planck Free Floater program, ERC starting grant (ERC-StG iVIP, 311339), ERC consolidator grant (ERC-CoG ProDAP, 817798), Infect-Era and the German Federal Ministry of Education and Research (ERASE), the German Research Foundation (PI 1084/2, PI 1084/3, P1083/4 TRR179 and TRR237) to A.P. and (MS 632/15) to M.S. This work was also supported by NIH grant R01-AI091707 (to C.M.R.).	Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Benjamini Y, 2001, ANN STAT, V29, P1165; Chapat C, 2013, EMBO J, V32, P688, DOI 10.1038/emboj.2013.11; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Chen Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006727; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; de Wilde AH, 2015, J VIROL, V89, P8318, DOI 10.1128/JVI.01029-15; Fogeron ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2517; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Gebhardt A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9192; Goffinet C, 2016, CURR HIV RES, V14, P211, DOI 10.2174/1570162X14666151216145521; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Holze C, 2018, NAT IMMUNOL, V19, P130, DOI 10.1038/s41590-017-0013-y; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ito K, 2011, PROTEIN CELL, V2, P755, DOI 10.1007/s13238-011-1092-4; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Long JS, 2016, NATURE, V529, P101, DOI 10.1038/nature16474; Ma J, 2016, J BIOL CHEM, V291, P26670, DOI 10.1074/jbc.M116.752444; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Rodriguez-Gil A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03708-7; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Wang IH, 2017, J CELL SCI, V130, P2185, DOI 10.1242/jcs.203794; White MJV, 2015, J IMMUNOL, V195, P1858, DOI 10.4049/jimmunol.1500365; Xiong Y, 2013, APOPTOSIS, V18, P925, DOI 10.1007/s10495-013-0846-2; York A, 2014, J VIROL, V88, P13284, DOI 10.1128/JVI.01813-14; Zhao K, 2016, J IMMUNOL, V196, P1209, DOI 10.4049/jimmunol.1501224	40	67	69	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					493	+		10.1038/s41590-019-0323-3	http://dx.doi.org/10.1038/s41590-019-0323-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30833792				2022-12-18	WOS:000461904200019
J	Kuan, EL; Ziegler, SF				Kuan, Emma L.; Ziegler, Steven F.			A tumor-myeloid cell axis, mediated via the cytokines IL-1 alpha and TSLP, promotes the progression of breast cancer	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; AIRWAY EPITHELIAL-CELLS; ALLERGIC INFLAMMATION; EXPRESSION; GROWTH; INTERLEUKIN-1-ALPHA; HOMEOSTASIS; INDUCTION; DISEASE; MODEL	Tumors actively manipulate the immune response through the production of factors that attract immune cells and subsequently alter their ability to recognize and effectively remove the tumor. While this mechanism for evading the immune system is an important aspect of tumor survival, the factors that serve as primary growth factors for the tumor are less understood. Here we demonstrate a previously unknown mechanism by which breast-cancer cells manipulate tumor-infiltrating myeloid cells to maintain their survival. Tumor-derived interleukin 1 alpha (IL-1 alpha), acting on infiltrating myeloid cells, induced the expression of a critical tumor survival factor, the cytokine TSLP. TSLP promoted the survival of the tumor cells through induction of the expression of the anti-apoptotic molecule Bcl-2. TSLP signaling was also required for metastasis to the lungs. These studies define a novel IL-1 alpha-TSLP-mediated crosstalk between tumor-infiltrating myeloid cells and tumor cells in the control of metastatic breast cancer.	[Kuan, Emma L.; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA	Benaroya Research Institute	Ziegler, SF (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org		Ziegler, Steven/0000-0003-0657-5529	NCI NIH HHS [R01 CA182783] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA182783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barooei R, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0653-4; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Cipolat S, 2014, ELIFE, V3, DOI 10.7554/eLife.01888; Cremers N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151468; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Demehri S, 2016, J CLIN INVEST, V126, P1458, DOI 10.1172/JCI83724; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; Feng AL, 2011, CLIN EXP IMMUNOL, V164, P57, DOI 10.1111/j.1365-2249.2011.04321.x; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Ghirelli C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178438; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Kashiwagi M, 2017, NAT IMMUNOL, V18, P334, DOI 10.1038/ni.3661; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kumar S, 2003, AM J PATHOL, V163, P2531, DOI 10.1016/S0002-9440(10)63608-5; Kurtzman SH, 1999, ONCOL REP, V6, P65; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Li Z, 2016, PHARMACOL THERAPEUT, V161, P79, DOI 10.1016/j.pharmthera.2016.03.003; Liao B, 2015, ALLERGY, V70, P1169, DOI 10.1111/all.12667; Miazgowicz MM, 2013, J INFLAMM RES, V6, P53, DOI 10.2147/JIR.S42381; MILLER BE, 1983, CANCER RES, V43, P4102; Nakajima S, 2014, LEUKEMIA LYMPHOMA, V55, P2605, DOI 10.3109/10428194.2014.881478; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Roan F, 2012, J LEUKOCYTE BIOL, V91, P877, DOI 10.1189/jlb.1211622; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Scheeren FA, 2010, EUR J IMMUNOL, V40, P955, DOI 10.1002/eji.200939419; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Shi GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058017; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Taranova AG, 2008, CANCER RES, V68, P8582, DOI 10.1158/0008-5472.CAN-08-1673; Vetter T, 2016, LEUKEMIA RES, V40, P38, DOI 10.1016/j.leukres.2015.10.003; West Erin E, 2012, Drug Discov Today Dis Mech, V9, DOI 10.1016/j.ddmec.2012.09.003; Xie F, 2015, CANCER LETT, V364, P106, DOI 10.1016/j.canlet.2015.04.029; Xie F, 2013, AM J REPROD IMMUNOL, V70, P69, DOI 10.1111/aji.12104; Yue WJ, 2016, ONCOTARGET, V7, P16840, DOI 10.18632/oncotarget.7614; Zhang KQ, 2007, AM J PHYSIOL-LUNG C, V293, pL375, DOI 10.1152/ajplung.00045.2007; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	49	67	67	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					366	+		10.1038/s41590-018-0066-6	http://dx.doi.org/10.1038/s41590-018-0066-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29556001	Green Accepted			2022-12-18	WOS:000428151000016
J	Kwong, B; Rua, R; Gao, YY; Flickinger, J; Wang, Y; Kruhlak, MJ; Zhu, JF; Vivier, E; McGavern, DB; Lazarevic, V				Kwong, Brandon; Rua, Rejane; Gao, Yuanyuan; Flickinger, John, Jr.; Wang, Yan; Kruhlak, Michael J.; Zhu, Jinfang; Vivier, Eric; McGavern, Dorian B.; Lazarevic, Vanja			T-bet-dependent NKp46(+) innate lymphoid cells regulate the onset of T(H)17-induced neuroinflammation	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T(H)17 CELLS; NK CELLS; CNS; DIFFERENTIATION; CYTOKINE; ENCEPHALITOGENICITY; INFLAMMATION; LYMPHOCYTES	The transcription factor T-bet has been associated with increased susceptibility to systemic and organ-specific autoimmunity, but the mechanism by which T-bet expression promotes neuroinflammation remains unknown. In this study, we demonstrate a cardinal role of T-bet-dependent NKp46(+) innate lymphoid cells (ILCs) in the initiation of CD4(+) T(H)17-mediated neuroinflammation. Loss of T-bet specifically in NKp46(+) ILCs profoundly impaired the ability of myelin-reactive T(H)17 cells to invade central nervous system (CNS) tissue and protected the mice from autoimmunity. T-bet-dependent NKp46(+) ILCs localized in the meninges and acted as chief coordinators of meningeal inflammation by inducing the expression of proinflammatory cytokines, chemokines and matrix metalloproteinases, which together facilitated T cell entry into CNS parenchyma. Our findings uncover a detrimental role of T-bet-dependent NKp46(+) ILCs in the development of CNS autoimmune disease.	[Kwong, Brandon; Gao, Yuanyuan; Flickinger, John, Jr.; Wang, Yan; Kruhlak, Michael J.; Lazarevic, Vanja] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Rua, Rejane; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Zhu, Jinfang] NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Vivier, Eric] Hop La Timone, AP HM, Serce Immunol, Marseille, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lazarevic, V (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	lazarevicv@mail.nih.gov	Rua, Rejane/GLQ-7139-2022; McGavern, Dorian/HCH-3601-2022; Zhu, Jinfang/B-7574-2012; Vivier, Eric/F-8939-2010	Rua, Rejane/0000-0002-4289-3498; McGavern, Dorian/0000-0001-9568-545X; Zhu, Jinfang/0000-0002-0117-4745; Vivier, Eric/0000-0001-7022-8287; Lazarevic, Vanja/0000-0002-5783-7130; Flickinger, John/0000-0003-3180-1524	US National Institutes of Health, National Cancer Institute, Center for Cancer Research [ZIA BC 011431, ZIA BC 011432]; National Institute of Neurological Disorders and Stroke [1ZIA NS 003111-08, 1ZIA NS 003112-08]; NATIONAL CANCER INSTITUTE [ZIABC011431, ZICBC010915, ZIABC011432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Belkaid and A. Singer for critical review of the manuscript; S. Sharrow, L. Granger and A. Adams for flow cytometry and cell sorting; T. Loo for technical assistance; and the members of the laboratories of A. Singer and H. Park for discussions. S. Reiner (Columbia University) generously provided the Tbx21<SUP>f/f</SUP> mice. This study was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research (ZIA BC 011431 and ZIA BC 011432 to V.L.) and National Institute of Neurological Disorders and Stroke (1ZIA NS 003111-08 and 1ZIA NS 003112-08 to D.B.M.).	Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dungan LS, 2014, EUR J IMMUNOL, V44, P2903, DOI 10.1002/eji.201444612; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gossa S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06664; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Morandi B, 2008, PHARMACOL RES, V57, P1, DOI 10.1016/j.phrs.2007.11.003; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	50	67	68	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1117	+		10.1038/ni.3816	http://dx.doi.org/10.1038/ni.3816			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28805812	Green Submitted, Green Accepted			2022-12-18	WOS:000411134000016
J	Kim, SJ; Schatzle, S; Ahmed, SS; Haap, W; Jang, SH; Gregersen, PK; Georgiou, G; Diamond, B				Kim, Sun Jung; Schatzle, Sebastian; Ahmed, S. Sohail; Haap, Wolfgang; Jang, Su Hwa; Gregersen, Peter K.; Georgiou, George; Diamond, Betty			Increased cathepsin S in Prdm1(-/-) dendritic cells alters the T-FH cell repertoire and contributes to lupus	NATURE IMMUNOLOGY			English	Article							ANTIGEN PRESENTATION; ERYTHEMATOSUS; ALPHA; DIFFERENTIATION; SUSCEPTIBILITY; INFLAMMATION; ACTIVATION; GENERATION; EXPRESSION; RESPONSES	Aberrant population expansion of follicular helper T cells (TFH cells) occurs in patients with lupus. An unanswered question is whether an altered repertoire of T cell antigen receptors (TCRs) is associated with such expansion. Here we found that the transcription factor Blimp-1 (encoded by Prdm1) repressed expression of the gene encoding cathepsin S (Ctss), a cysteine protease that cleaves invariant chains and produces antigenic peptides for loading onto major histocompatibility complex (MHC) class II molecules. The increased CTSS expression in dendritic cells (DCs) from female mice with dendritic cell-specific conditional knockout of Prdm1 (CKO mice) altered the presentation of antigen to CD4(+) T cells. Analysis of complementarity-determining region 3 (CDR3) regions containing the beta-chain variable region (V-beta) demonstrated a more diverse repertoire of T-FH cells from female CKO mice than of those from wild-type mice. In vivo treatment of CKO mice with a CTSS inhibitor abolished the lupus-related phenotype and reduced the diversity of the TFH cell TCR repertoire. Thus, Blimp-1 deficiency in DCs led to loss of appropriate regulation of Ctss expression in female mice and thereby modulated antigen presentation and the T-FH cell repertoire to contribute to autoimmunity.	[Kim, Sun Jung; Jang, Su Hwa; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Schatzle, Sebastian; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ahmed, S. Sohail; Haap, Wolfgang] F Hoffmann La Roche, Roche Pharma Res & Early Dev, Roche Innovat Ctr Basel, Immunol Inflammat & Infect Dis Dis & Therapeut Ar, Basel, Switzerland; [Gregersen, Peter K.] Feinstein Inst Med Res, Ctr Genom & Human Genet, Manhasset, NY USA	Northwell Health; University of Texas System; University of Texas Austin; Roche Holding; Northwell Health	Diamond, B (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	bdiamond@northwell.edu		Jang, Su Hwa/0000-0002-3022-6612; Diamond, Betty/0000-0002-3250-3804	National Institute of Arthritis and Musculoskeletal and Skin Diseases; Alliance of Lupus Research; Defense Threat Reduction Agency [HDTRA 1-12-C-0105];  [R01 AR065209]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065209] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Alliance of Lupus Research; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Borrero and C. Colon for assistance with the flow cytometry; G. Klein and M. DeFranco RN for recruiting PRDM1-genotyped subjects; and C. Chrysostomou for discussions and assistance in bioinformatics analysis. Supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases, the US National Institutes of Health (R01 AR065209 to S.J.K. and B.D.), the Alliance of Lupus Research (B.D.) and the Defense Threat Reduction Agency (HDTRA 1-12-C-0105 for G.G.).	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Ndifon W, 2012, P NATL ACAD SCI USA, V109, P15865, DOI 10.1073/pnas.1203916109; PAVLI P, 1993, IMMUNOLOGY, V78, P132; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; Raj P, 2016, ELIFE, V5, DOI 10.7554/eLife.12089; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Rogers PR, 1999, J IMMUNOL, V163, P1205; Rupanagudi KV, 2015, ANN RHEUM DIS, V74, P452, DOI 10.1136/annrheumdis-2013-203717; Seillet C, 2013, J IMMUNOL, V190, P5459, DOI 10.4049/jimmunol.1203312; SHI GP, 1994, J BIOL CHEM, V269, P11530; Stoeckle C, 2012, J AUTOIMMUN, V38, P332, DOI 10.1016/j.jaut.2012.02.003; TATO M, 2017, SCI REP UK, V7; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Walker B, 2000, BIOCHEM BIOPH RES CO, V275, P401, DOI 10.1006/bbrc.2000.3311; Xu HH, 2015, CELL IMMUNOL, V295, P46, DOI 10.1016/j.cellimm.2015.01.014; Yang H, 2005, J IMMUNOL, V174, P1729, DOI 10.4049/jimmunol.174.3.1729; Yang H, 2014, J EXP MED, V211, P2467, DOI 10.1084/jem.20140283; Yang HY, 1999, J INVEST MED, V47, P236; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	43	67	78	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					1016	+		10.1038/ni.3793	http://dx.doi.org/10.1038/ni.3793			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28692065	Green Accepted			2022-12-18	WOS:000408137700011
J	Boudil, A; Matei, IR; Shih, HY; Bogdanoski, G; Yuan, JS; Chang, SG; Montpellier, B; Kowalski, PE; Voisin, V; Bashir, S; Bader, GD; Krangel, MS; Guidos, CJ				Boudil, Amine; Matei, Irina R.; Shih, Han-Yu; Bogdanoski, Goce; Yuan, Julie S.; Chang, Stephen G.; Montpellier, Bertrand; Kowalski, Paul E.; Voisin, Veronique; Bashir, Shaheena; Bader, Gary D.; Krangel, Michael S.; Guidos, Cynthia J.			IL-7 coordinates proliferation, differentiation and Tcra recombination during thymocyte beta-selection	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; GERMINAL-CENTER FORMATION; TRANSCRIPTION FACTORS; EXPRESSION; NOTCH; BCL6; ACTIVATION; SURVIVAL; STAT5; DOWNSTREAM	Signaling via the pre-T cell antigen receptor (pre-TCR) and the receptor Notch1 induces transient self-renewal (beta-selection) of TCR beta(+) CD4(-)CD8(-) double-negative stage 3 (DN3) and DN4 progenitor cells that differentiate into CD4(+)CD8(+) double-positive (DP) thymocytes, which then rearrange the locus encoding the TCR alpha-chain (Tcra). Interleukin 7 (IL-7) promotes the survival of TCR beta(-) DN thymocytes by inducing expression of the pro-survival molecule BcI-2, but the functions of IL-7 during beta-selection have remained unclear. Here we found that IL-7 signaled TCR beta(+) DN3 and DN4 thymocytes to upregulate genes encoding molecules involved in cell growth and repressed the gene encoding the transcriptional repressor BcI-6. Accordingly, IL-7-deficient DN4 cells lacked trophic receptors and did not proliferate but rearranged Tcra prematurely and differentiated rapidly. Deletion of BcI6 partially restored the self-renewal of DN4 cells in the absence of IL-7, but overexpression of BCL2 did not. Thus, IL-7 critically acts cooperatively with signaling via the pre-TCR and Notchl to coordinate proliferation, differentiation and Tcra recombination during beta-selection.	[Boudil, Amine; Matei, Irina R.; Bogdanoski, Goce; Yuan, Julie S.; Chang, Stephen G.; Montpellier, Bertrand; Kowalski, Paul E.; Guidos, Cynthia J.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Boudil, Amine; Montpellier, Bertrand; Guidos, Cynthia J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Shih, Han-Yu; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Voisin, Veronique; Bashir, Shaheena; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Duke University; University of Toronto; University of Toronto	Guidos, CJ (corresponding author), Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cynthia.guidos@sickkids.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Shih, Han-Yu/0000-0002-7525-5433	Genome Canada/Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Institute for Cancer Research; McEwen Centre for Regenerative Medicine; SickKids Foundation; Canadian Institutes of Health Research [FRN 11530]; US National Institutes of Health [R37 GM41052]; National Center for Research Resources of the US National Institutes of Health [P41 GM103504]; NATIONAL CANCER INSTITUTE [R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052, P41GM103504] Funding Source: NIH RePORTER	Genome Canada/Ontario Genomics Institute(Genome Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Institute for Cancer Research; McEwen Centre for Regenerative Medicine; SickKids Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Gerstein (University of Massachusetts) for Il7<SUP>-/-</SUP> mice; and R. Dalla-Favera (Columbia University) for Bcl6<SUP>+/-</SUP> mice. Microarray analyses were performed at The Centre for Applied Genomics, Hospital for Sick Children with support from Genome Canada/Ontario Genomics Institute and the Canada Foundation for Innovation; flow cytometry was performed at The SickKids-UHN Flow Cytometry Facility, supported by the Ontario Institute for Cancer Research, the McEwen Centre for Regenerative Medicine, the Canada Foundation for Innovation and the SickKids Foundation. Supported by the Canadian Institutes of Health Research (FRN 11530 to C.J.G.), the US National Institutes of Health (R37 GM41052 to M.S.K.), the National Center for Research Resources of the US National Institutes of Health (P41 GM103504 to G.D.B.).	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; del Blanco B, 2012, J IMMUNOL, V188, P3278, DOI 10.4049/jimmunol.1100271; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guidos CJ, 2006, J EXP MED, V203, P2233, DOI 10.1084/jem.20060998; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hernandez-Munain C, 1998, MOL CELL BIOL, V18, P3223, DOI 10.1128/MCB.18.6.3223; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Magri M, 2009, EUR J IMMUNOL, V39, P1231, DOI 10.1002/eji.200838765; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shih HY, 2011, IMMUNOL RES, V49, P192, DOI 10.1007/s12026-010-8181-y; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Timblin GA, 2013, J IMMUNOL, V191, P4676, DOI 10.4049/jimmunol.1301675; Trigueros C, 2003, EUR J IMMUNOL, V33, P1968, DOI 10.1002/eji.200323831; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yuan JS, 2011, BLOOD, V117, P1184, DOI 10.1182/blood-2010-07-296616; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003	41	67	69	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					397	405		10.1038/ni.3122	http://dx.doi.org/10.1038/ni.3122			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25729925	Green Accepted			2022-12-18	WOS:000351333700012
J	Rajasekaran, K; Kumar, P; Schuldt, KM; Peterson, EJ; Vanhaesebroeck, B; Dixit, V; Thakar, MS; Malarkannan, S				Rajasekaran, Kamalakannan; Kumar, Pawan; Schuldt, Kristina M.; Peterson, Erik J.; Vanhaesebroeck, Bart; Dixit, Vishva; Thakar, Monica S.; Malarkannan, Subramaniam			Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GRANULE POLARIZATION; TERMINAL MATURATION; KINASE ACTIVATION; PROTEIN; COMPLEX; BINDING; CARMA1	Inflammation is a critical component of the immune response. However, acute or chronic inflammation can be highly destructive. Uncontrolled inflammation forms the basis for allergy, asthma and various autoimmune disorders. Here we identified a signaling pathway that was exclusively responsible for the production of inflammatory cytokines but not for cytotoxicity. Recognition of tumor cells expressing the NK cell-activatory ligands H60 or CD137L by mouse natural killer (NK) cells led to efficient cytotoxicity and the production of inflammatory cytokines. Both of those effector functions required the kinases Lck, Fyn and PI(3) K (subunits p85 alpha and p110 delta) and the signaling protein PLC-gamma 2. However, a complex of Fyn and the adaptor ADAP exclusively regulated the production of inflammatory cytokines but not cytotoxicity in NK cells. That unique function of ADAP required a Carma1-Bcl-10-MAP3K7 signaling axis. Our results have identified molecules that can be targeted to regulate inflammation without compromising NK cell cytotoxicity.	[Rajasekaran, Kamalakannan; Kumar, Pawan; Schuldt, Kristina M.; Thakar, Monica S.; Malarkannan, Subramaniam] Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI USA; [Peterson, Erik J.] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Vanhaesebroeck, Bart] Queen Mary Univ London, Barts Canc Inst, Ctr Cell Signaling, London, England; [Dixit, Vishva] Genentech Inc, San Francisco, CA 94080 USA; [Thakar, Monica S.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Microbiol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; University of London; Queen Mary University London; Roche Holding; Genentech; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Malarkannan, S (corresponding author), Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI USA.	subra.malar@bcw.edu	Malarkannan, Subramaniam/AAQ-3934-2020; Peterson, Erik/M-9365-2013; Malarkannan, Subra/AAQ-9617-2020; dixit, vishva m/A-4496-2012; RAJASEKARAN, KAMALAKANNAN/F-7350-2015	Malarkannan, Subramaniam/0000-0002-7511-2731; dixit, vishva m/0000-0001-6983-0326; RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007	US National Institutes of Health [R01 A1064828, R01 AI102893]; American Cancer Society; Midwest Athletes Against Childhood Cancer Fund; Hyundai Hope on Wheels; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064828, R01AI102893] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Midwest Athletes Against Childhood Cancer Fund; Hyundai Hope on Wheels; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Sammarco and her Lulu's Lemonade Stand for support through Blood Center's Research Foundation, inspiration and motivation; K. E. Nichols (Children's Hospital, Philadelphia) for Adap<SUP>-/-</SUP> mice; D. R. Littman (New York University) for Carma1<SUP>-/-</SUP> mice; J. Zhang and Y. Xiao (Loyola University Chicago Stritch School of Medicine) for Map3k7<SUP>fl/fl</SUP> and Map3k7<SUP>fl/fl</SUP>Mx1-Cre spleens; Y. Chen and B. Ren (Blood Research Institute, Milwaukee) for wild-type and Fyn<SUP>-/-</SUP> spleens; V. Arumugam and T. Foster for technical help; and T. Heil, L. Savatski, P. J. Newman and Q. Shi for critical reading. Supported by the US National Institutes of Health (R01 A1064828 and R01 AI102893 to S. M.), the American Cancer Society (S. M. and M. S. T.), Midwest Athletes Against Childhood Cancer Fund (M. S. T. and S. M.) and Hyundai Hope on Wheels (M. S. T.).	Baessler T, 2010, BLOOD, V115, P3058, DOI 10.1182/blood-2009-06-227934; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; BIONDI A, 1991, EUR J IMMUNOL, V21, P843, DOI 10.1002/eji.1830210348; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Filipp D, 2008, J BIOL CHEM, V283, P26409, DOI 10.1074/jbc.M710372200; Fostel LV, 2006, INT IMMUNOL, V18, P1305, DOI 10.1093/intimm/dxl063; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KARNITZ LM, 1994, J EXP MED, V179, P1799, DOI 10.1084/jem.179.6.1799; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; KIM YJ, 1993, J IMMUNOL, V151, P1255; Kudlacz EM, 2001, AM J RESP CELL MOL, V24, P469, DOI 10.1165/ajrcmb.24.4.4266; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Manciulea M, 1996, CELL IMMUNOL, V167, P63, DOI 10.1006/cimm.1996.0008; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; May RM, 2013, BLOOD, V121, P3135, DOI 10.1182/blood-2012-12-474361; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Myers LM, 2005, TRENDS IMMUNOL, V26, P440, DOI 10.1016/j.it.2005.06.003; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; Rajasekaran K, 2011, J BIOL CHEM, V286, P31213, DOI 10.1074/jbc.M111.261917; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Srivastava R, 2010, J BIOL CHEM, V285, P11100, DOI 10.1074/jbc.M109.068999; Susa M, 1996, BIOCHEM BIOPH RES CO, V220, P729, DOI 10.1006/bbrc.1996.0472; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	50	67	70	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1127	U122		10.1038/ni.2708	http://dx.doi.org/10.1038/ni.2708			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24036998	Green Accepted			2022-12-18	WOS:000326023400009
J	Beemiller, P; Jacobelli, J; Krummel, MF				Beemiller, Peter; Jacobelli, Jordan; Krummel, Matthew F.			Integration of the movement of signaling microclusters with cellular motility in immunological synapses	NATURE IMMUNOLOGY			English	Article							MYOSIN-II INHIBITOR; JURKAT T-CELLS; DENDRITIC CELLS; ACTIN POLYMERIZATION; LYMPH-NODES; IN-VIVO; RECEPTOR MICROCLUSTERS; F-ACTIN; ACTIVATION; DYNAMICS	Immune synapses form between T cells and antigen-presenting cells (APCs). Increasing evidence suggests synapses must form flexibly to accommodate ongoing motility and displacement of the synapse. Here, time-lapse total internal reflection fluorescence (TIRF) microscopy showed that signaling via the T cell antigen receptor (TCR) occurred during synapse translation. TCR microclusters in motile synapses did not flow directly into supramolecular activating complexes (SMACs) but were directed, independently of myosin II contractility, toward an F-actin-poor 'sink' region. Inward microcluster flow often followed collapse of the leading edge, which suggested that actin depolymerization regulated microcluster flow and the formation of SMACs. The coordination of TCR movement with the translocation of this 'sink' shows how T cells coordinate TCR signaling and microcluster flow in dynamic physiological synapses.	[Beemiller, Peter; Jacobelli, Jordan; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	matthew.krummel@ucsf.edu		Beemiller, Peter/0000-0002-2736-3405	Cancer Research Institute; US National Institutes of Health [AI52116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER	Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Rogers (University of Manchester) for the polynomial fit Gaussian weight function; R. Wedlich-Soldner (Max Planck Institute of Biochemistry) for Lifeact-GFP; B. Lillemeier (Salk Institute) and M. Davis (Stanford University) for the histidine-tagged ICAM construct; M. Werner and K. Austgen for assistance in preparing histidine-tagged ICAM; and J. Altman (US National Institutes of Health Tetramer Facility at Emory University) for biotinylated pMHC monomers. Supported by the Cancer Research Institute (P.B.) and the US National Institutes of Health (AI52116 to M.F.K.).	Beemiller P., 2012, NAT PROTOC, DOI DOI 10.1038/PROTEX.2012.028; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030704	42	67	68	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					787	+		10.1038/ni.2364	http://dx.doi.org/10.1038/ni.2364			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22751140	Green Accepted			2022-12-18	WOS:000306569600015
J	Deng, L; Langley, RJ; Brown, PH; Xu, G; Teng, L; Wang, Q; Gonzales, MI; Callender, GG; Nishimura, MI; Topalian, SL; Mariuzza, RA				Deng, Lu; Langley, Ries J.; Brown, Patrick H.; Xu, Gang; Teng, Leslie; Wang, Qian; Gonzales, Monica I.; Callender, Glenda G.; Nishimura, Michael I.; Topalian, Suzanne L.; Mariuzza, Roy A.			Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor	NATURE IMMUNOLOGY			English	Article							LIGAND-SPECIFIC OLIGOMERIZATION; ANTIGEN RECOGNITION; PEPTIDE-MHC; ANALYTICAL ULTRACENTRIFUGATION; CRYSTAL-STRUCTURE; COMPLEX; AUTOIMMUNITY; BINDING; PROTEIN; ACTIVATION	Structural studies of complexes of T cell receptor ( TCR) and peptide-major histocompatibility complex ( MHC) have focused on TCRs specific for foreign antigens or native self. An unexplored category of TCRs includes those specific for self determinants bearing alterations resulting from disease, notably cancer. We determined here the structure of a human melanoma-specific TCR ( E8) bound to the MHC molecule HLA-DR1 and an epitope from mutant triosephosphate isomerase. The structure had features intermediate between 'anti-foreign' and autoimmune TCR-peptide-MHC class II complexes that may reflect the hybrid nature of altered self. E8 manifested very low affinity for mutant triosephosphate isomerase-HLA-DR1 despite the highly tumor-reactive properties of E8 cells. A second TCR ( G4) had even lower affinity but underwent peptide-specific formation of dimers, suggesting this as a mechanism for enhancing low-affinity TCR-peptide-MHC interactions for T cell activation.	NCI, Canc Res Ctr, NIH, Surg Branch, Bethesda, MD 20892 USA; Univ Maryland, Ctr Adv Res Biotechnol, WM Keck Lab Struct Biol, Inst Biotechnol, Rockville, MD 20850 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA; NIH, Div Bioengn & Phys Sci, Off Res Serv, Bethesda, MD 20892 USA; Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University of Chicago; National Institutes of Health (NIH) - USA; Medical University of South Carolina; Johns Hopkins University; Johns Hopkins Medicine	Topalian, SL (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1, New Zealand.	stopali1@jhmi.edu; mariuzza@carb.nist.gov	Deng, Lu/AAE-1635-2021	Langley, Ries/0000-0001-8606-2197	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036900, R01AI036900] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI036900, R37 AI036900] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P240; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; CLEMENTS CS, 2006, CURR OPIN STRUC BIOL, V16, P1; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Houghton AN, 2004, J CLIN INVEST, V114, P468, DOI 10.1172/JCI200422685; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009; NISHIMURA MI, 1994, J IMMUNOTHER, V16, P85, DOI 10.1097/00002371-199408000-00002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	53	67	70	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					398	408		10.1038/ni1447	http://dx.doi.org/10.1038/ni1447			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17334368				2022-12-18	WOS:000245075900015
J	Camacho, SA; Heath, WR; Carbone, FR; Sarvetnick, N; LeBon, A; Karlsson, L; Peterson, PA; Webb, SR				Camacho, SA; Heath, WR; Carbone, FR; Sarvetnick, N; LeBon, A; Karlsson, L; Peterson, PA; Webb, SR			A key role for ICAM-I in generating effector cells mediating inflammatory responses	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; INTERCELLULAR-ADHESION MOLECULE-1; CHEMOATTRACTANT PROTEIN-1 MCP-1; COSTIMULATORY MOLECULES; AUTOIMMUNE-DISEASE; INDUCED ARTHRITIS; CD28; CHEMOKINES; TH2; ACTIVATION	We investigated how the accessory molecule interactions encountered during T cell priming influence T cell-mediated destruction of insulin-producing beta cells and lead to type I diabetes. T cell receptor (TCR)-transgenic CD4(+) T cells were primed under controlled conditions in vitro before being adoptively transferred into transgenic recipients expressing membrane ovalbumin under the control of the rat insulin promoter (RIP-mOVA), During priming, antigen-presenting cell expression of B7-1 without intracellular adhesion molecule 1 (ICAM-1) led to the generation of effector cells that migrated to the pancreata of RIP-mOVA recipients but did not cause diabetes. In contrast, when T cells were primed with APCs expressing both B7-1 and ICAM-1, pronounced destruction of beta cells and a rapid onset of diabetes were observed. Pathogenicity was associated with T cell production of the macrophage-attracting chemokines CCL3 and CCL4. Thus, interactions of lymphocyte function-associated antigen 1 with ICAM-1 during priming induce both qualitative and quantitative alterations in T effector function and induce potentially autodestructive responses.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; Alfred Hosp, Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia; Edward Jenner Inst Vaccine Res, Newbury, Berks, England; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Scripps Research Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Johnson & Johnson; Johnson & Johnson USA	Webb, SR (corresponding author), Scripps Res Inst, Dept Immunol, IMM4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	swebb@scripps.edu	Carbone, Francis/ABF-2141-2020; Le Bon, Agnes/L-3237-2017	Le Bon, Agnes/0000-0003-4204-8136; Heath, William/0000-0001-9670-259X	NATIONAL CANCER INSTITUTE [P01CA025803, R01CA041993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039664] Funding Source: NIH RePORTER; NCI NIH HHS [CA41993, CA25803] Funding Source: Medline; NIAID NIH HHS [AI39664] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1995, SCIENCE, V270, P932, DOI 10.1126/science.270.5238.932; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Benoist C, 1997, CELL, V89, P1, DOI 10.1016/S0092-8674(00)80174-9; Bradley LM, 1999, J IMMUNOL, V162, P2511; Brunmark A, 1997, J IMMUNOL, V159, P1676; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; DAMLE NK, 1992, J IMMUNOL, V148, P1985; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Delovitch TL, 1998, IMMUNITY, V8, pU9; DeVries ME, 1999, SEMIN IMMUNOL, V11, P95, DOI 10.1006/smim.1999.0165; DUBEY C, 1995, J IMMUNOL, V155, P45; Dustin ML, 1996, J IMMUNOL, V157, P2014; Falcone M, 1999, CLIN IMMUNOL, V90, P2, DOI 10.1006/clim.1998.4619; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Gause WC, 1995, IMMUNOL RES, V14, P176, DOI 10.1007/BF02918215; Glabinski AR, 1998, NEUROIMMUNOMODULAT, V5, P166, DOI 10.1159/000026333; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Grewal IS, 1997, J IMMUNOL, V159, P401; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; KING CL, 1995, EUR J IMMUNOL, V25, P587, DOI 10.1002/eji.1830250242; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KUHLMAN P, 1991, J IMMUNOL, V146, P1773; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lafaille JJ, 1998, CYTOKINE GROWTH F R, V9, P139, DOI 10.1016/S1359-6101(98)00009-4; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Luksch CR, 1999, P NATL ACAD SCI USA, V96, P3023, DOI 10.1073/pnas.96.6.3023; Nelson PJ, 1998, CURR OPIN IMMUNOL, V10, P265, DOI 10.1016/S0952-7915(98)80164-7; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V; Ranger AM, 1996, INT IMMUNOL, V8, P1549, DOI 10.1093/intimm/8.10.1549; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Rothe H, 1997, J AUTOIMMUN, V10, P251, DOI 10.1006/jaut.1997.0135; Rulifson IC, 1997, J IMMUNOL, V158, P658; Sabzevari H, 1997, EUR J IMMUNOL, V27, P1901, DOI 10.1002/eji.1830270813; Salomon B, 1998, J IMMUNOL, V161, P5138; Schimmer RC, 1997, J IMMUNOL, V159, P4103; Schrier DJ, 1998, J LEUKOCYTE BIOL, V63, P359, DOI 10.1002/jlb.63.3.359; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Suri A, 1999, IMMUNOL REV, V169, P55, DOI 10.1111/j.1600-065X.1999.tb01306.x; van Seventer GA, 1998, TRANSPLANT P, V30, P4270, DOI 10.1016/S0041-1345(98)01410-9; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Vyth-Dreese FA, 1998, IMMUNOLOGY, V94, P580, DOI 10.1046/j.1365-2567.1998.00550.x; Yashiro Y, 1998, EUR J IMMUNOL, V28, P926, DOI 10.1002/(SICI)1521-4141(199803)28:03<926::AID-IMMU926>3.3.CO;2-S; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	52	67	71	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					523	529		10.1038/88720	http://dx.doi.org/10.1038/88720			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376339				2022-12-18	WOS:000169078000015
J	Wang, L; Simons, DL; Lug, XY; Tu, TY; Solomon, S; Wang, R; Rosario, A; Avalos, C; Schmolze, D; Yim, J; Waismans, J; Lee, PP				Wang, Lei; Simons, Diana L.; Lug, Xuyang; Tu, Travis Y.; Solomon, Shawn; Wang, Roger; Rosario, Anthony; Avalos, Christian; Schmolze, Daniel; Yim, John; Waismans, James; Lee, Peter P.			Connecting blood and intratumoral T-reg cell activity in predicting future relapse in breast cancer	NATURE IMMUNOLOGY			English	Article							PERIPHERAL-BLOOD; FOXP3 EXPRESSION; GROWTH; CARCINOMA; LYMPHOCYTES; RECRUITMENT; INDUCTION; TOLERANCE; EFFECTOR; RECEPTOR	Regulatory T (T-reg) cells play a major role in the development of an immunosuppressive tumor microenvironment. The origin of intratumoral T-reg cells and their relationship with peripheral blood T (reg) cells remain unclear. T-reg cells consist of at least three functionally distinct subpopulations. Here we show that peripheral blood CD45RA-FOXP3(hi) T-reg cells (T-reg II cells) are phenotypically closest to intratumoral T-reg cells, including in their expression of CCR8. Analyses of T cell antigen receptor repertoires further support the hypothesis that intratumoral T-reg cells may originate primarily from peripheral blood T-reg II cells. Moreover, the signaling responsiveness of peripheral blood T-reg II cells to immunosuppressive, T helper type 1 (T(H)1) and T helper type 2 (T(H)2) cytokines reflects intratumoral immunosuppressive potential, and predicts future relapse in two independent cohorts of patients with breast cancer. Together, our findings give important insights into the relationship between peripheral blood T-reg cells and intratumoral T-reg cells, and highlight cytokine signaling responsiveness as a key determinant of intratumoral immunosuppressive potential and clinical outcome.	[Wang, Lei; Simons, Diana L.; Tu, Travis Y.; Solomon, Shawn; Wang, Roger; Rosario, Anthony; Avalos, Christian; Lee, Peter P.] City Hope Natl Med Ctr, Comprehens Canc Ctr, Dept Immunooncol, Beckman Res Inst, Duarte, CA 91010 USA; [Lug, Xuyang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Schmolze, Daniel] City Hope Natl Med Ctr, Dept Pathol, Comprehens Canc Ctr, Duarte, CA USA; [Yim, John] City Hope Natl Med Ctr, Dept Surg, Comprehens Canc Ctr, Duarte, CA USA; [Waismans, James] City Hope Natl Med Ctr, Dept Med Oncol, Comprehens Canc Ctr, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; City of Hope; City of Hope; City of Hope	Lee, PP (corresponding author), City Hope Natl Med Ctr, Comprehens Canc Ctr, Dept Immunooncol, Beckman Res Inst, Duarte, CA 91010 USA.	plee@coh.org		Schmolze, Daniel/0000-0002-6947-2546; Lee, Peter P./0000-0002-2660-4377; Avalos, Christian/0000-0001-8852-9520; Tu, Travis/0000-0002-8167-313X	Department of Defense Breast Cancer Research Program; Stand Up to Cancer; Breast Cancer Research Foundation; V Foundation; National Cancer Institute of the National Institutes of Health [P30CA33572]	Department of Defense Breast Cancer Research Program(United States Department of Defense); Stand Up to Cancer; Breast Cancer Research Foundation; V Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. Kirschenbaum for obtaining consent from patients and acquiring samples at City of Hope Comprehensive Cancer Center. We would like to thank D. Dunkley for organizing the collection of blood samples from age-matched healthy controls. This work was supported by the Department of Defense Breast Cancer Research Program, Stand Up to Cancer, the Breast Cancer Research Foundation and the V Foundation. Research reported in this publication included work performed in the Analytical Cytometry Core and Pathology Research Services Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeegbe DO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00190; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Baras AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134412; Barsheshet Y, 2017, P NATL ACAD SCI USA, V114, P6086, DOI 10.1073/pnas.1621280114; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Carstens JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15095; Chaudhary B, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030028; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Kumar V, 2013, PURINERG SIGNAL, V9, P145, DOI 10.1007/s11302-012-9349-9; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Loyher PL, 2016, CANCER RES, V76, P6483, DOI 10.1158/0008-5472.CAN-16-0984; Lu L, 2017, NAT REV IMMUNOL, V17, P703, DOI 10.1038/nri.2017.75; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Redjimi N, 2012, CANCER RES, V72, P4351, DOI 10.1158/0008-5472.CAN-12-0579; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Sun W, 2017, BRIT J CANCER, V117, P1631, DOI 10.1038/bjc.2017.329; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Yao X, 2012, BLOOD, V119, P5688, DOI 10.1182/blood-2011-10-386482	48	66	69	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1220	+		10.1038/s41590-019-0429-7	http://dx.doi.org/10.1038/s41590-019-0429-7			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31285626	Green Accepted			2022-12-18	WOS:000482212600021
J	Hong, JS; Ge, CH; Jothikumar, P; Yuan, Z; Liu, BY; Bai, K; Li, KT; Rittase, W; Shinzawa, M; Zhang, Y; Palin, A; Love, P; Yu, XH; Salaita, K; Evavold, BD; Singer, A; Zhu, C				Hong, Jinsung; Ge, Chenghao; Jothikumar, Prithiviraj; Yuan, Zhou; Liu, Baoyu; Bai, Ke; Li, Kaitao; Rittase, William; Shinzawa, Miho; Zhang, Yun; Palin, Amy; Love, Paul; Yu, Xinhua; Salaita, Khalid; Evavold, Brian D.; Singer, Alfred; Zhu, Cheng			A TCR mechanotransduction signaling loop induces negative selection in the thymus	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; CD4(+)CD8(+) THYMOCYTES; CATCH BONDS; KINETICS; CD8; LIGAND; AFFINITY; BINDING; CD8/P56(LCK); RECRUITMENT	The T cell antigen receptor (TCR) expressed on thymocytes interacts with self-peptide major histocompatibility complex (pMHC) ligands to signal apoptosis or survival. Here, we found that negative-selection ligands induced thymocytes to exert forces on the TCR and the co-receptor CD8 and formed cooperative TCR-pMHC-CD8 trimolecular 'catch bonds', whereas positive-selection ligands induced less sustained thymocyte forces on TCR and CD8 and formed shorter-lived, independent TCR-pMHC and pMHC-CD8 bimolecular 'slip bonds'. Catch bonds were not intrinsic to either the TCR-pMHC or the pMHC-CD8 arm of the trans (cross-junctional) heterodimer but resulted from coupling of the extracellular pMHC-CD8 interaction to the intracellular interaction of CD8 with TCR-CD3 via associated kinases to form a cis (lateral) heterodimer capable of inside-out signaling. We suggest that the coupled trans-cis heterodimeric interactions form a mechanotransduction loop that reinforces negative-selection signaling that is distinct from positive-selection signaling in the thymus.	[Hong, Jinsung; Rittase, William; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Hong, Jinsung; Ge, Chenghao; Jothikumar, Prithiviraj; Yuan, Zhou; Liu, Baoyu; Bai, Ke; Li, Kaitao; Rittase, William; Zhu, Cheng] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Ge, Chenghao; Jothikumar, Prithiviraj; Yuan, Zhou; Liu, Baoyu; Bai, Ke; Li, Kaitao; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Shinzawa, Miho; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD USA; [Zhang, Yun; Salaita, Khalid] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Palin, Amy; Love, Paul] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Sect Hematopoiesis & Lymphocyte Biol, Natl Inst Hlth, Bethesda, MD USA; [Yu, Xinhua] Univ Memphis, Div Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA; [Evavold, Brian D.] Emory Univ, Sch Med, Dept Immunol & Microbiol, Atlanta, GA USA; [Hong, Jinsung] NIAID, Vaccine Prod Program Lab, Vaccine Res Ctr, NIH, Gaithersburg, MD USA; [Liu, Baoyu; Evavold, Brian D.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Bai, Ke] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Palin, Amy] NCI, NIH, Expt Immunol Branch, Bethesda, MD USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Memphis; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhu, C (corresponding author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Zhu, C (corresponding author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	salaita, khalid/C-4414-2008	Palin, Amy/0000-0002-7724-9563; Zhu, Cheng/0000-0002-1718-565X	NIH [CA214354, AI124680, NS071518, AI096879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA214354, ZIABC011116] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124680, R01AI096879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Lawrence for maintaining the mouse colonies; L. Doudy for thymocyte purification; W. Chen and Z. Li for assistance with experiments and discussions; and the NIH Tetramer Core Facility at Emory University for providing the pMHC monomers. This work was supported by NIH grants CA214354 and AI124680 (to C.Z.), and NS071518 and AI096879 (to B.D.E.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Dushek O, 2014, TRENDS IMMUNOL, V35, P153, DOI 10.1016/j.it.2014.02.002; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Feng YN, 2017, P NATL ACAD SCI USA, V114, pE8204, DOI 10.1073/pnas.1703559114; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Hailman E, 2005, J IMMUNOL, V175, P4847, DOI 10.4049/jimmunol.175.8.4847; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Hwang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7982; Hwang S, 2012, J EXP MED, V209, P1781, DOI 10.1084/jem.20120058; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Ju LN, 2013, J BIOL CHEM, V288, P32289, DOI 10.1074/jbc.M113.504001; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Lo WL, 2018, NAT IMMUNOL, V19, P733, DOI 10.1038/s41590-018-0131-1; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Manz BN, 2015, ELIFE, V4, DOI 10.7554/eLife.08088; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Martinez RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13848; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; Puls KL, 2002, INT IMMUNOL, V14, P249, DOI 10.1093/intimm/14.3.249; R Core Team, 2017, R LANG ENV STAT COMP; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; Sauer K., 2009, CURR PROTOC IMMUNOL, V87; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Thome M, 1996, EUR J IMMUNOL, V26, P2093, DOI 10.1002/eji.1830260920; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6167	55	66	68	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1379	+		10.1038/s41590-018-0259-z	http://dx.doi.org/10.1038/s41590-018-0259-z			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30420628	Green Accepted			2022-12-18	WOS:000452873000018
J	Bansal, K; Yoshida, H; Benoist, C; Mathis, D				Bansal, Kushagra; Yoshida, Hideyuki; Benoist, Christophe; Mathis, Diane			The transcriptional regulator Aire binds to and activates super-enhancers	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; GENE-EXPRESSION PATTERNS; DOUBLE-STRAND BREAKS; AUTOIMMUNE REGULATOR; TOPOISOMERASE 1; IMMUNOLOGICAL-TOLERANCE; RNA-POLYMERASE; IDENTITY GENES; DNA BREAKS; P-TEFB	Aire is a transcription factor that controls T cell tolerance by inducing the expression of a large repertoire of genes specifically in thymic stromal cells. It interacts with scores of protein partners of diverse functional classes. We found that Aire and some of its partners, notably those implicated in the DNA-damage response, preferentially localized to and activated long chromatin stretches that were overloaded with transcriptional regulators, known as super-enhancers. We also identified topoisomerase 1 as a cardinal Aire partner that colocalized on super-enhancers and was required for the interaction of Aire with all of its other associates. We propose a model that entails looping of super-enhancers to efficiently deliver Aire-containing complexes to local and distal transcriptional start sites.	[Bansal, Kushagra; Yoshida, Hideyuki; Benoist, Christophe; Mathis, Diane] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Benoist, C (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu			NIH [HHSN272201300006C, R01 DK060027, R01 AI088204]; American Diabetes Association Mentor-Based Postdoctoral Fellowship [7-12-MN-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Mentor-Based Postdoctoral Fellowship(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Buruzula, K. Rothamel, A. Rhoads, K. Hattori, A. Lopez, G. Gopalan, K. Waraska, M. Thorsen for experimental assistance and C. Laplace for help with manuscript preparation. The NIH Tetramer Core Facility (contract HHSN272201300006C) kindly provided tetramers. This work was supported by NIH grants R01 DK060027 and R01 AI088204. K.B. was supported by American Diabetes Association Mentor-Based Postdoctoral Fellowship #7-12-MN-51 to D.M.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Baranello L, 2013, TRANSCR-AUSTIN, V4, P232, DOI 10.4161/trns.26598; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Husain A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10549; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; LaFlam TN, 2015, J EXP MED, V212, P1993, DOI 10.1084/jem.20151069; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Trotter KW, 2015, MOL CELL BIOL, V35, P2799, DOI 10.1128/MCB.00230-15; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Witte S, 2015, TRENDS IMMUNOL, V36, P519, DOI 10.1016/j.it.2015.07.005; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112	49	66	67	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					263	273		10.1038/ni.3675	http://dx.doi.org/10.1038/ni.3675			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28135252	Green Accepted			2022-12-18	WOS:000394413400006
J	Lu, W; You, R; Yuan, XY; Yang, TS; Samuel, ELG; Marcano, DC; Sildcema, WKA; Tour, JM; Rodriguez, A; Kheradmand, F; Corry, DB				Lu, Wen; You, Ran; Yuan, Xiaoyi; Yang, Tianshu; Samuel, Errol L. G.; Marcano, Daniela C.; Sildcema, William K. A.; Tour, James M.; Rodriguez, Antony; Kheradmand, Farrah; Corry, David B.			The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; PPAR-GAMMA; TRANSCRIPTION; PROTEIN; MOUSE; LUNG; PROLIFERATION; ACTIVATION; SUPPRESSOR	Smoking-related emphysema is a chronic inflammatory disease driven by the T(H)17 subset of helper T cells through molecular mechanisms that remain obscure. Here we explored the role of the microRNA miR-22 in emphysema. We found that miR-22 was upregulated in lung myeloid dendritic cells (mDCs) of smokers with emphysema and antigen-presenting cells (APCs) of mice exposed to smoke or nanoparticulate carbon black (nCB) through a mechanism that involved the transcription factor NF-kappa B. Mice deficient in miR-22, but not wild-type mice, showed attenuated T(H)17 responses and failed to develop emphysema after exposure to smoke or nCB. We further found that miR-22 controlled the activation of APCs and T(H)17 responses through the activation of AP-1 transcription factor complexes and the histone deacetylase HDAC4. Thus, miR-22 is a critical regulator of both emphysema and T(H)17 responses.	[Lu, Wen; You, Ran; Yuan, Xiaoyi; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Yang, Tianshu; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Samuel, Errol L. G.; Marcano, Daniela C.; Sildcema, William K. A.; Tour, James M.] Rice Univ, Dept Chem, Houston, TX USA; [Rodriguez, Antony] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Biol Inflammat Ctr, Houston, TX USA; [Kheradmand, Farrah; Corry, David B.] Michael E DeBakey Virginia Ctr Translat Res Infla, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Baylor College of Medicine; Baylor College of Medicine	Corry, DB (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	farrahk@bcm.edu; dcorry@bcm.edu	Samuel, Errol/AAF-3065-2022; Lu, Wen/C-6543-2019; Samuel, Errol/AEM-2173-2022	Samuel, Errol/0000-0003-4381-9203; Samuel, Errol/0000-0003-4381-9203; Sikkema, William/0000-0001-9614-3935; Tour, James/0000-0002-8479-9328; Marcano, Daniela C./0000-0002-3446-8010	US National Institutes of Health [R01HL117181, R0IHL110883, AI036211, CA125123, RR024574]; US Veterans Administration Office of Research and Development [1I01BX002221]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117181, R01HL110883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000104, I01BX002221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration Office of Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	We thank J. Levitt (Baylor College of Medicine) for CD11c-Cre mice; E. Olson (UT Southwestern Medical Center) for Hdac4<SUP>fl</SUP> mice; and W. Decker, J. Sederstrom, Y. Qian and L.-Z. Song for technical assistance. Supported by the US National Institutes of Health (R01HL117181 to F.K.; R0IHL110883 to F.K. and D.B.C.; and AI036211, CA125123 and RR024574 to the Cytometry and Cell Sorting Core at Baylor College of Medicine) and the US Veterans Administration Office of Research and Development (1I01BX002221 to D.B.C.).	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Gurha P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075882; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Han SY, 2006, BIOCHEM J, V400, P439, DOI 10.1042/BJ20061085; Hart JE, 2012, CURR OPIN PULM MED, V18, P151, DOI 10.1097/MCP.0b013e32834f0eaa; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Hoyert D.L., 2012, NATL VITAL STAT SYST, V61, P51; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jovicic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054222; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parra M, 2015, FEBS J, V282, P1736, DOI 10.1111/febs.13061; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sandhu SK, 2012, P NATL ACAD SCI USA, V109, P20047, DOI 10.1073/pnas.1213764109; Shan M, 2014, J CLIN INVEST, V124, P1371, DOI 10.1172/JCI70587; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Tang YY, 2015, MOL MED REP, V11, P454, DOI 10.3892/mmr.2014.2682; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang XS, 2012, J IMMUNOL, V189, P3092, DOI 10.4049/jimmunol.1200573; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Xu C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00267; Xu QF, 2014, BRAIN PATHOL, V24, P568, DOI 10.1111/bpa.12136; Yang Q, 2015, MOL CELL BIOL, V35, P63, DOI 10.1128/MCB.00805-14; You R, ELIFE IN PRESS; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	46	66	69	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1185	1194		10.1038/ni.3292	http://dx.doi.org/10.1038/ni.3292			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26437241	Green Accepted			2022-12-18	WOS:000363096000012
J	Malissen, B; Gregoire, C; Malissen, M; Roncagalli, R				Malissen, Bernard; Gregoire, Claude; Malissen, Marie; Roncagalli, Romain			Integrative biology of T cell activation	NATURE IMMUNOLOGY			English	Article							ADAPTER PROTEIN LAT; KINASE PKC-THETA; LYMPHOPROLIFERATIVE DISORDER; PHOSPHOPROTEOMIC ANALYSIS; SIGNALING MOLECULES; MULTIPOINT BINDING; CD8(+) T; RECEPTOR; TCR; ANTIGEN	The activation of T cells mediated by the T cell antigen receptor (TCR) requires the interaction of dozens of proteins, and its malfunction has pathological consequences. Our major focus is on new developments in the systems-level understanding of the TCR signal-transduction network. To make sense of the formidable complexity of this network, we argue that 'fine-grained' methods are needed to assess the relationships among a few components that interact on a nanometric scale, and those should be integrated with high-throughput '-omic' approaches that simultaneously capture large numbers of parameters. We illustrate the utility of this integrative approach with the transmembrane signaling protein Lat, which is a key signaling hub of the TCR signal-transduction network, as a connecting thread.	[Malissen, Bernard; Gregoire, Claude; Malissen, Marie; Roncagalli, Romain] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, Marseille, France; [Malissen, Bernard; Gregoire, Claude; Malissen, Marie; Roncagalli, Romain] INSERM, U1104, F-13258 Marseille, France; [Malissen, Bernard; Gregoire, Claude; Malissen, Marie; Roncagalli, Romain] CNRS, UMR7280, Marseille, France; [Malissen, Bernard; Malissen, Marie] Aix Marseille Univ, UM2, Ctr Immunophen, Marseille, France; [Malissen, Bernard; Malissen, Marie] INSERM, US012, F-13258 Marseille, France; [Malissen, Bernard; Malissen, Marie] CNRS, UMS3367, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy, Marseille, France.	bernardm@ciml.univ-mrs.fr	Roncagalli, Romain/ABB-8786-2020; Malissen, Bernard/AAK-4659-2020	Malissen, Marie/0000-0003-2331-1445; Malissen, Bernard/0000-0003-1340-9342; Roncagalli, Romain/0000-0001-7554-0552	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicate; Aix-Marseille Universite; French National Infrastructure for Mouse Phenogenomics (PHENOMIN); Agence Nationale de Recherche; European Research Council	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicate; Aix-Marseille Universite; French National Infrastructure for Mouse Phenogenomics (PHENOMIN); Agence Nationale de Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	This paper is dedicated to the memory of Francois Kourilsky. We thank R. Germain and P. Bongrand for discussions. Supported by the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicate, Aix-Marseille Universite, French National Infrastructure for Mouse Phenogenomics (PHENOMIN), Agence Nationale de Recherche (Basilic project to MA.) and European Research Council ("Integrate" grant to B.M.).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Archambaud C, 2009, J IMMUNOL, V182, P2680, DOI 10.4049/jimmunol.0803257; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Balagopalan L, 2013, J IMMUNOL, V190, P3849, DOI 10.4049/jimmunol.1202760; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Brodovitch A, 2013, J IMMUNOL, V191, P2064, DOI 10.4049/jimmunol.1300523; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Cao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046725; Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461; Chakraborty A.K.W., 2014, NAT IMMUNOL, V15, P815; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chevrier S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00027; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Cruz-Orcutt N, 2014, CELL SIGNAL, V26, P797, DOI 10.1016/j.cellsig.2013.12.022; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Genton C, 2006, J IMMUNOL, V177, P2285, DOI 10.4049/jimmunol.177.4.2285; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Hogquist K.A.J., 2014, NAT IMMUNOL, V15, pXXX; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Hsu CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032398; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huppa JB, 2013, ADV IMMUNOL, V119, P1, DOI 10.1016/B978-0-12-407707-2.00001-1; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Kortum RL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004494; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Larghi P, 2013, NAT IMMUNOL, V14, P723, DOI 10.1038/ni.2609; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; Malissen B, 2011, NAT IMMUNOL, V12, P592, DOI 10.1038/ni.2054; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; McDonald CB, 2012, BIOCHEMISTRY-US, V51, P2122, DOI 10.1021/bi3000534; Michel F., 2002, SCI STKE, V2002, pe35; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Navarro M.N.C., 2014, NAT IMMUNOL, V15, pXXX; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ophir MJ, 2013, J CELL BIOL, V203, P1021, DOI 10.1083/jcb.201305088; Ou-Yang CW, 2012, MOL CELL BIOL, V32, P2674, DOI 10.1128/MCB.00356-12; Pagan AJ, 2012, J IMMUNOL, V189, P2909, DOI 10.4049/jimmunol.1103231; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Pauker MH, 2011, MOL CELL BIOL, V31, P2653, DOI 10.1128/MCB.01358-10; Pitcher LA, 2003, IMMUNOL REV, V191, P47, DOI 10.1034/j.1600-065X.2003.00003.x; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Roncagalli R, 2010, TRENDS IMMUNOL, V31, P253, DOI 10.1016/j.it.2010.05.001; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Salek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077423; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Sangani D, 2009, MOL MEMBR BIOL, V26, P159, DOI 10.1080/09687680802637660; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Sherman E, 2013, METHODS, V59, P261, DOI 10.1016/j.ymeth.2012.12.002; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/nmeth.2400, 10.1038/NMETH.2400]; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	104	66	67	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					790	797		10.1038/ni.2959	http://dx.doi.org/10.1038/ni.2959			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137453				2022-12-18	WOS:000340739400002
J	You, FP; Wang, PH; Yang, L; Yang, G; Zhao, YO; Qian, F; Walker, W; Sutton, R; Montgomery, R; Lin, RT; Iwasaki, A; Fikrig, E				You, Fuping; Wang, Penghua; Yang, Long; Yang, Guang; Zhao, Yang O.; Qian, Feng; Walker, Wendy; Sutton, Richard; Montgomery, Ruth; Lin, Rongtuan; Iwasaki, Akiko; Fikrig, Erol			ELF4 is critical for induction of type I interferon and the host antiviral response	NATURE IMMUNOLOGY			English	Article							WEST-NILE-VIRUS; ETS PROTEIN MEF; CD8(+) T-CELLS; ADAPTER PROTEIN; TRANSCRIPTION FACTORS; NATURAL-KILLER; CYTOSOLIC DNA; INNATE; BINDING; ACTIVATION	Induction of type I interferon is a central event of innate immunity, essential for host defense. Here we report that the transcription factor ELF4 is induced by type I interferon and upregulates interferon expression in a feed-forward loop. ELF4 deficiency leads to reduced interferon production, resulting in enhanced susceptibility to West Nile virus encephalitis in mice. After viral infection, ELF4 is recruited by STING, interacts with and is activated by the MAVS-TBK1 complex, and translocates into the nucleus to bind interferon promoters. Cooperative binding with ELF4 increases the binding affinity of interferon regulatory factors IRF3 and IRF7, which is mediated by EICE elements. Thus, in addition to identifying a regulator of innate immune signaling, we uncovered a role for EICE elements in interferon transactivation.	[You, Fuping; Wang, Penghua; Yang, Long; Yang, Guang; Zhao, Yang O.; Walker, Wendy; Sutton, Richard; Fikrig, Erol] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; [Zhao, Yang O.; Walker, Wendy; Iwasaki, Akiko; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA; [Qian, Feng; Montgomery, Ruth] Yale Univ, Sch Med, Dept Internal Med, Sect Rheumatol, New Haven, CT 06510 USA; [Lin, Rongtuan] McGill Univ, Dept Med, Lady Davis Inst, Montreal, PQ, Canada; [Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Lady Davis Institute; McGill University; Yale University	Fikrig, E (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Lin, Rongtuan/A-1442-2008; Walker, Wendy/GQB-0819-2022; wang, Penghua/AAL-4011-2020; Iwasaki, Akiko/Z-1591-2019; Qian, Feng/F-8186-2010	Lin, Rongtuan/0000-0002-2238-3503; Iwasaki, Akiko/0000-0002-7824-9856; Montgomery, Ruth/0000-0002-8661-4454	US National Institutes of Health [N01-HHSN272201100019C, AI099625, AI08992]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089992, R01AI062428, R03AI099625] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Nimer (University of Miami) for the Elf4<SUP>-/-</SUP> mice, Z. Jiang (Peking University) for the reporter plasmids. This work was supported by the US National Institutes of Health (N01-HHSN272201100019C, AI099625 and AI08992). E. F. and A. I. are funded by the Howard Hughes Medical Institute.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collett GP, 2006, CARCINOGENESIS, V27, P1285, DOI 10.1093/carcin/bgi368; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gobin SJP, 2003, BLOOD, V101, P3058, DOI 10.1182/blood-2002-09-2924; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyahira AK, 2009, J IMMUNOL, V182, P2248, DOI 10.4049/jimmunol.0802466; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Sivina M, 2011, ARTERIOSCL THROM VAS, V31, P1185, DOI 10.1161/ATVBAHA.111.224436; Suico MA, 2002, BBA-GENE STRUCT EXPR, V1577, P113, DOI 10.1016/S0167-4781(02)00370-6; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; VARGIN VV, 1986, ACTA VIROL, V30, P303; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yao JJ, 2007, ONCOGENE, V26, P4032, DOI 10.1038/sj.onc.1210170; Yokoyama M, 2004, GASTROENTEROLOGY, V127, P892, DOI 10.1053/j.gastro.2004.06.020; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	49	66	71	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1237	+		10.1038/ni.2756	http://dx.doi.org/10.1038/ni.2756			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24185615	Green Accepted			2022-12-18	WOS:000327149400009
J	Palmer, MT; Weaver, CT				Palmer, Matthew T.; Weaver, Casey T.			Autoimmunity: increasing suspects in the CD4(+) T cell lineup	NATURE IMMUNOLOGY			English	Article							FOLLICULAR-HELPER-CELLS; MEDIATED INTESTINAL INFLAMMATION; COLLAGEN-INDUCED ARTHRITIS; CXC CHEMOKINE RECEPTOR-5; CENTRAL-NERVOUS-SYSTEM; INTERFERON-GAMMA; TH17 CELLS; TGF-BETA; EXPERIMENTAL COLITIS; TRANSCRIPTION FACTOR	Chronic reactivity of CD4(+) T cells to autoantigens and to components of the commensal flora drive destructive inflammation in a variety of mouse models of autoimmunity. Insight gained using these models is empowering translational research into human disease. Immunologists are trying to assign disease culpability to one of the ever-growing number of T helper (T-H) cell subsets. Although recent discovery of the interleukin 17-producing T-H-17 lineage appeared to supplant the pre-eminence of T(H)1 cells in promoting autoimmunity, the newest data defy simple paradigms. Here we speculate on the respective contributions to autoimmunity made by an increasingly complex list of T-H subsets and argue that the T(H)1 phenotype may be staging a comeback.	[Palmer, Matthew T.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Palmer, MT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	mpalmer@uab.edu; cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793	US National Institutes of Health; Crohn's and Colitis Foundation of America	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America	Supported by the US National Institutes of Health (C. T. W. and M. T. P.) and the Crohn's and Colitis Foundation of America (C. T. W. and M. T. P.).	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Betti M, 2006, ANN ONCOL, V17, P235; BOISSIER MC, 1995, EUR J IMMUNOL, V25, P1184, DOI 10.1002/eji.1830250508; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; GERMANN T, 1995, P NATL ACAD SCI USA, V92, P4823, DOI 10.1073/pnas.92.11.4823; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Harries-Rees K, 2005, CHEM WORLD-UK, V2, P6; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Sornasse T, 1996, J EXP MED, V184, P473, DOI 10.1084/jem.184.2.473; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; WINSLET MC, 1994, GUT, V35, P236, DOI 10.1136/gut.35.2.236; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	86	66	72	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					36	40		10.1038/ni.1802	http://dx.doi.org/10.1038/ni.1802			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016508				2022-12-18	WOS:000272855300007
J	Wu, WH; Hsu, YMS; Bi, LK; Zhou, SY; Lin, X				Wu, Weihui; Hsu, Yen-Michael S.; Bi, Liangkuan; Zhou Songyang; Lin, Xin			CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex	NATURE IMMUNOLOGY			English	Article							GDP-DISSOCIATION INHIBITOR; INNATE IMMUNE-RESPONSES; ADAPTER PROTEIN CARD9; GTP-BINDING PROTEINS; NADPH OXIDASE; LISTERIA-MONOCYTOGENES; LIVING CELLS; PHAGOSOME MATURATION; RHO GTPASES; ACTIVATION	In response to invading microorganisms, macrophages engage in phagocytosis and rapidly release reactive oxygen species (ROS), which serve an important microbicidal function. However, how phagocytosis induces ROS production remains largely unknown. CARD9, a caspase-recruitment domain (CARD)-containing protein, is important for resistance to fungal and bacterial infection. The mechanism of CARD9-mediated bacterial clearance is still mostly unknown. Here we show that CARD9 is required for killing intracellular bacteria in macrophages. CARD9 associated with the GDP-dissociation inhibitor LyGDI in phagosomes after bacterial and fungal infection and binding of CARD9 suppressed LyGDI-mediated inhibition of the GTPase Rac1, thereby leading to ROS production and bacterial killing in macrophages. Thus, our studies identify a key pathway that leads to microbe-elicited ROS production.	[Wu, Weihui; Hsu, Yen-Michael S.; Bi, Liangkuan; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	xllin@mdanderson.org			National Institutes of Health [RO1AI050848, R01GM065899, R01GM069572]; Welch Foundation; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Li and F. Southwick (University of Florida) for GFP-L. monocytogenes, and X. Qin (University of Texas MD Anderson Cancer Center) for the retroviral packaging vector pCGP and pVSV-G. Supported by the National Institutes of Health (RO1AI050848 and R01GM065899 to X. L. and R01GM069572 to Z. S.), the Welch Foundation (Z. S.) and the Leukemia and Lymphoma Society (X. L. and Z.S.).	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Liu D, 2000, ONCOGENE, V19, P5964, DOI 10.1038/sj.onc.1203992; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; PICK E, 1993, EUR J BIOCHEM, V217, P441, DOI 10.1111/j.1432-1033.1993.tb18264.x; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zal T, 2008, ADV EXP MED BIOL, V640, P183, DOI 10.1007/978-0-387-09789-3_14	40	66	69	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1208	U95		10.1038/ni.1788	http://dx.doi.org/10.1038/ni.1788			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19767757				2022-12-18	WOS:000270955900014
J	Kong, XF; Martinez-Barricarte, R; Kennedy, J; Mele, F; Lazarov, T; Deenick, EK; Ma, CS; Breton, G; Lucero, KB; Langlais, D; Bousfiha, A; Aytekin, C; Markle, J; Trouillet, C; Jabot-Hanin, F; Arlehamn, CSL; Rao, G; Picard, C; Lasseau, T; Latorre, D; Hambleton, S; Deswarte, C; Itan, Y; Abarca, K; Moraes-Vasconcelos, D; Ailal, F; Ikinciogullari, A; Dogu, F; Benhsaien, I; Sette, A; Abel, L; Boisson-Dupuis, S; Schroder, B; Nussenzweig, MC; Liu, K; Geissmann, F; Tangye, SG; Gros, P; Sallusto, F; Bustamante, J; Casanova, JL				Kong, Xiao-Fei; Martinez-Barricarte, Ruben; Kennedy, James; Mele, Federico; Lazarov, Tomi; Deenick, Elissa K.; Ma, Cindy S.; Breton, Gaelle; Lucero, Kimberly B.; Langlais, David; Bousfiha, Aziz; Aytekin, Caner; Markle, Janet; Trouillet, Celine; Jabot-Hanin, Fabienne; Arlehamn, Cecilia S. Lindestam; Rao, Geetha; Picard, Capucine; Lasseau, Theo; Latorre, Daniela; Hambleton, Sophie; Deswarte, Caroline; Itan, Yuval; Abarca, Katia; Moraes-Vasconcelos, Dewton; Ailal, Fatima; Ikinciogullari, Aydan; Dogu, Figen; Benhsaien, Ibtihal; Sette, Alessandro; Abel, Laurent; Boisson-Dupuis, Stephanie; Schroeder, Bernd; Nussenzweig, Michel C.; Liu, Kang; Geissmann, Frederic; Tangye, Stuart G.; Gros, Philippe; Sallusto, Federica; Bustamante, Jacinta; Casanova, Jean-Laurent			Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency	NATURE IMMUNOLOGY			English	Article							SIGNAL-PEPTIDE-PEPTIDASE; REGULATED INTRAMEMBRANE PROTEOLYSIS; TUMOR-NECROSIS-FACTOR; IFN-GAMMA IMMUNITY; B-CELL; MYCOBACTERIAL DISEASE; INTERFERON-GAMMA; PROTEASE SPPL2A; INVARIANT CHAIN; TNF-ALPHA	Human inborn errors of IFN-gamma immunity underlie mycobacterial diseases. We describe patients with Mycobacterium bovis (BCG) disease who are homozygous for loss-of-function mutations of SPPL2A. This gene encodes a transmembrane protease that degrades the N-terminal fragment (NTF) of CD74 (HLA invariant chain) in antigen-presenting cells. The CD74 NTF therefore accumulates in the HLA class II+ myeloid and lymphoid cells of SPPL2a-deficient patients. This toxic fragment selectively depletes IL-12-and IL-23-producing CD1c(+) conventional dendritic cells (cDC2s) and their circulating progenitors. Moreover, SPPL2a-deficient memory T(H)1(star) cells selectively fail to produce IFN-gamma when stimulated with mycobacterial antigens in vitro. Finally, Sppl2a(-/-) mice lack cDC2s, have CD4(+) T cells that produce small amounts of IFN-gamma after BCG infection, and are highly susceptible to infection with BCG or Mycobacterium tuberculosis. These findings suggest that inherited SPPL2a deficiency in humans underlies mycobacterial disease by decreasing the numbers of cDC2s and impairing IFN-gamma production by mycobacterium-specific memory T(H)1(star) cells.	[Kong, Xiao-Fei; Martinez-Barricarte, Ruben; Markle, Janet; Lasseau, Theo; Itan, Yuval; Abel, Laurent; Boisson-Dupuis, Stephanie; Bustamante, Jacinta; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Kennedy, James; Langlais, David; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Mele, Federico; Latorre, Daniela; Sallusto, Federica] Univ Italian Switzerland, Inst Res Biomed, Fac Biomed Sci, Ctr Med Immunol, Bellinzona, Switzerland; [Lazarov, Tomi; Trouillet, Celine; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Deenick, Elissa K.; Ma, Cindy S.; Rao, Geetha; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia; [Deenick, Elissa K.; Ma, Cindy S.; Rao, Geetha; Tangye, Stuart G.] UNSW Sydney, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW, Australia; [Breton, Gaelle; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Lucero, Kimberly B.; Liu, Kang] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA; [Bousfiha, Aziz; Ailal, Fatima; Benhsaien, Ibtihal] King Hassan II Univ, Fac Med & Pharm Casablanca, Lab Clin Immunol Inflammat & Allergy, Casablanca, Morocco; [Bousfiha, Aziz; Ailal, Fatima; Benhsaien, Ibtihal] CHU Averroes, Childrens Hosp, Dept Pediat Infect Dis, Clin Immunol Unit, Casablanca, Morocco; [Aytekin, Caner] Dr Sami Ulus Matern & Childrens Hlth & Dis Traini, Dept Pediat Immunol, Ankara, Turkey; [Jabot-Hanin, Fabienne; Deswarte, Caroline; Abel, Laurent; Boisson-Dupuis, Stephanie; Bustamante, Jacinta; Casanova, Jean-Laurent] Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM,U1163, Paris, France; [Jabot-Hanin, Fabienne; Picard, Capucine; Deswarte, Caroline; Abel, Laurent; Boisson-Dupuis, Stephanie; Bustamante, Jacinta; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Arlehamn, Cecilia S. Lindestam; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Picard, Capucine; Bustamante, Jacinta] Necker Hosp Sick Children, AP HP, Study Ctr Immunodeficiencies, Paris, France; [Picard, Capucine; Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol & Immunol Unit, Paris, France; [Hambleton, Sophie] Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Abarca, Katia] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Sch Med, Dept Pediat Infect Dis & Immunol, Santiago, Chile; [Moraes-Vasconcelos, Dewton] Univ Sao Paulo, Lab Invest Dermatol & Immunodeficiencies, Med Sch, Sao Paulo, Brazil; [Ikinciogullari, Aydan; Dogu, Figen] Ankara Univ, Sch Med, Dept Pediat Immunol & Allergy, Ankara, Turkey; [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Schroeder, Bernd] Christian Albrechts Univ Kiel, Biochem Inst, Kiel, Germany; [Schroeder, Bernd] Tech Univ Dresden, Inst Physiol Chem, Dresden, Germany; [Nussenzweig, Michel C.; Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	Rockefeller University; McGill University; Universita della Svizzera Italiana; Memorial Sloan Kettering Cancer Center; Garvan Institute of Medical Research; University of New South Wales Sydney; Rockefeller University; Columbia University; Hassan II University of Casablanca; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; Dr. Sami Ulus Education & Research Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; La Jolla Institute for Immunology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; Pontificia Universidad Catolica de Chile; Universidade de Sao Paulo; Ankara University; University of California System; University of California San Diego; University of Kiel; Technische Universitat Dresden; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.; Casanova, JL (corresponding author), Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM,U1163, Paris, France.; Casanova, JL (corresponding author), Paris Descartes Univ, Imagine Inst, Paris, France.; Casanova, JL (corresponding author), Necker Hosp Sick Children, AP HP, Pediat Hematol & Immunol Unit, Paris, France.; Casanova, JL (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	casanova@rockefeller.edu	Barricarte, Ruben Martinez/W-8695-2019; Sette, Alessandro/AFO-8916-2022; Tangye, Stuart G/H-4023-2014; Markle, Janet/X-1975-2019; Nussenzweig, Michel/AAE-7292-2019; ABARCA, KATIA/HDM-9351-2022; Boisson-Dupuis, Stephanie/AAF-5066-2021; S, Cindy/B-2340-2012; Dogu, Figen/AAI-1316-2020; Deenick, Elissa/AAY-8998-2020; İkinciogullari, Aydan/AAQ-3841-2020; Bustamante, Jacinta/H-7877-2017; Langlais, David/ABE-8455-2020	Barricarte, Ruben Martinez/0000-0001-7925-449X; Tangye, Stuart G/0000-0002-5360-5180; S, Cindy/0000-0001-5387-8413; Dogu, Figen/0000-0002-7869-4941; Deenick, Elissa/0000-0002-9271-0004; İkinciogullari, Aydan/0000-0003-1145-0843; Bustamante, Jacinta/0000-0002-3439-2482; Langlais, David/0000-0003-4429-0110; Latorre, Daniela/0000-0003-1031-1534; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; JABOT-HANIN, Fabienne/0000-0001-9294-7135; Hambleton, Sophie/0000-0001-7954-3267; Kong, Xiao-Fei/0000-0001-9983-2373; Markle, Janet/0000-0003-2189-4368; Boisson-Dupuis, Stephanie/0000-0002-7115-116X	Jerome Lejeune Foundation; Stony Wold-Herbert Fund; Choh-Hao Li Memorial Fund Scholar Award; Shanghai Educational Development Foundation; European Molecular Biology Organization (EMBO); Charles H. Revson Senior Fellowship in Biomedical Sciences; Deutsche Forschungsgemeinschaft [SFB877]; Cluster of Excellence 'Inflammation at Interfaces'; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science (National Center for Research Resources) [UL1TR001866]; Rockefeller University Center for Clinical and Translational Science (National Center for Advancing Sciences (NCATS)); National Institutes of Health, the National Institute of Allergy and Infectious Diseases [5R01AI089970-02, 5R37AI095983]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French National Research Agency (ANR) [ANR-10-IAHU-01]; ANR-IFNGPHOX [ANR-13-ISV3-0001-01]; ANR-GENMSMD [ANR-16-CE17-0005-01]; Institut National de la Sante et de la Recherche Medicale (INSERM); Rockefeller University; National Health and Medical Research Council of Australia; Fonds de Recherche du Quebec Sante; National Institute of Allergy and Infectious Diseases [R01AI035237-19]; ERC [323183 PREDICT]; Swiss National Science Foundation [170213]; Helmut Horten Foundation; NIH NIAID [U19AI118626]; Paris Descartes University;  [SCHR 1284/1-1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, UL1TR001866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130345, U19AI118626, R37AI095983, R01AI035237, R01AI089970] Funding Source: NIH RePORTER	Jerome Lejeune Foundation; Stony Wold-Herbert Fund; Choh-Hao Li Memorial Fund Scholar Award; Shanghai Educational Development Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Charles H. Revson Senior Fellowship in Biomedical Sciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence 'Inflammation at Interfaces'; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science (National Center for Research Resources); Rockefeller University Center for Clinical and Translational Science (National Center for Advancing Sciences (NCATS)); National Institutes of Health, the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French National Research Agency (ANR)(French National Research Agency (ANR)); ANR-IFNGPHOX; ANR-GENMSMD(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Rockefeller University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paris Descartes University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Coller, C. Rice, X. Ma, M. Ciancanelli, and G. Vogt for helpful discussions and critical reading. We thank Y. Nemirovskaya, E. Anderson, T. Kochetkov, M. Romanick, L. Amar, C. Patissier, C. Desvallees, M. Woollett, D. Papandrea, A. Gall, and J. Gonzalez for technical and secretarial assistance, and all members of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions. We thank F. Batteux and M. Bahuad from the Laboratory of Immunology, Cochin Hospital, Paris, France, for serological testing of patients, and F. B. Menozzi and the rest of the Microbiology Institute, EOC, Bellinzona, for providing microbial products. X.-F.K. was supported by the Jerome Lejeune Foundation, the Stony Wold-Herbert Fund, the Choh-Hao Li Memorial Fund Scholar Award, and the Shanghai Educational Development Foundation. R.M.B. was funded by a European Molecular Biology Organization (EMBO) long-term fellowship. J. M. was supported by the Charles H. Revson Senior Fellowship in Biomedical Sciences. B.S. received support from the Deutsche Forschungsgemeinschaft as part of the SFB877 and the Cluster of Excellence 'Inflammation at Interfaces', and the SCHR 1284/1-1 grant. The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the St. Giles Foundation (J.-L.C.), The Rockefeller University Center for Clinical and Translational Science (grant UL1TR001866 from the National Center for Research Resources and the National Center for Advancing Sciences (NCATS) to R.M.-B. and X.-F.K.), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (5R01AI089970-02 and 5R37AI095983 to J.-L.C.), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID, and the French National Research Agency (ANR) under the 'Investments for the future' program (ANR-10-IAHU-01 to L.A.), ANR-IFNGPHOX (ANR-13-ISV3-0001-01, to J.B.), and ANR-GENMSMD (ANR-16-CE17-0005-01, to J.B.), Institut National de la Sante et de la Recherche Medicale (INSERM), Paris Descartes University, and The Rockefeller University. E.K.D., C.S.M., and S.G.T. are supported by research grants and fellowships from the National Health and Medical Research Council of Australia. D. L. was supported by a fellowship from the Fonds de Recherche du Quebec Sante. Work in P.G.'s laboratory was supported by a grant from the National Institute of Allergy and Infectious Diseases (R01AI035237-19). The work at the Institute for Research in Biomedicine was supported by grants from the ERC (323183 PREDICT, to F.S.), the Swiss National Science Foundation (170213, to F.S.), and the Helmut Horten Foundation. This work was supported by award U19AI118626, NIH NIAID (to A.S. and F.S.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ai JW, 2015, J RHEUMATOL, V42, P2229, DOI 10.3899/jrheum.150057; Arlehamn CSL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005760; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Berghout J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003491; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Bigley V, 2016, CURR OPIN ALLERGY CL, V16, P530, DOI 10.1097/ACI.0000000000000322; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Brady OA, 2014, J BIOL CHEM, V289, P19670, DOI 10.1074/jbc.M113.515700; Breton G, 2015, NAT PROTOC, V10, P1407, DOI 10.1038/nprot.2015.092; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Bridgeford EC, 2008, J CLIN MICROBIOL, V46, P1881, DOI 10.1128/JCM.01875-07; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Fleck D, 2016, J BIOL CHEM, V291, P318, DOI 10.1074/jbc.M115.697995; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; GROS P, 1981, J IMMUNOL, V127, P2417; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Itan Y, 2013, P NATL ACAD SCI USA, V110, P5558, DOI [10.1073/pnas.1218167110, 10.1073/PNAS.1218167110]; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kong XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058286; Kreins AY, 2015, J EXP MED, V212, P1641, DOI 10.1084/jem.20140280; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martinez-Barricarte R, 2016, CURR PROTOC IMMUNOL, V115; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; Rieux-Laucat F, 2006, CURR DIRECT AUTOIMMU, V9, P18; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Schneppenheim J, 2014, BIOCHEM BIOPH RES CO, V451, P48, DOI 10.1016/j.bbrc.2014.07.051; Schneppenheim J, 2014, MOL CELL BIOL, V34, P1398, DOI 10.1128/MCB.00038-14; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Thiant S, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.29; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang Y, 2015, NAT IMMUNOL, V16, P1001, DOI 10.1038/ni.3275	71	65	69	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					973	+		10.1038/s41590-018-0178-z	http://dx.doi.org/10.1038/s41590-018-0178-z			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127434	Green Published, Green Accepted			2022-12-18	WOS:000442365100019
J	Crawford, G; Hayes, MD; Seoane, RC; Ward, S; Dalessandri, T; Lai, C; Healy, E; Kipling, D; Proby, C; Moyes, C; Green, K; Best, K; Haniffa, M; Botto, M; Dunn-Walters, D; Strid, J				Crawford, Greg; Hayes, Mark David; Seoane, Rocio Castro; Ward, Sophie; Dalessandri, Tim; Lai, Chester; Healy, Eugene; Kipling, David; Proby, Charlotte; Moyes, Colin; Green, Kile; Best, Katie; Haniffa, Muzlifah; Botto, Marina; Dunn-Walters, Deborah; Strid, Jessica			Epithelial damage and tissue gamma delta T cells promote a unique tumor-protective IgE response	NATURE IMMUNOLOGY			English	Article							NONMELANOMA SKIN-CANCER; IMMUNOGLOBULIN-E; REPERTOIRE; DIVERSITY; GENES; MICE; AUTOANTIBODIES; SURVEILLANCE; AUTOIMMUNITY; ANAPHYLAXIS	IgE is an ancient and conserved immunoglobulin isotype with potent immunological function. Nevertheless, the regulation of IgE responses remains an enigma, and evidence of a role for IgE in host defense is limited. Here we report that topical exposure to a common environmental DNA-damaging xenobiotic initiated stress surveillance by gamma d TCR+ intraepithelial lymphocytes that resulted in class switching to IgE in B cells and the accumulation of autoreactive IgE. High-throughput antibody sequencing revealed that gamma d T cells shaped the IgE repertoire by supporting specific variable-diversity-joining ( VDJ) rearrangements with unique characteristics of the complementarity-determining region CDRH3. This endogenous IgE response, via the IgE receptor Fce RI, provided protection against epithelial carcinogenesis, and expression of the gene encoding Fce RI in human squamouscell carcinoma correlated with good disease prognosis. These data indicate a joint role for immunosurveillance by T cells and by B cells in epithelial tissues and suggest that IgE is part of the host defense against epithelial damage and tumor development.	[Crawford, Greg; Hayes, Mark David; Seoane, Rocio Castro; Ward, Sophie; Dalessandri, Tim; Botto, Marina; Strid, Jessica] Imperial Coll London, Dept Med, London, England; [Lai, Chester; Healy, Eugene] Univ Southampton, Fac Med, Dermatopharmacol Clin & Expt Sci, Southampton, Hants, England; [Lai, Chester; Healy, Eugene] Univ Hosp Southampton NHS Fdn Trust, Dermatol, Southampton, Hants, England; [Kipling, David] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales; [Proby, Charlotte] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Canc Res, Dundee, Scotland; [Moyes, Colin] Greater Glasgow & Clyde NHS, Queen Elizabeth Univ Hosp, Dept Pathol, Glasgow, Lanark, Scotland; [Green, Kile; Best, Katie; Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Best, Katie; Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne, Tyne & Wear, England; [Best, Katie; Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, Royal Victoria Infirm, Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Dunn-Walters, Deborah] Univ Surrey, Sch Biosci & Med, Fac Hlth & Med Sci, Guildford, Surrey, England	Imperial College London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Cardiff University; University of Dundee; Queen Elizabeth University Hospital (QEUH); Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Surrey	Strid, J (corresponding author), Imperial Coll London, Dept Med, London, England.	j.strid@imperial.ac.uk		Green, Kile/0000-0002-4777-5458; Best, Katie/0000-0002-1745-6392; Dalessandri, Tim/0000-0001-5690-295X; Healy, Eugene/0000-0001-5591-6970; Lai, Chester/0000-0003-2282-5655; Castro Seoane, Rocio/0000-0002-2938-3872; Dunn-Walters, Deborah/0000-0002-7172-3893	Wellcome Trust [100999/Z/13/Z]; Cancer Research UK [C21010/A19788]; NIHR Newcastle Biomedical Research Centre; Wellcome Trust Research Training Fellowship; MRC [MR/L01257X/1, MR/L01257X/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NIHR Newcastle Biomedical Research Centre; Wellcome Trust Research Training Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Norzawani, C. Margreitter, C. Townsend and B. Hunt for computational assistance and advice during antibody sequencing analysis; H.R. Rodewald (German Cancer Research Center) for Cpa3<SUP>Cre/+</SUP> mice; A. Hayday (King's College London and The Francis Crick Institute) for Tcrg-V5<SUP>-/-</SUP>Tcrd-V1<SUP>-/-</SUP> mice; the staff of the Imperial Central Biomedical Services for the care of the animals; the LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility for FACS support for flow cytometry; A. Mowat for critical reading of the manuscript; and colleagues for informed advice. This work was supported by the Wellcome Trust (100999/Z/13/Z) and in part by the Cancer Research UK (C21010/A19788) and the NIHR Newcastle Biomedical Research Centre. C.L. was supported by a Wellcome Trust Research Training Fellowship.	Altrichter S, 2008, J INVEST DERMATOL, V128, P2232, DOI 10.1038/jid.2008.80; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; Dalessandri T, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00347; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Goon PKC, 2016, ACTA DERM-VENEREOL, V96, P820, DOI 10.2340/00015555-2310; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hara H, 2000, J IMMUNOL, V165, P3695, DOI 10.4049/jimmunol.165.7.3695; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Hidaka T, 2017, NAT IMMUNOL, V18, P64, DOI 10.1038/ni.3614; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Josephs DH, 2017, CANCER RES, V77, P1127, DOI 10.1158/0008-5472.CAN-16-1829; Josephs DH, 2014, MABS-AUSTIN, V6, P54, DOI 10.4161/mabs.27029; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Leonardi-Bee J, 2012, ARCH DERMATOL, V148, P939, DOI 10.1001/archdermatol.2012.1374; Lippman SM, 2009, CANCER RES, V69, P5269, DOI 10.1158/0008-5472.CAN-09-1750; Luger E, 2001, EUR J IMMUNOL, V31, P2319, DOI 10.1002/1521-4141(200108)31:8<2319::AID-IMMU2319>3.0.CO;2-T; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Martin VG, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00546; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Messingham KAN, 2014, IMMUNOL RES, V59, P273, DOI 10.1007/s12026-014-8547-7; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; NAKAI K, 1988, PROTEIN ENG, V2, P93, DOI 10.1093/protein/2.2.93; Nelde A, 2001, INT ARCH ALLERGY IMM, V124, P461, DOI 10.1159/000053781; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rogosch T, 2010, J IMMUNOL, V184, P4947, DOI 10.4049/jimmunol.0900859; Rosner K, 2001, IMMUNOLOGY, V103, P179, DOI 10.1046/j.1365-2567.2001.01220.x; Sherman PW, 2008, Q REV BIOL, V83, P339, DOI 10.1086/592850; Starkl P, 2016, J ALLERGY CLIN IMMUN, V137, P246, DOI 10.1016/j.jaci.2015.08.005; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Totlandsdal AI, 2012, TOXICOL LETT, V208, P262, DOI 10.1016/j.toxlet.2011.10.025; Van Hemelrijck M, 2010, CANCER CAUSE CONTROL, V21, P1657, DOI 10.1007/s10552-010-9594-6; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vernersson M, 2004, DEV COMP IMMUNOL, V28, P61, DOI 10.1016/S0145-305X(03)00084-3; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu YC, 2015, METHODS MOL BIOL, V1343, P199, DOI 10.1007/978-1-4939-2963-4_16	63	65	68	1	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					859	+		10.1038/s41590-018-0161-8	http://dx.doi.org/10.1038/s41590-018-0161-8			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30013146	Green Submitted, Green Accepted			2022-12-18	WOS:000439470900022
J	Herjan, T; Hong, LZ; Bubenik, J; Bulek, K; Qian, W; Liu, CN; Li, X; Chen, X; Yang, H; Ouyang, SD; Zhou, H; Zhao, JJ; Vasu, K; Cockman, E; Aronica, M; Asosingh, K; Licatalosi, DD; Qin, J; Fox, PL; Hamilton, TA; Driscol, D; Li, XX				Herjan, Tomasz; Hong, Lingzi; Bubenik, Jodi; Bulek, Katarzyna; Qian, Wen; Liu, Caini; Li, Xiao; Chen, Xing; Yang, Hui; Ouyang, Suidong; Zhou, Hao; Zhao, Junjie; Vasu, Kommireddy; Cockman, Eric; Aronica, Mark; Asosingh, Kewal; Licatalosi, Donny D.; Qin, Jun; Fox, Paul L.; Hamilton, Thomas A.; Driscol, Donna; Li, Xiaoxia			IL-17-receptor-associated adaptor Acti directly stabilizes mRNAs to mediate IL-17 inflammatory signaling	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; PULMONARY INFLAMMATION; RECEPTOR; PROTEIN; DOMAIN; CXCL1; DECAY; INTERLEUKIN-17; ACTIVATION; DISTINCT	Mechanisms that degrade inflammatory mRNAs are well known; however, stabilizing mechanisms are poorly understood. Here, we show that Act1, an interleukin-17 (IL-17)-receptor-complex adaptor, binds and stabilizes mRNAs encoding key inflammatory proteins. The Act1 SEFIR domain binds a stem-loop structure, the SEFIR-binding element (SBE), in the 3' untranslated region (UTR) of Cxcil mRNA, encoding an inflammatory chemokine. mRNA-bound Act1 directs formation of three compartmentally distinct RNA-protein complexes (RNPs) that regulate three disparate events in inflammatory-mRNA metabolism: preventing mRNA decay in the nucleus, inhibiting mRNA decapping in P bodies and promoting translation. SBE RNA aptamers decreased IL-17-mediated mRNA stabilization in vitro, IL-17-induced skin inflammation and airway inflammation in a mouse asthma model, thus providing a therapeutic strategy for autoimmune diseases. These results reveal a network in which Act1 assembles RNPs on the 3' UTRs of select mRNAs and consequently controls receptor-mediated mRNA stabilization and translation during inflammation.	[Herjan, Tomasz; Hong, Lingzi; Bulek, Katarzyna; Qian, Wen; Liu, Caini; Chen, Xing; Yang, Hui; Ouyang, Suidong; Zhou, Hao; Zhao, Junjie; Hamilton, Thomas A.; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Herjan, Tomasz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Krakow, Poland; [Bubenik, Jodi; Vasu, Kommireddy; Cockman, Eric; Fox, Paul L.; Driscol, Donna] Cleveland Clin Fdn, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Bulek, Katarzyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Immunol, Krakow, Poland; [Li, Xiao] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Aronica, Mark; Asosingh, Kewal] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Licatalosi, Donny D.] Case Western Reserve Univ, Dept Biochem, Case Comprehens Canc Ctr, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Qin, Jun] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Jagiellonian University; Cleveland Clinic Foundation; Jagiellonian University; Stanford University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021; Kommireddy, Vasu/C-3928-2018; Herjan, Tomasz/AAM-9625-2020; Hamilton, Thomas A/A-7756-2009	Kommireddy, Vasu/0000-0002-7608-7566; Qin, Jun/0000-0002-2647-9270; Hamilton, Thomas/0000-0002-9817-242X	NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL103453] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA062220] Funding Source: Medline; NHLBI NIH HHS [U10 HL109250, P01 HL029582, P01 HL103453] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bresson S, 2017, MOL CELL, V65, P787, DOI 10.1016/j.molcel.2017.01.005; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chesne J, 2015, J ALLERGY CLIN IMMUN, V135, P1643, DOI 10.1016/j.jaci.2014.12.1872; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059; Herjan T, 2013, J IMMUNOL, V191, P640, DOI 10.4049/jimmunol.1203315; Huynh N, 2009, BIOCHEMISTRY-US, V48, P11432, DOI 10.1021/bi901107q; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu CN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8823; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Nakatsu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094999; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Stumpo DJ, 2010, WIRES RNA, V1, P60, DOI 10.1002/wrna.1; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Velichko S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163323; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Zhang B, 2014, ACTA CRYSTALLOGR D, V70, P1476, DOI 10.1107/S1399004714005227; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	49	65	69	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					354	+		10.1038/s41590-018-0071-9	http://dx.doi.org/10.1038/s41590-018-0071-9			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563620	Green Accepted			2022-12-18	WOS:000428151000015
J	Manni, M; Gupta, S; Ricker, E; Chinenov, Y; Park, SH; Shi, M; Pannellini, T; Jessberger, R; Ivashkiv, LB; Pernis, AB				Manni, Michela; Gupta, Sanjay; Ricker, Edd; Chinenov, Yurii; Park, Sung Ho; Shi, Man; Pannellini, Tania; Jessberger, Rolf; Ivashkiv, Lionel B.; Pernis, Alessandra B.			Regulation of age-associated B cells by IRF5 in systemic autoimmunity	NATURE IMMUNOLOGY			English	Article							FACTOR T-BET; TRANSCRIPTION FACTOR; SWAP-70-LIKE ADAPTER; DIFFERENTIATION; EXPRESSION; DISEASE; LUPUS; MICE; SLE; INTERLEUKIN-21	Age-associated B cells (ABCs) are a subset of B cells dependent on the transcription factor T-bet that accumulate prematurely in autoimmune settings. The pathways that regulate ABCs in autoimmunity are largely unknown. SWAP-70 and DEF6 (also known as IBP or SLAT) are the only two members of the SWEF family, a unique family of Rho GTPase-regulatory proteins that control both cytoskeletal dynamics and the activity of the transcription factor IRF4. Notably, DEF6 is a newly identified human risk variant for systemic lupus erythematosus. Here we found that the lupus syndrome that developed in SWEF-deficient mice was accompanied by the accumulation of ABCs that produced autoantibodies after stimulation. ABCs from SWEF-deficient mice exhibited a distinctive transcriptome and a unique chromatin landscape characterized by enrichment for motifs bound by transcription factors of the IRF and AP-1 families and the transcription factor T-bet. Enhanced ABC formation in SWEF-deficient mice was controlled by the cytokine IL-21 and IRF5, whose variants are strongly associated with lupus. The lack of SWEF proteins led to dysregulated activity of IRF5 in response to stimulation with IL-21. These studies thus elucidate a previously unknown signaling pathway that controls ABCs in autoimmunity.	[Manni, Michela; Gupta, Sanjay; Shi, Man; Pernis, Alessandra B.] Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA; [Ricker, Edd; Ivashkiv, Lionel B.; Pernis, Alessandra B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Chinenov, Yurii; Park, Sung Ho; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Chinenov, Yurii; Park, Sung Ho; Ivashkiv, Lionel B.; Pernis, Alessandra B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Pannellini, Tania] Hosp Special Surg, Div Res, 535 E 70th St, New York, NY 10021 USA; [Pannellini, Tania] Hosp Special Surg, Precis Med Lab, 535 E 70th St, New York, NY 10021 USA; [Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, Dresden, Germany; [Ivashkiv, Lionel B.; Pernis, Alessandra B.] Cornell Univ, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technische Universitat Dresden; Cornell University	Pernis, AB (corresponding author), Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA.; Pernis, AB (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA.; Pernis, AB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.; Pernis, AB (corresponding author), Cornell Univ, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA.	pernisa@hss.edu		Pernis, Alessandra/0000-0001-8259-1446; Ivashkiv, Lionel/0000-0002-9951-0646	NATIONAL CANCER INSTITUTE [F31CA196209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044938, R01AI046712, R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064883, R01AR070146] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019986] Funding Source: NIH RePORTER; NCI NIH HHS [F31 CA196209] Funding Source: Medline; NIAID NIH HHS [R21 AI044938, R01 AI046712, R01 AI044938] Funding Source: Medline; NIAMS NIH HHS [R01 AR064883, R01 AR070146] Funding Source: Medline; NIH HHS [S10 OD019986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Audzevich T, 2013, J IMMUNOL, V190, P4946, DOI 10.4049/jimmunol.1203014; Ban T, 2016, IMMUNITY, V45, P319, DOI 10.1016/j.immuni.2016.07.015; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Becart S, 2009, IMMUNOL REV, V232, P319, DOI 10.1111/j.1600-065X.2009.00839.x; Biswas Partha S, 2012, Methods Mol Biol, V900, P233, DOI 10.1007/978-1-60761-720-4_11; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Cham CM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/780436; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Eames HL, 2016, TRANSL RES, V167, P167, DOI 10.1016/j.trsl.2015.06.018; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106; Kreher S, 2014, P NATL ACAD SCI USA, V111, pE4513, DOI 10.1073/pnas.1406985111; Lazzari E, 2014, CLIN IMMUNOL, V153, P343, DOI 10.1016/j.clim.2014.06.001; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Lu D, 2014, J EXP MED, V211, P2183, DOI 10.1084/jem.20140338; Manni M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141927; Matta B, 2017, CYTOKINE, V98, P15, DOI 10.1016/j.cyto.2017.02.006; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ripich T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161060; Rogatsky I, 2014, AUTOIMMUNITY, V47, P242, DOI 10.3109/08916934.2013.853050; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sarra M, 2013, BIOFACTORS, V39, P368, DOI 10.1002/biof.1105; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Shen H, 2010, J MOL CELL BIOL, V2, P284, DOI 10.1093/jmcb/mjq023; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Vinuesa CG, 2013, NAT IMMUNOL, V14, P119, DOI 10.1038/ni.2511; Wang ZL, 2016, DNA CELL BIOL, V35, P628, DOI 10.1089/dna.2016.3304; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Yasuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103478	53	65	67	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					407	+		10.1038/s41590-018-0056-8	http://dx.doi.org/10.1038/s41590-018-0056-8			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29483597	Green Accepted			2022-12-18	WOS:000428151000020
J	Miyajima, M; Zhang, BH; Sugiura, Y; Sonomura, K; Guerrini, MM; Tsutsui, Y; Maruya, M; Vogelzang, A; Chamoto, K; Honda, K; Hikida, T; Ito, S; Qin, HY; Sanuki, R; Suzuki, K; Furukawa, T; Ishihama, Y; Matsuda, F; Suematsu, M; Honjo, T; Fagarasan, S				Miyajima, Michio; Zhang, Baihao; Sugiura, Yuki; Sonomura, Kazuhiro; Guerrini, Matteo M.; Tsutsui, Yumi; Maruya, Mikako; Vogelzang, Alexis; Chamoto, Kenji; Honda, Kurara; Hikida, Takatoshi; Ito, Satomi; Qin, Hongyan; Sanuki, Rikako; Suzuki, Keiichiro; Furukawa, Takahisa; Ishihama, Yasushi; Matsuda, Fumihiko; Suematsu, Makoto; Honjo, Tasuku; Fagarasan, Sidonia			Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior	NATURE IMMUNOLOGY			English	Article							MASS-SPECTROMETRY; PD-1; MOUSE; FEAR; IMMUNOMETABOLISM; SUPPRESSION; PERFORMANCE; EXPRESSION; ANTIGEN	T cells reorganize their metabolic profiles after being activated, but the systemic metabolic effect of sustained activation of the immune system has remained unexplored. Here we report that augmented T cell responses in Pdcd1(-/-)mice, which lack the inhibitory receptor PD-1, induced a metabolic serum signature characterized by depletion of amino acids. We found that the depletion of amino acids in serum was due to the accumulation of amino acids in activated Pdcd1(-/-)T cells in the lymph nodes. A systemic decrease in tryptophan and tyrosine led to substantial deficiency in the neurotransmitters serotonin and dopamine in the brain, which resulted in behavioral changes dominated by anxiety-like behavior and exacerbated fear responses. Together these data indicate that excessive activation of T cells causes a systemic metabolomic shift with consequences that extend beyond the immune system.	[Miyajima, Michio; Zhang, Baihao; Guerrini, Matteo M.; Tsutsui, Yumi; Maruya, Mikako; Vogelzang, Alexis; Ito, Satomi; Suzuki, Keiichiro; Fagarasan, Sidonia] RIKEN, Yokohama Inst, Ctr Integrat Med Sci, Lab Mucosal Immun, Yokohama, Kanagawa, Japan; [Zhang, Baihao; Chamoto, Kenji; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Sugiura, Yuki; Honda, Kurara; Suematsu, Makoto] Keio Univ, Dept Biochem & Integrat Biol, Tokyo, Japan; [Sonomura, Kazuhiro; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Qin, Hongyan] 4th Mil Med Univ, Dept Med Genet & Dev Biol, Xian, Shaanxi, Peoples R China; [Sanuki, Rikako; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Osaka, Japan; [Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Bioanal, Kyoto, Japan	RIKEN; Kyoto University; Keio University; Kyoto University; Kyoto University; Air Force Military Medical University; Osaka University; Kyoto University	Fagarasan, S (corresponding author), RIKEN, Yokohama Inst, Ctr Integrat Med Sci, Lab Mucosal Immun, Yokohama, Kanagawa, Japan.	sidonia.fagarasan@riken.jp	Hikida, Takatoshi/J-5561-2017; Sanuki, Rikako/AAV-7143-2021; Suematsu, Makoto/O-5762-2018; Honjo, Tasuku/N-4470-2016; Suematsu, Makoto/I-8135-2013; Fagarasan, Sidonia/A-5258-2016; Ishihama, Yasushi/B-3101-2016	Hikida, Takatoshi/0000-0002-8653-311X; Sanuki, Rikako/0000-0001-9862-9840; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Fagarasan, Sidonia/0000-0003-2086-6402; Ishihama, Yasushi/0000-0001-7714-203X; Qin, Hongyan/0000-0003-1038-7037; Sugiura, Yuki/0000-0002-6983-8958; Zhang, Baihao/0000-0002-3456-2509; Vogelzang, Alexis/0000-0002-2921-1755	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology [14532135]; Japan Agency for Medical Research and Development [145208, 16770835]; Cell Science Foundation; Grants-in-Aid for Scientific Research [15H04275] Funding Source: KAKEN	Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology(Japan Agency for Medical Research and Development (AMED)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Cell Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamamoto, S. Oonawa and Y. Doi for technical help; S. Kawamoto, T. Chaya, and T. Kozuka for the help with metabolome and brain dissection and preparations; S. Narumiya, T. Sato and K. Tanaka for discussions and suggestion; Y. Iwakura (Tokyo University of Science) and M. Kubo (IMS RIKEN) for Ifng<SUP>-/-</SUP> mice; B. Malissen (Centre d'Immunologie de Marseille-Luminy) for Cd3e<SUP>-/-</SUP> mice; and N. Lonberg (Bristol-Myers Squibb) for anti-PD-1. Supported by Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (14532135 to S.F.), Japan Agency for Medical Research and Development (145208 and 16770835 to T.H.) and the Cell Science Foundation (K.C).	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Anthony J., 2015, KATZUNG TREVORS PHAR; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bauer EP, 2015, BEHAV BRAIN RES, V277, P68, DOI 10.1016/j.bbr.2014.07.028; BENVENISTE H, 1991, MICRODIALYSIS NEUROS, P81, DOI DOI 10.1016/B978-0-444-81194-3.50009-5; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Darvas M, 2014, P NATL ACAD SCI USA, V111, P2764, DOI 10.1073/pnas.1400332111; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; HAYAISHI O, 1957, J BIOL CHEM, V229, P889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu S, 2015, ANAL CHEM, V87, P6371, DOI 10.1021/acs.analchem.5b01350; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Koshimizu H, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00085; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Maki Y, 2000, EUR J PHARMACOL, V406, P411, DOI 10.1016/S0014-2999(00)00706-8; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; MOROJI T, 1977, J MICROWAVE POWER EE, V12, P273; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oka M, 2017, J CELL SCI, V130, P3568, DOI 10.1242/jcs.200519; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Santos JM, 2006, EUR J PHARMACOL, V542, P121, DOI 10.1016/j.ejphar.2006.06.019; Shariatgorji M, 2014, NEURON, V84, P697, DOI 10.1016/j.neuron.2014.10.011; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sugiura Y, 2014, PROTEOMICS, V14, P829, DOI 10.1002/pmic.201300047; Sugiyama E, 2015, ANAL CHEM, V87, P11176, DOI 10.1021/acs.analchem.5b02672; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; TAKIKAWA O, 1991, ADV EXP MED BIOL, V294, P437; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhou Z, 2016, RAPID COMMUN MASS SP, V30, P1941, DOI 10.1002/rcm.7675	45	65	70	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1342	+		10.1038/ni.3867	http://dx.doi.org/10.1038/ni.3867			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29058703				2022-12-18	WOS:000415324900012
J	Jin, J; Xie, XP; Xiao, YC; Hu, HB; Zou, Q; Cheng, XH; Sun, SC				Jin, Jin; Xie, Xiaoping; Xiao, Yichuan; Hu, Hongbo; Zou, Qiang; Cheng, Xuhong; Sun, Shao-Cong			Epigenetic regulation of the expression of II12 and II23 and autoimmune inflammation by the deubiquitinase Trabid	NATURE IMMUNOLOGY			English	Article							MACROPHAGE IL-12 PRODUCTION; IL-23 P19 PROMOTER; C-REL; ADAPTIVE IMMUNITY; DENDRITIC CELLS; GENE ACTIVATION; HISTONE; TRANSCRIPTION; METHYLATION; CHROMATIN	The proinflammatory cytokines interleukin 12 (IL-12) and IL-23 connect innate responses and adaptive immune responses and are also involved in autoimmune and inflammatory diseases. Here we describe an epigenetic mechanism for regulation of the genes encoding IL-12 (II12a and II12b; collectively called 'II12' here) and IL-23 (II23a and II12b; collectively called 'II23' here) involving the deubiquitinase Trabid. Deletion of Zranb1 (which encodes Trabid) in dendritic cells inhibited induction of the expression of II12 and II23 by Toll-like receptors (TLRs), which impaired the differentiation of inflammatory T cells and protected mice from autoimmune inflammation. Trabid facilitated TLR-induced histone modifications at the promoters of II12 and II23, which involved deubiqutination and stabilization of the histone demethylase Jmjd2d. Our findings highlight an epigenetic mechanism for the regulation of II12 and II23 and establish Trabid as an innate immunological regulator of inflammatory T cell responses.	[Jin, Jin] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Jin; Xie, Xiaoping; Xiao, Yichuan; Hu, Hongbo; Zou, Qiang; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Xiao, Yichuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xiao, Yichuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Hu, Hongbo] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Hu, Hongbo] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Sichuan University; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sun, SC (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA.	ssun@mdanderson.org	Xie, Xiaoping/K-5710-2018; Hu, Hongbo/J-8059-2016	Xie, Xiaoping/0000-0001-6616-1059; Hu, Hongbo/0000-0002-8177-7641; Jin, Jin/0000-0001-7887-5972; Zou, Qiang/0000-0002-1362-2007	National Cancer Institute of the US National Institutes of Health [P30CA016672]; US National Institutes of Health [AI064639, AI057555, AI104519]; Center for Inflammation and Cancer at M.D. Anderson Cancer Center; National Natural Science Foundation of China [81572651]; Thousand Young Talents Plan of China; Zhejiang University Special Fund for Fundamental Research; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI104519, R37AI064639, R01AI057555] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Inflammation and Cancer at M.D. Anderson Cancer Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Young Talents Plan of China; Zhejiang University Special Fund for Fundamental Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Bienz (Medical Research Council, UK) for the plasmid pHM6-HA-Trabid; the EUCOMM Consortium for mice in which Zranbl was targeted; and personnel from M.D. Anderson Cancer Center resources (flow cytometry, DNA analysis and animal facilities) supported by the National Cancer Institute of the US National Institutes of Health (P30CA016672). Supported by the US National Institutes of Health (AI064639, AI057555 and AI104519), the Center for Inflammation and Cancer at M.D. Anderson Cancer Center, the National Natural Science Foundation of China (81572651), the Thousand Young Talents Plan of China, and the Zhejiang University Special Fund for Fundamental Research.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cho YC, 2012, ARCH PHARM RES, V35, P1961, DOI 10.1007/s12272-012-1113-8; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Feng GJ, 1999, J IMMUNOL, V163, P6403; Fernando MDA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004117; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Garrett S, 2008, INFLAMMATION, V31, P235, DOI 10.1007/s10753-008-9070-6; Hayes MP, 1998, BLOOD, V91, P4645, DOI 10.1182/blood.V91.12.4645.412k36_4645_4651; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011	41	65	69	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					259	268		10.1038/ni.3347	http://dx.doi.org/10.1038/ni.3347			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26808229	Green Accepted			2022-12-18	WOS:000370469300010
J	Zugasti, O; Bose, N; Squiban, B; Belougne, J; Kurz, CL; Schroeder, FC; Pujol, N; Ewbank, JJ				Zugasti, Olivier; Bose, Neelanjan; Squiban, Barbara; Belougne, Jerome; Kurz, C. Leopold; Schroeder, Frank C.; Pujol, Nathalie; Ewbank, Jonathan J.			Activation of a G protein-coupled receptor by its endogenous ligand triggers the innate immune response of Caenorhabditis elegans	NATURE IMMUNOLOGY			English	Article							TRANSLATIONAL INHIBITION; CHEMOSENSORY CELLS; PATHOGEN; INFECTION; TRANSCRIPTION; AVOIDANCE; VIRULENCE; BITTER; ACID	Immune defenses are triggered by microbe-associated molecular patterns or as a result of damage to host cells. The elicitors of immune responses in the nematode Caenorhabditis elegans are unclear. Using a genome-wide RNA-mediated interference (RNAi) screen, we identified the G protein-coupled receptor (GPCR) DCAR-1 as being required for the response to fungal infection and wounding. DCAR-1 acted in the epidermis to regulate the expression of antimicrobial peptides via a conserved p38 mitogen-activated protein kinase pathway. Through targeted metabolomics analysis we identified the tyrosine derivative 4-hydroxyphenyllactic acid (HPLA) as an endogenous ligand. Our findings reveal DCAR-1 and its cognate ligand HPLA to be triggers of the epidermal innate immune response in C. elegans and highlight the ancient role of GPCRs in host defense.	[Zugasti, Olivier; Squiban, Barbara; Belougne, Jerome; Kurz, C. Leopold; Pujol, Nathalie; Ewbank, Jonathan J.] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Case 906, Marseille, France; [Zugasti, Olivier; Squiban, Barbara; Belougne, Jerome; Kurz, C. Leopold; Pujol, Nathalie; Ewbank, Jonathan J.] INSERM, U1104, F-13288 Marseille, France; [Zugasti, Olivier; Squiban, Barbara; Belougne, Jerome; Kurz, C. Leopold; Pujol, Nathalie; Ewbank, Jonathan J.] CNRS, UMR7280, Marseille, France; [Bose, Neelanjan; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Dept Chem & Chem Biol, Ithaca, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Cornell University; Boyce Thompson Institute for Plant Research	Zugasti, O (corresponding author), UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Case 906, Marseille, France.	zugasti@ciml.univ-mrs.fr; ewbank@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010; Bose, Neelanjan/B-8054-2017; Pujol, Nathalie/K-3880-2012; Zugasti, Olivier/P-1352-2017; Kurz, Cyril/L-7615-2016	Ewbank, Jonathan J/0000-0002-1257-6862; Bose, Neelanjan/0000-0002-3817-4757; Pujol, Nathalie/0000-0001-8889-3197; Zugasti, Olivier/0000-0002-5616-734X; Schroeder, Frank/0000-0002-4420-0237	Office of Research Infrastructure Programs of the US National Institutes of Health [P40 0D010440]; INSERM; CNRS; PACA Regional Council; Agence Nationale de Recherche [MIME-2007, ANR-12-BSV3-0001-01, ANR-11-LABX-0054, ANR-11-IDEX-0001-02]; US National Institutes of Health [GM088290]; Fondation Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088290] Funding Source: NIH RePORTER	Office of Research Infrastructure Programs of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); PACA Regional Council(Region Provence-Alpes-Cote d'Azur); Agence Nationale de Recherche(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chisholm (University of California, San Diego) for vector pCZGY1434; S. Mitani (Tokyo Women's Medical University School of Medicine) for strain tir-1(tm3036); Y. Goshima (Yokohama City University) for strains dcar- I (nj66) and dear-l(tm 2484), dcar-1 cDNA, and plasmids sra-6p : : dear- I : Venus and sra-6p ::dcar-I; C. Bargmann, A. Chisholm, C. Couillault, P. Golstein and E. Vivier for critical reading of the manuscript; M. Metwaly, F. Montariana-Sanchis, S. Omi, J. Soule and the staff at WormBase and ModulBio for technical support; and C. Melon for advice. Nematode strains pmk-1(km25) and gpa-12(pk322) were provided by the Caenorhabditis Genetics Center, which is funded by the Office of Research Infrastructure Programs of the US National Institutes of Health (P40 0D010440); dcarl(tm2484) was provided by the National Bioresource Project coordinated by S. Mitani. Supported by INSERM, CNRS, the PACA Regional Council, the Agence Nationale de Recherche (MIME-2007, ANR-12-BSV3-0001-01, ANR-11-LABX-0054 (Investissements d'Avenir-Labex INFORM) and ANR-11-IDEX-0001-02 (Investissements d'Avenir-A*MIDEX)), the US National Institutes of Health (GM088290 to F.C.S.) and the Fondation Association pour la Recherche sur le Cancer (B.S.).	Aoki R, 2011, J NEUROSCI, V31, P16603, DOI 10.1523/JNEUROSCI.4018-11.2011; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bargmann C.I., 2006, CHEMOSENSATION C ELE, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; COX GN, 1980, GENETICS, V95, P317; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; DIJKSTERHUIS J, 1990, MYCOL RES, V94, P1, DOI 10.1016/S0953-7562(09)81257-4; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020; Hodgkin J, 2013, CURR BIOL, V23, P2157, DOI 10.1016/j.cub.2013.08.060; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim TH, 2005, FEBS LETT, V579, P53, DOI 10.1016/j.febslet.2004.11.044; Labed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033887; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MAYATEPEK E, 1995, EUR J PEDIATR, V154, P755, DOI 10.1007/BF02276727; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; MROCHEK JE, 1973, CLIN CHEM, V19, P927; Muir RE, 2008, APPL ENVIRON MICROB, V74, P4185, DOI 10.1128/AEM.00381-08; Partridge FA, 2010, DEV DYNAM, V239, P1330, DOI 10.1002/dvdy.22232; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N., 2003, TOLL RECEPTORS; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Pukkila-Worley R, 2012, CURR OPIN IMMUNOL, V24, P3, DOI 10.1016/j.coi.2011.10.004; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Squiban B, 2012, JOVE-J VIS EXP, DOI 10.3791/3448; Stewart MR, 2005, GENETICS, V169, P1985, DOI 10.1534/genetics.104.035329; Thomas JH, 2005, P NATL ACAD SCI USA, V102, P4476, DOI 10.1073/pnas.0406469102; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Visvikis O, 2014, IMMUNITY, V40, P896, DOI 10.1016/j.immuni.2014.05.002; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006	39	65	69	5	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					833	838		10.1038/ni.2957	http://dx.doi.org/10.1038/ni.2957			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25086774	Green Accepted			2022-12-18	WOS:000340739400010
J	Derudder, E; Cadera, EJ; Vahl, JC; Wang, J; Fox, CJ; Zha, S; van Loo, G; Pasparakis, M; Schlissel, MS; Schmidt-Supprian, M; Rajewsky, K				Derudder, Emmanuel; Cadera, Emily J.; Vahl, J. Christoph; Wang, Jing; Fox, Casey J.; Zha, Shan; van Loo, Geert; Pasparakis, Manolis; Schlissel, Mark S.; Schmidt-Supprian, Marc; Rajewsky, Klaus			Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappa B signals	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE DEVELOPMENT; RECEPTOR SIGNALS; TRANSCRIPTION; REARRANGEMENT; EXPRESSION; PROMOTES; MICE; TOLERANCE; SUPPRESSION; GENERATION	By genetically ablating I kappa B kinase (IKK)-mediated activation of the transcription factor NF-kappa B in the B cell lineage and by analyzing a mouse mutant in which immunoglobulin lambda-chain-positive B cells are generated in the absence of rearrangements in the locus encoding immunoglobulin kappa-chain, we define here two distinct, consecutive phases of early B cell development that differ in their dependence on IKK-mediated NF-kappa B signaling. During the first phase, in which NF-kappa B signaling is dispensable, predominantly kappa-chain-positive B cells are generated, which undergo efficient receptor editing. In the second phase, predominantly lambda-chain-positive B cells are generated whose development is ontogenetically timed to occur after rearrangements of the locus encoding kappa-chain. This second phase of development is dependent on NF-kappa B signals, which can be substituted by transgenic expression of the prosurvival factor Bcl-2.	[Derudder, Emmanuel; Vahl, J. Christoph; Wang, Jing; Schmidt-Supprian, Marc; Rajewsky, Klaus] Immune Dis Inst, Boston, MA USA; [Cadera, Emily J.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Vahl, J. Christoph; Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Fox, Casey J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zha, Shan] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst,Dept Genet, Boston, MA 02115 USA; [van Loo, Geert] VIB, Dept Mol Biomed Res, Ghent, Belgium; [van Loo, Geert] Univ Ghent, B-9000 Ghent, Belgium; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med, D-5000 Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-5000 Cologne, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of California System; University of California Berkeley; Max Planck Society; Jackson Laboratory; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Flanders Institute for Biotechnology (VIB); Ghent University; University of Cologne; University of Cologne	Derudder, E (corresponding author), Immune Dis Inst, Boston, MA USA.	derudder@idi.harvard.edu; supprian@biochem.mpg.de; rajewsky@idi.harvard.edu	Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019; , van Loo Geert/AAD-1220-2019; Schmidt-Supprian, Marc/F-5893-2011; van Loo, Geert/C-1505-2009	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; , van Loo Geert/0000-0002-8427-4775; Schmidt-Supprian, Marc/0000-0002-8543-6166; Rajewsky, Klaus/0000-0002-6633-6370; Derudder, Emmanuel/0000-0003-1421-4045; Zha, Shan/0000-0002-6568-1818; Vahl, Christoph/0000-0002-1683-8196	US National Institutes of Health; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636, R01AI057947] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We regret that for space reasons we often had to quote reviews instead of the original papers. We thank S. Akira (Osaka University), F. Alt (Children's Hospital, Boston), R. Bram (Mayo Medical School, Rochester), R. Geha (Children's Hospital, Boston), T. Mak (Campbell Family Institute for Cancer Research), D. Nemazee (The Scripps Research Institute) and M. Reth (University of Freiburg) for Myd88<SUP>-/-</SUP>, Atm<SUP>-/-</SUP>, Taci<SUP>-/-</SUP>, Bcl10<SUP>-/-</SUP>, kappa-macroself and mb1-cre cells and mouse strains; S. Weiss (Helmholtz Centre for Infection Research) for anti-lambda<INF>1</INF>-chain; N. Rice (US National Cancer Institute) for anti-p52; T. Chakraborty, G. Galler and S. Koralov for help with quantitative real-time PCR, EMSA and cell-cycle analysis; M. Bamberg for antibody preparation; N. Barteneva for cell sorting; and D. Ghitza, A. Pellerin, J. Grundy and J. Xia for technical assistance with mouse work. Supported by the US National Institutes of Health (M. S. S. and K. R.) and Deutsche Forschungsgemeinschaft (Emmy Noether grant to M.S.-S.).	Ait-Azzouzene D, 2005, J EXP MED, V201, P817, DOI 10.1084/jem.20041854; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Bendall HH, 2001, J IMMUNOL, V167, P264, DOI 10.4049/jimmunol.167.1.264; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Debnath I, 2007, J IMMUNOL, V178, P7139, DOI 10.4049/jimmunol.178.11.7139; Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.3.CO;2-8; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Grandien A, 1996, SCAND J IMMUNOL, V43, P47, DOI 10.1046/j.1365-3083.1996.d01-13.x; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Jimi E, 2005, INT IMMUNOL, V17, P815, DOI 10.1093/intimm/dxh263; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kistler B, 1998, J IMMUNOL, V160, P2308; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Scherer DC, 1996, IMMUNITY, V5, P563, DOI 10.1016/S1074-7613(00)80271-X; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Seagal J, 2004, INT IMMUNOL, V16, P905, DOI 10.1093/intimm/dxh092; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; Vela JL, 2008, IMMUNITY, V28, P161, DOI 10.1016/j.immuni.2007.12.011; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	48	65	67	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					647	U118		10.1038/ni.1732	http://dx.doi.org/10.1038/ni.1732			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19412180	Green Accepted			2022-12-18	WOS:000266384100017
J	Vilcek, J				Vilcek, J			Novel interferons	NATURE IMMUNOLOGY			English	Editorial Material							CYTOKINE	Type I IFNs are important in antiviral immunity. Two studies report the identification of another family of molecules that have similar properties to the type I IFNs but are otherwise structurally and genetically distinct.	NYU, Sch Med, New York, NY 10016 USA	New York University	Vilcek, J (corresponding author), NYU, Sch Med, New York, NY 10016 USA.							BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Biron C.A., 2001, FIELDS VIROLOGY, P321; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3	12	65	97	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					8	9		10.1038/ni0103-8	http://dx.doi.org/10.1038/ni0103-8			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496969				2022-12-18	WOS:000180053000005
J	Leung, RKM; Thomson, K; Gallimore, A; Jones, E; Van den Broek, M; Sierro, S; Alsheikhly, AR; McMichael, A; Rahemtulla, A				Leung, RKM; Thomson, K; Gallimore, A; Jones, E; Van den Broek, M; Sierro, S; Alsheikhly, AR; McMichael, A; Rahemtulla, A			Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment	NATURE IMMUNOLOGY			English	Article							T-CELL RECEPTOR; POSITIVE SELECTION; INTERMEDIATE STEPS; INSTRUCTIVE MODEL; TRANSGENIC MICE; CLASS-II; EXPRESSION; GENE; DIFFERENTIATION; CD4(+)8(+)	The mechanism of T cell lineage commitment remains controversial; to examine it we deleted the CD4-silencer element in the germ line of a mouse using a combination of gene targeting and Cre/LoxP-mediated recombination. We found that these mice were unable to extinguish CD4 expression either in immature thymocytes or mature CD8(+) cytotoxic T cells (CTLs), which resulted in the development of major histocompatibility complex class II-restricted double-positive CTLs in the periphery. This finding strongly supports a stochastic over an instructive mechanism of coreceptor down-regulation.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Zurich, Inst Pathol, CH-8091 Zurich, Switzerland; Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford; University of Zurich; University of Oxford	Rahemtulla, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Haematol, Du Cane Rd, London W12 0NN, England.		van den Broek, Maries/L-6532-2019; van den Broek, Maries/G-4128-2016	Jones, Emma/0000-0002-0298-2859; Gallimore, Awen/0000-0001-6675-7004; van den Broek, Maries/0000-0002-9489-3692				BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; Benveniste P, 1996, EUR J IMMUNOL, V26, P461, DOI 10.1002/eji.1830260229; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHAN SH, 1993, IMMUNOL REV, V135, P119, DOI 10.1111/j.1600-065X.1993.tb00646.x; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; JAMESON SC, 1990, J IMMUNOL, V145, P1324; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KYDD R, 1995, J IMMUNOL, V155, P3806; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; McCready PM, 1997, BBA-GENE STRUCT EXPR, V1351, P181, DOI 10.1016/S0167-4781(96)00194-7; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; PATERSON RK, 1994, J IMMUNOL, V153, P3491; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; Rushton JJ, 1997, EUR J BIOCHEM, V245, P768, DOI 10.1111/j.1432-1033.1997.00768.x; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	38	65	65	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1167	1173		10.1038/ni733	http://dx.doi.org/10.1038/ni733			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11694883				2022-12-18	WOS:000172473200020
J	Takagi, T; Harada, J; Ishii, S				Takagi, T; Harada, J; Ishii, S			Murine Schnurri-2 is required for positive selection of thymocytes	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ZINC-FINGER PROTEIN; ENHANCER-BINDING-PROTEIN; MAD-RELATED PROTEIN; NEGATIVE SELECTION; SIGNALING PATHWAYS; T-CELLS; LYMPHOCYTE LINEAGE; EPITHELIAL-CELLS; BETA	A key step in T cell development involves the positive selection of cells that recognize antigen presented by self-major histocompatibility complex. Yet, the signals that are activated by T cell receptor engagement and lead to cell survival remain unclear. We show here that mice lacking the transcription factor Schnurri-2 (Shn-2), a large metal-finger protein, had severely defective positive selection of CD4(+) and CD8(+) cells. Drosophila Shn acts as a cofactor of Smad homolog and is required for Decapentaplegic signaling. Vertebrates have at least three Shn orthologs (Shn-1, Shn-2 and Shn-3), which are thought to act as nuclear targets in the bone morphogenetic protein-transforming growth factor-beta -activin signaling pathways. These data raised the possibility that the Smad-Shn-2 complex is involved in the thymic selection of T cells.	RIKEN, Tsukuba Inst, CREST, Res Project,JST,Lab Mol Genet, Tsukuba, Ibaraki 3050074, Japan	Japan Science & Technology Agency (JST); RIKEN	Ishii, S (corresponding author), RIKEN, Tsukuba Inst, CREST, Res Project,JST,Lab Mol Genet, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.		Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478				ACHAORBEA H, 1995, CELL RECEPTORS, P224; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; IWABUCHI K, 1992, P NATL ACAD SCI USA, V89, P9000, DOI 10.1073/pnas.89.19.9000; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MAEKAWA T, 1989, J BIOL CHEM, V264, P14591; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAKAMURA T, 1990, MOL CELL BIOL, V10, P3700, DOI 10.1128/MCB.10.7.3700; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x; VANTVEER LJ, 1992, P NATL ACAD SCI USA, V89, P8971, DOI 10.1073/pnas.89.19.8971; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	53	65	67	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1048	1053		10.1038/ni728	http://dx.doi.org/10.1038/ni728			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668343				2022-12-18	WOS:000172049800018
J	Zinkernagel, RM				Zinkernagel, RM			What is missing in immunology to understand immunity?	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; POSITIVE SELECTION; LYMPHOID ORGANS; B-CELLS; MICE; RESPONSES; TOLERANCE; MEMORY; DISCRIMINATION; PERSISTENCE	The question of how we acquire immunity has been investigated for a century or more. What have we learned from all of this endeavor! We asked Rolf Zinkernagel to provide, for the young investigator, food for thought about that which we still don't know-even if we think we do.	Univ Zurich, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich	Zinkernagel, RM (corresponding author), Univ Zurich, Inst Expt Immunol, Dept Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	rolf.zinkernagel@pty.usz.ch						Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; BERNET FM, 1949, PRODUCTION ANTIBODIE; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; BOS NA, 1991, EUR J IMMUNOL, V21, P1893, DOI 10.1002/eji.1830210817; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Coutinho A, 1975, Adv Immunol, V21, P113, DOI 10.1016/S0065-2776(08)60220-5; DINTZIS HM, 1990, IMMUNOL REV, V115, P243, DOI 10.1111/j.1600-065X.1990.tb00796.x; FELDMANN M, 1975, TRANSPLANT REV, V23, P78; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FREY JR, 1957, INT ARCH ALLER A IMM, V11, P81, DOI 10.1159/000228405; GUPTA SC, 1986, P NATL ACAD SCI USA, V83, P2604, DOI 10.1073/pnas.83.8.2604; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kindred B, 1979, Prog Allergy, V26, P137, DOI 10.1159/000314466; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; LAFFERTY KJ, 1963, VIROLOGY, V21, P76, DOI 10.1016/0042-6822(63)90306-4; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; Ludewig B, 1999, IMMUNOL REV, V169, P45, DOI 10.1111/j.1600-065X.1999.tb01305.x; MACKANESS GB, 1970, SEMIN HEMATOL, V7, P172; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MATZINGER P, 1993, IMMUNOL REV, V135, P81, DOI 10.1111/j.1600-065X.1993.tb00645.x; Mims C. A., 1987, PATHOGENESIS INFECT; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nathanson Neal, 1997, P85; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NOSSAL GJV, 1992, ADV IMMUNOL, V52, P283, DOI 10.1016/S0065-2776(08)60878-0; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; WEBB SR, 1991, ADV EXP MED BIOL, V292, P149; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333; Zinkernagel RM, 1999, P NATL ACAD SCI USA, V96, P8092, DOI 10.1073/pnas.96.14.8092; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	40	65	69	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					181	185		10.1038/79712	http://dx.doi.org/10.1038/79712			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973269				2022-12-18	WOS:000089815100004
J	Muto, T; Walker, CS; Choi, K; Hueneman, K; Smith, MA; Gul, Z; Garcia-Manero, G; Ma, AV; Zheng, Y; Starczynowski, DT				Muto, Tomoya; Walker, Callum S.; Choi, Kwangmin; Hueneman, Kathleen; Smith, Molly A.; Gul, Zartash; Garcia-Manero, Guillermo; Ma, Averil; Zheng, Yi; Starczynowski, Daniel T.			Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; CUTTING EDGE; TET2; CELLS; PATHWAY; MICE; IDENTIFICATION; PATHOGENESIS; INVOLVEMENT	Despite evidence of chronic inflammation in myelodysplastic syndrome (MDS) and cell-intrinsic dysregulation of Toll-like receptor (TLR) signaling in MDS hematopoietic stem and progenitor cells (HSPCs), the mechanisms responsible for the competitive advantage of MDS HSPCs in an inflammatory milieu over normal HSPCs remain poorly defined. Here, we found that chronic inflammation was a determinant for the competitive advantage of MDS HSPCs and for disease progression. The cell-intrinsic response of MDS HSPCs, which involves signaling through the noncanonical NF-kappa B pathway, protected these cells from chronic inflammation as compared to normal HSPCs. In response to inflammation, MDS HSPCs switched from canonical to noncanonical NF-kappa B signaling, a process that was dependent on TLR-TRAF6-mediated activation of A20. The competitive advantage of TLR-TRAF6-primed HSPCs could be restored by deletion of A20 or inhibition of the noncanonical NF-kappa B pathway. These findings uncover the mechanistic basis for the clonal dominance of MDS HSPCs and indicate that interfering with noncanonical NF-kappa B signaling could prevent MDS progression. Starczynowski and colleagues show that myelodysplastic syndrome HSPCs have a competitive advantage as compared to normal HSPCs during chronic inflammation due to a switch from canonical to noncanonical signaling for the activation of NF-kappa B.	[Muto, Tomoya; Walker, Callum S.; Choi, Kwangmin; Hueneman, Kathleen; Smith, Molly A.; Zheng, Yi; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Gul, Zartash] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Zheng, Yi; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Starczynowski, Daniel T.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.; Starczynowski, DT (corresponding author), Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45221 USA.	Daniel.Starczynowski@cchmc.org		Starczynowski, Daniel/0000-0002-5771-7462; Smith, Molly/0000-0002-2913-6847	National Institutes of Health [R35HL135787, R01DK102759, R01DK113639]; Cancer Free Kids; Cincinnati Children's Hospital Research Foundation; Uehara Memorial Foundation; Waksman Foundation of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science; Ohio State University Comprehensive Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Free Kids; Cincinnati Children's Hospital Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ohio State University Comprehensive Cancer Center	This work was supported in parts by the National Institutes of Health (grant nos. R35HL135787, R01DK102759, R01DK113639 to D.T.S.), Cancer Free Kids (D.T.S.), Cincinnati Children's Hospital Research Foundation (D.T.S.), The Uehara Memorial Foundation (T.M.), The Waksman Foundation of Japan (T.M.), The Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.M.), Japan Society for the Promotion of Science (T.M.) and Ohio State University Comprehensive Cancer Center (T.M.). T.M. is a Leukemia and Lymphoma Society Special Fellow. D.T.S. is a Leukemia and Lymphoma Society Scholar. We thank J. Bailey and V. Summey for assistance with transplantations (Comprehensive Mouse and Cancer Core at CCHMC), and M.-D. Filippi, D. Lucas, D. Reynaud and the Starczynowski laboratory for insightful suggestions and feedback.	Barreyro L, 2018, BLOOD, V132, P1553, DOI 10.1182/blood-2018-03-784116; Bird L, 2015, NAT REV IMMUNOL, V15, P598, DOI 10.1038/nri3912; Cai ZG, 2018, CELL STEM CELL, V23, P833, DOI 10.1016/j.stem.2018.10.013; Chavakis T, 2019, NAT IMMUNOL, V20, P802, DOI 10.1038/s41590-019-0402-5; Choi K, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5548-x; Cull AH, 2017, EXP HEMATOL, V55, P56, DOI 10.1016/j.exphem.2017.08.001; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fang J, 2018, CELL REP, V22, P1250, DOI 10.1016/j.celrep.2018.01.013; Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Fang J, 2014, CELL REP, V8, P1328, DOI 10.1016/j.celrep.2014.07.062; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee SCW, 2018, CANCER CELL, V34, P225, DOI 10.1016/j.ccell.2018.07.003; Leoni C, 2017, P NATL ACAD SCI USA, V114, pE1490, DOI 10.1073/pnas.1616420114; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Ma SX, 2017, J EXP MED, V214, P1471, DOI 10.1084/jem.20161149; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nakagawa MM, 2015, J EXP MED, V212, P203, DOI 10.1084/jem.20132544; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Pollyea DA, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.214155; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Rhyasen GW, 2013, CANCER CELL, V24, P90, DOI 10.1016/j.ccr.2013.05.006; Sanz C, 2002, HAEMATOLOGICA, V87, P1005; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Shi HF, 2018, CANCER SCI, V109, P3826, DOI 10.1111/cas.13809; Smith MA, 2019, NAT CELL BIOL, V21, P640, DOI 10.1038/s41556-019-0314-5; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; Varney ME, 2017, LEUKEMIA, V31, P491, DOI [10.1038/leu.2016.276, 10.1038/leu.2017.95]; Varney ME, 2015, J EXP MED, V212, P1967, DOI 10.1084/jem.20141898; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamaguchi N, 2013, SCI REP-UK, V3, DOI 10.1038/srep02568; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	55	64	65	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					535	+		10.1038/s41590-020-0663-z	http://dx.doi.org/10.1038/s41590-020-0663-z		APR 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32313245	Green Accepted			2022-12-18	WOS:000527507900003
J	Ward, JK; Peretti-Watel, P; Bocquier, A; Seror, V; Verger, P				Ward, Jeremy K.; Peretti-Watel, Patrick; Bocquier, Aurelie; Seror, Valerie; Verger, Pierre			Vaccine hesitancy and coercion: all eyes on France	NATURE IMMUNOLOGY			English	Article									[Ward, Jeremy K.] Univ Paris Sorbonne, CNRS, GEMASS, Paris, France; [Ward, Jeremy K.; Peretti-Watel, Patrick; Bocquier, Aurelie; Seror, Valerie; Verger, Pierre] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France; [Peretti-Watel, Patrick; Bocquier, Aurelie; Seror, Valerie; Verger, Pierre] IHU Mediterranee Infect, Marseille, France; [Peretti-Watel, Patrick; Bocquier, Aurelie; Verger, Pierre] Southeastern Hlth Reg Observ, ORS PACA, Marseille, France; [Peretti-Watel, Patrick; Verger, Pierre] INSERM, F CRIN, Innovat Clin Res Network Vaccinol I REIVAC, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ward, JK (corresponding author), Univ Paris Sorbonne, CNRS, GEMASS, Paris, France.; Ward, JK (corresponding author), Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France.	jeremy.ward.socio@gmail.com		ward, jeremy/0000-0003-3389-6870; Seror, Valerie/0000-0001-8002-435X	Institut Hospitalo-Universitaire (IHU) Mediterranee Infection; National Research Agency [15-CE36-0008-01]; program 'Investissements d'avenir' [ANR-10-IAHU-03]; Region Provence-Alpes-Cote d'Azur; European funding FEDER PRIMI; Institute for Research in Public Health [17-PREV-39]; ITMO Cancer (Plan cancer 2014-2019); CNRS Momentum grant	Institut Hospitalo-Universitaire (IHU) Mediterranee Infection; National Research Agency(French National Research Agency (ANR)); program 'Investissements d'avenir'(French National Research Agency (ANR)); Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); European funding FEDER PRIMI; Institute for Research in Public Health; ITMO Cancer (Plan cancer 2014-2019); CNRS Momentum grant	The authors would like to thank Sante Publique France for providing access to the Health Barometers databases. This work was supported by a CNRS Momentum grant (to J.K.W.), funds by the Institut Hospitalo-Universitaire (IHU) Mediterranee Infection, the National Research Agency (convention. 15-CE36-0008-01) and the program 'Investissements d'avenir' (convention ANR-10-IAHU-03), the Region Provence-Alpes-Cote d'Azur, the European funding FEDER PRIMI, the Institute for Research in Public Health (convention 17-PREV-39), and the ITMO Cancer (Plan cancer 2014-2019). The funding sources had no involvement in the research nor any role in the writing of the manuscript and the decision to submit it for publication.	Attwell K, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2018.100342; Bertrand, 2004, LIBERTES INDIVIDUELL; Betsch C, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.106; Bocquier A, 2018, VACCINE, V36, P7666, DOI 10.1016/j.vaccine.2018.10.085; Boulton Geoffrey, 2019, CONT GLOBAL CONTEXT; Conis Elena, 2014, VACCINE NATION AM CH; Gagneur A, 2018, VACCINE, V36, P6553, DOI 10.1016/j.vaccine.2017.10.049; Karafillakis E, 2018, CLIN MICROBIOL INFEC, V24, P799, DOI 10.1016/j.cmi.2018.04.001; Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4; Omer SB, 2019, NATURE, V571, P469, DOI 10.1038/d41586-019-02232-0; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Poland G. A., 2017, NEW ENGL J MED, V364, P97; Reich J.A., 2016, CALLING SHOTS WHY PA; Sante Publique France, 2019, B SANT PUBL VACC; Schmid P, 2019, NAT HUM BEHAV, V3, P931, DOI 10.1038/s41562-019-0632-4; Verger P, 2016, EUROSURVEILLANCE, V21, P14, DOI 10.2807/1560-7917.ES.2016.21.47.30406; Ward J. K., SOCIOLOGIE; Ward JK, 2018, VACCINE, V36, P1801, DOI 10.1016/j.vaccine.2018.02.095; Ward JK, 2016, SOC SCI MED, V159, P48, DOI 10.1016/j.socscimed.2016.05.003; Wilson R, 2019, HUM VACC IMMUNOTHER, V15, P2423, DOI 10.1080/21645515.2019.1587274	20	64	65	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1257	1259		10.1038/s41590-019-0488-9	http://dx.doi.org/10.1038/s41590-019-0488-9			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31477920				2022-12-18	WOS:000486615900001
J	Gautam, S; Fioravanti, J; Zhu, W; Le Gall, JB; Brohawn, P; Lacey, NE; Hu, JH; Hocker, JD; Hawk, NV; Kapoor, V; Telford, WG; Gurusamy, D; Yu, ZY; Bhandoola, A; Xue, HH; Roychoudhuri, R; Higgs, BW; Restifo, NP; Bender, TP; Ji, Y; Gattinoni, L				Gautam, Sanjivan; Fioravanti, Jessica; Zhu, Wei; Le Gall, John B.; Brohawn, Philip; Lacey, Neal E.; Hu, Jinhui; Hocker, James D.; Hawk, Nga Voong; Kapoor, Veena; Telford, William G.; Gurusamy, Devikala; Yu, Zhiya; Bhandoola, Avinash; Xue, Hai-Hui; Roychoudhuri, Rahul; Higgs, Brandon W.; Restifo, Nicholas P.; Bender, Timothy P.; Ji, Yun; Gattinoni, Luca			The transcription factor c-Myb regulates CD8(+) T cell stemness and antitumor immunity	NATURE IMMUNOLOGY			English	Article							SELF-RENEWAL; TERMINAL DIFFERENTIATION; BCL-2 EXPRESSION; EFFECTOR; APOPTOSIS; PROLIFERATION; REPRESSION; GENERATION; INDUCTION; PROGRAM	Stem cells are maintained by transcriptional programs that promote self-renewal and repress differentiation. Here, we found that the transcription factor c-Myb was essential for generating and maintaining stem cells in the CD8(+) T cell memory compartment. Following viral infection, CD8(+) T cells lacking Myb underwent terminal differentiation and generated fewer stem cell-like central memory cells than did Myb-sufficient T cells. c-Myb acted both as a transcriptional activator of Tcf7 (which encodes the transcription factor Tcf1) to enhance memory development and as a repressor of Zeb2 (which encodes the transcription factor Zeb2) to hinder effector differentiation. Domain-mutagenesis experiments revealed that the transactivation domain of c-Myb was necessary for restraining differentiation, whereas its negative regulatory domain was critical for cell survival. Myb overexpression enhanced CD8(+) T cell memory formation, polyfunctionality and recall responses that promoted curative antitumor immunity after adoptive transfer. These findings identify c-Myb as a pivotal regulator of CD8(+) T cell stemness and highlight its therapeutic potential.	[Gautam, Sanjivan; Fioravanti, Jessica; Le Gall, John B.; Lacey, Neal E.; Hu, Jinhui; Hocker, James D.; Hawk, Nga Voong; Kapoor, Veena; Telford, William G.; Ji, Yun; Gattinoni, Luca] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Zhu, Wei] Inova Translat Med Inst, Dept Bioinformat, Fairfax, VA USA; [Brohawn, Philip; Higgs, Brandon W.] MedImmune, Gaithersburg, MD USA; [Gurusamy, Devikala; Yu, Zhiya; Restifo, Nicholas P.] NCI, Surg Branch, Ctr Canc Res, Bethesda, MD USA; [Bhandoola, Avinash] NCI, Lab Genome Integr, Ctr Canc Res, Bethesda, MD 20892 USA; [Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Roychoudhuri, Rahul] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Bender, Timothy P.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Bender, Timothy P.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA; [Ji, Yun] Cellular Biomed Grp, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); AstraZeneca; Medimmune; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Virginia; University of Virginia	Gattinoni, L (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	gattinol@mail.nih.gov	Gattinoni, Luca/A-2281-2008; Hu, Jinhui/AAG-9000-2021; Restifo, Nicholas Phillip/M-6549-2019; Gurusamy, Devikala/T-3410-2019; Restifo, Nicholas Phillip/Z-1614-2019; Fioravanti, Jessica/AAS-1245-2020; Roychoudhuri, Rahul/A-7442-2010	Gattinoni, Luca/0000-0003-2239-3282; Fioravanti, Jessica/0000-0001-6263-4306; Roychoudhuri, Rahul/0000-0002-5392-1853; Lacey, Neal/0000-0002-3633-5924; Restifo, Nicholas P./0000-0003-4229-4580; Gurusamy, Devikala/0000-0002-1727-8653; Hocker, James/0000-0001-5770-0559	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research [ZIABC011480]; US National Institutes of Health [GM100776, CA85842]; Wellcome Trust/Royal Society [105663/Z/14/Z]; UK Biotechnology and Biological Sciences Research Council [BB/N007794/1]; Cancer Research UK [C52623/A22597]; BBSRC [BBS/E/B/000C0428, 1642652, BB/N007794/1, BBS/E/B/000C0409, BBS/E/B/000C0427, BBS/E/B/000C0407] Funding Source: UKRI; MRC [MR/S024468/1, MC_UP_1502/3, 1947452] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC011633, P30CA086862] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust/Royal Society; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research (ZIABC011480) (to L.G.); the US National Institutes of Health grants (GM100776 and CA85842) (to T.P.B.); the Wellcome Trust/Royal Society (105663/Z/14/Z), the UK Biotechnology and Biological Sciences Research Council (BB/N007794/1) and Cancer Research UK (C52623/A22597) (to R.R.). We thank K. Hanada for providing B16 (H-2<SUP>b</SUP>)-hgp100. This work used the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Chen ZY, 2017, CELL REP, V20, P2584, DOI 10.1016/j.celrep.2017.08.060; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; Dias S, 2017, IMMUNITY, V46, P78, DOI 10.1016/j.immuni.2016.12.017; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gattinoni L, 2014, IMMUNITY, V41, P7, DOI 10.1016/j.immuni.2014.07.003; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; MIZUGUCHI G, 1995, J BIOL CHEM, V270, P9384, DOI 10.1074/jbc.270.16.9384; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Peng S, 2007, EUR J IMMUNOL, V37, P2868, DOI 10.1002/eji.200636979; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Roychoudhuri R, 2015, VACCINE, V33, P914, DOI 10.1016/j.vaccine.2014.10.007; Sabatino M, 2016, BLOOD, V128, P519, DOI 10.1182/blood-2015-11-683847; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	57	64	67	7	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					337	+		10.1038/s41590-018-0311-z	http://dx.doi.org/10.1038/s41590-018-0311-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30778251	Green Accepted			2022-12-18	WOS:000458893600018
J	Wen, ZK; Jin, K; Shen, Y; Yang, Z; Li, YY; Wu, BW; Tian, L; Shoor, S; Roche, NE; Goronzy, JJ; Weyand, CM				Wen, Zhenke; Jin, Ke; Shen, Yi; Yang, Zhen; Li, Yinyin; Wu, Bowen; Tian, Lu; Shoor, Stanford; Roche, Niall E.; Goronzy, Jorg J.; Weyand, Cornelia M.			N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation	NATURE IMMUNOLOGY			English	Article							METABOLIC-CONTROL; PROTEIN-KINASE; T-CELLS; ENERGY; PHOSPHORYLATION; MYRISTOYLATION; MTORC1; N-MYRISTOYLTRANSFERASE-1; AUTOPHAGY; COMPLEX	N-myristoyltransferase (NMT) attaches the fatty acid myristate to the N-terminal glycine of proteins to sort them into soluble and membrane-bound fractions. Function of the energy-sensing AMP-activated protein kinase, AMPK, is myristoylation dependent. In rheumatoid arthritis (RA), pathogenic T cells shift glucose away from adenosine tri-phosphate production toward synthetic and proliferative programs, promoting proliferation, cytokine production, and tissue invasion. We found that RA T cells had a defect in NMT1 function, which prevented AMPK activation and enabled unopposed mTORC1 signaling. Lack of the myristate lipid tail disrupted the lysosomal translocation and activation of AMPK. Instead, myristoylation-incompetent RA T cells hyperactivated the mTORC1 pathway and differentiated into pro-inflammatory T(H)1 and T(H)17 helper T cells. In vivo, NMT1 loss caused robust synovial tissue inflammation, whereas forced NMT1 overexpression rescued AMPK activation and suppressed synovitis. Thus, NMT1 has tissue-protective functions by facilitating lysosomal recruitment of AMPK and dampening mTORC1 signaling.	[Wen, Zhenke; Jin, Ke; Shen, Yi; Yang, Zhen; Li, Yinyin; Wu, Bowen; Shoor, Stanford; Goronzy, Jorg J.; Weyand, Cornelia M.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Tian, Lu] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Roche, Niall E.] Stanford Hlth Care ValleyCare, Arthrit Ctr, Pleasanton, CA USA	Stanford University; Stanford University	Weyand, CM (corresponding author), Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.	cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021; Wu, Bowen/GVR-9161-2022	Goronzy, Jorg/0000-0001-7670-1856; tian, lu/0000-0002-5893-0169; Jin, Ke/0000-0003-4457-0753; Wen, Zhenke/0000-0003-0542-0349	National Institutes of Health [R01 AR042527, R01 HL 117913, R01 AI108906, P01 HL129941, R01 AI108891, R01 AG045779, U19 AI057266, I01 BX001669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL142068, P01HL129941, R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108906, R01AI108891, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045779] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health (grant nos. R01 AR042527, R01 HL 117913, R01 AI108906 and P01 HL129941 to C.M.W. and nos. R01 AI108891, R01 AG045779, U19 AI057266 and I01 BX001669 to J.J.G.).	Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Dudek E, 2015, BIOCHEM BIOPH RES CO, V468, P889, DOI 10.1016/j.bbrc.2015.11.052; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Huang N, 2018, TRENDS IMMUNOL, V39, P562, DOI 10.1016/j.it.2018.04.006; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim S, 2017, CANCER RES, V77, P6950, DOI 10.1158/0008-5472.CAN-17-0981; Lai ZW, 2018, LANCET, V391, P1186, DOI 10.1016/S0140-6736(18)30485-9; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Lochner M, 2015, TRENDS IMMUNOL, V36, P81, DOI 10.1016/j.it.2014.12.005; Ma EH, 2017, CURR OPIN IMMUNOL, V46, P45, DOI 10.1016/j.coi.2017.04.004; Navarro MN, 2014, NAT IMMUNOL, V15, P808, DOI 10.1038/ni.2941; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ohta H, 2015, BIOCHEM BIOPH RES CO, V463, P988, DOI 10.1016/j.bbrc.2015.06.047; Perl A, 2017, ARTHRITIS RHEUMATOL, V69, P2259, DOI 10.1002/art.40223; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Tsokos GC, 2017, NAT IMMUNOL, V18, P955, DOI 10.1038/ni.3810; Tsokos GC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4953; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; Wang CW, 2016, BBA-MOL CELL BIOL L, V1861, P793, DOI 10.1016/j.bbalip.2015.12.010; Wen ZK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3322; Weyand CM, 2006, NAT CLIN PRACT RHEUM, V2, P201, DOI 10.1038/ncprheum0142; Weyand CM, 2018, FREE RADICAL BIO MED, V125, P36, DOI 10.1016/j.freeradbiomed.2018.03.004; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275; Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014	50	64	68	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					313	+		10.1038/s41590-018-0296-7	http://dx.doi.org/10.1038/s41590-018-0296-7			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30718913	Green Accepted			2022-12-18	WOS:000458893600016
J	Wyss, L; Stadinski, BD; King, CG; Schallenberg, S; McCarthy, NI; Lee, JY; Kretschmer, K; Terracciano, LM; Anderson, G; Surh, CD; Huseby, ES; Palmer, E				Wyss, Lena; Stadinski, Brian D.; King, Carolyn G.; Schallenberg, Sonja; McCarthy, Nicholas I.; Lee, Jun Young; Kretschmer, Karsten; Terracciano, Luigi M.; Anderson, Graham; Surh, Charles D.; Huseby, Eric S.; Palmer, Ed			Affinity for self antigen selects T-reg cells with distinct functional properties	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; INDUCED REGULATORY T; DENDRITIC CELLS; IN-VIVO; RECEPTOR DIVERSITY; SUBSETS; THYMUS; TCR; DIFFERENTIATION; RECIRCULATION	The manner in which regulatory T cells (T-reg cells) control lymphocyte homeostasis is not fully understood. We identified two T-reg cell populations with differing degrees of self-reactivity and distinct regulatory functions. We found that GITR(hi)PD-1(hi)CD25(hi) (Triple(hi)) T-reg cells were highly self-reactive and controlled lympho-proliferation in peripheral lymph nodes. GITR(lo)PD-1(lo)CD25(lo) (Triple(lo)) T-reg cells were less self-reactive and limited the development of colitis by promoting the conversion of CD4(+) T-conv cells into induced T-reg cells (iT(reg) cells). Although Foxp3-deficient (Scurfy) mice lacked T-reg cells, they contained Triple(hi)-like and Triple(lo)-like CD4(+) T cells with distinct pathological properties. Scurfy Triple(hi)CD4(+) T cells infiltrated the skin, whereas Scurfy. Triple(lo)CD4(+) T cells induced colitis and wasting disease. These findings indicate that the affinity of the T cell antigen receptor for self antigen drives the differentiation of T-reg cells into distinct subsets with non-overlapping regulatory activities.	[Wyss, Lena; King, Carolyn G.; Palmer, Ed] Univ Basel Hosp, Dept Biomed, Basel, Switzerland; [Wyss, Lena; King, Carolyn G.; Palmer, Ed] Univ Basel, Basel, Switzerland; [Wyss, Lena; Palmer, Ed] Univ Basel Hosp, Dept Nephrol, Basel, Switzerland; [Stadinski, Brian D.; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Schallenberg, Sonja; Kretschmer, Karsten] Tech Univ Dresden, Mol & Cellular Immunol Immune Regulat, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [McCarthy, Nicholas I.; Anderson, Graham] Univ Birmingham, Inst Immunol & Immunotherapy, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Lee, Jun Young; Surh, Charles D.] Acad Immunol & Microbiol, Inst Basic Sci, Pohang, South Korea; [Lee, Jun Young; Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Kretschmer, Karsten] German Ctr Diabet Res DZD, Paul Langerhans Inst Dresden, Dresden, Germany; [Terracciano, Luigi M.] Univ Basel Hosp, Mol Pathol Div, Inst Pathol, Basel, Switzerland; [Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA	University of Basel; University of Basel; University of Basel; University of Massachusetts System; University of Massachusetts Worcester; Technische Universitat Dresden; University of Birmingham; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Technische Universitat Dresden; University of Basel; La Jolla Institute for Immunology	Palmer, E (corresponding author), Univ Basel Hosp, Dept Biomed, Basel, Switzerland.; Palmer, E (corresponding author), Univ Basel, Basel, Switzerland.; Palmer, E (corresponding author), Univ Basel Hosp, Dept Nephrol, Basel, Switzerland.	ed.palmer@unibas.ch	Terracciano, Luigi M./AAB-5335-2022; Kretschmer, Karsten/E-8174-2010; Schallenberg, Sonja/F-6220-2012	Terracciano, Luigi M./0000-0002-9393-9660; Kretschmer, Karsten/0000-0001-6770-4078; anderson, graham/0000-0002-2917-4085; King, Carolyn G./0000-0001-6059-323X	SNF [310030-149972/1]; Sybilla [EU FP7]; TerraIncognita [ERC]; UMass DERC grant [DK32520]; Federal Ministry of Education and Research grant (BMBF); German Center for Diabetes Research (grant DZD e.V.) [FKZ01GI0924]; Center for Regenerative Therapies Dresden, Cluster of Excellence grant [FZT 111]; MRC; Inst. for Basic Science [IBS-R005-D1]; Oncosuisse [KFS-3169]; Korean Ministry of Science;  [RO1-DK095077];  [U19 AI109858];  [T32 AI 007349]; MRC [MR/N000919/1] Funding Source: UKRI; Medical Research Council [MR/N000919/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007349, U19AI109858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077, P30DK032520] Funding Source: NIH RePORTER	SNF; Sybilla [EU FP7]; TerraIncognita [ERC]; UMass DERC grant; Federal Ministry of Education and Research grant (BMBF); German Center for Diabetes Research (grant DZD e.V.); Center for Regenerative Therapies Dresden, Cluster of Excellence grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Inst. for Basic Science; Oncosuisse; Korean Ministry of Science; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank U. Schneider for animal husbandry, E. Traunecker and T. Krebs for cell sorting, and G. DeLibero, L. Jeker and O. Stepanek for reviewing the manuscript. This study was funded by grants 310030-149972/1 [SNF], Sybilla [EU FP7], and TerraIncognita [ERC] (E.P.); RO1-DK095077, U19 AI109858 and UMass DERC grant DK32520 (E.S.H.); T32 AI 007349 (B.D.S.); Federal Ministry of Education and Research grant (BMBF), German Center for Diabetes Research (grant DZD e.V., FKZ01GI0924) and Center for Regenerative Therapies Dresden, Cluster of Excellence grant FZT 111 (K.K.), Programme Grant from MRC (G.A.); Project IBS-R005-D1 from the Inst. for Basic Science, Korean Ministry of Science (C.D.S.) and Oncosuisse KFS-3169 (L.M.T.).	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cowan JE, 2016, CELL REP, V14, P1041, DOI 10.1016/j.celrep.2016.01.003; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Haribhai D, 2016, J IMMUNOL, V196, P3305, DOI 10.4049/jimmunol.1501956; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Harrison O.J., 2013, COLD SPRING HARB PER, V5, P5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Killebrew JR, 2011, J IMMUNOL, V187, P861, DOI 10.4049/jimmunol.1004009; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Klein L, 2012, IMMUNITY, V37, P441, DOI 10.1016/j.immuni.2012.09.002; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Schmidt AM, 2015, J IMMUNOL, V194, P4362, DOI 10.4049/jimmunol.1402384; Sharma R, 2012, J AUTOIMMUN, V38, P322, DOI 10.1016/j.jaut.2012.02.001; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang EJ, 2014, EUR J IMMUNOL, V44, P2712, DOI 10.1002/eji.201444529; Zelante T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00161; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	47	64	66	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1093	1101		10.1038/ni.3522	http://dx.doi.org/10.1038/ni.3522			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27478940	Green Published, Green Accepted			2022-12-18	WOS:000381832000013
J	Xia, PY; Wang, S; Ye, BQ; Du, Y; Huang, GL; Zhu, PP; Fan, ZS				Xia, Pengyan; Wang, Shuo; Ye, Buqing; Du, Ying; Huang, Guanling; Zhu, Pingping; Fan, Zusen			Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; EMBRYONIC STEM-CELLS; CYCLIC GMP-AMP; CYTOSOLIC DNA; LISTERIA-MONOCYTOGENES; TRANSCRIPTION FACTORS; INTRACELLULAR DNA; DENDRITIC CELLS; ACTIVATION; DEFENSE	Neutrophils express Toll-like receptors (TLRs) for the recognition of conserved bacterial elements to initiate antimicrobial responses. However, whether other cytosolic DNA sensors are expressed by neutrophils remains elusive. Here we found constitutive expression of the transcription factor Sox2 in the cytoplasm of mouse and human neutrophils. Neutrophil-specific Sox2 deficiency exacerbated bacterial infection. Sox2 directly recognized microbial DNA through its high-mobility-group (HMG) domain. Upon challenge with bacterial DNA, Sox2 dimerization was needed to activate a complex of the kinase TAK1 and its binding partner TAB2, which led to activation of the transcription factors NE-kappa B and AP-1 in neutrophils. Deficiency in TAK1 or TAB2 impaired Sox2-mediated antibacterial immunity. Overall, we reveal a previously unrecognized role for Sox2 as a cytosolic sequence-specific DNA sensor in neutrophils, which might provide potential therapeutic strategies for the treatment of infectious diseases.	[Xia, Pengyan; Wang, Shuo; Ye, Buqing; Du, Ying; Huang, Guanling; Zhu, Pingping; Fan, Zusen] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun CAS, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun CAS, Beijing 100080, Peoples R China.	fanz@moon.ibp.ac.cn	Huang, Guanling/AAE-3779-2020	Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [91419308, 81330047, 31300645]; 973 Program of the MOST of China [2010CB911902, 2015CB533705]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of the MOST of China(National Basic Research Program of China); Strategic Priority Research Programs of the Chinese Academy of Sciences	We thank J. Hao, J. Jia and Y. Teng for technical support. Supported by the National Natural Science Foundation of China (91419308, 81330047 and 31300645), the 973 Program of the MOST of China (2010CB911902 and 2015CB533705) and the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDA01010407).	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	38	64	69	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					366	375		10.1038/ni.3117	http://dx.doi.org/10.1038/ni.3117			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25729924				2022-12-18	WOS:000351333700009
J	Jiao, S; Zhang, Z; Li, CC; Huang, M; Shi, ZB; Wang, YY; Song, XM; Liu, H; Li, CY; Chen, M; Wang, WJ; Zhao, Y; Jiang, ZF; Wang, HY; Wong, CCL; Wang, C; Zhou, ZC				Jiao, Shi; Zhang, Zhen; Li, Chuanchuan; Huang, Min; Shi, Zhubing; Wang, Yanyan; Song, Xiaomin; Liu, Heng; Li, Chunyang; Chen, Min; Wang, Wenjia; Zhao, Yun; Jiang, Zhengfan; Wang, Hongyan; Wong, Catherine C. L.; Wang, Chen; Zhou, Zhaocai			The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; STE20-RELATED KINASE; PROVIDES INSIGHTS; CELL-GROWTH; I RECEPTOR; ACTIVATION; COMPLEX; UBIQUITINATION; MECHANISM; CANCER	Immune responses need to be tightly controlled to avoid excessive inflammation and prevent unwanted host damage. Here we report that germinal center kinase MST4 responded dynamically to bacterial infection and acted as a negative regulator of inflammation. We found that MST4 directly interacted with and phosphorylated the adaptor TRAF6 to prevent its oligomerization and autoubiquitination. Accordingly, MST4 did not inhibit lipopolysaccharide-induced cytokine production in Traf6(-/-) embryonic fibroblasts transfected to express a mutant form of TRAF6 that cannot be phosphorylated at positions 463 and 486 ( with substitution of alanine for threonine at those positions). Upon developing septic shock, mice in which MST4 was knocked down showed exacerbated inflammation and reduced survival, whereas heterozygous deletion of Traf6 (Traf6(+/-)) alleviated such deleterious effects. Our findings reveal a mechanism by which TRAF6 is regulated and highlight a role for MST4 in limiting inflammatory responses.	[Jiao, Shi; Zhang, Zhen; Li, Chuanchuan; Huang, Min; Shi, Zhubing; Wang, Yanyan; Song, Xiaomin; Liu, Heng; Li, Chunyang; Chen, Min; Wang, Wenjia; Zhao, Yun; Wang, Hongyan; Wong, Catherine C. L.; Wang, Chen; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Jiang, Zhengfan] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, State Key Lab Prot & Plant Gene Res,Minist Educ, Beijing 100871, Peoples R China; [Jiang, Zhengfan] Peking Univ Tsinghua Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Zhou, Zhaocai] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Peking University; Tsinghua University; ShanghaiTech University	Zhou, ZC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China.	cwang01@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010; Liu, Heng/K-7734-2019; wang, chen/GWM-9481-2022	Shi, Zhubing/0000-0002-9624-4960; Wong, Catherine CL/0000-0001-7270-980X; Li, Chunyang/0000-0002-5798-2274; Liu, Heng/0000-0002-7878-4998	973 program of the Ministry of Science and Technology of China [2012CB910204, 2012CB910200]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868, 31030021, 81161120542]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences	We thank H. Ji (Shanghai Institute of Biochemistry and Cell Biology) for the pLKO.1-puro backbone; and D. Li, J. Zhou, G. Pei, B. Sun, L. Li, A. Lin and M. Lei for support. Supported by the 973 program of the Ministry of Science and Technology of China (2012CB910204 and 2012CB910200), the National Natural Science Foundation of China (31270808, 31300734, 31470736, 31470868, 31030021 and 81161120542), the Science and Technology Commission of Shanghai Municipality (11JC14140000 and 13ZR1446400), and the "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Chen CC, 2014, J BIOL CHEM, V289, P9651, DOI 10.1074/jbc.M113.529297; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Gudey SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004207; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Liu GG, 2014, J STRUCT BIOL, V185, P366, DOI 10.1016/j.jsb.2014.01.008; Liu YF, 2013, STAT INTERFACE, V6, P1; Lou XW, 2011, J IMMUNOL, V186, P539, DOI 10.4049/jimmunol.1001650; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Madsen CD, 2015, NAT CELL BIOL, V17, P68, DOI 10.1038/ncb3083; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Qian ZJ, 2001, J BIOL CHEM, V276, P22439, DOI 10.1074/jbc.M009323200; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang R, 2011, ARCH BIOCHEM BIOPHYS, V508, P93, DOI 10.1016/j.abb.2011.01.019; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williams JM, 2010, AM J PATHOL, V176, P2732, DOI 10.2353/ajpath.2010.080486; Wu YF, 2009, CELL SIGNAL, V21, P143, DOI 10.1016/j.cellsig.2008.10.001; Xu XY, 2013, STRUCTURE, V21, P1059, DOI 10.1016/j.str.2013.04.007; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang M, 2013, STRUCTURE, V21, P680, DOI 10.1016/j.str.2013.02.015; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	48	64	70	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					246	U204		10.1038/ni.3097	http://dx.doi.org/10.1038/ni.3097			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25642822				2022-12-18	WOS:000349842100008
J	Meissner, F; Mann, M				Meissner, Felix; Mann, Matthias			Quantitative shotgun proteomics: considerations for a high-quality workflow in immunology	NATURE IMMUNOLOGY			English	Article							MASS-SPECTROMETRY; CELL-CULTURE; AMINO-ACIDS; EXPRESSION; STRATEGIES; ACCURATE; REVEALS; NETWORK	Proteomics based on high-resolution mass spectrometry has become a powerful tool for the analysis of protein abundance, modifications and interactions. Here we describe technical aspects of proteomics workflows, instrumentation as well as computational considerations to obtain high-quality proteomics data.	[Meissner, Felix; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Meissner, F (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	meissner@biochem.mpg.de; mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013; MEISSNER, Felix/C-8767-2015	Mann, Matthias/0000-0003-1292-4799; MEISSNER, Felix/0000-0003-1000-7989				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Altelaar AFM, 2012, CURR OPIN CHEM BIOL, V16, P206, DOI 10.1016/j.cbpa.2011.12.011; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; [Anonymous], 2008, ANN ICRP, V38, P1; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Cutillas PR, 2010, METHODS MOL BIOL, V658, P1, DOI 10.1007/978-1-60761-780-8; Diercks A, 2013, CURR TOP MICROBIOL, V363, P1, DOI 10.1007/82_2012_246; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ens W, 2005, METHOD ENZYMOL, V402, P49, DOI 10.1016/S0076-6879(05)02002-1; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoppes R, 2010, J PROTEOMICS, V73, P1945, DOI 10.1016/j.jprot.2010.05.009; Howden AJM, 2013, NAT METHODS, V10, P343, DOI [10.1038/NMETH.2401, 10.1038/nmeth.2401]; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Leon IR, 2013, MOL CELL PROTEOMICS, V12, P2992, DOI 10.1074/mcp.M112.025585; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Meissner F, 2013, SCIENCE, V340, P475, DOI 10.1126/science.1232578; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001839; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Plasman K, 2013, CURR OPIN CHEM BIOL, V17, P66, DOI 10.1016/j.cbpa.2012.11.026; Rebsamen M, 2013, TRENDS IMMUNOL, V34, P610, DOI 10.1016/j.it.2013.05.002; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Sandra K, 2008, J CHROMATOGR B, V866, P48, DOI 10.1016/j.jchromb.2007.10.034; Scigelova M, 2006, PROTEOMICS, P16, DOI 10.1002/pmic.200600528; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800	40	64	66	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					112	117		10.1038/ni.2781	http://dx.doi.org/10.1038/ni.2781			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448568				2022-12-18	WOS:000330150600002
J	Yang, S; Wang, BW; Humphries, F; Jackson, R; Healy, ME; Bergin, R; Aviello, G; Hall, B; McNamara, D; Darby, T; Quinlan, A; Shanahan, F; Melgar, S; Fallon, PG; Moynagh, PN				Yang, Shuo; Wang, Bingwei; Humphries, Fiachra; Jackson, Ruaidhri; Healy, Marc E.; Bergin, Ronan; Aviello, Gabriella; Hall, Barry; McNamara, Deirdre; Darby, Trevor; Quinlan, Aoife; Shanahan, Fergus; Melgar, Silvia; Fallon, Padraic G.; Moynagh, Paul N.			Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; TOLL-LIKE RECEPTOR; CARD15 MUTATIONS; CROHNS-DISEASE; LIGASE PELLINO; NOD2; POLYUBIQUITINATION; PROTEINS; IDENTIFICATION; RECRUITMENT	Mutations that result in loss of function of Nod2, an intracellular receptor for bacterial peptidoglycan, are associated with Crohn's disease. Here we found that the E3 ubiquitin ligase Pellino3 was an important mediator in the Nod2 signaling pathway. Pellino3-deficient mice had less induction of cytokines after engagement of Nod2 and had exacerbated disease in various experimental models of colitis. Furthermore, expression of Pellino3 was lower in the colons of patients with Crohn's disease. Pellino3 directly bound to the kinase RIP2 and catalyzed its ubiquitination. Loss of Pellino3 led to attenuation of Nod2-induced ubiquitination of RIP2 and less activation of the transcription factor NF-kappa B and mitogen-activated protein kinases (MAPKs). Our findings identify RIP2 as a substrate for Pellino3 and Pellino3 as an important mediator in the Nod2 pathway and regulator of intestinal inflammation.	[Yang, Shuo; Wang, Bingwei; Humphries, Fiachra; Jackson, Ruaidhri; Healy, Marc E.; Bergin, Ronan; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland; [Aviello, Gabriella; Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Hall, Barry; McNamara, Deirdre] Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland; [Hall, Barry; McNamara, Deirdre] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Darby, Trevor; Quinlan, Aoife; Shanahan, Fergus; Melgar, Silvia] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Sch Med, Inst Mol Med, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Maynooth University; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Cork; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland.	paul.moynagh@nuim.ie	Melgar, Silvia/I-4191-2019; Fallon, Padraic/Y-2711-2019; Shanahan, Fergus/ABF-2390-2020	Melgar, Silvia/0000-0001-7463-3343; Fallon, Padraic/0000-0002-8401-7293; Shanahan, Fergus/0000-0003-0467-0936; Healy, Marc/0000-0001-9441-1166; Moynagh, Paul/0000-0002-4139-3061; wang, Bingwei/0000-0002-9306-4323; Humphries, Fiachra/0000-0003-0216-5776; Darby, Trevor/0000-0002-7379-3836; Bergin, Ronan/0000-0003-4685-7176; McNamara, Deirdre/0000-0003-2324-3382	Science Foundation Ireland [07/IN.1/B972, 10/IN.1/B3004, 02/CE/B124, 07/CE/B1368]; Health Research Board of Ireland [PhD/2007/09]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland	We thank P. A. Barker and M. Saleh (McGill University) for Flag-tagged RIP2 and Nod2; M. Parkers and the Broad Institute for help and use of the Ricopili search tool; and G. Holleran for assistance in collecting biopsy samples from human subjects. Supported by Science Foundation Ireland (07/IN.1/B972 to P.N.M.; 10/IN.1/B3004 to P. G. F.; 02/CE/B124 and 07/CE/B1368 to F. S.; and funding for the Alimentary Pharmabiotic Centre as a Centre for Science, Engineering and Technology) and the Health Research Board of Ireland (PhD/2007/09).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hall LJ, 2013, MUCOSAL IMMUNOL, V6, P1016, DOI 10.1038/mi.2012.140; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Moynagh PN, 2011, NAT IMMUNOL, V12, P927, DOI 10.1038/ni.2108; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Murphy CT, 2012, INFECT IMMUN, V80, P2712, DOI 10.1128/IAI.06319-11; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Siednienko J, 2012, NAT IMMUNOL, V13, P1055, DOI 10.1038/ni.2429; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Strelow A, 2003, FEBS LETT, V547, P157, DOI 10.1016/S0014-5793(03)00697-5; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	50	64	72	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					927	+		10.1038/ni.2669	http://dx.doi.org/10.1038/ni.2669			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23892723	Green Accepted			2022-12-18	WOS:000323377700010
J	Do-Umehara, HC; Chen, C; Urich, D; Zhou, L; Qiu, J; Jang, S; Zander, A; Baker, MA; Eilers, M; Sporn, PHS; Ridge, KM; Sznajder, JI; Budinger, GRS; Mutlu, GM; Lin, AN; Liu, J				Do-Umehara, Hanh Chi; Chen, Cong; Urich, Daniela; Zhou, Liang; Qiu, Ju; Jang, Samuel; Zander, Alia; Baker, Margaret A.; Eilers, Martin; Sporn, Peter H. S.; Ridge, Karen M.; Sznajder, Jacob I.; Budinger, G. R. Scott; Mutlu, Goekhan M.; Lin, Anning; Liu, Jing			Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-delta	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR MIZ-1; INDUCED JNK ACTIVATION; IMMUNE-RESPONSE; GENETIC-CONTROL; RECEPTOR; MICE; MYC; ASSOCIATION; APOPTOSIS	Inflammation is essential for host defense but can cause tissue damage and organ failure if unchecked. How the inflammation is resolved remains elusive. Here we report that the transcription factor Miz1 was required for terminating lipopolysaccharide (LPS)-induced inflammation. Genetic disruption of the Miz1 POZ domain, which is essential for the transactivation or repression activity of Miz1, resulted in hyperinflammation, lung injury and greater mortality in LPS-treated mice but a lower bacterial load and mortality in mice with Pseudomonas aeruginosa pneumonia. Loss of the Miz1 POZ domain prolonged the expression of proinflammatory cytokines. After stimulation, Miz1 was phosphorylated at Ser178, which was required for recruitment of the histone deacetylase HDAC1 to repress transcription of the gene encoding C/EBP-delta, an amplifier of inflammation. Our data provide a long-sought mechanism underlying the resolution of LPS-induced inflammation.	[Do-Umehara, Hanh Chi; Chen, Cong; Urich, Daniela; Jang, Samuel; Zander, Alia; Baker, Margaret A.; Sporn, Peter H. S.; Ridge, Karen M.; Sznajder, Jacob I.; Budinger, G. R. Scott; Mutlu, Goekhan M.; Liu, Jing] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Zhou, Liang; Qiu, Ju] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhou, Liang; Qiu, Ju] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Eilers, Martin] Univ Marburg, Inst Mol Biol & Tumorforsch, D-35032 Marburg, Germany; [Sporn, Peter H. S.; Ridge, Karen M.; Budinger, G. R. Scott] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lin, Anning] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Philipps University Marburg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Chicago; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	jing@northwestern.edu	Qiu, Ju/AAW-7301-2021	Sporn, Peter/0000-0002-1006-9437; /0000-0003-2678-5056; Jang, Samuel/0000-0002-8398-7263; Eilers, Martin/0000-0002-0376-6533	US National Institutes of Health [GM081603, GM095313, ES015024, ES013995, P01HL071643, AI 089954, AI 091962]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL107629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091962, R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081603, R01GM095313, R01GM103868] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hauser, K. Gates, A. Gonzalez and F. Aguilar for help with animal experiments; J. Radder for isolating ATII cells; L. He for isolating lung cells derived from the hematopoietic compartment; A. Yemelyanov for lentivirus preparation; and J. Dewille (Ohio State University College of Veterinary Medicine) for the Cebpd luciferase reporter gene construct. Supported by the US National Institutes of Health (GM081603 to J. L., GM095313 to A. L., ES015024 to G. M. M., ES013995 to G. R. S. B., P01HL071643 to J. I. S., and AI 089954 and AI 091962 to L.Z.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kaner RJ, 1999, AM J RESP CELL MOL, V20, P361, DOI 10.1165/ajrcmb.20.3.3398; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Kung VL, 2012, P NATL ACAD SCI USA, V109, P1275, DOI 10.1073/pnas.1109285109; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lin AN, 2011, ADV EXP MED BIOL, V691, P127, DOI 10.1007/978-1-4419-6612-4_13; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mutlu GM, 2007, AM J RESP CRIT CARE, V176, P582, DOI 10.1164/rccm.200608-1246OC; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Urich D, 2011, J CELL SCI, V124, P2927, DOI 10.1242/jcs.080911; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Zarbock A, 2009, J IMMUNOL, V183, P4715, DOI 10.4049/jimmunol.0802592; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	48	64	69	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					461	+		10.1038/ni.2566	http://dx.doi.org/10.1038/ni.2566			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23525087	Green Accepted			2022-12-18	WOS:000317732100011
J	Rathinam, C; Matesic, LE; Flavell, RA				Rathinam, Chozhavendan; Matesic, Lydia E.; Flavell, Richard A.			The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							LONG-TERM REPOPULATION; UBIQUITIN LIGASE; SELF-RENEWAL; IMMUNE-SYSTEM; NOTCH; MICE; EXPRESSION; LINEAGE; FAMILY; FATE	Although hematopoietic stem cells (HSCs) are the most thoroughly characterized type of adult stem cell, the intricate molecular machinery that regulates their self-renewal properties remains elusive. Here we showed that the E3 ubiquitin ligase Itch negatively regulated the development and function of HSCs. Itch(-/-) mice had HSCs with enhanced frequency, competence and long-term repopulating activity. Itch-deficient HSCs showed accelerated proliferation rates and sustained progenitor properties, as well as more signaling by the transcription factor Notch1, due to more accumulation of activated Notch1. Knockdown of Notch1 in Itch-mutant HSCs resulted in reversion of the phenotype. Thus, we identify Itch as a previously unknown negative regulator of HSC homeostasis and function.	[Rathinam, Chozhavendan; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Matesic, Lydia E.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu			Yale Cell Sorter Facility; Howard Hughes Medical Institute; administrative core of the National Institutes of Health Center for Biomedical Research Excellence at Roger Williams Medical Center [P20RR018757]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757, P20RR017698] Funding Source: NIH RePORTER	Yale Cell Sorter Facility; Howard Hughes Medical Institute(Howard Hughes Medical Institute); administrative core of the National Institutes of Health Center for Biomedical Research Excellence at Roger Williams Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank F. Manzo for help with manuscript submission; and the Yale Cell Sorter Facility for support. Supported by the Howard Hughes Medical Institute (R. A. F.) and the administrative core of the National Institutes of Health Center for Biomedical Research Excellence at Roger Williams Medical Center (P20RR018757).	Allman D, 2002, IMMUNOL REV, V187, P75, DOI 10.1034/j.1600-065X.2002.18707.x; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Garrison BS, 2010, NAT IMMUNOL, V11, P193, DOI 10.1038/ni0310-193; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LERNER C, 1990, EXP HEMATOL, V18, P114; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Radtke F, 2004, CURR OPIN IMMUNOL, V16, P174, DOI 10.1016/j.coi.2004.01.002; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rathinam C, 2006, LEUKEMIA, V20, P870, DOI 10.1038/sj.leu.2404157; Rathinam C, 2008, BLOOD, V112, P3534, DOI 10.1182/blood-2008-07-167759; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokomizo T, 2008, GENE DEV, V22, P960, DOI 10.1101/gad.1669908	48	64	65	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					399	U52		10.1038/ni.2021	http://dx.doi.org/10.1038/ni.2021			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21478879	Green Accepted			2022-12-18	WOS:000289666600010
J	Hu, TS; Simmons, A; Yuan, J; Bender, TP; Alberola-Ila, J				Hu, Taishan; Simmons, Amie; Yuan, Joan; Bender, Timothy P.; Alberola-Ila, Jose			The transcription factor c-Myb primes CD4(+)CD8(+) immature thymocytes for selection into the iNKT lineage	NATURE IMMUNOLOGY			English	Article							NKT CELL-DEVELOPMENT; CUTTING EDGE; GENE; SAP; PROLIFERATION; HOMEOSTASIS; EXPRESSION; MATURATION; SURVIVAL; SLAMF1	Type I invariant NKT cells (iNKT cells) are a subset of ab T cells characterized by the expression of an invariant alpha-chain variable region 14-alpha-chain joining region 18 (V(alpha)14J(alpha)18) T cell antigen receptor (TCR) alpha-chain. The iNKT cells derive from CD4(+)CD8(+) double-positive (DP) thymocytes, and their generation requires a long half-life of DP thymocytes to allow V(alpha)14-J(alpha)18 rearrangements, expression of glycolipid-loaded CD1d on DP thymocytes, and signaling through the signaling-activation molecule SLAM-adaptor SAP pathway. Here we show that the transcription factor c-Myb has a central role in priming DP thymocytes to enter the iNKT lineage by simultaneously regulating CD1d expression, the half-life of DP cells and expression of SLAMF1, SLAMF6 and SAP.	[Hu, Taishan; Simmons, Amie; Alberola-Ila, Jose] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Yuan, Joan; Bender, Timothy P.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Alberola-Ila, Jose] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Virginia; University of Oklahoma System; University of Oklahoma Health Sciences Center	Alberola-Ila, J (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jose-alberola-ila@omrf.org	yuan, joan/A-8185-2013; Lin, Zongli/L-6084-2019	yuan, joan/0000-0001-9129-8356; alberola-ila, Jose/0000-0003-2439-553X	US National Institutes of Health [AI059302]; American Heart Association [0855002F]; National Cancer Institute; National Institutes of Health [CA85842]; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059302, R21AI088546] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Bendelac (Howard Hughes Medical Institute) for the Va14-transgenic mice; A. Veillette (Clinical Research Institute, Montreal) for the antibody to SAP; X.-H. Sun (Oklahoma Medical Research Foundation) for the Mig-ROR.t vector; M. Lang (University of Oklahoma Health Science Center) for CD1d-deficient-and Ja18-deficient-bone marrow; the National Institutes of Health Tetramer Facility for the CD1d-PBS57 tetramer; and S. Kovats for discussions. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (AI059302 to J.A.-I.), the American Heart Association (0855002F to J. A.-I.), the National Cancer Institute of the National Institutes of Health (CA85842 to T. B. P.) and the Robert R. Wagner Fellowship Fund (J. Y.).	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Chao DT, 1997, INT IMMUNOL, V9, P1375, DOI 10.1093/intimm/9.9.1375; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Eberl G, 1999, J IMMUNOL, V163, P4091; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Esteban LM, 2003, J IMMUNOL, V171, P2873, DOI 10.4049/jimmunol.171.6.2873; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Gapin L, 2008, NAT IMMUNOL, V9, P1009, DOI 10.1038/ni0908-1009; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Guo WJ, 2002, WORLD J GASTROENTERO, V8, P476, DOI 10.3748/wjg.v8.i3.476; Hernandez-Hoyos G, 2005, METHOD ENZYMOL, V392, P199, DOI 10.1016/S0076-6879(04)92012-5; HernandezMunain C, 1996, J EXP MED, V183, P289, DOI 10.1084/jem.183.1.289; Hossain MZ, 2008, INT IMMUNOL, V20, P925, DOI 10.1093/intimm/dxn051; HSIANG YHH, 1995, J IMMUNOL, V154, P5195; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pearson R, 2000, EMBO J, V19, P6112, DOI 10.1093/emboj/19.22.6112; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Williams JA, 2008, J IMMUNOL, V181, P907, DOI 10.4049/jimmunol.181.2.907; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981	47	64	65	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					435	U98		10.1038/ni.1865	http://dx.doi.org/10.1038/ni.1865			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20383148	Green Accepted			2022-12-18	WOS:000276852200013
J	Min, B				Min, Booki			Basophils: what they 'can do' versus what they 'actually do'	NATURE IMMUNOLOGY			English	Review							PERIPHERAL-BLOOD BASOPHILS; HUMAN IGE SYNTHESIS; CHRONIC ALLERGIC INFLAMMATION; EPSILON-RI EXPRESSION; MAJOR BASIC-PROTEIN; HUMAN MAST-CELLS; IN-VIVO; T-CELLS; HISTAMINE-RELEASE; IL-4 PRODUCTION	Basophils, the least abundant granulocytes, have poorly understood functions. They have been linked to the development of T helper type 2 immunity during parasite infection and allergic inflammation. Emerging evidence has not only shown the critical involvement of basophils in the development of T helper type 2 immunity but also provided useful animal models with which basophil functions can be further examined. However, distinctions must be made between what basophils 'can do' after in vitro manipulation and what they 'actually do' during in vivo immune responses; these may be very different. In this review, the functions of basophils determined on the basis of analysis of in vitro and in vivo systems and their potential involvement in clinical settings are discussed.	Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Min, B (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	minb@ccf.org						Agis H, 1996, IMMUNOLOGY, V87, P535, DOI 10.1046/j.1365-2567.1996.493578.x; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; AOKI I, 1995, P NATL ACAD SCI USA, V92, P2534, DOI 10.1073/pnas.92.7.2534; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Boumiza R, 2003, CLIN EXP ALLERGY, V33, P259, DOI 10.1046/j.1365-2222.2003.01594.x; BROWN SJ, 1982, J IMMUNOL, V129, P790; BRUNNER T, 1993, J EXP MED, V177, P605, DOI 10.1084/jem.177.3.605; Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; BUTTERWORTH AE, 1979, J IMMUNOL, V122, P221; DAHINDEN CA, 1989, J EXP MED, V170, P1787, DOI 10.1084/jem.170.5.1787; de Paulis A, 2000, J IMMUNOL, V165, P7171, DOI 10.4049/jimmunol.165.12.7171; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Devouassoux G, 1999, J ALLERGY CLIN IMMUN, V104, P811, DOI 10.1016/S0091-6749(99)70292-7; Eberlein-Konig B, 2006, ALLERGY, V61, P1084, DOI 10.1111/j.1398-9995.2006.01122.x; ELSE KJ, 1993, PARASITE IMMUNOL, V15, P595; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Falcone FH, 1996, EUR J IMMUNOL, V26, P1147, DOI 10.1002/eji.1830260528; Falcone FH, 2005, INFLAMM RES, V54, pS13, DOI 10.1007/s00011-004-0405-y; Falcone FH, 2006, EXP DERMATOL, V15, P855, DOI 10.1111/j.1600-0625.2006.00477.x; Florio C, 2000, AIDS, V14, P931, DOI 10.1097/00002030-200005260-00004; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Galli SJ, 2008, IMMUNITY, V28, P495, DOI 10.1016/j.immuni.2008.03.010; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; GENTA RM, 1983, LAB INVEST, V48, P633; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gibbs BF, 2008, CLIN EXP ALLERGY, V38, P480, DOI 10.1111/j.1365-2222.2007.02919.x; Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033; Gonzalez-Munoz M, 1999, AM J TROP MED HYG, V60, P974, DOI 10.4269/ajtmh.1999.60.974; Haas H, 1999, INT ARCH ALLERGY IMM, V119, P86, DOI 10.1159/000024182; Haisch K, 2001, PARASITE IMMUNOL, V23, P427, DOI 10.1046/j.1365-3024.2001.00392.x; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Irani AMA, 1998, J ALLERGY CLIN IMMUN, V101, P354, DOI 10.1016/S0091-6749(98)70248-9; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; JUHLIN L, 1977, LANCET, V1, P1233; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; KEMP DH, 1980, PARASITOLOGY, V80, P487, DOI 10.1017/S0031182000000950; KEPLEY CL, 1995, J IMMUNOL, V154, P6548; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; KIERSZENBAUM F, 1981, AM J TROP MED HYG, V30, P775, DOI 10.4269/ajtmh.1981.30.775; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Koshino T, 1996, J ASTHMA, V33, P89, DOI 10.3109/02770909609054536; KURIMOTO Y, 1989, J EXP MED, V170, P467, DOI 10.1084/jem.170.2.467; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lantz CS, 1997, J IMMUNOL, V158, P2517; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; LEGROS G, 1990, J IMMUNOL, V145, P2500; Li Y, 2001, BLOOD, V97, P3484, DOI 10.1182/blood.V97.11.3484; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; Macfarlane AJ, 2000, J ALLERGY CLIN IMMUN, V105, P99, DOI 10.1016/S0091-6749(00)90184-2; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Marone G, 2001, TRENDS IMMUNOL, V22, P229, DOI 10.1016/S1471-4906(01)01903-2; Marone G, 2005, TRENDS IMMUNOL, V26, P25, DOI 10.1016/j.it.2004.10.010; Marone G, 2001, IMMUNOL REV, V179, P128, DOI 10.1034/j.1600-065X.2001.790113.x; Marsland BJ, 2005, IMMUNOL CELL BIOL, V83, P40, DOI [10.1111/j.1440-1711.2004.01303.x, 10.1111/j.1440-1711.2005.01303.x]; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min B, 2008, NAT IMMUNOL, V9, P223, DOI 10.1038/ni0308-223; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Mitre E, 2004, J IMMUNOL, V172, P2439, DOI 10.4049/jimmunol.172.4.2439; Mitre E, 2003, AM J TROP MED HYG, V69, P87, DOI 10.4269/ajtmh.2003.69.87; Mitre E, 2006, CHEM IMMUNOL ALLERGY, V90, P141, DOI 10.1159/000088886; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; NIELSEN BW, 1994, ALLERGY, V49, P427, DOI 10.1111/j.1398-9995.1994.tb00835.x; Norton SK, 2008, J IMMUNOL, V180, P2848, DOI 10.4049/jimmunol.180.5.2848; Nouri-Aria KT, 2001, J ALLERGY CLIN IMMUN, V108, P205, DOI 10.1067/mai.2001.117175; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; PAUL DH, 1991, DESAL WATER REUSE, V1, P8; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Shakib F, 1998, IMMUNOL TODAY, V19, P313, DOI 10.1016/S0167-5699(98)01284-5; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tamachi T, 2006, INT ARCH ALLERGY IMM, V140, P59, DOI 10.1159/000092713; Tan JQ, 2000, J ALLERGY CLIN IMMUN, V106, P313, DOI 10.1067/mai.2000.108108; TRACEY R, 1978, BLOOD CELLS, V4, P291; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yamaguchi M, 2001, INT IMMUNOL, V13, P843, DOI 10.1093/intimm/13.7.843; Yanagihara Y, 1997, CLIN EXP IMMUNOL, V108, P295, DOI 10.1046/j.1365-2249.1997.d01-1001.x; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yoshimoto Tomohiro, 2006, Allergol Int, V55, P105, DOI 10.2332/allergolint.55.105; Youssef LA, 2007, J IMMUNOL, V178, P4584, DOI 10.4049/jimmunol.178.7.4584	99	64	66	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1333	1339		10.1038/ni.f.217	http://dx.doi.org/10.1038/ni.f.217			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008933				2022-12-18	WOS:000260888700007
J	Wang, L; Tassiulas, I; Park-Min, KH; Reid, AC; Gil-Henn, H; Schlessinger, J; Baron, R; Zhang, JJ; Ivashkiv, LB				Wang, Lu; Tassiulas, Ioannis; Park-Min, Kyung-Hyun; Reid, Alicia C.; Gil-Henn, Hava; Schlessinger, Joseph; Baron, Roland; Zhang, J. Jillian; Ivashkiv, Lionel B.			'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages	NATURE IMMUNOLOGY			English	Article							COUPLED RECEPTOR ACTIVATION; EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE; AMPLIFIES INFLAMMATION; CUTTING EDGE; IFN-GAMMA; JAK-STAT; C-SRC; PYK2; INTEGRIN	Immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors modulate the amplitude and nature of macrophage responses to Toll-like receptor and cytokine receptor stimulation. However, the molecular mechanisms enabling this receptor crosstalk are not known. Here we investigated the function of the calcium-dependent kinases CaMK and Pyk2 'downstream' of ITAM-associated receptors in the regulation of cytokine-induced activation of Jak kinases and STAT transcription factors. CaMK and Pyk2 relayed signals from integrins and the ITAM-containing adaptor DAP12 to augment interleukin 10-and interferon-alpha-induced Jak activation and STAT1-dependent gene expression. CaMK inhibition suppressed STAT1-mediated interferon-alpha signaling in a mouse model of systemic lupus erythematosus. Our results associate Pyk2 and Jak kinases with the linkage of signals emanating from cytokine and heterologous ITAM-dependent receptors.	[Wang, Lu; Tassiulas, Ioannis; Park-Min, Kyung-Hyun; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Reid, Alicia C.; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Phys & Biophys, New York, NY 10021 USA; [Gil-Henn, Hava; Schlessinger, Joseph] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Baron, Roland] Yale Univ, Sch Med, Dept Orthoped, New Haven, CT 06520 USA; [Baron, Roland] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Ivashkiv, Lionel B.] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA	Cornell University; Yale University; Yale University; Yale University; Cornell University	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu			NIAMS NIH HHS [P50 AR 054086, AR 051448, AR 051886] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051886, R01AR051448, P50AR054086] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Benbernou N, 2000, J BIOL CHEM, V275, P7060, DOI 10.1074/jbc.275.10.7060; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Han HS, 2003, J EXP MED, V197, P63, DOI 10.1084/jem.20021638; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Ivashkiv LB, 2003, AUTOIMMUNITY, V36, P473, DOI 10.1080/08916930310001605882; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	50	64	64	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					186	193		10.1038/ni1548	http://dx.doi.org/10.1038/ni1548			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18084294				2022-12-18	WOS:000252503000015
J	Hirano, M; Davis, RS; Fine, WD; Nakamura, S; Shimizu, K; Yagi, H; Kato, K; Stephan, RP; Cooper, MD				Hirano, Masayuki; Davis, Randall S.; Fine, W. David; Nakamura, Shugo; Shimizu, Kentaro; Yagi, Hirokazu; Kato, Koichi; Stephan, Robert P.; Cooper, Max D.			IgE(b) immune complexes activate macrophages through Fc gamma RIV binding	NATURE IMMUNOLOGY			English	Article							SCHISTOSOMA-MANSONI; ANTIBODY-RESPONSES; ALLERGIC RESPONSES; RECEPTOR HOMOLOGS; DEFICIENT MICE; MAST-CELLS; EPSILON-RI; IGG; INFECTION; POLYMORPHISMS	Because functional analysis of Fc receptors (FcRs) relies heavily on mouse models, the identification of another Fc gamma receptor is particularly noteworthy. We demonstrate that Fc gamma RIV, identified here as the mouse ortholog of primate Fc gamma RIII, required association of the FcR gamma-chain for optimal expression and function on myeloid cells; its signaling potential was also enhanced by a cytoplasmic 'YEEP' motif that was able to recruit the adaptor molecule Crk-L and phosphatidylinositol-3-OH kinase. Unexpectedly, Fc gamma RIV 'preferentially' bound immunoglobulin E antibodies of the 'b' allotype (IgE(b)) as well as IgG2a and IgG2b antibodies. Ligation of Fc gamma RIV by antigen-IgE(b) immune complexes promoted macrophage-mediated phagocytosis, presentation of antigen to T cells, production of proinflammatory cytokines and the late phase of cutaneous allergic reactions. IgE(b) antibody-mediated modification of macrophage responses may therefore influence mouse asthma models and strain-dependent differences in parasite susceptibility.	Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Div Hematol Oncol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tokyo; Nagoya City University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cooper, MD (corresponding author), Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	max.cooper@ccc.uab.edu	Yagi, Hirokazu/ABH-6151-2020	Yagi, Hirokazu/0000-0001-9296-0225	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039816, R37AI039816, K08AI055638, R01AI067467] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067467-01A1, AI 39816, R01 AI067467, AI55638] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aban JL, 1999, VET PARASITOL, V83, P107, DOI 10.1016/S0304-4017(99)00053-9; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; BARTLETT WC, 1995, J IMMUNOL, V154, P4240; BUTTERWORTH AE, 1984, ADV PARASIT, V23, P143, DOI 10.1016/S0065-308X(08)60287-0; CAMPBELL PA, 1996, CURRENT PROTOCOL IMM; Cernadas M, 1999, AM J RESP CELL MOL, V20, P1; CHEEVER AW, 1965, AM J TROP MED HYG, V14, P227, DOI 10.4269/ajtmh.1965.14.227; Davis RS, 2005, EUR J IMMUNOL, V35, P674, DOI 10.1002/eji.200425886; Davis RS, 2004, INT IMMUNOL, V16, P1343, DOI 10.1093/intimm/dxh137; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; FINKELMAN FD, 1991, IMMUNOL TODAY, V12, P62; Haczku A, 1997, AM J RESP CRIT CARE, V156, P1945, DOI 10.1164/ajrccm.156.6.9701087; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HIBBS ML, 1985, IMMUNOGENETICS, V22, P335, DOI 10.1007/BF00430917; HOLDEN CA, 1993, CLIN EXP DERMATOL, V18, P201, DOI 10.1111/j.1365-2230.1993.tb02171.x; Hughes AL, 1996, J MOL EVOL, V43, P4, DOI 10.1007/BF02352293; JAMES SL, 1989, J IMMUNOL, V143, P4208; JAMES SL, 1993, CURR OPIN IMMUNOL, V5, P518, DOI 10.1016/0952-7915(93)90032-N; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; MAURER D, 1995, J IMMUNOL, V154, P6285; Mechetina LV, 2002, IMMUNOGENETICS, V54, P463, DOI 10.1007/s00251-002-0486-0; NAGAI H, 1995, BIOL PHARM BULL, V18, P239; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Onah DN, 2000, INFECT IMMUN, V68, P4968, DOI 10.1128/IAI.68.9.4968-4971.2000; Onishi M, 1996, EXP HEMATOL, V24, P324; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pandey JP, 2006, SCIENCE, V311, P1376; Paterson T, 1998, IMMUNOTECHNOLOGY, V4, P37, DOI 10.1016/S1380-2933(98)00005-0; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; SHER A, 1983, J IMMUNOL, V131, P1460; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; SHINKAI Y, 1988, IMMUNOGENETICS, V27, P288, DOI 10.1007/BF00376124; Strong P, 2003, CLIN EXP IMMUNOL, V134, P181, DOI 10.1046/j.1365-2249.2003.02281.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tsutsui H, 1996, J IMMUNOL, V157, P3967; van der Pol WL, 1998, IMMUNOGENETICS, V48, P222, DOI 10.1007/s002510050426; van Hage-Hamsten M, 2002, CLIN EXP ALLERGY, V32, P838, DOI 10.1046/j.1365-2222.2002.01402.x; VONLICHTENBERG F, 1980, AM J TROP MED HYG, V29, P1286, DOI 10.4269/ajtmh.1980.29.1286; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	64	68	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					762	771		10.1038/ni1477	http://dx.doi.org/10.1038/ni1477			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17558411				2022-12-18	WOS:000247718100017
J	Narayan, K; Chou, CL; Kim, A; Hartman, IZ; Dalai, S; Khoruzhenko, S; Sadegh-Nasseri, S				Narayan, Kedar; Chou, Chih-Ling; Kim, AeRyon; Hartman, Isamu Z.; Dalai, Sarat; Khoruzhenko, Stanislav; Sadegh-Nasseri, Scheherazade			HLA-DM targets the hydrogen bond between the histidine at position beta 81 and peptide to dissociate HLA-DR-peptide complexes	NATURE IMMUNOLOGY			English	Article							MHC CLASS-II; INDUCED CONFORMATIONAL-CHANGE; ANTIGEN PRESENTATION; PROTEIN HLA-DR1; INTRACELLULAR-TRANSPORT; GLUCOCORTICOID-RECEPTOR; KINETIC STABILITY; CRYSTAL-STRUCTURE; LYSOSOMAL PH; MOLECULES	The peptide editor HLA-DM ( DM) mediates exchange of peptides bound to major histocompatibility ( MHC) class II molecules during antigen processing; however, the mechanism by which DM displaces peptides remains unclear. Here we generated a soluble mutant HLA-DR1 with a histidine-to-asparagine substitution at position 81 of the beta-chain ( DR1 beta H81N) to perturb an important hydrogen bond between MHC class II and peptide. Peptide-DR1 beta H81N complexes dissociated at rates similar to the dissociation rates of DM-induced peptide-wild-type DR1, and DM did not enhance the dissociation of peptide-DR1 beta H81N complexes. Reintroduction of an appropriate hydrogen bond ( DR1 beta H81N beta V85H) restored DM-mediated peptide dissociation. Thus, DR1 beta H81N might represent a 'post-DM effect' conformation. We suggest that DM may mediate peptide dissociation by a 'hit-and-run' mechanism that results in conformational changes in MHC class II molecules and disruption of hydrogen bonds between beta His81 and bound peptide.	Johns Hopkins Univ, Grad Program Immunol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Grad Program Mol & Computat Biophys, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sadegh-Nasseri, S (corresponding author), Johns Hopkins Univ, Grad Program Immunol, Baltimore, MD 21205 USA.	ssadegh@jhmi.edu	Khoruzhenko, Stanislav/A-4438-2012	Khoruzhenko, Stanislav/0000-0002-8876-7729; Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720	NIAID NIH HHS [R01 AI063764-01A2, R56 AI063764, R01AI063764, R56 AI063764-01A1, R01 AI063764] Funding Source: Medline; NIGMS NIH HHS [R01 GM053549-09, R01 GM053549-08, R01 GM053549-06A1, R01 GM053549-07, R01GM53549, R01 GM053549] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063764, R56AI063764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Castellino F, 1997, HUM IMMUNOL, V54, P159, DOI 10.1016/S0198-8859(97)00078-5; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DeLano W. L, 2002, PYMOL; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GREEN JM, 1995, J IMMUNOL, V155, P3759; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2005, J MOL BIOL, V350, P170, DOI 10.1016/j.jmb.2005.04.069; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SADEGHNASSERI S, 1992, IMMUNOL TODAY, V13, P43, DOI 10.1016/0167-5699(92)90131-P; Saito K, 2004, MICROBIOL IMMUNOL, V48, P53, DOI 10.1111/j.1348-0421.2004.tb03487.x; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; Vogt AB, 1997, IMMUNOL LETT, V57, P209, DOI 10.1016/S0165-2478(97)00061-8; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wilson N, 2001, IMMUNITY, V14, P513, DOI 10.1016/S1074-7613(01)00140-6; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	48	64	64	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					92	100		10.1038/ni1414	http://dx.doi.org/10.1038/ni1414			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17143275	Green Accepted			2022-12-18	WOS:000242934400018
J	Di Gioia, M; Spreafico, R; Springstead, JR; Mendelson, MM; Joehanes, R; Levy, D; Zanoni, I				Di Gioia, Marco; Spreafico, Roberto; Springstead, James R.; Mendelson, Michael M.; Joehanes, Roby; Levy, Daniel; Zanoni, Ivan			Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY MACROPHAGES; SUCCINATE-DEHYDROGENASE; GENE-EXPRESSION; DENDRITIC CELL; OXIDATION; ITACONATE; IMMUNITY; LINKS; MICE; TOLL-LIKE-RECEPTOR-4	Pathogen-associated molecular patterns (PAMPs) have the capacity to couple inflammatory gene expression to changes in macrophage metabolism, both of which influence subsequent inflammatory activities. Similar to their microbial counterparts, several self-encoded damage-associated molecular patterns (DAMPs) induce inflammatory gene expression. However, whether this symmetry in host responses between PAMPs and DAMPs extends to metabolic shifts is unclear. Here, we report that the self-encoded oxidized phospholipid oxPAPC alters the metabolism of macrophages exposed to lipopolysaccharide. While cells activated by lipopolysaccharide rely exclusively on glycolysis, macrophages exposed to oxPAPC also use mitochondrial respiration, feed the Krebs cycle with glutamine, and favor the accumulation of oxaloacetate in the cytoplasm. This metabolite potentiates interleukin-1 beta production, resulting in hyperinflammation. Similar metabolic adaptions occur in vivo in hypercholesterolemic mice and human subjects. Drugs that interfere with oxPAPC-driven metabolic changes reduce atherosclerotic plaque formation in mice, thereby underscoring the importance of DAMP-mediated activities in pathophysiological conditions.	[Di Gioia, Marco; Zanoni, Ivan] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Di Gioia, Marco; Zanoni, Ivan] Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Spreafico, Roberto] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci, Los Angeles, CA USA; [Springstead, James R.] Western Michigan Univ, Dept Chem & Paper Engn, Kalamazoo, MI 49008 USA; [Mendelson, Michael M.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Joehanes, Roby; Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zanoni, Ivan] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; Western Michigan University; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Milano-Bicocca	Zanoni, I (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Zanoni, I (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Zanoni, I (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	ivan.zanoni@childrens.harvard.edu	Levy, Daniel/ABB-2752-2021; Spreafico, Roberto/AAY-7867-2021; Levy, Daniel/ABF-6873-2021; Di Gioia, Marco/AAC-4192-2019	Spreafico, Roberto/0000-0001-8282-7658; Levy, Daniel/0000-0003-1843-8724; Di Gioia, Marco/0000-0001-9499-5771; Zanoni, Ivan/0000-0002-3423-7474	National Institutes of Health (NIH) [1R01AI121066, 1R01DK115217, NIAID-DAIT-NIHAI201700100]; NIH [1R15HL12177001A1, N01-HC-25195, HHSN268201500001I, K99HL136875]; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. Granucci, J. C. Kagan and L. R. Marek for discussions, help and support. R.S. thanks the UCLA QCBio Collaboratory community, directed by M. Pellegrini. I.Z. is supported by National Institutes of Health (NIH) grants 1R01AI121066, 1R01DK115217 and NIAID-DAIT-NIHAI201700100. J.R.S. is supported by NIH grant 1R15HL12177001A1. The FHS is funded by NIH contracts N01-HC-25195 and HHSN268201500001I. The laboratory work for the FHS investigation was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH, and by a Director's Challenge Award, NIH (principal investigator: D.L.). This study utilized the computational resources of the Biowulf system at the NIH in Bethesda, Maryland (http://hpc.nih.gov).M.M.M.is supported by NIH grant K99HL136875. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bailey JD, 2019, CELL REP, V28, P218, DOI 10.1016/j.celrep.2019.06.018; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Carnevale R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22076-4; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Hitzel J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04602-0; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6; Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Jung J, 2019, NAT CELL BIOL, V21, P85, DOI 10.1038/s41556-018-0217-x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim K, 2018, CIRC RES, V123, P1127, DOI 10.1161/CIRCRESAHA.118.312804; Koelwyn GJ, 2018, NAT IMMUNOL, V19, P526, DOI 10.1038/s41590-018-0113-3; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Philippova M, 2019, FREE RADICAL BIO MED, V144, P167, DOI 10.1016/j.freeradbiomed.2019.05.027; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sanin DE, 2018, IMMUNITY, V49, P1021, DOI 10.1016/j.immuni.2018.10.011; Serbulea V, 2018, P NATL ACAD SCI USA, V115, pE6254, DOI 10.1073/pnas.1800544115; Serbulea V, 2018, MOL METAB, V7, P23, DOI 10.1016/j.molmet.2017.11.002; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tavakoli S, 2017, ARTERIOSCL THROM VAS, V37, P1840, DOI 10.1161/ATVBAHA.117.308848; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; Wang FL, 2018, CELL METAB, V28, P463, DOI 10.1016/j.cmet.2018.08.012; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Yuan M, 2019, NAT PROTOC, V14, P313, DOI 10.1038/s41596-018-0102-x; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	57	63	64	7	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					42	+		10.1038/s41590-019-0539-2	http://dx.doi.org/10.1038/s41590-019-0539-2			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31768073	Green Accepted			2022-12-18	WOS:000515136500012
J	Hasegawa, T; Kikuta, J; Sudo, T; Matsuura, Y; Matsui, T; Simmons, S; Ebina, K; Hirao, M; Okuzaki, D; Yoshida, Y; Hirao, A; Kalinichenko, VV; Yamaoka, K; Takeuchi, T; Ishii, M				Hasegawa, Tetsuo; Kikuta, Junichi; Sudo, Takao; Matsuura, Yoshinobu; Matsui, Takahiro; Simmons, Szandor; Ebina, Kosuke; Hirao, Makoto; Okuzaki, Daisuke; Yoshida, Yuichi; Hirao, Atsushi; Kalinichenko, Vladimir V.; Yamaoka, Kunihiro; Takeuchi, Tsutomu; Ishii, Masaru			Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1	NATURE IMMUNOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTORS; INFLAMMATORY ARTHRITIS; RHEUMATOID-ARTHRITIS; MITOCHONDRIAL BIOGENESIS; BONE DESTRUCTION; DENDRITIC CELLS; M-CSF; MONOCYTES; FRACTALKINE	Osteoclasts have a unique bone-destroying capacity, playing key roles in steady-state bone remodeling and arthritic bone erosion. Whether the osteoclasts in these different tissue settings arise from the same precursor states of monocytoid cells is presently unknown. Here, we show that osteoclasts in pannus originate exclusively from circulating bone marrow-derived cells and not from locally resident macrophages. We identify murine CX(3)CR1(hi)Ly6C(int)F4/80(+)I-A(+)/I-E+ macrophages (termed here arthritis-associated osteoclastogenic macrophages (AtoMs)) as the osteoclast precursor-containing population in the inflamed synovium, comprising a subset distinct from conventional osteoclast precursors in homeostatic bone remodeling. Tamoxifen-inducible Foxml deletion suppressed the capacity of AtoMs to differentiate into osteoclasts in vitro and in vivo. Furthermore, synovial samples from human patients with rheumatoid arthritis contained CX(3)CR1(+)HLA-DR(hi)D11c(+)CD80(-)CD86(+) cells that corresponded to mouse AtoMs, and human osteoclastogenesis was inhibited by the FoxM1 inhibitor thiostrepton, constituting a potential target for rheumatoid arthritis treatment.	[Hasegawa, Tetsuo; Kikuta, Junichi; Sudo, Takao; Matsuura, Yoshinobu; Matsui, Takahiro; Simmons, Szandor; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan; [Hasegawa, Tetsuo; Yamaoka, Kunihiro; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Kikuta, Junichi; Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Ebina, Kosuke; Hirao, Makoto] Osaka Univ, Dept Orthopaed Surg, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Genome Informat Res Ctr, Microbial Dis Res Inst, Osaka, Japan; [Yoshida, Yuichi] Osaka Univ, Dept Gastroenterol & Hepatol, Osaka, Japan; [Hirao, Atsushi] Kanazawa Univ, WPI Nano Life Sci Inst, Canc Res Inst, Div Mol Genet, Kanazawa, Ishikawa, Japan; [Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Med Ctr, Ctr Lung Regenerat Med, Div Pulm Biol, Cincinnati, OH 45229 USA	Osaka University; Keio University; Osaka University; Osaka University; Osaka University; Osaka University; Kanazawa University; Cincinnati Children's Hospital Medical Center	Ishii, M (corresponding author), Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan.; Ishii, M (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan.	mishii@icb.med.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; Takeuchi, Tsutomu/L-2327-2013; Ebina, Kosuke/AAH-6171-2019; Takeuchi, Tsutomu/AFM-8316-2022	Okuzaki, Daisuke/0000-0002-4552-783X; Takeuchi, Tsutomu/0000-0003-1111-8218; Simmons, Szandor/0000-0002-5309-9863; Matsui, Takahiro/0000-0002-6753-1688	CREST at the Japan Science and Technology Agency [J170701506]; Japan Society for the Promotion of Science [19H056570, 15H056710]; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Sciences; Mochida Memorial Foundation; Takeda Science Foundation; PRIME at the Japan Agency for Medical Research and Development [19gm6210005h]	CREST at the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Sciences; Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); PRIME at the Japan Agency for Medical Research and Development	We thank R. N. Germain (NIAID/NIH, USA) for critically reviewing this manuscript. This work was supported by CREST at the Japan Science and Technology Agency (J170701506 to M. I.), Grants-in-Aid for Scientific Research (S) from the Japan Society for the Promotion of Science (19H056570 to M.I.), a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science (15H056710 to J.K.), and grants from the Uehara Memorial Foundation (to M.I.), Kanae Foundation for the Promotion of Medical Sciences (to M.I.), Mochida Memorial Foundation (to M.I.), Takeda Science Foundation (to M.I.) and PRIME at the Japan Agency for Medical Research and Development (19gm6210005h to J.K.).	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Ando W, 2006, J BONE MINER METAB, V24, P274, DOI 10.1007/s00774-006-0684-1; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Blaschke S, 2003, J RHEUMATOL, V30, P1918; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; CAMPBELL IK, 1993, BIOCHIM BIOPHYS ACTA, V1182, P57, DOI 10.1016/0925-4439(93)90153-R; Charles JF, 2012, J CLIN INVEST, V122, P4592, DOI 10.1172/JCI60920; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hasegawa T, 2017, JOINT BONE SPINE, V84, P379, DOI 10.1016/j.jbspin.2016.05.010; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/nchem.1114, 10.1038/NCHEM.1114]; Hutamekalin P, 2009, J IMMUNOL METHODS, V343, P49, DOI 10.1016/j.jim.2009.01.009; Ibanez L, 2016, J BONE MINER RES, V31, P1899, DOI 10.1002/jbmr.2868; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Murata K, 2017, IMMUNITY, V47, P66, DOI 10.1016/j.immuni.2017.06.018; Nakano K, 2007, RHEUMATOLOGY, V46, P597, DOI 10.1093/rheumatology/kel356; Nanki T, 2017, MOD RHEUMATOL, V27, P392, DOI 10.1080/14397595.2016.1213481; O'Brien W, 2016, ARTHRITIS RHEUMATOL, V68, P2889, DOI 10.1002/art.39837; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Seeling M, 2013, P NATL ACAD SCI USA, V110, P10729, DOI 10.1073/pnas.1301001110; Sucur A, 2014, INT ORTHOP, V38, P1893, DOI 10.1007/s00264-014-2386-y; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tanaka Y, 2018, MOD RHEUMATOL, V28, P58, DOI 10.1080/14397595.2017.1337056; Wakkach A, 2008, BLOOD, V112, P5074, DOI 10.1182/blood-2008-01-132787; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Werner D, 2017, ARTHRITIS RHEUMATOL, V69, P1580, DOI 10.1002/art.40148; Yokota K, 2014, ARTHRITIS RHEUMATOL, V66, P121, DOI 10.1002/art.38218; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	52	63	63	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1631	+		10.1038/s41590-019-0526-7	http://dx.doi.org/10.1038/s41590-019-0526-7			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31740799				2022-12-18	WOS:000497949800018
J	Zhu, C; Chen, W; Lou, JZ; Rittase, W; Li, KT				Zhu, Cheng; Chen, Wei; Lou, Jizhong; Rittase, William; Li, Kaitao			Mechanosensing through immunoreceptors	NATURE IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; CATCH BONDS; CONFORMATIONAL-CHANGES; MECHANICAL REGULATION; CYTOSKELETAL CONTROL; RECEPTOR; TCR; FORCE; KINETICS; TENSION	The immune response is orchestrated by a variety of immune cells. The function of each cell is determined by the collective signals from various immunoreceptors, whose expression and activity depend on the developmental stages of the cell and its environmental context. Recent studies have highlighted the presence of mechanical force on several immunoreceptor-ligand pairs and the important role of force in regulating their interaction and function. In this Perspective, we use the T cell antigen receptor as an example with which to review the current understanding of the mechanosensing properties of immunoreceptors. We discuss the types of forces that immunoreceptors may encounter and the effects of force on ligand bonding, conformational change and the triggering of immunoreceptors, as well as the effects of force on the downstream signal transduction, cell-fate decisions and effector function of immune cells.	[Zhu, Cheng; Rittase, William; Li, Kaitao] Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgie W Woodruff Sch Mech Engn, Atlanta, GA 30313 USA; [Zhu, Cheng; Rittase, William; Li, Kaitao] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Chen, Wei] Zhejiang Univ, Sch Med, Dept Neurobiol, Inst Neurosci,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Chen, Wei] Zhejiang Univ, Sch Med, Dept Cardiol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Lou, Jizhong] Chinese Acad Sci, Key Lab RNA Biol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing, Peoples R China	University System of Georgia; Georgia Institute of Technology; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, C (corresponding author), Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Zhu, C (corresponding author), Georgie W Woodruff Sch Mech Engn, Atlanta, GA 30313 USA.; Zhu, C (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu		Chen, Wei/0000-0001-5366-7253	US National Institutes of Health [U01CA214354, R01AI124680, R01GM122489, R21Al135753]; National Basic Research Program of China [2015CB910800, 2014CB910202]; National Science Foundation of China [31470900, 31522021, 11672317, 31222022]; NATIONAL CANCER INSTITUTE [U01CA214354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008433] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the US National Institutes of Health (U01CA214354, R01AI124680, R01GM122489 and R21Al135753 to C.Z.), from the National Basic Research Program of China (2015CB910800 to W.C. and 2014CB910202 to J.L.) and from the National Science Foundation of China (31470900 and 31522021 to W. C. and 11672317 and 31222022 to J.L.).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Aramesh M, 2019, CURR OPIN BIOMED ENG, V10, P134, DOI 10.1016/j.cobme.2019.05.004; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bashour KT, 2014, MOL CELL BIOL, V34, P955, DOI 10.1128/MCB.00842-13; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Basu R, 2017, TRENDS CELL BIOL, V27, P241, DOI 10.1016/j.tcb.2016.10.005; Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Brazin KN, 2018, IMMUNITY, V49, P829, DOI 10.1016/j.immuni.2018.09.007; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Brunner-Weinzierl MC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02737; Cai E, 2017, SCIENCE, V356, DOI 10.1126/science.aal3118; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen YF, 2017, MOL BIOL CELL, V28, P3134, DOI 10.1091/mbc.E17-04-0228; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Colin-York H, 2019, CELL REP, V26, P3369, DOI 10.1016/j.celrep.2019.02.074; Comrie WA, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00068; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; Elosegui-Artola A, 2018, TRENDS CELL BIOL, V28, P356, DOI 10.1016/j.tcb.2018.01.008; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Feng YN, 2018, TRENDS IMMUNOL, V39, P596, DOI 10.1016/j.it.2018.05.005; Feng YN, 2017, P NATL ACAD SCI USA, V114, pE8204, DOI 10.1073/pnas.1703559114; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hivroz C, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00046; Hong JS, 2018, NAT IMMUNOL, V19, P1379, DOI 10.1038/s41590-018-0259-z; Hong JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183174; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Hu KH, 2016, J CELL BIOL, V213, P535, DOI 10.1083/jcb.201511053; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hui KL, 2015, MOL BIOL CELL, V26, P685, DOI 10.1091/mbc.E14-03-0830; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Ju L, CURR OPIN CHEM BIOL; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Jung YM, 2016, P NATL ACAD SCI USA, V113, pE5916, DOI 10.1073/pnas.1605399113; Jurchenko C, 2015, MOL CELL BIOL, V35, P2570, DOI 10.1128/MCB.00195-15; Kim JK, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801332; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Klieger Y, 2014, EUR J IMMUNOL, V44, P58, DOI 10.1002/eji.201243099; Kolawole EM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02348; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; LaCroix AS, 2018, ELIFE, V7, DOI 10.7554/eLife.33927; Lee CY, 2013, P NATL ACAD SCI USA, V110, P5022, DOI 10.1073/pnas.1218407110; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Lever M, 2014, NAT REV IMMUNOL, V14, P619, DOI 10.1038/nri3728; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Liu BY, 2015, EUR J IMMUNOL, V45, P2099, DOI 10.1002/eji.201445358; Liu BY, 2015, ANNU REV PHYS CHEM, V66, P427, DOI 10.1146/annurev-physchem-040214-121742; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Liu CSC, 2018, J IMMUNOL, V200, P1255, DOI 10.4049/jimmunol.1701118; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Ma VPY, 2016, NANO LETT, V16, P4552, DOI 10.1021/acs.nanolett.6b01817; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Murugesan S, 2016, J CELL BIOL, V215, P383, DOI 10.1083/jcb.201603080; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Nishi H, 2017, J CLIN INVEST, V127, P3810, DOI 10.1172/JCI94039; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Pageon SV, 2018, MOL BIOL CELL, V29, P1919, DOI 10.1091/mbc.E18-02-0120; Pageon SV, 2016, P NATL ACAD SCI USA, V113, pE5454, DOI 10.1073/pnas.1607436113; Pielak RM, 2017, P NATL ACAD SCI USA, V114, P12190, DOI 10.1073/pnas.1613140114; Pryshchep S, 2014, J IMMUNOL, V193, P68, DOI 10.4049/jimmunol.1303436; Reinherz EL, 2015, TRENDS IMMUNOL, V36, P300, DOI 10.1016/j.it.2015.03.004; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Ringer P, 2017, NAT METHODS, V14, P1090, DOI [10.1038/NMETH.4431, 10.1038/nmeth.4431]; Rossy J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02638; Roy NH, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat3178; Saggu G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07506-1; Saitakis M, 2017, ELIFE, V6, DOI 10.7554/eLife.23190; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Shaheen S, 2017, ELIFE, V6, DOI 10.7554/eLife.23060; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Siller-Farfan JA, 2018, IMMUNOL REV, V285, P194, DOI 10.1111/imr.12690; Spillane KM, 2018, MOL IMMUNOL, V101, P319, DOI 10.1016/j.molimm.2018.07.018; Spillane KM, 2017, J CELL BIOL, V216, P217, DOI 10.1083/jcb.201607064; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tolar P, 2017, NAT REV IMMUNOL, V17, P621, DOI 10.1038/nri.2017.67; Upadhyaya A, 2017, SEMIN CELL DEV BIOL, V71, P137, DOI 10.1016/j.semcdb.2017.08.031; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wahl A, 2019, P NATL ACAD SCI USA, V116, P5908, DOI 10.1073/pnas.1811516116; Wan ZP, 2020, CELL IMMUNOL, V350, DOI 10.1016/j.cellimm.2019.103926; Wan ZP, 2018, J CELL BIOL, V217, P2565, DOI 10.1083/jcb.201711055; Wan ZP, 2015, ELIFE, V4, DOI 10.7554/eLife.06925; Wan ZP, 2013, J IMMUNOL, V190, P4661, DOI 10.4049/jimmunol.1202976; Wang JY, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai9192; Wu P, 2019, MOL CELL, V73, P1015, DOI 10.1016/j.molcel.2018.12.018; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yang W, 2017, NAT STRUCT MOL BIOL, V24, P1081, DOI 10.1038/nsmb.3489; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zarnitsyna V, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045005; Zeng YY, 2015, EUR J IMMUNOL, V45, P1621, DOI 10.1002/eji.201444777; Zhang Y, 2018, P NATL ACAD SCI USA, V115, P325, DOI 10.1073/pnas.1710828115; Zhu C, 2013, IMMUNOL REV, V251, P49, DOI 10.1111/imr.12016	120	63	65	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1269	1278		10.1038/s41590-019-0491-1	http://dx.doi.org/10.1038/s41590-019-0491-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31534240	Green Accepted			2022-12-18	WOS:000486615900011
J	Fang, J; Bolanos, LC; Choi, KM; Liu, XN; Christie, S; Akunuru, S; Kumar, R; Wang, DH; Chen, XT; Greis, KD; Stoilov, P; Filippi, MD; Maciejewski, JP; Garcia-Manero, G; Weirauch, MT; Salamonis, N; Geiger, H; Zheng, Y; Starczynowski, DT				Fang, Jing; Bolanos, Lyndsey C.; Choi, Kwangmin; Liu, Xiaona; Christie, Susanne; Akunuru, Shailaja; Kumar, Rupali; Wang, Dehua; Chen, Xiaoting; Greis, Kenneth D.; Stoilov, Peter; Filippi, Marie-Dominique; Maciejewski, Jaroslaw P.; Garcia-Manero, Guillermo; Weirauch, Matthew T.; Salamonis, Nathan; Geiger, Hartmut; Zheng, Yi; Starczynowski, Daniel T.			Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; CDC42 GTPASE; IN-VIVO; EXPRESSION; PROTEINS; REVEALS; GENE; A1; RECOGNITION	Toll-like receptor (TLR) activation contributes to premalignant hematologic conditions, such as myelodysplastic syndromes (MDS). TRAF6, a TLR effector with ubiquitin (Ub) ligase activity, is overexpressed in MDS hematopoietic stem/progenitor cells (HSPCs). We found that TRAF6 overexpression in mouse HSPC results in impaired hematopoiesis and bone marrow failure. Using a global Ub screen, we identified hnRNPA1, an RNA-binding protein and auxiliary splicing factor, as a substrate of TRAF6. TRAF6 ubiquitination of hnRNPA1 regulated alternative splicing of Arhgap1, which resulted in activation of the GTP-binding Rho family protein Cdc42 and accounted for hematopoietic defects in TRAF6-expressing HSPCs. These results implicate Ub signaling in coordinating RNA processing by TLR pathways during an immune response and in premalignant hematologic diseases, such as MDS.h	[Fang, Jing; Bolanos, Lyndsey C.; Choi, Kwangmin; Liu, Xiaona; Christie, Susanne; Akunuru, Shailaja; Kumar, Rupali; Filippi, Marie-Dominique; Geiger, Hartmut; Zheng, Yi; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Wang, Dehua] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Wang, Dehua] Cincinnati Childrens Hosp Med Ctr, Lab Med, Cincinnati, OH 45229 USA; [Chen, Xiaoting; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Greis, Kenneth D.; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Dept Canc Biol, Cincinnati, OH 45229 USA; [Stoilov, Peter] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Maciejewski, Jaroslaw P.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA; [Garcia-Manero, Guillermo] Maryland Anderson Canc Ctr, Dept Leukemia, Houston, TX USA; [Weirauch, Matthew T.; Salamonis, Nathan] Cincinnati Childrens Hosp Res Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Res Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Fang, Jing] Univ South Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; West Virginia University; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Canc Biol, Cincinnati, OH 45229 USA.	daniel.starczynowski@cchmc.org	Weirauch, Matthew/M-5459-2019	Bolanos, Lyndsey/0000-0002-5447-5277; Greis, Kenneth/0000-0002-5316-3351	Cincinnati Children's Hospital Research Foundation; American Society of Hematology (ASH); National Institute of Health [RO1HL111103, RO1DK102759, RO1HL114582]; Gabrielle's Angel Foundation for Cancer Research; Edward P. Evans Foundation grants; NIDDK Centers of Excellence in Experimental Hematology [P30DK090971]; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114582, R01HL111103, R35HL135787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971, R01DK102759] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation; American Society of Hematology (ASH); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; Edward P. Evans Foundation grants; NIDDK Centers of Excellence in Experimental Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Starczynowski laboratory for discussions. We thank J. Bailey and V. Summey for assistance with transplantations (Comprehensive Mouse and Cancer Core). We also thank L. Salati (West Virginia University) for advice on the RIP assays, and H. Singh (CCHMC) for helpful discussion. MDSL cells were kindly provided by K. Tohyama (Kawasaki Medical University). Traf6-floxed mice were kindly provided by Y. Choi (University of Pennsylvania). This work was supported by Cincinnati Children's Hospital Research Foundation, American Society of Hematology (ASH), National Institute of Health (RO1HL111103, RO1DK102759, RO1HL114582), Gabrielle's Angel Foundation for Cancer Research, and Edward P. Evans Foundation grants to D.T.S. D.T.S. is a Leukemia Lymphoma Society Scholar. Cores are supported through the NIDDK Centers of Excellence in Experimental Hematology (P30DK090971).	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dimicoli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071120; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Iglesias MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032306; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kristinsson SY, 2011, J CLIN ONCOL, V29, P2897, DOI 10.1200/JCO.2011.34.8540; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Ogilvy S, 1999, BLOOD, V94, P1855; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Varney ME, 2015, J EXP MED, V212, P1967, DOI 10.1084/jem.20141898; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Wei Y, 2013, LEUKEMIA, V27, P1832, DOI 10.1038/leu.2013.180; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang WJ, 2013, J BIOL CHEM, V288, P22636, DOI 10.1074/jbc.M113.463901	41	63	67	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					236	245		10.1038/ni.3654	http://dx.doi.org/10.1038/ni.3654			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28024152	Green Accepted			2022-12-18	WOS:000392360900017
J	Krammer, F; Palese, P				Krammer, Florian; Palese, Peter			Universal influenza virus vaccines: need for clinical trials	NATURE IMMUNOLOGY			English	Article							HEMAGGLUTININ STALK ANTIBODIES; PANDEMIC INFLUENZA; INFECTION; CELLS; VACCINATION; EFFICACY; PIGS		[Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA.	florian.krammer@mssm.edu; peter.palese@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Palese, Peter/0000-0002-0337-5823	NIAID NIH HHS [1P01AI097092-01A1] Funding Source: Medline; PHS HHS [HHSN26620070010C] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; Cowling BJ, 2012, CLIN INFECT DIS, V55, P695, DOI 10.1093/cid/cis518; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Miller MS, 2013, J INFECT DIS, V207, P98, DOI 10.1093/infdis/jis652; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Racaniello V, 2010, VIROLOGY BLOG; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Vincent AL, 2008, VET MICROBIOL, V126, P310, DOI 10.1016/j.vetmic.2007.07.011; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	31	63	63	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					3	5		10.1038/ni.2761	http://dx.doi.org/10.1038/ni.2761			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24352315	Bronze			2022-12-18	WOS:000328800500003
J	Ubelhart, R; Bach, MP; Eschbach, C; Wossning, T; Reth, M; Jumaa, H				Uebelhart, Rudolf; Bach, Martina P.; Eschbach, Cathrin; Wossning, Thomas; Reth, Michael; Jumaa, Hassan			N-linked glycosylation selectively regulates autonomous precursor BCR function	NATURE IMMUNOLOGY			English	Article							B-CELL RECEPTOR; SURROGATE LIGHT-CHAIN; ADAPTER PROTEIN SLP-65; PRE-B; SURFACE EXPRESSION; ANTIGEN RECEPTOR; IMMUNOGLOBULIN-M; MU-CHAIN; H-CHAIN; IGM	Developing B cells express distinct classes of B cell antigen receptors (BCRs) that differ in their heavy chain (HC). Although only mu HC is expressed in early stages, delta HC-containing BCRs dominate on the surface of mature B cells. The reason for the tightly regulated expression of these receptors is poorly understood. Here we show that mu HC was specifically required for precursor BCR (pre-BCR) function and that delta HC was unable to form a functional pre-BCR. A conserved asparagine (N)-linked glycosylation site at position 46 (N46) in the first conserved domain of mu HC was absolutely required for pre-BCR function, and swapping that domain with delta HC resulted in a functional delta HC-containing pre-BCR. When tested in the context of the BCR, mu HC with a mutant N46 showed normal function, which indicated that N46-glycosylation is specifically required for pre-BCR function. Our results suggest an unexpected mode of pre-BCR function, in which binding of the surrogate light chain to N46 mediates autonomous crosslinking and, concomitantly, receptor formation.	[Uebelhart, Rudolf; Bach, Martina P.; Eschbach, Cathrin; Wossning, Thomas; Reth, Michael; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signalling Studies, Freiburg, Germany; [Uebelhart, Rudolf; Bach, Martina P.; Eschbach, Cathrin; Wossning, Thomas; Reth, Michael; Jumaa, Hassan] Univ Freiburg, Dept Mol Immunol, Fac Biol, Freiburg, Germany; [Uebelhart, Rudolf; Bach, Martina P.; Eschbach, Cathrin; Wossning, Thomas; Reth, Michael; Jumaa, Hassan] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany; [Uebelhart, Rudolf] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany	University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg	Jumaa, H (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies, Freiburg, Germany.	jumaa@immunbio.mpg.de			Deutsche Forschungsgemeinschaft [SFB746, SFB 620]; German Federal and State Governments [GSC-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal and State Governments	We thank R.Y. Tsien (University of California) for tdTomato; A.G. Rolink (University of Basel) for phycoerythrin-biotin-anti-lambda 5; J.C. Cambier (National Jewish Medical and Research Center and University of Colorado Health Sciences Center) for anti-immunoglobulin-alpha; P.J. Nielsen and F. Kohler for reading the manuscript and discussions; A. Wuerch and S. Hobitz for help with cell sorting; and U. Stauffer, N. Joswig and C. Johner for mouse work. Supported by Deutsche Forschungsgemeinschaft (SFB746 and SFB 620) and the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School).	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Galler GR, 2004, J EXP MED, V199, P1523, DOI 10.1084/jem.20031523; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Guloglu FB, 2006, J IMMUNOL, V176, P6862, DOI 10.4049/jimmunol.176.11.6862; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KIM KM, 1995, J EXP MED, V181, P1005, DOI 10.1084/jem.181.3.1005; KIM KM, 1992, J IMMUNOL, V148, P29; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Lutz C, 1998, NATURE, V393, P797, DOI 10.1038/31716; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; MURAOKA S, 1989, J IMMUNOL, V142, P695; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Schuh W, 2003, J IMMUNOL, V171, P3343, DOI 10.4049/jimmunol.171.7.3343; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, J EXP MED, V198, P1699, DOI 10.1084/jem.20031428; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; ten Boekel E, 1998, IMMUNITY, V8, P199; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wang F, 2003, ANAL BIOCHEM, V314, P266, DOI 10.1016/S0003-2697(02)00693-0; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WRIGHT JF, 1990, J BIOL CHEM, V265, P10506	40	63	64	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					759	U130		10.1038/ni.1903	http://dx.doi.org/10.1038/ni.1903			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20622883				2022-12-18	WOS:000280149400018
J	Phee, H; Abraham, RT; Weiss, A				Phee, H; Abraham, RT; Weiss, A			Dynamic recruitment of PAK1 to the immunological synapse is mediated by PIX independently of SLP-76 and Vav1	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ANTIGEN RECEPTOR; P21-ACTIVATED KINASE; ACTIN CYTOSKELETON; ADAPTER PROTEINS; GENE-EXPRESSION; ACTIVATION; FAMILY; LAT; TCR	T cell receptor engagement activates p21-activated kinase 1 (PAK1) through a LAT - SLP- 76 - Nck - Vav- Rac - dependent pathway. A second independent pathway involving a GIT-PIX- PAK1 trimolecular complex is also activated by T cell receptor ligation. Here we show a Vav- independent pathway exists that leads to PAK1 activation. In addition, PAK1, PIX and GIT1 were recruited to the T cell - antigen-presenting cell contact site independently of SLP- 76 and Vav1. PAK1 recruitment to the T cell - antigen-presenting cell interface required interaction with PIX, which also led to optimal PLC-gamma 1 activation and T cell receptor - dependent transcriptional responses. These data indicate that a pathway involving the GIT-PIX- PAK1 complex has a crucial function in PAK1 activation by recruiting PAK1 to the immunological synapse.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; Burnham Inst, Program Signal Transduct Res, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Sanford Burnham Prebys Medical Discovery Institute	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu		Phee, Hyewon/0000-0002-1942-0414	NCI NIH HHS [CA72531] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072531] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chu PC, 2004, J IMMUNOL, V172, P7324, DOI 10.4049/jimmunol.172.12.7324; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; DeFranco AL, 2001, NAT IMMUNOL, V2, P482, DOI 10.1038/88669; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Jacobelli J, 2004, CURR OPIN IMMUNOL, V16, P345, DOI 10.1016/j.coi.2004.03.008; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Natarajan K, 2004, MOL PHARMACOL, V65, P822, DOI 10.1124/mol.65.4.822; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	53	63	66	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					608	617		10.1038/ni1199	http://dx.doi.org/10.1038/ni1199			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15864311				2022-12-18	WOS:000229385900016
J	Brandtzaeg, P; Baekkevold, ES; Morton, HC				Brandtzaeg, P; Baekkevold, ES; Morton, HC			From B to A the mucosal way	NATURE IMMUNOLOGY			English	Editorial Material							IGA PLASMA-CELLS; PEYERS-PATCHES; IMMUNE-RESPONSE; SMALL-INTESTINE; LAMINA PROPRIA; J-CHAIN; IMMUNOCYTES; PRECURSORS; SYSTEM		Univ Oslo, Rikshosp, Inst Pathol, LIIPAT, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Brandtzaeg, P (corresponding author), Univ Oslo, Rikshosp, Inst Pathol, LIIPAT, N-0027 Oslo, Norway.		Morton, H. Craig/H-8600-2012	Morton, H. Craig/0000-0002-9440-5759				Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; BRANDTZAEG P, 1974, NATURE, V252, P418, DOI 10.1038/252418a0; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; DunnWalters DK, 1997, EUR J IMMUNOL, V27, P463, DOI 10.1002/eji.1830270217; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; ENDERS GA, 1988, IMMUNOLOGY, V63, P411; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Farstad IN, 2000, IMMUNOLOGY, V101, P354, DOI 10.1046/j.1365-2567.2000.00118.x; HAMILTON SR, 1981, IMMUNOLOGY, V42, P431; HEATLEY RV, 1981, IMMUNOLOGY, V44, P543; Hiroi T, 2000, J IMMUNOL, V165, P4329, DOI 10.4049/jimmunol.165.8.4329; KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226; Kushnir N, 2001, J VIROL, V75, P5482, DOI 10.1128/JVI.75.12.5482-5490.2001; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; MAYRHOFER G, 1979, EUR J IMMUNOL, V9, P85, DOI 10.1002/eji.1830090118; STENSVOLD K, 1984, BRIT J HAEMATOL, V56, P417, DOI 10.1111/j.1365-2141.1984.tb03972.x; WILLIAMS AF, 1975, J EXP MED, V141, P335, DOI 10.1084/jem.141.2.335	19	63	68	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1093	1094		10.1038/ni1201-1093	http://dx.doi.org/10.1038/ni1201-1093			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725295				2022-12-18	WOS:000172473200007
J	Caputa, G; Castoldi, A; Pearce, EJ				Caputa, George; Castoldi, Angela; Pearce, Edward J.			Metabolic adaptations of tissue-resident immune cells	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; DENDRITIC CELL; FATTY-ACID; ORCHESTRATE DEVELOPMENT; MAJOR ORGANS; CRUCIAL ROLE; PPAR-GAMMA	Unlike other cells in the body, immune cells have to be able to enter and adapt to life within diverse tissues. Immune cells develop within dedicated immune system organs, such as the bone marrow, thymus and lymphoid tissues, but also inhabit other tissues, wherein they not only provide defense against infection and malignancies but also contribute to homeostatic tissue function. Because different tissues have widely divergent metabolic rates and fuel requirements, this raises interesting questions about the adaptation of immune cells in specific tissues. When immune cells take up residence in different tissues, they develop a transcriptional signature that reflects adaptation to life and function within that tissue. Genes encoding metabolic-pathway proteins are strongly represented within these signatures, reflective of the importance of metabolic adaptation to tissue residence. In this Review, we discuss the available data on the metabolic adaptation of immune cells to life in different tissue sites, within the broader framework of how functional adaptation versus maladaptation in the niche can affect tissue homeostasis.	[Caputa, George; Castoldi, Angela; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Pearce, Edward J.] Univ Freiburg, Freiburg, Germany	Max Planck Society; University of Freiburg	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Castoldi, Angela/K-1889-2015	Castoldi, Angela/0000-0002-8434-7989	US National Institutes of Health [AI110481]; Alexander von Humboldt Foundation; Max Planck Society	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck Society)	We thank E. Pearce and members of the Pearce laboratories for advice and discussions. Supported by grants from the US National Institutes of Health (AI110481 to E.J.P.) and the Alexander von Humboldt Foundation (A.C.) and by the Max Planck Society.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baker AD, 2010, J LIPID RES, V51, P1325, DOI 10.1194/jlr.M001651; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bettencourt IA, 2017, J IMMUNOL, V198, P999, DOI 10.4049/jimmunol.1601318; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carrero JA, 2017, P NATL ACAD SCI USA, V114, pE10418, DOI 10.1073/pnas.1713543114; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; COHN ZA, 1960, J EXP MED, V111, P689, DOI 10.1084/jem.111.5.689; Crosby CM, 2018, NAT REV IMMUNOL, V18, P559, DOI 10.1038/s41577-018-0034-2; Cuevas-Ramos D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00037; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Davies LC, 2019, J LEUKOCYTE BIOL, V105, P37, DOI 10.1002/JLB.4RI0518-195R; Davies LC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02092-0; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Divakaruni AS, 2018, CELL METAB, V28, P490, DOI 10.1016/j.cmet.2018.06.001; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Ferris ST, 2017, J EXP MED, V214, P2369, DOI 10.1084/jem.20170074; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Hallowell RW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14208; Han JM, 2015, J IMMUNOL, V194, P4777, DOI 10.4049/jimmunol.1500020; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang LH, 2019, CELL METAB, V29, P475, DOI 10.1016/j.cmet.2018.10.006; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Kalin S, 2017, CELL METAB, V26, P475, DOI 10.1016/j.cmet.2017.08.008; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li Q, 2018, IMMUNITY, V48, P258, DOI 10.1016/j.immuni.2017.12.013; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Mauro C, 2017, CELL METAB, V25, P593, DOI 10.1016/j.cmet.2017.01.008; McKinney EF, 2016, IMMUNOL CELL BIOL, V94, P935, DOI 10.1038/icb.2016.81; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2015, CURR OPIN IMMUNOL, V36, P67, DOI 10.1016/j.coi.2015.07.003; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; Postat J, 2018, IMMUNITY, V49, P654, DOI 10.1016/j.immuni.2018.07.014; Prajapati B, 2014, CURR DIABETES REV, V10, P190, DOI 10.2174/1573399810666140515112609; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; Ramani K, 2019, CYTOKINE, V120, P282, DOI 10.1016/j.cyto.2018.11.003; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Spinelli FR, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/6730421; Su CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22920-7; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Takikawa A, 2016, DIABETES, V65, P3649, DOI 10.2337/db16-0012; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Teixeira TFS, 2012, CLIN NUTR, V31, P735, DOI 10.1016/j.clnu.2012.02.009; Thwe PM, 2017, CELL METAB, V26, P558, DOI 10.1016/j.cmet.2017.08.012; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van den Bossche J, 2018, CELL IMMUNOL, V330, P54, DOI 10.1016/j.cellimm.2018.01.009; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang ZM, 2012, OBESITY, V20, P95, DOI 10.1038/oby.2011.256; Wang ZM, 2011, AM J HUM BIOL, V23, P333, DOI 10.1002/ajhb.21137; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang B, 2018, GENES CELLS, V23, P136, DOI 10.1111/gtc.12558; Zhang S, 2019, CELL METAB, V29, P443, DOI 10.1016/j.cmet.2018.12.004; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	122	62	64	4	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					793	801		10.1038/s41590-019-0407-0	http://dx.doi.org/10.1038/s41590-019-0407-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213715				2022-12-18	WOS:000471891900011
J	Russo, MV; Latour, LL; McGavern, DB				Russo, Matthew V.; Latour, Lawrence L.; McGavern, Dorian B.			Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury	NATURE IMMUNOLOGY			English	Article							BARRIER DISRUPTION; MACROPHAGE SUBSETS; MONOCYTE SUBSETS; SPINAL-CORD; IN-VIVO; TISSUE; CNS; NEUROPROTECTION; FIBRIN; MICE	Mild traumatic brain injury (mTBI) can cause meningeal vascular injury and cell death that spreads into the brain parenchyma and triggers local inflammation and recruitment of peripheral immune cells. The factors that dictate meningeal recovery after mTBI are unknown at present. Here we demonstrated that most patients who had experienced mTBI resolved meningeal vascular damage within 2-3 weeks, although injury persisted for months in a subset of patients. To understand the recovery process, we studied a mouse model of mTBI and found extensive meningeal remodeling that was temporally reliant on infiltrating myeloid cells with divergent functions. Inflammatory myelomonocytic cells scavenged dead cells in the lesion core, whereas wound-healing macrophages proliferated along the lesion perimeter and promoted angiogenesis through the clearance of fibrin and production of the matrix metalloproteinase MMP-2. Notably, a secondary injury experienced during the acute inflammatory phase aborted this repair program and enhanced inflammation, but a secondary injury experienced during the wound-healing phase did not. Our findings demonstrate that meningeal vasculature can undergo regeneration after mTBI that is dependent on distinct myeloid cell subsets.	[Russo, Matthew V.; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Russo, Matthew V.] Johns Hopkins Univ, Grad Partnership Program, Baltimore, MD USA; [Latour, Lawrence L.] NINDS, Acute Cerebrovasc Diagnost Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Latour, Larry/AAH-5663-2021; McGavern, Dorian/HCH-3601-2022	Latour, Larry/0000-0001-6160-5263; McGavern, Dorian/0000-0001-9568-545X	US National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003120, ZIANS003112] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the US National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS) and the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences, a collaborative effort among NIH, the Department of Defense, and Walter Reed National Military Medical Center to develop innovative approaches for brain injury diagnosis and recovery.	Adams RA, 2004, MOL INTERV, V4, P163; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Elkington Paul T., 2009, V531, P253, DOI 10.1007/978-1-59745-396-7_16; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Faust N, 2000, BLOOD, V96, P719; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hubbard NE, 2005, CELL IMMUNOL, V234, P102, DOI 10.1016/j.cellimm.2005.06.001; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Krause TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094313; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Manglani M, 2018, CURR PROTOC IMMUNOL, V120, P2421; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Motley MP, 2016, BLOOD, V127, P1085, DOI 10.1182/blood-2015-05-644260; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Weavers H, 2016, CURR BIOL, V26, P1975, DOI 10.1016/j.cub.2016.06.012; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	58	62	62	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					442	+		10.1038/s41590-018-0086-2	http://dx.doi.org/10.1038/s41590-018-0086-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29662169	Green Accepted			2022-12-18	WOS:000430562400008
J	Iwata, A; Durai, V; Tussiwand, R; Briseo, CG; Wu, XD; Grajales-Reyes, GE; Egawa, T; Murphy, TL; Murphy, KM				Iwata, Arifumi; Durai, Vivek; Tussiwand, Roxane; Briseo, Carlos G.; Wu, Xiaodi; Grajales-Reyes, Gary E.; Egawa, Takeshi; Murphy, Theresa L.; Murphy, Kenneth M.			Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER B; CELL-DIFFERENTIATION; REGULATORY NETWORK; IRF4; EXPANSION; REVEALS	Variable strengths of signaling via the T cell antigen receptor (TCR) can produce divergent outcomes, but the mechanism of this remains obscure. The abundance of the transcription factor IRF4 increases with TCR signal strength, but how this would induce distinct types of responses is unclear. We compared the expression of genes in the TH2 subset of helper T cells to enhancer occupancy by the BATF-IRF4 transcription factor complex at varying strengths of TCR stimulation. Genes dependent on BATF-IRF4 clustered into groups with distinct TCR sensitivities. Enhancers exhibited a spectrum of occupancy by the BATF-IRF4 ternary complex that correlated with the sensitivity of gene expression to TCR signal strength. DNA sequences immediately flanking the previously defined AICE motif controlled the affinity of BATF-IRF4 for direct binding to DNA. Analysis by the chromatin immunoprecipitation-exonuclease (ChIP-exo) method allowed the identification of a previously unknown high-affinity AICE2 motif at a human single-nucleotide polymorphism (SNP) of the gene encoding the immunomodulatory receptor CTLA-4 that was associated with resistance to autoimmunity. Thus, the affinity of different enhancers for the BATF-IRF4 complex might underlie divergent signaling outcomes in response to various strengths of TCR signaling.	[Iwata, Arifumi; Durai, Vivek; Briseo, Carlos G.; Wu, Xiaodi; Grajales-Reyes, Gary E.; Egawa, Takeshi; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Tussiwand, Roxane] Univ Basel, Dept Biomed, Basel, Switzerland; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Basel; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu		Briseno, Carlos/0000-0002-4159-3864; Egawa, Takeshi/0000-0001-7489-1051; Tussiwand, Roxane/0000-0002-1712-868X	Howard Hughes Medical Institute; US National Institutes of Health [RO1 AI097244-01A1, F30DK108498, 1F31CA189491-01]; NATIONAL CANCER INSTITUTE [F31CA189491, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244, R56AI114593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108498] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. Supported by the Howard Hughes Medical Institute (K.M.M.) and the US National Institutes of Health (RO1 AI097244-01A1 to T.E., F30DK108498 to V.D., 1F31CA189491-01 to G.E.G.-R.).	Allison KA, 2016, ELIFE, V5, DOI 10.7554/eLife.10134; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Chen M, 2010, NAT REV RHEUMATOL, V6, P653, DOI 10.1038/nrrheum.2010.158; Chung SA, 2012, ARTHRITIS RHEUM-US, V64, P3463, DOI 10.1002/art.34496; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lenardo M, 2016, ANNU REV IMMUNOL, V34, P121, DOI 10.1146/annurev-immunol-041015-055620; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mayya V, 2016, TRENDS IMMUNOL, V37, P513, DOI 10.1016/j.it.2016.06.005; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nayar R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144826; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Tubo NJ, 2014, TRENDS IMMUNOL, V35, P591, DOI 10.1016/j.it.2014.09.008; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	40	62	62	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					563	572		10.1038/ni.3714	http://dx.doi.org/10.1038/ni.3714			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28346410	Green Accepted			2022-12-18	WOS:000399378700013
J	Shen, XL; Burguillos, MA; Osman, AM; Frijhoff, J; Carrillo-Jimenez, A; Kanatani, S; Augsten, M; Saidi, D; Rodhe, J; Kavanagh, E; Rongvaux, A; Rraklli, V; Nyman, U; Holmberg, J; Ostman, A; Flavell, RA; Barragan, A; Venero, JL; Blomgren, K; Joseph, B				Shen, Xianli; Burguillos, Miguel A.; Osman, Ahmed M.; Frijhoff, Jeroen; Carrillo-Jimenez, Alejandro; Kanatani, Sachie; Augsten, Martin; Saidi, Dalel; Rodhe, Johanna; Kavanagh, Edel; Rongvaux, Anthony; Rraklli, Vilma; Nyman, Ulrika; Holmberg, Johan; Ostman, Arne; Flavell, Richard A.; Barragan, Antonio; Venero, Jose Luis; Blomgren, Klas; Joseph, Bertrand			Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype	NATURE IMMUNOLOGY			English	Article							S-NITROSYLATION; NITRIC-OXIDE; PERIPHERAL MACROPHAGES; RESIDENT MICROGLIA; CELLS; ACTIVATION; INVASIVENESS; THIOREDOXIN; GROWTH	Glioma cells recruit and exploit microglia (the resident immune cells of the brain) for their proliferation and invasion ability. The underlying molecular mechanism used by glioma cells to transform microglia into a tumor-supporting phenotype has remained elusive. We found that glioma-induced microglia conversion was coupled to a reduction in the basal activity of microglial caspase-3 and increased S-nitrosylation of mitochondria-associated caspase-3 through inhibition of thioredoxin-2 activity, and that inhibition of caspase-3 regulated microglial tumor-supporting function. Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity. Repression of glioma NOS2 expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth. Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells.	[Shen, Xianli; Burguillos, Miguel A.; Frijhoff, Jeroen; Augsten, Martin; Saidi, Dalel; Rodhe, Johanna; Kavanagh, Edel; Ostman, Arne; Joseph, Bertrand] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Osman, Ahmed M.; Blomgren, Klas] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Osman, Ahmed M.; Blomgren, Klas] Karolinska Univ Hosp, Dept Pediat Oncol, Stockholm, Sweden; [Carrillo-Jimenez, Alejandro; Venero, Jose Luis] Univ Seville, Dept Bioquim & Biol Mol, Seville, Spain; [Carrillo-Jimenez, Alejandro; Venero, Jose Luis] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Seville, Spain; [Kanatani, Sachie; Barragan, Antonio] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Kanatani, Sachie; Barragan, Antonio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Rongvaux, Anthony; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Rraklli, Vilma; Nyman, Ulrika; Holmberg, Johan] Karolinska Inst, Ludwig Inst Canc Res, Dept Cell & Mol Biol, Stockholm, Sweden; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Burguillos, Miguel A.] Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Frijhoff, Jeroen] CARIM, Dept Pharmacol & Personalized Med, Maastricht, Netherlands; [Augsten, Martin] German Canc Res Ctr, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Rongvaux, Anthony] Fred Hutchinson Canc Ctr, Program Immunol, Seattle, WA USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Karolinska Institutet; Stockholm University; Yale University; Karolinska Institutet; Ludwig Institute for Cancer Research; Howard Hughes Medical Institute; Yale University; University of London; Queen Mary University London; Maastricht University; Maastricht University Medical Centre (MUMC); Helmholtz Association; German Cancer Research Center (DKFZ); Fred Hutchinson Cancer Center	Joseph, B (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden.	bertrand.joseph@ki.se	Shen, Xianli/AAZ-2229-2021; Barragan, Antonio/P-6278-2015; Barragan, Antonio/AAL-8618-2020; Burguillos, Miguel/N-4806-2019; IBIS, ENVEJECIMIENTO/O-9381-2015; CARRILLO JIMENEZ, ALEJANDRO/H-9351-2015	Shen, Xianli/0000-0003-4375-2993; Barragan, Antonio/0000-0001-7746-9964; Barragan, Antonio/0000-0001-7746-9964; Burguillos, Miguel/0000-0002-3165-9997; Blomgren, Klas/0000-0002-0476-7271; Joseph, Bertrand/0000-0001-5655-9979; , Ahmed/0000-0002-5255-2136; kanatani, sachie/0000-0002-7072-0447; CARRILLO JIMENEZ, ALEJANDRO/0000-0002-3023-4268	Knut and Alice Wallenberg Foundation; Karolinska Institutet Foundation; Swedish Childhood Cancer Foundation; Swedish Research Council; Strategic Research Programme in Cancer; Strategic Research Programme in Neuroscience; Swedish Cancer Foundation; Spanish MINECO/FEDER/UE; Swedish Cancer Society; Swedish Brain Foundation; Swedish governmental grants; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet Foundation(Karolinska Institutet); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Cancer; Strategic Research Programme in Neuroscience; Swedish Cancer Foundation; Spanish MINECO/FEDER/UE; Swedish Cancer Society(Swedish Cancer Society); Swedish Brain Foundation; Swedish governmental grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Brown (University of Cambridge) for the BV2 cell line; R. Glass (Max Delbruck Center) for the GL261 cell line; O. Hermanson (Karolinska Institutet) for the C6 cell line; M. Nister (Karolinska Institutet) for the U-251MG, U-343MG, U-373MG, U-87MG and U-1241MG cell lines; M. Schultzberg (Karolinska Institutet) for the CHME3 cell line; and the CLICK Imaging Facility (supported by the Knut and Alice Wallenberg Foundation) for technical support. Supported by the Karolinska Institutet Foundation (X.S. and B.J.), the Swedish Childhood Cancer Foundation (A.M.O., B.J. and K.B.), the Swedish Research Council (M.A.B. and B.J.), the Strategic Research Programme in Cancer (B.J.), the Strategic Research Programme in Neuroscience (K.B.), the Swedish Cancer Foundation (B.J.), Spanish MINECO/FEDER/UE (J.L.V.), the Swedish Cancer Society (B.J.), the Swedish Brain Foundation (B.).) and Swedish governmental grants for researchers working in healthcare (K.B.).	Badn W, 2010, CURR PHARM DESIGN, V16, P428, DOI 10.2174/138161210790232158; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Brandenburg S, 2016, ACTA NEUROPATHOL, V131, P365, DOI 10.1007/s00401-015-1529-6; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kavanagh E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.514; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Muller A, 2015, INT J CANCER, V137, P278, DOI 10.1002/ijc.29379; Oh T, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-107; Ostrom QT, 2015, CANCER TREAT RES, V163, P1, DOI 10.1007/978-3-319-12048-5_1; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Tanaka K, 2014, LIFE SCI, V100, P85, DOI 10.1016/j.lfs.2014.01.079; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Voisin Pierre, 2010, Front Neuroenergetics, V2, P131, DOI 10.3389/fnene.2010.00131; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wang JY, 2014, NEUROSCI BULL, V30, P667, DOI 10.1007/s12264-014-1454-4; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zhang J, 2012, CARCINOGENESIS, V33, P312, DOI 10.1093/carcin/bgr289	39	62	62	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1282	1290		10.1038/ni.3545	http://dx.doi.org/10.1038/ni.3545			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27618552	Green Submitted			2022-12-18	WOS:000386193200008
J	Sellars, M; Huh, JR; Day, K; Issuree, PD; Galan, C; Gobeil, S; Absher, D; Green, MR; Littman, DR				Sellars, MacLean; Huh, Jun R.; Day, Kenneth; Issuree, Priya D.; Galan, Carolina; Gobeil, Stephane; Absher, Devin; Green, Michael R.; Littman, Dan R.			Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages	NATURE IMMUNOLOGY			English	Article							RUNX PROTEINS; 5-METHYLCYTOSINE; DNMT3A; 5-FORMYLCYTOSINE; DIFFERENTIATION; COMMITMENT; REPRESSION; CHOICE; SYSTEM; LEADS	During development, progenitor cells with binary potential give rise to daughter cells that have distinct functions. Heritable epigenetic mechanisms then lock in gene-expression programs that define lineage identity. Regulation of the gene encoding the T cell-specific coreceptor CD4 in helper and cytotoxic T cells exemplifies this process, with enhancer- and silencer-regulated establishment of epigenetic memory for stable gene expression and repression, respectively. Using a genetic screen, we identified the DNA-methylation machinery as essential for maintaining silencing of Cd4 in the cytotoxic lineage. Furthermore, we found a requirement for the proximal enhancer in mediating the removal of DNA-methylation marks from Cd4, which allowed stable expression of Cd4 in helper T cells. Our findings suggest that stage-specific methylation and demethylation events in Cd4 regulate its heritable expression in response to the distinct signals that dictate lineage 'choice' during T cell development.	[Sellars, MacLean; Huh, Jun R.; Issuree, Priya D.; Galan, Carolina; Littman, Dan R.] NYU, Kimmel Ctr Biol & Med, Skirball Inst, Sch Med, New York, NY 11201 USA; [Sellars, MacLean; Huh, Jun R.; Issuree, Priya D.; Galan, Carolina; Littman, Dan R.] NYU, Howard Hughes Med Inst, Sch Med, New York, NY USA; [Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Day, Kenneth; Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Gobeil, Stephane; Green, Michael R.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Gobeil, Stephane; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA	New York University; Howard Hughes Medical Institute; New York University; University of Massachusetts System; University of Massachusetts Worcester; HudsonAlpha Institute for Biotechnology; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Littman, DR (corresponding author), NYU, Kimmel Ctr Biol & Med, Skirball Inst, Sch Med, New York, NY 11201 USA.	dan.littman@med.nyu.edu		Day, Kenneth/0000-0001-8235-8302; Issuree, Priya/0000-0002-8886-6436	US National Institutes of Health [R00DK091508, 5 T32 CA009161-36, GM033977]; Jane Coffin Childs Fund; Cancer Research Institute; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK091508, R00DK091508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Fund; Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Jaenisch (Whitehead Institute for Biomedical Research) for Dnmt1<SUP>L2</SUP> and Dnmt1<SUP>chip</SUP> mouse strains; the University of Massachusetts Medical School RNAi Core Facility for shRNAs; A. Cuesta and A. Chen for technical help; and members of the Littman laboratory for discussion. Supported by the US National Institutes of Health (R00DK091508 to J.R.H., 5 T32 CA009161-36 to M.S., and GM033977 to M.R.G.), the Jane Coffin Childs Fund (J.R.H.), the Cancer Research Institute (M.S. and P.D.I.) and the Howard Hughes Medical Institute (M.R.G. and D.R.L.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cheng CK, 2011, BLOOD, V118, P6638, DOI 10.1182/blood-2011-05-354712; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; Day K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111756; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gialitakis M, 2012, CURR TOP MICROBIOL, V356, P165, DOI 10.1007/82_2011_175; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Henson DM, 2014, J IMMUNOL, V192, P4620, DOI 10.4049/jimmunol.1302374; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jimenez-Useche I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02121; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Penit C, 1997, J IMMUNOL, V159, P4848; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	42	62	63	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					746	+		10.1038/ni.3198	http://dx.doi.org/10.1038/ni.3198			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26030024	Green Accepted			2022-12-18	WOS:000356445600011
J	Ramond, C; Berthault, C; Burlen-Defranoux, O; de Sousa, AP; Guy-Grand, D; Vieira, P; Pereira, P; Cumano, A				Ramond, Cyrille; Berthault, Claire; Burlen-Defranoux, Odile; de Sousa, Ana Pereira; Guy-Grand, Delphine; Vieira, Paulo; Pereira, Pablo; Cumano, Ana			Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE PRECURSOR CELLS; T-CELL; MYELOID LINEAGE; CYCLIC RENEWAL; STEM-CELLS; NOTCH; IDENTIFICATION; ADULT; COMMITMENT; THYMOCYTES	The generation of T cells depends on the migration of hematopoietic progenitor cells to the thymus throughout life. The identity of the thymus-settling progenitor cells has been a matter of considerable debate. Here we found that thymopoiesis was initiated by a first wave of T cell lineage-restricted progenitor cells with limited capacity for population expansion but accelerated differentiation into mature T cells. They gave rise to alpha beta and gamma delta T cells that constituted V(gamma)3(+) dendritic epithelial T cells. Thymopoiesis was subsequently maintained by less-differentiated progenitor cells that retained the potential to develop into B cells and myeloid cells. In that second wave, which started before birth, progenitor cells had high proliferative capacity but delayed differentiation capacity and no longer gave rise to embryonic gamma delta T cells. Our work reconciles conflicting hypotheses on the nature of thymus-settling progenitor cells.	[Ramond, Cyrille; Berthault, Claire; Burlen-Defranoux, Odile; de Sousa, Ana Pereira; Guy-Grand, Delphine; Vieira, Paulo; Pereira, Pablo; Cumano, Ana] INSERM, Dept Immunol, Unit Lymphopoiesis, U668, Paris, France; [Ramond, Cyrille] Univ Paris 06, Paris, France; [Berthault, Claire] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Cumano, A (corresponding author), INSERM, Res Ctr Growth & Signaling, Fac Inst Cochin, U845, Paris, France.	ana.cumano@pasteur.fr	VOUGNY, Marie-Christine/K-8938-2017; Pereira, Pablo/M-7224-2014	Berthault, Claire/0000-0001-6848-0993; Pereira, Pablo/0000-0003-1784-2776; Vieira, Paulo/0000-0003-1307-5119	Pasteur Institute; INSERM; Agence Nationale de Recherche (grant 'Lymphopoiesis'); REVIVE Future Investment Program; La Ligue contre le Cancer	Pasteur Institute; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche (grant 'Lymphopoiesis')(French National Research Agency (ANR)); REVIVE Future Investment Program; La Ligue contre le Cancer(Ligue nationale contre le cancer)	We thank F. Melchers (Berlin, Germany) for myeloma cell lines transfected with cytokine-encoding cDNA; I. Prinz (Hannover, Germany) and R. Tigelaar (London, UK) for antibody 17D1; A Bandeira for critical reading of the manuscript and advice; the Freitas laboratory (Pasteur Institute) for Cd3<SUP>-/-</SUP> mice; A. Louise, P.-H. Commere and M. Nguyen from the flow cytometry core facility of the Pasteur Institute for technical advice; the staff of the animal facility of the Pasteur Institute for mouse care; V. Villaret and B. Gerstmayer for whole-mouse genome microarrays; and P. de la Grange for biostatistical analysis. Supported by the Pasteur Institute, INSERM, Agence Nationale de Recherche (grant 'Lymphopoiesis' to A.C.), the REVIVE Future Investment Program (A.C.) and La Ligue contre le Cancer (A.C. and C.R.).	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Belyaev NN, 2012, IMMUNOGENETICS, V64, P591, DOI 10.1007/s00251-012-0620-6; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Jin YH, 2009, BBA-MOL CELL RES, V1793, P290, DOI 10.1016/j.bbamcr.2008.10.002; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; JOTEREAU FV, 1982, J IMMUNOL, V129, P1869; Kawamoto H, 1998, J IMMUNOL, V161, P3799; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Luche H, 2013, J EXP MED, V210, P699, DOI 10.1084/jem.20122609; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Wurbel MA, 2006, EUR J IMMUNOL, V36, P73, DOI 10.1002/eji.200535203; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	50	62	63	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					27	35		10.1038/ni.2782	http://dx.doi.org/10.1038/ni.2782			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24317038				2022-12-18	WOS:000328800500009
J	De Obaldia, ME; Bell, JJ; Wang, XX; Harly, C; Yashiro-Ohtani, Y; DeLong, JH; Zlotoff, DA; Sultana, DA; Pear, WS; Bhandoola, A				De Obaldia, Maria Elena; Bell, J. Jeremiah; Wang, Xinxin; Harly, Christelle; Yashiro-Ohtani, Yumi; DeLong, Jonathan H.; Zlotoff, Daniel A.; Sultana, Dil Afroz; Pear, Warren S.; Bhandoola, Avinash			T cell development requires constraint of the myeloid regulator C/EBP-alpha by the Notch target and transcriptional repressor Hes1	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX FACTORS; DENDRITIC CELLS; LINEAGE SPECIFICATION; CHROMOSOMAL LOCUS; DROSOPHILA-HAIRY; B-CELL; PROGENITORS; ENHANCER; GENE; EXPRESSION	Notch signaling induces gene expression of the T cell lineage and discourages alternative fate outcomes. Hematopoietic deficiency in the Notch target Hes1 results in severe T cell lineage defects; however, the underlying mechanism is unknown. We found here that Hes1 constrained myeloid gene-expression programs in T cell progenitor cells, as deletion of the myeloid regulator C/EBP-alpha restored the development of T cells from Hes1-deficient progenitor cells. Repression of Cebpa by Hes1 required its DNA-binding and Groucho-recruitment domains. Hes1-deficient multipotent progenitor cells showed a developmental bias toward myeloid cells and dendritic cells after Notch signaling, whereas Hes1-deficient lymphoid progenitor cells required additional cytokine signaling for diversion into the myeloid lineage. Our findings establish the importance of constraining developmental programs of the myeloid lineage early in T cell development.	[De Obaldia, Maria Elena; Bell, J. Jeremiah; Wang, Xinxin; Harly, Christelle; Yashiro-Ohtani, Yumi; DeLong, Jonathan H.; Zlotoff, Daniel A.; Sultana, Dil Afroz; Pear, Warren S.; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; De Obaldia, Maria/0000-0003-2488-3672; Harly, Christelle/0000-0002-8045-9166	US National Institutes of Health [AI059621, AI098428, AI047833, T32 GM-007229, T32 CA-009140, 1-F32-AI-080091-01A1, F30-HL-099271]; NATIONAL CANCER INSTITUTE [P30CA016520, T32CA009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098428, R56AI059621, R01AI047833, R01AI059621, F32AI080091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Raetzman (University of Illinois at Urbana-Champaign) for Hes1<SUP>-/-</SUP> mice (used with permission from R. Kageyama (Kyoto University Institute for Virus Research)); P. Zweidler-McKay (University of Texas MD Anderson Cancer Center) for mutant Hes1 constructs; A. Chi for advice on the design of luciferase reporter constructs; and N. Speck, D. Allman, S. Reiner, Q. Yang, S. Zhang, W. Bailis and D. Northrup for critical comments on the manuscript. Supported by the US National Institutes of Health (AI059621 and AI098428 to A. B., AI047833 to W. S. P., T32 GM-007229 and T32 CA-009140 to M. E. D., 1-F32-AI-080091-01A1 to J.J.B. and F30-HL-099271 to D.A.Z.).	ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Obaldia ME, 2013, BLOOD, V121, P64, DOI 10.1182/blood-2012-08-451773; de Pooter RF, 2006, J IMMUNOL, V176, P5267, DOI 10.4049/jimmunol.176.9.5267; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Welner RS, 2013, BLOOD, V121, P4073, DOI 10.1182/blood-2012-10-463448; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang P, 2010, ONCOGENE, V29, P2916, DOI 10.1038/onc.2010.62	50	62	64	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1277	+		10.1038/ni.2760	http://dx.doi.org/10.1038/ni.2760			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24185616	Green Accepted			2022-12-18	WOS:000327149400013
J	Jankovic, D; Trinchieri, G				Jankovic, Dragana; Trinchieri, Giorgio			IL-10 or not IL-10: that is the question	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INTERLEUKIN-10; INFLAMMATION	Four new papers focused on how interleukin 10-producing cells are induced have led to some unexpected and intriguing observations on the nature of interleukin 17-producing T helper cells.	NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NCI, Tumor Immunobiol Sect, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jankovic, D (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	trinchig@mail.nih.gov	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464				Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104	9	62	67	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1281	1283		10.1038/ni1207-1281	http://dx.doi.org/10.1038/ni1207-1281			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026076				2022-12-18	WOS:000251267000005
J	Li, PC; Jiang, MD; Li, KT; Li, H; Zhou, YZ; Xiao, XY; Xu, Y; Krishfield, S; Lipsky, PE; Tsokos, GC; Zhang, X				Li, Pengchong; Jiang, Mengdi; Li, Ketian; Li, Hao; Zhou, Yangzhong; Xiao, Xinyue; Xu, Yue; Krishfield, Suzanne; Lipsky, Peter E.; Tsokos, George C.; Zhang, Xuan			Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity	NATURE IMMUNOLOGY			English	Article							LUPUS-ERYTHEMATOSUS; CELL-DEATH; EXTRACELLULAR TRAPS; DISEASE; EXPRESSION; CREM; CLASSIFICATION; INCREASES; CRITERIA; DAMAGE	Zhang and colleagues identify a role for cell death by glutathione peroxidase 4 (GPX4)-regulated ferroptosis in neutrophils from patients with systemic lupus erythematosus, which is triggered by type I interferons and autoreactive antibodies and contributes to lupus pathogenesis. Inhibiting accumulation of oxidative mediators by GPX4 suppresses ferroptosis. The linkage between neutrophil death and the development of autoimmunity has not been thoroughly explored. Here, we show that neutrophils from either lupus-prone mice or patients with systemic lupus erythematosus (SLE) undergo ferroptosis. Mechanistically, autoantibodies and interferon-alpha present in the serum induce neutrophil ferroptosis through enhanced binding of the transcriptional repressor CREM alpha to the glutathione peroxidase 4 (Gpx4, the key ferroptosis regulator) promoter, which leads to suppressed expression of Gpx4 and subsequent elevation of lipid-reactive oxygen species. Moreover, the findings that mice with neutrophil-specific Gpx4 haploinsufficiency recapitulate key clinical features of human SLE, including autoantibodies, neutropenia, skin lesions and proteinuria, and that the treatment with a specific ferroptosis inhibitor significantly ameliorates disease severity in lupus-prone mice reveal the role of neutrophil ferroptosis in lupus pathogenesis. Together, our data demonstrate that neutrophil ferroptosis is an important driver of neutropenia in SLE and heavily contributes to disease manifestations.	[Li, Pengchong; Jiang, Mengdi; Li, Ketian; Xiao, Xinyue] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China; [Li, Pengchong; Jiang, Mengdi; Li, Ketian; Xu, Yue] Chinese Acad Med Sci & Peking Union Med Coll, Clin Immunol Ctr, Beijing, Peoples R China; [Li, Hao; Krishfield, Suzanne; Tsokos, George C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Zhou, Yangzhong] Chinese Acad Med Sci & Peking Union Med Coll, Dept Internal Med, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Lipsky, Peter E.] RILITE Res Inst, Charlottesville, VA 28217 USA; [Lipsky, Peter E.] AMPEL BioSolut, Charlottesville, VA 28217 USA; [Zhang, Xuan] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Dept Rheumatol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Tsokos, GC (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.; Lipsky, PE (corresponding author), RILITE Res Inst, Charlottesville, VA 28217 USA.; Lipsky, PE (corresponding author), AMPEL BioSolut, Charlottesville, VA 28217 USA.; Zhang, X (corresponding author), Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Dept Rheumatol, Beijing, Peoples R China.	peterlipsky@comcast.net; gtsokos@bidmc.harvard.edu; zxpumch2003@sina.com	Zhang, Xiaoyu/GQQ-1959-2022; zhang, xuan/AAN-9914-2020; zhang, xu/GRX-9733-2022; zhang, xuan/GQO-8953-2022; zhang, xiang/GQI-2806-2022; Tsokos, George/O-3360-2013	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; Lipsky, Peter/0000-0002-9287-1676; Li, Pengchong/0000-0002-7347-9652; Tsokos, George/0000-0001-9589-2360	National Natural Science Foundation of China [81788101, 81630044]; Chinese Academy of Medical Science Innovation Fund for Medical Sciences [CIFMS2016-12M-1-003, 2017-12M-1-008, 2017-I2M-3-011, 2016-12M-1-008]; Capital's Funds for Health Improvement and Research [2020-2-4019]; NIH [R01AR064350, R37AI049954]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Science Innovation Fund for Medical Sciences; Capital's Funds for Health Improvement and Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Natural Science Foundation of China grants no. 81788101 (to X.Z.) and no. 81630044 (to X.Z.); Chinese Academy of Medical Science Innovation Fund for Medical Sciences grants no. CIFMS2016-12M-1-003 (to X.Z.), no. 2017-12M-1-008 (to X.Z.), no. 2017-I2M-3-011 (to X.Z.) and no. 2016-12M-1-008 (to X.Z.); Capital's Funds for Health Improvement and Research (grant no. 2020-2-4019) (to X.Z.); and NIH grants no. R01AR064350 (to G.C.T) and no. R37AI049954 (to G.C.T). We thank A. Davidson at Feinstein Institutes for Medical Research for providing the adenovirus IFN-alpha. We thank the staff of the Rheumatology and Immunology Laboratory and Medical Scientific Research Center in Peking Union Medical College Hospital (PUMCH) for providing experimental equipment. We thank the doctors at PUMCH, Anyang District Hospital of Henan Province, Xiangya Hospital, Huaian No.1 People's Hospital and People's Hospital of Xinjiang Uygur Autonomous Region for patient recruitment.	Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bosch X, 2011, NEW ENGL J MED, V365, P758, DOI 10.1056/NEJMcibr1107085; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Davatchi F, 2014, J EUR ACAD DERMATOL, V28, P338, DOI 10.1111/jdv.12107; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; DUBOIS EL, 1966, J AMER MED ASSOC, V195, P285, DOI 10.1001/jama.195.4.285; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Hedrich CM, 2012, P NATL ACAD SCI USA, V109, P16606, DOI 10.1073/pnas.1210129109; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu CL, 2019, J NEUROCHEM, V148, P426, DOI 10.1111/jnc.14604; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI200522854; Kay J, 2012, RHEUMATOLOGY, V51, P5, DOI 10.1093/rheumatology/kes279; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Kolb JP, 2017, TRENDS IMMUNOL, V38, P705, DOI 10.1016/j.it.2017.06.009; Legrand AJ, 2019, MOL CELL, V76, P232, DOI 10.1016/j.molcel.2019.09.006; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Maeshima E, 2007, CLIN RHEUMATOL, V26, P401, DOI 10.1007/s10067-006-0477-x; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pisetsky DS, 2016, NAT REV RHEUMATOL, V12, P102, DOI 10.1038/nrrheum.2015.151; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Speckmann B, 2011, J BIOL CHEM, V286, P10764, DOI 10.1074/jbc.M110.216028; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0794-4; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Uribe AG, 2004, J RHEUMATOL, V31, P1934; van Vollenhoven RF, 2018, LANCET, V392, P1330, DOI 10.1016/S0140-6736(18)32167-6; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhuang HY, 2014, ARTHRITIS RHEUMATOL, V66, P140, DOI 10.1002/art.38189	45	61	63	19	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1107	+		10.1038/s41590-021-00993-3	http://dx.doi.org/10.1038/s41590-021-00993-3		AUG 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34385713	Green Accepted			2022-12-18	WOS:000684510900001
J	Brunetta, E; Folci, M; Bottazzi, B; De Santis, M; Gritti, G; Protti, A; Mapelli, SN; Bonovas, S; Piovani, D; Leone, R; My, I; Zanon, V; Spata, G; Bacci, M; Supino, D; Carnevale, S; Sironi, M; Davoudian, S; Peano, C; Landi, F; Di Marco, F; Raimondi, F; Gianatti, A; Angelini, C; Rambaldi, A; Garlanda, C; Ciccarelli, M; Cecconi, M; Mantovani, A				Brunetta, Enrico; Folci, Marco; Bottazzi, Barbara; De Santis, Maria; Gritti, Giuseppe; Protti, Alessandro; Mapelli, Sarah N.; Bonovas, Stefanos; Piovani, Daniele; Leone, Roberto; My, Ilaria; Zanon, Veronica; Spata, Gianmarco; Bacci, Monica; Supino, Domenico; Carnevale, Silvia; Sironi, Marina; Davoudian, Sadaf; Peano, Clelia; Landi, Francesco; Di Marco, Fabiano; Raimondi, Federico; Gianatti, Andrea; Angelini, Claudio; Rambaldi, Alessandro; Garlanda, Cecilia; Ciccarelli, Michele; Cecconi, Maurizio; Mantovani, Alberto			Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19	NATURE IMMUNOLOGY			English	Article							KAWASAKI-LIKE DISEASE; SHORT-TERM MORTALITY; INNATE IMMUNITY; INFECTION; INFLAMMATION; CORRELATE; SITES	Mantovani and colleagues report elevated circulating concentrations of the long pentraxin PTX3 in patients with severe COVID-19. Within this cohort, early detection of high PTX3 concentrations emerged as a strong predictor of decreased survival. Long pentraxin 3 (PTX3) is an essential component of humoral innate immunity, involved in resistance to selected pathogens and in the regulation of inflammation(1-3). The present study was designed to assess the presence and significance of PTX3 in Coronavirus Disease 2019 (COVID-19)(4-7). RNA-sequencing analysis of peripheral blood mononuclear cells, single-cell bioinformatics analysis and immunohistochemistry of lung autopsy samples revealed that myelomonocytic cells and endothelial cells express high levels of PTX3 in patients with COVID-19. Increased plasma concentrations of PTX3 were detected in 96 patients with COVID-19. PTX3 emerged as a strong independent predictor of 28-d mortality in multivariable analysis, better than conventional markers of inflammation, in hospitalized patients with COVID-19. The prognostic significance of PTX3 abundance for mortality was confirmed in a second independent cohort (54 patients). Thus, circulating and lung myelomonocytic cells and endothelial cells are a major source of PTX3, and PTX3 plasma concentration can serve as an independent strong prognostic indicator of short-term mortality in COVID-19.	[Brunetta, Enrico; Folci, Marco; Bottazzi, Barbara; De Santis, Maria; Protti, Alessandro; Mapelli, Sarah N.; Bonovas, Stefanos; Piovani, Daniele; Leone, Roberto; My, Ilaria; Zanon, Veronica; Spata, Gianmarco; Bacci, Monica; Sironi, Marina; Davoudian, Sadaf; Peano, Clelia; Angelini, Claudio; Garlanda, Cecilia; Ciccarelli, Michele; Cecconi, Maurizio; Mantovani, Alberto] Humanitas Clin & Res Ctr IRCCS, Milan, Italy; [Brunetta, Enrico; Folci, Marco; Protti, Alessandro; Bonovas, Stefanos; Piovani, Daniele; My, Ilaria; Supino, Domenico; Carnevale, Silvia; Garlanda, Cecilia; Cecconi, Maurizio; Mantovani, Alberto] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Gritti, Giuseppe; Landi, Francesco; Rambaldi, Alessandro] Azienda Osped Socio Sanit Terr Papa Giovanni XXII, Unit Hematol, Bergamo, Italy; [Peano, Clelia] CNR, UoS Milan, Inst Genet & Biomed Res, Milan, Italy; [Di Marco, Fabiano; Raimondi, Federico] Azienda Osped Socio Sanit Terr Papa Giovanni XXII, Unit Pneumol, Bergamo, Italy; [Di Marco, Fabiano] Univ Milan, Dept Hlth Sci, Milan, Italy; [Gianatti, Andrea] Azienda Osped Socio Sanit Terr Papa Giovanni XXII, Unit Pathol, Bergamo, Italy; [Rambaldi, Alessandro] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Mantovani, Alberto] Queen Mary Univ London, William Harvey Res Inst, London, England	Humanitas University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; University of Milan; University of London; Queen Mary University London	Garlanda, C; Ciccarelli, M; Cecconi, M; Mantovani, A (corresponding author), Humanitas Clin & Res Ctr IRCCS, Milan, Italy.; Garlanda, C; Cecconi, M; Mantovani, A (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Rambaldi, A (corresponding author), Azienda Osped Socio Sanit Terr Papa Giovanni XXII, Unit Hematol, Bergamo, Italy.; Rambaldi, A (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.; Mantovani, A (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	arambaldi@asst-pg23.it; cecilia.garlanda@humanitasresearch.it; michele.ciccarelli@humanitas.it; maurizio.cecconi@humanitas.it; alberto.mantovani@humanitasresearch.it	Cecconi, Maurizio/HDN-8785-2022; mapelli, sarah natalia/AAC-6093-2022; Garlanda, Cecilia/K-4601-2016; Peano, Clelia/C-4015-2018; Brunetta, Enrico/AAT-6524-2021; Leone, Roberto/HGE-8714-2022; bottazzi, barbara/ABH-9274-2020; Supino, Domenico/HDO-4231-2022; Marco, Folci/ABB-9609-2021; Cecconi, Maurizio/A-6241-2012; Carnevale, Silvia/HGD-0054-2022; sironi, marina/AAB-5757-2020; Gritti, Giuseppe/K-7321-2019; My, Ilaria/AAK-8169-2021; De Santis, Maria/K-2644-2018; Ciccarelli, Michele/GZG-8536-2022; mapelli, sarah/AAC-7679-2022; Mantovani, Alberto/HCI-7449-2022	Cecconi, Maurizio/0000-0002-4376-6538; mapelli, sarah natalia/0000-0002-0129-2055; Garlanda, Cecilia/0000-0002-1510-7703; Peano, Clelia/0000-0001-7055-3629; Leone, Roberto/0000-0003-4978-7847; bottazzi, barbara/0000-0002-1930-9257; Supino, Domenico/0000-0001-9690-1791; Marco, Folci/0000-0001-5618-2876; Cecconi, Maurizio/0000-0002-4376-6538; Carnevale, Silvia/0000-0002-9176-5636; sironi, marina/0000-0002-3342-1149; Gritti, Giuseppe/0000-0002-6789-5123; De Santis, Maria/0000-0002-3196-1336; Ciccarelli, Michele/0000-0002-8617-4153; mapelli, sarah/0000-0002-0129-2055; Mantovani, Alberto/0000-0001-5578-236X; Bonovas, Stefanos/0000-0001-6102-6579; Protti, Alessandro/0000-0002-0172-6079; Bacci, Monica/0000-0002-5702-9408; Raimondi, Federico/0000-0001-9599-6864; zanon, veronica/0000-0002-6232-1438; Brunetta, Enrico/0000-0002-0676-1228; ANGELINI, CLAUDIO/0000-0002-4814-8712; My, Ilaria/0000-0002-1676-4633	Ministero della Salute for COVID-19; European Research Council (ERC) [PHII-669415]; European Sepsis Academy/Innovative Training Networks (ESA/ITN) from the European Commission (H2020-MSCA-ITN-2015) [676129]; CINECA; ELIXIR	Ministero della Salute for COVID-19; European Research Council (ERC)(European Research Council (ERC)European Commission); European Sepsis Academy/Innovative Training Networks (ESA/ITN) from the European Commission (H2020-MSCA-ITN-2015); CINECA(CINECA, Italy); ELIXIR	This work was supported by institutional funds, by a donation from the Dolce & Gabbana fashion house (to A.M. and C.G.), by a grant from Ministero della Salute for COVID-19 (to A.M. and C.G.) and by the European Research Council (ERC project PHII-669415 to A.M.). S.D. was supported by the European Sepsis Academy/Innovative Training Networks (ESA/ITN) from the European Commission (H2020-MSCA-ITN-2015; grant no. 676129). We acknowledge CINECA and ELIXIR for the availability of high performance computing resources and support. This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force (the members are listed in the Supplementary Note).	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alhazzani W., 2020, INTENS CARE MED, V46, P854, DOI [10.1007/s00134-020-06022-5, DOI 10.1007/s00134-020-06022-5, DOI 10.1016/S0140-6736(21)01825-0]; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Bastrup-Birk S, 2015, J INTERN MED, V277, P562, DOI 10.1111/joim.12294; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caironi P, 2017, EUR J CLIN INVEST, V47, P73, DOI 10.1111/eci.12704; Cecconi M, 2020, INTENS CARE MED, V46, P1590, DOI 10.1007/s00134-020-06140-0; Cecconi M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051548; Chen RC, 2020, J ALLERGY CLIN IMMUN, V146, P89, DOI 10.1016/j.jaci.2020.05.003; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escher F, 2020, ESC HEART FAIL, V7, P2440, DOI 10.1002/ehf2.12805; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Garlanda C, 2018, PHYSIOL REV, V98, P623, DOI 10.1152/physrev.00016.2017; Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hansen CB, 2020, J INFECTION, V80, P378, DOI 10.1016/j.jinf.2020.01.010; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hou H, 2020, CLIN EXP IMMUNOL, V201, P76, DOI 10.1111/cei.13450; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Katsube Y, 2011, J AM COLL CARDIOL, V57, pE2038, DOI 10.1016/S0735-1097(11)62038-X; Knoflach M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031474; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lee YT, 2018, J INFECTION, V76, P1, DOI 10.1016/j.jinf.2017.10.016; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Locatelli M, 2013, J NEUROIMMUNOL, V260, P99, DOI 10.1016/j.jneuroim.2013.04.009; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mantovani A, 2020, NEW ENGL J MED, V383, P1078, DOI 10.1056/NEJMcibr2011679; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Pepys MB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02382; Rambaldi A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.152001; Ramirez GA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01135; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7; Ristagno G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00823; Song J, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020495; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Viner RM, 2020, LANCET, V395, P1741, DOI 10.1016/S0140-6736(20)31129-6; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhu LN, 2020, IMMUNITY, V53, P685, DOI 10.1016/j.immuni.2020.07.009; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	62	61	62	2	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					19	24		10.1038/s41590-020-00832-x	http://dx.doi.org/10.1038/s41590-020-00832-x		NOV 2020	6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33208929	Green Published, Bronze			2022-12-18	WOS:000590992100001
J	Schuijs, MJ; Png, S; Richard, AC; Tsyben, A; Hamm, G; Stockis, J; Garcia, C; Pinaud, S; Nicholls, A; Ros, XR; Su, J; Eldridge, MD; Riedel, A; Serrao, EM; Rodewald, HR; Mack, M; Shields, JD; Cohen, ES; McKenzie, ANJ; Goodwin, RJA; Brindle, KM; Marioni, JC; Halim, TYF				Schuijs, Martijn J.; Png, Shaun; Richard, Arianne C.; Tsyben, Anastasia; Hamm, Gregory; Stockis, Julie; Garcia, Celine; Pinaud, Silvain; Nicholls, Ashley; Ros, Xavier Romero; Su, Jing; Eldridge, Matthew D.; Riedel, Angela; Serrao, Eva M.; Rodewald, Hans-Reimer; Mack, Matthias; Shields, Jacqueline D.; Cohen, E. Suzanne; McKenzie, Andrew N. J.; Goodwin, Richard J. A.; Brindle, Kevin M.; Marioni, John C.; Halim, Timotheus Y. F.			ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung	NATURE IMMUNOLOGY			English	Article							RNA-SEQ EXPERIMENTS; T-CELLS; LYMPHOID-CELLS; EXPRESSION; METASTASIS; TISSUE; INTERLEUKIN-33; RECRUITMENT; ACTIVATION; INITIATION	Metastasis constitutes the primary cause of cancer-related deaths, with the lung being a commonly affected organ. We found that activation of lung-resident group 2 innate lymphoid cells (ILC2s) orchestrated suppression of natural killer (NK) cell-mediated innate antitumor immunity, leading to increased lung metastases and mortality. Using multiple models of lung metastasis, we show that interleukin (IL)-33-dependent ILC2 activation in the lung is involved centrally in promoting tumor burden. ILC2-driven innate type 2 inflammation is accompanied by profound local suppression of interferon-gamma production and cytotoxic function of lung NK cells. ILC2-dependent suppression of NK cells is elaborated via an innate regulatory mechanism, which is reliant on IL-5-induced lung eosinophilia, ultimately limiting the metabolic fitness of NK cells. Therapeutic targeting of IL-33 or IL-5 reversed NK cell suppression and alleviated cancer burden. Thus, we reveal an important function of IL-33 and ILC2s in promoting tumor metastasis via their capacity to suppress innate type 1 immunity. Pathological group 2 innate lymphoid cells (ILC2s) have mainly been implicated in allergy. Halim and colleagues demonstrate that ILC2s orchestrate a prometastatic pathway via the recruitment of eosinophils that suppress NK cell function.	[Schuijs, Martijn J.; Png, Shaun; Richard, Arianne C.; Tsyben, Anastasia; Stockis, Julie; Garcia, Celine; Pinaud, Silvain; Nicholls, Ashley; Su, Jing; Eldridge, Matthew D.; Serrao, Eva M.; Brindle, Kevin M.; Marioni, John C.; Halim, Timotheus Y. F.] Univ Cambridge, CRUK Cambridge Inst, Cambridge, England; [Richard, Arianne C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Tsyben, Anastasia] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Hamm, Gregory; Goodwin, Richard J. A.] AstraZeneca, Imaging & Data Analyt Clin Pharmacol & Safety Sci, BioPharmaceut R&D, Cambridge, England; [Ros, Xavier Romero; Cohen, E. Suzanne] AstraZeneca, Biosci Asthma Res & Early Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England; [Riedel, Angela; Shields, Jacqueline D.] Univ Cambridge, MRC Canc Unit, Cambridge, England; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med, Regensburg, Germany; [McKenzie, Andrew N. J.] MRC Lab Mol Biol, Cambridge, England; [Goodwin, Richard J. A.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge, England; [Marioni, John C.] EMBL European Bioinformat Inst, Cambridge, England; [Marioni, John C.] Wellcome Genome Campus, Wellcome Sanger Inst, Cambridge, England	CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; AstraZeneca; AstraZeneca; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; MRC Laboratory Molecular Biology; University of Glasgow; University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Halim, TYF (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Cambridge, England.	Tim.Halim@cruk.cam.ac.uk	Riedel, Angela/ABC-7207-2020; Halim, Timotheus/B-3117-2018; PINAUD, Silvain/O-1658-2014	Eldridge, Matthew/0000-0002-5799-8911; Marioni, John/0000-0001-9092-0852; Richard, Arianne/0000-0002-8708-9997; Stockis, Julie/0000-0003-4911-6891; Halim, Timotheus/0000-0001-9773-0023; PINAUD, Silvain/0000-0002-9541-3611; Png, Shaun/0000-0002-2364-4621	EMBO long-term post-doctoral fellowship [ALTF 423-2017]; MRC Skills Development Fellowship [MR/P014178/1]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (Pan-ILC) [840501]; Wallonie-Bruxelles International Grant of Excellence WBI.WORLD [SUB/2019/441873]; Royal Society; Wellcome Trust [204622/Z/16/Z]; Cancer Research UK (CRUK) core award [A24995]; CRUK Grand Challenge Rosetta Consortium [C197/A25040]; MRC [MC_U105178805, MC_UU_12022/5, MR/P014178/1] Funding Source: UKRI	EMBO long-term post-doctoral fellowship(European Molecular Biology Organization (EMBO)); MRC Skills Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (Pan-ILC); Wallonie-Bruxelles International Grant of Excellence WBI.WORLD; Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Cancer Research UK (CRUK) core award; CRUK Grand Challenge Rosetta Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the following funding sources: EMBO long-term post-doctoral fellowship (no. ALTF 423-2017 to M.J.S.); MRC Skills Development Fellowship (no. MR/P014178/1 to A.C.R.); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (Pan-ILC no. 840501 to J.S.); Wallonie-Bruxelles International Grant of Excellence WBI.WORLD (SUB/2019/441873 to J.S.); the Royal Society and Wellcome Trust (no. 204622/Z/16/Z to T.Y.H.); Cancer Research UK (CRUK) core award (no. A24995 to T.Y.H.); and the CRUK Grand Challenge Rosetta Consortium (no. C197/A25040 to K.M.B., R.J.A.G., A.T. and G.H.). DESI-MSI optimization was supported by N. Strittmatter. We thank the CRUK Cambridge Institute Research Instrumentation, flow cytometry, genomics, bioinformatics, histopathology, imaging and BRU cores for their expertise and help.	Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Chevalier MF, 2017, J CLIN INVEST, V127, P2916, DOI 10.1172/JCI89717; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Crome SQ, 2017, NAT MED, V23, P368, DOI 10.1038/nm.4278; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Dougan M, 2019, IMMUNITY, V50, P796, DOI 10.1016/j.immuni.2019.03.022; Fairfax KA, 2018, J LEUKOCYTE BIOL, V104, P195, DOI 10.1002/JLB.6MA1117-451R; Fournie JJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02506; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Kedia-Mehta N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10015-4; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Lawrence MG, 2018, ANN ALLERG ASTHMA IM, V120, P376, DOI 10.1016/j.anai.2018.01.009; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Long A, 2018, J IMMUNOL, V201, P3456, DOI 10.4049/jimmunol.1800173; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu Thomas X, 2014, Bio Protoc, V4; Lucarini V, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1317420; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; O'Brien KL, 2019, NAT REV IMMUNOL, V19, P282, DOI 10.1038/s41577-019-0139-2; Porter L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01404; Qi L, 2020, INT J CANCER, V146, P1421, DOI 10.1002/ijc.32779; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Saranchova I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20608-6; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schuijs MJ, 2018, ANN NY ACAD SCI, V1417, P87, DOI 10.1111/nyas.13604; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P5914, DOI 10.1073/pnas.90.13.5914; Taranova AG, 2008, CANCER RES, V68, P8582, DOI 10.1158/0008-5472.CAN-08-1673; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Wu H, 2015, BIOINFORMATICS, V31, P233, DOI 10.1093/bioinformatics/btu640; Zaynagetdinov R, 2015, CANCER RES, V75, P1624, DOI 10.1158/0008-5472.CAN-14-2379	73	61	64	4	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					998	+		10.1038/s41590-020-0745-y	http://dx.doi.org/10.1038/s41590-020-0745-y		AUG 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32747815	Green Submitted, Green Accepted			2022-12-18	WOS:000555415800001
J	Kwak, K; Akkaya, M; Pierce, SK				Kwak, Kihyuck; Akkaya, Munir; Pierce, Susan K.			B cell signaling in context	NATURE IMMUNOLOGY			English	Review							GERMINAL-CENTER; PLASMA-CELL; MEMORY B; TRANSCRIPTION FACTOR; ANTIGEN; AFFINITY; RECEPTOR; ACTIVATION; RESPONSES; TOLERANCE	Over the past several decades, B cell antigen receptor (BCR)-induced signaling pathways have been described in extraordinary molecular detail, mainly from studies of B cell responses to antigens in vitro. BCR signaling has been shown to govern the initiation of transcriptional programs associated with B cell activation and fate decisions, as well as the BCR-dependent processing of antigen and presentation of antigen to T cells. However, although the potential of the BCR to orchestrate B cell behavior was known, there was no clear appreciation of the context in which B cells signal in secondary lymphoid organs in vivo or how that context influences signaling. In this Review, we describe the current view of the cellular consequences of BCR signaling and advances in the understanding of B cell signaling in context in vivo.	[Kwak, Kihyuck; Akkaya, Munir; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589; AKKAYA, Munir/0000-0002-9949-9424; Pierce, Susan/0000-0001-7261-3437	Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health	Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health. The authors thank R. Kissinger (of that institution) for expert preparation of the illustrations presented here.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Akkaya M, 2018, NAT IMMUNOL, V19, P255, DOI 10.1038/s41590-018-0052-z; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Benhamron S, 2015, MOL CELL BIOL, V35, P153, DOI 10.1128/MCB.01187-14; Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Bufi N, 2015, BIOPHYS J, V108, P2181, DOI 10.1016/j.bpj.2015.03.047; Burnett DL, 2018, SCIENCE, V360, P223, DOI 10.1126/science.aao3859; Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Chen YZ, 2018, J EXP MED, V215, P1397, DOI 10.1084/jem.20171761; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Engels N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6456; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Kwak K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6598; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu BY, 2015, ANNU REV PHYS CHEM, V66, P427, DOI 10.1146/annurev-physchem-040214-121742; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Munoz-Fernandez R, 2014, IMMUNOL CELL BIOL, V92, P851, DOI 10.1038/icb.2014.61; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Noviski M, 2018, ELIFE, V7, DOI 10.7554/eLife.35074; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sabouri Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13381; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Sacquin A, 2017, EUR J IMMUNOL, V47, P1295, DOI 10.1002/eji.201746952; Schroeder KMS, 2017, CURR OPIN IMMUNOL, V47, P26, DOI 10.1016/j.coi.2017.06.004; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shinnakasu R, 2017, CURR OPIN IMMUNOL, V45, P126, DOI 10.1016/j.coi.2017.03.003; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Spillane KM, 2017, J CELL BIOL, V216, P217, DOI 10.1083/jcb.201607064; Tangye SG, 2015, CELL, V162, DOI 10.1016/j.cell.2015.07.055; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tipton CM, 2018, IMMUNOL REV, V284, P120, DOI 10.1111/imr.12660; Tolar P, 2017, NAT REV IMMUNOL, V17, P621, DOI 10.1038/nri.2017.67; Tsui C, 2018, IMMUNITY, V48, P1144, DOI 10.1016/j.immuni.2018.04.031; Turner JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15072; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wan ZP, 2015, ELIFE, V4, DOI 10.7554/eLife.06925; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	78	61	63	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					963	969		10.1038/s41590-019-0427-9	http://dx.doi.org/10.1038/s41590-019-0427-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31285625				2022-12-18	WOS:000476621200011
J	Clayton, KL; Collins, DR; Lengieza, J; Ghebremichael, M; Dotiwala, F; Lieberman, J; Walker, BD				Clayton, Kiera L.; Collins, David R.; Lengieza, Josh; Ghebremichael, Musie; Dotiwala, Farokh; Lieberman, Judy; Walker, Bruce D.			Resistance of HIV-infected macrophages to CD8(+) T lymphocyte-mediated killing drives activation of the immune system	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; INTERFERON-GAMMA; VIRUS; REPLICATION; EXPRESSION; PERFORIN; CD4(+); TYPE-1; SUSCEPTIBILITY; MONOCYTES	CD4(+) T lymphocytes are the principal target of human immunodeficiency virus (HIV), but infected macrophages also contribute to viral pathogenesis. The killing of infected cells by CD8(+) cytotoxic T lymphocytes (CTLs) leads to control of viral replication. Here we found that the killing of macrophages by CTLs was impaired relative to the killing of CD4(+) T cells by CTLs, and this resulted in inefficient suppression of HIV. The killing of macrophages depended on caspase-3 and granzyme B, whereas the rapid killing of CD4(+) T cells was caspase independent and did not require granzyme B. Moreover, the impaired killing of macrophages was associated with prolonged effector cell-target cell contact time and higher expression of interferon-gamma by CTLs, which induced macrophage production of pro-inflammatory chemokines that recruited monocytes and T cells. Similar results were obtained when macrophages presented other viral antigens, suggestive of a general mechanism for macrophage persistence as antigen-presenting cells that enhance inflammation and adaptive immunity. Inefficient killing of macrophages by CTLs might contribute to chronic inflammation, a hallmark of chronic disease caused by HIV.	[Clayton, Kiera L.; Collins, David R.; Lengieza, Josh; Ghebremichael, Musie; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Collins, David R.; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Dotiwala, Farokh; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Dotiwala, Farokh; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Walker, Bruce D.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Walker, BD (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Walker, BD (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bwalker@mgh.harvard.edu	Lieberman, Judy/A-2717-2015; Dotiwala, Farokh/S-5367-2019	Dotiwala, Farokh/0000-0002-7387-2219; Collins, David/0000-0001-7903-346X; Walker, Bruce D/0000-0001-6122-9245	Howard Hughes Medical Institute; Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; Canadian Institute of Health Research; US National Institutes of Health [R01 AI118544]; amfAR [109326-59-RGRL]; Harvard University Center for AIDS Research [P30 AI060354]; US National Institutes of Health: NIAID; US National Institutes of Health: NCI; US National Institutes of Health: NICHD; US National Institutes of Health: NHLBI; US National Institutes of Health: NIDA; US National Institutes of Health: NIMH; US National Institutes of Health: NIA; US National Institutes of Health: FIC; US National Institutes of Health: OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118544, F32AI143480, P30AI060354] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); amfAR; Harvard University Center for AIDS Research; US National Institutes of Health: NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health: NCI; US National Institutes of Health: NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health: NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health: NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health: NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institutes of Health: FIC; US National Institutes of Health: OAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Buus (University of Copenhagen) for monomers; G. Mylvaganam, G. Gaiha, T. Diefenbach and A. Balazs for comments; J. Trapani for discussions about granzymes; A. Piechocka-Trocha for experimental help; and the Flow Cytometry and Sample Processing Cores at the Ragon Institute for help with instrumentation and processing of the samples. Supported by the Howard Hughes Medical Institute (D.R.C. and B.D.W.), the Ragon Institute of MGH, MIT and Harvard (B.D.W.), the Canadian Institute of Health Research (K.L.C.), the US National Institutes of Health (R01 AI118544 to B.D.W.), amfAR (109326-59-RGRL to K.L.C. and B.D.W.) and the Harvard University Center for AIDS Research (P30 AI060354 to B.D.W.), which is supported by the following institutes and centers co-funded by and participating with the US National Institutes of Health: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC and OAR.	Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Avalos CR, 2017, MBIO, V8, DOI 10.1128/mBio.01186-17; Avalos CR, 2016, J VIROL, V90, P5643, DOI 10.1128/JVI.00290-16; Belizario J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/128076; Bellucci R, 2012, J CLIN INVEST, V122, P2369, DOI 10.1172/JCI58457; Calabia-Linares C, 2011, J CELL SCI, V124, P820, DOI 10.1242/jcs.078832; Collins DR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005054; Corbera-Bellalta M, 2016, ANN RHEUM DIS, V75, P1177, DOI 10.1136/annrheumdis-2015-208371; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; de Poot SAH, 2014, CELL DEATH DIFFER, V21, P416, DOI 10.1038/cdd.2013.155; DiNapoli SR, 2016, J VIROL, V90, P7596, DOI 10.1128/JVI.00672-16; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13; Ewen CL, 2013, MOL IMMUNOL, V54, P309, DOI 10.1016/j.molimm.2012.12.020; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Fujiwara M, 2007, BLOOD, V109, P4832, DOI 10.1182/blood-2006-07-037481; Goulder PJR, 1999, NAT MED, V5, P1233, DOI 10.1038/15184; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Hsu DC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-29; Jenkins MR, 2015, J EXP MED, V212, P307, DOI 10.1084/jem.20140964; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kataoka T, 1996, J IMMUNOL, V156, P3678; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lieberman J., 2013, FUNDAMENTAL IMMUNOLO; Liu J, 2007, CYTOM PART A, V71A, P94, DOI 10.1002/cyto.a.20363; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nowlin BT, 2015, AM J PATHOL, V185, P1649, DOI 10.1016/j.ajpath.2015.01.033; Pachlopnik SJ, 2009, EMBO MOL MED, V1, P112, DOI DOI 10.1002/EMMM.200900009; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Rainho JN, 2015, J VIROL, V89, P10625, DOI 10.1128/JVI.01699-15; Reinhart TA, 2002, BLOOD, V99, P3119, DOI 10.1182/blood.V99.9.3119; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Sattentau QJ, 2016, CELL HOST MICROBE, V19, P304, DOI 10.1016/j.chom.2016.02.013; Severino ME, 2000, J VIROL, V74, P6695, DOI 10.1128/JVI.74.14.6695-6699.2000; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Sutton VR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.73; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Vojnov L, 2012, J VIROL, V86, P4682, DOI 10.1128/JVI.06324-11; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Walker-Sperling VE, 2016, AIDS RES HUM RETROV, V32, P1097, DOI 10.1089/aid.2016.0082; Walker-Sperling VEK, 2014, J VIROL, V88, P9789, DOI 10.1128/JVI.00860-14; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	54	61	61	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					475	+		10.1038/s41590-018-0085-3	http://dx.doi.org/10.1038/s41590-018-0085-3			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670239	Green Accepted			2022-12-18	WOS:000430562400011
J	Ntziachristos, P; Abdel-Wahab, O; Aifantis, I				Ntziachristos, Panagiotis; Abdel-Wahab, Omar; Aifantis, Iannis			Emerging concepts of epigenetic dysregulation in hematological malignancies	NATURE IMMUNOLOGY			English	Review							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; REPRESSIVE COMPLEX 2; RECURRENT MUTATIONS; SUPER-ENHANCERS; HISTONE H3; TUMOR-SUPPRESSOR; COHESIN COMPLEX; GENE-EXPRESSION; THERAPEUTIC STRATEGY	The past decade brought a revolution in understanding of the structure, topology and disease-inducing lesions of RNA and DNA, fueled by unprecedented progress in next-generation sequencing. This technological revolution has also affected understanding of the epigenome and has provided unique opportunities for the analysis of DNA and histone modifications, as well as the first map of the non-protein-coding genome and three-dimensional (3D) chromosomal interactions. Overall, these advances have facilitated studies that combine genetic, transcriptomics and epigenomics data to address a wide range of issues ranging from understanding the role of the epigenome in development to targeting the transcription of noncoding genes in human cancer. Here we describe recent insights into epigenetic dysregulation characteristic of the malignant differentiation of blood stem cells based on studies of alterations that affect epigenetic complexes, enhancers, chromatin, long noncoding RNAs (IncRNAs), RNA splicing, nuclear topology and the 3D conformation of chromatin.	[Ntziachristos, Panagiotis] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Ntziachristos, Panagiotis] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Aifantis, Iannis] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10016 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; New York University	Ntziachristos, P (corresponding author), Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA.; Ntziachristos, P (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Aifantis, I (corresponding author), NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10016 USA.	panos.ntz@northwestern.edu; abdelwao@mskcc.org; iannis.aifantis@nyumc.org	Ntziachristos, Panagiotis/CAG-2071-2022		US National Institutes of Health [1K08CA160647-01, R01 HL128239, RO1CA133379, RO1CA105129, RO1CA149655, 5RO1CA173636, 1RO1CA194923, R01 CA190509]; National Cancer Institute [R00CA188293-02]; American Society of Hematology; Zell Foundation; Chicago Region Physical Science-Oncology Center; Department of Defense [BM150092, W81XWH-12-1-0041]; Damon Runyon Foundation; Edward P. Evans Foundation; V Foundation; Starr Foundation; Josie Robertson Investigator Program; Pershing Square Sohn Cancer Research Alliance; Leukemia and Lymphoma Society; NYSTEM program of the New York State Health Department; William Lawrence and Blanche Hughes Foundation; Chemotherapy Foundation; NATIONAL CANCER INSTITUTE [R01CA105129, K08CA160647, R01CA202027, R01CA133379, P30CA060553, R00CA188293, R01CA173636, R01CA149655, R01CA190509, R01CA169784, R01CA194923, R01CA202025] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128239] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematology; Zell Foundation; Chicago Region Physical Science-Oncology Center; Department of Defense(United States Department of Defense); Damon Runyon Foundation; Edward P. Evans Foundation; V Foundation; Starr Foundation; Josie Robertson Investigator Program; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NYSTEM program of the New York State Health Department; William Lawrence and Blanche Hughes Foundation; Chemotherapy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the members of all laboratories, and M. Guillamot and L. Cimmino for comments and illustrations. Supported by the US National Institutes of Health (1K08CA160647-01 and R01 HL128239 for the Abdel-Wahab laboratory; and RO1CA133379, RO1CA105129, RO1CA149655, 5RO1CA173636, 1RO1CA194923 and R01 CA190509 for the Aifantis laboratory); the National Cancer Institute (R00CA188293-02), the American Society of Hematology, the Zell Foundation and the Chicago Region Physical Science-Oncology Center (all for the Ntziachristos laboratory); the Department of Defense (BM150092 and W81XWH-12-1-0041), the Damon Runyon Foundation, the Edward P. Evans Foundation, the V Foundation, the Starr Foundation, the Josie Robertson Investigator Program and the Pershing Square Sohn Cancer Research Alliance (all for the Abdel-Wahab laboratory); and the Leukemia and Lymphoma Society, the NYSTEM program of the New York State Health Department, The William Lawrence and Blanche Hughes Foundation and the Chemotherapy Foundation (all for the Aifantis laboratory).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benyoucef A, 2016, GENE DEV, V30, P508, DOI 10.1101/gad.276790.115; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Danis E, 2016, CELL REP, V14, P1953, DOI 10.1016/j.celrep.2016.01.064; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Garding A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003373; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Inoue D, 2016, GENE DEV, V30, P989, DOI 10.1101/gad.278424.116; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Y, 2012, ONCOGENE, V31, P5007, DOI 10.1038/onc.2012.8; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mayle A, 2015, BLOOD, V125, P629, DOI 10.1182/blood-2014-08-594648; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Meyer SE, 2016, CANCER DISCOV, V6, P501, DOI 10.1158/2159-8290.CD-16-0008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shields BJ, 2016, GENE DEV, V30, P78, DOI 10.1101/gad.268425.115; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shirai CL, 2015, CANCER CELL, V27, P631, DOI 10.1016/j.ccell.2015.04.008; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Stilgenbauer S, 1998, ONCOGENE, V16, P1891, DOI 10.1038/sj.onc.1201764; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; van Kruijsbergen H, 2015, INT J BIOCHEM CELL B, V67, P177, DOI 10.1016/j.biocel.2015.05.006; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Watrin E, 2016, CURR OPIN GENET DEV, V37, P59, DOI 10.1016/j.gde.2015.12.004; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamazaki H, 2014, CANCER CELL, V25, P415, DOI 10.1016/j.ccr.2014.02.008; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang J, 2014, 2014 INTERNATIONAL CONFERENCE ON MECHANICAL ENGINEERING AND AUTOMATION (ICMEA), P14; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	130	61	62	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1016	1024		10.1038/ni.3517	http://dx.doi.org/10.1038/ni.3517			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27478938	Green Accepted			2022-12-18	WOS:000381832000005
J	Chuprin, A; Avin, A; Goldfarb, Y; Herzig, Y; Levi, B; Jacob, A; Sela, A; Katz, S; Grossman, M; Guyon, C; Rathaus, M; Cohen, HY; Sagi, I; Giraud, M; McBurney, MW; Husebye, ES; Abramson, J				Chuprin, Anna; Avin, Ayelet; Goldfarb, Yael; Herzig, Yonatan; Levi, Ben; Jacob, Adi; Sela, Asaf; Katz, Shir; Grossman, Moran; Guyon, Clotilde; Rathaus, Moran; Cohen, Haim Y.; Sagi, Irit; Giraud, Matthieu; McBurney, Michael W.; Husebye, Eystein S.; Abramson, Jakub			The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; AUTOIMMUNE REGULATOR; GENE-EXPRESSION; HISTONE H3K4; MICE DEVELOP; REPERTOIRE; SIR2-ALPHA; SELECTION; PROTEIN	Aire is a transcriptional regulator that induces the promiscuous expression of thousands of tissue-restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs), a step critical for the induction of immunological self-tolerance. Studies have offered molecular insights into how Aire operates, but more comprehensive understanding of this process still remains elusive. Here we found abundant expression of the protein deacetylase Sirtuin-1 (Sirt1) in mature Aire(+) mTECs, wherein it was required for the expression of Aire-dependent TRA-encoding genes and the subsequent induction of immunological self-tolerance. Our study elucidates a previously unknown molecular mechanism for Aire-mediated transcriptional regulation and identifies a unique function for Sirt1 in preventing organ-specific autoimmunity.	[Chuprin, Anna; Avin, Ayelet; Goldfarb, Yael; Herzig, Yonatan; Levi, Ben; Jacob, Adi; Sela, Asaf; Katz, Shir; Abramson, Jakub] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Grossman, Moran; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Guyon, Clotilde; Giraud, Matthieu] Univ Paris 05, Sorbonne Paris Cite, INSERM U1016, Inst Cochin,Dept Immunol, Paris, France; [Rathaus, Moran; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [McBurney, Michael W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Husebye, Eystein S.] Univ Bergen, Dept Clin Sci, Bergen, Norway	Weizmann Institute of Science; Weizmann Institute of Science; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Bar Ilan University; University of Ottawa; Ottawa Hospital Research Institute; University of Bergen	Abramson, J (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	jakub.abramson@weizmann.ac.il	Kornweitz, Haya/L-6469-2018; Giraud, Matthieu/E-4972-2017	Kornweitz, Haya/0000-0002-3562-0141; Giraud, Matthieu/0000-0002-1208-9677; Cohen, Haim Y./0000-0002-6613-8710	Minerva Stiftung [711423]; Israel Science Foundation [1825/10, 722/14]; Sy Syms Foundation; Agence Nationale de Recherche [2011-CHEX-001-R12004KK]; Novo Nordisk Fonden [NNF14OC0011005] Funding Source: researchfish; European Foundation for the Study of Diabetes [MSD 2014_1] Funding Source: researchfish	Minerva Stiftung; Israel Science Foundation(Israel Science Foundation); Sy Syms Foundation; Agence Nationale de Recherche(French National Research Agency (ANR)); Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	We thank D. Graf (University of Zurich) for B6.Foxn1-Cre mice (with the consent of N. Manley (University of Georgia)); D. Mathis and C. Benoist (Harvard Medical School) for Aire<SUP>-/-</SUP> (NOD) mice; M. Anderson (University of California at San Francisco) for Aire-GFP mice; M. Oren (Weizmann Institute) for plasmid pCMV-P300; and N. Or Geva, Z. Porat, G. Hecht, Y. Peleg and O. Brenner for experimental expertise and help. Supported by the Minerva Stiftung (711423), the Israel Science Foundation (1825/10 and 722/14) and the Sy Syms Foundation (J.A.) and the Agence Nationale de Recherche (2011-CHEX-001-R12004KK to M.Gi.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Akimova T, 2014, MUCOSAL IMMUNOL, V7, P1209, DOI 10.1038/mi.2014.10; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Biason-Lauber A, 2013, CELL METAB, V17, P448, DOI 10.1016/j.cmet.2013.02.001; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Husebye ES, 2010, IMMUNITY, V32, P479, DOI 10.1016/j.immuni.2010.03.016; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11	42	61	64	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					737	+		10.1038/ni.3194	http://dx.doi.org/10.1038/ni.3194			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26006015				2022-12-18	WOS:000356445600010
J	Davey, MS; Tamassia, N; Rossato, M; Bazzoni, F; Calzetti, F; Bruderek, K; Sironi, M; Zimmer, L; Bottazzi, B; Mantovani, A; Brandau, S; Moser, B; Eberl, M; Cassatella, MA				Davey, Martin S.; Tamassia, Nicola; Rossato, Marzia; Bazzoni, Flavia; Calzetti, Federica; Bruderek, Kirsten; Sironi, Marina; Zimmer, Lisa; Bottazzi, Barbara; Mantovani, Alberto; Brandau, Sven; Moser, Bernhard; Eberl, Matthias; Cassatella, Marco A.			Failure to detect production of IL-10 by activated human neutrophils	NATURE IMMUNOLOGY			English	Letter							CELLS		[Davey, Martin S.; Moser, Bernhard; Eberl, Matthias] Cardiff Univ, Dept Infect Immun & Biochem, Sch Med, Cardiff, S Glam, Wales; [Tamassia, Nicola; Rossato, Marzia; Bazzoni, Flavia; Calzetti, Federica; Cassatella, Marco A.] Univ Verona, Dept Pathol & Diagnost, Div Gen Pathol, I-37100 Verona, Italy; [Bruderek, Kirsten; Brandau, Sven] Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany; [Sironi, Marina; Bottazzi, Barbara; Mantovani, Alberto] Ist Ricovero & Cura Carattere Sci, Ist Clin Humanitas, Milan, Italy; [Sironi, Marina; Bottazzi, Barbara; Mantovani, Alberto] Univ Milan, Milan, Italy; [Zimmer, Lisa] Univ Hosp Essen, Dept Dermatol, Essen, Germany	Cardiff University; University of Verona; University of Duisburg Essen; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Humanitas Research Hospital; University of Milan; University of Duisburg Essen	Davey, MS (corresponding author), Cardiff Univ, Dept Infect Immun & Biochem, Sch Med, Cardiff, S Glam, Wales.	eberlm@cf.ac.uk; marco.cassatella@univr.it	sironi, marina/AAB-5757-2020; Eberl, Matthias/A-5970-2009; Rossato, Marzia/AAB-7827-2019; Zimmer, Lisa/AAP-8495-2021; bottazzi, barbara/ABH-9274-2020; Cassatella, M A/B-8037-2013; Mantovani, Alberto/HCI-7449-2022; Bazzoni, Flavia/AAB-7674-2019; Tamassia, Nicola/J-8621-2016	sironi, marina/0000-0002-3342-1149; Eberl, Matthias/0000-0002-9390-5348; Rossato, Marzia/0000-0002-6101-1550; Zimmer, Lisa/0000-0002-3680-3521; bottazzi, barbara/0000-0002-1930-9257; Cassatella, M A/0000-0001-7824-1806; Mantovani, Alberto/0000-0001-5578-236X; Bazzoni, Flavia/0000-0001-6768-8012; Tamassia, Nicola/0000-0003-2990-3003; Davey, Martin/0000-0002-3463-3127; Brandau, Sven/0000-0002-2702-4163; Moser, Bernhard/0000-0002-4354-4572	MRC [G1000800] Funding Source: UKRI; Medical Research Council [G1000800] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Davey MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002040; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Reglier H, 1998, CYTOKINE, V10, P192, DOI 10.1006/cyto.1997.0272; Sasazuki S, 2010, CARCINOGENESIS, V31, P712, DOI 10.1093/carcin/bgq010; Smedman C, 2009, J IMMUNOL METHODS, V346, P1, DOI 10.1016/j.jim.2009.04.001; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	11	61	62	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1017	1018		10.1038/ni.2111	http://dx.doi.org/10.1038/ni.2111			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012430				2022-12-18	WOS:000296500100001
J	Krangel, MS				Krangel, Michael S.			T cell development: better living through chromatin	NATURE IMMUNOLOGY			English	Review							CD4/CD8 LINEAGE CHOICE; HEAVY-CHAIN GENE; ALLELIC EXCLUSION; V(D)J RECOMBINATION; NUCLEAR-ORGANIZATION; HISTONE ACETYLATION; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; GENOMIC ORGANIZATION; SILENT CHROMATIN	T lymphocyte development is directed by a gene-expression program that occurs in the complex nucleoprotein environment of chromatin. This review examines basic principles of chromatin regulation and evaluates ongoing progress toward understanding how the chromatin template is manipulated to control gene expression and gene recombination in developing thymocytes. Special attention is devoted to the loci encoding T cell receptors alpha and beta, T cell coreceptors CD4 and CD8, and the enzyme terminal deoxynucleotidyl transferase. The properties of SATB1, a notable organizer of thymocyte chromatin, are also addressed.	Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	krang001@mc.duke.edu			NIAID NIH HHS [R01 AI049934, R01 AI49934] Funding Source: Medline; NIGMS NIH HHS [R37 GM041052, R37 GM41052] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Alvarez JD, 2000, GENE DEV, V14, P521; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Delaire S, 2004, J EXP MED, V200, P1427, DOI 10.1084/jem.20041041; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hawwari A, 2005, J EXP MED, V202, P467, DOI 10.1084/jem.20050680; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Jackson AM, 2005, J IMMUNOL, V175, P5186, DOI 10.4049/jimmunol.175.8.5186; Jia JQ, 2007, EMBO J, V26, P2387, DOI 10.1038/sj.emboj.7601671; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Mauvieux L, 2003, EUR J IMMUNOL, V33, P2216, DOI 10.1002/eji.200323867; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Patenge N, 2004, J BIOL CHEM, V279, P35360, DOI 10.1074/jbc.M405790200; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Ryu CJ, 2004, MOL CELL BIOL, V24, P7015, DOI 10.1128/MCB.24.16.7015-7023.2004; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; Warmflash A, 2006, J IMMUNOL, V177, P3857, DOI 10.4049/jimmunol.177.6.3857; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	92	61	65	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					686	693		10.1038/ni1484	http://dx.doi.org/10.1038/ni1484			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579647				2022-12-18	WOS:000247718100009
J	Miller, AT; Sandberg, M; Huang, YH; Young, M; Sutton, S; Sauer, K; Cooke, MP				Miller, Andrew T.; Sandberg, Mark; Huang, Yina H.; Young, Michael; Sutton, Susan; Sauer, Karsten; Cooke, Michael P.			Production of Ins(1,3,4,5)P-4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation	NATURE IMMUNOLOGY			English	Article							INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; LYMPHOCYTE DEVELOPMENT; POSITIVE SELECTION; ANTIGEN RECEPTOR; SELF-TOLERANCE; MARGINAL ZONE; HOMEOSTASIS; MEMBRANE; CHECKPOINTS; COMMITMENT	Antigen receptor-mediated production of inositol-1,4,5-trisphosphate ( Ins( 1,4,5)P-3) in lymphocytes triggers the release of Ca2+ from intracellular stores; this release of Ca2+ results in the opening of store-operated Ca2+ channels in the plasma membrane. Here we report that mice lacking Ins( 1,4,5)P-3 3-kinase B (Itpkb), which converts Ins( 1,4,5) P-3 to inositol-1,3,4,5-tetrakisphosphate (Ins( 1,3,4,5)P-4), had impaired B lymphocyte development and defective immunoglobulin G3 antibody responses to a T lymphocyte-independent antigen. Itpkb-deficient B lymphocytes had the phenotypic and functional features of tolerant B lymphocytes and showed enhanced activity of store-operated Ca2+ channels after B lymphocyte receptor stimulation, which was reversed by the provision of exogenous Ins( 1,3,4,5) P-4. Our data identify Itpkb and its product Ins( 1,3,4,5) P-4 as inhibitors of store-operated Ca2+ channels and crucial regulators of B cell selection and activation.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis	Cooke, MP (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	mcooke@gnf.org		Huang, Yina/0000-0002-0125-9351				Benschop RJ, 2001, J IMMUNOL, V167, P4172, DOI 10.4049/jimmunol.167.8.4172; Bird GSJ, 1996, J BIOL CHEM, V271, P6766, DOI 10.1074/jbc.271.12.6766; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; Chamberlain PP, 2005, BIOCHEMISTRY-US, V44, P14486, DOI 10.1021/bi051256q; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cullen PJ, 1997, BIOCHEM SOC T, V25, P991, DOI 10.1042/bst0250991; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Harnett MA, 2005, IMMUNOL LETT, V98, P33, DOI 10.1016/j.imlet.2004.11.002; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; King LB, 1999, J IMMUNOL, V162, P2655; Kurosaki T, 2000, IMMUNOL REV, V176, P19; LANE PJL, 1986, EUR J IMMUNOL, V16, P1569, DOI 10.1002/eji.1830161216; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Miosge L, 2005, IMMUNOL CELL BIOL, V83, P318, DOI 10.1111/j.1440-1711.2005.01353.x; MONGINI PKA, 1981, J EXP MED, V153, P1, DOI 10.1084/jem.153.1.1; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srivastava B, 2005, SEMIN IMMUNOL, V17, P175, DOI 10.1016/j.smim.2005.02.008; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Thurnheer MC, 2003, J IMMUNOL, V170, P4564, DOI 10.4049/jimmunol.170.9.4564; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; WILCOX RA, 1993, MOL PHARMACOL, V44, P810; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270	40	61	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					514	521		10.1038/ni1458	http://dx.doi.org/10.1038/ni1458			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17417640				2022-12-18	WOS:000245831600016
J	Colonna, M; Pulendran, B; Iwasaki, A				Colonna, M; Pulendran, B; Iwasaki, A			Dendritic cells at the host-pathogen interface	NATURE IMMUNOLOGY			English	Editorial Material							EPITHELIAL-CELLS; T-CELLS; IN-VIVO; INDUCTION; PROTEIN; ACTIVATION; RESPONSES; IMMUNITY; ANTIGEN; TRIGGER	How DCs integrate information from pathogens, tissues, and innate leukocytes for the induction of immune responses was presented at the second International Conference on Dendritic Cells at the Host-Pathogen Interface.	Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; Emory Vaccine Ctr, Atlanta, GA 30329 USA; Dept Pathol, Atlanta, GA 30329 USA	Washington University (WUSTL); Emory University	Colonna, M (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019; Pulendran, Bali/AAW-9550-2021	Iwasaki, Akiko/0000-0002-7824-9856; Colonna, Marco/0000-0001-5222-4987				Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	19	61	66	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					117	120		10.1038/ni0206-117	http://dx.doi.org/10.1038/ni0206-117			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424884				2022-12-18	WOS:000234801700002
J	Hawwari, A; Bock, C; Krangel, MS				Hawwari, A; Bock, C; Krangel, MS			Regulation of T cell receptor alpha gene assembly by a complex hierarchy of germline J(alpha) promoters	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTIONAL INTERFERENCE; V(D)J RECOMBINATION; BETA-GLOBIN; LOCUS; SEGMENT; REARRANGEMENTS; ACCESSIBILITY; MECHANISM; SELECTION; SURVIVAL	Assembly of the gene encoding T cell receptor alpha (Tcra) is characterized by an orderly progression of primary and secondary V-alpha-to-J(alpha) recombination events across the J(alpha) array, but the targeting mechanisms responsible for this progression are mostly unknown. Studies have shown that the T early-alpha promoter is important in targeting primary Tcra rearrangements. We found that T early-alpha and a previously unknown promoter associated with J(alpha)49 targeted primary recombination to discrete sets of constant a region (C-alpha) - distal J alpha segments and together directed nearly all normal primary recombination events. Furthermore, deletion of the T early-alpha promoter activated previously suppressed downstream promoters and stimulated primary rearrangement to centrally located J(alpha) segments. Central promoter derepression also occurred after primary rearrangement, thereby providing a mechanism to target secondary recombination events.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	krang001@mc.duke.edu	Hawwari, Abbas/L-1934-2019	Hawwari, Abbas/0000-0001-9643-6500	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041052, R37GM041052] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041052, R37 GM041052, GM41052] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; KRANGEL MS, 2004, MOL BIOL B CELLS, P127; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Mauvieux L, 2003, EUR J IMMUNOL, V33, P2216, DOI 10.1002/eji.200323867; Mauvieux L, 2001, EUR J IMMUNOL, V31, P2080, DOI 10.1002/1521-4141(200107)31:7<2080::AID-IMMU2080>3.3.CO;2-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471	30	61	61	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					481	489		10.1038/ni1189	http://dx.doi.org/10.1038/ni1189			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15806105	Green Accepted			2022-12-18	WOS:000228634300020
J	Reynaud, CA; Aoufouchi, S; Faili, A; Weill, JC				Reynaud, CA; Aoufouchi, S; Faili, A; Weill, JC			What role for AID: mutator, or assembler of the immunoglobulin mutasome?	NATURE IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; DNA-POLYMERASE-ETA; MISMATCH-REPAIR PROTEIN; CYTIDINE DEAMINASE AID; B-CELL LINE; DOUBLE-STRAND BREAKS; XERODERMA-PIGMENTOSUM VARIANT; CHRONIC LYMPHOCYTIC-LEUKEMIA; RNA EDITING ENZYME; V GENE CONVERSION	Activation-induced cytidine deaminase (AID) has been shown to trigger three mechanisms for diversifying immunoglobulin genes-somatic hypermutation, isotype switch recombination and gene conversion-most probably by initiating cytidine deamination at the immunoglobulin locus. Although this deamination process has been shown to be potentially mutagenic by itself, most of the mutations generated in the physiological hypermutation process seem to be created through the AID-mediated assembly of a mutasome complex involving specific repair activities and error-prone DNA polymerases.	Fac Med Necker Enfants Malad, INSERM, U373, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Reynaud, CA (corresponding author), Fac Med Necker Enfants Malad, INSERM, U373, 156 Rue Vaugirard, F-75730 Paris 15, France.		Aoufouchi, Said/I-2985-2016; AOUFOUCHI, Said/P-9926-2019	AOUFOUCHI, Said/0000-0001-6547-2664				Alabyev B, 2002, J IMMUNOL, V169, P3819, DOI 10.4049/jimmunol.169.7.3819; Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kong QZ, 2001, GENETICS, V158, P369; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Pan-Hammarstrom Q, 2003, J IMMUNOL, V170, P3707, DOI 10.4049/jimmunol.170.7.3707; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Phung QH, 1999, J IMMUNOL, V162, P3121; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Spencer J, 1999, J IMMUNOL, V162, P6596; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tissier A, 2000, GENE DEV, V14, P1642; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; Weill JC, 2002, ADV IMMUNOL, V80, P183, DOI 10.1016/S0065-2776(02)80015-3; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yavuz S, 2002, J IMMUNOL, V169, P3825, DOI 10.4049/jimmunol.169.7.3825; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	107	61	74	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					631	638		10.1038/ni0703-631	http://dx.doi.org/10.1038/ni0703-631			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830138				2022-12-18	WOS:000183952500006
J	Imler, JL; Hoffmann, JA				Imler, JL; Hoffmann, JA			Toll signaling: the TIReless quest for specificity	NATURE IMMUNOLOGY			English	Editorial Material							TRANSDUCTION; ACTIVATION; PATHWAY	The identification of a third TIR domain adaptor molecule involved in TLR3-mediated interferon-induction helps explain TLR signaling specificity.	Inst Biol Mol & Cellulaire, CNRS, UPR9022, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Imler, JL (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR9022, 15 Rue Rene Descartes, F-67000 Strasbourg, France.		Imler, Jean-Luc/GXH-4323-2022					Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	14	61	65	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					105	106		10.1038/ni0203-105	http://dx.doi.org/10.1038/ni0203-105			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555093				2022-12-18	WOS:000180686500007
J	Mak, TW; Hakem, A; McPherson, JP; Shehabeldin, A; Zablocki, E; Migon, E; Duncan, GS; Bouchard, D; Wakeham, A; Cheung, A; Karaskova, J; Sarosi, I; Squire, J; Marth, J; Hakem, R				Mak, TW; Hakem, A; McPherson, JP; Shehabeldin, A; Zablocki, E; Migon, E; Duncan, GS; Bouchard, D; Wakeham, A; Cheung, A; Karaskova, J; Sarosi, I; Squire, J; Marth, J; Hakem, R			BracI required for T cell linage development but not TCR loci rearrangement	NATURE IMMUNOLOGY			English	Article							EARLY EMBRYONIC LETHALITY; DNA-DAMAGE RESPONSE; IN-VIVO; BRCA1; GENE; BCL-2; MICE; CYCLE; P53; PHOSPHORYLATION	Brca1 (breast cancer1, early onset) deficiency results in early embryonic lethality. As Brca1 is highly expressed in the T cell lineage, a T cell-specific disruption of Brca1 was generated to assess the role of BrcaI in relation to T lymphocyte development. We found that thymocyte development in Brca1(-/-) mice was impaired not as a result of V(D)J T cell receptor (TCR) recombination but because thymocytes had increased expression of tumor protein p53, Chromosomal damage accumulation and abnormal cell death were observed in mutant cells. We found that cell death inhibitor Bcl-2 overexpression, or p53(-/-) backgrounds, completely restored survival and development of Brca1(-/-)thymocytes; peripheral T cell numbers were not totally restored in Brca1(-/-) p53(-/-) mice; and that a mutant background for p21 (cyclin-dependent kinase inhibitor IA) did not restore Brca1(-)/(-) thymocyte development, but partially restored peripheral T cell development. Thus, the outcome of Brca1 deficiency was dependent on cellular context, with the major defects being increased apoptosis in thymocytes, and defective proliferation in peripheral T cells.	Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Amgen Inst, Thousand Oaks, CA 91320 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hakem, R (corresponding author), Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Squire, Jeremy/A-9352-2012	Hakem, Razqallah/0000-0001-5948-7931; Squire, Jeremy/0000-0002-9863-468X				BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chen YM, 1996, CANCER RES, V56, P3168; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dracopoli NC, 1999, CURRENT PROTOCOLS HU; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gudas JM, 1996, CELL GROWTH DIFFER, V7, P717; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Mild Y, 1994, SCIENCE, V266, P66; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	37	61	61	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					77	82		10.1038/76950	http://dx.doi.org/10.1038/76950			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881179				2022-12-18	WOS:000089814800018
J	Kroemer, G; Galassi, C; Zitvogel, L; Galluzzi, L				Kroemer, Guido; Galassi, Claudia; Zitvogel, Laurence; Galluzzi, Lorenzo			Immunogenic cell stress and death	NATURE IMMUNOLOGY			English	Review							DISULFIDE-ISOMERASE A3; CLASS-I EXPRESSION; CALRETICULIN EXPOSURE; ENDOPLASMIC-RETICULUM; ANTICANCER CHEMOTHERAPY; ANTITUMOR IMMUNITY; APOPTOTIC CELLS; CANCER; PROTEIN; RECEPTOR	Immunogenic cell death (ICD) is central to both homeostatic and pathophysiological events. Kroemer et al. review the mechanisms of ICD and its role in therapy and disease. Dying mammalian cells emit numerous signals that interact with the host to dictate the immunological correlates of cellular stress and death. In the absence of reactive antigenic determinants (which is generally the case for healthy cells), such signals may drive inflammation but cannot engage adaptive immunity. Conversely, when cells exhibit sufficient antigenicity, as in the case of infected or malignant cells, their death can culminate with adaptive immune responses that are executed by cytotoxic T lymphocytes and elicit immunological memory. Suggesting a key role for immunogenic cell death (ICD) in immunosurveillance, both pathogens and cancer cells evolved strategies to prevent the recognition of cell death as immunogenic. Intriguingly, normal cells succumbing to conditions that promote the formation of post-translational neoantigens (for example, oxidative stress) can also drive at least some degree of antigen-specific immunity, pointing to a novel implication of ICD in the etiology of non-infectious, non-malignant disorders linked to autoreactivity.	[Kroemer, Guido] Sorbonne Univ, Univ Paris, Inst Univ France, Ctr Rech Cordeliers,INSERM U1138,Equipe Labellise, Paris, France; [Kroemer, Guido] Gustave Roussy Canc Ctr, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Galassi, Claudia; Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10021 USA; [Zitvogel, Laurence] Gustave Roussy Comprehens Canc Inst, Villejuif, France; [Zitvogel, Laurence] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] INSERM U1015, Villejuif, France; [Zitvogel, Laurence] Equipe Labellisee Ligue Canc, Villejuif, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT BIOTHERIS, Villejuif, France; [Galluzzi, Lorenzo] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo] Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Cornell University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Kroemer, G (corresponding author), Sorbonne Univ, Univ Paris, Inst Univ France, Ctr Rech Cordeliers,INSERM U1138,Equipe Labellise, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Canc Ctr, Metabol & Cell Biol Platforms, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10021 USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA.	kroemer@orange.fr; deadoc80@gmail.com	; Kroemer, Guido/B-4263-2013	ZITVOGEL, laurence/0000-0003-1596-0998; Kroemer, Guido/0000-0002-9334-4405	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR)-Projets blancs; AMMICa [US23/CNRS UMS3655]; Association pour la recherche sur le cancer (ARC); Association "Ruban Rose"; Canceropole Ile-de-France; Fondation pour la Recherche Medicale (FRM); Equipex Onco-Pheno-Screen; European Joint Programme on Rare Diseases (EJPRD); Gustave Roussy Odyssea; European Union Horizon 2020 Project Oncobiome; European Union Horizon 2020 Project Crimson; Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LabEx Immuno-Oncology [ANR-18-IDEX-0001]; Leducq Foundation; Cancer Research ASPIRE Award from the Mark Foundation; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Breakthrough Level 2 grant from the US DoD BRCP [BC180476P1]; 2019 Laura Ziskin Prize in Translational Research from the Stand Up to Cancer (SU2C) [ZP-6177]; Mantle Cell Lymphoma Research Initiative (MCL-RI) grant from the Leukemia and Lymphoma Society (LLS); Department of Radiation Oncology at Weill Cornell Medicine; Rapid Response Grant from the Functional Genomics Initiative; Lytix Biopharma; Phosplatin	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR)-Projets blancs(French National Research Agency (ANR)); AMMICa; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association "Ruban Rose"; Canceropole Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Equipex Onco-Pheno-Screen; European Joint Programme on Rare Diseases (EJPRD); Gustave Roussy Odyssea; European Union Horizon 2020 Project Oncobiome; European Union Horizon 2020 Project Crimson; Fondation Carrefour; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Inserm (HTE); Institut Universitaire de France; LabEx Immuno-Oncology; Leducq Foundation(Leducq Foundation); Cancer Research ASPIRE Award from the Mark Foundation; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Breakthrough Level 2 grant from the US DoD BRCP; 2019 Laura Ziskin Prize in Translational Research from the Stand Up to Cancer (SU2C); Mantle Cell Lymphoma Research Initiative (MCL-RI) grant from the Leukemia and Lymphoma Society (LLS); Department of Radiation Oncology at Weill Cornell Medicine; Rapid Response Grant from the Functional Genomics Initiative; Lytix Biopharma; Phosplatin	We are indebted to G. Petroni (Weill Cornell Medical College) for help with figure preparation. G. K. is supported by the Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR)-Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association "Ruban Rose"; Canceropole Ile-de-France; Fondation pour la Recherche Medicale (FRM); a donation by Elior; Equipex Onco-Pheno-Screen; the European Joint Programme on Rare Diseases (EJPRD); Gustave Roussy Odyssea, the European Union Horizon 2020 Projects Oncobiome and Crimson; Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); the Leducq Foundation; a Cancer Research ASPIRE Award from the Mark Foundation; the RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Universite de Paris ANR-18-IDEX-0001. L. G.'s lab is supported by a Breakthrough Level 2 grant from the US DoD BRCP (#BC180476P1), by the 2019 Laura Ziskin Prize in Translational Research (no. ZP-6177, PI: Formenti) from the Stand Up to Cancer (SU2C), by a Mantle Cell Lymphoma Research Initiative (MCL-RI, PI: Chen-Kiang) grant from the Leukemia and Lymphoma Society (LLS), by a startup grant from the Department of Radiation Oncology at Weill Cornell Medicine, by a Rapid Response Grant from the Functional Genomics Initiative, by industrial collaborations with Lytix Biopharma and Phosplatin, and by donations from Phosplatin, the Luke Heller TECPR2 Foundation, Sotio a.s., Onxeo and Noxopharm (Chatswood, Australia).	Aaes TL, 2021, CELL DEATH DIFFER, V28, P843, DOI 10.1038/s41418-020-00658-y; Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Allard B, 2020, NAT REV CLIN ONCOL, V17, P611, DOI 10.1038/s41571-020-0382-2; Anderton H, 2020, NAT REV RHEUMATOL, V16, P496, DOI 10.1038/s41584-020-0455-8; Apavaloaei A, 2020, CANCERS, V12, DOI 10.3390/cancers12092607; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Aslam B, 2015, GENET MOL RES, V14, P4215, DOI 10.4238/2015.April.28.4; Bagchi P, 2020, INT REV CEL MOL BIO, V350, P265, DOI 10.1016/bs.ircmb.2019.10.005; Banstola A, 2021, J CONTROL RELEASE, V337, P505, DOI 10.1016/j.jconrel.2021.07.038; Baracco EE, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1647760; Barreda DR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0007-2015; Bedoui S, 2020, NAT REV MOL CELL BIO, V21, P678, DOI 10.1038/s41580-020-0270-8; Bezu L, 2018, CELL DEATH DIFFER, V25, P1375, DOI 10.1038/s41418-017-0044-9; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Bommareddy PK, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1591875; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Bruschi M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051348; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Bugaut H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065181; Buqu? A., 2020, NAT COMMUN, V11; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; Canton J, 2021, NAT IMMUNOL, V22, P140, DOI 10.1038/s41590-020-00824-x; Caorsi C, 2016, TRANSL RES, V171, P17, DOI 10.1016/j.trsl.2015.12.013; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chapon M, 2019, J VIROL, V93, DOI 10.1128/JVI.01446-19; Chen YY, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02791-9; Choi J, 2021, ACS NANO, V15, P12086, DOI 10.1021/acsnano.1c03416; ChonL HJ, 2019, J CANCER, V10, P4932, DOI 10.7150/jca.32806; Christensen MH, 2016, EMBO J, V35, P1385, DOI 10.15252/embj.201593458; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Clement CC, 2021, IMMUNITY, V54, P721, DOI 10.1016/j.immuni.2021.02.019; Cordova MJ, 2017, LANCET PSYCHIAT, V4, P330, DOI 10.1016/S2215-0366(17)30014-7; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15; de Oca RM, 2021, MOL CANCER THER, V20, P1941, DOI 10.1158/1535-7163.MCT-21-0035; Derosa L, 2021, CANCER DISCOV, V11, P2396, DOI 10.1158/2159-8290.CD-21-0236; Di Maio M, 2005, LANCET ONCOL, V6, P669, DOI 10.1016/S1470-2045(05)70255-2; Dorward DA, 2017, THORAX, V72, P928, DOI 10.1136/thoraxjnl-2017-210030; Dufour F, 2011, APOPTOSIS, V16, P256, DOI 10.1007/s10495-010-0560-2; Ekanayaka P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009057; Engelhard VH, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000262; Rodriguez-Ruiz ME, 2020, NAT IMMUNOL, V21, P120, DOI 10.1038/s41590-019-0561-4; Fabian KP, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.728018; Feng MY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05211-7; Ferrere G, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145207; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Fucikova J, 2021, CELL RES, V31, P5, DOI 10.1038/s41422-020-0383-9; Fucikova J, 2016, BLOOD, V128, P3113, DOI [10.1182/blood-2016-08-731737, 10.1182/blood-2016-08731737]; Fucikova J, 2016, CANCER RES, V76, P1746, DOI 10.1158/0008-5472.CAN-15-1142; Fucikova J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00402; Galaine J, 2019, INT J CANCER, V145, P3112, DOI 10.1002/ijc.32620; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Galluzzi L, 2020, NAT REV CLIN ONCOL, V17, P725, DOI 10.1038/s41571-020-0413-z; Galluzzi Lorenzo, 2020, J Immunother Cancer, V8, DOI 10.1136/jitc-2019-000337; Galluzzi L, 2018, NAT REV MOL CELL BIO, V19, P731, DOI 10.1038/s41580-018-0068-0; Galluzzi L, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7807; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gao B, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008690; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garnett TO, 2006, CELL DEATH DIFFER, V13, P1915, DOI 10.1038/sj.cdd.4401886; Garrido F, 2019, ADV EXP MED BIOL, V1151, P79, DOI 10.1007/978-3-030-17864-2_3; Georgieva M, 2019, NAT REV IMMUNOL, V19, P55, DOI 10.1038/s41577-018-0092-5; Giampazolias E, 2021, CELL, V184, P4016, DOI 10.1016/j.cell.2021.05.021; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28518; Gomes-da-Silva LC, 2018, EMBO J, V37, DOI 10.15252/embj.201798354; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gulla A, 2021, BLOOD CANCER DISCOV, V2, P468, DOI 10.1158/2643-3230.BCD-21-0047; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hangai S, 2021, NAT IMMUNOL, V22, P947, DOI 10.1038/s41590-021-00967-5; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Harvey IB, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007711; Hayashi K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19970-9; Herr RA, 2012, J BIOL CHEM, V287, P14467, DOI 10.1074/jbc.M111.325340; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Humeau J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2642-6; Humeau J, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911622; Imre G, 2020, INT REV CEL MOL BIO, V353, P211, DOI 10.1016/bs.ircmb.2019.12.008; Jaime-Sanchez P, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000528; Jhunjhunwala S, 2021, NAT REV CANCER, V21, P298, DOI 10.1038/s41568-021-00339-z; Kallwellis-Opara A, 2007, CLIN RES CARDIOL, V96, P469, DOI 10.1007/s00392-007-0524-x; Kasikova L, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0781-z; Katayama H, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002549; Kepp O, 2021, EMBO J, V40, DOI 10.15252/embj.2021108130; Kepp O, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1795995; Kepp O, 2020, NAT REV CLIN ONCOL, V17, P49, DOI 10.1038/s41571-019-0272-7; Kepp O, 2009, CELL CYCLE, V8, P3971, DOI 10.4161/cc.8.23.10191; Kim H., 2020, SCI TRANSL MED, V12; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klionsky DJ, 2021, EMBO J, V40, DOI 10.15252/embj.2021108863; Knowles A, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.645161; Komurasaki R, 2010, DRUG METAB PHARMACOK, V25, P84, DOI 10.2133/dmpk.25.84; Kraehenbuehl L, 2022, NAT REV CLIN ONCOL, V19, P37, DOI 10.1038/s41571-021-00552-7; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kvansakul M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100290; Kwon WY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018538118; Ladoire S, 2016, AUTOPHAGY, V12, P864, DOI 10.1080/15548627.2016.1154244; Larson RC, 2021, NAT REV CANCER, V21, P145, DOI 10.1038/s41568-020-00323-z; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Le Naour J, 2021, CANCER DISCOV, V11, P408, DOI 10.1158/2159-8290.CD-20-0465; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1771143; Lhuillier C, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138740; Li ZG, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe9890; Liang YS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007075; Lin H, 2021, CANCER CELL, V39, P480, DOI 10.1016/j.ccell.2020.12.023; Lind NA, 2022, NAT REV IMMUNOL, V22, P224, DOI 10.1038/s41577-021-00577-0; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Liu P, 2020, MOL CELL, V77, P748, DOI 10.1016/j.molcel.2019.11.004; Liu P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09415-3; Liu YZ, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01362-6; Liu ZJ, 2021, IMMUNITY, V54, P247, DOI 10.1016/j.immuni.2020.11.020; Lochhead RB, 2021, NAT REV RHEUMATOL, V17, P449, DOI 10.1038/s41584-021-00648-5; Lopez-Otin C, 2021, CELL, V184, P33, DOI 10.1016/j.cell.2020.11.034; Luchetti G, 2021, CELL HOST MICROBE, V29, P1521, DOI 10.1016/j.chom.2021.08.010; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Madeo F, 2009, CELL CYCLE, V8, P639, DOI 10.4161/cc.8.4.7794; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mandujano-Tinoco EA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081853; Manganelli V, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/4570715; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Melacarne A, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109312; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Menetrier-Caux C, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0549-5; Meric-Bernstam F, 2021, LANCET, V397, P1010, DOI 10.1016/S0140-6736(20)32598-8; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mihaylova N, 2020, CLIN EXP IMMUNOL, V199, P278, DOI 10.1111/cei.13399; Minute L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000325; Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774; Moesta AK, 2020, NAT REV IMMUNOL, V20, P739, DOI 10.1038/s41577-020-0376-4; Mukherjee S, 2019, SCAND J IMMUNOL, V90, DOI 10.1111/sji.12771; Ngwa W, 2018, NAT REV CANCER, V18, P313, DOI 10.1038/nrc.2018.6; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Nooraei S, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-021-00806-7; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Obradovic MMS, 2019, NATURE, V567, P540, DOI 10.1038/s41586-019-1019-4; Osei-Owusu P, 2019, NATURE, V574, P57, DOI 10.1038/s41586-019-1570-z; Paillet J, 2021, J EXP MED, V218, DOI 10.1084/jem.20200853; Paludan SR, 2021, NAT REV IMMUNOL, V21, P137, DOI 10.1038/s41577-020-0391-5; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pandolfi JB, 2016, J IMMUNOL, V196, P3287, DOI 10.4049/jimmunol.1502506; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Patel P, 2020, INT REV CEL MOL BIO, V353, P153, DOI 10.1016/bs.ircmb.2019.11.005; Pauleau AL, 2007, ONCOGENE, V26, P7067, DOI 10.1038/sj.onc.1210511; Petrazzuolo A, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03997-x; Petroni G, 2021, CANCER CELL, V39, P310, DOI 10.1016/j.ccell.2020.11.009; Petroni G, 2020, NAT REV IMMUNOL, V20, P669, DOI 10.1038/s41577-020-0300-y; Picardo M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.11; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pozzi C, 2016, NAT MED, V22, P624, DOI 10.1038/nm.4078; Rabouw HH, 2020, NAT MICROBIOL, V5, P1361, DOI 10.1038/s41564-020-0759-0; Raffin C, 2020, NAT REV IMMUNOL, V20, P158, DOI 10.1038/s41577-019-0232-6; Ranta A, 2020, INT REV CEL MOL BIO, V357, P1, DOI 10.1016/bs.ircmb.2020.09.008; Rasmussen ML, 2020, INT REV CEL MOL BIO, V353, P255, DOI 10.1016/bs.ircmb.2019.12.005; Regent A, 2014, CLIN IMMUNOL, V153, P123, DOI 10.1016/j.clim.2014.03.020; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rieder M, 2011, J VIROL, V85, P842, DOI 10.1128/JVI.01427-10; Roberti MP, 2020, NAT MED, V26, P919, DOI 10.1038/s41591-020-0882-8; Robertson-Tessi M, 2012, J THEOR BIOL, V294, P56, DOI 10.1016/j.jtbi.2011.10.027; Roda G, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0156-2; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Rothlin CV, 2021, NAT REV IMMUNOL, V21, P292, DOI 10.1038/s41577-020-00456-0; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Rubartelli A, 2009, ANTIOXID REDOX SIGN, V11, P2621, DOI 10.1089/ars.2009.2377; Rubio RM, 2019, P NATL ACAD SCI USA, V116, P26941, DOI 10.1073/pnas.1915139116; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Rybstein MD, 2018, NAT CELL BIOL, V20, P243, DOI 10.1038/s41556-018-0042-2; Saelens X, 2005, J CELL BIOL, V168, P545, DOI 10.1083/jcb.200407162; Safa Ahmad R, 2019, Biomark J, V5, DOI 10.36648/2472-1646.5.1.59; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Salas-Benito D, 2021, CANCER DISCOV, V11, P1353, DOI 10.1158/2159-8290.CD-20-1312; Sanchez D, 2016, AUTOIMMUNITY, V49, P554, DOI 10.1080/08916934.2016.1214822; Sarhan M, 2018, PHYSIOL REV, V98, P727, DOI 10.1152/physrev.00041.2016; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Schaper F, 2017, CLIN EXP IMMUNOL, V188, P412, DOI 10.1111/cei.12951; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Senovilla L, 2012, ONCOTARGET, V3, P1270; Sequeira GR, 2021, CANCER RES, V81, P1375, DOI 10.1158/0008-5472.CAN-20-1441; Shalapour S, 2020, ANNU REV IMMUNOL, V38, P649, DOI 10.1146/annurev-immunol-082019-081656; Shekarian T, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat5025; Shiode Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72294-y; Sikic BI, 2019, J CLIN ONCOL, V37, P946, DOI 10.1200/JCO.18.02018; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Song XX, 2020, CANCER DISCOV, V10, P1872, DOI 10.1158/2159-8290.CD-20-0402; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Sprooten J, 2020, INT REV CEL MOL BIO, V350, P63, DOI 10.1016/bs.ircmb.2019.10.004; Stoll G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1299302; Sukkurwala AQ, 2014, CELL DEATH DIFFER, V21, P59, DOI 10.1038/cdd.2013.73; Suresh S, 2021, TRENDS CANCER, V7, P580, DOI 10.1016/j.trecan.2021.04.002; Suresh S, 2020, NAT CANCER, V1, DOI 10.1038/s43018-020-0056-0; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Szekanecz Z, 2021, NAT REV RHEUMATOL, V17, P585, DOI 10.1038/s41584-021-00652-9; Sztupinszki Z, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2020.1859064; Tal MC, 2020, MBIO, V11, DOI 10.1128/mBio.01293-20; Tatsuno K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1819-3; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Tokuhiro K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14254; Tonnus W, 2021, NAT REV ENDOCRINOL, V17, P497, DOI 10.1038/s41574-021-00499-w; Toroney R, 2010, J MOL BIOL, V400, P393, DOI 10.1016/j.jmb.2010.04.059; Truxova I, 2020, HAEMATOLOGICA, V105, P1868, DOI 10.3324/haematol.2019.223933; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Vacchelli E, 2016, CANCER RES, V76, P3122, DOI 10.1158/0008-5472.CAN-16-0294; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Vanpouille-Box C, 2018, CANCER CELL, V34, P361, DOI 10.1016/j.ccell.2018.05.013; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vazquez C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253089; Veglia F, 2021, NAT REV IMMUNOL, V21, P485, DOI 10.1038/s41577-020-00490-y; Wang ZY, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009940; Wang ZN, 2019, J CLIN INVEST, V129, P4850, DOI 10.1172/JCI127471; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wen W, 2019, VIROLOGY, V535, P122, DOI 10.1016/j.virol.2019.06.017; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Winter M, 2017, MOL CELL PROTEOMICS, V16, P855, DOI 10.1074/mcp.M116.066597; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; Xie W, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1656502; Yamamoto K, 2020, NATURE, V581, P100, DOI 10.1038/s41586-020-2229-5; Yamazaki T, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1797292; Yamazaki T, 2020, NAT IMMUNOL, V21, P1160, DOI 10.1038/s41590-020-0751-0; Yamazaki T, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1721810; Yang H, 2019, NAT MED, V25, P1428, DOI 10.1038/s41591-019-0566-4; Yang WQ, 2020, CLIN IMMUNOL, V212, P67, DOI 10.1016/j.clim.2020.108350; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yla-Anttila P, 2021, AUTOPHAGY, V17, P3461, DOI 10.1080/15548627.2021.1874660; Yonekura, CANCER DISCOV; Yuen CK, 2016, J VIROL, V90, P3902, DOI 10.1128/JVI.00129-16; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhao RY, 2017, MICROB CELL, V4, P311, DOI 10.15698/mic2017.10.592; Zhou YX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025840118; Zitvogel L, 2021, NAT REV CLIN ONCOL, V18, P591, DOI 10.1038/s41571-021-00508-x; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	251	60	60	82	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					487	500		10.1038/s41590-022-01132-2	http://dx.doi.org/10.1038/s41590-022-01132-2		FEB 2022	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35145297	Bronze			2022-12-18	WOS:000753930000001
J	Xu, HN; Jiang, Y; Xu, XQ; Su, XP; Liu, Y; Ma, YW; Zhao, Y; Shen, ZY; Huang, B; Cao, XT				Xu, Henan; Jiang, Yan; Xu, Xiaoqing; Su, Xiaoping; Liu, Yang; Ma, Yuanwu; Zhao, Yong; Shen, Zhongyang; Huang, Bo; Cao, Xuetao			Inducible degradation of lncRNA Sros1 promotes IFN-gamma-mediated activation of innate immune responses by stabilizing Stat1 mRNA	NATURE IMMUNOLOGY			English	Article							LONG NONCODING RNA; LISTERIA-MONOCYTOGENES; SUSCEPTIBILITY; PHOSPHORYLATION; MICRORNAS; CAPRIN-1; GRANULES; PROTEIN; SYSTEM; ROLES	Interferon-gamma (IFN-gamma) is essential for the innate immune response to intracellular bacteria. Noncoding RNAs and RNA-binding proteins (RBPs) need to be further considered in studies of regulation of the IFN-gamma-activated signaling pathway in macrophages. In the present study, we found that the microRNA miR-1 promoted IFN-gamma-mediated clearance of Listeria monocytogenes in macrophages by indirectly stabilizing the Stat1 messenger RNA through the degradation of the cytoplasmic long noncoding RNA Sros1. Inducible degradation or genetic loss of Sros1 led to enhanced IFN-gamma-dependent activation of the innate immune response. Mechanistically, Sros1 blocked the binding of Stat1 mRNA to the RBP CAPRIN1, which stabilized the Stat1 mRNA and, consequently, promoted IFN-gamma-STAT1-mediated innate immunity. These observations shed light on the complex RNA-RNA regulatory networks involved in cytokine-initiated innate responses in host-pathogen interactions.	[Xu, Henan; Jiang, Yan; Xu, Xiaoqing; Liu, Yang; Huang, Bo; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Xu, Henan; Jiang, Yan; Xu, Xiaoqing; Liu, Yang; Huang, Bo; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China; [Xu, Henan; Su, Xiaoping; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Xu, Henan; Su, Xiaoping; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Ma, Yuanwu] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Med Sci, Fuwai Cent China Cardiovasc Hosp, Zhengzhou, Henan, Peoples R China; [Shen, Zhongyang] Tianjin First Ctr Hosp, Tianjin, Peoples R China; [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Nankai University	Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	caoxt@immunol.org		Ma, Yuanwu/0000-0002-1882-1777	National Natural Science Foundation of China [81788101]; Chinese Academy of Medical Sciences' Innovation Fund for Medical Sciences [2016-12M-1-003]; National Key Research and Development Program of China [2018YFA0507403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences' Innovation Fund for Medical Sciences; National Key Research and Development Program of China	This work is supported by grants from the National Natural Science Foundation of China (grant no. 81788101), Chinese Academy of Medical Sciences' Innovation Fund for Medical Sciences (grant no. 2016-12M-1-003) and the National Key Research and Development Program of China (grant no. 2018YFA0507403). We thank H. Lin for technical help.	Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bettencourt P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00019; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Chen YG, 2017, NAT IMMUNOL, V18, P962, DOI 10.1038/ni.3771; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jiang MH, 2018, CELL, V173, P906, DOI 10.1016/j.cell.2018.03.064; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu S, 2018, NAT IMMUNOL, V19, P41, DOI 10.1038/s41590-017-0003-0; Lu D, 2015, NAT IMMUNOL, V16, P1263, DOI 10.1038/ni.3278; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Nakayama K, 2017, ELIFE, V6, DOI 10.7554/eLife.29677; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Scortti M, 2006, NAT MED, V12, P515, DOI 10.1038/nm1396; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Su XP, 2015, CANCER RES, V75, P2875, DOI 10.1158/0008-5472.CAN-14-2218; Su XP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3903; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wei YS, 2014, CELL RES, V24, P278, DOI 10.1038/cr.2014.12; Witte S, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.44; Wu UI, 2015, LANCET INFECT DIS, V15, P968, DOI 10.1016/S1473-3099(15)00089-4; Wu YH, 2016, ACTA CRYSTALLOGR D, V72, P718, DOI 10.1107/S2059798316004903; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang Q, 2019, NAT REV IMMUNOL, V19, P417, DOI 10.1038/s41577-019-0151-6	48	60	62	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1621	+		10.1038/s41590-019-0542-7	http://dx.doi.org/10.1038/s41590-019-0542-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31740800				2022-12-18	WOS:000497949800017
J	Radermecker, C; Sabatel, C; Vanwinge, C; Ruscitti, C; Marechal, P; Perin, F; Schyns, J; Rocks, N; Toussaint, M; Cataldo, D; Johnston, SL; Bureau, F; Marichal, T				Radermecker, Coraline; Sabatel, Catherine; Vanwinge, Celine; Ruscitti, Cecilia; Marechal, Pauline; Perin, Fabienne; Schyns, Joey; Rocks, Natacha; Toussaint, Marie; Cataldo, Didier; Johnston, Sebastian L.; Bureau, Fabrice; Marichal, Thomas			Locally instructed CXCR4(hi) neutrophils trigger environment-driven allergic asthma through the release of neutrophil extracellular traps	NATURE IMMUNOLOGY			English	Article							RESPIRATORY-INFECTIONS; DENDRITIC CELLS; DUST; IMMUNITY; SUSCEPTIBILITY; ENDOTOXIN; RESPONSES; EXPOSURE; PROMOTES; RISK	Low exposure to microbial products, respiratory viral infections and air pollution are major risk factors for allergic asthma, yet the mechanistic links between such conditions and host susceptibility to type 2 allergic disorders remain unclear. Through the use of single-cell RNA sequencing, we characterized lung neutrophils in mice exposed to a pro-allergic low dose of lipopolysaccharide (LPS) or a protective high dose of LPS before exposure to house dust mites. Unlike exposure to a high dose of LPS, exposure to a low dose of LPS instructed recruited neutrophils to upregulate their expression of the chemokine receptor CXCR4 and to release neutrophil extracellular traps. Low-dose LPS-induced neutrophils and neutrophil extracellular traps potentiated the uptake of house dust mites by CD11b(+)Ly-6C(+) dendritic cells and type 2 allergic airway inflammation in response to house dust mites. Neutrophil extracellular traps derived from CXCR4(hi) neutrophils were also needed to mediate allergic asthma triggered by infection with influenza virus or exposure to ozone. Our study indicates that apparently unrelated environmental risk factors can shape recruited lung neutrophils to promote the initiation of allergic asthma.	[Radermecker, Coraline; Sabatel, Catherine; Schyns, Joey; Bureau, Fabrice; Marichal, Thomas] Univ Liege, GIGA Inst, Lab Cellular & Mol Immunol, Liege, Belgium; [Radermecker, Coraline; Ruscitti, Cecilia; Marechal, Pauline; Schyns, Joey; Marichal, Thomas] Univ Liege, GIGA Inst, Immunophysiol Lab, Liege, Belgium; [Radermecker, Coraline; Sabatel, Catherine; Ruscitti, Cecilia; Marechal, Pauline; Schyns, Joey; Bureau, Fabrice; Marichal, Thomas] Univ Liege, Fac Vet Med, Liege, Belgium; [Vanwinge, Celine; Perin, Fabienne; Rocks, Natacha; Cataldo, Didier] Univ Liege, Lab Tumor & Dev Biol, GIGA Inst, Liege, Belgium; [Toussaint, Marie] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Toussaint, Marie; Johnston, Sebastian L.] MRC, London, England; [Toussaint, Marie; Johnston, Sebastian L.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Johnston, Sebastian L.] Imperial Coll Healthcare Natl Hlth Serv Trust, London, England; [Bureau, Fabrice; Marichal, Thomas] Walloon Excellence Life Sci & Biotechnol, Wallonia, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; Imperial College London; University of London; King's College London; Imperial College London; WELBIO	Marichal, T (corresponding author), Univ Liege, GIGA Inst, Immunophysiol Lab, Liege, Belgium.; Bureau, F; Marichal, T (corresponding author), Univ Liege, Fac Vet Med, Liege, Belgium.; Bureau, F; Marichal, T (corresponding author), Walloon Excellence Life Sci & Biotechnol, Wallonia, Belgium.	fabrice.bureau@uliege.be; t.marichal@uliege.be	Johnston, Sebastian Lennox/I-2423-2012; Cataldo, Didier/GPG-3453-2022	Johnston, Sebastian Lennox/0000-0003-3009-9200; 	Asthma UK [CH11SJ]; Medical Research Council Center grant [G1000758]; F.R.S.-FNRS for the FRFS-WELBIO [CR-2012S-01R]; Excellence Of Science (EOS) grant; 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS [F.4508.18]; FRFS-WELBIO [CR-2017s-04]; Acteria Foundation; ERC [ERC-StG-2018 IM-ID 801823]	Asthma UK; Medical Research Council Center grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); F.R.S.-FNRS for the FRFS-WELBIO; Excellence Of Science (EOS) grant; 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS; FRFS-WELBIO(WELBIO); Acteria Foundation; ERC(European Research Council (ERC)European Commission)	We thank F. Trottein (Pasteur Institute, Lille, France) for providing us with the Influenza A virus H1N1 PR8/34 strain; S. Ormenese, R. Stefan, J.-J. Goval and A. Hego from the GIGA Flow Cytometry and Cell Imaging Platform; P. Drion and all staff members from the GIGA Mouse facility and Transgenics Platform; C. Humblet and staff members from the GIGA Immunohistology Platform; B. Charloteaux, M. Deckers, L. Karim and members from the GIGA Genomics Platform; C. Desmet and D. Pirottin for insightful discussions; and C. Francois, R. Fares and I. Sbai for their excellent technical and administrative support. C.Radermecker and C.S. were research fellows of the F.R.SFNRS; S.L.J. was supported by a Chair from Asthma UK (no. CH11SJ, to S.L.J.) and Medical Research Council Center grant (no. G1000758, to S.L.J.); F.B. is supported by the F.R.S.-FNRS for the FRFS-WELBIO (grant no. CR-2012S-01R to F.B.) and by an Excellence Of Science (EOS) grant. T.M. is a Research Associate of the F.R.S.-FNRS and is supported by an 'Incentive Grant for Scientific Research' of the F.R.S.-FNRS (grant no. F.4508.18 to T.M.), by the FRFS-WELBIO (grant no. CR-2017s-04 to T.M.), by the Acteria Foundation and by an ERC Starting Grant (grant no. ERC-StG-2018 IM-ID 801823 to T.M.).	Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Al-Garawi AA, 2009, J IMMUNOL, V182, P3095, DOI 10.4049/jimmunol.0802837; Bonnelykke K, 2015, J ALLERGY CLIN IMMUN, V136, P81, DOI 10.1016/j.jaci.2015.02.024; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Dwyer MP, 2006, J MED CHEM, V49, P7603, DOI 10.1021/jm0609622; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hollingsworth JW, 2010, J ALLERGY CLIN IMMUN, V125, P1167, DOI 10.1016/j.jaci.2010.03.001; Janss T, 2016, EUR J IMMUNOL, V46, P2614, DOI 10.1002/eji.201646513; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Lachowicz-Scroggins ME, 2019, AM J RESP CRIT CARE, V199, P1076, DOI 10.1164/rccm.201810-1869OC; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Larche M, 1998, J IMMUNOL, V161, P6375; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Mesnil C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053242; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Peden DB, 2005, J ALLERGY CLIN IMMUN, V115, P213, DOI 10.1016/j.jaci.2004.12.003; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Radermecker C, 2018, CURR OPIN IMMUNOL, V54, P28, DOI 10.1016/j.coi.2018.05.006; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wang YH, 2011, CURR ALLERGY ASTHM R, V11, P388, DOI 10.1007/s11882-011-0210-y; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	44	60	63	4	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1444	+		10.1038/s41590-019-0496-9	http://dx.doi.org/10.1038/s41590-019-0496-9			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591573	Green Accepted, Green Submitted			2022-12-18	WOS:000492309600015
J	Liang, Y; Tsoi, LC; Xing, XY; Beamer, MA; Swindell, WR; Sarkar, MK; Berthier, CC; Stuart, PE; Harms, PW; Nair, RP; Elder, JT; Voorhees, JJ; Kahlenberg, JM; Gudjonsson, JE				Liang, Yun; Tsoi, Lam C.; Xing, Xianying; Beamer, Maria A.; Swindell, William R.; Sarkar, Mrinal K.; Berthier, Celine C.; Stuart, Philip E.; Harms, Paul W.; Nair, Rajan P.; Elder, James T.; Voorhees, John J.; Kahlenberg, J. Michelle; Gudjonsson, Johann E.			A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REPLACEMENT THERAPY; SALIVARY-GLANDS; EXPRESSION; INTERLEUKIN-7; INTERFERON; SIGNATURE; CELLS; EPIDEMIOLOGY; PATHOGENESIS	Autoimmune diseases affect 7.5% of the US population, and they are among the leading causes of death and disability. A notable feature of many autoimmune diseases is their greater prevalence in females than in males, but the underlying mechanisms of this have remained unclear. Through the use of high-resolution global transcriptome analyses, we demonstrated a female-biased molecular signature associated with susceptibility to autoimmune disease and linked this to extensive sex-dependent co-expression networks. This signature was independent of biological age and sex-hormone regulation and was regulated by the transcription factor VGLL3, which also had a strong female-biased expression. On a genome-wide level, VGLL3-regulated genes had a strong association with multiple autoimmune diseases, including lupus, scleroderma and Sjogren's syndrome, and had a prominent transcriptomic overlap with inflammatory processes in cutaneous lupus. These results identified a VGLL3-regulated network as a previously unknown inflammatory pathway that promotes female-biased autoimmunity. They demonstrate the importance of studying immunological processes in females and males separately and suggest new avenues for therapeutic development.	[Liang, Yun; Tsoi, Lam C.; Xing, Xianying; Beamer, Maria A.; Swindell, William R.; Sarkar, Mrinal K.; Stuart, Philip E.; Harms, Paul W.; Nair, Rajan P.; Elder, James T.; Voorhees, John J.; Gudjonsson, Johann E.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Berthier, Celine C.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Harms, Paul W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Kahlenberg, J. Michelle] Univ Michigan, Div Rheumatol, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gudjonsson, JE (corresponding author), Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA.	johanng@med.umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Harms, Paul/0000-0002-0802-2883; Kahlenberg, J. Michelle/0000-0002-4006-8945; Tsoi, Lam Cheung/0000-0003-1627-5722; Sarkar, Mrinal/0000-0001-8505-4259	US National Institutes of Health [K08-AR060802, R01-AR069071, R03-AR066337, K08-AR063668]; A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award; Doris Duke Charitable Foundation [2013106]; Pfizer Aspire Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069071, K08AR060802, K08AR063668, T32AR007197, R03AR066337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Pfizer Aspire Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A.A. Dlugosz for critical discussions and reading of the manuscript; S. Stoll, Y. Xu, T. Quan, Y. Li, L. Wolterink and L. Reingold for technical help; and A. Libs for help with biopsy samples and files. Supported by the US National Institutes of Health (K08-AR060802 and R01-AR069071to J.E.G.; and R03-AR066337 and K08-AR063668 to J.M.K.), an A. Alfred Taubman Medical Research Institute Kenneth and Frances Eisenberg Emerging Scholar Award (J.E.G.), the Doris Duke Charitable Foundation (2013106 to J.E.G.) and a Pfizer Aspire Award (J.E.G.).	Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4; [Anonymous], 2011, AUTOIMMUNE DIS; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barson NJ, 2015, NATURE, V528, P405, DOI 10.1038/nature16062; Ben-Chetrit E, 2006, RHEUMATOLOGY, V45, P274, DOI 10.1093/rheumatology/kei140; Bikker A, 2011, ANN RHEUM DIS, V70, pA63, DOI 10.1136/ard.2010.149005.14; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gudjonsson JE, 2007, CLIN DERMATOL, V25, P535, DOI 10.1016/j.clindermatol.2007.08.007; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hillen MR, 2016, ANN RHEUM DIS, V75, P1735, DOI 10.1136/annrheumdis-2016-209236; Holroyd CR, 2009, CLIMACTERIC, V12, P378, DOI 10.1080/13697130903025449; Horvath S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4081; Jin JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077605; Jin JO, 2013, ARTHRITIS RHEUM-US, V65, P2132, DOI 10.1002/art.38007; Kachgal S, 2012, CELL ADHES MIGR, V6, P457, DOI 10.4161/cam.22164; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Leitenberger JJ, 2009, ARCH DERMATOL, V145, P545, DOI 10.1001/archdermatol.2009.79; Mackay IR, 2000, BMJ-BRIT MED J, V321, P93, DOI 10.1136/bmj.321.7253.93; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Mok CC, 1998, SCAND J RHEUMATOL, V27, P342, DOI 10.1080/03009749850154357; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2884, DOI 10.1002/art.30493; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rovere P, 2000, BLOOD, V96, P4300; Sanchez-Guerrero J, 2007, ARTHRITIS RHEUM-US, V56, P3070, DOI 10.1002/art.22855; Seligman VA, 2002, AM J MED, V112, P726, DOI 10.1016/S0002-9343(02)01118-X; Shang Y., 2014, J IMMUNOL, V192, P62; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Umazume T, 2015, INVEST OPHTH VIS SCI, V56, P8392, DOI 10.1167/iovs.15-17477; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Woodruff TK, 2014, P NATL ACAD SCI USA, V111, P5063, DOI 10.1073/pnas.1404203111; WUTHRICH RP, 1990, AM J PATHOL, V136, P441; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006	50	60	60	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					152	160		10.1038/ni.3643	http://dx.doi.org/10.1038/ni.3643			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27992404	Green Accepted			2022-12-18	WOS:000392360900009
J	Santambrogio, L; Potolicchio, I; Fessler, SP; Wong, SH; Raposo, G; Strominger, JL				Santambrogio, L; Potolicchio, I; Fessler, SP; Wong, SH; Raposo, G; Strominger, JL			Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells	NATURE IMMUNOLOGY			English	Article							CLASS-II TRANSPORT; DOMAIN-CONTAINING PROTEIN; INVARIANT CHAIN; NITRIC-OXIDE; GAMMA-ADAPTIN; ERYTHROID-DIFFERENTIATION; ANTIGEN PRESENTATION; SORTING SIGNALS; GOLGI NETWORK; ACTIVATION	The involvement of the tetrameric adaptor protein 1 (AP-1) complex in protein sorting in intracellular compartments is not yet completely defined. Here we report that in immature dendritic cells, the beta 1- and gamma-subunits of AP-1 underwent caspase 3-catalyzed cleavage in their hinge regions, resulting in removal of the C-terminal 'ear' domains. Cleavage was inhibited by lipopolysaccharide or caspase inhibitors, each of which led to maturation of the dendritic cells, demonstrated by endosomal remodeling and an increase in surface expression of peptide-loaded major histocompatibility complex class II. Overexpression of similarly truncated AP-1 together with 'silencing' of the endogenous genes in immature dendritic cells did not compromise delivery of major histocompatibility complex class II invariant chain to endosomal compartments. However, after lipopolysaccharide- induced maturation, overexpression of truncated AP-1 and 'silencing' of endogenous genes did result in the anomalous surface accumulation of invariant chain and the peptide-editing molecule H2-DM. Thus, at least one function for intact AP-1 is to retain some proteins in endosomes during the dendritic cell maturation process in which others are allowed to egress to the cell surface.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; CNRS, UMR 144, Inst Curie, F-75005 Paris, France; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Harvard University	Strominger, JL (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	lsantamb@aecom.yu.edu		Raposo, graca/0000-0001-9590-1298	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049524, R01AI048832] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49524, AI48832] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x; Barton GM, 1998, INT IMMUNOL, V10, P1159, DOI 10.1093/intimm/10.8.1159; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brachet V, 1999, MOL BIOL CELL, V10, P2891, DOI 10.1091/mbc.10.9.2891; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; CORRADIN SB, 1993, GLIA, V7, P255, DOI 10.1002/glia.440070309; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Glickman JN, 1996, J CELL BIOL, V132, P769, DOI 10.1083/jcb.132.5.769; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hofmann MW, 1999, J BIOL CHEM, V274, P36153, DOI 10.1074/jbc.274.51.36153; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Kang S, 1998, J BIOL CHEM, V273, P20644, DOI 10.1074/jbc.273.32.20644; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Kongsvik TL, 2002, J BIOL CHEM, V277, P16484, DOI 10.1074/jbc.M201583200; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mayhew TM, 2004, HISTOCHEM CELL BIOL, V122, P171, DOI 10.1007/s00418-004-0685-x; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Moretti A, 2002, P NATL ACAD SCI USA, V99, P11860, DOI 10.1073/pnas.182373099; Mukerjee N, 2001, BIOCHEM BIOPH RES CO, V285, P1192, DOI 10.1006/bbrc.2001.5278; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Nordeng TW, 2002, MOL BIOL CELL, V13, P1846, DOI 10.1091/mbc.01-10-0478; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; RAPOSO G, 1997, HDB EXPT IMMUNOLOGY, P1; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Salamero J, 1996, J BIOL CHEM, V271, P30318, DOI 10.1074/jbc.271.48.30318; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	51	60	63	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1020	1028		10.1038/ni1250	http://dx.doi.org/10.1038/ni1250			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16170319				2022-12-18	WOS:000232027200021
J	Unniraman, S; Zhou, SM; Schatz, DG				Unniraman, S; Zhou, SM; Schatz, DG			Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRAND BREAKS; INDUCED CYTIDINE DEAMINASE; CENTER B-CELLS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; DNA BREAKS; NEOPLASTIC DEVELOPMENT; GENOMIC INSTABILITY; ANTIBODY DIVERSITY	Chromosomal translocations involving immunoglobulin heavy chain (Igh) switch regions and an oncogene such as Myc represent initiating events in the development of many B cell malignancies. These translocations are widely thought to result from aberrant class-switch recombination. To test this model, we measured translocations in mice deficient in activation-induced cytidine deaminase (AID) that lack class-switch recombination. We found that AID made no measurable contribution to the generation of initial translocations, indicating that the intrinsic fragility of the switch regions or a pathway unrelated to AID is responsible for these translocations. In contrast, the outgrowth of translocation-positive cells was dependent on AID, raising the possibility that AID is important in tumor progression, perhaps by virtue of its mutagenic properties.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Schatz, DG (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				BAAR J, 1995, J IMMUNOL, V155, P1911; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; JANZ S, 1993, P NATL ACAD SCI USA, V90, P7361, DOI 10.1073/pnas.90.15.7361; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KATAOKA T, 1983, P NATL ACAD SCI-BIOL, V80, P2666, DOI 10.1073/pnas.80.9.2666; Kenter A, 1999, ANN NY ACAD SCI, V870, P206, DOI 10.1111/j.1749-6632.1999.tb08880.x; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Muller JR, 1996, CANCER RES, V56, P419; Muller JR, 1997, BLOOD, V89, P291, DOI 10.1182/blood.V89.1.291.291_291_296; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; POTTER M, 1964, J NATL CANCER I, V33, P497; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Potter M, 1997, HEMATOL ONCOL CLIN N, V11, P323, DOI 10.1016/S0889-8588(05)70434-2; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; SHACTER E, 1992, BLOOD, V80, P194; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	61	60	60	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1117	1123		10.1038/ni1127	http://dx.doi.org/10.1038/ni1127			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15489857				2022-12-18	WOS:000224692700008
J	Yannoutsos, N; Barreto, V; Misulovin, Z; Gazumyan, A; Yu, W; Rajewsky, N; Peixoto, BR; Eisenreich, T; Nussenzweig, MC				Yannoutsos, N; Barreto, V; Misulovin, Z; Gazumyan, A; Yu, W; Rajewsky, N; Peixoto, BR; Eisenreich, T; Nussenzweig, MC			A cis element in the recombination activating gene locus regulates gene expression by counteracting a distant silencer	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; POSITION-EFFECT VARIEGATION; B-CELLS; V(D)J RECOMBINATION; TRANSGENIC MICE; CONTROL REGIONS; RAG2 PROTEINS; HETEROCHROMATIN; TRANSCRIPTION; THYMOCYTES	We have identified a silencer and an antisilencing element that interact at a distance of 85 kilobases to regulate expression of the recombination activating genes Rag1 and Rag2 in thymocytes. Transgenic experiments showed that Rag promoter-proximal cis elements directed tissue-specific expression and that a Runx-dependent intergenic silencer suppressed expression in developing T cells. Deletion of the antisilencing element from the genomic Rag locus unmasked the intergenic silencer and abrogated Rag expression in developing CD4(+) CD8(+) T cells. We speculate that the Rag antisilencing element belongs to a class of cis elements that might be useful for genome diversification by activating genes encoded by otherwise silent transposable elements.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Yannoutsos, N (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	yannoun@rockvax.rockefeller.edu; nussen@mail.rockefeller.edu	Barreto, Vasco/D-4275-2012; Nussenzweig, Michel/AAE-7292-2019; Barreto, Vasco M./H-2306-2018	Barreto, Vasco/0000-0002-0010-8607; Barreto, Vasco M./0000-0002-0010-8607; Rajewsky, Nikolaus/0000-0002-4785-4332				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; BONIFER C, 1994, NUCLEIC ACIDS RES, V22, P4202, DOI 10.1093/nar/22.20.4202; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Miranda GA, 2002, MOL IMMUNOL, V38, P1151, DOI 10.1016/S0161-5890(02)00007-X; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Monroe RJ, 1999, P NATL ACAD SCI USA, V96, P12713, DOI 10.1073/pnas.96.22.12713; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schluter SF, 2003, FASEB J, V17, P470, DOI 10.1096/fj.02-0565fje; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080; Zavolan M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P277, DOI 10.1109/CSB.2003.1227328	49	60	60	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					443	450		10.1038/ni1053	http://dx.doi.org/10.1038/ni1053			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15021880				2022-12-18	WOS:000220515900018
J	Durai, V; Bagadia, P; Granja, JM; Satpathy, AT; Kulkarni, DH; Davidson, JT; Wu, R; Patel, SJ; Iwata, A; Liu, TT; Huang, X; Briseno, CG; Grajales-Reyes, GE; Wohner, M; Tagoh, H; Kee, BL; Newberry, RD; Busslinger, M; Chang, HY; Murphy, TL; Murphy, KM				Durai, Vivek; Bagadia, Prachi; Granja, Jeffrey M.; Satpathy, Ansuman T.; Kulkarni, Devesha H.; Davidson, Jesse T.; Wu, Renee; Patel, Swapneel J.; Iwata, Arifumi; Liu, Tian-Tian; Huang, Xiao; Briseno, Carlos G.; Grajales-Reyes, Gary E.; Wohner, Miriam; Tagoh, Hiromi; Kee, Barbara L.; Newberry, Rodney D.; Busslinger, Meinrad; Chang, Howard Y.; Murphy, Theresa L.; Murphy, Kenneth M.			Cryptic activation of an Irf8 enhancer governs cDC1 fate specification	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL PROGENITORS; CENTER B-CELL; TRANSCRIPTION-FACTOR; PHENOTYPIC ROBUSTNESS; GENE-EXPRESSION; I INTERFERON; PU.1; CHROMATIN; IDENTIFICATION; REGULATOR	Induction of the transcription factor Irf8 in the common dendritic cell progenitor (CDP) is required for classical type 1 dendritic cell (cDC1) fate specification, but the mechanisms controlling this induction are unclear. In the present study Irf8 enhancers were identified via chromatin profiling of dendritic cells and CRISPR/Cas9 genome editing was used to assess their roles in Irf8 regulation. An enhancer 32 kilobases (kb) downstream of the Irf8 transcriptional start site (+32-kb Irf8) that was active in mature cDC1s was required for the development of this lineage, but not for its specification. Instead, a +41-kb Irf8 enhancer, previously thought to be active only in plasmacytoid dendritic cells, was found to also be transiently accessible in cDC1 progenitors, and deleting this enhancer prevented the induction of Irf8 in CDPs and abolished cDC1 specification. Thus, cryptic activation of the +41-kb Irf8 enhancer in dendritic cell progenitors is responsible for cDC1 fate specification.	[Durai, Vivek; Bagadia, Prachi; Davidson, Jesse T.; Wu, Renee; Iwata, Arifumi; Liu, Tian-Tian; Huang, Xiao; Briseno, Carlos G.; Grajales-Reyes, Gary E.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Granja, Jeffrey M.; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Kulkarni, Devesha H.; Newberry, Rodney D.] Washington Univ, Sch Med, John T Milliken Dept Med, Div Gastroenterol, St Louis, MO USA; [Patel, Swapneel J.] Washington Univ, Sch Med, John T Milliken Dept Med, Div Rheumatol, St Louis, MO USA; [Liu, Tian-Tian; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Wohner, Miriam; Tagoh, Hiromi; Busslinger, Meinrad] Res Inst Mol Pathol, Campus Vienna Bioctr 1, Vienna, Austria; [Kee, Barbara L.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Washington University (WUSTL); Stanford University; Stanford University; Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Chicago; University of Chicago; Howard Hughes Medical Institute; Stanford University	Murphy, TL; Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Huang, Xiao/GPF-9961-2022; Busslinger, Meinrad/J-1249-2016; Tagoh, Hiromi/B-2954-2009	Huang, Xiao/0000-0002-2754-5225; Busslinger, Meinrad/0000-0002-9111-9351; Tagoh, Hiromi/0000-0001-9905-6992; Patel, Swapneel/0000-0001-6088-4029; Satpathy, Ansuman/0000-0002-5167-537X; Wohner, Miriam/0000-0003-0965-5938; Durai, Vivek/0000-0002-2799-934X	Howard Hughes Medical Institute; US National Institutes of Health [NIH: F30 DK108498, K08 CA230188, P50 HG007735, R01 AI106352, R01 DK097317]; National Science Foundation [DGE-1745038]; Parker Institute for Cancer Immunotherapy; Boehringer Ingelheim; Career Award for Medical Scientists from the Burroughs Wellcome Fund; National Cancer Institute's Cancer Center Support grant [P30 CA91842]; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resources (NCRR), a component of the NIH [UL1TR000448]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106352] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Parker Institute for Cancer Immunotherapy; Boehringer Ingelheim(Boehringer Ingelheim); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Cancer Institute's Cancer Center Support grant; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resources (NCRR), a component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute (K.M. and H.C.), the US National Institutes of Health (NIH: F30 DK108498 to V.D.; K08 CA230188 to A.S.; P50 HG007735 to H.C.; R01 AI106352 to B.K.; R01 DK097317 to R.N.), the National Science Foundation (DGE-1745038 to P.B.), the Parker Institute for Cancer Immunotherapy (A.S. and H.C.) and Boehringer Ingelheim (M.W., H.T. and M.B.). A.S. was supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund. This work benefitted from data assembled by the ImmGen consortium<SUP>48</SUP>. We thank the Genome Technology Access Center in the Department of Genetics at Washington University in St Louis School of Medicine for help with genomic analysis. The Center is partially supported by the National Cancer Institute's Cancer Center Support grant no. P30 CA91842 to the Siteman Cancer Center and by the Institute of Clinical and Translational Sciences/Clinical and Translational Science Award grant no. UL1TR000448 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or the NIH.	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CHEN HM, 1995, ONCOGENE, V11, P1549; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Durai V, 2018, J EXP MED, V215, P1417, DOI 10.1084/jem.20171784; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Saxena M, 2018, TRENDS CANCER, V4, P119, DOI 10.1016/j.trecan.2017.12.007; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002; Zhang P, 2000, BLOOD, V96, P2641; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	57	59	59	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1161	+		10.1038/s41590-019-0450-x	http://dx.doi.org/10.1038/s41590-019-0450-x			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31406378	Green Accepted			2022-12-18	WOS:000482212600016
J	Liu, QK; Johnson, EM; Lam, RK; Wang, Q; Ye, HB; Wilson, EN; Minhas, PS; Liu, L; Swarovski, MS; Tran, S; Wang, J; Mehta, SS; Yang, X; Rabinowitz, JD; Yang, SS; Shamloo, M; Mueller, C; James, ML; Andreasson, KI				Liu, Qingkun; Johnson, Emily M.; Lam, Rachel K.; Wang, Qian; Ye, Hong Bo; Wilson, Edward N.; Minhas, Paras S.; Liu, Ling; Swarovski, Michelle S.; Tran, Stephanie; Wang, Jing; Mehta, Swapnil S.; Yang, Xi; Rabinowitz, Joshua D.; Yang, Samuel S.; Shamloo, Mehrdad; Mueller, Christoph; James, Michelle L.; Andreasson, Katrin I.			Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity	NATURE IMMUNOLOGY			English	Article							18 KDA TSPO; MYELOID CELLS-1; CUTTING EDGE; INFLAMMATORY RESPONSES; SPLEEN CONTRIBUTES; ISCHEMIC-STROKE; RECEPTOR; MACROPHAGES; NEUROINFLAMMATION; IDENTIFICATION	Stroke is a multiphasic process in which initial cerebral ischemia is followed by secondary injury from immune responses to ischemic brain components. Here we demonstrate that peripheral CD11b(+)CD45(+) myeloid cells magnify stroke injury via activation of triggering receptor expressed on myeloid cells 1 (TREM1), an amplifier of proinflammatory innate immune responses. TREM1 was induced within hours after stroke peripherally in CD11b(+)CD45(+) cells trafficking to ischemic brain. TREM1 inhibition genetically or pharmacologically improved outcome via protective antioxidant and anti-inflammatory mechanisms. Positron electron tomography imaging using radiolabeled antibody recognizing TREM1 revealed elevated TREM1 expression in spleen and, unexpectedly, in intestine. In the lamina propria, noradrenergic-dependent increases in gut permeability induced TREM1 on inflammatory Ly6C(+)MHCII(+) macrophages, further increasing epithelial permeability and facilitating bacterial translocation across the gut barrier. Thus, following stroke, peripheral TREM1 induction amplifies proinflammatory responses to both brain-derived and intestinal-derived immunogenic components. Critically, targeting this specific innate immune pathway reduces cerebral injury.	[Liu, Qingkun; Johnson, Emily M.; Wang, Qian; Ye, Hong Bo; Wilson, Edward N.; Minhas, Paras S.; Swarovski, Michelle S.; Tran, Stephanie; Wang, Jing; Mehta, Swapnil S.; James, Michelle L.; Andreasson, Katrin I.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA USA; [Johnson, Emily M.; James, Michelle L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; [Lam, Rachel K.; Shamloo, Mehrdad] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA; [Liu, Ling; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Liu, Ling; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Yang, Xi; Yang, Samuel S.] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA USA; [Mueller, Christoph] Univ Bern, Inst Pathol, Bern, Switzerland; [James, Michelle L.; Andreasson, Katrin I.] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Princeton University; Princeton University; Stanford University; University of Bern; Stanford University; Stanford University	Andreasson, KI (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA USA.; Andreasson, KI (corresponding author), Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA.	kandreas@stanford.edu	Rabinowitz, Joshua/GPP-4019-2022; Wilson, Edward/AFJ-8275-2022; Smalyukh, Ivan/AAC-9232-2020; Liu, Qing/GWC-9222-2022; Mueller, Christoph/F-2233-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Smalyukh, Ivan/0000-0003-3444-1966; Johnson, Emily/0000-0002-0542-3083; Wilson, Edward/0000-0003-0640-5247; Mueller, Christoph/0000-0002-3921-8678; Yang, Samuel/0000-0003-1123-9036	National Institutes of Health (NIH) grant [R01NS045727, R21NS087639, R01NS100180, RO1AG053001]; Paul and Daisy Soros Fellowship for New Americans; Gerald J. Lieberman Fellowship; Stanford Medicine Dean's Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG053001] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; Gerald J. Lieberman Fellowship; Stanford Medicine Dean's Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grant (nos. R01NS045727, R21NS087639, R01NS100180 and RO1AG053001 to K.I.A.), The Paul and Daisy Soros Fellowship for New Americans (to P.S.M.), the Gerald J. Lieberman Fellowship (to P.S.M.) and Stanford Medicine Dean's Fellowship (to E.N.W.). The authors would like to thank W.Lu for LC-MS expertise, the Stanford Shared FACS Facility, the Stanford Human Immune Monitoring Center, and the Protein and Nucleic Acid Facility.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chen C, 2019, BIOMED PHARMACOTHER, V109, P547, DOI 10.1016/j.biopha.2018.10.103; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Crapser J, 2016, AGING-US, V8, P1049, DOI 10.18632/aging.100952; Dotson AL, 2015, J NEUROIMMUNOL, V278, P289, DOI 10.1016/j.jneuroim.2014.11.020; Fang MC, 2010, J HOSP MED, V5, P406, DOI 10.1002/jhm.689; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Garcia-Bonilla L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0750-0; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gibot S, 2006, INFECT IMMUN, V74, P2823, DOI 10.1128/IAI.74.5.2823-2830.2006; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, ANN INTERN MED, V141, P9, DOI 10.7326/0003-4819-141-1-200407060-00009; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Lin B., 2010, CARDIOVASC PSYCHIAT, V2010, P16, DOI [10.1155/2010/506952, DOI 10.1155/2010/506952]; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Nguyen-Lefebvre AT, 2018, J CLIN INVEST, V128, P4870, DOI 10.1172/JCI98156; Park JJ, 2009, DIGEST DIS SCI, V54, P1525, DOI 10.1007/s10620-008-0514-5; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Saurer L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14516-4; Schenk M, 2005, J IMMUNOL, V174, P517, DOI 10.4049/jimmunol.174.1.517; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Seifert HA, 2012, METAB BRAIN DIS, V27, P131, DOI 10.1007/s11011-012-9283-0; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900; Yasuda T, 2008, CRIT CARE MED, V36, P2048, DOI 10.1097/CCM.0b013e31817b8824; Zhang ZY, 2017, J AM CHEM SOC, V139, P14368, DOI 10.1021/jacs.7b08012; Zysset D., 2016, NATURE COMMUNICATION, V7, P1, DOI DOI 10.1038/NC0MMS13151	62	59	61	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1023	+		10.1038/s41590-019-0421-2	http://dx.doi.org/10.1038/s41590-019-0421-2			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31263278	Green Accepted			2022-12-18	WOS:000476621200017
J	Anzilotti, C; Swan, DJ; Boisson, B; Deobagkar-Lele, M; Oliveira, C; Chabosseau, P; Engelhardt, KR; Xu, XJ; Chen, R; Alvarez, L; Berlinguer-Palmini, R; Bull, KR; Cawthorne, E; Cribbs, AP; Crockford, TL; Dang, TS; Fearn, A; Fenech, EJ; de Jong, SJ; Lagerholm, BC; Ma, CS; Sims, D; van den Berg, B; Xu, YB; Cant, AJ; Kleiner, G; Leahy, TR; de la Morena, MT; Puck, JM; Shapiro, RS; van der Burg, M; Chapman, JR; Christianson, JC; Davies, B; McGrath, JA; Przyborski, S; Koref, MS; Tangye, SG; Werner, A; Rutter, GA; Padilla-Parra, S; Casanova, JL; Cornall, RJ; Conley, ME; Hambleton, S				Anzilotti, Consuelo; Swan, David J.; Boisson, Bertrand; Deobagkar-Lele, Mukta; Oliveira, Catarina; Chabosseau, Pauline; Engelhardt, Karin R.; Xu, Xijin; Chen, Rui; Alvarez, Luis; Berlinguer-Palmini, Rolando; Bull, Katherine R.; Cawthorne, Eleanor; Cribbs, Adam P.; Crockford, Tanya L.; Dang, Tarana Singh; Fearn, Amy; Fenech, Emma J.; de Jong, Sarah J.; Lagerholm, B. Christoffer; Ma, Cindy S.; Sims, David; van den Berg, Bert; Xu, Yaobo; Cant, Andrew J.; Kleiner, Gary; Leahy, T. Ronan; de la Morena, M. Teresa; Puck, Jennifer M.; Shapiro, Ralph S.; van der Burg, Mirjam; Chapman, J. Ross; Christianson, John C.; Davies, Benjamin; McGrath, John A.; Przyborski, Stefan; Koref, Mauro Santibanez; Tangye, Stuart G.; Werner, Andreas; Rutter, Guy A.; Padilla-Parra, Sergi; Casanova, Jean-Laurent; Cornall, Richard J.; Conley, Mary Ellen; Hambleton, Sophie			An essential role for the Zn2+ transporter ZIP7 in B cell development	NATURE IMMUNOLOGY			English	Article							ZINC TRANSPORTERS; READ ALIGNMENT; EXPRESSION; GENERATION; FOXO1; AGAMMAGLOBULINEMIA; PHOSPHATASE; RESOLUTION; INHIBITION; FRAMEWORK	Despite the known importance of zinc for human immunity, molecular insights into its roles have remained limited. Here we report a novel autosomal recessive disease characterized by absent B cells, agammaglobulinemia and early onset infections in five unrelated families. The immunodeficiency results from hypomorphic mutations of SLC39A7, which encodes the endoplasmic reticulum-to-cytoplasm zinc transporter ZIP7. Using CRISPR-Cas9 mutagenesis we have precisely modeled ZIP7 deficiency in mice. Homozygosity for a null allele caused embryonic death, but hypomorphic alleles reproduced the block in B cell development seen in patients. B cells from mutant mice exhibited a diminished concentration of cytoplasmic free zinc, increased phosphatase activity and decreased phosphorylation of signaling molecules downstream of the pre-B cell and B cell receptors. Our findings highlight a specific role for cytosolic Zn2+ in modulating B cell receptor signal strength and positive selection.	[Anzilotti, Consuelo; Deobagkar-Lele, Mukta; Xu, Xijin; Bull, Katherine R.; Cawthorne, Eleanor; Crockford, Tanya L.; Lagerholm, B. Christoffer; Cornall, Richard J.] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Swan, David J.; Engelhardt, Karin R.; Chen, Rui; Dang, Tarana Singh; Hambleton, Sophie] Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Boisson, Bertrand; de Jong, Sarah J.; Casanova, Jean-Laurent; Conley, Mary Ellen] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Boisson, Bertrand; Casanova, Jean-Laurent] Necker Hosp Sick Children, Necker Branch, INSERM, Lab Human Genet Infect Dis,U1163, Paris, France; [Boisson, Bertrand; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Oliveira, Catarina; Alvarez, Luis; Chapman, J. Ross; Davies, Benjamin; Padilla-Parra, Sergi] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Chabosseau, Pauline; Rutter, Guy A.] Imperial Coll, Dept Med, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, London, England; [Berlinguer-Palmini, Rolando] Newcastle Univ, Med Sch, Bioimaging Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Cribbs, Adam P.; Sims, David] Univ Oxford, Weatherall Inst Mol Med, MRC WIMM Ctr Computat Biol, Oxford, England; [Fearn, Amy; van den Berg, Bert; Werner, Andreas] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Fenech, Emma J.; Christianson, John C.] Univ Oxford, Ludwig Inst Canc Res, Oxford, England; [Ma, Cindy S.; Tangye, Stuart G.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Ma, Cindy S.; Tangye, Stuart G.] Univ NSW, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Xu, Yaobo; Koref, Mauro Santibanez] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Cant, Andrew J.; Hambleton, Sophie] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Kleiner, Gary] Univ Miami, Miller Sch Med, Pediat Allergy & Immunol, Miami, FL 33136 USA; [Leahy, T. Ronan] Our Ladys Childrens Hosp, Paediat Immunol & Infect Dis, Dublin, Ireland; [de la Morena, M. Teresa] Univ Washington, Dept Pediat, Div Immunol, Seattle, WA 98195 USA; [de la Morena, M. Teresa] Seattle Childrens Hosp, Seattle, WA USA; [Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, Div Allergy Immunol & Blood & Bone Marrow Transpl, San Francisco, CA USA; [Puck, Jennifer M.] UCSF Benioff Childrens Hosp, San Francisco, CA USA; [Shapiro, Ralph S.] Midwest Immunol Clin, Plymouth, MN USA; [van der Burg, Mirjam] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands; [McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Przyborski, Stefan] Univ Durham, Dept Biosci, Durham, England; [Padilla-Parra, Sergi] Biocruces Hlth Res Inst, Dynam Struct Virol Grp, Baracaldo, Spain; [Padilla-Parra, Sergi] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA	University of Oxford; Newcastle University - UK; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Newcastle University - UK; University of Oxford; Newcastle University - UK; Ludwig Institute for Cancer Research; University of Oxford; Garvan Institute of Medical Research; University of New South Wales Sydney; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Miami; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Durham University; Basque Foundation for Science; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute	Cornall, RJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Hambleton, S (corresponding author), Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne, Tyne & Wear, England.; Conley, ME (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.; Hambleton, S (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England.	richard.cornall@ndm.ox.ac.uk; conley.maryellen@gmail.com; sophie.hambleton@newcastle.ac.uk	Palmini, Rolando Berlinguer/K-8764-2013; Cribbs, Adam/U-4055-2019; Leahy, Ronan/AAL-5008-2021; Chapman, Ross/GYD-7815-2022; Padilla-Parra, Sergi/N-8725-2019; Christianson, John C/Y-4567-2019; Cribbs, Adam/AAN-4387-2020; McGrath, John/N-3529-2019; Boisson, Bertrand/I-2485-2017; Davies, Ben/GYD-9163-2022; Bull, Katherine/AAC-2411-2019; S, Cindy/B-2340-2012; Padilla-Parra, Sergi/S-3017-2018; Casanova, Jean-Laurent/Y-2771-2019; Boisson, Bertrand/AAC-6058-2019; McGrath, John/D-6824-2012	Palmini, Rolando Berlinguer/0000-0002-1786-496X; Leahy, Ronan/0000-0001-6419-9328; Chapman, Ross/0000-0002-6477-4254; Padilla-Parra, Sergi/0000-0002-8010-9481; Cribbs, Adam/0000-0001-5288-3077; Boisson, Bertrand/0000-0001-5240-3555; Davies, Ben/0000-0003-3405-507X; Bull, Katherine/0000-0003-0656-0917; S, Cindy/0000-0001-5387-8413; Casanova, Jean-Laurent/0000-0002-7782-4169; Boisson, Bertrand/0000-0001-5240-3555; Rutter, Guy/0000-0001-6360-0343; Oliveira, Catarina/0000-0002-9060-5112; van den Berg, Bert/0000-0003-1966-8804; McGrath, John/0000-0002-3708-9964; Alvarez, Luis/0000-0003-1316-1906; Fenech, Emma/0000-0003-4414-3233; Lagerholm, Christoffer/0000-0003-4678-5168; Swan, David/0000-0002-6480-9621; Anzilotti, Consuelo/0000-0003-4528-0651; Hambleton, Sophie/0000-0001-7954-3267; Chen, Rui/0000-0003-2887-2751; Deobagkar, Mukta/0000-0002-8543-6801; Davies, Benjamin/0000-0003-3623-600X; Engelhardt, Karin Regine/0000-0001-8513-9682	Medical Research Council [MR/J0003042/1, MR/N00275X/1, MR/L020149/1: DIVA]; Sir Jules Thorn Trust [12/JTA]; St Giles Foundation; Rockefeller University; INSERM; Paris Descartes University; Howard Hughes Medical Institute; National Institutes of Health [5P01AI061093, 5R01AI104857]; French National Research Agency [ANR 14-CE15-0009-01]; Wellcome Trust [WT098424AIA, 090532/Z/09/Z, 207556/Z/17/Z]; Cancer Research UK [C52690/A19270]; Diabetes UK [BDA11/0004210, BDA/15/0005275]; Northern Counties Kidney Research Fund [14.06]; National Health and Medical Research Council of Australia; Ludwig Institute for Cancer Research; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MR/K001981/1, MR/N00275X/1, MR/M012646/1, MC_UU_00008/6, MC_PC_15065, MR/M009971/1, MR/R017549/1, MR/N020472/1, MR/L02036X/1, MR/R007748/1, MR/R010676/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061093] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Trust; St Giles Foundation; Rockefeller University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Research Agency(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Diabetes UK(Diabetes UK); Northern Counties Kidney Research Fund; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ludwig Institute for Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank colleagues in the Newcastle University Flow Cytometry and Bioimaging Facilities for assistance. We acknowledge N. Ashley, A. Mead, P. Sopp and C. Waugh for assistance with single cell experiments and flow cytometry, D. Biggs and C. Preece for generation of the mouse models and staff at the Oxford Functional Genomics Facility for animal care. We also thank the National Diagnostic Epidermolysis Bullosa Laboratory (St Thomas' Hospital, London) and the NIHR Newcastle Biomedical Research Centre. We thank K. Taylor for helpful discussions. This work was supported by the Medical Research Council (MR/J0003042/1, MR/N00275X/1 and MR/L020149/1: DIVA) (C.A., R.J.C., E.F., J.C.C.and G.A.R.); the Sir Jules Thorn Trust (12/JTA) (S.H., D.S., T.S.D. and K.E.); the St Giles Foundation, the Rockefeller University, INSERM, Paris Descartes University, Howard Hughes Medical Institute, National Institutes of Health (5P01AI061093 and 5R01AI104857) and the French National Research Agency (ANR 14-CE15-0009-01) (B.B., S.J.d.J., J.-L.C. and M.E.C.); the Wellcome Trust (WT098424AIA; 090532/Z/09/Z and 207556/Z/17/Z) (P. C., G.A.R., J.R.C., S.P.-P., B.D. and S.H.); Cancer Research UK (C52690/A19270) (C.O. and J.R.C.); Diabetes UK (BDA11/0004210 and BDA/15/0005275) (P. C., G.A.R.); the Northern Counties Kidney Research Fund (14.06) (A.F. and A.W.); the National Health and Medical Research Council of Australia (C.S.M., S.G.T.) and the Ludwig Institute for Cancer Research (E.J.F. and J.C.C.). S.H. is a Wellcome Investigator and R.J.C. is a Principal Investigator of the MRC Human Immunology Unit.	Aw A, 2017, DRUG AGING, V34, P509, DOI 10.1007/s40266-017-0468-4; Bin BH, 2017, J INVEST DERMATOL, V137, P1682, DOI 10.1016/j.jid.2017.03.031; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Conley ME, 2009, CURR OPIN IMMUNOL, V21, P466, DOI 10.1016/j.coi.2009.07.003; Corfe SA, 2007, J IMMUNOL METHODS, V325, P9, DOI 10.1016/j.jim.2007.05.010; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Geiser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072543; Groth C, 2013, DEVELOPMENT, V140, P3018, DOI 10.1242/dev.088336; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hessels AM, 2016, METALLOMICS, V8, P211, DOI 10.1039/c5mt00257e; Hojyo S, 2014, P NATL ACAD SCI USA, V111, P11786, DOI 10.1073/pnas.1323557111; Holl TM, 2010, J IMMUNOL METHODS, V354, P53, DOI 10.1016/j.jim.2010.01.007; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Markovich D, 2008, NAT PROTOC, V3, P1975, DOI 10.1038/nprot.2008.151; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merola F, 2014, BIOTECHNOL J, V9, P180, DOI 10.1002/biot.201300198; Moores M, 2018, J TRACE ELEM MED BIO, V49, P296, DOI 10.1016/j.jtemb.2018.01.004; Ohashi W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006349; Padilla-Parra S, 2008, BIOPHYS J, V95, P2976, DOI 10.1529/biophysj.108.131276; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plum LM, 2014, METALLOMICS, V6, P1277, DOI 10.1039/c3mt00197k; Reth M, 2014, ADV IMMUNOL, V122, P129, DOI 10.1016/B978-0-12-800267-4.00004-3; Sims D, 2014, BIOINFORMATICS, V30, P1290, DOI 10.1093/bioinformatics/btt756; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; Taniguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058022; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; Tussiwand R, 2012, EUR J IMMUNOL, V42, P206, DOI 10.1002/eji.201141957; Ubieta K, 2017, J EXP MED, V214, P2059, DOI 10.1084/jem.20160514; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Woodruff G, 2018, MOL PHARMACOL, V94, P1092, DOI 10.1124/mol.118.112557; Yan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042939; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344	55	59	61	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					350	+		10.1038/s41590-018-0295-8	http://dx.doi.org/10.1038/s41590-018-0295-8			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30718914	Green Submitted, Green Accepted			2022-12-18	WOS:000458893600019
J	Zuberbuehler, MK; Parker, ME; Wheaton, JD; Espinosa, JR; Salzler, HR; Park, E; Ciofani, M				Zuberbuehler, Matthew K.; Parker, Morgan E.; Wheaton, Joshua D.; Espinosa, Jaclyn R.; Salzler, Harmony R.; Park, Eunchong; Ciofani, Maria			The transcription factor c-Maf is essential for the commitment of IL-17-producing gamma delta T cells	NATURE IMMUNOLOGY			English	Article							ALPHA-BETA; READ ALIGNMENT; EXPRESSION; TCR; INTERLEUKIN-17; NOTCH; DIFFERENTIATION; ROR-GAMMA-T(+); RECEPTORS; EFFICIENT	gamma delta T cells that produce the cytokineIL- 17 (T gamma delta 17 cells) are innate-like mediators of immunity that undergo effector programming in the thymus. While regulators of T gamma delta 17 specialization restricted to various V gamma subsets are known, a commitment factor essential to all T gamma delta 17 cells has remained undefined. In this study, we identified the transcription factor c-Maf as a universal regulator of T gamma delta 17 cell differentiation and maintenance. Maf deficiency caused an absolute lineage block at the immature CD24(+)CD45RB(lo) gamma delta thymocyte stage, which revealed a critical checkpoint in the acquisition of effector functions. Here, c-Maf enforced T gamma delta 17 cell identity by promoting chromatin accessibility and expression of key type 17 program genes, notably Rorc and Blk, while antagonizing the transcription factor TCF1, which promotes interferon-gamma-producing gamma delta T cells (T gamma delta 1 cells). Furthermore, gamma delta T cell antigen receptor (gamma delta TCR) signal strength tuned c-Maf expression, which indicates that c-Maf is a core node that connects gamma delta TCR signals to T gamma delta 17 cell transcriptional programming.	[Zuberbuehler, Matthew K.; Parker, Morgan E.; Wheaton, Joshua D.; Espinosa, Jaclyn R.; Salzler, Harmony R.; Park, Eunchong; Ciofani, Maria] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA	Duke University	Ciofani, M (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.	maria.ciofani@duke.edu		Ciofani, Maria/0000-0001-6472-5260; Wheaton, Joshua D/0000-0002-2785-3463; Parker, Morgan/0000-0003-2610-8530	Whitehead Scholar Award; NIH [R01 GM115474]; Career Development Award from the Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115474] Funding Source: NIH RePORTER	Whitehead Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Birchmeier (Max Delbruck Center for Molecular Medicine, Germany) for providing Maf conditional mice; J.C. Zuniga-Pflucker (University of Toronto) for providing OP9-DL1 cells; H. Kawamoto (Kyoto University, Japan) for providing TCF1 antibody; J. Heitman (Duke University) for providing C. albicans strain SC5314; and R. DePooter for critical reading of the manuscript. We acknowledge the expert assistance of N. Martin and L. Martinek with flow cytometry. This work was funded by a Whitehead Scholar Award (to M.C.). J.D.W. and M.C. were supported by NIH grant R01 GM115474. M.C. was supported by a Career Development Award from the Crohn's and Colitis Foundation of America.	Auderset F, 2013, J IMMUNOL, V191, P2344, DOI 10.4049/jimmunol.1300643; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barros-Martins J, 2016, J IMMUNOL, V196, P3642, DOI 10.4049/jimmunol.1501921; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Carr TM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00380-3; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; In TSH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02225-5; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee SY, 2014, IMMUNITY, V41, P934, DOI 10.1016/j.immuni.2014.10.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munoz-Ruiz M, 2017, TRENDS IMMUNOL, V38, P336, DOI 10.1016/j.it.2017.01.007; Muro R, 2018, J CLIN INVEST, V128, P415, DOI 10.1172/JCI95837; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Papotto PH, 2018, J AUTOIMMUN, V87, P26, DOI 10.1016/j.jaut.2017.11.006; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajaram N, 2004, MOL CELL BIOL, V24, P5694, DOI 10.1128/MCB.24.13.5694-5709.2004; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramsdell F., 2006, CURR PROTOC IMMUNOL, V71, P3181; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Sumaria N, 2017, CELL REP, V19, P2469, DOI 10.1016/j.celrep.2017.05.071; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wheaton JD, 2017, J IMMUNOL, V199, P3931, DOI 10.4049/jimmunol.1701134; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yu JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01399; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	64	59	60	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					73	+		10.1038/s41590-018-0274-0	http://dx.doi.org/10.1038/s41590-018-0274-0			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538336	Green Accepted			2022-12-18	WOS:000456273900016
J	Ruscher, R; Kummer, RL; Lee, YJ; Jameson, SC; Hogquist, KA				Ruscher, Roland; Kummer, Rebecca L.; Lee, You Jeong; Jameson, Stephen C.; Hogquist, Kristin A.			CD8 alpha alpha intraepithelial lymphocytes arise from two main thymic precursors	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; PROGENITOR LOCALIZATION; THYMOCYTES; TRAFFICKING; CYTOMETRY; SELECTION; LINEAGE; EGRESS; FATE	TCR alpha b(+)CD4(-)CD8 alpha(+)CD8 beta-intestinal intraepithelial lymphocytes (CD8 alpha alpha IELs) are an abundant population of thymus-derived T cells that protect the gut barrier surface. We sought to better define the thymic IEL precursor (IELp) through analysis of its maturation, localization and emigration. We defined two precursor populations among TCR beta(+)CD4(-)CD8(-) thymocytes by dependence on the kinase TAK1 and rigorous lineage-exclusion criteria. Those IELp populations included a nascent PD-1(+) population and a T-bet(+) population that accumulated with age. Both gave rise to intestinal CD8 alpha alpha IELs after adoptive transfer. The PD-1(+) IELp population included more strongly self-reactive clones and was largely restricted by classical major histocompatibility complex (MHC) molecules. Those cells localized to the cortex and efficiently emigrated in a manner dependent on the receptor S1PR1. The T-bet(+) IELp population localized to the medulla, included cells restricted by non-classical MHC molecules and expressed the receptor NK1.1, the integrin CD103 and the chemokine receptor CXCR3. The two IELp populations further differed in their use of the T cell antigen receptor (TCR) alpha-chain variable region (V-alpha) and beta-chain variable region (V-beta). These data provide a foundation for understanding the biology of CD8 alpha alpha IELs.	[Ruscher, Roland; Kummer, Rebecca L.; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Ruscher, Roland; Kummer, Rebecca L.; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Lee, You Jeong] Pohang Univ Sci & Technol, Inst Basic Sci, Acad Immunol & Microbiol, Pohang, South Korea; [Lee, You Jeong] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Hogquist, KA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu	Ruscher, Roland/AAQ-1219-2020; Jameson, Stephen C/D-9892-2013; Lee, You Jeong/T-6086-2019	Ruscher, Roland/0000-0002-8600-6985; Jameson, Stephen C/0000-0001-9137-1146; 	US National Institutes of Health [R37 AI39560, PO1 AI35296, K99 AI114889, T35 AI118620-01]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039560, R01AI039560, T35AI118620, P01AI035296] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Ding and J. Lam for technical assistance; and T.A. Baldwin, D.P. Golec and H. Borges de Silva for reading the manuscript and providing feedback and suggestions. B. Rudd inspired the use of Cd4<SUP>CreERT2</SUP> mice to 'time-stamp' progenitor cells. Some results mentioned in the manuscript but not presented here were derived from experiments by H. Wang. Supported by the US National Institutes of Health (R37 AI39560 and PO1 AI35296 to K.A.H.; K99 AI114889 to Y.J.L.; and T35 AI118620-01 to R.L.K.).	Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blair-Handon R, 2010, LAB ANIMAL, V39, P248, DOI 10.1038/laban0810-248; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Drennan MB, 2009, J IMMUNOL, V183, P2213, DOI 10.4049/jimmunol.0901213; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fujiura Y, 1996, J IMMUNOL, V156, P2710; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gemer M. Y., 2012, IMMUNITY, V37, P364; Guo XH, 2015, IMMUNOL LETT, V163, P40, DOI 10.1016/j.imlet.2014.11.007; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Klose CSN, 2014, IMMUNITY, V41, P230, DOI 10.1016/j.immuni.2014.06.018; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lefrancois L., 2001, CURR PROTOC IMMUNOL; Ma LJ, 2009, J IMMUNOL, V183, P1044, DOI 10.4049/jimmunol.0900420; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Penn T., 2004, J EXP MED, V200, P493; Perlin C., 1993, CELL, V74, P185; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sanjo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128761; Schierl M. P., 1999, J IMMUNOL, V162, P6641; Sheridan Brian S, 2010, Curr Gastroenterol Rep, V12, P513, DOI 10.1007/s11894-010-0148-6; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Stritesky GL, 2012, NAT IMMUNOL, V13, P528, DOI 10.1038/ni.2311; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; White AJ, 2014, J IMMUNOL, V192, P2659, DOI 10.4049/jimmunol.1303057; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	43	59	61	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					771	+		10.1038/ni.3751	http://dx.doi.org/10.1038/ni.3751			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28530714	Green Accepted			2022-12-18	WOS:000403676300012
J	Cibrian, D; Saiz, ML; de la Fuente, H; Sanchez-Diaz, R; Moreno-Gonzalo, O; Jorge, I; Ferrarini, A; Vazquez, J; Punzon, C; Fresno, M; Vicente-Manzanares, M; Dauden, E; Fernandez-Salguero, PM; Martin, P; Sanchez-Madrid, F				Cibrian, Danay; Laura Saiz, Maria; de la Fuente, Hortensia; Sanchez-Diaz, Raquel; Moreno-Gonzalo, Olga; Jorge, Inmaculada; Ferrarini, Alessia; Vazquez, Jesus; Punzon, Carmen; Fresno, Manuel; Vicente-Manzanares, Miguel; Dauden, Esteban; Fernandez-Salguero, Pedro M.; Martin, Pilar; Sanchez-Madrid, Francisco			CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis	NATURE IMMUNOLOGY			English	Article							ARYL-HYDROCARBON RECEPTOR; DELTA T-CELLS; AMINO-ACID-TRANSPORT; EPIDERMAL DIFFERENTIATION; PHYSIOLOGICAL-ROLE; SKIN INFLAMMATION; POTENTIAL ROLE; GAMMA; MICE; MECHANISMS	The activation marker CD69 is expressed by skin gamma delta T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by gamma delta T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating V(gamma)9(+) gamma delta T cells of psoriatic patients. Thus, CD69 serves as a key mediator of the pathogenesis of psoriasis by controlling LAT1-CD98-mediated metabolic cues.	[Cibrian, Danay; Laura Saiz, Maria; de la Fuente, Hortensia; Moreno-Gonzalo, Olga; Vicente-Manzanares, Miguel; Sanchez-Madrid, Francisco] Univ Autonoma Madrid, Hosp Princesa, Immunol Serv, Madrid, Spain; [Sanchez-Diaz, Raquel; Jorge, Inmaculada; Ferrarini, Alessia; Vazquez, Jesus; Martin, Pilar; Sanchez-Madrid, Francisco] Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, Madrid, Spain; [Punzon, Carmen; Fresno, Manuel] Univ Autonoma Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Dauden, Esteban] Hosp Princesa, Dermatol Serv, Madrid, Spain; [Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Sci, Dept Biochem Mol Biol & Genet, Badajoz, Spain	Autonomous University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Extremadura	Sanchez-Madrid, F (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Immunol Serv, Madrid, Spain.; Sanchez-Madrid, F (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, Madrid, Spain.	fsmadrid@salud.madrid.org	Vazquez, Jesus/B-7697-2015; Vicente-Manzanares, Miguel/H-1010-2018; Fernandez-Salguero, Pedro M./J-8437-2014; Sanchez-Madrid, Francisco/M-7889-2016; Martin, Pilar/F-8193-2014; de la Fuente, Hortensia/J-9890-2014; Ferrarini, Alessia/ABD-6403-2021	Vazquez, Jesus/0000-0003-1461-5092; Vicente-Manzanares, Miguel/0000-0001-5943-3220; Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Martin, Pilar/0000-0002-2392-1764; de la Fuente, Hortensia/0000-0001-8708-753X; Ferrarini, Alessia/0000-0002-4587-6095; cibrian vera, danay/0000-0002-4908-2639; Saiz Alvarez, Maria Laura/0000-0002-3966-212X; Jorge, Inmaculada/0000-0001-8645-9477	Spanish Ministry of Economy and Competitiveness [SAF2011-25834, SAF2014-55579-R, SAF2011-27330, SAF2013-42850]; Comunidad de Madrid [INDISNET-S2011/BMD-2332, 2010/BMD-2332]; Instituto Salud Carlos III (Red Cardiovascular RD) [12-0042-0056]; Instituto Salud Carlos III (BIOIMID); European Research Council [ERC-2011-AdG 294340-GENTRIS]; Ramon Areces foundation	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto Salud Carlos III (Red Cardiovascular RD); Instituto Salud Carlos III (BIOIMID); European Research Council(European Research Council (ERC)European Commission); Ramon Areces foundation	We thank D. Rotin (University of Toronto) for the plasmid for the expression of LAT1-mCherry; P. Taylor (University of Dundee) for antiserum to human LAT1; M. Navarro (Universidad Autonoma de Madrid, Spain) for IL-23R-GFP reporter mice; S. Bartlett for English editing; and T. Hernandez and R. Brid Doohan for technical assistance with immunohistochemistry. Supported by the Spanish Ministry of Economy and Competitiveness (SAF2011-25834 and SAF2014-55579-R to F.S.-M.; SAF2011-27330 to P. M.; and SAF2013-42850 to M. F.), Comunidad de Madrid (INDISNET-S2011/BMD-2332 to F. S.-M.; and 2010/BMD-2332 from M. F. and F. S.-M.), Instituto Salud Carlos III (Red Cardiovascular RD 12-0042-0056 to F.S.-M.; BIOIMID to M. F. and F. S.-M.), the European Research Council (ERC-2011-AdG 294340-GENTRIS to F. S.-M.) and the Ramon Areces foundation (M.F. and F.S.-M.).	Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; Di Meglio P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015354; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Furue M, 2015, J DERMATOL SCI, V80, P83, DOI 10.1016/j.jdermsci.2015.07.011; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Harden J. L., J ALLERGY CLIN; Kashiwagi H, 2009, AMINO ACIDS, V36, P219, DOI 10.1007/s00726-008-0050-9; Kondo M., 2011, JOVE, V55, P3152; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Mukai M, 2007, TOXICOL SCI, V95, P172, DOI 10.1093/toxsci/kfl126; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Prans E, 2013, HUM IMMUNOL, V74, P792, DOI 10.1016/j.humimm.2013.01.006; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Serre K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00431; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Shimauchi T, 2013, J DERMATOL, V40, P805, DOI 10.1111/1346-8138.12248; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smirnova A, 2016, CHEM RES TOXICOL, V29, P75, DOI 10.1021/acs.chemrestox.5b00416; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van den Bogaard EH, 2015, J INVEST DERMATOL, V135, P1320, DOI 10.1038/jid.2015.6; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	59	63	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					985	+		10.1038/ni.3504	http://dx.doi.org/10.1038/ni.3504			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27376471	Green Accepted, Green Submitted			2022-12-18	WOS:000380647000017
J	Boucheron, N; Tschismarov, R; Goeschl, L; Moser, MA; Lagger, S; Sakaguchi, S; Winter, M; Lenz, F; Vitko, D; Breitwieser, FP; Muller, L; Hassan, H; Bennett, KL; Colinge, J; Schreiner, W; Egawa, T; Taniuchi, I; Matthias, P; Seiser, C; Ellmeier, W				Boucheron, Nicole; Tschismarov, Roland; Goeschl, Lisa; Moser, Mirjam A.; Lagger, Sabine; Sakaguchi, Shinya; Winter, Mircea; Lenz, Florian; Vitko, Dijana; Breitwieser, Florian P.; Mueller, Lena; Hassan, Hammad; Bennett, Keiryn L.; Colinge, Jacques; Schreiner, Wolfgang; Egawa, Takeshi; Taniuchi, Ichiro; Matthias, Patrick; Seiser, Christian; Ellmeier, Wilfried			CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2	NATURE IMMUNOLOGY			English	Article							DOUBLE-POSITIVE THYMOCYTES; SAMPLE PREPARATION; CD8 EXPRESSION; RUNX PROTEINS; DIFFERENTIATION; INFLAMMATION; COMMITMENT; GENE; IDENTIFICATION; PROGRESSION	Molecular mechanisms that maintain lineage integrity of helper T cells are largely unknown. Here we show histone deacetylases 1 and 2 (HDAC1 and HDAC2) as crucial regulators of this process. Loss of HDAC1 and HDAC2 during late T cell development led to the appearance of major histocompatibility complex (MHC) class II-selected CD4(+) helper T cells that expressed CD8-lineage genes such as Cd8a and Cd8b1. HDAC1 and HDAC2-deficient T helper type 0 (T(H)0) and T(H)1 cells further upregulated CD8-lineage genes and acquired a CD8(+) effector T cell program in a manner dependent on Runx-CBFb complexes, whereas T(H)2 cells repressed features of the CD8(+) lineage independently of HDAC1 and HDAC2. These results demonstrate that HDAC1 and HDAC2 maintain integrity of the CD4 lineage by repressing Runx-CBFb complexes that otherwise induce a CD8(+) effector T cell-like program in CD4(+) T cells.	[Boucheron, Nicole; Tschismarov, Roland; Goeschl, Lisa; Sakaguchi, Shinya; Mueller, Lena; Hassan, Hammad; Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immunobiol, Vienna, Austria; [Goeschl, Lisa] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Moser, Mirjam A.; Lagger, Sabine; Winter, Mircea; Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Lenz, Florian; Schreiner, Wolfgang] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Div Biosimulat & Bioinformat, Vienna, Austria; [Vitko, Dijana; Breitwieser, Florian P.; Bennett, Keiryn L.; Colinge, Jacques] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Taniuchi, Ichiro] RIKEN Ctr Allergy & Immunol, RIKEN Ctr Integrat Med Sci, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Washington University (WUSTL); RIKEN; Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel	Ellmeier, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immunobiol, Vienna, Austria.	christian.seiser@meduniwien.ac.at; wilfried.ellmeier@meduniwien.ac.at	Colinge, Jacques/Z-2613-2019; Hassan, Hammad/J-2125-2012; Colinge, Jacques/D-1578-2017; Lagger, Sabine/GQP-6676-2022; Taniuchi, Ichiro/N-6399-2015	Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Taniuchi, Ichiro/0000-0002-9853-9068; Muller, Lena/0000-0002-6351-1786; Breitwieser, Florian P/0000-0001-6192-0853; Boucheron, Nicole/0000-0002-4979-8311; Sakaguchi, Shinya/0000-0002-0591-2469; Lagger, Sabine/0000-0002-3032-9910; Ellmeier, Wilfried/0000-0001-8192-8481; Bennett, Keiryn L./0000-0001-9356-7708; Seiser, Christian/0000-0002-7046-9352	Vienna Science and Technology Fund [LS09-031]; Austrian Science Fund (FWF); MedUni Vienna doctoral program [DK W1212]; FWF projects [P19930, P23641, I00698, P25807, W1220, P24265, P23669]; Genome Research in Austria project " Epigenetic Regulation of Cell Fate Decisions"; Innovative Medicines Initiative Joint Undertaking [115142]; European Union; European Federation of Pharmaceutical Industries and Associations companies; NIH [AI097244]; Austrian Science Fund (FWF) [P 25807, P 23641, P 23669, P 24321] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21229008, 26293109, 26114720] Funding Source: KAKEN	Vienna Science and Technology Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MedUni Vienna doctoral program; FWF projects; Genome Research in Austria project " Epigenetic Regulation of Cell Fate Decisions"; Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. Glaser for performing the microarray experiments, D. Printz for cell sorting, C. Humer for help with immunoblot analysis, E. Pfeiffer for help with irradiation, R. Bosselut (US National Cancer Institute, National Institutes of Health (NIH)) for the anti-Th-POK antibody and J. Zhu (US National Institute of Allergy and Infectious Diseases, NIH) for the GATA-3 vector. This study was funded by the Vienna Science and Technology Fund (WWTF) through project LS09-031 (to W. E. and C. S.). This work in the laboratory of W. E. was also supported by the Austrian Science Fund (FWF) and MedUni Vienna doctoral program (DK W1212) " Inflammation and Immunity" and by FWF projects (P19930, P23641 and I00698). The work in the laboratory of C. S. was supported by the FWF ( P25807 and DKplus W1220) and the Genome Research in Austria project " Epigenetic Regulation of Cell Fate Decisions" ( Federal Ministry of Science, Research and Economy, BMWFW). N. B. and S. S. are funded by the FWF (P24265 and P23669, respectively). L. G. has been supported from the Innovative Medicines Initiative Joint Undertaking under grant agreement 115142 (BTCure), resources of which are composed of financial contribution from the FP7 of the European Union and the European Federation of Pharmaceutical Industries and Associations companies' in kind contribution. T. E. is supported by NIH grant AI097244.	Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bartl S, 1997, MOL CELL BIOL, V17, P5033, DOI 10.1128/MCB.17.9.5033; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hancock WW, 2012, ANN RHEUM DIS, V71, P46, DOI 10.1136/annrheumdis-2011-200593; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Kasler HG, 2012, EMBO J, V31, P4453, DOI 10.1038/emboj.2012.295; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Maurer M, 2013, J PROTEOME RES, V12, P1040, DOI 10.1021/pr301009u; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Pozzesi N, 2014, CELL DEATH DIFFER, V21, P226, DOI 10.1038/cdd.2013.166; Rui JX, 2012, J IMMUNOL, V189, P1380, DOI 10.4049/jimmunol.1201077; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Zhang M, 2010, J IMMUNOL, V185, P3960, DOI 10.4049/jimmunol.1001462	45	59	62	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					439	+		10.1038/ni.2864	http://dx.doi.org/10.1038/ni.2864			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24681565	Green Accepted			2022-12-18	WOS:000334667900009
J	Wilhelm, C; Turner, JE; Snick, J; Stockinger, B				Wilhelm, Christoph; Turner, Jan-Eric; Van Snick, Jacques; Stockinger, Brigitta			The many lives of IL-9: a question of survival?	NATURE IMMUNOLOGY			English	Article							LUNG EPITHELIAL-CELLS; T-CELLS; GROWTH-FACTOR; AIRWAY INFLAMMATION; TGF-BETA; EXPRESSION CLONING; INTERLEUKIN-9; DIFFERENTIATION; INDUCTION; RECEPTOR	Although the cytokine interleukin 9 (IL-9) was discovered decades ago, it remains one of the most enigmatic cytokines identified so far, in particular because its functional activities remain far from clear. Breakthroughs made through the use of IL-9 reporter mice have allowed the identification of cell types that produce IL-9 in vivo and, contrary to expectations based on previous results obtained in vitro, it is not T cells but instead a previously unknown type of innate lymphoid cell, called the 'ILC2 cell', that is the main cell type that expresses IL-9 in vivo. In this perspective, we put forward a hypothesis about the potential biological functions of IL-9 in the immune system and beyond.	[Wilhelm, Christoph; Turner, Jan-Eric; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Van Snick, Jacques] Univ Louvain, Christian Duve Inst Cellular Pathol, Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; [Van Snick, Jacques] Univ Louvain, Christian Duve Inst Cellular Pathol, Ludwig Inst Canc Res, Expt Med Unit, Brussels, Belgium	MRC National Institute for Medical Research; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	Wilhelm, Christoph/ABE-7176-2020; Turner, Jan-Eric/ABC-1214-2021	Wilhelm, Christoph/0000-0002-9839-0291; Stockinger, Brigitta/0000-0001-8781-336X	MRC [MC_U117512792] Funding Source: UKRI; Medical Research Council [MC_U117512792] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoniu SA, 2010, CURR OPIN MOL THER, V12, P233; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Dong Q, 1999, EUR J IMMUNOL, V29, P2130, DOI 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S; DUGAS B, 1993, EUR J IMMUNOL, V23, P1687, DOI 10.1002/eji.1830230743; EKLUND KK, 1993, J IMMUNOL, V151, P4266; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fallon PG, 2000, INFECT IMMUN, V68, P6005, DOI 10.1128/IAI.68.10.6005-6011.2000; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Fontaine RH, 2008, CELL DEATH DIFFER, V15, P1542, DOI 10.1038/cdd.2008.79; Gounni AS, 2000, BLOOD, V96, P2163; Gounni AS, 2004, J IMMUNOL, V173, P2771, DOI 10.4049/jimmunol.173.4.2771; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; HOUSSIAU FA, 1992, J IMMUNOL, V148, P3147; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Kajiyama Y, 2007, INT ARCH ALLERGY IMM, V143, P71, DOI 10.1159/000101409; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; MOCK BA, 1990, IMMUNOGENETICS, V31, P265, DOI 10.1007/BF00204898; MODI WS, 1991, CYTOGENET CELL GENET, V57, P114, DOI 10.1159/000133126; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; SCHMITT E, 1994, J IMMUNOL, V153, P3989; SCHMITT E, 1989, EUR J IMMUNOL, V19, P2167, DOI 10.1002/eji.1830191130; Singhera GK, 2008, EXP LUNG RES, V34, P579, DOI 10.1080/01902140802369372; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Uyttenhove C, 2010, EUR J IMMUNOL, V40, P2230, DOI 10.1002/eji.200940281; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vink A, 1999, J EXP MED, V189, P1413, DOI 10.1084/jem.189.9.1413; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; YANG YC, 1989, BLOOD, V74, P1880	48	59	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					637	641		10.1038/ni.2303	http://dx.doi.org/10.1038/ni.2303			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22713829				2022-12-18	WOS:000305483800008
J	Prasad, A; Jia, YH; Chakraborty, A; Li, YT; Jain, SK; Zhong, J; Roy, SG; Loison, F; Mondal, S; Sakai, J; Blanchard, C; Snyder, SH; Luo, HR				Prasad, Amit; Jia, Yonghui; Chakraborty, Anutosh; Li, Yitang; Jain, Supriya K.; Zhong, Jia; Roy, Saurabh Ghosh; Loison, Fabien; Mondal, Subhanjan; Sakai, Jiro; Blanchard, Catlyn; Snyder, Solomon H.; Luo, Hongbo R.			Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling	NATURE IMMUNOLOGY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PLECKSTRIN HOMOLOGY DOMAIN; OVARIAN-CARCINOMA CELLS; TUMOR-SUPPRESSOR PTEN; HYDROGEN-PEROXIDE; NADPH-OXIDASE; DIPHOSPHOINOSITOL POLYPHOSPHATES; PYROPHOSPHATES; CHEMOTAXIS; P47(PHOX)	Inositol phosphates are widely produced throughout animal and plant tissues. Diphosphoinositol pentakisphosphate (InsP7) contains an energetic pyrophosphate bond. Here we demonstrate that disruption of inositol hexakisphosphate kinase 1 (InsP6K1), one of the three mammalian inositol hexakisphosphate kinases (InsP6Ks) that convert inositol hexakisphosphate (InsP6) to InsP7, conferred enhanced phosphatidylinositol-(3,4,5)-trisphosphate (PtdIns(3,4,5)P(3))-mediated membrane translocation of the pleckstrin homology domain of the kinase Akt and thus augmented downstream PtdIns(3,4,5)P(3) signaling in mouse neutrophils. Consequently, these neutrophils had greater phagocytic and bactericidal ability and amplified NADPH oxidase-mediated production of superoxide. These phenotypes were replicated in human primary neutrophils with pharmacologically inhibited InsP6Ks. In contrast, an increase in intracellular InsP7 blocked chemoattractant-elicited translocation of the pleckstrin homology domain to the membrane and substantially suppressed PtdIns(3,4,5)P(3)-mediated cellular events in neutrophils. Our findings establish a role for InsP7 in signal transduction and provide a mechanism for modulating PtdIns(3,4,5)P(3) signaling in neutrophils.	[Prasad, Amit; Jia, Yonghui; Li, Yitang; Jain, Supriya K.; Zhong, Jia; Roy, Saurabh Ghosh; Loison, Fabien; Mondal, Subhanjan; Sakai, Jiro; Blanchard, Catlyn; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Dept Lab Med,Childrens Hosp Boston, Boston, MA 02115 USA; [Chakraborty, Anutosh; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Chakraborty, Anutosh; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Luo, Hongbo R.] Harvard Univ, Sch Med, Dana Farber Harvard Canc Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Luo, HR (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dept Lab Med,Childrens Hosp Boston, Boston, MA 02115 USA.	hongbo.luo@childrens.harvard.edu	loison, fabien/G-3385-2014	loison, fabien/0000-0002-6678-1730; Sakai, Jiro/0000-0002-2526-2766	US National Institutes of Health [HL085100, AI076471, HL092020, GM076084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085100, P01HL095489, R01HL092020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Silberstein, J. Manis and L. Chai for discussions. Supported by the US National Institutes of Health (HL085100, AI076471, HL092020 and GM076084 to H.R.L.).	Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; CLARK RA, 1979, J CLIN INVEST, V64, P913, DOI 10.1172/JCI109557; DAHLGREN C, 1989, BIOCHIM BIOPHYS ACTA, V1010, P41, DOI 10.1016/0167-4889(89)90182-1; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; DINAUER MC, 1992, ANNU REV MED, V43, P117, DOI 10.1146/annurev.med.43.1.117; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Li YT, 2009, BLOOD, V113, P4930, DOI 10.1182/blood-2008-06-161414; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Matute JD, 2005, BLOOD CELL MOL DIS, V35, P291, DOI 10.1016/j.bcmd.2005.06.010; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Morrison BH, 2002, ONCOGENE, V21, P1882, DOI 10.1038/sj.onc.1205265; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Safrany ST, 1998, EMBO J, V17, P1710, DOI 10.1093/emboj/17.6.1710; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; VOGLMAIER SM, 1992, BIOCHEM BIOPH RES CO, V187, P158, DOI 10.1016/S0006-291X(05)81473-1; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103	49	59	66	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					752	U144		10.1038/ni.2052	http://dx.doi.org/10.1038/ni.2052			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21685907	Green Accepted			2022-12-18	WOS:000292870700013
J	Yu, MC; Su, LL; Zou, L; Liu, Y; Wu, N; Kong, L; Zhuang, ZH; Sun, L; Liu, HP; Hu, JH; Li, DS; Strominger, JL; Zang, JW; Pei, G; Ge, BX				Yu, Ming-Can; Su, Liu-Li; Zou, Lin; Liu, Ye; Wu, Na; Kong, Ling; Zhuang, Zi-Heng; Sun, Lei; Liu, Hai-Peng; Hu, Jun-Hao; Li, Dangsheng; Strominger, Jack L.; Zang, Jing-Wu; Pei, Gang; Ge, Bao-Xue			An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells	NATURE IMMUNOLOGY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; MICROTUBULE-ORGANIZING CENTER; NK CELLS; TYROSINE PHOSPHATASES; DOWN-REGULATION; IMMUNE SYNAPSE; BETA-ARRESTINS; PIVOTAL ROLE; HLA-C; RECEPTORS	The inhibitory signaling of natural killer (NK) cells is crucial in the regulation of innate immune responses. Here we show that the association of KIR2DL1, an inhibitory receptor of NK cells, with beta-arrestin 2 mediated recruitment of the tyrosine phosphatases SHP-1 and SHP-2 to KIR2DL1 and facilitated 'downstream' inhibitory signaling. Consequently, the cytotoxicity of NK cells was higher in beta-arrestin 2-deficient mice but was inhibited in beta-arrestin 2-transgenic mice. Moreover, beta-arrestin 2-deficient mice were less susceptible than wild-type mice to mouse cytomegalovirus infection, an effect that was abolished by depletion of NK cells. Our findings identify a previously unknown mechanism by which the inhibitory signaling in NK cells is regulated.	[Zou, Lin; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Yu, Ming-Can; Su, Liu-Li; Liu, Ye; Wu, Na; Kong, Ling; Zhuang, Zi-Heng; Sun, Lei; Liu, Hai-Peng; Hu, Jun-Hao; Ge, Bao-Xue] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Signal Transduct, Shanghai 200025, Peoples R China; [Kong, Ling; Zhuang, Zi-Heng; Sun, Lei] Chinese Acad Sci, Grad Sch, Shanghai 200025, Peoples R China; [Strominger, Jack L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Harvard University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn; gebaoxue@sibs.ac.cn	yang, min/H-5792-2011	Liu, Haipeng/0000-0002-3338-6291				Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borrego F, 2002, MOL IMMUNOL, V38, P637, DOI 10.1016/S0161-5890(01)00107-9; BUKOWSKI JF, 1984, J VIROL, V52, P119, DOI 10.1128/JVI.52.1.119-128.1984; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Gu XG, 2003, J IMMUNOL, V170, P4095, DOI 10.4049/jimmunol.170.8.4095; Hoelsbrekken SE, 2003, J IMMUNOL, V170, P2259, DOI 10.4049/jimmunol.170.5.2259; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Kuroiwa A, 1998, J BIOL CHEM, V273, P1070, DOI 10.1074/jbc.273.2.1070; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Long EO, 1997, CURR OPIN IMMUNOL, V9, P344, DOI 10.1016/S0952-7915(97)80080-5; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Olcese L, 1996, J IMMUNOL, V156, P4531; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; SHELLAM GR, 1981, P NATL ACAD SCI-BIOL, V78, P5104, DOI 10.1073/pnas.78.8.5104; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sjolin H, 2002, J EXP MED, V195, P825, DOI 10.1084/jem.20011427; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tay CH, 1998, CURR TOP MICROBIOL, V230, P193; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang LL, 1999, J IMMUNOL, V162, P1318; Wang LL, 1997, J IMMUNOL, V158, P13; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com	56	59	77	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					898	907		10.1038/ni.1635	http://dx.doi.org/10.1038/ni.1635			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604210				2022-12-18	WOS:000257780700013
J	Nardone, J; Lee, DU; Ansel, KM; Rao, A				Nardone, J; Lee, DU; Ansel, KM; Rao, A			Bioinformatics for the 'bench biologist': how to find regulatory regions in genomic DNA	NATURE IMMUNOLOGY			English	Editorial Material							SPECIES SEQUENCE COMPARISONS; T-CELL DIFFERENTIATION; GENE-EXPRESSION; IL-4 GENE; TRANSCRIPTION FACTOR; MAST-CELLS; HYPERSENSITIVE SITES; COORDINATE REGULATOR; CHROMATIN-STRUCTURE; LINEAGE COMMITMENT	The combination of bioinformatic and biological approaches constitutes a powerful method for identifying gene regulatory elements. High-quality genome sequences are available in public databases for several vertebrate species. Comparative cross-species sequence analysis of these genomes shows considerable conservation of noncoding sequences in DNA. Biological analyses show that an unexpectedly high number of the conserved sequences correspond to functional cis-regulatory regions that influence gene transcription. Because research biologists are often unfamiliar with the bioinformatic resources at their disposal, this commentary discusses how to integrate biological and bioinformatic methods in the discovery of gene regulatory regions and includes a tutorial on widely available comparative genomics programs.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Nardone, J (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu						Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bergman CM, 2001, GENOME RES, V11, P1335, DOI 10.1101/gr.178701; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Brudno M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-66; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Carey M, 2000, TRANSCRIPTIONAL REGU; Chapman MA, 2003, GENOMICS, V81, P249, DOI 10.1016/S0888-7543(03)00005-3; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Davidson EH, 2001, GENOMIC REGULATORY S; Doyle JJ, 2000, PLANT MOL BIOL, V42, P1, DOI 10.1023/A:1006349518932; Durbin R., 1998, BIOL SEQUENCE ANAL P; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Falcone FH, 2000, BLOOD, V96, P4028; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Gross J, 1997, PHARMACOL BIOCHEM BE, V57, P159, DOI 10.1016/S0091-3057(96)00309-7; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kel-Margoulis Olga V., 2003, In Silico Biology, V3, P145; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; LENHARD B, 2003, J BIOL, V2; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Pennacchio LA, 2003, J CLIN INVEST, V111, P1099, DOI 10.1172/JCI200317842; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pollard DA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-6; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weiss DL, 2001, IMMUNOL REV, V179, P35, DOI 10.1034/j.1600-065X.2001.790104.x; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200	76	59	61	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					768	774		10.1038/ni0804-768	http://dx.doi.org/10.1038/ni0804-768			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282556				2022-12-18	WOS:000222955600004
J	Martin, R; Sturzebecher, CS; McFarland, HF				Martin, R; Sturzebecher, CS; McFarland, HF			Immunotherapy of multiple sclerosis: Where are we? Where should we go?	NATURE IMMUNOLOGY			English	Editorial Material							ALTERED PEPTIDE LIGAND; AUTOIMMUNE ENCEPHALOMYELITIS; TRIAL; INDUCTION; DISEASES; LESIONS	Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is proposed that gene expression profiling in conjunction with magnetic resonance imaging be used to optimize future treatment approaches.	NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; Schering AG, Clin Dev CNS, D-13342 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Schering AG	Martin, R (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 10,Room 5B-16,10 Ctr DR MSC 1400, Bethesda, MD 20892 USA.			Martin, Roland/0000-0002-0982-1329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002205] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bielekova, 1999, Curr Treat Options Neurol, V1, P201, DOI 10.1007/s11940-999-0004-x; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; KENNEDY MK, 1990, J IMMUNOL, V145, P117; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; MCFARLAND HF, 1992, ANN NEUROL, V32, P758, DOI 10.1002/ana.410320609; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1246, DOI 10.1056/NEJM198211113072005; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Prineas JW., 1985, HDB CLIN NEUROLOGY, V3, P213; WANDINGER K, 2001, IN PRESS ANN NEUROL, V10; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	23	59	65	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					785	788		10.1038/ni0901-785	http://dx.doi.org/10.1038/ni0901-785			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526386				2022-12-18	WOS:000170781200011
J	Sperling, AI; Bluestone, JA				Sperling, AI; Bluestone, JA			ICOS costimulation: it's not just for T(H)2 cells anymore	NATURE IMMUNOLOGY			English	News Item							MOLECULE ICOS; RESPONSES		Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA	University of Chicago; University of Chicago; University of California System; University of California San Francisco	Sperling, AI (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA.	asperlin@medicine.bsd.uchicago.edu; jbluest@diabetes.ucsf.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212				Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Guo J, 2001, J IMMUNOL, V166, P5578, DOI 10.4049/jimmunol.166.9.5578; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; SPORICI R, 2001, IN PRESS CLIN IMMUNO; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; TESCIUBA AG, 2001, IN PRESS J IMMUNOL	14	59	67	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					573	574		10.1038/89709	http://dx.doi.org/10.1038/89709			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429535				2022-12-18	WOS:000169682100005
J	Aschenbrenner, D; Foglierini, M; Jarrossay, D; Hu, D; Weiner, HL; Kuchroo, VK; Lanzavecchia, A; Notarbartolo, S; Sallusto, F				Aschenbrenner, Dominik; Foglierini, Mathilde; Jarrossay, David; Hu, Dan; Weiner, Howard L.; Kuchroo, Vijay K.; Lanzavecchia, Antonio; Notarbartolo, Samuele; Sallusto, Federica			An immunoregulatory and tissue-residency program modulated by c-MAF in human T(H)17 cells	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IL-10; DIFFERENTIATION; MEMORY; INDUCTION; INTERLEUKIN-17; LYMPHOCYTES; MACROPHAGE	Different types of effector and memory T lymphocytes are induced and maintained in protective or pathological immune responses. Here we characterized two human CD4(+) T(H)17 helper cell subsets that, in the recently activated state, could be distinguished on the basis of their expression of the anti-inflammatory cytokine IL-10. IL-10(+) T(H)17 cells upregulated a variety of genes encoding immunoregulatory molecules, as well as genes whose expression is characteristic of tissue-resident T cells. In contrast, IL-10-T(H)17 cells maintained a pro-inflammatory gene-expression profile and upregulated the expression of homing receptors that guide recirculation from tissues to blood. Expression of the transcription factor c-MAF was selectively upregulated in IL-10(+) T(H)17 cells, and it was bound to a large set of enhancer-like regions and modulated the immunoregulatory and tissue-residency program. Our results identify c-MAF as a relevant factor that drives two highly divergent post-activation fates of human T(H)17 cells and provide a framework with which to investigate the role of these cells in physiology and immunopathology.	[Aschenbrenner, Dominik; Foglierini, Mathilde; Jarrossay, David; Lanzavecchia, Antonio; Notarbartolo, Samuele; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Fac Biomed Sci, Bellinzona, Switzerland; [Foglierini, Mathilde] Swiss Inst Bioinformat, Lausanne, Switzerland; [Hu, Dan; Weiner, Howard L.; Kuchroo, Vijay K.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA USA; [Hu, Dan; Weiner, Howard L.; Kuchroo, Vijay K.] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA USA; [Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Aschenbrenner, Dominik] Univ Oxford, Translat Gastroenterol Unit, NDM Expt Med, Oxford, England	Universita della Svizzera Italiana; Swiss Institute of Bioinformatics; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford	Notarbartolo, S; Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Fac Biomed Sci, Bellinzona, Switzerland.; Sallusto, F (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	samuele.notarbartolo@irb.usi.ch; federica.sallusto@irb.usi.ch	Notarbartolo, Samuele/X-9697-2019	Notarbartolo, Samuele/0000-0001-5910-4910; Foglierini, Mathilde/0000-0001-7538-4262; Aschenbrenner, Dominik/0000-0001-7580-2567; Sallusto, Federica/0000-0003-3750-2752	European Research Council [323183]; Swiss National Science Foundation [149475, 170213]; US National Institutes of Health [NS076410]; Helmut Horten Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843, P01NS076410] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmut Horten Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Monticelli (Institute for Research in Biomedicine, Bellinzona) for reagents and for critical reading of the manuscript; and I. Barozzi for discussion of ChIP-seq analyses. Supported by the European Research Council (grant 323183 PREDICT to F.S.), the Swiss National Science Foundation (grants 149475 and 170213 to F.S.), the US National Institutes of Health (P01 grant NS076410 to H.L.W.) and the Helmut Horten Foundation (F.S. and the Institute for Research in Biomedicine).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Barozzi I, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-51; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dong J, 2007, J IMMUNOL, V179, P2389, DOI 10.4049/jimmunol.179.4.2389; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Evans HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4199; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hahn SA, 2013, BLOOD, V122, P1182, DOI 10.1182/blood-2012-12-474478; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	72	58	60	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1126	+		10.1038/s41590-018-0200-5	http://dx.doi.org/10.1038/s41590-018-0200-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30201991	Green Accepted			2022-12-18	WOS:000445968600018
J	Hons, M; Kopf, A; Hauschild, R; Leithner, A; Gaertner, F; Abe, J; Renkawitz, J; Stein, JV; Sixt, M				Hons, Miroslav; Kopf, Aglaja; Hauschild, Robert; Leithner, Alexander; Gaertner, Florian; Abe, Jun; Renkawitz, Jorg; Stein, Jens V.; Sixt, Michael			Chemokines and integrins independently tune actin flow and substrate friction during intranodal migration of T cells	NATURE IMMUNOLOGY			English	Article							LYMPH-NODE; F-ACTIN; IMMUNOLOGICAL SYNAPSE; MEMBRANE FLOW; IN-VIVO; MOTILITY; ADHESION; LYMPHOCYTES; ICAM-1; DOCK2	Although much is known about the physiological framework of T cell motility, and numerous rate-limiting molecules have been identified through loss-of-function approaches, an integrated functional concept of T cell motility is lacking. Here, we used in vivo precision morphometry together with analysis of cytoskeletal dynamics in vitro to deconstruct the basic mechanisms of T cell migration within lymphatic organs. We show that the contributions of the integrin LFA-1 and the chemokine receptor CCR7 are complementary rather than positioned in a linear pathway, as they are during leukocyte extravasation from the blood vasculature. Our data demonstrate that CCR7 controls cortical actin flows, whereas integrins mediate substrate friction that is sufficient to drive locomotion in the absence of considerable surface adhesions and plasma membrane flux.	[Hons, Miroslav; Kopf, Aglaja; Hauschild, Robert; Leithner, Alexander; Gaertner, Florian; Renkawitz, Jorg; Sixt, Michael] IST Austria, Klosterneuburg, Austria; [Hons, Miroslav; Abe, Jun; Stein, Jens V.] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	Institute of Science & Technology - Austria; University of Bern	Hons, M (corresponding author), IST Austria, Klosterneuburg, Austria.; Hons, M (corresponding author), Univ Bern, Theodor Kocher Inst, Bern, Switzerland.	miroslav.hons@ist.ac.at; jens.stein@tki.unibe.ch; sixt@ist.ac.at	Gaertner, Florian/GXG-7213-2022; Renkawitz, Jörg/AAD-5932-2022; Hons, Miroslav/AAK-5115-2021; Gaertner, Florian/AAY-1420-2021	Gaertner, Florian/0000-0001-6120-3723; Renkawitz, Jörg/0000-0003-2856-3369; Hons, Miroslav/0000-0002-6625-3348; Stein, Jens V/0000-0002-8199-9586; Leithner, Alexander/0000-0002-1073-744X; Sixt, Michael/0000-0002-6620-9179; Abe, Jun/0000-0001-7511-4502; Kopf, Aglaja/0000-0002-2187-6656	European Research Council [ERC StG 281556, CoG 724373]; Austrian Science Foundation (FWF); Swiss National Foundation (SNF) [31003A_135649, 31003A_153457, CR23I3_156234]; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant [747687]; EMBO long-term fellowship [ALTF 1396-2014]	European Research Council(European Research Council (ERC)European Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant; EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	We thank N. Darwish-Miranda, S. Caballero Mancebo, J. Schwarz, J. Alanko and F.P. Assen for advice and help with experiments. Further, we thank the Microscopy Imaging Center of the University of Bern for contribution to optical setups and the scientific support facilities of IST Austria for technical support. This work was funded by grants from the European Research Council (ERC StG 281556 and CoG 724373) and the Austrian Science Foundation (FWF) to M.S. and by Swiss National Foundation (SNF) project grants 31003A_135649, 31003A_153457 and CR23I3_156234 to J.V.S. F.G. received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 747687, and J.R. was funded by an EMBO long-term fellowship (ALTF 1396-2014).	Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Bieling P, 2016, CELL, V164, P115, DOI 10.1016/j.cell.2015.11.057; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Callan-Jones AC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.028102; Campbell EJ, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4990543; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Comrie WA, 2015, J CELL BIOL, V208, P475, DOI 10.1083/jcb.201406121; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dobbs K, 2015, NEW ENGL J MED, V372, P2409, DOI 10.1056/NEJMoa1413462; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Katakai T, 2013, J IMMUNOL, V191, P1188, DOI 10.4049/jimmunol.1300739; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lehmann JCU, 2003, J IMMUNOL, V171, P2588, DOI 10.4049/jimmunol.171.5.2588; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mayya V, 2018, CELL REP, V22, P340, DOI 10.1016/j.celrep.2017.12.052; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mueller J, 2017, CELL, V171, P188, DOI 10.1016/j.cell.2017.07.051; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Nordenfelt P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01848-y; Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schweitzer Y, 2013, SOFT MATTER, V9, P5186, DOI 10.1039/c3sm50723h; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stein JV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00559; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Takeda A, 2016, ELIFE, V5, DOI 10.7554/eLife.10561; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; WILSON RW, 1993, J IMMUNOL, V151, P1571; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Worbs T, 2007, TRENDS IMMUNOL, V28, P274, DOI 10.1016/j.it.2007.04.002	55	58	58	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					606	+		10.1038/s41590-018-0109-z	http://dx.doi.org/10.1038/s41590-018-0109-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777221				2022-12-18	WOS:000433041500026
J	Kim, JS; Sklarz, T; Banks, LB; Gohil, M; Waickman, AT; Skuli, N; Krock, BL; Luo, CT; Hu, WH; Pollizzi, KN; Li, MO; Rathmell, JC; Birnbaum, MJ; Powell, JD; Jordan, MS; Koretzky, GA				Kim, Jiyeon S.; Sklarz, Tammarah; Banks, Lauren B.; Gohil, Mercy; Waickman, Adam T.; Skuli, Nicolas; Krock, Bryan L.; Luo, Chong T.; Hu, Weihong; Pollizzi, Kristin N.; Li, Ming O.; Rathmell, Jeffrey C.; Birnbaum, Morris J.; Powell, Jonathan D.; Jordan, Martha S.; Koretzky, Gary A.			RETRACTED: Natural and inducible T(H)17 cells are regulated differently by Akt and mTOR pathways (Retracted article. See vol. 15, pg. 996, 2014)	NATURE IMMUNOLOGY			English	Article; Retracted Publication							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTORS; FOXP3 EXPRESSION; T-CELLS; ACTIVATION; ISOFORMS; ALPHA; ROLES; PHOSPHORYLATION; AUTOIMMUNITY	Natural T helper 17 (nT(H)17) cells are a population of interleukin 17 (IL-17)-producing cells that acquire effector function in the thymus during development. Here we demonstrate that the serine/threonine kinase Akt has a critical role in regulating nT(H)17 cell development. Although Akt and the downstream mTORC1-ARNT-HIF alpha axis were required for generation of inducible T(H)17 (iT(H)17) cells, nT(H)17 cells developed independently of mTORC1. In contrast, mTORC2 and inhibition of Foxo proteins were critical for development of nT(H)17 cells. Moreover, distinct isoforms of Akt controlled the generation of T(H)17 cell subsets, as deletion of Akt2, but not of Akt1, led to defective generation of iT(H)17 cells. These findings define mechanisms regulating nT(H)17 cell development and reveal previously unknown roles of Akt and mTOR in shaping subsets of T cells.	[Kim, Jiyeon S.; Sklarz, Tammarah; Banks, Lauren B.; Gohil, Mercy; Skuli, Nicolas; Krock, Bryan L.; Koretzky, Gary A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Kim, Jiyeon S.; Banks, Lauren B.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Waickman, Adam T.; Pollizzi, Kristin N.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21205 USA; [Luo, Chong T.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Hu, Weihong; Rathmell, Jeffrey C.] Duke Univ, Dept Immunol, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Jordan, Martha S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Jordan, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jordanm@mail.med.upenn.edu; koretzky@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021	li, ming/0000-0002-1383-0535; Waickman, Adam/0000-0002-4536-6714; Birnbaum, Morris/0000-0001-9972-8680	US National Institutes of Health [R01 DK56886, 5K01AR52802, R37GM053256]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053256] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Stiles (University of Southern California) for tissue from Akt1<SUP>-/-</SUP> mice; members of the Stem Cell and Xenotransplantation Core facility of the University of Pennsylvania for assistance with obtaining previously collected and de-identified human fetal thymic tissue; B. Monks for invaluable technical assistance and animal husbandry; L. Dipilato (University of Pennsylvania) for Akt inhibitors and helpful suggestions; S. Carty and T. Kambayashi for critically reading the manuscript; J. Stadanlick for editorial assistance; and members of the Koretzky and Jordan laboratories for helpful discussions. This work was supported by grants from US National Institutes of Health R01 DK56886 (M.J.B.), 5K01AR52802 (M.S.J.) and R37GM053256 (G.A.K.).	Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Elson DA, 2000, CANCER RES, V60, P6189; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulen MF, 2012, IMMUNITY, V37, P800, DOI 10.1016/j.immuni.2012.08.019; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	48	58	67	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					611	+		10.1038/ni.2607	http://dx.doi.org/10.1038/ni.2607			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23644504	Green Accepted			2022-12-18	WOS:000319107600014
J	van Gisbergen, KPJM; Kragten, NAM; Hertoghs, KML; Wensveen, FM; Jonjic, S; Hamann, J; Nolte, MA; van Lier, RAW				van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Hertoghs, Kirsten M. L.; Wensveen, Felix M.; Jonjic, Stipan; Hamann, Joerg; Nolte, Martijn A.; van Lier, Rene A. W.			Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation	NATURE IMMUNOLOGY			English	Article							NK1(+) T-CELLS; NATURAL-KILLER; MICROBIAL INFECTION; CYTOKINE PRODUCTION; GENE-EXPRESSION; CUTTING EDGE; ACTIVATION; INTERFERON; MATURATION; LINEAGE	The transcriptional repressor Blimp-1 mediates the terminal differentiation of many cell types, including T cells. Here we identified Hobit (Znf683) as a previously unrecognized homolog of Blimp-1 that was specifically expressed in mouse natural killer T cells (NKT cells). Through studies of Hobit-deficient mice, we found that Hobit was essential for the formation of mature thymic NKT cells. In the periphery, Hobit repressed the accumulation of interferon-gamma (IFN-gamma)-producing NK1.1(lo) NKT cells at steady state. After antigenic stimulation, Hobit repressed IFN-gamma expression, whereas after innate stimulation, Hobit induced granzyme B expression. Thus, reminiscent of the function of Blimp-1 in other lymphocytes, Hobit controlled the maintenance of quiescent, fully differentiated NKT cells and regulated their immediate effector functions.	[van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Nolte, Martijn A.; van Lier, Rene A. W.] Landsteiner Lab, Amsterdam, Netherlands; [van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Hertoghs, Kirsten M. L.; Hamann, Joerg; Nolte, Martijn A.; van Lier, Rene A. W.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Wensveen, Felix M.; Jonjic, Stipan] Univ Rijeka, Dept Histol & Embryol, Rijeka, Croatia; [van Gisbergen, Klaas P. J. M.; Kragten, Natasja A. M.; Nolte, Martijn A.; van Lier, Rene A. W.] Sanquin Res CLB, Dept Hematopoiesis, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Rijeka	van Gisbergen, KPJM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Immunol, Parkville, Vic 3050, Australia.	k.vangisbergen@sanquin.nl	Nolte, Martijn A./AAC-8092-2022; Wensveen, Felix/O-3122-2018; Jonjic, Stipan/C-5657-2016	Nolte, Martijn A./0000-0002-5447-0839; Wensveen, Felix/0000-0002-1333-8882; Jonjic, Stipan/0000-0001-5003-3108; Hamann, Jorg/0000-0002-9448-1727; van Gisbergen, Klaas/0000-0003-3623-7555; van Lier, Rene/0000-0002-3201-7144	Netherlands Organization of Scientific Research; Landsteiner Foundation for Blood Transfusion Research	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Transfusion Research	We thank L. Boon (Bioceros) for antibodies to CD1d, CD122 and the receptors Fc gamma RII-Fc gamma RIII; J.C. Zuniga-Pflucker (Sunnybrook Research Institute) for OP9-DL1 cells; the staff of the animal facility of the Academic Medical Center for animal care; A. de Bruin for technical assistance; B. Hooibrink, E. Mul and F. van Alphen for cell sorting; D. Edo-Matas for help with phylogenetic analysis; and A. Kallies for critical reading of the manuscript. Supported by The Netherlands Organization of Scientific Research (M.A.N. and R.A.W.v.L.) and the Landsteiner Foundation for Blood Transfusion Research (N.A.M.K.).	BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Mcnab FW, 2007, J IMMUNOL, V179, P6630, DOI 10.4049/jimmunol.179.10.6630; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Stenstrom M, 2005, IMMUNOLOGY, V114, P336, DOI 10.1111/j.1365-2567.2004.02111.x; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018	41	58	58	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					864	871		10.1038/ni.2393	http://dx.doi.org/10.1038/ni.2393			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22885984				2022-12-18	WOS:000307863600015
J	Berger, M; Krebs, P; Crozat, K; Li, XH; Croker, BA; Siggs, OM; Popkin, D; Du, X; Lawson, BR; Theofilopoulos, AN; Xia, Y; Khovananth, K; Moresco, EMY; Satoh, T; Takeuchi, O; Akira, S; Beutler, B				Berger, Michael; Krebs, Philippe; Crozat, Karine; Li, Xiaohong; Croker, Ben A.; Siggs, Owen M.; Popkin, Daniel; Du, Xin; Lawson, Brian R.; Theofilopoulos, Argyrios N.; Xia, Yu; Khovananth, Kevin; Moresco, Eva Marie Y.; Satoh, Takashi; Takeuchi, Osamu; Akira, Shizuo; Beutler, Bruce			An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence	NATURE IMMUNOLOGY			English	Article							NAIVE T-CELLS; L-SELECTIN; GENE-EXPRESSION; ACTIVATION; RESPONSES; MUTAGENESIS; HOMEOSTASIS; PHENOTYPE; INFECTION; SCHLAFEN	Here we describe a previously unknown form of inherited immunodeficiency revealed by an N-ethyl-N-nitrosourea-induced mutation called elektra. Mice homozygous for this mutation showed enhanced susceptibility to bacterial and viral infection and diminished numbers of T cells and inflammatory monocytes that failed to proliferate after infection and died via the intrinsic apoptotic pathway in response to diverse proliferative stimuli. They also had a greater proportion of T cells poised to replicate DNA, and their T cells expressed a subset of activation markers, suggestive of a semi-activated state. We positionally ascribe the elektra phenotype to a mutation in the gene encoding Schlafen-2 (Slfn2). Our findings identify a physiological role for Slfn2 in the defense against pathogens through the regulation of quiescence in T cells and monocytes.	[Berger, Michael; Krebs, Philippe; Crozat, Karine; Li, Xiaohong; Croker, Ben A.; Siggs, Owen M.; Du, Xin; Xia, Yu; Khovananth, Kevin; Moresco, Eva Marie Y.; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Popkin, Daniel; Lawson, Brian R.; Theofilopoulos, Argyrios N.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Satoh, Takashi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan	Scripps Research Institute; Scripps Research Institute; Osaka University	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA.	bruce@scripps.edu	Krebs, Philippe/A-3449-2012; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Crozat, Karine/L-7297-2019; Takeuchi, Osamu/D-6007-2011	Krebs, Philippe/0000-0003-4918-6654; Takeuchi, Osamu/0000-0002-1260-6232; Crozat, Karine/0000-0003-4761-3675; Moresco, Eva Marie/0000-0002-2049-7291; Siggs, Owen/0000-0003-2840-4851; Croker, Ben/0000-0002-0885-3599	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167, R01AI076396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM067759] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI070167-01, P01 AI070167, R01 AI076396] Funding Source: Medline; NIAMS NIH HHS [R01 AR031203] Funding Source: Medline; NIGMS NIH HHS [R37 GM067759] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chao CC, 1997, J IMMUNOL, V159, P1686; Chechlinska M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-261; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dooms H, 1998, J IMMUNOL, V161, P2141; Ferguson DA, 2005, GENE EXPR PATTERNS, V5, P619, DOI 10.1016/j.modgep.2005.03.003; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Glynne R, 2000, IMMUNOL REV, V176, P216; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Kaufmann A, 2001, IMMUNOBIOLOGY, V204, P603, DOI 10.1078/0171-2985-00099; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krebs P, 2009, BLOOD, V113, P6593, DOI 10.1182/blood-2009-01-201467; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Oehen S, 1998, J IMMUNOL, V161, P5338; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; REEVES JP, 2009, CURRENT PROTOCOLS IM; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Rutschmann S, 2006, J IMMUNOL, V176, P7525, DOI 10.4049/jimmunol.176.12.7525; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Webb JR, 2002, GENES IMMUN, V3, P250, DOI 10.1038/sj.gene.6363876; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	46	58	61	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					335	U55		10.1038/ni.1847	http://dx.doi.org/10.1038/ni.1847			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20190759	Green Accepted			2022-12-18	WOS:000275849500013
J	Riol-Blanco, L; Delgado-Martin, C; Sanchez-Sanchez, N; Alonso, LM; Gutierrez-Lopez, MD; del Hoyo, GM; Navarro, J; Sanchez-Madrid, F; Cabanas, C; Sanchez-Mateos, P; Rodriguez-Fernandez, JL				Riol-Blanco, Lorena; Delgado-Martin, Cristina; Sanchez-Sanchez, Noelia; Alonso-C, Luis M.; Dolores Gutierrez-Lopez, Maria; Martinez del Hoyo, Gloria; Navarro, Joaquin; Sanchez-Madrid, Francisco; Cabanas, Carlos; Sanchez-Mateos, Paloma; Luis Rodriguez-Fernandez, Jose			Immunological synapse formation inhibits, via NF-kappa B and FOXO1, the apoptosis of dendritic cells	NATURE IMMUNOLOGY			English	Article							LYMPH-NODES; T-CELLS; IN-VIVO; ANTIGEN RECOGNITION; LIFE-SPAN; ACTIVATION; BINDING; DEATH; LYMPHOCYTES; MOLECULES	The immunological synapse (IS) is a cell-cell junction formed between CD4(+) T cells and dendritic cells (DCs). Here we show in vitro and in vivo that IS formation inhibits apoptosis of DCs. Consistent with these results, IS formation induced antiapoptotic signaling events, including activation of the kinase Akt1 and localization of the prosurvival transcription factor NF-kappa B and the proapoptotic transcription factor FOXO1 to the nucleus and cytoplasm, respectively. Inhibition of phosphatidylinositol 3-OH kinase and Akt1 partially prevented the antiapoptotic effects of IS formation. Direct stimulation of the IS component CD40 on DCs leads to the activation of Akt1, suggesting the involvement of this receptor in the antiapoptotic effects observed upon IS formation.	[Riol-Blanco, Lorena; Delgado-Martin, Cristina; Sanchez-Sanchez, Noelia; Luis Rodriguez-Fernandez, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Alonso-C, Luis M.] Univ Complutense, Ctr Microscopia & Citometria, E-28040 Madrid, Spain; [Dolores Gutierrez-Lopez, Maria; Cabanas, Carlos] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Martinez del Hoyo, Gloria; Sanchez-Madrid, Francisco] Univ Autonoma Madrid, Hosp La Princesa, Serv Inmunol, Madrid, Spain; [Navarro, Joaquin; Sanchez-Mateos, Paloma] Hosp Gen Gregorio Maranon, Lab Inmunooncol, Madrid, Spain; [Sanchez-Madrid, Francisco] Ctr Nacl Invest Cardiovasc, Dept Biol Vasc & Inflamac, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital de La Princesa; General University Gregorio Maranon Hospital; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Rodriguez-Fernandez, JL (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	rodrifer@cib.csic.es	Sanchez-Mateos, Paloma/E-8931-2013; Rodriguez-Fernandez, Jose Luis/Q-5021-2019; CABAÑAS, CARLOS/J-4595-2012; MD, Gutierrez-Lopez/P-2965-2014; Sanchez-Madrid, Francisco/M-7889-2016; Alonso-Colmenar, Luis Miguel/K-6957-2018; Martinez del Hoyo, Gloria/K-4750-2015	Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425; CABAÑAS, CARLOS/0000-0002-8767-060X; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Alonso-Colmenar, Luis Miguel/0000-0003-3869-6309; Martinez del Hoyo, Gloria/0000-0003-2588-2575; Gutierrez Lopez, Maria Dolores/0000-0002-9979-5573; Sanchez-Mateos, Paloma/0000-0001-6589-4445				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Boisvert J, 2004, J IMMUNOL, V173, P3647, DOI 10.4049/jimmunol.173.6.3647; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim KD, 2001, J LEUKOCYTE BIOL, V69, P426; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lovborg H, 2004, MOL CANCER THER, V3, P521; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Pozarowski P, 2003, CYTOM PART A, V55A, P50, DOI 10.1002/cyto.a.10074; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Rodriguez-Fernandez JL, 2001, J BIOL CHEM, V276, P40518, DOI 10.1074/jbc.M102896200; Rodriguez-Fernandez Jose Luis, 2005, Curr Opin Investig Drugs, V6, P1103; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2002, CURR OPIN IMMUNOL, V14, P293, DOI 10.1016/S0952-7915(02)00350-3; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	50	58	64	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					753	U110		10.1038/ni.1750	http://dx.doi.org/10.1038/ni.1750			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19503105				2022-12-18	WOS:000267142600015
J	Tanaka, Y; Hamano, S; Gotoh, K; Murata, Y; Kunisaki, Y; Nishikimi, A; Takii, R; Kawaguchi, M; Inayoshi, A; Masuko, S; Himeno, K; Sasazuki, T; Fukui, Y				Tanaka, Yoshihiko; Hamano, Shinjiro; Gotoh, Kazuhito; Murata, Yuzo; Kunisaki, Yuya; Nishikimi, Akihiko; Takii, Ryosuke; Kawaguchi, Makiko; Inayoshi, Ayumi; Masuko, Sadahiko; Himeno, Kunisuke; Sasazuki, Takehiko; Fukui, Yoshinori			T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2	NATURE IMMUNOLOGY			English	Article							CELL-RECEPTOR LIGATION; STIMULATORY FACTOR-I; LINEAGE COMMITMENT; DOWN-REGULATION; TH1 DEVELOPMENT; CYTOKINE GENES; LIGAND; MICROTUBULE; LYMPHOCYTES; EXPRESSION	The lineage commitment of CD4(+) T cells is coordinately regulated by signals through the T cell receptor and cytokine receptors, yet how these signals are integrated remains elusive. Here we find that mice lacking Dock2, a Rac activator in lymphocytes, developed allergic disease through a mechanism dependent on CD4+ T cells and the interleukin 4 receptor (IL-4R). Dock2-deficient CD4(+) T cells showed impaired antigen-driven downregulation of IL-4R surface expression, resulting in sustained IL-4R signaling and excessive T helper type 2 responses. Dock2 was required for T cell receptor-mediated phosphorylation of the microtubule-destabilizing protein stathmin and for lysosomal trafficking and the degradation of IL-4R alpha. Thus, Dock2 links T cell receptor signals to downregulation of IL-4R alpha to control the lineage commitment of CD4+ T cells.	Kyushu Univ, Fac Med, Inst Med Bioregulat, Dept Neurosci & Immunol,Div Immunogenet, Fukuoka 812, Japan; Kyushu Univ, Fac Med, Dept Parasitol, Fukuoka 812, Japan; Saga Univ, Fac Med, Dept Anat & Physiol, Saga 849, Japan; Int Med Ctr, Tokyo 162, Japan	Kyushu University; Kyushu University; Saga University	Fukui, Y (corresponding author), Kyushu Univ, Fac Med, Inst Med Bioregulat, Dept Neurosci & Immunol,Div Immunogenet, Fukuoka 812, Japan.	fukui@bioreg.kyushu-u.ac.jp	Nishikimi, Akihiko/I-4692-2018; Hamano, Shinjiro/A-7932-2011; Gotoh, Kazuhito/AAY-6782-2020	Nishikimi, Akihiko/0000-0001-9497-7557; Hamano, Shinjiro/0000-0003-3881-8337; Gotoh, Kazuhito/0000-0002-9965-9977; TANAKA, Yoshihiko/0000-0002-6458-5082; Fukui, Yoshinori/0000-0003-2335-8745				ABBAS AK, 1996, NATURE, V383, P797; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Croker BA, 2002, IMMUNOL CELL BIOL, V80, P231, DOI 10.1046/j.1440-1711.2002.01077.x; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Fallon EM, 2000, J BIOL CHEM, V275, P6790, DOI 10.1074/jbc.275.10.6790; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; LEZZI G, 1999, EUR J IMMUNOL, V29, P4092; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; MCGRAW TE, 1993, J CELL PHYSIOL, V155, P579, DOI 10.1002/jcp.1041550316; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; MOZO L, 1993, J IMMUNOL, V150, P4261; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Rahimpour R, 1999, J IMMUNOL, V162, P2299; Reddy CC, 1996, NAT BIOTECHNOL, V14, P1696, DOI 10.1038/nbt1296-1696; Regis G, 2006, TRENDS IMMUNOL, V27, P96, DOI 10.1016/j.it.2005.12.002; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skrenta H, 2000, J IMMUNOL, V164, P3506, DOI 10.4049/jimmunol.164.7.3506; Sonee M, 1998, AM J PHYSIOL-CELL PH, V275, pC1630, DOI 10.1152/ajpcell.1998.275.6.C1630; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	49	58	59	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1067	1075		10.1038/ni1506	http://dx.doi.org/10.1038/ni1506			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17767160				2022-12-18	WOS:000249691400021
J	Liu, EH; Siegel, RM; Harlan, DM; O'Shea, JJ				Liu, Eric H.; Siegel, Richard M.; Harlan, David M.; O'Shea, John J.			T cell-directed therapies: lessons learned and future prospects	NATURE IMMUNOLOGY			English	Article							MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS; ALLOGRAFT-REJECTION; BLOCKADE; TRIAL; TRANSPLANTATION; PLACEBO; FTY720; CALCINEURIN; NATALIZUMAB	Agents interfering with T cell function are therapeutic mainstays for various autoimmune diseases and for transplant approaches to organ failure. The understanding of T cell biology has blossomed since the development of most agents now in use. Here we discuss T cell - specific agents now in use, others recently added to the therapeutic armamentarium and promising agents being investigated in clinical and preclinical studies. In addition, we reflect on the risks and benefits involved in the testing of such agents clinically, with examples of agents that have successfully been used in the clinic and agents that failed to reach therapeutic use.	NIDDK, Diabet Branch, Bethesda, MD 20892 USA; NIAMSD, Autoimmun Branch, Bethesda, MD 20892 USA; NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Liu, EH (corresponding author), NIDDK, Diabet Branch, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041174, Z01AR041159, ZIAAR041159, Z01AR041133, Z01AR041106, ZIAAR041106, ZIAAR041133, ZIAAR041174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055111, ZIADK055112, ZIADK062002, ZIADK055111, Z01DK055112, Z01DK062002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Baslund B, 2005, ARTHRITIS RHEUM-US, V52, P2686, DOI 10.1002/art.21249; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; CALNE R, 2006, TRANSPLANT P, V36, pS13; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chambers CA, 1999, P NATL ACAD SCI USA, V96, P8603, DOI 10.1073/pnas.96.15.8603; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; CHARPENTIER B, 1992, TRANSPLANTATION, V54, P997, DOI 10.1097/00007890-199212000-00011; CHOY EHS, 1992, SCAND J IMMUNOL, V36, P291, DOI 10.1111/j.1365-3083.1992.tb03102.x; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; CRITCHFIELD JM, 1995, CLIN IMMUNOL IMMUNOP, V75, P13, DOI 10.1006/clin.1995.1046; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Daikh DI, 1997, J IMMUNOL, V159, P3104; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; FRIEND PJ, 1989, TRANSPLANTATION, V48, P248, DOI 10.1097/00007890-198908000-00013; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Hale G, 1994, J Hematother, V3, P15, DOI 10.1089/scd.1.1994.3.15; HALE G, 1983, BLOOD, V62, P873; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Isaacs JD, 1996, BRIT J RHEUMATOL, V35, P231; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Starzl T. E., 1967, TRANSPLANTATION, V5, P1100; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tedesco-Silva H, 2005, TRANSPLANTATION, V79, P1553, DOI 10.1097/01.TP.0000121761.02129.A6; Utset TO, 2002, J RHEUMATOL, V29, P1907; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Vitetta ES, 2006, SCIENCE, V313, P308, DOI 10.1126/science.1130482; Waldmann TA, 2003, TRENDS MOL MED, V9, P517, DOI 10.1016/j.molmed.2003.10.005; WEINSHENKER BG, 1991, NEUROLOGY, V41, P1047, DOI 10.1212/WNL.41.7.1047; Wendling D, 1998, J RHEUMATOL, V25, P1457; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562; Yakupoglu Yarkin K, 2003, Exp Clin Transplant, V1, P8	63	58	62	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					25	30		10.1038/ni1429	http://dx.doi.org/10.1038/ni1429			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179969				2022-12-18	WOS:000242934400010
J	Huan, CM; Kelly, ML; Steele, R; Shapira, I; Gottesman, SRS; Roman, CAJ				Huan, Chongmin; Kelly, Matthew L.; Steele, Ryan; Shapira, Iuliana; Gottesman, Susan R. S.; Roman, Christopher A. J.			Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity	NATURE IMMUNOLOGY			English	Article							HELIX-LOOP-HELIX; T-CELL DEVELOPMENT; LEUCINE-ZIPPER; DNA-BINDING; OSTEOCLAST DEVELOPMENT; NUCLEAR-FACTOR; B-CELLS; MICROPHTHALMIA; PROTEINS; ACTIVATION	TFE3 and TFEB are broadly expressed transcription factors related to the transcription factor Mitf. Although they have been linked to cytokine signaling pathways in nonlymphoid cells, their function in T cells is unknown. TFE3-deficient mice are phenotypically normal, whereas TFEB deficiency causes early embryonic death. We now show that combined inactivation of TFE3 and TFEB in T cells resulted in a hyper-immunoglobulin M syndrome due to impaired expression of CD40 ligand by CD4(+) T cells. Native TFE3 and TFEB bound to multiple cognate sites in the promoter of the gene encoding CD40 ligand ( Cd40lg), and maximum Cd40lg promoter activity and gene expression required TFE3 or TFEB. Thus, TFE3 and TFEB are direct, physiological and mutually redundant activators of Cd40lg expression in activated CD4(+) T cells critical for T cell dependent antibody responses.	SUNY Hlth Sci Ctr, Program Mol & Cellular Biol, Sch Grad Studies, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Med, Div Hematol & Oncol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Roman, CAJ (corresponding author), SUNY Hlth Sci Ctr, Program Mol & Cellular Biol, Sch Grad Studies, Brooklyn, NY 11203 USA.	christopher.roman@downstate.edu		Steele, Ryan/0000-0002-9008-5102	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK065011] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK065011, R21 DK065011-02, DK65011] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; Danese S, 2005, CRIT REV IMMUNOL, V25, P103; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; Fisher DE, 2000, PIGM CELL RES, V13, P145, DOI 10.1034/j.1600-0749.13.s8.26.x; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; GROSS JA, 1992, J IMMUNOL, V149, P380; Harris NL, 2006, MICROBES INFECT, V8, P232, DOI 10.1016/j.micinf.2005.06.020; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huan CM, 2005, J BIOL CHEM, V280, P30225, DOI 10.1074/jbc.M502380200; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; JERNE NK, 1974, TRANSPLANT REV-DENMA, V18, P130; KERKHOFF E, 1991, P NATL ACAD SCI USA, V88, P4323, DOI 10.1073/pnas.88.10.4323; Kuiper RP, 2004, NUCLEIC ACIDS RES, V32, P2315, DOI 10.1093/nar/gkh571; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Lindgren H, 2001, J IMMUNOL, V166, P4578, DOI 10.4049/jimmunol.166.7.4578; Lobo FM, 2000, BIOCHEM BIOPH RES CO, V279, P245, DOI 10.1006/bbrc.2000.3914; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Parra E, 2001, J IMMUNOL, V166, P2437, DOI 10.4049/jimmunol.166.4.2437; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Rehli M, 2005, J IMMUNOL, V174, P7111, DOI 10.4049/jimmunol.174.11.7111; Rehli M, 1999, J IMMUNOL, V162, P1559; Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588; ROMAN C, 1991, SCIENCE, V254, P94, DOI 10.1126/science.1840705; ROMAN C, 1992, MOL CELL BIOL, V12, P817, DOI 10.1128/MCB.12.2.817; Roundy K, 1999, J IMMUNOL, V163, P6671; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schattner EJ, 2000, LEUKEMIA LYMPHOMA, V37, P461, DOI 10.3109/10428190009058499; Seyama K, 1998, BLOOD, V92, P2421, DOI 10.1182/blood.V92.7.2421.2421_2421_2434; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Skov S, 2003, BLOOD, V101, P1430, DOI 10.1182/blood-2002-07-2073; Slomiany BA, 2000, BIOTECHNIQUES, V28, P938, DOI 10.2144/00285st08; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Steingrimsson E, 1998, DEVELOPMENT, V125, P4607; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yi YJ, 2000, J IMMUNOL, V165, P6627, DOI 10.4049/jimmunol.165.11.6627	54	58	62	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1082	1091		10.1038/ni1378	http://dx.doi.org/10.1038/ni1378			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16936731	Green Accepted			2022-12-18	WOS:000241437100014
J	Pearce, G; Angeli, V; Randolph, GJ; Junt, T; von Andrian, U; Schnittler, HJ; Jessberger, R				Pearce, Glen; Angeli, Veronique; Randolph, Gwendalyn J.; Junt, Tobias; von Andrian, Ulrich; Schnittler, Hans-Joachim; Jessberger, Rolf			Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs	NATURE IMMUNOLOGY			English	Article							TRANSENDOTHELIAL MIGRATION; LEUKOCYTE FUNCTION; LYMPHOCYTES; NODES; NEUTROPHILS; CHEMOKINES; ADHESION; ACTIN; ACTIVATION; POLARITY	The migration of B cells into secondary lymphoid organs is required for the generation of an effective immune response. Here we analyzed the involvement of SWAP-70, a Rac-interacting protein involved in actin rearrangement, in B cell entry into lymph nodes. We noted reduced migration of Swap70(-/-) B cells into lymph nodes in vivo. Swap70(-/-) B cells rolled and adhered, yet accumulated in lymph node high endothelial venules. This defect was not due to impaired integrin expression or chemotaxis. Instead, Swap70(-/-) B cells aberrantly regulated integrin-mediated adhesion. During attachment, Swap70(-/-) B cells showed defective polarization and did not form uropods or stabilize lamellipodia at a defined region. Thus, SWAP-70 selectively regulates processes essential for B cell entry into lymph nodes.	Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany; CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Tech Univ Dresden, Inst Physiol, D-01307 Dresden, Germany	Technische Universitat Dresden; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Technische Universitat Dresden	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany.	rolf.jessberger@tu-dresden.de	Junt, Tobias/AAE-4389-2021; von Andrian, Ulrich H/A-5775-2008		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049470, R21AI049470] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL056949] Funding Source: Medline; NIAID NIH HHS [AI49470] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Davey EJ, 1998, J IMMUNOL, V160, P5366; DAVEY EJ, 1995, EUR J IMMUNOL, V25, P1224, DOI 10.1002/eji.1830250514; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Gismondi A, 2003, J IMMUNOL, V170, P3065, DOI 10.4049/jimmunol.170.6.3065; Greicius G, 1998, SCAND J IMMUNOL, V48, P642; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Nolte MA, 2004, J IMMUNOL, V172, P3620, DOI 10.4049/jimmunol.172.6.3620; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	47	58	58	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					827	834		10.1038/ni1365	http://dx.doi.org/10.1038/ni1365			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16845395				2022-12-18	WOS:000239147200018
J	Hyatt, G; Melamed, R; Park, R; Seguritan, R; Laplace, C; Poirot, L; Zucchelli, S; Obst, R; Matos, M; Venanzi, E; Goldrath, A; Nguyen, L; Luckey, J; Yamagata, T; Herman, A; Jacobs, J; Mathis, D; Benoist, C				Hyatt, Gordon; Melamed, Rachel; Park, Richard; Seguritan, Reuben; Laplace, Catherine; Poirot, Laurent; Zucchelli, Silvia; Obst, Reinhard; Matos, Michael; Venanzi, Emily; Goldrath, Ananda; Nguyen, Linh; Luckey, John; Yamagata, Tetsuya; Herman, Ann; Jacobs, Jonathan; Mathis, Diane; Benoist, Christophe			Gene expression microarrays: glimpses of the immunological genome	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-SYSTEM; T-CELLS; REGULATORY NETWORKS; SIGNATURES; DISCOVERY; MODULES; PROGRESSION; LYMPHOCYTES; PLASTICITY; PATTERNS	Successful microarray experimentation can generate enormous amounts of data, potentially very rich but also very unwieldy. Bold outlooks and new methods for data analysis and presentation should yield additional insight into the complexities of the immune system.	Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Hyatt, G (corresponding author), Brigham & Womens Hosp, Dept Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu		Zucchelli, Silvia/0000-0003-4556-2990; Melamed, Rachel/0000-0003-3089-9806; Jacobs, Jonathan/0000-0003-4698-0254; Obst, Reinhard/0000-0002-4839-207X	NIAID NIH HHS [AI51530, AI52343] Funding Source: Medline; NIAMS NIH HHS [AR046580] Funding Source: Medline; NIDDK NIH HHS [DK59658, DK60027] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530, R37AI051530, P01AI052343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059658, R01DK060027, R37DK060027] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Adarichev VA, 2005, ARTHRITIS RES THER, V7, pR196, DOI 10.1186/ar1472; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Battle A, 2005, J COMPUT BIOL, V12, P909, DOI 10.1089/cmb.2005.12.909; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; CRAMPTON J, 1980, NUCLEIC ACIDS RES, V8, P6007, DOI 10.1093/nar/8.24.6007; DAVIS MM, 1982, UCLA SYMP MOL CELL B, V24, P215; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hashimoto SI, 2003, BLOOD, V101, P3509, DOI 10.1182/blood-2002-06-1866; Hoffmann R, 2003, J IMMUNOL, V170, P1339, DOI 10.4049/jimmunol.170.3.1339; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keefe DF, 2005, IEEE COMPUT GRAPH, V25, P18, DOI 10.1109/MCG.2005.34; Kluger Y, 2004, P NATL ACAD SCI USA, V101, P6508, DOI 10.1073/pnas.0401136101; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Matos M, 2004, DIABETES, V53, P2310, DOI 10.2337/diabetes.53.9.2310; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shortman K, 2006, NAT MED, V12, P167, DOI 10.1038/nm0206-167; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Wilson SB, 2001, CURR OPIN IMMUNOL, V13, P555, DOI 10.1016/S0952-7915(00)00258-2; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yamagata T, 2006, IMMUNOL REV, V210, P52, DOI 10.1111/j.0105-2896.2006.00371.x; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	51	58	59	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					686	691		10.1038/ni0706-686	http://dx.doi.org/10.1038/ni0706-686			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785882				2022-12-18	WOS:000238377700003
J	Mazaki, Y; Hashimoto, S; Tsujimura, T; Morishige, M; Hashimoto, A; Aritake, K; Yamada, A; Nam, JM; Kiyonari, H; Nakao, K; Sabe, H				Mazaki, Yuichi; Hashimoto, Shigeru; Tsujimura, Tohru; Morishige, Masaki; Hashimoto, Ari; Aritake, Kosuke; Yamada, Atsuko; Nam, Jin-Min; Kiyonari, Hiroshi; Nakao, Kazuki; Sabe, Hisataka			Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2	NATURE IMMUNOLOGY			English	Article							G-BETA-GAMMA; EXCHANGE FACTOR; BREFELDIN-A; FAMILY; RECEPTOR; ARF6; PIX; LOCALIZATION; PHAGOCYTOSIS; RECRUITMENT	In neutrophils, superoxide anion production generally accompanies chemotaxis and functions in killing invading pathogens. The GIT2 GTPase-activating protein binds to the guanine nucleotide-exchange factor alpha PIX. Here we show that GIT2 was necessary for directional chemotaxis and for the suppression of superoxide production in G protein-coupled receptor-stimulated neutrophils. GIT2 was also necessary for the orientation of superoxide production toward chemoattractant sources. GIT2 suppressed the activity of ADP ribosylation factor 1 and was a component of the G beta gamma subunit-mediated direction-sensing machinery 'downstream' of G protein-coupled receptor signaling. This study establishes a function for GIT2 in linking chemotaxis and superoxide production in neutrophils and shows that loss of GIT2 in vivo leads to an immunodeficient state.	Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 5650874, Japan; Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Oita Univ, Sch Med, Dept Neurosurg, Oita 8795593, Japan; Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 5650874, Japan; RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Hyogo College of Medicine; Oita University; RIKEN; Kyoto University	Sabe, H (corresponding author), Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 5650874, Japan.	sabe@obi.or.jp	Sabe, Hisataka/GPF-4385-2022; Hashimoto, Shigeru/D-7138-2012; Kiyonari, Hiroshi/N-7936-2015; Hashimoto, Ari/D-7125-2012; Nam, Jin-Min/D-6468-2012; Sabe, Hisataka/A-4066-2012	zhong wei, he gui/0000-0002-3066-3564; Mazaki, Yuichi/0000-0003-4192-0834				Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dana RR, 2000, J BIOL CHEM, V275, P32566, DOI 10.1074/jbc.M005406200; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; GROCOTT RG, 1955, AM J CLIN PATHOL, V25, P975, DOI 10.1093/ajcp/25.8_ts.0975; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; HIRAI KI, 1991, EXP CELL RES, V194, P19, DOI 10.1016/0014-4827(91)90124-D; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kaldi K, 2002, J LEUKOCYTE BIOL, V71, P695; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Mocsai A, 1999, J IMMUNOL, V162, P1120; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Parent CA, 2002, CELL, V109, P541, DOI 10.1016/S0092-8674(02)00765-1; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Roth MG, 2000, FR MOLEC B, V24, P176; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmalzigaug R, 2003, PROTEINS CELL REG, V1, P159; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	49	58	63	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					724	731		10.1038/ni1349	http://dx.doi.org/10.1038/ni1349			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16715100				2022-12-18	WOS:000238377700017
J	Zhang, ZX; Espinoza, CR; Yu, ZH; Stephan, R; He, T; Williams, GS; Burrows, PD; Hagman, J; Feeney, AJ; Cooper, MD				Zhang, Zhixin; Espinoza, Celia R.; Yu, Zhihong; Stephan, Robert; He, Ti; Williams, G. Stuart; Burrows, Peter D.; Hagman, James; Feeney, Ann J.; Cooper, Max D.			Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V-H-to-DJ(H) rearrangement of immunoglobulin genes	NATURE IMMUNOLOGY			English	Article							B-CELL DIFFERENTIATION; SURROGATE LIGHT-CHAIN; V(D)J RECOMBINATION; SEQUENCE RECOGNITION; HISTONE ACETYLATION; PAIRED DOMAIN; PROTEINS; EXPRESSION; E2A; LOCUS	Immunoglobulin rearrangement from variable heavy chain (V-H) to diversity (D)-joining heavy chain (J(H)), which occurs exclusively in B lineage cells, is impaired in mice deficient for the B lineage-specific transcription factor Pax5. Conversely, ectopic Pax5 expression in thymocytes promotes the rearrangement of D-H-proximal V(H)7183 genes. In exploring the mechanism for Pax5 regulation of V-H-to-DJ(H) recombination, we have identified multiple Pax5 binding sites in the coding regions of human and mouse V-H gene segments. Pax5 bound to those sites in vitro and occupied V-H genes in early human and mouse B lineage cells. Moreover, Pax5 interacted with the recombination-activating gene 1 (RAG1)-RAG2 complex to enhance RAG-mediated V-H recombination signal sequence cleavage and recombination of a V-H gene substrate. These findings indicate a direct activating function for Pax5 in RAG-mediated immunoglobulin V-H-to-DJ(H) recombination.	Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; National Jewish Health; Scripps Research Institute	Zhang, ZX (corresponding author), Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	zhixin.zhang@ccc.uab.edu; max.cooper@ccc.uab.edu	Hagman, James/R-7013-2019	Hagman, James/0000-0002-5436-8455; Zhang, Zhixin/0000-0003-3924-1082	NCI NIH HHS [CA107478] Funding Source: Medline; NIAID NIH HHS [AI54661, AI56322, AI52313, AI39816, AI48098] Funding Source: Medline; NIAMS NIH HHS [K01 AR048592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA107478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048098, R01AI056322, R01AI054661, R01AI039816, R37AI039816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; BURROWS P, 1979, NATURE, V280, P838, DOI 10.1038/280838a0; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eberhard D, 1999, CANCER RES, V59, p1716S; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Ghosh JK, 2001, J EXP MED, V193, P769, DOI 10.1084/jem.193.6.769; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIEBER MR, 1988, P NATL ACAD SCI USA, V85, P8588, DOI 10.1073/pnas.85.22.8588; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Love VA, 2000, MOL IMMUNOL, V37, P29, DOI 10.1016/S0161-5890(00)00023-7; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Roth DB, 2000, CELL, V103, P699, DOI 10.1016/S0092-8674(00)00173-2; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wang YH, 2003, BLOOD, V101, P1030, DOI 10.1182/blood-2002-06-1828; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	51	58	58	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					616	624		10.1038/ni1339	http://dx.doi.org/10.1038/ni1339			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16680144				2022-12-18	WOS:000237751200017
J	Huntington, ND; Xu, YK; Puthalakath, H; Light, A; Willis, SN; Strasser, A; Tarlinton, DM				Huntington, ND; Xu, YK; Puthalakath, H; Light, A; Willis, SN; Strasser, A; Tarlinton, DM			CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers	NATURE IMMUNOLOGY			English	Article							PHOSPHATASE-DEFICIENT MICE; T-CELL; SOMATIC HYPERMUTATION; IMMUNE-RESPONSE; MOLECULAR CHARACTERIZATION; LYMPHOCYTE DEVELOPMENT; CD45-DEFICIENT MICE; TRANSGENIC MICE; SELECTION; MEMORY	To segregate the many contributions that B cell receptor (BCR)-mediated signals make to immune responses, we have analyzed here B cells deficient in the 'pan-leukocyte' marker CD45. BCR ligation of Cd45(-/-) B cells failed to activate phosphatidylinositol-3-OH kinase, NF-kappa B, Erk1 or Erk2 kinases or to upregulate cell survival proteins and instead induced apoptosis. Immunization of Cd45(-/-) B cell chimeras induced germinal centers and antigen-specific immunoglobulin G1 antibody-forming cells early, but both cellular compartments decreased by day 14. Proliferation of Cd45(-/-) B cells induced by CD40 ligand in vitro was impaired as a result of abrogation by BCR ligation of the upregulation of prosurvival proteins. In contrast, enforced expression of the antiapoptotic factor Bcl-x(L) prevented the collapse of Cd45(-/-) B cell germinal centers. These results show mechanistic differences in B cell survival during germinal center initiation and propagation; CD40 signaling is sufficient for the former, whereas the latter requires signaling from the BCR.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Tarlinton, DM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	tarlinton@wehi.edu.au	Puthalakath, Hamsa/B-8541-2011; Strasser, Andreas/C-7581-2013; Huntington, NICHOLAS/AAV-4704-2020	Strasser, Andreas/0000-0002-5020-4891; Huntington, NICHOLAS/0000-0002-5267-7211; Tarlinton, David/0000-0001-9928-686X				ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; BEAUERLE PA, 1996, CELL, V87, P13; Benatar T, 1996, J EXP MED, V183, P329, DOI 10.1084/jem.183.1.329; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Ghia P, 1998, BLOOD, V91, P244, DOI 10.1182/blood.V91.1.244.244_244_251; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; HAN SH, 1995, J IMMUNOL, V155, P556; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Janas ML, 1999, J IMMUNOL, V163, P4192; Kim N, 2003, MOL IMMUNOL, V39, P577, DOI 10.1016/S0161-5890(02)00201-8; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kong YY, 1995, EUR J IMMUNOL, V25, P3431, DOI 10.1002/eji.1830251234; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; NOSSAL GJV, 1993, P NATL ACAD SCI USA, V90, P3088, DOI 10.1073/pnas.90.7.3088; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Pani G, 1997, J EXP MED, V186, P581, DOI 10.1084/jem.186.4.581; PULENDRAN B, 1994, P NATL ACAD SCI USA, V91, P2639, DOI 10.1073/pnas.91.7.2639; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Ridderstad A, 1996, J IMMUNOL, V157, P3357; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Shrivastava P, 2004, BLOOD, V103, P1425, DOI 10.1182/blood-2003-03-0716; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Tarlinton D, 1998, CURR OPIN IMMUNOL, V10, P245, DOI 10.1016/S0952-7915(98)80161-1; THOMAS ML, 1994, CURR OPIN CELL BIOL, V6, P247, DOI 10.1016/0955-0674(94)90143-0; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tuscano JM, 1996, BLOOD, V88, P1359, DOI 10.1182/blood.V88.4.1359.bloodjournal8841359; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Xu YK, 2002, J IMMUNOL, V169, P6910, DOI 10.4049/jimmunol.169.12.6910	54	58	58	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					190	198		10.1038/ni1292	http://dx.doi.org/10.1038/ni1292			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16378097				2022-12-18	WOS:000234801700020
J	Perchellet, A; Stromnes, I; Pang, JM; Goverman, J				Perchellet, A; Stromnes, I; Pang, JM; Goverman, J			CD8(+) T cells maintain tolerance to myelin basic protein by 'epitope theft'	NATURE IMMUNOLOGY			English	Article							RECEPTOR TRANSGENIC MICE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; NEGATIVE SELECTION; IN-VIVO; GOLLI-MBP; THYMOCYTES; GENE; EXPRESSION; ANTIGEN	Myelin basic protein-specific CD8(+) T cells can induce central nervous system autoimmunity; however, immune tolerance prevents these autoreactive cells from causing disease. To define the mechanisms that mediate tolerance, we developed two T cell receptor-transgenic mouse lines with different affinities for the H-2K(k)-restricted myelin basic protein epitope consisting of amino acids 79-87 (MBP(79-87)). We observed both thymic deletion and peripheral tolerance in the lower-affinity T cells. The higher-affinity T cells, however, showed no evidence of tolerance induction and were able to prevent tolerance of the lower-affinity T cells by removing H-2K(k)-MBP(79-87) complexes from antigen-presenting cells without proliferating. This form of immune regulation could limit responses of self-reactive T cells that escape other tolerance mechanisms.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goverman, J (corresponding author), Univ Washington, Dept Immunol, Box 357650, Seattle, WA 98195 USA.	goverman@u.washington.edu		Goverman, Joan/0000-0002-7361-9424	NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NINDS NIH HHS [NS43417, NS35126] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043417, R01NS035126] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUPHAN N, 1994, EUR J IMMUNOL, V24, P1572, DOI 10.1002/eji.1830240718; AUPHAN N, 1992, INT IMMUNOL, V4, P541, DOI 10.1093/intimm/4.4.541; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; BURGERT HG, 1989, J EXP MED, V170, P1887, DOI 10.1084/jem.170.6.1887; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; Feng JM, 2000, J IMMUNOL, V165, P5443, DOI 10.4049/jimmunol.165.10.5443; Gay FW, 1997, BRAIN, V120, P1461, DOI 10.1093/brain/120.8.1461; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; GRIMA B, 1992, J NEUROCHEM, V59, P2318; Hellings N, 2002, IMMUNOL RES, V25, P27, DOI 10.1385/IR:25:1:27; Huseby ES, 1999, J IMMUNOL, V163, P1115; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; MARTIN R, 1997, MULTIPLE SCLEROSIS C, P221; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P649, DOI 10.1002/eji.1830190412; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Voskuhl RR, 2003, J NEUROIMMUNOL, V139, P44, DOI 10.1016/S0165-5728(03)00161-9; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZELENIKA D, 1993, J NEUROCHEM, V60, P1574, DOI 10.1111/j.1471-4159.1993.tb03325.x; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	38	58	59	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					606	614		10.1038/ni1073	http://dx.doi.org/10.1038/ni1073			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15146180				2022-12-18	WOS:000221664000019
J	Costello, PS; Nicolas, RH; Watanabe, Y; Rosewell, I; Treisman, R				Costello, PS; Nicolas, RH; Watanabe, Y; Rosewell, I; Treisman, R			Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; SERUM RESPONSE ELEMENT; RECEPTOR GENE NUR77; LOOP-HELIX PROTEIN; T-CELL DEVELOPMENT; C-FOS PROMOTER; NEGATIVE SELECTION; GROWTH-FACTOR; TRANSGENIC MICE; TRANSCRIPTIONAL ACTIVATION	Thymocyte selection and differentiation requires extracellular signal-regulated kinase (Erk) signaling, but transcription factor substrates of Erk in thymocytes are unknown. We have characterized the function of SAP-1 (Elk4), an Erk-regulated transcription factor, in thymocyte development. Early thymocyte development was normal, but single-positive thymocyte and peripheral T cell numbers were reduced, reflecting a T cell-autonomous defect. T cell receptor-induced activation of SAP-1 target genes such as Egr1 was substantially impaired in double-positive thymocytes, although Erk activation was normal. Analysis of T cell receptor transgenes showed that positive selection was reduced by 80-90% in SAP-1-deficient mice; heterozygous mice showed a moderate defect. Negative selection was unimpaired. SAP-1 thus directly links Erk signaling to the transcriptional events required for thymocyte positive selection.	London Res Inst, Lincolns Inn Fields Labs, Canc Rs UK, Transcript Lab, London WC2A 3PX, England; London Res Inst, Lincolns Inn Fields Labs, Canc Rs UK, Biol Resources Unit, London WC2A 3PX, England		Treisman, R (corresponding author), London Res Inst, Lincolns Inn Fields Labs, Canc Rs UK, Transcript Lab, 44 Lincolns Fields, London WC2A 3PX, England.	richard.treisman@cancer.org.uk		Treisman, Richard/0000-0002-9658-0067				Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Bommhardt U, 1999, J IMMUNOL, V163, P715; CALNAN BJ, 1995, IMMUNITY, V3, P273; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; CHENG LE, 1997, EUR J IMMUNOL, V27, P2048; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Latinkic BV, 1996, NUCLEIC ACIDS RES, V24, P1345, DOI 10.1093/nar/24.7.1345; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; MCMAHON SB, 1995, MOL CELL BIOL, V15, P1086; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Murai K, 2002, MOL CELL BIOL, V22, P7083, DOI 10.1128/MCB.22.20.7083-7092.2002; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; Palestro G, 1999, Adv Clin Path, V3, P11; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; YOON JK, 1993, J BIOL CHEM, V268, P9148; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	51	58	58	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					289	298		10.1038/ni1038	http://dx.doi.org/10.1038/ni1038			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14770179				2022-12-18	WOS:000189344600012
J	Regner, M; Lambert, PH				Regner, M; Lambert, PH			Autoimmunity through infection or immunization?	NATURE IMMUNOLOGY			English	Editorial Material									Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva, Switzerland; Ctr Med Univ Geneva, Ctr Vaccinol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Regner, M (corresponding author), Ctr Med Univ Geneva, Dept Pathol, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.								0	58	59	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					185	188		10.1038/85228	http://dx.doi.org/10.1038/85228			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224510				2022-12-18	WOS:000167413800004
J	Yao, Y; Chen, Z; Zhang, H; Chen, CL; Zeng, M; Yunis, J; Wei, YB; Wan, YN; Wang, NA; Zhou, MZ; Qiu, C; Zeng, QX; Ong, HS; Wang, H; Makota, FV; Yang, Y; Yang, ZH; Wang, N; Deng, J; Shen, C; Xia, Y; Yuan, L; Lian, ZQ; Deng, YK; Guo, CL; Huang, AO; Zhou, PC; Shi, HB; Zhang, WT; Yi, HL; Li, DM; Xia, M; Fu, J; Wu, N; de Haan, JB; Shen, N; Zhang, WH; Liu, Z; Yu, D				Yao, Yin; Chen, Zhian; Zhang, Hao; Chen, Cailing; Zeng, Ming; Yunis, Joseph; Wei, Yunbo; Wan, Yanmin; Wang, Naiqi; Zhou, Mingzhe; Qiu, Chao; Zeng, Qunxiong; Ong, Hong Sheng; Wang, Hao; Makota, Fadzai Victor; Yang, Yang; Yang, Zhaohui; Wang, Nan; Deng, Jun; Shen, Chao; Xia, Yan; Yuan, Lin; Lian, Zhaoqin; Deng, Yike; Guo, Cuilian; Huang, Ao; Zhou, Pengcheng; Shi, Haibo; Zhang, Weitian; Yi, Hongliang; Li, Dongmei; Xia, Ming; Fu, Jing; Wu, Ning; de Haan, Judy B.; Shen, Nan; Zhang, Wenhong; Liu, Zheng; Yu, Di			Selenium-GPX4 axis protects follicular helper T cells from ferroptosis	NATURE IMMUNOLOGY			English	Article							LIPID-PEROXIDATION; B-CELLS; DEATH; ACTIVATION; ANTIGEN; APOPTOSIS; RESPONSES; IMMUNITY; SUBSETS; BIOLOGY	Follicular helper T (T-FH) cells are a specialized subset of CD4(+) T cells that essentially support germinal center responses where high-affinity and long-lived humoral immunity is generated. The regulation of T-FH cell survival remains unclear. Here we report that T-FH cells show intensified lipid peroxidation and altered mitochondrial morphology, resembling the features of ferroptosis, a form of programmed cell death that is driven by iron-dependent accumulation of lipid peroxidation. Glutathione peroxidase 4 (GPX4) is the major lipid peroxidation scavenger and is necessary for T-FH cell survival. The deletion of GPX4 in T cells selectively abrogated T-FH cells and germinal center responses in immunized mice. Selenium supplementation enhanced GPX4 expression in T cells, increased T-FH cell numbers and promoted antibody responses in immunized mice and young adults after influenza vaccination. Our findings reveal the central role of the selenium-GPX4-ferroptosis axis in regulating T-FH homeostasis, which can be targeted to enhance T-FH cell function in infection and following vaccination. T follicular helper (T-FH) cells are important for the generation of effective antibody responses. Yu and colleagues find that T-FH cells are exceptionally sensitive to death by ferroptosis and that this process is regulated by the activity of the selenoenzyme GPX4.	[Yao, Yin; Zeng, Ming; Wang, Nan; Yuan, Lin; Lian, Zhaoqin; Deng, Yike; Guo, Cuilian; Huang, Ao; Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Peoples R China; [Yao, Yin; Chen, Zhian; Yunis, Joseph; Wang, Naiqi; Yang, Yang; Yu, Di] Univ Queensland, Univ Queensland Diamantina Inst, Fac Med, Brisbane, Qld, Australia; [Yao, Yin; Chen, Zhian; Yunis, Joseph; Ong, Hong Sheng; Wang, Hao; Makota, Fadzai Victor; Zhou, Pengcheng; Yu, Di] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Zhang, Hao; Wei, Yunbo; Yu, Di] Qilu Univ Technol, Shandong Acad Sci, Lab Immunol Environm & Hlth, Shandong Anal & Test Ctr, Jinan, Peoples R China; [Zhang, Hao; Yang, Zhaohui; Deng, Jun; Xia, Yan; Yu, Di] Hubei Minzu Univ, Minda Hosp, Hubei Prov Key Lab Occurrence & Intervent Rheumat, Enshi, Peoples R China; [Wan, Yanmin; Zhang, Wenhong; Yu, Di] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Wan, Yanmin] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai, Peoples R China; [Zhou, Mingzhe] Simcere Diagnost Co Ltd, State Key Lab Translat Med & Innovat Drug Dev, Nanjing, Peoples R China; [Qiu, Chao] Fudan Univ, Minhang Hosp, Shanghai, Peoples R China; [Qiu, Chao] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China; [Qiu, Chao; Yu, Di] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Zeng, Qunxiong; Deng, Jun; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Shanghai, Peoples R China; [Shen, Chao] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Shi, Haibo; Zhang, Weitian; Yi, Hongliang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Li, Dongmei] Shandong Univ, Qilu Childrens Hosp, Dept Otolaryngol, Jinan, Peoples R China; [Xia, Ming] Shandong First Med Univ, Shandong Prov Hosp, Key Lab Hearing Reconstruct Shandong Prov, Dept Otolaryngol, Jinan, Peoples R China; [Fu, Jing] Key Lab Hearing Reconstruct Shandong Prov, Jinan, Peoples R China; [Wu, Ning] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic, Australia; [de Haan, Judy B.] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China; [de Haan, Judy B.] Monash Univ, Baker Heart & Diabet Inst, Melbourne, Vic, Australia	Huazhong University of Science & Technology; University of Queensland; Australian National University; John Curtin School of Medical Research; Qilu University of Technology; Hubei Minzu University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Wuhan University; Shanghai Jiao Tong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Monash University; Huazhong University of Science & Technology; Monash University	Liu, Z (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Peoples R China.; Yu, D (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.; Yu, D (corresponding author), Qilu Univ Technol, Shandong Acad Sci, Lab Immunol Environm & Hlth, Shandong Anal & Test Ctr, Jinan, Peoples R China.; Yu, D (corresponding author), Hubei Minzu Univ, Minda Hosp, Hubei Prov Key Lab Occurrence & Intervent Rheumat, Enshi, Peoples R China.; Yu, D (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China.; Yu, D (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.	zhengliuent@hotmail.com; di.yu@uq.edu.au	Wei, Yunbo/AHE-8248-2022; Shen, Nan/AGK-6807-2022; Zhou, Pengcheng/GRR-4171-2022; hb, s/HGB-5402-2022; Zhou, Pengcheng/AAQ-1320-2020; Chen, Zhian/ABA-6813-2021; Zhou, Mingzhe/AED-5236-2022	Zhou, Pengcheng/0000-0002-7736-2902; Zhou, Pengcheng/0000-0002-7736-2902; Chen, Zhian/0000-0003-0073-2941; Yin, Yao/0000-0002-5833-5263; Yu, Di/0000-0003-1721-8922; Zhou, Mingzhe/0000-0002-5518-7330; Fu, Jing/0000-0002-7752-5417; Yang, Yang/0000-0002-4840-3023; Wan, Yanmin/0000-0001-5027-9423; Wang, Hao/0000-0001-8228-5633	Australian National Health and Medical Research Council [GNT1085509]; Bellberry-Viertel Senior Medical Research fellowship; National Natural Science Foundation of China [81630024, 81920108011, 82071792]; Health Commission of Hubei Province Scientific Research [WJ2019H136, WJ2019H137]; Natural Science Foundation of Shandong Province [ZR2020ZD41, ZR2019BB080]; Taishan Scholars Program of Shandong Province; China Scholarship Council scholarship [201706160045]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bellberry-Viertel Senior Medical Research fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Commission of Hubei Province Scientific Research; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Taishan Scholars Program of Shandong Province; China Scholarship Council scholarship(China Scholarship Council)	We thank the Imaging and Cytometry Facility and the Biomolecular Research Facility at the John Curtin School of Medical Research and the Biomolecular Research Facility at Translational Research Institute for technical support; the Centre of Advanced Microscopy at the Australian National University for the scientific and technical assistance for TEM; R. Steptoe and Y. Zhan for the hybridoma cell line; D. Gray for Foxp3-GFP reporter mice; S. Ming Man for Casp1/11<SUP>-/-</SUP> mice; J. Adams for Bcl2-transgenic mice; H. Wu and Q. Li for tissue imaging and E. Bartlett for reading the manuscript. This study was supported by Australian National Health and Medical Research Council project GNT1085509; the Bellberry-Viertel Senior Medical Research fellowship; National Natural Science Foundation of China grants 81630024, 81920108011 and 82071792; Health Commission of Hubei Province Scientific Research Project WJ2019H136 and WJ2019H137; Natural Science Foundation of Shandong Province ZR2020ZD41 and ZR2019BB080; Taishan Scholars Program of Shandong Province; and a China Scholarship Council scholarship 201706160045.	Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Deng J, 2019, NAT REV RHEUMATOL, V15, P475, DOI 10.1038/s41584-019-0254-2; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Edner NM, 2020, NAT IMMUNOL, V21, P1244, DOI 10.1038/s41590-020-0744-z; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Jun D., NAT COMMUN, DOI [10.1038/s41467-021-23220-x(2021, DOI 10.1038/S41467-021-23220-X(2021]; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Kunzli M, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay5552; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li WJ, 2019, J CLIN INVEST, V129, P2293, DOI 10.1172/JCI126428; Linterman Michelle A, 2016, F1000Res, V5, DOI 10.12688/f1000research.7388.1; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Magtanong L, 2019, CELL CHEM BIOL, V26, P420, DOI 10.1016/j.chembiol.2018.11.016; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mak TW, 2017, IMMUNITY, V46, P1089, DOI 10.1016/j.immuni.2017.06.009; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Muri J, 2019, CELL REP, V29, P2731, DOI 10.1016/j.celrep.2019.10.070; Nagata S, 2017, NAT REV IMMUNOL, V17, P333, DOI 10.1038/nri.2016.153; Peperzak V, 2012, IMMUNOL REV, V247, P93, DOI 10.1111/j.1600-065X.2012.01123.x; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345	50	57	58	12	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1127	+		10.1038/s41590-021-00996-0	http://dx.doi.org/10.1038/s41590-021-00996-0		AUG 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34413521				2022-12-18	WOS:000686467300002
J	Hatzioannou, A; Banos, A; Sakelaropoulos, T; Fedonidis, C; Vidali, MS; Kohne, M; Handler, K; Boon, L; Henriques, A; Koliaraki, V; Georgiadis, P; Zoidakis, J; Termentzi, A; Beyer, M; Chavakis, T; Boumpas, D; Tsirigos, A; Verginis, P				Hatzioannou, Aikaterini; Banos, Aggelos; Sakelaropoulos, Theodore; Fedonidis, Constantinos; Vidali, Maria-Sophia; Koehne, Maren; Haendler, Kristian; Boon, Louis; Henriques, Ana; Koliaraki, Vasiliki; Georgiadis, Panagiotis; Zoidakis, Jerome; Termentzi, Aikaterini; Beyer, Marc; Chavakis, Triantafyllos; Boumpas, Dimitrios; Tsirigos, Aristotelis; Verginis, Panayotis			An intrinsic role of IL-33 in T-reg cell-mediated tumor immunoevasion	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTION-FACTOR; IMMUNE CHECKPOINT; CHROMATIN; CYTOKINE; BET; STABILITY; INTERLEUKIN-33; HOMEOSTASIS; ACTIVATION	Regulatory T (T-reg) cells accumulate into tumors, hindering the success of cancer immunotherapy. Yet, therapeutic targeting of T-reg cells shows limited efficacy or leads to autoimmunity. The molecular mechanisms that guide T-reg cell stability in tumors remain elusive. In the present study, we identify a cell-intrinsic role of the alarmin interleukin (IL)-33 in the functional stability of T-reg cells. Specifically, IL-33-deficient T-reg cells demonstrated attenuated suppressive properties in vivo and facilitated tumor regression in a suppression of tumorigenicity 2 receptor (ST2) (IL-33 receptor)-independent fashion. On activation, Il33(-/-) T-reg cells exhibited epigenetic re-programming with increased chromatin accessibility of the Ifng locus, leading to elevated interferon (IFN)-. production in a nuclear factor (NF)-kappa B-T-bet-dependent manner. IFN-gamma was essential for T-reg cell defective function because its ablation restored Il33(-/-) T-reg cell-suppressive properties. Importantly, genetic ablation of Il33 potentiated the therapeutic effect of immunotherapy. Our findings reveal a new and therapeutically important intrinsic role of IL-33 in T-reg cell stability in cancer.	[Hatzioannou, Aikaterini; Banos, Aggelos; Boumpas, Dimitrios; Verginis, Panayotis] Biomed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Athens, Greece; [Sakelaropoulos, Theodore; Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Sakelaropoulos, Theodore; Tsirigos, Aristotelis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Sakelaropoulos, Theodore] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA; [Fedonidis, Constantinos] Biomed Res Fdn Acad Athens, Ctr Basic Res, Athens, Greece; [Vidali, Maria-Sophia; Georgiadis, Panagiotis] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Koehne, Maren; Beyer, Marc] German Ctr Neurodegenerat Dis, Mol Immunol Neurodegenerat, Bonn, Germany; [Haendler, Kristian; Beyer, Marc] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, PRECISE, Bonn, Germany; [Haendler, Kristian; Beyer, Marc] Univ Bonn, Bonn, Germany; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Henriques, Ana; Koliaraki, Vasiliki] Biomed Sci Res Ctr Alexander Fleming, Dept Immunol, Vari, Greece; [Zoidakis, Jerome] Acad Athens, Biomed Res Fdn, Biotechnol Div, Athens, Greece; [Termentzi, Aikaterini] Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Athens, Greece; [Chavakis, Triantafyllos; Verginis, Panayotis] Univ Hosp, Inst Clin Chem, Dresden, Germany; [Chavakis, Triantafyllos; Verginis, Panayotis] Univ Hosp, Lab Med, Dresden, Germany; [Chavakis, Triantafyllos; Verginis, Panayotis] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany; [Chavakis, Triantafyllos] Natl Ctr Tumor Dis, Partner Site Dresden, Heidelberg, Germany; [Chavakis, Triantafyllos] German Canc Res Ctr, Heidelberg, Germany; [Boumpas, Dimitrios] Natl & Kapodistrian Univ Athens, Sch Med, Attikon Univ Hosp, Joint Rheumatol Program,Dept Internal Med 4, Athens, Greece	Academy of Athens; New York University; New York University; New York University; Academy of Athens; National Hellenic Research Foundation; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Bioceros B.V.; Alexander Fleming Biomedical Sciences Research Center; Academy of Athens; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Verginis, P (corresponding author), Biomed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Athens, Greece.; Verginis, P (corresponding author), Univ Hosp, Inst Clin Chem, Dresden, Germany.; Verginis, P (corresponding author), Univ Hosp, Lab Med, Dresden, Germany.; Verginis, P (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany.	pverginis@bioacademy.gr	Zoidakis, Jerome/AAO-8236-2021; Koliaraki, Vasiliki/B-8618-2015; Chavakis, Triantafyllos/ABE-8845-2020; Zoidakis, Jerome/P-9599-2018; Boon, Laurence/HCI-3629-2022; GEORGIADIS, PANAGIOTIS/M-1898-2017	Zoidakis, Jerome/0000-0002-4557-3430; Koliaraki, Vasiliki/0000-0003-1694-6987; Zoidakis, Jerome/0000-0002-4557-3430; Boon, Louis/0000-0002-0937-9171; Henriques, Ana/0000-0002-2421-4308; GEORGIADIS, PANAGIOTIS/0000-0003-4889-1095; Handler, Kristian/0000-0001-5273-5277; Tsirigos, Aristotelis/0000-0002-7512-8477	GGSRT [Aristeia II 3468]; German Research Foundation [BE 4427/3-1, SFB 1181]; ERC [DEMETINL-683145]; ERC under the European Union's Horizon 2020 research and innovation program [742390]; IKY Fellowship of Excellence for Postgraduate Studies in Greece; IKY Fellowship of 'Stratigos' grant of the Hellenic Society of Melanoma Study; European Union (European Social Fund) through the Operational Program 'Human Resources Development, Education and Lifelong Learning' [MIS-5001552]; European Union's Horizon 2020 research and innovation program [733100]; IKY Fellowship of Siemens Program	GGSRT; German Research Foundation(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); ERC under the European Union's Horizon 2020 research and innovation program; IKY Fellowship of Excellence for Postgraduate Studies in Greece; IKY Fellowship of 'Stratigos' grant of the Hellenic Society of Melanoma Study; European Union (European Social Fund) through the Operational Program 'Human Resources Development, Education and Lifelong Learning'; European Union's Horizon 2020 research and innovation program; IKY Fellowship of Siemens Program	We thank T. Alissafi for fruitful conversations and critical reading of the manuscript, R.M. Barouni for technical assistance, P. Alexakos for technical assistance on animal handling and maintenance and A. Apostolidou for technical assistance on flow cytometry and cell sorting. We also thank M. Makridakis and G. Kontostathi for PRM analysis. This work was supported by grants from the GGSRT (no. Aristeia II 3468 to P.V.). M.B. was funded by the German Research Foundation (grant no. BE 4427/3-1) and is a member of the excellence cluster ImmunoSensation. T.C. was supported by the ERC (grant no. DEMETINL-683145) and the German Research Foundation (grant no. SFB 1181, CO7). D.B. was supported by the ERC under the European Union's Horizon 2020 research and innovation program (grant agreement no. 742390). A.Hatzioannou is supported by IKY Fellowships of Excellence for Postgraduate Studies in Greece, Siemens Program and 'Stratigos' grant of the Hellenic Society of Melanoma Study. A.B. is financed by Greece and the European Union (European Social Fund) through the Operational Program 'Human Resources Development, Education and Lifelong Learning' in the context of the project 'Reinforcement of Postdoctoral Researchers' (no. MIS-5001552), implemented by the State Scholarships Foundation. D.B. and P.V. were supported by the European Union's Horizon 2020 research and innovation program (grant agreement no. 733100).	Abdel-Wahab N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160221; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Alissafi T, 2019, J AUTOIMMUN, V104, DOI 10.1016/j.jaut.2019.102310; Andersson P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122375; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Braun H, 2018, BIOCHEM PHARMACOL, V148, P238, DOI 10.1016/j.bcp.2018.01.010; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Choi YS, 2012, BIOCHEM BIOPH RES CO, V421, P305, DOI 10.1016/j.bbrc.2012.04.005; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Gong YX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3817-0; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hatziioannou A, 2017, J LEUKOCYTE BIOL, V102, P407, DOI 10.1189/jlb.5VMR1116-493R; Hatzioannou A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1216289; Hori S, 2014, IMMUNOL REV, V259, P159, DOI 10.1111/imr.12175; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jenkins RW, 2018, BRIT J CANCER, V118, P9, DOI 10.1038/bjc.2017.434; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JH, 2015, IMMUNITY, V42, P1062, DOI 10.1016/j.immuni.2015.05.016; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06954-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makridakis M, 2018, METHODS MOL BIOL, V1788, P165, DOI 10.1007/7651_2017_76; Martin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4143; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Overacre-Delgoffe AE, 2018, CANCER IMMUNOL RES, V6, P882, DOI 10.1158/2326-6066.CIR-18-0066; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Polesso F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14965-x; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Travers J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05485-x; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Yu XY, 2018, J EXP MED, V215, P2463, DOI 10.1084/jem.20180397; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	59	57	61	5	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					75	+		10.1038/s41590-019-0555-2	http://dx.doi.org/10.1038/s41590-019-0555-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31844326	Green Accepted			2022-12-18	WOS:000515136500015
J	Waterfield, M; Khan, IS; Cortez, JT; Fan, U; Metzger, T; Greer, A; Fasano, K; Martinez-Llordella, M; Pollack, JL; Erle, DJ; Su, M; Anderson, MS				Waterfield, Michael; Khan, Imran S.; Cortez, Jessica T.; Fan, Una; Metzger, Todd; Greer, Alexandra; Fasano, Kayla; Martinez-Llordella, Marc; Pollack, Joshua L.; Erle, David J.; Su, Maureen; Anderson, Mark S.			The transcriptional regulator Aire coopts the repressive ATF7ip-MBD1 complex for the induction of immunotolerance	NATURE IMMUNOLOGY			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; METHYL-CPG; IMMUNOLOGICAL-TOLERANCE; BINDING-PROTEIN; TARGET GENES; SAND DOMAIN; DNA; CHROMATIN; FAMILY	The maintenance of immunological tolerance requires the deletion of self-reactive T cells in the thymus. The expression of genes encoding tissue-specific antigens (TSAs) by thymic epithelial cells is critical for this process and depends on activity of the transcriptional regulator Aire; however, the molecular mechanisms Aire uses to target loci encoding TSAs are unknown. Here we identified two Aire-interacting proteins known to be involved in gene repression, ATF7ip and MBD1, that were required for Aire's targeting of loci encoding TSAs. Moreover, Mbd1(-/-) mice developed pathological autoimmunity and had a defect in Aire-dependent thymic expression of genes encoding TSAs, which underscores the importance of Aire's interaction with the ATF7ip-MBD1 protein complex in maintaining central tolerance.	[Waterfield, Michael; Khan, Imran S.; Cortez, Jessica T.; Fan, Una; Metzger, Todd; Fasano, Kayla; Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Waterfield, Michael] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Greer, Alexandra] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Martinez-Llordella, Marc] Kings Coll London, Dept Liver Sci, Div Transplantat Immunol & Mucosal Biol, Inst Liver Studies, London WC2R 2LS, England; [Pollack, Joshua L.; Erle, David J.; Anderson, Mark S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Su, Maureen] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; King's College London; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Anderson, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu		Khan, Imran/0000-0003-4570-4143; Erle, David/0000-0002-2171-0648; Su, Maureen/0000-0002-3680-9982	Arthritis Foundation; Rheumatology Research Foundation; Burroughs Welcome Fund; US National Institutes of Health; Diabetes and Endocrinology Research Center [DK59958]; Medical Research Council [MR/J006742/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097457, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK059958, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079683] Funding Source: NIH RePORTER	Arthritis Foundation; Rheumatology Research Foundation; Burroughs Welcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Abramson (Weizmann Institute of Science) for Flag-tagged Aire; J. Bluestone, A. Abbas and members of the Bluestone and Abbas laboratories for discussions; and M. Cheng and T. LaFlam for feedback on the manuscript. Supported by the Arthritis Foundation (MW), the Rheumatology Research Foundation (MW), the Burroughs Welcome Fund (M.S.A.), the US National Institutes of Health (M.S.A.) and the Diabetes and Endocrinology Research Center (program project grant DK59958 for microarray and microscopy experiments).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Christensen J, 1999, MOL CELL BIOL, V19, P7741; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Consortium F-GA, NAT GENET, V17, P399; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Sillanpaa N, 2004, MOL IMMUNOL, V41, P1185, DOI 10.1016/j.molimm.2004.06.004; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	43	57	59	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					258	265		10.1038/ni.2820	http://dx.doi.org/10.1038/ni.2820			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24464130	Green Accepted, Green Submitted			2022-12-18	WOS:000331683100011
J	Wang, J; Shiratori, I; Uehori, J; Ikawa, M; Arase, H				Wang, Jing; Shiratori, Ikuo; Uehori, Junji; Ikawa, Masahito; Arase, Hisashi			Neutrophil infiltration during inflammation is regulated by PILR alpha via modulation of integrin activation	NATURE IMMUNOLOGY			English	Article							TYPE-2 RECEPTOR-ALPHA; ADHESION; BINDING; CELLS; RECOGNITION; DEFICIENCY; MIGRATION; MOLECULE; IMMUNITY; MOTILITY	Acute inflammatory responses are important in host defense, whereas dysregulated inflammation results in life-threatening complications. Here we found that paired immunoglobulin-like type 2 receptor alpha (PILR alpha), an inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs), negatively regulated neutrophil infiltration during inflammation. Pilra(-/-) mice had increased neutrophil recruitment to inflammatory sites and were highly susceptible to endotoxin shock. Pilra(-/-) neutrophils showed enhanced transmigration ability and increased adhesion to the beta(2) integrin ligand ICAM-1. PILR alpha expressed on neutrophils constitutively associated in cis with its ligands, resulting in clustering of PILR alpha during stimulation with a chemoattractant. Clustering of PILR alpha enhanced ITIM-mediated signaling, thus modulating beta(2) integrin inside-out activation. These data demonstrate that neutrophil recruitment in inflammatory responses is regulated by PILR alpha via modulation of integrin activation.	[Wang, Jing; Shiratori, Ikuo; Uehori, Junji; Arase, Hisashi] Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, Osaka, Japan; [Wang, Jing; Uehori, Junji; Arase, Hisashi] Osaka Univ, World Premier Int WPI Immunol Frontier Res Ctr, Lab Immunochem, Osaka, Japan; [Ikawa, Masahito] Osaka Univ, Dept Expt Genome Res, Microbial Dis Res Inst, Osaka, Japan; [Arase, Hisashi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Arase, H (corresponding author), Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, Osaka, Japan.	arase@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Arase, Hisashi/C-8442-2009	ikawa, masahito/0000-0001-9859-6217; Arase, Hisashi/0000-0002-1153-3166; Wang, Jing/0000-0001-8758-1693; Shiratori, Ikuo/0000-0003-3713-4910	JST; CREST; Ministry of Education, Science and Culture, Japan; The Osaka Foundation for Promotion of Clinical Immunology; Grants-in-Aid for Scientific Research [20670006] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Osaka Foundation for Promotion of Clinical Immunology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Matsumoto, K. Shida and R. Hirohata for technical assistance, T. Suenaga, M. Kohyama, K. Hirayasu and F. Saito for discussions, and M. Okabe, A. Kawai and M. Tanaka for advice and technical assistance with the generation of the gene-targeted mice. This work was supported by research grants from JST, CREST, a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan and The Osaka Foundation for Promotion of Clinical Immunology (H.A.).	Arii J, 2010, J VIROL, V84, P10773, DOI 10.1128/JVI.01166-10; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; Fan Q, 2010, J VIROL, V84, P8664, DOI 10.1128/JVI.01039-10; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; Gonzalez-Rey E, 2006, J EXP MED, V203, P563, DOI 10.1084/jem.20052017; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; HEWETT JA, 1992, LAB INVEST, V66, P347; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kim CH, 1999, J EXP MED, V190, P681, DOI 10.1084/jem.190.5.681; Kogure A, 2011, BIOCHEM BIOPH RES CO, V405, P428, DOI 10.1016/j.bbrc.2011.01.047; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sasawatari S, 2010, IMMUNITY, V32, P200, DOI 10.1016/j.immuni.2010.01.012; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Sun YL, 2012, J BIOL CHEM, V287, P15837, DOI 10.1074/jbc.M111.286633; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wilson MD, 2006, PHYSIOL GENOMICS, V27, P201, DOI 10.1152/physiolgenomics.00284.2005; Wu DQ, 2000, J CELL SCI, V113, P2935; Wu Y, 2005, J IMMUNOL, V175, P3484, DOI 10.4049/jimmunol.175.6.3484; Xiao WB, 2011, IMMUNITY, V34, P893, DOI 10.1016/j.immuni.2011.04.010; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	47	57	58	1	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					34	40		10.1038/ni.2456	http://dx.doi.org/10.1038/ni.2456			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23142774				2022-12-18	WOS:000312433800008
J	Hewitt, SL; Farmer, D; Marszalek, K; Cadera, E; Liang, HE; Xu, Y; Schlissel, MS; Skok, JA				Hewitt, Susannah L.; Farmer, Deborah; Marszalek, Katarzyna; Cadera, Emily; Liang, Hong-Erh; Xu, Yang; Schlissel, Mark S.; Skok, Jane A.			Association between the Igk and Igh immunoglobulin loci mediated by the 3 ' Igk enhancer induces 'decontraction' of the Igh locus in pre-B cells	NATURE IMMUNOLOGY			English	Article							HEAVY-CHAIN GENE; X-INACTIVATION; REARRANGEMENT; KAPPA; TRANSCRIPTION; COLOCALIZATION; RECOMBINATION; LYMPHOCYTES; CONTRACTION; MECHANISM	Variable-(diversity)-joining (V(D)J) recombination at loci encoding the immunoglobulin heavy chain (Igh) and immunoglobulin light chain (Igk) takes place sequentially during successive stages in B cell development. Using three-dimensional DNA fluorescence in situ hybridization, here we identify a lineage-specific and stage-specific interchromosomal association between these two loci that marks the transition between Igh and Igk recombination. Colocalization occurred between pericentromerically located alleles in pre-B cells and was mediated by the 3' Igk enhancer. Deletion of this regulatory element prevented association of the Igh and Igk loci, inhibited pericentromeric recruitment and locus 'decontraction' of an Igh allele, and resulted in greater distal rearrangement of the gene encoding the variable heavy-chain region. Our data indicate involvement of the Igk locus and its 3' enhancer in directing the Igh locus to a repressive nuclear subcompartment and inducing the Igh locus to decontract.	[Hewitt, Susannah L.; Marszalek, Katarzyna; Skok, Jane A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Farmer, Deborah; Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, Div Infect Immun, London W1T 4JF, England; [Cadera, Emily; Liang, Hong-Erh; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Xu, Yang] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	New York University; University of London; University College London; University of California System; University of California Berkeley; University of California System; University of California San Diego	Skok, JA (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	jane.skok@med.nyu.edu	Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; Xu, Yang/0000-0001-5574-921X	NHLBI NIH HHS [R01 HL048702-16, R01 HL48702, R01 HL048702] Funding Source: Medline; NIAID NIH HHS [R01 AI40227, R37 AI040227, R01 AI040227, R37 AI040227-12] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227, R01AI040227] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; CAMPBELL R, 1989, STAT BIOL, P107; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2006, J EXP MED, V203, P1721, DOI 10.1084/jem.20052310; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Sato H, 2004, J IMMUNOL, V172, P4858, DOI 10.4049/jimmunol.172.8.4858; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	24	57	68	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					396	404		10.1038/ni1567	http://dx.doi.org/10.1038/ni1567			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18297074	Green Accepted			2022-12-18	WOS:000254123200015
J	Guo, YG; Xie, YQ; Gao, M; Zhao, Y; Franco, F; Wenes, M; Siddiqui, I; Bevilacqua, A; Wang, HP; Yang, HS; Feng, B; Xie, X; Sabatel, CM; Tschumi, B; Chaiboonchoe, A; Wang, YX; Li, WM; Xiao, WH; Held, W; Romero, P; Ho, PC; Tang, L				Guo, Yugang; Xie, Yu-Qing; Gao, Min; Zhao, Yang; Franco, Fabien; Wenes, Mathias; Siddiqui, Imran; Bevilacqua, Alessio; Wang, Haiping; Yang, Hanshuo; Feng, Bing; Xie, Xin; Sabatel, Catherine M.; Tschumi, Benjamin; Chaiboonchoe, Amphun; Wang, Yuxi; Li, Weimin; Xiao, Weihua; Held, Werner; Romero, Pedro; Ho, Ping-Chih; Tang, Li			Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity	NATURE IMMUNOLOGY			English	Article							CANCER; TUMORS; IMMUNOTHERAPY; PROMOTES; SUBSETS; MODELS; PD-1; MICE	T cell exhaustion presents one of the major hurdles to cancer immunotherapy. Among exhausted CD8(+) tumor-infiltrating lymphocytes, the terminally exhausted subset contributes directly to tumor cell killing owing to its cytotoxic effector function. However, this subset does not respond to immune checkpoint blockades and is difficult to be reinvigorated with restored proliferative capacity. Here, we show that a half-life-extended interleukin-10-Fc fusion protein directly and potently enhanced expansion and effector function of terminally exhausted CD8(+) tumor-infiltrating lymphocytes by promoting oxidative phosphorylation, a process that was independent of the progenitor exhausted T cells. Interleukin-10-Fc was a safe and highly efficient metabolic intervention that synergized with adoptive T cell transfer immunotherapy, leading to eradication of established solid tumors and durable cures in the majority of treated mice. These findings show that metabolic reprogramming by upregulating mitochondrial pyruvate carrier-dependent oxidative phosphorylation can revitalize terminally exhausted T cells and enhance the response to cancer immunotherapy. Tang and colleagues show that a half-life-extended IL-10-Fc fusion protein acts directly on terminally exhausted PD1(+)TIM-3(+)CD8(+) T cells to enhance their proliferation and effector function by reprogramming the cellular metabolism to oxidative phosphorylation in a mitochondrial pyruvate carrier-dependent manner. Treatment of tumor-bearing mice with IL-10-Fc and adoptive T cell therapy led to eradication of their established solid tumors and durable cures.	[Guo, Yugang; Xie, Yu-Qing; Gao, Min; Zhao, Yang; Feng, Bing; Tang, Li] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lausanne, Switzerland; [Guo, Yugang; Feng, Bing; Tang, Li] Ecole Polytech Fed Lausanne, Inst Mat Sci & Engn, Lausanne, Switzerland; [Franco, Fabien; Wenes, Mathias; Siddiqui, Imran; Bevilacqua, Alessio; Wang, Haiping; Sabatel, Catherine M.; Tschumi, Benjamin; Held, Werner; Romero, Pedro; Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Epalinges, Switzerland; [Franco, Fabien; Bevilacqua, Alessio; Wang, Haiping; Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland; [Yang, Hanshuo] Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, West China Hosp, Chengdu, Peoples R China; [Yang, Hanshuo] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Xie, Xin] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Chaiboonchoe, Amphun] Mahidol Univ, Siriraj Ctr Res Excellence Syst Pharmacol, Dept Pharmacol, Fac Med,Siriraj Hosp, Bangkok, Thailand; [Wang, Yuxi; Li, Weimin] Sichuan Univ, Dept Resp & Crit Care Med, West China Med Sch, West China Hosp, Chengdu, Peoples R China; [Xiao, Weihua] Univ Sci & Technol China, Dept Oncol, Affiliated Hosp 1,Hefei Natl Lab Phys Sci Microsc, Div Life Sci & Med,CAS Key Lab Innate Immun & Chr, Hefei, Peoples R China	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Sichuan University; Mahidol University; Sichuan University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tang, L (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lausanne, Switzerland.; Tang, L (corresponding author), Ecole Polytech Fed Lausanne, Inst Mat Sci & Engn, Lausanne, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Dept Oncol, Epalinges, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Epalinges, Switzerland.	ping-chih.ho@unil.ch; li.tang@epfl.ch		Siddiqui, Imran/0000-0002-6792-8730; GUO, Yugang/0000-0003-4499-8274; Gao, Min/0000-0003-2106-0267; Wenes, Mathias/0000-0001-8478-8592; Tang, Li/0000-0002-6393-982X; Ho, Ping-Chih/0000-0003-3078-3774; Bevilacqua, Alessio/0000-0001-7009-4362; Xie, Yu-Qing/0000-0003-3996-2234	Swiss National Science Foundation [173243] Funding Source: Medline	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)		Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cheng WC, 2019, NAT IMMUNOL, V20, P206, DOI 10.1038/s41590-018-0290-0; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Floros T, 2015, SEMIN ONCOL, V42, P539, DOI 10.1053/j.seminoncol.2015.05.015; Franco F, 2020, NAT METAB, V2, P1001, DOI 10.1038/s42255-020-00280-9; Fujii S, 2001, BLOOD, V98, P2143, DOI 10.1182/blood.V98.7.2143; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Guo YG, 2012, PROTEIN EXPRES PURIF, V83, P152, DOI 10.1016/j.pep.2012.03.012; Hamaidi I, 2020, CELL METAB, V32, P420, DOI 10.1016/j.cmet.2020.07.008; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Klapper JA, 2008, CANCER-AM CANCER SOC, V113, P293, DOI 10.1002/cncr.23552; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; LaFleur MW, 2019, NAT IMMUNOL, V20, P1335, DOI 10.1038/s41590-019-0480-4; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Lim AR, 2020, ELIFE, V9, DOI 10.7554/eLife.55185; Ma L, 2019, SCIENCE, V365, P162, DOI 10.1126/science.aav8692; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Naing A, 2019, LANCET ONCOL, V20, P1544, DOI 10.1016/S1470-2045(19)30514-5; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pai CCS, 2019, IMMUNITY, V50, P477, DOI 10.1016/j.immuni.2019.01.006; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qiao J, 2019, CANCER CELL, V35, P901, DOI 10.1016/j.ccell.2019.05.005; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Santos JM, 2018, MOL THER, V26, P2243, DOI 10.1016/j.ymthe.2018.06.001; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; TAN JC, 1993, J BIOL CHEM, V268, P21053; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Tschumi BO, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0385-z; Vanderperre B, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006056; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Wang JL, 1998, J IMMUNOL, V161, P5516; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3; Zhang LJ, 2018, TRENDS MOL MED, V24, P30, DOI 10.1016/j.molmed.2017.11.005; ZHENG XX, 1995, J IMMUNOL, V154, P5590	57	56	56	19	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					746	+		10.1038/s41590-021-00940-2	http://dx.doi.org/10.1038/s41590-021-00940-2		MAY 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34031618	Green Submitted, Green Accepted			2022-12-18	WOS:000653628400001
J	Williams, JW; Zaitsev, K; Kim, KW; Ivanov, S; Saunders, BT; Schrank, PR; Kim, K; Elvington, A; Kim, SH; Tucker, CG; Wohltmann, M; Fife, BT; Epelman, S; Artyomov, MN; Lavine, KJ; Zinselmeyer, BH; Choi, JH; Randolph, GJ				Williams, Jesse W.; Zaitsev, Konstantin; Kim, Ki-Wook; Ivanov, Stoyan; Saunders, Brian T.; Schrank, Patricia R.; Kim, Kyeongdae; Elvington, Andrew; Kim, Seung Hyeon; Tucker, Christopher G.; Wohltmann, Mary; Fife, Brian T.; Epelman, Slava; Artyomov, Maxim N.; Lavine, Kory J.; Zinselmeyer, Bernd H.; Choi, Jae-Hoon; Randolph, Gwendalyn J.			Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION PROFILES; DENDRITIC CELLS; MECHANISMS; IDENTIFICATION; INFLAMMATION; PRECURSORS; DIVERSITY; DISEASE; BURDEN; ZBTB46	Williams and colleagues investigate the origin, dynamics and transcriptional profiles of aortic intima macrophages during atherosclerosis disease progression. Early atherosclerosis depends upon responses by immune cells resident in the intimal aortic wall. Specifically, the healthy intima is thought to be populated by vascular dendritic cells (DCs) that, during hypercholesterolemia, initiate atherosclerosis by being the first to accumulate cholesterol. Whether these cells remain key players in later stages of disease is unknown. Using murine lineage-tracing models and gene expression profiling, we reveal that myeloid cells present in the intima of the aortic arch are not DCs but instead specialized aortic intima resident macrophages (Mac(AIR)) that depend upon colony-stimulating factor 1 and are sustained by local proliferation. Although Mac(AIR)comprise the earliest foam cells in plaques, their proliferation during plaque progression is limited. After months of hypercholesterolemia, their presence in plaques is overtaken by recruited monocytes, which induce Mac(AIR)-defining genes. These data redefine the lineage of intimal phagocytes and suggest that proliferation is insufficient to sustain generations of macrophages during plaque progression.	[Williams, Jesse W.; Schrank, Patricia R.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Williams, Jesse W.; Schrank, Patricia R.; Tucker, Christopher G.; Fife, Brian T.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Williams, Jesse W.; Kim, Ki-Wook; Ivanov, Stoyan; Saunders, Brian T.; Elvington, Andrew; Wohltmann, Mary; Artyomov, Maxim N.; Zinselmeyer, Bernd H.; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg, Russia; [Kim, Ki-Wook; Kim, Seung Hyeon] Univ Illinois, Coll Med, Dept Pharmacol & Regenerat Med, Chicago, IL USA; [Kim, Kyeongdae; Choi, Jae-Hoon] Hanyang Univ, Res Inst Nat Sci, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Tucker, Christopher G.; Fife, Brian T.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Epelman, Slava; Lavine, Kory J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ivanov, Stoyan] Univ Cote Azur, Ctr Mediterraneen Med Mol C3M, INSERM, U1065, Nice, France; [Epelman, Slava] Univ Toronto, Dept Cardiovasc Med, Toronto, ON, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); ITMO University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hanyang University; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto	Williams, JW (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.; Williams, JW (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.; Williams, JW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jww@umn.edu	Zaitsev, Konstantin/AAU-5733-2021; Epelman, Slava/AAO-1728-2020; Fife, Brian/D-2042-2013; Zinselmeyer, Bernd/X-4802-2018	Zaitsev, Konstantin/0000-0003-3749-0886; Epelman, Slava/0000-0003-3400-4475; Williams, Jesse/0000-0003-3815-0891; Kim, Seung Hyeon/0000-0001-9197-5978; Kim, Kyeongdae/0000-0002-7545-6366; Ivanov, Stoyan/0000-0002-0527-2297; Fife, Brian/0000-0001-9826-5637; /0000-0002-7207-4389; Zinselmeyer, Bernd/0000-0003-4172-6767	National Institutes of Health (NIH) [R00 HL138163, AHA 16SDGG30480008, T32 AI007313, P01 AI35296, R37 AI049653, DP1DK109668]; NIH [2T32DK007120-41]; AHA [17POST33410473]; Korean Health Technology RD project [HI15C0399]; Ministry of Health, Welfare & Family Affairs (South Korea); Government of Russian Federation [08-08]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Korean Health Technology RD project; Ministry of Health, Welfare & Family Affairs (South Korea); Government of Russian Federation	Flt3Cre mice were provided by D. Mann (Washington University School of Medicine; WUSM); Flt3-/-, Flt3l-/-, SNZ22GFP, L-MycGFP and Zbtb46GFP mice were provided by K. Murphy (WUSM); IL- 34-/- and CCR2GFP mice were provided by M. Colonna (WUSM); op/op mice were provided by E. Unanue (WUSM); and Csf2rb-/- mice were provided B. Edelson (WUSM). We also thank M. Vail (University of Minnesota), the WUSM Flow Cytometry Core Facility, WUSM McDonnell Genome Institute and WUSM Genome Technology Access Center for technical assistance on this study. Research was supported by the National Institutes of Health (NIH) R00 HL138163 (to J.W.W.), AHA 16SDGG30480008 (to B.H.Z.), T32 AI007313 (to C.G.T.), P01 AI35296 (to B.T.F.) and NIH R37 AI049653 and DP1DK109668 (to G.J.R.). J.W.W. was supported by NIH 2T32DK007120-41 and AHA 17POST33410473. J-H.C. was supported by the Korean Health Technology R&D project HI15C0399 and Ministry of Health, Welfare & Family Affairs (South Korea). K.Z. was supported by the Government of Russian Federation (grant no. 08-08).	[Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Dick SA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02146; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fernandez DM, 2019, NAT MED, V25, P1576, DOI 10.1038/s41591-019-0590-4; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geovanini GR, 2018, CLIN SCI, V132, P1243, DOI 10.1042/CS20180306; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Kim K, 2018, CIRC RES, V123, P1127, DOI 10.1161/CIRCRESAHA.118.312804; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Lin JD, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124574; Linderman GC, 2019, NAT METHODS, V16, P243, DOI 10.1038/s41592-018-0308-4; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Ohta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23505; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Roufaiel M, 2016, NAT IMMUNOL, V17, P1263, DOI 10.1038/ni.3564; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian M, 2015, CIRC RES, V116, pE13, DOI 10.1161/CIRCRESAHA.116.304794; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wang M, 2014, ARTERIOSCL THROM VAS, V34, P976, DOI 10.1161/ATVBAHA.113.303097; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wiesmann F, 2000, AM J PHYSIOL-HEART C, V278, pH652, DOI 10.1152/ajpheart.2000.278.2.H652; Williams JW, 2019, IMMUNITY, V50, P941, DOI 10.1016/j.immuni.2019.03.007; Williams JW, 2018, J AM COLL CARDIOL, V72, P2166, DOI 10.1016/j.jacc.2018.08.2148; Williams JW, 2018, ARTERIOSCL THROM VAS, V38, P1702, DOI 10.1161/ATVBAHA.118.311319; Williams JW, 2017, CIRC RES, V121, P662, DOI 10.1161/CIRCRESAHA.117.311519; Wumesh KC, 2014, NATURE, V507, P243, DOI 10.1038/nature12967; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zernecke A, 2020, CIRC RES, V127, P402, DOI 10.1161/CIRCRESAHA.120.316903; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	54	56	56	2	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1194	+		10.1038/s41590-020-0768-4	http://dx.doi.org/10.1038/s41590-020-0768-4		SEP 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32895539	Green Accepted			2022-12-18	WOS:000566874900003
J	De Maeyer, RPH; van de Merwe, RC; Louie, R; Bracken, OV; Devine, OP; Goldstein, DR; Uddin, M; Akbar, AN; Gilroy, DW				De Maeyer, Roel P. H.; van de Merwe, Rachel C.; Louie, Rikah; Bracken, Olivia, V; Devine, Oliver P.; Goldstein, Daniel R.; Uddin, Mohib; Akbar, Arne N.; Gilroy, Derek W.			Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHATIDYLSERINE RECEPTOR TIM-4; APOPTOTIC CELLS; NEUTROPHIL MIGRATION; SIGNAL-TRANSDUCTION; TNF-ALPHA; PHAGOCYTOSIS; MACROPHAGES; CLEARANCE; DEGRADATION	Increasing age alters innate immune-mediated responses; however, the mechanisms underpinning these changes in humans are not fully understood. Using a human dermal model of acute inflammation, we found that, although inflammatory onset is similar between young and elderly individuals, the resolution phase was substantially impaired in elderly individuals. This arose from a reduction in T cell immunoglobulin mucin receptor-4 (TIM-4), a phosphatidylserine receptor expressed on macrophages that enables the engulfment of apoptotic bodies, so-called efferocytosis. Reduced TIM-4 in elderly individuals was caused by an elevation in macrophage p38 mitogen-activated protein kinase (MAPK) activity. Administering an orally active p38 inhibitor to elderly individuals rescued TIM-4 expression, cleared apoptotic bodies and restored a macrophage resolution phenotype. Thus, inhibiting p38 in elderly individuals rejuvenated their resolution response to be more similar to that of younger people. This is the first resolution defect identified in humans that has been successfully reversed, thereby highlighting the tractability of targeting pro-resolution biology to treat diseases driven by chronic inflammation. Human aging is characterized by an elevated basal inflammatory state. Gilroy and colleagues use a tractable in vivo human inflammation model to demonstrate a mechanism whereby efferocytosis is impaired in the elderly but is reversible by p38 inhibition.	[De Maeyer, Roel P. H.; van de Merwe, Rachel C.; Louie, Rikah; Bracken, Olivia, V; Gilroy, Derek W.] UCL, Div Med, London, England; [Devine, Oliver P.; Akbar, Arne N.] UCL, Div Infect & Immun, London, England; [Goldstein, Daniel R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Uddin, Mohib] AstraZeneca, Resp Global Med Dev, Gothenburg, Sweden	University of London; University College London; University of London; University College London; University of Michigan System; University of Michigan; AstraZeneca	Gilroy, DW (corresponding author), UCL, Div Med, London, England.	d.gilroy@ucl.ac.uk	Uddin, Mohib/E-1459-2019; Gilroy, Derek W/C-2588-2009; De Maeyer, Roel/AAP-2919-2020; Gilroy, Derek/AAP-7227-2020	Uddin, Mohib/0000-0002-2412-2657; De Maeyer, Roel/0000-0003-4041-0867; Gilroy, Derek/0000-0003-3476-0844; Devine, Oliver/0000-0001-7621-9699; Goldstein, Daniel/0000-0001-6695-979X; Akbar, Arne/0000-0002-3763-9380	AstraZenecaMRC Industrial CASE PhD studentship [MR/J006610/1]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Grand Challenge in Experimental Medicine [MR/M003833/1]; National Institutes of Health [R01AG028082, R01HL127687]; Wellcome Trust; MRC [MR/M003833/1] Funding Source: UKRI	AstraZenecaMRC Industrial CASE PhD studentship; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); MRC Grand Challenge in Experimental Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the volunteers who participated in this study; M. Berkeley and M. Harries for assistance with recruitment; and V. Birault, I. Laws, R. Glaser, L. Sarov-Blat and R. Henderson from GSK for the provision of losmapimod (MRC Industry Collaboration Agreement)-specifically the losmapimod team at GSK for organizing the dispatch of the clinical supply of the drug in this investigator-led study. We thank our colleagues for invaluable discussion, especially E. Chambers. R.P.H.M. was funded by an AstraZenecaMRC Industrial CASE PhD studentship (no. MR/J006610/1), jointly awarded to D.W.G. (UCL) and M.U. (AstraZeneca), and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. R.C.M. was funded by the MRC Grand Challenge in Experimental Medicine grant no. MR/M003833/1 awarded to A.N.A. and D.W.G. D.R.G. was funded by the National Institutes of Health (grant nos. R01AG028082, R01HL127687 and R01HL127687). D.W.G. was further funded by the Wellcome Trust.	Albacker LA, 2013, MUCOSAL IMMUNOL, V6, P580, DOI 10.1038/mi.2012.100; Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Bewley MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163139; Biasi D, 1996, INFLAMMATION, V20, P673, DOI 10.1007/BF01488803; Bonnefoy F, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1084-0; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fehr S, 2015, CELL PHYSIOL BIOCHEM, V36, P2237, DOI 10.1159/000430188; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Foks AC, 2016, ARTERIOSCL THROM VAS, V36, P456, DOI 10.1161/ATVBAHA.115.306860; Fond AM, 2016, ADV EXP MED BIOL, V930, P25, DOI 10.1007/978-3-319-39406-0_2; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gilroy D, 2015, SEMIN IMMUNOL, V27, P161, DOI 10.1016/j.smim.2015.05.003; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hilligan KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158775; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jenner W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089375; Jenner WJ, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012009; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Laplante P, 2017, J INVEST DERMATOL, V137, P2005, DOI 10.1016/j.jid.2017.04.030; Larbi Anis, 2005, Immun Ageing, V2, P6, DOI 10.1186/1742-4933-2-6; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MOSER R, 1989, J CLIN INVEST, V83, P444, DOI 10.1172/JCI113903; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Newson J, 2017, CELL REP, V20, P3162, DOI 10.1016/j.celrep.2017.08.098; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8; Phong HDD, 2011, BRIT J CLIN PHARMACO, V72, P912, DOI 10.1111/j.1365-2125.2011.04020.x; PIERARDFRANCHIMONT C, 1988, AM J DERMATOPATH, V10, P419; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; SENN H, 1969, J LAB CLIN MED, V74, P742; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sheth K, 2001, SURGERY, V130, P242, DOI 10.1067/msy.2001.115902; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tortorella C, 1998, J CLIN IMMUNOL, V18, P321, DOI 10.1023/A:1023286831246; Vukmanovic-Stejic M, 2018, J ALLERGY CLIN IMMUN, V142, P844, DOI 10.1016/j.jaci.2017.10.032; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Watz H, 2014, LANCET RESP MED, V2, P63, DOI 10.1016/S2213-2600(13)70200-5; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21336; Yi ZA, 2009, BLOOD, V114, P3191, DOI 10.1182/blood-2009-03-207522	55	56	56	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					615	+		10.1038/s41590-020-0646-0	http://dx.doi.org/10.1038/s41590-020-0646-0		APR 2020	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32251403	Green Submitted, Green Accepted			2022-12-18	WOS:000523953200001
J	Bakker, OB; Aguirre-Gamboa, R; Sanna, S; Oosting, M; Smeekens, SP; Jaeger, M; Zorro, M; Vosa, U; Withoff, S; Netea-Maier, RT; Koenen, HJPM; Joosten, I; Xavier, RJ; Franke, L; Joosten, LAB; Kumar, V; Wijmenga, C; Netea, MG; Li, Y				Bakker, Olivier B.; Aguirre-Gamboa, Raul; Sanna, Serena; Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Zorro, Maria; Vosa, Urmo; Withoff, Sebo; Netea-Maier, Romana T.; Koenen, Hans J. P. M.; Joosten, Irma; Xavier, Ramnik J.; Franke, Lude; Joosten, Leo A. B.; Kumar, Vinod; Wijmenga, Cisca; Netea, Mihai G.; Li, Yang			Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; RECENT POSITIVE SELECTION; CHAIN FATTY-ACIDS; SUSCEPTIBILITY LOCI; GENETIC RISK; DISEASE; LEPTIN; INFLAMMATION; TESTOSTERONE; GLUTAMINE	The immune response to pathogens varies substantially among people. Whereas both genetic and nongenetic factors contribute to interperson variation, their relative contributions and potential predictive power have remained largely unknown. By systematically correlating host factors in 534 healthy volunteers, including baseline immunological parameters and molecular profiles (genome, metabolome and gut microbiome), with cytokine production after stimulation with 20 pathogens, we identified distinct patterns of co-regulation. Among the 91 different cytokine-stimulus pairs, 11 categories of host factors together explained up to 67% of interindividual variation in cytokine production induced by stimulation. A computational model based on genetic data predicted the genetic component of stimulus-induced cytokine production (correlation 0.28-0.89), and nongenetic factors influenced cytokine production as well.	[Bakker, Olivier B.; Aguirre-Gamboa, Raul; Sanna, Serena; Zorro, Maria; Vosa, Urmo; Withoff, Sebo; Franke, Lude; Kumar, Vinod; Wijmenga, Cisca; Li, Yang] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Joosten, Leo A. B.; Kumar, Vinod; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Joosten, Leo A. B.; Kumar, Vinod; Netea, Mihai G.] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands; [Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Div Endocrinol, Nijmegen, Netherlands; [Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, Nijmegen, Netherlands; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Wijmenga, Cisca] Univ Oslo, Oslo Univ Hosp, Rikshosp, Dept Immunol, Oslo, Norway; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, Bonn, Germany	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oslo; National Hospital Norway; University of Bonn	Wijmenga, C; Li, Y (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands.; Wijmenga, C (corresponding author), Univ Oslo, Oslo Univ Hosp, Rikshosp, Dept Immunol, Oslo, Norway.; Netea, MG (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, Bonn, Germany.	c.wijmenga@umcg.nl; mihai.netea@radboudumc.nl; y.li01@umcg.nl	Kumar, Vinod/ABC-4866-2020; Wijmenga, Cisca/AAE-7719-2019; Li, Yang/HGT-8446-2022; Koenen, Hans J.P.M./A-2852-2014; Smeekens, Sanne/G-8307-2011; sanna, serena/H-3009-2019; Smeekens, Sanne/AAZ-2061-2021; Joosten, Irma/N-4418-2013; Netea, Mihai/N-5155-2014; Oosting, Marije/H-7437-2015; Jaeger, Martin/H-3359-2015; Joosten, Leo AB/H-3138-2015; Võsa, Urmo/AAJ-5928-2020	Kumar, Vinod/0000-0002-2775-6049; Wijmenga, Cisca/0000-0002-5635-1614; Li, Yang/0000-0003-4022-7341; Smeekens, Sanne/0000-0002-7835-914X; sanna, serena/0000-0002-3768-1749; Smeekens, Sanne/0000-0002-7835-914X; Joosten, Irma/0000-0003-2950-4977; Jaeger, Martin/0000-0001-6994-493X; Joosten, Leo AB/0000-0001-6166-9830; Võsa, Urmo/0000-0003-3476-1652; Zorro Manrique, Maria Magdalena/0000-0001-9664-0050; Bakker, Olivier/0000-0002-1447-1327; Withoff, Sebo/0000-0001-7704-3437	European Research Council (ERG) Consolidator grant [ERG 310372]; IN CONTROL CVON grant [CVON2012-03]; Netherlands Organization for Scientific Research (NWO) Spinoza prize [NWO SPI 94-212]; ERC [2012-322698]; NWO Spinoza prize [NWO SPI 92-266]; European Union Seventh Framework Programme grant (EU EP7) TANDEM project [HEALTH-F3-2012-305279]; NWO VENT grant [NWO 863.13.011]; ZonMw-OffRoad [91215206]; NWO VENI grant [016.176.006]; National Institutes of Health [DK43351, AT009708, AI137325]; National Center for Complementary & Integrative Health [R01AT009708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	European Research Council (ERG) Consolidator grant; IN CONTROL CVON grant; Netherlands Organization for Scientific Research (NWO) Spinoza prize(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); NWO Spinoza prize; European Union Seventh Framework Programme grant (EU EP7) TANDEM project; NWO VENT grant; ZonMw-OffRoad; NWO VENI grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all of the volunteers in the 500FG and GoNL cohorts for their participation. We thank T. A. Wassenaar and L. Steenhuis of the Hanle University of Applied Science for providing input on the project and helping with the analyses. Ste thank K. Mc Intyre for editing the text. We thank the EAGLE eczema consortium for making their summary statistics publicly available. The HFGP is supported by a European Research Council (ERG) Consolidator grant (ERG 310372). This study was further supported by an IN CONTROL CVON grant (CVON2012-03) and a Netherlands Organization for Scientific Research (NWO) Spinoza prize (NWO SPI 94-212) to M.G.N.; an ERC advanced grant (EP/2007-2013/ERC grant 2012-322698) and an NWO Spinoza prize (NWO SPI 92-266) to C.W., a European Union Seventh Framework Programme grant (EU EP7) TANDEM project (HEALTH-F3-2012-305279) to C.W, and V.K.; and an NWO VENT grant (NWO 863.13.011) and an ZonMw-OffRoad-91215206 grant to Y.L. M.O. was supported by an NWO VENI grant (016.176.006). R.J.X. was supported by National Institutes of Health grants DK43351, AT009708 and AI137325,	Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Behre HM, 1997, CLIN ENDOCRINOL, V47, P237, DOI 10.1046/j.1365-2265.1997.2681067.x; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Brannian JD, 1999, HUM REPROD, V14, P1445, DOI 10.1093/humrep/14.6.1445; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Casals F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-202; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Coeffier M, 2003, CLIN NUTR, V22, P407, DOI 10.1016/S0261-5614(03)00040-2; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Harle P, 2004, ANN RHEUM DIS, V63, P809, DOI 10.1136/ard.2003.011619; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kumar V, 2014, CURR OPIN IMMUNOL, V31, P51, DOI 10.1016/j.coi.2014.09.007; Lecleire S, 2008, J NUTR, V138, P2481, DOI 10.3945/jn.108.099127; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lvovs D, 2012, ACTA NATURAE, V4, P59, DOI 10.32607/20758251-2012-4-3-59-71; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Putov N V, 1977, Vrach Delo, P52; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Shah S, 2015, AM J HUM GENET, V97, P75, DOI 10.1016/j.ajhg.2015.05.014; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Voight BF, 2006, PLOS BIOL, V4, P659, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wang F, 2016, NAT IMMUNOL, V17, P844, DOI 10.1038/ni.3462; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xu T, 2007, CELL ADHES MIGR, V1, P115, DOI 10.4161/cam.1.3.4984; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	56	56	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					776	+		10.1038/s41590-018-0121-3	http://dx.doi.org/10.1038/s41590-018-0121-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29784908	Green Accepted			2022-12-18	WOS:000436341300022
J	Liu, CH; Abrams, ND; Carrick, DM; Chander, P; Dwyer, J; Hamlet, MRJ; Macchiarini, F; PrabhuDas, M; Shen, GL; Tandon, P; Vedamony, MM				Liu, Christina H.; Abrams, Natalie D.; Carrick, Danielle M.; Chander, Preethi; Dwyer, Johanna; Hamlet, Michelle R. J.; Macchiarini, Francesca; PrabhuDas, Mercy; Shen, Grace L.; Tandon, Pushpa; Vedamony, Merriline M.			Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities	NATURE IMMUNOLOGY			English	Editorial Material							CANCER; AGE	The US National Institutes of Health convened a workshop on disease-promoting chronic inflammation to identify the challenges and needs in the development of clinically feasible strategies for monitoring a person's inflammation status before, during and after disease occurrence.	[Liu, Christina H.] NCI, NIH, Bethesda, MD 20892 USA; [Abrams, Natalie D.; Carrick, Danielle M.; Tandon, Pushpa] NCI, NIH, Rockville, MD USA; [Chander, Preethi] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Dwyer, Johanna] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA; [Hamlet, Michelle R. J.] NINR, NIH, Bethesda, MD 20892 USA; [Macchiarini, Francesca] NIA, NIH, Bethesda, MD 20892 USA; [PrabhuDas, Mercy; Vedamony, Merriline M.] NIAID, NIH, Rockville, MD USA; [Shen, Grace L.] NEI, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Liu, CH (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	liuch2@mail.nih.gov	Abrams, Natalie/AAM-5468-2021; Dwyer, Johanna/AAI-5027-2020	Abrams, Natalie/0000-0001-9698-2819; Liu, Christina/0000-0002-5723-177X				Abram TJ, 2016, ORAL ONCOL, V60, P103, DOI 10.1016/j.oraloncology.2016.07.002; Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Dzutsev A, 2017, ANNU REV IMMUNOL, V35, P199, DOI 10.1146/annurev-immunol-051116-052133; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Kreisl WC, 2016, NEUROBIOL AGING, V44, P53, DOI 10.1016/j.neurobiolaging.2016.04.011; Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004; Martins MD, 2016, J DENT RES, V95, P215, DOI 10.1177/0022034515611876; Morrison L, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2115-6; Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004; Newman AB, 2016, INT J EPIDEMIOL, V45, P1135, DOI 10.1093/ije/dyw092; Roy NS, 2017, INVEST OPHTH VIS SCI, V58, pBIO1, DOI 10.1167/iovs.17-21709; Shin SH, 2017, RADIOLOGY, V282, P194, DOI 10.1148/radiol.2016152387; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; Varadhan R, 2014, J GERONTOL A-BIOL, V69, P165, DOI 10.1093/gerona/glt023; Wang LHV, 2016, NAT METHODS, V13, P627, DOI [10.1038/NMETH.3925, 10.1038/nmeth.3925]; Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010; Zhen YB, 2015, MOL MED REP, V12, P5239, DOI 10.3892/mmr.2015.4079; Zierer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37646	20	56	57	4	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1175	1180		10.1038/ni.3828	http://dx.doi.org/10.1038/ni.3828			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3EU	29044245				2022-12-18	WOS:000447605300001
J	Sasai, M; Sakaguchi, N; Ma, JS; Nakamura, S; Kawabata, T; Bando, H; Lee, Y; Saitoh, T; Akira, S; Iwasaki, A; Standley, DM; Yoshimori, T; Yamamoto, M				Sasai, Miwa; Sakaguchi, Naoya; Ma, Ji Su; Nakamura, Shuhei; Kawabata, Tsuyoshi; Bando, Hironori; Lee, Youngae; Saitoh, Tatsuya; Akira, Shizuo; Iwasaki, Akiko; Standley, Daron M.; Yoshimori, Tamotsu; Yamamoto, Masahiro			Essential role for GABARAP autophagy proteins in interferon-inducible GTPase-mediated host defense	NATURE IMMUNOLOGY			English	Article							IMMUNITY-RELATED GTPASES; TOXOPLASMA-GONDII; INTRACELLULAR PATHOGENS; LC3-ASSOCIATED PHAGOCYTOSIS; CONJUGATION SYSTEMS; TRANSPORT MODULATOR; IN-VIVO; MEMBRANE; LC3; INFECTION	Mammalian autophagy-related 8 (Atg8) homologs consist of LC3 proteins and GABARAPs, all of which are known to be involved in canonical autophagy. In contrast, the roles of Atg8 homologs in noncanonical autophagic processes are not fully understood. Here we show a unique role of GABARAPs, in particular gamma-aminobutyric acid (GABA)-A-receptor-associated protein-like 2 (Gabarapl2; also known as Gate-16), in interferon-gamma (IFN-gamma)-mediated antimicrobial responses. Cells that lacked GABARAPs but not LC3 proteins and mice that lacked Gate-16 alone were defective in the IFN-gamma-induced clearance of vacuolar pathogens such as Toxoplasma. Gate-16 but not LC3b specifically associated with the small GTPase ADP-ribosylation factor 1 (Arf1) to mediate uniform distribution of interferon-inducible GTPases. The lack of GABARAPs reduced Arf1 activation, which led to formation of interferon-inducible GTPase-containing aggregates and hampered recruitment of interferon-inducible GTPases to vacuolar pathogens. Thus, GABARAPs are uniquely required for antimicrobial host defense through cytosolic distribution of interferon-inducible GTPases.	[Sasai, Miwa; Sakaguchi, Naoya; Ma, Ji Su; Bando, Hironori; Yamamoto, Masahiro] Osaka Univ, Res Inst Microbial Dis, Dept Immunoparasitol, Osaka, Japan; [Sasai, Miwa; Sakaguchi, Naoya; Lee, Youngae; Yamamoto, Masahiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunoparasitol, Osaka, Japan; [Nakamura, Shuhei; Kawabata, Tsuyoshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Osaka, Japan; [Nakamura, Shuhei; Kawabata, Tsuyoshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Osaka, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Osaka, Japan; [Saitoh, Tatsuya] Univ Tokushima, Inst Enzyme Res, Div Inflammat Biol, Tokushima, Japan; [Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA; [Standley, Daron M.] Osaka Univ, Res Inst Microbial Dis, Dept Genome Informat, Osaka, Japan; [Standley, Daron M.] Osaka Univ, Lab Syst Immunol, WPI Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Tokushima University; Howard Hughes Medical Institute; Yale University; Osaka University; Osaka University	Yamamoto, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Immunoparasitol, Osaka, Japan.; Yamamoto, M (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunoparasitol, Osaka, Japan.	myamamoto@biken.osaka-u.ac.jp	Iwasaki, Akiko/Z-1591-2019; Shuhei, Nakamura/AGZ-2173-2022; Bando, Hironori/CAH-1923-2022; Akira, Shizuo/C-3134-2009	Iwasaki, Akiko/0000-0002-7824-9856; Shuhei, Nakamura/0000-0002-1488-8317; Sasai, Miwa/0000-0001-6440-3958; Kawabata, Tsuyoshi/0000-0003-0899-0750	Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development (AMED) [17fk0108120h0001]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17H0557, 26117713]; Cooperative Research Grant of the Institute for Enzyme Research; Joint Usage/Research Center of Tokushima University; Takeda Science Foundation; Ohyama Health Foundation; Heiwa Nakajima Foundation; Cell Science Research Foundation; Research Foundation for Microbial Diseases of Osaka University; Naito Foundation; Grants-in-Aid for Scientific Research [17K19556] Funding Source: KAKEN	Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research Grant of the Institute for Enzyme Research; Joint Usage/Research Center of Tokushima University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ohyama Health Foundation; Heiwa Nakajima Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Research Foundation for Microbial Diseases of Osaka University; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Enomoto (Osaka University) for secretarial and technical assistance, D. Soldati-Favre (University of Geneva), J.C. Howard (Instituto Gulbenkian de Ciencia) and E.M. Frickel (Francis Crick Institute) for providing antibodies, M. Komatsu (Niigata University) for Atg7-deficient MEFs and H.W. Virgin (Washington University at St. Louis) for helpful discussion. Supported by the Research Program on Emerging and Re-emerging Infectious Diseases (grant no. 17fk0108120h0001) from the Agency for Medical Research and Development (AMED) (M.Y.), the Grant-in-Aid for Scientific Research on Innovative Areas ("Homeostatic regulation by various types of cell death", grant no. 17H0557 (M.Y.), and "Matoryoshka-type evolution", grant no. 26117713 (M.Y.)) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.Y.), a Cooperative Research Grant of the Institute for Enzyme Research (M.Y.), the Joint Usage/Research Center of Tokushima University (M.Y.), the Takeda Science Foundation (M.Y.), the Ohyama Health Foundation (M.Y.), the Heiwa Nakajima Foundation (M.Y.), the Cell Science Research Foundation (M.Y.), the Research Foundation for Microbial Diseases of Osaka University (M.Y.) and the Naito Foundation (M.S.).	Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Haldar AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086684; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Le Grand JN, 2011, AUTOPHAGY, V7, P1302, DOI 10.4161/auto.7.11.16723; Lee Y, 2015, CELL REP, V13, P223, DOI 10.1016/j.celrep.2015.09.005; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Meunier E, 2016, CELL MICROBIOL, V18, P168, DOI 10.1111/cmi.12546; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakayama K, 2005, METHOD ENZYMOL, V404, P367, DOI 10.1016/S0076-6879(05)04032-2; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Papic N, 2008, J BIOL CHEM, V283, P32143, DOI 10.1074/jbc.M804846200; Park S, 2016, AUTOPHAGY, V12, P1153, DOI 10.1080/15548627.2016.1178447; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/BSE0550051, 10.1042/bse0550051]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wild P, 2014, J CELL SCI, V127, P3, DOI 10.1242/jcs.140426; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	57	56	59	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					899	+		10.1038/ni.3767	http://dx.doi.org/10.1038/ni.3767			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28604719				2022-12-18	WOS:000405821100013
J	Klein, RS; Voskuhl, R; Segal, BM; Dittel, BN; Lane, TE; Bethea, JR; Carson, MJ; Colton, C; Rosi, S; Anderson, A; Piccio, L; Goverman, JM; Benveniste, EN; Brown, MA; Tiwari-Woodruff, SK; Harris, TH; Cross, AH				Klein, Robyn S.; Voskuhl, Rhonda; Segal, Benjamin M.; Dittel, Bonnie N.; Lane, Thomas E.; Bethea, John R.; Carson, Monica J.; Colton, Carol; Rosi, Susanna; Anderson, Aileen; Piccio, Laura; Goverman, Joan M.; Benveniste, Etty N.; Brown, Melissa A.; Tiwari-Woodruff, Seema Kaushalya; Harris, Tajie H.; Cross, Anne H.			Speaking out about gender imbalance in invited speakers improves diversity	NATURE IMMUNOLOGY			English	Article							WORKFORCE; PROGRAMS; STUDENTS	Omissions of qualified women scientists from major meeting programs continue to occur despite a surge in articles indicating persistent gender-discriminatory practices in hiring and promotion, and calls for gender balance in conference organizing committees.	[Klein, Robyn S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Voskuhl, Rhonda] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Segal, Benjamin M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Dittel, Bonnie N.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Lane, Thomas E.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Bethea, John R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Carson, Monica J.; Tiwari-Woodruff, Seema Kaushalya] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Colton, Carol] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Anderson, Aileen] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA; [Anderson, Aileen] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Piccio, Laura; Cross, Anne H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goverman, Joan M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Benveniste, Etty N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Brown, Melissa A.] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Tajie H.] Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Versiti Blood Center of Wisconsin; Utah System of Higher Education; University of Utah; Drexel University; University of California System; University of California Riverside; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Irvine; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; University of Virginia	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.	rklein@wustl.ed	Piccio, Laura/AAE-1706-2020	Piccio, Laura/0000-0002-8760-109X; Cross, Anne/0000-0003-0829-7569; Colton, Carol/0000-0003-3305-370X; Goverman, Joan/0000-0002-7361-9424	NINDS NIH HHS [R21 NS096363, R01 NS052632] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, R21NS096363] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta D, 2006, ACAD MED, V81, P863, DOI 10.1097/01.ACM.0000238047.48977.05; Beck MM, 2003, J ANIM SCI, V81, P2895; Byrd D, 2010, CLIN NEUROPSYCHOL, V24, P1279, DOI 10.1080/13854046.2010.521769; Casadevall A, 2015, MBIO, V6, DOI 10.1128/mBio.01146-15; Casadevall A, 2014, MBIO, V5, DOI [10.1128/mBio.00064-14, 10.1128/mBio.00846-13, 10.1128/mBio.01730-14, 10.1128/mBio.01342-14]; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Dalley B, 2009, ACAD MED, V84, P1373, DOI 10.1097/ACM.0b013e3181b6c76b; Drew JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119548; Goins G, 2010, CBE-LIFE SCI EDUC, V9, P241, DOI 10.1187/cbe.10-03-0043; Haynes C, 2015, ANAL CHEM, V87, P6989, DOI 10.1021/acs.analchem.5b02454; Holsti M, 2015, CTS-CLIN TRANSL SCI, V8, P87, DOI 10.1111/cts.12258; Logan N S, 1997, J Dent Educ, V61, P273; Monroe AK, 2015, J WOMENS HEALTH, V24, P837, DOI 10.1089/jwh.2014.5054; Nnedu Cordelia Chinwe, 2009, ABNF J, V20, P93; Noonan A, 2013, AM J PUBLIC HEALTH, V103, P412, DOI 10.2105/AJPH.2012.300726; O'Reilly SL, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0458-3; Pilkington F. B, 2013, INT J NURS ED SCHOLA, V10, P123; Sinkford Jeanne C, 2003, J Dent Educ, V67, P468; Smith SG, 2009, J NATL MED ASSOC, V101, P836, DOI 10.1016/S0027-9684(15)31030-0; Whittaker Joseph A, 2012, J Undergrad Neurosci Educ, V11, pA44; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002	21	56	57	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					475	478		10.1038/ni.3707	http://dx.doi.org/10.1038/ni.3707			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418385	Green Accepted, Green Submitted			2022-12-18	WOS:000399378700001
J	Gil-Cruz, C; Perez-Shibayama, C; Onder, L; Chai, Q; Cupovic, J; Cheng, HW; Novkovic, M; Lang, PA; Geuking, MB; Mccoy, KD; Abe, S; Cui, G; Ikuta, K; Scandella, E; Ludewig, B				Gil-Cruz, Cristina; Perez-Shibayama, Christian; Onder, Lucas; Chai, Qian; Cupovic, Jovana; Cheng, Hung -Wei; Novkovic, Mario; Lang, Philipp A.; Geuking, Markus B.; McCoy, Kathy D.; Abe, Shinya; Cui, Guangwei; Ikuta, Koichi; Scandella, Elke; Ludewig, Burkhard			Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; NK CELLS; TRANS-PRESENTATION; HOST PROTECTION; IFN-GAMMA; T-CELLS; HOMEOSTASIS; IMMUNITY; INFECTION; DISEASE	Fibroblastic reticular cells (FRCs) of secondary lymphoid organs form distinct niches for interaction with hematopoietic cells. We found here that production of the cytokine IL-15 by FRCs was essential for the maintenance of group 1 innate lymphoid cells (ILCs) in Peyer's patches and mesenteric lymph nodes. Moreover, FRC-specific ablation of the innate immunological sensing adaptor MyD88 unleashed IL-15 production by FRCs during infection with an enteropathogenic virus, which led to hyperactivation of group 1 ILCs and substantially altered the differentiation of helper T cells. Accelerated clearance of virus by group 1 ILCs precipitated severe intestinal inflammatory disease with commensal dysbiosis, loss of intestinal barrier function and diminished resistance to colonization. In sum, FRCs act as an 'on-demand' immunological 'rheostat' by restraining activation of group 1 ILCs and thereby preventing immunopathological damage in the intestine.	[Gil-Cruz, Cristina; Perez-Shibayama, Christian; Onder, Lucas; Chai, Qian; Cupovic, Jovana; Cheng, Hung -Wei; Novkovic, Mario; Scandella, Elke; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Lang, Philipp A.] Heinrich Heine Univ, Fac Med, Dept Mol Med 2, Dusseldorf, Germany; [Geuking, Markus B.; McCoy, Kathy D.] Univ Bern, Div Gastroenterol, Dept Clin Res, Bern, Switzerland; [Abe, Shinya; Cui, Guangwei; Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto, Japan; [Abe, Shinya] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Kantonsspital St. Gallen; Heinrich Heine University Dusseldorf; University of Bern; Kyoto University; Kyoto University	Scandella, E; Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland.	elke.scandella@kssg.ch; burkhard.ludewig@kssg.ch	McCoy, Kathy/ABD-5814-2021	Gil Cruz, Cristina/0000-0001-5285-6503; Ikuta, Koichi/0000-0003-1319-1021; Novkovic, Mario/0000-0001-7654-5777	Swiss National Science Foundation [146133, 141918, 151370]; Promedica Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460589, 16H05172, 15H01153]; German Research Council [SFB974, GRK1949]; Japanese Society for the Promotion of Science	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Promedica Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Council(German Research Foundation (DFG)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K.J. Maloy (University of Oxford) for C. rodentium strain ICC169; and C. Mooser, R. De Guili, A. Printz and A. De Martin for technical support. Supported by the Swiss National Science Foundation (146133 and 141918 to B.L.; and 151370 to as.), the Promedica Foundation (B.L.), Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25460589, 16H05172 and 15H01153 to K.I.), the German Research Council (SFB974 and GRK1949 to P.A.L.) and the Japanese Society for the Promotion of Science (G.C.). The funders had no role in study design, data collection or analysis, the decision to publish or preparation of the manuscript.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Baranek T, 2012, CELL HOST MICROBE, V12, P571, DOI 10.1016/j.chom.2012.09.002; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Goldberg R, 2015, NAT REV GASTRO HEPAT, V12, P271, DOI 10.1038/nrgastro.2015.52; Huntington ND, 2016, CURR OPIN IMMUNOL, V38, P86, DOI 10.1016/j.coi.2015.11.008; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Klose CSN, 2014, CURR TOP MICROBIOL, V381, P215, DOI 10.1007/82_2014_381; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; LAVI E, 1986, LAB ANIM SCI, V36, P130; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Macpherson AJ, 2007, SEMIN IMMUNOL, V19, P57, DOI 10.1016/j.smim.2007.04.001; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Tassi I, 2006, IMMUNOL REV, V214, P92, DOI 10.1111/j.1600-065X.2006.00463.x; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901	42	56	57	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1388	1396		10.1038/ni.3566	http://dx.doi.org/10.1038/ni.3566			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27798617	Green Published, Bronze			2022-12-18	WOS:000388056400009
J	Ding, YY; Guo, ZH; Liu, YQ; Li, X; Zhang, Q; Xu, XF; Gu, Y; Zhang, Y; Zhao, DZ; Cao, XT				Ding, Yuanyuan; Guo, Zhenhong; Liu, Yiqi; Li, Xia; Zhang, Qian; Xu, Xiongfei; Gu, Yan; Zhang, Yi; Zhao, Dezhi; Cao, Xuetao			The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation	NATURE IMMUNOLOGY			English	Article							LISTERIA-MONOCYTOGENES; REACTIVE OXYGEN; ANTIGEN; COMPARTMENT; INFECTION; PHAGOSOMES; RESPONSES; PATHWAYS; DELIVERY; CYTOSOL	CD8 alpha(+) dendritic cells (DCs) are specialized at cross-presenting extracellular antigens on major histocompatibility complex (MHC) class I molecules to initiate cytotoxic T lymphocyte (CTL) responses; however, details of the mechanisms that regulate cross-presentation remain unknown. We found lower expression of the lectin family member Siglec-G in CD8 alpha(+) DCs, and Siglec-G deficient (Siglecg(-/-)) mice generated more antigen-specific CTLs to inhibit intracellular bacterial infection and tumor growth. MHC class I-peptide complexes were more abundant on Siglecg(-/-) CD8 alpha(+) DCs than on Siglecg(+/+) CD8 alpha(+) DCs. Mechanistically, phagosome-expressed Siglec-G recruited the phosphatase SHP-1, which dephosphorylated the NADPH oxidase component p47(phox) and inhibited the activation of NOX2 on phagosomes. This resulted in excessive hydrolysis of exogenous antigens, which led to diminished formation of MHC class I-peptide complexes for cross-presentation. Therefore, Siglec-G inhibited DC cross-presentation by impairing such complex formation, and our results add insight into the regulation of cross-presentation in adaptive immunity.	[Ding, Yuanyuan; Liu, Yiqi; Cao, Xuetao] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Ding, Yuanyuan; Guo, Zhenhong; Zhang, Qian; Xu, Xiongfei; Gu, Yan; Zhang, Yi; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Ding, Yuanyuan; Guo, Zhenhong; Zhang, Qian; Xu, Xiongfei; Gu, Yan; Zhang, Yi; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Ding, Yuanyuan; Li, Xia; Zhao, Dezhi; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy,Natl Key Lab Med Mol Biol, Beijing, Peoples R China; [Ding, Yuanyuan; Li, Xia; Zhao, Dezhi; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy,Dept Immunol, Beijing, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, XT (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy,Natl Key Lab Med Mol Biol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy,Dept Immunol, Beijing, Peoples R China.	caoxt@immunol.org	Li, Xia/AAB-9647-2019; Guo, Zhenhong/HGB-4912-2022; Liu, Yiqi/AAK-1630-2020	Xu, Xiongfei/0000-0001-9532-4582	National Key Basic Research Program of China [2013CB530502, 2014CB542101]; National Natural Science Foundation of China [81522019, 31390431, 31270966, 81471567]; Shanghai Pujiang Program [14PJ1410800]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	We thank Y. Liu (Children's National Medical Center, Washington) for Siglecg<SUP>-/-</SUP> mice; H. Shen (University of Pennsylvania) for LM; H. Nie (Shanghai JiaoTong University) for the B16-OVA cell line; G. Liu (Chinese Academy of Sciences) for the plasmid pKSV7; S. Xu, Z. Jiang for technical assistance; and T. Chen and L. Lu for discussions. Supported by the National Key Basic Research Program of China (2013CB530502 and 2014CB542101), the National Natural Science Foundation of China (81522019, 31390431, 31270966 and 81471567) and the Shanghai Pujiang Program (14PJ1410800).	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Baghdadi M, 2013, IMMUNITY, V39, P1070, DOI 10.1016/j.immuni.2013.09.014; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092340; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hamilton SE, 2006, J IMMUNOL, V177, P4012, DOI 10.4049/jimmunol.177.6.4012; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kaneko T, 2012, J IMMUNOL, V188, P5397, DOI 10.4049/jimmunol.1103210; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Manca C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074082; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Segura E, 2013, J EXP MED, V210, P1035, DOI 10.1084/jem.20121103; Simmons DP, 2012, J IMMUNOL, V188, P3116, DOI 10.4049/jimmunol.1101313; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763	43	56	61	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1167	+		10.1038/ni.3535	http://dx.doi.org/10.1038/ni.3535			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27548433				2022-12-18	WOS:000384302900008
J	Haniuda, K; Fukao, S; Kodama, T; Hasegawa, H; Kitamura, D				Haniuda, Kei; Fukao, Saori; Kodama, Tadahiro; Hasegawa, Hitoshi; Kitamura, Daisuke			Autonomous membrane IgE signaling prevents IgE-memory formation	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER B; CELL MEMORY; ANTIGEN; APOPTOSIS; LYMPHOCYTES; ACTIVATION; REVEALS; CENTERS	Aberrant production of IgE antibodies can lead to allergic diseases. Normally, IgE(+) B cells rarely differentiate into memory B cells (B-mem) or long-lived plasma cells (LLPCs), as they only transiently participate in the germinal center (GC), but the mechanism behind this remains elusive. We found that membrane IgE (mIgE) autonomously triggered rapid plasma-cell differentiation and apoptosis independently of antigen or cellular context, predominantly through the mutually independent CD19-PI3K-Akt-IRF4 and BLNK-Jnk/p38 pathways, respectively, and we identified the ectodomains of mIgE as being responsible. Accordingly, deregulated GC IgE(+) B cell proliferation and prolonged IgE production with exaggerated anaphylaxis were observed in CD19- and BLNK-deficient mice. Our findings reveal an autonomous mIgE signaling mechanism that normally prevents IgE(+) B-mem and LLPC formation, providing insights into the molecular pathogenesis of allergic diseases.	[Haniuda, Kei; Fukao, Saori; Kodama, Tadahiro; Hasegawa, Hitoshi; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Biol, Noda, Chiba, Japan	Tokyo University of Science	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Biol, Noda, Chiba, Japan.	kitamura@rs.noda.tus.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25293116, 15K19138, 12J08178]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H07238] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Rajewsky and colleagues (Max Delbruck Center for Molecular Medicine) for B1-8f, C<INF>gamma</INF>1-Cre and Cd19<SUP>-/-</SUP> mice, F. Alt (Harvard Medical School) and T. Tsubata (Tokyo Medical and Dental University) for Igk<SUP>-1-</SUP> mice, T. Azuma (Research Institute for Biomedical Sciences) for N1G9 cDNA, M. Ohkura and J. Nakai (Saitama University) for G-CaMP6, T. Kitamura (University of Tokyo) for pMXs-IRES-GFP and Plat-E cells, J. Yagi (Tokyo Women's Medical University School of Medicine) for CA-Akt, RIKEN BRC for BaIb/c 3T3 cells, J. Nakayama, M. Yamamoto and S. Horiuchi for plasmid constructs, T. Nojima, R. Goitsuka, M. Kubo and other members of the Research Institute for Biomedical Sciences for technical advice and comments, and P. Burrows for critical reading. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (25293116 to D.K., 15K19138 and 12J08178 to K.H.) and Takeda Science Foundation (D.K.). K.H. was a JSPS Fellow when he started this study.	Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Achatz-Straussberger G, 2008, EUR J IMMUNOL, V38, P3167, DOI 10.1002/eji.200838456; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Casale S., 2006, P NATL ACAD SCI USA, V103, P7396; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Geisberger Roland, 2002, Dev Immunol, V9, P127, DOI 10.1080/1044667031000137584; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; Hobeika E, 2015, EMBO J, V34, P925, DOI 10.15252/embj.201489732; Hug E, 2014, ONCOGENE, V33, P3730, DOI 10.1038/onc.2013.326; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lafaille JJ, 2012, NAT IMMUNOL, V13, P623, DOI 10.1038/ni.2313; Laffleur B, 2015, CELL REP, V10, P900, DOI 10.1016/j.celrep.2015.01.023; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; lshiai M., 1999, IMMUNITY, V10, P117; Minamitani T, 2015, P NATL ACAD SCI USA, V112, P11612, DOI 10.1073/pnas.1514484112; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Oberndorfer I, 2006, J IMMUNOL, V177, P1139, DOI 10.4049/jimmunol.177.2.1139; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Shade KTC, 2015, J EXP MED, V212, P457, DOI 10.1084/jem.20142182; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	42	56	57	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1109	1117		10.1038/ni.3508	http://dx.doi.org/10.1038/ni.3508			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27428827				2022-12-18	WOS:000381832000015
J	Hou, Y; Li, W; Sheng, Y; Li, LP; Huang, Y; Zhang, ZH; Zhu, TY; Peace, D; Quigley, JG; Wu, WS; Zhao, YY; Qian, ZJ				Hou, Yu; Li, Wen; Sheng, Yue; Li, Liping; Huang, Yong; Zhang, Zhonghui; Zhu, Tongyu; Peace, David; Quigley, John G.; Wu, Wenshu; Zhao, You-yang; Qian, Zhijian			The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							SELF-RENEWAL; ENDOTHELIAL-CELLS; GENE-EXPRESSION; MOUSE MODELS; PROLIFERATION; MICE; TRANSPLANTATION; PROGRESSION; PROGENITOR; SURVIVAL	Foxm1 is known as a typical proliferation-associated transcription factor. Here we found that Foxm1 was essential for maintenance of the quiescence and self-renewal capacity of hematopoietic stem cells (HSCs) in vivo in mice. Reducing expression of FOXM1 also decreased the quiescence of human CD34(+) HSCs and progenitor cells, and its downregulation was associated with a subset of myelodysplastic syndrome (MDS). Mechanistically, Foxm1 directly bound to the promoter region of the gene encoding the receptor Nurr1 (Nr4a2; called 'Nurr1' here), inducing transcription, while forced expression of Nurr1 reversed the loss of quiescence observed in Foxm1-deficient cells in vivo. Thus, our studies reveal a previously unrecognized role for Foxm1 as a critical regulator of the quiescence and self-renewal of HSCs mediated at least in part by control of Nurr1 expression.	[Hou, Yu; Li, Wen; Sheng, Yue; Li, Liping; Zhang, Zhonghui; Peace, David; Quigley, John G.; Wu, Wenshu; Qian, Zhijian] Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Chicago, IL 60612 USA; [Hou, Yu; Li, Wen; Sheng, Yue; Li, Liping; Zhang, Zhonghui; Peace, David; Quigley, John G.; Wu, Wenshu; Qian, Zhijian] Univ Illinois Hosp & Hlth Sci Syst, Canc Res Ctr, Chicago, IL USA; [Li, Liping; Zhu, Tongyu] Fudan Univ, ZhongShan Hosp, Shanghai 200433, Peoples R China; [Huang, Yong] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA; [Zhao, You-yang] Univ Illinois Hosp & Hlth Sci Syst, Dept Pharmacol, Chicago, IL USA	Fudan University; University of Chicago	Qian, ZJ (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Chicago, IL 60612 USA.	zjqian@uic.edu	Quigley, John/X-4366-2019; li, liping/ABC-8119-2020; Liping, Li/R-3877-2017	li, liping/0000-0002-6884-6059; Hou, Yu/0000-0002-3896-5321; ZHAO, YOU-YANG/0000-0002-0041-0339; Hou, Yu/0000-0002-7774-0846	US National Institutes of Health [RO1 CA140979]; NATIONAL CANCER INSTITUTE [R01CA140979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125350, R01HL123957, P01HL077806] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M.A. Goodell (Baylor College of Medicine) for the plasmid MSCV-FlagNurr1. Supported by the US National Institutes of Health (RO1 CA140979 to Z.Q.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hou Y, 2015, LEUKEMIA, V29, P615, DOI 10.1038/leu.2014.254; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Nimer Stephen D, 2008, Hematology Am Soc Hematol Educ Program, P43, DOI 10.1182/asheducation-2008.1.43; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Wierstra I, 2006, BIOL CHEM, V387, P963, DOI 10.1515/BC.2006.120; Wierstra I, 2013, ADV CANCER RES, V118, P97, DOI 10.1016/B978-0-12-407173-5.00004-2; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie ZQ, 2010, NUCLEIC ACIDS RES, V38, P8027, DOI 10.1093/nar/gkq715; Xue L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009229; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	49	56	57	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					810	+		10.1038/ni.3204	http://dx.doi.org/10.1038/ni.3204			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147687	Green Accepted			2022-12-18	WOS:000358299200008
J	McMichael, AJ; Koff, WC				McMichael, Andrew J.; Koff, Wayne C.			Vaccines that stimulate T cell immunity to HIV-1: the next step	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIGHLY PATHOGENIC SIV; RHESUS-MONKEYS; LYMPHOCYTE RESPONSES; EFFICACY TRIAL; INFECTION; REPLICATION; VACCINATION; INDUCTION; EPITOPES	The search for a vaccine against human immunodeficiency virus type 1 (HIV-1) has many hurdles to overcome. Ideally, the stimulation of both broadly neutralizing antibodies and cell-mediated immune responses remains the best option, but no candidate in clinical trials at present has elicited such antibodies, and efficacy trials have not demonstrated any benefit for vaccines designed to stimulate immune responses of CD8(+) T cells. Findings obtained with the simian immunodeficiency virus (SIV) monkey model have provided new evidence that stimulating effective CD8(+) T cell immunity could provide protection, and in this Perspective we explore the path forward for optimizing such responses in humans.	[McMichael, Andrew J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY USA	University of Oxford; International AIDS Vaccine Initiative	McMichael, AJ (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	andrew.mcmichael@ndm.ox.ac.uk			Medical Research Council UK; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1 AI 00645]; International AIDS Vaccine Initiative (including the US Agency for International Development and the Bill & Melinda Gates Foundation); Medical Research Council [MR/K012037/1] Funding Source: researchfish; MRC [MR/K012037/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; International AIDS Vaccine Initiative (including the US Agency for International Development and the Bill & Melinda Gates Foundation)(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Medical Research Council UK, the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health, the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1 AI 00645) and donors to the International AIDS Vaccine Initiative (including the US Agency for International Development and the Bill & Melinda Gates Foundation). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Parks CL, 2013, CURR OPIN HIV AIDS, V8, P402, DOI 10.1097/COH.0b013e328363d389; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Shapiro SZ, 2014, AIDS RES HUM RETROV, V30, P325, DOI [10.1089/aid.2013.0114, 10.1089/AID.2013.0114]; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379	35	56	59	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					319	322		10.1038/ni.2844	http://dx.doi.org/10.1038/ni.2844			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646598	Green Accepted, Bronze			2022-12-18	WOS:000333252000006
J	Monticelli, S; Natoli, G				Monticelli, Silvia; Natoli, Gioacchino			Short-term memory of danger signals and environmental stimuli in immune cells	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; ACTIVE DNA DEMETHYLATION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NONCODING RNAS; TET PROTEINS; ACCESSIBLE CHROMATIN; ENHANCER LANDSCAPE; MESSENGER-RNAS; SELF-RENEWAL	Standard definitions of immunological memory are all built on the idea that once infected, animals are protected more efficiently against a second infection. This common view overlooks an unavoidable consequence of the exposure of cells to pathogens, danger signals and environmental agents in general: stimuli change cell properties and activity in a transient yet sustained manner that extends beyond the exposure time and modulates the response of cells of both the innate and adaptive immune systems to secondary stimulation. We suggest that this transient phenomenon represents 'short-term memory' of environmental exposure and discuss the evidence that this is mediated by the persistence of long-lived regulatory molecules, notably a subset of newly deposited chromatin modifications and inducible noncoding RNAs.	[Monticelli, Silvia] Inst Res Biomed, Bellinzona, Switzerland; [Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, Milan, Italy	Universita della Svizzera Italiana; IRCCS European Institute of Oncology (IEO)	Monticelli, S (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	silvia.monticelli@irb.usi.ch; gioacchino.natoli@ieo.eu	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020; Monticelli, Silvia/ABE-7054-2020		Swiss National Science Foundation [31003A_138343]; Novartis Stiftung fur Medizinisch Biologische Forschung; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Medizinisch Biologische Forschung; European Research Council(European Research Council (ERC)European Commission)	We thank K.M. Ansel for encouragement. Supported by the Swiss National Science Foundation (31003A_138343 for the S.M. laboratory), Novartis Stiftung fur Medizinisch Biologische Forschung (S.M. laboratory) and the European Research Council (G.N. laboratory).	Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Marangoni F, 2013, IMMUNITY, V38, P237, DOI 10.1016/j.immuni.2012.09.012; Mayoral RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026133; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Montagner S., 2013, IMMUNOL REV IN PRESS; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas MF, 2012, BLOOD, V120, P130, DOI 10.1182/blood-2011-11-394072; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342	131	56	60	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					777	784		10.1038/ni.2636	http://dx.doi.org/10.1038/ni.2636			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN					2022-12-18	WOS:000322010600006
J	Nagarajan, NA; Gonzalez, F; Shastri, N				Nagarajan, Niranjana A.; Gonzalez, Federico; Shastri, Nilabh			Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum	NATURE IMMUNOLOGY			English	Article							IN-VIVO; AMINOPEPTIDASE ERAAP; EXPRESSION; MOLECULES; PEPTIDES; MICE; REPERTOIRE; DEFICIENT; ERAP1; GENERATION	The aminopeptidase ERAAP is essential for trimming peptides presented by major histocompatibility complex (MHC) class I molecules. Inhibition of ERAAP by cytomegalovirus results in evasion of the immune response by this virus, and polymorphisms in ERAAP are associated with autoimmune disorders. How normal ERAAP function is monitored is unknown. We found that inhibition of ERAAP rapidly induced presentation of the peptide FYAEATPML (FL9) by the MHC class Ib molecule Qa-1(b). Antigen-experienced T cells specific for the Qa-1(b)-FL9 complex were frequent in naive mice. Wild-type mice immunized with ERAAP-deficient cells mounted a potent CD8(+) T cell response specific for Qa-1(b)-FL9. MHC class Ib-restricted cytolytic effector cells specifically eliminated ERAAP-deficient cells in vitro and in vivo. Thus, nonclassical Qa-1(b)-peptide complexes direct cytotoxic T cells to targets with defective antigen processing in the endoplasmic reticulum.	[Nagarajan, Niranjana A.; Gonzalez, Federico; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu			Cancer Research Institute; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044864, R21AI101751, R01AI039548, R01AI060040, R37AI060040] Funding Source: NIH RePORTER	Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Tetramer Core Facility of the US National Institutes of Health for tetramer reagents; K. Soderstrom and E. Engleman (Stanford University) for Qa-1<SUP>b</SUP>-deficient mice generated by H. Cantor and colleagues (Harvard University); H. Cantor (Harvard University) for lentiviral vectors expressing Qa-1<SUP>b</SUP>; D. King for peptide synthesis; H. Nolla for assistance with cell sorting; K. C. Lind and A.H. Bakker for discussions and comments on the manuscript; and H. Dani for technical assistance. Supported by Irvington Institute Fellowship Program of the Cancer Research Institute (N.A.N.) and the US National Institutes of Health (N.S.).	ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Bouwer HGA, 2001, INFECT IMMUN, V69, P2286, DOI 10.1128/IAI.69.4.2286-2292.2001; Cho H, 2011, P NATL ACAD SCI USA, V108, P13241, DOI 10.1073/pnas.1105118108; Cho HS, 2011, J IMMUNOL, V186, P489, DOI 10.4049/jimmunol.1002639; Cifaldi L, 2011, CANCER RES, V71, P1597, DOI 10.1158/0008-5472.CAN-10-3326; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Fruci D, 2008, J CELL PHYSIOL, V216, P742, DOI 10.1002/jcp.21454; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kim S, 2011, NAT IMMUNOL, V12, P984, DOI 10.1038/ni.2097; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lu LR, 2006, IMMUNOL REV, V212, P51, DOI 10.1111/j.0105-2896.2006.00418.x; Mach N, 2000, CANCER RES, V60, P3239; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Oliveira CC, 2010, J EXP MED, V207, P207, DOI 10.1084/jem.20091429; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Petroziello J, 2004, ONCOGENE, V23, P7734, DOI 10.1038/sj.onc.1207921; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yamagata T, 2006, IMMUNOL REV, V210, P52, DOI 10.1111/j.0105-2896.2006.00371.x; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	44	56	57	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					579	+		10.1038/ni.2282	http://dx.doi.org/10.1038/ni.2282			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22522492	Green Accepted			2022-12-18	WOS:000304203900012
J	Shen, XZ; Billet, S; Lin, CT; Okwan-Duodu, D; Chen, X; Lukacher, AE; Bernstein, KE				Shen, Xiao Z.; Billet, Sandrine; Lin, Chentao; Okwan-Duodu, Derick; Chen, Xu; Lukacher, Aron E.; Bernstein, Kenneth E.			The carboxypeptidase ACE shapes the MHC class I peptide repertoire	NATURE IMMUNOLOGY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; DISTINCT PROTEOLYTIC PROCESSES; ENDOPLASMIC-RETICULUM; TRIMS PRECURSORS; DENDRITIC CELLS; ANTIGEN; COMPLEX; EXPRESSION; MOLECULES; MICE	The surface presentation of peptides by major histocompatibility complex (MHC) class I molecules is critical to CD8(+) T cell-mediated adaptive immune responses. Aminopeptidases have been linked to the editing of peptides for MHC class I loading, but carboxy-terminal editing is thought to be due to proteasome cleavage. By analysis of wild-type mice and mice genetically deficient in or overexpressing the dipeptidase angiotensin-converting enzyme (ACE), we have now identified ACE as having a physiological role in the processing of peptides for MHC class I. ACE edited the carboxyl terminus of proteasome-produced MHC class I peptides. The lack of ACE exposed new antigens but also abrogated some self antigens. ACE had substantial effects on the surface expression of MHC class I in a haplotype-dependent manner. We propose a revised model of peptide processing for MHC class I by introducing carboxypeptidase activity into the process.	[Shen, Xiao Z.; Billet, Sandrine; Lin, Chentao; Okwan-Duodu, Derick; Chen, Xu; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Lukacher, Aron E.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Emory University; Cedars Sinai Medical Center	Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.	kbernst@cshs.org		Bernstein, Kenneth/0000-0001-8097-3272	US National Institutes of Health [R01 DK 039777, R01 CA 71971]; NATIONAL CANCER INSTITUTE [R01CA071971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039777] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Fuchs and E. Bernstein for vector construction; D. Roopenian and G. Christianson (Jackson Laboratories) for the minor histocompatibility CTL clones and assistance with cultures; G. Khitrov for assistance in liquid chromatography-mass spectrometry; G.E. Hammer for technical assistance with immunization; Q. Xu for assistance with RT-PCR; S. McLachlan (Cedars-Sinai Medical Center) for A20 cells; C. Ried (University of Munich) for Cd11c promoter DNA; R. Germain (US National Institutes of Health) for antibody 25D-1.16; R. Ahmed (Emory University) for L. monocytogenes strain EGD; and B. Taylor for administrative support. Supported by the US National Institutes of Health (R01 DK 039777 to K.E.B. and R01 CA 71971 to A.E.L.).	Andrews NP, 2008, J VIROL, V82, P4697, DOI 10.1128/JVI.02698-07; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; CUSHMAN DW, 1977, BIOCHEMISTRY-US, V16, P5484, DOI 10.1021/bi00644a014; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; Esther CR, 1996, LAB INVEST, V74, P953; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kemball CC, 2005, J IMMUNOL, V174, P7950, DOI 10.4049/jimmunol.174.12.7950; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; KOZLOWSKI S, 1992, J EXP MED, V175, P1417, DOI 10.1084/jem.175.6.1417; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Lauterbach H, 2006, J IMMUNOL, V176, P4600, DOI 10.4049/jimmunol.176.8.4600; Mo XY, 1999, J IMMUNOL, V163, P5851; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Purcell AW, 2008, CURR OPIN IMMUNOL, V20, P75, DOI 10.1016/j.coi.2007.12.005; Rammensee HG, 2006, IMMUNITY, V25, P693, DOI 10.1016/j.immuni.2006.10.008; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Saijonmaa O, 2007, AM J PHYSIOL-HEART C, V292, pH1917, DOI 10.1152/ajpheart.00920.2006; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; Skidgel R A, 1989, Adv Exp Med Biol, V247A, P25; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005	42	56	57	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1078	U83		10.1038/ni.2107	http://dx.doi.org/10.1038/ni.2107			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21964607	Green Accepted			2022-12-18	WOS:000296500100013
J	Schlimgen, RJ; Reddy, KL; Singh, H; Krangel, MS				Schlimgen, Ryan J.; Reddy, Karen L.; Singh, Harinder; Krangel, Michael S.			Initiation of allelic exclusion by stochastic interaction of Tcrb alleles with repressive nuclear compartments	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; V(D)J RECOMBINATION; CENTROMERIC HETEROCHROMATIN; GENE REARRANGEMENTS; B-CELL; BETA; ORGANIZATION; CHROMATIN; DIFFERENTIATION	Studies of antigen-receptor loci have linked directed monoallelic association with pericentromeric heterochromatin to the initiation or maintenance of allelic exclusion. Here we provide evidence for a fundamentally different basis for T cell antigen receptor-beta (Tcrb) allelic exclusion. Using three-dimensional immunofluorescence in situ hybridization, we found that germline Tcrb alleles associated stochastically and at high frequency with the nuclear lamina or with pericentromeric heterochromatin in developing thymocytes and that such interactions inhibited variable-to-diversity-joining (V-beta-to-D(beta)J(beta)) recombination before beta-selection. The introduction of an ectopic enhancer into Tcrb resulted in fewer such interactions and impaired allelic exclusion. We propose that initial V-beta-to-D(beta)J(beta) recombination events are generally monoallelic in developing thymocytes because of frequent stochastic, rather than directed, interactions of Tcrb alleles with repressive nuclear compartments. Such interactions may be essential for Tcrb allelic exclusion.	[Schlimgen, Ryan J.; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Reddy, Karen L.; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Duke University; Howard Hughes Medical Institute; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hsingh@midway.uchicago.edu; krang001@mc.duke.edu		Reddy, Karen/0000-0003-4548-5999	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041052, R37GM041052] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI049934, AI49934, R01 AI049934-08] Funding Source: Medline; NIGMS NIH HHS [GM41052, R01 GM041052, R37 GM041052-19, R37 GM041052] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Brown CR, 2006, NAT CELL BIOL, V8, P430, DOI 10.1038/ncb0506-430; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Jackson AM, 2006, J IMMUNOL, V176, P6824, DOI 10.4049/jimmunol.176.11.6824; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Khor B, 2005, EUR J IMMUNOL, V35, P964, DOI 10.1002/eji.200425806; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Schlissel M, 2002, SEMIN IMMUNOL, V14, P207, DOI 10.1016/S1044-5323(02)00044-1; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; SMITHSON G, 1995, J IMMUNOL, V155, P3409; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	46	56	57	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					802	809		10.1038/ni.1624	http://dx.doi.org/10.1038/ni.1624			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18536719	Green Accepted			2022-12-18	WOS:000256904900019
J	Lu, MF; Zhang, M; Takashima, A; Weiss, J; Apicella, MA; Li, XH; Yuan, D; Munford, RS				Lu, MF; Zhang, M; Takashima, A; Weiss, J; Apicella, MA; Li, XH; Yuan, D; Munford, RS			Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria	NATURE IMMUNOLOGY			English	Article							PERITONEAL INFLAMMATORY EXUDATE; ACYLOXYACYL HYDROLASE; NEISSERIAL PORINS; IMMUNE-RESPONSES; EXTRACELLULAR COMPONENTS; POLYCLONAL ACTIVATION; ENDOTOXIN EXPOSURE; C57BL/10SCCR MICE; GENETIC-CONTROL; IN-VIVO	T cell - independent type 1 agonists such as Gram-negative bacterial lipopolysaccharides can stimulate B lymphocytes to proliferate and produce antibodies by signaling through Toll-like receptors. This phenomenon is well established in vitro, yet polyclonal B cell responses after bacterial infection in vivo are often weak and short-lived. We show here that B cell proliferation and polyclonal antibody production in response to Gram-negative bacterial infection are modulated by acyloxyacyl hydrolase, a host enzyme that deacylates bacterial lipopolysaccharides. Deacylation of lipopolysaccharide occurred over several days, allowing lipopolysaccharide to act as an innate immune stimulant yet limiting the eventual amount of B cell proliferation and polyclonal antibody production. Control of lipopolysaccharide activation by acyloxyacyl hydrolase indicates that mammals can regulate immune responses to bacterial infection by chemical modification of a Toll-like receptor agonist.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Dermatol, Dallas, TX 75390 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Iowa; University of Iowa; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Munford, RS (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.munford@utsouthwestern.edu	Yuan, D/G-3424-2010	Weiss, Jerrold/0000-0003-1476-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R37AI018188, R56AI018188, R01AI018188] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18188, AI44642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bhasin N, 2001, INFECT IMMUN, V69, P5031, DOI 10.1128/IAI.69.8.5031-5036.2001; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Cody MJ, 1997, J ENDOTOXIN RES, V4, P371, DOI 10.1177/096805199700400509; COUTINHO A, 1974, J EXP MED, V139, P74, DOI 10.1084/jem.139.1.74; COUTINHO A, 1975, J EXP MED, V142, P253, DOI 10.1084/jem.142.1.253; Cross AS, 2002, J ENDOTOXIN RES, V8, P83, DOI 10.1179/096805102125000227; Douwes J, 2002, THORAX, V57, P86, DOI 10.1136/thorax.57.1.86; DZIARSKI R, 1982, J IMMUNOL, V128, P1026; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; DZIARSKI R, 1982, INFECT IMMUN, V35, P507, DOI 10.1128/IAI.35.2.507-514.1982; ERWIN AL, 1991, INFECT IMMUN, V59, P1881, DOI 10.1128/IAI.59.6.1881-1887.1991; ERWIN AL, 1990, J BIOL CHEM, V265, P16444; Feulner JA, 2004, INFECT IMMUN, V72, P3171, DOI 10.1128/IAI.72.6.3171-3178.2004; Forestier C, 1999, INFECT IMMUN, V67, P4048, DOI 10.1128/IAI.67.8.4048-4054.1999; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Heyman B, 2003, IMMUNOL LETT, V88, P157, DOI 10.1016/S0165-2478(03)00078-6; Katz SS, 1999, J BIOL CHEM, V274, P36579, DOI 10.1074/jbc.274.51.36579; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Lu MF, 2003, J EXP MED, V197, P1745, DOI 10.1084/jem.20030420; LUCHI M, 1993, J IMMUNOL, V151, P959; Manthey CL, 1994, J ENDOTOXIN RES, V1, P84; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; MUNFORD RS, 1992, METHOD ENZYMOL, V209, P485; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nagai Y, 2005, J IMMUNOL, V174, P7043, DOI 10.4049/jimmunol.174.11.7043; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Poltorak A, 2000, J ENDOTOXIN RES, V6, P51, DOI 10.1177/09680519000060010701; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Saito H, 2004, HEPATOL RES, V30, P193, DOI 10.1016/j.hepres.2004.08.016; Snapper CM, 1997, INFECT IMMUN, V65, P3203, DOI 10.1128/IAI.65.8.3203-3208.1997; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Uhr J W, 1968, Adv Immunol, V8, P81, DOI 10.1016/S0065-2776(08)60465-4; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; WATSON J, 1974, J EXP MED, V140, P1147, DOI 10.1084/jem.140.5.1147; Weinrauch Y, 1999, INFECT IMMUN, V67, P3376, DOI 10.1128/IAI.67.7.3376-3382.1999; Wilder JA, 1996, J IMMUNOL, V156, P146; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005	50	56	59	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					989	994		10.1038/ni1246	http://dx.doi.org/10.1038/ni1246			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16155573				2022-12-18	WOS:000232027200017
J	Cherry, LK; Li, XY; Schwab, P; Lim, B; Klickstein, LB				Cherry, LK; Li, XY; Schwab, P; Lim, B; Klickstein, LB			RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes	NATURE IMMUNOLOGY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; TRANSGENIC MICE; CELL-ADHESION; ACTIVATION; LIGAND; CHEMOKINES; RECEPTOR; ANTIBODY; DISTINCT; PROTEIN	Lymphocyte function-associated antigen 1 (LFA-1) is relatively nonadhesive on resting lymphocytes; however, the mechanisms underlying changes in its adhesiveness are poorly understood. In this study, we generated a Jurkat T cell clone, J+hi1.14, that contained low amounts of mRNA for RhoH, a leukocyte-specific inhibitory Rho family member. J+hi1.14 cells expressed constitutively adhesive LFA-1 and the cells bound spontaneously to intracellular adhesion molecules 1, 2 and 3. Reconstitution of RhoH mRNA expression in J+hi1.14 cells reverted the adhesion phenotype to that of wild-type. We obtained similar results using RNA interference in peripheral blood lymphocytes. These data demonstrate that RhoH is required for maintenance of lymphocyte LFA-1 in a nonadhesive state.	Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Klickstein, LB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg Room 650,1 Jimmy Fund Way, Boston, MA 02115 USA.	lklickstein@rics.bwh.Harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008632, R01AR047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR47243, F32AR08632] Funding Source: Medline; NIDDK NIH HHS [R01DK047636] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; CHANG W, 1993, VIROLOGY, V193, P737, DOI 10.1006/viro.1993.1182; CHANGELIAN PS, 1985, J IMMUNOL, V134, P1851; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Cherry LK, 2001, J IMMUNOL, V167, P6171, DOI 10.4049/jimmunol.167.11.6171; DALLERY E, 1995, ONCOGENE, V10, P2171; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; LARSON RS, 1990, CELL REGUL, V1, P359, DOI 10.1091/mbc.1.4.359; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Liu L, 2002, J IMMUNOL, V169, P2330, DOI 10.4049/jimmunol.169.5.2330; Liu Z, 2002, EUR PHYS J A, V13, P277, DOI 10.1007/s10050-002-8755-8; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Otabor I, 2004, MOL IMMUNOL, V41, P185, DOI 10.1016/j.molimm.2004.03.029; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SORIANO P, 1986, SCIENCE, V234, P1409, DOI 10.1126/science.3024318; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Szabo MC, 1997, EUR J IMMUNOL, V27, P1061, DOI 10.1002/eji.1830270504; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Weber KSC, 1997, J IMMUNOL, V158, P273; Weber KSC, 1998, EUR J IMMUNOL, V28, P2245, DOI 10.1002/(SICI)1521-4141(199807)28:07<2245::AID-IMMU2245>3.0.CO;2-V; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074	47	56	59	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					961	967		10.1038/ni1103	http://dx.doi.org/10.1038/ni1103			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15300248				2022-12-18	WOS:000223612500025
J	Perfettini, JL; Kroemer, G				Perfettini, JL; Kroemer, G			Caspase activation is not death	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR-NECROSIS-FACTOR; INHIBITION; RECEPTOR; DOMAIN; CELLS	Is apoptotic cell death due to the action of caspases? Caspase inhibition can actually encourage death in tumor necrosis factor-induced shock, indicating that caspase activation is not synonymous with apoptotic demise.	Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Perfettini, JL (corresponding author), Inst Gustave Roussy, CNRS, UMR 8125, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@igr.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; PERFETTINI, Jean-Luc/N-4699-2017	KROEMER, Guido/0000-0002-9334-4405; PERFETTINI, Jean-Luc/0000-0002-2427-2604				Boone E, 2000, J BIOL CHEM, V275, P37596, DOI 10.1074/jbc.M007166200; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Horvitz HR, 1999, CANCER RES, V59, p1701S; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477	11	56	58	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					308	310		10.1038/ni0403-308	http://dx.doi.org/10.1038/ni0403-308			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660728				2022-12-18	WOS:000181987700007
J	Hensel, N; Gu, ZG; Sagar; Wieland, D; Jechow, K; Kemming, J; Llewellyn-Lacey, S; Gosticle, E; Sogukpinar, O; Emmerich, F; Price, DA; Bengsch, B; Boettler, T; Neumann-Haefelin, C; Eils, R; Conrad, C; Bartenschlager, R; Grun, D; Ishaque, N; Thimme, R; Hofmann, M				Hensel, Nina; Gu, Zuguang; Sagar; Wieland, Dominik; Jechow, Katharina; Kemming, Janine; Llewellyn-Lacey, Sian; Gosticle, Emma; Sogukpinar, Oezlem; Emmerich, Florian; Price, David A.; Bengsch, Bertram; Boettler, Tobias; Neumann-Haefelin, Christoph; Eils, Roland; Conrad, Christian; Bartenschlager, Ralf; Gruen, Dominic; Ishaque, Naveed; Thimme, Robert; Hofmann, Maike			Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection	NATURE IMMUNOLOGY			English	Article							VIRUS PERSISTENCE; PD-1 EXPRESSION; EXHAUSTION; DIFFERENTIATION; DYSFUNCTION; RESTORATION; ALIGNMENT; SUBSETS	In chronic hepatitis C virus (HCV) infection, exhausted HCV-specific CD8(+) T cells comprise memory-like and terminally exhausted subsets. However, little is known about the molecular profile and fate of these two subsets after the elimination of chronic antigen stimulation by direct-acting antiviral (DAA) therapy. Here, we report a progenitor-progeny relationship between memory-like and terminally exhausted HCV-specific CD8(+) T cells via an intermediate subset. Single-cell transcriptomics implicated that memory-like cells are maintained and terminally exhausted cells are lost after DAA-mediated cure, resulting in a memory polarization of the overall HCV-specific CD8(+) T cell response. However, an exhausted core signature of memory-like CD8(+) T cells was still detectable, including, to a smaller extent, in HCV-specific CD8(+) T cells targeting variant epitopes. These results identify a molecular signature of T cell exhaustion that is maintained as a chronic scar in HCV-specific CD8(+) T cells even after the cessation of chronic antigen stimulation. Thimme and colleagues identify a molecular signature of T cell exhaustion resembling a 'chronic scar' that is imprinted in hepatitis C virus-specific CD8(+) T cells and cannot simply be reversed by viral clearance.	[Hensel, Nina; Sagar; Wieland, Dominik; Kemming, Janine; Sogukpinar, Oezlem; Bengsch, Bertram; Boettler, Tobias; Neumann-Haefelin, Christoph; Thimme, Robert; Hofmann, Maike] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany; [Hensel, Nina; Wieland, Dominik; Kemming, Janine; Sogukpinar, Oezlem; Emmerich, Florian; Bengsch, Bertram; Boettler, Tobias; Neumann-Haefelin, Christoph; Thimme, Robert; Hofmann, Maike] Univ Freiburg, Fac Med, Freiburg, Germany; [Hensel, Nina; Kemming, Janine] Univ Freiburg, Fac Biol, Freiburg, Germany; [Gu, Zuguang] German Canc Res Ctr, Heidelberg Ctr Personalised Oncol DKFZ HIPO, Heidelberg, Germany; [Sagar; Gruen, Dominic] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Jechow, Katharina; Eils, Roland; Conrad, Christian; Ishaque, Naveed] Charite Univ Med Berlin, Berlin, Germany; [Jechow, Katharina; Eils, Roland; Conrad, Christian; Ishaque, Naveed] Berlin Inst Hlth, Digital Hlth Ctr, Berlin, Germany; [Llewellyn-Lacey, Sian; Gosticle, Emma; Price, David A.] Cardiff Univ, Div Infect & Immun, Sch Med, Cardiff, Wales; [Emmerich, Florian] Univ Freiburg, Univ Med Ctr, Inst Transfus Med & Gene Therapy, Freiburg, Germany; [Price, David A.] Cardiff Univ, Syst Immun Res Inst, Sch Med, Cardiff, Wales; [Bengsch, Bertram; Gruen, Dominic] Univ Freiburg, Signalling Res Ctr BIOSS & CIBSS, Freiburg, Germany; [Eils, Roland] Heidelberg Univ, Fac Med, Hlth Data Sci Unit, Heidelberg, Germany; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany; [Bartenschlager, Ralf] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Cardiff University; University of Freiburg; Cardiff University; University of Freiburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); German Center for Infection Research	Thimme, R; Hofmann, M (corresponding author), Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany.; Thimme, R; Hofmann, M (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	robert.thimme@uniklinik-freiburg.de; maike.hofmann@uniklinik-freiburg.de	Boettler, Tobias/E-3331-2012; Eils, Roland/B-6121-2009; Bengsch, Bertram/ABF-2142-2020; Ishaque, Naveed/AAF-3454-2020; Price, David A/C-7876-2013; Gu, Zuguang/C-5914-2009; Neumann-Haefelin, Christoph/E-5550-2011	Boettler, Tobias/0000-0002-1195-055X; Eils, Roland/0000-0002-0034-4036; Bengsch, Bertram/0000-0003-2552-740X; Ishaque, Naveed/0000-0002-8426-901X; Price, David A/0000-0001-9416-2737; Neumann-Haefelin, Christoph/0000-0001-7351-1387; Kemming, Janine/0000-0002-7967-9313; Gu, Zuguang/0000-0002-7395-8709; Conrad, Christian/0000-0001-7036-342X	German Research Foundation (DFG) [01, 02, 04, 09, 20, 21, Z2, 272983813]; Margarete von Wrangell fellowship; Max Planck Society; Behrens-Weise-Foundation; DFG [GR4980/3-1]; Wellcome Trust Senior Investigator Award [100326/Z/12/Z]	German Research Foundation (DFG)(German Research Foundation (DFG)); Margarete von Wrangell fellowship; Max Planck Society(Max Planck SocietyFoundation CELLEX); Behrens-Weise-Foundation; DFG(German Research Foundation (DFG)); Wellcome Trust Senior Investigator Award(Wellcome Trust)	We thank all participants in the current study and H. Pircher, I. Schulien, K. Heim, V. Oberhardt and T. Gross for critical reading of the manuscript. The work presented here was supported by the CRC/TRR 179-Project (no. 01 to R.T., no. 02 to C.N.-H., no. 04 to T.B., no. 09 to R.B., no. 20 to M.H., no. 21 to B.B. and no. Z2 to R.E. of the German Research Foundation (DFG; TRR179 project no. 272983813). M.H. was supported by a Margarete von Wrangell fellowship. D.G. was supported by the Max Planck Society, the Behrens-Weise-Foundation and the DFG (no. GR4980/3-1). D.A.P. was supported by a Wellcome Trust Senior Investigator Award (no. 100326/Z/12/Z).	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Aregay A, 2019, J HEPATOL, V71, P889, DOI 10.1016/j.jhep.2019.06.025; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barili V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14137-7; Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fisicaro P, 2017, NAT MED, V23, P327, DOI 10.1038/nm.4275; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim HD, 2018, GASTROENTEROLOGY, V155, P1936, DOI 10.1053/j.gastro.2018.08.030; Kurktschiev PD, 2014, J EXP MED, V211, P2047, DOI 10.1084/jem.20131333; Langfelder P, 2012, J STAT SOFTW, V46, P1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wolski D, 2017, IMMUNITY, V47, P648, DOI 10.1016/j.immuni.2017.09.006; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	55	55	55	3	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					229	U246		10.1038/s41590-020-00817-w	http://dx.doi.org/10.1038/s41590-020-00817-w		JAN 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398179				2022-12-18	WOS:000604865800006
J	Povoleri, GAM; Nova-Lamperti, E; Scotta, C; Fanelli, G; Chen, YC; Becker, PD; Boardman, D; Costantini, B; Romano, M; Pavlidis, P; McGregor, R; Pantazi, E; Chauss, D; Sun, HW; Shih, HY; Cousins, DJ; Cooper, N; Powell, N; Kemper, C; Pirooznia, M; Laurence, A; Kordasti, S; Kazemian, M; Lombardi, G; Afzali, B				Povoleri, Giovanni A. M.; Nova-Lamperti, Estefania; Scotta, Cristiano; Fanelli, Giorgia; Chen, Yun-Ching; Becker, Pablo D.; Boardman, Dominic; Costantini, Benedetta; Romano, Marco; Pavlidis, Polychronis; McGregor, Reuben; Pantazi, Eirini; Chauss, Daniel; Sun, Hong-Wei; Shih, Han-Yu; Cousins, David J.; Cooper, Nichola; Powell, Nick; Kemper, Claudia; Pirooznia, Mehdi; Laurence, Arian; Kordasti, Shahram; Kazemian, Majid; Lombardi, Giovanna; Afzali, Behdad			Human retinoic acid-regulated CD161(+) regulatory T cells support wound repair in intestinal mucosa	NATURE IMMUNOLOGY			English	Article							HUMAN NKR-P1A; FOXP3 GENE; IN-VITRO; EXPRESSION; INNATE; SUBSETS; HOMEOSTASIS; INDUCTION; SIGNATURE; EXPANSION	Repair of tissue damaged during inflammatory processes is key to the return of local homeostasis and restoration of epithelial integrity. Here we describe CD161(+) regulatory T (T-reg) cells as a distinct, highly suppressive population of T-reg cells that mediate wound healing. These Treg cells were enriched in intestinal lamina propria, particularly in Crohn's disease. CD161(+) T-reg cells had an all-trans retinoic acid (ATRA)-regulated gene signature, and CD161 expression on T-reg cells was induced by ATRA, which directly regulated the CD161 gene. CD161 was co-stimulatory, and ligation with the T cell antigen receptor induced cytokines that accelerated the wound healing of intestinal epithelial cells. We identified a transcription-factor network, including BACH2, ROR gamma t, FOSL2, AP-1 and RUNX1, that controlled expression of the wound-healing program, and found a CD161(+) T-reg cell signature in Crohn's disease mucosa associated with reduced inflammation. These findings identify CD161(+) T-reg cells as a population involved in controlling the balance between inflammation and epithelial barrier healing in the gut.	[Povoleri, Giovanni A. M.; Nova-Lamperti, Estefania; Scotta, Cristiano; Fanelli, Giorgia; Becker, Pablo D.; Boardman, Dominic; Romano, Marco; Pavlidis, Polychronis; McGregor, Reuben; Pantazi, Eirini; Powell, Nick; Lombardi, Giovanna; Afzali, Behdad] Kings Coll London, Ctr Transplantat, MRC, London, England; [Povoleri, Giovanni A. M.; Nova-Lamperti, Estefania; Scotta, Cristiano; Fanelli, Giorgia; Becker, Pablo D.; Boardman, Dominic; Romano, Marco; Pavlidis, Polychronis; McGregor, Reuben; Pantazi, Eirini; Lombardi, Giovanna] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth, Biomed Res Ctr, London, England; [Povoleri, Giovanni A. M.; Nova-Lamperti, Estefania; Scotta, Cristiano; Fanelli, Giorgia; Becker, Pablo D.; Boardman, Dominic; Romano, Marco; Pavlidis, Polychronis; McGregor, Reuben; Pantazi, Eirini; Powell, Nick; Lombardi, Giovanna] Kings Coll London, London, England; [Chen, Yun-Ching; Pirooznia, Mehdi] NHLBI, Bioinformat & Computat Biol Core, NIH, Bldg 10, Bethesda, MD 20892 USA; [Costantini, Benedetta; Kordasti, Shahram] Kings Coll London, Sch Canc & Pharmaceut Sci, Comprehens Canc Ctr, London, England; [Chauss, Daniel; Afzali, Behdad] Natl Inst Diabet & Digest & Kidney Dis, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Shih, Han-Yu] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Cousins, David J.] Univ Leicester, NIHR Leicester Resp Biomed Res Unit, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Cooper, Nichola] Imperial Coll London, Dept Med, London, England; [Kemper, Claudia] NHLBI, Complement & Inflammat Res Sect, NIH, Bldg 10, Bethesda, MD 20892 USA; [Laurence, Arian] Newcastle Univ, Inst Cellular Med, Newcastle, NSW, Australia; [Kazemian, Majid] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Kazemian, Majid] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Afzali, Behdad] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Leicester; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Newcastle; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Afzali, B (corresponding author), Kings Coll London, Ctr Transplantat, MRC, London, England.; Afzali, B (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD USA.; Afzali, B (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	behdad.afzali@nih.gov	Pirooznia, Mehdi/AAG-1878-2019; McGregor, Reuben/AAZ-6168-2021; Boardman, Dominic/AAZ-4264-2020; Afzali, Behdad/H-8565-2013; Kordasti, Shahram/W-3826-2017; Laurence, Arian/A-8770-2009	Pirooznia, Mehdi/0000-0002-4210-6458; Boardman, Dominic/0000-0001-7387-8293; Afzali, Behdad/0000-0003-2968-1156; Kordasti, Shahram/0000-0002-0347-4207; Chauss, Daniel/0000-0002-8343-0860; Pavlidis, Polychronis/0000-0003-4864-2208; Laurence, Arian/0000-0003-0942-8292; Povoleri, Giovanni/0000-0003-0342-651X; Romano, Marco/0000-0001-6089-5828; Cousins, David/0000-0003-3821-9596; Powell, Nick/0000-0003-3231-6950; fanelli, giorgia/0000-0002-2003-529X; Scotta, Cristiano/0000-0003-3942-5201; Shih, Han-Yu/0000-0002-7525-5433; Kemper, Claudia/0000-0003-4196-1417; Pantazi, Eirini/0000-0001-8309-0440; Becker, Pablo Daniel/0000-0003-1980-1230	Wellcome Trust [097261/Z/11/Z, WT101159]; Crohn's and Colitis Foundation of America [3765 - CCFA]; British Heart Foundation [RG/13/12/30395]; Purdue University; National Heart, Lung, and Blood Institute [5K22HL125593-02]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute of the National Institutes of Health; Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL125593, ZIAHL006223, ZICHL006228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075149] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Crohn's and Colitis Foundation of America; British Heart Foundation(British Heart Foundation); Purdue University; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust(National Institute for Health Research (NIHR)); King's College London; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank patients who contributed samples toward this study. This work was supported by the Wellcome Trust (grant 097261/Z/11/Z to B.A. and WT101159 to N.P.), the Crohn's and Colitis Foundation of America (grant CCFA no. 3765 - CCFA genetics initiative to A.L.), British Heart Foundation (grant RG/13/12/30395 to G.L.), institutional start-up fund from Purdue University and National Heart, Lung, and Blood Institute (grant 5K22HL125593-02 to M.K.). Research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This research was supported (in part) by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung, and Blood Institute of the National Institutes of Health. The authors thank J. O'Shea (National Institutes of Health) for his support and for providing access to ATAC-seq, the National Heart, Lung, and Blood Institute DNA Sequencing and Genomics Core for performing single-cell sequencing experiment and acknowledge the assistance of M. Arno (Genomics Centre, King's College London) with gene expression microarray studies as well as S. Heck and R. Ellis (Biomedical Research Centre Flow Core Facility, King's College London) for CyTOF data acquisition. In addition, the authors thank E. Mathe (Ohio State University) for critically reading the manuscript.	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Afzali B, 2013, CLIN J AM SOC NEPHRO, V8, P1396, DOI 10.2215/CJN.12931212; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Edozie FC, 2014, TRANSPLANTATION, V98, P370, DOI 10.1097/TP.0000000000000243; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Gong WM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2226-y; Hasler R, 2017, GUT, V66, P2087, DOI 10.1136/gutjnl-2016-311651; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong SN, 2017, INFLAMM BOWEL DIS, V23, P1098, DOI 10.1097/MIB.0000000000001066; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Kim BS, 2017, CELL REP, V21, P195, DOI 10.1016/j.celrep.2017.09.021; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Kordasti S, 2016, BLOOD, V128, P1193, DOI 10.1182/blood-2016-03-703702; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Peake MA, 2014, WOUND REPAIR REGEN, V22, P399, DOI 10.1111/wrr.12170; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Povoleri GAM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00169; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Venturi V, 2008, J IMMUNOL METHODS, V329, P67, DOI 10.1016/j.jim.2007.09.016; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wolfkamp SCS, 2012, EUR J GASTROEN HEPAT, V24, P965, DOI 10.1097/MEG.0b013e328354f3d5; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	75	55	59	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1403	+		10.1038/s41590-018-0230-z	http://dx.doi.org/10.1038/s41590-018-0230-z			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30397350	Green Submitted, Green Accepted			2022-12-18	WOS:000452873000020
J	Rossboth, B; Arnold, AM; Ta, H; Platzer, R; Kellner, F; Huppa, JB; Brameshuber, M; Baumgart, F; Schutz, GJ				Rossboth, Benedikt; Arnold, Andreas M.; Ta, Haisen; Platzer, Rene; Kellner, Florian; Huppa, Johannes B.; Brameshuber, Mario; Baumgart, Florian; Schuetz, Gerhard J.			TCRs are randomly distributed on the plasma membrane of resting antigen-experienced T cells	NATURE IMMUNOLOGY			English	Article							PAIR CORRELATION-ANALYSIS; PEPTIDE-MHC; LOCALIZATION MICROSCOPY; FLUORESCENT-PROBES; RECEPTOR; ORGANIZATION; DISCRIMINATION; SENSITIVITY; INITIATION; MOLECULES	The main function of T cells is to identify harmful antigens as quickly and precisely as possible. Super-resolution microscopy data have indicated that global clustering of T cell antigen receptors (TCRs) occurs before T cell activation. Such pre-activation clustering has been interpreted as representing a potential regulatory mechanism that fine tunes the T cell response. We found here that apparent TCR nanoclustering could be attributed to overcounting artifacts inherent to single-molecule-localization microscopy. Using complementary super-resolution approaches and statistical image analysis, we found no indication of global nanoclustering of TCRs on antigen-experienced CD4(+) T cells under non-activating conditions. We also used extensive simulations of super-resolution images to provide quantitative limits for the degree of randomness of the TCR distribution. Together our results suggest that the distribution of TCRs on the plasma membrane is optimized for fast recognition of antigen in the first phase of T cell activation.	[Rossboth, Benedikt; Arnold, Andreas M.; Brameshuber, Mario; Baumgart, Florian; Schuetz, Gerhard J.] TU Wien, Inst Appl Phys, Vienna, Austria; [Ta, Haisen] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany; [Platzer, Rene; Kellner, Florian; Huppa, Johannes B.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Vienna, Austria	Technische Universitat Wien; Max Planck Society; Medical University of Vienna	Brameshuber, M; Baumgart, F; Schutz, GJ (corresponding author), TU Wien, Inst Appl Phys, Vienna, Austria.	brameshuber@iap.tuwien.ac.at; baumgart@iap.tuwien.ac.at; schuetz@iap.tuwien.ac.at	Schuetz, Gerhard/B-1243-2008; Huppa, Johannes Bernhard/AAY-9471-2021; Arnold, Andreas Maximilian/GPP-4113-2022	Schuetz, Gerhard/0000-0003-1542-1089; Huppa, Johannes Bernhard/0000-0003-2634-8198; Arnold, Andreas Maximilian/0000-0001-9236-1775; Brameshuber, Mario/0000-0001-8672-2255; Baumgart, Florian/0000-0003-1352-8632; Kellner, Florian/0000-0001-5931-3798; Rossboth, Benedikt/0000-0002-9002-9434	Austrian Science Fund (FWF) [P 26337-B21, P 25730-B21, P 30214-N36, P27941-B28, 1953-B20]; Vienna Science and Technology Fund (WWTF) [LS13-030]; Boehringer Ingelheim PhD Fellowship; DOC Fellowship from the Austrian Academy of Sciences [24793]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Boehringer Ingelheim PhD Fellowship(Boehringer Ingelheim); DOC Fellowship from the Austrian Academy of Sciences	We thank S. Hell for providing infrastructure for the STED experiments. This work was supported by the Austrian Science Fund (FWF) projects P 26337-B21, P 25730-B21, P 30214-N36 (G.J.S.), P27941-B28 (EB.) and 1953-B20 (M.B.); and by the Vienna Science and Technology Fund (WWTF) LS13-030 (J.B.H. and G.J.S.). Funding was further provided by a Boehringer Ingelheim PhD Fellowship (R.P.) and a DOC Fellowship (24793) from the Austrian Academy of Sciences (A.M.A.).	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Baumgart F, 2016, NAT METHODS, V13, P661, DOI 10.1038/nmeth.3897; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Cai E, 2017, SCIENCE, V356, DOI 10.1126/science.aal3118; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chung W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044444; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Garcia-Parajo MF, 2014, J CELL SCI, V127, P4995, DOI 10.1242/jcs.146340; GOLDSTEIN B, 1983, BIOPHYS J, V43, P121, DOI 10.1016/S0006-3495(83)84330-6; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hu YS, 2016, P NATL ACAD SCI USA, V113, P7201, DOI 10.1073/pnas.1512331113; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Jung YM, 2016, P NATL ACAD SCI USA, V113, pE5916, DOI 10.1073/pnas.1605399113; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Klotzsch E, 2013, BIOPHYS J, V104, P1670, DOI 10.1016/j.bpj.2013.03.023; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Maimon OZ, 2005, DATA MINING KNOWLEDG; Mutch SA, 2007, BIOPHYS J, V92, P2926, DOI 10.1529/biophysj.106.101428; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pageon SV, 2016, P NATL ACAD SCI USA, V113, pE5454, DOI 10.1073/pnas.1607436113; Quan TW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505017; Robertson C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.080801; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sahl SJ, 2017, NAT REV MOL CELL BIO, V18, P685, DOI 10.1038/nrm.2017.71; Santos AM, 2018, NAT IMMUNOL, V19, P203, DOI 10.1038/s41590-018-0048-8; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/NMETH.1704, 10.1038/nmeth.1704]; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Spahn C, 2016, NAT METHODS, V13, P961, DOI 10.1038/nmeth.4065; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049	50	55	56	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					821	+		10.1038/s41590-018-0162-7	http://dx.doi.org/10.1038/s41590-018-0162-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30013143	Green Accepted			2022-12-18	WOS:000439470900019
J	Gallegos, AM; Xiong, HZ; Leiner, IM; Susac, B; Glickman, MS; Pamer, EG; van Heijst, JWJ				Gallegos, Alena M.; Xiong, Huizhong; Leiner, Ingrid M.; Susac, Boze; Glickman, Michael S.; Pamer, Eric G.; van Heijst, Jeroen W. J.			Control of T cell antigen reactivity via programmed TCR downregulation	NATURE IMMUNOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; REPERTOIRE SELECTION; IN-VIVO; PEPTIDE; AFFINITY; EXPRESSION; DIFFERENTIATION; STIMULATION; COMPLEXES; INFECTION	The T cell antigen receptor (TCR) is unique in that its affinity for ligand is unknown before encounter and can vary by orders of magnitude. How the immune system regulates individual T cells that display very different reactivity to antigen remains unclear. Here we found that activated CD4(+) T cells, at the peak of clonal expansion, persistently downregulated their TCR expression in proportion to the strength of the initial antigen recognition. This programmed response increased the threshold for cytokine production and recall proliferation in a clone-specific manner and ultimately excluded clones with the highest antigen reactivity. Thus, programmed downregulation of TCR expression represents a negative feedback mechanism for constraining T cell effector function with a suitable time delay to thereby allow pathogen control while avoiding excess inflammatory damage.	[Gallegos, Alena M.; Xiong, Huizhong; Leiner, Ingrid M.; Susac, Boze; Glickman, Michael S.; Pamer, Eric G.; van Heijst, Jeroen W. J.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Glickman, Michael S.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Gallegos, Alena M.] Natl Inst Res TB, Madras, Tamil Nadu, India; [van Heijst, Jeroen W. J.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of Amsterdam	van Heijst, JWJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; van Heijst, JWJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.w.vanheijst@amc.uva.nl		Glickman, Michael S/0000-0001-7918-5164; Susac, Boze/0000-0003-4330-949X; van Heijst, Jeroen WJ/0000-0002-8879-3521	US National Institutes of Health (F32 grant) [AI074248, AI080619, P30 CA008748]; Netherlands Organisation for Scientific Research (Veni grant) [91614038]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080619, F32AI074248] Funding Source: NIH RePORTER	US National Institutes of Health (F32 grant); Netherlands Organisation for Scientific Research (Veni grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Samstein, H. Yan and S. Reddy for technical assistance. Supported by the US National Institutes of Health (F32 grant AI074248 to A.M.G.; AI080619 to M.S.G. and E.G.P.; and P30 CA008748) and the Netherlands Organisation for Scientific Research (Veni grant 91614038 to J.W.J.v.H.).	Anderton SM, 2002, NAT REV IMMUNOL, V2, P487, DOI 10.1038/nri842; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Germain RN, 2012, NAT IMMUNOL, V13, P902, DOI 10.1038/ni.2404; Hebeisen M, 2013, J CLIN INVEST, V123, P1044, DOI 10.1172/JCI65325; Hmama Z, 1998, J IMMUNOL, V161, P4882; Itoh Y, 1999, J IMMUNOL, V162, P2073; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; McCue D, 2004, J NEUROIMMUNOL, V156, P96, DOI 10.1016/j.jneuroim.2004.07.010; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Vigano S., 2012, CLIN DEV IMMUNOL, V2012, DOI DOI 10.1155/2012/153863; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	50	55	57	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					379	+		10.1038/ni.3386	http://dx.doi.org/10.1038/ni.3386			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26901151	Green Accepted			2022-12-18	WOS:000372508000011
J	Sacks, DL				Sacks, David L.			Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem	NATURE IMMUNOLOGY			English	Article							LONG-TERM IMMUNITY; T-CELL IMMUNITY; PROTECTIVE IMMUNITY; IRRADIATED SPOROZOITES; LEISHMANIA-MAJOR; MALARIA; MEMORY; IMMUNIZATION; CD8(+); MAINTENANCE		NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sacks, DL (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	dsacks@niaid.nih.gov			Intramural NIH HHS [Z01 AI000494-21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000494] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008; Khamesipour A, 2005, VACCINE, V23, P3642, DOI 10.1016/j.vaccine.2005.02.015; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Nelson RW, 2013, J IMMUNOL, V190, P2828, DOI 10.4049/jimmunol.1202183; Noazin S, 2008, VACCINE, V26, P6759, DOI 10.1016/j.vaccine.2008.09.085; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; SACKS DL, 2008, FUNDAMENTAL IMMUNOLO, P1097; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Tse SW, 2011, MEM I OSWALDO CRUZ, V106, P172, DOI 10.1590/S0074-02762011000900022; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zinkernagel RM, 2012, CELL MOL LIFE SCI, V69, P1635, DOI 10.1007/s00018-012-0972-y	25	55	55	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					403	405		10.1038/ni.2853	http://dx.doi.org/10.1038/ni.2853			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747701	Green Accepted, Bronze			2022-12-18	WOS:000334667900001
J	Kundu, M; Pathak, SK; Kumawat, K; Basu, S; Chatterjee, G; Pathak, S; Noguchi, T; Takeda, K; Ichijo, H; Thien, CBF; Langdon, WY; Basu, J				Kundu, Manikuntala; Pathak, Sushil Kumar; Kumawat, Kuldeep; Basu, Sanchita; Chatterjee, Gargi; Pathak, Shresh; Noguchi, Takuya; Takeda, Kohsuke; Ichijo, Hidenori; Thien, Christine B. F.; Langdon, Wallace Y.; Basu, Joyoti			A TNF- and c-Cbl-dependent FLIPS-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INDUCED CELL-DEATH; TYROSINE KINASE; UBIQUITIN; RECEPTOR; PHOSPHORYLATION; ACTIVATION; INHIBITOR; LIGASE	Apoptosis is central to the interaction between pathogenic mycobacteria and host macrophages. Caspase-8-dependent apoptosis of infected macrophages, which requires activation of the mitogen-activated protein (MAP) kinase p38, lowers the spread of mycobacteria. Here we establish a link between the release of tumor necrosis factor (TNF) and mycobacteria-mediated macrophage apoptosis. TNF activated a pathway involving the kinases ASK1, p38 and c-Abl. This pathway led to phosphorylation of FLIPS, which facilitated its interaction with the E3 ubiquitin ligase c-Cbl. This interaction triggered proteasomal degradation of FLIPS, which promoted activation of caspase-8 and apoptosis. Our findings identify a previously unappreciated signaling pathway needed for Mycobacterium tuberculosis-triggered macrophage cell death.	[Kundu, Manikuntala; Pathak, Sushil Kumar; Kumawat, Kuldeep; Basu, Sanchita; Chatterjee, Gargi; Pathak, Shresh; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata, India; [Noguchi, Takuya; Takeda, Kohsuke; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Thien, Christine B. F.; Langdon, Wallace Y.] Univ Western Australia, Sch Pathol, Crawley, WA, Australia; [Thien, Christine B. F.; Langdon, Wallace Y.] Univ Western Australia, Lab Med, Crawley, WA, Australia	Department of Science & Technology (India); Bose Institute; University of Tokyo; University of Western Australia; University of Western Australia	Basu, J (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	joyoti@vsnl.com	Noguchi, Takuya/T-6767-2019; PATHAK, SHRESH/I-6938-2012; Thien, Christine/GQP-0424-2022	Noguchi, Takuya/0000-0001-6187-6645; Takeda, Kohsuke/0000-0002-8359-8399; Ichijo, Hidenori/0000-0002-5005-6438; Thien, Christine/0000-0003-3884-5546; PATHAK, SHRESH/0000-0001-5275-1816	Council of Scientific and Industrial Research of the Government of India; Department of Science and Technology of the Government of India	Council of Scientific and Industrial Research of the Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology of the Government of India(Department of Science & Technology (India))	We thank R. Davis (University of Massachusetts Medical School) for Flagtagged p38 and p38(dn) and for Jnk and its dominant negative mutant; J. Han (Scripps Research Institute) for bacterial MKK6(E) and p38 constructs; and G. Superti-Furga (Austrian Academy of Science) for c-Abl and kinaseinactive c-Abl in pSGT. Supported by the Council of Scientific and Industrial Research of the Government of India (S. K. P.) and the Department of Science and Technology of the Government of India (J. B.).	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bhattacharyya A, 2003, J BIOL CHEM, V278, P26517, DOI 10.1074/jbc.M300852200; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kyo S, 2003, GENES CELLS, V8, P825, DOI 10.1046/j.1365-2443.2003.00679.x; Le Q, 1998, J IMMUNOL, V160, P3330; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Perez D, 2003, J VIROL, V77, P2651, DOI 10.1128/JVI.77.4.2651-2662.2003; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200	49	55	62	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					918	U155		10.1038/ni.1754	http://dx.doi.org/10.1038/ni.1754			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19597496				2022-12-18	WOS:000268141400022
J	Rao, A				Rao, Anjana			Signaling to gene expression: calcium, calcineurin and NFAT	NATURE IMMUNOLOGY			English	Article							ACTIVATED T-CELLS; KAPPA-B SITE; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; IMMUNOSUPPRESSIVE DRUGS; CYCLOSPORINE-A; CRAC CHANNEL; FOS; PROMOTER; TARGET		Dept Pathol, Boston, MA 02115 USA; [Rao, Anjana] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rao, A (corresponding author), Dept Pathol, Boston, MA 02115 USA.	arao@idi.harvard.edu						Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; JAIN JN, 1993, J IMMUNOL, V151, P837; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; LARSON CJ, 1992, NUCLEIC ACIDS RES, V20, P3525, DOI 10.1093/nar/20.13.3525; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; VALGEARCHER VE, 1990, J IMMUNOL, V145, P4355; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	26	55	58	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					3	5		10.1038/ni0109-3	http://dx.doi.org/10.1038/ni0109-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088731				2022-12-18	WOS:000261788800002
J	Sriskantharajah, S; Belich, MP; Papoutsopoulou, S; Janzen, J; Tybulewicz, V; Seddon, B; Ley, SC				Sriskantharajah, Srividya; Belich, Monica P.; Papoutsopoulou, Stamatia; Janzen, Julia; Tybulewicz, Victor; Seddon, Benedict; Ley, Steven C.			Proteolysis of NF-kappa B1 p105 is essential for T cell antigen receptor-induced proliferation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; SEVERE LIVER DEGENERATION; PRECURSOR P105; MICE LACKING; MAP KINASE; ACTIVATION; P50; PHOSPHORYLATION; UBIQUITINATION; DEFICIENCY	To investigate the importance of proteolysis of NF-kappa B1 p105 induced by the kinase IKK in activation of the transcription factor NF-kappa B, we generated 'Nfkb1(SSAA/SSAA)' mice, in which the IKK-target serine residues of p105 were substituted with alanine. Nfkb1(SSAA/SSAA) mice had far fewer CD4(+) regulatory and memory T cells because of cell-autonomous defects. These T cell subtypes require activation of NF-kappa B by the T cell antigen receptor for their generation, and the Nfkb1(SSAA) mutation resulted in less activation of NF-kappa B in CD4(+) T cells and proliferation of CD4(+) T cells after stimulation of the T cell antigen receptor. The Nfkb1(SSAA) mutation also blocked the ability of CD4(+) T cells to provide help to wild-type B cells during a primary antibody response. IKK-induced p105 proteolysis is therefore essential for optimal T cell antigen receptor-induced activation of NF-kappa B and mature CD4(+) T cell function.	[Sriskantharajah, Srividya; Belich, Monica P.; Papoutsopoulou, Stamatia; Janzen, Julia; Tybulewicz, Victor; Seddon, Benedict; Ley, Steven C.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Ley, SC (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	sley@nimr.mrc.ac.uk	Papoutsopoulou, Stamatia/AAK-8066-2021; Papoutsopoulou, Stamatia/K-6420-2019		UK Medical Research Council; Medical Research Council [MC_U117573801, MC_U117527252, U117532003] Funding Source: researchfish; MRC [MC_U117573801, MC_U117527252] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Tsichlis ( Tufts University) and Thomas Jefferson University for Map3k8<SUP>-/-</SUP> mice; B. Stockinger and A. O'Garra for advice and critical reading of the manuscript; H. Allen for encouragement at the start of the project; G. Kassiotis for advice on assays for T cell helper function; and the National Institute for Medical Research PhotoGraphics section, Biological Services and flow cytometry service and members of the Ley laboratory for help during the course of this work. Supported by the UK Medical Research Council.	ALGARTE M, 1995, EMBO J, V14, P5060, DOI 10.1002/j.1460-2075.1995.tb00188.x; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Greve B, 2007, J IMMUNOL, V179, P179, DOI 10.4049/jimmunol.179.1.179; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x; Orian A, 1999, MOL CELL BIOL, V19, P3664; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rudolph D, 2000, GENE DEV, V14, P854; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Schmidt-Supprian M, 2004, J IMMUNOL, V173, P1612, DOI 10.4049/jimmunol.173.3.1612; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	44	55	57	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					38	47		10.1038/ni.1685	http://dx.doi.org/10.1038/ni.1685			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19060899				2022-12-18	WOS:000261788800010
J	Erlich, Z; Shlomovitz, I; Edry-Botzer, L; Cohen, H; Frank, D; Wang, HQ; Lew, AM; Lawlor, KE; Zhan, YF; Vince, JE; Gerlic, M				Erlich, Ziv; Shlomovitz, Inbar; Edry-Botzer, Liat; Cohen, Hadar; Frank, Daniel; Wang, Hanging; Lew, Andrew M.; Lawlor, Kate E.; Zhan, Yifan; Vince, James E.; Gerlic, Motti			Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model	NATURE IMMUNOLOGY			English	Article							NLRP3 INFLAMMASOME; DENDRITIC CELLS; ACTIVATION; MONOCYTES; DIFFERENTIATION; HETEROGENEITY; IL-1-BETA; TRIGGERS; PLATFORM; LIGAND	Inflammasomes are one of the most important mechanisms for innate immune defense against microbial infection but are also known to drive various inflammatory disorders via processing and release of the cytokine IL-1 beta. As research into the regulation and effects of inflammasomes in disease has rapidly expanded, a variety of cell types, including dendritic cells (DCs), have been suggested to be inflammasome competent. Here we describe a major fault in the widely used DC-inflammasome model of bone marrow-derived dendritic cells (BMDCs) generated with the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). We found that among GM-CSF bone marrow-derived cell populations, monocyte-derived macrophages, rather than BMDCs, were responsible for inflammasome activation and IL-1 beta secretion. Therefore, GM-CSF bone marrow-derived cells should not be used to draw conclusions about DC-dependent inflammasome biology, although they remain a useful tool for analysis of inflammasome responses in monocytes-macrophages.	[Erlich, Ziv; Shlomovitz, Inbar; Edry-Botzer, Liat; Cohen, Hadar; Gerlic, Motti] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Frank, Daniel; Vince, James E.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Frank, Daniel; Lew, Andrew M.; Zhan, Yifan; Vince, James E.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Wang, Hanging] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Paediat, Guangzhou, Guangdong, Peoples R China; [Lew, Andrew M.; Zhan, Yifan] Walter & Eliza Hall Inst Med Res, Immunol Div, Parkville, Vic, Australia; [Lawlor, Kate E.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Lawlor, Kate E.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia	Tel Aviv University; Sackler Faculty of Medicine; Walter & Eliza Hall Institute; University of Melbourne; Guangzhou Medical University; Walter & Eliza Hall Institute; Hudson Institute of Medical Research; Monash University	Gerlic, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.	mgerlic@post.tau.ac.il	Gerlic, Motti/U-3484-2017	Gerlic, Motti/0000-0001-9518-1833; Zhan, Yifan/0000-0001-6974-0486; Lawlor, Kate/0000-0003-0471-6842	Israel Science Foundation (ISF) [1416/15, 818/18]; alpha-1 Foundation; Recanati Foundation (Tel Aviv University); Varda and Boaz Dotan Research Center; National Health and Medical Research Council (NHMRC) of Australia [1037321, 1105209, 1080321, 1143976]; NHMRC [1101405, 1145788, 1141466]	Israel Science Foundation (ISF)(Israel Science Foundation); alpha-1 Foundation; Recanati Foundation (Tel Aviv University); Varda and Boaz Dotan Research Center; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was performed in partial fulfillment of the requirements for a Ph.D. degree (for Z.E. and I.S.), the Sackler Faculty of Medicine, Tel Aviv University, Israel. The research of M.G. was supported by the Israel Science Foundation (ISF) (grants 1416/15 and 818/18), alpha-1 Foundation, Recanati Foundation (Tel Aviv University) and individual research grants from the Varda and Boaz Dotan Research Center. The research of Y.Z. and A. M. L. was supported by the National Health and Medical Research Council (NHMRC) of Australia (grants 1037321, 1105209, 1080321 and 1143976). This work was also made possible by NHMRC project grants 1101405 (J.E.V.) and 1145788 (J.E.V. and K. E.L.) and NHMRC Fellowship 1141466 (J.E.V.).	Alcantara-Hernandez M, 2017, IMMUNITY, V47, P1037, DOI 10.1016/j.immuni.2017.11.001; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chow KV, 2017, IMMUNOL CELL BIOL, V95, P244, DOI 10.1038/icb.2016.104; Chow KV, 2016, J IMMUNOL, V196, P624, DOI 10.4049/jimmunol.1501202; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Croker BA, 2014, CURR OPIN IMMUNOL, V26, P128, DOI 10.1016/j.coi.2013.12.002; Drutman SB, 2012, J IMMUNOL, V188, P3603, DOI 10.4049/jimmunol.1102741; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Lawlor KE, 2017, CELL REP, V20, P668, DOI 10.1016/j.celrep.2017.06.073; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mortimer L, 2016, NAT IMMUNOL, V17, P1176, DOI 10.1038/ni.3538; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Ray A, 2016, MBIO, V7, DOI 10.1128/mBio.01077-16; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Sun L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01922; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	37	54	55	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					397	+		10.1038/s41590-019-0313-5	http://dx.doi.org/10.1038/s41590-019-0313-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30742078				2022-12-18	WOS:000461904200011
J	Johanson, TM; Lun, ATL; Coughlan, HD; Tan, T; Smyth, GK; Nutt, SL; Allan, RS				Johanson, Timothy M.; Lun, Aaron T. L.; Coughlan, Hannah D.; Tan, Tania; Smyth, Gordon K.; Nutt, Stephen L.; Allan, Rhys S.			Transcription-factor-mediated supervision of global genome architecture maintains B cell identity	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DIVERSE ANTIBODY REPERTOIRE; GENE-EXPRESSION; FACTOR PAX5; T-CELLS; DIFFERENTIAL EXPRESSION; REGULATORY ELEMENTS; TOPOLOGICAL DOMAINS; MAMMALIAN GENOMES; TARGET GENES	Recent studies have elucidated cell-lineage-specific three-dimensional genome organization; however, how such specific architecture is established or maintained is unclear. We hypothesized that lineage-defining transcription factors maintain cell identity via global control of genome organization. These factors bind many genomic sites outside of the genes that they directly regulate and thus are potentially implicated in three-dimensional genome organization. Using chromosome-conformation-capture techniques, we show that the transcription factor Paired box 5 (Pax5) is critical for the establishment and maintenance of the global lineage-specific architecture of B cells. Pax5 was found to supervise genome architecture throughout B cell differentiation, until the plasmablast stage, in which Pax5 is naturally silenced and B cell-specific genome structure is lost. Crucially, Pax5 did not rely on ongoing transcription to organize the genome. These results implicate sequence-specific DNA-binding proteins in global genome organization to establish and maintain lineage fidelity.	[Johanson, Timothy M.; Lun, Aaron T. L.; Coughlan, Hannah D.; Tan, Tania; Smyth, Gordon K.; Nutt, Stephen L.; Allan, Rhys S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Johanson, Timothy M.; Lun, Aaron T. L.; Coughlan, Hannah D.; Tan, Tania; Nutt, Stephen L.; Allan, Rhys S.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Nutt, SL; Allan, RS (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Nutt, SL; Allan, RS (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.	nutt@wehi.edu.au; rallan@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Smyth, Gordon/B-5276-2008	Nutt, Stephen L/0000-0002-0020-6637; Smyth, Gordon/0000-0001-9221-2892; Allan, Rhys/0000-0003-0906-2980; Coughlan, Hannah/0000-0002-2392-9942	National Health and Medical Research Council of Australia [1054925, 1058238, 1058892, 1054618, 1049307, 1100451, 1124081]; Australian Research Council [130100541]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank T. Mason for animal husbandry and N. Iannarella for technical support. This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (S.L.N., 1054925 and 1058238; G.K.S., 1058892; A.T.L.L. and G.K.S., 1054618; R.S.A. and T.M.J., 1049307 and 1100451; T.M.J., 1124081) and the Australian Research Council (R.S.A., 130100541). This study was made possible through the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; Choukrallah MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9324; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Dang JJ, 2015, BLOOD, V125, P3609, DOI 10.1182/blood-2015-02-626127; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hu G., IMMUNITY, V48, P227; Hug CB, 2017, CELL, V169, P216, DOI 10.1016/j.cell.2017.03.024; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kato A, 2009, J IMMUNOL, V182; Ke Y., CELL, V170, P367; Kieffer-Kwon KR, 2017, MOL CELL, V67, P566, DOI 10.1016/j.molcel.2017.07.013; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lun Aaron T L, 2016, F1000Res, V5, P950, DOI 10.12688/f1000research.8759.2; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Lun ATL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0683-0; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Montefiori L, 2016, CELL REP, V14, P896, DOI 10.1016/j.celrep.2015.12.083; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Serra F., 2016, PREPRINT; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	64	54	54	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1257	+		10.1038/s41590-018-0234-8	http://dx.doi.org/10.1038/s41590-018-0234-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323344				2022-12-18	WOS:000447632200020
J	Kreslavsky, T; Vilagos, B; Tagoh, H; Poliakova, DK; Schwickert, TA; Wohner, M; Jaritz, M; Weiss, S; Taneja, R; Rossner, MJ; Busslinger, M				Kreslavsky, Taras; Vilagos, Bojan; Tagoh, Hiromi; Poliakova, Daniela Kostanova; Schwickert, Tanja A.; Woehner, Miriam; Jaritz, Markus; Weiss, Siegfried; Taneja, Reshma; Rossner, Moritz J.; Busslinger, Meinrad			Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells	NATURE IMMUNOLOGY			English	Article							CENTER B-CELL; POSITIVE SELECTION; FETAL; EXPRESSION; DISTINCT; SINGLE; MICE; IDENTIFICATION; PROLIFERATION; LYMPHOPOIESIS	Innate-like B-1a cells provide a first line of defense against pathogens, yet little is known about their transcriptional control. Here we identified an essential role for the transcription factor Bhlhe41, with a lesser contribution by Bhlhe40, in controlling B-1a cell differentiation. Bhlhe41(-/-)Bhlhe40(-/-) B-1a cells were present at much lower abundance than were their wild-type counterparts. Mutant B-1a cells exhibited an abnormal cell-surface phenotype and altered B cell receptor (BCR) repertoire exemplified by loss of the phosphatidylcholine-specific V(H)12V kappa 4 BCR. Expression of a pre-rearranged V(H)12V kappa 4 BCR failed to 'rescue' the mutant phenotype and revealed enhanced proliferation accompanied by increased cell death. Bhlhe41 directly repressed the expression of cell-cycle regulators and inhibitors of BCR signaling while enabling pro-survival cytokine signaling. Thus, Bhlhe41 controls the development, BCR repertoire and self-renewal of B-1a cells.	[Kreslavsky, Taras; Vilagos, Bojan; Tagoh, Hiromi; Poliakova, Daniela Kostanova; Schwickert, Tanja A.; Woehner, Miriam; Jaritz, Markus; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Campus Vienna Bioctr 1, Vienna, Austria; [Weiss, Siegfried] Helmholtz Ctr Infect Res, Dept Mol Immunol, Braunschweig, Germany; [Weiss, Siegfried] Sch Med, Inst Immunol, Hannover, Germany; [Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Rossner, Moritz J.] Ludwig Maximillian Univ Munich, Dept Psychiat, Munich, Germany; [Vilagos, Bojan] Austrian Acad Sci, Res Ctr Mol Med, Vienna, Austria; [Tagoh, Hiromi] Univ Oxford, Ludwig Inst Canc Res, Oxford, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Helmholtz Association; Helmholtz-Center for Infection Research; National University of Singapore; University of Munich; Austrian Academy of Sciences; Ludwig Institute for Cancer Research; University of Oxford	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Campus Vienna Bioctr 1, Vienna, Austria.	busslinger@imp.ac.at	Taneja, Reshma/F-9658-2014; Busslinger, Meinrad/J-1249-2016; Tagoh, Hiromi/B-2954-2009	Taneja, Reshma/0000-0002-2151-2094; Jaritz, Markus/0000-0002-9326-2047; Schwickert, Tanja/0000-0002-3371-2376; Kreslavsky, Taras/0000-0002-6672-1914; Reshma, Taneja/0000-0001-6214-6177; Wohner, Miriam/0000-0003-0965-5938; Busslinger, Meinrad/0000-0002-9111-9351; Tagoh, Hiromi/0000-0001-9905-6992	Boehringer Ingelheim; European Community's Seventh Framework Program (European Research Council Advanced Grant) [291740-LymphoControl]; Austrian Industrial Research Promotion Agency (Headquarter Grant) [FFG-852936]; Austrian Science Fund [P28841]; Marie Sklodowaska-Curie action of the European Community's Framework Program [PIIF-GA-2013-628065]	Boehringer Ingelheim(Boehringer Ingelheim); European Community's Seventh Framework Program (European Research Council Advanced Grant); Austrian Industrial Research Promotion Agency (Headquarter Grant); Austrian Science Fund(Austrian Science Fund (FWF)); Marie Sklodowaska-Curie action of the European Community's Framework Program	We thank S.H. Clarke and S.-R. Lee (University of North Carolina at Chapel Hill, USA) and H. Wang (National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA) for V<INF>H</INF>12- and V<INF>kappa</INF>4-transgenic mice; K. Rajewsky (Max Delbruck Center for Molecular Medicine) for anti-V<INF>H</INF>12; K. Schindler for help with signaling experiments; M. Fischer for bioinformatics analysis; C. Theussl for the generation of transgenic mice; K. Aumayr and colleagues for sorting by flow cytometry; and A. Sommer and colleagues for Illumina sequencing. Supported by Boehringer Ingelheim, the European Community's Seventh Framework Program (European Research Council Advanced Grant 291740-LymphoControl to M.B.), the Austrian Industrial Research Promotion Agency (Headquarter Grant FFG-852936 to M.B.), the Austrian Science Fund (P28841 to T.K.) and the Marie Sklodowaska-Curie action of the European Community's Framework Program (PIIF-GA-2013-628065 to T.K.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold LW, 2000, J IMMUNOL, V164, P2924, DOI 10.4049/jimmunol.164.6.2924; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Aszodi A, 2012, BIOINFORMATICS, V28, P3318, DOI 10.1093/bioinformatics/bts607; Baier PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110310; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chew V, 2007, J BIOL CHEM, V282, P27181, DOI 10.1074/jbc.M704625200; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Duber S, 2009, BLOOD, V114, P4960, DOI 10.1182/blood-2009-04-218156; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Guo BC, 2016, J IMMUNOL, V196, P2583, DOI 10.4049/jimmunol.1502132; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Holodick NE, 2009, MOL IMMUNOL, V46, P3029, DOI 10.1016/j.molimm.2009.06.011; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Humbert PO, 1997, J IMMUNOL, V159, P5273; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Kretschmer K, 2004, J IMMUNOL, V173, P197, DOI 10.4049/jimmunol.173.1.197; Kristiansen TA, 2016, IMMUNITY, V45, P346, DOI 10.1016/j.immuni.2016.07.014; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LALOR PA, 1989, EUR J IMMUNOL, V19, P507, DOI 10.1002/eji.1830190315; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pedersen GK, 2014, P NATL ACAD SCI USA, V111, pE4119, DOI 10.1073/pnas.1415866111; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Scott CL, 2000, BLOOD, V96, P1588, DOI 10.1182/blood.V96.4.1588.h8001588_1588_1590; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang HS, 2004, IMMUNOL REV, V197, P51, DOI 10.1111/j.0105-2896.2004.0098.x; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510	67	54	55	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					442	+		10.1038/ni.3694	http://dx.doi.org/10.1038/ni.3694			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28250425	Green Accepted, Green Submitted			2022-12-18	WOS:000396815800012
J	Beyer, M; Abdullah, Z; Chemnitz, JM; Maisel, D; Sander, J; Lehmann, C; Thabet, Y; Shinde, PV; Schmidleithner, L; Kohne, M; Trebicka, J; Schierwagen, R; Hofmann, A; Popov, A; Lang, KS; Oxenius, A; Buch, T; Kurts, C; Heikenwalder, M; Fatkenheuer, G; Lang, PA; Hartmann, P; Knolle, PA; Schultze, JL				Beyer, Marc; Abdullah, Zeinab; Chemnitz, Jens M.; Maisel, Daniela; Sander, Jil; Lehmann, Clara; Thabet, Yasser; Shinde, Prashant V.; Schmidleithner, Lisa; Koehne, Maren; Trebicka, Jonel; Schierwagen, Robert; Hofmann, Andrea; Popov, Alexey; Lang, Karl S.; Oxenius, Annette; Buch, Thorsten; Kurts, Christian; Heikenwalder, Mathias; Faetkenheuer, Gerd; Lang, Philipp A.; Hartmann, Pia; Knolle, Percy A.; Schultze, Joachim L.			Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NF-KAPPA-B; PERSISTENT LCMV INFECTION; FACTOR-ALPHA; TYPE-1 INFECTION; I INTERFERONS; TNF-ALPHA; EXHAUSTION; DIFFERENTIATION; ACTIVATION	Persistent viral infections are characterized by the simultaneous presence of chronic inflammation and T cell dysfunction. In prototypic models of chronicity-infection with human immunodeficiency virus (HIV) or lymphocytic choriomeningitis virus (LCMV)-we used transcriptome-based modeling to reveal that CD4(+) T cells were co-exposed not only to multiple inhibitory signals but also to tumor-necrosis factor (TNF). Blockade of TNF during chronic infection with LCMV abrogated the inhibitory gene-expression signature in CD4(+) T cells, including reduced expression of the inhibitory receptor PD-1, and reconstituted virus-specific immunity, which led to control of infection. Preventing signaling via the TNF receptor selectively in T cells sufficed to induce these effects. Targeted immunological interventions to disrupt the TNF-mediated link between chronic inflammation and T cell dysfunction might therefore lead to therapies to overcome persistent viral infection.	[Beyer, Marc; Sander, Jil; Thabet, Yasser; Schmidleithner, Lisa; Koehne, Maren; Popov, Alexey; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Bonn, Genom & Immunoregulat, Bonn, Germany; [Beyer, Marc; Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, Bonn, Germany; [Beyer, Marc; Schultze, Joachim L.] Univ Bonn, Bonn, Germany; [Abdullah, Zeinab; Kurts, Christian; Knolle, Percy A.] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany; [Chemnitz, Jens M.; Maisel, Daniela; Lehmann, Clara; Faetkenheuer, Gerd; Hartmann, Pia] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Lehmann, Clara; Faetkenheuer, Gerd; Hartmann, Pia] Partner Site Bonn Cologne, German Ctr Infect Res, Cologne, Germany; [Thabet, Yasser; Shinde, Prashant V.; Lang, Philipp A.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Trebicka, Jonel; Schierwagen, Robert] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Hofmann, Andrea] Univ Bonn, Inst Human Genet, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Lang, Karl S.] Univ Duisburg Essen, Inst Immunol, Fac Med, Essen, Germany; [Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Buch, Thorsten] Univ Zurich, Inst Lab Anim Sci, Schlieren, Switzerland; [Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Lang, Philipp A.] Univ Dusseldorf, Dept Mol Med 2, Dusseldorf, Germany; [Hartmann, Pia] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Knolle, Percy A.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-80290 Munich, Germany; [Maisel, Daniela] Roche Diagnost, Bioinformat & Exploratory Data Anal, Pharma Res & Early Dev, Penzberg, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; University of Cologne; German Center for Infection Research; University of Cologne; Heinrich Heine University Dusseldorf; University of Bonn; University of Bonn; University of Duisburg Essen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; University of Cologne; Technical University of Munich; Roche Holding	Beyer, M; Schultze, JL (corresponding author), Univ Bonn, Life & Med Sci Bonn, Genom & Immunoregulat, Bonn, Germany.; Beyer, M; Schultze, JL (corresponding author), German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, Bonn, Germany.; Beyer, M; Schultze, JL (corresponding author), Univ Bonn, Bonn, Germany.; Knolle, PA (corresponding author), Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany.; Knolle, PA (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-80290 Munich, Germany.	marc.beyer@uni-bonn.de; percy.knolle@tum.de; joachim.schultze@uni-bonn.de	Buch, Thorsten/P-1659-2019; Lehmann, Clara/F-9671-2016; Schierwagen, Robert/AAE-6305-2019; Schultze, Joachim L./ABA-8176-2020; Heikenwalder, Mathias/AAA-2269-2020; Lang, Karl S/R-2505-2016; Beyer, Marc/ABE-1408-2021	Buch, Thorsten/0000-0002-2236-9074; Lehmann, Clara/0000-0002-7042-1578; Schierwagen, Robert/0000-0002-2195-3666; Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Knolle, Percy A./0000-0003-2983-0414; Lang, Karl/0000-0001-9783-7605	US National Institutes of Health [HHSN272201300006C]; Koln Fortune Program of the Faculty of Medicine of the University of Cologne; German Research Foundation [SFB 832, SFB 704, INST 217/575-1, INST 217/576-1, INST 217/577-1, SFB TRR36, SFB TRR57, LA2558/3-1, SFB974, TRR60]; German Research Foundation excellence cluster ImmunoSensation; German Federal Ministry of Research and Education [01KI0771, 01KI1017]; German Center for Infection Research; H.J. & W. Hector Foundation; Alexander von Humboldt Foundation [SKA2008, SKA2010]; Jurgen Manchot Foundati (MOI II)	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koln Fortune Program of the Faculty of Medicine of the University of Cologne; German Research Foundation(German Research Foundation (DFG)); German Research Foundation excellence cluster ImmunoSensation; German Federal Ministry of Research and Education; German Center for Infection Research; H.J. & W. Hector Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Jurgen Manchot Foundati (MOI II)	We thank J.L. Riley (University of Pennsylvania) for anti-CD28; J.G. Gribben (Queen Mary University of London) for anti-CTLA-4; M. Schell, M. Kraut, C. Nabakowski, S. Winter and N. Koch for technical assistance; colleagues at the Division of Transfusion Medicine (University Hospital Bonn) for technical support; A. Sharpe for discussions; and the US National Institutes of Health Tetramer Core Facility (contract HHSN272201300006C) for gp66 tetramers. Supported by the Koln Fortune Program of the Faculty of Medicine of the University of Cologne (J.M.C.), the German Research Foundation (SFB 832, SFB 704, INST 217/575-1, INST 217/576-1 and INST 217/577-1 to J.L.S. and M.B.; SFB TRR57 and SFB TRR36 to Z.A., P.A.K. and C.K.; SFB TRR57 to J.T.; and LA2558/3-1, SFB974 and TRR60 to P.A.L. and K.S.L.), the German Research Foundation excellence cluster ImmunoSensation (M.B., Z.A., J.L.S., C.K. and P.A.K.), the German Federal Ministry of Research and Education (01KI0771 and 01KI1017 to C.L., G.F. and P.H.), the German Center for Infection Research (Z.A., P.A.K. and C.K.; partner site Bonn, J.T.), the H.J. & W. Hector Foundation (J.T.), the Alexander von Humboldt Foundation (SKA2008 and SKA2010) and the Jurgen Manchot Foundati (MOI II).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Aukrust P, 1997, J INFECT DIS, V176, P913, DOI 10.1086/516510; AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Belnoue E, 2007, J VIROL, V81, P7338, DOI 10.1128/JVI.00062-07; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Brunasso AMG, 2011, RHEUMATOLOGY, V50, P1700, DOI 10.1093/rheumatology/ker190; Cepeda EJ, 2008, ANN RHEUM DIS, V67, P710, DOI 10.1136/ard.2007.081513; Chemnitz JM, 2007, BLOOD, V110, P3226, DOI 10.1182/blood-2006-12-064360; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; De Pablo-Bernal RS, 2014, J ANTIMICROB CHEMOTH, V69, P3041, DOI 10.1093/jac/dku263; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; DOYLE LB, 1980, IMMUNOLOGY, V40, P589; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Graham CM, 2007, IMMUNOLOGY, V121, P238, DOI 10.1111/j.1365-2567.2007.02563.x; Habib SF, 2009, J CROHNS COLITIS, V3, P302, DOI 10.1016/j.crohns.2009.06.002; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Kim SY, 2010, NAT REV RHEUMATOL, V6, P165, DOI 10.1038/nrrheum.2009.279; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Nokta M, 1997, AIDS RES HUM RETROV, V13, P1633, DOI 10.1089/aid.1997.13.1633; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Planes R, 2014, J VIROL, V88, P6672, DOI 10.1128/JVI.00825-14; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Youngblood B, 2012, CURR OPIN HIV AIDS, V7, P50, DOI 10.1097/COH.0b013e32834ddcf2	50	54	56	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					593	+		10.1038/ni.3399	http://dx.doi.org/10.1038/ni.3399			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26950238				2022-12-18	WOS:000374323100019
J	Nakatsukasa, H; Zhang, DF; Maruyama, T; Chen, H; Cui, KR; Ishikawa, M; Deng, LS; Zanvit, P; Tu, E; Jin, WW; Abbatiello, B; Goldberg, N; Chen, QM; Sun, LY; Zhao, KJ; Chen, WJ				Nakatsukasa, Hiroko; Zhang, Dunfang; Maruyama, Takashi; Chen, Hua; Cui, Kairong; Ishikawa, Masaki; Deng, Lisa; Zanvit, Peter; Tu, Eric; Jin, Wenwen; Abbatiello, Brittany; Goldberg, Nathan; Chen, Qianming; Sun, Lingyun; Zhao, Keji; Chen, WanJun			The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							TGF-BETA; GENE-EXPRESSION; DIFFERENTIATION; INDUCTION; GENERATION; PATHWAYS; IMMUNITY; T(H)17; GAMMA	The molecular mechanisms by which signaling via transforming growth factor-beta (TGF-beta) and interleukin 4 (IL-4) control the differentiation of CD4(+) IL-9-producing helper T cells (T(H)9 cells) remain incompletely understood. We found here that the DNA-binding inhibitor Id3 regulated T(H)9 differentiation, as deletion of Id3 increased IL-9 production from CD4(+) T cells. Mechanistically, TGF-beta 1 and IL-4 downregulated Id3 expression, and this process required the kinase TAK1. A reduction in Id3 expression enhanced binding of the transcription factors E2A and GATA-3 to the Il9 promoter region, which promoted Il9 transcription. Notably, Id3-mediated control of T(H)9 differentiation regulated anti-tumor immunity in an experimental melanomabearing model in vivo and also in human CD4(+) T cells in vitro. Thus, our study reveals a previously unrecognized TAK1-Id3-E2A-GATA-3 pathway that regulates T(H)9 differentiation.	[Nakatsukasa, Hiroko; Zhang, Dunfang; Maruyama, Takashi; Chen, Hua; Deng, Lisa; Zanvit, Peter; Tu, Eric; Jin, Wenwen; Abbatiello, Brittany; Goldberg, Nathan; Chen, WanJun] NIDCR, Mucosal Immunol Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Zhang, Dunfang; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Ishikawa, Masaki] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Nanjing 210008, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Sichuan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Nanjing University	Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA.	wchen@dir.nidcr.nih.gov	MaruYama, Takashi/N-5994-2014	MaruYama, Takashi/0000-0003-0820-3219; Zhang, Dunfang/0000-0001-7545-9930; Goldberg, Nathan/0000-0002-5265-9793	National Institute of Dental and Craniofacial Research (US National Institutes of Health); JSPS Research Fellowship Program for Japanese Biomedical and Behavioral Researchers at the US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); JSPS Research Fellowship Program for Japanese Biomedical and Behavioral Researchers at the US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J.E. Konkel and C. Chia for critical reading of the manuscript; Y. Zhuang (Duke University) for Id3<SUP>f/f</SUP>Cd4-Cre<SUP>+</SUP> mice; X.C. Li (Harvard Medical School) for antigen-presenting cells with transgenic expression of the ligand for OX40; Y. Wan (University of North Carolina) for Tak1<SUP>f/f</SUP>ER-Cre mice; and A. Yoshimura (Keio University of Medicine) for Smad2<SUP>f/f</SUP>Lck-Cre<SUP>+</SUP> mice. Supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research (US National Institutes of Health) and the JSPS Research Fellowship Program for Japanese Biomedical and Behavioral Researchers at the US National Institutes of Health (H.N).	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jash A, 2012, J BIOL CHEM, V287, P15445, DOI 10.1074/jbc.M112.340356; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang AB, 2013, J IMMUNOL, V191, P4908, DOI 10.4049/jimmunol.1300433; Wei G, 2012, METHOD ENZYMOL, V513, P297, DOI 10.1016/B978-0-12-391938-0.00013-6; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	35	54	62	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1077	+		10.1038/ni.3252	http://dx.doi.org/10.1038/ni.3252			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26322481	Green Accepted			2022-12-18	WOS:000361686500013
J	Germain, RN				Germain, Ronald N.			Maintaining system homeostasis: the third law of Newtonian immunology	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ADAPTIVE IMMUNE-SYSTEM; NETWORK MOTIFS; REACTIVE OXYGEN; INNATE IMMUNITY; TGF-BETA; TOLERANCE; EFFECTOR; AUTOIMMUNITY; RESPONSES	Because of the potent effector mechanisms of the immune system, the potential for self-destructive immune responses is especially high and many negative regulatory modalities exist to prevent excessive tissue damage. This Commentary places such regulatory mechanisms in the larger context of system organization on many scales. The sometimes counterintuitive nature of feedback control is discussed and a case is made for greater attention to quantitative spatiotemporal aspects of regulation, rather than limiting the discussion to the qualitative descriptions of pathways that dominate at present.	NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI000758-15, ZIA AI000403-29, ZIA AI000545-24] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allam R, 2008, CURR OPIN RHEUMATOL, V20, P538, DOI 10.1097/BOR.0b013e3283025ed4; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chatenoud L, 2006, EUR J IMMUNOL, V36, P2296, DOI 10.1002/eji.200636591; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev.bioeng-071811-150118, 10.1146/annurev-bioeng-071811-150118]; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Glauser DA, 2007, FASEB J, V21, P3240, DOI 10.1096/fj.06-7798com; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Joller N, 2012, IMMUNOL REV, V248, P122, DOI 10.1111/j.1600-065X.2012.01136.x; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohchi C, 2009, ANTICANCER RES, V29, P817; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Ozaki Y, 2005, J BIOCHEM, V137, P659, DOI 10.1093/jb/mvi084; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Paolino M, 2009, EUR J IMMUNOL, V39, P2337, DOI 10.1002/eji.200939662; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Segel LA, 1999, J IMMUNOL, V163, P1342; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SISSONS JGP, 1980, J INFECT DIS, V142, P114, DOI 10.1093/infdis/142.1.114; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Wahl SM, 2004, J LEUKOCYTE BIOL, V76, P15, DOI 10.1189/jlb.1103539; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wuest TY, 2008, J LEUKOCYTE BIOL, V84, P973, DOI 10.1189/jlb.1107778; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	54	54	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					902	906		10.1038/ni.2404	http://dx.doi.org/10.1038/ni.2404			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990887	Green Accepted			2022-12-18	WOS:000309038600002
J	Liu, WM; Quinto, I; Chen, XN; Palmieri, C; Rabin, RL; Schwartz, OM; Nelson, DL; Scala, G				Liu, WM; Quinto, I; Chen, XN; Palmieri, C; Rabin, RL; Schwartz, OM; Nelson, DL; Scala, G			Direct inhibition of Brurton's tyrosine kinase by IBtk, a Btk-binding protein	NATURE IMMUNOLOGY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; B-CELL RECEPTOR; IMMUNODEFICIENT XID MICE; FACTOR-KAPPA-B; DEFICIENT EXPRESSION; SH3 DOMAIN; ACTIVATION; MUTATION; FAMILY; GENE	Bruton's tyrosine kinase (Btk) is required for human and mouse B cell development. Btk deficiency causes X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency in mice. Unlike Src proteins, Btk lacks a negative regulatory domain at the COOH terminus and may rely on cytoplasmic Btk-binding proteins to regulates its kinase activity by trans-inhibitor mechanisms. Consistent with this possibility, IBtk, which we identified as an inhibitor of Btk, bound to the PH domain of Btk. IBtk downregulated Btk kinase activity, Btk-mediated calcium mobilization and nuclear factor-kappaB-driven transcription. These results define a potential mechanism for the regulation of Btk function in B cells.	Univ Catanzaro, Dept Clin & Expt Med, Sch Med, I-88100 Catanzaro, Italy; Univ Naples Federico II, Sch Med, Dept Biochem & Biomed Technol, I-80131 Naples, Italy; NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; NIAID, Biol Imaging Facil, NIH, Bethesda, MD 20892 USA; NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	Magna Graecia University of Catanzaro; University of Naples Federico II; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scala, G (corresponding author), Univ Catanzaro, Dept Clin & Expt Med, Sch Med, I-88100 Catanzaro, Italy.		SCALA, GIUSEPPE/A-3280-2009; Palmieri, Camillo/A-3195-2009	QUINTO, Ileana/0000-0001-8212-8515; Palmieri, Camillo/0000-0001-6707-4723	Telethon [A.045] Funding Source: Medline	Telethon(Fondazione Telethon)		Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; BRUTON OC, 1952, PEDIATRICS, V9, P722; Bykowsky MJ, 1996, AM J HUM GENET, V58, P477; Chen XN, 1997, BLOOD, V90, P156; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Futatani T, 1998, BLOOD, V91, P595; Giordano V, 1997, J IMMUNOL, V158, P4097; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; HARPER JW, 1993, CELL, V75, P805; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; Kornfeld SJ, 1996, MOL MED, V2, P619, DOI 10.1007/BF03401645; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Oda A, 2000, BLOOD, V95, P1663; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Rabin RL, 1999, J IMMUNOL, V162, P3840; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P2081, DOI 10.1002/eji.1830191117; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STEWART DM, 1995, J IMMUNOL, V155, P2770; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1994, FEBS LETT, V350, P263, DOI 10.1016/0014-5793(94)00783-7; Vihinen M, 1998, NUCLEIC ACIDS RES, V26, P242, DOI 10.1093/nar/26.1.242; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; YAMADA N, 1993, BIOCHEM BIOPH RES CO, V192, P231, DOI 10.1006/bbrc.1993.1404; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	52	54	57	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					939	946		10.1038/ni1001-939	http://dx.doi.org/10.1038/ni1001-939			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577348				2022-12-18	WOS:000171361500013
J	O'Shea, JJ; Visconti, R				O'Shea, JJ; Visconti, R			Type IIFNs and regulation of THI responses: enigmas both resolved and emerge	NATURE IMMUNOLOGY			English	News Item							IFN-ALPHA; STAT4; PHOSPHORYLATION; LYMPHOCYTES; INTERFERONS; ACTIVATION; TYROSINE	STATs are critical in immune responses to type I IFNs. The human and mouse pathways differ, partly due to differences in STAT2, but unpredicted responses after viral infections raise new questions.	NIAMSD, Lymphocyte Cell Biol Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Arthrit & Rheumatism Branch, NIH, Bldg 10,Room 9N252,10 Ctr Dr,MSC-1820, Bethesda, MD 20892 USA.		Visconti, Roberta/C-5299-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Cho SS, 1996, J IMMUNOL, V157, P4781; FARRAR, 2000, NATURE IMMUNOL, V1, P65; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Hoey T, 1999, Adv Immunol, V71, P145; Karp CL, 2000, IMMUNOL TODAY, V21, P24, DOI 10.1016/S0167-5699(99)01541-8; Laman JD, 1998, IMMUNOL TODAY, V19, P489, DOI 10.1016/S0167-5699(98)01320-6; NGUYEN, 2000, NATURE IMMUNOL, V1, P70; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Rogge L, 1998, J IMMUNOL, V161, P6567; Sinigaglia F, 1999, DEV COMP IMMUNOL, V23, P657, DOI 10.1016/S0145-305X(99)00039-7; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227	14	54	73	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					17	19		10.1038/76872	http://dx.doi.org/10.1038/76872			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881168				2022-12-18	WOS:000089814800008
J	Gavin, AL; Huang, DL; Huber, C; Martensson, A; Tardif, V; Skog, PD; Blane, TR; Thinnes, TC; Osborn, K; Chong, HS; Kargaran, F; Kimm, P; Zeitjian, A; Sielski, RL; Briggs, M; Schulz, SR; Zarpellon, A; Cravatt, B; Pang, ES; Teijaro, J; de la Torre, JC; O'Keeffe, M; Hochrein, H; Damme, M; Teyton, L; Lawson, BR; Nemazee, D				Gavin, Amanda L.; Huang, Deli; Huber, Christoph; Martensson, Annica; Tardif, Virginie; Skog, Patrick D.; Blane, Tanya R.; Thinnes, Therese C.; Osborn, Kent; Chong, Hayley S.; Kargaran, Farnaz; Kimm, Phoebe; Zeitjian, Armen; Sielski, Rachel L.; Briggs, Megan; Schulz, Sebastian R.; Zarpellon, Alessandro; Cravatt, Benjamin; Pang, Ee Shan; Teijaro, John; de la Torre, Juan Carlos; O'Keeffe, Meredith; Hochrein, Hubertus; Damme, Markus; Teyton, Luc; Lawson, Brian R.; Nemazee, David			PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing	NATURE IMMUNOLOGY			English	Article							INTERFERON-GAMMA; DNASE-II; GENE; LUPUS; ACTIVATION; EXPRESSION; MUTATIONS; TREX1; REQUIREMENT; DISEASE	The sensing of microbial genetic material by leukocytes often elicits beneficial pro-inflammatory cytokines, but dysregulated responses can cause severe pathogenesis. Genome-wide association studies have linked the gene encoding phospholipase D3 (PLD3) to Alzheimer's disease and have linked PLD4 to rheumatoid arthritis and systemic sclerosis. PLD3 and PLD4 are endolysosomal proteins whose functions are obscure. Here, PLD4-deficient mice were found to have an inflammatory disease, marked by elevated levels of interferon-gamma (IFN-gamma) and splenomegaly. These phenotypes were traced to altered responsiveness of PLD4-deficient dendritic cells to ligands of the single-stranded DNA sensor TLR9. Macrophages from PLD3-deficient mice also had exaggerated TLR9 responses. Although PLD4 and PLD3 were presumed to be phospholipases, we found that they are 5' exonucleases, probably identical to spleen phosphodiesterase, that break down TLR9 ligands. Mice deficient in both PLD3 and PLD4 developed lethal liver inflammation in early life, which indicates that both enzymes are needed to regulate inflammatory cytokine responses via the degradation of nucleic acids.	[Gavin, Amanda L.; Huang, Deli; Huber, Christoph; Martensson, Annica; Tardif, Virginie; Skog, Patrick D.; Blane, Tanya R.; Thinnes, Therese C.; Kimm, Phoebe; Zarpellon, Alessandro; Teijaro, John; de la Torre, Juan Carlos; Teyton, Luc; Lawson, Brian R.; Nemazee, David] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Osborn, Kent; Chong, Hayley S.; Kargaran, Farnaz; Zeitjian, Armen; Sielski, Rachel L.; Briggs, Megan] Univ Calif San Diego, La Jolla, CA 92093 USA; [Schulz, Sebastian R.] Univ Erlangen Nurnberg, Div Mol Immunol, Erlangen, Germany; [Cravatt, Benjamin] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA; [Pang, Ee Shan; O'Keeffe, Meredith] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Hochrein, Hubertus] Bavarian Nord, Martinsried, Germany; [Damme, Markus] Univ Kiel, Biochem Inst, Kiel, Germany; [Martensson, Annica] Sophiris Bio, La Jolla, CA USA; [Tardif, Virginie] Drexel Univ, Dept Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA	Scripps Research Institute; University of California System; University of California San Diego; University of Erlangen Nuremberg; Scripps Research Institute; Monash University; Bavarian Nordic; University of Kiel; Drexel University	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	nemazee@scripps.edu	O'Keeffe, Meredith/U-9347-2017; 黄, 德力/GWU-7847-2022; Tardif, Virginie/M-9665-2019; TARDIF, Virginie/U-4383-2019; Hochrein, Hubertus/L-3697-2013	O'Keeffe, Meredith/0000-0002-0779-4654; 黄, 德力/0000-0002-6989-639X; TARDIF, Virginie/0000-0001-5604-6524; Pang, Ee Shan/0000-0003-4325-6260; Damme, Markus/0000-0002-9699-9351; Hochrein, Hubertus/0000-0001-9904-1934	US National Institutes of Health [R21AI126011, R21AI101692, R37AI059714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082493, R37AI059714, R01AI059714, R01AI123210, R01AI142945, R21AI126011, R21AI101692] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Beutler (University of Texas Southwestern Medical Center) for Unc93b<SUP>3d/3d</SUP> mice; Y. Doyon (Centre Hospitalier Universitaire de Quebec) for plasmid eSpCas9(1.1)<SUP>51</SUP>; and S. Kupriyanov and G. Martin (The Scripps Research Institute Genetics Core) and S. Head and P. Natarajan (The Scripps Research Institute NGS Core) for technical assistance. This project was supported by the US National Institutes of Health (R21AI126011, R21AI101692 and R37AI059714).	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; BERNARDI A, 1969, J BIOL CHEM, V244, P1468; BERNARDI A, 1968, BIOCHIM BIOPHYS ACTA, V155, P360, DOI 10.1016/0005-2787(68)90180-9; Bracaglia C, 2017, ANN RHEUM DIS, V76, P166, DOI 10.1136/annrheumdis-2015-209020; Canna SW, 2012, CURR OPIN RHEUMATOL, V24, P113, DOI 10.1097/BOR.0b013e32834dd37e; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Chen JH, 2010, AM J SURG PATHOL, V34, P852, DOI 10.1097/PAS.0b013e3181dbbb17; Chen WC, 2017, ONCOTARGET, V8, P64180, DOI 10.18632/oncotarget.19419; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Erdal E, 2017, GENE DEV, V31, P353, DOI 10.1101/gad.289769.116; Fazzari P, 2017, NATURE, V541, pE1, DOI 10.1038/nature21030; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Gonzalez AC, 2018, CELL REP, V22, P1040, DOI 10.1016/j.celrep.2017.12.100; Heilmann S, 2015, NATURE, V520, pE3, DOI 10.1038/nature14039; HILMOE RJ, 1960, J BIOL CHEM, V235, P2117; Hooli BV, 2015, NATURE, V520, pE7, DOI 10.1038/nature14040; IPATA PL, 1969, EUR J BIOCHEM, V8, P174, DOI 10.1111/j.1432-1033.1969.tb00511.x; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Langenmayer MC, 2018, J VET INTERN MED, V32, P853, DOI 10.1111/jvim.15040; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MANDECKI W, 1988, DNA-J MOLEC CELL BIO, V7, P57, DOI 10.1089/dna.1988.7.57; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Ohto U, 2018, IMMUNITY, V48, P649, DOI 10.1016/j.immuni.2018.03.013; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Osisami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033341; Otani Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027544; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; RAZZELL WE, 1961, J BIOL CHEM, V236, P3028; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Sepulveda FE, 2017, CURR OPIN IMMUNOL, V49, P20, DOI 10.1016/j.coi.2017.08.004; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Terao C, 2013, ARTHRITIS RHEUM-US, V65, P472, DOI 10.1002/art.37777; Vremec David, 2008, V415, P163, DOI 10.1007/978-1-59745-570-1_10; Waite M, 1999, BBA-MOL CELL BIOL L, V1439, P187, DOI 10.1016/S1388-1981(99)00094-3; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932; Zhang DF, 2016, MOL NEUROBIOL, V53, P4034, DOI 10.1007/s12035-015-9353-5; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	57	53	53	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					942	+		10.1038/s41590-018-0179-y	http://dx.doi.org/10.1038/s41590-018-0179-y			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30111894	Green Accepted			2022-12-18	WOS:000442365100016
J	Campisi, L; Barbet, G; Ding, Y; Esplugues, E; Flavell, RA; Blander, JM				Campisi, Laura; Barbet, Gaetan; Ding, Yi; Esplugues, Enric; Flavell, Richard A.; Blander, J. Magarian			Apoptosis in response to microbial infection induces autoreactive T(H)17 cells	NATURE IMMUNOLOGY			English	Article							T-CELLS; AUTOIMMUNE-DISEASES; CELIAC-DISEASE; TH17 CELLS; SELECTION; TOLERANCE; INSIGHTS; ALPHA; BETA; HETEROGENEITY	Microbial infections often precede the onset of autoimmunity. How infections trigger autoimmunity remains poorly understood. We investigated the possibility that infection might create conditions that allow the stimulatory presentation of self peptides themselves and that this might suffice to elicit autoreactive T cell responses that lead to autoimmunity. Self-reactive CD4(+) T cells are major drivers of autoimmune disease, but their activation is normally prevented through regulatory mechanisms that limit the immunostimulatory presentation of self antigens. Here we found that the apoptosis of infected host cells enabled the presentation of self antigens by major histocompatibility complex class II molecules in an inflammatory context. This was sufficient for the generation of an autoreactive T(H)17 subset of helper T cells, prominently associated with autoimmune disease. Once induced, the self-reactive T(H)17 cells promoted auto-inflammation and autoantibody generation. Our findings have implications for how infections precipitate autoimmunity.	[Barbet, Gaetan; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Barbet, Gaetan; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ding, Yi] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Esplugues, Enric; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Campisi, Laura; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Campisi, Laura] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	julie.blander@mssm.edu	Campisi, Laura/AAL-2064-2021; Barbet, Gaetan/ABB-5618-2020; Esplugues, Enric/AAD-4245-2020; Barbet, Gaetan/AAJ-1675-2021	Campisi, Laura/0000-0003-4173-4521; Barbet, Gaetan/0000-0002-0152-3650; Esplugues, Enric/0000-0002-8130-0413; Blander, Julie Magarian/0000-0001-9207-1700	National Institute of Diabetes and Digestive and Kidney Diseases [DK072201]; National Institute of Allergy and Infectious Diseases [AI073899, AI080959, AI095245]; Arthritis Foundation; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund; Irma Hirschl and Monique Weill-Caulier Charitable Trust Funds; American Cancer Society; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245, R01AI073899, R56AI073899, R21AI080959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111862, P01DK072201] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Irma Hirschl and Monique Weill-Caulier Charitable Trust Funds; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Lira, G. Furtado, H. Xiong, G. Yeretssian, M.K. Jenkins and members of the Blander laboratory for discussions; D. Amsen and R.J. Cummings for critical reading of the manuscript; A. Rialdi for help with statistical analyses; J. Ochando and C. Bare for flow cytometry; A. Soto and M.J. Suarez (the NIH Tetramer Core Facility at Emory University) for I-A<SUP>b</SUP>-OVA(328-337) and control tetramers; H. Xiong (The Icahn School of Medicine at Mount Sinai) for LM-OVA bacteria; A. Morelli (University of Pittsburgh) for 1H3.1 mice; B. Finlay and M. Croxen (University of British Columbia) for wild-type and Delta EspF C. rodentium and plasmid pMAC5; H.P. Schweizer (Colorado State University) for plasmid pTNS2; D. Mazel (Institut Pasteur) for MFDpir bacteria; and I. Marazzi, V. Verhasselt, S.E.F. Campisi, G.C. Chiesa, Jr., M.A. Blander, S.J. Blander and the late L. Mayer for advice and support. Supported by the National Institute of Diabetes and Digestive and Kidney Diseases (DK072201 to J.M.B.), the National Institute of Allergy and Infectious Diseases (AI073899, AI080959 and AI095245 to J.M.B.), the Arthritis Foundation (L.C.), the Crohn's and Colitis Foundation of America (G.B.), the Burroughs Wellcome Fund (J.M.B.), the Irma Hirschl and Monique Weill-Caulier Charitable Trust Funds (J.M.B.), the American Cancer Society (J.M.B.) and the Leukemia and Lymphoma Society (J.M.B.).	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Blander JM, 2012, IMMUNOL RES, V54, P50, DOI 10.1007/s12026-012-8311-9; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brereton CF, 2011, J LEUKOCYTE BIOL, V89, P565, DOI 10.1189/jlb.0710421; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Cho JH, 2015, NAT MED, V21, P730, DOI 10.1038/nm.3897; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Di Sabatino A, 2015, AUTOIMMUN REV, V14, P1161, DOI 10.1016/j.autrev.2015.08.004; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Ito Y, 2014, SCIENCE, V346, P363, DOI 10.1126/science.1259077; JALKANEN S, 1989, EUR J IMMUNOL, V19, P63, DOI 10.1002/eji.1830190111; Kazemi-Shirazi L, 2002, CLIN EXP IMMUNOL, V128, P102, DOI 10.1046/j.1365-2249.2002.01804.x; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Pordeus V, 2008, CLIN REV ALLERG IMMU, V34, P283, DOI 10.1007/s12016-007-8048-8; Richards DM, 2016, TRENDS IMMUNOL, V37, P114, DOI 10.1016/j.it.2015.12.005; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Rosenblum MD, 2015, J CLIN INVEST, V125, P2228, DOI 10.1172/JCI78088; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Simons DM, 2010, J LEUKOCYTE BIOL, V88, P1099, DOI 10.1189/jlb.0310183; Suurmond J, 2015, J CLIN INVEST, V125, P2194, DOI 10.1172/JCI78084; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	50	53	60	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1084	1092		10.1038/ni.3512	http://dx.doi.org/10.1038/ni.3512			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27455420	Green Accepted			2022-12-18	WOS:000381832000012
J	Yang, MJ; Chen, TY; Li, XL; Yu, Z; Tang, SQ; Wang, C; Gu, Y; Liu, YF; Xu, S; Li, WH; Zhang, XM; Wang, JL; Cao, XT				Yang, Mingjin; Chen, Taoyong; Li, Xuelian; Yu, Zhou; Tang, Songqing; Wang, Chen; Gu, Yan; Liu, Yanfang; Xu, Sheng; Li, Weihua; Zhang, Xuemin; Wang, Jianli; Cao, Xuetao			K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CBL-B; C-CBL; AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR DEGRADATION; PHOSPHORYLATION SITE; LIGASE ITCH; ZAP-70; MICE; UBIQUITINATION	The key molecular mechanisms that control signaling via T cell antigen receptors (TCRs) remain to be fully elucidated. Here we found that Nrdp1, a ring finger-type E3 ligase, mediated Lys33 (K33)-linked polyubiquitination of the signaling kinase Zap70 and promoted the dephosphorylation of Zap70 by the acidic phosphatase-like proteins Sts1 and Sts2 and thereby terminated early TCR signaling in CD8(+) T cells. Nrdp1 deficiency significantly promoted the activation of naive CD8(+) T cells but not that of naive CD4(+) T cells after engagement of the TCR. Nrdp1 interacted with Zap70 and with Sts1 and Sts2 and connected K33 linkage of Zap70 to Sts1- and Sts2-mediated dephosphorylation. Our study suggests that Nrdp1 terminates early TCR signaling by inactivating Zap70 and provides new mechanistic insights into the non-proteolytic regulation of TCR signaling by E3 ligases.	[Yang, Mingjin; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Yang, Mingjin; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; [Yang, Mingjin; Chen, Taoyong; Li, Xuelian; Wang, Chen; Gu, Yan; Liu, Yanfang; Xu, Sheng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Yang, Mingjin; Chen, Taoyong; Li, Xuelian; Wang, Chen; Gu, Yan; Liu, Yanfang; Xu, Sheng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Yu, Zhou; Tang, Songqing; Wang, Jianli] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Weihua; Zhang, Xuemin] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China.	chenty@immunol.org; caoxt@immunol.org	wang, jian/GVS-0711-2022; Chen, Taoyong/U-1735-2017	Chen, Taoyong/0000-0002-2507-0027; xu, sheng/0000-0002-9547-8052	National Key Basic Research Program of China [2010CB911903, 2013CB530500]; National Natural Science Foundation of China [81222039, 81172851, 81471566, 31170863, 81123006, 31390431]; National Excellent Doctoral Dissertation of China [200775]; Shanghai Committee of Science and Technology [11QH1402900]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank H. Shen (University of Pennsylvania School of Medicine) for virulent recombinant L. monocytogenes (LM-OVA) and attenuated recombinant L. monocytogenes (Delta actA-LM-OVA); H. Shen, X. Zhu and Z. Li for technical assistance; L. Lu for discussions; and Q. Guo for assistance with confocal microscopy. Supported by the National Key Basic Research Program of China (2010CB911903 and 2013CB530500), the National Natural Science Foundation of China (81222039, 81172851, 81471566, 31170863, 81123006 and 31390431), the National Excellent Doctoral Dissertation of China (200775) and the Shanghai Committee of Science and Technology (11QH1402900).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Denic A, 2013, EXPERT OPIN THER TAR, V17, P1053, DOI 10.1517/14728222.2013.815726; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Ferber IA, 1996, J IMMUNOL, V156, P5; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Paolini R, 2001, P NATL ACAD SCI USA, V98, P9611, DOI 10.1073/pnas.161298098; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; San Luis B., 2011, J BIOL CHEM, V286, P15943; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Thien CBF, 1999, J IMMUNOL, V162, P7133; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Ye S, 2012, J BIOL CHEM, V287, P26740, DOI 10.1074/jbc.M112.383265; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319	43	53	59	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1253	1262		10.1038/ni.3258	http://dx.doi.org/10.1038/ni.3258			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26390156				2022-12-18	WOS:000365062100009
J	Hauri-Hohl, M; Zuklys, S; Hollander, GA; Ziegler, SF				Hauri-Hohl, Mathias; Zuklys, Saulius; Hollaender, Georg A.; Ziegler, Steven F.			A regulatory role for TGF-beta signaling in the establishment and function of the thymic medulla	NATURE IMMUNOLOGY			English	Article							POSITIVELY SELECTED THYMOCYTES; T-CELL DEVELOPMENT; EPITHELIAL-CELLS; NEGATIVE SELECTION; DEVELOPMENTAL PATHWAY; ACTIVATION THRESHOLD; SELF-TOLERANCE; REPERTOIRE; MIGRATION; DIFFERENTIATION	Medullary thymic epithelial cells (mTECs) are critical in establishing and maintaining the appropriate microenvironment for negative selection and maturation of immunocompetent T cells with a self-tolerant T cell antigen receptor repertoire. Cues that direct proliferation and maturation of mTECs are provided by members of the tumor necrosis factor (TNF) superfamily expressed on developing thymocytes. Here we demonstrate a negative role of the morphogen TGF-beta in tempering these signals under physiological conditions, limiting both growth and function of the thymic medulla. Eliminating TGF-beta signaling specifically in TECs or by pharmacological means increased the size of the mTEC compartment, enhanced negative selection and functional maturation of medullary thymocytes as well as the production of regulatory T cells, thus reducing the autoreactive potential of peripheral T cells.	[Hauri-Hohl, Mathias; Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA 98101 USA; [Zuklys, Saulius; Hollaender, Georg A.] Univ Basel, Dept Biomed, Lab Pediat Immunol, Basel, Switzerland; [Zuklys, Saulius; Hollaender, Georg A.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Hollaender, Georg A.] Univ Oxford, Dept Pediat, Oxford, England	Benaroya Research Institute; Virginia Mason Medical Center; University of Basel; University of Basel; University of Oxford	Ziegler, SF (corresponding author), Benaroya Res Inst Virginia Mason, Program Immunol, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org	Hauri-Hohl, Mathias M/X-5691-2018	Hauri-Hohl, Mathias M/0000-0003-4618-3319; Hollander, Georg/0000-0002-8790-0874	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank D.J. Campbell and J.A. Hamerman for helpful discussions about these data, and S. McCarty for help with preparation of the manuscript. This work was partially supported by grants from the Swiss National Science Foundation (M.H.-H. and G.A.H.).	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Coquet JM, 2013, J EXP MED, V210, P715, DOI 10.1084/jem.20112061; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Eck SC, 2006, J IMMUNOL, V176, P2229, DOI 10.4049/jimmunol.176.4.2229; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Hauri-Hohl MM, 2008, BLOOD, V112, P626, DOI 10.1182/blood-2007-10-115618; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hinterberger M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00030; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hsu FC, 2011, J EXP MED, V208, P1291, DOI 10.1084/jem.20101874; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Klein L, 2011, SEMIN IMMUNOL, V23, P401, DOI 10.1016/j.smim.2011.06.003; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MEILIN A, 1995, SCAND J IMMUNOL, V42, P185, DOI 10.1111/j.1365-3083.1995.tb03644.x; Nitta T, 2011, CURR OPIN IMMUNOL, V23, P190, DOI 10.1016/j.coi.2010.12.002; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Spence PJ, 2008, P NATL ACAD SCI USA, V105, P973, DOI 10.1073/pnas.0709071105; Stephen TL, 2012, P NATL ACAD SCI USA, V109, P7415, DOI 10.1073/pnas.1119272109; Stephen TL, 2009, J IMMUNOL, V183, P5554, DOI 10.4049/jimmunol.0901104; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Ewijk W, 2011, IMMUNOL LETT, V138, P7, DOI 10.1016/j.imlet.2011.02.009; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x; Wirnsberger G, 2011, IMMUNOL CELL BIOL, V89, P45, DOI 10.1038/icb.2010.123; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	50	53	56	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					554	561		10.1038/ni.2869	http://dx.doi.org/10.1038/ni.2869			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24728352				2022-12-18	WOS:000336419300012
J	Yan, DP; Wang, XY; Luo, LJ; Cao, XT; Ge, BX				Yan, Dapeng; Wang, Xingyu; Luo, Lijun; Cao, Xuetao; Ge, Baoxue			Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs	NATURE IMMUNOLOGY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; RODENTIUM-INDUCED COLITIS; ACTIN-PEDESTAL FORMATION; CITROBACTER-RODENTIUM; INTIMATE ADHERENCE; HOST-DEFENSE; TIR; PHOSPHATASE	The protein fir (translocated intimin receptor) in enteric bacteria shares sequence similarity with the host cellular immunoreceptor tyrosine-based inhibition motifs (ITIMs). Despite the importance of fir in pedestal formation, relatively little is known about the role of fur and its ITIMs in the regulation of the host immune response. Here we demonstrate that fir from enteropathogenic Escherichia coli (EPEC) interacted with the host cellular tyrosine phosphatase SHP-1 in an ITIM phosphorylation dependent manner. The association of fir with SHP-1 facilitated the recruitment of SHP-1 to the adaptor TRAF6 and inhibited the ubiquitination of TRAF6. Moreover, the ITIMs of fir suppressed EPEC-stimulated expression of proinflammatory cytokines and inhibited intestinal immunity to infection with Citrobacter rodentium. Our findings identify a previously unknown mechanism by which bacterial ITIM-containing proteins can inhibit innate immune responses.	[Yan, Dapeng; Luo, Lijun; Ge, Baoxue] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yan, Dapeng; Luo, Lijun; Ge, Baoxue] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Yan, Dapeng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Xingyu; Ge, Baoxue] Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Wang, Xingyu; Ge, Baoxue] Tongji Univ, Dept Microbiol & Immunol, Sch Med, Shanghai 200092, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tongji University; Tongji University; Naval Medical University; Naval Medical University	Ge, BX (corresponding author), Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	gebaoxue@sibs.ac.cn			National Basic Research Program of China (973 Programs) [2012CB578100, 2011CB505000]; National Natural Science Foundation of China [31030028]; Science and Technology Commission of Shanghai Municipality [10JC1416400]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We thank J. Leong (University of Massachusetts Medical School) for cDNA encoding Tir and for JPN15 and JPN15 Delta Tir; R. Longnecker (Northwestern University) for cDNA encoding LMP2A; H. Gu (University of Colorado Denver) for the SHP-1 construct; B. Finlay and W. Deng (University of British Columbia) for C. rodentium, C. rodentium Delta Tir, EPEC strain E2348/69 and Delta escN and technical help; X. Song for help with animal infection; and members of the B. Ge laboratory for discussions and technical assistance. Supported by the National Basic Research Program of China (973 Programs 2012CB578100 and 2011CB505000), the National Natural Science Foundation of China (project 31030028) and the Science and Technology Commission of Shanghai Municipality (Program 10JC1416400).	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; de Grado M, 1999, CELL MICROBIOL, V1, P7, DOI 10.1046/j.1462-5822.1999.00001.x; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Deng WY, 2003, MOL MICROBIOL, V48, P95, DOI 10.1046/j.1365-2958.2003.03429.x; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Goncalves NS, 2001, INFECT IMMUN, V69, P6651, DOI 10.1128/IAI.69.11.6651-6659.2001; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Marches O, 2000, INFECT IMMUN, V68, P2171, DOI 10.1128/IAI.68.4.2171-2182.2000; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Nandan D, 1999, INFECT IMMUN, V67, P4055, DOI 10.1128/IAI.67.8.4055-4063.1999; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Royan SV, 2010, MOL MICROBIOL, V78, P1232, DOI 10.1111/j.1365-2958.2010.07400.x; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; Salazar-Gonzalez H, 2011, SCAND J IMMUNOL, V73, P268, DOI 10.1111/j.1365-3083.2011.02507.x; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620	44	53	58	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1063	1071		10.1038/ni.2417	http://dx.doi.org/10.1038/ni.2417			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23001144				2022-12-18	WOS:000310091700009
J	Bansal, G; Xie, Z; Ra, S; Nocka, KH; Druey, KM				Bansal, Geetanjali; Xie, Zhihui; Ra, Sudhir; Nocka, Karl H.; Druey, Kirk M.			Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; MAST-CELL ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; RGS PROTEINS; CYTOKINE PRODUCTION; B-LYMPHOCYTES; RECEPTOR; DEGRANULATION; KINASE	Mast cells elicit allergic responses through degranulation and release of proinflammatory mediators after antigen crosslinking of the immunoglobulin E receptor Fc epsilon RI. Proteins of the 'regulator of G protein signaling' MISS) family negatively control signaling mediated by G protein-coupled receptors through GTPase-accelerating protein activity. Here we show that RGS13 inhibited allergic responses by physically interacting with the regulatory p85 alpha subunit of phosphatidylinositol-3-OH kinase in mast cells and disrupting its association with an Fc epsilon RI-activated scaffolding complex. Rgs13(-/-) mice had enhanced immunoglobulin E-mediated mast cell degranulation and anaphylaxis. Thus, RGS13 inhibits the assembly of immune receptor-induced signalosomes in mast cells. Abnormal RGS13 expression or function may contribute to disorders of amplified mast cell activity, such as idiopathic anaphylaxis.	[Bansal, Geetanjali; Xie, Zhihui; Druey, Kirk M.] NIH, NIAID, Lab Allerg Dis, Mol Signal Transduct Sect, Bethesda, MD 20892 USA; [Ra, Sudhir; Nocka, Karl H.] UCB Pharma, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UCB Pharma SA	Druey, KM (corresponding author), NIH, NIAID, Lab Allerg Dis, Mol Signal Transduct Sect, Bldg 10, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Bansal, Geetanjali/C-3854-2009		Intramural NIH HHS [Z01 AI000746-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000746] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrade MVM, 2004, J IMMUNOL, V172, P7254, DOI 10.4049/jimmunol.172.12.7254; Beadling C, 1999, J IMMUNOL, V162, P2677; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; DRUEY KM, 2001, SCI STKE, V104, pRE14, DOI DOI 10.1126/STKE.2001.1104.RE1114; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fukao T, 2003, J MOL MED, V81, P524, DOI 10.1007/s00109-003-0475-2; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HEXIMER SP, 2007, SCI STKE, V370, pPE2, DOI DOI 10.1126/STKE.3702007PE3702002; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; RA C, 1989, J BIOL CHEM, V264, P15323; Reischl IG, 1999, BIOCHEM PHARMACOL, V58, P1841, DOI 10.1016/S0006-2952(99)00226-9; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; Youssef LA, 2007, J IMMUNOL, V178, P4584, DOI 10.4049/jimmunol.178.7.4584; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Zhang C, 1997, J IMMUNOL, V158, P4968; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhong H, 2003, J IMMUNOL, V171, P338, DOI 10.4049/jimmunol.171.1.338; Zhu MH, 2006, J BIOL CHEM, V281, P18408, DOI 10.1074/jbc.M601535200	49	53	53	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					73	80		10.1038/ni1533	http://dx.doi.org/10.1038/ni1533			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18026105	Green Accepted			2022-12-18	WOS:000251820800013
J	Rohn, TA; Boes, M; Wolters, D; Spindeldreher, S; Muller, B; Langen, H; Ploegh, H; Vogt, AB; Kropshofer, H				Rohn, TA; Boes, M; Wolters, D; Spindeldreher, S; Muller, B; Langen, H; Ploegh, H; Vogt, AB; Kropshofer, H			Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; HLA-DR MOLECULES; PROTEIN IDENTIFICATION TECHNOLOGY; INVARIANT CHAIN PEPTIDE; IMMUNOLOGICAL SYNAPSE; TETRASPAN MICRODOMAINS; ANTIGEN PRESENTATION; MHC; RECOGNITION; BINDING	Dendritic cells (DCs) initiate and regulate immunity against foreign and self antigens. Here we identified more than 200 individual major histocompatibility complex class II-associated peptides on human DCs and found that mature DCs selectively upregulated the self peptide CLIP. CLIP cosegregated together with foreign antigenic peptides in tetraspan microdomains on the surface and localized to DC-T cell synapses. The increased representation of CLIP-major histocompatibility complex class 11 complexes favored polarization of autologous naive T cells toward the nonpolarized and T helper type 2 (T(H)2) phenotype. There was also a considerably higher T(H)2/T(H)1 ratio in H2-DM-deficient mice, which have a CLIPhi phenotype, in contrast to wild-type, CLIPlo mice. Thus, the self peptide CLIP on DCs qualifies as an endogenous regulator in priming of T helper cells by antagonizing the polarization toward the T(H)1 phenotype.	Basel Inst Immunol, Basel, Switzerland; Hoffmann La Roche Ag, CH-4002 Basel, Switzerland; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Roche Holding; Harvard University; Harvard Medical School	Kropshofer, H (corresponding author), Basel Inst Immunol, Basel, Switzerland.	harald.kropshofer@roche.com		Boes, Marianne/0000-0003-2590-1692				Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; Arneson LS, 2000, J IMMUNOL, V165, P2059, DOI 10.4049/jimmunol.165.4.2059; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; Chaturvedi P, 2000, INT IMMUNOL, V12, P757, DOI 10.1093/intimm/12.6.757; Chen XJ, 2002, J EXP MED, V195, P1053, DOI 10.1084/jem.20012066; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Germain RN, 2002, ADV EXP MED BIOL, V512, P97; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HU RM, 1992, AUTOIMMUNITY, V12, P103, DOI 10.3109/08916939209150316; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; Kropshofer H, 1999, IMMUNOL REV, V172, P267, DOI 10.1111/j.1600-065X.1999.tb01371.x; Kropshofer H, 1998, EMBO J, V17, P2971, DOI 10.1093/emboj/17.11.2971; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Reed AM, 1997, J IMMUNOL, V159, P6260; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Smith MH, 1998, MOL IMMUNOL, V35, P1033, DOI 10.1016/S0161-5890(98)00096-0; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Topilski I, 2002, J IMMUNOL, V168, P1610, DOI 10.4049/jimmunol.168.4.1610; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Vogt AB, 2002, IMMUNOL REV, V189, P136, DOI 10.1034/j.1600-065X.2002.18912.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	50	53	54	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					909	918		10.1038/ni1108	http://dx.doi.org/10.1038/ni1108			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15322540				2022-12-18	WOS:000223612500019
J	Tam, SY; Tsai, M; Snouwaert, JN; Kalesnikoff, J; Scherrer, D; Nakae, S; Chatterjea, D; Bouley, DM; Galli, SJ				Tam, SY; Tsai, M; Snouwaert, JN; Kalesnikoff, J; Scherrer, D; Nakae, S; Chatterjea, D; Bouley, DM; Galli, SJ			RabGEF1 is a negative regulator of mast cell activation and skin inflammation	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; NUCLEOTIDE EXCHANGE; SIGNAL-TRANSDUCTION; ARACHIDONIC-ACID; BINDING-PROTEIN; INNATE IMMUNITY; RAS ACTIVATION; KINASE; RAB5	Mast cell activation induced by aggregation of FcepsilonRI receptors with immunoglobulin E and antigen is mediated through the activation of multiple protein kinase cascades. Here we report that the regulatory protein RabGEF1 bound to Ras and negatively regulated Ras activation and its 'downstream' effector pathways in FcepsilonRI-dependent mast cell activation. RabGEF1-deficient mast cells showed enhanced degranulation and release of lipid mediators and cytokines in response to FcepsilonRI aggregation. RabGEF1-deficient mice developed severe skin inflammation and had increased numbers of mast cells. Thus, RabGEF1 is a negative regulator of FcepsilonRI-dependent mast cell activation, and a lack of RabGEF1 results in the development of skin inflammation in vivo.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL067674, P01HL067674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER; NCI NIH HHS [CA-72024] Funding Source: Medline; NHLBI NIH HHS [HL-67674] Funding Source: Medline; NIAID NIH HHS [AI-23990] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Barbieri MA, 1998, J BIOL CHEM, V273, P19367, DOI 10.1074/jbc.273.31.19367; Beaven MA, 1996, CURR OPIN IMMUNOL, V8, P766, DOI 10.1016/S0952-7915(96)80002-1; Burd CG, 1996, MOL CELL BIOL, V16, P2369; COLICELLI J, 1991, P NATL ACAD SCI USA, V88, P2913, DOI 10.1073/pnas.88.7.2913; Dhaka A, 2003, J NEUROSCI, V23, P748; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; EISEMAN E, 1992, NATURE, V355, P78; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gagari E, 1997, BLOOD, V89, P2654, DOI 10.1182/blood.V89.8.2654; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu K, 1998, J BIOL CHEM, V273, P10087, DOI 10.1074/jbc.273.17.10087; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; ORTEGA E, 1989, EUR J IMMUNOL, V19, P2251, DOI 10.1002/eji.1830191211; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tsai M, 1996, FASEB J, V10, P1268; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Xu R, 1999, J IMMUNOL, V163, P1110; YOUNG JDE, 1987, P NATL ACAD SCI USA, V84, P9175, DOI 10.1073/pnas.84.24.9175	50	53	54	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					844	852		10.1038/ni1093	http://dx.doi.org/10.1038/ni1093			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15235600				2022-12-18	WOS:000222955600016
J	Qin, ZH; Blankenstein, T				Qin, ZH; Blankenstein, T			A cancer immunosurveillance controversy	NATURE IMMUNOLOGY			English	Letter							INTERFERON-GAMMA; IFN-GAMMA; MICE; EXPRESSION		Free Univ Berlin, Inst Immunol, D-12200 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Qin, ZH (corresponding author), Free Univ Berlin, Inst Immunol, D-12200 Berlin, Germany.		Smyth, Mark/H-8709-2014	Smyth, Mark/0000-0001-7098-7240; Schreiber, Robert/0000-0003-1590-2341				COCKFIELD SM, 1990, J IMMUNOL, V144, P2967; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Engel AM, 1997, SCAND J IMMUNOL, V45, P463, DOI 10.1046/j.1365-3083.1997.d01-419.x; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; HALLORAN PF, 1992, J IMMUNOL, V148, P3837; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; SCHREIBER H, 1972, JNCI-J NATL CANCER I, V49, P1107; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063	10	53	56	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					3	4		10.1038/ni0104-3	http://dx.doi.org/10.1038/ni0104-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699396				2022-12-18	WOS:000187635800002
J	Smale, ST				Smale, ST			The establishment and maintenance of lymphocyte identity through gene silencing	NATURE IMMUNOLOGY			English	Review							POLYCOMB-GROUP GENES; HISTONE-H3 LYSINE-9 METHYLATION; T-CELL DEVELOPMENT; DNA METHYLATION; X-INACTIVATION; CD4 GENE; TRANSCRIPTIONAL REPRESSION; NUCLEAR-ORGANIZATION; CHROMATIN STRUCTURE; METHYLTRANSFERASE ACTIVITY	Cell identity is determined by selective gene activation and by the maintenance of other regulated genes in a silent state. Although activation mechanisms have been dissected in considerable depth, great strides towards an understanding of the molecular control of gene silencing have been made only recently. Molecular hallmarks of silent chromatin and proteins involved in its assembly and maintenance have been identified through genetic, cytological and biochemical studies in a variety of organisms. Immunologists are now beginning to use this knowledge to elucidate mechanisms underlying cell fate decisions and key developmental steps. This review surveys the current knowledge of gene silencing, with an emphasis on studies in lymphocytes that are advancing our general understanding of silencing mechanisms during development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.							Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; Annunziato AT, 2000, GENE EXPRESSION, V9, P37; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD A, 1999, CELL, V7, P889; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dhillon N, 2002, CURR OPIN GENET DEV, V12, P188, DOI 10.1016/S0959-437X(02)00285-X; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Feng Q, 2001, GENE DEV, V15, P827; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Fisher AG, 2002, NAT REV IMMUNOL, V2, P977, DOI 10.1038/nri958; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hasegawa M, 1998, MOL IMMUNOL, V35, P559, DOI 10.1016/S0161-5890(98)00048-0; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jenuwein H, 2002, SCIENCE, V297, P2215, DOI 10.1126/science.1077903; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim WWS, 1999, J EXP MED, V190, P281, DOI 10.1084/jem.190.2.281; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mostoslavsky R, 1997, BBA-REV CANCER, V1333, pF29, DOI 10.1016/S0304-419X(97)00010-3; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Ringrose L, 2001, BIOESSAYS, V23, P566, DOI 10.1002/bies.1082; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; Tie F, 2001, DEVELOPMENT, V128, P275; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Wheeler JC, 2000, SEMIN CELL DEV BIOL, V11, P369, DOI 10.1006/scdb.2000.0184; WHITE RA, 1996, CELL, V47, P311; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	119	53	58	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					607	615		10.1038/ni0703-607	http://dx.doi.org/10.1038/ni0703-607			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830135				2022-12-18	WOS:000183952500003
J	Dowell, AC; Butler, MS; Jinks, E; Tut, G; Lancaster, T; Sylla, P; Begum, J; Bruton, R; Pearce, H; Verma, K; Logan, N; Tyson, G; Spalkova, E; Margielewska-Davies, S; Taylor, GS; Syrimi, E; Baawuah, F; Beckmann, J; Okike, I; Ahmad, S; Garstang, J; Brent, AJ; Brent, B; Ireland, G; Aiano, F; Amin-Chowdhury, Z; Jones, S; Borrow, R; Linley, E; Wright, J; Azad, R; Waiblinger, D; Davis, C; Thomson, E; Palmarini, M; Willett, BJ; Barclay, WS; Poh, J; Amirthalingam, G; Brown, KE; Ramsay, ME; Zuo, JM; Moss, P; Ladhani, S				Dowell, Alexander C.; Butler, Megan S.; Jinks, Elizabeth; Tut, Gokhan; Lancaster, Tara; Sylla, Panagiota; Begum, Jusnara; Bruton, Rachel; Pearce, Hayden; Verma, Kriti; Logan, Nicola; Tyson, Grace; Spalkova, Eliska; Margielewska-Davies, Sandra; Taylor, Graham S.; Syrimi, Eleni; Baawuah, Frances; Beckmann, Joanne; Okike, Ifeanyichukwu; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J.; Brent, Bernadette; Ireland, Georgina; Aiano, Felicity; Amin-Chowdhury, Zahin; Jones, Samuel; Borrow, Ray; Linley, Ezra; Wright, John; Azad, Rafaq; Waiblinger, Dagmar; Davis, Chris; Thomson, Emma; Palmarini, Massimo; Willett, Brian J.; Barclay, Wendy S.; Poh, John; Amirthalingam, Gayatri; Brown, Kevin E.; Ramsay, Mary E.; Zuo, Jianmin; Moss, Paul; Ladhani, Shamez			Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection	NATURE IMMUNOLOGY			English	Article							CORONAVIRUS; COVID-19; OC43; 229E; NL63	SARS-CoV-2 infection is milder in children, but direct comparison with adults is rare. Here the authors show that immune responses are higher in children, retained for 12 months or longer and can neutralize Alpha, Beta and Delta variants. SARS-CoV-2 infection is generally mild or asymptomatic in children but a biological basis for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged 3-11 years) and adults. Antibody responses against spike protein were high in children and seroconversion boosted responses against seasonal Beta-coronaviruses through cross-recognition of the S2 domain. Neutralization of viral variants was comparable between children and adults. Spike-specific T cell responses were more than twice as high in children and were also detected in many seronegative children, indicating pre-existing cross-reactive responses to seasonal coronaviruses. Importantly, children retained antibody and cellular responses 6 months after infection, whereas relative waning occurred in adults. Spike-specific responses were also broadly stable beyond 12 months. Therefore, children generate robust, cross-reactive and sustained immune responses to SARS-CoV-2 with focused specificity for the spike protein. These findings provide insight into the relative clinical protection that occurs in most children and might help to guide the design of pediatric vaccination regimens.	[Dowell, Alexander C.; Butler, Megan S.; Jinks, Elizabeth; Tut, Gokhan; Lancaster, Tara; Sylla, Panagiota; Begum, Jusnara; Bruton, Rachel; Pearce, Hayden; Verma, Kriti; Spalkova, Eliska; Margielewska-Davies, Sandra; Taylor, Graham S.; Syrimi, Eleni; Zuo, Jianmin; Moss, Paul] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Logan, Nicola; Tyson, Grace; Davis, Chris; Thomson, Emma; Palmarini, Massimo; Willett, Brian J.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Baawuah, Frances; Okike, Ifeanyichukwu; Ireland, Georgina; Aiano, Felicity; Amin-Chowdhury, Zahin; Jones, Samuel; Poh, John; Amirthalingam, Gayatri; Brown, Kevin E.; Ramsay, Mary E.; Ladhani, Shamez] Publ Hlth England, 61 Colindale Ave, London, England; [Beckmann, Joanne] East London NHS Fdn Trust, London, England; [Okike, Ifeanyichukwu] Univ Hosp Derby & Burton NHS Fdn Trust, Derby, England; [Ahmad, Shazaad] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Garstang, Joanna] Birmingham Community Healthcare NHS Trust, Aston, England; [Garstang, Joanna] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Brent, Andrew J.; Brent, Bernadette] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Brent, Andrew J.] Univ Oxford, Wellington Sq, Oxford, England; [Borrow, Ray; Linley, Ezra] Manchester Royal Infirm, Publ Hlth England, Manchester, Lancs, England; [Wright, John; Azad, Rafaq; Waiblinger, Dagmar] Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Barclay, Wendy S.] Imperial Coll, Dept Infect Dis, London, England; [Ladhani, Shamez] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	University of Birmingham; University of Glasgow; Public Health England; University of Birmingham; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Public Health England; University of Manchester; Imperial College London; St Georges University London	Moss, P (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	p.moss@bham.ac.uk	Willett, Brian J/F-3396-2011; Thomson, Emma C/M-8690-2017; Moss, Paul/D-1728-2009	Thomson, Emma C/0000-0003-1482-0889; Poh, John/0000-0003-2874-4290; davis, chris/0000-0002-7317-3266; Ireland, Georgina/0000-0001-8932-2783; Zuo, Jianmin/0000-0002-8341-465X; Tyson, Grace/0000-0001-9496-5660; Barclay, Wendy/0000-0002-3948-0895; Pearce, Hayden/0000-0002-8380-8122; Moss, Paul/0000-0002-6895-1967; Dowell, Alexander/0000-0002-1909-7047; Lancaster, Tara/0000-0002-2872-4794; Garstang, Joanna/0000-0001-9268-0581	UK Research and Innovation (UKRI)/National Institute for Health Research through the UK Coronavirus Immunology Consortium; G2P-UK National Virology Consortium - UKRI [MR/W005611/1]; Medical Research Council [MC UU 1201412]	UK Research and Innovation (UKRI)/National Institute for Health Research through the UK Coronavirus Immunology Consortium; G2P-UK National Virology Consortium - UKRI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly funded by UK Research and Innovation (UKRI)/National Institute for Health Research through the UK Coronavirus Immunology Consortium (P.M.). We acknowledge support from the G2P-UK National Virology Consortium (no. MR/W005611/1) funded by the UKRI (W. S.B., M.P.). The study was also funded in part by the Medical Research Council (no. MC UU 1201412, C.D., B.J.W.). We thank the staff, parents and especially the children at Addison Primary School, Avonmore Primary School, Beacon Primary, Canon Johnson CofE Primary, Carpenters Primary School, Cravenwood Primary, Curzon CofE Primary School, Didsbury CofE Primary, Ellen Wilkinson Primary School, Europa School UK, Hallsville Primary School, Hertsmere Jewish Primary School (Rimon), Highgate School, Kay Rowe Nursery School, Kilburn Grange, Little Eaton Primary School, London Fields (Hammersmith), Manor Primary School, Melcombe School, Milford Primary, Monega Primary School, Normand Croft School (Hammersmith), Park Primary School, Parochial CofE Primary and Nursery School, Portway Primary, Rimon Jewish Primary School (Rimon), Sandringham Primary School, Sacks Morasha Jewish Primary School (Rimon), Scott Wilkie Primary School, Selwyn Primary School, Shaftesbury Primary School, Southern Road Primary School, St Anne's CofE Lydgate Primary, St Edward's Catholic Primary School, St John's CofE Primary, St Mary's Catholic Primary School, St Paul's CofE Primary, St Peter's Smithills Dean CofE Primary School, St. Joseph's Primary, Unity Community Primary, Wolfson Hillel Primary School (Rimon) and Zaytouna Primary School for their participation in this study, without whom this work would not have been possible.	Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; [Anonymous], 2021, PROT BLAST; Bartsch YC, 2021, NAT MED, V27, P454, DOI 10.1038/s41591-021-01263-3; Bates TA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25479-6; Bird PK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7222-2; Booth A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247461; Chan KH, 2005, CLIN DIAGN LAB IMMUN, V12, P1317, DOI 10.1128/CDLI.12.11.1317-1321.2005; Cohen CA, 2021, NAT COMMUN, V12, DOI [10.1101/2021.02.02.21250988, 10.1038/s41467-021-24938-4]; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Cook AM, 2021, J IMMUNOL METHODS, V494, DOI 10.1016/j.jim.2021.113046; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davis C, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1010022; Dijkman R, 2008, J CLIN MICROBIOL, V46, P2368, DOI 10.1128/JCM.00533-08; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Flood J, 2021, LANCET REG HEALTH-EU, V3, DOI 10.1016/j.lanepe.2021.100075; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Khan T, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144499; Ladhani SN, 2021, LANCET CHILD ADOLESC, V5, P417, DOI 10.1016/S2352-4642(21)00061-4; Madera S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81934-w; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meade P, 2020, MBIO, V11, DOI 10.1128/mBio.03243-19; Neeland MR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21414-x; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Reynolds CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abf3698; Rihn SJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001091; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Saletti G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78506-9; Shaman J, 2020, SCIENCE, V370, P527, DOI 10.1126/science.abe5960; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; Tosif S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19545-8; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Westerhuis BM., 2020, MEDRXIV, DOI [DOI 10.1101/2020.10.10.20210070, 10.1101/2020.10.10.20210070]; Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	39	52	53	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					40	+		10.1038/s41590-021-01089-8	http://dx.doi.org/10.1038/s41590-021-01089-8		DEC 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937928	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000733875700001
J	Hildreth, AD; Ma, FY; Wong, YY; Sun, R; Pellegrini, M; O'Sullivan, TE				Hildreth, Andrew D.; Ma, Feiyang; Wong, Yung Yu; Sun, Ryan; Pellegrini, Matteo; O'Sullivan, Timothy E.			Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity	NATURE IMMUNOLOGY			English	Article								White adipose tissue (WAT) is an essential regulator of energy storage and systemic metabolic homeostasis. Regulatory networks consisting of immune and structural cells are necessary to maintain WAT metabolism, which can become impaired during obesity in mammals. Using single-cell transcriptomics and flow cytometry, we unveil a large-scale comprehensive cellular census of the stromal vascular fraction of healthy lean and obese human WAT. We report new subsets and developmental trajectories of adipose-resident innate lymphoid cells, dendritic cells and monocyte-derived macrophage populations that accumulate in obese WAT. Analysis of cell-cell ligand-receptor interactions and obesity-enriched signaling pathways revealed a switch from immunoregulatory mechanisms in lean WAT to inflammatory networks in obese WAT. These results provide a detailed and unbiased cellular landscape of homeostatic and inflammatory circuits in healthy human WAT. Immune cells exert important effects on white adipose tissue (WAT) in metabolic diseases. O'Sullivan and colleagues generate a comprehensive single-cell atlas of WAT cells in both health and disease to identify new cellular networks and differentiation trajectories.	[Hildreth, Andrew D.; Wong, Yung Yu; Sun, Ryan; O'Sullivan, Timothy E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Hildreth, Andrew D.; O'Sullivan, Timothy E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Ma, Feiyang; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Ma, Feiyang; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	O'Sullivan, TE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; O'Sullivan, TE (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	tosullivan@mednet.ucla.edu	Ma, Feiyang/GLN-6180-2022; O'Sullivan, Timothy/D-3422-2018	Pellegrini, Matteo/0000-0001-9355-9564; Ma, Feiyang/0000-0002-6260-0787; O'Sullivan, Timothy/0000-0003-1435-8188	Ruth L. Kirschstein National Research Service [AI007323]; National Institutes of Health [P30DK063491, AI145997]; Whitcome Fellowship at UCLA	Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Fellowship at UCLA	We thank members of the following labs for helpful discussions: A. Freud, T.E.O., M.P. and M. Su. We thank D. Barrett for discarded surgical subcutaneous adipose tissue samples. We thank R. Modlin for assistance with IPA. A.D.H was supported by the Ruth L. Kirschstein National Research Service (award no. AI007323). T.E.O. was supported by the National Institutes of Health (grant nos. P30DK063491 and AI145997). F.M. was supported by the Whitcome Fellowship at UCLA.	Bar-Ephraim YE, 2019, J IMMUNOL, V202, P171, DOI 10.4049/jimmunol.1701153; Bar-Ephraim YE, 2017, CELL REP, V21, P823, DOI 10.1016/j.celrep.2017.09.070; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Cuff AO, 2016, J IMMUNOL, V197, P4283, DOI 10.4049/jimmunol.1601424; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Gulati GS, 2020, SCIENCE, V367, P405, DOI 10.1126/science.aax0249; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Holmes TD, 2014, P NATL ACAD SCI USA, V111, pE5688, DOI 10.1073/pnas.1411072112; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kim HM, 2011, FEBS LETT, V585, P579, DOI 10.1016/j.febslet.2011.01.011; Kim J, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2015.51; Koay HF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay6039; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Macdougall CE, 2018, CELL METAB, V27, P588, DOI 10.1016/j.cmet.2018.02.007; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Mittelsteadt KL., 2019, J IMMUNOL, V202; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015; Raredon MSB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw3851; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Roden M, 2019, NATURE, V576, P51, DOI 10.1038/s41586-019-1797-8; Shafiei-Jahani P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18601-7; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stewart BJ, 2019, SCIENCE, V365, P1461, DOI 10.1126/science.aat5031; Sun WF, 2020, NATURE, V587, P98, DOI 10.1038/s41586-020-2856-x; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zhao JJ, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0157-z; ZHENG GX, 2017, NATURE, V0008	58	52	52	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					639	+		10.1038/s41590-021-00922-4	http://dx.doi.org/10.1038/s41590-021-00922-4		APR 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33907320	Green Accepted, Green Submitted			2022-12-18	WOS:000644803000001
J	Guilliams, M; Svedberg, FR				Guilliams, Martin; Svedberg, Freya R.			Does tissue imprinting restrict macrophage plasticity?	NATURE IMMUNOLOGY			English	Article							SURFACTANT PROTEIN-A; RESIDENT ALVEOLAR MACROPHAGES; FETAL MONOCYTES; CELLULAR-RESPONSE; DENDRITIC CELLS; I INTERFERON; LUNG; INFECTION; HEMATOPOIESIS; INFLAMMATION	Macrophages have long been considered as particularly plastic cells. However, recent work combining fate mapping, single-cell transcriptomics and epigenetics has undermined the macrophage plasticity dogma. Here, we discuss recent studies that have carefully dissected the response of individual macrophage subsets to pulmonary insults and call for an adjustment of the macrophage plasticity concept. We hypothesize that prolonged tissue residency shuts down much of the plasticity of macrophages and propose that the restricted plasticity of resident macrophages has been favored by evolution to safeguard tissue homeostasis. Recruited monocytes are more plastic and their differentiation into resident macrophages during inflammation can result in a dual imprinting from both the ongoing inflammation and the macrophage niche. This results in inflammation-imprinted resident macrophages, and we speculate that rewired niche circuits could maintain this inflammatory state. We believe that this revisited plasticity model offers opportunities to reset the macrophage pool after a severe inflammatory episode.	[Guilliams, Martin; Svedberg, Freya R.] VIB Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Ghent, Belgium; [Guilliams, Martin; Svedberg, Freya R.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Guilliams, M; Svedberg, FR (corresponding author), VIB Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Ghent, Belgium.; Guilliams, M; Svedberg, FR (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	martin.guilliams@ugent.vib.be; Freya.Svedberg@ugent.vib.be	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570				Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Aoshiba K, 2003, EUR RESPIR J, V22, P436, DOI 10.1183/09031936.03.00011903; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Archambaud C, 2010, EUR J IMMUNOL, V40, P3458, DOI 10.1002/eji.201040497; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Joshi N, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00646-2019; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kolter J, 2019, IMMUNITY, V50, P1482, DOI 10.1016/j.immuni.2019.05.009; Kulikauskaite J, 2020, TRENDS IMMUNOL, V41, P864, DOI 10.1016/j.it.2020.08.008; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; McGrath KE, 2015, SEMIN IMMUNOL, V27, P379, DOI 10.1016/j.smim.2016.03.013; McQuattie-Pimentel, 2019, AGING MICROENVIRONME, DOI DOI 10.1101/717033; Meziani L, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02120-2017; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Naessens T, 2012, AM J PATHOL, V181, P174, DOI 10.1016/j.ajpath.2012.03.015; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Polosukhin VV, 2012, EXP LUNG RES, V38, P135, DOI 10.3109/01902148.2012.658595; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sajti E, 2020, NAT IMMUNOL, V21, P221, DOI 10.1038/s41590-019-0582-z; Sano H, 1999, J IMMUNOL, V163, P387; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Sieweke MH, 2015, CELL STEM CELL, V16, P7, DOI 10.1016/j.stem.2014.12.009; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Trapnell BC, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0066-3; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Wainberg ZA, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.4_suppl.tps465; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Ydens E, 2020, NAT NEUROSCI, V23, P676, DOI 10.1038/s41593-020-0618-6; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007	93	52	54	3	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					118	127		10.1038/s41590-020-00849-2	http://dx.doi.org/10.1038/s41590-020-00849-2		JAN 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33462453	Bronze			2022-12-18	WOS:000608675100004
J	Verma, V; Jafarzadeh, N; Boi, S; Kundu, S; Jiang, ZN; Fan, YP; Lopez, J; Nandre, R; Zeng, P; Alolaqi, F; Ahmad, S; Gaur, P; Barry, ST; Valge-Archer, VE; Smith, PD; Banchereau, J; Mkrtichyan, M; Youngblood, B; Rodriguez, PC; Gupta, S; Khleif, SN				Verma, Vivek; Jafarzadeh, Nazli; Boi, Shannon; Kundu, Subhadip; Jiang, Zhinuo; Fan, Yiping; Lopez, Jose; Nandre, Rahul; Zeng, Peng; Alolaqi, Fatmah; Ahmad, Shamim; Gaur, Pankaj; Barry, Simon T.; Valge-Archer, Viia E.; Smith, Paul D.; Banchereau, Jacques; Mkrtichyan, Mikayel; Youngblood, Benjamin; Rodriguez, Paulo C.; Gupta, Seema; Khleif, Samir N.			MEK inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects	NATURE IMMUNOLOGY			English	Article							SIGNALING PATHWAY; COMBINATION; METABOLISM; PD-1; DIFFERENTIATION; ACTIVATION; EXPRESSION; ANTIGEN	Stem cell-like memory (T-SCM) CD8(+) T cells are beneficial in antitumor responses, in part due to their ability to self-renew. Khleif and colleagues demonstrate that inhibition of the kinase MEK in CD8(+) T cells favors induction of T-SCM and superior antitumor responses. Regenerative stem cell-like memory (T-SCM) CD8(+) T cells persist longer and produce stronger effector functions. We found that MEK1/2 inhibition (MEKi) induces T-SCM that have naive phenotype with self-renewability, enhanced multipotency and proliferative capacity. This is achieved by delaying cell division and enhancing mitochondrial biogenesis and fatty acid oxidation, without affecting T cell receptor-mediated activation. DNA methylation profiling revealed that MEKi-induced T-SCM cells exhibited plasticity and loci-specific profiles similar to bona fide T-SCM isolated from healthy donors, with intermediate characteristics compared to naive and central memory T cells. Ex vivo, antigenic rechallenge of MEKi-treated CD8(+) T cells showed stronger recall responses. This strategy generated T cells with higher efficacy for adoptive cell therapy. Moreover, MEKi treatment of tumor-bearing mice also showed strong immune-mediated antitumor effects. In conclusion, we show that MEKi leads to CD8(+) T cell reprogramming into T-SCM that acts as a reservoir for effector T cells with potent therapeutic characteristics.	[Verma, Vivek; Jafarzadeh, Nazli; Kundu, Subhadip; Jiang, Zhinuo; Lopez, Jose; Nandre, Rahul; Alolaqi, Fatmah; Gaur, Pankaj; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Loop Immunooncol Lab, Washington, DC 20007 USA; [Verma, Vivek; Zeng, Peng; Ahmad, Shamim; Rodriguez, Paulo C.; Gupta, Seema; Khleif, Samir N.] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA; [Boi, Shannon; Youngblood, Benjamin] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Ctr Appl Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Barry, Simon T.; Valge-Archer, Viia E.; Smith, Paul D.] AstraZeneca, Early Oncol, Biosci, Cambridge, England; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Nandre, Rahul] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Zeng, Peng] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Ahmad, Shamim] Kite Pharma, Emeryville, CA USA; [Rodriguez, Paulo C.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	Georgetown University; University System of Georgia; Augusta University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; AstraZeneca; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Case Western Reserve University; H Lee Moffitt Cancer Center & Research Institute	Khleif, SN (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Loop Immunooncol Lab, Washington, DC 20007 USA.; Khleif, SN (corresponding author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.	snk48@georgetown.edu	Rodríguez, Paulo/HDM-9539-2022; Gaur, Pankaj/AAG-2765-2020; Verma, Vivek/AFL-8809-2022; Gupta, Seema/AAK-9898-2020	Gaur, Pankaj/0000-0002-9718-3565; Verma, Vivek/0000-0001-8129-4140; Gupta, Seema/0000-0003-0106-595X; Jiang, Zhinuo/0000-0003-2059-2077; Rodriguez, Paulo/0000-0001-7480-6566	Georgia Cancer Center, Augusta University; NIH/NCI/CCSG grant [P30-CA051008]; NIH [S10OD016213, 1 R01 CA237311 01A1, R01-CA184185, R01-CA233512, P30-CA076292]; Florida Department of Health [20B04]	Georgia Cancer Center, Augusta University; NIH/NCI/CCSG grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health	We are grateful to Jeannie and Tony Loop for their generous support to SNK's laboratory. We acknowledge the Georgia Cancer Center, Augusta University internal support grant to S.N.K. and Flow Cytometry Core Facility at Lombardi Comprehensive Cancer Center. We acknowledge the Metabolomics and Flow Cytometry/Cell Sorting Shared Resource in Georgetown University, which is partially supported by NIH/NCI/CCSG grant P30-CA051008 and NIH S10 grant S10OD016213. We thank S. Bansal for technical assistance with LC-MS data acquisition and S. Li for LC-MS data processing and analysis. This study was supported in part by NIH grant 1 R01 CA237311 01A1 to B.Y. and NIH grants R01-CA184185, R01-CA233512 and P30-CA076292 and The Florida Department of Health grant no. 20B04 to P.C.R. We acknowledge the contribution of P. Finger from the electron microscopy service at the Jackson Laboratory for assistance with electron microscopy.	Abdelsamed HA, 2020, NAT IMMUNOL, V21, P578, DOI 10.1038/s41590-020-0633-5; Abdelsamed HA, 2017, J EXP MED, V214, P1593, DOI 10.1084/jem.20161760; Ahmed R, 2016, CELL REP, V17, P2811, DOI 10.1016/j.celrep.2016.11.037; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bhalla K, 2014, DIABETES, V63, P3266, DOI 10.2337/db13-1283; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; HONG JJ, 2013, PLOS ONE, V8; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Ibitokou SA, 2018, J IMMUNOL, V200, P643, DOI 10.4049/jimmunol.1602110; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; JI Y, 2014, PLOS ONE, V9; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Jones RG, 2017, IMMUNITY, V46, P730, DOI 10.1016/j.immuni.2017.04.028; Jung YW, 2016, P NATL ACAD SCI USA, V113, P8278, DOI 10.1073/pnas.1602899113; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; Kretschmer L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13788-w; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lin KY, 1996, CANCER RES, V56, P21; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Ruby CE, 2007, EUR J IMMUNOL, V37, P157, DOI 10.1002/eji.200636428; Rusilowicz M, 2016, METABOLOMICS, V12; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; SCHUMANN J, 2015, PLOS ONE, V10; Shrimali RK, 2017, CANCER IMMUNOL RES, V5, P755, DOI 10.1158/2326-6066.CIR-17-0292; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Terada Y, 1999, KIDNEY INT, V56, P1258, DOI 10.1046/j.1523-1755.1999.00704.x; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; Traves PG, 2012, J IMMUNOL, V188, P1402, DOI 10.4049/jimmunol.1101781; Troiani T, 2012, BRIT J CANCER, V106, P1648, DOI 10.1038/bjc.2012.129; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Verma V, 2019, NAT IMMUNOL, V20, P1231, DOI 10.1038/s41590-019-0441-y; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whittaker E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33499-4; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	56	52	52	6	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					53	56		10.1038/s41590-020-00818-9	http://dx.doi.org/10.1038/s41590-020-00818-9		NOV 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33230330				2022-12-18	WOS:000591944600001
J	Suzuki, T; Hidaka, T; Kumagai, Y; Yamamoto, M				Suzuki, Takafumi; Hidaka, Takanori; Kumagai, Yoshito; Yamamoto, Masayuki			Environmental pollutants and the immune response	NATURE IMMUNOLOGY			English	Review							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR NRF2; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; OXIDATIVE STRESS; ATOPIC-DERMATITIS; AIR-POLLUTION; ALLERGIC SENSITIZATION; PROMOTER POLYMORPHISM; ENDOCRINE DISRUPTORS	Environmental pollution is one of the most serious challenges to health in the modern world. Pollutants alter immune responses and can provoke immunotoxicity. In this Review, we summarize the major environmental pollutants that are attracting wide-ranging concern and the molecular basis underlying their effects on the immune system. Xenobiotic receptors, including the aryl hydrocarbon receptor (AHR), sense and respond to a subset of environmental pollutants by activating the expression of detoxification enzymes to protect the body. However, chronic activation of the AHR leads to immunotoxicity. KEAP1-NRF2 is another important system that protects the body against environmental pollutants. KEAP1 is a sensor protein that detects environmental pollutants, leading to activation of the transcription factor NRF2. NRF2 protects the body from immunotoxicity by inducing the expression of genes involved in detoxification, antioxidant and anti-inflammatory activities. Intervening in these sensor-response systems could protect the body from the devastating immunotoxicity that can be induced by environmental pollutants. Exposure to environmental pollutants can lead to immune system dysfunction with severe pathological consequences. Yamamoto and colleagues review the impact of pollutants on immune function and describe potential means to ameliorate these effects.	[Suzuki, Takafumi; Hidaka, Takanori; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Ibaraki, Japan	Tohoku University; University of Tsukuba	Yamamoto, M (corresponding author), Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan.	masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Takafumi/ABC-6582-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Takafumi/0000-0002-3425-8208	MEXT/JSPS KAKENHI [19H05649, 17KK0183, 19K07340]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [JP20am0101095]; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from AMED [JP20cm0106101]; Core Research for Evolutional Science and Technology (CREST) (chronic inflammation) from AMED; Takeda Science Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from AMED; Core Research for Evolutional Science and Technology (CREST) (chronic inflammation) from AMED(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank T. O'Connor at Trinity College Dublin for critical reading and professional editing of the manuscript. This work was supported in part by MEXT/JSPS KAKENHI (19H05649 to M. Y. and 17KK0183 and 19K07340 to T. S.), the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under grant no. JP20am0101095, the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from AMED under grant no. JP20cm0106101, the Core Research for Evolutional Science and Technology (CREST) (chronic inflammation) from AMED, and the Takeda Science Foundation (T.S.).	Alexandrov K, 2010, TOXICOL LETT, V198, P63, DOI 10.1016/j.toxlet.2010.04.009; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Arisawa T, 2008, HEPATO-GASTROENTEROL, V55, P394; Arisawa T, 2007, INT J MOL MED, V19, P143; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Bennett PM, 2001, ENVIRON POLLUT, V112, P33, DOI 10.1016/S0269-7491(00)00105-6; Bent S, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0218-4; Boru UT, 2020, ACTA NEUROL SCAND, V141, P431, DOI 10.1111/ane.13223; Brennecke D, 2016, ESTUAR COAST SHELF S, V178, P189, DOI 10.1016/j.ecss.2015.12.003; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Chen JG, 2019, AM J CLIN NUTR, V110, P675, DOI 10.1093/ajcn/nqz122; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Chu I, 1996, FOOD CHEM TOXICOL, V34, P267, DOI 10.1016/0278-6915(95)00112-3; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; COOK JA, 1975, P SOC EXP BIOL MED, V150, P741, DOI 10.3181/00379727-150-39117; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; DEAN JH, 1983, CLIN EXP IMMUNOL, V52, P199; DEHEER C, 1994, TOXICOL APPL PHARM, V128, P97, DOI 10.1006/taap.1994.1185; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; DURRIN LK, 1987, MOL CELL BIOL, V7, P3008, DOI 10.1128/MCB.7.8.3008; Edamitsu T, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00190-19; EWERS U, 1982, ENVIRON RES, V29, P351, DOI 10.1016/0013-9351(82)90036-6; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866; Fent K, 1996, CRIT REV TOXICOL, V26, P3, DOI 10.3109/10408449609089891; Fiorito F, 2017, ENVIRON RES, V153, P27, DOI 10.1016/j.envres.2016.11.004; Flora S. J. S., 2009, Al Ameen Journal of Medical Sciences, V2, P4; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; FOTH H, 1988, FOOD CHEM TOXICOL, V26, P45, DOI 10.1016/0278-6915(88)90040-3; Fries G F, 1995, Rev Environ Contam Toxicol, V141, P71; Furman DP, 2009, COMPUT BIOL CHEM, V33, P465, DOI 10.1016/j.compbiolchem.2009.10.004; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Ganguly K, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0122-2017; Gauthier PT, 2014, AQUAT TOXICOL, V154, P253, DOI 10.1016/j.aquatox.2014.05.026; Germolec Dori, 2017, Current Opinion in Toxicology, V5, P55, DOI 10.1016/j.cotox.2017.08.002; GLEICHMANN E, 1989, ARCH TOXICOL, V63, P257, DOI 10.1007/BF00278639; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hayashi M, 2015, MOL CELL BIOL, V35, P3590, DOI 10.1128/MCB.00506-15; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hidaka T, 2017, NAT IMMUNOL, V18, P64, DOI 10.1038/ni.3614; Higashi C, 2017, EUR J PHARMACOL, V802, P76, DOI 10.1016/j.ejphar.2017.02.044; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Horne BD, 2018, AM J RESP CRIT CARE, V198, P759, DOI [10.1164/rccm.201709-1883OC, 10.1164/rccm.201709-1883oc]; Hua CC, 2010, DIS MARKERS, V28, P185, DOI [10.1155/2010/143142, 10.3233/DMA-2010-0700]; Hudson CA, 2003, J TOXICOL ENV HEAL A, V66, P895, DOI 10.1080/15287390306456; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Inadera H, 2006, TOXICOL LETT, V164, P191, DOI 10.1016/j.toxlet.2006.03.006; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Iso T, 2016, MOL CELL BIOL, V36, P3100, DOI 10.1128/MCB.00389-16; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jakober CA, 2007, ENVIRON SCI TECHNOL, V41, P4548, DOI 10.1021/es062967u; Jedrychowski WA, 2010, PEDIAT ALLERG IMM-UK, V21, pE723, DOI 10.1111/j.1399-3038.2010.01034.x; Jiang ZY, 2014, J MED CHEM, V57, P2736, DOI 10.1021/jm5000529; KAO J, 1985, TOXICOL APPL PHARM, V81, P502, DOI 10.1016/0041-008X(85)90421-1; Kato T, 2013, TOXICOL APPL PHARM, V273, P10, DOI 10.1016/j.taap.2013.08.029; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Keleku-Lukwete N, 2019, BLOOD ADV, V3, P1285, DOI 10.1182/bloodadvances.2018017574; Keleku-Lukwete N, 2015, P NATL ACAD SCI USA, V112, P12169, DOI 10.1073/pnas.1509158112; Kensler TW, 2012, CARCINOGENESIS, V33, P101, DOI 10.1093/carcin/bgr229; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; KERKVLIET NI, 1990, ENVIRON RES, V52, P146, DOI 10.1016/S0013-9351(05)80249-X; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kirschvink N, 2006, FREE RADICAL RES, V40, P241, DOI 10.1080/10715760500494657; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kumagai Y, 2017, CHEM RES TOXICOL, V30, P203, DOI 10.1021/acs.chemrestox.6b00326; KURATSUN.M, 1971, HEALTH SERV REP, V86, P1083, DOI 10.2307/4594392; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Lawrence DA, 2002, INT IMMUNOPHARMACOL, V2, P293, DOI 10.1016/S1567-5769(01)00180-1; Lazzara PR, 2020, J MED CHEM, V63, P6547, DOI 10.1021/acs.jmedchem.9b01074; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Leffel EK, 2003, TOXICOLOGY, V188, P233, DOI 10.1016/S0300-483X(03)00092-1; Lehmann I, 2011, METAL IONS LIFE SCI, V8, P157, DOI 10.1039/978184973211600157; Li B, 2013, EXP NEUROL, V250, P239, DOI 10.1016/j.expneurol.2013.10.002; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Liska D J, 1998, Altern Med Rev, V3, P187; LUSTER MI, 1994, TOXICOLOGY, V92, P229, DOI 10.1016/0300-483X(94)90180-5; Luster MI, 2014, J IMMUNOTOXICOL, V11, P197, DOI 10.3109/1547691X.2013.837121; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; McMillan BJ, 2007, J BIOL CHEM, V282, P12590, DOI 10.1074/jbc.M611446200; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Nadeem A, 2019, BEHAV BRAIN RES, V364, P213, DOI 10.1016/j.bbr.2019.02.031; Nagai N, 2009, FREE RADICAL BIO MED, V47, P300, DOI 10.1016/j.freeradbiomed.2009.04.033; Nagashima R, 2019, J IMMUNOL, V202, P1331, DOI 10.4049/jimmunol.1801180; Naidu SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26269-9; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; Noel S, 2015, J AM SOC NEPHROL, V26, P2989, DOI 10.1681/ASN.2014100978; Okada K, 2012, J GASTROENTEROL, V47, P924, DOI 10.1007/s00535-012-0552-9; Pareek TK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00201; Pavlova SI, 2000, MUTAT RES-GEN TOX EN, V466, P57, DOI 10.1016/S1383-5718(00)00003-6; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Perzanowski MS, 2013, J ALLERGY CLIN IMMUN, V131, P886, DOI 10.1016/j.jaci.2012.12.666; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Queiroz MLS, 1997, IMMUNOPHARM IMMUNOT, V19, P499, DOI 10.3109/08923979709007671; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Ritz B, 1998, ARCH ENVIRON HEALTH, V53, P272, DOI 10.1080/00039899809605708; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Saito M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020202; Saito R, 2016, MOL CELL BIOL, V36, P271, DOI 10.1128/MCB.00868-15; SAPIN C, 1977, CLIN EXP IMMUNOL, V28, P173; Sharma RS, 2018, CELL MOL GASTROENTER, V5, P367, DOI 10.1016/j.jcmgh.2017.11.016; Sharma RK, 2005, J ENVIRON BIOL, V26, P301; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Sireesh D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22913-6; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; SNOEIJ NJ, 1988, INT J IMMUNOPHARMACO, V10, P891, DOI 10.1016/0192-0561(88)90014-8; SPENGLER JD, 1983, SCIENCE, V221, P9, DOI 10.1126/science.6857273; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Suzuki T, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00063-17; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Talbot J, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1609-9; Tauchi M, 2005, MOL CELL BIOL, V25, P9360, DOI 10.1128/MCB.25.21.9360-9368.2005; Temchura VV, 2005, EUR J IMMUNOL, V35, P2738, DOI 10.1002/eji.200425641; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Totlandsdal AI, 2012, TOXICOL LETT, V208, P262, DOI 10.1016/j.toxlet.2011.10.025; Turley AE, 2015, CYTOKINE, V71, P289, DOI 10.1016/j.cyto.2014.11.006; Uruno A, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00467-19; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Weisglas-Kuperus N, 2004, TOXICOL LETT, V149, P281, DOI 10.1016/j.toxlet.2003.12.039; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023618; Wu Q, 2017, J IMMUNOL, V198, P3069, DOI 10.4049/jimmunol.1601532; Yagishita Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24193593; Yagishita Y, 2019, J ENDOCRINOL, V240, P403, DOI 10.1530/JOE-18-0355; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yamamoto T, 2004, BIOCHEM BIOPH RES CO, V321, P72, DOI 10.1016/j.bbrc.2004.06.112; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38619	176	52	52	12	64	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1486	1495		10.1038/s41590-020-0802-6	http://dx.doi.org/10.1038/s41590-020-0802-6		OCT 2020	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33046888				2022-12-18	WOS:000577043300003
J	Kulkarni, S; Lied, A; Kulkarni, V; Rucevic, M; Martin, MP; Walker-Sperling, V; Anderson, SK; Ewy, R; Singh, S; Nguyen, H; McLaren, PJ; Viard, M; Naranbhai, V; Zou, C; Lin, ZS; Gatanaga, H; Oka, S; Takiguchi, M; Thio, CL; Margolick, J; Kirk, GD; Goedert, JJ; Hoots, WK; Deeks, SG; Haas, DW; Michael, N; Walker, B; Le Gall, S; Chowdhury, FZ; Yu, XG; Carrington, M				Kulkarni, Smita; Lied, Alexandra; Kulkarni, Viraj; Rucevic, Marijana; Martin, Maureen P.; Walker-Sperling, Victoria; Anderson, Stephen K.; Ewy, Rodger; Singh, Sukhvinder; Nguyen, Hoang; McLaren, Paul J.; Viard, Mathias; Naranbhai, Vivek; Zou, Chengcheng; Lin, Zhansong; Gatanaga, Hiroyuki; Oka, Shinichi; Takiguchi, Masafumi; Thio, Chloe L.; Margolick, Joseph; Kirk, Gregory D.; Goedert, James J.; Hoots, W. Keith; Deeks, Steven G.; Haas, David W.; Michael, Nelson; Walker, Bruce; Le Gall, Sylvie; Chowdhury, Fatema Z.; Yu, Xu G.; Carrington, Mary			CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome	NATURE IMMUNOLOGY			English	Article							LONG NONCODING RNAS; HOST GENETIC-VARIATION; MESSENGER-RNA; VIRUS REPLICATION; EXPRESSION; INFECTION; PROGRESSION; CELLS; HEPATITIS; DENSITY	Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis for the strongest of these associations, rs1015164A/G, is unknown. We found that rs1015164 marks variation in an activating transcription factor 1 binding site that controls expression of the antisense long noncoding RNA (lncRNA) CCR5AS. Knockdown or enhancement of CCR5AS expression resulted in a corresponding change in CCR5 expression on CD4(+) Tcells. CCR5AS interfered with interactions between the RNA-binding protein Raly and the CCR5 3' untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation. Reduction in CCR5 expression through inhibition of CCR5AS diminished infection of CD4(+) Tcells with CCR5-tropic HIV in vitro. These data represent a rare determination of the functional importance of a genome-wide disease association where expression of a lncRNA affects HIV infection and disease progression.	[Kulkarni, Smita; Ewy, Rodger; Singh, Sukhvinder; Nguyen, Hoang] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Kulkarni, Smita; Lied, Alexandra; Kulkarni, Viraj; Rucevic, Marijana; Naranbhai, Vivek; Walker, Bruce; Le Gall, Sylvie; Chowdhury, Fatema Z.; Yu, Xu G.; Carrington, Mary] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kulkarni, Smita; Lied, Alexandra; Kulkarni, Viraj; Rucevic, Marijana; Naranbhai, Vivek; Walker, Bruce; Le Gall, Sylvie; Chowdhury, Fatema Z.; Yu, Xu G.; Carrington, Mary] Harvard Univ, Cambridge, MA 02138 USA; [Rucevic, Marijana] Olink Prote, Watertown, MA USA; [Martin, Maureen P.; Anderson, Stephen K.; Viard, Mathias; Carrington, Mary] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21701 USA; [Walker-Sperling, Victoria] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [McLaren, Paul J.] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada; [McLaren, Paul J.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Zou, Chengcheng; Lin, Zhansong; Gatanaga, Hiroyuki; Oka, Shinichi; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Thio, Chloe L.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Margolick, Joseph] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Kirk, Gregory D.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Goedert, James J.] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Rockville, MD USA; [Hoots, W. Keith] NHLBI, Div Blood Dis & Resources, NIH, Bldg 10, Bethesda, MD 20892 USA; [Deeks, Steven G.] San Francisco Gen Hosp, Med Ctr, San Francisco, CA 94110 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Michael, Nelson] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Walker, Bruce] Howard Hughes Med Inst, Chevy Chase, MD USA; [Walker, Bruce] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Texas Biomedical Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Public Health Agency of Canada; University of Manitoba; Kumamoto University; National Center for Global Health & Medicine - Japan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); San Francisco General Hospital Medical Center; Vanderbilt University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kulkarni, S (corresponding author), Texas Biomed Res Inst, San Antonio, TX 78227 USA.; Kulkarni, S; Carrington, M (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kulkarni, S; Carrington, M (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Carrington, M (corresponding author), Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21701 USA.	skulkarni@txbiomed.org; carringm@mail.nih.gov	Singh, Sukhvinder/I-8846-2019	Le Gall, Sylvie/0000-0003-0385-926X; Zou, Chengcheng/0000-0003-4802-723X; Oka, Shinichi/0000-0002-9283-2167; Deeks, Steven/0000-0001-6371-747X; Anderson, Stephen/0000-0002-7856-4266; Lin, Zhansong/0000-0001-9714-442X	NIAID [AI120900, AI140956]; HU-CFAR; Cowles fellowship; Texas Biomedical Research Institute; Ragon Institute of MGH, MIT and Harvard; Frederick National Laboratory [HHSN261200800001E]; Intramural Research Program of the NIH; Frederick National Lab; Center for Cancer Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL146201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069496, R21AI140956, U01AI035042, R21AI120900] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HU-CFAR; Cowles fellowship; Texas Biomedical Research Institute; Ragon Institute of MGH, MIT and Harvard; Frederick National Laboratory; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Lab; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by NIAID (grant nos AI120900 and AI140956 to S.K.), HU-CFAR (to S.K.), Cowles fellowship (to S. S.), institutional funds from the Texas Biomedical Research Institute and the Ragon Institute of MGH, MIT and Harvard. This project has been funded in whole or in part with federal funds from the Frederick National Laboratory (contract no. HHSN261200800001E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Lab and Center for Cancer Research. See extended acknowledgements in Supplementary Information for full details.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chen YG, 2017, NAT IMMUNOL, V18, P962, DOI 10.1038/ni.3771; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Gervaix A, 2002, J INFECT DIS, V185, P1055, DOI 10.1086/339802; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Joshi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00192-x; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Li H, 2016, GENES IMMUN, V17, P66, DOI 10.1038/gene.2015.56; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren PJ, 2015, P NATL ACAD SCI USA, V112, P14658, DOI 10.1073/pnas.1514867112; McLaren PJ, 2015, NAT IMMUNOL, V16, P577, DOI 10.1038/ni.3147; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Naranbhai V, 2017, IMMUNOGENETICS, V69, P489, DOI 10.1007/s00251-017-1000-z; Naruto T, 2012, J VIROL, V86, P10870, DOI 10.1128/JVI.00689-12; Noh JH, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1471; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Picton ACP, 2012, IMMUNOLOGY, V136, P397, DOI 10.1111/j.1365-2567.2012.03592.x; Qiu LP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01621; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Rautanen A, 2016, AM J HUM GENET, V98, P1092, DOI 10.1016/j.ajhg.2016.03.025; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; Reynes J, 2004, JAMA-J AM MED ASSOC, V291, P46, DOI 10.1001/jama.291.1.46; Sciaranghella G, 2015, J INFECT DIS, V212, P1397, DOI 10.1093/infdis/jiv233; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Thio CL, 2007, J VIROL, V81, P441, DOI 10.1128/JVI.01897-06; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	61	52	57	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					824	+		10.1038/s41590-019-0406-1	http://dx.doi.org/10.1038/s41590-019-0406-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31209403	Green Accepted, Green Submitted			2022-12-18	WOS:000471891900014
J	Knier, B; Hiltensperger, M; Sie, C; Aly, L; Lepennetier, G; Engleitner, T; Garg, G; Muschaweckh, A; Mitsdorffer, M; Koedel, U; Hochst, B; Knolle, P; Gunzer, M; Hemmer, B; Rad, R; Merkler, D; Korn, T				Knier, Benjamin; Hiltensperger, Michael; Sie, Christopher; Aly, Lilian; Lepennetier, Gildas; Engleitner, Thomas; Garg, Garima; Muschaweckh, Andreas; Mitsdoerffer, Meike; Koedel, Uwe; Hoechst, Bastian; Knolle, Percy; Gunzer, Matthias; Hemmer, Bernhard; Rad, Roland; Merkler, Doron; Korn, Thomas			Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; MOUSE MODEL; ENCEPHALOMYELITIS; MICE; INFLAMMATION; NEUTROPHILS; ACTIVATION; INITIATION; EXPRESSION	Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) have been characterized in the context of malignancies. Here we show that PMN-MDSCs can restrain B cell accumulation during central nervous system (CNS) autoimmunity. Ly6G(+) cells were recruited to the CNS during experimental autoimmune encephalomyelitis (EAE), interacted with B cells that produced the cytokines GM-CSF and interleukin-6 (IL-6), and acquired properties of PMN-MDSCs in the CNS in a manner dependent on the signal transducer STAT3. Depletion of Ly6G(+) cells or dysfunction of Ly6G(+) cells through conditional ablation of STAT3 led to the selective accumulation of GM-CSF-producing B cells in the CNS compartment, which in turn promoted an activated microglial phenotype and lack of recovery from EAE. The frequency of CD138(+) B cells in the cerebrospinal fluid (CSF) of human subjects with multiple sclerosis was negatively correlated with the frequency of PMN-MDSCs in the CSF. Thus PMN-MDSCs might selectively control the accumulation and cytokine secretion of B cells in the inflamed CNS.	[Knier, Benjamin; Hiltensperger, Michael; Sie, Christopher; Aly, Lilian; Lepennetier, Gildas; Garg, Garima; Muschaweckh, Andreas; Mitsdoerffer, Meike; Korn, Thomas] Tech Univ Munich, Dept Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany; [Knier, Benjamin; Aly, Lilian; Lepennetier, Gildas; Mitsdoerffer, Meike; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Engleitner, Thomas; Rad, Roland] Tech Univ Munich, Inst Mol Oncol & Funct Genom, TranslaTUM Canc Ctr, Munich, Germany; [Engleitner, Thomas; Rad, Roland] Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, Munich, Germany; [Koedel, Uwe] Ludwig Maximilians Univ Munchen, Dept Neurol, Klinikum Grosshadern, Munich, Germany; [Hoechst, Bastian; Knolle, Percy] Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Gunzer, Matthias] Univ Duisburg Essen, Univ Hosp Essen, Inst Expt Immunol & Imaging, Essen, Germany; [Hemmer, Bernhard; Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Merkler, Doron] Univ Geneva, Div Clin Pathol, Dept Pathol & Immunol, Geneva, Switzerland	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; University of Duisburg Essen; University of Munich; University of Geneva	Korn, T (corresponding author), Tech Univ Munich, Dept Expt Neuroimmunol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	thomas.korn@tum.de	Korn, Thomas/AAE-6960-2019; Höchst, Bastian/ABG-2094-2020; Gunzer, Matthias/AAW-7026-2021; Hemmer, Bernhard/GPX-8451-2022; Merkler, Doron/N-9157-2016; Hemmer, Bernhard/AAT-8388-2021; Knier, Benjamin/AAB-3222-2019	Korn, Thomas/0000-0002-3633-0955; Höchst, Bastian/0000-0002-5567-1173; Gunzer, Matthias/0000-0002-5534-6055; Hemmer, Bernhard/0000-0001-5985-6784; Merkler, Doron/0000-0002-0247-2007; Muschaweckh, Andreas/0000-0002-6870-1378; Knier, Benjamin/0000-0003-4187-9472; Lepennetier, Gildas/0000-0002-1899-3149; Hiltensperger, Michael/0000-0003-4600-1394; Aly, Lilian/0000-0002-7051-124X; Knolle, Percy A./0000-0003-2983-0414	Deutsche Forschungsgemeinschaft [SFB1054-B06, TRR128]; German Ministry of Education and Research (BMBF, T-B in NMO); ERC [CoG 647215]; Technical University of Munich; Deutsche Forschungsgemeinschaft (Synergy); Swiss National Science Foundation; Deutsche Forschungsgemeinschaft (Kompetenznetz Multiple Sklerose KKNMS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF, T-B in NMO)(Federal Ministry of Education & Research (BMBF)); ERC(European Research Council (ERC)European Commission); Technical University of Munich; Deutsche Forschungsgemeinschaft (Synergy); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (Kompetenznetz Multiple Sklerose KKNMS)(German Research Foundation (DFG))	We thank all members of the Korn Group and especially V. Husterer for her skillful technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (SFB1054-B06 to T.K., TRR128 to T.K., SyNergy to T.K. and Kompetenznetz Multiple Sklerose KKNMS to B.K.), the German Ministry of Education and Research (BMBF, T-B in NMO to T.K.,) and by the ERC (CoG 647215 to T.K.). B.K. received intramural funding from the Technical University of Munich. L.A. is supported by a clinical scientist program provided by the Deutsche Forschungsgemeinschaft (Synergy). D.M. is supported by the Swiss National Science Foundation.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Arocena AR, 2014, EUR J IMMUNOL, V44, P184, DOI 10.1002/eji.201343606; Bartosik-Psujek H, 2005, EUR J NEUROL, V12, P49, DOI 10.1111/j.1468-1331.2004.00951.x; Bennett JL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000104; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cheretakis C, 2006, BLOOD, V108, P2821, DOI 10.1182/blood-2006-04-018184; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Dabritz J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20584; Dufait I, 2016, ONCOTARGET, V7, P42698, DOI 10.18632/oncotarget.8311; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Flach AC, 2016, P NATL ACAD SCI USA, V113, P3323, DOI 10.1073/pnas.1519608113; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gotot J, 2012, P NATL ACAD SCI USA, V109, P10468, DOI 10.1073/pnas.1201131109; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Koutrolos M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0163-1; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; LAPPAT EJ, 1964, CANCER RES, V24, P302; Lelis FJN, 2017, IMMUNOL LETT, V188, P108, DOI 10.1016/j.imlet.2017.07.003; Levesque SA, 2016, J EXP MED, V213, P929, DOI 10.1084/jem.20151437; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Li Y, 2014, J IMMUNOL, V193, P2127, DOI 10.4049/jimmunol.1400857; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Park MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2717, DOI 10.1002/art.39767; Pierson ER, 2018, CLIN IMMUNOL, V189, P23, DOI 10.1016/j.clim.2016.06.017; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rumble JM, 2015, J EXP MED, V212, P23, DOI 10.1084/jem.20141015; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Steinbach K, 2013, J IMMUNOL, V191, P4531, DOI 10.4049/jimmunol.1202613; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Takeda K, 1998, J IMMUNOL, V161, P4652; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Wang C, 2017, J IMMUNOL, V199, P3094, DOI 10.4049/jimmunol.1700671; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xu X, 2017, CELL MOL IMMUNOL, V14, P597, DOI 10.1038/cmi.2015.103; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zehntner SP, 2005, J IMMUNOL, V174, P5124, DOI 10.4049/jimmunol.174.8.5124	60	52	53	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1341	+		10.1038/s41590-018-0237-5	http://dx.doi.org/10.1038/s41590-018-0237-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30374128	Green Accepted			2022-12-18	WOS:000452873000015
J	McKinney, EF; Smith, KGC				McKinney, E. F.; Smith, K. G. C.			Metabolic exhaustion in infection, cancer and autoimmunity	NATURE IMMUNOLOGY			English	Review							T-CELL EXHAUSTION; CHRONIC VIRAL-INFECTION; FORKHEAD TRANSCRIPTION FACTOR; INHIBITORY RECEPTOR PD-1; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; MEMORY; DIFFERENTIATION; SURVIVAL; FOXO1	It has become increasingly clear that changes in metabolism are not just consequences of T cell activation but instead are also essential drivers of that process that shape the extent and nature of differentiation and function. The process of T cell exhaustion has been linked to the outcome of chronic immune responses in multiple contexts, including chronic infection, cancer and autoimmunity. Factors that regulate the development and maintenance of exhaustion are of increasing interest as targets of therapeutic modulation. Studies have shown T cell immunometabolism to be integral to the control and development of T cell exhaustion. Early metabolic changes are responsible for the later emergence of exhaustion, do not simply reflect changes secondary to chronic activation and are modifiable. Increased understanding of this metabolic control promises to improve the ability to modulate T cell immunity to chronic antigen stimulation in multiple contexts.	[McKinney, E. F.; Smith, K. G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge Biomed Campus, Cambridge, England	University of Cambridge	McKinney, EF (corresponding author), Univ Cambridge, Sch Clin Med, Dept Med, Cambridge Biomed Campus, Cambridge, England.	efm30@medschl.cam.ac.uk		Smith, Kenneth/0000-0003-3829-4326				Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fisicaro P, 2017, NAT MED, V23, P327, DOI 10.1038/nm.4275; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freitag J, 2016, IMMUNOL CELL BIOL, V94, P925, DOI 10.1038/icb.2016.77; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Long SA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7793; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McKinney EF, 2016, IMMUNOL CELL BIOL, V94, P935, DOI 10.1038/icb.2016.81; McKinney EF, 2016, CURR OPIN IMMUNOL, V43, P74, DOI 10.1016/j.coi.2016.09.005; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Oldstone MBA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000523; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sullivan JA, 2012, J VIROL, V86, P9025, DOI 10.1128/JVI.00942-12; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Tkachev V, 2015, J IMMUNOL, V194, P5789, DOI 10.4049/jimmunol.1402180; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004; Zhao J, 2017, NAT GENET, V49, P433, DOI 10.1038/ng.3782; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	90	52	54	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					213	221		10.1038/s41590-018-0045-y	http://dx.doi.org/10.1038/s41590-018-0045-y			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29403049	Green Submitted			2022-12-18	WOS:000427007500011
J	Torre, S; Polyak, MJ; Langlais, D; Fodil, N; Kennedy, JM; Radovanovic, I; Berghout, J; Leiva-Torres, GA; Krawczyk, CM; Ilangumaran, S; Mossman, K; Liang, C; Knobeloch, KP; Healy, LM; Antel, J; Arbour, N; Prat, A; Majewski, J; Lathrop, M; Vidal, SM; Gros, P				Torre, Sabrina; Polyak, Maria J.; Langlais, David; Fodil, Nassima; Kennedy, James M.; Radovanovic, Irena; Berghout, Joanne; Leiva-Torres, Gabriel A.; Krawczyk, Connie M.; Ilangumaran, Subburaj; Mossman, Karen; Liang, Chen; Knobeloch, Klaus-Peter; Healy, Luke M.; Antel, Jack; Arbour, Nathalie; Prat, Alexandre; Majewski, Jacek; Lathrop, Mark; Vidal, Silvia M.; Gros, Philippe			USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation	NATURE IMMUNOLOGY			English	Article							CEREBRAL MALARIA DEVELOPMENT; E3 UBIQUITIN LIGASE; DEUBIQUITYLATING ENZYME; DISEASE; PROTECTION; MORTALITY; CHILDREN; FINGER; MODELS	Genes and pathways in which inactivation dampens tissue inflammation present new opportunities for understanding the pathogenesis of common human inflammatory diseases, including inflammatory bowel disease, rheumatoid arthritis and multiple sclerosis. We identified a mutation in the gene encoding the deubiquitination enzyme USP15 (Usp15(L749R)) that protected mice against both experimental cerebral malaria (ECM) induced by Plasmodium berghei and experimental autoimmune encephalomyelitis (EAE). Combining immunophenotyping and RNA sequencing in brain (ECM) and spinal cord (EAE) revealed that Usp15(L749)R-associated resistance to neuroinflammation was linked to dampened type I interferon responses in situ. In hematopoietic cells and in resident brain cells, USP15 was coexpressed with, and functionally acted together with the E3 ubiquitin ligase TRIM25 to positively regulate type I interferon responses and to promote pathogenesis during neuroinflammation. The USP15-TRIM25 dyad might be a potential target for intervention in acute or chronic states of neuroinflammation.	[Torre, Sabrina; Leiva-Torres, Gabriel A.; Majewski, Jacek; Lathrop, Mark; Vidal, Silvia M.; Gros, Philippe] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Torre, Sabrina; Polyak, Maria J.; Langlais, David; Fodil, Nassima; Kennedy, James M.; Radovanovic, Irena; Berghout, Joanne; Leiva-Torres, Gabriel A.; Vidal, Silvia M.; Gros, Philippe] McGill Univ, McGill Ctr Complex Traits, Montreal, PQ, Canada; [Polyak, Maria J.; Langlais, David; Fodil, Nassima; Kennedy, James M.; Radovanovic, Irena; Berghout, Joanne; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Krawczyk, Connie M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Ilangumaran, Subburaj] Univ Sherbrooke, Dept Pediat, Fac Med, Sherbrooke, PQ, Canada; [Mossman, Karen] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Liang, Chen] Lady Davis Inst Med Res, Dept Med, Montreal, PQ, Canada; [Knobeloch, Klaus-Peter] Univ Clin Freiburg, Inst Neuropathol, Freiburg, Germany; [Healy, Luke M.; Antel, Jack] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Arbour, Nathalie; Prat, Alexandre] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Majewski, Jacek; Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Majewski, Jacek; Lathrop, Mark] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; University of Sherbrooke; McMaster University; Lady Davis Institute; McGill University; University of Freiburg; McGill University; Universite de Montreal; McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Gros, P (corresponding author), McGill Univ, McGill Ctr Complex Traits, Montreal, PQ, Canada.; Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca	Healy, Luke/Y-5604-2019; Langlais, David/ABE-8455-2020; Berghout, Joanne/M-5493-2017	Healy, Luke/0000-0001-9496-2216; Langlais, David/0000-0003-4429-0110; Berghout, Joanne/0000-0002-9250-9159; Radovanovic, Irena/0000-0002-3823-3729; Prat, Alexandre/0000-0001-6188-0580; Ilangumaran, Subburaj/0000-0002-7563-576X; Polyak, Maria/0000-0003-3762-9278; Leiva-Torres, Gabriel Andre/0000-0002-8144-1443; Arbour, Nathalie/0000-0002-3718-1584; antel, jack/0000-0002-5148-0636	Canadian Institutes of Health Research [MOP119342, MOP133487]; Amorchem [PT63088]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amorchem	We thank R. Van Bruggen, S. Gauthier, P. D'Arcy and G. Perreault for assistance in the ENU project, and C. Meunier for technical assistance. Supported by the Canadian Institutes of Health Research (MOP119342 and MOP133487 to P.G. and S.V.) and Amorchem (PT63088).	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Ball EA, 2013, J IMMUNOL, V190, P5118, DOI 10.4049/jimmunol.1300114; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berghout J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003491; Bongfen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031012; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Caignard G, 2014, GENES-BASEL, V5, P887, DOI 10.3390/genes5040887; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Cornelissen T, 2014, HUM MOL GENET, V23, P5227, DOI 10.1093/hmg/ddu244; de Jong RN, 2006, J BIOL CHEM, V281, P5026, DOI 10.1074/jbc.M510993200; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Fodil N, 2016, TRENDS IMMUNOL, V37, P126, DOI 10.1016/j.it.2015.12.006; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Iyengar PV, 2015, SCI REP-UK, V5, DOI 10.1038/srep14733; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kennedy JM, 2014, J EXP MED, V211, P2519, DOI 10.1084/jem.20140455; Kim H, 2014, INFECT IMMUN, V82, P371, DOI 10.1128/IAI.01246-13; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Longley R, 2011, MAMM GENOME, V22, P32, DOI 10.1007/s00335-010-9302-6; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Miller JL, 2014, CELL REP, V7, P436, DOI 10.1016/j.celrep.2014.03.018; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palomo J, 2013, EUR J IMMUNOL, V43, P2683, DOI 10.1002/eji.201343327; Pauli EK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004577; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Senaldi G, 1999, J IMMUNOL, V163, P6820; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Torre S, 2013, GENES IMMUN, V14, P249, DOI 10.1038/gene.2013.16; Torre S, 2015, INFECT IMMUN, V83, P759, DOI 10.1128/IAI.02586-14; Villeneuve NF, 2013, MOL CELL, V51, P68, DOI 10.1016/j.molcel.2013.04.022; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11220; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	49	52	52	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					54	63		10.1038/ni.3581	http://dx.doi.org/10.1038/ni.3581			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27721430				2022-12-18	WOS:000390080000010
J	Navarro, MN; Cantrell, DA				Navarro, Maria N.; Cantrell, Doreen A.			Serine-threonine kinases in TCR signaling	NATURE IMMUNOLOGY			English	Review							T-LYMPHOCYTE ACTIVATION; QUANTITATIVE PHOSPHOPROTEOMIC ANALYSIS; PATHOGENIC T(H)17 CELLS; KRUPPEL-LIKE FACTOR-2; PROTEIN-KINASE; ANTIGEN RECEPTOR; MTOR COMPLEX; PKC-THETA; PHOSPHOINOSITIDE 3-KINASE; SERINE/THREONINE KINASES	T lymphocyte proliferation and differentiation are controlled by signaling pathways initiated by the T cell antigen receptor. Here we explore how key serine-threonine kinases and their substrates mediate T cell signaling and coordinate T cell metabolism to meet the metabolic demands of participating in an immune response.	[Navarro, Maria N.] Univ Autonoma Madrid, Hosp Univ Princesa, Inst Invest Sanitaria, Madrid, Spain; [Cantrell, Doreen A.] Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland	Autonomous University of Madrid; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk		Navarro, Maria N./0000-0003-3977-812X	Wellcome Trust [097418] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bar-Peled L., 2014, TRENDS CELL BIOL; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dustin ML, 2011, NAT IMMUNOL, V12, P1031, DOI 10.1038/ni.2141; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Lin JX, 2008, BLOOD, V111, P525, DOI 10.1182/blood-2007-02-072207; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Lovric J, 1998, J BIOL CHEM, V273, P22848; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Matthews SA, 2009, IMMUNOL REV, V228, P241, DOI 10.1111/j.1600-065X.2008.00759.x; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Nakaya M., 2014, IMMUNITY; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Preston GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077537; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Ruperez P, 2012, MOL CELL PROTEOMICS, V11, P171, DOI 10.1074/mcp.M112.017863; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; WEISS A, 1984, J IMMUNOL, V133, P123; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	99	52	53	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					808	814		10.1038/ni.2941	http://dx.doi.org/10.1038/ni.2941			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137455	Green Accepted			2022-12-18	WOS:000340739400004
J	Begitt, A; Droescher, M; Meyer, T; Schmid, CD; Baker, M; Antunes, F; Owen, MR; Naumann, R; Decker, T; Vinkemeier, U				Begitt, Andreas; Droescher, Mathias; Meyer, Thomas; Schmid, Christoph D.; Baker, Michelle; Antunes, Filipa; Owen, Markus R.; Naumann, Ronald; Decker, Thomas; Vinkemeier, Uwe			STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; NUCLEAR ACCUMULATION; STAT1; SEQUENCE; GAMMA; PHOSPHORYLATION; GENE; INACTIVATION; RECRUITMENT; MACROPHAGES	STAT1 is an indispensable component of a heterotrimer (ISGF3) and a STAT1 homodimer (GAF) that function as transcription regulators in type 1 and type 2 interferon signaling, respectively. To investigate the importance of STAT1-cooperative DNA binding, we generated gene-targeted mice expressing cooperativity-deficient STAT1 with alanine substituted for Phe77. Neither ISGF3 nor GAF bound DNA cooperatively in the STAT1F77A mouse strain, but type 1 and type 2 interferon responses were affected differently. Type 2 interferon mediated transcription and antibacterial immunity essentially disappeared owing to defective promoter recruitment of GAF. In contrast, STAT1 recruitment to ISGF3 binding sites and type 1 interferon dependent responses, including antiviral protection, remained intact. We conclude that STAT1 cooperativity is essential for its biological activity and underlies the cellular responses to type 2, but not type 1 interferon.	[Begitt, Andreas; Droescher, Mathias; Antunes, Filipa; Vinkemeier, Uwe] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Meyer, Thomas] Univ Med Gottingen, Klin Psychosomat Med & Psychotherapie, Gottingen, Germany; [Schmid, Christoph D.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schmid, Christoph D.] Univ Basel, Basel, Switzerland; [Baker, Michelle; Owen, Markus R.] Univ Nottingham, Sch Math Sci, Ctr Math Med & Biol, Nottingham NG7 2RD, England; [Naumann, Ronald] Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany; [Decker, Thomas] Univ Vienna, Dept Mikrobiol & Immunbiol, Vienna, Austria	University of Nottingham; University of Gottingen; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Nottingham; Max Planck Society; University of Vienna	Vinkemeier, U (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	uwe.vinkemeier@nottingham.ac.uk	Owen, Markus/F-3082-2011	Owen, Markus/0000-0002-3028-9138; Vinkemeier, Uwe/0000-0001-6924-1783; Baker, Michelle/0000-0002-8926-7689	University of Nottingham Pump Priming; Deutsche Forschungsgemeinschaft [VI 218/3, ME 1648/4-1]; Austrian Science Foundation [SFB28]; Biotechnology and Biological Sciences Research Council [BB/G019290/1, BB/I532353/1]; Pfizer; Wellcome Trust; BBSRC [BB/G019290/1] Funding Source: UKRI; MRC [MR/L001276/1] Funding Source: UKRI; Austrian Science Fund (FWF) [F 2802] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [973180] Funding Source: researchfish; Medical Research Council [MR/L001276/1] Funding Source: researchfish	University of Nottingham Pump Priming; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Foundation(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Mee, C. Pelzel and N. Wenta for immunoblot or EMSA results; N. Salhat for data on Listeria-infected macrophages; V. Ruppert and). Staab for animal data; K.-P. Knobeloch, Universitat Freiburg, for advice and cloning reagents; U. Kalinke (Universitat Hannover) for VSV; L. Olohan (University of Liverpool) for microarray scanning; and K. Weber, E. Louis and I. Macdonald for manuscript review. Supported by University of Nottingham Pump Priming (U.V.), Deutsche Forschungsgemeinschaft (VI 218/3 to U.V. and ME 1648/4-1 to T.M.), Austrian Science Foundation (SFB28 to T.D.), Biotechnology and Biological Sciences Research Council (BB/G019290/1 to U.V. and BB/I532353/1 to M.B.), Pfizer (M.B.) and the Wellcome Trust (A.B.).	Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bonham AJ, 2013, NUCLEIC ACIDS RES, V41, P754, DOI 10.1093/nar/gks1085; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ptashne M, 2004, GENETIC SWITCH PHAGE; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Schmid CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011425; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Speil J, 2011, BIOPHYS J, V101, P2592, DOI 10.1016/j.bpj.2011.10.006; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Wormald S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-254; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	42	52	54	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					168	176		10.1038/ni.2794	http://dx.doi.org/10.1038/ni.2794			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24413774				2022-12-18	WOS:000330150600011
J	Hume, DA; Mabbott, N; Raza, S; Freeman, TC				Hume, David A.; Mabbott, Neil; Raza, Sobia; Freeman, Tom C.			Can DCs be distinguished from macrophages by molecular signatures?	NATURE IMMUNOLOGY			English	Letter							GENE-EXPRESSION; MONOCYTES; TISSUE		[Hume, David A.; Mabbott, Neil; Raza, Sobia; Freeman, Tom C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk	Hume, David A/C-7695-2013; Mabbott, Neil/AAF-8777-2020	Mabbott, Neil/0000-0001-7395-1796; Hume, David/0000-0002-2615-1478; Freeman, Thomas/0000-0001-5235-8483	BBSRC [BBS/E/D/20231759, BBS/E/D/05191131, BB/G022607/1, BB/F019726/1, BB/I001107/1, BBS/E/D/20251969, BBS/E/D/20211552] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231759, BBS/E/D/20251969] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019726/1, BBS/E/D/05191131, BB/I001107/1, BB/G022607/1, BBS/E/D/20211552] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hume DA, 2012, J LEUKOCYTE BIOL, V92, P433, DOI 10.1189/jlb.0312166; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; PAVLI P, 1990, IMMUNOLOGY, V70, P40; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142	12	52	52	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					187	189		10.1038/ni.2516	http://dx.doi.org/10.1038/ni.2516			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416664				2022-12-18	WOS:000315065400001
J	Wang, D; Zheng, MZ; Lei, L; Ji, J; Yao, YL; Qiu, YJ; Ma, L; Lou, J; Ouyang, C; Zhang, X; He, YW; Chi, J; Wang, L; Kuang, Y; Wang, JL; Cao, XT; Lu, LR				Wang, Di; Zheng, Mingzhu; Lei, Lei; Ji, Jian; Yao, Yunliang; Qiu, Yuanjun; Ma, Lie; Lou, Jun; Ouyang, Chuan; Zhang, Xue; He, Yuewei; Chi, Jun; Wang, Lie; Kuang, Ying; Wang, Jianli; Cao, Xuetao; Lu, Linrong			Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling	NATURE IMMUNOLOGY			English	Article							T-CELL DEVELOPMENT; NEGATIVE SELECTION; POSITIVE SELECTION; LINEAGE FATE; DIFFERENTIATION; APOPTOSIS; THEMIS; ACTIVATION; MECHANISMS; THRESHOLD	Signaling via the T cell antigen receptor (TCR) during the CD4(+)CD8(+) double-positive developmental stage determines thymocyte selection and lineage commitment. Here we describe a previously uncharacterized T cell-expressed protein, Tespa1, with critical functions during the positive selection of thymocytes. Tespa1(-/-) mice had fewer mature thymic CD4(+) and CD8(+) T cells, which reflected impaired thymocyte development. Tespa1 associated with the TCR signaling components PLC-gamma 1 and Grb2, and Tespa1 deficiency resulted in attenuated TCR signaling, as reflected by defective activation of the Erk-AP-1 and Ca2+-NFAT pathways. Our findings demonstrate that Tespa1 is a component of the TCR signalosome and is essential for T cell selection and maturation through the regulation of TCR signaling during T cell development.	[Wang, Di; Zheng, Mingzhu; Lei, Lei; Yao, Yunliang; Qiu, Yuanjun; Ma, Lie; Lou, Jun; Ouyang, Chuan; Wang, Lie; Wang, Jianli; Cao, Xuetao; Lu, Linrong] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Di; Zheng, Mingzhu; Lei, Lei; Yao, Yunliang; Qiu, Yuanjun; Ma, Lie; Lou, Jun; Ouyang, Chuan; Zhang, Xue; Lu, Linrong] Zhejiang Univ, Sch Med, Program Mol & Cellular Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Ji, Jian] Zhejiang Univ, Sch Med, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xue] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Yuewei; Chi, Jun; Kuang, Ying] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Naval Medical University; Naval Medical University	Lu, LR (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	lu_linrong@zju.edu.cn	wang, jian/GVS-0711-2022; Lu, Linrong/A-1429-2013; Zheng, Mingzhu/AAF-6010-2019; Zheng, Mingzhu/AAC-7818-2022	Zheng, Mingzhu/0000-0002-9399-9225; Yao, Yunliang/0000-0002-6864-2021; Lu, Linrong/0000-0002-0171-4115; Ouyang, Chuan/0000-0003-1667-191X	National Natural Science Foundation of China [30972724, 31070782, 30901311, 31170842]; Zhejiang Provincial Natural Science Foundation of China [R2090202, Y2090401]; National Basic Research Program of China (973 Program) [2011CB944100, 2012CB945004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	We thank X. Li, C. Xu and B. Li for discussions; H. Cantor, Y. Ke and H. Hu for critical reading; and A. Alison for assistance with manuscript editing. Supported by the National Natural Science Foundation of China (30972724 and 31070782 to L. L., and 30901311 and 31170842 to D. W.), the Zhejiang Provincial Natural Science Foundation of China (R2090202 to L. L., and Y2090401 to D. W.) and the National Basic Research Program of China (973 Program; 2011CB944100 and 2012CB945004 to L.L.).	AMARAL MC, 1993, IMMUNOLOGY, V79, P24; Anderson Graham, 2007, Methods Mol Biol, V380, P185; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CALNAN BJ, 1995, IMMUNITY, V3, P273; Cao YH, 2011, EMBO J, V30, P2083, DOI 10.1038/emboj.2011.116; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hermiston ML, 2009, P NATL ACAD SCI USA, V106, P546, DOI 10.1073/pnas.0811647106; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kane LP, 1996, J IMMUNOL, V156, P4594; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Penninger JM, 1998, ADV IMMUNOL, V68, P51, DOI 10.1016/S0065-2776(08)60558-1; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	34	52	67	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					560	+		10.1038/ni.2301	http://dx.doi.org/10.1038/ni.2301			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22561606				2022-12-18	WOS:000304203900010
J	O'Garra, A; Gabrysova, L; Spits, H				O'Garra, Anne; Gabrysova, Leona; Spits, Hergen			Quantitative events determine the differentiation and function of helper T cells	NATURE IMMUNOLOGY			English	Article							CYTOKINE GENE-EXPRESSION; DENDRITIC CELLS; RETINOIC-ACID; IMMUNE-SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; ANTIBODY PRODUCTION; LINEAGE COMMITMENT; REGULATORY CELLS; INTERLEUKIN 22; T(H)2 CELLS	In recent years, numerous qualitative discoveries have been made in immunology research. However, the effect of quantitative events, long recognized as the driving factors for determinism in developmental biology, that dictate the quality of the immune response elicited to an antigen in concert with microbial products still requires serious attention. Here we discuss how the often-neglected issue of quantification affects the specification, differentiation and commitment of helper T cells. As reductionist in vitro approaches have been instrumental in the elucidation of the factors determining the development of helper T cells, in this perspective we highlight the need for the standardization of protocols, also fundamental for the comparison of immune responses in mice and humans. Improving understanding of how these in vitro quantitative events translate to immune responses in vivo, which can be studied in mouse models, is of importance in obtaining information on immune responses in humans, thus empowering translational research.	[O'Garra, Anne; Gabrysova, Leona] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands	MRC National Institute for Medical Research; University of Amsterdam; Academic Medical Center Amsterdam	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Gabrysova, Leona/0000-0003-3529-1306; O'Garra, Anne/0000-0001-9845-6134	Medical Research Council UK; MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Langhorne, A. Potocnik, G. Kassiotis and A. Howes for review of the manuscript and comments, and P. Redford for compiling Figure 2. Supported by the Medical Research Council UK (A.O.G. and L.G.).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; Akdis CA, 2001, INT ARCH ALLERGY IMM, V124, P180, DOI 10.1159/000053704; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; DRESSER DW, 1962, IMMUNOLOGY, V5, P378; DRESSER DW, 1962, IMMUNOLOGY, V5, P161; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Gabrysova L, 2010, EUR J IMMUNOL, V40, P1386, DOI 10.1002/eji.200940151; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glimcher LH, 2000, GENE DEV, V14, P1693; GREEN JBA, 1991, TRENDS GENET, V7, P245, DOI 10.1016/0168-9525(91)90323-I; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Jakob T, 2008, J ALLERGY CLIN IMMUN, V121, P179, DOI 10.1016/j.jaci.2007.07.018; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oliveira VG, 2011, EUR J IMMUNOL, V41, P1249, DOI 10.1002/eji.201040896; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; SARAIVA M, 2009, NAT REV IMMUNOL, V10, P167; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tao X, 1997, J IMMUNOL, V159, P5956; Tato CM, 2008, IMMUNOL REV, V226, P103, DOI 10.1111/j.1600-065X.2008.00715.x; Trifari S, 2010, EUR J IMMUNOL, V40, P2369, DOI 10.1002/eji.201040848; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wohlfert E, 2010, MUCOSAL IMMUNOL, V3, P213, DOI 10.1038/mi.2010.11; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	100	52	52	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					288	294		10.1038/ni.2003	http://dx.doi.org/10.1038/ni.2003			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21423225				2022-12-18	WOS:000288593400006
J	Hitomi, K; Tahara-Hanaoka, S; Someya, S; Fujiki, A; Tada, H; Sugiyama, T; Shibayama, S; Shibuya, K; Shibuya, A				Hitomi, Kaori; Tahara-Hanaoka, Satoko; Someya, Satoru; Fujiki, Akira; Tada, Hideaki; Sugiyama, Tetsuya; Shibayama, Shiro; Shibuya, Kazuko; Shibuya, Akira			An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions	NATURE IMMUNOLOGY			English	Article							MAST-CELL ACTIVATION; FC-EPSILON-RI; SYSTEMIC-ANAPHYLAXIS; NEGATIVE REGULATION; BASOPHILS PLAY; GAMMA RIII; IGE; IDENTIFICATION; DEGRANULATION; MOTIFS	Anaphylaxis is a life-threatening immediate hypersensitivity reaction triggered by antigen capture by immunoglobulin E (IgE) bound to the high-affinity IgE receptor (Fc epsilon RI) on mast cells. However, the regulatory mechanism of mast cell activation is not completely understood. Here we identify an immunoglobulin-like receptor, Allergin-1, that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM)-like domain, and show it was preferentially expressed on mast cells. Mouse Allergin-1 recruited the tyrosine phosphatases SHP-1 and SHP-2 and the inositol phosphatase SHIP. Coligation of Allergin-1 and FceRI suppressed IgE-mediated degranulation of bone marrow-derived cultured mast cells. Moreover, mice deficient in Allergin-1 developed enhanced passive systemic and cutaneous anaphylaxis. Thus, Allergin-1 suppresses IgE-mediated, mast cell-dependent anaphylaxis in mice.	[Hitomi, Kaori; Tahara-Hanaoka, Satoko; Someya, Satoru; Shibuya, Kazuko; Shibuya, Akira] Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Fujiki, Akira; Tada, Hideaki; Sugiyama, Tetsuya; Shibayama, Shiro] Tsukuba Res Inst, Exploratory Res Labs, Tsukuba, Ibaraki, Japan	University of Tsukuba; Novartis	Shibuya, A (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan.	tokothr@md.tsukuba.ac.jp; ashibuya@md.tsukuba.ac.jp		Shibuya, Kazuko/0000-0002-8203-2342	Ministry of Education, Science and Culture of Japan; National Institute of Biomedical Innovation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	We thank T. Honjo, H. Karasuyama and K. Mukai for discussions and S. Mitsuishi for secretarial assistance. Supported by the Ministry of Education, Science and Culture of Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation.	AIZAWA S, 1994, EXP HEMATOL, V22, P482; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; BLANCHARD MM, 1994, GENET ANAL-BIOMOL E, V11, P7, DOI 10.1016/1050-3862(94)90003-5; Bruhns P, 1999, J IMMUNOL, V162, P3168; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Clark S, 2007, IMMUNOL ALLERGY CLIN, V27, P145, DOI 10.1016/j.iac.2007.03.002; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daheshia M, 2001, J EXP MED, V194, P227, DOI 10.1084/jem.194.2.227; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gebhardt T, 2005, GUT, V54, P928, DOI 10.1136/gut.2004.054650; Gebhardt T, 2005, EUR J IMMUNOL, V35, P1124, DOI 10.1002/eji.200425869; Hjertson M, 2003, J INVEST DERMATOL, V120, P239, DOI 10.1046/j.1523-1747.2003.12030.x; Ishida S, 2003, ALLERGY, V58, P1044, DOI 10.1034/j.1398-9995.2003.00270.x; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; JACOBY W, 1984, J INVEST DERMATOL, V83, P302, DOI 10.1111/1523-1747.ep12340431; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Jurgens L, 1996, EUR J IMMUNOL, V26, P84, DOI 10.1002/eji.1830260113; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Li LX, 2004, CELL MOL IMMUNOL, V1, P408; Lienard H, 1999, J BIOL CHEM, V274, P32493, DOI 10.1074/jbc.274.45.32493; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Malbec O, 1998, J IMMUNOL, V160, P1647; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oda H, 2009, J IMMUNOL, V182, P957, DOI 10.4049/jimmunol.182.2.957; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; PIROZZI G, 1995, J IMMUNOL, V155, P5811; Royer B, 2001, CLIN EXP ALLERGY, V31, P694, DOI 10.1046/j.1365-2222.2001.01069.x; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; Shibuya Akira, 2009, Immune Netw, V9, P41, DOI 10.4110/in.2009.9.2.41; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Xu R, 2001, J IMMUNOL, V167, P6394, DOI 10.4049/jimmunol.167.11.6394; Yamashita Y, 1998, J IMMUNOL, V161, P4042; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786	50	52	58	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					601	U61		10.1038/ni.1886	http://dx.doi.org/10.1038/ni.1886			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20526344	Green Submitted			2022-12-18	WOS:000278926400016
J	Tarakhovsky, A				Tarakhovsky, Alexander			Tools and landscapes of epigenetics	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; CHROMATIN MODIFICATIONS; HISTONE MODIFICATIONS; P53 ACTIVITY; TRANSCRIPTION; METHYLATION; PROTEIN; RNA; G9A		Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Tarakhovsky, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	tarakho@mail.rockefeller.edu						Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Carrera I, 2008, CURR OPIN GENET DEV, V18, P397, DOI 10.1016/j.gde.2008.07.007; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Henkels CH, 2007, MOL CELL, V27, P521, DOI 10.1016/j.molcel.2007.08.002; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Leperchey F., 1998, Morphologie, V82, P19; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; MOSAMMAPARAST N, 2010, ANN REV BIOCH   0407, DOI DOI 10.1146/ANNUREV.BIO-CHEM.78.070907.10394; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nolz JC, 2005, TRENDS CELL BIOL, V15, P514, DOI 10.1016/j.tcb.2005.08.003; Ogawa M, 2003, IMMUNOL LETT, V86, P57, DOI 10.1016/S0165-2478(02)00293-6; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Robertson A, 1977, Biogr Mem Fellows R Soc, V23, P575, DOI 10.1098/rsbm.1977.0022; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; WADDINGTON CH, 1939, INTRO MODERN GENETIC, P154; Weidner-Glunde M, 2010, FRONT BIOSCI-LANDMRK, V15, P537, DOI 10.2741/3632; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	60	52	54	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					565	568		10.1038/ni0710-565	http://dx.doi.org/10.1038/ni0710-565			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562839				2022-12-18	WOS:000278926400009
J	Jha, MK; Badou, A; Meissner, M; McRory, JE; Freichel, M; Flockerzi, V; Flavell, RA				Jha, Mithilesh K.; Badou, Abdallah; Meissner, Marcel; McRory, John E.; Freichel, Marc; Flockerzi, Veit; Flavell, Richard A.			Defective survival of naive CD8(+) T lymphocytes in the absence of the beta 3 regulatory subunit of voltage-gated calcium channels	NATURE IMMUNOLOGY			English	Article							CELL-ACTIVATION; CA2+ CHANNELS; MICE LACKING; PORE SUBUNIT; CRAC CHANNEL; FILAMIN-A; MEMBRANE; TRANSCRIPTION; SIGNAL; CALCINEURIN	The survival of T lymphocytes requires sustained, Ca2+ influx-dependent gene expression. The molecular mechanism that governs sustained Ca2+ influx in naive T lymphocytes is unknown. Here we report an essential role for the beta 3 regulatory subunit of voltage-gated calcium (Ca-v) channels in the maintenance of naive CD8(+) T cells. Deficiency in beta 3 resulted in a profound survival defect of CD8(+) T cells. This defect correlated with depletion of the pore-forming subunit Ca(v)1.4 and attenuation of T cell antigen receptor (TCR)-mediated global Ca2+ entry in CD8(+) T cells. Ca(v)1.4 and beta 3 associated with T cell signaling machinery and Ca(v)1.4 localized in lipid rafts. Our data demonstrate a mechanism by which Ca2+ entry is controlled by a Ca(v)1.4-beta 3 channel complex in T cells.	[Jha, Mithilesh K.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Badou, Abdallah] Univ Cadi Ayyad, Fac Polydisciplinaire Safi, Safi, Morocco; [Meissner, Marcel; Freichel, Marc; Flockerzi, Veit] Univ Saarland, Inst Expt & Clin Pharmacol & Toxicol, D-6650 Homburg, Germany; [McRory, John E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Saarland University; University of Calgary; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Tuluc, Petronel/C-2527-2011	Badou, Abdallah/0000-0003-4849-9085	Arthritis Foundation; Fondation pour la Recherche Medicale; Arthritis National Research Foundation; Deutsche Forschungsgemeinschaft; Homburger Forschungsforderungsprogramm; Canadian Institutes of Health Research; Howard Hughes Medical Institute	Arthritis Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Arthritis National Research Foundation(National Research Foundation of Korea); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Homburger Forschungsforderungsprogramm; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank E. Eynon for suggestions; F. Manzo for preparing the manuscript; C. Rathinam for critical reading of the manuscript; D. Butkus for thymectomies; T. Taylor for fluorescence-activated cell sorting; and F. Balamuth for advice on lipid raft isolation. Supported by the Arthritis Foundation (M.K.J.), the Fondation pour la Recherche Medicale (A.B.), the Arthritis National Research Foundation (A.B.), Deutsche Forschungsgemeinschaft (V.F. and M.F.), Homburger Forschungsforderungsprogramm (V.F. and M.F.), the Canadian Institutes of Health Research (J.E.M.) and the Howard Hughes Medical Institute (M.K.J., A.B. and R.A.F.).	Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Doering CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002538; Entschladen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263mr3; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Freise D, 1999, BIOL CHEM, V380, P897, DOI 10.1515/BC.1999.110; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gomes B, 2004, CRIT REV IMMUNOL, V24, P425, DOI 10.1615/CritRevImmunol.v24.i6.30; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hayashi K, 2006, J IMMUNOL, V177, P1721, DOI 10.4049/jimmunol.177.3.1721; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kim Ki-Bum, 2008, V424, P413, DOI 10.1007/978-1-60327-064-9_32; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manicassamy S, 2008, J IMMUNOL, V180, P106, DOI 10.4049/jimmunol.180.1.106; Markiewicz MA, 2003, EUR J IMMUNOL, V33, P2917, DOI 10.1002/eji.200324273; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Matza D, 2009, P NATL ACAD SCI USA, V106, P9785, DOI 10.1073/pnas.0902844106; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zweifach A, 2000, J CELL BIOL, V148, P603, DOI 10.1083/jcb.148.3.603	46	52	53	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1275	U7		10.1038/ni.1793	http://dx.doi.org/10.1038/ni.1793			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19838200	Green Accepted			2022-12-18	WOS:000271872800011
J	Glimcher, LH				Glimcher, Laurie H.			Trawling for treasure: tales of T-bet	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; IFN-GAMMA PRODUCTION; DENDRITIC CELLS; C-MAF; LINEAGE COMMITMENT; TH1; EXPRESSION; PROTEINS; ANTIGEN; GENE	Discovering the transcription factors that direct lineage commitment in the T helper cell was a formidable task. Laurie Glimcher describes how she and Susanne Szabo hunted down T-bet, a transcription factor that is a 'master regulator' of commitment to the T helper type 1 lineage.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu						Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; BOOTHBY M, 1988, SCIENCE, V242, P1559, DOI 10.1126/science.3144043; CANTOR H, 1975, J EXP MED, V141, P1376, DOI 10.1084/jem.141.6.1376; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; LIOU HC, 1988, SCIENCE, V242, P69, DOI 10.1126/science.3140376; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Peng SL, 2004, CANCER RES, V64, P452, DOI 10.1158/0008-5472.CAN-03-3401; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tantisira KG, 2004, P NATL ACAD SCI USA, V101, P18099, DOI 10.1073/pnas.0408532102; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	29	52	58	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					448	450		10.1038/ni0507-448	http://dx.doi.org/10.1038/ni0507-448			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440449				2022-12-18	WOS:000245831600004
J	Subramanian, N; Qadri, A				Subramanian, Naeha; Qadri, Ayub			Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-5; HUMAN DENDRITIC CELLS; LYSOPHOSPHATIDIC ACID; BACTERIAL FLAGELLIN; T-CELLS; MONOCLONAL-ANTIBODIES; PHOSPHOLIPASE A(2); IMMUNE-RESPONSE; CROHNS-DISEASE; TYPHOID-FEVER	Flagellin induces inflammatory and innate immune responses through activation of Toll-like receptor 5. Here we show that proinflammatory monomeric flagellin produced by salmonella during infection of intestinal epithelial cells was not derived from polymeric bacterial cell wall-associated flagellum but instead was synthesized and secreted de novo by the bacterium after direct sensing of host-produced lysophospholipids. Inhibition of lysophospholipid biosynthesis in intestinal epithelial cells reduced flagellin production and release from salmonella. Lysophospholipids induced a cAMP-dependent signaling pathway in salmonella that resulted in production and secretion of active flagellin. The induction of Toll-like receptor ligand synthesis and secretion by a host signal represents a previously unknown regulatory mechanism for inflammation and innate immunity during infection with a bacterial pathogen.	Natl Inst Immunol, Hybridoma Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Qadri, A (corresponding author), Natl Inst Immunol, Hybridoma Lab, New Delhi 110067, India.	ayub@nii.res.in		Subramanian, Naeha/0000-0003-3754-0521				Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; CHANTRET I, 1988, CANCER RES, V48, P1936; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; CondeFrieboes K, 1996, J AM CHEM SOC, V118, P5519, DOI 10.1021/ja953553w; Cookson BT, 1997, J IMMUNOL, V158, P4310; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; FRANSON RC, 1991, PROSTAG LEUKOTR ESS, V43, P63, DOI 10.1016/0952-3278(91)90173-3; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Henderson RJT, 1992, LIPID ANAL; Karlinsey JE, 2000, CELL, V102, P487, DOI 10.1016/S0092-8674(00)00053-2; KEUTER M, 1995, J INFECT DIS, V172, P305, DOI 10.1093/infdis/172.1.305; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; La Ragione RM, 2003, INT J MED MICROBIOL, V293, P261, DOI 10.1078/1438-4221-00263; MCCLEARY WR, 1993, SIGNAL TRANSDUCTION; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Ochoa-Reparaz J, 2004, VET RES, V35, P291, DOI 10.1051/vetres:2004011; Panther E, 2002, J IMMUNOL, V169, P4129, DOI 10.4049/jimmunol.169.8.4129; QADRI A, 1988, J CLIN MICROBIOL, V26, P2292, DOI 10.1128/JCM.26.11.2292-2296.1988; QADRI A, 1989, HYBRIDOMA, V8, P353, DOI 10.1089/hyb.1989.8.353; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Robertson JMC, 2003, J MED MICROBIOL, V52, P91, DOI 10.1099/jmm.0.04901-0; Sbrogio-Almeida ME, 2001, FEMS IMMUNOL MED MIC, V30, P203, DOI 10.1111/j.1574-695X.2001.tb01571.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668	47	52	54	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					583	589		10.1038/ni1336	http://dx.doi.org/10.1038/ni1336			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16648855				2022-12-18	WOS:000237751200013
J	McCarty, N; Paust, S; Ikizawa, K; Dan, I; Li, XY; Cantor, H				McCarty, N; Paust, S; Ikizawa, K; Dan, I; Li, XY; Cantor, H			Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; JUN NH2-TERMINAL KINASE; BCL-2 FAMILY MEMBER; POSITIVE SELECTION; C-JUN; MAMMALIAN-CELLS; GENE-EXPRESSION; JNK PATHWAY; APOPTOSIS; ACTIVATION	Signaling through the T cell antigen receptor leading to elimination (negative selection) or differentiation (positive selection) of developing thymocytes generates a self-tolerant T cell repertoire. Here we report that the serine-threonine kinase MINK selectively connects the T cell receptor to a signaling pathway that mediates negative but not positive selection. Analysis of this pathway suggested that the essential function of MINK in the elimination of self-reactive thymocytes may be associated with 'downstream' activation of Jun kinase and enhancement of expression of the proapoptotic molecule Bim.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Natl Food Res Inst, Div Food Engn, Tsukuba, Ibaraki 305, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu	Dan, Ippeita/F-9179-2011	Dan, Ippeita/0000-0002-1779-9205; Paust, Silke/0000-0002-0526-3999	NCI NIH HHS [T32 CA070083] Funding Source: Medline; NIAID NIH HHS [T32 AI07386] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007386] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 1998, P NATL ACAD SCI USA, V95, P2486, DOI 10.1073/pnas.95.5.2486; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Ali M, 2003, J IMMUNOL, V171, P6290, DOI 10.4049/jimmunol.171.11.6290; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Baribaud F, 2001, J VIROL, V75, P7453, DOI 10.1128/JVI.75.16.7453-7461.2001; Behrens A, 2001, P NATL ACAD SCI USA, V98, P1769, DOI 10.1073/pnas.98.4.1769; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Harris CA, 2001, J BIOL CHEM, V276, P37754; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; McCarty JH, 1998, BIOESSAYS, V20, P913, DOI 10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T; McCarty N, 2004, P NATL ACAD SCI USA, V101, P9339, DOI 10.1073/pnas.0402654101; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Zhan YF, 2003, P NATL ACAD SCI USA, V100, P1197, DOI 10.1073/pnas.0237316100	36	52	55	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					65	72		10.1038/ni1145	http://dx.doi.org/10.1038/ni1145			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15608642				2022-12-18	WOS:000225888500019
J	Johnston, JA; O'Shea, JJ				Johnston, JA; O'Shea, JJ			Matching SOCS with function	NATURE IMMUNOLOGY			English	Editorial Material							CYTOKINE	Overexpression studies suggest that SOCS3 is a pleiotropic negative regulator of cytokines. The generation of Socs3(-/-) mice indicates that SOCS3 actually functions in a remarkably specific manner.	Queens Univ Belfast, Dept Immunol, Belfast, Antrim, North Ireland; NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Johnston, JA (corresponding author), Queens Univ Belfast, Dept Immunol, Belfast, Antrim, North Ireland.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ASTUMI T, 1997, J EXP MED, V196, P979; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Karp CL, 2001, CURR OPIN NEUROL, V14, P361, DOI 10.1097/00019052-200106000-00016; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	10	52	53	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					507	509		10.1038/ni0603-507	http://dx.doi.org/10.1038/ni0603-507			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774070				2022-12-18	WOS:000183175500005
J	Myou, S; Sano, H; Fujimura, M; Zhu, XD; Kurashima, K; Kita, T; Nakao, S; Nonomura, A; Shioya, T; Kim, KP; Munoz, NM; Cho, WH; Leff, AR				Myou, S; Sano, H; Fujimura, M; Zhu, XD; Kurashima, K; Kita, T; Nakao, S; Nonomura, A; Shioya, T; Kim, KP; Munoz, NM; Cho, WH; Leff, AR			Blockade of eosinophil migration and airway hyperresponsiveness by cPLA(2)-inhibition	NATURE IMMUNOLOGY			English	Article							PLATELET-ACTIVATING-FACTOR; SENSITIZED GUINEA-PIGS; CYTOSOLIC PHOSPHOLIPASE A(2); INDUCED ASTHMATIC RESPONSES; M-2 MUSCARINIC RECEPTORS; FACTOR ANTAGONIST; INFLAMMATION; ACID; BRONCHOCONSTRICTION; RESPONSIVENESS	We examined the role of a cytosolic phospholipase A(2) (cPLA(2)) in antigen-induced eosinophil infiltration of airways and in airway hyperresponsiveness to methacholine. Inhibition of cPLA(2), or blockade of the platelet-activating faster (PAF) receptor, blocked antigen-induced airway hyperresponsiveness and suppressed eosinophil infiltration. Neither cyclooxygenase nor 5-lipoxygenase inhibition had either effect. We show here that, in antigen-sensitized guinea pigs, cPLA(2) inhibition prevents both eosinophilic infiltration and subsequent airway hyperresponsiveness after antigen challenge. We also show that this effect is mediated by first-step hydrolysis of membrane phospholipid into lysophospholipid rather than by prostanoid or leukotriene metabolites of arachidonate.	Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Kanazawa Univ Hosp, Pathol Sect, Kanazawa, Ishikawa 9208641, Japan; Univ Illinois, Dept Chem, Chicago, IL 60680 USA; Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 9208641, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Clin Pharmacol & Cell Physiol, Chicago, IL 60637 USA	University of Chicago; Kanazawa University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Kanazawa University; University of Chicago; University of Chicago	Leff, AR (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA.	aleff@medicine.bsd.uchicago.edu		Kim, Kwang Pyo/0000-0003-0095-3787; zhu, xiangdong/0000-0002-5627-8082; Kita, Toshiyuki/0000-0001-6158-7683	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, R01HL046368] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-56399, R01-HL46368] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON P, 1981, INT ARCH ALLER A IMM, V64, P249, DOI 10.1159/000232701; ARIMA M, 1995, CHEST, V108, P529, DOI 10.1378/chest.108.2.529; ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Chilton FH, 1996, J EXP MED, V183, P2235, DOI 10.1084/jem.183.5.2235; CUSS FM, 1986, LANCET, V2, P189; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Evans DJ, 1997, AM J RESP CRIT CARE, V156, P11, DOI 10.1164/ajrccm.156.1.9611112; FISCHER AR, 1995, AM J RESP CRIT CARE, V152, P1203, DOI 10.1164/ajrccm.152.4.7551371; FITZGERALD MF, 1986, BRIT J PHARMACOL, V88, P149, DOI 10.1111/j.1476-5381.1986.tb09481.x; Fryer AD, 1997, J CLIN INVEST, V99, P2036, DOI 10.1172/JCI119372; FULLER RW, 1986, AM REV RESPIR DIS, V133, P252; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360; Henig NR, 2000, AM J RESP CRIT CARE, V162, P523, DOI 10.1164/ajrccm.162.2.9911084; Heuer HO, 1999, EUR J PHARMACOL, V369, P225, DOI 10.1016/S0014-2999(99)00080-1; HIRATA K, 1990, J IMMUNOL, V44, P1880; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; JONES GL, 1992, AM REV RESPIR DIS, V145, P1270, DOI 10.1164/ajrccm/145.6.1270; JONES T, 1982, PROSTAG OTH LIPID M, V24, P279, DOI 10.1016/0090-6980(82)90154-X; Kagoshima M, 1997, INFLAMM RES, V46, P147, DOI 10.1007/s000110050539; KANEKO T, 1995, EUR J PHARM-ENVIRON, V292, P251; Konzett H, 1940, N-S ARCH EX PATH PH, V195, P71, DOI 10.1007/BF01861842; KUITERT LM, 1995, AM J RESP CRIT CARE, V151, P1331, DOI 10.1164/ajrccm.151.5.7735582; Kurashima K, 1997, CLIN EXP ALLERGY, V27, P337; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; MINAMI S, 1983, JPN J CHEST DIS, V21, P252; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; PENNOCK BE, 1979, J APPL PHYSIOL, V46, P399, DOI 10.1152/jappl.1979.46.2.399; POWELL WS, 1995, J IMMUNOL, V154, P4123; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; RICHARDS IM, 1991, ANN NY ACAD SCI, V629, P274; Serhan CN, 1997, PROSTAG OTH LIPID M, V53, P107, DOI 10.1016/S0090-6980(97)00001-4; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; SUN FF, 1991, J LEUKOCYTE BIOL, V50, P140, DOI 10.1002/jlb.50.2.140; SUN FF, 1989, J LEUKOCYTE BIOL, V46, P152, DOI 10.1002/jlb.46.2.152; Tohda Y, 1997, CLIN EXP ALLERGY, V27, P110, DOI 10.1046/j.1365-2222.1997.d01-426.x; Tsunoda H, 1990, Agents Actions Suppl, V31, P251; TSUNODA H, 1991, ARZNEIMITTEL-FORSCH, V41-1, P224; Uchida Y, 1996, J PHARMACOL EXP THER, V277, P1622; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470; Zhu XD, 1999, J IMMUNOL, V163, P3423	45	52	52	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					145	149		10.1038/84244	http://dx.doi.org/10.1038/84244			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175812				2022-12-18	WOS:000166778700014
J	Baharom, F; Ramirez-Valdez, RA; Tobin, KKS; Yamane, H; Dutertre, CA; Khalilnezhad, A; Reynoso, GV; Coble, VL; Lynn, GM; Mule, MP; Martins, AJ; Finnigan, JP; Zhang, XM; Hamerman, JA; Bhardwaj, N; Tsang, JS; Hickman, HD; Ginhoux, F; Ishizuka, AS; Seder, RA				Baharom, Faezzah; Ramirez-Valdez, Ramiro A.; Tobin, Kennedy K. S.; Yamane, Hidehiro; Dutertre, Charles-Antoine; Khalilnezhad, Ahad; Reynoso, Glennys, V; Coble, Vincent L.; Lynn, Geoffrey M.; Mule, Matthew P.; Martins, Andrew J.; Finnigan, John P.; Zhang, Xiao Meng; Hamerman, Jessica A.; Bhardwaj, Nina; Tsang, John S.; Hickman, Heather D.; Ginhoux, Florent; Ishizuka, Andrew S.; Seder, Robert A.			Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; RESPONSES; EFFECTOR; SUBSETS; IMMUNOTHERAPY; DYSFUNCTION; IMMUNITY	Personalized cancer vaccines are a promising approach for inducing T cell immunity to tumor neoantigens. Using a self-assembling nanoparticle vaccine that links neoantigen peptides to a Toll-like receptor 7/8 agonist (SNP-7/8a), we show how the route and dose alter the magnitude and quality of neoantigen-specific CD8(+) T cells. Intravenous vaccination (SNP-IV) induced a higher proportion of TCF1(+)PD-1(+)CD8(+) T cells as compared to subcutaneous immunization (SNP-SC). Single-cell RNA sequencing showed that SNP-IV induced stem-like genes (Tcf7, Slamf6, Xcl1) whereas SNP-SC enriched for effector genes (Gzmb, Klrg1, Cx3cr1). Stem-like cells generated by SNP-IV proliferated and differentiated into effector cells upon checkpoint blockade, leading to superior antitumor response as compared to SNP-SC in a therapeutic model. The duration of antigen presentation by dendritic cells controlled the magnitude and quality of CD8(+) T cells. These data demonstrate how to optimize antitumor immunity by modulating vaccine parameters for specific generation of effector or stem-like CD8(+) T cells. Seder and colleagues use a self-assembling nanoparticle vaccine and adjuvant to expand stem-like CD8(+) T cells and trigger potent antitumor responses.	[Baharom, Faezzah; Ramirez-Valdez, Ramiro A.; Tobin, Kennedy K. S.; Yamane, Hidehiro; Ishizuka, Andrew S.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dutertre, Charles-Antoine; Khalilnezhad, Ahad; Zhang, Xiao Meng; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Dutertre, Charles-Antoine] Duke Natl Univ Singapore Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Dutertre, Charles-Antoine; Ginhoux, Florent] Singhlth Translat Immunol & Inflammat Ctr, Singapore, Singapore; [Khalilnezhad, Ahad] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Reynoso, Glennys, V; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Coble, Vincent L.; Lynn, Geoffrey M.; Ishizuka, Andrew S.] Avidea Technol, Baltimore, MD USA; [Mule, Matthew P.; Martins, Andrew J.; Tsang, John S.] NIAID, Syst Genom & Bioinformat Unit, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mule, Matthew P.] Univ Cambridge, Dept Med, Cambridge, England; [Finnigan, John P.; Bhardwaj, Nina] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA; [Hamerman, Jessica A.] Benaroya Res Inst, Immunol Program, Seattle, WA USA; [Ginhoux, Florent] Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge; Icahn School of Medicine at Mount Sinai; Benaroya Research Institute; Chinese Academy of Sciences	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@nih.gov	Martins, Andrew/AAU-7039-2021; Baharom, Faezzah/AAC-4466-2019	Martins, Andrew/0000-0002-1832-1924; Dutertre, Charles-Antoine/0000-0001-7950-3652; Finnigan, John/0000-0003-3216-298X; Mule, Matthew/0000-0001-8457-2716; , Geoffrey/0000-0001-9653-6691; Bhardwaj, Nina/0000-0003-1865-4187	Intramural Research Program of the U.S. NIH; EMBO YIP; Singapore Immunology Network core funding	Intramural Research Program of the U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore Immunology Network core funding	We thank members of the Seder lab for scientific discussions; S. Darko, A. Ransier and D. Douek for scRNA-seq advice; and M. Dillon, G. Salbador, S. Rush, L. Gilliam, O. Hernandez, C. Chiedi and D. Scorpio of the Translational Research Program (Vaccine Research Center) for their valuable support with the animal studies. This work was supported by the Intramural Research Program of the U.S. NIH (R.A.S., H.D.H. and J.S.T.), EMBO YIP and Singapore Immunology Network core funding (F.G.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Baeyens A, 2015, TRENDS IMMUNOL, V36, P778, DOI 10.1016/j.it.2015.10.005; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lynn GM, 2020, NAT BIOTECHNOL, V38, P320, DOI 10.1038/s41587-019-0390-x; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Melief CJM, 2017, NATURE, V547, P165, DOI 10.1038/nature23093; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Reynoso GV, 2019, NAT IMMUNOL, V20, P602, DOI 10.1038/s41590-019-0342-0; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Versluis JM, 2020, NAT MED, V26, P475, DOI 10.1038/s41591-020-0829-0; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	57	51	51	12	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					41	52		10.1038/s41590-020-00810-3	http://dx.doi.org/10.1038/s41590-020-00810-3		NOV 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33139915	Green Accepted			2022-12-18	WOS:000584409800001
J	Laidlaw, BJ; Duan, LH; Xu, Y; Vazquez, SE; Cyster, JG				Laidlaw, Brian J.; Duan, Lihui; Xu, Ying; Vazquez, Sara E.; Cyster, Jason G.			The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER FORMATION; HOMEODOMAIN PROTEIN; BCL-6 EXPRESSION; GENE-EXPRESSION; DARK ZONE; SELECTION; DIFFERENTIATION; REPRESSION; IDENTIFICATION; DISRUPTION	Memory B cells (MBCs) are essential for long-lived humoral immunity. However, the transcription factors involved in MBC differentiation are poorly defined. Here, using single-cell RNA sequencing analysis, we identified a population of germinal center (GC) B cells in the process of differentiating into MBCs. Using an inducible CRISPR-Cas9 screening approach, we identified the hematopoietically expressed homeobox protein Hhex as a transcription factor regulating MBC differentiation. The corepressor Tle3 was also identified in the screen and was found to interact with Hhex to promote MBC development. Bcl-6 directly repressedHhexin GC B cells. Reciprocally, Hhex-deficient MBCs exhibited increasedBcl6expression and reduced expression of the Bcl-6 target geneBcl2. Overexpression of Bcl-2 was able to rescue MBC differentiation in Hhex-deficient cells. We also identified Ski as an Hhex-induced transcription factor involved in MBC differentiation. These findings establish an important role for Hhex-Tle3 in regulating the transcriptional circuitry governing MBC differentiation. Generation of memory B cells is crucial for protective immunity to infectious agents. Cyster and colleagues show that the transcription factor Hhex interacting with Tle3 promotes memory B cell generation.	[Laidlaw, Brian J.; Duan, Lihui; Xu, Ying; Vazquez, Sara E.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Laidlaw, Brian J.; Duan, Lihui; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Vazquez, Sara E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Laidlaw, Brian J.] Washington Univ, Sch Med, Dept Med, Div Allergy & Immunol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Vazquez, Sara/0000-0002-0601-7001	NIH [R01AI045073, R01AI040098, T32AI07019]; Howard Hughes Medical Institute Fellow of the Damon Runyon Cancer Research Foundation [DRG-2265-16]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Fellow of the Damon Runyon Cancer Research Foundation	We thank T. Roth and A. Marson (University of California, San Francisco) for the pTR plasmid, T. Okada for the S1pr2-Cre-ERT2 mice, J. An for expert technical assistance, J. Derisi for support and P. S. Jayaraman for helpful discussions. This work was supported by grants from the NIH (R01AI045073 and R01AI040098 to J.G.C. and T32AI07019 to B.J.L.). B.J.L. is a Howard Hughes Medical Institute Fellow of the Damon Runyon Cancer Research Foundation (DRG-2265-16). J.G.C. is an investigator of the Howard Hughes Medical Institute.	Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chevrier S, 2017, IMMUNOL CELL BIOL, V95, P925, DOI 10.1038/icb.2017.71; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Jackson JT, 2017, STEM CELLS, V35, P1948, DOI 10.1002/stem.2648; Jackson JT, 2015, BLOOD, V125, P803, DOI 10.1182/blood-2014-06-579813; Jangal M, 2014, NUCLEIC ACIDS RES, V42, P11339, DOI 10.1093/nar/gku791; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kasamatsu S, 2004, J BIOCHEM, V135, P217, DOI 10.1093/jb/mvh025; Koike T, 2019, ELIFE, V8, DOI 10.7554/eLife.44245; Kurachi M, 2019, IMMUNITY, V51, P591, DOI 10.1016/j.immuni.2019.09.010; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; McCarthy KR, 2018, IMMUNITY, V48, P174, DOI 10.1016/j.immuni.2017.12.009; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Pritchard GH., 2019, 564351 BIORXIV, DOI [10.1101/564351, DOI 10.1101/564351]; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shields BJ, 2016, GENE DEV, V30, P78, DOI 10.1101/gad.268425.115; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Takatsuka S, 2018, NAT IMMUNOL, V19, P1025, DOI 10.1038/s41590-018-0177-0; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Xing SJ, 2018, J EXP MED, V215, P2211, DOI 10.1084/jem.20171514; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	54	51	51	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1082	+		10.1038/s41590-020-0713-6	http://dx.doi.org/10.1038/s41590-020-0713-6		JUN 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32601467	Green Accepted, Green Submitted			2022-12-18	WOS:000544172900003
J	Ichikawa, T; Hirahara, K; Kokubo, K; Kiuchi, M; Aoki, A; Morimoto, Y; Kumagai, J; Onodera, A; Mato, N; Tumes, DJ; Goto, Y; Hagiwara, K; Inagaki, Y; Sparwasser, T; Tobe, K; Nakayama, T				Ichikawa, Tomomi; Hirahara, Kiyoshi; Kokubo, Kota; Kiuchi, Masahiro; Aoki, Ami; Morimoto, Yuki; Kumagai, Jin; Onodera, Atsushi; Mato, Naoko; Tumes, Damon J.; Goto, Yoshiyuki; Hagiwara, Koichi; Inagaki, Yutaka; Sparwasser, Tim; Tobe, Kazuyuki; Nakayama, Toshinori			CD103(hi) T-reg cells constrain lung fibrosis induced by CD103(lo) tissue-resident pathogenic CD4 T cells	NATURE IMMUNOLOGY			English	Article							TH2 CELLS; AIRWAY INFLAMMATION; MEMORY; EFFECTOR; IMMUNITY; DIFFERENTIATION; MECHANISMS; MACROPHAGE; RESPONSES; LINEAGE	Tissue-resident memory T cells (T-RM cells) are crucial mediators of adaptive immunity in nonlymphoid tissues. However, the functional heterogeneity and pathogenic roles of CD4(+) T-RM cells that reside within chronic inflammatory lesions remain unknown. We found that CD69(hi)CD103(lo) CD4(+) T-RM cells produced effector cytokines and promoted the inflammation and fibrotic responses induced by chronic exposure to Aspergillus fumigatus. Simultaneously, immunosuppressive CD69(hi)CD103(hi)Foxp3(+) CD4(+) regulatory T cells were induced and constrained the ability of pathogenic CD103(lo) T-RM cells to cause fibrosis. Thus, lung tissue-resident CD4(+) T cells play crucial roles in the pathology of chronic lung inflammation, and CD103 expression defines pathogenic effector and immunosuppressive tissue-resident cell subpopulations in the inflamed lung.	[Ichikawa, Tomomi; Hirahara, Kiyoshi; Kokubo, Kota; Kiuchi, Masahiro; Aoki, Ami; Morimoto, Yuki; Kumagai, Jin; Onodera, Atsushi; Tumes, Damon J.; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Ichikawa, Tomomi; Tobe, Kazuyuki] Univ Toyama, Dept Internal Med 1, Toyama, Japan; [Hirahara, Kiyoshi] AMED, AMED PRIME, Chiba, Japan; [Onodera, Atsushi] Chiba Univ, Inst Global Prominent Res, Chiba, Japan; [Mato, Naoko; Hagiwara, Koichi] Jichi Med Univ, Div Pulm Med, Dept Med, Shimotsuke, Tochigi, Japan; [Tumes, Damon J.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Tumes, Damon J.] SA Pathol, Adelaide, SA, Australia; [Goto, Yoshiyuki] Chiba Univ, Div Mol Immunol, Med Mycol Res Ctr, Chiba, Japan; [Goto, Yoshiyuki] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Mucosal Symbiosis, Tokyo, Japan; [Inagaki, Yutaka] Tokai Univ, Grad Sch Med, Ctr Matrix Biol & Med, Isehara, Kanagawa, Japan; [Sparwasser, Tim] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol, Mainz, Germany; [Nakayama, Toshinori] AMED, AMED CREST, Chiba, Japan	Chiba University; University of Toyama; Chiba University; Jichi Medical University; Centre for Cancer Biology; University of South Australia; SA Pathology; Chiba University; University of Tokyo; Tokai University; Johannes Gutenberg University of Mainz	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.; Nakayama, T (corresponding author), AMED, AMED CREST, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Sparwasser, Tim D/AAA-4306-2022; Tumes, Damon J/B-9917-2009; Sparwasser, Tim/AAF-7085-2019; Hirahara, Kiyoshi/E-2460-2017	Tumes, Damon J/0000-0001-5709-857X; Sparwasser, Tim/0000-0001-5645-902X; Hirahara, Kiyoshi/0000-0002-9128-9449; Kiuchi, Masahiro/0000-0002-0227-4502	Ministry of Education, Culture, Sports, Science and Technology [26221305, JP19H05650, 17K08876, 18K07164, 19K16683]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED [JP19ek0410060, JP19ek0410045]; AMED-PRIME, AMED [JP19gm6110005]; AMED-CREST, AMED [JP19gm1210003]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Takeda Science Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED; AMED-PRIME, AMED; AMED-CREST, AMED; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	We are grateful to Y. Kanno for critically reading and providing valuable suggestions on the manuscript. We are grateful to N. Iijima and K. J. Ishii for providing valuable suggestions on the parabiosis surgery. We are grateful to N. Takayama and K. Eto for providing valuable suggestions on the ATAC-Seq experiments. We thank T. Ito, K. Sugaya, M. Kato and T. Wada for excellent technical assistance. This work was supported by the following grants: Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (S) 26221305, JP19H05650, (C) 17K08876, 18K07164 and 19K16683; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from AMED (numbers JP19ek0410060 and JP19ek0410045); AMED-PRIME, AMED (number JP19gm6110005); AMED-CREST, AMED (number JP19gm1210003); the Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; the Naito Foundation and the Takeda Science Foundation.	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Foster PS, 2017, IMMUNOL REV, V278, P20, DOI 10.1111/imr.12549; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Garg G, 2019, CELL REP, V26, P1854, DOI 10.1016/j.celrep.2019.01.070; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Greenberger PA, 2014, J ALLER CL IMM-PRACT, V2, P703, DOI 10.1016/j.jaip.2014.08.007; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kimura MY, 2017, IMMUNOL REV, V278, P87, DOI 10.1111/imr.12559; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mato N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06962-x; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Morimoto Y, 2018, IMMUNITY, V49, P134, DOI 10.1016/j.immuni.2018.04.023; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Onodera A, 2017, J IMMUNOL, V199, P1153, DOI 10.4049/jimmunol.1602129; Onodera A, 2015, MOL CELL BIOL, V35, P3841, DOI 10.1128/MCB.00677-15; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029421; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shinoda K, 2016, P NATL ACAD SCI USA, V113, pE2842, DOI 10.1073/pnas.1512600113; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wuthrich M, 2012, ANNU REV IMMUNOL, V30, P115, DOI 10.1146/annurev-immunol-020711-074958	62	51	53	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1469	+		10.1038/s41590-019-0494-y	http://dx.doi.org/10.1038/s41590-019-0494-y			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591568				2022-12-18	WOS:000492309600017
J	Hemann, EA; Green, R; Turnbull, JB; Langlois, RA; Savan, R; Gale, M				Hemann, Emily A.; Green, Richard; Turnbull, J. Bryan; Langlois, Ryan A.; Savan, Ram; Gale, Michael, Jr.			Interferon-lambda modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus	NATURE IMMUNOLOGY			English	Article							IFN-LAMBDA; HETEROSUBTYPIC IMMUNITY; ANTIVIRAL PROTECTION; III INTERFERON; MICE; RESPONSES; ANTIGEN; EXPRESSION; INDUCTION; LUNGS	Type III interferon (IFN-lambda) is important for innate immune protection at mucosal surfaces and has therapeutic benefit against influenza A virus (IAV) infection. However, the mechanisms by which IFN-lambda programs adaptive immune protection against IAV are undefined. Here we found that IFN-lambda signaling in dendritic cell (DC) populations was critical for the development of protective IAV-specific CD8(+) T cell responses. Mice lacking the IFN-lambda receptor (Ifnlr1(-/-)) had blunted CD8(+) T cell responses relative to wild type and exhibited reduced survival after heterosubtypic IAV re-challenge. Analysis of DCs revealed IFN-lambda signaling directed the migration and function of CD103(+) DCs for development of optimal antiviral CD8(+) T cell responses, and bioinformatic analyses identified IFN-lambda regulation of a DC IL-10 immunoregulatory network. Thus, IFN-lambda serves a critical role in bridging innate and adaptive immunity from lung mucosa to lymph nodes to program DCs to direct effective T cell immunity against IAV.	[Hemann, Emily A.; Green, Richard; Turnbull, J. Bryan; Savan, Ram; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Langlois, Ryan A.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Gale, M (corresponding author), Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.	mgale@uw.edu		Gale, Michael/0000-0002-6332-7436; Savan, Ram/0000-0002-3087-1355; Hemann, Emily/0000-0002-6398-3492; Green, Richard/0000-0001-8851-7204; Turnbull, J. Bryan/0000-0003-3167-3374	American Heart Association [17POST33660907]; National Institutes of Health [T32AI007509, AI132962, AI108765, AI104002, AI118916, AI083019, AI127463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007509, R01AI127463, R01AI132962, U19AI083019, R01AI118916, R01AI108765] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the Cell Analysis Facility Flow Cytometry and Imaging Core in the Department of Immunology at the University of Washington and E. Smith for technical assistance. We would like to thank A.M. Kell and M.E. Long for their critical reading of this manuscript. E.A.H. is supported by American Heart Association award 17POST33660907. This work was also supported by National Institutes of Health grants T32AI007509 (E.A.H.), AI132962 (R.A.L.), AI108765 (R.S.), AI104002 (M.G.), AI118916 (M.G.), AI083019 (M.G.) and AI127463 (M.G.).	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Aparicio-Siegmund S, 2015, CYTOKINE GROWTH F R, V26, P579, DOI 10.1016/j.cytogfr.2015.07.008; Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16; BENNINK J, 1978, IMMUNOLOGY, V35, P503; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; EFFROS RB, 1978, CELL IMMUNOL, V36, P345, DOI 10.1016/0008-8749(78)90278-2; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Flannery B, 2018, MMWR-MORBID MORTAL W, V67, P180, DOI 10.15585/mmwr.mm6706a2; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Kim S, 2017, AM J RESP CELL MOL, V56, P202, DOI 10.1165/rcmb.2016-0174OC; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lee S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00749; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; LIANG SH, 1994, J IMMUNOL, V152, P1653; Llopiz D, 2017, ONCOTARGET, V8, P2659, DOI 10.18632/oncotarget.13736; Loraine AE, 2015, METHODS MOL BIOL, V1284, P481, DOI 10.1007/978-1-4939-2444-8_24; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Schmidt ME, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006810; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Smith LK, 2018, IMMUNITY, V48, P299, DOI 10.1016/j.immuni.2018.01.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004; Topham DJ, 1997, J IMMUNOL, V159, P5197; Wang YS, 2017, J IMMUNOL, V199, P1012, DOI 10.4049/jimmunol.1601430; Waring BM, 2018, J VIROL, V92, DOI 10.1128/JVI.01741-17; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038	57	51	52	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1035	+		10.1038/s41590-019-0408-z	http://dx.doi.org/10.1038/s41590-019-0408-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31235953	Green Accepted			2022-12-18	WOS:000476621200018
J	Weizman, OE; Song, E; Adams, NM; Hildreth, AD; Riggan, L; Krishna, C; Aguilar, OA; Leslie, CS; Carlyle, JR; Sun, JC; O'Sullivan, TE				Weizman, Orr-El; Song, Eric; Adams, Nicholas M.; Hildreth, Andrew D.; Riggan, Luke; Krishna, Chirag; Aguilar, Oscar A.; Leslie, Christina S.; Carlyle, James R.; Sun, Joseph C.; O'Sullivan, Timothy E.			Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ADAPTIVE IMMUNITY; TISSUE RESIDENCY; NK CELLS; ACTIVATION; INFECTION; CHROMATIN; DIFFERENTIATION; PROTECTION; INSIGHTS	Innate lymphoid cells (ILCs) are tissue-resident sentinels that are essential for early host protection from pathogens at initial sites of infection. However, whether pathogen-derived antigens directly modulate the responses of tissue-resident ILCs has remained unclear. In the present study, it was found that liver-resident type 1 ILCs (ILC1s) expanded locally and persisted after the resolution of infection with mouse cytomegalovirus (MCMV). ILC1s acquired stable transcriptional, epigenetic and phenotypic changes a month after the resolution of MCMV infection, and showed an enhanced protective effector response to secondary challenge with MCMV consistent with a memory lymphocyte response. Memory ILC1 responses were dependent on the MCMV-encoded glycoprotein m12, and were independent of bystander activation by proinflammatory cytokines after heterologous infection. Thus, liver ILC1s acquire adaptive features in an MCMV-specific manner.	[Weizman, Orr-El; Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Weizman, Orr-El; Song, Eric] Yale Univ, Dept Immunobiol, New Haven, CT USA; [Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Hildreth, Andrew D.; Riggan, Luke; O'Sullivan, Timothy E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Hildreth, Andrew D.; Riggan, Luke; O'Sullivan, Timothy E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Krishna, Chirag; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Aguilar, Oscar A.; Carlyle, James R.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY USA; [Aguilar, Oscar A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Yale University; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; University of Toronto; Cornell University; University of California System; University of California San Francisco	O'Sullivan, TE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; O'Sullivan, TE (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	tosullivan@mednet.ucla.edu	Carlyle, James R/A-1224-2008; O'Sullivan, Timothy/D-3422-2018	O'Sullivan, Timothy/0000-0003-1435-8188; Sun, Joseph/0000-0001-8062-9033; Adams, Nicholas/0000-0001-5751-0480; Aguilar-Alfaro, Oscar Alberto/0000-0002-7990-8745; Carlyle, James/0000-0002-3579-0300	National Institutes of Health (NIH) Medical Scientist Training Program training grant [T32GM007205]; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH [T32GM007739]; National Institute of Allergy and Infectious Diseases of the NIH [F30 AI136239]; Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund; American Cancer Society; NIH [P30DK063491, AI145997, AI100874, AI130043, P30CA008748]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI136239, R01AI145997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Medical Scientist Training Program training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH; National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ludwig Center for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the labs of T.E.O., C.S.L., J.R.C., A. Iwasaki and J.C.S. for helpful comments and discussions. We thank J. Reichel and S. Jonjic for reagents. E.S. was supported by the National Institutes of Health (NIH) Medical Scientist Training Program training grant (no. T32GM007205). N.M.A. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH (no. T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD/PhD Program) and an F30 Predoctoral Fellowship from the National Institute of Allergy and Infectious Diseases of the NIH (no. F30 AI136239). J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the Burroughs Wellcome Fund, the American Cancer Society and grants from the NIH (nos. AI100874, AI130043 and P30CA008748). T.E.O. was supported by the NIH (nos. P30DK063491 and AI145997).	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, VIRUSES-BASEL, V1, P362, DOI 10.3390/v1030362; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tokuyama M, 2018, P NATL ACAD SCI USA, V115, P12565, DOI 10.1073/pnas.1814589115; van der Veeken J, 2016, CELL, V166, P977, DOI 10.1016/j.cell.2016.07.006; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou J, 2019, IMMUNITY, V50, P403, DOI 10.1016/j.immuni.2018.12.024; Zigler CM, 2011, ANN APPL STAT, V5, P1876, DOI 10.1214/11-AOAS477	47	51	53	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1004	+		10.1038/s41590-019-0430-1	http://dx.doi.org/10.1038/s41590-019-0430-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31263280	Green Accepted, Green Submitted			2022-12-18	WOS:000476621200015
J	Hosokawa, H; Romero-Wolf, M; Yui, MA; Ungerback, J; Quiloan, MLG; Matsumoto, M; Nakayama, KI; Tanaka, T; Rothenberg, EV				Hosokawa, Hiroyuki; Romero-Wolf, Maile; Yui, Mary A.; Ungerback, Jonas; Quiloan, Maria L. G.; Matsumoto, Masaki; Nakayama, Keiichi I.; Tanaka, Tomoaki; Rothenberg, Ellen V.			Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16	NATURE IMMUNOLOGY			English	Article							ACTIVATES GENE-EXPRESSION; LINEAGE COMMITMENT; PLZF; IDENTITY; REGULATOR; CHROMATIN; PROGRAM; ROLES; DIFFERENTIATION; MAINTENANCE	Multipotent progenitor cells confirm their T cell-lineage identity in the CD4-CD8-double-negative (DN) pro-T cell DN2 stages, when expression of the essential transcription factor Bcl11b begins. In vivo and in vitro stage-specific deletions globally identified Bcl11b-controlled target genes in pro-T cells. Proteomics analysis revealed that Bcl11b associated with multiple cofactors and that its direct action was needed to recruit those cofactors to selective target sites. Regions near functionally regulated target genes showed enrichment for those sites of Bcl11b-dependent recruitment of cofactors, and deletion of individual cofactors relieved the repression of many genes normally repressed by Bcl11b. Runx1 collaborated with Bcl11b most frequently for both activation and repression. In parallel, Bcl11b indirectly regulated a subset of target genes by a gene network circuit via the transcription inhibitor Id2 (encoded by Id2) and transcription factor PLZF (encoded by Zbtb16); Id2 and Zbtb16 were directly repressed by Bcl11b, and Id2 and PLZF controlled distinct alternative programs. Thus, our study defines the molecular basis of direct and indirect Bcl11b actions that promote T cell identity and block alternative potentials.	[Hosokawa, Hiroyuki; Romero-Wolf, Maile; Yui, Mary A.; Ungerback, Jonas; Quiloan, Maria L. G.; Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ungerback, Jonas] Lund Univ, Div Mol Hematol, Lund, Sweden; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka, Fukuoka, Japan; [Tanaka, Tomoaki] Chiba Univ, Dept Mol Diag, Chuo Ku, Chiba, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, AMED CREST, Chuo Ku, Chiba, Japan	California Institute of Technology; Lund University; Kyushu University; Chiba University; Chiba University	Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Hosokawa, Hiroyuki/0000-0002-9592-2889; Tanaka, Tomoaki/0000-0002-9761-1750; Yui, Mary/0000-0002-3136-2181; Romero-Wolf, Maile/0000-0002-8024-7198; Quiloan, Maria Lerica/0000-0003-2075-3141; Matsumoto, Masaki/0000-0002-6987-0288; Rothenberg, Ellen/0000-0002-3901-347X	Manpei Suzuki Diabetes Foundation; US Public Health Service [R01AI083514, R01HD076915]; Takeda Science Foundation; SENSHINE Medical Research Foundation; Swedish Research Council; California Institute of Regenerative Medicine Bridges to Stem Cell Research Program (Pasadena City College); California Institute of Regenerative Medicine Bridges to Stem Cell Research Program (Caltech); L. A. Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; Division of Biology & Biological Engineering of Caltech; Albert Billings Ruddock Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083514] Funding Source: NIH RePORTER	Manpei Suzuki Diabetes Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHINE Medical Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); California Institute of Regenerative Medicine Bridges to Stem Cell Research Program (Pasadena City College); California Institute of Regenerative Medicine Bridges to Stem Cell Research Program (Caltech); L. A. Garfinkle Memorial Laboratory Fund; Al Sherman Foundation; Division of Biology & Biological Engineering of Caltech; Albert Billings Ruddock Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Perez, J. Tijerina, and R. Diamond for cell sorting and advice; I. Soto for mouse colony care; V. Kumar for library preparation and sequencing; H. Amrhein and D. Trout for computational assistance; I. Antoshechkin for sequencing management; X. Wang for related exploratory experiments; and members of the Rothenberg group for discussions and reagents. Supported by the Manpei Suzuki Diabetes Foundation (H. H.), the US Public Health Service (R01AI083514 and R01HD076915 to E.V.R.), Grants-in-Aid for Advanced Research and Development Programs for Medical Innovation (T.T.), the Takeda Science Foundation (T.T.), the SENSHINE Medical Research Foundation (T.T.), the Swedish Research Council (J.U.), the California Institute of Regenerative Medicine Bridges to Stem Cell Research Program (Pasadena City College and Caltech; M.R.-W.), the L. A. Garfinkle Memorial Laboratory Fund and the Al Sherman Foundation, special project funds from the Provost and Division of Biology & Biological Engineering of Caltech, and the Albert Billings Ruddock Professorship (E.V.R.). This work was performed in part in the Collaborative Research Project Program of the Medical Institute of Bioregulation, Kyushu University.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Avram D, 2014, J IMMUNOL, V193, P2059, DOI 10.4049/jimmunol.1400930; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Di Santo JP, 2014, IMMUNOL REV, V261, P169, DOI 10.1111/imr.12202; Dionne CJ, 2005, DEV BIOL, V280, P448, DOI 10.1016/j.ydbio.2005.01.027; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Hirose S, 2015, INT IMMUNOL, V27, P205, DOI 10.1093/intimm/dxu104; Hosokawa H., 2012, P NATL ACAD SCI USA, V110, P4601; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kang H, 2017, GENE DEV, V31, P1988, DOI 10.1101/gad.305987.117; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Kojo S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00768-1; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Longabaugh WJR, 2017, P NATL ACAD SCI USA, V114, P5800, DOI 10.1073/pnas.1610617114; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Miyazaki M, 2017, IMMUNITY, V46, P818, DOI 10.1016/j.immuni.2017.04.022; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mowel WK, 2017, IMMUNITY, V47, P435, DOI 10.1016/j.immuni.2017.08.012; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rankin L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/281569; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Uddin MN, 2016, P NATL ACAD SCI USA, V113, P7608, DOI 10.1073/pnas.1521846113; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xu W, 2013, BLOOD, V121, P1534, DOI 10.1182/blood-2012-08-449447; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105	70	51	51	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1427	+		10.1038/s41590-018-0238-4	http://dx.doi.org/10.1038/s41590-018-0238-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30374131	Green Accepted			2022-12-18	WOS:000452873000022
J	Preite, S; Cannons, JL; Radtke, AJ; Vujkovic-Cvijin, I; Gomez-Rodriguez, J; Volpi, S; Huang, B; Cheng, J; Collins, N; Reilley, J; Handon, R; Dobbs, K; Huq, L; Raman, I; Zhu, CS; Li, QZ; Li, MO; Pittaluga, S; Uzel, G; Notarangelo, LD; Belkaid, Y; Germain, RN; Schwartzberg, PL				Preite, Silvia; Cannons, Jennifer L.; Radtke, Andrea J.; Vujkovic-Cvijin, Ivan; Gomez-Rodriguez, Julio; Volpi, Stefano; Huang, Bonnie; Cheng, Jun; Collins, Nicholas; Reilley, Julie; Handon, Robin; Dobbs, Kerry; Huq, Lutfi; Raman, Indu; Zhu, Chengsong; Li, Quan-Zhen; Li, Ming O.; Pittaluga, Stefania; Uzel, Gulbu; Notarangelo, Luigi D.; Belkaid, Yasmine; Germain, Ronald N.; Schwartzberg, Pamela L.			Hyperactivated PI3K delta promotes self and commensal reactivity at the expense of optimal humoral immunity	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELLS; HOST-MICROBIOTA MUTUALISM; B-CELL; T-CELLS; AKKERMANSIA-MUCINIPHILA; AFFINITY MATURATION; PEYERS-PATCHES; PI3 KINASE; ANTIGEN; RESPONSES	Gain-of-function mutations in the gene encoding the phosphatidylinositol-3-OH kinase catalytic subunit pI3K delta (PI3K delta) result in a human primary immunodeficiency characterized by lymphoproliferation, respiratory infections and inefficient responses to vaccines. However, what promotes these immunological disturbances at the cellular and molecular level remains unknown. We generated a mouse model that recapitulated major features of this disease and used this model and patient samples to probe how hyperactive PI3K delta fosters aberrant humoral immunity. We found that mutant PI3K delta led to co-stimulatory receptor ICOS-independent increases in the abundance of follicular helper T cells (T-FH cells) and germinal-center (GC) B cells, disorganized GCs and poor class-switched antigen-specific responses to immunization, associated with altered regulation of the transcription factor FOXO1 and pro-apoptotic and anti-apoptotic members of the BCL-2 family. Notably, aberrant responses were accompanied by increased reactivity to gut bacteria and a broad increase in autoantibodies that were dependent on stimulation by commensal microbes. Our findings suggest that proper regulation of PI3K delta is critical for ensuring optimal host-protective humoral immunity despite tonic stimulation from the commensal microbiome.	[Preite, Silvia; Cannons, Jennifer L.; Gomez-Rodriguez, Julio; Huang, Bonnie; Cheng, Jun; Reilley, Julie; Handon, Robin; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Preite, Silvia; Cannons, Jennifer L.; Radtke, Andrea J.; Gomez-Rodriguez, Julio; Huang, Bonnie; Reilley, Julie; Germain, Ronald N.; Schwartzberg, Pamela L.] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vujkovic-Cvijin, Ivan; Collins, Nicholas; Huq, Lutfi; Belkaid, Yasmine] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA; [Volpi, Stefano] Ist Giannina Gaslini, Clin Pediat & Reumatol, Ctr Malattie Autoinfiammatorie & Immunodeficienze, Genoa, Italy; [Volpi, Stefano] Univ Genoa, Genoa, Italy; [Dobbs, Kerry; Uzel, Gulbu; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Raman, Indu; Zhu, Chengsong; Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Pittaluga, Stefania] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Preite, S; Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.; Preite, S; Schwartzberg, PL (corresponding author), NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	silvia.preite@nih.gov; ivc@nih.gov; pams@mail.nih.gov	Vujkovic-Cvijin, Ivan/AAT-6248-2020; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Volpi, Stefano/O-3717-2014	Vujkovic-Cvijin, Ivan/0000-0002-8611-4900; Volpi, Stefano/0000-0002-7129-868X; li, ming/0000-0002-1383-0535; Radtke, Andrea/0000-0003-4379-8967; Dobbs, Kerry/0000-0002-3432-3137	US National Institutes of Health (National Human Genome Research Institute); US National Institutes of Health (National Institute of Allergy and Infectious Diseases); US National Institutes of Health [R01 AI102888-01A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, ZICHG200349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545, ZICAI001233, ZIAAI001115, ZIAAI001222, ZIAAI001240, R01AI102888] Funding Source: NIH RePORTER	US National Institutes of Health (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Kapnick for discussions and protocol suggestions; K. Mao for help with gut 'Swiss roll' preparation; S. Wincovitch for help with bright- field microscopy; S. Anderson and M. Kirby for cell sorting; L. Perez for sharing protocols; M. Yan for help with autoantibody arrays; F. Sallusto (Institute for Research in Biomedicine, Bellinzona, CH) for reagents; and S. Crotty for helpful discussions. Supported by the US National Institutes of Health (funds from intramural programs of the National Human Genome Research Institute and National Institute of Allergy and Infectious Diseases; and R01 AI102888-01A1 to M.O.L.).	Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Chen J, 2010, EUR J IMMUNOL, V40, P1890, DOI 10.1002/eji.200939817; Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; Coulter TI, 2017, J ALLERGY CLIN IMMUN, V139, P597, DOI 10.1016/j.jaci.2016.06.021; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Dillenburg-Pilla Patricia, 2016, Bio Protoc, V6; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Florea AED, 2017, J ALLERGY CLIN IMMUN, V139, P1032, DOI 10.1016/j.jaci.2016.08.028; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Macpherson AJ, 2015, TRENDS IMMUNOL, V36, P460, DOI 10.1016/j.it.2015.06.006; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2016, CURR TOP MICROBIOL, V393, P123, DOI 10.1007/82_2015_484; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Peperzak V, 2012, IMMUNOL REV, V247, P93, DOI 10.1111/j.1600-065X.2012.01123.x; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; Preite S, 2015, EUR J IMMUNOL, V45, P3010, DOI 10.1002/eji.201545920; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Radtke AJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004637; Rao VK, 2017, BLOOD, V130, P2307, DOI 10.1182/blood-2017-08-801191; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sayin I, 2018, J EXP MED, V215, P1531, DOI 10.1084/jem.20171940; Schickel JN, 2017, J EXP MED, V214, P1991, DOI 10.1084/jem.20160201; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Ueno H, 2016, CURR OPIN IMMUNOL, V43, P24, DOI 10.1016/j.coi.2016.08.003; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wensveen FM, 2016, SCI REP-UK, V6, DOI 10.1038/srep35673; Zarate-Blades CR, 2016, DNA CELL BIOL, V35, P455, DOI 10.1089/dna.2016.3432; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	57	51	52	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					986	+		10.1038/s41590-018-0182-3	http://dx.doi.org/10.1038/s41590-018-0182-3			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127432	Green Accepted			2022-12-18	WOS:000442365100020
J	Kang, SJ; Nakanishi, Y; Kioi, Y; Okuzaki, D; Kimura, T; Takamatsu, H; Koyama, S; Nojima, S; Nishide, M; Hayama, Y; Kinehara, Y; Kato, Y; Nakatani, T; Shimogori, T; Takagi, J; Toyofuku, T; Kumanogoh, A				Kang, Sujin; Nakanishi, Yoshimitsu; Kioi, Yoshiyuki; Okuzaki, Daisuke; Kimura, Tetsuya; Takamatsu, Hyota; Koyama, Shohei; Nojima, Satoshi; Nishide, Masayuki; Hayama, Yoshitomo; Kinehara, Yuhei; Kato, Yasuhiro; Nakatani, Takeshi; Shimogori, Tomomi; Takagi, Junichi; Toyofuku, Toshihiko; Kumanogoh, Atsushi			Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization	NATURE IMMUNOLOGY			English	Article							ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; M2 MACROPHAGES; INNATE; CELLS; MTOR; INTEGRIN; HOMEOSTASIS; EXPRESSION; MONOCYTES	Polarization of macrophages into pro-inflammatory or anti-inflammatory states has distinct metabolic requirements, with mechanistic target of rapamycin (mTOR) kinase signaling playing a critical role. However, it remains unclear how mTOR regulates metabolic status to promote polarization of these cells. Here we show that an mTOR-Semaphorin 6D (Sema6D)-Peroxisome proliferator receptor gamma (PPAR gamma) axis plays critical roles in macrophage polarization. Inhibition of mTOR or loss of Sema6D blocked anti-inflammatory macrophage polarization, concomitant with severe impairments in PPAR gamma expression, uptake of fatty acids, and lipid metabolic reprogramming. Macrophage expression of the receptor Plexin-A4 is responsible for Sema6D-mediated anti-inflammatory polarization. We found that a tyrosine kinase, c-Abl, which associates with the cytoplasmic region of Sema6D, is required for PPAR gamma expression. Furthermore, Sema6D is important for generation of intestinal resident CX3CR1(hi) macrophages and prevents development of colitis. Collectively, these findings highlight crucial roles for Sema6D reverse signaling in macrophage polarization, coupling immunity, and metabolism via PPAR gamma.	[Kang, Sujin; Nakanishi, Yoshimitsu; Kioi, Yoshiyuki; Kimura, Tetsuya; Takamatsu, Hyota; Koyama, Shohei; Nojima, Satoshi; Nishide, Masayuki; Hayama, Yoshitomo; Kinehara, Yuhei; Kato, Yasuhiro; Nakatani, Takeshi; Toyofuku, Toshihiko; Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka, Japan; [Kang, Sujin; Nakanishi, Yoshimitsu; Kioi, Yoshiyuki; Takamatsu, Hyota; Koyama, Shohei; Nishide, Masayuki; Hayama, Yoshitomo; Kinehara, Yuhei; Kato, Yasuhiro; Nakatani, Takeshi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Genome Informat Res Ctr, Res Inst Microbial Dis, Suita, Osaka, Japan; [Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka, Japan; [Kang, Sujin] Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, Suita, Osaka, Japan; [Toyofuku, Toshihiko] Osaka Univ, Grad Sch Med, Dept Immunol & Regenerat Med, Suita, Osaka, Japan; [Nojima, Satoshi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Shimogori, Tomomi] RIKEN, Brain Sci Inst, Lab Mol Mech Thalamus Dev, Saitama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; RIKEN	Kang, SJ (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka, Japan.; Kang, SJ (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka, Japan.; Kang, SJ (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, Suita, Osaka, Japan.	kang@imed3.med.osaka-u.ac.jp; kumanogo@imed3.med.osaka-u.ac.jp	Koyama, Shohei/AAU-4113-2021; Okuzaki, Daisuke/AAN-5641-2020; Shimogori, Tomomi/L-2893-2013; Nishide, Masayuki/AHE-4839-2022	Koyama, Shohei/0000-0002-6897-9417; Okuzaki, Daisuke/0000-0002-4552-783X; Shimogori, Tomomi/0000-0002-6931-5401; Kimura, Tetsuya/0000-0001-6367-7818; Nishide, Masayuki/0000-0001-6060-1228	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; AMED-CREST [JP17gm0410015]; AMED; MEXT; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST; AMED(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank H. Inoue for technical support. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to S. Kang); grants from AMED-CREST (JP17gm0410015) and AMED (to A.K.); COI stream and SRIP grants from MEXT (to A.K.); and grants from the Ministry of Health, Labour and Welfare of Japan (to A.K.).	Angela M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13683; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen W, 2012, CANCER RES, V72, P1363, DOI 10.1158/0008-5472.CAN-11-2684; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26252; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Keshet R, 2014, P NATL ACAD SCI USA, V111, P16365, DOI 10.1073/pnas.1411086111; Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; O'Connor BP, 2008, P NATL ACAD SCI USA, V105, P13015, DOI 10.1073/pnas.0803386105; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009; Sahin E, 2014, J IMMUNOL, V193, P1717, DOI 10.4049/jimmunol.1302167; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	43	51	58	4	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					561	+		10.1038/s41590-018-0108-0	http://dx.doi.org/10.1038/s41590-018-0108-0			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777213				2022-12-18	WOS:000433041500022
J	Katz, ZB; Novotna, L; Blount, A; Lillemeier, BF				Katz, Zachary B.; Novotna, Lucie; Blount, Amy; Lillemeier, Bjorn F.			A cycle of Zap70 kinase activation and release from the TCR amplifies and disperses antigenic stimuli	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; TANDEM SH2 DOMAINS; IMMUNOLOGICAL SYNAPSE; SIGNAL-TRANSDUCTION; TYROSINE KINASES; STRUCTURAL BASIS; PLASMA-MEMBRANE; IMMUNE SYNAPSE; ZAP-70; PHOSPHORYLATION	Cell-surface-receptor pathways amplify weak, rare and local stimuli to induce cellular responses. This task is accomplished despite signaling components that segregate into nanometer-scale membrane domains. Here we describe a 'catch-and-release' mechanism that amplified and dispersed stimuli by releasing activated kinases from receptors lacking intrinsic catalytic activity. Specifically, we discovered a cycle of recruitment, activation and release for Zap70 kinases at phosphorylated T cell antigen receptors (TCRs). This turned the TCR into a 'catalytic unit' that amplified antigenic stimuli. Zap70 released from the TCR remained at the membrane, translocated, and phosphorylated spatially distinct substrates. The mechanisms described here are based on widely used protein domains and post-translational modifications; therefore, many membrane-associated pathways might employ similar mechanisms for signal amplification and dispersion.	[Lillemeier, Bjorn F.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Lillemeier, BF (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	blillemeier@salk.edu	Katz, Zachary/AAA-3215-2020	Katz, Zachary/0000-0002-2864-062X; Lillemeier, Bjorn/0000-0002-9425-6327	Nomis Foundation; Waitt Foundation; James B. Pendleton Charitable Trust; US National Institutes of Health [1DP2GM105455-01, T32 CA009370]; Salk Institute Cancer Center core facilities (National Cancer Institute) [CA014195]; Mass Spectrometry Core of the Salk Institute (National Cancer Institute Cancer Center Support Grants of the US National Institutes of Health) [P30 014195]; Helmsley Center for Genomic Medicine; NATIONAL CANCER INSTITUTE [T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105455] Funding Source: NIH RePORTER	Nomis Foundation; Waitt Foundation; James B. Pendleton Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salk Institute Cancer Center core facilities (National Cancer Institute); Mass Spectrometry Core of the Salk Institute (National Cancer Institute Cancer Center Support Grants of the US National Institutes of Health); Helmsley Center for Genomic Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Williamson (the Scripps Research Institute) for use of the BLI instrument; the Salk Biophotonics Core for assistance with FRAP acquisition; the Salk Flow Cytometry Core Facility for assistance with flow-cytometry-based analysis of calcium flux and cell sorting; Jolene Diedrich and James Moresco for mass spectrometry analyses; M. Hetzer, T. Hunter, P. Hogan, G. Lemke, and J. Karlseder for critical reading of the manuscript; A. Weiss (University of California San Francisco, San Francisco, California, USA) for parental Jurkat cell lines; M.M. Davis (Stanford University, Stanford, California) for HEK293T cells; and the Nomis Foundation, the Waitt Foundation and the James B. Pendleton Charitable Trust for support. Supported by the US National Institutes of Health (1DP2GM105455-01 to B.F.L. and T32 CA009370 to Z.B.K.), the Salk Institute Cancer Center core facilities (funded by CA014195 from the National Cancer Institute), the Mass Spectrometry Core of the Salk Institute (supported by P30 014195 from the National Cancer Institute Cancer Center Support Grants of the US National Institutes of Health) and the Helmsley Center for Genomic Medicine.	BANIYASH M, 1988, J BIOL CHEM, V263, P18225; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Klammt C, 2015, NAT IMMUNOL, V16, P961, DOI 10.1038/ni.3231; Klammt C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00291; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lovering F, 2012, CHEM BIOL DRUG DES, V80, P657, DOI 10.1111/j.1747-0285.2012.01443.x; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; O'Brien R, 2000, PROTEIN SCI, V9, P570; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Szabo M, 2012, INT IMMUNOL, V24, P79, DOI 10.1093/intimm/dxr105; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VEILLETTE A, 1992, ONCOGENE, V7, P971; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105	50	51	51	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					86	95		10.1038/ni.3631	http://dx.doi.org/10.1038/ni.3631			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27869819	Green Accepted			2022-12-18	WOS:000390080000013
J	Zhang, Q; Kuang, H; Chen, C; Yan, J; Do-Umehara, HC; Liu, XY; Dada, L; Ridge, KM; Chandel, NS; Liu, J				Zhang, Qiao; Kuang, Hong; Chen, Cong; Yan, Jie; Do-Umehara, Hanh Chi; Liu, Xin-Yuan; Dada, Laura; Ridge, Karen M.; Chandel, Navdeep S.; Liu, Jing			The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE; AUTOPHAGY; UBIQUITINATION; ACTIVATION; PARKIN; PHOSPHORYLATION; P62/SQSTM1; MECHANISMS; SQSTM1/P62; P19(ARF)	Mitophagy is essential for cellular homeostasis, but how mitophagy is regulated is largely unknown. Here we found that the kinase Jnk2 was required for stress-induced mitophagy. Jnk2 promoted ubiquitination and proteasomal degradation of the small mitochondrial form of the tumor suppressor ARF (smARF). Loss of Jnk2 led to the accumulation of smARF, which induced excessive autophagy that resulted in lysosomal degradation of the mitophagy adaptor p62 at steady state. Depletion of p62 prevented Jnk2-deficient cells from mounting mitophagy upon stress. Jnk2-deficient mice displayed defective mitophagy, which resulted in tissue damage under hypoxic stress, as well as hyperactivation of inflammasomes and increased mortality in sepsis. Our findings define a unique mechanism of maintaining immunological homeostasis that protects the host from tissue damage and mortality.	[Zhang, Qiao; Kuang, Hong; Chen, Cong; Do-Umehara, Hanh Chi; Dada, Laura; Ridge, Karen M.; Chandel, Navdeep S.; Liu, Jing] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhang, Qiao; Kuang, Hong; Liu, Xin-Yuan] Zhejiang Sci Tech Univ, Coll Life Sci, State Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Yan, Jie] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Ridge, Karen M.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Zhejiang Sci-Tech University; University of Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Liu, J (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	jing@northwestern.edu	Liu, Xinyuan/HDM-5505-2022		US National Institutes of Health [HL114763]; American Asthma Foundation [13-0114]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081603] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Karin (University of California, San Diego) for Jnk2<SUP>-/-</SUP> mice; R. Youle (National Institute of Neurological Disorders and Stroke, National Institutes of Health) for the mCherry-parkin plasmid; Y. Cheng and M. A. Baker for help with the analysis of inflammasome activation; A. Yemelyanov for lentivirus preparation; and J. Hou for help with animal work. Supported by the US National Institutes of Health (HL114763 to J.L.) and the American Asthma Foundation (13-0114 to J.L.).	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Balaburski GM, 2010, TRENDS CELL BIOL, V20, P363, DOI 10.1016/j.tcb.2010.02.007; Bianchi ME, 2014, CELL DEATH DIFFER, V21, P1, DOI 10.1038/cdd.2013.147; Budina-Kolomets A, 2013, AUTOPHAGY, V9, P1553, DOI 10.4161/auto.25831; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fuchs SY, 1996, ONCOGENE, V13, P1531; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li N, 2013, J CLIN INVEST, V123, P2231, DOI 10.1172/JCI64498; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Medzhitov R, 2013, IMMUNITY, V39, P799, DOI 10.1016/j.immuni.2013.10.012; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Pimkina J, 2009, AUTOPHAGY, V5, P397, DOI 10.4161/auto.5.3.7782; Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005; Reef S, 2008, AUTOPHAGY, V4, P866, DOI 10.4161/auto.6691; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	50	51	51	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					458	U162		10.1038/ni.3130	http://dx.doi.org/10.1038/ni.3130			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25799126	Green Accepted			2022-12-18	WOS:000353305200007
J	Alsina, L; Israelsson, E; Altman, MC; Dang, KK; Ghandil, P; Israel, L; von Bernuth, H; Baldwin, N; Qin, H; Jin, Z; Banchereau, R; Anguiano, E; Ionan, A; Abel, L; Puel, A; Picard, C; Pascual, V; Casanova, JL; Chaussabel, D				Alsina, Laia; Israelsson, Elisabeth; Altman, Matthew C.; Dang, Kristen K.; Ghandil, Pegah; Israel, Laura; von Bernuth, Horst; Baldwin, Nicole; Qin, Huanying; Jin, Zongbo; Banchereau, Romain; Anguiano, Esperanza; Ionan, Alexei; Abel, Laurent; Puel, Anne; Picard, Capucine; Pascual, Virginia; Casanova, Jean Laurent; Chaussabel, Damien			A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; IMMUNE-RESPONSE; HOST-DEFENSE; OTHERWISE REDUNDANT; PROTECTIVE IMMUNITY; GENE-EXPRESSION; INNATE IMMUNITY; INFECTIONS; DEFICIENCY	Loss of function of the kinase IRAK4 or the adaptor MyD88 in humans interrupts a pathway critical for pathogen sensing and ignition of inflammation. However, patients with loss-of-function mutations in the genes encoding these factors are, unexpectedly, susceptible to only a limited range of pathogens. We employed a systems approach to investigate transcriptome responses following in vitro exposure of patients' blood to agonists of Toll-like receptors (TLRs) and receptors for interleukin 1 (IL-1Rs) and to whole pathogens. Responses to purified agonists were globally abolished, but variable residual responses were present following exposure to whole pathogens. Further delineation of the latter responses identified a narrow repertoire of transcriptional programs affected by loss of MyD88 function or IRAK4 function. Our work introduces the use of a systems approach for the global assessment of innate immune responses and the characterization of human primary immunodeficiencies.	[Alsina, Laia; Baldwin, Nicole; Qin, Huanying; Jin, Zongbo; Banchereau, Romain; Anguiano, Esperanza; Ionan, Alexei; Pascual, Virginia; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Alsina, Laia; Baldwin, Nicole; Qin, Huanying; Jin, Zongbo; Banchereau, Romain; Anguiano, Esperanza; Ionan, Alexei; Pascual, Virginia; Chaussabel, Damien] Baylor Res Inst, Dallas, TX USA; [Alsina, Laia] Univ Barcelona, Hosp St Joan de Deu, Allergy & Clin Immunol Dept, Barcelona, Spain; [Israelsson, Elisabeth; Altman, Matthew C.; Dang, Kristen K.; Chaussabel, Damien] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Ghandil, Pegah; Israel, Laura; von Bernuth, Horst; Abel, Laurent; Puel, Anne; Picard, Capucine; Casanova, Jean Laurent] IMAGINE Inst, INSERM, UMR 1163, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Ghandil, Pegah; Israel, Laura; von Bernuth, Horst; Abel, Laurent; Puel, Anne; Picard, Capucine; Casanova, Jean Laurent] Paris Descartes Univ, Paris, France; [von Bernuth, Horst] Humboldt Univ, Charite Hosp, Dept Pediat Pneumol & Immunol, D-10099 Berlin, Germany; [Puel, Anne; Picard, Capucine; Casanova, Jean Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Picard, Capucine; Casanova, Jean Laurent] Howard Hughes Med Inst, New York, NY USA; [Casanova, Jean Laurent] Hop Necker Enfants Malad, AP HP, Pediatr Hematol Immunol Unit, Paris, France; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar	Baylor Scott & White Health; Baylor Scott & White Health; Baylor University Medical Center; University of Barcelona; Benaroya Research Institute; Virginia Mason Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Sidra Medical & Research Center	Chaussabel, D (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	lalsina@hsjdbcn.org; dchaussabel@benaroyaresearch.org	Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; Ghandil, Pegah/K-4186-2018; Chaussabel, Damien/AAX-1909-2020; Picard, Capucine/H-3914-2017; Abel, Laurent/H-8888-2017; von Bernuth, Horst/AAQ-9797-2021; Pascual, Virginia/ABD-3099-2020; Alsina, Laia/AID-4372-2022; Alsina, Laia/GQI-3516-2022	Puel, Anne/0000-0003-2603-0323; Ghandil, Pegah/0000-0001-7828-6465; Picard, Capucine/0000-0001-8788-5056; Abel, Laurent/0000-0001-7016-6493; von Bernuth, Horst/0000-0002-5812-7675; Casanova, Jean-Laurent/0000-0002-7782-4169; Dang, Kristen/0000-0002-7512-4476; Chaussabel, Damien/0000-0002-6131-7242; Alsina, Laia/0000-0002-3559-0018	US National Institutes of Health [1R21AI085523-01, U01AI082110, U19-AI089987, U19-AI057234, R01ARO50770-02]; Dana Foundation, La Fundacio La Caixa; Instituto de Salud Carlos III (European Regional Development Fund) [PFIS12/01990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082110, R21AI085523, U19AI057234, U19AI089987] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation, La Fundacio La Caixa; Instituto de Salud Carlos III (European Regional Development Fund)(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Marodi, J.C. Rodriguez Gallego, G. Davies, Y. Camcioglu, A. Bousfiha, J. Vasconcelos and J.I. Arostegui for blood from the patients with deficiency in IRAK4 or MyD88; B. Lemoine and P. Nguyen for sample processing; E. Varon (Assistance Publique-Hopitaux de Paris) for bacterial strains; F.J. Barrat (Dynavax Technologies) for CpG reagents; M. Chrabieh for technical help; and the patients and their families for help. Supported by the US National Institutes of Health (1R21AI085523-01, U01AI082110, U19-AI089987, U19-AI057234 and R01ARO50770-02), the Dana Foundation, La Fundacio La Caixa (L.Al., 2008-2010) and the Instituto de Salud Carlos III (PFIS12/01990 (also financed by the European Regional Development Fund) to L.Al., 2012 to the present).	Ahmad R, 2008, BLOOD, V112, P2360, DOI 10.1182/blood-2008-02-137711; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allantaz F, 2007, CURR OPIN IMMUNOL, V19, P623, DOI 10.1016/j.coi.2007.10.003; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Caruso Calogero, 2009, Immun Ageing, V6, P10, DOI 10.1186/1742-4933-6-10; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kielian T, 2004, J NEUROPATH EXP NEUR, V63, P381, DOI 10.1093/jnen/63.4.381; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; Nau GJ, 2003, J IMMUNOL, V170, P5203, DOI 10.4049/jimmunol.170.10.5203; Nicolle DM, 2004, LAB INVEST, V84, P1305, DOI 10.1038/labinvest.3700149; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Trautmann L, 2011, NAT IMMUNOL, V12, P729, DOI 10.1038/ni.2078; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Zola TA, 2008, J IMMUNOL, V181, P7909, DOI 10.4049/jimmunol.181.11.7909	48	51	52	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1134	1142		10.1038/ni.3028	http://dx.doi.org/10.1038/ni.3028			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25344726	Green Accepted			2022-12-18	WOS:000344841900010
J	Parmentier, N; Stroobant, V; Colau, D; de Diesbach, P; Morel, S; Chapiro, J; van Endert, P; Van den Eynde, BJ				Parmentier, Nicolas; Stroobant, Vincent; Colau, Didier; de Diesbach, Philippe; Morel, Sandra; Chapiro, Jacques; van Endert, Peter; Van den Eynde, Benoit J.			Production of an antigenic peptide by insulin-degrading enzyme	NATURE IMMUNOLOGY			English	Article							CYTOLYTIC T-LYMPHOCYTES; TRIPEPTIDYL-PEPTIDASE; CELL RESPONSES; ANTIBODY 57B; GENERATION; IDENTIFICATION; PURIFICATION; DEGRADATION; PROTEASOME; MELANOMA	Most antigenic peptides presented by major histocompatibility complex (MHC) class I molecules are produced by the proteasome. Here we show that a proteasome-independent peptide derived from the human tumor protein MAGE-A3 is produced directly by insulin-degrading enzyme (IDE), a cytosolic metallopeptidase. Cytotoxic T lymphocyte recognition of tumor cells was reduced after metallopeptidase inhibition or IDE silencing. Separate inhibition of the metallopeptidase and the proteasome impaired degradation of MAGE-A3 proteins, and simultaneous inhibition of both further stabilized MAGE-A3 proteins. These results suggest that MAGE-A3 proteins are degraded along two parallel pathways that involve either the proteasome or IDE and produce different sets of antigenic peptides presented by MHC class I molecules.	[Parmentier, Nicolas; Stroobant, Vincent; Colau, Didier; Morel, Sandra; Chapiro, Jacques; Van den Eynde, Benoit J.] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; [Parmentier, Nicolas; Stroobant, Vincent; Colau, Didier; Morel, Sandra; Chapiro, Jacques; Van den Eynde, Benoit J.] Catholic Univ Louvain, Cellular Genet Unit, Duve Inst, B-1200 Brussels, Belgium; [de Diesbach, Philippe] Catholic Univ Louvain, Cell Unit, Duve Inst, B-1200 Brussels, Belgium; [van Endert, Peter] INSERM, U103, Paris, France; [van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, Paris, France	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Van den Eynde, BJ (corresponding author), Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium.	benoit.vandeneynde@bru.licr.org	van Endert, Peter/R-4606-2017	van Endert, Peter/0000-0003-3782-0750				Authier F, 1996, CLIN INVEST MED, V19, P149; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; Chow KM, 2003, BIOCHEMISTRY-US, V42, P2239, DOI 10.1021/bi027178d; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; de Diesbach P, 2000, NUCLEIC ACIDS RES, V28, P868; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; FAGAN JM, 1991, BIOCHEM J, V277, P779, DOI 10.1042/bj2770779; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Kawahara M, 2009, J IMMUNOL, V183, P6069, DOI 10.4049/jimmunol.0803564; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; KOCHER T, 1995, CANCER RES, V55, P2236; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Landry C, 2000, INT J CANCER, V86, P835, DOI 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N; LESSLEY BA, 1990, BIOL REPROD, V43, P643, DOI 10.1095/biolreprod43.4.643; Lonchay C, 2004, P NATL ACAD SCI USA, V101, P14631, DOI 10.1073/pnas.0405743101; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; Mzhavia N, 1999, DNA CELL BIOL, V18, P369, DOI 10.1089/104454999315268; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rimoldi D, 2000, INT J CANCER, V86, P749; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Schultz ES, 2002, J EXP MED, V195, P391, DOI 10.1084/jem.20011974; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; van Endert P, 2008, EUR J IMMUNOL, V38, P609, DOI 10.1002/eji.200838181; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wolfel C, 2000, INT J CANCER, V88, P432; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X	45	51	52	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					449	U114		10.1038/ni.1862	http://dx.doi.org/10.1038/ni.1862			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20364150				2022-12-18	WOS:000276852200015
J	Osipovich, O; Cobb, RM; Oestreich, KJ; Pierce, S; Ferrier, P; Oltz, EM				Osipovich, Oleg; Cobb, Robin Milley; Oestreich, Kenneth J.; Pierce, Steven; Ferrier, Pierre; Oltz, Eugene M.			Essential function for SWI-SNF chromatin-remodeling complexes in the promoter-directed assembly	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; V(D)J RECOMBINATION; HISTONE ACETYLATION; ENHANCER ELEMENTS; GENE SEGMENTS; SWI/SNF; NUCLEOSOME; TRANSCRIPTION; MECHANISM; DELETION	The assembly of genes encoding antigen receptors is regulated by developmental changes in chromatin that either permit or deny access to a single variable-(diversity)-joining recombinase. These changes are guided by transcriptional promoters and enhancers, which serve as accessibility-control elements in antigen-receptor loci. The function of each accessibility-control element and the factors they recruit to remodel chromatin remain obscure. Here we show that the recruitment of SWI-SNF chromatin-remodeling complexes compensated for the accessibility-control element function of a promoter but not an enhancer of the T cell receptor-b locus (Tcrb). Loss of SWI-SNF function in thymocytes inactivated recombinase targets at the endogenous Tcrb locus. Thus, initiation of Tcrb gene assembly and T cell development is contingent on the recruitment of SWI-SNF to promoters, which exposes gene segments to variable-(diversity)-joining recombinase.	Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Univ Mediterranee, CNRS, Inst Natl Sante Rech Med, Ctr Immunol Marseille Luminy, Marseille 09, France	Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Oltz, EM (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	eugene.oltz@vanderbilt.edu			NATIONAL CANCER INSTITUTE [R01CA100905, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NCI NIH HHS [CA 100905, P30 CA68485] Funding Source: Medline; NHLBI NIH HHS [P01 HL68744] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; MOMBAERTS P, 1995, P NATL ACAD SCI USA, V92, P7420, DOI 10.1073/pnas.92.16.7420; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sikes ML, 1998, J IMMUNOL, V161, P1399; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Sikes ML, 1999, J IMMUNOL METHODS, V224, P25, DOI 10.1016/S0022-1759(99)00003-4; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066	51	51	52	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					809	816		10.1038/ni1481	http://dx.doi.org/10.1038/ni1481			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17589511				2022-12-18	WOS:000248169400008
J	Yabuki, M; Fujii, MM; Maizels, N				Yabuki, M; Fujii, MM; Maizels, N			The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions	NATURE IMMUNOLOGY			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; MRE11 COMPLEX; BREAKAGE SYNDROME; FOCUS FORMATION; REPAIR; MUTATIONS; CELLS; NBS1	Targeted diversification of immunoglobulin variable regions is induced by activation-induced deaminase and may occur by either somatic hypermutation or gene conversion. MRE11-RAD50-NBS1 (MRN) is a ubiquitous and conserved nuclease complex critical for DNA break repair and is essential in class-switch recombination. Here we show that ectopic expression of NBS1, the regulatory subunit of MRN, accelerated hypermutation in the human B cell line Ramos and accelerated gene conversion in the chicken B cell line DT40. In both cases, accelerated diversification depended on MRN complex formation. These data suggest that MRN promotes DNA cleavage and/or mutagenic repair of lesions initiated by activation-induced deaminase, acting in the shared pathway of immunoglobulin gene diversification.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	maizels@u.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799, R01GM041712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041712, R01 GM41712, R01 GM39799] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Luria SE, 1943, GENETICS, V28, P491; MAIZELS N, IN PRESS ANN REV GEN; MCCORMACK WT, 1993, MOL CELL BIOL, V13, P821, DOI 10.1128/MCB.13.2.821; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; NOVE J, 1986, MUTAT RES, V163, P255, DOI 10.1016/0027-5107(86)90023-0; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2003, J IMMUNOL, V170, P3707, DOI 10.4049/jimmunol.170.7.3707; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	50	51	56	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					730	736		10.1038/ni1215	http://dx.doi.org/10.1038/ni1215			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15937485				2022-12-18	WOS:000229975500017
J	Nolte, MA; Arens, R; van Os, R; van Oosterwijk, M; Hooibrink, B; van Lier, RAW; van Oers, MHJ				Nolte, MA; Arens, R; van Os, R; van Oosterwijk, M; Hooibrink, B; van Lier, RAW; van Oers, MHJ			Immune activation modulates hematopoiesis through interactions between CD27 and CD70	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR RECEPTOR; MEMORY B-CELLS; N-TERMINAL KINASE; BONE-MARROW; STEM-CELLS; T-CELLS; CD27/CD70 INTERACTION; PLASMA-CELLS; PROGENITOR CELLS; SELF-RENEWAL	The differentiation of hematopoietic stem cells into mature blood cell lineages is tightly regulated. Here we report that CD27, which is expressed on stem and early progenitor cells in bone marrow, can be important in this process. Deletion of CD27 increased the myeloid colony - forming potential of stem and early progenitor cells and enhanced B lymphoid reconstitutive capacity in competitive transplantation experiments. Conversely, stimulation of CD27(+) progenitor cells with CD70, the unique ligand for CD27, inhibited colony-forming potential in vitro and lymphocyte outgrowth in vivo. As CD70 is expressed only on activated immune cells, we suggest that CD27 triggering on early progenitor cells provides a negative feedback signal to leukocyte differentiation during immune activation.	Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; Univ Groningen, Dept Cell Biol, Div Stem Cell Biol, NL-9713 AV Groningen, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	van Lier, RAW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, L1-105,Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.vanlier@amc.uva.nl	van Os, Ronald/I-1516-2013; Arens, Ramon/V-4010-2018; Nolte, Martijn A./AAC-8092-2022	Arens, Ramon/0000-0001-5058-4110; Nolte, Martijn A./0000-0002-5447-0839; van Lier, Rene/0000-0002-3201-7144				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Agematsu K, 1998, BLOOD, V91, P173, DOI 10.1182/blood.V91.1.173; Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; BOWMAN MR, 1994, J IMMUNOL, V152, P1756; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DEJONG R, 1991, J IMMUNOL, V146, P2488; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; FIBBE WE, 1992, J IMMUNOL, V148, P417; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gravestein LA, 1998, EUR J IMMUNOL, V28, P2208, DOI 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; HINTZEN RQ, 1994, J IMMUNOL, V152, P1762; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Jacquot S, 1997, J IMMUNOL, V159, P2652; KERST JM, 1992, EXP HEMATOL, V20, P1188; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KOBATA T, 1995, P NATL ACAD SCI USA, V92, P11249, DOI 10.1073/pnas.92.24.11249; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lens SMA, 1997, IMMUNOLOGY, V90, P38, DOI 10.1046/j.1365-2567.1997.00134.x; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Nagumo H, 1998, J IMMUNOL, V161, P6496; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; PLOEMACHER RE, 1991, BLOOD, V78, P2527; PLOEMACHER RE, 1994, CULTURE HEMATOPOIETI, V1, P1; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Tesselaar K, 2003, J IMMUNOL, V170, P33, DOI 10.4049/jimmunol.170.1.33; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; VANLIER RAW, 1987, J IMMUNOL, V139, P1589; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; Xiao YL, 2004, J IMMUNOL, V172, P7432, DOI 10.4049/jimmunol.172.12.7432; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZOUMBOS NC, 1984, J IMMUNOL, V133, P769	49	51	52	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					412	418		10.1038/ni1174	http://dx.doi.org/10.1038/ni1174			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15723067				2022-12-18	WOS:000227860000016
J	Barouch, DH; Powers, J; Truitt, DM; Kishko, MG; Arthur, JC; Peyerl, FW; Kuroda, MJ; Gorgone, DA; Lifton, MA; Lord, CI; Hirsch, VM; Montefiori, DC; Carville, A; Mansfield, KG; Kunstman, KJ; Wolinsky, SM; Letvin, NL				Barouch, DH; Powers, J; Truitt, DM; Kishko, MG; Arthur, JC; Peyerl, FW; Kuroda, MJ; Gorgone, DA; Lifton, MA; Lord, CI; Hirsch, VM; Montefiori, DC; Carville, A; Mansfield, KG; Kunstman, KJ; Wolinsky, SM; Letvin, NL			Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants	NATURE IMMUNOLOGY			English	Article							VACCINATED RHESUS-MONKEYS; VIRAL ESCAPE; DISEASE PROGRESSION; PRIMARY INFECTION; CELL RESPONSES; PATHOGENIC SIV; VIREMIA; AIDS; SELECTION; TRANSMISSION	Viral escape from cytotoxic T lymphocytes (CTLs) can undermine immune control of human immunodeficiency virus 1. It is therefore important to assess the stability of viral mutations in CTL epitopes after transmission to naive hosts. Here we demonstrate the persistence of mutations in a dominant CTL epitope after transmission of simian immunodeficiency virus variants to major histocompatibility complex-matched rhesus monkeys. Transient reversions to wild-type sequences occurred and elicited CTLs specific for the wild-type epitope, resulting in immunological pressure that rapidly reselected the mutant viruses. These data suggest that mutations in dominant human immunodeficiency virus 1 CTL epitopes may accumulate in human populations with limited major histocompatibility complex heterogeneity by a mechanism involving dynamic CTL control of transiently reverted wild-type virus.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; New England Primate Res Ctr, Southborough, MA 01772 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, 330 Brookline Ave, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Wolinsky, Steven/B-2893-2012	Arthur, Janelle/0000-0002-4796-0207; Wolinsky, Steven/0000-0002-9625-6697	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020729, R01AI058727, R37AI020729, Z01AI000686, K08AI051223, ZIAAI000686] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR-00168] Funding Source: Medline; NIAID NIH HHS [AI-51223, AI-58727, AI-20729] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; MILLER MD, 1991, J IMMUNOL, V147, P320; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Peyerl FW, 2003, J VIROL, V77, P12572, DOI 10.1128/JVI.77.23.12572-12578.2003; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seth A, 2000, J VIROL, V74, P2502, DOI 10.1128/JVI.74.6.2502-2509.2000	30	51	53	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					247	252		10.1038/ni1167	http://dx.doi.org/10.1038/ni1167			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15685174				2022-12-18	WOS:000227117400016
J	Levy, DE; Marie, IJ				Levy, DE; Marie, IJ			RIGging an antiviral defense - it's in the CARDs	NATURE IMMUNOLOGY			English	Editorial Material							DOUBLE-STRANDED-RNA; ACTIVATION; INFECTION; PATHWAY; INNATE; CELLS; IRF-3	How do cells fend off intracellular viruses that slip in below extracellular defensive `radar screens'? The identification of a cytoplasmic RNA helicase that signals through CARD interactions links viral detection to the interferon-beta induction pathway.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University	Levy, DE (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	del243@med.nyu.edu	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788; Marie, Isabelle/0000-0002-3091-7624				Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	12	51	52	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					699	701		10.1038/ni0704-699	http://dx.doi.org/10.1038/ni0704-699			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224097				2022-12-18	WOS:000222331200013
J	Andres, PG; Howland, KC; Nirula, A; Kane, LP; Barron, L; Dresnek, D; Sadra, A; Imboden, J; Weiss, A; Abbas, AK				Andres, PG; Howland, KC; Nirula, A; Kane, LP; Barron, L; Dresnek, D; Sadra, A; Imboden, J; Weiss, A; Abbas, AK			Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE ASSOCIATION; COSTIMULATORY RECEPTOR CD28; IL-4 GENE-EXPRESSION; CD28-MEDIATED COSTIMULATION; TYROSINE KINASE; CELL-DIFFERENTIATION; SH3 DOMAIN; IN-VIVO; ACTIVATION	CD28 costimulation is essential for CD4(+) T cell proliferation, survival, interleukin 2 (IL-2) production and T helper type 2 development. To define the nature of the signals that may drive different T cell responses, we have done a structure-function analysis of the CD28 cytoplasmic tail in primary T cells. CD28-mediated T cell proliferation and IL-2 production did not require a particular cytoplasmic domain. In contrast, IL-4 production was driven by the cooperative activity of specific motifs within the CD28 cytoplasmic tail. Using a gene-complementation approach, we provide evidence that one component of this T helper type 2 differentiation signal was mediated by 3-phosphoinositide- dependent protein kinase 1. Thus, different mechanisms underlie the induction of distinct T cell functional responses by CD28.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Rosalind Russell Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Abbas, AK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	aabbas@itsa.ucsf.edu		Kane, Lawrence/0000-0001-5198-516X; Sadra, Ali/0000-0002-1938-1072	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062343] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI25022] Funding Source: Medline; NIDDK NIH HHS [K08 DK62343-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gibson S, 1998, BIOCHEM J, V330, P1123, DOI 10.1042/bj3301123; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Hehner SP, 2000, J IMMUNOL, V164, P3829, DOI 10.4049/jimmunol.164.7.3829; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Hutchcroft JE, 1996, J BIOL CHEM, V271, P13362, DOI 10.1074/jbc.271.23.13362; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Sadra A, 1999, J IMMUNOL, V162, P1966; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schafer PH, 1999, J IMMUNOL, V162, P7110; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Schroeder JT, 1998, J LEUKOCYTE BIOL, V63, P692, DOI 10.1002/jlb.63.6.692; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Skapenko A, 2001, J IMMUNOL, V166, P4283, DOI 10.4049/jimmunol.166.7.4283; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Sperling AI, 1996, J IMMUNOL, V157, P3909; TAICHMAN R, 1993, J BIOL CHEM, V268, P20031; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Truitt KE, 1996, J IMMUNOL, V156, P4539; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; VOGEL LB, 1993, MOL CELL BIOL, V13, P7408, DOI 10.1128/MCB.13.12.7408; VONWILLEBRAND M, 1994, EUR J IMMUNOL, V24, P234, DOI 10.1002/eji.1830240137; WARD SG, 1993, EUR J IMMUNOL, V23, P2572, DOI 10.1002/eji.1830231029; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yang WC, 1999, EUR J IMMUNOL, V29, P1842, DOI 10.1002/(SICI)1521-4141(199906)29:06<1842::AID-IMMU1842>3.0.CO;2-D; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607	53	51	51	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					435	442		10.1038/ni1044	http://dx.doi.org/10.1038/ni1044			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15004555				2022-12-18	WOS:000220515900017
J	Kiner, E; Willie, E; Vijaykumar, B; Chowdhary, K; Schmutz, H; Chandler, J; Schnell, A; Thakore, PI; LeGros, G; Mostafavi, S; Mathis, D; Benoist, C				Kiner, Evgeny; Willie, Elijah; Vijaykumar, Brinda; Chowdhary, Kaitavjeet; Schmutz, Hugo; Chandler, Jodie; Schnell, Alexandra; Thakore, Pratiksha I.; LeGros, Graham; Mostafavi, Sara; Mathis, Diane; Benoist, Christophe		Immunological Genome Project Con	Gut CD4(+) T cell phenotypes are a continuum molded by microbes, not by T-H archetypes	NATURE IMMUNOLOGY			English	Article							FUNCTIONAL-HETEROGENEITY; REGULATORY NETWORK; TGF-BETA; TRANSCRIPTION; PLASTICITY; ACCESSIBILITY; LYMPHOCYTES; GENERATION; INFECTION; SUBSETS	CD4(+) effector lymphocytes (T-eff) are traditionally classified by the cytokines they produce. To determine the states that T-eff cells actually adopt in frontline tissues in vivo, we applied single-cell transcriptome and chromatin analyses to colonic T-eff cells in germ-free or conventional mice or in mice after challenge with a range of phenotypically biasing microbes. Unexpected subsets were marked by the expression of the interferon (IFN) signature or myeloid-specific transcripts, but transcriptome or chromatin structure could not resolve discrete clusters fitting classic helper T cell (T-H) subsets. At baseline or at different times of infection, transcripts encoding cytokines or proteins commonly used as T-H markers were distributed in a polarized continuum, which was functionally validated. Clones derived from single progenitors gave rise to both IFN-gamma- and interleukin (IL)-17-producing cells. Most of the transcriptional variance was tied to the infecting agent, independent of the cytokines produced, and chromatin variance primarily reflected activities of activator protein (AP)-1 and IFN-regulatory factor (IRF) transcription factor (TF) families, not the canonical subset master regulators T-bet, GATA3 or ROR gamma.	[Kiner, Evgeny; Vijaykumar, Brinda; Chowdhary, Kaitavjeet; Schmutz, Hugo; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Kiner, Evgeny; Vijaykumar, Brinda; Chowdhary, Kaitavjeet; Schmutz, Hugo; Schnell, Alexandra; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Kiner, Evgeny; Vijaykumar, Brinda; Chowdhary, Kaitavjeet; Schmutz, Hugo; Schnell, Alexandra; Mathis, Diane; Benoist, Christophe] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Willie, Elijah] Univ British Columbia, Bioinformat Program, Vancouver, BC, Canada; [Chandler, Jodie; LeGros, Graham] Malaghan Inst Med Res, Wellington, New Zealand; [Thakore, Pratiksha I.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Mostafavi, Sara] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Mostafavi, Sara] Canadian Inst Adv Res, Toronto, ON, Canada; [Mostafavi, Sara] Vector Inst, Toronto, ON, Canada; [Kiner, Evgeny] Immunai, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of British Columbia; Malaghan Institute; Victoria University Wellington; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of British Columbia; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Mathis, D; Benoist, C (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Thakore, Pratiksha I./HDM-5197-2022; Nutt, Stephen/C-9256-2013; Grieshaber-Bouyer, Dr. Ricardo/R-7512-2016	Schnell, Alexandra/0000-0003-3442-7750; Le Gros, Graham/0000-0002-5721-0442; Allan, Rhys/0000-0003-0906-2980; Tellier, Julie/0000-0003-2787-8174; Nutt, Stephen/0000-0002-0020-6637; Omilusik, Kyla/0000-0003-3675-048X; Grieshaber-Bouyer, Dr. Ricardo/0000-0002-2873-5135	NIH [AI125603, AI072073]; Boehringer Ingelheim Fonds; Harvard Stem Cell Institute MD/PhD Training Fellowship;  [NIGMS-T32GM007753]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Harvard Stem Cell Institute MD/PhD Training Fellowship; 	We thank K. Murphy, N. Yosef, V. Kuchroo, R. Ramirez, D. Ramanan, M. Sassone-Corsi, E. Pamer, A. Anderson and J. Huh for insightful discussions, data and mouse lines and K. Hattori, C. Araneo, K. Seddu, D. Dionne and the Klarman Cell Observatory team and N. El-Ali and the Bauer Core Facility for help with mice, cell sorting and single-cell profiling. This work was supported by grants from the NIH to C.B. and D.M. (AI125603) and to the ImmGen consortium (AI072073). E.K. was supported by a PhD fellowship from Boehringer Ingelheim Fonds. K.C. was supported by NIGMS-T32GM007753 and a Harvard Stem Cell Institute MD/PhD Training Fellowship.	Aghaeepour N, 2018, BIOINFORMATICS, V34, P4131, DOI 10.1093/bioinformatics/bty430; Alexander TB, 2018, NATURE, V562, P373, DOI 10.1038/s41586-018-0436-0; ARANEO BA, 1975, J IMMUNOL, V114, P747; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baron CS, 2019, CELL, V179, P527, DOI 10.1016/j.cell.2019.08.006; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Becht E, 2019, BIOINFORMATICS, V35, P301, DOI 10.1093/bioinformatics/bty491; Bielecki P., 2018, BIORXIV, DOI [10.1101/461228, DOI 10.1101/461228]; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Burel JG, 2020, CYTOM PART A, V97, P1127, DOI 10.1002/cyto.a.24027; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Cano-Gamez E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15543-y; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hess J, 1996, J IMMUNOL, V156, P3321; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; KILLAR L, 1987, J IMMUNOL, V138, P1674; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Pavlidis NG, 2016, J MACH LEARN RES, V17; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Wang C., 2020, CELL, DOI [10.1101/2020.01.23.911966, DOI 10.1101/2020.01.23.911966]; Wei SC, 2019, IMMUNITY, V50, P1084, DOI 10.1016/j.immuni.2019.03.004; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	65	50	50	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					216	U219		10.1038/s41590-020-00836-7	http://dx.doi.org/10.1038/s41590-020-00836-7		JAN 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33462454	Green Accepted, Green Submitted			2022-12-18	WOS:000608675100002
J	Tu, AA; Gierahn, TM; Monian, B; Morgan, DM; Mehta, NK; Ruiter, B; Shreffler, WG; Shalek, AK; Love, JC				Tu, Ang A.; Gierahn, Todd M.; Monian, Brinda; Morgan, Duncan M.; Mehta, Naveen K.; Ruiter, Bert; Shreffler, Wayne G.; Shalek, Alex K.; Love, J. Christopher			TCR sequencing paired with massively parallel 3 ' RNA-seq reveals clonotypic T cell signatures	NATURE IMMUNOLOGY			English	Article							EXPRESSION; ALPHA; RESPONSES; GENOME; CHAINS; FATE	High-throughput 3' single-cell RNA-sequencing (scRNA-seq) allows cost-effective, detailed characterization of individual immune cells from tissues. Current techniques, however, are limited in their ability to elucidate essential immune cell features, including variable sequences of T cell antigen receptors (TCRs) that confer antigen specificity. Here, we present a strategy that enables simultaneous analysis of TCR sequences and corresponding full transcriptomes from 3'-barcoded scRNA-seq samples. This approach is compatible with common 3' scRNA-seq methods, and adaptable to processed samples post hoc. We applied the technique to identify transcriptional signatures associated with T cells sharing common TCRs from immunized mice and from patients with food allergy. We observed preferential phenotypes among subsets of expanded clonotypes, including type 2 helper CD4(+) Tcell (T(H)2) states associated with food allergy. These results demonstrate the utility of our method when studying diseases in which clonotype-driven responses are critical to understanding the underlying biology.	[Tu, Ang A.; Gierahn, Todd M.; Monian, Brinda; Morgan, Duncan M.; Mehta, Naveen K.; Shalek, Alex K.; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tu, Ang A.; Mehta, Naveen K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Monian, Brinda; Morgan, Duncan M.] MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ruiter, Bert; Shreffler, Wayne G.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Ruiter, Bert; Shreffler, Wayne G.] Harvard Med Sch, Boston, MA 02115 USA; [Shreffler, Wayne G.] Massachusetts Gen Hosp, Food Allergy Ctr, Boston, MA 02114 USA; [Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.; Love, J. Christopher] Broad Inst & Harvard, Cambridge, MA USA; [Love, J. Christopher] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Shalek, AK; Love, JC (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK; Love, JC (corresponding author), Broad Inst & Harvard, Cambridge, MA USA.; Love, JC (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA.	shalek@mit.edu; clove@mit.edu		Shalek, Alex K./0000-0001-5670-8778; Love, John/0000-0003-0921-3144; Morgan, Duncan/0000-0002-3253-1362; Ruiter, Bert/0000-0003-3945-3202	Koch Institute Support (core) NIH Grant from the National Cancer Institute [P30-CA14051]; Koch Institute-Dana-Farber/Harvard Cancer Center Bridge Project; Food Allergy Science Initiative at the Broad Institute; NIH [1DP2GM119419, 2U19AI089992, 2R01HL095791, 1U54CA217377, 2P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 1R01AI138546, 1R01HL134539, 1R01DA046277, 1U2CCA23319501, 5P01AI039671, 5U19AI089992, U19AI095261]; Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; Sloan Fellowship in Chemistry; Agilent Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089992, P01AI039671] Funding Source: NIH RePORTER	Koch Institute Support (core) NIH Grant from the National Cancer Institute; Koch Institute-Dana-Farber/Harvard Cancer Center Bridge Project; Food Allergy Science Initiative at the Broad Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Beckman Young Investigator Program; Pew-Stewart Scholars Program for Cancer Research; Sloan Fellowship in Chemistry; Agilent Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Blainey and M. Birnbaum for fruitful discussions. This work was supported in part by the Koch Institute Support (core) NIH Grant P30-CA14051 from the National Cancer Institute, as well as the Koch Institute -Dana-Farber/Harvard Cancer Center Bridge Project. This work was also supported by the Food Allergy Science Initiative at the Broad Institute and the NIH (5P01AI039671, 5U19AI089992, U19AI095261). A.K.S. was supported by the Searle Scholars Program, the Beckman Young Investigator Program, the Pew-Stewart Scholars Program for Cancer Research, a Sloan Fellowship in Chemistry, the NIH (1DP2GM119419, 2U19AI089992, 2R01HL095791, 1U54CA217377, 2P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 1R01AI138546, 1R01HL134539, 1R01DA046277, 1U2CCA23319501) and Agilent Technologies.	Avraham R, 2015, CELL, V162, P1309, DOI 10.1016/j.cell.2015.08.027; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.a.22317, 10.1002/cyto.22317]; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Crosby EJ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1421891; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gupta I, 2018, NAT BIOTECHNOL, V36, P1197, DOI 10.1038/nbt.4259; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Huang WS, 2015, J LEUKOCYTE BIOL, V97, P477, DOI 10.1189/jlb.1RI0614-293R; Hughes T.K., 2019, HIGHLY EFFICIENT MAS, DOI [10.1101/689273, DOI 10.1101/689273]; Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060; Khodadoust MS, 2017, NATURE, V543, P723, DOI 10.1038/nature21433; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lossius A, 2014, EUR J IMMUNOL, V44, P3439, DOI 10.1002/eji.201444662; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mousset CM, 2019, CYTOM PART A, V95A, P647, DOI 10.1002/cyto.a.23724; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Nish SA, 2017, J EXP MED, V214, P39, DOI 10.1084/jem.20161046; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ritvo PG, 2018, P NATL ACAD SCI USA, V115, P9604, DOI 10.1073/pnas.1808594115; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rosati E, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0379-9; Saikia M, 2019, NAT METHODS, V16, P59, DOI 10.1038/s41592-018-0259-9; Schrama D, 2017, SEMIN IMMUNOPATHOL, V39, P255, DOI 10.1007/s00281-016-0614-9; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Seumois G, 2016, J IMMUNOL, V197, P655, DOI 10.4049/jimmunol.1600397; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Singh M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11049-4; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Syed A, 2013, IMMUNOTHERAPY-UK, V5, P931, DOI 10.2217/imt.13.93; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	53	50	51	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1692	+		10.1038/s41590-019-0544-5	http://dx.doi.org/10.1038/s41590-019-0544-5			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745340	Green Accepted			2022-12-18	WOS:000497949800023
J	Morou, A; Brunet-Ratnasingham, E; Dube, M; Charlebois, R; Mercier, E; Darko, S; Brassard, N; Nganou-Makamdop, K; Arumugam, S; Gendron-Lepage, G; Yang, LF; Niessl, J; Baxter, AE; Billingsley, JM; Rajakumar, PA; Lefebvre, F; Johnson, RP; Tremblay, C; Routy, JP; Wyatt, RT; Finzi, A; Douek, DC; Kaufmann, DE				Morou, Antigoni; Brunet-Ratnasingham, Elsa; Dube, Mathieu; Charlebois, Roxanne; Mercier, Eloi; Darko, Sam; Brassard, Nathalie; Nganou-Makamdop, Krystelle; Arumugam, Sahaana; Gendron-Lepage, Gabrielle; Yang, Lifei; Niessl, Julia; Baxter, Amy E.; Billingsley, James M.; Rajakumar, Premeela A.; Lefebvre, Francois; Johnson, R. Paul; Tremblay, Cecile; Routy, Jean-Pierre; Wyatt, Richard T.; Finzi, Andres; Douek, Daniel C.; Kaufmann, Daniel E.			Altered differentiation is central to HIV-specific CD4(+) T cell dysfunction in progressive disease	NATURE IMMUNOLOGY			English	Article							HUMAN TH17 CELLS; IMMUNE ACTIVATION; ANTIBODY-RESPONSE; DYSBIOSIS; ALIGNMENT; ROLES	Dysfunction of virus-specific CD4(+) T cells in chronic human infections is poorly understood. We performed genome-wide transcriptional analyses and functional assays of CD4(+) T cells specific for human immunodeficiency virus (HIV) from HIV-infected people before and after initiation of antiretroviral therapy (ART). A follicular helper T cell (T-FH cell)-like profile characterized HIV-specific CD4(+) T cells in viremic infection. HIV-specific CD4(+) T cells from people spontaneously controlling the virus (elite controllers) robustly expressed genes associated with the T(H)1, T(H)17 and T(H)22 subsets of helper T cells. Viral suppression by ART resulted in a distinct transcriptional landscape, with a reduction in the expression of genes associated with T-FH cells, but persistently low expression of genes associated with T(H)1, T(H)17 and T(H)22 cells compared to the elite controller profile. Thus, altered differentiation is central to the impairment of HIV-specific CD4(+) T cells and involves both gain of function and loss of function.	[Morou, Antigoni; Brunet-Ratnasingham, Elsa; Dube, Mathieu; Charlebois, Roxanne; Brassard, Nathalie; Gendron-Lepage, Gabrielle; Niessl, Julia; Baxter, Amy E.; Tremblay, Cecile; Finzi, Andres; Kaufmann, Daniel E.] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Morou, Antigoni; Brunet-Ratnasingham, Elsa; Gendron-Lepage, Gabrielle; Niessl, Julia; Baxter, Amy E.; Tremblay, Cecile; Finzi, Andres; Kaufmann, Daniel E.] Univ Montreal, Montreal, PQ, Canada; [Dube, Mathieu; Niessl, Julia; Baxter, Amy E.; Wyatt, Richard T.; Kaufmann, Daniel E.] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Mercier, Eloi; Lefebvre, Francois] Canadian Ctr Computat Genom Montreal Node, Montreal, PQ, Canada; [Darko, Sam; Nganou-Makamdop, Krystelle; Arumugam, Sahaana; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Yang, Lifei; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Billingsley, James M.; Rajakumar, Premeela A.; Johnson, R. Paul] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Billingsley, James M.; Rajakumar, Premeela A.; Johnson, R. Paul] Emory Univ, Atlanta, GA 30322 USA; [Routy, Jean-Pierre] McGill Univ, Hlth Ctr, Chron Viral Illnesses Serv, Montreal, PQ, Canada; [Routy, Jean-Pierre] McGill Univ, Hlth Ctr, Div Hematol, Montreal, PQ, Canada; [Baxter, Amy E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Emory University; McGill University; McGill University; University of Pennsylvania; Pennsylvania Medicine	Kaufmann, DE (corresponding author), Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada.; Kaufmann, DE (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Kaufmann, DE (corresponding author), Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.	daniel.kaufmann@umontreal.ca	YANG, LIFEI/B-6557-2015; Dubé, Mathieu/AAN-7908-2020	YANG, LIFEI/0000-0002-1348-4265; Dube, Mathieu/0000-0002-5522-9019; Niessl, Julia/0000-0001-8852-1924; Arumugam, Sahaana/0000-0002-0739-8045; Brassard, Nathalie/0000-0002-4320-9416	National Institutes of Health [HL092565, AI100663, OD011103, OD011132]; Canadian Institutes for Health Research [137694, 152977, MOP-93770, 352417]; Canada Foundation for Innovation Program Leader grant [31756]; FRQS AIDS and Infectious Diseases Network; Intramural Program of the National Institutes of Health; Senior Research Scholar Awards of the Quebec Health Research Fund (FRQS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005133, ZIAAI005031, UM1AI100663] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Program Leader grant(Canada Foundation for Innovation); FRQS AIDS and Infectious Diseases Network; Intramural Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Research Scholar Awards of the Quebec Health Research Fund (FRQS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Girouard, the clinical staff at the McGill University Health Centre in Montreal, the Ragon/MGH clinical and technical staff and all study participants for their invaluable role in this project; B. Walker for providing clinical samples; D. Gauchat and the CRCHUM Flow Cytometry Platform for technical assistance; N. Hamel and McGill University and Genome Quebec Innovation Centre for microarray analysis; and J. Boss and S. Crotty for their input on this manuscript. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 IIIB p24 Recombinant Protein from ImmunoDX, LLC. This study was supported by the National Institutes of Health grants (no. HL092565 to D.E.K.; no. AI100663 CHAVI-ID to D.E.K. and R.T.W. (Consortium PI: D. Burton); nos. OD011103 and OD011132 to R.P.J.); the Canadian Institutes for Health Research grants (nos. 137694 and 152977 to D.E.K.; no. MOP-93770 to C.T.; and foundation no. 352417 to A.F.); the Canada Foundation for Innovation Program Leader grant (no. 31756 to D.E.K.); and the FRQS AIDS and Infectious Diseases Network. This work was funded in part by the Intramural Program of the National Institutes of Health (D.C.D., S.D.). D.E.K. and C.T. are supported by Senior Research Scholar Awards of the Quebec Health Research Fund (FRQS). J.-P.R. is the holder of the Louis Lowenstein Chair in Hematology & Oncology, McGill University. A.F. is a .Canada Research Chair on Retroviral Entry	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baxter AE, 2017, NAT PROTOC, V12, P2029, DOI 10.1038/nprot.2017.079; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; FAVRE D, 2010, R LANG ENV STAT COMP, V2, DOI DOI 10.1126/SCITRANSLMED.3000632; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Kahan SM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aap9339; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kim CJ, 2012, MUCOSAL IMMUNOL, V5, P670, DOI 10.1038/mi.2012.72; Klase Z, 2015, MUCOSAL IMMUNOL, V8, P1009, DOI 10.1038/mi.2014.128; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larsson J., 2018, EULERR AREA PROPORTI, P4; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Morou A, 2014, CURR OPIN HIV AIDS, V9, P446, DOI 10.1097/COH.0000000000000094; Neff CP, 2018, EBIOMEDICINE, V30, P192, DOI 10.1016/j.ebiom.2018.03.024; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oksanen J., 2020, VEGAN COMMUNITY ECOL, V2, P1; Ono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111405; Ortiz AM, 2016, MUCOSAL IMMUNOL, V9, P458, DOI 10.1038/mi.2015.75; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Vella LA, 2017, TRENDS MOL MED, V23, P1072, DOI 10.1016/j.molmed.2017.10.001; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Warnes G, 2005, GPLOTS VARIOUS R PRO; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038510	56	50	50	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1059	+		10.1038/s41590-019-0418-x	http://dx.doi.org/10.1038/s41590-019-0418-x			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31308541	Green Accepted			2022-12-18	WOS:000476621200020
J	Choi, YJ; Kim, S; Choi, Y; Nielsen, TB; Yan, J; Lu, A; Ruan, JB; Lee, HR; Wu, H; Spellberg, B; Jung, JU				Choi, Youn Jung; Kim, Stephanie; Choi, Younho; Nielsen, Travis B.; Yan, Jun; Lu, Alvin; Ruan, Jianbin; Lee, Hye-Ra; Wu, Hao; Spellberg, Brad; Jung, Jae U.			SERPINB1-mediated checkpoint of inflammatory caspase activation	NATURE IMMUNOLOGY			English	Article							NLRP3 INFLAMMASOME; MECHANISM; INHIBITOR; SERPINS; EVOLUTION; DEFENSE; TOXINS; ENZYME; ASC	Inflammatory caspases (caspase-1, caspase-4, caspase-5 and caspase-11 (caspase-1/-4/-5/-11)) mediate host defense against microbial infections, processing pro-inflammatory cytokines and triggering pyroptosis. However, precise checkpoints are required to prevent their unsolicited activation. Here we report that serpin family B member 1 (SERPINB1) limited the activity of those caspases by suppressing their caspase-recruitment domain (CARD) oligomerization and enzymatic activation. While the reactive center loop of SERPINB1 inhibits neutrophil serine proteases, its carboxy-terminal CARD-binding motif restrained the activation of pro-caspase-1/-4/-5/-11. Consequently, knockdown or deletion of SERPINB1 prompted spontaneous activation of caspase-1/-4/-5/-11, release of the cytokine IL-1 beta and pyroptosis, inducing elevated inflammation after non-hygienic co-housing with pet-store mice and enhanced sensitivity to lipopolysaccharide- or Acinetobacter baumannii-induced endotoxemia. Our results reveal that SERPINB1 acts as a vital gatekeeper of inflammation by restraining neutrophil serine proteases and inflammatory caspases in a genetically and functionally separable manner.	[Choi, Youn Jung; Kim, Stephanie; Choi, Younho; Nielsen, Travis B.; Yan, Jun; Spellberg, Brad; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Choi, Youn Jung; Jung, Jae U.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Nielsen, Travis B.; Yan, Jun; Spellberg, Brad] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Lu, Alvin; Ruan, Jianbin; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Lu, Alvin; Ruan, Jianbin; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Lee, Hye-Ra] Korea Univ, Collage Sci & Technol, Dept Biotechnol & Bioinformat, Sejong, South Korea	University of Southern California; University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Korea University	Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Jung, JU (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.	jaeujung@med.usc.edu	Nielsen, Travis/A-5862-2019; Choi, Younho/Y-7282-2019	Nielsen, Travis/0000-0003-3366-7912; Choi, Younho/0000-0003-4719-3279; Lu, Alvin/0000-0003-2353-848X; Choi, Youn Jung (Chloe)/0000-0001-6879-0115	 [CA180779];  [CA200422];  [AI073099];  [AI116585];  [AI129496];  [AI140718];  [AI140705];  [DE023926];  [DE027888];  [DE028521];  [NRF-2016R1D1A1B03931761];  [Al124491];  [HD087988];  [AI081719];  [AI117211];  [AI127954];  [AI106375]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA180779, R35CA200422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129496, R01AI140718, R42AI106375, R01AI116585, R21AI127954, R01AI124491, R01AI140705, R01AI117211, R01AI073099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023926, R21DE027888] Funding Source: NIH RePORTER	; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank E. Remold-O'Donnell (Boston Children's Hospital) for Serpinb1a<SUP>-/-</SUP> mice, J. Yuan (Harvard Medical School) for Casp11<SUP>-/-</SUP> mice, T. S. Xiao (Case Western Reserve University), H.D. Beer (University of Zurich) and K.L. Rock (University of Massachusetts Medical School) for reagents, M.J. Kwak and B.H. Oh for protein purification, and J.W. Bowman and R. Amatya for manuscript preparation. This work was partly supported by grant nos. CA180779, CA200422, AI073099, AI116585, AI129496, AI140718, AI140705, DE023926, DE027888 and DE028521 (J.U.J.), NRF-2016R1D1A1B03931761 (H.-R.L.), Al124491 and HD087988 (H.W.), and AI081719, AI117211, AI127954 and AI106375 (B.S.).	Annand RR, 1999, BIOCHEM J, V342, P655, DOI 10.1042/0264-6021:3420655; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bitto NJ, 2018, IMMUNOL CELL BIOL, V96, P1120, DOI 10.1111/imcb.12190; Broz P, 2014, CELL HOST MICROBE, V16, P153, DOI 10.1016/j.chom.2014.07.010; Bruhn KW, 2015, J INFECT DIS, V211, P1296, DOI 10.1093/infdis/jiu593; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Dobo J, 2006, J BIOL CHEM, V281, P38781, DOI 10.1074/jbc.M605151200; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lagrange B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02682-y; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Le HT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00275; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Ng TM, 2013, CELL HOST MICROBE, V14, P9, DOI 10.1016/j.chom.2013.06.009; Pedraza-Alva G, 2015, IMMUNOL REV, V265, P231, DOI 10.1111/imr.12294; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; Robbins GR, 2014, MOL CELL, V54, P297, DOI 10.1016/j.molcel.2014.03.029; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simonovic M, 2000, PROTEIN SCI, V9, P1423, DOI 10.1110/ps.9.8.1423; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Young JL, 2000, J EXP MED, V191, P1535, DOI 10.1084/jem.191.9.1535; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	51	50	52	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					276	+		10.1038/s41590-018-0303-z	http://dx.doi.org/10.1038/s41590-018-0303-z			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30692621	Green Accepted			2022-12-18	WOS:000458893600013
J	Wang, XM; Xiao, G; Zhang, YF; Wen, XM; Gao, X; Okada, S; Liu, XL				Wang, Xiaoming; Xiao, Gang; Zhang, Yafeng; Wen, Xiaomin; Gao, Xiang; Okada, Seiji; Liu, Xiaolong			Regulation of Tcrb recombination ordering by c-Fos-dependent RAG deposition	NATURE IMMUNOLOGY			English	Article							CELL-RECEPTOR-BETA; V(D)J RECOMBINATION; ALLELIC EXCLUSION; TRANSCRIPTIONAL REGULATION; ACTIVATOR PROTEIN-1; 12/23 RULE; IN-VITRO; V-BETA; GENE; REARRANGEMENT	Antigen receptor variable-(diversity)-joining (V(D)J)recombination at the locus encoding the T cell antigen receptor-beta (Tcrb)is ordered, with D-beta-to-J(beta) assembly preceding V-beta-to-DJ(beta) joining. The molecular mechanism underlying this 'preferred' order of rearrangement remains unclear. Here we show that the D-beta 23-base pair recombination signal sequence (D-beta 23-RSS)contains a specific AP-1 transcription factor-binding site bound by AP-1 and its component c-Fos expressed at a specific stage. Cell-based recombination assays suggested that c-Fos interacted directly with the RAG recombinase and enhanced its deposition to Db 23-RSSs, thus conferring the priority of DJ(beta) recombination. Loss of c-Fos decreased Tcrb recombination efficiency and disrupted recombination ordering in vivo. Our results show an unexpected function for c-Fos as a direct regulator of Tcrb recombination, rather than its usual function as a transcription regulator, and provide new insight into the mechanisms of recombination ordering.	[Wang, Xiaoming; Xiao, Gang; Zhang, Yafeng; Wen, Xiaomin; Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210093, Peoples R China; [Okada, Seiji] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Kumamoto 8600811, Japan	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University; Kumamoto University	Liu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	liux@sibs.ac.cn	Wen, Xiaomin/H-5611-2019; Okada, Seiji/F-5785-2013; Wang, Xiaoming/E-9029-2015	WEN, XIAOMIN/0000-0002-0472-9021; Wang, Xiaoming/0000-0003-0679-9768; Xiao, Gang/0000-0002-9476-3847				Arbuckle JL, 2001, J BIOL CHEM, V276, P37093, DOI 10.1074/jbc.M105988200; Ardouin L, 1998, J EXP MED, V187, P105, DOI 10.1084/jem.187.1.105; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Borner C, 2002, MOL PHARMACOL, V61, P800, DOI 10.1124/mol.61.4.800; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Farina AR, 1997, CELL GROWTH DIFFER, V8, P789; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Jung D, 2003, IMMUNITY, V18, P65, DOI 10.1016/S1074-7613(02)00507-1; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Khor B, 2005, EUR J IMMUNOL, V35, P964, DOI 10.1002/eji.200425806; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McBride' K, 2003, ONCOGENE, V22, P8403, DOI 10.1038/sj.onc.1206877; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Olaru A, 2005, J IMMUNOL, V174, P6220, DOI 10.4049/jimmunol.174.10.6220; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Peak MM, 2003, J BIOL CHEM, V278, P18235, DOI 10.1074/jbc.M302041200; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki D, 2005, INT IMMUNOL, V17, P1553, DOI 10.1093/intimm/dxh333; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tillman RE, 2003, J IMMUNOL, V170, P5, DOI 10.4049/jimmunol.170.1.5; Tsai CL, 2002, GENE DEV, V16, P1934, DOI 10.1101/gad.984502; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	47	50	51	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					794	801		10.1038/ni.1614	http://dx.doi.org/10.1038/ni.1614			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18500346				2022-12-18	WOS:000256904900018
J	Hansen, TH; Huang, SX; Arnold, PL; Fremont, DH				Hansen, Ted H.; Huang, Shouxiong; Arnold, Phoebe L.; Fremont, Daved H.			Patterns of nonclassical MHC antigen presentation	NATURE IMMUNOLOGY			English	Article							INVARIANT T-CELLS; TCR ALPHA-CHAIN; I-RELATED GENE; CRYSTAL-STRUCTURE; NKT CELLS; POSITIVE SELECTION; MR1 GENE; MOLECULE; REVEALS; CD1D	The identification of pattern-recognition receptors that selectively respond to evolutionarily conserved chemical (often pathogen-derived) moieties has provided key insight into how innate immune cells facilitate rapid and relatively specific antimicrobial immune activity. In contrast, relatively slower adaptive immune responses rely on T cell clonal expansion that develops in response to variable peptides bound to the groove of classical major histocompatibility complex (MHC) proteins. For certain nonclassical 'MHC-like' class Ib proteins, such as H2-M3 and CD1d, their respective binding grooves seem to have been adapted to present to T cells unique molecular patterns analogous to those involved in innate signaling. Here we propose that another MHC class Ib protein, MR1, which is required for the gut flora-dependent development of mucosa-associated invariant T cells, presents either a microbe-produced or a microbe-induced pattern.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hansen, TH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	hansen@wustl.edu; fremont@wustl.edu		Huang, Shouxiong/0000-0001-7797-3626; Fremont, Daved/0000-0002-8544-2689				BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Cannarile MA, 2004, J IMMUNOL, V173, P4799, DOI 10.4049/jimmunol.173.8.4799; Chiu NM, 1999, J EXP MED, V190, P423, DOI 10.1084/jem.190.3.423; Chun T, 2001, J IMMUNOL, V167, P1507, DOI 10.4049/jimmunol.167.3.1507; Colmone A, 2006, MICROBES INFECT, V8, P2277, DOI 10.1016/j.micinf.2006.03.020; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Doyle CK, 2003, J IMMUNOL, V171, P836, DOI 10.4049/jimmunol.171.2.836; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miley MJ, 2003, J IMMUNOL, V170, P6090, DOI 10.4049/jimmunol.170.12.6090; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Okamoto N, 2005, CHEM BIOL, V12, P677, DOI 10.1016/j.chembiol.2005.04.014; Parra-Cuadrado JF, 2000, TISSUE ANTIGENS, V56, P170, DOI 10.1034/j.1399-0039.2000.560211.x; Ploss A, 2005, INFECT IMMUN, V73, P4423, DOI 10.1128/IAI.73.7.4423-4426.2005; Riegert P, 1998, J IMMUNOL, V161, P4066; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Shiina T, 2001, GENOME RES, V11, P789, DOI 10.1101/gr.175801; Shimamura M, 2002, FEBS LETT, V516, P97, DOI 10.1016/S0014-5793(02)02509-7; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Walter L, 1998, IMMUNOGENETICS, V47, P477, DOI 10.1007/s002510050385; Wang CR, 1996, RES IMMUNOL, V147, P313, DOI 10.1016/0923-2494(96)89644-1; WANG CR, 1995, IMMUNOGENETICS, V42, P63, DOI 10.1007/BF00164989; Xu HL, 2006, J EXP MED, V203, P449, DOI 10.1084/jem.20051866; Yamaguchi H, 1997, BIOCHEM BIOPH RES CO, V238, P697, DOI 10.1006/bbrc.1997.7379; Yamaguchi H, 1998, BIOCHEM BIOPH RES CO, V250, P558, DOI 10.1006/bbrc.1998.9353; Yamaguchi H, 2002, BIOCHEM BIOPH RES CO, V290, P722, DOI 10.1006/bbrc.2001.6277; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zwickey HL, 1999, J IMMUNOL, V162, P6341	47	50	53	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					563	568		10.1038/ni1475	http://dx.doi.org/10.1038/ni1475			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514210				2022-12-18	WOS:000246703300009
J	Zhao, H; Nguyen, H; Kang, JS				Zhao, H; Nguyen, H; Kang, JS			Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS LB MOLECULE; HISTONE ACETYLATION; V(D)J RECOMBINATION; POSITIVE SELECTION; PEYERS-PATCHES; NATURAL-KILLER; DEFICIENT MICE; IL-7 RECEPTOR; LOCUS	The gamma delta T cells are prevalent in the mucosal epithelia and are postulated to act as 'sentries' for maintaining tissue integrity. What these gamma delta T cells recognize is poorly defined, but given the restricted T cell receptor (TCR) repertoire, the idea that they are selected by self antigens of low complexity has been widely disseminated. Here we present data showing that the generation of the restricted TCR variable gamma-region gene repertoire of intestinal intraepithelial lymphocytes was regulated by interleukin 15, which induced local chromatin modifications specific for the variable gamma-region gene segment and enhanced accessibility conducive to subsequent targeted gene rearrangement. This cytokine-directed tissue-specific TCR repertoire formation probably reflects distinct TCR repertoire selection criteria for gamma delta and alpha beta T cell lineages adopted for different antigen-recognition strategies.	Univ Massachusetts, Sch Med, Grad Program Immunol & Virol, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Kang, JS (corresponding author), Univ Massachusetts, Sch Med, Grad Program Immunol & Virol, Dept Pathol, Worcester, MA 01655 USA.	joonsoo.kang@umassmed.edu		kang, joonsoo/0000-0001-8419-7995	NCI NIH HHS [R01 CA100382, R01 CA100382-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100382] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Baker JE, 1999, J EXP MED, V190, P669, DOI 10.1084/jem.190.5.669; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fujihashi K, 1996, P NATL ACAD SCI USA, V93, P3613, DOI 10.1073/pnas.93.8.3613; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Grigoriadou K, 2002, J IMMUNOL, V169, P3736, DOI 10.4049/jimmunol.169.7.3736; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Huang JQ, 2001, J IMMUNOL, V167, P6073, DOI 10.4049/jimmunol.167.11.6073; InagakiOhara K, 1997, EUR J IMMUNOL, V27, P2885, DOI 10.1002/eji.1830271121; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kang J, 1999, J EXP MED, V190, P973, DOI 10.1084/jem.190.7.973; Kang JS, 2004, J IMMUNOL, V173, P2307, DOI 10.4049/jimmunol.173.4.2307; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Leclercq G, 1996, J EXP MED, V184, P325, DOI 10.1084/jem.184.2.325; LEFRANCOIS L, 1990, CELL, V63, P333, DOI 10.1016/0092-8674(90)90166-C; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Murray AM, 1998, CYTOKINE, V10, P337, DOI 10.1006/cyto.1997.0302; Nonaka S, 2005, J IMMUNOL, V174, P1906, DOI 10.4049/jimmunol.174.4.1906; Pardigon N, 2004, INT IMMUNOL, V16, P1305, DOI 10.1093/intimm/dxh133; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Pereira P, 1997, P NATL ACAD SCI USA, V94, P5761, DOI 10.1073/pnas.94.11.5761; Perumal NB, 1997, J IMMUNOL, V158, P5744; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Xiong N, 2004, P NATL ACAD SCI USA, V101, P260, DOI 10.1073/pnas.0303738101; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8	54	50	52	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1263	1271		10.1038/ni1267	http://dx.doi.org/10.1038/ni1267			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16273100	Green Accepted			2022-12-18	WOS:000233371900015
J	Yamazaki, T; Kurosaki, T				Yamazaki, T; Kurosaki, T			Contribution of BCAP to maintenance of mature B cells through c-Rel	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; ANTIGEN-RECEPTOR; TRANSCRIPTION FACTORS; SUBUNIT COMPOSITION; ADAPTER PROTEINS; EXPRESSION; APOPTOSIS; BAFF; PROTOONCOGENE	Mice deficient in the B cell adaptor for phosphoinositide 3-kinase (BCAP) have reduced numbers of mature B lymphocytes, which show defects in cell survival and proliferation. We found here that the NF-kappaB (Rel) pathway was impaired in BCAP-deficient mature B cells and that NF-kappaB target genes, indispensable for cell survival and division, were not induced in response to B cell receptor (BCR) stimulation. Among the NF-kappaB (Rel) family, expression of c-Rel was specifically reduced in BCAP-deficient B cells. Retrovirus-mediated reintroduction of c-Rel restored the pool size of immunoglobulin (Ig)M(lo)IgD(hi) mature B cells in the spleen as well as proliferative responses to BCR stimulation. These results indicate BCAP is essential in the maintenance of mature B cells through functional coupling with c-Rel.	Kansai Med Univ, Dept Mol Genet, Inst Liver Res, Moriguchi, Osaka 5708506, Japan; RIKEN, Lab Lymphocyte Differentiat, Res Ctr Allergy & Immunol, Moriguchi, Osaka 5708506, Japan	Kansai Medical University; RIKEN	Kurosaki, T (corresponding author), Kansai Med Univ, Dept Mol Genet, Inst Liver Res, 10-15 Fumizono Cho, Moriguchi, Osaka 5708506, Japan.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; CARRASCO D, 1994, DEVELOPMENT, V120, P2991; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; GRUMONT RJ, 1990, ONCOGENE RES, V5, P245; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Hu CJ, 2001, IMMUNITY, V15, P545, DOI 10.1016/S1074-7613(01)00219-9; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Leo A, 2001, CURR OPIN IMMUNOL, V13, P307, DOI 10.1016/S0952-7915(00)00220-X; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751	50	50	52	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					780	786		10.1038/ni949	http://dx.doi.org/10.1038/ni949			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12833156				2022-12-18	WOS:000184441500015
J	Li, PS; Lu, M; Shi, JY; Gong, Z; Hua, L; Li, Q; Lim, B; Zhang, XHF; Chen, XW; Li, S; Shultz, LD; Ren, GW				Li, Peishan; Lu, Ming; Shi, Jiayuan; Gong, Zheng; Hua, Li; Li, Qing; Lim, Bora; Zhang, Xiang H. -F.; Chen, Xiaowen; Li, Sheng; Shultz, Leonard D.; Ren, Guangwen			Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis	NATURE IMMUNOLOGY			English	Article							MACROPINOCYTOSIS; COLONIZATION; INFLAMMATION; PATHWAY; GROWTH; ENERGY	Acquisition of a lipid-laden phenotype by immune cells has been defined in infectious diseases and atherosclerosis but remains largely uncharacterized in cancer. Here, in breast cancer models, we found that neutrophils are induced to accumulate neutral lipids upon interaction with resident mesenchymal cells in the premetastatic lung. Lung mesenchymal cells elicit this process through repressing the adipose triglyceride lipase (ATGL) activity in neutrophils in prostaglandin E2-dependent and -independent manners. In vivo, neutrophil-specific deletion of genes encoding ATGL or ATGL inhibitory factors altered neutrophil lipid profiles and breast tumor lung metastasis in mice. Mechanistically, lipids stored in lung neutrophils are transported to metastatic tumor cells through a macropinocytosis-lysosome pathway, endowing tumor cells with augmented survival and proliferative capacities. Pharmacological inhibition of macropinocytosis significantly reduced metastatic colonization by breast tumor cells in vivo. Collectively, our work reveals that neutrophils serve as an energy reservoir to fuel breast cancer lung metastasis. Phagocytes can acquire lipids and this modulates their function in a variety of disease states, such as atherosclerosis. Ren and colleagues demonstrate that neutrophils accumulate lipids and deliver them to tumor cells, which supports their proliferation, survival and metastasis.	[Li, Peishan; Lu, Ming; Shi, Jiayuan; Gong, Zheng; Hua, Li; Li, Qing; Shultz, Leonard D.; Ren, Guangwen] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Li, Peishan] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Sch Basic Med Sci,Cheeloo Coll Med, Jinan, Peoples R China; [Li, Peishan] Shandong Univ, Dept Mol Med & Genet, Sch Basic Med Sci, Cheeloo Coll Med, Jinan, Peoples R China; [Lu, Ming] Fudan Univ, Canc Metastasis Inst, Huashan Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Lim, Bora] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Zhang, Xiang H. -F.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Zhang, Xiang H. -F.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chen, Xiaowen; Li, Sheng] Jackson Lab Genom Med, Farmington, CT USA; [Li, Sheng; Shultz, Leonard D.; Ren, Guangwen] Jackson Lab, Ctr Canc, 600 Main St, Bar Harbor, ME 04609 USA; [Li, Sheng] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT USA; [Li, Sheng] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA	Jackson Laboratory; Shandong University; Shandong University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Jackson Laboratory; Jackson Laboratory; University of Connecticut; University of Connecticut	Ren, GW (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.; Ren, GW (corresponding author), Jackson Lab, Ctr Canc, 600 Main St, Bar Harbor, ME 04609 USA.	Gary.Ren@jax.org	, 0000-0002-4182-6058/F-9978-2014	, 0000-0002-4182-6058/0000-0002-4182-6058; Li, Peishan/0000-0002-6881-396X; Lu, Ming/0000-0002-3749-5321; Ren, Guangwen/0000-0003-2436-9593; Zhang, Xiang/0000-0002-5674-8670	National Institutes of Health [R00-CA188093, R37-CA237307, P30-CA034196, R35-GM133562, R24-OD026440, R01-AI132963]; U.S. Department of Defense [W81XWH-18-1-0013]; Leukemia Research Foundation New Investigator Grant; Jackson Laboratory Director's Innovation Fund [19000-17-31]; Pyewacket Fund at The Jackson Laboratory	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Leukemia Research Foundation New Investigator Grant; Jackson Laboratory Director's Innovation Fund; Pyewacket Fund at The Jackson Laboratory	We thank S.I. Abrams (Roswell Park Comprehensive Cancer Center) for providing the AT3 breast cancer cell line, Y. Kang (Princeton University) for providing the MDA-4175 breast cancer cell line and R.A. Weinberg (Whitehead Institute for Biomedical Research) for providing the lentiviralvector expressing mouse Csf3. This work was supported by grants from the National Institutes of Health (R00-CA188093 to G.R.; R37-CA237307 to G.R.; P30-CA034196 to G.R., L.D.S. and S.L.; R35-GM133562 to S.L.; and R24-OD026440 and R01-AI132963 to L.D.S.), the U.S. Department of Defense (W81XWH-18-1-0013 to G.R.), Leukemia Research Foundation New Investigator Grant (to S.L.) and The Jackson Laboratory Director's Innovation Fund (19000-17-31 to S.L.). Q.L. is supported by the Pyewacket Fund at The Jackson Laboratory. We acknowledge critical comments from E. T. Liu, N. A. Rosenthal, K. Seburn and C. Robinett. We also thank G. Stafford for RNA-seq analysis and W. Schott for cell sorting, as well as The Jackson Laboratory Scientific Service for assistance.	Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Basnet H, 2019, ELIFE, V8, DOI 10.7554/eLife.43627; Breitkopf SB, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1157-8; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8; Christen S, 2016, CELL REP, V17, P837, DOI 10.1016/j.celrep.2016.09.042; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Das KMP, 2018, J LIPID RES, V59, P531, DOI 10.1194/jlr.M082388; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; den Brok MH, 2018, TRENDS IMMUNOL, V39, P380, DOI 10.1016/j.it.2018.01.012; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Kim SM, 2018, CANCER DISCOV, V8, P866, DOI 10.1158/2159-8290.CD-17-1215; Knight M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006874; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Messmer MN, 2015, CANCER IMMUNOL IMMUN, V64, P1, DOI 10.1007/s00262-014-1639-3; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Missaglia S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020187; Munir R, 2019, BRIT J CANCER, V120, P1090, DOI 10.1038/s41416-019-0451-4; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ohs I, 2017, CANCER RES, V77, P7059, DOI 10.1158/0008-5472.CAN-17-1032; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Schild T, 2018, CANCER CELL, V33, P347, DOI 10.1016/j.ccell.2018.02.001; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Vallochi AL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01022; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang YY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87489; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Zhang MM, 2018, CANCER DISCOV, V8, P1006, DOI 10.1158/2159-8290.CD-17-1371; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang XD, 2017, ELIFE, V6, DOI 10.7554/eLife.31132; Zhang YJ, 2019, TRENDS CANCER, V5, P332, DOI 10.1016/j.trecan.2019.04.002	51	49	51	4	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1444	+		10.1038/s41590-020-0783-5	http://dx.doi.org/10.1038/s41590-020-0783-5		SEP 2020	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32958928	Green Accepted			2022-12-18	WOS:000571701700003
J	Liu, C; Somasundaram, A; Manne, S; Gocher, AM; Szymczak-Workman, AL; Vignali, KM; Scott, EN; Normolle, DP; Wherry, EJ; Lipson, EJ; Ferris, RL; Bruno, TC; Workman, CJ; Vignali, DAA				Liu, Chang; Somasundaram, Ashwin; Manne, Sasikanth; Gocher, Angela M.; Szymczak-Workman, Andrea L.; Vignali, Kate M.; Scott, Ellen N.; Normolle, Daniel P.; Wherry, E. John; Lipson, Evan J.; Ferris, Robert L.; Bruno, Tullia C.; Workman, Creg J.; Vignali, Dario A. A.			Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity	NATURE IMMUNOLOGY			English	Article							EXHAUSTION; DIFFERENTIATION; SEMAPHORIN; STABILITY; GENES; ID3	Robust CD8(+)T cell memory is essential for long-term protective immunity but is often compromised in cancer, where T cell exhaustion leads to loss of memory precursors. Immunotherapy via checkpoint blockade may not effectively reverse this defect, potentially underlying disease relapse. Here we report that mice with a CD8(+)T cell-restricted neuropilin-1 (NRP1) deletion exhibited substantially enhanced protection from tumor rechallenge and sensitivity to anti-PD1 immunotherapy, despite unchanged primary tumor growth. Mechanistically, NRP1 cell-intrinsically limited the self-renewal of the CD44(+)PD1(+)TCF1(+)TIM3(-)progenitor exhausted T cells, which was associated with their reduced ability to induce c-Jun/AP-1 expression on T cell receptor restimulation, a mechanism that may contribute to terminal T cell exhaustion at the cost of memory differentiation in wild-type tumor-bearing hosts. These data indicate that blockade of NRP1, a unique 'immune memory checkpoint', may promote the development of long-lived tumor-specific T(mem)that are essential for durable antitumor immunity. T cell exhaustion limits antitumor immune responses. Vignali and colleagues identify neuropilin-1 as a novel immune checkpoint that cell-intrinsically operates to limit memory cell formation and can be targeted to enhance antitumor responses.	[Liu, Chang; Gocher, Angela M.; Szymczak-Workman, Andrea L.; Vignali, Kate M.; Scott, Ellen N.; Bruno, Tullia C.; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Liu, Chang; Somasundaram, Ashwin; Gocher, Angela M.; Vignali, Kate M.; Scott, Ellen N.; Ferris, Robert L.; Bruno, Tullia C.; Workman, Creg J.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Somasundaram, Ashwin] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Manne, Sasikanth; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Manne, Sasikanth; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Scott, Ellen N.] Univ Pittsburgh, Sch Med, Grad Program Microbiol & Immunol, Pittsburgh, PA USA; [Normolle, Daniel P.] UPMC Hillman Canc Ctr, Biostat Facil, Pittsburgh, PA USA; [Lipson, Evan J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr SKCCC, Baltimore, MD 21205 USA; [Lipson, Evan J.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21205 USA; [Ferris, Robert L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Ferris, Robert L.; Bruno, Tullia C.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	Wherry, John/ABI-1280-2020	Wherry, E John/0000-0003-0477-1956; Lipson, Evan/0000-0003-2976-0911; Somasundaram, Ashwin/0000-0003-3167-406X	National Institutes of Health [R01 CA203689, P01 AI108545, AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944, T32 CA082084, F32 CA247004]; NCI Comprehensive Cancer Center Support CORE grants [P30 CA047904, P50 CA097190, P30 CA006973]; Stand Up 2 Cancer (SU2C) research grant; Parker Institute for Cancer Immunotherapy; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Barney Family Foundation; Laverna Hahn Charitable Trust; NIH [S10 OD011925-01]; Moving for Melanoma of Delaware;  [NIH 1S10 OD019942-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grants; Stand Up 2 Cancer (SU2C) research grant; Parker Institute for Cancer Immunotherapy; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Barney Family Foundation; Laverna Hahn Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moving for Melanoma of Delaware; 	We thank all the current and former members in the Vignali Laboratory (https://www.Vignali-lab.com; @Vignali_Lab) for all their constructive comments and advice during this project. We also thank K. Adams, D. Pardoll, M. Schollenberger and S. Topalian for assistance in procuring biospecimens from patients at Johns Hopkins; L. D'Cruz (Univeristy of Pittsburgh) for providing the Id3-GFP reporter mouse strain and helpful discussion; H. Shen, D. Falkner and A. McIntyre from the Immunology Flow Core for cell sorting; C. Schmidt, E. Brunazzi and the staff of the Division of Laboratory Animals for genotyping and animal husbandry; S. Canna (University of Pittsburgh) for the LCMV C13 strain; A. Lund (New York University) for the attenuated LM-Ova; and W. Horne, J. Kolls and the University of Pittsburgh HSCRF Genomics Research Core for assistance with sequencing. This work was supported by the National Institutes of Health (grant nos. R01 CA203689 and P01 AI108545 to D.A.A.V.; AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944 to E.J.W.; and T32 CA082084 and F32 CA247004 to A.M.G), NCI Comprehensive Cancer Center Support CORE grants (nos. P30 CA047904 and P50 CA097190 to R.L.F. and D.A.A.V. and P30 CA006973 to E.J.L.) and the Stand Up 2 Cancer (SU2C) research grant to E.J.W. E.J.W. is supported by the Parker Institute for Cancer Immunotherapy that supports the cancer immunology program at UPenn. E.J.L. is supported by the Bloomberg-Kimmel Institute for Cancer Immunotherapy, the Barney Family Foundation, Moving for Melanoma of Delaware and The Laverna Hahn Charitable Trust. This project benefited from a SPECIAL ORDER BD LSR FORTESSA (funded by NIH grant no. S10 OD011925-01) and an IMAGESTREAMx MARK II (funded by grant no. NIH 1S10 OD019942-01), used in the UPSOM Unified Flow Core. This project also used the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory that is supported in part by award no. P30 CA047904.	Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Battaglia A, 2009, CANCER IMMUNOL IMMUN, V58, P1363, DOI 10.1007/s00262-008-0646-7; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; BURSUKER I, 1986, INT J CANCER, V37, P275, DOI 10.1002/ijc.2910370216; Byrne KT, 2011, J CLIN INVEST, V121, P1797, DOI 10.1172/JCI44849; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fares Charlene M, 2019, Am Soc Clin Oncol Educ Book, V39, P147, DOI 10.1200/EDBK_240837; Fleissner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015373; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gullicksrud JA, 2017, J IMMUNOL, V199, P911, DOI 10.4049/jimmunol.1700595; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ito D, 2015, J IMMUNOL, V195, P934, DOI 10.4049/jimmunol.1403038; Jackson SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110707; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Reading JL, 2018, IMMUNOL REV, V283, P194, DOI 10.1111/imr.12657; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01228; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singh NJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw092; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang Y, 2019, 2019 IEEE 2ND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTER TECHNOLOGIES (ICICT), P1, DOI 10.1109/INFOCT.2019.8711180; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264	54	49	50	6	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1010	+		10.1038/s41590-020-0733-2	http://dx.doi.org/10.1038/s41590-020-0733-2		JUL 2020	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32661362	Bronze, Green Accepted			2022-12-18	WOS:000555034000002
J	Giladi, A; Wagner, LK; Li, HJ; Dorr, D; Medaglia, C; Paul, F; Shemer, A; Jung, S; Yona, S; Mack, M; Leutz, A; Amit, I; Mildner, A				Giladi, Amir; Wagner, Lisa Katharina; Li, Hanjie; Doerr, Dorothea; Medaglia, Chiara; Paul, Franziska; Shemer, Anat; Jung, Steffen; Yona, Simon; Mack, Matthias; Leutz, Achim; Amit, Ido; Mildner, Alexander			Cxcl10(+) monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation	NATURE IMMUNOLOGY			English	Article							CLASSICAL DENDRITIC CELLS; GM-CSF; DIFFERENTIATION; MACROPHAGES; PROGENITORS; MICROGLIA; CNS	Mildner and colleagues characterize two subsets (Cxcl10(+) and Saa3(+)) of monocytes with pathogenic potential in the central nervous system of mice with experimentally induced autoimmune encephalomyelitis and show these pathogenic cells are not derived from Ly6C(+) monocytes, but from early myeloid cell progenitors. Multiple sclerosis (MS) is characterized by pathological inflammation that results from the recruitment of lymphoid and myeloid immune cells from the blood into the brain. Due to subset heterogeneity, defining the functional roles of the various cell subsets in acute and chronic stages of MS has been challenging. Here, we used index and transcriptional single-cell sorting to characterize the mononuclear phagocytes that infiltrate the central nervous system from the periphery in mice with experimentally induced autoimmune encephalomyelitis, a model of MS. We identified eight monocyte and three dendritic cell subsets at acute and chronic disease stages in which the defined transcriptional programs pointed toward distinct functions. Monocyte-specific cell ablation identified Cxcl10(+) and Saa3(+) monocytic subsets with a pathogenic potential. Transfer experiments with different monocyte and precursor subsets indicated that these Cxcl10(+) and Saa3(+) pathogenic cells were not derived from Ly6C(+) monocytes but from early myeloid cell progenitors. These results suggest that blocking specific pathogenic monocytic subsets, including Cxcl10(+) and Saa3(+) monocytes, could be used for targeted therapeutic interventions.	[Giladi, Amir; Li, Hanjie; Medaglia, Chiara; Paul, Franziska; Shemer, Anat; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Wagner, Lisa Katharina; Doerr, Dorothea; Leutz, Achim; Mildner, Alexander] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Yona, Simon] Hebrew Univ Jerusalem, Fac Med Dent, Jerusalem, Israel; [Mack, Matthias] Univ Klinikum Regensburg, Dept Nephrol, Regensburg, Germany; [Leutz, Achim] Humboldt Univ, Inst Biol, Berlin, Germany	Weizmann Institute of Science; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hebrew University of Jerusalem; University of Regensburg; Humboldt University of Berlin	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Mildner, A (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	ido.amit@weizmann.ac.il; alexander.mildner@mdc-berlin.de	Jung, Steffen/K-1409-2012; Mildner, Alexander/ABG-6122-2020; Yona, Simon/ABE-6572-2020; mildner, alexander/AAF-9451-2022; mildner, alexander/AFK-2161-2022; mildner, alexander/GQA-3761-2022; Leutz, Achim/K-9643-2013	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Leutz, Achim/0000-0001-8259-927X; Yona, Simon/0000-0002-3984-2008; Paul, Franziska/0000-0003-0344-6764; Dorr, Dorothea/0000-0001-8575-7560	DFG [MI1328]; Chan-Zuckerberg Initiative; HHMI International Scholar award; European Research Council Consolidator grant [724471-HemTree2.0]; Thompson Family Foundation; MRA Established Investigator Award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; International Progressive MS Alliance/NMSS [PA-1604-08459]; Adelis Foundation	DFG(German Research Foundation (DFG)); Chan-Zuckerberg Initiative; HHMI International Scholar award(Howard Hughes Medical Institute); European Research Council Consolidator grant(European Research Council (ERC)); Thompson Family Foundation; MRA Established Investigator Award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; International Progressive MS Alliance/NMSS; Adelis Foundation	We thank V. Malchin for excellent technical assistance, J. Priller for support, the MDC animal facility (especially J. Bergemann) and the MDC and WIS FACS facilities (especially H.-P. Rahn). A.M. is a Heisenberg fellow supported by the DFG (MI1328). I.A. is supported by the Chan-Zuckerberg Initiative, the HHMI International Scholar award, the European Research Council Consolidator grant (724471-HemTree2.0), the Thompson Family Foundation, an MRA Established Investigator Award (509044), the Israel Science Foundation (703/15), the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine, the Helen and Martin Kimmel award for innovative investigation, an International Progressive MS Alliance/NMSS PA-1604-08459 and an Adelis Foundation grant. S.J. is supported by the International Progressive MS Alliance/NMSS PA-1604-08459.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Blecher-Gonen R, 2019, CELL SYST, V8, P109, DOI 10.1016/j.cels.2019.01.001; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caravagna C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22872-y; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; ESIRI MM, 1987, NEUROPATH APPL NEURO, V13, P451, DOI 10.1111/j.1365-2990.1987.tb00074.x; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hirako IC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13277; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Locatelli G, 2018, NAT NEUROSCI, V21, P1196, DOI 10.1038/s41593-018-0212-3; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Melero-Jerez C, 2016, BBA-MOL BASIS DIS, V1862, P368, DOI 10.1016/j.bbadis.2015.10.015; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Pare A, 2018, P NATL ACAD SCI USA, V115, pE1194, DOI 10.1073/pnas.1714948115; Ronchi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11541; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wolf Y, 2018, EUR J IMMUNOL, V48, P1308, DOI 10.1002/eji.201847540; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	45	49	49	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					525	+		10.1038/s41590-020-0661-1	http://dx.doi.org/10.1038/s41590-020-0661-1		APR 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32313246				2022-12-18	WOS:000527507900005
J	Mattiola, I; Tomay, F; De Pizzol, M; Silva-Gomes, R; Savino, B; Gulic, T; Doni, A; Lonardi, S; Boutet, MA; Nerviani, A; Carriero, R; Molgora, M; Stravalaci, M; Morone, D; Shalova, IN; Lee, Y; Biswas, SK; Mantovani, G; Sironi, M; Pitzalis, C; Vermi, W; Bottazzi, B; Mantovani, A; Locati, M				Mattiola, Irene; Tomay, Federica; De Pizzol, Maria; Silva-Gomes, Rita; Savino, Benedetta; Gulic, Tamara; Doni, Andrea; Lonardi, Silvia; Boutet, Marie Astrid; Nerviani, Alessandra; Carriero, Roberta; Molgora, Martina; Stravalaci, Matteo; Morone, Diego; Shalova, Irina N.; Lee, Yunquin; Biswas, Subhra K.; Mantovani, Giovanna; Sironi, Marina; Pitzalis, Costantino; Vermi, William; Bottazzi, Barbara; Mantovani, Alberto; Locati, Massimo			The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis	NATURE IMMUNOLOGY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PATTERN-RECOGNITION; BETA-SUBUNIT; DECTIN-1; RECEPTOR; CD20; IGE; IMMUNITY; FAMILY; POLARIZATION	The plasma membrane tetraspan molecule MS4A4A is selectively expressed by macrophage-lineage cells, but its function is unknown. Here we report that MS4A4A was restricted to murine and human mononuclear phagocytes and was induced during monocyte-to-macrophage differentiation in the presence of interleukin 4 or dexamethasone. Human MS4A4A was co-expressed with M2/M2-like molecules in subsets of normal tissue-resident macrophages, infiltrating macrophages from inflamed synovium and tumor-associated macrophages. MS4A4A interacted and colocalized with the beta-glucan receptor dectin-1 in lipid rafts. In response to dectin-1 ligands, Ms4a4a-deficient macrophages showed defective signaling and defective production of effector molecules. In experimental models of tumor progression and metastasis, Ms4a4a deficiency in macrophages had no impact on primary tumor growth, but was essential for dectin-1-mediated activation of macrophages and natural killer (NK) cell-mediated metastasis control. Thus, MS4A4A is a tetraspan molecule selectively expressed in macrophages during differentiation and polarization, essential for dectin-1-dependent activation of NK cell-mediated resistance to metastasis.	[Mattiola, Irene; Tomay, Federica; De Pizzol, Maria; Silva-Gomes, Rita; Savino, Benedetta; Gulic, Tamara; Doni, Andrea; Carriero, Roberta; Morone, Diego; Sironi, Marina; Bottazzi, Barbara; Mantovani, Alberto; Locati, Massimo] Sci Inst Res & Healthcare, Humanitas Clin & Res Ctr, Rozzano, Italy; [Mattiola, Irene] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Lab Innate Immun, Berlin, Germany; [Mattiola, Irene] Berlin Inst Hlth, Berlin, Germany; [Mattiola, Irene] Deutsch Rheuma Forschungszentrum, Mucosal & Dev Immunol, Berlin, Germany; [Mattiola, Irene; Tomay, Federica; De Pizzol, Maria; Savino, Benedetta; Gulic, Tamara; Locati, Massimo] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Silva-Gomes, Rita] Univ Porto, Inst Ciencias Biomed Abel Salazar, Grad Program Areas Basic & Appl Biol, Porto, Portugal; [Lonardi, Silvia; Vermi, William] Univ Brescia, Sch Med, Dept Mol & Translat Med, Brescia, Italy; [Boutet, Marie Astrid; Nerviani, Alessandra; Pitzalis, Costantino; Mantovani, Alberto] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Expt Med & Rheumatol, London, England; [Molgora, Martina; Stravalaci, Matteo; Mantovani, Alberto] Humanitas Univ, Pieve Emanuele, Italy; [Shalova, Irina N.; Lee, Yunquin; Biswas, Subhra K.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Mantovani, Giovanna] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Endocrinol Unit, Dept Clin Sci & Community Hlth, Milan, Italy; [Molgora, Martina; Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [De Pizzol, Maria] Dompe Farmaceutici, Milan, Italy; [Gulic, Tamara] Univ Rijeka, Dept Physiol & Immunol, Med Fac, Rijeka, Croatia; [Morone, Diego] Univ Svizzera Italiana, Inst Res Biomed, Fac Biomed Sci, Bellinzona, Switzerland	IRCCS Humanitas Research Hospital; Berlin Institute of Health; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Milan; Universidade do Porto; University of Brescia; University of London; Queen Mary University London; Humanitas University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Washington University (WUSTL); University of Rijeka; Universita della Svizzera Italiana	Mantovani, A; Locati, M (corresponding author), Sci Inst Res & Healthcare, Humanitas Clin & Res Ctr, Rozzano, Italy.; Locati, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.; Mantovani, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Expt Med & Rheumatol, London, England.; Mantovani, A (corresponding author), Humanitas Univ, Pieve Emanuele, Italy.	alberto.mantovani@humanitasresearch.it; massimo.locati@humanitasresearch.it	Boutet, Marie-Astrid/ABH-2968-2021; sironi, marina/AAB-5757-2020; Carriero, Roberta/AAA-4709-2019; Mattiola, Irene/AAA-4976-2020; Savino, Benedetta/AGP-4952-2022; Mantovani, Alberto/HCI-7449-2022; Locati, Massimo/ABF-6807-2021; Doni, Andrea/AAB-6096-2022; Stravalaci, Matteo/AAB-8963-2019; bottazzi, barbara/ABH-9274-2020	Boutet, Marie-Astrid/0000-0002-1519-6902; sironi, marina/0000-0002-3342-1149; Savino, Benedetta/0000-0002-2996-9515; Mantovani, Alberto/0000-0001-5578-236X; Stravalaci, Matteo/0000-0002-5636-4204; bottazzi, barbara/0000-0002-1930-9257; Pitzalis, Costantino/0000-0003-1326-5051; Gomes, Ana Rita/0000-0003-1529-3777; Nerviani, Alessandra/0000-0003-4064-4014; Mattiola, Irene/0000-0002-2922-9947; Carriero, Roberta/0000-0001-8619-6152; Morone, Diego/0000-0002-6847-3811; TOMAY, FEDERICA/0000-0001-7396-6496	Fondazione Cariplo [2015-0564]; Cluster Alisei [MEDINTECH CTN01_00177_962865]; European Research Council [669415-PHII]; Italian Association for Cancer Research [19014]; AIRC 5 x 1000 grant [21147]; AIRC [19213]; Medical Research Council (Pathobiology of Early Arthritis Cohort) [36661, 20022]; Mario and Valeria Rindi fellowship; Italian Foundation for Cancer Research; European Federation of Immunological Societies-IL short-term fellowship; Ministero della Salute (progetto Finalizzata) [GR-201302356522, PD/BD/114138/2016]; Fundacao para a Ciencia e Tecnologia, Portugal; Singapore Immunology Network-Agency for Science, Technology AMP; Research (A*STAR), Singapore; A*STAR Research Attachment Program, Singapore; Fondazione Beretta, Italy; MRC [G0800648] Funding Source: UKRI	Fondazione Cariplo(Fondazione Cariplo); Cluster Alisei; European Research Council(European Research Council (ERC)European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); AIRC 5 x 1000 grant(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Medical Research Council (Pathobiology of Early Arthritis Cohort); Mario and Valeria Rindi fellowship; Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); European Federation of Immunological Societies-IL short-term fellowship; Ministero della Salute (progetto Finalizzata); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Singapore Immunology Network-Agency for Science, Technology AMP; Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR Research Attachment Program, Singapore; Fondazione Beretta, Italy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank C. Garlanda and M. Kallikourdis (Humanitas Clinical and Research Center, Scientific Institute for Research and Healthcare (IRCCS)) for providing cDNAs of murine leukocyte subsets, and T. Irimura (Juntendo University School of Medicine, Tokyo, Japan) and R. Giavazzi (Mario Negri Institute, Milan, Italy) for providing MC38 and SL4 cells. Technical assistance from A. Fontanini, C. Perrucchini, T. Schorn, R. Porte and F. Pasqualini is acknowledged. A. Inforzato (Humanitas Clinical and Research Center, IRCCS), A. Diefenbach (Charite - Universitatsmedizin Berlin, Germany) and L. Florin (University Medical Centre of the Johannes Gutenberg University, Mainz, Germany) are gratefully acknowledged for their support and discussion. Financial support came from Fondazione Cariplo (grant no. 2015-0564 to A. M.), Cluster Alisei (grant no. MEDINTECH CTN01_00177_962865 to A.M.), the European Research Council (grant no. 669415-PHII to A.M.), the Italian Association for Cancer Research (AIRC IG-2016 grant no. 19014 to A.M.; AIRC 5 x 1000 grant no. 21147 to A. M.; AIRC IG-2016 grant no. 19213 to M.L.), Medical Research Council (Pathobiology of Early Arthritis Cohort grant no. 36661 to C.P.) and Arthritis Research UK Experimental Treatment Centre (grant no. 20022 to C.P.). I.M. was supported by a Mario and Valeria Rindi fellowship and a Fellowship for abroad from the Italian Foundation for Cancer Research, and by a European Federation of Immunological Societies-IL short-term fellowship. B.S. was supported by Ministero della Salute (progetto Finalizzata GR-201302356522). R.S.G. was supported by a PhD studentship (PD/BD/114138/2016) from Fundacao para a Ciencia e Tecnologia, Portugal. S.K.B. was supported by core funding from Singapore Immunology Network-Agency for Science, Technology & Research (A*STAR), Singapore. F.T. was supported by a fellowship from the A*STAR Research Attachment Program, Singapore. S.L. was supported by Fondazione Beretta, Italy.	ADRA CN, 1994, P NATL ACAD SCI USA, V91, P10178, DOI 10.1073/pnas.91.21.10178; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cruse G, 2015, MOL BIOL CELL, V26, P1711, DOI 10.1091/mbc.E14-07-1221; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Franks SE, 2016, CURR OPIN IMMUNOL, V43, P39, DOI 10.1016/j.coi.2016.09.003; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; HUPP K, 1989, J IMMUNOL, V143, P3787; Ishibashi K, 2001, GENE, V264, P87, DOI 10.1016/S0378-1119(00)00598-9; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kelly S, 2015, ANN RHEUM DIS, V74, P611, DOI 10.1136/annrheumdis-2013-204603; Kodelja V, 1998, J IMMUNOL, V160, P1411; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Majety M, 2018, FEBS J, V285, P763, DOI 10.1111/febs.14277; MANTOVANI A, 1980, INT J CANCER, V25, P617, DOI 10.1002/ijc.2910250511; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Massara M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03080-8; Mattiola I, 2015, J IMMUNOL, V195, P2818, DOI 10.4049/jimmunol.1500325; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Millington M, 2007, BIOPHYS CHEM, V127, P155, DOI 10.1016/j.bpc.2007.01.008; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; Molgora M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00149; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sanyal R, 2017, IMMUNOL CELL BIOL, V95, P611, DOI 10.1038/icb.2017.18; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wuthrich M, 2012, ANNU REV IMMUNOL, V30, P115, DOI 10.1146/annurev-immunol-020711-074958; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	54	49	49	2	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					1012	+		10.1038/s41590-019-0417-y	http://dx.doi.org/10.1038/s41590-019-0417-y			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31263276	Green Accepted, Green Submitted			2022-12-18	WOS:000476621200016
J	Wang, YF; Zhang, YB; Yi, P; Dong, WJ; Nalin, AP; Zhang, JY; Zhu, Z; Chen, LC; Benson, DM; Mundy-Bosse, BL; Freud, AG; Caligiuri, MA; Yu, JH				Wang, Yufeng; Zhang, Yibo; Yi, Ping; Dong, Wenjuan; Nalin, Ansel P.; Zhang, Jianying; Zhu, Zheng; Chen, Lichao; Benson, Don M.; Mundy-Bosse, Bethany L.; Freud, Aharon G.; Caligiuri, Michael A.; Yu, Jianhua			The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NATURAL-KILLER-CELLS; TERMINAL MATURATION; PROTEIN-SYNTHESIS; XBP1; INTERLEUKIN-15; P110-DELTA; EXPRESSION; REGULATOR; DIFFERENTIATION	Interleukin 15 (IL-15) is one of the most important cytokines that regulate the biology of natural killer (NK) cells(1). Here we identified a signaling pathway-involving the serine-threonine kinase AKT and the transcription factor XBP1s, which regulates unfolded protein response genes(2,3)-that was activated in response to IL-15 in human NK cells. IL-15 induced the phosphorylation of AKT, which led to the deubiquitination, increased stability and nuclear accumulation of XBP1s protein. XBP1s bound to and recruited the transcription factor T-BET to the gene encoding granzyme B, leading to increased transcription. XBP1s positively regulated the cytolytic activity of NK cells against leukemia cells and was also required for IL-15-mediated NK cell survival through an anti-apoptotic mechanism. Thus, the newly identified IL-15-AKT-XBP1s signaling pathway contributes to enhanced effector functions and survival of human NK cells.	[Wang, Yufeng; Zhang, Yibo; Yi, Ping; Dong, Wenjuan; Nalin, Ansel P.; Zhu, Zheng; Chen, Lichao; Benson, Don M.; Mundy-Bosse, Bethany L.; Freud, Aharon G.; Yu, Jianhua] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Wang, Yufeng; Benson, Don M.; Mundy-Bosse, Bethany L.; Yu, Jianhua] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Yi, Ping] Third Mil Med Univ, Affiliated Hosp 3, Chongqing, Peoples R China; [Dong, Wenjuan; Zhu, Zheng; Caligiuri, Michael A.; Yu, Jianhua] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplant, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Nalin, Ansel P.] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Zhang, Jianying] City Hope Natl Med Ctr, Dept Informat Sci, Div Biostat, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Freud, Aharon G.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Caligiuri, Michael A.; Yu, Jianhua] City Hope Natl Med Ctr, Hematol Malignancies & Stem Cell Transplantat Ins, 1500 E Duarte Rd, Duarte, CA 91010 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Army Medical University; City of Hope; University System of Ohio; Ohio State University; City of Hope; University System of Ohio; Ohio State University; City of Hope	Yu, JH (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Yu, JH (corresponding author), Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.; Yu, JH (corresponding author), City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplant, 1500 E Duarte Rd, Duarte, CA 91010 USA.; Yu, JH (corresponding author), City Hope Natl Med Ctr, Hematol Malignancies & Stem Cell Transplantat Ins, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jiayu@coh.org	Zhu, Zheng/AAI-8264-2020; zhu, zheng/W-8259-2019; Wang, Yufeng/N-9531-2019	Wang, Yufeng/0000-0002-4576-1984; zhu, zheng/0000-0002-3093-4360; chen, lichao/0000-0001-5923-5494	National Institutes of Health [AI129582, NS106170, CA185301, CA210087, CA068458]; Leukemia and Lymphoma Society [6503-17, 1364-19]; American Cancer Society [RSG-14-243-01-LIB]; Gabrielle's Angel Cancer Research Foundation [87]; NATIONAL CANCER INSTITUTE [R35CA210087, R01CA185301, R01CA068458, P01CA163205, R01CA208353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS106170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Gabrielle's Angel Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (AI129582 and NS106170 to J.Y. and CA185301, CA210087 and CA068458 to M.A.C.), the Leukemia and Lymphoma Society (6503-17 and 1364-19 to J.Y.), the American Cancer Society (RSG-14-243-01-LIB to J.Y.) and the Gabrielle's Angel Cancer Research Foundation (#87 to J.Y.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Akha AAS, 2011, J BIOL CHEM, V286, P30344, DOI 10.1074/jbc.M111.220541; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Bettigole SE, 2015, NAT IMMUNOL, V16, P829, DOI 10.1038/ni.3225; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chu J, 2014, LEUKEMIA, V28, P917, DOI 10.1038/leu.2013.279; Chu JH, 2014, CLIN CANCER RES, V20, P3989, DOI 10.1158/1078-0432.CCR-13-2510; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Jahrsdorfer B, 2010, BLOOD, V115, P1156, DOI 10.1182/blood-2009-07-235382; Jiang SW, 1997, NAT IMMUN, V15, P312; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lee MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8769; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Mai B, 1997, MOL CELL BIOL, V17, P6491, DOI 10.1128/MCB.17.11.6491; MCKEEHAN W, 1969, BIOCHEM BIOPH RES CO, V36, P625, DOI 10.1016/0006-291X(69)90351-9; Meinke S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00003; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Viant C, 2017, J EXP MED, V214, P491, DOI 10.1084/jem.20160869; Vidal RL, 2013, CELL RES, V23, P463, DOI 10.1038/cr.2013.9; Wang YF, 2017, INT J ONCOL, V50, P606, DOI 10.3892/ijo.2016.3804; Wang YF, 2015, ONCOTARGET, V6, P39692, DOI 10.18632/oncotarget.5625; Wang YF, 2015, ONCOTARGET, V6, P25252, DOI 10.18632/oncotarget.4487; Xu D, 2015, ELIFE, V4, DOI 10.7554/eLife.10510; Yano S, 2003, BIOCHEM BIOPH RES CO, V301, P841, DOI 10.1016/S0006-291X(03)00060-3; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016; Zambricki E, 2005, AM J TRANSPLANT, V5, P2623, DOI 10.1111/j.1600-6143.2005.01075.x; Zebedin E, 2008, BLOOD, V112, P4655, DOI 10.1182/blood-2008-02-139105	46	49	51	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					10	+		10.1038/s41590-018-0265-1	http://dx.doi.org/10.1038/s41590-018-0265-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538328	Green Accepted			2022-12-18	WOS:000456273900010
J	Moffett, HF; Cartwright, ANR; Kim, HJ; Godec, J; Pyrdol, J; Aijo, T; Martinez, GJ; Rao, A; Lu, J; Golub, TR; Cantor, H; Sharpe, AH; Novina, CD; Wucherpfennig, KW				Moffett, Howell F.; Cartwright, Adam N. R.; Kim, Hye-Jung; Godec, Jernej; Pyrdol, Jason; Aijo, Tarmo; Martinez, Gustavo J.; Rao, Anjana; Lu, Jun; Golub, Todd R.; Cantor, Harvey; Sharpe, Arlene H.; Novina, Carl D.; Wucherpfennig, Kai W.			The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection	NATURE IMMUNOLOGY			English	Article							I INTERFERON; ACTIVATION; EXHAUSTION; IDENTIFICATION; RESPONSES; ABSENCE; VIRUS; DIFFERENTIATION; INTERLEUKIN-2; PROLIFERATION	During infection, antigen-specific T cells undergo tightly regulated developmental transitions controlled by transcriptional and post-transcriptional regulation of gene expression. We found that the microRNA miR-31 was strongly induced by activation of the T cell antigen receptor (TCR) in a pathway involving calcium and activation of the transcription factor NFAT. During chronic infection with lymphocytic choriomeningitis virus (LCMV) clone 13, miR-31-deficent mice recovered from clinical disease, while wild-type mice continued to show signs of disease. This disease phenotype was explained by the presence of larger numbers of cytokine-secreting LCMV-specific CD8(+) T cells in miR-31-deficent mice than in wild-type mice. Mechanistically, miR-31 increased the sensitivity of T cells to type I interferons, which interfered with effector T cell function and increased the expression of several proteins related to T cell dysfunction during chronic infection. These studies identify miR-31 as an important regulator of T cell exhaustion in chronic infection.	[Moffett, Howell F.; Cartwright, Adam N. R.; Kim, Hye-Jung; Pyrdol, Jason; Cantor, Harvey; Novina, Carl D.; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Godec, Jernej; Sharpe, Arlene H.; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Aijo, Tarmo] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Aalto, Finland; [Martinez, Gustavo J.; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Lu, Jun; Golub, Todd R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Martinez, Gustavo J.] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, N Chicago, IL USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Aalto University; La Jolla Institute for Immunology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Chicago Medical School; Rosalind Franklin University Medical & Science	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu		Aijo, Tarmo/0000-0002-3008-4634; Moffett, Howell/0000-0002-7799-1688	US National Institutes of Health [R01CA173750, R01DK102165, R01CA140986, P01AI056299, R01AI007386]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA173750, R01CA140986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, R01AI040127, T32AI007386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102165] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Webby (St. Jude Children's Research Hospital) for recombinant influenza virus containing the LCMV GP33-41 epitope inserted into the neuraminidase protein stalk region; J. Maiarana for technical assistance; and the Dana Farber Cancer Institute Molecular Biology Core Facility for RNA sequencing. Supported by the US National Institutes of Health (R01CA173750 to K.W.W.; R01DK102165 and R01CA140986 to C.N.; P01AI056299 to A.S.; and R01AI007386 to H.C.) and the Cancer Research Institute (A.N.R.C.).	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bahl K, 2006, J IMMUNOL, V176, P4284, DOI 10.4049/jimmunol.176.7.4284; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063; Fan W, 2012, ARTHRITIS RHEUM-US, V64, P3715, DOI 10.1002/art.34596; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Rutledge H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1732-9; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Stamm A, 2012, VIROLOGY, V425, P122, DOI 10.1016/j.virol.2012.01.005; Stetansson B., CELL CYCLE, V6, P1386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Welsh R. M., 2008, CURRENT PROTOCOLS MI, V11; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wu DP, 2015, CLIN LAB, V61, P1625, DOI 10.7754/Clin.Lab.2015.150404; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Xue F, 2013, GENES IMMUN, V14, P127, DOI 10.1038/gene.2012.58; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	63	49	52	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					791	+		10.1038/ni.3755	http://dx.doi.org/10.1038/ni.3755			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28530712	Green Accepted			2022-12-18	WOS:000403676300014
J	Hammad, H; Vanderkerken, M; Pouliot, P; Deswarte, K; Toussaint, W; Vergote, K; Vandersarren, L; Janssens, S; Ramou, I; Savvides, SN; Haigh, JJ; Hendriks, R; Kopf, M; Craessaerts, K; de Strooper, B; Kearney, JF; Conrad, DH; Lambrecht, BN				Hammad, Hamida; Vanderkerken, Matthias; Pouliot, Philippe; Deswarte, Kim; Toussaint, Wendy; Vergote, Karl; Vandersarren, Lana; Janssens, Sophie; Ramou, Ioanna; Savvides, Savvas N.; Haigh, Jody J.; Hendriks, Rudi; Kopf, Manfred; Craessaerts, Katleen; de Strooper, Bart; Kearney, John F.; Conrad, Daniel H.; Lambrecht, Bart N.			Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; IMMUNE-RESPONSES; B1B CELLS; IN-VIVO; NOTCH2; MATURE; MICE; DELTA-LIKE-1; DIMERIZATION; LYMPHOCYTES	Notch2 and B cell antigen receptor (BCR) signaling determine whether transitional B cells become marginal zone B (MZB) or follicular B (FoB) cells in the spleen, but it is unknown how these pathways are related. We generated Taok3(-/-) mice, lacking the serine/threonine kinase Taok3, and found cell-intrinsic defects in the development of MZB but not FoB cells. Type 1 transitional (T1) B cells required Taok3 to rapidly respond to ligation by the Notch ligand Delta-like 1. BCR ligation by endogenous or exogenous ligands induced the surface expression of the metalloproteinase ADAM10 on T1 B cells in a Taok3-dependent manner. T1 B cells expressing surface ADAM10 were committed to becoming MZB cells in vivo, whereas T1 B cells lacking expression of ADAM10 were not. Thus, during positive selection in the spleen, BCR signaling causes immature T1 B cells to become receptive to Notch ligands via Taok3-mediated surface expression of ADAM10.	[Hammad, Hamida; Vanderkerken, Matthias; Pouliot, Philippe; Deswarte, Kim; Toussaint, Wendy; Vergote, Karl; Vandersarren, Lana; Janssens, Sophie; Ramou, Ioanna; Savvides, Savvas N.; Haigh, Jody J.; Lambrecht, Bart N.] Univ Ghent VIB, Inflammat Res Ctr, Ghent, Belgium; [Hammad, Hamida; Vanderkerken, Matthias; Pouliot, Philippe; Deswarte, Kim; Toussaint, Wendy; Vergote, Karl; Vandersarren, Lana; Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, Ghent, Belgium; [Ramou, Ioanna; Savvides, Savvas N.] Univ Ghent, Lab Prot Biochem & Biomol Engn L Probe, Ghent, Belgium; [Hendriks, Rudi; Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Kopf, Manfred] ETH, Inst Mol Hlth Sci, Zurich, Switzerland; [Craessaerts, Katleen; de Strooper, Bart] VIB, Ctr Brain & Dis, Leuven, Belgium; [Craessaerts, Katleen; de Strooper, Bart] KULeuven, Ctr Human Genet, Leuven, Belgium; [Kearney, John F.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Conrad, Daniel H.] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Lambrecht, BN (corresponding author), Univ Ghent VIB, Inflammat Res Ctr, Ghent, Belgium.; Lambrecht, BN (corresponding author), Univ Ghent, Dept Resp Med, Ghent, Belgium.; Lambrecht, BN (corresponding author), Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands.	bart.lambrecht@irc.vib-ugent.be	Hammad, Hamida/J-9391-2015; Kopf, Manfred/B-6907-2009; Lambrecht, Bart N/K-2484-2014; Kearney, John/GOV-3123-2022; de+Strooper, Bart/Z-1638-2019; Janssens, Sophie/HHN-1756-2022	Hammad, Hamida/0000-0003-3762-8603; Kopf, Manfred/0000-0002-0628-7140; Lambrecht, Bart N/0000-0003-4376-6834; Hendriks, Rudi/0000-0003-2291-0382; Deswarte, Kim/0000-0002-9761-6973; RAMOU, IOANNA/0000-0002-0083-510X; haigh, jody/0000-0002-7319-8922	Ghent University [GOA 01G02817]; FWO Fellowship [3F023515W]; Marie Curie grant [MC 237581]; FWO [G085915N]; University of Ghent; Swiss National Science Foundation [SNF 310030-163443/1]; NIAID [AI14782, AI100005]; ERC [261231]; University of Ghent Multidisciplinary Research Platform (MRP-GROUP-ID); Medical Research Council [MC_PC_17116] Funding Source: researchfish; MRC [MC_PC_17116] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100005, R01AI014782] Funding Source: NIH RePORTER	Ghent University(Ghent University); FWO Fellowship(FWO); Marie Curie grant(European Commission); FWO(FWO); University of Ghent(Ghent University); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ERC(European Research Council (ERC)European Commission); University of Ghent Multidisciplinary Research Platform (MRP-GROUP-ID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H.H. is supported by Ghent University Grant (GOA 01G02817). M.V. is supported by a FWO Fellowship (grant 3F023515W). P.P was supported by Marie Curie grant (MC 237581). S.J. is supported by FWO grant G085915N and a University of Ghent grant (MRP-GROUP-ID). M.K. is supported by the Swiss National Science Foundation (SNF 310030-163443/1). J.F.K. was supported by NIAID AI14782 and AI100005. B.N.L. was supported by an ERC consolidator grant 261231, the University of Ghent Multidisciplinary Research Platform (MRP-GROUP-ID) and a Ghent University grant (GOA 01G02817).	Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Boyce KJ, 2011, TRENDS MICROBIOL, V19, P400, DOI 10.1016/j.tim.2011.04.006; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; Chuang HC, 2016, ADV IMMUNOL, V129, P277, DOI 10.1016/bs.ai.2015.09.006; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Deng W, 2014, P NATL ACAD SCI USA, V111, P15987, DOI 10.1073/pnas.1409354111; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Fasnacht N, 2014, J EXP MED, V211, P2265, DOI 10.1084/jem.20132528; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hampel F, 2011, BLOOD, V118, P6321, DOI 10.1182/blood-2010-12-325944; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Kapfhamer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050594; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kin NW, 2008, J IMMUNOL, V180, P6663, DOI 10.4049/jimmunol.180.10.6663; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Roundy KM, 2010, EUR J IMMUNOL, V40, P1139, DOI 10.1002/eji.200939661; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Simonetti G, 2013, J EXP MED, V210, P2887, DOI 10.1084/jem.20131026; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689	42	49	51	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					313	320		10.1038/ni.3657	http://dx.doi.org/10.1038/ni.3657			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28068307	Green Submitted			2022-12-18	WOS:000394413400011
J	Pedros, C; Zhang, YY; Hu, JK; Choi, YS; Canonigo-Balancio, AJ; Yates, JR; Altman, A; Crotty, S; Kong, KF				Pedros, Christophe; Zhang, Yaoyang; Hu, Joyce K.; Choi, Youn Soo; Canonigo-Balancio, Ann J.; Yates, John R., III; Altman, Amnon; Crotty, Shane; Kong, Kok-Fai			A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center T-FH cells via the kinase TBK1	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; NF-KAPPA-B; TANK-BINDING KINASE-1; PHOSPHOINOSITIDE 3-KINASE; IMMUNOLOGICAL SYNAPSE; ANTIGEN PRESENTATION; ANTIVIRAL RESPONSE; IMMUNE-RESPONSES; RECEPTOR; DIFFERENTIATION	Signaling via the inducible costimulator ICOS fuels the stepwise development of follicular helper T cells (T-FH cells). However, a signaling pathway unique to ICOS has not been identified. We found here that the kinase TBK1 associated with ICOS via a conserved motif, IProx, that shares homology with the tumor-necrosis-factor receptor (TNFR)-associated factors TRAF2 and TRAF3. Disruption of this motif abolished the association of TBK1 with ICOS, TRAF2 and TRAF3, which identified a TBK1-binding consensus. Alteration of this motif in ICOS or depletion of TBK1 in T cells severely impaired the differentiation of germinal center (GC) T-FH cells and the development of GCs, interfered with B cell differentiation and disrupted the development of antibody responses, but the IProx motif and TBK1 were dispensable for the early differentiation of T-FH cells. These results reveal a previously unknown ICOS-TBK1 signaling pathway that specifies the commitment of GC T-FH cells.	[Pedros, Christophe; Canonigo-Balancio, Ann J.; Altman, Amnon; Kong, Kok-Fai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Zhang, Yaoyang; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Hu, Joyce K.; Choi, Youn Soo; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Sch Med, Div Infect Dis, La Jolla, CA 92093 USA; [Zhang, Yaoyang] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Ctr Biol & Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China; [Choi, Youn Soo] Seoul Natl Univ, Coll Med, Dept Med, Transplantat Res Inst, Seoul, South Korea	La Jolla Institute for Immunology; Scripps Research Institute; La Jolla Institute for Immunology; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Seoul National University (SNU)	Kong, KF (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA.; Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.; Crotty, S (corresponding author), Univ Calif San Diego, Sch Med, Div Infect Dis, La Jolla, CA 92093 USA.	shane@lji.org; kfkong@lji.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262; Yates, John/0000-0001-5267-1672; Zhang, Yaoyang/0000-0001-5363-9834	US National Institutes of Health [CA35299, AI109976, AI063107, AI072543]; Melanoma Research Alliance (Young Investigator Award) [270056]; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109976, R01AI072543, R01AI063107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance (Young Investigator Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Altman and Crotty laboratories for discussions; the Flow Cytometry Core Unit, the Microscopy Unit and the Animal Husbandry Unit of the La Jolla Institute for Allergy and Immunology for services; P. Beemiller for imaging and bioinformatics services and assistance in computational analyses of immunohistochemistry with Matlab software; and the National Disease Resource Interchange for clinical samples. Supported by the US National Institutes of Health (CA35299 to A. A.; and AI109976, AI063107 and AI072543 to S.C.) and the Melanoma Research Alliance (Young Investigator Award 270056 to K.-F.K.). This is publication number 1794 from the La Jolla Institute for Allergy and Immunology.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Leavenworth JW, 2015, NAT IMMUNOL, V16, P96, DOI 10.1038/ni.3050; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Li J, 2013, J IMMUNOL, V191, P200, DOI 10.4049/jimmunol.1203485; Linterman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03180; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Nance JP, 2015, P NATL ACAD SCI USA, V112, P13324, DOI 10.1073/pnas.1507312112; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Weinstein JS, 2014, J IMMUNOL, V192, P3166, DOI 10.4049/jimmunol.1302617; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	55	49	52	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					825	+		10.1038/ni.3463	http://dx.doi.org/10.1038/ni.3463			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27135603	Green Accepted			2022-12-18	WOS:000378283200015
J	Kim, H; Seed, B				Kim, Hwijin; Seed, Brian			The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; HUMAN PANCREATIC-ISLETS; VIRUS-INFECTION; BETA-CELLS; RIG-I; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; NOD MICE; INTERFERON	Viral infection induces type I interferons (IFN-alpha and IFN-beta) that recruit unexposed cells in a self-amplifying response. We report that the transcription factor MafB thwarts auto-amplification by a metastable switch activity. MafB acted as a weak positive basal regulator of transcription at the IFNB1 promoter through activity at transcription factor AP-1-like sites. Interferon elicitors recruited the transcription factor IRF3 to the promoter, whereupon MafB acted as a transcriptional antagonist, impairing the interaction of coactivators with IRF3. Mathematical modeling supported the view that prepositioning of MafB on the promoter allows the system to respond rapidly to fluctuations in IRF3 activity. Higher expression of MafB in human pancreatic islet beta cells might increase cellular vulnerability to viral infections associated with the etiology of type 1 diabetes.	[Kim, Hwijin; Seed, Brian] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Kim, Hwijin; Seed, Brian] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Seed, B (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	bseed@ccib.mgh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK057521-019001] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chehadeh W, 2000, J VIROL, V74, P10153, DOI 10.1128/JVI.74.21.10153-10164.2000; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Drescher KM, 2004, VIROLOGY, V329, P381, DOI 10.1016/j.virol.2004.06.049; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FOULIS AK, 1990, DIABETOLOGIA, V33, P290, DOI 10.1007/BF00403323; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim HJ, 2006, PLOS COMPUT BIOL, V2, P1232, DOI 10.1371/journal.pcbi.0020135; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Mizukami J, 1997, BIOCHEM BIOPH RES CO, V240, P61, DOI 10.1006/bbrc.1997.7602; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Pouponnot C, 2006, ONCOGENE, V25, P1299, DOI 10.1038/sj.onc.1209171; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; SEE DM, 1995, J INFECT DIS, V171, P1131, DOI 10.1093/infdis/171.5.1131; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Wang PW, 1999, GENOMICS, V59, P275, DOI 10.1006/geno.1999.5884; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Ylipaasto P, 2005, DIABETOLOGIA, V48, P1510, DOI 10.1007/s00125-005-1839-7; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	50	49	51	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					743	U113		10.1038/ni.1897	http://dx.doi.org/10.1038/ni.1897			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20581830	Green Accepted			2022-12-18	WOS:000280149400016
J	Butler, B; Kastendieck, DH; Cooper, JA				Butler, Boyd; Kastendieck, Diana H.; Cooper, John A.			Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells	NATURE IMMUNOLOGY			English	Article							TYROSINE PHOSPHORYLATION; HEMATOPOIETIC LINEAGE; IMMUNOLOGICAL SYNAPSE; VASCULAR ENDOTHELIUM; ACTIN POLYMERIZATION; PROTEIN-1 HS1; TARGET-CELLS; NK CELLS; LFA-1; CYTOTOXICITY	Here we investigated the involvement of HS1, the hematopoietic cell-specific homolog of cortactin, in the actin-based functions of natural killer cells. Involvement of HS1 in T cell regulation has been established, as HS1 is required for the formation of immune synapses. 'Knockdown' of HS1 in natural killer cells resulted in defective lysis of target cells, cell adhesion, chemotaxis and actin assembly at the lytic synapse. Phosphorylation of the tyrosine residue at position 397 (Tyr397) was required for adhesion to the integrin ligand ICAM-1 and for cytolysis, whereas phosphorylation of Tyr378 was required for chemotaxis. Phosphorylation of Tyr397 was also required for integrin signaling and recruitment of integrins, adaptors and actin to the lytic synapse. Thus, HS1 is essential for signaling and actin assembly in natural killer cells, and the functions of the two phosphorylated tyrosine residues are distinct and separable.	[Butler, Boyd; Kastendieck, Diana H.; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Butler, B (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	boyd.butler@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571	NCI NIH HHS [P30 CA91842, P30 CA091842] Funding Source: Medline; NIGMS NIH HHS [R01 GM038542, R01 GM038542-20, GM 38542] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAVENA P, 1991, J EXP MED, V173, P439, DOI 10.1084/jem.173.2.439; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Ballestrem C, 1998, J CELL SCI, V111, P1649; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Brunati AM, 2005, J BIOL CHEM, V280, P21029, DOI 10.1074/jbc.M412634200; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; CARPEN O, 1983, J IMMUNOL, V131, P2695; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Donskov F, 1996, NAT IMMUN, V15, P134; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Galandrini R, 1999, J IMMUNOL, V162, P3148; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Green CE, 2006, BLOOD, V107, P2101, DOI 10.1182/blood-2005-06-2303; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Khurana D, 2003, J LEUKOCYTE BIOL, V73, P333, DOI 10.1189/jlb.0802385; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Loubani O, 2005, ANTICANCER RES, V25, P735; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Ruzzene M, 1996, BIOCHEMISTRY-US, V35, P5327, DOI 10.1021/bi9528614; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weber KSC, 2001, CURR BIOL, V11, P1969, DOI 10.1016/S0960-9822(01)00597-8; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631	47	49	51	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					887	897		10.1038/ni.1630	http://dx.doi.org/10.1038/ni.1630			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18587398	Green Accepted			2022-12-18	WOS:000257780700012
J	Hayday, AC; Peakman, M				Hayday, Adrian C.; Peakman, Mark			The habitual, diverse and surmountable obstacles to human immunology research	NATURE IMMUNOLOGY			English	Editorial Material								The need to translate basic research in the field of human immunology may be much more urgent, and the rewards potentially much greater, than is often acknowledged. Yet a commonly perceived coercion to undertake translational research may be unhelpful. Instead, we propose clear incentives for integrating key skill sets, together with achievable cultural adjustments in research and medicine that span training, recruitment and promotion.	[Hayday, Adrian C.; Peakman, Mark] Guys & St Thomas Hosp Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London SE1 9RT, England; [Hayday, Adrian C.; Peakman, Mark] Guys Hosp, Univ London Kings Coll, Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, AC (corresponding author), Guys & St Thomas Hosp Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		Peakman, Mark/0000-0003-3328-3513; HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust [071534] Funding Source: Medline; Medical Research Council [G0600698B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bernard D, 2008, CLIN EXP IMMUNOL, V152, P406, DOI 10.1111/j.1365-2249.2008.03659.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; SCHWARTZ ND, 2008, INT HERALD TRIB 0325, P15; Towie N, 2007, NAT MED, V13, P653, DOI 10.1038/nm0607-653a; Warry P, 2006, INCREASING EC IMPACT; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	9	49	49	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					575	580		10.1038/ni0608-575	http://dx.doi.org/10.1038/ni0608-575			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490903				2022-12-18	WOS:000256067900003
J	Chess, L; Jiang, H				Chess, L; Jiang, H			Resurrecting CD8(+) suppressor T cells	NATURE IMMUNOLOGY			English	Editorial Material							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; IDENTIFICATION; PATHWAYS; MOLECULE; MICE; TCR	The idea that Qa-1-dependent CD8(+) suppressor T cells regulate peripheral immune responses was unpopular during the era of 'suppressor skepticism' in the late 1980s, but this has now been resurrected.	Columbia Univ, Dept Med, Div Rheumatol, New York, NY 10032 USA	Columbia University	Chess, L (corresponding author), Columbia Univ, Dept Med, Div Rheumatol, New York, NY 10032 USA.	lc19@columbia.edu						ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Bendelac A, 1997, CURR OPIN IMMUNOL, V9, P1, DOI 10.1016/S0952-7915(97)80151-3; CANTOR H, 1978, J EXP MED, V148, P871, DOI 10.1084/jem.148.4.871; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; GREEN DR, 1983, ANNU REV IMMUNOL, V1, P439, DOI 10.1146/annurev.iy.01.040183.002255; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; JANEWAY CA, 1988, SCAND J IMMUNOL, V27, P621, DOI 10.1111/j.1365-3083.1988.tb02392.x; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423	15	49	51	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					469	471		10.1038/ni0504-469	http://dx.doi.org/10.1038/ni0504-469			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116110				2022-12-18	WOS:000221101100006
J	O'Garra, A; Vieira, P				O'Garra, A; Vieira, P			Twenty-first century Foxp3	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; IMMUNITY; SCURFIN	The transcription factor(s) controlling T-Reg cell development are not definitely known. The finding that these cells specifically express Foxp3 provides a better understanding of their development and function at the molecular level.	Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, F-757015 Paris, France	MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	O'Garra, A (corresponding author), Natl Inst Med Res, Div Immunoregulat, Mill Hill, London NW7 1AA, England.		Vieira, Paulo/D-4500-2013	Vieira, Paulo/0000-0003-1307-5119; O'Garra, Anne/0000-0001-9845-6134				Annacker O, 2001, IMMUNOL REV, V182, P5, DOI 10.1034/j.1600-065X.2001.1820101.x; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821	16	49	50	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					304	306		10.1038/ni0403-304	http://dx.doi.org/10.1038/ni0403-304			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660726				2022-12-18	WOS:000181987700005
J	Ganz, T				Ganz, T			Paneth cells - guardians of the gut cell hatchery	NATURE IMMUNOLOGY			English	News Item							SMALL-INTESTINE; HOST-DEFENSE; EPITHELIUM; CRYPTDIN	Protection of the small intestine from harmful bacteria is a never-ending job. Paneth cells of the intestinal crypts function as prime producers of defensins in response to the microbial onslaught of the gut.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ganz, T (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.		Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Ganz, Tomas/0000-0002-2830-5469				Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; JONES DE, 1992, J BIOL CHEM, V267, P23216; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; SATOH Y, 1988, CELL TISSUE RES, V251, P87, DOI 10.1007/BF00215451; SATOH Y, 1988, ACTA HISTOCHEM, V83, P185, DOI 10.1016/S0065-1281(88)80055-2; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	13	49	51	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					99	100		10.1038/77884	http://dx.doi.org/10.1038/77884			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248797				2022-12-18	WOS:000089814900006
J	Yang, T; Velagapudi, R; Terrando, N				Yang, Ting; Velagapudi, Ravikanth; Terrando, Niccolo			Neuroinflammation after surgery: from mechanisms to therapeutic targets	NATURE IMMUNOLOGY			English	Review							C-REACTIVE PROTEIN; HIP FRACTURE PATIENTS; CEREBROSPINAL-FLUID S100B; BRAIN-BARRIER BREAKDOWN; COGNITIVE DECLINE; POSTOPERATIVE DELIRIUM; IMMUNE-RESPONSE; COMPLEMENT ACTIVATION; GENERAL-ANESTHESIA; ALARMIN HMGB1	Injury is a key driver of inflammation, a critical yet necessary response involving several mediators that is aimed at restoring tissue homeostasis. Inflammation in the central nervous system can be triggered by a variety of stimuli, some intrinsic to the brain and others arising from peripheral signals. Fine-tuned regulation of this response is crucial in a system that is vulnerable due to, for example, aging and ongoing neurodegeneration. In this context, seemingly harmless interventions like a common surgery to repair a broken limb can overwhelm the immune system and become the driver of further complications such as delirium and other perioperative neurocognitive disorders. Here, we discuss potential mechanisms by which the immune system affects the central nervous system after surgical trauma. Together, these neuroimmune interactions are becoming hallmarks of and potential therapeutic targets for multiple neurologic conditions, including those affecting the perioperative space. Terrando and colleagues review key mechanisms related to postoperative inflammation and the implications for developing perioperative neurocognitive disorders, with a focus on neuroinflammation and key cellular targets affected by surgical trauma.	[Yang, Ting] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Velagapudi, Ravikanth; Terrando, Niccolo] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Terrando, Niccolo] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Terrando, N (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.; Terrando, N (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	niccolo.terrando@duke.edu	Velagapudi, Ravikanth/I-3101-2019	Velagapudi, Ravikanth/0000-0001-9363-3154; Terrando, Niccolo/0000-0003-1803-5853	NIA NIH HHS [R21 AG055877, R01 AG057525, R03 AG064260] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Alawieh A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6459; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bettcher BM, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00025; Bi JJ, 2017, ONCOTARGET, V8, P51817, DOI 10.18632/oncotarget.15545; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Davis DHJ, 2017, JAMA PSYCHIAT, V74, P244, DOI 10.1001/jamapsychiatry.2016.3423; Degos V, 2013, ANESTHESIOLOGY, V118, P527, DOI 10.1097/ALN.0b013e3182834d94; Deiner S, 2020, BRIT J ANAESTH, V125, P282, DOI 10.1016/j.bja.2020.04.085; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Evered L, 2017, BRIT J ANAESTH, V119, P1241, DOI 10.1093/bja/aex404; Evered LA, 2018, ANESTH ANALG, V127, P496, DOI 10.1213/ANE.0000000000003514; Feng XM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91229; Fick DM, 2002, J AM GERIATR SOC, V50, P1723, DOI 10.1046/j.1532-5415.2002.50468.x; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Fong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5; Fonken LK, 2016, J NEUROSCI, V36, P7946, DOI 10.1523/JNEUROSCI.1161-16.2016; Forsberg A, 2017, ANN NEUROL, V81, P572, DOI 10.1002/ana.24909; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hall RJ, 2013, AM J GERIAT PSYCHIAT, V21, P1239, DOI 10.1016/j.jagp.2012.12.024; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Henjum K, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1331-1; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Hoedemaekers C, 2010, ANN THORAC SURG, V89, P710, DOI 10.1016/j.athoracsur.2009.11.049; Hov KR, 2017, DEMENT GER COGN D EX, V7, P374, DOI 10.1159/000481853; Hov KR, 2016, DEMENT GERIATR COGN, V41, P192, DOI 10.1159/000443789; Hu J, 2018, BRIT J ANAESTH, V120, P537, DOI 10.1016/j.bja.2017.11.096; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Hughes CG, 2016, CRIT CARE MED, V44, pE809, DOI 10.1097/CCM.0000000000001739; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan BA, 2020, CRIT CARE MED, V48, P353, DOI 10.1097/CCM.0000000000004139; Kooij G, 2020, HAEMATOLOGICA, V105, P2056, DOI 10.3324/haematol.2019.219519; Koster S, 2012, ANN THORAC SURG, V93, P705, DOI 10.1016/j.athoracsur.2011.07.006; Kotfis K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02882-x; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee HB, 2017, AM J GERIAT PSYCHIAT, V25, P308, DOI 10.1016/j.jagp.2016.10.008; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Li ZQ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00105; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Linnartz-Gerlach B, 2019, GLIA, V67, P539, DOI 10.1002/glia.23563; Lopez MG, 2020, ANESTHESIOLOGY, V132, P551, DOI 10.1097/ALN.0000000000003016; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Malawista SE, 2008, P NATL ACAD SCI USA, V105, P17949, DOI 10.1073/pnas.0802572105; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; Marcos-Contreras OA, 2020, P NATL ACAD SCI USA, V117, P3405, DOI 10.1073/pnas.1912012117; Mcneil JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226412; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Mikhailoyich A, 2015, J AM GERIATR SOC, V63, P843, DOI 10.1111/jgs.13406; Miller-Rhodes P, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1582-5; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Ni P, 2018, J NEUROINFLAMM, V15, P6267879; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Owen DR, 2014, J CEREBR BLOOD F MET, V34, P989, DOI 10.1038/jcbfm.2014.46; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Pluvinage JV, 2020, NAT REV NEUROSCI, V21, P93, DOI 10.1038/s41583-019-0255-9; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Rappold T, 2016, BRIT J ANAESTH, V116, P83, DOI 10.1093/bja/aev415; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Rempe RG, 2018, J NEUROSCI, V38, P4301, DOI 10.1523/JNEUROSCI.2751-17.2018; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Senatorov VV, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8283; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Soares HD, 1995, J NEUROSCI, V15, P8223; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Takizawa F, 1996, FEBS LETT, V397, P269, DOI 10.1016/S0014-5793(96)01197-0; Terrando N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00441; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Thordardottir S, 2016, SCAND J IMMUNOL, V83, P219, DOI 10.1111/sji.12411; Vacas S, 2014, ANESTHESIOLOGY, V120, P1160, DOI 10.1097/ALN.0000000000000045; Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015; Velagapudi R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02675; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang P, 2020, ALZHEIMERS DEMENT, V16, P734, DOI 10.1002/alz.12064; Westhoff D, 2015, BBA CLIN, V4, P115, DOI 10.1016/j.bbacli.2015.10.002; Xiong C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1292-4; Yang SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00902; Yang T, 2019, BRIT J ANAESTH, V122, P350, DOI 10.1016/j.bja.2018.10.062; Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4; Zhang X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0592-9; Zheng B, 2017, BRAIN BEHAV IMMUN, V61, P365, DOI 10.1016/j.bbi.2017.01.005; Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847	108	48	49	4	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1319	1326		10.1038/s41590-020-00812-1	http://dx.doi.org/10.1038/s41590-020-00812-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	OD0BT	33077953	Bronze, Green Accepted			2022-12-18	WOS:000579520600009
J	Pikor, NB; Morbe, U; Lutge, M; Gil-Cruz, C; Perez-Shibayama, C; Novkovic, M; Cheng, HW; Nombela-Arrieta, C; Nagasawa, T; Linterman, MA; Onder, L; Ludewig, B				Pikor, Natalia B.; Moerbe, Urs; Luetge, Mechthild; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Novkovic, Mario; Cheng, Hung-Wei; Nombela-Arrieta, Cesar; Nagasawa, Takashi; Linterman, Michelle A.; Onder, Lucas; Ludewig, Burkhard			Remodeling of light and dark zone follicular dendritic cells governs germinal center responses	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; CENTER SELECTION; ANTIGEN; ACTIVATION; MATURATION; MEMORY; CXCR4; CYCLE; STATE; TLR4	Ludewig and colleagues use fate-mapping reporter cells, single-cell RNA-seq analysis and high-resolution microscopy to identify and track the spatial reorganization of follicular reticular cells within germinal centers during the course of an immune response. Efficient generation of germinal center (GC) responses requires directed movement of B cells between distinct microenvironments underpinned by specialized B cell-interacting reticular cells (BRCs). How BRCs are reprogrammed to cater to the developing GC remains unclear, and studying this process is largely hindered by incomplete resolution of the cellular composition of the B cell follicle. Here we used genetic targeting of Cxcl13-expressing cells to define the molecular identity of the BRC landscape. Single-cell transcriptomic analysis revealed that BRC subset specification was predetermined in the primary B cell follicle. Further topological remodeling of light and dark zone follicular dendritic cells required CXCL12-dependent crosstalk with B cells and dictated GC output by retaining B cells in the follicle and steering their interaction with follicular helper T cells. Together, our results reveal that poised BRC-defined microenvironments establish a feed-forward system that determines the efficacy of the GC reaction.	[Pikor, Natalia B.; Moerbe, Urs; Luetge, Mechthild; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Novkovic, Mario; Cheng, Hung-Wei; Onder, Lucas; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, Med Res Ctr, St Gallen, Switzerland; [Nombela-Arrieta, Cesar] Univ Hosp, Dept Expt Hematol & Oncol, Zurich, Switzerland; [Nombela-Arrieta, Cesar] Univ Zurich, Zurich, Switzerland; [Nagasawa, Takashi] Osaka Univ, Grad Sch Frontier Biosci, Lab Stem Cell Biol & Dev Immunol, Osaka, Japan; [Nagasawa, Takashi] Osaka Univ, Grad Sch Med, Osaka, Japan; [Linterman, Michelle A.] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Kantonsspital St. Gallen; University of Zurich; University Zurich Hospital; University of Zurich; Osaka University; Osaka University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, Med Res Ctr, St Gallen, Switzerland.	burkhard.ludewig@kssg.ch	Mörbe, Urs Michael/AAM-2757-2020; Linterman, Michelle/AAN-4210-2021; Mörbe, Urs/GPX-7383-2022	Mörbe, Urs Michael/0000-0001-8747-437X; Linterman, Michelle/0000-0001-6047-1996; Nombela-Arrieta, Cesar/0000-0003-0415-259X; Novkovic, Mario/0000-0001-7654-5777; Nagasawa, Takashi/0000-0002-1085-0960; Pikor, Natalia/0000-0002-6564-4232; Lutge, Mechthild/0000-0001-9011-5319	Swiss National Science Foundation [177208, 166500, 159188, 180011]; Novartis Foundation for Biomedical Research; BBSRC [BBS/E/B/000C0428, BBS/E/B/000C0427] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Biomedical Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study received financial support from the Swiss National Science Foundation (grants 177208, 166500 and 159188 to B.L. and grant 180011 to N.B.P.) and the Novartis Foundation for Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Cervantes-Barragan L, 2009, EUR J IMMUNOL, V39, P126, DOI 10.1002/eji.200838185; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dubey LK, 2016, CELL REP, V15, P1527, DOI 10.1016/j.celrep.2016.04.023; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fink K, 2007, J IMMUNOL, V179, P5877, DOI 10.4049/jimmunol.179.9.5877; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Gil-Cruz C, 2016, NAT IMMUNOL, V17, P1388, DOI 10.1038/ni.3566; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Kalinke U, 1996, IMMUNITY, V5, P639, DOI 10.1016/S1074-7613(00)80277-0; Kolde R, 2012, PHEATMAP PRETTY HEAT, V61, P617; Ludewig B, 2000, EUR J IMMUNOL, V30, P185, DOI 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.3.CO;2-C; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Moran I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05772-7; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Perez-Shibayama C, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4539; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; Reich M, 2017, CELL SYST, V5, P149, DOI 10.1016/j.cels.2017.07.003; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Spillane KM, 2017, J CELL BIOL, V216, P217, DOI 10.1083/jcb.201607064; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832; ZHENG GX, 2017, NATURE, V0008	53	48	48	3	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					649	+		10.1038/s41590-020-0672-y	http://dx.doi.org/10.1038/s41590-020-0672-y		MAY 2020	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424359	Green Accepted			2022-12-18	WOS:000533852800007
J	Han, CH; Liu, ZD; Zhang, YJ; Shen, AJ; Dong, CB; Zhang, AL; Moore, C; Ren, ZH; Lu, CZ; Cao, XH; Zhang, CL; Qiao, J; Fu, YX				Han, Chuanhui; Liu, Zhida; Zhang, Yunjia; Shen, Aijun; Dong, Chunbo; Zhang, Anli; Moore, Casey; Ren, Zhenhua; Lu, Changzheng; Cao, Xuezhi; Zhang, Chun-Li; Qiao, Jian; Fu, Yang-Xin			Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; I INTERFERONS; CGAS; DNA; TRAFFICKING; THERAPY	Therapeutic irradiation can trigger DNA-sensing pathways and trigger antitumor immunity. Fu and colleagues demonstrate that tumors can co-opt intrinsic apoptotic pathways to avoid immunogenic cell death following irradiation. High-dose radiation activates caspases in tumor cells to produce abundant DNA fragments for DNA sensing in antigen-presenting cells, but the intrinsic DNA sensing in tumor cells after radiation is rather limited. Here we demonstrate that irradiated tumor cells hijack caspase 9 signaling to suppress intrinsic DNA sensing. Instead of apoptotic genomic DNA, tumor-derived mitochondrial DNA triggers intrinsic DNA sensing. Specifically, loss of mitochondrial DNA sensing in Casp9(-/-) tumors abolishes the enhanced therapeutic effect of radiation. We demonstrated that combining emricasan, a pan-caspase inhibitor, with radiation generates synergistic therapeutic effects. Moreover, loss of CASP9 signaling in tumor cells led to adaptive resistance by upregulating programmed death-ligand 1 (PD-L1) and resulted in tumor relapse. Additional anti-PD-L1 blockade can further overcome this acquired immune resistance. Therefore, combining radiation with a caspase inhibitor and anti-PD-L1 can effectively control tumors by sequentially blocking both intrinsic and extrinsic inhibitory signaling.	[Han, Chuanhui; Liu, Zhida; Shen, Aijun; Dong, Chunbo; Zhang, Anli; Moore, Casey; Ren, Zhenhua; Lu, Changzheng; Cao, Xuezhi; Qiao, Jian; Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Zhang, Yunjia; Zhang, Chun-Li] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX USA; [Moore, Casey; Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Qiao, J; Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.; Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	Jian.Qiao@UTSouthwestern.edu; Yang-Xin.Fu@UTSouthwestern.edu	Ren, Zhenhua/R-3751-2018; Lu, Changzheng/AAY-4048-2021	Ren, Zhenhua/0000-0002-2560-5618; Lu, Changzheng/0000-0002-0904-0303; ZHANG, ANLI/0000-0001-7847-6541	NCI [CA134563]; Texas CPRIT grant [RR150072, RR180725]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Texas CPRIT grant	We thank R. W. Welchselbaum for providing reagents and assisting with experiments and the UT southwestern Flow Cytometry Facility and Animal Resources Center. YXF holds the Mary Nell and Ralph B. Rogers Professorship in Immunology. This work was supported by NCI CA134563, Texas CPRIT grant RR150072 and RR180725 (established CPRIT scholar in cancer research) to Y.-X. F.	Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Bai M, 2001, BREAST CANCER RES, V3, P276, DOI 10.1186/bcr306; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Brumatti G, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3099; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Deng LF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28499; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Dovedi SJ, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1016709; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Flanagan L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.7; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Giampazolias E, 2017, NAT CELL BIOL, V19, P1116, DOI 10.1038/ncb3596; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hauff P, 2015, EXPERT OPIN INV DRUG, V24, P309, DOI 10.1517/13543784.2015.997874; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hu Q, 2014, INT J CLIN EXP PATHO, V7, P5057; Huang JS, 2017, ONCOTARGET, V8, P84237, DOI 10.18632/oncotarget.20494; Kim KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002275; Lama L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08620-4; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Liu ZD, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav6473; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maier P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010102; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Mehta G, 2018, J CLIN EXP HEPATOL, V8, P224, DOI 10.1016/j.jceh.2017.11.006; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Rodriguez-Ruiz ME, 2018, TRENDS IMMUNOL, V39, P644, DOI 10.1016/j.it.2018.06.001; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Werthmoller N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.129; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang ZX, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0166-1; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	47	48	49	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					546	+		10.1038/s41590-020-0641-5	http://dx.doi.org/10.1038/s41590-020-0641-5		MAR 2020	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32231300				2022-12-18	WOS:000522383000003
J	Schober, K; Voit, F; Grassmann, S; Muller, TR; Eggert, J; Jarosch, S; Weissbrich, B; Hoffmann, P; Borkner, L; Nio, E; Fanchi, L; Clouser, CR; Radhakrishnan, A; Mihatsch, L; Luckemeier, P; Leube, J; Dossinger, G; Klein, L; Neuenhahn, M; Oduro, JD; Cicin-Sain, L; Buchholz, VR; Busch, DH				Schober, Kilian; Voit, Florian; Grassmann, Simon; Mueller, Thomas R.; Eggert, Joel; Jarosch, Sebastian; Weissbrich, Bianca; Hoffmann, Patrick; Borkner, Lisa; Nio, Enzo; Fanchi, Lorenzo; Clouser, Christopher R.; Radhakrishnan, Aditya; Mihatsch, Lorenz; Lueckemeier, Philipp; Leube, Justin; Doessinger, Georg; Klein, Ludger; Neuenhahn, Michael; Oduro, Jennifer D.; Cicin-Sain, Luka; Buchholz, Veit R.; Busch, Dirk H.			Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; NEGATIVE SELECTION; DIVERSITY; AVIDITY; LYMPHOCYTES; SENESCENCE; RESPONSES; VIRUS; EXHAUSTION; PRECURSOR	Adaptive evolution is a key feature of T cell immunity. During acute immune responses, T cells harboring high-affinity T cell antigen receptors (TCRs) are preferentially expanded, but whether affinity maturation by clonal selection continues through the course of chronic infections remains unresolved. Here we investigated the evolution of the TCR repertoire and its affinity during the course of infection with cytomegalovirus, which elicits large T cell populations in humans and mice. Using single-cell and bulk TCR sequencing and structural affinity analyses of cytomegalovirus-specific T cells, and through the generation and in vivo monitoring of defined TCR repertoires, we found that the immunodominance of high-affinity T cell clones declined during the chronic infection phase, likely due to cellular senescence. These data showed that under conditions of chronic antigen exposure, low-affinity TCRs preferentially expanded within the TCR repertoire, with implications for immunotherapeutic strategies. Busch and colleagues use single-cell and bulk TCR sequencing and structural affinity analyses of CMV-specific T cells to show that the immunodominance of high-affinity T cell clones declines during chronic infection with CMV, likely due to cellular senescence.	[Schober, Kilian; Voit, Florian; Grassmann, Simon; Mueller, Thomas R.; Eggert, Joel; Jarosch, Sebastian; Weissbrich, Bianca; Hoffmann, Patrick; Mihatsch, Lorenz; Lueckemeier, Philipp; Leube, Justin; Doessinger, Georg; Neuenhahn, Michael; Buchholz, Veit R.; Busch, Dirk H.] TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Mueller, Thomas R.; Cicin-Sain, Luka; Busch, Dirk H.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Borkner, Lisa; Oduro, Jennifer D.; Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Nio, Enzo; Fanchi, Lorenzo] ENPICOM BV, Shertogenbosch, Netherlands; [Clouser, Christopher R.; Radhakrishnan, Aditya] Juno Therapeut Celgene, Seattle, WA USA; [Klein, Ludger] Ludwig Maximilians Univ Munchen, Inst Immunol, Munich, Germany; [Cicin-Sain, Luka] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany; [Busch, Dirk H.] TUM, Focus Grp Clin Cell Proc & Purificat, Inst Adv Study, Munich, Germany	Technical University of Munich; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich; Hannover Medical School; Technical University of Munich	Schober, K; Busch, DH (corresponding author), TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Busch, DH (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.; Busch, DH (corresponding author), TUM, Focus Grp Clin Cell Proc & Purificat, Inst Adv Study, Munich, Germany.	kilian.schober@tum.de; dirk.busch@tum.de	Cicin-Sain, Luka/S-7504-2018; Buchholz, Veit R./AAF-6966-2021	Cicin-Sain, Luka/0000-0003-3978-778X; Buchholz, Veit R./0000-0003-0441-3913; Voit, Florian Maximilian/0000-0002-6957-6628; Mihatsch, Lorenz Leopold/0000-0003-3835-7964; Borkner, Lisa/0000-0001-5718-649X; Luckemeier, Philipp/0000-0002-3830-059X; Radhakrishnan, Aditya/0000-0001-9119-0679; Jarosch, Sebastian/0000-0002-2908-8590; Eggert, Joel/0000-0002-2982-6020; Muller, Thomas R/0000-0001-5331-5522	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft (DFG) [SFB 1321/TP17, SFB 1054/B09, SFB 1371/TP04]; DFG [FOR2830/TP5]	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank members of the Busch laboratory for experimental help and critical discussion, particularly M. Hammel, A. Hochholzer, F. Graml and E. d'Ippolito. We also thank A. Eltahla and F. Luciani for their advice on RNA-seq, A. Briggs for support with CDR3 sequencing and J. Leidinger for support with TRBV NMDS analysis. This work was mainly supported by the German Center for Infection Research (DZIF) and the Deutsche Forschungsgemeinschaft (DFG) (SFB 1321/TP17; SFB 1054/B09 and SFB 1371/TP04). L.C.S. was supported by the FOR2830/TP5 grant (DFG).	Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Baumann NS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007785; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Cicin-Sain L, 2018, TRENDS MICROBIOL, V26, P498, DOI 10.1016/j.tim.2017.11.012; Cui JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02729; Davenport MP, 2002, J IMMUNOL, V168, P3309, DOI 10.4049/jimmunol.168.7.3309; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Dekhtiarenko I, 2013, J IMMUNOL, V190, P3399, DOI 10.4049/jimmunol.1203173; Dossinger G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061384; Effenberger M, 2019, J IMMUNOL, V202, P2164, DOI 10.4049/jimmunol.1801435; Eltahla AA, 2016, IMMUNOL CELL BIOL, V94, P604, DOI 10.1038/icb.2016.16; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Griffiths SJ, 2013, J IMMUNOL, V190, P5363, DOI 10.4049/jimmunol.1203267; Guedan S, 2019, ANNU REV IMMUNOL, V37, P145, DOI 10.1146/annurev-immunol-042718-041407; Hebeisen M, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00582; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Iancu EM, 2009, J IMMUNOL, V183, P319, DOI 10.4049/jimmunol.0803647; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marchi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00197; Martinez RJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00468; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Nauerth M, 2016, CYTOM PART A, V89A, P816, DOI 10.1002/cyto.a.22933; Nauerth M, 2013, EXPERT REV CLIN IMMU, V9, P1151, DOI 10.1586/1744666X.2013.855609; Nauerth M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005958; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; Redeker A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01953; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Renyi A., 1961, P 4 BERKELEY S MATH, V1; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schober K, 2018, IMMUNOL REV, V283, P113, DOI 10.1111/imr.12654; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Tscharke DC, 2015, NAT REV IMMUNOL, V15, P705, DOI 10.1038/nri3905; Vigano S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/153863; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	61	48	48	2	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					434	+		10.1038/s41590-020-0628-2	http://dx.doi.org/10.1038/s41590-020-0628-2		MAR 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205883				2022-12-18	WOS:000519843600006
J	Bagadia, P; Huang, X; Liu, TT; Durai, V; Grajales-Reyes, GE; Nitschke, M; Modrusan, Z; Granja, JM; Satpathy, AT; Briseno, CG; Gargaro, M; Iwata, A; Kim, S; Chang, HY; Shaw, AS; Murphy, TL; Murphy, KM				Bagadia, Prachi; Huang, Xiao; Liu, Tian-Tian; Durai, Vivek; Grajales-Reyes, Gary E.; Nitschke, Maximilian; Modrusan, Zora; Granja, Jeffrey M.; Satpathy, Ansuman T.; Briseno, Carlos G.; Gargaro, Marco; Iwata, Arifumi; Kim, Sunkyung; Chang, Howard Y.; Shaw, Andrey S.; Murphy, Theresa L.; Murphy, Kenneth M.			An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELL; TRANSCRIPTION FACTOR E2-2; EXPRESSION; CD8-ALPHA(+); PROGENITORS; IDENTIFICATION; ID2; SPECIFICATION; COMMITMENT; REPRESSION	Classical type 1 dendritic cells (cDC1s) are required for antiviral and antitumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E-protein-dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor Irf8 (+41-kb Irf8 enhancer), but its maturation instead requires the Batf3-dependent +32-kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2 and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2(h)(i) and Id2(Io) CDPs to Zeb2(Io) and Id2(hi) CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E-protein activity to exclude plasmacytoid dendritic cell potential and explains the switch in Irf8 enhancer usage during cDC1 development.	[Bagadia, Prachi; Huang, Xiao; Liu, Tian-Tian; Durai, Vivek; Grajales-Reyes, Gary E.; Kim, Sunkyung; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Liu, Tian-Tian; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Nitschke, Maximilian; Shaw, Andrey S.] Genentech Inc, Res Biol, San Francisco, CA USA; [Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Granja, Jeffrey M.; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Briseno, Carlos G.] Amgen Inc, Dept Oncol, San Francisco, CA USA; [Gargaro, Marco] Univ Perugia, Dept Expt Med, Perugia, Italy; [Iwata, Arifumi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Roche Holding; Genentech; Roche Holding; Genentech; Stanford University; Stanford University; Stanford University; Stanford University; Amgen; University of Perugia; Chiba University; Howard Hughes Medical Institute; Stanford University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Huang, Xiao/GPF-9961-2022; Gargaro, Marco/K-7077-2016	Huang, Xiao/0000-0002-2754-5225; Gargaro, Marco/0000-0003-0645-9800; Durai, Vivek/0000-0002-2799-934X; Satpathy, Ansuman/0000-0002-5167-537X	National Cancer Institute's Cancer Center Support grant [P30 CA91842]; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1TR000448]; NIH Roadmap for Medical Research; Howard Hughes Medical Institute; National Science Foundation [DGE-1745038]; US NIH [F30DK108498, K08 CA23188-01, P50-HG007735]; Parker Institute for Cancer Immunotherapy; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG007735, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108498] Funding Source: NIH RePORTER	National Cancer Institute's Cancer Center Support grant; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Chen and L. Goldstein for technical assistance. We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by the National Cancer Institute's Cancer Center Support grant no. P30 CA91842 to the Siteman Cancer Center and by the Institute of Clinical and Translational Sciences/Clinical and Translational Science Award grant no. UL1TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or NIH. This work benefitted from data assembled by the ImmGen consortium<SUP>47</SUP>. This work was supported by the Howard Hughes Medical Institute (K.M.M. and H.Y.C.), the National Science Foundation (grant no. DGE-1745038 to P.B.), the US NIH (grant nos. F30DK108498 to V.D., K08 CA23188-01 to A.T.S. and P50-HG007735 to H.Y.C.) and the Parker Institute for Cancer Immunotherapy (A.T.S. and H.Y.C.). A.T.S. was supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Briseno CG, 2018, P NATL ACAD SCI USA, V115, P10726, DOI 10.1073/pnas.1809925115; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calero-Nieto FJ, 2014, EMBO J, V33, P1212, DOI 10.1002/embj.201386825; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Estrada J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151740; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kusunoki T, 2003, J ALLERGY CLIN IMMUN, V111, P136, DOI 10.1067/mai.2003.29; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McInnes L., 2018, UMAP UNIFORM MANIFOL; McInnes L., 2018, J OPEN SOURCE SOFTW, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nishizaki Y, 2014, GENESIS, V52, P56, DOI 10.1002/dvg.22726; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Saxena M, 2018, TRENDS CANCER, V4, P119, DOI 10.1016/j.trecan.2017.12.007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Wu XD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064800, 10.1371/journal.pone.0071258]; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	55	48	48	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1174	+		10.1038/s41590-019-0449-3	http://dx.doi.org/10.1038/s41590-019-0449-3			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31406377	Green Accepted			2022-12-18	WOS:000482212600017
J	Harly, C; Kenney, D; Ren, G; Lai, BB; Raabe, T; Yang, Q; Cam, MC; Xue, HH; Zhao, KJ; Bhandoola, A				Harly, Christelle; Kenney, Devin; Ren, Gang; Lai, Binbin; Raabe, Tobias; Yang, Qi; Cam, Margaret C.; Xue, Hai-Hui; Zhao, Keji; Bhandoola, Avinash			The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; T-CELLS; PROGENITORS; IDENTIFICATION; SEQ; DIFFERENTIATION; SPECIFICATION; POPULATIONS; EXPRESSION; PRECURSOR	Innate lymphoid cells (ILCs) play important functions in immunity and tissue homeostasis, but their development is poorly understood. Through the use of single-cell approaches, we examined the transcriptional and functional heterogeneity of ILC progenitors, and studied the precursor-product relationships that link the subsets identified. This analysis identified two successive stages of ILC development within T cell factor 1-positive (TCF-1(+)) early innate lymphoid progenitors (EILPs), which we named 'specified EILPs' and 'committed EILPs'. Specified EILPs generated dendritic cells, whereas this potential was greatly decreased in committed EILPs. TCF-1 was dispensable for the generation of specified EILPs, but required for the generation of committed EILPs. TCF-1 used a pre-existing regulatory landscape established in upstream lymphoid precursors to bind chromatin in EILPs. Our results provide insight into the mechanisms by which TCF-1 promotes developmental progression of ILC precursors, while constraining their dendritic cell lineage potential and enforcing commitment to ILC fate.	[Harly, Christelle; Kenney, Devin; Bhandoola, Avinash] NCI, Lab Genome Integr, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Harly, Christelle] Univ Nantes, Univ Angers, CNRS, CRCINA,INSERM, Nantes, France; [Harly, Christelle] LabEx IGO Immunotherapy, Graft, Oncol, Nantes, France; [Ren, Gang; Lai, Binbin; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Raabe, Tobias] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yang, Qi] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA; [Cam, Margaret C.] NCI, Off Sci & Technol Resources, Off Director, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Interdisciplinary Immunol Grad Program, Iowa City, IA USA; [Xue, Hai-Hui] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Albany Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bhandoola, A (corresponding author), NCI, Lab Genome Integr, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	avinash.bhandoola@nih.gov	Raabe, Tobias D/V-5606-2018; Lai, Binbin/I-6249-2015	Kenney, Devin/0000-0002-8758-1930; REN, GANG/0000-0001-9690-5995; Xue, Hai-Hui/0000-0002-9163-7669; Harly, Christelle/0000-0002-8045-9166; Lai, Binbin/0000-0002-2831-2677; Bhandoola, Avinash/0000-0002-4657-8372	Intramural Research Program of the NIH; National Cancer Institute and Center for Cancer Research; NIH [AI121080, AI139874]; Veteran Affairs BLR&D Merit Review Program [BX002903A]; Foundation pour la Recherche Medicale [DEQ20170839118]; National Research Agency Investissements d'Avenir via the program LabEX IGO [ANR-11-LABX-0016-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121080, R01AI139874] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002903] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs BLR&D Merit Review Program; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Research Agency Investissements d'Avenir via the program LabEX IGO(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	We thank H.-R. Rodewald for sharing Il7r-iCre mice and J. Richa from the Transgenic and Chimeric Mouse Facility, University of Pennsylvania, for injection of Tcf7<SUP>YFP</SUP> embryonic stem cells into mouse blastocysts. We thank T. Ciucci, R. Bosselut, J. Chen, the CCR Sequencing Facility, the CCR Flow Cytometry Core Facility, and the DNA Sequencing Facility of the University of Pennsylvania for technical support. This work utilized the computational resources of the NIH high-performance computing Biowulf cluster (http://hpc.nih.gov).This research was supported by the Intramural Research Program of the NIH, National Cancer Institute and Center for Cancer Research, and by grants from the NIH (AI121080 and AI139874 to H.-H.X.), Veteran Affairs BLR&D Merit Review Program (BX002903A to H.-H.X.), and Foundation pour la Recherche Medicale (DEQ20170839118 to C.H.) and National Research Agency Investissements d'Avenir via the program LabEX IGO (ANR-11-LABX-0016-01 to C.H.).	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cooper J, 2017, NAT PROTOC, V12, P2342, DOI 10.1038/nprot.2017.099; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ishikawa F, 2007, BLOOD, V110, P3591, DOI 10.1182/blood-2007-02-071613; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; JI ZC, 2016, NUCLEIC ACIDS RES, V44, DOI DOI 10.1093/NAR/GKW430; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Ku WL, 2019, NAT METHODS, V16, P323, DOI 10.1038/s41592-019-0361-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leek JT, 2017, SVA SURROGATE VARIAB; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ohmura S, 2016, J CLIN INVEST, V126, P865, DOI 10.1172/JCI83894; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; R Development Core Team, 2014, R FDN STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothenberg EV, 2016, IMMUNOL REV, V271, P72, DOI 10.1111/imr.12417; Satija R., 2018, SEURAT TOOLS SINGLE; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Specht AT, 2017, BIOINFORMATICS, V33, P764, DOI 10.1093/bioinformatics/btw729; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	48	49	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1150	+		10.1038/s41590-019-0445-7	http://dx.doi.org/10.1038/s41590-019-0445-7			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31358996	Green Accepted			2022-12-18	WOS:000482212600015
J	Kisielow, J; Obermair, FJ; Kopf, M				Kisielow, Jan; Obermair, Franz-Josef; Kopf, Manfred			Deciphering CD4(+) T cell specificity using novel MHC-TCR chimeric receptors	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; RECOGNITION; DIFFERENTIATION; REPERTOIRE; COMPLEX; ANTIGEN; IDENTIFICATION; AUTOANTIGEN; LIBRARIES; EPITOPES	alpha beta T cell antigen receptors (TCRs) bind complexes of peptide and major histocompatibility complex (pMHC) with low affinity, which poses a considerable challenge for the direct identification of alpha beta T cell cognate peptides. Here we describe a platform for the discovery of MHC class II epitopes based on the screening of engineered reporter cells expressing novel pMHC-TCR (MCR) hybrid molecules carrying cDNA-derived peptides. This technology identifies natural epitopes of CD4(+) T cells in an unbiased and efficient manner and allows detailed analysis of TCR cross-reactivity that provides recognition patterns beyond discrete peptides. We determine the cognate peptides of virus-and tumor-specific T cells in mouse disease models and present a proof of concept for human T cells. Furthermore, we use MCR to identify immunogenic tumor neo-antigens and show that vaccination with a peptide naturally recognized by tumor-infiltrating lymphocytes efficiently protects mice from tumor challenge. Thus, the MCR technology holds promise for basic research and clinical applications, allowing the personalized identification of T cell-specific neo-antigens in patients.	[Kisielow, Jan; Obermair, Franz-Josef; Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kisielow, J; Kopf, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland.	jan.kisielow@biol.ethz.ch; manfred.kopf@ethz.ch	Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Kisielow, Jan/0000-0002-4482-5202	Swiss National Science Foundation [310030-163443]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank T. Schumacher (the Netherlands Cancer Institute, Amsterdam) for plasmids encoding mouse I-A<SUP>b</SUP> MHC class II alpha and beta chains, H. Kawamoto (Institute for Frontier Medical Sciences, Kyoto University, Japan) for the Tst-4/DLL1 cells, Ch. Munz and J. Ruehl (University Zurich) for the hTCCs, L. Tortola and J. Penninger (Institute of Molecular Biotechnology, Vienna, Austria) for the E0771 cell line, L. Ignatowicz (Medical College of Georgia, Augusta University, USA) for Ep splenocytes. We thank R. Martin for discussions, A. Schutz and M. Kisielow for help with cell sorting, L. Opitz for exome sequencing, E. Rosenwald and F. Ampenberger for technical assistance, and P. Nielsen and P. Kisielow for critical reading of the manuscript. Fluorescent timer proteins were designed at UCSD, and FT plasmids were acquired from Addgene (www.addgene.org).Financial support of M.K. by the Swiss National Science Foundation (grant no. 310030-163443) is appreciated.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Bending D, 2018, J CELL BIOL, V217, P2931, DOI 10.1083/jcb.201711048; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Borras E, 2002, J IMMUNOL METHODS, V267, P81; BROCKER T, 1993, EUR J IMMUNOL, V23, P1435, DOI 10.1002/eji.1830230705; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Dogan I, 2004, EUR J IMMUNOL, V34, P598, DOI 10.1002/eji.200324721; Dotti G, 2014, IMMUNOL REV, V257, P107, DOI 10.1111/imr.12131; Dow C, 2008, J VIROL, V82, P11734, DOI 10.1128/JVI.00435-08; Geiger TL, 1999, J IMMUNOL, V162, P5931; Geiger TL, 2001, BLOOD, V98, P2364, DOI 10.1182/blood.V98.8.2364; Gundlach BR, 1996, J IMMUNOL METHODS, V192, P149, DOI 10.1016/0022-1759(96)00040-3; HAYASHI H, 1992, J IMMUNOL, V149, P1223; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Judkowski V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024091; Jyothi MD, 2002, NAT BIOTECHNOL, V20, P1215, DOI 10.1038/nbt758; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Rosenthal KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032562; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Siewert K, 2012, NAT MED, V18, P824, DOI 10.1038/nm.2720; Sospedra M, 2010, J IMMUNOL METHODS, V353, P93, DOI 10.1016/j.jim.2009.12.006; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Subach FV, 2009, NAT CHEM BIOL, V5, P118, DOI 10.1038/nchembio.138; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wei JJ, 2017, NAT MED, V23, P409, DOI 10.1038/nm.4317; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Zhang T, 2004, FASEB J, V18, P600, DOI 10.1096/fj.03-0881fje	44	48	49	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					652	+		10.1038/s41590-019-0335-z	http://dx.doi.org/10.1038/s41590-019-0335-z			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30858620	Bronze			2022-12-18	WOS:000465084800021
J	Cheng, M; Anderson, MS				Cheng, Mickie; Anderson, Mark S.			Thymic tolerance as a key brake on autoimmunity	NATURE IMMUNOLOGY			English	Review							T-CELL TOLERANCE; PROMISCUOUS GENE-EXPRESSION; SYNDROME TYPE-I; CHRONIC MUCOCUTANEOUS CANDIDIASIS; POLYENDOCRINE SYNDROME TYPE-1; SELF-ANTIGEN EXPRESSION; AIRE-DEFICIENT MICE; EPITHELIAL-CELLS; MYASTHENIA-GRAVIS; IMMUNE TOLERANCE	Although the thymus has long been recognized as a key organ for T cell selection, the intricate details linking these selection events to human autoimmunity have been challenging to decipher. Over the last two decades, there has been rapid progress in understanding the role of thymic tolerance mechanisms in autoimmunity through genetics. Here we review some of the recent progress in understanding key thymic tolerance processes that are critical for preventing autoimmune disease.	[Cheng, Mickie; Anderson, Mark S.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.	mark.anderson@ucsf.edu			US National Institutes of Health; Helmsley Charitable Trust; California Institute of Regenerative Medicine; Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI097457, P01AI118688, R01AI138479] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.S.A. is supported by the US National Institutes of Health, the Helmsley Charitable Trust, the California Institute of Regenerative Medicine and the Larry L. Hillblom Foundation.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Alimohammadi M, 2008, NEW ENGL J MED, V358, P1018, DOI 10.1056/NEJMoa0706487; Alimohammadi M, 2009, P NATL ACAD SCI USA, V106, P4396, DOI 10.1073/pnas.0809986106; Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bakhru P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93265; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Bruserud O, 2016, CURR OPIN IMMUNOL, V43, P8, DOI 10.1016/j.coi.2016.07.003; Chan AY, 2016, J EXP MED, V213, P155, DOI 10.1084/jem.20150888; Cheng MH, 2010, NEW ENGL J MED, V362, P764, DOI 10.1056/NEJMc0909510; Cosway EJ, 2017, J EXP MED, V214, P3183, DOI 10.1084/jem.20171000; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guha M, 2017, J BIOL CHEM, V292, P6542, DOI 10.1074/jbc.M116.764704; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kawano H, 2015, J IMMUNOL, V195, P5149, DOI 10.4049/jimmunol.1501000; Khan IS, 2014, J EXP MED, V211, P761, DOI 10.1084/jem.20131889; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leonard JD, 2017, IMMUNITY, V47, P107, DOI 10.1016/j.immuni.2017.06.015; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liu YM, 2014, IMMUNOL LETT, V161, P50, DOI 10.1016/j.imlet.2014.04.008; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Marx A, 2010, AUTOIMMUNITY, V43, P413, DOI 10.3109/08916930903555935; Marx A, 2010, J THORAC ONCOL, V5, pS266, DOI 10.1097/JTO.0b013e3181f1f63f; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; Meloni A, 2008, J CLIN ENDOCR METAB, V93, P4389, DOI 10.1210/jc.2008-0935; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nitta T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5165; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Pontynen N, 2006, J AUTOIMMUN, V27, P96, DOI 10.1016/j.jaut.2006.06.001; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Renton AE, 2015, JAMA NEUROL, V72, P396, DOI 10.1001/jamaneurol.2014.4103; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2012, IMMUNOL CELL BIOL, V90, P277, DOI 10.1038/icb.2012.4; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Shum AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006998; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	76	48	48	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					659	664		10.1038/s41590-018-0128-9	http://dx.doi.org/10.1038/s41590-018-0128-9			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925986	Green Accepted			2022-12-18	WOS:000436341300011
J	Jin, L; Guo, XM; Shen, CB; Hao, X; Sun, P; Li, PP; Xu, T; Hu, CM; Rose, O; Zhou, HN; Yang, MD; Qin, CF; Guo, JY; Peng, H; Zhu, MZ; Cheng, G; Qi, XP; Lai, R				Jin, Lin; Guo, Xiaomin; Shen, Chuanbin; Hao, Xue; Sun, Peng; Li, Pengpeng; Xu, Tao; Hu, Chunmiao; Rose, Ombati; Zhou, Hongning; Yang, Mingdong; Qin, Cheng-Feng; Guo, Jingya; Peng, Hua; Zhu, Mingzhao; Cheng, Gong; Qi, Xiaopeng; Lai, Ren			Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-beta receptor	NATURE IMMUNOLOGY			English	Article							FLY LUTZOMYIA-LONGIPALPIS; PLATELET-AGGREGATION; BINDING PROTEIN; MOSQUITO; VECTOR; DISEASE; ENHANCEMENT; ACTIVATION; INHIBITOR; IMMUNITY	Pathogens have co-evolved with mosquitoes to optimize transmission to hosts. Mosquito salivary-gland extract is known to modulate host immune responses and facilitate pathogen transmission, but the underlying molecular mechanisms of this have remained unknown. In this study, we identified and characterized a prominent 15-kilodalton protein, LTRIN, obtained from the salivary glands of the mosquito Aedes aegypti. LTRIN expression was upregulated in blood-fed mosquitoes, and LTRIN facilitated the transmission of Zika virus (ZIKV) and exacerbated its pathogenicity by interfering with signaling through the lymphotoxin-beta receptor (LT beta R). Mechanically, LTRIN bound to LT beta R and 'preferentially' inhibited signaling via the transcription factor NF-kappa B and the production of inflammatory cytokines by interfering with the dimerization of LT beta R during infection with ZIKV. Furthermore, treatment with antibody to LTRIN inhibited mosquito-mediated infection with ZIKV, and abolishing LT beta R potentiated the infectivity of ZIKV both in vitro and in vivo. This study provides deeper insight into the transmission of mosquito-borne diseases in nature and supports the therapeutic potential of inhibiting the action of LTRIN to disrupt ZIKV transmission.	[Jin, Lin; Guo, Xiaomin; Shen, Chuanbin; Hao, Xue; Li, Pengpeng; Xu, Tao; Hu, Chunmiao; Rose, Ombati; Qi, Xiaopeng; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming, Yunnan, Peoples R China; [Jin, Lin; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Sinoafrica Joint Res Ctr, Kunming, Yunnan, Peoples R China; [Sun, Peng; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Li, Pengpeng] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Rose, Ombati] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhou, Hongning; Yang, Mingdong] Yunnan Inst Parasit Dis, Puer, Yunnan, Peoples R China; [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Guo, Jingya; Peng, Hua; Zhu, Mingzhao] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Tsinghua University; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Qi, XP; Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming, Yunnan, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Sinoafrica Joint Res Ctr, Kunming, Yunnan, Peoples R China.; Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.	gongcheng@mail.tsinghua.edu.cn; qixiaopeng@mail.kiz.ac.cn; rlai@mail.kiz.ac.cn	Qin, Cheng-Feng/I-6839-2019; Zhu, Mingzhao/L-8662-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Xu, Tao/0000-0001-9516-817X; Jin, Lin/0000-0001-6273-9140; Shen, Chuanbin/0000-0002-4635-5160				Anisuzzaman, 2014, J CLIN INVEST, V124, P4429, DOI 10.1172/JCI74917; Anisuzzaman, 2013, Methods Mol Biol, V963, P127, DOI 10.1007/978-1-62703-230-8_9; Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8; Assumpcao TCF, 2013, J BIOL CHEM, V288, P14341, DOI 10.1074/jbc.M113.466995; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Caraballo Hector, 2014, Emerg Med Pract, V16, P1; Chagas AC, 2014, P NATL ACAD SCI USA, V111, P6946, DOI 10.1073/pnas.1404179111; Collin N, 2012, ARTERIOSCL THROM VAS, V32, P2185, DOI 10.1161/ATVBAHA.112.253906; Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941; Coutinho-Abreu IV, 2015, CURR OPIN INSECT SCI, V10, P98, DOI 10.1016/j.cois.2015.04.014; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jones AV, 2017, HUM MOL GENET, V26, P1391, DOI 10.1093/hmg/ddx036; Juhn J., 2011, AEDES AEGYPTI PARASI, V4, P1, DOI DOI 10.1186/1756-3305-4-1; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365; Ma DY, 2012, THROMB HAEMOSTASIS, V107, P111, DOI 10.1160/TH11-10-0685; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002; Qi XP, 2013, IMMUNITY, V39, P97, DOI 10.1016/j.immuni.2013.06.012; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Spahn TW, 2005, INFECT IMMUN, V73, P7077, DOI 10.1128/IAI.73.11.7077-7088.2005; Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110; Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Upadhyay V, 2013, NAT REV IMMUNOL, V13, P270, DOI 10.1038/nri3406; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260; Xu XQ, 2013, ACTA CRYSTALLOGR D, V69, P105, DOI 10.1107/S0907444912043326; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904; Yang S, 2012, MOL CELL PROTEOMICS, V11, P640, DOI 10.1074/mcp.M112.018853; Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018	42	48	51	6	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					342	+		10.1038/s41590-018-0063-9	http://dx.doi.org/10.1038/s41590-018-0063-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29507355				2022-12-18	WOS:000428151000014
J	Shang, YL; Coppo, M; He, T; Ning, F; Yu, L; Kang, L; Zhang, B; Ju, CY; Qiao, Y; Zhao, BH; Gessler, M; Rogatsky, I; Hu, XY				Shang, Yingli; Coppo, Maddalena; He, Teng; Ning, Fei; Yu, Li; Kang, Lan; Zhang, Bin; Ju, Chanyang; Qiao, Yu; Zhao, Baohong; Gessler, Manfred; Rogatsky, Inez; Hu, Xiaoyu			The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; UP-REGULATION; NOTCH; ACTIVATION; CHEMOKINES; GENES; CELLS; RECRUITMENT; MACROPHAGES; NEUTROPHILS	Most of the known regulatory mechanisms that curb inflammatory gene expression target pre-transcription-initiation steps, and evidence for post-initiation regulation of inflammatory gene expression remains scarce. We found that the transcriptional repressor Hes1 suppressed production of CXCL1, a chemokine that is crucial for recruiting neutrophils. Hes1 negatively regulated neutrophil recruitment in vivo in a manner that was dependent on macrophage-produced CXCL1, and it attenuated the severity of inflammatory arthritis. Mechanistically, inhibition of Cxcl1 expression by Hes1 did not involve modification of transcription initiation. Instead, Hes1 inhibited signal-induced recruitment of the positive transcription-elongation complex P-TEFb and thereby prevented phosphorylation of RNA polymerase II at Ser2 and productive elongation. Thus, our results identify Hes1 as a homeostatic suppressor of inflammatory responses that exerts its suppressive function by regulating transcription elongation.	[Shang, Yingli; Ning, Fei; Yu, Li; Kang, Lan; Zhang, Bin; Hu, Xiaoyu] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Shang, Yingli; Ning, Fei; Yu, Li; Kang, Lan; Zhang, Bin; Hu, Xiaoyu] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Coppo, Maddalena; Ju, Chanyang; Qiao, Yu; Zhao, Baohong; Rogatsky, Inez] Hosp Special Surg, Div Res, 535 E 70th St, New York, NY 10021 USA; [Coppo, Maddalena; Ju, Chanyang; Qiao, Yu; Zhao, Baohong; Rogatsky, Inez] David Z Rosensweig Genom Ctr, New York, NY USA; [He, Teng] Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [He, Teng] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhao, Baohong] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Gessler, Manfred] Wuerzburg Univ, Bioctr, Theodor Boveri Inst, Dev Biochem, Wurzburg, Germany; [Gessler, Manfred] Wuerzburg Univ, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Rogatsky, Inez] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Hu, Xiaoyu] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Peking University; Cornell University; University of Wurzburg; University of Wurzburg; Cornell University; Tsinghua University	Hu, XY (corresponding author), Tsinghua Univ, Inst Immunol, Beijing, Peoples R China.; Hu, XY (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.; Hu, XY (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing, Peoples R China.	xiaoyuhu@tsinghua.edu.cn	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998; zhang, bin/0000-0001-6232-6768; Ju, Chanyang/0000-0002-1213-1601; Gessler, Manfred/0000-0002-7915-6045; Kang, Lan/0000-0002-8643-9174	Ministry of Science and Technology of China [2015CB943201]; National Natural Science Foundation of China [81422019]; Tsinghua-Peking Center for Life Sciences; Institute for Immunology at Tsinghua University; David Rosensweig HSS Genomics Center; Rheumatology Research Foundation; US Department of Defense; US National Institutes of Health; Academy of Medical Sciences (AMS) [NAF003\\1001] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071463, R00AR062047, R01AR068970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099087] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Institute for Immunology at Tsinghua University; David Rosensweig HSS Genomics Center; Rheumatology Research Foundation; US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Kageyama (Koyto University) for Hes1<SUP>fl/fl</SUP> mice; K. F. Roby (University of Kansas Medical Center) for Cxcl1 reporter plasmids; L.B. Ivashkiv for discussion; S. Chakravarty, K. Au, S. Smith and J. Zhu for technical assistance; and C. Tang, J. Lu, Z. Zhang, X. Yang and J. Zhang (Peking University) for advice on bioinformatics analysis. Supported by the Ministry of Science and Technology of China (National Key Research Project 2015CB943201 to X.H.), the National Natural Science Foundation of China (Young Investigator Award 81422019 to X.H.), the Tsinghua-Peking Center for Life Sciences (X.H.), the Institute for Immunology at Tsinghua University (X.H.), The David Rosensweig HSS Genomics Center (M.C., I.R.), the Rheumatology Research Foundation (I.R.), the US Department of Defense (I.R.) and the US National Institutes of Health (I.R. and B.Z.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Antoniv TT, 2006, ARTHRITIS RHEUM, V54, P2711, DOI 10.1002/art.22055; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Chinenov Y, 2012, P NATL ACAD SCI USA, V109, P11776, DOI 10.1073/pnas.1206059109; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lima TFA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/752923; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Monach P.A., 2008, CURR PROTOC IMMUNOL, V15, P1522; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rogatsky I, 2014, MOL CELL, V54, P245, DOI 10.1016/j.molcel.2014.03.038; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Saponaro M, 2014, CELL, V157, P1037, DOI 10.1016/j.cell.2014.03.048; Shang YL, 2016, PROTEIN CELL, V7, P159, DOI 10.1007/s13238-016-0250-0; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sodsal P, 2008, LUPUS, V17, P645, DOI 10.1177/0961203308089406; Son DS, 2006, MOL ENDOCRINOL, V20, P2999, DOI 10.1210/me.2006-0001; Stender JD, 2013, CURR OPIN PHARMACOL, V13, P582, DOI 10.1016/j.coph.2013.06.002; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wongchana W, 2015, J IMMUNOL, V195, P5337, DOI 10.4049/jimmunol.1401770; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	49	48	53	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					930	+		10.1038/ni.3486	http://dx.doi.org/10.1038/ni.3486			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27322654	Green Accepted			2022-12-18	WOS:000380647000010
J	Vacchio, MS; Wang, L; Bouladoux, N; Carpenter, AC; Xiong, Y; Wohlfert, E; Song, KD; Belkaid, Y; Love, PE; Bosselut, R				Vacchio, Melanie S.; Wang, Lie; Bouladoux, Nicolas; Carpenter, Andrea C.; Xiong, Yumei; Wohlfert, Elizabeth; Song, Ki-Duk; Belkaid, Yasmine; Love, Paul E.; Bosselut, Remy			A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							ZINC-FINGER PROTEIN; CD4-CD8 LINEAGE DIFFERENTIATION; HELPER TYPE-1 CELLS; EXPRESSION; REPRESSION; COMMITMENT; THYMOCYTES; LIGAND; RUNX3; GENE	The transcription factor ThPOK promotes CD4(+) T cell differentiation in the thymus. Here, using a mouse strain that allows post-thymic gene deletion, we show that ThPOK maintains CD4(+) T lineage integrity and couples effector differentiation to environmental cues after antigenic stimulation. ThPOK preserved the integrity and amplitude of effector responses and was required for proper differentiation of types 1 and 2 helper T cells in vivo by restraining the expression and function of Runx3, a nuclear factor crucial for cytotoxic T cell differentiation. The transcription factor LRF acts redundantly with ThPOK to prevent the transdifferentiation of mature CD4(+) T cells into CD8(+) T cells. As such, the ThPOK-LRF transcriptional module was essential for CD4(+) T cell integrity and responses.	[Vacchio, Melanie S.; Wang, Lie; Carpenter, Andrea C.; Xiong, Yumei; Wohlfert, Elizabeth; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Wohlfert, Elizabeth; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Song, Ki-Duk; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular & Dev Biol, Program Genom Differentiat, NIH, Bethesda, MD USA; [Wohlfert, Elizabeth] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Song, Ki-Duk] Seoul Natl Univ, Ctr Agr Biomat, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Seoul National University (SNU)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov	wohlfert, beth/ABA-2255-2020	Bouladoux, Nicolas/0000-0003-1593-671X; Bohrer, Andrea/0000-0003-4268-4853; Belkaid, Yasmine/0000-0001-9962-3571	US National Institutes of Health Intramural Research Programs of the National Cancer Institute, Center for Cancer Research; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER	US National Institutes of Health Intramural Research Programs of the National Cancer Institute, Center for Cancer Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Ciucci for experimental assistance and discussions; T.-A. Lewis for animal care and genotyping; M. McGinty and Q. Xiao for technical assistance; X. Wu for microarray analyses; D. Littman, P.P. Pandolfi and S. Reiner for mice; M. Grigg for the T. gondii strain; J. Grainger, T. Hand and S. Spencer for discussions; and J. Ashwell and J. Brenchley for reading the manuscript. Supported by the US National Institutes of Health Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Carpenter AC, 2012, IMMUNITY, V37, P622, DOI 10.1016/j.immuni.2012.06.019; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; GUYGRAND D, 1993, CURR OPIN IMMUNOL, V5, P247, DOI 10.1016/0952-7915(93)90012-H; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; LUCAS B, 1993, J IMMUNOL, V151, P4574; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; OSWALD IP, 1994, J IMMUNOL, V153, P1707; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rui JX, 2012, J IMMUNOL, V189, P1380, DOI 10.4049/jimmunol.1201077; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Vinton C, 2011, J VIROL, V85, P8702, DOI 10.1128/JVI.00332-11; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	56	48	50	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					947	U192		10.1038/ni.2960	http://dx.doi.org/10.1038/ni.2960			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25129370	Green Accepted			2022-12-18	WOS:000342564800010
J	Tiruppathi, C; Soni, D; Wang, DM; Xue, JP; Singh, V; Thippegowda, PB; Cheppudira, BP; Mishra, RK; DebRoy, A; Qian, ZJ; Bachmaier, K; Zhao, YY; Christman, JW; Vogel, SM; Ma, A; Malik, AB				Tiruppathi, Chinnaswamy; Soni, Dheeraj; Wang, Dong-Mei; Xue, Jiaping; Singh, Vandana; Thippegowda, Prabhakar B.; Cheppudira, Bopaiah P.; Mishra, Rakesh K.; DebRoy, Auditi; Qian, Zhijian; Bachmaier, Kurt; Zhao, You-Yang; Christman, John W.; Vogel, Stephen M.; Ma, Averil; Malik, Asrar B.			The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; GENE; ACTIVATION; EXPRESSION; RESPONSES; INJURY; ALPHA; CELLS; MICE	Here we found that the transcription repressor DREAM bound to the promoter of the gene encoding A20 to repress expression of this deubiquitinase that suppresses inflammatory NF-kappa B signaling. DREAM-deficient mice displayed persistent and unchecked A20 expression in response to endotoxin. DREAM functioned by transcriptionally repressing A20 through binding to downstream regulatory elements (DREs). In contrast, binding of the transcription factor USF1 to the DRE-associated E-box domain in the gene encoding A20 activated its expression in response to inflammatory stimuli. Our studies define the critical opposing functions of DREAM and USF1 in inhibiting and inducing A20 expression, respectively, and thereby the strength of NF-kappa B signaling. Targeting of DREAM to induce USF1-mediated A20 expression is therefore a potential anti-inflammatory strategy for the treatment of diseases associated with unconstrained NF-kappa B activity, such as acute lung injury.	[Tiruppathi, Chinnaswamy; Soni, Dheeraj; Wang, Dong-Mei; Xue, Jiaping; Singh, Vandana; Thippegowda, Prabhakar B.; Cheppudira, Bopaiah P.; Mishra, Rakesh K.; DebRoy, Auditi; Bachmaier, Kurt; Zhao, You-Yang; Christman, John W.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Tiruppathi, Chinnaswamy; Soni, Dheeraj; Wang, Dong-Mei; Xue, Jiaping; Singh, Vandana; Thippegowda, Prabhakar B.; Cheppudira, Bopaiah P.; Mishra, Rakesh K.; DebRoy, Auditi; Bachmaier, Kurt; Zhao, You-Yang; Christman, John W.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Chicago, IL USA; [Qian, Zhijian] Univ Illinois, Coll Med, Dept Hematol Oncol, Chicago, IL USA; [Ma, Averil] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco	Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA.	tiruc@uic.edu	Mishra, Rakesh/G-7920-2015; WANG, DONG-MEI/K-5799-2016; BT, Prabhakar/AAU-5199-2021; Soni, Dheeraj/P-5496-2017; Bachmaier, Kurt/AHC-5491-2022; Bachmaier, Kurt/B-6331-2014	Soni, Dheeraj/0000-0002-5555-2051; Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; ZHAO, YOU-YANG/0000-0002-0041-0339; Malik, Asrar/0000-0002-8205-7128; BT, Prabhakar/0000-0003-2377-9179	US National Institutes of Health [P01 HL077806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, R01HL075557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095693, P30DK026743] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J.M. Penninger (Institute of Molecular Biotechnology of the Austrian Academy of Sciences) for DREAM-deficient mice, and Y.B. Wu for help with the isolation and culture of LECs. Supported by the US National Institutes of Health (P01 HL077806).	Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; HAIES DM, 1981, AM REV RESPIR DIS, V123, P533; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; LADAROLA MJ, 1988, PAIN, V35, P313; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Savignac M, 2010, J IMMUNOL, V185, P7527, DOI 10.4049/jimmunol.1000152; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Yin XX, 2010, MOL CELL BIOCHEM, V333, P251, DOI 10.1007/s11010-009-0226-y; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407	34	48	52	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					239	247		10.1038/ni.2823	http://dx.doi.org/10.1038/ni.2823			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24487321	Green Accepted			2022-12-18	WOS:000331683100009
J	Jankovic, M; Nussenzweig, A; Nussenzweig, MC				Jankovic, Mila; Nussenzweig, Andre; Nussenzweig, Michel C.			Antigen receptor diversification and chromosome translocations	NATURE IMMUNOLOGY			English	Review							CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; DOUBLE-STRAND BREAKS; DNA-LIGASE-IV; DEPENDENT PROTEIN-KINASE; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; GENOMIC INSTABILITY; ATAXIA-TELANGIECTASIA; SOMATIC HYPERMUTATION	Double-stranded DNA breaks (DSBs) can result in chromosomal abnormalities, including deletions, translocations and aneuploidy, which can promote neoplastic transformation. DSBs arise accidentally during DNA replication and can be induced by environmental factors such as ultraviolet light or ionizing radiation, and they are generated during antigen receptor-diversification reactions in lymphocytes. Cellular pathways that maintain genomic integrity use sophisticated mechanisms that recognize and repair all DSBs regardless of their origin. Such pathways, along with DNA-damage checkpoints, ensure that either the damage is properly repaired or cells with damaged DNA are eliminated. Here we review how impaired DNA-repair or DNA-damage checkpoints can lead to genetic instability and predispose lymphocytes undergoing diversification of antigen receptor genes to malignant transformation.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019		NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brandt VL, 2004, IMMUNOL REV, V200, P249, DOI 10.1111/j.0105-2896.2004.00161.x; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; CALLEN E, 2007, CELL ADV, DOI DOI 10.1016/J.CELL.2007.06.016; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CARROLL AM, 1991, GENE DEV, V5, P1357, DOI 10.1101/gad.5.8.1357; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cook AJL, 2003, J IMMUNOL, V171, P6556, DOI 10.4049/jimmunol.171.12.6556; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; DORSETT Y, IN PRESS J EXP MED; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; ENDO Y, 2007, ONCOGENE ADV, DOI DOI 10.1038/S.J.ONC.1210344; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Gladdy RA, 2006, MOL CANCER RES, V4, P311, DOI 10.1158/1541-7786.MCR-05-0258; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Grawunder U, 2001, CURR OPIN IMMUNOL, V13, P186, DOI 10.1016/S0952-7915(00)00203-X; Gregorek H, 2002, CLIN EXP IMMUNOL, V130, P319, DOI 10.1046/j.1365-2249.2002.01971.x; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Harfst E, 2000, MOL IMMUNOL, V37, P915, DOI 10.1016/S0161-5890(01)00008-6; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; HSIEH CL, 1993, J BIOL CHEM, V268, P20105; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ichikawa HT, 2006, J IMMUNOL, V177, P355, DOI 10.4049/jimmunol.177.1.355; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kong QZ, 2001, GENETICS, V158, P369; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Liao MJ, 1999, GENE DEV, V13, P1246, DOI 10.1101/gad.13.10.1246; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Pan-Hammarstrom Q, 2006, J EXP MED, V203, P99, DOI 10.1084/jem.20050595; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramiro AR, 2006, CANCER RES, V66, P7837, DOI 10.1158/0008-5472.CAN-06-0863; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Rooney S, 2005, P NATL ACAD SCI USA, V102, P2471, DOI 10.1073/pnas.0409857102; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yeo TC, 2000, MOL IMMUNOL, V37, P1131, DOI 10.1016/S0161-5890(01)00026-8; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104; Zhou JQ, 2006, CANCER LETT, V243, P9, DOI 10.1016/j.canlet.2006.01.026; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	165	48	48	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					801	808		10.1038/ni1498	http://dx.doi.org/10.1038/ni1498			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17641661				2022-12-18	WOS:000248169400007
J	Jackson, A; Kondilis, HD; Khor, B; Sleckman, BP; Krangel, MS				Jackson, A; Kondilis, HD; Khor, B; Sleckman, BP; Krangel, MS			Regulation of T cell receptor beta allelic exclusion at a level beyond accessibility	NATURE IMMUNOLOGY			English	Article							TCR-BETA; V(D)J RECOMBINATION; DEVELOPMENTAL REGULATION; CD4(+)CD8(+) THYMOCYTE; HISTONE ACETYLATION; CHROMATIN STRUCTURE; DEFICIENT MICE; GENE ENHANCER; B-CELL; LOCUS	Allelic exclusion of V-beta-to- DJ(beta) recombination depends on asynchronous rearrangement of alleles of the gene encoding T cell receptor beta in double-negative thymocytes and feedback inhibition that is maintained in double-positive thymocytes. Feedback is thought to be enforced through downregulation of V-beta accessibility. In an attempt to override this negative regulation, we introduced the enhancer of the gene encoding T cell receptor alpha into the V-beta gene cluster downstream of Vbeta(12). In double-negative thymocytes, the introduced enhancer had no measurable effect on accessibility, but V(beta)12 rearrangement was stimulated and V(beta)12 allelic exclusion was partially subverted. In contrast, double-positive thymocytes showed increased V-beta transcription and accessibility, but feedback inhibition of V-beta-to- DJ(beta) recombination remained intact. Our results indicate additional regulatory constraints on V-beta-to-DJ(beta) recombination that operate beyond the accessibility barrier.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Duke University; Washington University (WUSTL)	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	krang001@mc.duke.edu		Khor, Bernard/0000-0003-4689-5092	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049934, T32AI052077] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49934, T32 AI052077] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bergman Y, 2003, CURR OPIN IMMUNOL, V15, P176, DOI 10.1016/S0952-7915(03)00016-5; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Chattopadhyay S, 1998, J IMMUNOL, V160, P1256; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; DAVODEAU F, 1995, J EXP MED, V181, P1391, DOI 10.1084/jem.181.4.1391; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Ji YH, 2003, P NATL ACAD SCI USA, V100, P7557, DOI 10.1073/pnas.0932635100; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Mathieu N, 2003, J BIOL CHEM, V278, P18101, DOI 10.1074/jbc.M212647200; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; Roberts JL, 1997, J EXP MED, V185, P131, DOI 10.1084/jem.185.1.131; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Ryu CJ, 2004, MOL CELL BIOL, V24, P7015, DOI 10.1128/MCB.24.16.7015-7023.2004; Ryu CJ, 2003, P NATL ACAD SCI USA, V100, P13465, DOI 10.1073/pnas.2235807100; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; Senoo M, 2001, INT IMMUNOL, V13, P1405, DOI 10.1093/intimm/13.11.1405; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Spicuglia S, 2000, EMBO J, V19, P2034, DOI 10.1093/emboj/19.9.2034; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X	49	48	50	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					189	197		10.1038/ni1157	http://dx.doi.org/10.1038/ni1157			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15640803				2022-12-18	WOS:000226468100022
J	Barton, GHM; Medzhitov, R				Barton, GHM; Medzhitov, R			Linking Toll-like receptors to IFN-alpha/beta expression	NATURE IMMUNOLOGY			English	Editorial Material							KINASE; TRANSCRIPTION; COMPLEX	Many infectious agents elicit a type I interferon response, but the molecular details that lead to IFN-alpha/beta expression have remained obscure. New details are emerging about how specific TLRs signal IFN-alpha/beta expression.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Barton, GHM (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 300 Cedar St,CAB S660, New Haven, CT 06520 USA.			Barton, Gregory/0000-0002-3793-0100				Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Peters RT, 2001, BBA-REV CANCER, V1471, pM57, DOI 10.1016/S0304-419X(00)00024-X; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	12	48	54	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					432	433		10.1038/ni0503-432	http://dx.doi.org/10.1038/ni0503-432			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719735				2022-12-18	WOS:000182665400009
J	Schubert, D; Schmidt, M; Zaiss, D; Jungblut, PR; Kamradt, T				Schubert, D; Schmidt, M; Zaiss, D; Jungblut, PR; Kamradt, T			Autoantibodies to GPI and creatine kinase in RA	NATURE IMMUNOLOGY			English	Letter							ARTHRITIS		Deutsch Rheumaforschungszentrum, Berlin, Germany; Max Planck Inst Infekt Biol, Berlin, Germany; Univ Klinikum Charite, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schubert, D (corresponding author), Deutsch Rheumaforschungszentrum, Berlin, Germany.		Kamradt, Thomas/E-9971-2018	Kamradt, Thomas/0000-0001-8443-5893; Zaiss, Dietmar M.W./0000-0003-3596-7062				Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Lamer S, 2001, J CHROMATOGR B, V752, P311, DOI 10.1016/S0378-4347(00)00446-1; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696	4	48	53	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					411	411		10.1038/ni0502-411a	http://dx.doi.org/10.1038/ni0502-411a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976711	Bronze			2022-12-18	WOS:000175411200002
J	Stockinger, B; Barthlott, T; Kassiotis, G				Stockinger, B; Barthlott, T; Kassiotis, G			T cell regulation: a special job or everyone's responsibility?	NATURE IMMUNOLOGY			English	Letter							SELF-TOLERANCE; PROLIFERATION; NAIVE; AUTOIMMUNITY; LYMPHOPENIA; HOMEOSTASIS; SURVIVAL; SUBSETS; LIGANDS; INDUCE		Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research	Stockinger, B (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk		Kassiotis, George/0000-0002-8457-2633; Stockinger, Brigitta/0000-0001-8781-336X				Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; BONOMO A, 1995, IMMUNOL TODAY, V16, P61, DOI 10.1016/0167-5699(95)80089-1; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cobbold SP, 1996, IMMUNOL REV, V149, P5, DOI 10.1111/j.1600-065X.1996.tb00897.x; Dorf M E, 1988, Int Rev Immunol, V3, P375, DOI 10.3109/08830188809051205; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; Freitas AA, 1999, CURR OPIN IMMUNOL, V11, P152, DOI 10.1016/S0952-7915(99)80026-0; Ge Q, 2001, P NATL ACAD SCI USA, V98, P1728, DOI 10.1073/pnas.98.4.1728; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; MALOY KJ, 2001, NATURE IMMUNOL, V2, P784; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; PAPLERNIK M, 1998, INT IMMUNOL, V10, P371; POUSSIER P, 1982, ENDOCRINOLOGY, V110, P1825, DOI 10.1210/endo-110-5-1825; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shevach EM, 2000, CURR BIOL, V10, pR572, DOI 10.1016/S0960-9822(00)00617-5; Suzuki H, 1999, J EXP MED, V190, P1561, DOI 10.1084/jem.190.11.1561; Tanchot C, 1998, IMMUNOL TODAY, V19, P575, DOI 10.1016/S0167-5699(98)01344-9	27	48	49	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					757	758		10.1038/ni0901-757	http://dx.doi.org/10.1038/ni0901-757			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526376				2022-12-18	WOS:000170781200002
J	Wang, GC; Chow, RD; Bai, ZG; Zhu, LY; Errami, Y; Dai, XY; Dong, MB; Ye, LP; Zhang, XY; Renauer, PA; Park, JJ; Shen, L; Ye, HH; Fuchs, CS; Chen, SD				Wang, Guangchuan; Chow, Ryan D.; Bai, Zhigang; Zhu, Lvyun; Errami, Youssef; Dai, Xiaoyun; Dong, Matthew B.; Ye, Lupeng; Zhang, Xiaoya; Renauer, Paul A.; Park, Jonathan J.; Shen, Li; Ye, Hanghui; Fuchs, Charles S.; Chen, Sidi			Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTIONAL ACTIVATION; CANCER-IMMUNOTHERAPY; SOMATIC MUTATION; READ ALIGNMENT; T-CELLS; TUMOR; EXPRESSION; ANTI-PD-1; VACCINES; SAFETY	Immunotherapy has transformed cancer treatment. However, current immunotherapy modalities face various limitations. In the present study, we developed multiplexed activation of endogenous genes as an immunotherapy (MAEGI), a new form of immunotherapy that elicits antitumor immunity through multiplexed activation of endogenous genes in tumors. We leveraged CRISPR activation (CRISPRa) to directly augment the in situ expression of endogenous genes, and thereby the presentation of tumor antigens, leading to dramatic antitumor immune responses. Deploying this as a cell-based vaccination strategy showed efficacy in both prophylactic and therapeutic settings. Intratumoral adeno-associated virus delivery of CRISPRa libraries elicited strong antitumor immunity across multiple cancer types. Precision targeting of mutated gene sets eradicated a large fraction of established tumors at both local and distant sites. This treatment modality led to alterations in the tumor microenvironment, marked by enhanced T cell infiltration and antitumor immune signatures. Multiplexed endogenous gene activation is a versatile and highly scalable strategy to elicit potent immune responses against cancer, distinct from all existing cancer therapies.	[Wang, Guangchuan; Chow, Ryan D.; Bai, Zhigang; Zhu, Lvyun; Errami, Youssef; Dai, Xiaoyun; Dong, Matthew B.; Ye, Lupeng; Zhang, Xiaoya; Renauer, Paul A.; Park, Jonathan J.; Shen, Li; Ye, Hanghui; Chen, Sidi] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Wang, Guangchuan; Chow, Ryan D.; Bai, Zhigang; Zhu, Lvyun; Errami, Youssef; Dai, Xiaoyun; Dong, Matthew B.; Ye, Lupeng; Zhang, Xiaoya; Renauer, Paul A.; Park, Jonathan J.; Shen, Li; Ye, Hanghui; Chen, Sidi] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Wang, Guangchuan; Chow, Ryan D.; Bai, Zhigang; Zhu, Lvyun; Errami, Youssef; Dai, Xiaoyun; Dong, Matthew B.; Ye, Lupeng; Zhang, Xiaoya; Renauer, Paul A.; Park, Jonathan J.; Shen, Li; Ye, Hanghui; Chen, Sidi] Yale Univ, Ctr Canc Syst Biol, West Haven, CT 06516 USA; [Chow, Ryan D.; Dong, Matthew B.; Park, Jonathan J.; Chen, Sidi] Yale Univ, MD PhD Program, New Haven, CT 06510 USA; [Dong, Matthew B.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Dong, Matthew B.; Chen, Sidi] Yale Univ, Immunobiol Program, New Haven, CT 06510 USA; [Renauer, Paul A.; Chen, Sidi] Yale Univ, Combined Program Biol & Biomed Sci, New Haven, CT 06510 USA; [Fuchs, Charles S.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fuchs, Charles S.] Smilow Canc Hosp, New Haven, CT USA; [Fuchs, Charles S.; Chen, Sidi] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Yale Ctr Biomed Data Sci, New Haven, CT 06510 USA; [Bai, Zhigang] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Capital Medical University	Chen, SD (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA.; Chen, SD (corresponding author), Yale Univ, Ctr Canc Syst Biol, West Haven, CT 06516 USA.; Chen, SD (corresponding author), Yale Univ, MD PhD Program, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Immunobiol Program, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Combined Program Biol & Biomed Sci, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA.; Chen, SD (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA.; Chen, SD (corresponding author), Yale Univ, Sch Med, Yale Ctr Biomed Data Sci, New Haven, CT 06510 USA.	sidi.chen@yale.edu	Bai, Zhigang/C-3872-2011; Zhu, Lv-yun/Y-5105-2019; Wang, Guangchuan/AAK-6197-2021; Chow, Ryan/ABF-1119-2021	Bai, Zhigang/0000-0001-9234-9354; Zhu, Lv-yun/0000-0003-2288-5981; Chow, Ryan/0000-0002-1872-6307; Errami, Youssef/0000-0002-0432-4331; Ye, Hanghui/0000-0001-9179-7577; Ye, Lupeng/0000-0003-3901-6598; Wang, Guangchuan/0000-0001-5315-1599; Park, Jonathan/0000-0001-5887-3953; Zhang, Xiaoya/0000-0002-1614-0011	Yale SBI/Genetics Startup Fund; National Institutes of Health/National Cancer Institute (NIH/NCI) [DP2CA238295, R01CA231112, R33CA225498, U54CA209992-8697, RF1DA048811, P50CA196530-A10805, P50CA121974-A08306]; Damon Runyon Dale Frey Award [DFS-13-15]; Melanoma Research Alliance [412806, 16-003524]; St Baldrick's Foundation [426685]; Breast Cancer Alliance; Cancer Research Institute; American Association for Cancer Research [499395, 17-20-01-CHEN]; Mary Kay Foundation [017-81]; V Foundation [V2017-022]; Ludwig Family Foundation, DoD [W81XWH-17-1-0235]; Sontag Foundation; Chenevert Family Foundation; NIH/NCI Cancer Center Support Grant [3P30CA016359]; CRI Irvington Postdoctoral Fellowship; NIH [T32GM007499, T32GM007205]; C Revson Postdoctoral Fellowship; RJ Anderson Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP2CA238295, R01CA231112, U54CA209992, P30CA016359, R33CA225498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM007499] Funding Source: NIH RePORTER	Yale SBI/Genetics Startup Fund; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Dale Frey Award; Melanoma Research Alliance; St Baldrick's Foundation; Breast Cancer Alliance; Cancer Research Institute; American Association for Cancer Research; Mary Kay Foundation; V Foundation; Ludwig Family Foundation, DoD; Sontag Foundation; Chenevert Family Foundation; NIH/NCI Cancer Center Support Grant; CRI Irvington Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C Revson Postdoctoral Fellowship; RJ Anderson Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Chen laboratory, as well as various colleagues in the Department of Genetics, Systems Biology Institute, Immunobiology Program, BBS Program, Comprehensive Cancer Center, Stem Cell Center and the School of Medicine at Yale, for their assistance and/or scientific discussion. We thank the Center for Genome Analysis, Center for Molecular Discovery, Pathology Tissue Services, Histology Services, High Performance Computing Center, West Campus Analytical Chemistry Core, and West Campus Imaging Core and Keck Biotechnology Resource Laboratory at Yale for technical support. We thank P. Cresswell for assistance with ELISpot. S.C. was supported by Yale SBI/Genetics Startup Fund, National Institutes of Health/National Cancer Institute (NIH/NCI) (grant nos DP2CA238295, R01CA231112, R33CA225498, U54CA209992-8697, RF1DA048811, P50CA196530-A10805, P50CA121974-A08306), Damon Runyon Dale Frey Award (grant no. DFS-13-15), Melanoma Research Alliance (grant nos 412806, 16-003524), St Baldrick's Foundation (grant no. 426685), Breast Cancer Alliance, Cancer Research Institute, American Association for Cancer Research (grant nos 499395, 17-20-01-CHEN), the Mary Kay Foundation (grant no. 017-81), the V Foundation (grant no. V2017-022), Ludwig Family Foundation, DoD (grant no. W81XWH-17-1-0235), Sontag Foundation and Chenevert Family Foundation. C.S.F. was supported by NIH/NCI Cancer Center Support Grant (no. 3P30CA016359). G.W. was supported by CRI Irvington and RJ Anderson Postdoctoral Fellowships. R.D.C., J.P. and M.B.D. were supported by the Yale MSTP training grant from the NIH (grant no. T32GM007205). P.R. was supported by a Yale PhD training grant from NIH grant no. T32GM007499). X.D. was supported by a C Revson Postdoctoral Fellowship.	Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Ciucci T, 2014, EUR J IMMUNOL, V44, P348, DOI 10.1002/eji.201344375; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kirsch I, 2015, MOL ONCOL, V9, P2063, DOI 10.1016/j.molonc.2015.09.003; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linderman G.C., 2018, ZERO PRESERVING IMPU, DOI [DOI 10.1101/397588, 10.1101/397588.]; Liu XS, 2017, CELL, V168, P600, DOI 10.1016/j.cell.2017.01.014; Marabelle A, 2017, ANN ONCOL, V28, P33, DOI 10.1093/annonc/mdx683; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sahin U, 2018, SCIENCE, V359, P1355, DOI 10.1126/science.aar7112; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; van den Boorn JG, 2013, IMMUNITY, V39, P27, DOI 10.1016/j.immuni.2013.07.011; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	63	47	51	6	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1494	+		10.1038/s41590-019-0500-4	http://dx.doi.org/10.1038/s41590-019-0500-4			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31611701	Green Accepted, Bronze			2022-12-18	WOS:000492309600019
J	Majumder, S; Amatya, N; Revu, S; Jawale, CV; Wu, DW; Rittenhouse, N; Menk, A; Kupul, S; Du, F; Raphael, I; Bhattacharjee, A; Siebenlist, U; Hand, TW; Delgoffe, GM; Poholek, AC; Gaffen, SL; Biswas, PS; McGeachy, MJ				Majumder, Saikat; Amatya, Nilesh; Revu, Shankar; Jawale, Chetan V.; Wu, Dongwen; Rittenhouse, Natalie; Menk, Ashley; Kupul, Saran; Du, Fang; Raphael, Itay; Bhattacharjee, Amrita; Siebenlist, Ulrich; Hand, Timothy W.; Delgoffe, Greg M.; Poholek, Amanda C.; Gaffen, Sarah L.; Biswas, Partha S.; McGeachy, Mandy J.			IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival	NATURE IMMUNOLOGY			English	Article							T-HELPER-CELLS; TH17 CELLS; SIGNALING PATHWAY; GENE; INTERLEUKIN-17; RECEPTOR; INFLAMMATION; POPULATIONS; HOMEOSTASIS; EXPRESSION	Lymph-node (LN) stromal cell populations expand during the inflammation that accompanies T cell activation. Interleukin-17 (IL-17)-producing helper T cells (T(H)17 cells) promote inflammation through the induction of cytokines and chemokines in peripheral tissues. We demonstrate a critical requirement for IL-17 in the proliferation of LN and splenic stromal cells, particularly fibroblastic reticular cells (FRCs), during experimental autoimmune encephalomyelitis and colitis. Without signaling via the IL-17 receptor, activated FRCs underwent cell cycle arrest and apoptosis, accompanied by signs of nutrient stress in vivo. IL-17 signaling in FRCs was not required for the development of T(H)17 cells, but failed FRC proliferation impaired germinal center formation and antigen-specific antibody production. Induction of the transcriptional co-activator I kappa B zeta via IL-17 signaling mediated increased glucose uptake and expression of the gene Cpt1a, encoding CPT1A, a rate-limiting enzyme of mitochondrial fatty acid oxidation. Hence, IL-17 produced by locally differentiating T(H)17 cells is an important driver of the activation of inflamed LN stromal cells, through metabolic reprogramming required to support proliferation and survival.	[Majumder, Saikat; Amatya, Nilesh; Revu, Shankar; Jawale, Chetan V.; Wu, Dongwen; Kupul, Saran; Du, Fang; Raphael, Itay; Gaffen, Sarah L.; Biswas, Partha S.; McGeachy, Mandy J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Rittenhouse, Natalie; Bhattacharjee, Amrita; Hand, Timothy W.; Poholek, Amanda C.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Menk, Ashley; Delgoffe, Greg M.] Univ Pittsburgh, Tumor Microenvironm Ctr, UPMC Hillman Canc Ctr, Pittsburgh, PA USA; [Siebenlist, Ulrich] NIAID, Immune Activat Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	McGeachy, MJ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA.	mandymcgeachy@pitt.edu	jawale, chetan/AAR-1894-2021; Gaffen, Sarah L/B-1560-2009; Delgoffe, Greg M./HCH-2805-2022; Majumder, Saikat/ABC-2194-2020; Hand, Timothy W/AAH-1216-2021	Gaffen, Sarah L/0000-0001-8511-2041; Delgoffe, Greg M./0000-0002-2957-8135; Majumder, Saikat/0000-0002-6591-9515; Hand, Timothy W/0000-0002-2684-9462; Raphael, Itay/0000-0002-7369-2752	NIH [AI110822, AI128991, T32-AI089443, DK104680, DE022550, DE023815, AI107825, DP2AI136598]; R.K. Mellon Institute for Pediatric Research [AACR SU2C-AACR-IRG-04-16]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI136598, R01AI110822, ZIAAI001095, R21AI128991, T32AI089443, R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023815, R01DE022550, R37DE022550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); R.K. Mellon Institute for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by the following grants: NIH Nos. AI110822 and AI128991 (to M.J.M.), No. T32-AI089443 (to I.R.), No. DK104680 (to P.S.B.), Nos. DE022550, DE023815 and AI107825 (to S.L.G.), and No. DP2AI136598 (to G.M.D); and R.K. Mellon Institute for Pediatric Research No. AACR SU2C-AACR-IRG-04-16 (to T.W.H). This research was supported in part by the University of Pittsburgh Center for Research Computing through the resources provided. We thank V. Kuchroo (Harvard University) for Il23r<SUP>-/-</SUP> mice, P. Kolattukudy (University of Central Florida) for Zc3h12a<SUP>+/-</SUP> mice, J. Kolls (Tulane University) for Il17ra<SUP>fl/fl</SUP> mice (now available at JAX labs) and L. D'Cruz for critical reading of the manuscript.	Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chung J, 2017, J CLIN INVEST, V127, P1574, DOI 10.1172/JCI89535; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garg AV, 2015, IMMUNITY, V43, P475, DOI 10.1016/j.immuni.2015.07.021; Gil-Cruz C, 2016, NAT IMMUNOL, V17, P1388, DOI 10.1038/ni.3566; Grogan JL, 2012, EUR J IMMUNOL, V42, P2255, DOI 10.1002/eji.201242656; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Jin ZQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0264-1; Johnson RF, 2011, CANCER RES, V71, P5588, DOI 10.1158/0008-5472.CAN-10-4252; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026138; Kityo C, 2018, J CLIN INVEST, V128, P2763, DOI 10.1172/JCI97377; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Loberg RD, 2002, J BIOL CHEM, V277, P41667, DOI 10.1074/jbc.M206405200; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15508; Wu L, 2015, J EXP MED, V212, P1571, DOI 10.1084/jem.20150204; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	56	47	49	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					534	+		10.1038/s41590-019-0367-4	http://dx.doi.org/10.1038/s41590-019-0367-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30962593	Green Accepted			2022-12-18	WOS:000465084800011
J	Sumida, T; Lincoln, MR; Ukeje, CM; Rodriguez, DM; Akazawa, H; Noda, T; Naito, AT; Komuro, I; Dominguez-Villar, M; Hafler, DA				Sumida, Tomokazu; Lincoln, Matthew R.; Ukeje, Chinonso M.; Rodriguez, Donald M.; Akazawa, Hiroshi; Noda, Tetsuo; Naito, Atsuhiko T.; Komuro, Issei; Dominguez-Villar, Margarita; Hafler, David A.			Activated beta-catenin in Foxp3(+) regulatory T cells links inflammatory environments to autoimmunity	NATURE IMMUNOLOGY			English	Article							HIGH-NACL; PROMOTES; DIFFERENTIATION; IDENTIFICATION; GENERATION; INDUCTION; TARGET; EP2	Foxp3(+) regulatory T cells (T-reg cells) are the central component of peripheral immune tolerance. Whereas a dysregulated T-reg cytokine signature has been observed in autoimmune diseases, the regulatory mechanisms underlying pro- and anti-inflammatory cytokine production are elusive. Here, we identify an imbalance between the cytokines IFN-gamma and IL-10 as a shared T-reg signature present in patients with multiple sclerosis and under high-salt conditions. RNA-sequencing analysis on human T-reg subpopulations revealed beta-catenin as a key regulator of IFN-gamma and IL-10 expression. The activated beta-catenin signature was enriched in human IFN-gamma(+) T-reg cells, as confirmed in vivo with T-reg-specific beta-catenin-stabilized mice exhibiting lethal autoimmunity with a dysfunctional Treg phenotype. Moreover, we identified prostaglandin E receptor 2 (PTGER2) as a regulator of IFN-gamma and IL-10 production under a high-salt environment, with skewed activation of the beta-catenin-SGK1-Foxo axis. Our findings reveal a novel PTGER2-beta-catenin loop in T-reg cells linking environmental high-salt conditions to autoimmunity.	[Sumida, Tomokazu; Lincoln, Matthew R.; Ukeje, Chinonso M.; Rodriguez, Donald M.; Dominguez-Villar, Margarita; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Sumida, Tomokazu; Lincoln, Matthew R.; Ukeje, Chinonso M.; Rodriguez, Donald M.; Dominguez-Villar, Margarita; Hafler, David A.] Yale Sch Med, Dept Immunol, New Haven, CT USA; [Sumida, Tomokazu; Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo, Japan; [Naito, Atsuhiko T.] Toho Univ, Dept Pharmacol, Fac Med, Sch Med, Tokyo, Japan; [Rodriguez, Donald M.] Univ Chicago, Chicago, IL 60637 USA; [Dominguez-Villar, Margarita] Imperial Coll London, Dept Med, Immunol, London, England	Yale University; Yale University; University of Tokyo; Japanese Foundation for Cancer Research; Toho University; University of Chicago; Imperial College London	Sumida, T (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT USA.; Sumida, T (corresponding author), Yale Sch Med, Dept Immunol, New Haven, CT USA.; Sumida, T (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan.	tomokazu.sumida@yale.edu	Lincoln, Matthew R/ABD-1504-2020	Lincoln, Matthew R/0000-0003-2962-6253; Dominguez-Villar, Margarita/0000-0002-9719-0028; Sumida, Tomokazu/0000-0002-9806-2642	Uehara Memorial Foundation Research Fellowship; MSD Life Science Foundation Research Fellowship; Tomy Digital Biology; Ministry of Education, Culture, Sports, Science and Technology (MEXT), JSPS KAKENHI [21229010]; Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency; National Institutes of Health [P01 AI045757, U19 AI046130, U19 AI070352, P01 AI039671]; Nancy Taylor Foundation for Chronic Diseases; BioLegend; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U19AI070352, P01AI045757, U19AI046130] Funding Source: NIH RePORTER	Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); MSD Life Science Foundation Research Fellowship; Tomy Digital Biology; Ministry of Education, Culture, Sports, Science and Technology (MEXT), JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Taylor Foundation for Chronic Diseases; BioLegend; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Devine, C. Wang, and H. Tomita for cell sorting; E. Cheng and M. Zhang for preparation of the RNA-seq library; K. Tanaka for microscopic imaging; and M. Shimizu, H. Taniwaki, and N. Yamanaka for technical support. FIC mice were a generous gift from S. Sakaguchi (Osaka University). This work was supported by grants from the Uehara Memorial Foundation Research Fellowship, MSD Life Science Foundation Research Fellowship, LEGEND Study Abroad Grant from BioLegend, and Tomy Digital Biology (to T.S.); the Ministry of Education, Culture, Sports, Science and Technology (MEXT), JSPS KAKENHI (grant 21229010), and the Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency (to I. K.); and the National Institutes of Health (grants P01 AI045757, U19 AI046130, U19 AI070352, and P01 AI039671) and the Nancy Taylor Foundation for Chronic Diseases (to D.A.H.). RNA-seq was conducted at the Yale Stem Cell Center Genomics Core facility, which is supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation.	Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fitzgerald KC, 2017, ANN NEUROL, V82, P20, DOI 10.1002/ana.24965; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; International Multiple SclerosisGenetics Consortium, 2017, MULT SCLER GEN MAP R; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kitz A, 2016, EMBO REP, V17, P1169, DOI 10.15252/embr.201541905; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kofler DM, 2014, J CLIN INVEST, V124, P2513, DOI 10.1172/JCI72973; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Li XL, 2012, J CLIN INVEST, V122, P963, DOI 10.1172/JCI59097; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Mahic M, 2006, J IMMUNOL, V177, P246, DOI 10.4049/jimmunol.177.1.246; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Okada K, 2015, CIRC-HEART FAIL, V8, P799, DOI 10.1161/CIRCHEARTFAILURE.114.001958; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; Pappalardo JL, 2016, CELL, V167, P894, DOI 10.1016/j.cell.2016.10.040; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Shin H, 2010, J DERMATOL SCI, V58, P91, DOI 10.1016/j.jdermsci.2010.02.011; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tubbs AL, 2017, J IMMUNOL, V199, P1051, DOI 10.4049/jimmunol.1700356; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang R, 2014, AM J PHYSIOL-CELL PH, V307, pC442, DOI 10.1152/ajpcell.00379.2013; Wei YF, 2017, ONCOTARGET, V8, P70, DOI 10.18632/oncotarget.13783; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yao CC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2684	50	47	50	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1391	+		10.1038/s41590-018-0236-6	http://dx.doi.org/10.1038/s41590-018-0236-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30374130	Green Accepted, Green Submitted			2022-12-18	WOS:000452873000019
J	Choi, S; Warzecha, C; Zvezdova, E; Lee, J; Argenty, J; Lesourne, R; Aravind, L; Love, PE				Choi, Seeyoung; Warzecha, Claude; Zvezdova, Ekaterina; Lee, Jan; Argenty, Jeremy; Lesourne, Renaud; Aravind, L.; Love, Paul E.			THEMIS enhances TCR signaling and enables positive selection by selective inhibition of the phosphatase SHP-1	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; T-CELL DEVELOPMENT; THYMOCYTE DEVELOPMENT; RECEPTOR STIMULATION; NEGATIVE SELECTION; REDOX REGULATION; ACTIVATION; GENERATION; DELETION; STRENGTH	THEMIS, a T cell-specific protein with high expression in CD4(+)CD8(+) thymocytes, has a crucial role in positive selection and T cell development. THEMIS lacks defined catalytic domains but contains two tandem repeats of a distinctive module of unknown function (CABIT). Here we found that THEMIS directly regulated the catalytic activity of the tyrosine phosphatase SHP-1. This action was mediated by the CABIT modules, which bound to the phosphatase domain of SHP-1 and promoted or stabilized oxidation of SHP-1's catalytic cysteine residue, which inhibited the tyrosine-phosphatase activity of SHP-1. Deletion of SHP-1 alleviated the developmental block in Themis(-/-) thymocytes. Thus, THEMIS facilitates thymocyte positive selection by enhancing the T cell antigen receptor signaling response to low-affinity ligands.	[Choi, Seeyoung; Warzecha, Claude; Zvezdova, Ekaterina; Lee, Jan; Love, Paul E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD 20892 USA; [Argenty, Jeremy; Lesourne, Renaud] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Argenty, Jeremy; Lesourne, Renaud] CNRS, INSERM, U1043, U5282, Toulouse, France; [Argenty, Jeremy; Lesourne, Renaud] Univ Paul Sabatier, Univ Toulouse, Toulouse, France; [Aravind, L.] NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Love, PE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Hematopoiesis & Lymphocyte Biol, NIH, Bethesda, MD 20892 USA.	lovep@mail.nih.gov	Lesourne, Renaud/M-1855-2014	Aravind, L/0000-0003-0771-253X; Lesourne, Renaud/0000-0003-3816-7087; Warzecha, Claude/0000-0002-3659-2867; ARGENTY, Jeremy/0000-0002-5263-1096	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [1ZIAHD001803]; Intramural Research Program of the National Library of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program of the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Muschen (University of California, San Francisco) for Ptpn6<SUP>flox/flox</SUP> mice; H. Gu (McGill University) for Grb2<SUP>fl/fl</SUP> mice; A. Ullrich (Max-Plank Institute, Germany) for Ptpn6 cDNA; L. Tautz (Sanford-Burnham Medical Research Institute) for Ptpn7 cDNA; J. Chernoff (Fox Chase Cancer Center) for plasmid encoding hemagglutinin-tagged PTPN1; and A. Bhandoola, R. Bosselut, R. Cornall, K. Pfeifer and A. Singer for critical review of the manuscript. Supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1ZIAHD001803 to P.E.L.) and by the Intramural Research Program of the National Library of Medicine (L.A.).	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Fang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040566; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gascoigne NRJ, 2015, CURR OPIN IMMUNOL, V33, P86, DOI 10.1016/j.coi.2015.01.020; Halliwell Barry, 2014, Biomed J, V37, P99, DOI 10.4103/2319-4170.128725; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Jin R, 2015, IMMUNOL CELL BIOL, V93, P744, DOI 10.1038/icb.2015.36; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Karisch R, 2013, FEBS J, V280, P459, DOI 10.1111/j.1742-4658.2012.08626.x; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lesourne R, 2012, J IMMUNOL, V189, P1154, DOI 10.4049/jimmunol.1200123; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; LOS M, 1995, EMBO J, V14, P3731, DOI 10.1002/j.1460-2075.1995.tb00043.x; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Moon EY, 2004, EUR J IMMUNOL, V34, P2119, DOI 10.1002/eji.200424962; Okada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089115; Ozawa T, 2007, INT IMMUNOL, V19, P1049, DOI 10.1093/intimm/dxm070; Pani G, 2000, BIOCHEM J, V347, P173, DOI 10.1042/0264-6021:3470173; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Paster W, 2015, EMBO J, V34, P393, DOI 10.15252/embj.201387725; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Pregel MJ, 1997, J BIOL CHEM, V272, P23552, DOI 10.1074/jbc.272.38.23552; Simeoni L, 2015, BIOL CHEM, V396, P555, DOI 10.1515/hsz-2014-0312; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Zvezdova E, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1576; Zvezdova E, 2014, IMMUNOL CELL BIOL, V92, P721, DOI 10.1038/icb.2014.43	49	47	47	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					433	+		10.1038/ni.3692	http://dx.doi.org/10.1038/ni.3692			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28250424	Green Accepted			2022-12-18	WOS:000396815800011
J	Nguyen, TTT; Klasener, K; Zurn, C; Castillo, PA; Brust-Mascher, I; Imai, DM; Bevins, CL; Reardon, C; Reth, M; Baumgarth, N				Nguyen, Trang T. T.; Klaesener, Kathrin; Zuern, Christa; Castillo, Patricia A.; Brust-Mascher, Ingrid; Imai, Denise M.; Bevins, Charles L.; Reardon, Colin; Reth, Michael; Baumgarth, Nicole			The IgM receptor Fc mu R limits tonic BCR signaling by regulating expression of the IgM BCR	NATURE IMMUNOLOGY			English	Article							B-CELLS; ANTIBODY-RESPONSES; DENDRITIC CELLS; MICE DEFICIENT; TOSO; IMMUNOGLOBULIN; SURFACE; B-1; LYMPHOCYTES; ACTIVATION	The Fc mu R receptor for the crystallizable fragment (Fc) of immunoglobulin M (IgM) can function as a cell-surface receptor for secreted IgM on a variety of cell types. We found here that Fc mu R was also expressed in the trans-Golgi network of developing B cells, where it constrained transport of the IgM-isotype BCR (IgM-BCR) but not of the IgD-isotype BCR (IgD-BCR). In the absence of Fc mu R, the surface expression of IgM-BCR was increased, which resulted in enhanced tonic BCR signaling. B-cell-specific deficiency in Fc mu R enhanced the spontaneous differentiation of B-1 cells, which resulted in increased serum concentrations of natural IgM and dysregulated homeostasis of B-2 cells; this caused the spontaneous formation of germinal centers, increased titers of serum autoantibodies and excessive accumulation of B cells. Thus, Fc mu R serves as a critical regulator of B cell biology by constraining the transport and cell-surface expression of IgM-BCR.	[Nguyen, Trang T. T.; Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Nguyen, Trang T. T.; Castillo, Patricia A.; Bevins, Charles L.; Baumgarth, Nicole] Univ Calif Davis, Immunol Grad Grp, Davis, CA 95616 USA; [Klaesener, Kathrin; Reth, Michael] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Klaesener, Kathrin; Reth, Michael] Univ Freiburg, Fac Biol, Inst Biol 3, Dept Mol Immunol, Freiburg, Germany; [Klaesener, Kathrin; Zuern, Christa; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Castillo, Patricia A.; Bevins, Charles L.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Brust-Mascher, Ingrid; Reardon, Colin] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Imai, Denise M.; Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Comparat Pathol Lab, Davis, CA 95616 USA; [Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Freiburg; University of Freiburg; Max Planck Society; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Baumgarth, N (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.; Baumgarth, N (corresponding author), Univ Calif Davis, Immunol Grad Grp, Davis, CA 95616 USA.; Baumgarth, N (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Pathol Lab, Davis, CA 95616 USA.; Baumgarth, N (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	nbaumgarth@ucdavis.edu	Baumgarth, Nicole/AAI-6949-2020; Bevins, Charles L/P-4438-2015	Bevins, Charles L/0000-0003-2725-2622; Nguyen, Trang/0000-0003-0488-5590; Klasener, Kathrin/0000-0002-5969-2553	US National Institutes of Health [AI51354, AI85568, U19AI109962]; UC Davis Graduate Group in Immunology; Vietnamese Education Fellowship; UC Davis Chancellor's Fellowship; Excellence Initiative of the German Federal and State Governments [EXC 294]; European Research Council [322972]; DFG [TRR130]; DFG (German Cancer Aid) [111026]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085568, R01AI055881, R01AI051354, U19AI109962, R37AI032738] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Graduate Group in Immunology; Vietnamese Education Fellowship; UC Davis Chancellor's Fellowship; Excellence Initiative of the German Federal and State Governments; European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); DFG (German Cancer Aid); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Spinner for help with flow cytometry; A. Treister for FlowJo software; R. Pohlmeyer for sharing flow cytometry data; J. Yang (University of Freiburg) for the GFP-IgD plasmid; M. Cavallari for help with image analysis; H. Kubagawa (Deutsches Rheuma Forschungszentrum) for BM from mice with global Fcmr deficiency; and the UC Davis Mouse Biology Program for generating Fcmr<SUP>flx/flx</SUP>Cd19-Cre mice. Supported by the US National Institutes of Health (AI51354, AI85568 and U19AI109962 to N.B.), the UC Davis Graduate Group in Immunology, a Vietnamese Education Fellowship (T.T.T.N.), a UC Davis Chancellor's Fellowship (N.B.), the Excellence Initiative of the German Federal and State Governments (EXC 294), the European Research Council (322972) and the DFG (TRR130 and project 111026 of the German Cancer Aid to M.R.).	ANDERSSON J, 1974, EUR J IMMUNOL, V4, P170, DOI 10.1002/eji.1830040305; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boes M, 1998, J IMMUNOL, V160, P4776; Brenner D, 2014, P NATL ACAD SCI USA, V111, P1060, DOI 10.1073/pnas.1323166111; Choi SC, 2013, J IMMUNOL, V190, P987, DOI 10.4049/jimmunol.1202227; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Honjo K, 2012, P NATL ACAD SCI USA, V109, P15882, DOI 10.1073/pnas.1206567109; Jackson SW, 2016, J EXP MED, V213, P733, DOI 10.1084/jem.20151724; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; LALOR PA, 1989, EUR J IMMUNOL, V19, P507, DOI 10.1002/eji.1830190315; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Lang PA, 2015, CELL DEATH DIFFER, V22, P164, DOI 10.1038/cdd.2014.138; Li FJ, 2011, BLOOD, V118, P4902, DOI 10.1182/blood-2011-04-350793; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Nguyen TTT, 2015, J IMMUNOL, V194, P1489, DOI 10.4049/jimmunol.1401880; Nguyen XH, 2011, BLOOD, V118, P598, DOI 10.1182/blood-2010-10-313643; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; O'Callaghan K, 2012, BLOOD, V119, P1717, DOI 10.1182/blood-2011-04-347518; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ouchida R, 2015, J IMMUNOL, V194, P3096, DOI 10.4049/jimmunol.1402352; Ouchida R, 2013, BLOOD, V121, P2368, DOI 10.1182/blood-2012-12-470906; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Rahman MJ, 2016, J IMMUNOL, V196, P2031, DOI 10.4049/jimmunol.1501239; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; SIECKMANN DG, 1991, HYBRIDOMA, V10, P121, DOI 10.1089/hyb.1991.10.121; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; THORENS B, 1985, EMBO J, V4, P361, DOI 10.1002/j.1460-2075.1985.tb03637.x; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; Vire B, 2011, J IMMUNOL, V187, P4040, DOI 10.4049/jimmunol.1100532; Werner M, 2010, IMMUNOL REV, V237, P55, DOI 10.1111/j.1600-065X.2010.00934.x; Yang JY, 2011, METHODS MOL BIOL, V813, P331, DOI 10.1007/978-1-61779-412-4_20	43	47	48	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					321	333		10.1038/ni.3677	http://dx.doi.org/10.1038/ni.3677			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28135254	Green Accepted, Green Submitted			2022-12-18	WOS:000394413400012
